Citrus Sinensis ID: 020888
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 320 | 2.2.26 [Sep-21-2011] | |||||||
| P18160 | 2410 | Dual specificity protein | yes | no | 0.840 | 0.111 | 0.382 | 3e-44 | |
| Q54R58 | 918 | Probable tyrosine-protein | no | no | 0.784 | 0.273 | 0.412 | 1e-42 | |
| Q54TM7 | 1288 | Probable serine/threonine | no | no | 0.862 | 0.214 | 0.379 | 4e-42 | |
| Q2MHE4 | 390 | Serine/threonine-protein | no | no | 0.840 | 0.689 | 0.374 | 2e-41 | |
| Q66L42 | 940 | Mitogen-activated protein | no | no | 0.787 | 0.268 | 0.379 | 5e-40 | |
| Q3U1V8 | 1077 | Mitogen-activated protein | no | no | 0.825 | 0.245 | 0.370 | 7e-40 | |
| Q54IP4 | 653 | Dual specificity protein | no | no | 0.834 | 0.408 | 0.371 | 8e-40 | |
| Q55GU0 | 916 | Probable serine/threonine | no | no | 0.906 | 0.316 | 0.372 | 9e-40 | |
| P80192 | 1104 | Mitogen-activated protein | yes | no | 0.825 | 0.239 | 0.370 | 1e-39 | |
| Q05609 | 821 | Serine/threonine-protein | no | no | 0.875 | 0.341 | 0.345 | 1e-39 |
| >sp|P18160|SPLA_DICDI Dual specificity protein kinase splA OS=Dictyostelium discoideum GN=splA PE=1 SV=3 | Back alignment and function desciption |
|---|
Score = 179 bits (454), Expect = 3e-44, Method: Composition-based stats.
Identities = 112/293 (38%), Positives = 168/293 (57%), Gaps = 24/293 (8%)
Query: 32 KCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEV 91
+ ++EID +EL+F + IGKG FGE+ + YWR T VAIK I + + F++EV
Sbjct: 2105 RSEYEIDFNELEFGQT--IGKGFFGEVKRGYWRETDVAIKIIYRDQFKTKSSLVMFQNEV 2162
Query: 92 NLLVKLRHPNIVQFLGAVTE--RKPLMLITEYLRGGDLHKYLKEKGAL---SPSTAVNFA 146
+L KLRHPN+VQFLGA T ++TE++ GG L ++L + L +P + A
Sbjct: 2163 GILSKLRHPNVVQFLGACTAGGEDHHCIVTEWMGGGSLRQFLTDHFNLLEQNPHIRLKLA 2222
Query: 147 LDIARGMAYLHNEPNVIIHRDLKPRNVLL----------VNSSAD-HLKVGDFGLSKLIK 195
LDIA+GM YLH I+HRDL RN+LL V+S D K+ DFGLS+L
Sbjct: 2223 LDIAKGMNYLHGWTPPILHRDLSSRNILLDHNIDPKNPVVSSRQDIKCKISDFGLSRLKM 2282
Query: 196 VQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYE 255
Q S +MT G YMAPEVFK +K DV+S+ M+L+E+L + P + +P +
Sbjct: 2283 EQAS----QMTQSVGCIPYMAPEVFKGDSNSEKSDVYSYGMVLFELLTSDEPQQDMKPMK 2338
Query: 256 AAKYVA-EGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKE 307
A A E +RP + + +E+ +CW ++ + RP+F I+ L+++++
Sbjct: 2339 MAHLAAYESYRPPIPLTT-SSKWKEILTQCWDSNPDSRPTFKQIIVHLKEMED 2390
|
Essential for spore differentiation. Dictyostelium discoideum (taxid: 44689) EC: 2EC: .EC: 7EC: .EC: 1EC: 0EC: .EC: 2 |
| >sp|Q54R58|YTYK2_DICDI Probable tyrosine-protein kinase DDB_G0283397 OS=Dictyostelium discoideum GN=DDB_G0283397 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 174 bits (440), Expect = 1e-42, Method: Compositional matrix adjust.
Identities = 109/264 (41%), Positives = 147/264 (55%), Gaps = 13/264 (4%)
Query: 50 IGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAV 109
IG+G FG++ KA WRG VA+K+I D + F EV+++ KL HP V F+GA
Sbjct: 183 IGQGFFGKVYKARWRGKSVALKKITLIKFRDLTETEIFDKEVSIMSKLCHPTCVMFIGAC 242
Query: 110 TERKPL---MLITEYLRGGDLHKYLKEKGA--LSPSTAVNFALDIARGMAYLHN--EPNV 162
+ P +I EY+ GG L + L EK + L PS ++ A DIA GM YLH +
Sbjct: 243 SLDGPSNDRSIIMEYMEGGSLRRLLDEKSSYHLPPSLQLSIARDIAEGMNYLHTNFKEGP 302
Query: 163 IIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH 222
I+HRDL N+LL NSS K+ DFGLSK +K + +MT GS +MAPE FK
Sbjct: 303 IVHRDLTSSNILL-NSSYTVAKINDFGLSKEMKPGPT----EMTAAMGSLAWMAPECFKA 357
Query: 223 RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTE 282
Y +KVDV+SFA+IL+E++ P EP A ++A GF P EL
Sbjct: 358 ENYTEKVDVYSFAIILWEIVTCRDPYNGMEPLRLA-FLASVEDYRLPLNGFPPYWVELIS 416
Query: 283 KCWAADMNQRPSFLDILKRLEKIK 306
KCW + RPSF +IL+ L +I+
Sbjct: 417 KCWNITPSLRPSFKEILQILNQIE 440
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|Q54TM7|DRKD_DICDI Probable serine/threonine-protein kinase drkD OS=Dictyostelium discoideum GN=drkD PE=2 SV=1 | Back alignment and function description |
|---|
Score = 171 bits (434), Expect = 4e-42, Method: Compositional matrix adjust.
Identities = 112/295 (37%), Positives = 155/295 (52%), Gaps = 19/295 (6%)
Query: 15 QNGSHFEPKPVPPP----LPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAI 70
QN H P P P + +WE+ SE+ A IG+G +G++ + WRGT VA+
Sbjct: 820 QNKDHQFPVPTIPAKIIEVEKPFEWEVPLSEIAIG--ARIGRGGYGQVFRGSWRGTEVAV 877
Query: 71 KRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHK- 129
K + + +L I D R EV+LL KLRHPNIV F+GA TE ++TEYL G L
Sbjct: 878 KMLFNDNVNLKL-ISDLRKEVDLLCKLRHPNIVLFMGACTEPSSPCIVTEYLSRGSLANI 936
Query: 130 YLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFG 189
L E + + D ARGM YLH+ +IIHRDLK N+L+ +S +KV DFG
Sbjct: 937 LLDESIEMDWGLRLQLGFDCARGMTYLHSRNPIIIHRDLKTDNLLVDDSW--QVKVADFG 994
Query: 190 LSKLIKVQNSHDVYK-MTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPL 248
L+ + SH K M G TG ++APEV Y +K DV+S+A++L+E+L P
Sbjct: 995 LATV----KSHTFAKTMCGTTG---WVAPEVLAEEGYTEKADVYSYAIVLWELLTRLIPY 1047
Query: 249 ANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLE 303
A + + + G R A P+ L +CW D RPSF +IL +E
Sbjct: 1048 AGKNTMQVVRSIDRGERLPMPA-WCPPKYAALMNRCWETDPTHRPSFPEILPIME 1101
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2MHE4|HT1_ARATH Serine/threonine-protein kinase HT1 OS=Arabidopsis thaliana GN=HT1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 169 bits (429), Expect = 2e-41, Method: Compositional matrix adjust.
Identities = 109/291 (37%), Positives = 160/291 (54%), Gaps = 22/291 (7%)
Query: 34 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRI-LPSLSDDRL--VIQDFRHE 90
+W D S+L + G+ I + ++ VA+K + +P+ ++ + Q F+ E
Sbjct: 78 EWTADLSQLFIGNK--FASGAHSRIYRGIYKQRAVAVKMVRIPTHKEETRAKLEQQFKSE 135
Query: 91 VNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL--KEKGALSPSTAVNFALD 148
V LL +L HPNIVQF+ A + +ITEY+ G+L YL KE +LS T + ALD
Sbjct: 136 VALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGNLRMYLNKKEPYSLSIETVLRLALD 195
Query: 149 IARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGE 208
I+RGM YLH++ +IHRDLK N+LL + +KV DFG S L + G
Sbjct: 196 ISRGMEYLHSQG--VIHRDLKSNNLLLNDEM--RVKVADFGTSCL-----ETQCREAKGN 246
Query: 209 TGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAE-GHRPF 267
G+YR+MAPE+ K + Y +KVDV+SF ++L+E+ P P +AA VAE RP
Sbjct: 247 MGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKNERPP 306
Query: 268 FRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEK----IKETLPTDHH 314
A P L L ++CW+ + ++RP F +I+ LEK +KE LP H
Sbjct: 307 LPA-SCQPALAHLIKRCWSENPSKRPDFSNIVAVLEKYDECVKEGLPLTSH 356
|
Serine/threonine kinase involved in the control of stomatal movement in response to CO(2). Shows a reduced response to ABA or light compared to CO(2). Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q66L42|M3K10_MOUSE Mitogen-activated protein kinase kinase kinase 10 OS=Mus musculus GN=Map3k10 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 165 bits (417), Expect = 5e-40, Method: Compositional matrix adjust.
Identities = 102/269 (37%), Positives = 144/269 (53%), Gaps = 17/269 (6%)
Query: 49 IIGKGSFGEILKAYWRGTPVAIK--RILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 106
IIG G FG++ +A WRG VA+K R+ P D + + R E L L+HPNI+
Sbjct: 103 IIGVGGFGKVYRAVWRGEEVAVKAARLDPE-RDPAVTAEQVRQEARLFGALQHPNIIALR 161
Query: 107 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE-PNVIIH 165
GA L L+ EY RGG L + L + + P VN+A+ +ARGM YLHN+ P IIH
Sbjct: 162 GACLSPPNLCLVMEYARGGALSRVLAGR-RVPPHVLVNWAVQVARGMNYLHNDAPVPIIH 220
Query: 166 RDLKPRNVLLVNSSADH------LKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV 219
RDLK N+L++ + +H LK+ DFGL++ H KM+ G+Y +MAPEV
Sbjct: 221 RDLKSINILILEAIENHNLADTVLKITDFGLAR-----EWHKTTKMSA-AGTYAWMAPEV 274
Query: 220 FKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRE 279
+ + K DV+SF ++L+E+L GE P + A VA
Sbjct: 275 IRLSLFSKSSDVWSFGVLLWELLTGEVPYREIDALAVAYGVAMNKLTLPIPSTCPEPFAR 334
Query: 280 LTEKCWAADMNQRPSFLDILKRLEKIKET 308
L E+CW D + RP F ILK+LE I+++
Sbjct: 335 LLEECWDPDPHGRPDFGSILKQLEVIEQS 363
|
Activates the JUN N-terminal pathway. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q3U1V8|M3K9_MOUSE Mitogen-activated protein kinase kinase kinase 9 OS=Mus musculus GN=Map3k9 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 164 bits (416), Expect = 7e-40, Method: Compositional matrix adjust.
Identities = 104/281 (37%), Positives = 147/281 (52%), Gaps = 17/281 (6%)
Query: 36 EIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDD-RLVIQDFRHEVNLL 94
EID +EL IIG G FG++ +A+W G VA+K +D I++ R E L
Sbjct: 131 EIDFAELTLEE--IIGIGGFGKVYRAFWAGDEVAVKAARHDPDEDISQTIENVRQEAKLF 188
Query: 95 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMA 154
L+HPNI+ G + L L+ E+ RGG L++ L K + P VN+A+ IARGM
Sbjct: 189 AMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK-RIPPDILVNWAVQIARGMN 247
Query: 155 YLHNEPNV-IIHRDLKPRNVLLVNS------SADHLKVGDFGLSKLIKVQNSHDVYKMTG 207
YLH+E V IIHRDLK N+L++ S LK+ DFGL++ H KM+
Sbjct: 248 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR-----EWHRTTKMSA 302
Query: 208 ETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPF 267
G+Y +MAPEV + + K DV+S+ ++L+E+L GE P + A VA
Sbjct: 303 -AGTYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLAL 361
Query: 268 FRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKET 308
+L E CW D + RPSF IL +L I+E+
Sbjct: 362 PIPSTCPEPFAKLMEDCWNPDPHSRPSFTSILDQLTTIEES 402
|
Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. Plays an important role in the cascades of cellular responses evoked by changes in the environment. Once activated, acts as an upstream activator of the MKK/JNK signal transduction cascade through the phosphorylation of MAP2K4/MKK4 and MAP2K7/MKK7 which in turn activate the JNKs. The MKK/JNK signaling pathway regulates stress response via activator protein-1 (JUN) and GATA4 transcription factors. Plays also a role in mitochondrial death signaling pathway, including the release cytochrome c, leading to apoptosis. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q54IP4|SHKB_DICDI Dual specificity protein kinase shkB OS=Dictyostelium discoideum GN=shkB PE=3 SV=1 | Back alignment and function description |
|---|
Score = 164 bits (415), Expect = 8e-40, Method: Compositional matrix adjust.
Identities = 106/285 (37%), Positives = 168/285 (58%), Gaps = 18/285 (6%)
Query: 35 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLL 94
WEID +E+ ++ A +G G+FG + K RG VAIK++ ++ ++ + +F+ EV+L+
Sbjct: 165 WEIDRNEISYNREAKLGSGAFGSVYKGIVRGKEVAIKKLTQTVFEEN-TMNEFKKEVSLM 223
Query: 95 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIAR--- 151
KLR+P+++ F+GA T + L ++TE + G +H L+ K S A+ IAR
Sbjct: 224 AKLRNPHLLLFMGACTAPEDLSIVTELMPKGSVHSLLRAKEDTSDFITFKRAILIARDTV 283
Query: 152 -GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETG 210
GM +LH + I+H DLKP N+L+ + +KV DFGLSK +K +S D K+ G+ G
Sbjct: 284 LGMTWLH--ASNILHLDLKPANLLVDQNWV--VKVADFGLSKYMK-PDSKD--KLLGQAG 336
Query: 211 SYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPP---LANYEPYEAAKYVAEGHRPF 267
S YMAPE+ ++ YD KVDVFSF+++L+E+L + P L + P V + +RP
Sbjct: 337 SPLYMAPEMLVNQPYDGKVDVFSFSILLWELLTKQEPYNKLYSSYPQLVEGVVNKKNRPI 396
Query: 268 FRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPTD 312
F L++L +CW ++RPSF +I K ++I ET+ D
Sbjct: 397 I-PDYFPTRLKDLLARCWDHYPSRRPSFAEISK--QRILETILID 438
|
Required for proper chemotaxis and phagocytosis; proper spatiotemporal control of F-actin levels in chemotaxing cells. Negative regulator of the PI3K (phosphatidylinositol 3 kinase) pathway. Predominantly phosphorylates serines and threonines and tyrosines at a lower level. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q55GU0|Y9955_DICDI Probable serine/threonine-protein kinase DDB_G0267514 OS=Dictyostelium discoideum GN=DDB_G0267514 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 164 bits (415), Expect = 9e-40, Method: Compositional matrix adjust.
Identities = 115/309 (37%), Positives = 169/309 (54%), Gaps = 19/309 (6%)
Query: 4 LLNAHGGLSYGQNGSHFEPKP--VPPPLPNK---CDWEIDPSELDFSSSAIIGKGSFGEI 58
L+N H Y G+ + V PP + D EI SEL SS +G+G+FG +
Sbjct: 619 LINNHSPNQYNNQGNILKNSGSVVEPPSQQQQYFSDIEISFSELKISSK--LGEGTFGVV 676
Query: 59 LKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 118
K WRG+ VAIK+I + + V+++FR E+ +L +LRHPNIV + A T L I
Sbjct: 677 YKGLWRGSSVAIKQIKINEDVNNQVLEEFRKELTILSRLRHPNIVLLMAACTAPPNLCFI 736
Query: 119 TEYLRGGDLHKYLKEKGA-LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN 177
TEYL GG L+ L K ++ A+ IA+GM YLH + +IHRD+K N+LL
Sbjct: 737 TEYLPGGSLYDALHSKKIKMNMQLYKKLAIQIAQGMNYLH--LSGVIHRDIKSLNLLL-- 792
Query: 178 SSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMI 237
++K+ DFGLSKL K +++ +MT GS +M+PE+ Y +KVDV++F +I
Sbjct: 793 DEHMNVKICDFGLSKL-KSKST----EMTKSIGSPIWMSPELLMGEDYTEKVDVYAFGII 847
Query: 238 LYEMLEGEPPLANYEPYEAAKYV-AEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFL 296
L+E+ GE P + + + A V + RP + +L L + CW D +RPSF
Sbjct: 848 LWELGTGELPYSGLDSVQLALAVTTKSLRPPI-PNAWPYQLSHLIQACWHQDPLKRPSFT 906
Query: 297 DILKRLEKI 305
+IL L +I
Sbjct: 907 EILNLLNEI 915
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P80192|M3K9_HUMAN Mitogen-activated protein kinase kinase kinase 9 OS=Homo sapiens GN=MAP3K9 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 164 bits (414), Expect = 1e-39, Method: Compositional matrix adjust.
Identities = 104/281 (37%), Positives = 148/281 (52%), Gaps = 17/281 (6%)
Query: 36 EIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDD-RLVIQDFRHEVNLL 94
EID +EL IIG G FG++ +A+W G VA+K +D I++ R E L
Sbjct: 138 EIDFAELTLEE--IIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLF 195
Query: 95 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMA 154
L+HPNI+ G + L L+ E+ RGG L++ L K + P VN+A+ IARGM
Sbjct: 196 AMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK-RIPPDILVNWAVQIARGMN 254
Query: 155 YLHNEPNV-IIHRDLKPRNVLLVNS------SADHLKVGDFGLSKLIKVQNSHDVYKMTG 207
YLH+E V IIHRDLK N+L++ S LK+ DFGL++ H KM+
Sbjct: 255 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR-----EWHRTTKMSA 309
Query: 208 ETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPF 267
G+Y +MAPEV + + K DV+S+ ++L+E+L GE P + A VA
Sbjct: 310 -AGTYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLAL 368
Query: 268 FRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKET 308
+L E CW D + RPSF +IL +L I+E+
Sbjct: 369 PIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTIEES 409
|
Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. Plays an important role in the cascades of cellular responses evoked by changes in the environment. Once activated, acts as an upstream activator of the MKK/JNK signal transduction cascade through the phosphorylation of MAP2K4/MKK4 and MAP2K7/MKK7 which in turn activate the JNKs. The MKK/JNK signaling pathway regulates stress response via activator protein-1 (JUN) and GATA4 transcription factors. Plays also a role in mitochondrial death signaling pathway, including the release cytochrome c, leading to apoptosis. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q05609|CTR1_ARATH Serine/threonine-protein kinase CTR1 OS=Arabidopsis thaliana GN=CTR1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 163 bits (413), Expect = 1e-39, Method: Compositional matrix adjust.
Identities = 103/298 (34%), Positives = 155/298 (52%), Gaps = 18/298 (6%)
Query: 24 PVPPPLPNKCDWEI-------DPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPS 76
P+ P+PN+ + E+ D D + IG GSFG + +A W G+ VA+K IL
Sbjct: 524 PISQPVPNRANRELGLDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVK-ILME 582
Query: 77 LSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA 136
+ +F EV ++ +LRHPNIV F+GAVT+ L ++TEYL G L++ L + GA
Sbjct: 583 QDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGA 642
Query: 137 ---LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 193
L ++ A D+A+GM YLHN I+HRDLK N+L+ +KV DFGLS+L
Sbjct: 643 REQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRDLKSPNLLVDKKYT--VKVCDFGLSRL 700
Query: 194 IKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEP 253
+ G+ +MAPEV + ++K DV+SF +IL+E+ + P N P
Sbjct: 701 ----KASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP 756
Query: 254 YEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEK-IKETLP 310
+ V + + P++ + E CW + +RPSF I+ L IK +P
Sbjct: 757 AQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVP 814
|
Acts as a negative regulator in the ethylene response pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 320 | ||||||
| 255562954 | 431 | protein kinase, putative [Ricinus commun | 1.0 | 0.742 | 0.931 | 1e-171 | |
| 449434754 | 446 | PREDICTED: dual specificity protein kina | 1.0 | 0.717 | 0.925 | 1e-170 | |
| 449478377 | 446 | PREDICTED: LOW QUALITY PROTEIN: dual spe | 1.0 | 0.717 | 0.921 | 1e-170 | |
| 356497930 | 427 | PREDICTED: dual specificity protein kina | 1.0 | 0.749 | 0.868 | 1e-168 | |
| 225462932 | 435 | PREDICTED: dual specificity protein kina | 1.0 | 0.735 | 0.903 | 1e-167 | |
| 356577296 | 423 | PREDICTED: dual specificity protein kina | 1.0 | 0.756 | 0.856 | 1e-167 | |
| 356521649 | 421 | PREDICTED: dual specificity protein kina | 1.0 | 0.760 | 0.856 | 1e-166 | |
| 224101399 | 440 | predicted protein [Populus trichocarpa] | 0.996 | 0.725 | 0.906 | 1e-166 | |
| 116643246 | 449 | flag-tagged protein kinase domain of put | 1.0 | 0.712 | 0.887 | 1e-164 | |
| 15223025 | 438 | VH1-interacting kinase [Arabidopsis thal | 1.0 | 0.730 | 0.887 | 1e-164 |
| >gi|255562954|ref|XP_002522482.1| protein kinase, putative [Ricinus communis] gi|223538367|gb|EEF39974.1| protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 605 bits (1561), Expect = e-171, Method: Compositional matrix adjust.
Identities = 298/320 (93%), Positives = 314/320 (98%)
Query: 1 MMELLNAHGGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILK 60
M+ELL ++GGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFS+SAIIGKGSFGEILK
Sbjct: 112 MIELLKSYGGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSNSAIIGKGSFGEILK 171
Query: 61 AYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120
AYWRGTPVA+KRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE+KPLMLITE
Sbjct: 172 AYWRGTPVAVKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTEKKPLMLITE 231
Query: 121 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSA 180
YLRGGDLH+YLKEKGALSPSTA+NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS+A
Sbjct: 232 YLRGGDLHQYLKEKGALSPSTAINFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSNA 291
Query: 181 DHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYE 240
DHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYE
Sbjct: 292 DHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYE 351
Query: 241 MLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILK 300
MLEGEPPLANYEPYEAAK+VAEGHRP F AKGFT ELRELT++CWAADMN+RPSFL+ILK
Sbjct: 352 MLEGEPPLANYEPYEAAKFVAEGHRPTFHAKGFTIELRELTDQCWAADMNRRPSFLEILK 411
Query: 301 RLEKIKETLPTDHHWNIFNA 320
RLEKIKE LP DHHW++FNA
Sbjct: 412 RLEKIKEVLPADHHWSLFNA 431
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449434754|ref|XP_004135161.1| PREDICTED: dual specificity protein kinase splA-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 604 bits (1557), Expect = e-170, Method: Compositional matrix adjust.
Identities = 296/320 (92%), Positives = 314/320 (98%)
Query: 1 MMELLNAHGGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILK 60
M+ELL ++GGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFS+SAIIGKGSFGEILK
Sbjct: 127 MIELLKSYGGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSNSAIIGKGSFGEILK 186
Query: 61 AYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120
AYWRGTPVA+KRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE+KPLMLITE
Sbjct: 187 AYWRGTPVAVKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTEKKPLMLITE 246
Query: 121 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSA 180
YLRGGDLH+YLK+KG+LSP+TA+NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS A
Sbjct: 247 YLRGGDLHQYLKDKGSLSPATAINFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSGA 306
Query: 181 DHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYE 240
DHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYE
Sbjct: 307 DHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYE 366
Query: 241 MLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILK 300
MLEG+PPLANYEPYEAAKYVAEGHRP FRAKG+ P LRELTE+CWA+DMN+RPSFL+ILK
Sbjct: 367 MLEGDPPLANYEPYEAAKYVAEGHRPMFRAKGYLPVLRELTEECWASDMNKRPSFLEILK 426
Query: 301 RLEKIKETLPTDHHWNIFNA 320
RLEKIKE LPTDHHWN+FNA
Sbjct: 427 RLEKIKENLPTDHHWNLFNA 446
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449478377|ref|XP_004155301.1| PREDICTED: LOW QUALITY PROTEIN: dual specificity protein kinase splA-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 602 bits (1551), Expect = e-170, Method: Compositional matrix adjust.
Identities = 295/320 (92%), Positives = 313/320 (97%)
Query: 1 MMELLNAHGGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILK 60
M+ELL ++GGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFS+SAIIGKGSFGEILK
Sbjct: 127 MIELLKSYGGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSNSAIIGKGSFGEILK 186
Query: 61 AYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120
AYWRGTPVA+KRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE+KPLMLITE
Sbjct: 187 AYWRGTPVAVKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTEKKPLMLITE 246
Query: 121 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSA 180
YLRGGDLH+YLK+KG+LSP+TA+NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS A
Sbjct: 247 YLRGGDLHQYLKDKGSLSPATAINFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSGA 306
Query: 181 DHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYE 240
DHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVD FSFAMILYE
Sbjct: 307 DHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDXFSFAMILYE 366
Query: 241 MLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILK 300
MLEG+PPLANYEPYEAAKYVAEGHRP FRAKG+ P LRELTE+CWA+DMN+RPSFL+ILK
Sbjct: 367 MLEGDPPLANYEPYEAAKYVAEGHRPMFRAKGYLPVLRELTEECWASDMNKRPSFLEILK 426
Query: 301 RLEKIKETLPTDHHWNIFNA 320
RLEKIKE LPTDHHWN+FNA
Sbjct: 427 RLEKIKENLPTDHHWNLFNA 446
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356497930|ref|XP_003517809.1| PREDICTED: dual specificity protein kinase pyk1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 597 bits (1540), Expect = e-168, Method: Compositional matrix adjust.
Identities = 278/320 (86%), Positives = 302/320 (94%)
Query: 1 MMELLNAHGGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILK 60
M+ELL +HGGLSYGQNGSHFEP PV PPLPNKCDWE+DPSELDFS+S IGKGSFGEILK
Sbjct: 108 MIELLKSHGGLSYGQNGSHFEPSPVLPPLPNKCDWEVDPSELDFSNSVCIGKGSFGEILK 167
Query: 61 AYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120
A+WRGTPVA+KRILPSLSDDRLVIQDFR EVNLLVKLRHPN+VQFLGAVT+RKPLMLITE
Sbjct: 168 AHWRGTPVAVKRILPSLSDDRLVIQDFRQEVNLLVKLRHPNVVQFLGAVTDRKPLMLITE 227
Query: 121 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSA 180
YLRGGDLHKYLK+KGALSPSTA+NF LDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSA
Sbjct: 228 YLRGGDLHKYLKDKGALSPSTAINFGLDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSA 287
Query: 181 DHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYE 240
DHLKVGDFGLSKLIKVQ++HDVYKMTGETGSYRYMAPEV KHR+YDKKVDVFSFAMILYE
Sbjct: 288 DHLKVGDFGLSKLIKVQSAHDVYKMTGETGSYRYMAPEVLKHRRYDKKVDVFSFAMILYE 347
Query: 241 MLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILK 300
MLEGEPP +NYEPY+ AKYVAEGHRP FR KG+ PELRELTE+CW ADM QRPSF++I+K
Sbjct: 348 MLEGEPPFSNYEPYDGAKYVAEGHRPSFRGKGYIPELRELTEQCWDADMKQRPSFIEIIK 407
Query: 301 RLEKIKETLPTDHHWNIFNA 320
LEKIKE LP+DHHW++F +
Sbjct: 408 HLEKIKENLPSDHHWHLFTS 427
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225462932|ref|XP_002266329.1| PREDICTED: dual specificity protein kinase pyk1 isoform 1 [Vitis vinifera] gi|296087790|emb|CBI35046.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 593 bits (1529), Expect = e-167, Method: Compositional matrix adjust.
Identities = 289/320 (90%), Positives = 308/320 (96%)
Query: 1 MMELLNAHGGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILK 60
M+ELL ++GGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFS+S+IIGKGSFGEILK
Sbjct: 116 MIELLKSYGGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSNSSIIGKGSFGEILK 175
Query: 61 AYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120
A WRGTPVA+KRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVT++KPLMLITE
Sbjct: 176 ACWRGTPVAVKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTDKKPLMLITE 235
Query: 121 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSA 180
YLRGGDLH+YLKEKG+LSPSTA+ FA+DIARGMAYLHNEPNVIIHRDLKPRNVLLVN+ A
Sbjct: 236 YLRGGDLHQYLKEKGSLSPSTAITFAMDIARGMAYLHNEPNVIIHRDLKPRNVLLVNTGA 295
Query: 181 DHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYE 240
DHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYE
Sbjct: 296 DHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYE 355
Query: 241 MLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILK 300
MLEG+PPL+NYEPYEAAKYVAEG RP FRAKG+ EL+ELTE+CWAADMN RPSFL+ILK
Sbjct: 356 MLEGDPPLSNYEPYEAAKYVAEGQRPMFRAKGYITELKELTEQCWAADMNHRPSFLEILK 415
Query: 301 RLEKIKETLPTDHHWNIFNA 320
RLEKIKE LP DHHWNIF A
Sbjct: 416 RLEKIKEILPPDHHWNIFTA 435
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356577296|ref|XP_003556763.1| PREDICTED: dual specificity protein kinase pyk1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 592 bits (1527), Expect = e-167, Method: Compositional matrix adjust.
Identities = 274/320 (85%), Positives = 306/320 (95%)
Query: 1 MMELLNAHGGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILK 60
++ELL +HGGLS+GQNGSHFEPKPV PPLPNKCDWE++P+ELDFS+S IGKGSFGEILK
Sbjct: 104 VIELLQSHGGLSFGQNGSHFEPKPVAPPLPNKCDWEVEPTELDFSNSVRIGKGSFGEILK 163
Query: 61 AYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120
A+WRGTPVA+KRILPSLS+DRLVIQDFRHEVNLLVKLRHPNIVQFLGAVT+RKPLMLITE
Sbjct: 164 AHWRGTPVAVKRILPSLSEDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTDRKPLMLITE 223
Query: 121 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSA 180
YLRGGDLH+YLKEKGALSP+TA++F++DI RGMAYLHNEPNVIIHRDLKPRNVLLVNSSA
Sbjct: 224 YLRGGDLHQYLKEKGALSPATAISFSMDIVRGMAYLHNEPNVIIHRDLKPRNVLLVNSSA 283
Query: 181 DHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYE 240
DHLKVGDFGLSKLI VQ+SHDVYKMTGETGSYRYMAPEVFKHR+YDKKVDV+SFAMILYE
Sbjct: 284 DHLKVGDFGLSKLITVQSSHDVYKMTGETGSYRYMAPEVFKHRRYDKKVDVYSFAMILYE 343
Query: 241 MLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILK 300
MLEGEPP A+ EPYE AKY AEGHRP FRAKG+TPEL+ELTE+CWA DM+QRPSF++ILK
Sbjct: 344 MLEGEPPFASREPYEGAKYAAEGHRPHFRAKGYTPELQELTEQCWAHDMSQRPSFIEILK 403
Query: 301 RLEKIKETLPTDHHWNIFNA 320
RLEKIKE LPT+HHW++F +
Sbjct: 404 RLEKIKENLPTEHHWHLFTS 423
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356521649|ref|XP_003529466.1| PREDICTED: dual specificity protein kinase pyk1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 592 bits (1525), Expect = e-166, Method: Compositional matrix adjust.
Identities = 274/320 (85%), Positives = 305/320 (95%)
Query: 1 MMELLNAHGGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILK 60
++ELL +HGGLS+GQNGSHFEPKPV PPLPNKCDWE++P+ELDFS+S IGKGSFGEILK
Sbjct: 102 VIELLQSHGGLSFGQNGSHFEPKPVAPPLPNKCDWEVEPTELDFSNSVRIGKGSFGEILK 161
Query: 61 AYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120
A+WRGTPVA+KRILPSLS+DRLVIQDFRHEVNLLVKLRHPNIVQFLGAVT RKPLMLITE
Sbjct: 162 AHWRGTPVAVKRILPSLSEDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTARKPLMLITE 221
Query: 121 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSA 180
YLRGGDLH+YLKEKGALSP+TA+NF++DI RGMAYLHNEPNVIIHRDLKPRNVLLVNSSA
Sbjct: 222 YLRGGDLHQYLKEKGALSPATAINFSMDIVRGMAYLHNEPNVIIHRDLKPRNVLLVNSSA 281
Query: 181 DHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYE 240
DHLKVGDFGLSKLI VQ+SHDVYKMTGETGSYRYMAPEVFKHR+YDKKVDV+SFAMILYE
Sbjct: 282 DHLKVGDFGLSKLITVQSSHDVYKMTGETGSYRYMAPEVFKHRRYDKKVDVYSFAMILYE 341
Query: 241 MLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILK 300
MLEGEPP A+ EPYE AKY AEGHRP FRAKG+TPEL+ELTE+CWA DM+QRPSF++ILK
Sbjct: 342 MLEGEPPFASREPYEGAKYAAEGHRPHFRAKGYTPELQELTEQCWAHDMSQRPSFIEILK 401
Query: 301 RLEKIKETLPTDHHWNIFNA 320
RLEKIKE LPT++HW++F +
Sbjct: 402 RLEKIKENLPTENHWHLFTS 421
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224101399|ref|XP_002312262.1| predicted protein [Populus trichocarpa] gi|222852082|gb|EEE89629.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 589 bits (1519), Expect = e-166, Method: Compositional matrix adjust.
Identities = 290/320 (90%), Positives = 309/320 (96%), Gaps = 1/320 (0%)
Query: 1 MMELLNAHGGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILK 60
M+ELL ++GGLSYGQNGSHFEPKPVPPP PNKCDWEI+PSELDFS+S IIGKGSFGEILK
Sbjct: 120 MIELLKSYGGLSYGQNGSHFEPKPVPPPQPNKCDWEIEPSELDFSNSNIIGKGSFGEILK 179
Query: 61 AYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120
A WRGTPVA+KRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE
Sbjct: 180 ASWRGTPVAVKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 239
Query: 121 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSA 180
YLRGGDLH+YLKEKGALSPSTA+NFALDIARGMA LHNEPNVI+HRDLKPRNVLLVNS+A
Sbjct: 240 YLRGGDLHQYLKEKGALSPSTAINFALDIARGMACLHNEPNVIVHRDLKPRNVLLVNSNA 299
Query: 181 DHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYE 240
DHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYE
Sbjct: 300 DHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYE 359
Query: 241 MLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTP-ELRELTEKCWAADMNQRPSFLDIL 299
MLEGEPP +N+EPYEAAKYVAEGHRP FR+KGF ELRELT++CWAADMN+RP+FL+IL
Sbjct: 360 MLEGEPPFSNFEPYEAAKYVAEGHRPTFRSKGFNVFELRELTDQCWAADMNRRPTFLEIL 419
Query: 300 KRLEKIKETLPTDHHWNIFN 319
KRLEKIKE LPTDHHW+IFN
Sbjct: 420 KRLEKIKENLPTDHHWHIFN 439
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|116643246|gb|ABK06431.1| flag-tagged protein kinase domain of putative mitogen-activated protein kinase kinase kinase [synthetic construct] | Back alignment and taxonomy information |
|---|
Score = 584 bits (1506), Expect = e-164, Method: Compositional matrix adjust.
Identities = 284/320 (88%), Positives = 308/320 (96%)
Query: 1 MMELLNAHGGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILK 60
M+ELL +HGGLSYGQNGSHFEPKPVPPP+P KCDWEI+P+ELDFS++A+IGKGSFGEI+K
Sbjct: 119 MIELLKSHGGLSYGQNGSHFEPKPVPPPIPKKCDWEIEPAELDFSNAAMIGKGSFGEIVK 178
Query: 61 AYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120
AYWRGTPVA+KRILPSLSDDRLVIQDFRHEV+LLVKLRHPNIVQFLGAVTERKPLMLITE
Sbjct: 179 AYWRGTPVAVKRILPSLSDDRLVIQDFRHEVDLLVKLRHPNIVQFLGAVTERKPLMLITE 238
Query: 121 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSA 180
YLRGGDLH+YLKEKG L+P+TAVNFALDIARGM YLHNEPNVIIHRDLKPRNVLLVNSSA
Sbjct: 239 YLRGGDLHQYLKEKGGLTPTTAVNFALDIARGMTYLHNEPNVIIHRDLKPRNVLLVNSSA 298
Query: 181 DHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYE 240
DHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR+YDKKVDVFSFAMILYE
Sbjct: 299 DHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRRYDKKVDVFSFAMILYE 358
Query: 241 MLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILK 300
MLEGEPP AN+EPYEAAK+V++GHRP FR+KG TP+LREL KCW ADMNQRPSFLDILK
Sbjct: 359 MLEGEPPFANHEPYEAAKHVSDGHRPTFRSKGCTPDLRELIVKCWDADMNQRPSFLDILK 418
Query: 301 RLEKIKETLPTDHHWNIFNA 320
RLEKIKETLP+DHHW +F +
Sbjct: 419 RLEKIKETLPSDHHWGLFTS 438
|
Source: synthetic construct Species: synthetic construct Genus: N/A Family: N/A Order: N/A Class: N/A Phylum: N/A Superkingdom: |
| >gi|15223025|ref|NP_172853.1| VH1-interacting kinase [Arabidopsis thaliana] gi|5080776|gb|AAD39286.1|AC007576_9 Similar to protein kinases [Arabidopsis thaliana] gi|111074450|gb|ABH04598.1| At1g14000 [Arabidopsis thaliana] gi|332190976|gb|AEE29097.1| VH1-interacting kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 584 bits (1506), Expect = e-164, Method: Compositional matrix adjust.
Identities = 284/320 (88%), Positives = 308/320 (96%)
Query: 1 MMELLNAHGGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILK 60
M+ELL +HGGLSYGQNGSHFEPKPVPPP+P KCDWEI+P+ELDFS++A+IGKGSFGEI+K
Sbjct: 119 MIELLKSHGGLSYGQNGSHFEPKPVPPPIPKKCDWEIEPAELDFSNAAMIGKGSFGEIVK 178
Query: 61 AYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120
AYWRGTPVA+KRILPSLSDDRLVIQDFRHEV+LLVKLRHPNIVQFLGAVTERKPLMLITE
Sbjct: 179 AYWRGTPVAVKRILPSLSDDRLVIQDFRHEVDLLVKLRHPNIVQFLGAVTERKPLMLITE 238
Query: 121 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSA 180
YLRGGDLH+YLKEKG L+P+TAVNFALDIARGM YLHNEPNVIIHRDLKPRNVLLVNSSA
Sbjct: 239 YLRGGDLHQYLKEKGGLTPTTAVNFALDIARGMTYLHNEPNVIIHRDLKPRNVLLVNSSA 298
Query: 181 DHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYE 240
DHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR+YDKKVDVFSFAMILYE
Sbjct: 299 DHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRRYDKKVDVFSFAMILYE 358
Query: 241 MLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILK 300
MLEGEPP AN+EPYEAAK+V++GHRP FR+KG TP+LREL KCW ADMNQRPSFLDILK
Sbjct: 359 MLEGEPPFANHEPYEAAKHVSDGHRPTFRSKGCTPDLRELIVKCWDADMNQRPSFLDILK 418
Query: 301 RLEKIKETLPTDHHWNIFNA 320
RLEKIKETLP+DHHW +F +
Sbjct: 419 RLEKIKETLPSDHHWGLFTS 438
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 320 | ||||||
| TAIR|locus:2014849 | 438 | VIK "VH1-interacting kinase" [ | 1.0 | 0.730 | 0.862 | 8.5e-152 | |
| TAIR|locus:2117129 | 459 | AT4G18950 [Arabidopsis thalian | 0.859 | 0.599 | 0.493 | 2.6e-63 | |
| TAIR|locus:2098999 | 471 | AT3G58760 [Arabidopsis thalian | 0.871 | 0.592 | 0.477 | 2.3e-62 | |
| TAIR|locus:2045258 | 476 | AT2G31800 [Arabidopsis thalian | 0.831 | 0.558 | 0.440 | 7.8e-55 | |
| TAIR|locus:2044034 | 479 | AT2G43850 [Arabidopsis thalian | 0.862 | 0.576 | 0.429 | 1.6e-54 | |
| TAIR|locus:2080517 | 477 | AT3G59830 [Arabidopsis thalian | 0.862 | 0.578 | 0.429 | 4e-51 | |
| TAIR|locus:2121154 | 575 | STY46 "serine/threonine/tyrosi | 0.812 | 0.452 | 0.416 | 2.3e-48 | |
| TAIR|locus:2128043 | 570 | STY17 "serine/threonine/tyrosi | 0.837 | 0.470 | 0.394 | 1.6e-47 | |
| TAIR|locus:2827943 | 546 | STY8 "serine/threonine/tyrosin | 0.815 | 0.478 | 0.404 | 3.3e-47 | |
| TAIR|locus:2061092 | 411 | AT2G24360 [Arabidopsis thalian | 0.831 | 0.647 | 0.393 | 4.4e-45 |
| TAIR|locus:2014849 VIK "VH1-interacting kinase" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1481 (526.4 bits), Expect = 8.5e-152, P = 8.5e-152
Identities = 276/320 (86%), Positives = 299/320 (93%)
Query: 1 MMELLNAHGGLSYGQNGSHFEXXXXXXXXXNKCDWEIDPSELDFSSSAIIGKGSFGEILK 60
M+ELL +HGGLSYGQNGSHFE KCDWEI+P+ELDFS++A+IGKGSFGEI+K
Sbjct: 119 MIELLKSHGGLSYGQNGSHFEPKPVPPPIPKKCDWEIEPAELDFSNAAMIGKGSFGEIVK 178
Query: 61 AYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120
AYWRGTPVA+KRILPSLSDDRLVIQDFRHEV+LLVKLRHPNIVQFLGAVTERKPLMLITE
Sbjct: 179 AYWRGTPVAVKRILPSLSDDRLVIQDFRHEVDLLVKLRHPNIVQFLGAVTERKPLMLITE 238
Query: 121 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSA 180
YLRGGDLH+YLKEKG L+P+TAVNFALDIARGM YLHNEPNVIIHRDLKPRNVLLVNSSA
Sbjct: 239 YLRGGDLHQYLKEKGGLTPTTAVNFALDIARGMTYLHNEPNVIIHRDLKPRNVLLVNSSA 298
Query: 181 DHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYE 240
DHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR+YDKKVDVFSFAMILYE
Sbjct: 299 DHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRRYDKKVDVFSFAMILYE 358
Query: 241 MLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILK 300
MLEGEPP AN+EPYEAAK+V++GHRP FR+KG TP+LREL KCW ADMNQRPSFLDILK
Sbjct: 359 MLEGEPPFANHEPYEAAKHVSDGHRPTFRSKGCTPDLRELIVKCWDADMNQRPSFLDILK 418
Query: 301 RLEKIKETLPTDHHWNIFNA 320
RLEKIKETLP+DHHW +F +
Sbjct: 419 RLEKIKETLPSDHHWGLFTS 438
|
|
| TAIR|locus:2117129 AT4G18950 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 646 (232.5 bits), Expect = 2.6e-63, P = 2.6e-63
Identities = 142/288 (49%), Positives = 188/288 (65%)
Query: 34 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPS-LSDDRLVIQDFRHEVN 92
++EI+PSELDF+ S I KG++ A WRG VA+K++ LSDD V + F E+
Sbjct: 150 EYEINPSELDFTQSKEITKGTY---CMAMWRGIQVAVKKLDDEVLSDDDQV-RKFHDELA 205
Query: 93 LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARG 152
LL +LRHPNIVQFLGAVT+ P+M++TEYL GDL + LK KG L P+TAV +ALDIARG
Sbjct: 206 LLQRLRHPNIVQFLGAVTQSNPMMIVTEYLPRGDLRELLKRKGQLKPATAVRYALDIARG 265
Query: 153 MAYLHN-EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGS 211
M+YLH + + IIHRDL+P N+L +S HLKV DFG+SKL+ V+ T + S
Sbjct: 266 MSYLHEIKGDPIIHRDLEPSNILRDDSG--HLKVADFGVSKLVTVKEDKP---FTCQDIS 320
Query: 212 YRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA- 270
RY+APEVF +YD K DVFSFA+I+ EM+EG P A E EA++ A HRP F+A
Sbjct: 321 CRYIAPEVFTSEEYDTKADVFSFALIVQEMIEGRMPFAEKEDSEASEAYAGKHRPLFKAP 380
Query: 271 -KGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPTDHHWNI 317
K + L+ L E+CW +RP+F +I+KRLE I + W +
Sbjct: 381 SKNYPHGLKTLIEECWHEKPAKRPTFREIIKRLESILHHMGHKRQWRM 428
|
|
| TAIR|locus:2098999 AT3G58760 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 637 (229.3 bits), Expect = 2.3e-62, P = 2.3e-62
Identities = 138/289 (47%), Positives = 184/289 (63%)
Query: 34 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNL 93
++EI P+ELDFS+S I KG+F KA WRG VA+K + D + FR E+ L
Sbjct: 156 EYEIHPTELDFSNSVKISKGTFN---KASWRGIDVAVKTFGEEMFTDEDKVNAFRDELAL 212
Query: 94 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGM 153
L K+RHPN+VQFLGAVT+ P+M++TEYL GDL +YL KG L P+ AV FAL+IARGM
Sbjct: 213 LQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRQYLDRKGPLMPAHAVKFALEIARGM 272
Query: 154 AYLH-NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS--HDVYKMTGETG 210
YLH ++P IIH DL+P N+L +S HLKV DFG+SKL+ V+ + D +T
Sbjct: 273 NYLHEHKPEAIIHCDLEPPNILRDDSG--HLKVADFGVSKLLVVKKTVKKDRPVVTCLDS 330
Query: 211 SYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA 270
S+RYMAPEV+++ +YD KVDVFSFA+IL EM+EG P E E K E RP F A
Sbjct: 331 SWRYMAPEVYRNEEYDTKVDVFSFALILQEMIEGCEPFHEIEDREVPKAYIEDERPPFNA 390
Query: 271 --KGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPTDHHWNI 317
K + L+EL + CW + ++RP+F I+ LE I + + W +
Sbjct: 391 PTKSYPFGLQELIQDCWDKEASKRPTFRVIISTLELISDRIARKRSWKV 439
|
|
| TAIR|locus:2045258 AT2G31800 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 566 (204.3 bits), Expect = 7.8e-55, P = 7.8e-55
Identities = 123/279 (44%), Positives = 174/279 (62%)
Query: 34 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNL 93
++E++P EL + I KG + ++ K W GT V++K + L D I F+HE+ L
Sbjct: 185 EYELNPQELQVRKADGISKGIY-QVAK--WNGTKVSVKILDKDLYKDSDTINAFKHELTL 241
Query: 94 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGM 153
K+RHPN+VQF+GAVT+ P+M+++EY GDL YL++KG LSP+ + FALDIARGM
Sbjct: 242 FEKVRHPNVVQFVGAVTQNVPMMIVSEYHPKGDLGSYLQKKGRLSPAKVLRFALDIARGM 301
Query: 154 AYLHN-EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG---ET 209
YLH +P +IH DLKP+N++L S HLKV FGL K+ + G +
Sbjct: 302 NYLHECKPEPVIHCDLKPKNIML--DSGGHLKVAGFGLISFAKLSSDKSKILNHGAHIDP 359
Query: 210 GSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA-EGHRPFF 268
+Y MAPEV+K +D+ VD +SF ++LYEM+EG P P EA K + EG RP F
Sbjct: 360 SNY-CMAPEVYKDEIFDRSVDSYSFGVVLYEMIEGVQPFHPKPPEEAVKLMCLEGRRPSF 418
Query: 269 RAKGFT-P-ELRELTEKCWAADMNQRPSFLDILKRLEKI 305
+AK + P E+REL E+CW + RP+F +I+ RL+KI
Sbjct: 419 KAKSKSCPQEMRELIEECWDTETFVRPTFSEIIVRLDKI 457
|
|
| TAIR|locus:2044034 AT2G43850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 563 (203.2 bits), Expect = 1.6e-54, P = 1.6e-54
Identities = 124/289 (42%), Positives = 178/289 (61%)
Query: 34 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNL 93
++E++P E+ S I KG++ ++ K W GT V++K + D I FRHE+ L
Sbjct: 188 EYELNPLEVQVRKSDGISKGAY-QVAK--WNGTRVSVKILDKDSYSDPERINAFRHELTL 244
Query: 94 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGM 153
L K+RHPN++QF+GAVT+ P+M++ EY GDL YL++KG LSPS A+ FALDIARGM
Sbjct: 245 LEKVRHPNVIQFVGAVTQNIPMMIVVEYNPKGDLSVYLQKKGRLSPSKALRFALDIARGM 304
Query: 154 AYLHN-EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV-QNSHDV--YKMTGET 209
YLH +P+ IIH DLKP+N+LL LK+ FG+ +L K+ Q+ V +K +
Sbjct: 305 NYLHECKPDPIIHCDLKPKNILL--DRGGQLKISGFGMIRLSKISQDKAKVANHKAHIDL 362
Query: 210 GSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA-EGHRPFF 268
+Y Y+APEV+K +D +VD SF +ILYE+ EG P P E A+ + EG RP F
Sbjct: 363 SNY-YIAPEVYKDEIFDLRVDAHSFGVILYEITEGVPVFHPRPPEEVARMMCLEGKRPVF 421
Query: 269 RAKG--FTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPTDHHW 315
+ K + P+++EL EKCW + RP+F +I+ RL+KI W
Sbjct: 422 KTKSRSYPPDIKELIEKCWHPEAGIRPTFSEIIIRLDKIVANCSKQGWW 470
|
|
| TAIR|locus:2080517 AT3G59830 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 531 (192.0 bits), Expect = 4.0e-51, P = 4.0e-51
Identities = 124/289 (42%), Positives = 173/289 (59%)
Query: 34 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRI-LPSLSDDRLVIQDFRHEVN 92
++E++P EL I KG++ ++ K W GT V++K S SD V F +E+
Sbjct: 186 EYELNPLELQVRKVDGISKGTY-QVAK--WNGTRVSVKIFDKDSYSDPERV-NAFTNELT 241
Query: 93 LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARG 152
LL K RHPNIVQF+GAVT+ P+M++ E GDL YL++KG LSPS A+ FALDIARG
Sbjct: 242 LLAKARHPNIVQFVGAVTQNLPMMIVVECNPKGDLSVYLQKKGRLSPSKALRFALDIARG 301
Query: 153 MAYLHN-EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV-QNSHDVYKMTGETG 210
M YLH +P+ IIH +L P+N+LL LK+ FGL KL K+ ++S V +
Sbjct: 302 MNYLHECKPDPIIHCELMPKNILL--DRGGQLKISGFGLIKLSKIGEDSAKVVNHEAQID 359
Query: 211 -SYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA-EGHRPFF 268
S Y+APE++K +DK+ DV SF +ILYE+ EG P E A+ + EG RP
Sbjct: 360 KSNYYIAPEIYKDEVFDKRADVHSFGVILYELTEGVSLFHPKPPEEVAESICIEGKRPTI 419
Query: 269 R--AKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPTDHHW 315
R +K + PEL+EL E+CW +++ RP F +I+ RL+KI W
Sbjct: 420 RTKSKSYPPELKELIEECWHPEISVRPIFSEIIIRLDKIVTNCSKQGWW 468
|
|
| TAIR|locus:2121154 STY46 "serine/threonine/tyrosine kinase 46" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 505 (182.8 bits), Expect = 2.3e-48, P = 2.3e-48
Identities = 115/276 (41%), Positives = 167/276 (60%)
Query: 35 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLL 94
WEI+ L F I GS+G++ K + VAIK + P D L ++F EV ++
Sbjct: 283 WEINLKHLKFGHK--IASGSYGDLYKGTYCSQEVAIKVLKPERLDSDLE-KEFAQEVFIM 339
Query: 95 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARGM 153
K+RH N+VQF+GA T+ L ++TE++ GG ++ YL K+KG T A+DI +GM
Sbjct: 340 RKVRHKNVVQFIGACTKPPHLCIVTEFMPGGSVYDYLHKQKGVFKLPTLFKVAIDICKGM 399
Query: 154 AYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYR 213
+YLH N IIHRDLK N+L+ + +KV DFG+++ +K Q MT ETG+YR
Sbjct: 400 SYLHQ--NNIIHRDLKAANLLMDENEV--VKVADFGVAR-VKAQTG----VMTAETGTYR 450
Query: 214 YMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAE-GHRPFFRAKG 272
+MAPEV +H+ YD K DVFS+ ++L+E+L G+ P P +AA V + G RP K
Sbjct: 451 WMAPEVIEHKPYDHKADVFSYGIVLWELLTGKLPYEYMTPLQAAVGVVQKGLRPTI-PKN 509
Query: 273 FTPELRELTEKCWAADMNQRPSFLDILKRLEKI-KE 307
P+L EL E+ W D QRP F +I+++L++I KE
Sbjct: 510 THPKLAELLERLWEHDSTQRPDFSEIIEQLQEIAKE 545
|
|
| TAIR|locus:2128043 STY17 "serine/threonine/tyrosine kinase 17" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 497 (180.0 bits), Expect = 1.6e-47, P = 1.6e-47
Identities = 112/284 (39%), Positives = 170/284 (59%)
Query: 34 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNL 93
+WEID +L + GS+GE+ + + VAIK + P + + +++F EV +
Sbjct: 284 EWEIDMKQLKIEKK--VACGSYGELFRGTYCSQEVAIKILKPERVNAEM-LREFSQEVYI 340
Query: 94 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARG 152
+ K+RH N+VQF+GA T L ++TE++ G ++ +L K KG + + ALD+++G
Sbjct: 341 MRKVRHKNVVQFIGACTRSPNLCIVTEFMTRGSIYDFLHKHKGVFKIQSLLKVALDVSKG 400
Query: 153 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSY 212
M YLH N IIHRDLK N+L+ + +KV DFG+++ VQ V MT ETG+Y
Sbjct: 401 MNYLHQ--NNIIHRDLKTANLLM--DEHEVVKVADFGVAR---VQTESGV--MTAETGTY 451
Query: 213 RYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAE-GHRPFFRAK 271
R+MAPEV +H+ YD + DVFS+A++L+E+L GE P + P +AA V + G RP K
Sbjct: 452 RWMAPEVIEHKPYDHRADVFSYAIVLWELLTGELPYSYLTPLQAAVGVVQKGLRPKI-PK 510
Query: 272 GFTPELRELTEKCWAADMNQRPSFLDILKRLEK-IKETLPTDHH 314
P+L EL EKCW D RP+F +I++ L + I+E + H
Sbjct: 511 ETHPKLTELLEKCWQQDPALRPNFAEIIEMLNQLIREVGDDERH 554
|
|
| TAIR|locus:2827943 STY8 "serine/threonine/tyrosine kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 494 (179.0 bits), Expect = 3.3e-47, P = 3.3e-47
Identities = 112/277 (40%), Positives = 172/277 (62%)
Query: 34 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNL 93
+WEID ++L + GS+G++ + + VAIK + P ++ + +++F EV +
Sbjct: 278 EWEIDVTQLKIEKK--VASGSYGDLHRGTYCSQEVAIKFLKPDRVNNEM-LREFSQEVFI 334
Query: 94 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARG 152
+ K+RH N+VQFLGA T L ++TE++ G ++ +L K+K A T + ALD+A+G
Sbjct: 335 MRKVRHKNVVQFLGACTRSPTLCIVTEFMARGSIYDFLHKQKCAFKLQTLLKVALDVAKG 394
Query: 153 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSY 212
M+YLH N IIHRDLK N+L+ +KV DFG+++ VQ V MT ETG+Y
Sbjct: 395 MSYLHQ--NNIIHRDLKTANLLMDEHGL--VKVADFGVAR---VQIESGV--MTAETGTY 445
Query: 213 RYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAE-GHRPFFRAK 271
R+MAPEV +H+ Y+ K DVFS+A++L+E+L G+ P A P +AA V + G RP K
Sbjct: 446 RWMAPEVIEHKPYNHKADVFSYAIVLWELLTGDIPYAFLTPLQAAVGVVQKGLRPKIPKK 505
Query: 272 GFTPELRELTEKCWAADMNQRPSFLDILKRLEKI-KE 307
P+++ L E+CW D QRP F +I++ L++I KE
Sbjct: 506 TH-PKVKGLLERCWHQDPEQRPLFEEIIEMLQQIMKE 541
|
|
| TAIR|locus:2061092 AT2G24360 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 474 (171.9 bits), Expect = 4.4e-45, P = 4.4e-45
Identities = 114/290 (39%), Positives = 177/290 (61%)
Query: 31 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRI-LPSLSDDR--LVIQDF 87
N +W ID +L+ + +G+FG++ K + G VAIK + P S ++ + Q F
Sbjct: 119 NYDEWTIDLRKLNMGPA--FAQGAFGKLYKGTYNGEDVAIKILERPENSPEKAQFMEQQF 176
Query: 88 RHEVNLLVKLRHPNIVQFLGAVTERKPLM--LITEYLRGGDLHKYL--KEKGALSPSTAV 143
+ EV++L L+HPNIV+F+GA RKP++ ++TEY +GG + ++L ++ A+ AV
Sbjct: 177 QQEVSMLANLKHPNIVRFIGAC--RKPMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAV 234
Query: 144 NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH-LKVGDFGLSKLIKVQNSHDV 202
ALD+ARGMAY+H N IHRDLK N+L+ SAD +K+ DFG+++ I+VQ
Sbjct: 235 KQALDVARGMAYVHGR-N-FIHRDLKSDNLLI---SADKSIKIADFGVAR-IEVQTEG-- 286
Query: 203 YKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAA-KYVA 261
MT ETG+YR+MAPE+ +HR Y++KVDV+SF ++L+E++ G P N +AA V
Sbjct: 287 --MTPETGTYRWMAPEMIQHRAYNQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVN 344
Query: 262 EGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPT 311
G RP P L ++ +CW A+ RP F++++K LE + + T
Sbjct: 345 RGVRPTV-PNDCLPVLSDIMTRCWDANPEVRPCFVEVVKLLEAAETEIMT 393
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 320 | |||
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-86 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-85 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-80 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-77 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-74 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-72 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-66 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-56 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 6e-53 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 7e-52 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-48 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-48 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-48 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-48 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 4e-48 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 5e-48 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-47 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 6e-46 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-44 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 5e-44 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 5e-44 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 7e-44 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 9e-44 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-43 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-43 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-42 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-42 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-41 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-41 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-41 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-40 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-40 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-40 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-39 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-39 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-39 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 8e-39 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-38 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-38 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 4e-38 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-38 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-37 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-37 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-37 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-37 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 5e-37 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-35 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-35 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-35 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-35 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-35 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-35 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 7e-35 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 8e-35 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-34 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-34 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-34 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-34 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 5e-34 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 5e-34 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 6e-34 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 8e-34 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-33 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-33 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 6e-33 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 7e-33 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-32 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-32 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-32 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 5e-32 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 5e-32 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 5e-32 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 5e-32 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 6e-32 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 6e-32 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 8e-32 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 8e-32 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 8e-32 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-31 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-31 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-31 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-31 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 5e-31 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 5e-31 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 7e-31 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 7e-31 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 8e-31 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 9e-31 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-30 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-30 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-30 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-30 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-30 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 6e-30 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 7e-30 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 9e-30 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-29 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-29 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-29 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-29 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-29 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-29 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-29 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-29 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-29 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-29 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-29 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 5e-29 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 5e-29 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 6e-29 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 9e-29 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-28 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-28 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-27 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-27 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-27 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-27 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-27 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-27 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-27 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-27 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 5e-27 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-27 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 6e-27 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-26 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-26 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-26 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-26 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-26 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-26 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-26 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-26 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-26 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-26 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-26 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-26 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-26 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 4e-26 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 5e-26 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 5e-26 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 6e-26 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 7e-26 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 8e-26 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 8e-26 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-25 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-25 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-25 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-25 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-25 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-25 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-25 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-25 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-25 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 4e-25 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 5e-25 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 5e-25 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 6e-25 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 7e-25 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-24 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-24 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 4e-24 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 7e-24 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 8e-24 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 9e-24 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-23 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-23 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-23 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-23 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-23 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-23 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-23 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 4e-23 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 7e-23 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 8e-23 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-22 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-22 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-22 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-22 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-22 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-22 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-22 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-22 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-21 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-21 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-21 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-21 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-21 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 5e-21 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 5e-21 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 6e-21 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 7e-21 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-20 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-20 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-20 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-20 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-20 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-20 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-20 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-20 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-20 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-20 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 4e-20 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 5e-20 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 5e-20 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 6e-20 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 6e-20 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-19 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-19 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-19 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-19 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-19 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-19 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-19 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-19 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-19 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 6e-19 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-18 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-18 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-18 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 4e-18 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-18 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 6e-18 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 7e-18 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 8e-18 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 9e-18 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-17 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-17 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-17 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-17 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-17 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-17 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-17 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-17 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-17 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-17 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-17 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-17 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 7e-17 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 8e-17 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-16 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-16 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-16 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-16 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-16 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-16 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-16 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-16 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-16 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-16 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 4e-16 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 4e-16 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 5e-16 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 5e-16 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 6e-16 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 6e-16 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 8e-16 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 9e-16 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-15 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-15 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-15 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-15 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-15 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-15 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-15 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-15 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-15 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-15 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 6e-15 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 9e-15 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-14 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-14 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 5e-14 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 6e-14 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-13 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-13 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-13 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 4e-13 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 6e-13 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 7e-13 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-12 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-11 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-11 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-11 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-11 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-11 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-11 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 5e-11 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 9e-11 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-10 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-10 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-10 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 5e-10 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 6e-10 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 9e-10 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-09 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 5e-09 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 7e-09 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 9e-09 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-08 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 7e-08 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-07 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 2e-07 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 6e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-06 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 2e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-06 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 9e-06 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 1e-05 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-05 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 2e-05 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 7e-05 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 1e-04 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-04 | |
| PRK09605 | 535 | PRK09605, PRK09605, bifunctional UGMP family prote | 0.001 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 259 bits (663), Expect = 4e-86
Identities = 97/262 (37%), Positives = 146/262 (55%), Gaps = 18/262 (6%)
Query: 49 IIGKGSFGEILKAYWRGTP------VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 102
+G+G+FGE+ K +G VA+K + S+ I++F E ++ KL HPN+
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQ--QIEEFLREARIMRKLDHPNV 63
Query: 103 VQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPN 161
V+ LG TE +PL ++ EY+ GGDL YL++ + LS S ++FAL IARGM YL ++
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESKN- 122
Query: 162 VIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFK 221
IHRDL RN L+ +K+ DFGLS+ + D Y+ G R+MAPE K
Sbjct: 123 -FIHRDLAARNCLV--GENLVVKISDFGLSRDLY---DDDYYRKRGGKLPIRWMAPESLK 176
Query: 222 HRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELREL 280
K+ K DV+SF ++L+E+ GE P E +Y+ G+R + PEL +L
Sbjct: 177 EGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRL-PQPPNCPPELYDL 235
Query: 281 TEKCWAADMNQRPSFLDILKRL 302
+CWA D RP+F ++++ L
Sbjct: 236 MLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 257 bits (659), Expect = 2e-85
Identities = 100/263 (38%), Positives = 148/263 (56%), Gaps = 19/263 (7%)
Query: 49 IIGKGSFGEILKAYWRG------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 102
+G+G+FGE+ K +G VA+K + S+ I++F E ++ KL HPNI
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQ--QIEEFLREARIMRKLDHPNI 63
Query: 103 VQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEP 160
V+ LG TE +PLM++ EY+ GGDL YL++ LS S ++FAL IARGM YL ++
Sbjct: 64 VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN 123
Query: 161 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF 220
IHRDL RN L+ +K+ DFGLS+ + D YK+ G R+MAPE
Sbjct: 124 --FIHRDLAARNCLV--GENLVVKISDFGLSRDLY---DDDYYKVKGGKLPIRWMAPESL 176
Query: 221 KHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRE 279
K K+ K DV+SF ++L+E+ GE P E +Y+ +G+R + PEL +
Sbjct: 177 KEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRL-PKPPNCPPELYK 235
Query: 280 LTEKCWAADMNQRPSFLDILKRL 302
L +CWA D RP+F ++++ L
Sbjct: 236 LMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 244 bits (625), Expect = 2e-80
Identities = 93/265 (35%), Positives = 147/265 (55%), Gaps = 25/265 (9%)
Query: 50 IGKGSFGEILKAYWRG------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 103
+G+G+FGE+ K +G T VA+K + S++ ++F E +++ KL HPNIV
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEE--EREEFLEEASIMKKLSHPNIV 64
Query: 104 QFLGAVTERKPLMLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNV 162
+ LG T+ +PL ++TEY+ GGDL +L++ G L+ + AL IA+GM YL ++
Sbjct: 65 RLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESKN-- 122
Query: 163 IIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET-GSYRYMAPEVFK 221
+HRDL RN L+ + +K+ DFGLS+ I D Y+ G ++MAPE K
Sbjct: 123 FVHRDLAARNCLV--TENLVVKISDFGLSRDIY---EDDYYRKRGGGKLPIKWMAPESLK 177
Query: 222 HRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHR---PFFRAKGFTPEL 277
K+ K DV+SF ++L+E+ GE P E + + +G+R P + EL
Sbjct: 178 DGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPRP----ENCPDEL 233
Query: 278 RELTEKCWAADMNQRPSFLDILKRL 302
EL +CWA D RP+F ++++ L
Sbjct: 234 YELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 237 bits (607), Expect = 1e-77
Identities = 94/271 (34%), Positives = 144/271 (53%), Gaps = 26/271 (9%)
Query: 49 IIGKGSFGEILKAYWRG-----TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 103
+G+G+FGE+ K +G T VA+K + S++ +DF E ++ KL HPN+V
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVV 59
Query: 104 QFLGAVTERKPLMLITEYLRGGDLHKYLKE---------KGALSPSTAVNFALDIARGMA 154
+ LG TE +PL L+ EY+ GGDL YL++ K LS ++FA+ IA+GM
Sbjct: 60 RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119
Query: 155 YLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSY-R 213
YL ++ +HRDL RN L+ +K+ DFGLS+ + D Y+ R
Sbjct: 120 YLASKK--FVHRDLAARNCLV--GEDLVVKISDFGLSRDV---YDDDYYRKKTGGKLPIR 172
Query: 214 YMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKG 272
+MAPE K + K DV+SF ++L+E+ G P E +Y+ +G+R + +
Sbjct: 173 WMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRL-PKPEY 231
Query: 273 FTPELRELTEKCWAADMNQRPSFLDILKRLE 303
EL EL CW D RP+F ++++RLE
Sbjct: 232 CPDELYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 228 bits (584), Expect = 4e-74
Identities = 88/256 (34%), Positives = 132/256 (51%), Gaps = 15/256 (5%)
Query: 49 IIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 106
+G+GSFG++ A + T VAIK I + + E+ +L KL+HPNIV+
Sbjct: 6 KLGEGSFGKVYLARDKKTGKLVAIKVI--KKKKIKKDRERILREIKILKKLKHPNIVRLY 63
Query: 107 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 166
+ L L+ EY GGDL LK++G LS A + I + YLH+ I+HR
Sbjct: 64 DVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHS--KGIVHR 121
Query: 167 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYD 226
DLKP N+LL H+K+ DFGL++ + K+T G+ YMAPEV + Y
Sbjct: 122 DLKPENILLDEDG--HVKLADFGLARQL-----DPGEKLTTFVGTPEYMAPEVLLGKGYG 174
Query: 227 KKVDVFSFAMILYEMLEGEPPL-ANYEPYEAAKYVAEGHRPF-FRAKGFTPELRELTEKC 284
K VD++S +ILYE+L G+PP + + E K + + PF +PE ++L K
Sbjct: 175 KAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKL 234
Query: 285 WAADMNQRPSFLDILK 300
D +R + + L+
Sbjct: 235 LVKDPEKRLTAEEALQ 250
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 223 bits (570), Expect = 4e-72
Identities = 95/260 (36%), Positives = 138/260 (53%), Gaps = 17/260 (6%)
Query: 49 IIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 106
+G GSFG + KA +GT VA+K + + R E+ +L +L HPNIV+ +
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARR-EIRILRRLSHPNIVRLI 64
Query: 107 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 166
A ++ L L+ EY GGDL YL G LS A AL I RG+ YLH+ IIHR
Sbjct: 65 DAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNG--IIHR 122
Query: 167 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV-FKHRKY 225
DLKP N+LL + +K+ DFGL+K + +S +T G+ YMAPEV Y
Sbjct: 123 DLKPENILLDEN--GVVKIADFGLAKKLLKSSSS----LTTFVGTPWYMAPEVLLGGNGY 176
Query: 226 DKKVDVFSFAMILYEMLEGEPPLAN---YEPYEAAKYVAEGHRPFFRAKGFT--PELREL 280
KVDV+S +ILYE+L G+PP + + + + + F K + E ++L
Sbjct: 177 GPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDL 236
Query: 281 TEKCWAADMNQRPSFLDILK 300
+KC D ++RP+ +IL+
Sbjct: 237 IKKCLNKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 206 bits (527), Expect = 4e-66
Identities = 88/257 (34%), Positives = 122/257 (47%), Gaps = 46/257 (17%)
Query: 50 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 107
+G+G FG + A + G VAIK I S L ++ E+ +L KL HPNIV+ G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLL--EELLREIEILKKLNHPNIVKLYG 58
Query: 108 AVTERKPLMLITEYLRGGDLHKYLKEKGA-LSPSTAVNFALDIARGMAYLHNEPNVIIHR 166
+ L L+ EY GG L LKE LS + L I G+ YLH+ IIHR
Sbjct: 59 VFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNG--IIHR 116
Query: 167 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR-KY 225
DLKP N+LL + + +K+ DFGLSKL+ + D + G+ YMAPEV + Y
Sbjct: 117 DLKPENILLDSDN-GKVKLADFGLSKLL----TSDKSLLKTIVGTPAYMAPEVLLGKGYY 171
Query: 226 DKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCW 285
+K D++S +ILYE+ PEL++L K
Sbjct: 172 SEKSDIWSLGVILYEL---------------------------------PELKDLIRKML 198
Query: 286 AADMNQRPSFLDILKRL 302
D +RPS +IL+ L
Sbjct: 199 QKDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 182 bits (464), Expect = 3e-56
Identities = 96/277 (34%), Positives = 148/277 (53%), Gaps = 27/277 (9%)
Query: 35 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLL 94
W I+ EL ++ IGKG FG+++ +RG VA+K L DD Q F E +++
Sbjct: 1 WAINSKELKLGAT--IGKGEFGDVMLGDYRGQKVAVK----CLKDDSTAAQAFLAEASVM 54
Query: 95 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARG 152
LRHPN+VQ LG V + PL ++TEY+ G L YL+ +G ++ + + FALD+ G
Sbjct: 55 TTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEG 114
Query: 153 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSY 212
M YL E +HRDL RNVL+ S KV DFGL+K + D K+
Sbjct: 115 MEYL--EEKNFVHRDLAARNVLV--SEDLVAKVSDFGLAK--EASQGQDSGKL-----PV 163
Query: 213 RYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHR---PFF 268
++ APE + +K+ K DV+SF ++L+E+ G P + +V +G+R P
Sbjct: 164 KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAP-- 221
Query: 269 RAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKI 305
+G PE+ ++ + CW D +RP+F + ++L I
Sbjct: 222 --EGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 174 bits (443), Expect = 6e-53
Identities = 77/267 (28%), Positives = 132/267 (49%), Gaps = 20/267 (7%)
Query: 43 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 100
+++ ++G+GSFG + A + T +A+K + D ++ E+ +L L+HP
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSV-ELSGDSEEELEALEREIRILSSLQHP 59
Query: 101 NIVQFLGAVTERKPLML--ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHN 158
NIV++ G+ + + L EY+ GG L LK+ G L + I G+AYLH+
Sbjct: 60 NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS 119
Query: 159 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET---GSYRYM 215
N I+HRD+K N+L+ S +K+ DFG +K + D+ G G+ +M
Sbjct: 120 --NGIVHRDIKGANILV--DSDGVVKLADFGCAKRL-----GDIETGEGTGSVRGTPYWM 170
Query: 216 APEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAA--KYVAEGHRPFFRAKGF 273
APEV + +Y + D++S + EM G+PP + AA K + G P +
Sbjct: 171 APEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEI-PEHL 229
Query: 274 TPELRELTEKCWAADMNQRPSFLDILK 300
+ E ++ KC D +RP+ ++L+
Sbjct: 230 SEEAKDFLRKCLRRDPKKRPTADELLQ 256
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 171 bits (435), Expect = 7e-52
Identities = 95/276 (34%), Positives = 142/276 (51%), Gaps = 20/276 (7%)
Query: 35 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGT-PVAIKRILPSLSDDRLVIQDFRHEVNL 93
WE E F+ +G G FGE+ + W+ VAIK + SDD L QDF+ EV
Sbjct: 1 WERPREE--FTLERKLGSGYFGEVWEGLWKNRVRVAIKILK---SDDLLKQQDFQKEVQA 55
Query: 94 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK--EKGALSPSTAVNFALDIAR 151
L +LRH +++ + +P+ +ITE + G L +L+ E L ++ ++ A +A
Sbjct: 56 LKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAE 115
Query: 152 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGS 211
GMAYL E IHRDL RN+L+ KV DFGL++LIK DVY + +
Sbjct: 116 GMAYL--EEQNSIHRDLAARNILVGEDLV--CKVADFGLARLIK----EDVYLSSDKKIP 167
Query: 212 YRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHR-PFFR 269
Y++ APE H + K DV+SF ++LYEM G+ P +E + G+R P
Sbjct: 168 YKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMP--C 225
Query: 270 AKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKI 305
E+ ++ +CWAA+ RPSF + + L+ I
Sbjct: 226 PAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 162 bits (413), Expect = 1e-48
Identities = 84/256 (32%), Positives = 135/256 (52%), Gaps = 18/256 (7%)
Query: 50 IGKGSFGEILKAYWR--GTPVAIKRI-LPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 106
IGKG FGE+ KA + G VAIK I L S +I E+ +L K +HPNIV++
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIIN----EIQILKKCKHPNIVKYY 63
Query: 107 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNF-ALDIARGMAYLHNEPNVIIH 165
G+ ++ L ++ E+ GG L LK + + + ++ +G+ YLH+ N IIH
Sbjct: 64 GSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHS--NGIIH 121
Query: 166 RDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKY 225
RD+K N+LL S +K+ DFGLS ++ ++ M G + +MAPEV + Y
Sbjct: 122 RDIKAANILL-TSDG-EVKLIDFGLSA--QLSDTKARNTMVG---TPYWMAPEVINGKPY 174
Query: 226 DKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR-AKGFTPELRELTEKC 284
D K D++S + E+ EG+PP + P +A +A P R + ++ E ++ +KC
Sbjct: 175 DYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKC 234
Query: 285 WAADMNQRPSFLDILK 300
+ +RP+ +LK
Sbjct: 235 LQKNPEKRPTAEQLLK 250
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 161 bits (410), Expect = 3e-48
Identities = 94/271 (34%), Positives = 145/271 (53%), Gaps = 21/271 (7%)
Query: 37 IDPSELDFSSSAIIGKGSFGEILKAYWRGT-PVAIKRILP-SLSDDRLVIQDFRHEVNLL 94
I+PSEL F +G G FG + WR VAIK I ++S++ DF E ++
Sbjct: 1 INPSELTFMKE--LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEE-----DFIEEAKVM 53
Query: 95 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGM 153
+KL HP +VQ G T++KPL ++TE++ G L YL+++ G LS ++ D+ GM
Sbjct: 54 MKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGM 113
Query: 154 AYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY-KMTGETGSY 212
YL E N IHRDL RN L+ SS +KV DFG+++ + D Y +G
Sbjct: 114 EYL--ERNSFIHRDLAARNCLV--SSTGVVKVSDFGMTRYV----LDDEYTSSSGAKFPV 165
Query: 213 RYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKYVAEGHRPFFRAK 271
++ PEVF KY K DV+SF ++++E+ EG+ P YE + ++ G R +R K
Sbjct: 166 KWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFR-LYRPK 224
Query: 272 GFTPELRELTEKCWAADMNQRPSFLDILKRL 302
+ + E+ CW RP+F ++L+ +
Sbjct: 225 LASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 162 bits (411), Expect = 3e-48
Identities = 96/273 (35%), Positives = 145/273 (53%), Gaps = 25/273 (9%)
Query: 37 IDPSELDFSSSAIIGKGSFGEILKAYWRGT-PVAIKRILP-SLSDDRLVIQDFRHEVNLL 94
IDPSEL F +G G FG + WRG VAIK I ++S+D DF E ++
Sbjct: 1 IDPSELTFLKE--LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSED-----DFIEEAKVM 53
Query: 95 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGM 153
+KL HPN+VQ G T+++P+ ++TEY+ G L YL+E KG L ++ D+ M
Sbjct: 54 MKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAM 113
Query: 154 AYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGS-- 211
YL E N IHRDL RN L+ + +KV DFGL++ + D Y T G+
Sbjct: 114 EYL--ESNGFIHRDLAARNCLV--GEDNVVKVSDFGLARYV----LDDQY--TSSQGTKF 163
Query: 212 -YRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKYVAEGHRPFFR 269
++ PEVF + ++ K DV+SF ++++E+ EG+ P + E + V+ G+R +R
Sbjct: 164 PVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYR-LYR 222
Query: 270 AKGFTPELRELTEKCWAADMNQRPSFLDILKRL 302
K E+ + CW RP+F +L +L
Sbjct: 223 PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 162 bits (410), Expect = 3e-48
Identities = 95/272 (34%), Positives = 141/272 (51%), Gaps = 23/272 (8%)
Query: 37 IDPSELDFSSSAIIGKGSFGEILKAYWRG-TPVAIKRILPSLSDDRLVIQDFRHEVNLLV 95
I PSEL IG G FG + YW VAIK I + +DF E +++
Sbjct: 1 IHPSELTLVQE--IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSE----EDFIEEAQVMM 54
Query: 96 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK-EKGALSPSTAVNFALDIARGMA 154
KL HP +VQ G TER P+ L+ E++ G L YL+ ++G S T + LD+ GMA
Sbjct: 55 KLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMA 114
Query: 155 YLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGS--- 211
YL E + +IHRDL RN L+ + +KV DFG+++ + D Y T TG+
Sbjct: 115 YL--ESSNVIHRDLAARNCLVGENQV--VKVSDFGMTRFV----LDDQY--TSSTGTKFP 164
Query: 212 YRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKYVAEGHRPFFRA 270
++ +PEVF KY K DV+SF ++++E+ EG+ P N E + + G R ++
Sbjct: 165 VKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFR-LYKP 223
Query: 271 KGFTPELRELTEKCWAADMNQRPSFLDILKRL 302
+ + + EL + CW RPSF +L +L
Sbjct: 224 RLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 161 bits (410), Expect = 4e-48
Identities = 102/284 (35%), Positives = 145/284 (51%), Gaps = 36/284 (12%)
Query: 37 IDPSELDFSSSAIIGKGSFGEILKAYWRGT-----PVAIKRILPSLSD-DRLVIQDFRHE 90
IDPS + +IG G FGE+ + + VAIK + SD RL DF E
Sbjct: 1 IDPS--YVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRL---DFLTE 55
Query: 91 VNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDI 149
+++ + HPNI++ G VT+ +P+M+ITEY+ G L K+L+E G + V I
Sbjct: 56 ASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGI 115
Query: 150 ARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHL--KVGDFGLSKLIKVQNSHDVYKMTG 207
A GM YL V HRDL RN+ LVNS +L KV DFGLS+ + ++S Y G
Sbjct: 116 ASGMKYLSEMNYV--HRDLAARNI-LVNS---NLVCKVSDFGLSRRL--EDSEATYTTKG 167
Query: 208 ETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYE-MLEGEPPLANYEPYEAAKYVAEGHR- 265
R+ APE +RK+ DV+SF ++++E M GE P + + K V +G+R
Sbjct: 168 GKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRL 227
Query: 266 PFFRAKGFTPE-----LRELTEKCWAADMNQRPSFLDILKRLEK 304
P P L +L CW D N+RP+F I+ L+K
Sbjct: 228 P-------PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDK 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 161 bits (410), Expect = 5e-48
Identities = 79/261 (30%), Positives = 140/261 (53%), Gaps = 22/261 (8%)
Query: 50 IGKGSFGEILKAYWR----GTPVAIKRI-LPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQ 104
IGKGSFG++ R G +K I L ++S+ +D +EV +L KL HPNI++
Sbjct: 8 IGKGSFGKVYLV--RRKSDGKLYVLKEIDLSNMSEK--EREDALNEVKILKKLNHPNIIK 63
Query: 105 FLGAVTERKPLMLITEYLRGGDLHKYLKEKGA----LSPSTAVNFALDIARGMAYLHNEP 160
+ + E+ L ++ EY GGDL + +K++ +++ + + + YLH+
Sbjct: 64 YYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS-- 121
Query: 161 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF 220
I+HRD+KP+N+ L +S +K+GDFG+SK+ + ++ D+ K G+ Y++PE+
Sbjct: 122 RKILHRDIKPQNIFL--TSNGLVKLGDFGISKV--LSSTVDLAKTV--VGTPYYLSPELC 175
Query: 221 KHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELREL 280
+++ Y+ K D++S +LYE+ + P E A + +G P ++ ++ ELR L
Sbjct: 176 QNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQ-YSSELRNL 234
Query: 281 TEKCWAADMNQRPSFLDILKR 301
D +RPS IL+
Sbjct: 235 VSSLLQKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 3e-47
Identities = 94/279 (33%), Positives = 136/279 (48%), Gaps = 30/279 (10%)
Query: 35 WEIDPSELDFSSSAIIGKGSFGEILKAYWRG-TPVAIKRILPSLSDDRLVIQDFRHEVNL 93
WEI L +G G FGE+ W G T VA+K + P + F E +
Sbjct: 1 WEIPRESLKLERK--LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS----PEAFLQEAQI 54
Query: 94 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK--EKGALSPSTAVNFALDIAR 151
+ KLRH +VQ +E +P+ ++TEY+ G L +LK E L V+ A IA
Sbjct: 55 MKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAE 114
Query: 152 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHL--KVGDFGLSKLIKVQNSHDVYKMTGET 209
GMAYL E IHRDL RN+L+ ++L K+ DFGL++LI+ D Y T
Sbjct: 115 GMAYL--ESRNYIHRDLAARNILV----GENLVCKIADFGLARLIED----DEY--TARE 162
Query: 210 GS---YRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKYVAEGHR 265
G+ ++ APE + ++ K DV+SF ++L E++ G P E + V G+R
Sbjct: 163 GAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYR 222
Query: 266 -PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLE 303
P R EL +L +CW D +RP+F + LE
Sbjct: 223 MP--RPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLE 259
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 156 bits (395), Expect = 6e-46
Identities = 78/256 (30%), Positives = 131/256 (51%), Gaps = 9/256 (3%)
Query: 49 IIGKGSFGEILKAYW--RGTPVAIKRI--LPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQ 104
++G+G+FG + Y G +A+K++ P + + + E+ LL L+H IVQ
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 105 FLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVII 164
+ G + + + L + EY+ GG + LK GAL+ + + I G+ YLH+ N+I+
Sbjct: 69 YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHS--NMIV 126
Query: 165 HRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRK 224
HRD+K N+L SA ++K+GDFG SK ++ S M TG+ +M+PEV
Sbjct: 127 HRDIKGANIL--RDSAGNVKLGDFGASKRLQTICSSGTG-MKSVTGTPYWMSPEVISGEG 183
Query: 225 YDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKC 284
Y +K DV+S + EML +PP A +E A +A +P+ R +
Sbjct: 184 YGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRRT 243
Query: 285 WAADMNQRPSFLDILK 300
+ + +RPS ++L+
Sbjct: 244 FVENAKKRPSAEELLR 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 152 bits (385), Expect = 1e-44
Identities = 79/260 (30%), Positives = 132/260 (50%), Gaps = 16/260 (6%)
Query: 50 IGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGA 108
IGKG+FG++ K + T VA+K +L D + + F E +L + HPNIV+ +G
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPD--LKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 109 VTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 167
+++P+ ++ E + GG L +L K+K L+ + +LD A GM YL E IHRD
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYL--ESKNCIHRD 118
Query: 168 LKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGS--YRYMAPEVFKHRKY 225
L RN L+ + LK+ DFG+S+ + +Y ++ ++ APE + +Y
Sbjct: 119 LAARNCLV--GENNVLKISDFGMSR----EEEGGIYTVSDGLKQIPIKWTAPEALNYGRY 172
Query: 226 DKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKC 284
+ DV+S+ ++L+E G+ P + + + G+R + E+ L +C
Sbjct: 173 TSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYR-MPAPQLCPEEIYRLMLQC 231
Query: 285 WAADMNQRPSFLDILKRLEK 304
WA D RPSF +I L+
Sbjct: 232 WAYDPENRPSFSEIYNELQI 251
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 151 bits (382), Expect = 5e-44
Identities = 96/277 (34%), Positives = 147/277 (53%), Gaps = 17/277 (6%)
Query: 36 EIDPSELDFSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFRHE 90
EI PS + + +IG G FGE+ + + VAIK + P ++ + QDF E
Sbjct: 1 EIHPSHI--TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQR--QDFLSE 56
Query: 91 VNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDI 149
+++ + H NI++ G VT+ KP M+ITEY+ G L KYL++ G S V I
Sbjct: 57 ASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGI 116
Query: 150 ARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET 209
A GM YL + V HRDL RN+ LVNS+ + KV DFGLS++++ + Y +G
Sbjct: 117 AAGMKYLSDMNYV--HRDLAARNI-LVNSNLE-CKVSDFGLSRVLE-DDPEGTYTTSGGK 171
Query: 210 GSYRYMAPEVFKHRKYDKKVDVFSFAMILYE-MLEGEPPLANYEPYEAAKYVAEGHRPFF 268
R+ APE +RK+ DV+SF ++++E M GE P + +E K + +G R
Sbjct: 172 IPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFR-LP 230
Query: 269 RAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKI 305
+ +L +CW D +RP F+DI+ L+K+
Sbjct: 231 APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 150 bits (382), Expect = 5e-44
Identities = 80/267 (29%), Positives = 127/267 (47%), Gaps = 21/267 (7%)
Query: 50 IGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQ--DFRHEVNLLVKLRHPNI 102
+G G+FG ++K + VA+K +L + + +F E +++ +L HP I
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVK----TLKQEHIAAGKKEFLREASVMAQLDHPCI 58
Query: 103 VQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNV 162
V+ +G V + +PLML+ E G L KYLK++ + S A +A GMAYL E
Sbjct: 59 VRLIG-VCKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYL--ESKH 115
Query: 163 IIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKM-TGETGSYRYMAPEVFK 221
+HRDL RNVLLVN K+ DFG+S+ + + D Y+ T ++ APE
Sbjct: 116 FVHRDLAARNVLLVNR--HQAKISDFGMSRALGAGS--DYYRATTAGRWPLKWYAPECIN 171
Query: 222 HRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELREL 280
+ K+ K DV+S+ + L+E G P + E + G R R + E+ +
Sbjct: 172 YGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGER-LPRPEECPQEIYSI 230
Query: 281 TEKCWAADMNQRPSFLDILKRLEKIKE 307
CW RP+F ++ + E
Sbjct: 231 MLSCWKYRPEDRPTFSELESTFRRDPE 257
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 151 bits (384), Expect = 7e-44
Identities = 82/267 (30%), Positives = 135/267 (50%), Gaps = 17/267 (6%)
Query: 38 DPSELDFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLV 95
DP EL + + IG+G+ GE+ KA R T VAIK++ + L+I E+ ++
Sbjct: 16 DPREL-YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIIN----EILIMK 70
Query: 96 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMA 154
+HPNIV + + L ++ EY+ GG L + + ++ ++ +G+
Sbjct: 71 DCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLE 130
Query: 155 YLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRY 214
YLH+ +IHRD+K N+LL S +K+ DFG + Q + + K G+ +
Sbjct: 131 YLHS--QNVIHRDIKSDNILL--SKDGSVKLADFGFA----AQLTKEKSKRNSVVGTPYW 182
Query: 215 MAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA-EGHRPFFRAKGF 273
MAPEV K + Y KVD++S ++ EM EGEPP P A + +G P + +
Sbjct: 183 MAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKW 242
Query: 274 TPELRELTEKCWAADMNQRPSFLDILK 300
+PE ++ KC D +RPS ++L+
Sbjct: 243 SPEFKDFLNKCLVKDPEKRPSAEELLQ 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 150 bits (382), Expect = 9e-44
Identities = 85/290 (29%), Positives = 143/290 (49%), Gaps = 35/290 (12%)
Query: 35 WEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLS-DDRLVIQD 86
WE+ ++ +G+GSFG + + +G T VAIK + + S +R+ +
Sbjct: 1 WELPREKITLIRE--LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERI---E 55
Query: 87 FRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK--------GALS 138
F +E +++ + ++V+ LG V+ +P +++ E + GDL YL+ + G
Sbjct: 56 FLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGP 115
Query: 139 PST--AVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 196
P+ + A +IA GMAYL +HRDL RN ++ + +K+GDFG+++ I
Sbjct: 116 PTLQKFIQMAAEIADGMAYLAA--KKFVHRDLAARNCMV--AEDLTVKIGDFGMTRDI-- 169
Query: 197 QNSHDVYKMTGETG-SYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPY 254
D Y+ G+ R+MAPE K + K DV+SF ++L+EM E P
Sbjct: 170 -YETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE 228
Query: 255 EAAKYVAEG-HRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLE 303
E K+V +G H + +L EL CW + RP+FL+I+ L+
Sbjct: 229 EVLKFVIDGGHLD--LPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 4e-43
Identities = 84/261 (32%), Positives = 130/261 (49%), Gaps = 24/261 (9%)
Query: 50 IGKGSFGEILKAYW-----RGTPVAIKRILPSLSDDRL--VIQDFRHEVNLLVKLRHPNI 102
+G GSFG + + W + PVA+K L D+L ++ DF E ++ L H N+
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVK----CLKSDKLSDIMDDFLKEAAIMHSLDHENL 58
Query: 103 VQFLGAVTERKPLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIARGMAYLHNEP 160
++ G V PLM++TE G L L++ G ST ++A+ IA GM YL ++
Sbjct: 59 IRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR 117
Query: 161 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETG-SYRYMAPEV 219
IHRDL RN+LL +S D +K+GDFGL + + + D Y M + + APE
Sbjct: 118 --FIHRDLAARNILL--ASDDKVKIGDFGLMRALP--QNEDHYVMEEHLKVPFAWCAPES 171
Query: 220 FKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYV-AEGHRPFFRAKGFTPEL 277
+ R + DV+ F + L+EM GE P A + K + EG R R + ++
Sbjct: 172 LRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGER-LERPEACPQDI 230
Query: 278 RELTEKCWAADMNQRPSFLDI 298
+ +CWA + RP+F +
Sbjct: 231 YNVMLQCWAHNPADRPTFAAL 251
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 4e-43
Identities = 92/275 (33%), Positives = 145/275 (52%), Gaps = 23/275 (8%)
Query: 35 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLL 94
W ++ EL + IGKG FG+++ +RG VA+K I + Q F E +++
Sbjct: 1 WALNMKELKLLQT--IGKGEFGDVMLGDYRGNKVAVKCI-----KNDATAQAFLAEASVM 53
Query: 95 VKLRHPNIVQFLGAVTERK-PLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIAR 151
+LRH N+VQ LG + E K L ++TEY+ G L YL+ +G L + F+LD+
Sbjct: 54 TQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 113
Query: 152 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGS 211
M YL E N +HRDL RNVL+ S + KV DFGL+K + ++ D K+
Sbjct: 114 AMEYL--EANNFVHRDLAARNVLV--SEDNVAKVSDFGLTK--EASSTQDTGKL-----P 162
Query: 212 YRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRA 270
++ APE + +K+ K DV+SF ++L+E+ G P + V +G++
Sbjct: 163 VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK-MDAP 221
Query: 271 KGFTPELRELTEKCWAADMNQRPSFLDILKRLEKI 305
G P + ++ ++CW D RPSFL + ++LE I
Sbjct: 222 DGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 147 bits (374), Expect = 1e-42
Identities = 85/254 (33%), Positives = 128/254 (50%), Gaps = 15/254 (5%)
Query: 50 IGKGSFGEILKAYWRGT--PVAIKRI-LPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 106
IGKGSFGE+ KA + T VAIK I L D+ I+D + E+ L + R P I ++
Sbjct: 9 IGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDE---IEDIQQEIQFLSQCRSPYITKYY 65
Query: 107 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 166
G+ + L +I EY GG LK G L + ++ G+ YLH E IHR
Sbjct: 66 GSFLKGSKLWIIMEYCGGGSCLDLLKP-GKLDETYIAFILREVLLGLEYLHEEGK--IHR 122
Query: 167 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYD 226
D+K N+LL + D +K+ DFG+S Q + + K G+ +MAPEV K YD
Sbjct: 123 DIKAANILL-SEEGD-VKLADFGVSG----QLTSTMSKRNTFVGTPFWMAPEVIKQSGYD 176
Query: 227 KKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWA 286
+K D++S + E+ +GEPPL++ P + + + P F+ ++ C
Sbjct: 177 EKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCLN 236
Query: 287 ADMNQRPSFLDILK 300
D +RPS ++LK
Sbjct: 237 KDPKERPSAKELLK 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 3e-42
Identities = 92/277 (33%), Positives = 142/277 (51%), Gaps = 26/277 (9%)
Query: 35 WEIDPSELDFSSSAIIGKGSFGEILKAYWRG-TPVAIKRILPSLSDDRLVIQDFRHEVNL 93
WEID + + +G G FGE+ + W TPVA+K + P D +DF E +
Sbjct: 1 WEIDRTSIQLLRK--LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD----PKDFLAEAQI 54
Query: 94 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK--EKGALSPSTAVNFALDIAR 151
+ KLRHP ++Q T +P+ ++TE ++ G L +YL+ AL ++ A +A
Sbjct: 55 MKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVAS 114
Query: 152 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKM-TGETG 210
GMAYL E IHRDL RNVL+ ++ KV DFGL+++IK D+Y+ G
Sbjct: 115 GMAYL--EAQNYIHRDLAARNVLVGENNI--CKVADFGLARVIK----EDIYEAREGAKF 166
Query: 211 SYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHR---P 266
++ APE + ++ K DV+SF ++L E++ G P E + V +G+R P
Sbjct: 167 PIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCP 226
Query: 267 FFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLE 303
G EL ++ CW D + RP+F + +LE
Sbjct: 227 ----PGCPKELYDIMLDCWKEDPDDRPTFETLQWKLE 259
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 1e-41
Identities = 76/265 (28%), Positives = 126/265 (47%), Gaps = 18/265 (6%)
Query: 39 PSELDFSSSAIIGKGSFGEILKAYWR------GTPVAIKRILPSLSDDRLVIQDFRHEVN 92
E + ++G G+FG + K W PVAIK + ++ E
Sbjct: 4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREE--TSPKANKEILDEAY 61
Query: 93 LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIAR 151
++ + HP++V+ LG + + LIT+ + G L Y++ K + +N+ + IA+
Sbjct: 62 VMASVDHPHVVRLLG-ICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAK 120
Query: 152 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGS 211
GM+YL E ++HRDL RNVL+ + H+K+ DFGL+KL+ V Y G
Sbjct: 121 GMSYL--EEKRLVHRDLAARNVLV--KTPQHVKITDFGLAKLLDVDEKE--YHAEGGKVP 174
Query: 212 YRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRA 270
++MA E HR Y K DV+S+ + ++E++ G P E + +G R +
Sbjct: 175 IKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGER-LPQP 233
Query: 271 KGFTPELRELTEKCWAADMNQRPSF 295
T ++ + KCW D RP+F
Sbjct: 234 PICTIDVYMVLVKCWMIDAESRPTF 258
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 2e-41
Identities = 79/252 (31%), Positives = 130/252 (51%), Gaps = 20/252 (7%)
Query: 49 IIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 106
+IG+G+FG + K G VAIK+I ++ E++LL L+HPNIV+++
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLE-KIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 107 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 166
G++ L +I EY G L + +K+ G S + + +G+AYLH + +IHR
Sbjct: 66 GSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG--VIHR 123
Query: 167 DLKPRNVLLVNSSADHLKVGDFGLS-KLIKV-QNSHDVYKMTGETGSYRYMAPEVFKHRK 224
D+K N+L + +K+ DFG++ KL V ++ V G+ +MAPEV +
Sbjct: 124 DIKAANILT--TKDGVVKLADFGVATKLNDVSKDDASV------VGTPYWMAPEVIEMSG 175
Query: 225 YDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKY--VAEGHRPFFRAKGFTPELRELTE 282
D++S + E+L G PP + P AA + V + H P +G +PEL++
Sbjct: 176 ASTASDIWSLGCTVIELLTGNPPYYDLNPM-AALFRIVQDDHPPL--PEGISPELKDFLM 232
Query: 283 KCWAADMNQRPS 294
+C+ D N RP+
Sbjct: 233 QCFQKDPNLRPT 244
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 2e-41
Identities = 81/277 (29%), Positives = 134/277 (48%), Gaps = 47/277 (16%)
Query: 49 IIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQ---DFRH-----------EVNLL 94
IGKGSFG + K ++R SD ++++ D+ + EVN+L
Sbjct: 7 TIGKGSFGTVRK---------VRRK----SDGKILVWKEIDYGNMTEKEKQQLVSEVNIL 53
Query: 95 VKLRHPNIVQFLGAVTER--KPLMLITEYLRGGDL----HKYLKEKGALSPSTAVNFALD 148
+L+HPNIV++ + +R + L ++ EY GGDL K KE+ +
Sbjct: 54 RELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQ 113
Query: 149 IARGMAYLHNEP---NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKM 205
+ + HN N ++HRDLKP N+ L + +++K+GDFGL+K++ HD
Sbjct: 114 LLLALYECHNRSDPGNTVLHRDLKPANIFL--DANNNVKLGDFGLAKIL----GHDSSFA 167
Query: 206 TGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHR 265
G+ YM+PE H YD+K D++S ++YE+ PP + A + EG
Sbjct: 168 KTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGK- 226
Query: 266 PFFR--AKGFTPELRELTEKCWAADMNQRPSFLDILK 300
FR ++ EL E+ + D ++RPS ++L+
Sbjct: 227 --FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 141 bits (359), Expect = 1e-40
Identities = 82/246 (33%), Positives = 127/246 (51%), Gaps = 14/246 (5%)
Query: 50 IGKGSFGEILKAYWRGTPV--AIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 107
+GKGSFG++L + T A+K + R ++ E N+L ++ HP IV+
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 108 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 167
A + L L+ EY GG+L +L ++G S A +A +I + YLH+ II+RD
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLG--IIYRD 118
Query: 168 LKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYD 226
LKP N+LL AD H+K+ DFGL+K + S + + G+ Y+APEV + Y
Sbjct: 119 LKPENILL---DADGHIKLTDFGLAK----ELSSEGSRTNTFCGTPEYLAPEVLLGKGYG 171
Query: 227 KKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWA 286
K VD +S ++LYEML G+PP + E + + + F + +PE R+L
Sbjct: 172 KAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKD-PLRF-PEFLSPEARDLISGLLQ 229
Query: 287 ADMNQR 292
D +R
Sbjct: 230 KDPTKR 235
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 1e-40
Identities = 89/279 (31%), Positives = 142/279 (50%), Gaps = 35/279 (12%)
Query: 50 IGKGSFGEILKAYWR-GTP------VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 102
+G+G+FG++ P VA+K + + S+D +DF E LL +H NI
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASND--ARKDFEREAELLTNFQHENI 70
Query: 103 VQFLGAVTERKPLMLITEYLRGGDLHKYLK--------------EKGALSPSTAVNFALD 148
V+F G TE P +++ EY+ GDL+K+L+ G L+ S + A+
Sbjct: 71 VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130
Query: 149 IARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHL-KVGDFGLSKLIKVQNSHDVYKMTG 207
IA GM YL ++ V HRDL RN L+ D + K+GDFG+S+ + + D Y++ G
Sbjct: 131 IASGMVYLASQHFV--HRDLATRNCLV---GYDLVVKIGDFGMSRDVY---TTDYYRVGG 182
Query: 208 ETG-SYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHR 265
T R+M PE +RK+ + DV+SF ++L+E+ G+ P E + + +G R
Sbjct: 183 HTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQG-R 241
Query: 266 PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEK 304
R + E+ ++ CW D QR + DI +RL+K
Sbjct: 242 LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 3e-40
Identities = 86/278 (30%), Positives = 147/278 (52%), Gaps = 27/278 (9%)
Query: 35 WEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVN 92
WE++ +++ +G G +GE+ + W+ VA+K +L +D + +++F E
Sbjct: 1 WEMERTDITMKHK--LGGGQYGEVYEGVWKKYSLTVAVK----TLKEDTMEVEEFLKEAA 54
Query: 93 LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIA 150
++ +++HPN+VQ LG T P +ITE++ G+L YL+E + ++ + A I+
Sbjct: 55 VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQIS 114
Query: 151 RGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHL-KVGDFGLSKLIKVQNSHDVYKMTGET 209
M YL E IHRDL RN L+ +HL KV DFGLS+L+ D Y T
Sbjct: 115 SAMEYL--EKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMT----GDTY--TAHA 163
Query: 210 GS---YRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHR 265
G+ ++ APE + K+ K DV++F ++L+E+ G P + + + + +G+R
Sbjct: 164 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYR 223
Query: 266 PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLE 303
R +G P++ EL CW + + RPSF +I + E
Sbjct: 224 -MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFE 260
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 140 bits (353), Expect = 1e-39
Identities = 93/274 (33%), Positives = 141/274 (51%), Gaps = 25/274 (9%)
Query: 37 IDPSELDFSSSAIIGKGSFGEILKAYWRGT-PVAIKRILP-SLSDDRLVIQDFRHEVNLL 94
IDP +L F +G G FG + WRG VAIK I S+S+D +F E ++
Sbjct: 1 IDPKDLTFLKE--LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-----EFIEEAKVM 53
Query: 95 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGM 153
+KL H +VQ G T+++P+ ++TEY+ G L YL+E G PS + D+ GM
Sbjct: 54 MKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGM 113
Query: 154 AYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGS-- 211
AYL E IHRDL RN LV+ +KV DFGLS+ + D Y T GS
Sbjct: 114 AYL--ESKQFIHRDLAARNC-LVDDQGC-VKVSDFGLSRYV----LDDEY--TSSVGSKF 163
Query: 212 -YRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFR 269
R+ PEV + K+ K DV++F ++++E+ G+ P + E + V++G R +R
Sbjct: 164 PVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLR-LYR 222
Query: 270 AKGFTPELRELTEKCWAADMNQRPSFLDILKRLE 303
+ ++ + CW +RP+F +L +E
Sbjct: 223 PHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 139 bits (351), Expect = 2e-39
Identities = 92/276 (33%), Positives = 139/276 (50%), Gaps = 17/276 (6%)
Query: 37 IDPSELDFSSSAIIGKGSFGEILKAYW-----RGTPVAIKRILPSLSDDRLVIQDFRHEV 91
ID S + +IG G FGE+ R PVAIK + ++ + +DF E
Sbjct: 1 IDASCIKIEK--VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQR--RDFLSEA 56
Query: 92 NLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIA 150
+++ + HPNI+ G VT+ KP+M++TEY+ G L +L K G + V IA
Sbjct: 57 SIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIA 116
Query: 151 RGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETG 210
GM YL + V HRDL RN+ LVNS+ KV DFGLS++++ + Y G
Sbjct: 117 SGMKYLSDMGYV--HRDLAARNI-LVNSNL-VCKVSDFGLSRVLE-DDPEAAYTTRGGKI 171
Query: 211 SYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFR 269
R+ APE +RK+ DV+S+ ++++E++ GE P + K + EG+R
Sbjct: 172 PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYR-LPA 230
Query: 270 AKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKI 305
L +L CW D N+RP F I+ L+K+
Sbjct: 231 PMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 3e-39
Identities = 74/257 (28%), Positives = 119/257 (46%), Gaps = 16/257 (6%)
Query: 50 IGKGSFGEILKAYWR--GTPVAIKR--ILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 105
+G GSFG + + G A+K + + ++ E+ LL KL+HPNIVQ+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 106 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 165
LG E L + E + GG L K LK+ G+ + I G+ YLH+ +H
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHD--RNTVH 125
Query: 166 RDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR-K 224
RD+K N+L+ + +K+ DFG++K + + +K GS +MAPEV +
Sbjct: 126 RDIKGANILVDTNGV--VKLADFGMAKQVVEFSFAKSFK-----GSPYWMAPEVIAQQGG 178
Query: 225 YDKKVDVFSFAMILYEMLEGEPPLANYEPYEAA-KYVAEGHRPFFRAKGFTPELRELTEK 283
Y D++S + EM G+PP + E A K P + E ++ K
Sbjct: 179 YGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPI-PDHLSDEAKDFILK 237
Query: 284 CWAADMNQRPSFLDILK 300
C D + RP+ ++L+
Sbjct: 238 CLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 8e-39
Identities = 81/279 (29%), Positives = 131/279 (46%), Gaps = 30/279 (10%)
Query: 50 IGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 103
+G+G FG++ + G VA+K + S + DF E+ +L L H NIV
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQ--HRSDFEREIEILRTLDHENIV 69
Query: 104 QFLGAVTE--RKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEP 160
++ G + + L LI EYL G L YL+ + ++ + F+ I +GM YL ++
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR 129
Query: 161 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF 220
IHRDL RN+L+ S D +K+ DFGL+K++ + K GE+ + Y APE
Sbjct: 130 --YIHRDLAARNILV--ESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APECL 184
Query: 221 KHRKYDKKVDVFSFAMILYEMLE-GEP---PLANYEPYEAAKYVAEGHRPFF-------- 268
+ K+ DV+SF + LYE+ G+P P A +
Sbjct: 185 RTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGER 244
Query: 269 --RAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKI 305
R E+ +L + CW A+ RPSF D++ ++++
Sbjct: 245 LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 1e-38
Identities = 86/276 (31%), Positives = 133/276 (48%), Gaps = 32/276 (11%)
Query: 49 IIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN 101
+G+G FGE+ A +G T V +K + + D + +FR E+++ KL H N
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKAL--QKTKDENLQSEFRRELDMFRKLSHKN 69
Query: 102 IVQFLGAVTERKPLMLITEYLRGGDLHKYLK-EKGA--------LSPSTAVNFALDIARG 152
+V+ LG E +P +I EY GDL ++L+ K LS V IA G
Sbjct: 70 VVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALG 129
Query: 153 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSY 212
M +L N +HRDL RN L+ SS +KV LSK V NS + YK+
Sbjct: 130 MDHLSN--ARFVHRDLAARNCLV--SSQREVKVSLLSLSK--DVYNS-EYYKLRNALIPL 182
Query: 213 RYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPP---LANYEPYEAAKYVAEGHRPFF 268
R++APE + + K DV+SF ++++E+ +GE P L++ E + G
Sbjct: 183 RWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQ---AGKLELP 239
Query: 269 RAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEK 304
+G L +L +CWA + RPSF +++ L +
Sbjct: 240 VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 3e-38
Identities = 86/272 (31%), Positives = 130/272 (47%), Gaps = 19/272 (6%)
Query: 50 IGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 107
I KG++G + A + T AIK I + + + E ++L + + P +V+
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 108 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 167
+ +K L L+ EYL GGDL L+ G+L A + +I + YLH+ N IIHRD
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHS--NGIIHRD 118
Query: 168 LKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET----GSYRYMAPEVFKHR 223
LKP N+L+ S HLK+ DFGLSK+ V+ ++ E G+ Y+APEV +
Sbjct: 119 LKPDNILI--DSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQ 176
Query: 224 KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEK 283
+ K VD +S ILYE L G PP P E + + G + + E +L K
Sbjct: 177 GHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISK 236
Query: 284 CWAADMNQRPSFLDILKRLEKIKETLPTDHHW 315
D +R K +E+IK +H +
Sbjct: 237 LLVPDPEKRLGA----KSIEEIK-----NHPF 259
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 4e-38
Identities = 87/259 (33%), Positives = 138/259 (53%), Gaps = 17/259 (6%)
Query: 49 IIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 107
++GKG+FGE+ K + TPVA+K L + L I+ F E +L + HPNIV+ +G
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQE-LKIK-FLSEARILKQYDHPNIVKLIG 59
Query: 108 AVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 166
T+R+P+ ++ E + GGD +L K+K L V FALD A GMAYL E IHR
Sbjct: 60 VCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYL--ESKNCIHR 117
Query: 167 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG-ETGSYRYMAPEVFKHRKY 225
DL RN L+ ++ LK+ DFG+S+ Q +Y +G + ++ APE + +Y
Sbjct: 118 DLAARNCLVGENNV--LKISDFGMSR----QEDDGIYSSSGLKQIPIKWTAPEALNYGRY 171
Query: 226 DKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPE-LRELTEK 283
+ DV+S+ ++L+E G P +A + V +G+R P+ + ++ ++
Sbjct: 172 SSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYR--MSCPQKCPDDVYKVMQR 229
Query: 284 CWAADMNQRPSFLDILKRL 302
CW RP F ++ K L
Sbjct: 230 CWDYKPENRPKFSELQKEL 248
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 138 bits (348), Expect = 5e-38
Identities = 73/207 (35%), Positives = 102/207 (49%), Gaps = 13/207 (6%)
Query: 50 IGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP-NIVQFLGA 108
+G+GSFGE+ A VA+K + L ++ F E+ +L L HP NIV+
Sbjct: 8 LGEGSFGEVYLAR-DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDF 66
Query: 109 VTERKPLMLITEYLRGGDLHKYLKE---KGALSPSTAVNFALDIARGMAYLHNEPNVIIH 165
+ L L+ EY+ GG L LK+ KG LS S A+ I + YLH IIH
Sbjct: 67 FQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH--SKGIIH 124
Query: 166 RDLKPRNVLLVNSSADHLKVGDFGLSKLIK--VQNSHDVYKMTGETGSYRYMAPEVFKH- 222
RD+KP N+LL + +K+ DFGL+KL+ S + G+ YMAPEV
Sbjct: 125 RDIKPENILL-DRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGL 183
Query: 223 --RKYDKKVDVFSFAMILYEMLEGEPP 247
D++S + LYE+L G PP
Sbjct: 184 SLAYASSSSDIWSLGITLYELLTGLPP 210
|
Length = 384 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 2e-37
Identities = 89/265 (33%), Positives = 136/265 (51%), Gaps = 19/265 (7%)
Query: 48 AIIGKGSFGEILKAY--WRGTPVAIKRI-LPSLSDD-----RLVIQDFRHEVNLLVKLRH 99
A+IG GSFG + G +A+K++ LPS+S R ++ E+ LL +L+H
Sbjct: 6 ALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQH 65
Query: 100 PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE 159
NIVQ+LG+ + L + EY+ GG + L GA + NF I +G+ YLHN
Sbjct: 66 ENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNR 125
Query: 160 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGE----TGSYRYM 215
IIHRD+K N+L+ N +K+ DFG+SK K++ + K G GS +M
Sbjct: 126 G--IIHRDIKGANILVDNKGG--IKISDFGISK--KLEANSLSTKTNGARPSLQGSVFWM 179
Query: 216 APEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTP 275
APEV K Y +K D++S ++ EML G+ P + +A + E P +
Sbjct: 180 APEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEI-PSNISS 238
Query: 276 ELRELTEKCWAADMNQRPSFLDILK 300
E + EK + D N+RP+ ++LK
Sbjct: 239 EAIDFLEKTFEIDHNKRPTAAELLK 263
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 2e-37
Identities = 83/253 (32%), Positives = 129/253 (50%), Gaps = 19/253 (7%)
Query: 50 IGKGSFGEILKAYWRG--TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 107
IG+G+FGE+ R TPVA+K +L D + F E +L + HPNIV+ +G
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPD--LKAKFLQEARILKQYSHPNIVRLIG 60
Query: 108 AVTERKPLMLITEYLRGGDLHKYLKEKGA-LSPSTAVNFALDIARGMAYLHNEPNVIIHR 166
T+++P+ ++ E ++GGD +L+ +G L + + A GM YL E IHR
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYL--ESKHCIHR 118
Query: 167 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG--ETGSYRYMAPEVFKHRK 224
DL RN L+ + LK+ DFG+S+ + VY TG + ++ APE + +
Sbjct: 119 DLAARNCLVTEKNV--LKISDFGMSR----EEEDGVYASTGGMKQIPVKWTAPEALNYGR 172
Query: 225 YDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPE-LRELTE 282
Y + DV+SF ++L+E G P AN + + + +G R P+ + L E
Sbjct: 173 YSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVR--LPCPELCPDAVYRLME 230
Query: 283 KCWAADMNQRPSF 295
+CW D QRPSF
Sbjct: 231 RCWEYDPGQRPSF 243
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 3e-37
Identities = 90/304 (29%), Positives = 147/304 (48%), Gaps = 40/304 (13%)
Query: 29 LPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTP-------VAIKRILPSLSDDR 81
LP +WE+ L + +G+G+FG+++KA G VA+K + ++
Sbjct: 1 LPLDPEWELPRDRL--TLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKD 58
Query: 82 LVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK------ 134
L D E+ ++ + +H NI+ LG T+ PL ++ EY G+L +L+ +
Sbjct: 59 LS--DLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEY 116
Query: 135 ----------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH-L 183
L+ V+FA +ARGM +L IHRDL RNVL+ + DH +
Sbjct: 117 ASPDDPRPPEETLTQKDLVSFAYQVARGMEFL--ASKKCIHRDLAARNVLV---TEDHVM 171
Query: 184 KVGDFGLSKLIKVQNSHDVYKMTGETG-SYRYMAPEVFKHRKYDKKVDVFSFAMILYE-M 241
K+ DFGL++ I + D Y+ T ++MAPE R Y + DV+SF ++L+E
Sbjct: 172 KIADFGLARDI---HHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIF 228
Query: 242 LEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301
G P E K + EG+R + + T EL L CW +QRP+F +++
Sbjct: 229 TLGGSPYPGIPVEELFKLLKEGYR-MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287
Query: 302 LEKI 305
L+++
Sbjct: 288 LDRM 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 4e-37
Identities = 71/204 (34%), Positives = 113/204 (55%), Gaps = 18/204 (8%)
Query: 49 IIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 106
+G+G++G + KA + G VA+K+I ++ + R E++LL +L+HPNIV+ L
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALR-EISLLKELKHPNIVKLL 64
Query: 107 GAVTERKPLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIH 165
+ + L L+ EY DL KYL ++ G LSP+ + + RG+AY H+ + I+H
Sbjct: 65 DVIHTERKLYLVFEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHS--HRILH 121
Query: 166 RDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGE--TGSYRYMAPEV-FKH 222
RDLKP+N+L+ + LK+ DFGL++ + T E T YR APE+
Sbjct: 122 RDLKPQNILI--NRDGVLKLADFGLARAF----GIPLRTYTHEVVTLWYR--APEILLGS 173
Query: 223 RKYDKKVDVFSFAMILYEMLEGEP 246
+ Y VD++S I EM+ G+P
Sbjct: 174 KHYSTAVDIWSVGCIFAEMITGKP 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 5e-37
Identities = 76/266 (28%), Positives = 130/266 (48%), Gaps = 21/266 (7%)
Query: 41 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR 98
E F +G+GS+G + KA + G VAIK ++P D +Q+ E+++L +
Sbjct: 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIK-VVPVEED----LQEIIKEISILKQCD 56
Query: 99 HPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFAL-DIARGMAYLH 157
P IV++ G+ + L ++ EY G + +K + L +G+ YLH
Sbjct: 57 SPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH 116
Query: 158 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAP 217
+ N IHRD+K N+LL + K+ DFG+S Q + + K G+ +MAP
Sbjct: 117 S--NKKIHRDIKAGNILL--NEEGQAKLADFGVSG----QLTDTMAKRNTVIGTPFWMAP 168
Query: 218 EVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRP---FFRAKGFT 274
EV + Y+ K D++S + EM EG+PP ++ P A + ++P + ++
Sbjct: 169 EVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI--PNKPPPTLSDPEKWS 226
Query: 275 PELRELTEKCWAADMNQRPSFLDILK 300
PE + +KC D +RPS + +L+
Sbjct: 227 PEFNDFVKKCLVKDPEERPSAIQLLQ 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 2e-35
Identities = 86/279 (30%), Positives = 135/279 (48%), Gaps = 36/279 (12%)
Query: 49 IIGKGSFGEILKAYWRGT------------PVAIKRILPSLSDDRLVIQDFRHEVNLLVK 96
+G G+FGE+ + GT VA+K + +D +F E +L+
Sbjct: 2 FLGSGAFGEV----YEGTATDILGPGSGPIRVAVKTLRKGATDQEKK--EFLKEAHLMSN 55
Query: 97 LRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA-------LSPSTAVNFALDI 149
HPNIV+ LG +P +I E + GGDL YL++ L+ ++ LD+
Sbjct: 56 FNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDV 115
Query: 150 ARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH---LKVGDFGLSKLIKVQNSHDVYKMT 206
A+G YL E IHRDL RN L+ D +K+GDFGL++ I D Y+
Sbjct: 116 AKGCVYL--EQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIY---KSDYYRKE 170
Query: 207 GETG-SYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGH 264
GE R+MAPE K+ + DV+SF ++++E+L G+ P E ++V G
Sbjct: 171 GEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGG 230
Query: 265 RPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLE 303
R + + ++ +L CWA D ++RP+F I + L+
Sbjct: 231 R-LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 3e-35
Identities = 87/289 (30%), Positives = 143/289 (49%), Gaps = 41/289 (14%)
Query: 49 IIGKGSFGEILKAY---WRG----TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN 101
+G+G FG+++KA +G T VA+K + + S L +D E NLL ++ HP+
Sbjct: 7 TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSEL--RDLLSEFNLLKQVNHPH 64
Query: 102 IVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPS--------------------- 140
+++ GA ++ PL+LI EY + G L +L+E + PS
Sbjct: 65 VIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERAL 124
Query: 141 ---TAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 197
++FA I+RGM YL ++HRDL RNVL+ +K+ DFGLS+ + +
Sbjct: 125 TMGDLISFAWQISRGMQYLAEMK--LVHRDLAARNVLVAEGRK--MKISDFGLSRDVYEE 180
Query: 198 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEA 256
+S+ K + ++MA E Y + DV+SF ++L+E++ G P P
Sbjct: 181 DSY--VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERL 238
Query: 257 AKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKI 305
+ G+R R + + E+ L CW + ++RP+F DI K LEK+
Sbjct: 239 FNLLKTGYR-MERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM 286
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 3e-35
Identities = 89/281 (31%), Positives = 140/281 (49%), Gaps = 39/281 (13%)
Query: 50 IGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 102
+G+G+FG++ A VA+K + + R QDF+ E LL L+H +I
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESAR---QDFQREAELLTVLQHQHI 69
Query: 103 VQFLGAVTERKPLMLITEYLRGGDLHKYLKEK---------------GALSPSTAVNFAL 147
V+F G TE +PL+++ EY+R GDL+++L+ G L+ + A
Sbjct: 70 VRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129
Query: 148 DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHL--KVGDFGLSKLIKVQNSHDVYKM 205
IA GM YL + +HRDL RN L+ L K+GDFG+S+ I S D Y++
Sbjct: 130 QIASGMVYLASLH--FVHRDLATRNCLV----GQGLVVKIGDFGMSRDIY---STDYYRV 180
Query: 206 TGETG-SYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEG 263
G T R+M PE +RK+ + D++SF ++L+E+ G+ P EA + + +G
Sbjct: 181 GGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQG 240
Query: 264 HRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEK 304
R R + PE+ + + CW + QR DI RL+
Sbjct: 241 -RELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 128 bits (322), Expect = 3e-35
Identities = 89/276 (32%), Positives = 142/276 (51%), Gaps = 29/276 (10%)
Query: 35 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLL 94
W ++ +L IIG+G FG +L+ + G VA+K I ++ Q F E ++
Sbjct: 1 WLLNLQKLTLG--EIIGEGEFGAVLQGEYTGQKVAVKNIKCDVT-----AQAFLEETAVM 53
Query: 95 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTA--VNFALDIARG 152
KL H N+V+ LG + L ++ E + G+L +L+ +G S + F+LD+A G
Sbjct: 54 TKLHHKNLVRLLGVILHNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEG 112
Query: 153 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHL-KVGDFGLSKL--IKVQNSHDVYKMTGET 209
M YL E ++HRDL RN+L+ S D + KV DFGL+++ + V NS K T
Sbjct: 113 MEYL--ESKKLVHRDLAARNILV---SEDGVAKVSDFGLARVGSMGVDNSKLPVKWT--- 164
Query: 210 GSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFF 268
APE KH+K+ K DV+S+ ++L+E+ G P E + V +G+R
Sbjct: 165 ------APEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYR-ME 217
Query: 269 RAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEK 304
+G ++ L CW + +RPSF + ++LEK
Sbjct: 218 PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 128 bits (322), Expect = 4e-35
Identities = 87/268 (32%), Positives = 137/268 (51%), Gaps = 21/268 (7%)
Query: 49 IIGKGSFGEILKAYW-----RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 103
+IG G FGE+ + R VAIK + ++ + +DF E +++ + HPNI+
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQR--RDFLSEASIMGQFDHPNII 68
Query: 104 QFLGAVTERKPLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNV 162
G VT+ +P+M+ITE++ G L +L++ G + V IA GM YL +E N
Sbjct: 69 HLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL-SEMNY 127
Query: 163 IIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGS---YRYMAPEV 219
+HRDL RN+ LVNS+ KV DFGLS+ ++ S Y T G R+ APE
Sbjct: 128 -VHRDLAARNI-LVNSNL-VCKVSDFGLSRFLEDDTSDPTY--TSSLGGKIPIRWTAPEA 182
Query: 220 FKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPE-L 277
+RK+ DV+S+ ++++E++ GE P + + + + +R P L
Sbjct: 183 IAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYR--LPPPMDCPTAL 240
Query: 278 RELTEKCWAADMNQRPSFLDILKRLEKI 305
+L CW D N RP F I+ L+K+
Sbjct: 241 HQLMLDCWQKDRNARPKFGQIVSTLDKM 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 4e-35
Identities = 74/260 (28%), Positives = 131/260 (50%), Gaps = 16/260 (6%)
Query: 50 IGKGSFGEILKAYW--RGTPVAIK--RILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 105
IG G+FG++ A G +A+K RI + D I++ E+ +L L+HPN+V++
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDN---DPKTIKEIADEMKVLELLKHPNLVKY 64
Query: 106 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 165
G R+ + + EY GG L + L+ L + L + G+AYLH+ + I+H
Sbjct: 65 YGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHS--HGIVH 122
Query: 166 RDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKY 225
RD+KP N+ L ++ +K+GDFG + +K + ++ G+ YMAPEV K
Sbjct: 123 RDIKPANIFLDHNGV--IKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKG 180
Query: 226 DKK---VDVFSFAMILYEMLEGEPPLANYEPYEAAKY-VAEGHRPFFRAK-GFTPELREL 280
D++S ++ EM G+ P + + + V GH+P +PE ++
Sbjct: 181 KGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDF 240
Query: 281 TEKCWAADMNQRPSFLDILK 300
++C +D +RP+ ++L+
Sbjct: 241 LDRCLESDPKKRPTASELLQ 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 7e-35
Identities = 78/259 (30%), Positives = 134/259 (51%), Gaps = 19/259 (7%)
Query: 49 IIGKGSFGEILKAYW--RGTPVAIKRI-LPSLSDDRLVIQDFRHEVNLLVKLRH---PNI 102
+IG+G++G + + G VA+K I L + DD + D + EV LL +LR PNI
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDD---VSDIQREVALLSQLRQSQPPNI 64
Query: 103 VQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNV 162
++ G+ + L +I EY GG + + L + G ++ ++ + Y+H
Sbjct: 65 TKYYGSYLKGPRLWIIMEYAEGGSV-RTLMKAGPIAEKYISVIIREVLVALKYIHKVG-- 121
Query: 163 IIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH 222
+IHRD+K N+L+ N+ ++K+ DFG++ L+ QNS K + G+ +MAPEV
Sbjct: 122 VIHRDIKAANILVTNTG--NVKLCDFGVAALL-NQNSS---KRSTFVGTPYWMAPEVITE 175
Query: 223 -RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELT 281
+ YD K D++S + +YEM G PP ++ + + A + + P G++ LRE
Sbjct: 176 GKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFV 235
Query: 282 EKCWAADMNQRPSFLDILK 300
C + +R S ++LK
Sbjct: 236 AACLDEEPKERLSAEELLK 254
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 8e-35
Identities = 72/250 (28%), Positives = 119/250 (47%), Gaps = 14/250 (5%)
Query: 50 IGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 107
+G+GS G + K + T A+K+I + D + E+ L P +V+ G
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIH--VDGDEEFRKQLLRELKTLRSCESPYVVKCYG 66
Query: 108 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 167
A + + ++ EY+ GG L LK+ G + A I +G+ YLH + + IIHRD
Sbjct: 67 AFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH-IIHRD 125
Query: 168 LKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDK 227
+KP N+L+ +S +K+ DFG+SK++ + T G+ YM+PE + Y
Sbjct: 126 IKPSNLLI--NSKGEVKIADFGISKVL---ENTLDQCNTFV-GTVTYMSPERIQGESYSY 179
Query: 228 KVDVFSFAMILYEMLEGEPPLA---NYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKC 284
D++S + L E G+ P +E + + +G P A+ F+PE R+ C
Sbjct: 180 AADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISAC 239
Query: 285 WAADMNQRPS 294
D +RPS
Sbjct: 240 LQKDPKKRPS 249
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 1e-34
Identities = 75/266 (28%), Positives = 130/266 (48%), Gaps = 21/266 (7%)
Query: 48 AIIGKGSFGEILKA--YWRGTPVAIKRIL---PSLSDDRLVIQDFRHEVNLLVKLRHPNI 102
+G G+F +A GT +A+K++ + S+ V++ R E+ L+ +L HP+I
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 103 VQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNV 162
++ LGA E L E++ GG + L + GA + +N+ + RG++YLH N
Sbjct: 66 IRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHE--NQ 123
Query: 163 IIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGE-----TGSYRYMAP 217
IIHRD+K N LL++S+ L++ DFG + + + + GE G+ +MAP
Sbjct: 124 IIHRDVKGAN-LLIDSTGQRLRIADFGAAARLAAKGTG-----AGEFQGQLLGTIAFMAP 177
Query: 218 EVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYE---PYEAAKYVAEGHRPFFRAKGFT 274
EV + +Y + DV+S ++ EM +PP + +A + +
Sbjct: 178 EVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLS 237
Query: 275 PELRELTEKCWAADMNQRPSFLDILK 300
P LR++T +C RP ++LK
Sbjct: 238 PGLRDVTLRCLELQPEDRPPSRELLK 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 1e-34
Identities = 59/201 (29%), Positives = 99/201 (49%), Gaps = 11/201 (5%)
Query: 49 IIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 106
+IGKG+FG++ R T A+K + ++ +++ +E +L +L HP +V
Sbjct: 7 VIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLW 66
Query: 107 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 166
+ + + + L+ + L GGDL +L +K S + +I + YLH+ IIHR
Sbjct: 67 YSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHS--KGIIHR 124
Query: 167 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYD 226
D+KP N+LL H+ + DF ++ + T +G+ YMAPEV + Y
Sbjct: 125 DIKPDNILLDEQG--HVHITDFNIATKV-----TPDTLTTSTSGTPGYMAPEVLCRQGYS 177
Query: 227 KKVDVFSFAMILYEMLEGEPP 247
VD +S + YE L G+ P
Sbjct: 178 VAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 4e-34
Identities = 83/273 (30%), Positives = 128/273 (46%), Gaps = 29/273 (10%)
Query: 50 IGKGSFGEILKAYWRGT-------PVAIKRI--LPSLSDDRLVIQDFRHEVNLLVKLRHP 100
+G G+FGE+ + +RG VA+K + S D+ DF E ++ K H
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDE----SDFLMEALIMSKFNHQ 69
Query: 101 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK-------GALSPSTAVNFALDIARGM 153
NIV+ +G ER P ++ E + GGDL +L+E +L+ + A D+A+G
Sbjct: 70 NIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGC 129
Query: 154 AYLHNEPNVIIHRDLKPRNVLLVNSSADHL-KVGDFGLSKLIKVQNSHDVYKMTGETG-S 211
YL E N IHRD+ RN LL + K+ DFG+++ I Y+ G
Sbjct: 130 KYL--EENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIY---RASYYRKGGRAMLP 184
Query: 212 YRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRA 270
++M PE F + K DV+SF ++L+E+ G P E ++V G R
Sbjct: 185 IKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLDPPK 244
Query: 271 KGFTPELRELTEKCWAADMNQRPSFLDILKRLE 303
P R +T+ CW RP+F IL+R++
Sbjct: 245 GCPGPVYRIMTD-CWQHTPEDRPNFATILERIQ 276
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 4e-34
Identities = 87/283 (30%), Positives = 135/283 (47%), Gaps = 45/283 (15%)
Query: 50 IGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 102
+G+G+FG++ K G T VAIK + + V Q+FR E L+ L+HPNI
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPK--VQQEFRQEAELMSDLQHPNI 70
Query: 103 VQFLGAVTERKPLMLITEYLRGGDLHKYL----------------KEKGALSPSTAVNFA 146
V LG T+ +P ++ EYL GDLH++L K +L S ++ A
Sbjct: 71 VCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIA 130
Query: 147 LDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHL--KVGDFGLSKLIKVQNSHDVYK 204
+ IA GM YL + + +HRDL RN L+ + L K+ DFGLS+ I S D Y+
Sbjct: 131 IQIAAGMEYLSS--HHFVHRDLAARNCLV----GEGLTVKISDFGLSRDIY---SADYYR 181
Query: 205 MTGETG-SYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAE 262
+ ++ R+M PE + K+ + D++SF ++L+E+ G P + E + +
Sbjct: 182 VQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRS 241
Query: 263 GH---RPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRL 302
P + + L +CW +RP F DI RL
Sbjct: 242 RQLLPCP----EDCPARVYALMIECWNEIPARRPRFKDIHTRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 5e-34
Identities = 78/273 (28%), Positives = 133/273 (48%), Gaps = 18/273 (6%)
Query: 43 DFSSSAIIGKGSFGEILKAYWRG-----TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL 97
D + IG+G FG++ + + VA+K S V + F E ++ +
Sbjct: 7 DITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPS--VREKFLQEAYIMRQF 64
Query: 98 RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARGMAYL 156
HP+IV+ +G +TE P+ ++ E G+L YL K +L ++ + ++ ++ +AYL
Sbjct: 65 DHPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYL 123
Query: 157 HNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMA 216
++ V HRD+ RNVL+ SS D +K+GDFGLS+ + YK + ++MA
Sbjct: 124 ESKRFV--HRDIAARNVLV--SSPDCVKLGDFGLSRYL---EDESYYKASKGKLPIKWMA 176
Query: 217 PEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTP 275
PE R++ DV+ F + ++E+L G P + + + G R P
Sbjct: 177 PESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPN-CPP 235
Query: 276 ELRELTEKCWAADMNQRPSFLDILKRLEKIKET 308
L L KCWA D ++RP F ++ +L I +
Sbjct: 236 TLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 5e-34
Identities = 83/253 (32%), Positives = 122/253 (48%), Gaps = 33/253 (13%)
Query: 68 VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDL 127
VA+K + P SD+ +DF EV +L +L PNI + LG T PL +I EY+ GDL
Sbjct: 49 VAVKVLRPDASDNAR--EDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDL 106
Query: 128 HKYLKE-----------KGALSPSTAVNFALDIARGMAYL--HNEPNVIIHRDLKPRNVL 174
+++L++ +LS ST + A IA GM YL N +HRDL RN
Sbjct: 107 NQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN----FVHRDLATRNC- 161
Query: 175 LVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETG-SYRYMAPEVFKHRKYDKKVDVFS 233
LV + +K+ DFG+S+ + S D Y++ G R+MA E K+ K DV++
Sbjct: 162 LVGKNY-TIKIADFGMSRNLY---SSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWA 217
Query: 234 FAMILYE--MLEGEPP---LANYEPYEAAKYV---AEGHRPFFRAKGFTPELRELTEKCW 285
F + L+E L E P L + + E A + R ++ EL +CW
Sbjct: 218 FGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECW 277
Query: 286 AADMNQRPSFLDI 298
D RP+F +I
Sbjct: 278 RRDEEDRPTFREI 290
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 125 bits (314), Expect = 6e-34
Identities = 74/259 (28%), Positives = 129/259 (49%), Gaps = 11/259 (4%)
Query: 49 IIGKGSFGEI-LKAYWRGTPVAIKRILPSLSDDRLVIQDFR---HEVNLLVKLRHPNIVQ 104
++GKG++G + +G +A+K++ S+ +++ EV+LL L+H NIVQ
Sbjct: 7 VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 105 FLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVII 164
+LG + + + E++ GG + L G L + I G+AYLHN N ++
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHN--NCVV 124
Query: 165 HRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK--MTGETGSYRYMAPEVFKH 222
HRD+K NV+L+ + +K+ DFG ++ + H + + G+ +MAPEV
Sbjct: 125 HRDIKGNNVMLMPNGI--IKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINE 182
Query: 223 RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR-AKGFTPELRELT 281
Y +K D++S ++EM G+PPLA+ + A Y+ R F+ +
Sbjct: 183 SGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAIDFV 242
Query: 282 EKCWAADMNQRPSFLDILK 300
C D ++RPS L +L+
Sbjct: 243 TSCLTRDQHERPSALQLLR 261
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 8e-34
Identities = 87/287 (30%), Positives = 134/287 (46%), Gaps = 43/287 (14%)
Query: 50 IGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 102
IG+G+FG + +A G T VA+K + S D + DF+ E L+ + HPNI
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASAD--MQADFQREAALMAEFDHPNI 70
Query: 103 VQFLGAVTERKPLMLITEYLRGGDLHKYLKE----------------------KGALSPS 140
V+ LG KP+ L+ EY+ GDL+++L+ LS +
Sbjct: 71 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCT 130
Query: 141 TAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 200
+ A +A GMAYL +HRDL RN L+ + +K+ DFGLS+ I S
Sbjct: 131 EQLCIAKQVAAGMAYLSE--RKFVHRDLATRNCLVGENMV--VKIADFGLSRNIY---SA 183
Query: 201 DVYKMTG-ETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAK 258
D YK + + R+M PE + +Y + DV+++ ++L+E+ G P E
Sbjct: 184 DYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIY 243
Query: 259 YVAEGHRPFFRAKGFTP-ELRELTEKCWAADMNQRPSFLDILKRLEK 304
YV +G+ P EL L CW+ + RPSF I + L++
Sbjct: 244 YVRDGN--VLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 2e-33
Identities = 87/283 (30%), Positives = 146/283 (51%), Gaps = 30/283 (10%)
Query: 50 IGKGSFGEILKAY-WRGTPVAIKRILP--SLSDDRLVI-QDFRHEVNLLVKLRHPNIVQF 105
+G+G+FG++ A + +P K ++ +L D L +DF+ E LL L+H +IV+F
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 106 LGAVTERKPLMLITEYLRGGDLHKYLK----------------EKGALSPSTAVNFALDI 149
G + PL+++ EY++ GDL+K+L+ KG L S ++ A I
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 150 ARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET 209
A GM YL ++ +HRDL RN L+ + +K+GDFG+S+ + S D Y++ G T
Sbjct: 133 ASGMVYLASQH--FVHRDLATRNCLVGANLL--VKIGDFGMSRDVY---STDYYRVGGHT 185
Query: 210 G-SYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPF 267
R+M PE +RK+ + DV+SF +IL+E+ G+ P E + + +G R
Sbjct: 186 MLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQG-RVL 244
Query: 268 FRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLP 310
R + E+ ++ CW + QR + +I K L + + P
Sbjct: 245 ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKATP 287
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 3e-33
Identities = 75/258 (29%), Positives = 132/258 (51%), Gaps = 13/258 (5%)
Query: 50 IGKGSFGEILKAYWR----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 105
+G G+FG + K ++ VA+K IL + ++D + + E N++ +L +P IV+
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVK-ILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 106 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 165
+G + E + ML+ E G L+K+L++ ++ ++ GM YL E +H
Sbjct: 62 IG-ICEAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYL--EETNFVH 118
Query: 166 RDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKY 225
RDL RNVLLV + + K+ DFGLSK + ++ K G+ ++ APE + K+
Sbjct: 119 RDLAARNVLLV--TQHYAKISDFGLSKALGADENYYKAKTHGKW-PVKWYAPECMNYYKF 175
Query: 226 DKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKC 284
K DV+SF ++++E G+ P + E + + G R + PE+ +L + C
Sbjct: 176 SSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGER-MECPQRCPPEMYDLMKLC 234
Query: 285 WAADMNQRPSFLDILKRL 302
W +++RP F + RL
Sbjct: 235 WTYGVDERPGFAVVELRL 252
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 6e-33
Identities = 83/282 (29%), Positives = 140/282 (49%), Gaps = 34/282 (12%)
Query: 50 IGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 103
+GKG+FG + + G VA+K++ S ++ ++DF E+ +L L+H NIV
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEH---LRDFEREIEILKSLQHDNIV 68
Query: 104 QFLGAVTE--RKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARGMAYLHNEP 160
++ G R+ L L+ EYL G L YL K + L + +A I +GM YL ++
Sbjct: 69 KYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR 128
Query: 161 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF 220
+HRDL RN+L+ + + +K+GDFGL+K++ + + GE+ + Y APE
Sbjct: 129 --YVHRDLATRNILVESEN--RVKIGDFGLTKVLPQDKEYYKVREPGESPIFWY-APESL 183
Query: 221 KHRKYDKKVDVFSFAMILYEML-----EGEPP------LANYEP-----YEAAKYVAEGH 264
K+ DV+SF ++LYE+ PP + N + Y + +
Sbjct: 184 TESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNG 243
Query: 265 RPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIK 306
R G E+ + ++CW D +QRPSF ++ ++E I+
Sbjct: 244 R-LPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 122 bits (306), Expect = 7e-33
Identities = 82/265 (30%), Positives = 133/265 (50%), Gaps = 18/265 (6%)
Query: 35 WEIDPSELDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNL 93
WEI + +G G FGE+ Y+ T VA+K + P + +Q F E NL
Sbjct: 1 WEIPRESIKLVKK--LGAGQFGEVWMGYYNNSTKVAVKTLKPG----TMSVQAFLEEANL 54
Query: 94 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK--EKGALSPSTAVNFALDIAR 151
+ L+H +V+ VT+ +P+ +ITEY+ G L +LK E G + ++F+ IA
Sbjct: 55 MKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAE 114
Query: 152 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGS 211
GMAY+ E IHRDL+ NVL+ S + K+ DFGL+++I+ ++ G
Sbjct: 115 GMAYI--ERKNYIHRDLRAANVLV--SESLMCKIADFGLARVIE---DNEYTAREGAKFP 167
Query: 212 YRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRA 270
++ APE + K DV+SF ++LYE++ G+ P + + G+R R
Sbjct: 168 IKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYR-MPRM 226
Query: 271 KGFTPELRELTEKCWAADMNQRPSF 295
+ EL ++ + CW +RP+F
Sbjct: 227 ENCPDELYDIMKTCWKEKAEERPTF 251
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 2e-32
Identities = 91/272 (33%), Positives = 136/272 (50%), Gaps = 21/272 (7%)
Query: 38 DPSELDFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLV 95
DP EL F+ IGKGSFGE+ K T VAIK I ++D I+D + E+ +L
Sbjct: 1 DPEEL-FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE--IEDIQQEITVLS 57
Query: 96 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 155
+ P + ++ G+ + L +I EYL GG L E G L + +I +G+ Y
Sbjct: 58 QCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL-EPGPLDETQIATILREILKGLDY 116
Query: 156 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS-KLIKVQNSHDVYKMTGETGSYRY 214
LH+E IHRD+K NVLL S +K+ DFG++ +L Q + + G+ +
Sbjct: 117 LHSEKK--IHRDIKAANVLL--SEHGEVKLADFGVAGQLTDTQIKRNTF-----VGTPFW 167
Query: 215 MAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFT 274
MAPEV K YD K D++S + E+ +GEPP + P + + + + P ++
Sbjct: 168 MAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGN-YS 226
Query: 275 PELRELTEKCWAADMNQRPSFLDILKRLEKIK 306
L+E E C +N+ PSF K L K K
Sbjct: 227 KPLKEFVEAC----LNKEPSFRPTAKELLKHK 254
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 3e-32
Identities = 93/299 (31%), Positives = 151/299 (50%), Gaps = 39/299 (13%)
Query: 26 PPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSL- 77
P LP WE + L F +G G+FG++++A G VA+K + P+
Sbjct: 21 PTQLPYDLKWEFPRNNLSFGK--TLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH 78
Query: 78 SDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA 136
S +R + E+ ++ L H NIV LGA T P+++ITEY GDL +L+ K
Sbjct: 79 SSER---EALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRE 135
Query: 137 --LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 194
L+ ++F+ +A+GMA+L IHRDL RNVLL + +K+ DFGL++ I
Sbjct: 136 SFLTLEDLLSFSYQVAKGMAFL--ASKNCIHRDLAARNVLLTHGKI--VKICDFGLARDI 191
Query: 195 KVQNSHDVYKMTGETG-SYRYMAPEVFKHRKYDKKVDVFSFAMILYEM--LEGEP-P--L 248
++ Y + G ++MAPE + Y + DV+S+ ++L+E+ L P P
Sbjct: 192 MNDSN---YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMP 248
Query: 249 ANYEPYEAAKYVAEGHR---PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEK 304
+ + Y K + EG+R P E+ ++ + CW AD +RP+F I++ + K
Sbjct: 249 VDSKFY---KLIKEGYRMAQPEHAPA----EIYDIMKTCWDADPLKRPTFKQIVQLIGK 300
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 4e-32
Identities = 63/201 (31%), Positives = 107/201 (53%), Gaps = 13/201 (6%)
Query: 50 IGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 107
IG+G+ G + KA R T VA+K++ + + Q R E+ L +HP +V+ L
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALR-EIKALQACQHPYVVKLLD 66
Query: 108 AVTERKPLMLITEYLRGGDLHKYLK-EKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 166
+L+ EY+ DL + L+ E+ L + ++ + +G+AY+H N I+HR
Sbjct: 67 VFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHA--NGIMHR 123
Query: 167 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV-FKHRKY 225
DLKP N+L+ S+ LK+ DFGL+ ++ + + + + + Y APE+ + RKY
Sbjct: 124 DLKPANLLI--SADGVLKIADFGLA---RLFSEEEPRLYSHQVATRWYRAPELLYGARKY 178
Query: 226 DKKVDVFSFAMILYEMLEGEP 246
D VD+++ I E+L G P
Sbjct: 179 DPGVDLWAVGCIFAELLNGSP 199
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 5e-32
Identities = 93/316 (29%), Positives = 150/316 (47%), Gaps = 38/316 (12%)
Query: 29 LPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG---------TPVAIKRILPSLSD 79
LP WE+ + L +G+G FG+++ A G VA+K + +D
Sbjct: 1 LPADPKWELSRTRLTLGKP--LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATD 58
Query: 80 DRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK---- 134
L D E+ ++ + +H NI+ LGA T+ PL ++ EY G+L +YL+ +
Sbjct: 59 KDL--SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPG 116
Query: 135 ------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH 182
L+ V+ A +ARGM YL ++ IHRDL RNVL+ +
Sbjct: 117 MDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK--CIHRDLAARNVLVTEDNV-- 172
Query: 183 LKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEML 242
+K+ DFGL++ V N K T ++MAPE R Y + DV+SF ++L+E+
Sbjct: 173 MKIADFGLAR--DVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIF 230
Query: 243 E-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301
G P E K + EGHR + T EL + +CW A +QRP+F +++
Sbjct: 231 TLGGSPYPGIPVEELFKLLKEGHR-MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289
Query: 302 LEKIKETLPTDHHWNI 317
L+++ TD + ++
Sbjct: 290 LDRVLTVTSTDEYLDL 305
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 5e-32
Identities = 84/267 (31%), Positives = 126/267 (47%), Gaps = 26/267 (9%)
Query: 43 DFSSSAIIGKGSFGEILKAYWR---GTPVAIKRI-LPSLSDDRLVIQDFRHEVNLLVKLR 98
DF +GKGS+G + K R A+K + L S+S +D +E+ +L +
Sbjct: 1 DFKVLKKLGKGSYGSVYKVK-RLSDNQFYALKEVDLGSMSQKER--EDAVNEIRILASVN 57
Query: 99 HPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL---KEKGALSPSTAV-NFALDIARGMA 154
HPNI+ + A + L ++ EY GDL K + K+K L P + + + RG+
Sbjct: 58 HPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQ 117
Query: 155 YLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET--GSY 212
LH I+HRDLK N+LLV + D +K+GD G+SK++K K +T G+
Sbjct: 118 ALHE--QKILHRDLKSANILLVAN--DLVKIGDLGISKVLK--------KNMAKTQIGTP 165
Query: 213 RYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKG 272
YMAPEV+K R Y K D++S +LYEM PP + V G P
Sbjct: 166 HYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPI- 224
Query: 273 FTPELRELTEKCWAADMNQRPSFLDIL 299
++ +L+ RP+ IL
Sbjct: 225 YSQDLQNFIRSMLQVKPKLRPNCDKIL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 5e-32
Identities = 77/260 (29%), Positives = 130/260 (50%), Gaps = 31/260 (11%)
Query: 43 DFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLV----IQDFRHEVNLLVK 96
DF +G GSFG ++ +G+ A+K LS ++V ++ +E +L
Sbjct: 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKI----LSKAKIVKLKQVEHVLNEKRILQS 57
Query: 97 LRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYL 156
+RHP +V G+ + L L+ EY+ GG+L +L++ G A +A + + YL
Sbjct: 58 IRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYL 117
Query: 157 HNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET----GSY 212
H+ I++RDLKP N+LL S ++K+ DFG +K +K G T G+
Sbjct: 118 HS--LDIVYRDLKPENLLL--DSDGYIKITDFGFAKRVK-----------GRTYTLCGTP 162
Query: 213 RYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKG 272
Y+APE+ + Y K VD ++ +++YEML G PP + P + + + EG F
Sbjct: 163 EYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRF--PSF 220
Query: 273 FTPELRELTEKCWAADMNQR 292
F+P+ ++L D+ +R
Sbjct: 221 FSPDAKDLIRNLLQVDLTKR 240
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 120 bits (301), Expect = 5e-32
Identities = 86/279 (30%), Positives = 137/279 (49%), Gaps = 17/279 (6%)
Query: 38 DPSELDFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLV 95
DP EL F+ IGKGSFGE+ K T VAIK I ++D I+D + E+ +L
Sbjct: 1 DPEEL-FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDE--IEDIQQEITVLS 57
Query: 96 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 155
+ P + ++ G+ + L +I EYL GG L+ G +I +G+ Y
Sbjct: 58 QCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLR-AGPFDEFQIATMLKEILKGLDY 116
Query: 156 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS-KLIKVQNSHDVYKMTGETGSYRY 214
LH+E IHRD+K NVLL S +K+ DFG++ +L Q + + G+ +
Sbjct: 117 LHSEKK--IHRDIKAANVLL--SEQGDVKLADFGVAGQLTDTQIKRNTF-----VGTPFW 167
Query: 215 MAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFT 274
MAPEV + YD K D++S + E+ +GEPP ++ P + + + P + F+
Sbjct: 168 MAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGE-FS 226
Query: 275 PELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPTDH 313
+E + C D + RP+ ++LK +K T +
Sbjct: 227 KPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAKKTSY 265
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 6e-32
Identities = 86/265 (32%), Positives = 131/265 (49%), Gaps = 19/265 (7%)
Query: 35 WEIDPSELDFSSSAIIGKGSFGEILKAYWRG-TPVAIKRILPSLSDDRLVIQDFRHEVNL 93
WEI L +G G FGE+ W G T VA+K + P + + F E +
Sbjct: 1 WEIPRESLQLIKK--LGNGQFGEVWMGTWNGNTKVAVKTLKPG----TMSPESFLEEAQI 54
Query: 94 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK--EKGALSPSTAVNFALDIAR 151
+ KLRH +VQ L AV +P+ ++TEY+ G L +LK E AL V+ A +A
Sbjct: 55 MKKLRHDKLVQ-LYAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAA 113
Query: 152 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGS 211
GMAY+ E IHRDL+ N+L+ + K+ DFGL++LI+ ++ G
Sbjct: 114 GMAYI--ERMNYIHRDLRSANILVGDGLV--CKIADFGLARLIE---DNEYTARQGAKFP 166
Query: 212 YRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKYVAEGHRPFFRA 270
++ APE + ++ K DV+SF ++L E++ +G P E + V G+R
Sbjct: 167 IKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYR-MPCP 225
Query: 271 KGFTPELRELTEKCWAADMNQRPSF 295
+ L EL +CW D +RP+F
Sbjct: 226 QDCPISLHELMLQCWKKDPEERPTF 250
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 6e-32
Identities = 74/201 (36%), Positives = 110/201 (54%), Gaps = 18/201 (8%)
Query: 50 IGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 107
+G G+FG + A G VAIK+I+ S L + +R E+ LL LRH NI+
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYR-ELKLLKHLRHENIISLSD 76
Query: 108 A-VTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 166
++ + + +TE L G DLH+ L + L F I RG+ Y+H+ ++HR
Sbjct: 77 IFISPLEDIYFVTE-LLGTDLHRLLTSR-PLEKQFIQYFLYQILRGLKYVHSAG--VVHR 132
Query: 167 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV-FKHRKY 225
DLKP N +L+N + D LK+ DFGL++ +Q+ MTG + Y APE+ +KY
Sbjct: 133 DLKPSN-ILINENCD-LKICDFGLAR---IQDPQ----MTGYVSTRYYRAPEIMLTWQKY 183
Query: 226 DKKVDVFSFAMILYEMLEGEP 246
D +VD++S I EMLEG+P
Sbjct: 184 DVEVDIWSAGCIFAEMLEGKP 204
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 8e-32
Identities = 87/265 (32%), Positives = 133/265 (50%), Gaps = 19/265 (7%)
Query: 35 WEIDPSELDFSSSAIIGKGSFGEILKAYWRG-TPVAIKRILPSLSDDRLVIQDFRHEVNL 93
WE+ L +G G FGE+ Y+ G T VAIK SL + + F E NL
Sbjct: 1 WEVPRETLKLVKK--LGAGQFGEVWMGYYNGHTKVAIK----SLKQGSMSPEAFLAEANL 54
Query: 94 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK--EKGALSPSTAVNFALDIAR 151
+ +L+HP +V+ L AV ++P+ +ITEY+ G L +LK E L+ + ++ A IA
Sbjct: 55 MKQLQHPRLVR-LYAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAE 113
Query: 152 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGS 211
GMA++ E IHRDL+ N+L+ S K+ DFGL++LI+ ++ G
Sbjct: 114 GMAFI--ERKNYIHRDLRAANILV--SETLCCKIADFGLARLIE---DNEYTAREGAKFP 166
Query: 212 YRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRA 270
++ APE + + K DV+SF ++L E++ G P E + + G+R R
Sbjct: 167 IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYR-MPRP 225
Query: 271 KGFTPELRELTEKCWAADMNQRPSF 295
EL EL CW +RP+F
Sbjct: 226 DNCPEELYELMRLCWKEKPEERPTF 250
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 8e-32
Identities = 74/263 (28%), Positives = 120/263 (45%), Gaps = 20/263 (7%)
Query: 50 IGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 107
IG G+ + A VAIKRI L + + + R EV + + HPN+V++
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRI--DLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66
Query: 108 AVTERKPLMLITEYLRGGDLH---KYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVII 164
+ L L+ YL GG L K +G L + ++ +G+ YLH+ N I
Sbjct: 67 SFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS--NGQI 124
Query: 165 HRDLKPRNVLLVNSSADHLKVGDFGLSKLI--KVQNSHDVYKMTGETGSYRYMAPEVFK- 221
HRD+K N+LL + +K+ DFG+S + + V K G+ +MAPEV +
Sbjct: 125 HRDIKAGNILLGEDGS--VKIADFGVSASLADGGDRTRKVRKTF--VGTPCWMAPEVMEQ 180
Query: 222 HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFF----RAKGFTPEL 277
YD K D++SF + E+ G P + Y P + + P K ++
Sbjct: 181 VHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSF 240
Query: 278 RELTEKCWAADMNQRPSFLDILK 300
R++ C D ++RP+ ++LK
Sbjct: 241 RKMISLCLQKDPSKRPTAEELLK 263
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 8e-32
Identities = 72/252 (28%), Positives = 123/252 (48%), Gaps = 16/252 (6%)
Query: 50 IGKGSFGEILKA--YWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 107
IGKG F + KA G VA+K++ D QD E++LL +L HPN++++L
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69
Query: 108 AVTERKPLMLITEYLRGGDLH---KYLKEKGALSPSTAV-NFALDIARGMAYLHNEPNVI 163
+ E L ++ E GDL K+ K++ L P + + + + + ++H++ I
Sbjct: 70 SFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR--I 127
Query: 164 IHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR 223
+HRD+KP NV + + +K+GD GL + + + + G+ YM+PE
Sbjct: 128 MHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAHSLV----GTPYYMSPERIHEN 181
Query: 224 KYDKKVDVFSFAMILYEMLEGEPPLANYEP--YEAAKYVAEGHRPFFRAKGFTPELRELT 281
Y+ K D++S +LYEM + P + Y K + + P A ++ ELR+L
Sbjct: 182 GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLV 241
Query: 282 EKCWAADMNQRP 293
+C D +RP
Sbjct: 242 SRCINPDPEKRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 2e-31
Identities = 84/263 (31%), Positives = 136/263 (51%), Gaps = 22/263 (8%)
Query: 49 IIGKGSFGEILKAYW--RGTPVAIKRIL--PSLSDDRLVIQDFRHEVNLLVKLRHPNIVQ 104
++G+G+FGE+ Y G +A+K++ P + + E+ LL LRH IVQ
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 105 FLGAVT--ERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNV 162
+ G + E K L + EY+ GG + LK GAL+ + + I +G++YLH+ N+
Sbjct: 69 YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHS--NM 126
Query: 163 IIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGE-----TGSYRYMAP 217
I+HRD+K N+L SA ++K+GDFG SK I+ + M+G TG+ +M+P
Sbjct: 127 IVHRDIKGANIL--RDSAGNVKLGDFGASKRIQT-----IC-MSGTGIKSVTGTPYWMSP 178
Query: 218 EVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPEL 277
EV Y +K DV+S A + EML +PP A YE A +A G +
Sbjct: 179 EVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDAC 238
Query: 278 RELTEKCWAADMNQRPSFLDILK 300
R+ ++ + + +RP+ +L+
Sbjct: 239 RDFLKQIFVEE-KRRPTAEFLLR 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 2e-31
Identities = 89/266 (33%), Positives = 132/266 (49%), Gaps = 17/266 (6%)
Query: 38 DPSELDFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLV 95
DP EL F+ IGKGSFGE+ K T VAIK I ++D I+D + E+ +L
Sbjct: 1 DPEEL-FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDE--IEDIQQEITVLS 57
Query: 96 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 155
+ P I ++ G+ + L +I EYL GG LK G L + +I +G+ Y
Sbjct: 58 QCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLK-PGPLEETYIATILREILKGLDY 116
Query: 156 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS-KLIKVQNSHDVYKMTGETGSYRY 214
LH+E IHRD+K NVLL S +K+ DFG++ +L Q + + G+ +
Sbjct: 117 LHSERK--IHRDIKAANVLL--SEQGDVKLADFGVAGQLTDTQIKRNTF-----VGTPFW 167
Query: 215 MAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFT 274
MAPEV K YD K D++S + E+ +GEPP ++ P + + P +
Sbjct: 168 MAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSK 227
Query: 275 PELRELTEKCWAADMNQRPSFLDILK 300
P +E E C D RP+ ++LK
Sbjct: 228 P-FKEFVEACLNKDPRFRPTAKELLK 252
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 3e-31
Identities = 62/201 (30%), Positives = 104/201 (51%), Gaps = 14/201 (6%)
Query: 50 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 107
IG+G++G + KA + G VAIK+I + + R E+ LL +L HPNI++ L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALR-EIKLLKELNHPNIIKLLD 65
Query: 108 AVTERKPLMLITEYLRGGDLHKYLKEKGA-LSPSTAVNFALDIARGMAYLHNEPNVIIHR 166
+ L L+ E++ DL+K +K++ L S ++ + +G+A+ H+ + I+HR
Sbjct: 66 VFRHKGDLYLVFEFMD-TDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHS--HGILHR 122
Query: 167 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV-FKHRKY 225
DLKP N+L+ ++ LK+ DFGL++ T + Y APE+ + Y
Sbjct: 123 DLKPENLLI--NTEGVLKLADFGLARSFGSPVRP----YTHYVVTRWYRAPELLLGDKGY 176
Query: 226 DKKVDVFSFAMILYEMLEGEP 246
VD++S I E+L P
Sbjct: 177 STPVDIWSVGCIFAELLSRRP 197
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 3e-31
Identities = 97/307 (31%), Positives = 148/307 (48%), Gaps = 44/307 (14%)
Query: 29 LPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG---------TPVAIKRILPSLSD 79
LP WE L +G+G FG++++A G VA+K + + +D
Sbjct: 1 LPLDPKWEFPRDRLVLGKP--LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATD 58
Query: 80 DRLVIQDFRHEVNLL-VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK---- 134
L D E+ L+ + +H NI+ LG T+ PL +I EY G+L ++L+ +
Sbjct: 59 KDLA--DLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPG 116
Query: 135 ------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH 182
LS V+ A +ARGM YL E IHRDL RNVL+ + +
Sbjct: 117 PDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYL--ESRRCIHRDLAARNVLV--TEDNV 172
Query: 183 LKVGDFGLSKLIKVQNSHDVYKMTGETG-SYRYMAPEVFKHRKYDKKVDVFSFAMILYEM 241
+K+ DFGL++ + + D YK T ++MAPE R Y + DV+SF ++++E+
Sbjct: 173 MKIADFGLARGV---HDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEI 229
Query: 242 --LEGEP-PLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDI 298
L G P P E E K + EGHR + T EL L +CW A QRP+F +
Sbjct: 230 FTLGGSPYPGIPVE--ELFKLLREGHR-MDKPSNCTHELYMLMRECWHAVPTQRPTFKQL 286
Query: 299 LKRLEKI 305
++ L+K+
Sbjct: 287 VEALDKV 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 5e-31
Identities = 80/268 (29%), Positives = 131/268 (48%), Gaps = 23/268 (8%)
Query: 49 IIGKGSFGEILKAY--WRGTPVAIKRI-LPSLSDDRL------VIQDFRHEVNLLVKLRH 99
+IGKG++G + A G +A+K++ LP+ R +++ R E+ L L H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 100 PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE 159
NIVQ+LG T + L + EY+ GG + L+ G F + G+AYLH++
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSK 127
Query: 160 PNVIIHRDLKPRNVLLVNSSADHL-KVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPE 218
I+HRDLK N+L+ AD + K+ DFG+SK K + +D + GS +MAPE
Sbjct: 128 G--ILHRDLKADNLLV---DADGICKISDFGISK--KSDDIYDNDQNMSMQGSVFWMAPE 180
Query: 219 VF--KHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAA-KYVAEGHRPFFR---AKG 272
V + Y KVD++S ++ EM G P ++ E A K + P +
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMN 240
Query: 273 FTPELRELTEKCWAADMNQRPSFLDILK 300
+P + C+ + + RP+ ++L+
Sbjct: 241 LSPVALDFLNACFTINPDNRPTARELLQ 268
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 5e-31
Identities = 84/283 (29%), Positives = 136/283 (48%), Gaps = 32/283 (11%)
Query: 44 FSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSL--SDDRLVIQDFRHEVNLLVK 96
F+ ++GKG FG + +A + VA+K + + S D I++F E + +
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSD---IEEFLREAACMKE 57
Query: 97 LRHPNIVQFLGAVTERKPL------MLITEYLRGGDLHKYL------KEKGALSPSTAVN 144
HPN+++ +G + M+I +++ GDLH +L +E L T V
Sbjct: 58 FDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVR 117
Query: 145 FALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK 204
F +DIA GM YL ++ IHRDL RN +L + + V DFGLSK I S D Y+
Sbjct: 118 FMIDIASGMEYLSSKN--FIHRDLAARNCMLNENMT--VCVADFGLSKKIY---SGDYYR 170
Query: 205 MTGETG-SYRYMAPEVFKHRKYDKKVDVFSFAMILYE-MLEGEPPLANYEPYEAAKYVAE 262
+ +++A E Y DV++F + ++E M G+ P A E E Y+ +
Sbjct: 171 QGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIK 230
Query: 263 GHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKI 305
G+R + ++ EL +CW+ + RPSF + +LE I
Sbjct: 231 GNR-LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 7e-31
Identities = 95/305 (31%), Positives = 146/305 (47%), Gaps = 40/305 (13%)
Query: 29 LPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG---------TPVAIKRILPSLSD 79
LP WE+ L +G+G FG+++ A G T VA+K + ++
Sbjct: 7 LPEDPRWEVPRDRLVLGKP--LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATE 64
Query: 80 DRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA-- 136
L D E+ ++ + +H NI+ LGA T+ PL +I EY G+L +YL+ +
Sbjct: 65 KDL--SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPG 122
Query: 137 --------------LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH 182
LS V+ A +ARGM YL ++ IHRDL RNVL+ +
Sbjct: 123 MEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNV-- 178
Query: 183 LKVGDFGLSKLIKVQNSHDVYKMTGETG-SYRYMAPEVFKHRKYDKKVDVFSFAMILYEM 241
+K+ DFGL++ I + D YK T ++MAPE R Y + DV+SF ++L+E+
Sbjct: 179 MKIADFGLARDI---HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 235
Query: 242 LE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILK 300
G P E K + EGHR + T EL + CW A +QRP+F +++
Sbjct: 236 FTLGGSPYPGVPVEELFKLLKEGHR-MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 294
Query: 301 RLEKI 305
L++I
Sbjct: 295 DLDRI 299
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 7e-31
Identities = 80/269 (29%), Positives = 133/269 (49%), Gaps = 36/269 (13%)
Query: 49 IIGKGSFGE-ILKAYWR---GTPVAIKRI-LPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 103
++GKG+FGE L Y R + V K + L LS+ +D +E+ +L L+HPNI+
Sbjct: 7 VLGKGAFGEATL--YRRTEDDSLVVWKEVNLTRLSEK--ERRDALNEIVILSLLQHPNII 62
Query: 104 QFLGAVTERKPLMLITEYLRGGDLH-KYLKEKGALSPSTAVNFAL-DIARGMAYLHNEPN 161
+ + L++ EY GG L+ K +++KG L V + L I ++Y+H
Sbjct: 63 AYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG- 121
Query: 162 VIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET--GSYRYMAPEV 219
I+HRD+K N+ L + A +K+GDFG+SK++ + S ET G+ YM+PE+
Sbjct: 122 -ILHRDIKTLNIFL--TKAGLIKLGDFGISKILGSEYSM------AETVVGTPYYMSPEL 172
Query: 220 FKHRKYDKKVDVFSFAMILYEML------EGEPPLANYEPYEAAKYVAEGHRPFFRAKGF 273
+ KY+ K D+++ +LYE+L + PL K V + P +
Sbjct: 173 CQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN-----LVVKIVQGNYTPV--VSVY 225
Query: 274 TPELRELTEKCWAADMNQRPSFLDILKRL 302
+ EL L D +RP+ ++L +
Sbjct: 226 SSELISLVHSLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 8e-31
Identities = 73/257 (28%), Positives = 127/257 (49%), Gaps = 25/257 (9%)
Query: 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRI-LPSLSDDRLVIQDFRHEVNLLVKLRH 99
D +G G+FG + R A+K + +P + + Q +E +L ++ H
Sbjct: 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQ-EQHVHNEKRVLKEVSH 60
Query: 100 PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE 159
P I++ +++ L ++ EY+ GG+L YL+ G S ST + +A +I + YLH++
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK 120
Query: 160 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET----GSYRYM 215
I++RDLKP N+LL H+K+ DFG +K K+ T G+ Y+
Sbjct: 121 E--IVYRDLKPENILL--DKEGHIKLTDFGFAK-----------KLRDRTWTLCGTPEYL 165
Query: 216 APEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTP 275
APEV + + ++K VD ++ +++YEML G PP + P+ + + G F R
Sbjct: 166 APEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRH--LDL 223
Query: 276 ELRELTEKCWAADMNQR 292
++L +K D +R
Sbjct: 224 YAKDLIKKLLVVDRTRR 240
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 9e-31
Identities = 79/254 (31%), Positives = 127/254 (50%), Gaps = 20/254 (7%)
Query: 50 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 107
IG G++G++ KA G VAIK I DD +IQ E+++L + RHPNIV + G
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQ---QEISMLKECRHPNIVAYFG 67
Query: 108 AVTERKPLMLITEYLRGGDLHK-YLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 166
+ R L ++ EY GG L Y +G LS + +G+AYLH IHR
Sbjct: 68 SYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHE--TGKIHR 125
Query: 167 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF---KHR 223
D+K N+LL + +K+ DFG+S + + + K G+ +MAPEV +
Sbjct: 126 DIKGANILL--TEDGDVKLADFGVSAQL----TATIAKRKSFIGTPYWMAPEVAAVERKG 179
Query: 224 KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHR--PFFRAKG-FTPELREL 280
YD K D+++ + E+ E +PP+ + P A +++ + P + K ++P +
Sbjct: 180 GYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDF 239
Query: 281 TEKCWAADMNQRPS 294
+KC D +RP+
Sbjct: 240 IKKCLTKDPKKRPT 253
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 1e-30
Identities = 79/263 (30%), Positives = 137/263 (52%), Gaps = 16/263 (6%)
Query: 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 100
DF IGKGSFG + K + A+K+I S +R ++ E +L KL
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLS-KMNRREREEAIDEARVLAKLDSS 59
Query: 101 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLK-EKGALSPSTAV-NFALDIARGMAYLHN 158
I+++ + ++ L ++ EY GDLHK LK ++G P V F + I G+A+LH+
Sbjct: 60 YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS 119
Query: 159 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPE 218
I+HRD+K N+ L + D++K+GD G++KL+ + T G+ Y++PE
Sbjct: 120 --KKILHRDIKSLNLFL--DAYDNVKIGDLGVAKLLSDNT---NFANT-IVGTPYYLSPE 171
Query: 219 VFKHRKYDKKVDVFSFAMILYEMLEGEPPL-ANYEPYEAAKYVAEGHRPFFRAKGFTPEL 277
+ + + Y++K DV++ ++LYE G+ P AN + K + P ++ ++ +L
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPV--SQMYSQQL 229
Query: 278 RELTEKCWAADMNQRPSFLDILK 300
+L ++C D QRP +L+
Sbjct: 230 AQLIDQCLTKDYRQRPDTFQLLR 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 1e-30
Identities = 75/226 (33%), Positives = 118/226 (52%), Gaps = 11/226 (4%)
Query: 42 LDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRIL--PSLSDDRLVIQDFRHEVNLLVKL 97
+++ ++G+G+FG + Y G +A K++ P + + E+ LL L
Sbjct: 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL 61
Query: 98 RHPNIVQFLGAVTER--KPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 155
+H IVQ+ G + +R K L + EY+ GG + LK GAL+ S + I GM+Y
Sbjct: 62 QHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSY 121
Query: 156 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYM 215
LH+ N+I+HRD+K N+L SA ++K+GDFG SK ++ + TG+ +M
Sbjct: 122 LHS--NMIVHRDIKGANIL--RDSAGNVKLGDFGASKRLQTICMSGT-GIRSVTGTPYWM 176
Query: 216 APEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA 261
+PEV Y +K DV+S + EML +PP A YE A +A
Sbjct: 177 SPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIA 222
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 2e-30
Identities = 74/277 (26%), Positives = 124/277 (44%), Gaps = 35/277 (12%)
Query: 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRH-----EVNLLV 95
DF IIG+GSF ++ A + AIK + D R +I++ + E +L
Sbjct: 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKIL-----DKRQLIKEKKVKYVKIEKEVLT 56
Query: 96 KL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMA 154
+L HP I++ + + L + EY G+L +Y+++ G+L +A +I +
Sbjct: 57 RLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALE 116
Query: 155 YLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK------------VQNSHDV 202
YLH+ IIHRDLKP N+LL H+K+ DFG +K++ +
Sbjct: 117 YLHS--KGIIHRDLKPENILL--DKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQI 172
Query: 203 YKMTGETGSY----RYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAK 258
K S+ Y++PE+ + K D+++ I+Y+ML G+PP Y +
Sbjct: 173 EKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQ 232
Query: 259 YVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSF 295
+ + F F P+ ++L EK D R
Sbjct: 233 KILKLEYSF--PPNFPPDAKDLIEKLLVLDPQDRLGV 267
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 2e-30
Identities = 81/267 (30%), Positives = 138/267 (51%), Gaps = 19/267 (7%)
Query: 49 IIGKGSFGEILKAYW-----RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 103
+IGKG FG + + A+K L ++D V Q F E ++ HPN++
Sbjct: 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKS-LNRITDLEEVEQ-FLKEGIIMKDFSHPNVL 59
Query: 104 QFLGAV--TERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARGMAYLHNEP 160
LG +E PL+++ Y++ GDL ++ E + + F L +A+GM YL ++
Sbjct: 60 SLLGICLPSEGSPLVVLP-YMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK 118
Query: 161 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF 220
V HRDL RN +L S +KV DFGL++ I + + V+ TG ++MA E
Sbjct: 119 FV--HRDLAARNCMLDESF--TVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESL 174
Query: 221 KHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPE-LR 278
+ +K+ K DV+SF ++L+E++ G PP + + ++ Y+ +G R + P+ L
Sbjct: 175 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRR--LLQPEYCPDPLY 232
Query: 279 ELTEKCWAADMNQRPSFLDILKRLEKI 305
E+ CW RP+F +++ R+E+I
Sbjct: 233 EVMLSCWHPKPEMRPTFSELVSRIEQI 259
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 3e-30
Identities = 90/305 (29%), Positives = 144/305 (47%), Gaps = 40/305 (13%)
Query: 29 LPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG---------TPVAIKRILPSLSD 79
LP WE +L +G+G FG+++ A G VA+K + ++
Sbjct: 4 LPEDPRWEFSRDKLTLGKP--LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATE 61
Query: 80 DRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALS 138
L D E+ ++ + +H NI+ LGA T+ PL +I EY G+L +YL+ +
Sbjct: 62 KDL--SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPG 119
Query: 139 ----------PSTAVNF------ALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH 182
P + F +ARGM YL ++ IHRDL RNVL+ ++
Sbjct: 120 MEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK--CIHRDLAARNVLVTENNV-- 175
Query: 183 LKVGDFGLSKLIKVQNSHDVYKMTGETG-SYRYMAPEVFKHRKYDKKVDVFSFAMILYEM 241
+K+ DFGL++ + N+ D YK T ++MAPE R Y + DV+SF ++++E+
Sbjct: 176 MKIADFGLARDV---NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 232
Query: 242 LE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILK 300
G P E K + EGHR + T EL + CW A + RP+F +++
Sbjct: 233 FTLGGSPYPGIPVEELFKLLKEGHR-MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVE 291
Query: 301 RLEKI 305
L++I
Sbjct: 292 DLDRI 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 6e-30
Identities = 84/283 (29%), Positives = 144/283 (50%), Gaps = 33/283 (11%)
Query: 50 IGKGSFGEILKAY-WRGTP------VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 102
+G+G+FG++ A + P VA+K + + + R +DF E LL L+H +I
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNAR---KDFHREAELLTNLQHEHI 69
Query: 103 VQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA-------------LSPSTAVNFALDI 149
V+F G E PL+++ EY++ GDL+K+L+ G L+ S ++ A I
Sbjct: 70 VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQI 129
Query: 150 ARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET 209
A GM YL ++ +HRDL RN L+ + +K+GDFG+S+ + S D Y++ G T
Sbjct: 130 AAGMVYLASQH--FVHRDLATRNCLVGENLL--VKIGDFGMSRDVY---STDYYRVGGHT 182
Query: 210 G-SYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPF 267
R+M PE +RK+ + DV+S ++L+E+ G+ P E + + +G R
Sbjct: 183 MLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQG-RVL 241
Query: 268 FRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLP 310
R + E+ +L CW + + R + +I L+ + + P
Sbjct: 242 QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKASP 284
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 7e-30
Identities = 81/260 (31%), Positives = 135/260 (51%), Gaps = 17/260 (6%)
Query: 50 IGKGSFGEILKAYWR----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 105
+G G+FG + K ++ VAIK +L + +++ V + E ++ +L +P IV+
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIK-VLKN-ENEKSVRDEMMREAEIMHQLDNPYIVRM 60
Query: 106 LGAVTERKPLMLITEYLRGGDLHKYLK-EKGALSPSTAVNFALDIARGMAYLHNEPNVII 164
+G V E + LML+ E GG L+K+L +K ++ S V ++ GM YL E +
Sbjct: 61 IG-VCEAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYL--EGKNFV 117
Query: 165 HRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKM-TGETGSYRYMAPEVFKHR 223
HRDL RNVLLVN + K+ DFGLSK + +S+ YK + ++ APE R
Sbjct: 118 HRDLAARNVLLVNQH--YAKISDFGLSKALGADDSY--YKARSAGKWPLKWYAPECINFR 173
Query: 224 KYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTE 282
K+ + DV+S+ + ++E G+ P + E ++ +G R A+ PE+ L +
Sbjct: 174 KFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAE-CPPEMYALMK 232
Query: 283 KCWAADMNQRPSFLDILKRL 302
CW RP+F + +R+
Sbjct: 233 DCWIYKWEDRPNFAKVEERM 252
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 9e-30
Identities = 90/275 (32%), Positives = 138/275 (50%), Gaps = 23/275 (8%)
Query: 35 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGT-PVAIKRILPSLSDDRLVIQDFRHEVNL 93
WEI L +G+G FGE+ W GT VAIK + P ++ + F E +
Sbjct: 1 WEIPRESLRLDVK--LGQGCFGEVWMGTWNGTTKVAIKTLKPG----TMMPEAFLQEAQI 54
Query: 94 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA--LSPSTAVNFALDIAR 151
+ KLRH +V V+E +P+ ++TE++ G L +LKE L V+ A IA
Sbjct: 55 MKKLRHDKLVPLYAVVSE-EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIAD 113
Query: 152 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHL--KVGDFGLSKLIKVQNSHDVYKMTGET 209
GMAY+ E IHRDL+ N+L+ D+L K+ DFGL++LI+ ++ G
Sbjct: 114 GMAYI--ERMNYIHRDLRAANILV----GDNLVCKIADFGLARLIE---DNEYTARQGAK 164
Query: 210 GSYRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKYVAEGHRPFF 268
++ APE + ++ K DV+SF ++L E++ +G P E + V G+R
Sbjct: 165 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYR-MP 223
Query: 269 RAKGFTPELRELTEKCWAADMNQRPSFLDILKRLE 303
+G L EL + CW D ++RP+F I LE
Sbjct: 224 CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 1e-29
Identities = 90/283 (31%), Positives = 134/283 (47%), Gaps = 36/283 (12%)
Query: 50 IGKGSFGE-ILKAY-----WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 103
+G+G FG+ L Y G VA+K + ++ E+N+L L H NIV
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNT--SGWKKEINILKTLYHENIV 69
Query: 104 QFLGAVTER--KPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPN 161
++ G +E+ K L LI EY+ G L YL K L+ + + FA I GMAYLH++
Sbjct: 70 KYKGCCSEQGGKGLQLIMEYVPLGSLRDYLP-KHKLNLAQLLLFAQQICEGMAYLHSQH- 127
Query: 162 VIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMT--GETGSYRYMAPEV 219
IHRDL RNVLL N +K+GDFGL+K V H+ Y++ G++ + Y A E
Sbjct: 128 -YIHRDLAARNVLLDNDRL--VKIGDFGLAK--AVPEGHEYYRVREDGDSPVFWY-AVEC 181
Query: 220 FKHRKYDKKVDVFSFAMILYEML-----EGEPPLANYEPYEAAK----------YVAEGH 264
K K+ DV+SF + LYE+L + PP E + + G
Sbjct: 182 LKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGM 241
Query: 265 RPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKE 307
R K E+ L + CW + RP+F ++ L+++
Sbjct: 242 R-LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMHH 283
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 1e-29
Identities = 82/261 (31%), Positives = 125/261 (47%), Gaps = 22/261 (8%)
Query: 50 IGKGSFGEIL----KAYWRGTPVAIKRILP--SLSDDRLVIQDFRHEVNLLVKLRHPNIV 103
+GKGSFG + K + + + +P L+ + V + E LL KL HP IV
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQ--EAQLLSKLDHPAIV 65
Query: 104 QFLGAVTERKPLMLITEYLRGGDL----HKYLKEKGALSPSTAVNFALDIARGMAYLHNE 159
+F + ER +ITEY G DL + LS + + + + G+ Y+H
Sbjct: 66 KFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR 125
Query: 160 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV 219
I+HRDLK +N+ L N + LK+GDFG+S+L+ S D+ T TG+ YM+PE
Sbjct: 126 R--ILHRDLKAKNIFLKN---NLLKIGDFGVSRLL--MGSCDL--ATTFTGTPYYMSPEA 176
Query: 220 FKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRE 279
KH+ YD K D++S ILYEM + EG P + ++ +L
Sbjct: 177 LKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSL-PETYSRQLNS 235
Query: 280 LTEKCWAADMNQRPSFLDILK 300
+ + D + RPS +IL+
Sbjct: 236 IMQSMLNKDPSLRPSAAEILR 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 1e-29
Identities = 85/282 (30%), Positives = 140/282 (49%), Gaps = 32/282 (11%)
Query: 38 DPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLV 95
DP+ F +IG+G++G++ KA + G VAIK I+ + D+ ++ + E N+L
Sbjct: 3 DPTG-IFELVEVIGEGTYGKVYKARHKKTGQLVAIK-IMDIIEDE---EEEIKEEYNILR 57
Query: 96 KL-RHPNIVQFLGAVTERKP------LMLITEYLRGG---DLHKYLKEKGALSPSTAVNF 145
K HPNI F GA ++ P L L+ E GG DL K L++KG + +
Sbjct: 58 KYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAY 117
Query: 146 AL-DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK 204
L + RG+AYLH N +IHRD+K +N+LL ++ +K+ DFG+S Q + +
Sbjct: 118 ILRETLRGLAYLHE--NKVIHRDIKGQNILLTKNA--EVKLVDFGVSA----QLDSTLGR 169
Query: 205 MTGETGSYRYMAPEVF-----KHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKY 259
G+ +MAPEV YD + DV+S + E+ +G+PPL + P A
Sbjct: 170 RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFK 229
Query: 260 VAEGHRP-FFRAKGFTPELRELTEKCWAADMNQRPSFLDILK 300
+ P + ++ + + +C + QRP ++L+
Sbjct: 230 IPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 1e-29
Identities = 86/287 (29%), Positives = 138/287 (48%), Gaps = 54/287 (18%)
Query: 50 IGKGSFGEI-------LKAY-------WRGTP--VAIKRILPSLSDDRLVIQDFRHEVNL 93
+G+G FGE+ L + + G P VA+K + ++ + DF E+ +
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVT--KTARNDFLKEIKI 70
Query: 94 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVN--------- 144
+ +L++PNI++ LG PL +ITEY+ GDL+++L ++ S T N
Sbjct: 71 MSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIAN 130
Query: 145 ---FALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHD 201
A+ IA GM YL + +HRDL RN L+ N +K+ DFG+S+ + S D
Sbjct: 131 LLYMAVQIASGMKYLASLN--FVHRDLATRNCLVGNHYT--IKIADFGMSRNLY---SGD 183
Query: 202 VYKMTGETG-SYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYE--AAK 258
Y++ G R+MA E K+ DV++F + L+EM L +PY + +
Sbjct: 184 YYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT----LCKEQPYSLLSDE 239
Query: 259 YVAEGHRPFFRAKGF------TP----ELRELTEKCWAADMNQRPSF 295
V E FFR +G TP + +L +CW+ D+ RP+F
Sbjct: 240 QVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTF 286
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 2e-29
Identities = 79/265 (29%), Positives = 136/265 (51%), Gaps = 19/265 (7%)
Query: 35 WEIDPSELDFSSSAIIGKGSFGEI-LKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNL 93
WEI L +G G FGE+ + Y + T VA+K + P + ++ F E N+
Sbjct: 1 WEIPRESLKLEKK--LGAGQFGEVWMATYNKHTKVAVKTMKPG----SMSVEAFLAEANV 54
Query: 94 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK-EKGALSP-STAVNFALDIAR 151
+ L+H +V+ L AV ++P+ +ITE++ G L +LK ++G+ P ++F+ IA
Sbjct: 55 MKTLQHDKLVK-LHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAE 113
Query: 152 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGS 211
GMA++ E IHRDL+ N+L+ S++ K+ DFGL+++I+ ++ G
Sbjct: 114 GMAFI--EQRNYIHRDLRAANILV--SASLVCKIADFGLARVIE---DNEYTAREGAKFP 166
Query: 212 YRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRA 270
++ APE + K DV+SF ++L E++ G P E + + G+R R
Sbjct: 167 IKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR-MPRP 225
Query: 271 KGFTPELRELTEKCWAADMNQRPSF 295
+ EL + +CW +RP+F
Sbjct: 226 ENCPEELYNIMMRCWKNRPEERPTF 250
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 2e-29
Identities = 76/253 (30%), Positives = 121/253 (47%), Gaps = 19/253 (7%)
Query: 50 IGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 107
+G G+ G + K R T +A+K I ++ + Q R E+++L K P IV F G
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLE-INEAIQKQILR-ELDILHKCNSPYIVGFYG 66
Query: 108 AVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 166
A + + EY+ GG L K LKE +G + A+ + +G+ YLH + IIHR
Sbjct: 67 AFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK-IIHR 125
Query: 167 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYD 226
D+KP N+L+ +S +K+ DFG+S ++ NS G+ YMAPE + Y
Sbjct: 126 DVKPSNILV--NSRGQIKLCDFGVSG--QLVNS----LAKTFVGTSSYMAPERIQGNDYS 177
Query: 227 KKVDVFSFAMILYEMLEGEPPLANYE-----PYEAAKYVAEGHRPFFRAKGFTPELRELT 281
K D++S + L E+ G P +E +Y+ P + F+P+ ++
Sbjct: 178 VKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFV 237
Query: 282 EKCWAADMNQRPS 294
C D +RPS
Sbjct: 238 NLCLIKDPRERPS 250
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 3e-29
Identities = 86/268 (32%), Positives = 132/268 (49%), Gaps = 25/268 (9%)
Query: 35 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTP-VAIKRILPSLSDDRLVIQDFRHEVNL 93
WEI L +G+G FGE+ W GT VAIK + P + + F E +
Sbjct: 1 WEIPRESLRLEVK--LGQGCFGEVWMGTWNGTTRVAIKTLKPG----TMSPEAFLQEAQV 54
Query: 94 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA--LSPSTAVNFALDIAR 151
+ KLRH +VQ V+E +P+ ++TEY+ G L +LK + L V+ A IA
Sbjct: 55 MKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIAS 113
Query: 152 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHL--KVGDFGLSKLIKVQNSHDVYKMTGET 209
GMAY+ E +HRDL+ N+L+ ++L KV DFGL++LI+ ++ G
Sbjct: 114 GMAYV--ERMNYVHRDLRAANILV----GENLVCKVADFGLARLIE---DNEYTARQGAK 164
Query: 210 GSYRYMAPEVFKHRKYDKKVDVFSFAMILYEM-LEGEPPLANYEPYEAAKYVAEGHRPFF 268
++ APE + ++ K DV+SF ++L E+ +G P E V G+R
Sbjct: 165 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR--M 222
Query: 269 RAKGFTPE-LRELTEKCWAADMNQRPSF 295
PE L +L +CW + +RP+F
Sbjct: 223 PCPPECPESLHDLMCQCWRKEPEERPTF 250
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 3e-29
Identities = 73/212 (34%), Positives = 103/212 (48%), Gaps = 27/212 (12%)
Query: 49 IIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 106
IG G++G + A G VAIK+I D + R E+ LL LRH NI+ L
Sbjct: 7 PIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILR-EIKLLRHLRHENIIGLL 65
Query: 107 GAVTERKP-----LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLH--NE 159
+ P + ++TE + DLHK +K L+ F I RG+ YLH N
Sbjct: 66 DILRPPSPEDFNDVYIVTELM-ETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSAN- 123
Query: 160 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGE--TGSYRYMAP 217
+IHRDLKP N +LVNS+ D LK+ DFGL++ + + +T T YR AP
Sbjct: 124 ---VIHRDLKPSN-ILVNSNCD-LKICDFGLARGVDPDEDEKGF-LTEYVVTRWYR--AP 175
Query: 218 EV---FKHRKYDKKVDVFSFAMILYEMLEGEP 246
E+ Y K +D++S I E+L +P
Sbjct: 176 ELLLSSSR--YTKAIDIWSVGCIFAELLTRKP 205
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 3e-29
Identities = 93/292 (31%), Positives = 138/292 (47%), Gaps = 36/292 (12%)
Query: 43 DFSSSAIIGKGSFGEILKAYWRG----TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL- 97
D +IG+G+FG++LKA + AIKR+ S D +DF E+ +L KL
Sbjct: 8 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH--RDFAGELEVLCKLG 65
Query: 98 RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK----------------GALSPST 141
HPNI+ LGA R L L EY G+L +L++ LS
Sbjct: 66 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 125
Query: 142 AVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHD 201
++FA D+ARGM YL + IHRDL RN+L+ + K+ DFGLS+ +
Sbjct: 126 LLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYV--AKIADFGLSR------GQE 175
Query: 202 VY-KMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKY 259
VY K T R+MA E + Y DV+S+ ++L+E++ G P E +
Sbjct: 176 VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK 235
Query: 260 VAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPT 311
+ +G+R + E+ +L +CW +RPSF IL L ++ E T
Sbjct: 236 LPQGYR-LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 286
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 4e-29
Identities = 86/274 (31%), Positives = 134/274 (48%), Gaps = 27/274 (9%)
Query: 41 ELDFSSS---AIIGKGSFGEILKAYWRGTPV--AIKRILPSLSDDRLVIQDFRHEVNLLV 95
E ++ + ++GKG++G + A T V AIK I D R V Q E+ L
Sbjct: 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEI--PERDSRYV-QPLHEEIALHS 60
Query: 96 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK-GALSP--STAVNFALDIARG 152
L+H NIVQ+LG+ +E + E + GG L L+ K G L T + + I G
Sbjct: 61 YLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEG 120
Query: 153 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK-LIKVQNSHDVYKMTGETGS 211
+ YLH+ N I+HRD+K NV LVN+ + +K+ DFG SK L + + + TG+
Sbjct: 121 LKYLHD--NQIVHRDIKGDNV-LVNTYSGVVKISDFGTSKRLAGINPCTETF-----TGT 172
Query: 212 YRYMAPEVFKH--RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKY---VAEGHRP 266
+YMAPEV R Y D++S + EM G+PP +AA + + + H
Sbjct: 173 LQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPE 232
Query: 267 FFRAKGFTPELRELTEKCWAADMNQRPSFLDILK 300
+ + E + +C+ D ++R S D+L+
Sbjct: 233 I--PESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 4e-29
Identities = 83/276 (30%), Positives = 137/276 (49%), Gaps = 31/276 (11%)
Query: 50 IGKGSFGEILKA--YWRGTPVAIKRILPSLSDDRLVIQ--DFRHEVNLLVKLRHPNIVQF 105
+G+ +FG+I K Y G A + +L D Q +F+ E +L+ +L HPNIV
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 106 LGAVTERKPLMLITEYLRGGDLHKYL-----------------KEKGALSPSTAVNFALD 148
LG VT+ +P+ ++ EYL GDLH++L K +L ++ A+
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 149 IARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGE 208
IA GM YL + + +H+DL RN+L+ H+K+ D GLS+ I S D Y++ +
Sbjct: 133 IAAGMEYLSS--HFFVHKDLAARNILI--GEQLHVKISDLGLSREIY---SADYYRVQPK 185
Query: 209 T-GSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRP 266
+ R+M PE + K+ D++SF ++L+E+ G P + E + V + +
Sbjct: 186 SLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRK-RQL 244
Query: 267 FFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRL 302
++ P + L +CW ++RP F DI RL
Sbjct: 245 LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 5e-29
Identities = 84/278 (30%), Positives = 131/278 (47%), Gaps = 32/278 (11%)
Query: 49 IIGKGSFGEILKAYWR---GTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 103
I+G+G FG +++ G+ VA+K + + I++F E + HPN++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYS-EIEEFLSEAACMKDFDHPNVM 64
Query: 104 QFLGAVTERKPL------MLITEYLRGGDLHKYL-KEKGALSP-----STAVNFALDIAR 151
+ +G E L M+I +++ GDLH +L + P T + F +DIA
Sbjct: 65 KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIAL 124
Query: 152 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKV--GDFGLSKLIKVQNSHDVYKMTGET 209
GM YL N IHRDL RN +L + + V DFGLSK I S D Y+
Sbjct: 125 GMEYLSNRN--FIHRDLAARNCML----REDMTVCVADFGLSKKIY---SGDYYRQGRIA 175
Query: 210 G-SYRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKYVAEGHRPF 267
+++A E R Y K DV++F + ++E+ G+ P E +E Y+ G+R
Sbjct: 176 KMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNR-L 234
Query: 268 FRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKI 305
+ + EL +L CW AD RP+F + + LE I
Sbjct: 235 KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 5e-29
Identities = 68/235 (28%), Positives = 106/235 (45%), Gaps = 31/235 (13%)
Query: 43 DFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 100
DF +IG+G+FGE+ + T A+K + S R I R E ++L P
Sbjct: 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSP 61
Query: 101 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP 160
IV+ + + + L L+ EY+ GGDL L K TA + ++ + +H
Sbjct: 62 WIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLG 121
Query: 161 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI--------KVQNSHDVYKMTGET--- 209
IHRD+KP N+L+ + H+K+ DFGL K + + +SH++
Sbjct: 122 --FIHRDIKPDNILI--DADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRR 177
Query: 210 --------------GSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLAN 250
G+ Y+APEV + Y + D +S +ILYEML G PP +
Sbjct: 178 RDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYS 232
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 6e-29
Identities = 77/277 (27%), Positives = 126/277 (45%), Gaps = 33/277 (11%)
Query: 35 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPV--AIKRILPSLSDDRLVIQDFRHEVN 92
WEI EL G G+FG++ KA + T + A K I ++ ++DF E++
Sbjct: 7 WEI-IGEL--------GDGAFGKVYKAQHKETGLFAAAKIIQIESEEE---LEDFMVEID 54
Query: 93 LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK--EKGALSPSTAVNFALDIA 150
+L + +HPNIV A L ++ E+ GG L + E+G P +
Sbjct: 55 ILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRY-VCRQML 113
Query: 151 RGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS-KLIKVQNSHDVYKMTGET 209
+ +LH+ + +IHRDLK N+LL + +K+ DFG+S K D +
Sbjct: 114 EALNFLHS--HKVIHRDLKAGNILL--TLDGDVKLADFGVSAKNKSTLQKRDTF-----I 164
Query: 210 GSYRYMAPEV-----FKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH 264
G+ +MAPEV FK YD K D++S + L E+ + EPP P + +
Sbjct: 165 GTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSE 224
Query: 265 RP-FFRAKGFTPELRELTEKCWAADMNQRPSFLDILK 300
P + ++ + + C D + RP+ ++LK
Sbjct: 225 PPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 9e-29
Identities = 79/275 (28%), Positives = 130/275 (47%), Gaps = 34/275 (12%)
Query: 38 DPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFR----HEV 91
DP + IG+GS G + A + G VA+K++ L Q R +EV
Sbjct: 16 DPRS-YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKM-------DLRKQQRRELLFNEV 67
Query: 92 NLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDL-----HKYLKEKGALSPSTAVNFA 146
++ +HPNIV+ + L ++ E+L GG L H + E+ + AV A
Sbjct: 68 VIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLAVLKA 127
Query: 147 LDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMT 206
L ++LH + +IHRD+K ++LL +S +K+ DFG Q S +V +
Sbjct: 128 L------SFLHAQG--VIHRDIKSDSILL--TSDGRVKLSDFGFCA----QVSKEVPRRK 173
Query: 207 GETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRP 266
G+ +MAPEV Y +VD++S +++ EM++GEPP N P +A K + + P
Sbjct: 174 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPP 233
Query: 267 FFR-AKGFTPELRELTEKCWAADMNQRPSFLDILK 300
+ +P LR ++ D QR + ++L
Sbjct: 234 KLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 3e-28
Identities = 94/290 (32%), Positives = 139/290 (47%), Gaps = 40/290 (13%)
Query: 43 DFSSSAIIGKGSFGEILKAYWRG----TPVAIKRI--LPSLSDDRLVIQDFRHEVNLLVK 96
D +IG+G+FG++++A + AIK + S +D R DF E+ +L K
Sbjct: 3 DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHR----DFAGELEVLCK 58
Query: 97 L-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL-------------KEKGALSPSTA 142
L HPNI+ LGA R L + EY G+L +L KE G S T+
Sbjct: 59 LGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTS 118
Query: 143 ---VNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 199
+ FA D+A GM YL + IHRDL RNVL+ + A K+ DFGLS+
Sbjct: 119 QQLLQFASDVATGMQYLSEKQ--FIHRDLAARNVLVGENLAS--KIADFGLSR------G 168
Query: 200 HDVY-KMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAA 257
+VY K T R+MA E + Y K DV+SF ++L+E++ G P E
Sbjct: 169 EEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELY 228
Query: 258 KYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKE 307
+ + +G+R + + E+ EL +CW +RP F I +L ++ E
Sbjct: 229 EKLPQGYR-MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE 277
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 4e-28
Identities = 74/215 (34%), Positives = 116/215 (53%), Gaps = 25/215 (11%)
Query: 43 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKL--- 97
DF+ ++GKGSFG+++ A +GT AIK L D ++IQD E ++ K
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIK----ILKKD-VIIQDDDVECTMVEKRVLA 55
Query: 98 ---RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMA 154
+ P + Q L + EY+ GGDL ++++ G AV +A +IA G+
Sbjct: 56 LPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLF 115
Query: 155 YLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET--GSY 212
+LH++ II+RDLK NV+L + H+K+ DFG+ K + T T G+
Sbjct: 116 FLHSKG--IIYRDLKLDNVML--DAEGHIKIADFGMCK------ENIFGGKTTRTFCGTP 165
Query: 213 RYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPP 247
Y+APE+ ++ Y K VD ++F ++LYEML G+PP
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPP 200
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 1e-27
Identities = 87/269 (32%), Positives = 131/269 (48%), Gaps = 47/269 (17%)
Query: 64 RGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY 121
+G P VA+K + P + + DF EV +L +L+ PNI++ LG + PL +ITEY
Sbjct: 43 KGRPLLVAVKILRPDANKN--ARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEY 100
Query: 122 LRGGDLHKYLKEKG-------------------ALSPSTAVNFALDIARGMAYLHNEPNV 162
+ GDL+++L A+S S+ ++ AL IA GM YL +
Sbjct: 101 MENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN-- 158
Query: 163 IIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETG-SYRYMAPEVFK 221
+HRDL RN L+ +K+ DFG+S+ + + D Y++ G R+MA E
Sbjct: 159 FVHRDLATRNCLV--GENLTIKIADFGMSRNLY---AGDYYRIQGRAVLPIRWMAWECIL 213
Query: 222 HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYE--AAKYVAEGHRPFFRAKG-----FT 274
K+ DV++F + L+E+L L +PY + V E FFR +G F
Sbjct: 214 MGKFTTASDVWAFGVTLWEILM----LCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFR 269
Query: 275 PE-----LRELTEKCWAADMNQRPSFLDI 298
P L EL +CW+ D +RPSF DI
Sbjct: 270 PPPCPQGLYELMLQCWSRDCRERPSFSDI 298
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 1e-27
Identities = 73/259 (28%), Positives = 140/259 (54%), Gaps = 17/259 (6%)
Query: 49 IIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQD---FRHEVNLLVKLRHPNIVQF 105
IG+GSFG+I A + + ++ + ++ +++ + EV LL K++HPNIV F
Sbjct: 7 KIGEGSFGKIYLA--KAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTF 64
Query: 106 LGAVTERKPLMLITEYLRGGDLHKYL-KEKGAL-SPSTAVNFALDIARGMAYLHNEPNVI 163
+ E L ++ EY GGDL K + +++G L S +++ + I+ G+ ++H+ I
Sbjct: 65 FASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK--I 122
Query: 164 IHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR 223
+HRD+K +N+ L + + K+GDFG+++ + +S ++ G+ Y++PE+ ++R
Sbjct: 123 LHRDIKSQNIFL-SKNGMVAKLGDFGIARQL--NDSMELAYTC--VGTPYYLSPEICQNR 177
Query: 224 KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH-RPFFRAKGFTPELRELTE 282
Y+ K D++S +LYE+ + P ++ + +G+ P + F+ +LR L
Sbjct: 178 PYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPI--SPNFSRDLRSLIS 235
Query: 283 KCWAADMNQRPSFLDILKR 301
+ + RPS ILKR
Sbjct: 236 QLFKVSPRDRPSITSILKR 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 2e-27
Identities = 75/255 (29%), Positives = 124/255 (48%), Gaps = 17/255 (6%)
Query: 50 IGKGSFGEILKAY--WRGTPVAIKRI-LPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 106
IG+G+ G + A G VAIK++ L L+I +E+ ++ + +HPNIV +L
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELII----NEILVMRENKHPNIVNYL 82
Query: 107 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 166
+ L ++ EYL GG L + E + + + + +LH+ N +IHR
Sbjct: 83 DSYLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHS--NQVIHR 139
Query: 167 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYD 226
D+K N+LL + +K+ DFG I + S K + G+ +MAPEV + Y
Sbjct: 140 DIKSDNILLGMDGS--VKLTDFGFCAQITPEQS----KRSTMVGTPYWMAPEVVTRKAYG 193
Query: 227 KKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAK-GFTPELRELTEKCW 285
KVD++S ++ EM+EGEPP N P A +A P + + R+ +C
Sbjct: 194 PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCL 253
Query: 286 AADMNQRPSFLDILK 300
D+ +R S ++L+
Sbjct: 254 EMDVEKRGSAKELLQ 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 2e-27
Identities = 83/280 (29%), Positives = 132/280 (47%), Gaps = 32/280 (11%)
Query: 50 IGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 103
+G+G FG++ + G VA+K + P + I D + E+ +L L H NIV
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNH--IADLKKEIEILRNLYHENIV 69
Query: 104 QFLGAVTER--KPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARGMAYLHNEP 160
++ G TE + LI E+L G L +YL + K ++ + +A+ I +GM YL +
Sbjct: 70 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ 129
Query: 161 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF 220
V HRDL RNVL+ + +K+GDFGL+K I+ + K ++ + Y APE
Sbjct: 130 YV--HRDLAARNVLVESEHQ--VKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY-APECL 184
Query: 221 KHRKYDKKVDVFSFAMILYEML----EGEPPLANY----EPYEAAKYVA-------EGHR 265
K+ DV+SF + LYE+L P+ + P V EG R
Sbjct: 185 IQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKR 244
Query: 266 PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKI 305
R E+ +L KCW ++R +F ++++ E I
Sbjct: 245 -LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 2e-27
Identities = 74/259 (28%), Positives = 137/259 (52%), Gaps = 22/259 (8%)
Query: 49 IIGKGSFGEILKAYWRGTP--VAIKRILPS---LSDDRLVIQDFRHEVNLLVKLRHPNIV 103
++G+G+FG + + V IK+I P D+RL Q+ E +L L HPNI+
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQI-PVEQMTKDERLAAQN---ECQVLKLLSHPNII 62
Query: 104 QFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA--LSPSTAVNFALDIARGMAYLHNEPN 161
++ E K LM++ EY GG L +Y++++ L T ++F + I + ++H +
Sbjct: 63 EYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK-- 120
Query: 162 VIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFK 221
+I+HRDLK +N+LL + +K+GDFG+SK++ ++ K G+ Y++PE+ +
Sbjct: 121 LILHRDLKTQNILL-DKHKMVVKIGDFGISKILSSKS-----KAYTVVGTPCYISPELCE 174
Query: 222 HRKYDKKVDVFSFAMILYEMLEGEPPL-ANYEPYEAAKYVAEGHRPFFRAKGFTPELREL 280
+ Y++K D+++ +LYE+ + A P K ++ P + ++P+LR+L
Sbjct: 175 GKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPI--SDRYSPDLRQL 232
Query: 281 TEKCWAADMNQRPSFLDIL 299
D ++RP I+
Sbjct: 233 ILSMLNLDPSKRPQLSQIM 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 3e-27
Identities = 76/266 (28%), Positives = 123/266 (46%), Gaps = 26/266 (9%)
Query: 50 IGKGSFGEILKAYWRGTP---VAIKRIL---PSLSDDRL----VIQDFRHEVNLLVK-LR 98
+G G+FG + K + +A+K I P+ D+ I D EV ++ + LR
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 99 HPNIVQFLGAVTERKPLMLITEYLRG---GDLHKYLKEKGALSPSTAV-NFALDIARGMA 154
HPNIV++ E L ++ + + G G+ LKEK + N + + +
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127
Query: 155 YLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRY 214
YLH E I+HRDL P N++L D + + DFGL+K K S K+T G+ Y
Sbjct: 128 YLHKEKR-IVHRDLTPNNIML--GEDDKVTITDFGLAKQ-KQPES----KLTSVVGTILY 179
Query: 215 MAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFT 274
PE+ K+ Y +K DV++F ILY+M +PP + A + E ++
Sbjct: 180 SCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYS 239
Query: 275 PELRELTEKCWAADMNQRPSFLDILK 300
++ ++ C D RP DI++
Sbjct: 240 EDVTDVITSCLTPDAEARP---DIIQ 262
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 3e-27
Identities = 81/267 (30%), Positives = 132/267 (49%), Gaps = 18/267 (6%)
Query: 38 DPSELDFSSSAIIGKGSFGEILKA--YWRGTPVAIKRI-LPSLSDDRLVIQDFRHEVNLL 94
DP + ++ IG+G+ G + A G VAIK+I L L+I +E+ ++
Sbjct: 16 DPKK-KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELII----NEILVM 70
Query: 95 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMA 154
+L++PNIV FL + L ++ EYL GG L + E + + + + +
Sbjct: 71 KELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALE 129
Query: 155 YLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRY 214
+LH N +IHRD+K NVLL + +K+ DFG I + S K + G+ +
Sbjct: 130 FLH--ANQVIHRDIKSDNVLLGMDGS--VKLTDFGFCAQITPEQS----KRSTMVGTPYW 181
Query: 215 MAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR-AKGF 273
MAPEV + Y KVD++S ++ EM+EGEPP N P A +A P + +
Sbjct: 182 MAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKL 241
Query: 274 TPELRELTEKCWAADMNQRPSFLDILK 300
+P R+ +C D+ +R S ++L+
Sbjct: 242 SPIFRDFLNRCLEMDVEKRGSAKELLQ 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 4e-27
Identities = 75/258 (29%), Positives = 128/258 (49%), Gaps = 24/258 (9%)
Query: 49 IIGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLV---KLRH 99
++G G FG + K W PVAIK I DR Q F+ + ++ L H
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTI-----QDRSGRQTFQEITDHMLAMGSLDH 68
Query: 100 PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHN 158
IV+ LG + L L+T+ G L ++++ + +L P +N+ + IA+GM YL
Sbjct: 69 AYIVRLLG-ICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYL-- 125
Query: 159 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPE 218
E + ++HR+L RN+LL S +++ DFG++ L+ + Y + ++MA E
Sbjct: 126 EEHRMVHRNLAARNILL--KSDSIVQIADFGVADLLYPDDKKYFY--SEHKTPIKWMALE 181
Query: 219 VFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPEL 277
+Y + DV+S+ + ++EM+ G P A P+E + +G R + + T ++
Sbjct: 182 SILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGER-LAQPQICTIDV 240
Query: 278 RELTEKCWAADMNQRPSF 295
+ KCW D N RP+F
Sbjct: 241 YMVMVKCWMIDENVRPTF 258
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 5e-27
Identities = 72/210 (34%), Positives = 107/210 (50%), Gaps = 25/210 (11%)
Query: 48 AIIGKGSFGEILKAYWRGTP--VAIKRILPS--LSDDRLVIQDFRHEVNLLVKLRHPNIV 103
++GKGSFG+++ A +GT AIK + L DD + V L + HP +
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRV-LALAWEHPFLT 59
Query: 104 QFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVI 163
++ L + EYL GGDL +++ G + A +A +I G+ +LH I
Sbjct: 60 HLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHK--KGI 117
Query: 164 IHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET------GSYRYMAP 217
I+RDLK NVLL H+K+ DFG+ K M GE G+ Y+AP
Sbjct: 118 IYRDLKLDNVLL--DKDGHIKIADFGMCKE----------NMNGEGKASTFCGTPDYIAP 165
Query: 218 EVFKHRKYDKKVDVFSFAMILYEMLEGEPP 247
E+ K +KY++ VD +SF ++LYEML G+ P
Sbjct: 166 EILKGQKYNESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 5e-27
Identities = 66/216 (30%), Positives = 107/216 (49%), Gaps = 25/216 (11%)
Query: 50 IGKGSFG--EILKAYWRGTPVAIKRILPSLSDDRLVIQDFR---H---EVNLLVKLRHPN 101
+G G FG E++K + A+K + + I + H E +L + HP
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCV------KKRHIVETGQQEHIFSEKEILEECNHPF 54
Query: 102 IVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPN 161
IV+ ++K + ++ EY GG+L L+++G TA + + YLHN
Sbjct: 55 IVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHN--R 112
Query: 162 VIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFK 221
II+RDLKP N+LL S ++K+ DFG +K K+++ + G Y+APE+
Sbjct: 113 GIIYRDLKPENLLL--DSNGYVKLVDFGFAK--KLKSGQKTWTFCGTPE---YVAPEIIL 165
Query: 222 HRKYDKKVDVFSFAMILYEMLEGEPPLAN--YEPYE 255
++ YD VD +S ++LYE+L G PP +P E
Sbjct: 166 NKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPME 201
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 6e-27
Identities = 67/208 (32%), Positives = 105/208 (50%), Gaps = 21/208 (10%)
Query: 48 AIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKL------RH 99
++GKGSFG++L A +GT A+K L D +++QD E + K +H
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVK----VLKKD-VILQDDDVECTMTEKRVLALAGKH 55
Query: 100 PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE 159
P + Q + L + EY+ GGDL +++ G A +A +I G+ +LH
Sbjct: 56 PFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHER 115
Query: 160 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV 219
II+RDLK NVLL S H+K+ DFG+ K + + G+ Y+APE+
Sbjct: 116 G--IIYRDLKLDNVLL--DSEGHIKIADFGMCK----EGILGGVTTSTFCGTPDYIAPEI 167
Query: 220 FKHRKYDKKVDVFSFAMILYEMLEGEPP 247
++ Y VD ++ ++LYEML G+ P
Sbjct: 168 LSYQPYGPAVDWWALGVLLYEMLAGQSP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-26
Identities = 76/216 (35%), Positives = 116/216 (53%), Gaps = 25/216 (11%)
Query: 43 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKL--- 97
DF+ ++GKGSFG+++ A +GT AIK L D +VIQD E ++ K
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIK----ILKKD-VVIQDDDVECTMVEKRVLA 55
Query: 98 ---RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMA 154
+ P + Q L + EY+ GGDL ++++ G AV +A +I+ G+
Sbjct: 56 LQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLF 115
Query: 155 YLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET--GSY 212
+LH II+RDLK NV+L S H+K+ DFG+ K H V +T T G+
Sbjct: 116 FLHRRG--IIYRDLKLDNVML--DSEGHIKIADFGMCK------EHMVDGVTTRTFCGTP 165
Query: 213 RYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPL 248
Y+APE+ ++ Y K VD +++ ++LYEML G+PP
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPF 201
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-26
Identities = 86/276 (31%), Positives = 124/276 (44%), Gaps = 34/276 (12%)
Query: 38 DPSELDFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLV 95
DP +L F+ IG GSFG + A T VAIK++ S QD EV L
Sbjct: 12 DPEKL-FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70
Query: 96 KLRHPNIVQFLGAVTERKPLMLITEYLRGG-----DLHKYLKEKGALSPSTAVNFA---L 147
+LRHPN +++ G L+ EY G ++HK P V A
Sbjct: 71 QLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHK--------KPLQEVEIAAICH 122
Query: 148 DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG 207
+G+AYLH+ IHRD+K N+LL + +K+ DFG + L+ NS
Sbjct: 123 GALQGLAYLHSHER--IHRDIKAGNILL--TEPGTVKLADFGSASLVSPANSF------- 171
Query: 208 ETGSYRYMAPEV---FKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH 264
G+ +MAPEV +YD KVDV+S + E+ E +PPL N A ++A+
Sbjct: 172 -VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND 230
Query: 265 RPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILK 300
P + ++ R + C RPS ++LK
Sbjct: 231 SPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLK 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 1e-26
Identities = 63/208 (30%), Positives = 101/208 (48%), Gaps = 28/208 (13%)
Query: 50 IGKGSFGEILKAYWR--GTPVAIKRI---LPSLSD-DRLVIQDFRHEVNLLVKL-RHPNI 102
+G G+FG + A + G VAIK++ S + L EV L KL HPNI
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNL------REVKSLRKLNEHPNI 60
Query: 103 VQFLGAVTERKPLMLITEYLRGGDLHKYLK--EKGALSPSTAVNFALDIARGMAYLHNEP 160
V+ E L + EY+ G +L++ +K + S S + I +G+A++H
Sbjct: 61 VKLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK-- 117
Query: 161 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYR-YMAPEV 219
+ HRDLKP N+L+ S + +K+ DFGL++ I+ + + Y T R Y APE+
Sbjct: 118 HGFFHRDLKPENLLV--SGPEVVKIADFGLAREIRSRPPYTDYVST------RWYRAPEI 169
Query: 220 F-KHRKYDKKVDVFSFAMILYEMLEGEP 246
+ Y VD+++ I+ E+ P
Sbjct: 170 LLRSTSYSSPVDIWALGCIMAELYTLRP 197
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 1e-26
Identities = 82/290 (28%), Positives = 142/290 (48%), Gaps = 33/290 (11%)
Query: 35 WEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQDF 87
WE+ ++ S +G+GSFG + + +G T VAIK + + S + +F
Sbjct: 1 WEVAREKITMSRE--LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERI--EF 56
Query: 88 RHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-------KGALSPS 140
+E +++ + ++V+ LG V++ +P ++I E + GDL YL+ +P
Sbjct: 57 LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPP 116
Query: 141 T---AVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 197
+ + A +IA GMAYL+ N +HRDL RN ++ +K+GDFG+++ I
Sbjct: 117 SLKKMIQMAGEIADGMAYLN--ANKFVHRDLAARNCMVAEDFT--VKIGDFGMTRDIY-- 170
Query: 198 NSHDVYKMTGE-TGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYE 255
D Y+ G+ R+M+PE K + DV+SF ++L+E+ E P +
Sbjct: 171 -ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ 229
Query: 256 AAKYVAEGHRPFFRAKGFTPE-LRELTEKCWAADMNQRPSFLDILKRLEK 304
++V EG P+ L EL CW + RPSFL+I+ +++
Sbjct: 230 VLRFVMEGG--LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 2e-26
Identities = 68/219 (31%), Positives = 112/219 (51%), Gaps = 11/219 (5%)
Query: 49 IIGKGSFGEILKAYW--RGTPVAIKRIL--PSLSDDRLVIQDFRHEVNLLVKLRHPNIVQ 104
++G+G+FG + Y G +A+K++ P + + E+ LL L H IVQ
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 105 FLGAV--TERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNV 162
+ G + + L + E++ GG + LK GAL+ + + I G++YLH+ N+
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHS--NM 126
Query: 163 IIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH 222
I+HRD+K N+L S ++K+GDFG SK ++ M TG+ +M+PEV
Sbjct: 127 IVHRDIKGANIL--RDSVGNVKLGDFGASKRLQTICLSGT-GMKSVTGTPYWMSPEVISG 183
Query: 223 RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA 261
Y +K D++S + EML +PP A +E A +A
Sbjct: 184 EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA 222
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-26
Identities = 76/273 (27%), Positives = 132/273 (48%), Gaps = 18/273 (6%)
Query: 41 ELDFSSSAIIGKGSFGEILKAYWR------GTPVAIKRILPSLSDDRLVIQDFRHEVNLL 94
E +F ++G G+FG + K W PVAIK + + S ++ E ++
Sbjct: 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK--ANKEILDEAYVM 63
Query: 95 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGM 153
+ +P++ + LG + + LIT+ + G L Y++E K + +N+ + IA+GM
Sbjct: 64 ASVDNPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 122
Query: 154 AYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYR 213
YL E ++HRDL RNVL+ H+K+ DFGL+KL+ Y G +
Sbjct: 123 NYL--EERRLVHRDLAARNVLVKTP--QHVKITDFGLAKLLGADEKE--YHAEGGKVPIK 176
Query: 214 YMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKG 272
+MA E HR Y + DV+S+ + ++E++ G P E + + +G R +
Sbjct: 177 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER-LPQPPI 235
Query: 273 FTPELRELTEKCWAADMNQRPSFLDILKRLEKI 305
T ++ + KCW D + RP F +++ K+
Sbjct: 236 CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 268
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-26
Identities = 70/209 (33%), Positives = 106/209 (50%), Gaps = 19/209 (9%)
Query: 48 AIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 105
A IG+G++G++ KA + T VA+K+I + I R E+ LL KLRHPNIV+
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIR-EIKLLQKLRHPNIVRL 63
Query: 106 LGAVTERKP--LMLITEYLRGGDLHKYLKEKGA-LSPSTAVNFALDIARGMAYLHNEPNV 162
VT + + ++ EY+ DL L + S + + G+ YLH+ N
Sbjct: 64 KEIVTSKGKGSIYMVFEYMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHS--NG 120
Query: 163 IIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGE--TGSYRYMAPEV- 219
I+HRD+K N+L+ N LK+ DFGL++ +NS D T T YR PE+
Sbjct: 121 ILHRDIKGSNILINNDG--VLKLADFGLARPYTKRNSAD---YTNRVITLWYR--PPELL 173
Query: 220 FKHRKYDKKVDVFSFAMILYEMLEGEPPL 248
+Y +VD++S IL E+ G+P
Sbjct: 174 LGATRYGPEVDMWSVGCILAELFLGKPIF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-26
Identities = 77/230 (33%), Positives = 120/230 (52%), Gaps = 21/230 (9%)
Query: 43 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKL--- 97
DF+ ++GKGSFG+++ A +GT AIK L D +VIQD E ++ K
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIK----ILKKD-VVIQDDDVECTMVEKRVLA 55
Query: 98 ---RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMA 154
+ P + Q L + EY+ GGDL +++ G AV +A +IA G+
Sbjct: 56 LSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLF 115
Query: 155 YLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRY 214
+LH++ II+RDLK NV+L S H+K+ DFG+ K +N D G+ Y
Sbjct: 116 FLHSKG--IIYRDLKLDNVML--DSEGHIKIADFGMCK----ENMWDGVTTKTFCGTPDY 167
Query: 215 MAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH 264
+APE+ ++ Y K VD ++F ++LYEML G+ P + E + + E +
Sbjct: 168 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN 217
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 2e-26
Identities = 76/277 (27%), Positives = 127/277 (45%), Gaps = 43/277 (15%)
Query: 44 FSSSAIIGKGSFGEILKAYWRGT------PVAIKRILPSLSDDRLVIQDFRHEVNLLVKL 97
+ S ++ +G+FG I V +K + S+ ++ + E LL L
Sbjct: 8 VTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTL--LLQESCLLYGL 65
Query: 98 RHPNIVQFLGAVTE-RKPLMLITEYLRGGDLHKYLK-----EKG---ALSPSTAVNFALD 148
H NI+ L E +P ++ Y+ G+L +L+ E ALS V+ A+
Sbjct: 66 SHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQ 125
Query: 149 IARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMT-- 206
IA GM+YLH +IH+D+ RN ++ +K+ D LS+ D++ M
Sbjct: 126 IACGMSYLHKRG--VIHKDIAARNCVIDEEL--QVKITDNALSR--------DLFPMDYH 173
Query: 207 ----GETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVA 261
E ++MA E +++Y DV+SF ++L+E++ G+ P +P+E A Y+
Sbjct: 174 CLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLK 233
Query: 262 EGHR---PFFRAKGFTPELRELTEKCWAADMNQRPSF 295
+G+R P EL + CWA D +RPSF
Sbjct: 234 DGYRLAQPI----NCPDELFAVMACCWALDPEERPSF 266
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 3e-26
Identities = 72/261 (27%), Positives = 123/261 (47%), Gaps = 20/261 (7%)
Query: 43 DFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 100
+F IG+G F E+ +A G PVA+K++ D D E++LL +L HP
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 101 NIVQFLGAVTERKPLMLITEYLRGGDLH---KYLKEKGALSPSTAV-NFALDIARGMAYL 156
N++++ + E L ++ E GDL K+ K++ L P V + + + + ++
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 157 HNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI--KVQNSHDVYKMTGETGSYRY 214
H+ ++HRD+KP NV + + +K+GD GL + K +H + G+ Y
Sbjct: 123 HSRR--VMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAHSL------VGTPYY 172
Query: 215 MAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPL--ANYEPYEAAKYVAEGHRPFFRAKG 272
M+PE Y+ K D++S +LYEM + P Y K + + P +
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDH 232
Query: 273 FTPELRELTEKCWAADMNQRP 293
++ ELR+L C D +RP
Sbjct: 233 YSEELRQLVNMCINPDPEKRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-26
Identities = 76/219 (34%), Positives = 111/219 (50%), Gaps = 21/219 (9%)
Query: 43 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKR----ILPSLSDDRLVIQDFRHEVNLLVK 96
DF +G+G +G++ A + T VA+KR +L L++ R V+ E ++L
Sbjct: 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLT----ERDILTT 57
Query: 97 LRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYL 156
+ +V+ L A + + L L EY+ GGD L G LS A + ++ + L
Sbjct: 58 TKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDAL 117
Query: 157 HNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMA 216
H IHRDLKP N L+ ++ H+K+ DFGLSK I V ++ V GS YMA
Sbjct: 118 HELG--YIHRDLKPENFLI--DASGHIKLTDFGLSKGI-VTYANSV------VGSPDYMA 166
Query: 217 PEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYE 255
PEV + + YD VD +S +LYE L G PP + P E
Sbjct: 167 PEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE 205
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 4e-26
Identities = 82/262 (31%), Positives = 116/262 (44%), Gaps = 18/262 (6%)
Query: 38 DPSELDFSSSAIIGKGSFGEILKA--YWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLV 95
DP +L FS IG GSFG + A VAIK++ S QD EV L
Sbjct: 12 DPEKL-FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70
Query: 96 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 155
KLRHPN +Q+ G L+ EY G K L +G+AY
Sbjct: 71 KLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAY 130
Query: 156 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYM 215
LH+ +IHRD+K N+LL S +K+GDFG + ++ N G+ +M
Sbjct: 131 LHSHN--MIHRDVKAGNILL--SEPGLVKLGDFGSASIMAPANXF--------VGTPYWM 178
Query: 216 APEV---FKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKG 272
APEV +YD KVDV+S + E+ E +PPL N A ++A+ P ++
Sbjct: 179 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGH 238
Query: 273 FTPELRELTEKCWAADMNQRPS 294
++ R + C RP+
Sbjct: 239 WSEYFRNFVDSCLQKIPQDRPT 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 4e-26
Identities = 74/241 (30%), Positives = 118/241 (48%), Gaps = 35/241 (14%)
Query: 86 DFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL-----------KEK 134
DF E+ ++ +L+ PNI++ L PL +ITEY+ GDL+++L +
Sbjct: 65 DFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADV 124
Query: 135 GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 194
+S ST + A IA GM YL + +HRDL RN L+ + +K+ DFG+S+ +
Sbjct: 125 VTISYSTLIFMATQIASGMKYLSSLN--FVHRDLATRNCLVGKNYT--IKIADFGMSRNL 180
Query: 195 KVQNSHDVYKMTGETG-SYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEP 253
S D Y++ G R+M+ E K+ DV++F + L+E+L L +P
Sbjct: 181 Y---SGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT----LCKEQP 233
Query: 254 YE--AAKYVAEGHRPFFRAKG---FTPE-------LRELTEKCWAADMNQRPSFLDILKR 301
Y + + V E FFR +G + P+ L +L CW + +RPSF +I
Sbjct: 234 YSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHAT 293
Query: 302 L 302
L
Sbjct: 294 L 294
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 4e-26
Identities = 91/282 (32%), Positives = 137/282 (48%), Gaps = 36/282 (12%)
Query: 49 IIGKGSFGEILKAYWRGTPV----AIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIV 103
+IG+G+FG++LKA + + AIKR+ S D +DF E+ +L KL HPNI+
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH--RDFAGELEVLCKLGHHPNII 59
Query: 104 QFLGAVTERKPLMLITEYLRGGDLHKYLKEK----------------GALSPSTAVNFAL 147
LGA R L L EY G+L +L++ LS ++FA
Sbjct: 60 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 119
Query: 148 DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY-KMT 206
D+ARGM YL + IHRDL RN+L+ + K+ DFGLS+ +VY K T
Sbjct: 120 DVARGMDYLSQKQ--FIHRDLAARNILVGENYVA--KIADFGLSR------GQEVYVKKT 169
Query: 207 GETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHR 265
R+MA E + Y DV+S+ ++L+E++ G P E + + +G+R
Sbjct: 170 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 229
Query: 266 PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKE 307
+ E+ +L +CW +RPSF IL L ++ E
Sbjct: 230 -LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 270
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 5e-26
Identities = 77/273 (28%), Positives = 135/273 (49%), Gaps = 18/273 (6%)
Query: 41 ELDFSSSAIIGKGSFGEILKAYWR------GTPVAIKRILPSLSDDRLVIQDFRHEVNLL 94
E + ++G G+FG + K W PVAIK IL + + ++ F E ++
Sbjct: 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIK-ILNETTGPKANVE-FMDEALIM 63
Query: 95 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGM 153
+ HP++V+ LG V + L+T+ + G L Y+ E K + +N+ + IA+GM
Sbjct: 64 ASMDHPHLVRLLG-VCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGM 122
Query: 154 AYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYR 213
YL E ++HRDL RNVL+ S +H+K+ DFGL++L+ + Y G +
Sbjct: 123 MYL--EERRLVHRDLAARNVLV--KSPNHVKITDFGLARLL--EGDEKEYNADGGKMPIK 176
Query: 214 YMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKG 272
+MA E +RK+ + DV+S+ + ++E++ G P E + +G R +
Sbjct: 177 WMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGER-LPQPPI 235
Query: 273 FTPELRELTEKCWAADMNQRPSFLDILKRLEKI 305
T ++ + KCW D + RP F ++ ++
Sbjct: 236 CTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM 268
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 5e-26
Identities = 71/214 (33%), Positives = 113/214 (52%), Gaps = 27/214 (12%)
Query: 47 SAIIGKGSFGEILKAYWR----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR---H 99
A IG+G++G + KA R G VA+K++ LS++ + + R E+ LL +L H
Sbjct: 4 LAEIGEGAYGTVYKA--RDLNTGRFVALKKVRVPLSEEGIPLSTLR-EIALLKQLESFEH 60
Query: 100 PNIVQFL----GAVTERK-PLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIARG 152
PNIV+ L G T+R+ L L+ E++ DL YL + K L P T + + RG
Sbjct: 61 PNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRG 119
Query: 153 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSY 212
+ +LH+ + I+HRDLKP+N+L+ +S +K+ DFGL+++ + +T +
Sbjct: 120 VDFLHS--HRIVHRDLKPQNILV--TSDGQVKIADFGLARIYSFE-----MALTSVVVTL 170
Query: 213 RYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEP 246
Y APEV Y VD++S I E+ P
Sbjct: 171 WYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRP 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 6e-26
Identities = 85/295 (28%), Positives = 142/295 (48%), Gaps = 43/295 (14%)
Query: 36 EIDPSELDFSSSAIIGKGSFGEILKAYWRGTP-------VAIKRILPSLSD--DRLVIQD 86
EI+ S + F +G+ FG++ K + GT VAIK +L D + + ++
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIK----TLKDKAEGPLREE 54
Query: 87 FRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL--------------- 131
F+HE + +L+HPNIV LG VT+ +PL +I Y DLH++L
Sbjct: 55 FKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDD 114
Query: 132 -KEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGL 190
K L P+ V+ IA GM +L + ++H+DL RNVL+ + ++K+ D GL
Sbjct: 115 KTVKSTLEPADFVHIVTQIAAGMEFLSSHH--VVHKDLATRNVLVFDKL--NVKISDLGL 170
Query: 191 SKLIKVQNSHDVYKMTGETG-SYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPL 248
+ + + D YK+ G + R+M+PE + K+ D++S+ ++L+E+ G P
Sbjct: 171 FREVY---AADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY 227
Query: 249 ANYEPYEAAKYVAEGHRPFFRAKGFTPE-LRELTEKCWAADMNQRPSFLDILKRL 302
Y + + + +R P + L +CW ++RP F DI RL
Sbjct: 228 CGYSNQDVIEMIR--NRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 7e-26
Identities = 81/258 (31%), Positives = 132/258 (51%), Gaps = 15/258 (5%)
Query: 49 IIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 106
++GKGS+GE+ R G IK++ + R + E LL +L+HPNIV +
Sbjct: 7 VVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRER-KAAEQEAQLLSQLKHPNIVAYR 65
Query: 107 GAVT-ERKPLMLITEYLRGGDLHKYLKE-KGALSP-STAVNFALDIARGMAYLHNEPNVI 163
+ E L ++ + GGDL+ LKE KG L P + V + + IA + YLH + I
Sbjct: 66 ESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH--I 123
Query: 164 IHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR 223
+HRDLK +NV L ++ +KVGD G++++++ Q + G+ YM+PE+F ++
Sbjct: 124 LHRDLKTQNVFLTRTNI--IKVGDLGIARVLENQCD----MASTLIGTPYYMSPELFSNK 177
Query: 224 KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEK 283
Y+ K DV++ +YEM + + + EG P K ++PEL EL
Sbjct: 178 PYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPM-PKDYSPELGELIAT 236
Query: 284 CWAADMNQRPSFLDILKR 301
+ +RPS IL++
Sbjct: 237 MLSKRPEKRPSVKSILRQ 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 8e-26
Identities = 80/275 (29%), Positives = 125/275 (45%), Gaps = 18/275 (6%)
Query: 38 DPSELDFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLV 95
DP +L F+ IG GSFG + A T VAIK++ S QD EV L
Sbjct: 22 DPEKL-FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQ 80
Query: 96 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 155
+++HPN +++ G L+ EY G K L +G+AY
Sbjct: 81 RIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAY 140
Query: 156 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYM 215
LH+ + +IHRD+K N+LL + +K+ DFG + + NS G+ +M
Sbjct: 141 LHS--HNMIHRDIKAGNILL--TEPGQVKLADFGSASIASPANSF--------VGTPYWM 188
Query: 216 APEV---FKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKG 272
APEV +YD KVDV+S + E+ E +PPL N A ++A+ P ++
Sbjct: 189 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNE 248
Query: 273 FTPELRELTEKCWAADMNQRPSFLDILKRLEKIKE 307
++ R + C RP+ ++LK + ++E
Sbjct: 249 WSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE 283
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 8e-26
Identities = 67/248 (27%), Positives = 106/248 (42%), Gaps = 17/248 (6%)
Query: 50 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHE-VNLLVKLRHPNIVQFL 106
I KG+FG + A R G AIK + S + + + + E ++++ P + +
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 107 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 166
+ + L L+ EYL GGD +K G L A + ++ G+ LH IIHR
Sbjct: 64 YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQ--RGIIHR 121
Query: 167 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYD 226
D+KP N+L+ HLK+ DFGLS+ G+ Y+APE D
Sbjct: 122 DIKPENLLI--DQTGHLKLTDFGLSRNGLENKKF--------VGTPDYLAPETILGVGDD 171
Query: 227 KKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEG--HRPFFRAKGFTPELRELTEKC 284
K D +S +++E L G PP P + + P + +PE +L +
Sbjct: 172 KMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRL 231
Query: 285 WAADMNQR 292
D +R
Sbjct: 232 LCMDPAKR 239
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 1e-25
Identities = 73/261 (27%), Positives = 125/261 (47%), Gaps = 20/261 (7%)
Query: 43 DFSSSAIIGKGSFGEILKA--YWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 100
+F IG+G F E+ +A PVA+K++ D QD E++LL +L HP
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 101 NIVQFLGAVTERKPLMLITEYLRGGDLH---KYLKEKGALSPSTAV-NFALDIARGMAYL 156
N++++L + E L ++ E GDL KY K++ L P V + + + + ++
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122
Query: 157 HNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI--KVQNSHDVYKMTGETGSYRY 214
H+ ++HRD+KP NV + + +K+GD GL + K +H + G+ Y
Sbjct: 123 HSRR--VMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAHSL------VGTPYY 172
Query: 215 MAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLAN--YEPYEAAKYVAEGHRPFFRAKG 272
M+PE Y+ K D++S +LYEM + P + + + + P +
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEH 232
Query: 273 FTPELRELTEKCWAADMNQRP 293
++ +LREL C D +QRP
Sbjct: 233 YSEKLRELVSMCIYPDPDQRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 2e-25
Identities = 69/225 (30%), Positives = 109/225 (48%), Gaps = 26/225 (11%)
Query: 31 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFR 88
NK WE+ P + + + +G G++G++ A+ T VAIK++ + +R
Sbjct: 7 NKTVWEV-PDR--YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYR 63
Query: 89 HEVNLLVKLRHPNIVQFLGAVTERKPLM------LITEYLRGGDLHKYLKEKGALSPSTA 142
E+ LL + H N++ L T L L+T L G DL+ +K + LS
Sbjct: 64 -ELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTH-LMGADLNNIVKCQ-KLSDDHI 120
Query: 143 VNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDV 202
I RG+ Y+H+ IIHRDLKP N + VN + LK+ DFGL++
Sbjct: 121 QFLVYQILRGLKYIHSAG--IIHRDLKPSN-IAVNEDCE-LKILDFGLAR----HTDD-- 170
Query: 203 YKMTGETGSYRYMAPEV-FKHRKYDKKVDVFSFAMILYEMLEGEP 246
+MTG + Y APE+ Y++ VD++S I+ E+L G+
Sbjct: 171 -EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKT 214
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-25
Identities = 79/268 (29%), Positives = 121/268 (45%), Gaps = 18/268 (6%)
Query: 38 DPSELDFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLV 95
DP E+ F IG GSFG + A T VA+K++ S QD EV L
Sbjct: 18 DPEEI-FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQ 76
Query: 96 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 155
+L+HPN +++ G + L+ EY G K L +G+AY
Sbjct: 77 QLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAY 136
Query: 156 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYM 215
LH+ + +IHRD+K N+LL + +K+ DFG + NS G+ +M
Sbjct: 137 LHS--HNMIHRDIKAGNILL--TEPGQVKLADFGSASKSSPANSF--------VGTPYWM 184
Query: 216 APEV---FKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKG 272
APEV +YD KVDV+S + E+ E +PPL N A ++A+ P ++
Sbjct: 185 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNE 244
Query: 273 FTPELRELTEKCWAADMNQRPSFLDILK 300
+T R + C +RP+ ++L+
Sbjct: 245 WTDSFRGFVDYCLQKIPQERPASAELLR 272
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 2e-25
Identities = 68/201 (33%), Positives = 105/201 (52%), Gaps = 13/201 (6%)
Query: 50 IGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 107
+G+G++G +LK + T VAIK+ S DD V + EV +L +LRH NIV
Sbjct: 9 VGEGAYGVVLKCRNKATGEIVAIKKFKES-EDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 108 AVTERKPLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHR 166
A + L L+ EY+ L + L+ G L P ++ + + +AY H+ + IIHR
Sbjct: 68 AFRRKGRLYLVFEYV-ERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHS--HNIIHR 124
Query: 167 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF-KHRKY 225
D+KP N+L+ S + LK+ DFG ++ ++ T YR APE+ Y
Sbjct: 125 DIKPENILV--SESGVLKLCDFGFARALR-ARPASPLTDYVATRWYR--APELLVGDTNY 179
Query: 226 DKKVDVFSFAMILYEMLEGEP 246
K VDV++ I+ E+L+GEP
Sbjct: 180 GKPVDVWAIGCIMAELLDGEP 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 2e-25
Identities = 72/273 (26%), Positives = 133/273 (48%), Gaps = 18/273 (6%)
Query: 41 ELDFSSSAIIGKGSFGEILKAYWR------GTPVAIKRILPSLSDDRLVIQDFRHEVNLL 94
E + ++G G+FG + K W PVAIK + + S ++ E ++
Sbjct: 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPK--ANKEILDEAYVM 63
Query: 95 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGM 153
+ P + + LG + + L+T+ + G L Y++E K + +N+ + IA+GM
Sbjct: 64 AGVGSPYVCRLLG-ICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGM 122
Query: 154 AYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYR 213
+YL E ++HRDL RNVL+ S +H+K+ DFGL++L+ + + Y G +
Sbjct: 123 SYL--EEVRLVHRDLAARNVLV--KSPNHVKITDFGLARLLDIDETE--YHADGGKVPIK 176
Query: 214 YMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKG 272
+MA E HR++ + DV+S+ + ++E++ G P E + +G R +
Sbjct: 177 WMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGER-LPQPPI 235
Query: 273 FTPELRELTEKCWAADMNQRPSFLDILKRLEKI 305
T ++ + KCW D RP F +++ ++
Sbjct: 236 CTIDVYMIMVKCWMIDSECRPRFRELVDEFSRM 268
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 2e-25
Identities = 74/259 (28%), Positives = 126/259 (48%), Gaps = 18/259 (6%)
Query: 50 IGKGSFGEILKAYWRGTPV-AIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGA 108
+G G+FG++ KA + T V A +++ + S++ L +D+ E+++L HPNIV+ L A
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEEL--EDYMVEIDILASCDHPNIVKLLDA 70
Query: 109 VTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 167
L ++ E+ GG + + E + L+ + YLH N IIHRD
Sbjct: 71 FYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHE--NKIIHRD 128
Query: 168 LKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF-----KH 222
LK N+L +K+ DFG+S +N+ + + G+ +MAPEV K
Sbjct: 129 LKAGNILFTLDG--DIKLADFGVS----AKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 182
Query: 223 RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFF-RAKGFTPELRELT 281
R YD K DV+S + L EM + EPP P +A+ P + ++ E ++
Sbjct: 183 RPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFL 242
Query: 282 EKCWAADMNQRPSFLDILK 300
+KC +++ R + +L+
Sbjct: 243 KKCLEKNVDARWTTTQLLQ 261
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 3e-25
Identities = 67/203 (33%), Positives = 108/203 (53%), Gaps = 17/203 (8%)
Query: 50 IGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 107
+G+G++ + K R T VA+K I L + E++L+ +L+H NIV+
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEI--HLDAEEGTPSTAIREISLMKELKHENIVRLHD 65
Query: 108 AVTERKPLMLITEYLRGGDLHKYLK---EKGALSPSTAVNFALDIARGMAYLHNEPNVII 164
+ LML+ EY+ DL KY+ +GAL P+T +F + +G+A+ H N ++
Sbjct: 66 VIHTENKLMLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE--NRVL 122
Query: 165 HRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF-KHR 223
HRDLKP+N LL+N + LK+ DFGL++ + V + E + Y AP+V R
Sbjct: 123 HRDLKPQN-LLINKRGE-LKLADFGLARAFGIP----VNTFSNEVVTLWYRAPDVLLGSR 176
Query: 224 KYDKKVDVFSFAMILYEMLEGEP 246
Y +D++S I+ EM+ G P
Sbjct: 177 TYSTSIDIWSVGCIMAEMITGRP 199
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 3e-25
Identities = 74/256 (28%), Positives = 111/256 (43%), Gaps = 19/256 (7%)
Query: 50 IGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 107
+GKG FGE+ + T A K++ R Q +E +L K+ IV
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 108 AVTERKPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIH 165
A + L L+ + GGDL ++ G + A+ +A I G+ +LH I++
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR--RIVY 118
Query: 166 RDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKY 225
RDLKP NVLL + ++++ D GL+ +K K+ G G+ YMAPEV + Y
Sbjct: 119 RDLKPENVLLDDHG--NVRISDLGLAVELKGGK-----KIKGRAGTPGYMAPEVLQGEVY 171
Query: 226 DKKVDVFSFAMILYEMLEGEPPLANY----EPYEAAKYVAEGHRPFFRAKGFTPELRELT 281
D VD F+ LYEM+ G P E E + E F+PE ++L
Sbjct: 172 DFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE--MAVEYPDKFSPEAKDLC 229
Query: 282 EKCWAADMNQRPSFLD 297
E D +R
Sbjct: 230 EALLQKDPEKRLGCRG 245
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 4e-25
Identities = 75/262 (28%), Positives = 135/262 (51%), Gaps = 26/262 (9%)
Query: 50 IGKGSFGE--ILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 107
IG+GSFG+ ++K+ G IK I S + ++ R EV +L ++HPNIVQ+
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKER-EESRKEVAVLSNMKHPNIVQYQE 66
Query: 108 AVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAV-NFALDIARGMAYLHNEPNVIIH 165
+ E L ++ +Y GGDL+K + ++G L P + ++ + I + ++H+ I+H
Sbjct: 67 SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK--ILH 124
Query: 166 RDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKY 225
RD+K +N+ L +K+GDFG++ +V NS T G+ Y++PE+ ++R Y
Sbjct: 125 RDIKSQNIFLTKDGT--IKLGDFGIA---RVLNSTVELARTC-IGTPYYLSPEICENRPY 178
Query: 226 DKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKY------VAEGHRPFFRAKGFTPELRE 279
+ K D+++ +LYEM + +EA + G P + ++ +LR
Sbjct: 179 NNKSDIWALGCVLYEMCTLK------HAFEAGNMKNLVLKIIRGSYPPVSSH-YSYDLRN 231
Query: 280 LTEKCWAADMNQRPSFLDILKR 301
L + + + RPS IL++
Sbjct: 232 LVSQLFKRNPRDRPSVNSILEK 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 4e-25
Identities = 69/232 (29%), Positives = 115/232 (49%), Gaps = 23/232 (9%)
Query: 43 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRL-VIQDFRHEVNLLVKLRH 99
DF +G GSFG + A +GT AIK L ++ +Q E ++L++L H
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIK-CLKKREILKMKQVQHVAQEKSILMELSH 77
Query: 100 PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE 159
P IV + + + + + E++ GG+L +L++ G A + ++ YLH++
Sbjct: 78 PFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSK 137
Query: 160 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET----GSYRYM 215
II+RDLKP N+LL + H+KV DFG +K K+ T G+ Y+
Sbjct: 138 D--IIYRDLKPENLLL--DNKGHVKVTDFGFAK-----------KVPDRTFTLCGTPEYL 182
Query: 216 APEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPF 267
APEV + + + K VD ++ ++LYE + G PP + P+ + + G F
Sbjct: 183 APEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKF 234
|
Length = 329 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 5e-25
Identities = 81/275 (29%), Positives = 128/275 (46%), Gaps = 29/275 (10%)
Query: 50 IGKGSFGEILKAYWRGT----PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 105
+G+G FG +++ VA+K + ++ R ++DF E + + HPN+++
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICT-RSEMEDFLSEAVCMKEFDHPNVMRL 65
Query: 106 LGAV---TERKPL---MLITEYLRGGDLHKYL------KEKGALSPSTAVNFALDIARGM 153
+G E + ++I +++ GDLH +L L V F DIA GM
Sbjct: 66 IGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGM 125
Query: 154 AYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSY- 212
YL ++ IHRDL RN +L N + + + V DFGLSK K+ N D Y+ G
Sbjct: 126 EYLSSKS--FIHRDLAARNCML-NENMN-VCVADFGLSK--KIYNG-DYYRQ-GRIAKMP 177
Query: 213 -RYMAPEVFKHRKYDKKVDVFSFAMILYEM-LEGEPPLANYEPYEAAKYVAEGHRPFFRA 270
+++A E R Y K DV+SF + ++E+ G+ P E E Y+ +G+R +
Sbjct: 178 VKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNR-LKQP 236
Query: 271 KGFTPELRELTEKCWAADMNQRPSFLDILKRLEKI 305
L L CW + RPSF + LEK
Sbjct: 237 PDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 5e-25
Identities = 80/258 (31%), Positives = 124/258 (48%), Gaps = 19/258 (7%)
Query: 49 IIGKGSFGEILKAYWRGTPV--AIKRILPSLSDDRLVIQDFRHEVNLLVK-LRHPNIVQF 105
+IGKGSFG++L A + A+K + + + E N+L+K ++HP +V
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 106 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 165
+ L + +Y+ GG+L +L+ + + A +A +IA + YLH+ II+
Sbjct: 62 HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLN--IIY 119
Query: 166 RDLKPRNVLLVNSSADHLKVGDFGLSKL-IKVQNSHDVYKMTGETGSYRYMAPEVFKHRK 224
RDLKP N+LL S H+ + DFGL K I+ + + T E Y+APEV + +
Sbjct: 120 RDLKPENILL--DSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPE-----YLAPEVLRKQP 172
Query: 225 YDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKC 284
YD+ VD + +LYEML G PP Y A Y ++P + R L E
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPPF--YSRDTAEMYDNILNKPLRLKPNISVSARHLLEGL 230
Query: 285 WAADMNQR----PSFLDI 298
D +R FL+I
Sbjct: 231 LQKDRTKRLGAKDDFLEI 248
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 6e-25
Identities = 77/259 (29%), Positives = 132/259 (50%), Gaps = 19/259 (7%)
Query: 49 IIGKGSFGEILKAYWRGT--PVAIKRI-LPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 105
++G+GSFG L + A+K I LP S ++D R E LL K++HPNIV F
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSA---VEDSRKEAVLLAKMKHPNIVAF 63
Query: 106 LGAVTERKPLMLITEYLRGGDLHKYLK-EKGALSPS-TAVNFALDIARGMAYLHNEPNVI 163
+ L ++ EY GGDL + +K ++G L P T + + + + G+ ++H + +
Sbjct: 64 KESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR--V 121
Query: 164 IHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR 223
+HRD+K +N+ L + +K+GDFG ++L+ + G+ Y+ PE++++
Sbjct: 122 LHRDIKSKNIFLTQNG--KVKLGDFGSARLL----TSPGAYACTYVGTPYYVPPEIWENM 175
Query: 224 KYDKKVDVFSFAMILYEMLEGEPPL-ANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTE 282
Y+ K D++S ILYE+ + P AN K ++P ++ ELR L +
Sbjct: 176 PYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPL--PSHYSYELRSLIK 233
Query: 283 KCWAADMNQRPSFLDILKR 301
+ + + RPS IL R
Sbjct: 234 QMFKRNPRSRPSATTILSR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 7e-25
Identities = 77/268 (28%), Positives = 133/268 (49%), Gaps = 33/268 (12%)
Query: 50 IGKGSFGEILKAYWR--GTPVAIKRI---LPSLSDDRLVIQDFRHEVNLLVKLRH---PN 101
+G+G++G + K GT +A+KRI + S RL++ +L + +R P
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLM-------DLDISMRSVDCPY 61
Query: 102 IVQFLGAVTERKPLMLITEYLRGG--DLHKYLKEKGALSPSTAVN-FALDIARGMAYLHN 158
V F GA+ + + E + +K + +KG P + A+ I + + YLH+
Sbjct: 62 TVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS 121
Query: 159 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS-KLIKVQNSHDVYKMTGETGSYRYMAP 217
+ +VI HRD+KP NVL+ + +K+ DFG+S L+ D T + G YMAP
Sbjct: 122 KLSVI-HRDVKPSNVLI--NRNGQVKLCDFGISGYLV------DSVAKTIDAGCKPYMAP 172
Query: 218 EVF----KHRKYDKKVDVFSFAMILYEMLEGEPPLANYE-PYEAAKYVAEGHRPFFRAKG 272
E + YD K DV+S + + E+ G P +++ P++ K V E P A+
Sbjct: 173 ERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEK 232
Query: 273 FTPELRELTEKCWAADMNQRPSFLDILK 300
F+PE ++ KC + +RP++ ++L+
Sbjct: 233 FSPEFQDFVNKCLKKNYKERPNYPELLQ 260
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 99.4 bits (247), Expect = 3e-24
Identities = 76/278 (27%), Positives = 134/278 (48%), Gaps = 27/278 (9%)
Query: 38 DPSELDFSSSAIIGKGSFGEILKA-YWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVK 96
DP+ + F ++G G++G++ K + + +A +++ D+ ++ + E+N+L K
Sbjct: 3 DPAGI-FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE---EEIKQEINMLKK 58
Query: 97 L-RHPNIVQFLGAVTERKP------LMLITEYLRGGDLHKYLKE-KG-ALSPSTAVNFAL 147
H NI + GA ++ P L L+ E+ G + +K KG L
Sbjct: 59 YSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICR 118
Query: 148 DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG 207
+I RG+++LH +IHRD+K +NVLL ++ +K+ DFG+S Q V +
Sbjct: 119 EILRGLSHLHQHK--VIHRDIKGQNVLLTENA--EVKLVDFGVS----AQLDRTVGRRNT 170
Query: 208 ETGSYRYMAPEVFK-----HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAE 262
G+ +MAPEV YD K D++S + EM EG PPL + P A +
Sbjct: 171 FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR 230
Query: 263 GHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILK 300
P ++K ++ + + E C + +QRP+ ++K
Sbjct: 231 NPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 3e-24
Identities = 78/275 (28%), Positives = 118/275 (42%), Gaps = 20/275 (7%)
Query: 41 ELDFSS---SAIIGKGSFGEILKAYW-----RGTPVAIKRILPSLSDDRLVIQDFRHEVN 92
ELD S I+G G FGE+ + R PVAI + SD + + F E
Sbjct: 1 ELDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQR--RGFLAEAL 58
Query: 93 LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIAR 151
L + H NIV+ G +T +M++TEY+ G L +L K +G L + +A
Sbjct: 59 TLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLAS 118
Query: 152 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGS 211
GM YL +H+ L V LVNS K+ F + K + +Y
Sbjct: 119 GMKYLSEMG--YVHKGLAAHKV-LVNSDLV-CKISGFRRLQEDKSEA---IYTTMSGKSP 171
Query: 212 YRYMAPEVFKHRKYDKKVDVFSFAMILYE-MLEGEPPLANYEPYEAAKYVAEGHRPFFRA 270
+ APE ++ + DV+SF ++++E M GE P + + K V +G R
Sbjct: 172 VLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFR-LPAP 230
Query: 271 KGFTPELRELTEKCWAADMNQRPSFLDILKRLEKI 305
+ L +L CW + +RP F I L K+
Sbjct: 231 RNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 4e-24
Identities = 79/258 (30%), Positives = 129/258 (50%), Gaps = 19/258 (7%)
Query: 49 IIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVK-LRHPNIVQF 105
+IGKGSFG++L A + G A+K + + +R + E N+L+K ++HP +V
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 106 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 165
+ + L + +++ GG+L +L+ + + A +A +IA + YLH+ I++
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSIN--IVY 119
Query: 166 RDLKPRNVLLVNSSADHLKVGDFGLSKL-IKVQNSHDVYKMTGETGSYRYMAPEVFKHRK 224
RDLKP N+LL S H+ + DFGL K I ++ + G+ Y+APEV + +
Sbjct: 120 RDLKPENILL--DSQGHVVLTDFGLCKEGIAQSDTTTTF-----CGTPEYLAPEVIRKQP 172
Query: 225 YDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPE----LREL 280
YD VD + +LYEML G PP + E + H+P G + L EL
Sbjct: 173 YDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNIL--HKPLVLRPGASLTAWSILEEL 230
Query: 281 TEKCWAADMNQRPSFLDI 298
EK + + FL+I
Sbjct: 231 LEKDRQRRLGAKEDFLEI 248
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 7e-24
Identities = 69/213 (32%), Positives = 110/213 (51%), Gaps = 19/213 (8%)
Query: 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 100
+ + + IG+G++G + A + G VAIK+I P + + Q E+ +L + +H
Sbjct: 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPF--EHQTFCQRTLREIKILRRFKHE 63
Query: 101 NIVQFL-----GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 155
NI+ L + + ++ E + DL+K +K + LS F I RG+ Y
Sbjct: 64 NIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQ-HLSNDHIQYFLYQILRGLKY 121
Query: 156 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYR-Y 214
+H+ NV+ HRDLKP N LL+N++ D LK+ DFGL+++ HD E + R Y
Sbjct: 122 IHS-ANVL-HRDLKPSN-LLLNTNCD-LKICDFGLARIA--DPEHDHTGFLTEYVATRWY 175
Query: 215 MAPEV-FKHRKYDKKVDVFSFAMILYEMLEGEP 246
APE+ + Y K +D++S IL EML P
Sbjct: 176 RAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRP 208
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 8e-24
Identities = 74/255 (29%), Positives = 126/255 (49%), Gaps = 17/255 (6%)
Query: 50 IGKGSFGEILKAY--WRGTPVAIKRI-LPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 106
IG+G+ G + A G VAIK++ L L+I +E+ ++ + ++PNIV +L
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELII----NEILVMRENKNPNIVNYL 82
Query: 107 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 166
+ L ++ EYL GG L + E + + + + +LH+ N +IHR
Sbjct: 83 DSYLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALDFLHS--NQVIHR 139
Query: 167 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYD 226
D+K N+LL + +K+ DFG I + S K + G+ +MAPEV + Y
Sbjct: 140 DIKSDNILLGMDGS--VKLTDFGFCAQITPEQS----KRSTMVGTPYWMAPEVVTRKAYG 193
Query: 227 KKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR-AKGFTPELRELTEKCW 285
KVD++S ++ EM+EGEPP N P A +A P + + + R+ +C
Sbjct: 194 PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCL 253
Query: 286 AADMNQRPSFLDILK 300
D+++R S ++L+
Sbjct: 254 EMDVDRRGSAKELLQ 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 9e-24
Identities = 77/254 (30%), Positives = 128/254 (50%), Gaps = 27/254 (10%)
Query: 49 IIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQD-----FRHEVNLLVKLRHPN 101
++GKGSFG++L A +G A+K +L D ++I D + L + +P
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVK----ALKKDVVLIDDDVECTMVEKRVLALAWENPF 57
Query: 102 IVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPN 161
+ ++ L + E+L GGDL ++++KG A +A +I G+ +LH+
Sbjct: 58 LTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHS--K 115
Query: 162 VIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFK 221
II+RDLK NV+L H+K+ DFG+ K +N + + G+ Y+APE+ +
Sbjct: 116 GIIYRDLKLDNVML--DRDGHIKIADFGMCK----ENVFGDNRASTFCGTPDYIAPEILQ 169
Query: 222 HRKYDKKVDVFSFAMILYEMLEGEPPLA---NYEPYEAAKYVAEGHRPFFRAKGFTPELR 278
KY VD +SF ++LYEML G+ P E +E+ + V H P + T E +
Sbjct: 170 GLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIR-VDTPHYP----RWITKESK 224
Query: 279 ELTEKCWAADMNQR 292
++ EK + D +R
Sbjct: 225 DILEKLFERDPTRR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 1e-23
Identities = 71/226 (31%), Positives = 112/226 (49%), Gaps = 17/226 (7%)
Query: 43 DFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 100
DF + +I G++G + + T A+K+I R IQ E ++L +P
Sbjct: 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENP 61
Query: 101 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP 160
+V + ++ L ++ EY+ GGD LK GAL A + + + YLHN
Sbjct: 62 FVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYG 121
Query: 161 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK--MTGET--------- 209
I+HRDLKP N+L+ +S H+K+ DFGLSK+ + + ++Y+ + +T
Sbjct: 122 --IVHRDLKPDNLLI--TSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVC 177
Query: 210 GSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYE 255
G+ Y+APEV + Y K VD ++ +ILYE L G P P E
Sbjct: 178 GTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE 223
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 97.3 bits (242), Expect = 2e-23
Identities = 75/275 (27%), Positives = 134/275 (48%), Gaps = 31/275 (11%)
Query: 50 IGKGSFGE----ILKAYWRGTP---VAIKRILPSLS-DDRLVIQDFRHEVNLLVKLRHPN 101
+G+GSFG + +G VA+K + S S +R+ +F +E +++ +
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI---EFLNEASVMKGFTCHH 70
Query: 102 IVQFLGAVTERKPLMLITEYLRGGDLHKYLK--------EKGALSPS--TAVNFALDIAR 151
+V+ LG V++ +P +++ E + GDL YL+ G P+ + A +IA
Sbjct: 71 VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 130
Query: 152 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGE-TG 210
GMAYL+ + +HRDL RN ++ + +K+GDFG+++ I D Y+ G+
Sbjct: 131 GMAYLNAKK--FVHRDLAARNCMVAHDFT--VKIGDFGMTRDIY---ETDYYRKGGKGLL 183
Query: 211 SYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFR 269
R+MAPE K + D++SF ++L+E+ E P + K+V +G +
Sbjct: 184 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGY-LDQ 242
Query: 270 AKGFTPELRELTEKCWAADMNQRPSFLDILKRLEK 304
+ +L CW + RP+FL+I+ L+
Sbjct: 243 PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 97.5 bits (242), Expect = 2e-23
Identities = 73/255 (28%), Positives = 125/255 (49%), Gaps = 17/255 (6%)
Query: 50 IGKGSFGEILKAY--WRGTPVAIKRI-LPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 106
IG+G+ G + A G VAI+++ L L+I +E+ ++ + ++PNIV +L
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII----NEILVMRENKNPNIVNYL 83
Query: 107 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 166
+ L ++ EYL GG L + E + + + + +LH+ N +IHR
Sbjct: 84 DSYLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHS--NQVIHR 140
Query: 167 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYD 226
D+K N+LL + +K+ DFG I + S K + G+ +MAPEV + Y
Sbjct: 141 DIKSDNILLGMDGS--VKLTDFGFCAQITPEQS----KRSTMVGTPYWMAPEVVTRKAYG 194
Query: 227 KKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR-AKGFTPELRELTEKCW 285
KVD++S ++ EM+EGEPP N P A +A P + + + R+ +C
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCL 254
Query: 286 AADMNQRPSFLDILK 300
D+ +R S ++L+
Sbjct: 255 DMDVEKRGSAKELLQ 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 2e-23
Identities = 77/252 (30%), Positives = 118/252 (46%), Gaps = 13/252 (5%)
Query: 49 IIGKGSFGEILKAYWRGTPV--AIKRILPSLSDDRLVIQDFRHEVNLLVK-LRHPNIVQF 105
+IGKGSFG++L A + A+K + + + E N+L+K ++HP +V
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 106 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 165
+ L + +Y+ GG+L +L+ + A +A +IA + YLH+ I++
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN--IVY 119
Query: 166 RDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKY 225
RDLKP N+LL S H+ + DFGL K +N + G+ Y+APEV + Y
Sbjct: 120 RDLKPENILL--DSQGHIVLTDFGLCK----ENIEHNGTTSTFCGTPEYLAPEVLHKQPY 173
Query: 226 DKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCW 285
D+ VD + +LYEML G PP Y A Y ++P T R L E
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPPF--YSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLL 231
Query: 286 AADMNQRPSFLD 297
D +R D
Sbjct: 232 QKDRTKRLGAKD 243
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 2e-23
Identities = 66/201 (32%), Positives = 107/201 (53%), Gaps = 12/201 (5%)
Query: 49 IIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 106
++G+GS+G ++K + G VAIK+ L S DD++V + E+ +L +LRH N+V +
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLES-EDDKMVKKIAMREIRMLKQLRHENLVNLI 66
Query: 107 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 166
+K L L+ E++ L K L S + I RG+ + H+ + IIHR
Sbjct: 67 EVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHS--HNIIHR 124
Query: 167 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPE-VFKHRKY 225
D+KP N+L+ S +K+ DFG ++ + +VY T YR APE + KY
Sbjct: 125 DIKPENILVSQSGV--VKLCDFGFARTLAAPG--EVYTDYVATRWYR--APELLVGDTKY 178
Query: 226 DKKVDVFSFAMILYEMLEGEP 246
+ VD+++ ++ EML GEP
Sbjct: 179 GRAVDIWAVGCLVTEMLTGEP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 3e-23
Identities = 58/160 (36%), Positives = 88/160 (55%), Gaps = 8/160 (5%)
Query: 88 RHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFAL 147
+ E N+L ++HP IV + A L LI EYL GG+L +L+ +G TA +
Sbjct: 48 KAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLS 107
Query: 148 DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG 207
+I+ + +LH + II+RDLKP N+LL + H+K+ DFGL K ++ H+
Sbjct: 108 EISLALEHLHQQG--IIYRDLKPENILL--DAQGHVKLTDFGLCK----ESIHEGTVTHT 159
Query: 208 ETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPP 247
G+ YMAPE+ + K VD +S ++Y+ML G PP
Sbjct: 160 FCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 4e-23
Identities = 66/204 (32%), Positives = 104/204 (50%), Gaps = 16/204 (7%)
Query: 50 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFR-HEVNLLVKLRHPNIVQFL 106
IG+G++G + KA R VA+KR+ L DD + E+ LL +L+H NIV+
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRV--RLDDDDEGVPSSALREICLLKELKHKNIVRLY 65
Query: 107 GAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIH 165
+ K L L+ EY DL KY G + P +F + +G+A+ H+ ++H
Sbjct: 66 DVLHSDKKLTLVFEYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN--VLH 122
Query: 166 RDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV-FKHRK 224
RDLKP+N LL+N + + LK+ DFGL++ + V + E + Y P+V F +
Sbjct: 123 RDLKPQN-LLINKNGE-LKLADFGLARAFGIP----VRCYSAEVVTLWYRPPDVLFGAKL 176
Query: 225 YDKKVDVFSFAMILYEMLEGEPPL 248
Y +D++S I E+ PL
Sbjct: 177 YSTSIDMWSAGCIFAELANAGRPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 4e-23
Identities = 67/205 (32%), Positives = 108/205 (52%), Gaps = 13/205 (6%)
Query: 48 AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVK-LRHPNIVQ 104
+IGKGSFG++L A + G+ A+K + + E N+L+K L+HP +V
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 105 FLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVII 164
+ + L + +Y+ GG+L +L+ + A +A ++A + YLH+ II
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLN--II 118
Query: 165 HRDLKPRNVLLVNSSADHLKVGDFGLSKL-IKVQNSHDVYKMTGETGSYRYMAPEVFKHR 223
+RDLKP N+LL S H+ + DFGL K ++ + + + G+ Y+APEV +
Sbjct: 119 YRDLKPENILL--DSQGHVVLTDFGLCKEGVEPEETTSTF-----CGTPEYLAPEVLRKE 171
Query: 224 KYDKKVDVFSFAMILYEMLEGEPPL 248
YD+ VD + +LYEML G PP
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 7e-23
Identities = 69/224 (30%), Positives = 112/224 (50%), Gaps = 17/224 (7%)
Query: 38 DPSELDFSSSAIIGKGSFGEILKA--YWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLV 95
+P E DF IG G++G++ KA G AIK I +D V+Q E+ ++
Sbjct: 6 NPQE-DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQ---QEIIMMK 61
Query: 96 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 155
+H NIV + G+ R L + E+ GG L G LS S + + +G+ Y
Sbjct: 62 DCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYY 121
Query: 156 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYM 215
LH++ +HRD+K N+LL ++ H+K+ DFG+S Q + + K G+ +M
Sbjct: 122 LHSKGK--MHRDIKGANILLTDNG--HVKLADFGVS----AQITATIAKRKSFIGTPYWM 173
Query: 216 APEVFK-HRK--YDKKVDVFSFAMILYEMLEGEPPLANYEPYEA 256
APEV RK Y++ D+++ + E+ E +PP+ + P A
Sbjct: 174 APEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA 217
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 8e-23
Identities = 65/204 (31%), Positives = 98/204 (48%), Gaps = 16/204 (7%)
Query: 49 IIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 106
IG+G++G + +A + VA+K++ D + I R E+ LL+ LRHPNIV+
Sbjct: 14 RIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR-EITLLLNLRHPNIVELK 72
Query: 107 GAVTERK--PLMLITEYLRGGDLHKYLKEKGALSPSTAVN-FALDIARGMAYLHNEPNVI 163
V + + L+ EY DL L + V L + RG+ YLH N I
Sbjct: 73 EVVVGKHLDSIFLVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHE--NFI 129
Query: 164 IHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV-FKH 222
IHRDLK N+LL + LK+ DFGL++ MT + + Y APE+
Sbjct: 130 IHRDLKVSNLLLTDKG--CLKIADFGLARTY----GLPAKPMTPKVVTLWYRAPELLLGC 183
Query: 223 RKYDKKVDVFSFAMILYEMLEGEP 246
Y +D+++ IL E+L +P
Sbjct: 184 TTYTTAIDMWAVGCILAELLAHKP 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 1e-22
Identities = 83/281 (29%), Positives = 132/281 (46%), Gaps = 31/281 (11%)
Query: 38 DPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLV 95
DPS+ + IGKG++G++ K + G+ A+K IL + D + ++ E N+L
Sbjct: 15 DPSD-TWEIIETIGKGTYGKVFKVLNKKNGSKAAVK-ILDPIHD---IDEEIEAEYNILK 69
Query: 96 KLR-HPNIVQFLGA-----VTERKPLMLITEYLRGG---DLHKYLKEKGALSPSTAVNFA 146
L HPN+V+F G V L L+ E GG DL K ++G + +
Sbjct: 70 ALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYI 129
Query: 147 LDIA-RGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKM 205
L A G+ +LH N IHRD+K N+LL +K+ DFG+S Q + +
Sbjct: 130 LHEALMGLQHLHV--NKTIHRDVKGNNILLTTEGG--VKLVDFGVS----AQLTSTRLRR 181
Query: 206 TGETGSYRYMAPEVFKHRK-----YDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYV 260
G+ +MAPEV + YD + DV+S + E+ +G+PPLA+ P A +
Sbjct: 182 NTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKI 241
Query: 261 AEGHRPFFRA-KGFTPELRELTEKCWAADMNQRPSFLDILK 300
P + ++ E + KC D +RP+ D+L+
Sbjct: 242 PRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQ 282
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 1e-22
Identities = 65/203 (32%), Positives = 104/203 (51%), Gaps = 12/203 (5%)
Query: 49 IIGKGSFGEI-LKAYWRGTPVAIKRILPSLSDDRLVIQD---FRHEVNLLVKLRHPNIVQ 104
++G+GSFG++ L G + L L ++D + E ++L ++ HP IV+
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62
Query: 105 FLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVII 164
A L LI ++LRGGDL L ++ + + ++A + +LH+ II
Sbjct: 63 LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG--II 120
Query: 165 HRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRK 224
+RDLKP N+LL H+K+ DFGLSK ++ K G+ YMAPEV R
Sbjct: 121 YRDLKPENILL--DEEGHIKLTDFGLSK----ESIDHEKKAYSFCGTVEYMAPEVVNRRG 174
Query: 225 YDKKVDVFSFAMILYEMLEGEPP 247
+ + D +SF ++++EML G P
Sbjct: 175 HTQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 1e-22
Identities = 78/278 (28%), Positives = 134/278 (48%), Gaps = 27/278 (9%)
Query: 38 DPSELDFSSSAIIGKGSFGEILKA-YWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVK 96
DP+ + F ++G G++G++ K + + +A +++ D+ ++ + E+N+L K
Sbjct: 13 DPAGI-FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE---EEIKLEINMLKK 68
Query: 97 L-RHPNIVQFLGAVTERKP------LMLITEYLRGGDLHKYLKE-KG-ALSPSTAVNFAL 147
H NI + GA ++ P L L+ E+ G + +K KG AL
Sbjct: 69 YSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICR 128
Query: 148 DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG 207
+I RG+A+LH + +IHRD+K +NVLL ++ +K+ DFG+S Q V +
Sbjct: 129 EILRGLAHLH--AHKVIHRDIKGQNVLLTENA--EVKLVDFGVS----AQLDRTVGRRNT 180
Query: 208 ETGSYRYMAPEVFK-----HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAE 262
G+ +MAPEV YD + D++S + EM EG PPL + P A +
Sbjct: 181 FIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPR 240
Query: 263 GHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILK 300
P ++K ++ + + E C + RPS +LK
Sbjct: 241 NPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 95.3 bits (238), Expect = 1e-22
Identities = 72/207 (34%), Positives = 111/207 (53%), Gaps = 17/207 (8%)
Query: 50 IGKGSFGEILKAYWR--GTPVAIKRI---LPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQ 104
+G+G++ + KA + G VAIK+I + D + R E+ LL +L+HPNI+
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALR-EIKLLQELKHPNIIG 66
Query: 105 FLGAVTERKPLMLITEYLRGGDLHKYLKEKGA-LSPSTAVNFALDIARGMAYLHNEPNVI 163
L + + L+ E++ DL K +K+K L+P+ ++ L RG+ YLH+ N I
Sbjct: 67 LLDVFGHKSNINLVFEFMET-DLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHS--NWI 123
Query: 164 IHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV-FKH 222
+HRDLKP N+L+ +S LK+ DFGL++ N KMT + + Y APE+ F
Sbjct: 124 LHRDLKPNNLLI--ASDGVLKLADFGLARSFGSPN----RKMTHQVVTRWYRAPELLFGA 177
Query: 223 RKYDKKVDVFSFAMILYEMLEGEPPLA 249
R Y VD++S I E+L P L
Sbjct: 178 RHYGVGVDMWSVGCIFAELLLRVPFLP 204
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 2e-22
Identities = 70/202 (34%), Positives = 107/202 (52%), Gaps = 15/202 (7%)
Query: 50 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 107
IG+G++G + KA + G VA+K+I ++D V E++LL +L HPNIV+ L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLE-TEDEGVPSTAIREISLLKELNHPNIVRLLD 65
Query: 108 AVTERKPLMLITEYLRGGDLHKYL--KEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 165
V L L+ E+L DL KY+ L P ++ + +G+AY H+ + ++H
Sbjct: 66 VVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS--HRVLH 122
Query: 166 RDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV-FKHRK 224
RDLKP+N LL++ LK+ DFGL++ V V T E + Y APE+ R+
Sbjct: 123 RDLKPQN-LLIDREGA-LKLADFGLARAFGVP----VRTYTHEVVTLWYRAPEILLGSRQ 176
Query: 225 YDKKVDVFSFAMILYEMLEGEP 246
Y VD++S I EM+ P
Sbjct: 177 YSTPVDIWSIGCIFAEMVNRRP 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 2e-22
Identities = 59/201 (29%), Positives = 95/201 (47%), Gaps = 13/201 (6%)
Query: 49 IIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQ-- 104
IG G++G + A + VAIK+I P D + + E+ +L +H NI+
Sbjct: 12 NIGSGAYGVVCSAIDTRSGKKVAIKKI-PHAFDVPTLAKRTLRELKILRHFKHDNIIAIR 70
Query: 105 --FLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNV 162
+ K + ++ + L DLH + L+ F + RG+ Y+H+
Sbjct: 71 DILRPPGADFKDVYVVMD-LMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSAN-- 127
Query: 163 IIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV-FK 221
+IHRDLKP N LLVN L++GDFG+++ + + Y MT + Y APE+
Sbjct: 128 VIHRDLKPSN-LLVNEDC-ELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLS 185
Query: 222 HRKYDKKVDVFSFAMILYEML 242
+Y +D++S I EML
Sbjct: 186 LPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 3e-22
Identities = 60/191 (31%), Positives = 86/191 (45%), Gaps = 15/191 (7%)
Query: 65 GTPVAIK--RILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL-GAVTERKPLMLITEY 121
G VAIK R + ++ + FR E L +L HPNIV L L + EY
Sbjct: 3 GHEVAIKLLRTD-APEEEHQRAR-FRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEY 60
Query: 122 LRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD 181
+ G L + L GAL L + +A HN I+HRDLKP+N+++ S
Sbjct: 61 VPGRTLREVLAADGALPAGETGRLMLQVLDALACAHN--QGIVHRDLKPQNIMV--SQTG 116
Query: 182 ---HLKVGDFGLSKLIKVQNSHDVYKMTGET---GSYRYMAPEVFKHRKYDKKVDVFSFA 235
H KV DFG+ L+ DV +T T G+ Y APE + D++++
Sbjct: 117 VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWG 176
Query: 236 MILYEMLEGEP 246
+I E L G+
Sbjct: 177 LIFLECLTGQR 187
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 3e-22
Identities = 78/274 (28%), Positives = 129/274 (47%), Gaps = 21/274 (7%)
Query: 36 EIDPSELDFSSSAIIGKGSFGEILKAYWRGTPV-AIKRILPSLSDDRLVIQDFRHEVNLL 94
++DP+E+ + +G G+FG++ KA + T A +++ + S++ L +D+ E+ +L
Sbjct: 7 DLDPNEV-WEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEEL--EDYMVEIEIL 63
Query: 95 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIARG 152
HP IV+ LGA L ++ E+ GG + + E +G P V +
Sbjct: 64 ATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV-ICRQMLEA 122
Query: 153 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSY 212
+ YLH+ IIHRDLK NVLL +K+ DFG+S +N + + G+
Sbjct: 123 LQYLHSMK--IIHRDLKAGNVLLTLDG--DIKLADFGVS----AKNVKTLQRRDSFIGTP 174
Query: 213 RYMAPEV-----FKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRP- 266
+MAPEV K YD K D++S + L EM + EPP P +A+ P
Sbjct: 175 YWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPT 234
Query: 267 FFRAKGFTPELRELTEKCWAADMNQRPSFLDILK 300
+ ++ E R+ + RPS +L+
Sbjct: 235 LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 1e-21
Identities = 73/272 (26%), Positives = 122/272 (44%), Gaps = 26/272 (9%)
Query: 36 EIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLV 95
++ +L+ S G G +K GT +A K + + V + E+ ++
Sbjct: 1 DLRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVH--IGAKSSVRKQILRELQIMH 58
Query: 96 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 155
+ R P IV F GA + + E++ G L + K+ G + A+ + G+ Y
Sbjct: 59 ECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTY 118
Query: 156 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS-KLIKVQNS-HDVYKMTGETGSYR 213
L+N I+HRD+KP N+ LVN S +K+ DFG+S +LI NS D + G+
Sbjct: 119 LYNVHR-IMHRDIKPSNI-LVN-SRGQIKLCDFGVSGELI---NSIADTF-----VGTST 167
Query: 214 YMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEG-----HR--- 265
YM+PE + KY K DV+S + + E+ G+ P A + + G +
Sbjct: 168 YMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQ 227
Query: 266 ---PFFRAKGFTPELRELTEKCWAADMNQRPS 294
P + F +LR+ + C D +RP+
Sbjct: 228 EPPPRLPSSDFPEDLRDFVDACLLKDPTERPT 259
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 1e-21
Identities = 68/211 (32%), Positives = 108/211 (51%), Gaps = 13/211 (6%)
Query: 49 IIGKGSFGEILKAYWRGTP--VAIKRILPS--LSDDRLVIQDFRHEVNLLVKLRHPNIVQ 104
++GKGSFG++ A +GT AIK + L DD + V L + HP +
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRV-LSLAWEHPFLTH 60
Query: 105 FLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVII 164
++ L + EYL GGDL +++ A +A +I G+ +LH++ I+
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG--IV 118
Query: 165 HRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRK 224
+RDLK N+LL + H+K+ DFG+ K +N K G+ Y+APE+ +K
Sbjct: 119 YRDLKLDNILL--DTDGHIKIADFGMCK----ENMLGDAKTCTFCGTPDYIAPEILLGQK 172
Query: 225 YDKKVDVFSFAMILYEMLEGEPPLANYEPYE 255
Y+ VD +SF ++LYEML G+ P ++ E
Sbjct: 173 YNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 1e-21
Identities = 71/264 (26%), Positives = 129/264 (48%), Gaps = 15/264 (5%)
Query: 50 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 107
IG+GS G + A + G VA+K + R ++ + EV ++ +H N+V+
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFN---EVVIMRDYQHQNVVEMYK 85
Query: 108 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 167
+ + L ++ E+L+GG L + + L+ + + + YLH++ +IHRD
Sbjct: 86 SYLVGEELWVLMEFLQGGALTDIVSQT-RLNEEQIATVCESVLQALCYLHSQG--VIHRD 142
Query: 168 LKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDK 227
+K ++LL +K+ DFG Q S DV K G+ +MAPEV Y
Sbjct: 143 IKSDSILLTLDG--RVKLSDFGFC----AQISKDVPKRKSLVGTPYWMAPEVISRTPYGT 196
Query: 228 KVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR-AKGFTPELRELTEKCWA 286
+VD++S +++ EM++GEPP + P +A K + + P + A +P LR+ E+
Sbjct: 197 EVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLT 256
Query: 287 ADMNQRPSFLDILKRLEKIKETLP 310
+ +R + ++L ++ LP
Sbjct: 257 REPQERATAQELLDHPFLLQTGLP 280
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 2e-21
Identities = 70/214 (32%), Positives = 109/214 (50%), Gaps = 26/214 (12%)
Query: 50 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF-- 105
+G GS G + A VA+K+I L+D + V R E+ ++ +L H NIV+
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKI--VLTDPQSVKHALR-EIKIIRRLDHDNIVKVYE 69
Query: 106 ------------LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGM 153
+G++TE + ++ EY+ DL L E+G LS A F + RG+
Sbjct: 70 VLGPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVL-EQGPLSEEHARLFMYQLLRGL 127
Query: 154 AYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYR 213
Y+H+ NV+ HRDLKP NV +N+ LK+GDFGL++++ SH Y G +
Sbjct: 128 KYIHS-ANVL-HRDLKPANVF-INTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKW- 183
Query: 214 YMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEP 246
Y +P + Y K +D+++ I EML G+P
Sbjct: 184 YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKP 217
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 3e-21
Identities = 72/257 (28%), Positives = 116/257 (45%), Gaps = 19/257 (7%)
Query: 44 FSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN 101
F ++GKG FGE+ R T A K++ R +E +L K+
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 102 IVQFLGAVTERKPLMLITEYLRGGDL--HKYLKEKGALSPSTAVNFALDIARGMAYLHNE 159
+V A + L L+ + GGDL H Y + AV +A +I G+ LH E
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE 121
Query: 160 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV 219
I++RDLKP N+LL + H+++ D GL+ + + + G G+ YMAPEV
Sbjct: 122 R--IVYRDLKPENILLDDHG--HIRISDLGLAVHVPEGQT-----IKGRVGTVGYMAPEV 172
Query: 220 FKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPY----EAAKYVAEGHRPFFRAKGFTP 275
K+ +Y D ++ +LYEM+ G+ P + E + V E + ++ F+P
Sbjct: 173 VKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEY--SEKFSP 230
Query: 276 ELRELTEKCWAADMNQR 292
+ R L + D +R
Sbjct: 231 DARSLCKMLLCKDPKER 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 5e-21
Identities = 72/251 (28%), Positives = 116/251 (46%), Gaps = 37/251 (14%)
Query: 43 DFSSSAIIGKGSFGEI--LKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 100
DF S +IG+G+FGE+ ++ G A+K + + ++ + R E ++LV+
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGA 61
Query: 101 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP 160
+V+ + +++ L LI E+L GGD+ L +K LS + + + +H
Sbjct: 62 WVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG 121
Query: 161 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY----------------- 203
IHRD+KP N+LL + H+K+ DFGL +K + + Y
Sbjct: 122 --FIHRDIKPDNLLL--DAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMN 177
Query: 204 -KMTGET-------------GSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLA 249
K ET G+ Y+APEVF Y+K D +S +I+YEML G PP
Sbjct: 178 SKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237
Query: 250 NYEPYEAAKYV 260
+ P E + V
Sbjct: 238 SETPQETYRKV 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 5e-21
Identities = 73/267 (27%), Positives = 126/267 (47%), Gaps = 28/267 (10%)
Query: 50 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH-PNIVQFL 106
IG+G+FG + K + GT +A+KRI + D + +++++++ P IV+F
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRI--RSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFY 69
Query: 107 GAV-TERKPLM---LITEYLRGGDLHK--YLKEKGALSPSTAVNFALDIARGMAYLHNEP 160
GA+ E + L+ L +K Y K + A+ + + YL E
Sbjct: 70 GALFREGDCWICMELMDISLD--KFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL 127
Query: 161 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPE-- 218
IIHRD+KP N+LL + ++K+ DFG+S ++ +S + K T + G YMAPE
Sbjct: 128 K-IIHRDVKPSNILLDRNG--NIKLCDFGISG--QLVDS--IAK-TRDAGCRPYMAPERI 179
Query: 219 -VFKHRKYDKKVDVFSFAMILYEMLEGEPPLANY-EPYEAAKYVAEGHRPFFR---AKGF 273
YD + DV+S + LYE+ G+ P + ++ V +G P + F
Sbjct: 180 DPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREF 239
Query: 274 TPELRELTEKCWAADMNQRPSFLDILK 300
+P C D ++RP + ++L+
Sbjct: 240 SPSFVNFINLCLIKDESKRPKYKELLE 266
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 6e-21
Identities = 62/198 (31%), Positives = 104/198 (52%), Gaps = 15/198 (7%)
Query: 50 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 107
IG+G++G + KA + G VA+K+I + + R E++LL +L HPNIV+ L
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLD 66
Query: 108 AVTERKPLMLITEYLRGGDLHKYLK--EKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 165
+ L L+ E+L DL K++ + ++ + +G+A+ H+ + ++H
Sbjct: 67 VIHTENKLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS--HRVLH 123
Query: 166 RDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV-FKHRK 224
RDLKP+N LL+N+ +K+ DFGL++ V V T E + Y APE+ +
Sbjct: 124 RDLKPQN-LLINTEG-AIKLADFGLARAFGVP----VRTYTHEVVTLWYRAPEILLGCKY 177
Query: 225 YDKKVDVFSFAMILYEML 242
Y VD++S I EM+
Sbjct: 178 YSTAVDIWSLGCIFAEMV 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 7e-21
Identities = 67/219 (30%), Positives = 100/219 (45%), Gaps = 25/219 (11%)
Query: 50 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 107
+G+G+FGE+ KA G VA+K+IL D I R E+ +L KL+HPN+V +
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR-EIKILKKLKHPNVVPLID 74
Query: 108 AVTERKP--------LMLITEYLRGGDLHKYLK-EKGALSPSTAVNFALDIARGMAYLHN 158
ER + ++T Y+ DL L+ L+ S + L + G+ YLH
Sbjct: 75 MAVERPDKSKRKRGSVYMVTPYM-DHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHE 133
Query: 159 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYR----- 213
N I+HRD+K N+L+ N LK+ DFGL++ + G T Y
Sbjct: 134 --NHILHRDIKAANILIDNQGI--LKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVT 189
Query: 214 --YMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLA 249
Y PE+ R+Y VD++ + EM P L
Sbjct: 190 RWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQ 228
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 1e-20
Identities = 63/212 (29%), Positives = 98/212 (46%), Gaps = 20/212 (9%)
Query: 44 FSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLV---KLR 98
F A++G+G FG++L A ++ T AIK + R ++ E + R
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER 60
Query: 99 HPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHN 158
HP +V + + EY GGDL ++ S AV +A + G+ YLH
Sbjct: 61 HPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTD-VFSEPRAVFYAACVVLGLQYLHE 119
Query: 159 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDV-YKMTGET--GSYRYM 215
N I++RDLK N+LL + +K+ DFGL K + + T G+ ++
Sbjct: 120 --NKIVYRDLKLDNLLL--DTEGFVKIADFGLCK-------EGMGFGDRTSTFCGTPEFL 168
Query: 216 APEVFKHRKYDKKVDVFSFAMILYEMLEGEPP 247
APEV Y + VD + +++YEML GE P
Sbjct: 169 APEVLTETSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 1e-20
Identities = 73/258 (28%), Positives = 110/258 (42%), Gaps = 20/258 (7%)
Query: 50 IGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 107
+GKG FGE+ R T A K++ R + E +L K+ IV
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 108 AVTERKPLMLITEYLRGGDLHKYL----KEKGALSPSTAVNFALDIARGMAYLHNEPNVI 163
A + L L+ + GGDL ++ +E A + I G+ +LH I
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ--RRI 118
Query: 164 IHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR 223
I+RDLKP NVLL N ++++ D GL+ +K S K G G+ +MAPE+ +
Sbjct: 119 IYRDLKPENVLLDN--DGNVRISDLGLAVELKDGQS----KTKGYAGTPGFMAPELLQGE 172
Query: 224 KYDKKVDVFSFAMILYEMLEGEPPL----ANYEPYEAAKYVAEGHRPFFRAKGFTPELRE 279
+YD VD F+ + LYEM+ P E E + + + F+P +
Sbjct: 173 EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRIL--NDSVTYPDKFSPASKS 230
Query: 280 LTEKCWAADMNQRPSFLD 297
E A D +R F D
Sbjct: 231 FCEALLAKDPEKRLGFRD 248
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 1e-20
Identities = 68/202 (33%), Positives = 107/202 (52%), Gaps = 14/202 (6%)
Query: 50 IGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 107
IG+G++G + KA R T +A+K+I D+ + R E++LL +++H NIV+
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIR-EISLLKEMQHGNIVRLQD 68
Query: 108 AVTERKPLMLITEYLRGGDLHKYLKEKGALS--PSTAVNFALDIARGMAYLHNEPNVIIH 165
V K L L+ EYL DL K++ + P + I RG+AY H+ + ++H
Sbjct: 69 VVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHS--HRVLH 125
Query: 166 RDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV-FKHRK 224
RDLKP+N LL++ + LK+ DFGL++ + V T E + Y APE+ R
Sbjct: 126 RDLKPQN-LLIDRRTNALKLADFGLARAFGIP----VRTFTHEVVTLWYRAPEILLGSRH 180
Query: 225 YDKKVDVFSFAMILYEMLEGEP 246
Y VD++S I EM+ +P
Sbjct: 181 YSTPVDIWSVGCIFAEMVNQKP 202
|
Length = 294 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 1e-20
Identities = 73/251 (29%), Positives = 115/251 (45%), Gaps = 37/251 (14%)
Query: 43 DFSSSAIIGKGSFGEI--LKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 100
DF S +IG+G+FGE+ ++ G A+K + + ++ + R E ++LV+
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61
Query: 101 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP 160
+V+ + ++ L LI E+L GGD+ L +K L+ + + + +H
Sbjct: 62 WVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLG 121
Query: 161 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY----------------- 203
IHRD+KP N+LL S H+K+ DFGL +K + + Y
Sbjct: 122 --FIHRDIKPDNLLL--DSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMN 177
Query: 204 -KMTGET-------------GSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLA 249
K ET G+ Y+APEVF Y+K D +S +I+YEML G PP
Sbjct: 178 SKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237
Query: 250 NYEPYEAAKYV 260
+ P E K V
Sbjct: 238 SETPQETYKKV 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 2e-20
Identities = 78/274 (28%), Positives = 127/274 (46%), Gaps = 38/274 (13%)
Query: 49 IIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 106
+G+G+ G + K + G A+K I + D L Q R E+ + + P IV++
Sbjct: 8 RLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPD-LQKQILR-ELEINKSCKSPYIVKYY 65
Query: 107 GAVTERKPLML--ITEYLRGGDL---HKYLKEKGA-LSPSTAVNFALDIARGMAYLHNEP 160
GA + + EY GG L +K +K++G + A + +G++YLH+
Sbjct: 66 GAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK 125
Query: 161 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGE-TGSYRYMAPEV 219
IIHRD+KP N+LL + +K+ DFG+S V + G TG+ YMAPE
Sbjct: 126 --IIHRDIKPSNILL--TRKGQVKLCDFGVS-------GELVNSLAGTFTGTSFYMAPER 174
Query: 220 FKHRKYDKKVDVFSFAMILYEML--------EGEPPLANYEPYEAAKYVAEGHRPFFR-- 269
+ + Y DV+S + L E+ EGEPPL P E Y+ P +
Sbjct: 175 IQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLG---PIELLSYIVNMPNPELKDE 231
Query: 270 ---AKGFTPELRELTEKCWAADMNQRPSFLDILK 300
++ E ++ ++C D +RP+ D+L+
Sbjct: 232 PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 2e-20
Identities = 70/255 (27%), Positives = 113/255 (44%), Gaps = 52/255 (20%)
Query: 43 DFSSSAIIGKGSFGE--ILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 100
DF S +IG+G+FGE +++ G A+K++ S ++ + R E ++L + +P
Sbjct: 2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNP 61
Query: 101 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNF------ALDIARGMA 154
+V+ + + L LI EYL GGD+ L +K + + A+D +
Sbjct: 62 WVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLG 121
Query: 155 YLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET----- 209
Y IHRD+KP N+LL H+K+ DFGL +K + + Y++
Sbjct: 122 Y--------IHRDIKPDNLLLDAKG--HIKLSDFGLCTGLKKSHRTEFYRILSHALPSNF 171
Query: 210 -----------------------------GSYRYMAPEVFKHRKYDKKVDVFSFAMILYE 240
G+ Y+APEVF Y+K+ D +S +I+YE
Sbjct: 172 LDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYE 231
Query: 241 MLEGEPPLANYEPYE 255
ML G PP + P E
Sbjct: 232 MLVGYPPFCSDNPQE 246
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 3e-20
Identities = 65/210 (30%), Positives = 106/210 (50%), Gaps = 16/210 (7%)
Query: 43 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 100
D++ IG+G++G + K + T VA+K+I S++ V E++LL +L+HP
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLE-SEEEGVPSTAIREISLLKELQHP 59
Query: 101 NIVQFLGAVTERKPLMLITEYLRGGDLHKYL---KEKGALSPSTAVNFALDIARGMAYLH 157
NIV + + L LI E+L DL KYL + + ++ I +G+ + H
Sbjct: 60 NIVCLQDVLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH 118
Query: 158 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAP 217
+ ++HRDLKP+N+L+ N +K+ DFGL++ + V T E + Y AP
Sbjct: 119 SRR--VLHRDLKPQNLLIDNKGV--IKLADFGLARAFGIP----VRVYTHEVVTLWYRAP 170
Query: 218 EVF-KHRKYDKKVDVFSFAMILYEMLEGEP 246
EV +Y VD++S I EM +P
Sbjct: 171 EVLLGSPRYSTPVDIWSIGTIFAEMATKKP 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 3e-20
Identities = 76/283 (26%), Positives = 118/283 (41%), Gaps = 34/283 (12%)
Query: 44 FSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN 101
F ++GKG FGE+ R G A K++ R +E +L K+
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 102 IVQFLGAVTERKPLMLITEYLRGGDL--HKYLKEKGALSPSTAVNFALDIARGMAYLHNE 159
+V A + L L+ + GGDL H Y AV +A +I G+ LH E
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE 121
Query: 160 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV 219
I++RDLKP N+LL H+++ D GL+ I + + G G+ YMAPEV
Sbjct: 122 R--IVYRDLKPENILL--DDYGHIRISDLGLAVEIP-----EGETIRGRVGTVGYMAPEV 172
Query: 220 FKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPY----EAAKYVAEGHRPFFRAKGFTP 275
K+ +Y D + ++YEM+EG+ P + E + V E + ++ F+
Sbjct: 173 VKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEY--SEKFSE 230
Query: 276 ELRELTEKCW--------------AADMNQRPSFLDIL-KRLE 303
R + + A ++ P F KRLE
Sbjct: 231 AARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLE 273
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 3e-20
Identities = 73/276 (26%), Positives = 126/276 (45%), Gaps = 23/276 (8%)
Query: 43 DFSSSAIIGKGSFGEILKAYWRG---TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH 99
DF+ +G GSFG ++ A ++ PVAIKR S + + E +L + H
Sbjct: 31 DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINH 90
Query: 100 PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE 159
P V G+ + L L+ E++ GG+ +L+ +A I YL +
Sbjct: 91 PFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSL 150
Query: 160 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV 219
I++RDLKP N+LL +K+ DFG +K++ + Y + G + Y+APE+
Sbjct: 151 N--IVYRDLKPENLLL--DKDGFIKMTDFGFAKVVDTRT----YTLCG---TPEYIAPEI 199
Query: 220 FKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRE 279
+ + K D ++ + +YE+L G PP EP + + EG + K +
Sbjct: 200 LLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEG--IIYFPKFLDNNCKH 257
Query: 280 LTEKCWAADMNQRPSFLDILKRLEKIKETLPTDHHW 315
L +K + D+ +R + ++ K + +KE H W
Sbjct: 258 LMKKLLSHDLTKR--YGNLKKGAQNVKE-----HPW 286
|
Length = 340 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 3e-20
Identities = 69/254 (27%), Positives = 124/254 (48%), Gaps = 15/254 (5%)
Query: 50 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 107
IG+GS G + A + G VA+K++ R ++ + EV ++ H N+V
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFN---EVVIMRDYHHENVVDMYN 86
Query: 108 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 167
+ L ++ E+L GG L + ++ L + R ++YLHN+ +IHRD
Sbjct: 87 SYLVGDELWVVMEFLEGGALTDIVTHT-RMNEEQIATVCLSVLRALSYLHNQG--VIHRD 143
Query: 168 LKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDK 227
+K ++LL +S +K+ DFG Q S +V K G+ +MAPEV Y
Sbjct: 144 IKSDSILL--TSDGRIKLSDFGFC----AQVSKEVPKRKSLVGTPYWMAPEVISRLPYGT 197
Query: 228 KVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR-AKGFTPELRELTEKCWA 286
+VD++S +++ EM++GEPP N P +A + + + P + + + LR +
Sbjct: 198 EVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLV 257
Query: 287 ADMNQRPSFLDILK 300
+ +QR + ++L+
Sbjct: 258 REPSQRATAQELLQ 271
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 4e-20
Identities = 74/245 (30%), Positives = 118/245 (48%), Gaps = 12/245 (4%)
Query: 50 IGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 107
IGKGSFG++++ R T A+K I + R + E +L ++ P IV
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 108 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 167
+ + L L+ ++ GG+L +L+ +G S A + ++ + LH + NVI +RD
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLH-KFNVI-YRD 118
Query: 168 LKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDK 227
LKP N+LL H+ + DFGL KL N D K G+ Y+APE+ Y K
Sbjct: 119 LKPENILL--DYQGHIALCDFGLCKL----NMKDDDKTNTFCGTPEYLAPELLLGHGYTK 172
Query: 228 KVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAA 287
VD ++ ++LYEML G PP + E + + + P GF + ++L +
Sbjct: 173 AVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQ--EPLRFPDGFDRDAKDLLIGLLSR 230
Query: 288 DMNQR 292
D +R
Sbjct: 231 DPTRR 235
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 5e-20
Identities = 58/207 (28%), Positives = 103/207 (49%), Gaps = 21/207 (10%)
Query: 49 IIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVK------LRHP 100
++GKGSFG+++ A +GT AIK L D +++QD + + K +HP
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIK----VLKKD-VILQDDDVDCTMTEKRILALAAKHP 56
Query: 101 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP 160
+ + L + EY+ GGDL ++ + +A ++ + +LH
Sbjct: 57 FLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHR-- 114
Query: 161 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF 220
+ +I+RDLK N+LL + H K+ DFG+ K + + T G+ Y+APE+
Sbjct: 115 HGVIYRDLKLDNILL--DAEGHCKLADFGMCK----EGILNGVTTTTFCGTPDYIAPEIL 168
Query: 221 KHRKYDKKVDVFSFAMILYEMLEGEPP 247
+ +Y VD ++ +++YEM+ G+PP
Sbjct: 169 QELEYGPSVDWWALGVLMYEMMAGQPP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 5e-20
Identities = 71/289 (24%), Positives = 121/289 (41%), Gaps = 49/289 (16%)
Query: 43 DFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 102
DF +G G+ G + K R + + + R L L + E+ +L + P I
Sbjct: 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYI 61
Query: 103 VQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNV 162
V F GA + + E++ GG L + LK+ G + + ++ + RG+ YL + +
Sbjct: 62 VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREK-HK 120
Query: 163 IIHRDLKPRNVLLVNSSADHLKVGDFGLS-KLI-KVQNSHDVYKMTGETGSYRYMAPEVF 220
I+HRD+KP N+L VNS + +K+ DFG+S +LI + NS G+ YM+PE
Sbjct: 121 IMHRDVKPSNIL-VNSRGE-IKLCDFGVSGQLIDSMANSF--------VGTRSYMSPERL 170
Query: 221 KHRKYDKKVDVFSFAMILYEMLEGEPPL-----ANYEP---------------------- 253
+ Y + D++S + L EM G P+ E
Sbjct: 171 QGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHP 230
Query: 254 ---------YEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRP 293
+E Y+ P + F+ E ++ +KC + +R
Sbjct: 231 PDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERA 279
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 90.2 bits (223), Expect = 6e-20
Identities = 84/286 (29%), Positives = 134/286 (46%), Gaps = 49/286 (17%)
Query: 50 IGKGSFGEILKAYWRGTP-----VAIK-RILPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 103
IG G FGE+ + T AI R L +LVI EVN++ +L+H NIV
Sbjct: 21 IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVI-----EVNVMRELKHKNIV 75
Query: 104 QFLGAVTER--KPLMLITEYLRGGDL----HKYLKEKGALSPSTAVNFALDIARGMAYLH 157
+++ + + L ++ E+ GDL K K G + V+ + +AY H
Sbjct: 76 RYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCH 135
Query: 158 N---EPN--VIIHRDLKPRNVLL---------VNSSADHL------KVGDFGLSKLIKVQ 197
N PN ++HRDLKP+N+ L + + A++L K+GDFGLSK I ++
Sbjct: 136 NLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIE 195
Query: 198 N-SHDVYKMTGETGSYRYMAPEVFKH--RKYDKKVDVFSFAMILYEMLEGEPPLANYEPY 254
+ +H G+ Y +PE+ H + YD K D+++ I+YE+ G+ P +
Sbjct: 196 SMAHSC------VGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNF 249
Query: 255 EAAKYVAEGHR-PFFRAKGFTPELRELTEKCWAADMNQRPSFLDIL 299
++ ++E R P KG + EL L + +RPS L L
Sbjct: 250 --SQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCL 293
|
Length = 1021 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 6e-20
Identities = 70/257 (27%), Positives = 113/257 (43%), Gaps = 19/257 (7%)
Query: 44 FSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN 101
F ++GKG FGE+ R T A KR+ R +E +L K+
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 102 IVQFLGAVTERKPLMLITEYLRGGDL--HKYLKEKGALSPSTAVNFALDIARGMAYLHNE 159
+V A + L L+ + GGDL H Y A+ +A +I G+ LH E
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE 121
Query: 160 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV 219
++RDLKP N+LL + H+++ D GL+ +K+ + G G+ YMAPEV
Sbjct: 122 N--TVYRDLKPENILLDDYG--HIRISDLGLA--VKIPEGESI---RGRVGTVGYMAPEV 172
Query: 220 FKHRKYDKKVDVFSFAMILYEMLEGEPPL----ANYEPYEAAKYVAEGHRPFFRAKGFTP 275
+++Y D + ++YEM+EG+ P + E + V E + + F+
Sbjct: 173 LNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVY--SAKFSE 230
Query: 276 ELRELTEKCWAADMNQR 292
E + + + D QR
Sbjct: 231 EAKSICKMLLTKDPKQR 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 1e-19
Identities = 69/210 (32%), Positives = 102/210 (48%), Gaps = 22/210 (10%)
Query: 50 IGKGSFGEILKAYWRGT----PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQ 104
+G+G++G + A T VAIK+I S L + R E+ LL R H NI
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALR-ELKLLRHFRGHKNITC 66
Query: 105 -------FLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLH 157
F G E + + E L DLH+ ++ L+ + +F I G+ Y+H
Sbjct: 67 LYDMDIVFPGNFNE----LYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIH 122
Query: 158 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAP 217
+ NV+ HRDLKP N LLVN+ + LK+ DFGL++ + MT + Y AP
Sbjct: 123 S-ANVL-HRDLKPGN-LLVNADCE-LKICDFGLARGFSENPGENAGFMTEYVATRWYRAP 178
Query: 218 EV-FKHRKYDKKVDVFSFAMILYEMLEGEP 246
E+ + Y K +DV+S IL E+L +P
Sbjct: 179 EIMLSFQSYTKAIDVWSVGCILAELLGRKP 208
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 1e-19
Identities = 79/269 (29%), Positives = 124/269 (46%), Gaps = 30/269 (11%)
Query: 50 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFL 106
IGKG++G++ K + G+ A+K IL +SD V ++ E N+L L HPN+V+F
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVK-ILDPISD---VDEEIEAEYNILQSLPNHPNVVKFY 85
Query: 107 GAVTERK-----PLMLITEYLRGG---DLHKYLKEKGALSPSTAVNFALDIAR-GMAYLH 157
G + L L+ E GG +L K L G +++ L A G+ +LH
Sbjct: 86 GMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH 145
Query: 158 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAP 217
N N IIHRD+K N+LL +K+ DFG+S Q + + G+ +MAP
Sbjct: 146 N--NRIIHRDVKGNNILLTTEGG--VKLVDFGVS----AQLTSTRLRRNTSVGTPFWMAP 197
Query: 218 EVFKHRK-----YDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR-AK 271
EV + YD + DV+S + E+ +G+PPL + P + + P +
Sbjct: 198 EVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLHPE 257
Query: 272 GFTPELRELTEKCWAADMNQRPSFLDILK 300
+ +C D RPS +L+
Sbjct: 258 KWCRSFNHFISQCLIKDFEARPSVTHLLE 286
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 87.2 bits (217), Expect = 1e-19
Identities = 66/205 (32%), Positives = 110/205 (53%), Gaps = 16/205 (7%)
Query: 50 IGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFL 106
+GKG++G + KA R T VA+K+I + + + FR E+ L +L HPNIV+ L
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFR-EIMFLQELGDHPNIVKLL 73
Query: 107 G---AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVI 163
A ++ + L+ EY+ DLH ++ L + + + Y+H+ +
Sbjct: 74 NVIKAENDKD-IYLVFEYMET-DLHAVIR-ANILEDVHKRYIMYQLLKALKYIHSGN--V 128
Query: 164 IHRDLKPRNVLLVNSSADHLKVGDFGLSKLI-KVQNSHDVYKMTGETGSYRYMAPEV-FK 221
IHRDLKP N+LL +S +K+ DFGL++ + +++ + + +T + Y APE+
Sbjct: 129 IHRDLKPSNILL--NSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLG 186
Query: 222 HRKYDKKVDVFSFAMILYEMLEGEP 246
+Y K VD++S IL EML G+P
Sbjct: 187 STRYTKGVDMWSVGCILGEMLLGKP 211
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 1e-19
Identities = 70/255 (27%), Positives = 114/255 (44%), Gaps = 25/255 (9%)
Query: 49 IIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQ-------DFRHEVNLLVKLRHPN 101
IIG+G FGE+ R + L R+ ++ + R ++L+ P
Sbjct: 1 IIGRGGFGEVYGC--RKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 58
Query: 102 IVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPN 161
IV A L I + + GGDLH +L + G S +A +I G+ ++HN
Sbjct: 59 IVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNR-- 116
Query: 162 VIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF- 220
+++RDLKP N+LL H+++ D GL+ + H G++ YMAPEV
Sbjct: 117 FVVYRDLKPANILL--DEHGHVRISDLGLACDFSKKKPH------ASVGTHGYMAPEVLQ 168
Query: 221 KHRKYDKKVDVFSFAMILYEMLEGEPPLANY---EPYEAAKYVAEGHRPFFRAKGFTPEL 277
K YD D FS +L+++L G P + + +E + + F+PEL
Sbjct: 169 KGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVEL--PDSFSPEL 226
Query: 278 RELTEKCWAADMNQR 292
+ L E D+++R
Sbjct: 227 KSLLEGLLQRDVSKR 241
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 1e-19
Identities = 67/210 (31%), Positives = 104/210 (49%), Gaps = 31/210 (14%)
Query: 50 IGKGSFGEILKAYWR------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 103
IG G+FG + W G VA+K+ +P++ + + + E+ +L +H N+
Sbjct: 8 IGYGAFGVV----WSVTDPRDGKRVALKK-MPNVFQNLVSCKRVFRELKMLCFFKHDNV- 61
Query: 104 QFLGAVTERKP--------LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 155
L A+ +P + ++TE ++ DLHK + LS F I RG+ Y
Sbjct: 62 --LSALDILQPPHIDPFEEIYVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQILRGLKY 118
Query: 156 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYM 215
LH+ I+HRD+KP N LLVNS+ LK+ DFGL+ +V+ + MT E + Y
Sbjct: 119 LHSAG--ILHRDIKPGN-LLVNSNC-VLKICDFGLA---RVEEPDESKHMTQEVVTQYYR 171
Query: 216 APEVFK-HRKYDKKVDVFSFAMILYEMLEG 244
APE+ R Y VD++S I E+L
Sbjct: 172 APEILMGSRHYTSAVDIWSVGCIFAELLGR 201
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 2e-19
Identities = 66/254 (25%), Positives = 123/254 (48%), Gaps = 15/254 (5%)
Query: 50 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 107
IG+GS G + A + G VA+K++ R ++ + EV ++ +H N+V+
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFN---EVVIMRDYQHENVVEMYN 84
Query: 108 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 167
+ L ++ E+L GG L + ++ L + + ++ LH + +IHRD
Sbjct: 85 SYLVGDELWVVMEFLEGGALTDIVTHT-RMNEEQIAAVCLAVLKALSVLHAQG--VIHRD 141
Query: 168 LKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDK 227
+K ++LL + +K+ DFG Q S +V + G+ +MAPE+ Y
Sbjct: 142 IKSDSILLTHDG--RVKLSDFGFC----AQVSKEVPRRKSLVGTPYWMAPELISRLPYGP 195
Query: 228 KVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR-AKGFTPELRELTEKCWA 286
+VD++S +++ EM++GEPP N P +A K + + P + +P L+ ++
Sbjct: 196 EVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLV 255
Query: 287 ADMNQRPSFLDILK 300
D QR + ++LK
Sbjct: 256 RDPAQRATAAELLK 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 2e-19
Identities = 74/275 (26%), Positives = 123/275 (44%), Gaps = 40/275 (14%)
Query: 50 IGKGSFGEILKA-YWRGTPVA---IKRILPSLSDDRLVIQD-FRHEVNLLVKLRHPNIVQ 104
IG G FG++L RG A +K + S + D Q F EV +L HPN++Q
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDE---QLLFLQEVQPYRELNHPNVLQ 59
Query: 105 FLGAVTERKPLMLITEYLRGGDLHKYLK-----EKGALSPSTAVNFALDIARGMAYLHNE 159
LG E P +L+ E+ GDL YL+ A ++A G+ +LH
Sbjct: 60 CLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ- 118
Query: 160 PNVIIHRDLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVYKMTGETGSY--RYMA 216
IH DL RN L +AD +K+GD+GL+ ++ + Y +T + + R++A
Sbjct: 119 -ADFIHSDLALRNCQL---TADLSVKIGDYGLA----LEQYPEDYYITKDCHAVPLRWLA 170
Query: 217 PEVFKHRKYD-------KKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGH---- 264
PE+ + R D KK +++S + ++E+ + P + + K V
Sbjct: 171 PELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKL 230
Query: 265 -RPFFRAKGFTPELRELTEKCWAADMNQRPSFLDI 298
+P K ++ E+ + CW D RP+ ++
Sbjct: 231 PKPQLDLK-YSDRWYEVMQFCW-LDPETRPTAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 85.7 bits (213), Expect = 3e-19
Identities = 61/203 (30%), Positives = 102/203 (50%), Gaps = 16/203 (7%)
Query: 50 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 107
I +G++G + +A + G VA+K++ + I R E+N+L+KL+HPNIV
Sbjct: 13 IEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLR-EINILLKLQHPNIVTVKE 71
Query: 108 AV--TERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVII 164
V + + ++ EY+ DL ++ K S L + G+A+LH+ N I+
Sbjct: 72 VVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHD--NWIL 128
Query: 165 HRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV-FKHR 223
HRDLK N+LL N LK+ DFGL++ + + T + Y APE+ +
Sbjct: 129 HRDLKTSNLLLNNRGI--LKICDFGLAR----EYGSPLKPYTQLVVTLWYRAPELLLGAK 182
Query: 224 KYDKKVDVFSFAMILYEMLEGEP 246
+Y +D++S I E+L +P
Sbjct: 183 EYSTAIDMWSVGCIFAELLTKKP 205
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 4e-19
Identities = 63/219 (28%), Positives = 109/219 (49%), Gaps = 16/219 (7%)
Query: 43 DFSSSAIIGKGSFGEILKA--YWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 100
D+ +G G++G++ KA G A+K I DD +IQ E+ ++ + +H
Sbjct: 10 DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQ---QEIFMVKECKHC 66
Query: 101 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP 160
NIV + G+ R+ L + EY GG L G LS + +G+AYLH++
Sbjct: 67 NIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKG 126
Query: 161 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF 220
+HRD+K N+LL ++ +K+ DFG++ I + + K G+ +MAPEV
Sbjct: 127 K--MHRDIKGANILLTDNG--DVKLADFGVAAKI----TATIAKRKSFIGTPYWMAPEVA 178
Query: 221 ---KHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEA 256
K+ Y++ D+++ + E+ E +PP+ + P A
Sbjct: 179 AVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA 217
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 6e-19
Identities = 66/212 (31%), Positives = 100/212 (47%), Gaps = 23/212 (10%)
Query: 49 IIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH-PNIVQF 105
IG+G++G++ KA + G VA+K+ + ++ + R E++LL L IV+
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALR-EISLLQMLSESIYIVRL 66
Query: 106 LGAV-TERKP----LMLITEYLRGGDLHKYLKEKG-----ALSPSTAVNFALDIARGMAY 155
L E K L L+ EYL DL K++ G L T +F + +G+A+
Sbjct: 67 LDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAH 125
Query: 156 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYM 215
H ++HRDLKP+N LLV+ LK+ D GL + + V T E + Y
Sbjct: 126 CHKHG--VMHRDLKPQN-LLVDKQKGLLKIADLGLGRAFSIP----VKSYTHEIVTLWYR 178
Query: 216 APEV-FKHRKYDKKVDVFSFAMILYEMLEGEP 246
APEV Y VD++S I EM +P
Sbjct: 179 APEVLLGSTHYSTPVDIWSVGCIFAEMSRKQP 210
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 1e-18
Identities = 68/246 (27%), Positives = 111/246 (45%), Gaps = 11/246 (4%)
Query: 49 IIGKGSFGEIL--KAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 106
++GKG+FG+++ K G A+K + + + + E +L RHP +
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61
Query: 107 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 166
+ L + EY GG+L +L + S A + +I + YLH+E NV+ +R
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVV-YR 120
Query: 167 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYD 226
DLK N++L H+K+ DFGL K + D M G+ Y+APEV + Y
Sbjct: 121 DLKLENLML--DKDGHIKITDFGLCK----EGIKDGATMKTFCGTPEYLAPEVLEDNDYG 174
Query: 227 KKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWA 286
+ VD + +++YEM+ G P N + + + + F R PE + L
Sbjct: 175 RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLS--PEAKSLLSGLLK 232
Query: 287 ADMNQR 292
D QR
Sbjct: 233 KDPKQR 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 2e-18
Identities = 61/207 (29%), Positives = 96/207 (46%), Gaps = 20/207 (9%)
Query: 49 IIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQ-------DFRHEVNLLVKLRHPN 101
IIG+G FGE+ R + L R+ ++ + R ++L+ P
Sbjct: 1 IIGRGGFGEVYGC--RKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 58
Query: 102 IVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPN 161
IV A L I + + GGDLH +L + G S + +A +I G+ ++HN
Sbjct: 59 IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNR-- 116
Query: 162 VIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF- 220
+++RDLKP N+LL H+++ D GL+ + H G++ YMAPEV
Sbjct: 117 FVVYRDLKPANILLDEHG--HVRISDLGLACDFSKKKPH------ASVGTHGYMAPEVLQ 168
Query: 221 KHRKYDKKVDVFSFAMILYEMLEGEPP 247
K YD D FS +L+++L G P
Sbjct: 169 KGVAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 4e-18
Identities = 74/283 (26%), Positives = 120/283 (42%), Gaps = 34/283 (12%)
Query: 44 FSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN 101
F ++GKG FGE+ R T A K++ R +E +L K+
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 102 IVQFLGAVTERKPLMLITEYLRGGDL--HKYLKEKGALSPSTAVNFALDIARGMAYLHNE 159
+V A + L L+ + GGDL H Y A+ +A ++ G+ L E
Sbjct: 62 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE 121
Query: 160 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV 219
I++RDLKP N+LL + H+++ D GL+ I + + G G+ YMAPEV
Sbjct: 122 R--IVYRDLKPENILLDDRG--HIRISDLGLAVQIP-----EGETVRGRVGTVGYMAPEV 172
Query: 220 FKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPY----EAAKYVAEGHRPFFRAKGFTP 275
+ KY D + ++YEM++G+ P + E + V E + ++ F+
Sbjct: 173 INNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEY--SEKFSE 230
Query: 276 ELRELTEKCW--------------AADMNQRPSFLDI-LKRLE 303
+ + + AA + Q P F +I KRLE
Sbjct: 231 DAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRLE 273
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 4e-18
Identities = 64/227 (28%), Positives = 96/227 (42%), Gaps = 33/227 (14%)
Query: 50 IGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 107
+GKG G + +GT A+K + R ++ E +L L HP +
Sbjct: 9 LGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYA 68
Query: 108 AVTERKPLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIARGMAYLHNEPNVIIH 165
+ L L+ +Y GG+L + L+ LS A +A ++ + YLH I++
Sbjct: 69 SFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHL--LGIVY 126
Query: 166 RDLKPRNVLLVNSSADHLKVGDFGLSK------------LIKVQNSHDVYKMTGET---- 209
RDLKP N+LL S H+ + DF LSK L K V + ET
Sbjct: 127 RDLKPENILLHESG--HIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEE 184
Query: 210 ---------GSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPP 247
G+ Y+APEV + VD ++ ++LYEML G P
Sbjct: 185 PSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 4e-18
Identities = 67/204 (32%), Positives = 99/204 (48%), Gaps = 21/204 (10%)
Query: 50 IGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 107
+G+GS+ + K + T VA+K I L + E +LL L+H NIV
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEI--RLEHEEGAPFTAIREASLLKDLKHANIVTLHD 70
Query: 108 AVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 166
+ +K L L+ EYL DL +Y+ G LS F + RG+AY H ++HR
Sbjct: 71 IIHTKKTLTLVFEYLD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR--VLHR 127
Query: 167 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN---SHDVYKMTGETGSYRYMAPEVF-KH 222
DLKP+N+L+ S LK+ DFGL++ V + S++V T YR P+V
Sbjct: 128 DLKPQNLLI--SERGELKLADFGLARAKSVPSKTYSNEVV-----TLWYR--PPDVLLGS 178
Query: 223 RKYDKKVDVFSFAMILYEMLEGEP 246
+Y +D++ I YEM G P
Sbjct: 179 TEYSTSLDMWGVGCIFYEMATGRP 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 6e-18
Identities = 67/210 (31%), Positives = 105/210 (50%), Gaps = 22/210 (10%)
Query: 49 IIGKGSFGEILKAYWR--GTPVAIKRI---LPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 103
+IGKGS+G + A G VAIK+I +SD +++ E+ LL LRHP+IV
Sbjct: 7 VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILR----EIKLLRLLRHPDIV 62
Query: 104 QFLGAV-----TERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHN 158
+ + E K + ++ E L DLH+ +K L+P F + R + Y+H
Sbjct: 63 EIKHIMLPPSRREFKDIYVVFE-LMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHT 121
Query: 159 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPE 218
+ HRDLKP+N+ L N+ LK+ DFGL+++ ++ T + Y APE
Sbjct: 122 --ANVFHRDLKPKNI-LANADCK-LKICDFGLARVAFNDTPTAIF-WTDYVATRWYRAPE 176
Query: 219 VFK--HRKYDKKVDVFSFAMILYEMLEGEP 246
+ KY +D++S I E+L G+P
Sbjct: 177 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKP 206
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 7e-18
Identities = 70/224 (31%), Positives = 104/224 (46%), Gaps = 24/224 (10%)
Query: 31 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFR 88
NK WE+ D +G G++G + A R G VAIK++ + + +R
Sbjct: 7 NKTIWEVPDRYRDLKQ---VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYR 63
Query: 89 HEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY-----LRGGDLHKYLKEKGALSPSTAV 143
E+ LL ++H N++ L T L ++ G DL K +K + LS
Sbjct: 64 -ELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHE-KLSEDRIQ 121
Query: 144 NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 203
+ +G+ Y+H IIHRDLKP N L VN + LK+ DFGL++
Sbjct: 122 FLVYQMLKGLKYIHAAG--IIHRDLKPGN-LAVNEDCE-LKILDFGLAR-------QTDS 170
Query: 204 KMTGETGSYRYMAPEV-FKHRKYDKKVDVFSFAMILYEMLEGEP 246
+MTG + Y APEV Y + VD++S I+ EML G+P
Sbjct: 171 EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKP 214
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 8e-18
Identities = 63/205 (30%), Positives = 101/205 (49%), Gaps = 18/205 (8%)
Query: 50 IGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 107
IG+G++G + A T VAIK+I + D+R+ + E+ LL L H N++
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAF-DNRIDAKRTLREIKLLRHLDHENVIAIKD 71
Query: 108 AVT-----ERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNV 162
+ + ++ E L DLH+ ++ LS F + RG+ Y+H+
Sbjct: 72 IMPPPHREAFNDVYIVYE-LMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSAN-- 128
Query: 163 IIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV-FK 221
++HRDLKP N LL+N++ D LK+ DFGL++ S MT + Y APE+
Sbjct: 129 VLHRDLKPSN-LLLNANCD-LKICDFGLART----TSEKGDFMTEYVVTRWYRAPELLLN 182
Query: 222 HRKYDKKVDVFSFAMILYEMLEGEP 246
+Y +DV+S I E+L +P
Sbjct: 183 CSEYTTAIDVWSVGCIFAELLGRKP 207
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 9e-18
Identities = 73/265 (27%), Positives = 117/265 (44%), Gaps = 28/265 (10%)
Query: 50 IGKGSFGEILKAYWRGTPV--AIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 107
+GKG++G + K R T V A+K I L + + E+++L K P IV F G
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKF--NQIIMELDILHKAVSPYIVDFYG 66
Query: 108 AVTERKPLMLITEYLRGGDLHKYLKEKGALS--PSTAVNF-ALDIARGMAYLHNEPNVII 164
A + + EY+ G L K A P + + +G+ +L E N II
Sbjct: 67 AFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN-II 125
Query: 165 HRDLKPRNVLLVNSSADHLKVGDFGLS-KLIKVQNSHDVYKMTGETGSYRYMAPEVFK-- 221
HRD+KP NVL+ + +K+ DFG+S L+ ++ G YMAPE K
Sbjct: 126 HRDVKPTNVLV--NGNGQVKLCDFGVSGNLVASLAKTNI-------GCQSYMAPERIKSG 176
Query: 222 ----HRKYDKKVDVFSFAMILYEMLEGE---PPLANYEPYEAAKYVAEGHRPFFRAKGFT 274
+ Y + DV+S + + EM G PP + + +G P G++
Sbjct: 177 GPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTL-PSGYS 235
Query: 275 PELRELTEKCWAADMNQRPSFLDIL 299
+ ++ KC N+RP++ +L
Sbjct: 236 DDAQDFVAKCLNKIPNRRPTYAQLL 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 1e-17
Identities = 58/206 (28%), Positives = 97/206 (47%), Gaps = 14/206 (6%)
Query: 49 IIGKGSFGEIL----KAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQ 104
++GKG+FG+++ KA R + I R ++ D + E +L RHP +
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE--VAHTVTESRVLQNTRHPFLTA 59
Query: 105 FLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVII 164
A L + EY GG+L +L + + A + +I + YLH+ ++
Sbjct: 60 LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VV 117
Query: 165 HRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRK 224
+RD+K N++L H+K+ DFGL K + D M G+ Y+APEV +
Sbjct: 118 YRDIKLENLMLDKDG--HIKITDFGLCK----EGISDGATMKTFCGTPEYLAPEVLEDND 171
Query: 225 YDKKVDVFSFAMILYEMLEGEPPLAN 250
Y + VD + +++YEM+ G P N
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLPFYN 197
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 81.7 bits (201), Expect = 1e-17
Identities = 56/206 (27%), Positives = 98/206 (47%), Gaps = 10/206 (4%)
Query: 49 IIGKGSFGEIL--KAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 106
++GKG+FG+++ + G A+K + + + + E +L RHP +
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 107 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 166
+ + L + EY+ GG+L +L + S + +I + YLH+ I++R
Sbjct: 62 YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHS--GKIVYR 119
Query: 167 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYD 226
DLK N++L H+K+ DFGL K + D M G+ Y+APEV + Y
Sbjct: 120 DLKLENLML--DKDGHIKITDFGLCK----EGITDAATMKTFCGTPEYLAPEVLEDNDYG 173
Query: 227 KKVDVFSFAMILYEMLEGEPPLANYE 252
+ VD + +++YEM+ G P N +
Sbjct: 174 RAVDWWGLGVVMYEMMCGRLPFYNQD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 1e-17
Identities = 63/212 (29%), Positives = 106/212 (50%), Gaps = 24/212 (11%)
Query: 48 AIIGKGSFGEILKAY---WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR---HPN 101
A IG+G++G++ KA G VA+KR+ ++ + + R EV +L L HPN
Sbjct: 7 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR-EVAVLRHLETFEHPN 65
Query: 102 IVQFLGAVT-----ERKPLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIARGMA 154
+V+ T L L+ E++ DL YL + + + T + + RG+
Sbjct: 66 VVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLD 124
Query: 155 YLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRY 214
+LH+ + ++HRDLKP+N+L+ +S+ +K+ DFGL+++ Q + +T Y
Sbjct: 125 FLHS--HRVVHRDLKPQNILV--TSSGQIKLADFGLARIYSFQMALTSVVVT-----LWY 175
Query: 215 MAPEVFKHRKYDKKVDVFSFAMILYEMLEGEP 246
APEV Y VD++S I EM +P
Sbjct: 176 RAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 1e-17
Identities = 75/274 (27%), Positives = 125/274 (45%), Gaps = 20/274 (7%)
Query: 43 DFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 102
DF + +G G+ G + K + + + + R L L + E+ +L + P I
Sbjct: 6 DFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 65
Query: 103 VQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNV 162
V F GA + + E++ GG L + LKE + ++ + RG+AYL E +
Sbjct: 66 VGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLR-EKHQ 124
Query: 163 IIHRDLKPRNVLLVNSSADHLKVGDFGLS-KLIKVQNSHDVYKMTGETGSYRYMAPEVFK 221
I+HRD+KP N+ LVNS + +K+ DFG+S +LI + V G+ YM+PE +
Sbjct: 125 IMHRDVKPSNI-LVNSRGE-IKLCDFGVSGQLIDSMANSFV-------GTRSYMSPERLQ 175
Query: 222 HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKG-----FTPE 276
Y + D++S + L E+ G P+ P +A + A RP + +P
Sbjct: 176 GTHYSVQSDIWSMGLSLVELAIGRYPIP---PPDAKELEAIFGRPVVDGEEGEPHSISPR 232
Query: 277 LRELTEKCWAADMNQRPSFLDILKRLEKIKETLP 310
R M+ RP+ + I + L+ I P
Sbjct: 233 PRPPGRPVSGHGMDSRPA-MAIFELLDYIVNEPP 265
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 2e-17
Identities = 70/220 (31%), Positives = 104/220 (47%), Gaps = 32/220 (14%)
Query: 43 DFSSSAIIGKGSFGEI-LKAYWRGTPV-AIKRILPSLSDDRLVIQD----FRHEVNLLVK 96
DF +IG+G+FGE+ L + V A+K LS ++ + F E +++
Sbjct: 44 DFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKL----LSKFEMIKRSDSAFFWEERDIMAH 99
Query: 97 LRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK-----EKGALSPSTAVNFALDIAR 151
IVQ A + K L ++ EY+ GGDL + EK A + V ALD
Sbjct: 100 ANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIH 159
Query: 152 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGS 211
M + IHRD+KP N+LL + HLK+ DFG +K+ + V T G+
Sbjct: 160 SMGF--------IHRDVKPDNMLL--DKSGHLKLADFG--TCMKMDANGMVRCDTA-VGT 206
Query: 212 YRYMAPEVFK----HRKYDKKVDVFSFAMILYEMLEGEPP 247
Y++PEV K Y ++ D +S + LYEML G+ P
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 2e-17
Identities = 66/206 (32%), Positives = 101/206 (49%), Gaps = 19/206 (9%)
Query: 50 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 107
+G+GS+ + K R G VA+K I S+ + V E +LL L+H NIV
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVI--SMKTEEGVPFTAIREASLLKGLKHANIVLLHD 70
Query: 108 AVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 166
+ ++ L + EY+ DL +Y+ + G L P F + RG+AY+H + I+HR
Sbjct: 71 IIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH--ILHR 127
Query: 167 DLKPRNVLLVNSSADHLKVGDFGL--SKLIKVQNSHDVYKMTGETGSYRYMAPEVF-KHR 223
DLKP+N+L+ S LK+ DFGL +K I Q + E + Y P+V
Sbjct: 128 DLKPQNLLI--SYLGELKLADFGLARAKSIPSQT------YSSEVVTLWYRPPDVLLGAT 179
Query: 224 KYDKKVDVFSFAMILYEMLEGEPPLA 249
Y +D++ I EML+G+P
Sbjct: 180 DYSSALDIWGAGCIFIEMLQGQPAFP 205
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 3e-17
Identities = 69/211 (32%), Positives = 105/211 (49%), Gaps = 23/211 (10%)
Query: 48 AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR---HPNI 102
A IG G++G + KA G VA+K + ++D L + R EV LL +L HPNI
Sbjct: 6 AEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVR-EVALLKRLEAFDHPNI 64
Query: 103 VQFL----GAVTERK-PLMLITEYLRGGDLHKYLKEKGA--LSPSTAVNFALDIARGMAY 155
V+ + + T+R+ + L+ E++ DL YL + L T + RG+ +
Sbjct: 65 VRLMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDF 123
Query: 156 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYM 215
LH N I+HRDLKP N+L+ +S +K+ DFGL+++ Q + +T Y
Sbjct: 124 LHA--NCIVHRDLKPENILV--TSGGQVKLADFGLARIYSCQMALTPVVVT-----LWYR 174
Query: 216 APEVFKHRKYDKKVDVFSFAMILYEMLEGEP 246
APEV Y VD++S I EM +P
Sbjct: 175 APEVLLQSTYATPVDMWSVGCIFAEMFRRKP 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 3e-17
Identities = 57/217 (26%), Positives = 99/217 (45%), Gaps = 28/217 (12%)
Query: 50 IGKGSFGEILKAYW----RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 105
IG+G++G + KA G AIK+ + Q E+ LL +L+H N+V
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67
Query: 106 LGAV---TERKPLMLI--TEYLRGGDL-----HKYLKEKGALSPSTAVNFALDIARGMAY 155
+ ++ +L E+ DL ++ ++ PS + I G+ Y
Sbjct: 68 VEVFLEHADKSVYLLFDYAEH----DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHY 123
Query: 156 LHNEPNVIIHRDLKPRNVLLVNSSADH--LKVGDFGLSKLIKVQNSHDVYKMTGETGSYR 213
LH+ N ++HRDLKP N+L++ + +K+GD GL++L + + +
Sbjct: 124 LHS--NWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLF-NAPLKPLADLDPVVVTIW 180
Query: 214 YMAPEVF---KHRKYDKKVDVFSFAMILYEMLEGEPP 247
Y APE+ +H Y K +D+++ I E+L EP
Sbjct: 181 YRAPELLLGARH--YTKAIDIWAIGCIFAELLTLEPI 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 3e-17
Identities = 66/278 (23%), Positives = 116/278 (41%), Gaps = 47/278 (16%)
Query: 50 IGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQD----------FRHEVNLLVKLRH 99
+G+G+F I K R + I+ + +V++ F +L+ +L H
Sbjct: 3 LGQGTFTNIYKGVLR--VQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSH 60
Query: 100 PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK-EKGALSPSTAVNFALDIARGMAYLHN 158
++V+ G V R +++ EY++ G L +L EK +S ++ A +A + YL
Sbjct: 61 KHLVKLYG-VCVRDENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYL-- 117
Query: 159 EPNVIIHRDLKPRNVLLVNSSADH-----LKVGDFGLSKLIKVQNSHDVYKMTGETGSYR 213
E ++H ++ +N+L+ + +K+ D G +T + R
Sbjct: 118 EDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG-------------IPITVLSREER 164
Query: 214 -----YMAPEVFK--HRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKYVAEGHR 265
++APE + D +SF L E+ GE PL+ E ++ + HR
Sbjct: 165 VERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHR 224
Query: 266 -PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRL 302
P EL L +CW D +RPSF IL+ L
Sbjct: 225 LPMPD----CAELANLINQCWTYDPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 4e-17
Identities = 67/250 (26%), Positives = 113/250 (45%), Gaps = 20/250 (8%)
Query: 49 IIGKGSFGEIL--KAYWRGTPVAIKRILPSLSDDRLVIQD-FRH---EVNLLVKLRHPNI 102
++GKG+FG+++ + G A+K L + ++ +D H E +L RHP +
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMK----ILKKEVIIAKDEVAHTLTESRVLQNTRHPFL 57
Query: 103 VQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNV 162
+ L + EY GG+L +L + S A + +I + YLH+
Sbjct: 58 TALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCD-- 115
Query: 163 IIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH 222
+++RDLK N++L H+K+ DFGL K + D M G+ Y+APEV +
Sbjct: 116 VVYRDLKLENLML--DKDGHIKITDFGLCK----EGISDGATMKTFCGTPEYLAPEVLED 169
Query: 223 RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTE 282
Y + VD + +++YEM+ G P N + + + + F R +PE + L
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRT--LSPEAKSLLA 227
Query: 283 KCWAADMNQR 292
D QR
Sbjct: 228 GLLKKDPKQR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 4e-17
Identities = 85/350 (24%), Positives = 146/350 (41%), Gaps = 103/350 (29%)
Query: 35 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGT-------PVAIK--RILPSLSDDRLVIQ 85
WE L +G+G+FG++++A G VA+K + + S+ + ++
Sbjct: 2 WEFPRDRLKLGKP--LGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMT 59
Query: 86 DFRHEVNLLVKL-RHPNIVQFLGAVTERK-PLMLITE---------YLRG---------- 124
E+ +L+ + H N+V LGA T+ PLM+I E YLR
Sbjct: 60 ----ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRN 115
Query: 125 --------------------------GDLHKYLKEKGA----------------LSPSTA 142
++++K L+
Sbjct: 116 KSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDL 175
Query: 143 VNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDV 202
++++ +ARGM +L + IHRDL RN+LL ++ +K+ DFGL++ D+
Sbjct: 176 ISYSFQVARGMEFLASRK--CIHRDLAARNILLSENNV--VKICDFGLAR--------DI 223
Query: 203 YKMTG--ETGSYR----YMAPEVFKHRKYDKKVDVFSFAMILYEM--LEGEP-PLANYEP 253
YK G R +MAPE + Y + DV+SF ++L+E+ L P P +
Sbjct: 224 YKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE 283
Query: 254 YEAAKYVAEGHRPFFRAKGF-TPELRELTEKCWAADMNQRPSFLDILKRL 302
E + + EG R RA + TPE+ + CW + RP+F ++++ L
Sbjct: 284 -EFCRRLKEGTR--MRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEIL 330
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 4e-17
Identities = 66/201 (32%), Positives = 97/201 (48%), Gaps = 15/201 (7%)
Query: 50 IGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 107
+G+G++ + K + T VA+K I L + EV+LL L+H NIV
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEI--RLEHEEGAPCTAIREVSLLKNLKHANIVTLHD 70
Query: 108 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVN-FALDIARGMAYLHNEPNVIIHR 166
+ + L L+ EYL DL +YL G L V F + RG++Y H I+HR
Sbjct: 71 IIHTERCLTLVFEYLD-SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK--ILHR 127
Query: 167 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV-FKHRKY 225
DLKP+N LL+N + LK+ DFGL++ V + E + Y P+V +Y
Sbjct: 128 DLKPQN-LLINEKGE-LKLADFGLARAKSVPTK----TYSNEVVTLWYRPPDVLLGSTEY 181
Query: 226 DKKVDVFSFAMILYEMLEGEP 246
+D++ ILYEM G P
Sbjct: 182 STPIDMWGVGCILYEMATGRP 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 7e-17
Identities = 62/211 (29%), Positives = 102/211 (48%), Gaps = 21/211 (9%)
Query: 50 IGKGSFGEI--LKAYWRGTPVAIKRI----LPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 103
+GKG FGE+ ++ G A K++ L S +++ + E +L K+ P IV
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALL----EKEILEKVNSPFIV 56
Query: 104 QFLGAVTERKPLMLITEYLRGGDL--HKYLKEKGALSPSTAVNFALDIARGMAYLHNEPN 161
A + L L+ + GGDL H Y + L ++++ I G+ +LH+
Sbjct: 57 NLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD- 115
Query: 162 VIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFK 221
I++RD+KP NVLL + ++ D GL+ +K D +T G+ YMAPE+ K
Sbjct: 116 -IVYRDMKPENVLL--DDQGNCRLSDLGLAVELK-----DGKTITQRAGTNGYMAPEILK 167
Query: 222 HRKYDKKVDVFSFAMILYEMLEGEPPLANYE 252
Y VD F+ +YEM+ G P +++
Sbjct: 168 EEPYSYPVDWFAMGCSIYEMVAGRTPFKDHK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 8e-17
Identities = 61/208 (29%), Positives = 103/208 (49%), Gaps = 13/208 (6%)
Query: 43 DFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 102
DF + +G G+ G + K + + + + R L L + E+ +L + P I
Sbjct: 6 DFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 65
Query: 103 VQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNV 162
V F GA + + E++ GG L + LK+ G + ++ + +G+ YL E +
Sbjct: 66 VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR-EKHK 124
Query: 163 IIHRDLKPRNVLLVNSSADHLKVGDFGLS-KLI-KVQNSHDVYKMTGETGSYRYMAPEVF 220
I+HRD+KP N+ LVNS + +K+ DFG+S +LI + NS G+ YM+PE
Sbjct: 125 IMHRDVKPSNI-LVNSRGE-IKLCDFGVSGQLIDSMANSF--------VGTRSYMSPERL 174
Query: 221 KHRKYDKKVDVFSFAMILYEMLEGEPPL 248
+ Y + D++S + L EM G P+
Sbjct: 175 QGTHYSVQSDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 1e-16
Identities = 60/215 (27%), Positives = 96/215 (44%), Gaps = 34/215 (15%)
Query: 47 SAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQ 104
A IG+G+FGE+ KA + T VA+K++L + I R E+ +L L+H N+V
Sbjct: 17 LAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALR-EIKILQLLKHENVVN 75
Query: 105 FLGAVTERKPLM---------LITEYLRGGDLHKYLKEKGALSPSTAVNFAL-DIAR--- 151
L + K L+ E+ DL L + V F L +I +
Sbjct: 76 -LIEICRTKATPYNRYKGSFYLVFEFCEH-DL-------AGLLSNKNVKFTLSEIKKVMK 126
Query: 152 ----GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG 207
G+ Y+H N I+HRD+K N+L+ LK+ DFGL++ + + + T
Sbjct: 127 MLLNGLYYIHR--NKILHRDMKAANILITKDGI--LKLADFGLARAFSLSKNSKPNRYTN 182
Query: 208 ETGSYRYMAPEV-FKHRKYDKKVDVFSFAMILYEM 241
+ Y PE+ R Y +D++ I+ EM
Sbjct: 183 RVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEM 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 1e-16
Identities = 58/205 (28%), Positives = 102/205 (49%), Gaps = 10/205 (4%)
Query: 44 FSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN 101
F ++G+G++G +LK + T VAIK+ S ++ + R E+ +L L+ N
Sbjct: 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLR-ELKMLRTLKQEN 61
Query: 102 IVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPN 161
IV+ A R L L+ EY+ L + + P ++ + + + + H N
Sbjct: 62 IVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHK--N 119
Query: 162 VIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFK 221
I+HRD+KP N+L+ S D LK+ DFG ++ + ++ + T + Y +PE+
Sbjct: 120 DIVHRDIKPENLLI--SHNDVLKLCDFGFARNLSEGSNAN---YTEYVATRWYRSPELLL 174
Query: 222 HRKYDKKVDVFSFAMILYEMLEGEP 246
Y K VD++S IL E+ +G+P
Sbjct: 175 GAPYGKAVDMWSVGCILGELSDGQP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 2e-16
Identities = 65/201 (32%), Positives = 98/201 (48%), Gaps = 15/201 (7%)
Query: 50 IGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 107
+G+G++ + K + T VA+K I L + EV+LL L+H NIV
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEI--RLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 108 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVN-FALDIARGMAYLHNEPNVIIHR 166
V K L L+ EYL DL +Y+ + G + V F I RG+AY H ++HR
Sbjct: 72 IVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK--VLHR 128
Query: 167 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV-FKHRKY 225
DLKP+N LL+N + LK+ DFGL++ V + E + Y P+V +Y
Sbjct: 129 DLKPQN-LLINERGE-LKLADFGLARAKSVPTK----TYSNEVVTLWYRPPDVLLGSSEY 182
Query: 226 DKKVDVFSFAMILYEMLEGEP 246
++D++ I +EM G P
Sbjct: 183 STQIDMWGVGCIFFEMASGRP 203
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 2e-16
Identities = 67/225 (29%), Positives = 109/225 (48%), Gaps = 16/225 (7%)
Query: 50 IGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVK---LRHPNIVQ 104
IGKG+FG++ + + T A+K + + + E N+LV+ P IV
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 105 FLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVII 164
+ L L+T+Y+ GG+L +L+++G S A + ++ + +LH I+
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHK--YDIV 118
Query: 165 HRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGE-TGSYRYMAPEVFKHR 223
+RDLKP N+LL + H+ + DFGLSK N K T G+ Y+APEV
Sbjct: 119 YRDLKPENILL--DATGHIALCDFGLSKANLTDN-----KTTNTFCGTTEYLAPEVLLDE 171
Query: 224 K-YDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPF 267
K Y K VD +S ++++EM G P + + + +A G F
Sbjct: 172 KGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRF 216
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 2e-16
Identities = 66/228 (28%), Positives = 105/228 (46%), Gaps = 14/228 (6%)
Query: 77 LSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKY----LK 132
L+D+R R E++ L H IV+ L+LI EY GGDL+K LK
Sbjct: 103 LNDERQAAYA-RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLK 161
Query: 133 EKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 192
E I + +H+ ++HRDLK N+ L+ + +K+GDFG SK
Sbjct: 162 EHLPFQEYEVGLLFYQIVLALDEVHSR--KMMHRDLKSANIFLMPTGI--IKLGDFGFSK 217
Query: 193 LIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYE 252
S DV + G+ Y+APE+++ ++Y KK D++S +ILYE+L P
Sbjct: 218 QYSDSVSLDV--ASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS 275
Query: 253 PYEAAKYVAEG-HRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDIL 299
E + V G + PF + ++ L + + + RP+ +L
Sbjct: 276 QREIMQQVLYGKYDPF--PCPVSSGMKALLDPLLSKNPALRPTTQQLL 321
|
Length = 478 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 3e-16
Identities = 73/280 (26%), Positives = 129/280 (46%), Gaps = 31/280 (11%)
Query: 35 WEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRL--VIQDFRHE 90
+ D ++L+ IG G+ G++ K ++ G +A+K++ + + + ++ D
Sbjct: 10 YPADLNDLENLGE--IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLD-- 65
Query: 91 VNLLVKLRH--PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFAL 147
+V H P IV+ G + I L L K LK +G + +
Sbjct: 66 ---VVLKSHDCPYIVKCYGYFI-TDSDVFICMELMSTCLDKLLKRIQGPIPEDILGKMTV 121
Query: 148 DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS-KLIKVQNSHDVYKMT 206
I + + YL + VI HRD+KP N+LL ++S + +K+ DFG+S +L+ D T
Sbjct: 122 AIVKALHYLKEKHGVI-HRDVKPSNILL-DASGN-VKLCDFGISGRLV------DSKAKT 172
Query: 207 GETGSYRYMAPEVF----KHRKYDKKVDVFSFAMILYEMLEGEPPLANYE-PYEAAKYVA 261
G YMAPE + KYD + DV+S + L E+ G+ P N + +E +
Sbjct: 173 RSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKIL 232
Query: 262 EGHRPFFR-AKGFTPELRELTEKCWAADMNQRPSFLDILK 300
+ P +GF+P+ + C D +RP + ++L+
Sbjct: 233 QEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQ 272
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 3e-16
Identities = 63/223 (28%), Positives = 102/223 (45%), Gaps = 29/223 (13%)
Query: 48 AIIGKGSFGEILKAY--WRGTPVAIKRI------LPSLSDDRLVIQDFRH-----EVNLL 94
A +G+G++G++ KAY G VAIK++ D +LV H E+ ++
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 95 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMA 154
+++H NI+ + E + L+ + + DL K + K L+ S L I G+
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILLQILNGLN 133
Query: 155 YLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS----------KLIKVQNSHDVYK 204
LH +HRDL P N+ + +S K+ DFGL+ L K + +
Sbjct: 134 VLHK--WYFMHRDLSPANIFI--NSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREE 189
Query: 205 MTGETGSYRYMAPEV-FKHRKYDKKVDVFSFAMILYEMLEGEP 246
MT + + Y APE+ KY VD++S I E+L G+P
Sbjct: 190 MTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKP 232
|
Length = 335 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 3e-16
Identities = 58/201 (28%), Positives = 92/201 (45%), Gaps = 15/201 (7%)
Query: 98 RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLH 157
R P +V A L LI +Y+ GG+L +L ++ + S + +I + +LH
Sbjct: 63 RCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLH 122
Query: 158 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAP 217
II+RD+K N+LL S H+ + DFGLSK + Y G + YMAP
Sbjct: 123 QLG--IIYRDIKLENILL--DSEGHVVLTDFGLSKEFLAEEEERAYSFCG---TIEYMAP 175
Query: 218 EVFK--HRKYDKKVDVFSFAMILYEMLEGEPPL----ANYEPYEAAKYVAEGHRPFFRAK 271
EV + +DK VD +S ++ +E+L G P E ++ + + PF K
Sbjct: 176 EVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPF--PK 233
Query: 272 GFTPELRELTEKCWAADMNQR 292
+ E R+ +K D +R
Sbjct: 234 TMSAEARDFIQKLLEKDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 3e-16
Identities = 67/222 (30%), Positives = 109/222 (49%), Gaps = 24/222 (10%)
Query: 31 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFR 88
NK WE+ + S +G G++G + A+ G VA+K++ + +R
Sbjct: 9 NKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 65
Query: 89 HEVNLLVKLRHPNIVQFLGAVTERKPL-----MLITEYLRGGDLHKYLKEKGALSPSTAV 143
E+ LL ++H N++ L T + L + + +L G DL+ +K + L+
Sbjct: 66 -ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQ 123
Query: 144 NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 203
I RG+ Y+H+ IIHRDLKP N L VN + LK+ DFGL++ H
Sbjct: 124 FLIYQILRGLKYIHSAD--IIHRDLKPSN-LAVNEDCE-LKILDFGLAR-------HTDD 172
Query: 204 KMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEG 244
+MTG + Y APE+ + Y++ VD++S I+ E+L G
Sbjct: 173 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 214
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 4e-16
Identities = 75/275 (27%), Positives = 120/275 (43%), Gaps = 48/275 (17%)
Query: 50 IGKGSFGEIL----KAYWRGTPVAIKRILPSLSDDRLVIQDFRH---EVNLLVKLRHPNI 102
IG G FG+++ + + V +K + S S +Q+ E L+H N+
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-----VQEQMKFLEEAQPYRSLQHSNL 57
Query: 103 VQFLGAVTERKPLMLITEYLRGGDLHKYLK-----EKGALSPSTAVNFALDIARGMAYLH 157
+Q LG TE P +L+ E+ GDL YL+ E P+T A +IA G+ +LH
Sbjct: 58 LQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH 117
Query: 158 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETG--SYRYM 215
N IH DL RN LL ++ +K+GD+GLS + Y +T + R++
Sbjct: 118 K--NNFIHSDLALRNCLL--TADLTVKIGDYGLSHN----KYKEDYYVTPDQLWVPLRWI 169
Query: 216 APEVFKHRKYD-------KKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPF 267
APE+ + K+ +V+S + ++E+ E G P + + Y
Sbjct: 170 APELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQ--- 226
Query: 268 FRAKGFTPELR--------ELTEKCWAADMNQRPS 294
+ K P L+ E+ + CW QRPS
Sbjct: 227 -QLKLPKPRLKLPLSDRWYEVMQFCWLQP-EQRPS 259
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 4e-16
Identities = 61/208 (29%), Positives = 102/208 (49%), Gaps = 21/208 (10%)
Query: 49 IIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVK------LRHP 100
++GKGSFG+++ A + G A+K L D +++QD E + K HP
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVK----VLKKD-VILQDDDVECTMTEKRILSLARNHP 56
Query: 101 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP 160
+ Q L + E++ GGDL ++++ + A +A +I + +LH++
Sbjct: 57 FLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKG 116
Query: 161 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF 220
II+RDLK NVLL + H K+ DFG+ K + + + G+ Y+APE+
Sbjct: 117 --IIYRDLKLDNVLLDHEG--HCKLADFGMCK----EGIFNGKTTSTFCGTPDYIAPEIL 168
Query: 221 KHRKYDKKVDVFSFAMILYEMLEGEPPL 248
+ Y VD ++ ++LYEML G P
Sbjct: 169 QEMLYGPSVDWWAMGVLLYEMLCGHAPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 4e-16
Identities = 52/172 (30%), Positives = 94/172 (54%), Gaps = 11/172 (6%)
Query: 136 ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 195
AL ++F+ +A+GM++L ++ IHRDL RN+LL + K+ DFGL++ I+
Sbjct: 210 ALDTEDLLSFSYQVAKGMSFLASKN--CIHRDLAARNILLTHGRIT--KICDFGLARDIR 265
Query: 196 VQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPY 254
+S+ V K ++MAPE + Y + DV+S+ ++L+E+ G P P
Sbjct: 266 -NDSNYVVKGNARL-PVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGM-PV 322
Query: 255 EAA--KYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEK 304
++ K + EG+R + E+ ++ + CW AD +RP+F I++ +E+
Sbjct: 323 DSKFYKMIKEGYR-MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 76.5 bits (189), Expect = 5e-16
Identities = 62/205 (30%), Positives = 100/205 (48%), Gaps = 22/205 (10%)
Query: 50 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFL 106
IG+G+F E+LKA R G AIK + V R E+ L +L HPNI++ +
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNN-LR-EIQALRRLSPHPNILRLI 64
Query: 107 GAVTERKP--LMLITEYLRGGDLHKYLK-EKGALSPSTAVNFALDIARGMAYLHNEPNVI 163
+ +RK L L+ E L +L++ +K K L ++ + + + ++H N I
Sbjct: 65 EVLFDRKTGRLALVFE-LMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHR--NGI 121
Query: 164 IHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYR-YMAPE-VFK 221
HRD+KP N+L+ D LK+ DFG + I + + Y T R Y APE +
Sbjct: 122 FHRDIKPENILI---KDDILKLADFGSCRGIYSKPPYTEYIST------RWYRAPECLLT 172
Query: 222 HRKYDKKVDVFSFAMILYEMLEGEP 246
Y K+D+++ + +E+L P
Sbjct: 173 DGYYGPKMDIWAVGCVFFEILSLFP 197
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 5e-16
Identities = 59/183 (32%), Positives = 94/183 (51%), Gaps = 13/183 (7%)
Query: 117 LITEYLRGGDLHKYLKEKGALSPSTAVNFA--LDIARGMAYLHNEPNVIIHRDLKPRNVL 174
L+ +Y GDL + +K + + + + A L I +A H +IHRD+K N+L
Sbjct: 116 LVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANIL 175
Query: 175 LVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET--GSYRYMAPEVFKHRKYDKKVDVF 232
L S +K+GDFG SK+ S DV G T G+ Y+APE+++ + Y KK D+F
Sbjct: 176 LC--SNGLVKLGDFGFSKMYAATVSDDV----GRTFCGTPYYVAPEIWRRKPYSKKADMF 229
Query: 233 SFAMILYEMLEGEPPLANYEPYEAA-KYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQ 291
S ++LYE+L + P E K +A + P +PE++E+ ++D +
Sbjct: 230 SLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPL--PPSISPEMQEIVTALLSSDPKR 287
Query: 292 RPS 294
RPS
Sbjct: 288 RPS 290
|
Length = 496 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 6e-16
Identities = 50/191 (26%), Positives = 80/191 (41%), Gaps = 14/191 (7%)
Query: 90 EVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALD 148
E LL + HP++++ + + + DL+ YL K L A+
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLV-SGAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQ 165
Query: 149 IARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGE 208
I G+ YLH + IIHRD+K N+ + + D + +GD G ++ V + G
Sbjct: 166 ILEGLRYLHAQR--IIHRDVKTENIFI--NDVDQVCIGDLGAAQF-PVVAPAFL----GL 216
Query: 209 TGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH---R 265
G+ APEV KY+ K D++S ++L+EML + P +YV H
Sbjct: 217 AGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLL 276
Query: 266 PFFRAKGFTPE 276
PE
Sbjct: 277 KIISTLKVHPE 287
|
Length = 357 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 6e-16
Identities = 86/349 (24%), Positives = 146/349 (41%), Gaps = 95/349 (27%)
Query: 35 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGT-------PVAIK--RILPSLSDDRLVIQ 85
WE L +G+G+FG++++A G VA+K + + S+ R ++
Sbjct: 2 WEFPRDRLKLGKP--LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMS 59
Query: 86 DFRHEVNLLVKL-RHPNIVQFLGAVTERK-PLMLI---------TEYLRG---------- 124
E+ +L+ + H N+V LGA T+ PLM+I + YLR
Sbjct: 60 ----ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKT 115
Query: 125 ------------GDLHKYLKE------------------------------------KGA 136
GD+ + LK K
Sbjct: 116 KDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKV 175
Query: 137 LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 196
L+ + ++ +A+GM +L + IHRDL RN+LL S + +K+ DFGL++ +
Sbjct: 176 LTLEDLICYSFQVAKGMEFLASRK--CIHRDLAARNILL--SENNVVKICDFGLAR--DI 229
Query: 197 QNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYE-PY 254
D + ++MAPE R Y + DV+SF ++L+E+ G P +
Sbjct: 230 YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 289
Query: 255 EAAKYVAEGHRPFFRAKGFT-PELRELTEKCWAADMNQRPSFLDILKRL 302
E + + EG R RA +T PE+ + CW + +QRP+F ++++ L
Sbjct: 290 EFCRRLKEGTR--MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 8e-16
Identities = 57/200 (28%), Positives = 98/200 (49%), Gaps = 12/200 (6%)
Query: 50 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 107
IG+GS+G + K R G VAIK+ + S DD ++ + E+ +L +L+HPN+V +
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVES-EDDPVIKKIALREIRMLKQLKHPNLVNLIE 67
Query: 108 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 167
++ L L+ EY L++ K + + + + H + IHRD
Sbjct: 68 VFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHK--HNCIHRD 125
Query: 168 LKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF-KHRKYD 226
+KP N+L+ + +K+ DFG ++++ D Y T YR APE+ +Y
Sbjct: 126 VKPENILI--TKQGQIKLCDFGFARILTGPG--DDYTDYVATRWYR--APELLVGDTQYG 179
Query: 227 KKVDVFSFAMILYEMLEGEP 246
VDV++ + E+L G+P
Sbjct: 180 PPVDVWAIGCVFAELLTGQP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 9e-16
Identities = 56/204 (27%), Positives = 102/204 (50%), Gaps = 13/204 (6%)
Query: 49 IIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQF 105
+IG+GS+ ++L + T A+K + L +D I + E ++ + HP +V
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 106 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 165
L + EY+ GGDL +++ + L A ++ +I+ + YLH II+
Sbjct: 62 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIY 119
Query: 166 RDLKPRNVLLVNSSADHLKVGDFGLSKL-IKVQNSHDVYKMTGETGSYRYMAPEVFKHRK 224
RDLK NVLL S H+K+ D+G+ K ++ ++ + G+ Y+APE+ +
Sbjct: 120 RDLKLDNVLL--DSEGHIKLTDYGMCKEGLRPGDTTSTF-----CGTPNYIAPEILRGED 172
Query: 225 YDKKVDVFSFAMILYEMLEGEPPL 248
Y VD ++ ++++EM+ G P
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 1e-15
Identities = 61/199 (30%), Positives = 100/199 (50%), Gaps = 15/199 (7%)
Query: 50 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 107
+G+GS+ + K + G VA+K I L ++ E +LL L+H NIV
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVI--RLQEEEGTPFTAIREASLLKGLKHANIVLLHD 70
Query: 108 AVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 166
+ ++ L L+ EY+ DL +Y+ K G L P F + RG++Y+H I+HR
Sbjct: 71 IIHTKETLTLVFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR--YILHR 127
Query: 167 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV-FKHRKY 225
DLKP+N+L+ S LK+ DFGL++ V + + + E + Y P+V +Y
Sbjct: 128 DLKPQNLLI--SDTGELKLADFGLARAKSVPS----HTYSNEVVTLWYRPPDVLLGSTEY 181
Query: 226 DKKVDVFSFAMILYEMLEG 244
+D++ I EM++G
Sbjct: 182 STCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 1e-15
Identities = 65/219 (29%), Positives = 101/219 (46%), Gaps = 28/219 (12%)
Query: 43 DFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQD----FRHEVNLLVKLR 98
D+ +IG+G+FGE+ + T L LS ++ + F E +++
Sbjct: 44 DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKL--LSKFEMIKRSDSAFFWEERDIMAFAN 101
Query: 99 HPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK-----EKGALSPSTAVNFALDIARGM 153
P +VQ A + + L ++ EY+ GGDL + EK A + V ALD M
Sbjct: 102 SPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSM 161
Query: 154 AYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYR 213
+ IHRD+KP N+LL S HLK+ DFG + N + + G+
Sbjct: 162 GF--------IHRDVKPDNMLLDKSG--HLKLADFGTCMKM---NKEGMVRCDTAVGTPD 208
Query: 214 YMAPEVFKHRK----YDKKVDVFSFAMILYEMLEGEPPL 248
Y++PEV K + Y ++ D +S + LYEML G+ P
Sbjct: 209 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 2e-15
Identities = 54/159 (33%), Positives = 78/159 (49%), Gaps = 11/159 (6%)
Query: 90 EVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVN-FALD 148
EV+LL L+H NIV + K L L+ EYL DL +YL + G V F
Sbjct: 54 EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQ 112
Query: 149 IARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGE 208
+ RG+ Y H ++HRDLKP+N LL+N + LK+ DFGL++ S + E
Sbjct: 113 LLRGLNYCHRRK--VLHRDLKPQN-LLINERGE-LKLADFGLAR----AKSIPTKTYSNE 164
Query: 209 TGSYRYMAPEV-FKHRKYDKKVDVFSFAMILYEMLEGEP 246
+ Y P++ Y ++D++ I YEM G P
Sbjct: 165 VVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRP 203
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 2e-15
Identities = 61/221 (27%), Positives = 98/221 (44%), Gaps = 31/221 (14%)
Query: 49 IIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 106
+IGKG GE+ AY VA+K+I LS++ L+ + F E + L HP IV
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 107 GAVTERKPLMLITEYLRGGDLHKYLK---EKGALSP----STAVNFALDI----ARGMAY 155
++ P+ Y+ G L LK +K +LS T+V L I + Y
Sbjct: 69 SICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEY 128
Query: 156 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN--------------SHD 201
+H++ ++HRDLKP N+LL + + D+G + K++
Sbjct: 129 VHSKG--VLHRDLKPDNILLGLFG--EVVILDWGAAIFKKLEEEDLLDIDVDERNICYSS 184
Query: 202 VYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEML 242
+ G+ YMAPE + D+++ +ILY+ML
Sbjct: 185 MTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQML 225
|
Length = 932 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 2e-15
Identities = 57/178 (32%), Positives = 89/178 (50%), Gaps = 26/178 (14%)
Query: 137 LSPSTA---VNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 193
SP T + ++ +ARGM +L + IHRDL RN+LL S + +K+ DFGL++
Sbjct: 168 KSPLTMEDLICYSFQVARGMEFLASRK--CIHRDLAARNILL--SENNVVKICDFGLAR- 222
Query: 194 IKVQNSHDVYKMTG--ETGSYR----YMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEP 246
D+YK GS R +MAPE + Y + DV+SF ++L+E+ G
Sbjct: 223 -------DIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGAS 275
Query: 247 PLANYEPYEA-AKYVAEGHRPFFRAKGF-TPELRELTEKCWAADMNQRPSFLDILKRL 302
P + E + + +G R RA TPE+ + CW D +RP+F +++ L
Sbjct: 276 PYPGVQINEEFCQRLKDGTR--MRAPENATPEIYRIMLACWQGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 3e-15
Identities = 48/157 (30%), Positives = 77/157 (49%), Gaps = 6/157 (3%)
Query: 39 PSELDFSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVK 96
PS +F I +G+FG++ A+K + + ++ ++ + E + L
Sbjct: 1 PSIEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALAL 60
Query: 97 LRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYL 156
+ P IV ++ + L+ EYL GGD+ L G AV + ++A + YL
Sbjct: 61 SKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYL 120
Query: 157 HNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 193
H IIHRDLKP N+L+ N H+K+ DFGLSK+
Sbjct: 121 HRHG--IIHRDLKPDNMLISNEG--HIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 3e-15
Identities = 67/221 (30%), Positives = 102/221 (46%), Gaps = 32/221 (14%)
Query: 43 DFSSSAIIGKGSFGEI-LKAYWRGTPVAIKRILPSL-----SDDRLVIQDFRHEVNLLVK 96
D+ +IG+G+FGE+ L + V ++L SD F E +++
Sbjct: 44 DYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAF----FWEERDIMAF 99
Query: 97 LRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK-----EKGALSPSTAVNFALDIAR 151
P +VQ A + K L ++ EY+ GGDL + EK A + V ALD
Sbjct: 100 ANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIH 159
Query: 152 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGS 211
M +IHRD+KP N+LL HLK+ DFG +K+ + V T G+
Sbjct: 160 SMG--------LIHRDVKPDNMLL--DKHGHLKLADFG--TCMKMDETGMVRCDTA-VGT 206
Query: 212 YRYMAPEVFKHRK----YDKKVDVFSFAMILYEMLEGEPPL 248
Y++PEV K + Y ++ D +S + L+EML G+ P
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 3e-15
Identities = 54/202 (26%), Positives = 98/202 (48%), Gaps = 11/202 (5%)
Query: 49 IIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLL-VKLRHPNIVQF 105
+IG+GS+ ++L + T A+K I L +D I + E ++ HP +V
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61
Query: 106 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 165
L + E++ GGDL +++ + L A ++ +I+ + +LH II+
Sbjct: 62 HSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG--IIY 119
Query: 166 RDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKY 225
RDLK NVLL + H+K+ D+G+ K + + G+ Y+APE+ + Y
Sbjct: 120 RDLKLDNVLL--DAEGHIKLTDYGMCK----EGIRPGDTTSTFCGTPNYIAPEILRGEDY 173
Query: 226 DKKVDVFSFAMILYEMLEGEPP 247
VD ++ ++++EM+ G P
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 3e-15
Identities = 69/224 (30%), Positives = 108/224 (48%), Gaps = 27/224 (12%)
Query: 31 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFR 88
NK WE+ ++S +G G++G + A + G VAIK++ + + +R
Sbjct: 7 NKTVWEL---PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYR 63
Query: 89 HEVNLLVKLRHPNIVQFLGAVT------ERKPLMLITEYLRGGDLHKYLKEKGALSPSTA 142
E+ LL ++H N++ L T E + L+ Y++ DL K + LS
Sbjct: 64 -ELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIMGHP--LSEDKV 119
Query: 143 VNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDV 202
+ G+ Y+H+ IIHRDLKP N L VN + LK+ DFGL++ H
Sbjct: 120 QYLVYQMLCGLKYIHSAG--IIHRDLKPGN-LAVNEDCE-LKILDFGLAR-------HAD 168
Query: 203 YKMTGETGSYRYMAPEV-FKHRKYDKKVDVFSFAMILYEMLEGE 245
+MTG + Y APEV Y++ VD++S I+ EML G+
Sbjct: 169 AEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 4e-15
Identities = 60/216 (27%), Positives = 97/216 (44%), Gaps = 16/216 (7%)
Query: 43 DFSSSAIIGKGSFGEI--LKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 100
DF +++G+G FGE+ ++ G A+K + S+ + + F E ++L P
Sbjct: 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSP 61
Query: 101 NIVQFLGAVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARGMAYLHNE 159
I Q A ++ L L+ EY GGDL L + + A + ++ + +H
Sbjct: 62 WIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQM 121
Query: 160 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV 219
V HRD+KP NVL+ H+K+ DFG + + N K+ G+ Y+APEV
Sbjct: 122 GYV--HRDIKPENVLI--DRTGHIKLADFGSAARLTA-NKMVNSKLP--VGTPDYIAPEV 174
Query: 220 FK------HRKYDKKVDVFSFAMILYEMLEGEPPLA 249
Y + D +S +I YEM+ G P
Sbjct: 175 LTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFH 210
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 6e-15
Identities = 64/258 (24%), Positives = 109/258 (42%), Gaps = 49/258 (18%)
Query: 43 DFSSSAIIGKGSFGEI--LKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 100
DF + +IGKG+FGE+ ++ G A+K +L S + + + E ++L + P
Sbjct: 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSP 61
Query: 101 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP 160
+V + + + L LI E+L GGDL L + S + + + +H
Sbjct: 62 WVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLG 121
Query: 161 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK--MTGET--------- 209
IHRD+KP N+L+ H+K+ DFGLS Q+ Y+ + G++
Sbjct: 122 --FIHRDIKPDNILI--DRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRN 177
Query: 210 --------------------------------GSYRYMAPEVFKHRKYDKKVDVFSFAMI 237
G+ Y+APE+F + Y ++ D +S I
Sbjct: 178 SVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAI 237
Query: 238 LYEMLEGEPPLANYEPYE 255
++E L G PP + +E
Sbjct: 238 MFECLIGWPPFCSENSHE 255
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 9e-15
Identities = 68/246 (27%), Positives = 111/246 (45%), Gaps = 36/246 (14%)
Query: 12 SYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGT--PVA 69
S + S P L SEL+ IG G+ G + K R T A
Sbjct: 57 SSSSSASGSAP-SAAKSL----------SELE--RVNRIGSGAGGTVYKVIHRPTGRLYA 103
Query: 70 IKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLH- 128
+K I + +D + Q R E+ +L + HPN+V+ + ++ E++ GG L
Sbjct: 104 LKVIYGN-HEDTVRRQICR-EIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEG 161
Query: 129 KYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF 188
++ ++ L+ + A I G+AYLH I+HRD+KP N LL+N SA ++K+ DF
Sbjct: 162 THIADEQFLA-----DVARQILSGIAYLHRRH--IVHRDIKPSN-LLIN-SAKNVKIADF 212
Query: 189 GLSKLIKVQNSHDVYKMTGETGSYRYMAPEV----FKHRKYDKKV-DVFSFAMILYEMLE 243
G+S+++ + + G+ YM+PE H YD D++S + + E
Sbjct: 213 GVSRIL----AQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYL 268
Query: 244 GEPPLA 249
G P
Sbjct: 269 GRFPFG 274
|
Length = 353 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 72.2 bits (178), Expect = 1e-14
Identities = 47/154 (30%), Positives = 78/154 (50%), Gaps = 11/154 (7%)
Query: 99 HPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHN 158
+PN ++ +VT K +LI +Y++ GDL LK++G LS + + + LH
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHK 127
Query: 159 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPE 218
+ IIH D+K NVL + + D + + D+GL K+I + +D G+ Y +PE
Sbjct: 128 --HNIIHNDIKLENVLY-DRAKDRIYLCDYGLCKIIGTPSCYD--------GTLDYFSPE 176
Query: 219 VFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYE 252
K YD D ++ ++ YE+L G+ P E
Sbjct: 177 KIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDE 210
|
Length = 267 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 3e-14
Identities = 65/262 (24%), Positives = 112/262 (42%), Gaps = 25/262 (9%)
Query: 42 LDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH 99
D I+G G+ G + KAY +A+K I ++ + + + E+ +L K
Sbjct: 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVE--LQKQIMSELEILYKCDS 58
Query: 100 PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE 159
P I+ F GA + + TE++ GG L Y + A+ + +G+ YL +
Sbjct: 59 PYIIGFYGAFFVENRISICTEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSL 114
Query: 160 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV 219
I+HRD+KP N +LVN+ +K+ DFG+S + V + Y G+ YMAPE
Sbjct: 115 K--ILHRDVKPSN-MLVNTRG-QVKLCDFGVSTQL-VNSIAKTY-----VGTNAYMAPER 164
Query: 220 FKHRKYDKKVDVFSFAMILYEMLEGEPPLANYE-------PYEAAKYVAEGHRPFFRAKG 272
+Y DV+S + E+ G P + P + + + + P
Sbjct: 165 ISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQ 224
Query: 273 FTPELRELTEKCWAADMNQRPS 294
F+ + +C +RP+
Sbjct: 225 FSEKFVHFITQCMRKQPKERPA 246
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 5e-14
Identities = 49/159 (30%), Positives = 76/159 (47%), Gaps = 8/159 (5%)
Query: 90 EVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDI 149
E ++L + HP+I+Q G T K LI + DL+ YL K ++ + +
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKT-DLYCYLAAKRNIAICDILAIERSV 191
Query: 150 ARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET 209
R + YLH N IIHRD+K N+ +N D + +GDFG + N++ Y G
Sbjct: 192 LRAIQYLHE--NRIIHRDIKAENIF-INHPGD-VCLGDFGAACFPVDINANKYY---GWA 244
Query: 210 GSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPL 248
G+ APE+ Y VD++S ++L+EM L
Sbjct: 245 GTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283
|
Length = 391 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 6e-14
Identities = 69/227 (30%), Positives = 112/227 (49%), Gaps = 32/227 (14%)
Query: 31 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGT--PVAIKRI---LPSLSDDRLVIQ 85
NK WE+ P + + +G G++G + AY VA+K++ SL R +
Sbjct: 7 NKTVWEV-PER--YQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYR 63
Query: 86 DFRHEVNLLVKLRHPNIVQFLGAVT------ERKPLMLITEYLRGGDLHKYLKEKGALSP 139
+ R LL ++H N++ L T + L+T L G DL+ +K + LS
Sbjct: 64 ELR----LLKHMKHENVIGLLDVFTPATSIENFNEVYLVTN-LMGADLNNIVKCQ-KLSD 117
Query: 140 STAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 199
+ RG+ Y+H+ IIHRDLKP NV VN + L++ DFGL++ +
Sbjct: 118 EHVQFLIYQLLRGLKYIHSAG--IIHRDLKPSNV-AVNEDCE-LRILDFGLAR-----QA 168
Query: 200 HDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGE 245
D +MTG + Y APE+ + Y++ VD++S I+ E+L+G+
Sbjct: 169 DD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 1e-13
Identities = 50/164 (30%), Positives = 79/164 (48%), Gaps = 10/164 (6%)
Query: 88 RHEVNLLVKLRH-PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFA 146
R E +L +R P +V A L LI +Y+ GG+L +L ++ ++
Sbjct: 52 RTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYS 111
Query: 147 LDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMT 206
+I + +LH II+RD+K N+LL S H+ + DFGLSK Y
Sbjct: 112 GEIVLALEHLHKLG--IIYRDIKLENILL--DSNGHVVLTDFGLSKEFHEDEVERAYSFC 167
Query: 207 GETGSYRYMAPEVFK--HRKYDKKVDVFSFAMILYEMLEGEPPL 248
G + YMAP++ + +DK VD +S +++YE+L G P
Sbjct: 168 G---TIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 1e-13
Identities = 89/364 (24%), Positives = 149/364 (40%), Gaps = 101/364 (27%)
Query: 26 PPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSL- 77
P LP WE L F +G G+FG++++A G VA+K + S
Sbjct: 24 PTQLPYNEKWEFPRDNLQFGK--TLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH 81
Query: 78 SDDR--------------------------------LVIQDFRHEVNLLVKLRHP----- 100
+D+R LVI ++ +LL LR
Sbjct: 82 TDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFL 141
Query: 101 NIVQFLGAVTER----KPLMLITEYLRGGD------LHKYLKEKGALSPSTA-------- 142
N V L ++E K + L +Y+R Y++ + S S+
Sbjct: 142 NFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEE 201
Query: 143 -------------VNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFG 189
+ F+ +A+GM +L ++ IHRD+ RNVLL + K+ DFG
Sbjct: 202 DTEDSWPLDLDDLLRFSSQVAQGMDFLASKN--CIHRDVAARNVLLTDGRV--AKICDFG 257
Query: 190 LSKLIKVQNSHDVYKMTGETGSYR----YMAPEVFKHRKYDKKVDVFSFAMILYEMLE-G 244
L++ I + +S+ V K G+ R +MAPE Y + DV+S+ ++L+E+ G
Sbjct: 258 LARDI-MNDSNYVVK-----GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLG 311
Query: 245 EPP----LANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILK 300
+ P L N + Y+ K + RP F PE+ + + CW + +RP+F I +
Sbjct: 312 KSPYPGILVNSKFYKMVKRGYQMSRPDFAP----PEIYSIMKMCWNLEPTERPTFSQISQ 367
Query: 301 RLEK 304
+++
Sbjct: 368 LIQR 371
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-13
Identities = 54/204 (26%), Positives = 100/204 (49%), Gaps = 13/204 (6%)
Query: 49 IIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQF 105
+IG+GS+ ++L + A+K + L D I + E ++ + +P +V
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 106 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 165
L L+ EY+ GGDL +++ + L A +A +I + +LH II+
Sbjct: 62 HSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERG--IIY 119
Query: 166 RDLKPRNVLLVNSSADHLKVGDFGLSKL-IKVQNSHDVYKMTGETGSYRYMAPEVFKHRK 224
RDLK NVLL + H+K+ D+G+ K + ++ + G+ Y+APE+ + +
Sbjct: 120 RDLKLDNVLL--DADGHIKLTDYGMCKEGLGPGDTTSTF-----CGTPNYIAPEILRGEE 172
Query: 225 YDKKVDVFSFAMILYEMLEGEPPL 248
Y VD ++ ++++EM+ G P
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 4e-13
Identities = 56/214 (26%), Positives = 100/214 (46%), Gaps = 15/214 (7%)
Query: 43 DFSSSAIIGKGSFGEILKAYWRGTPVAIK----RIL--PSLSDDRLVIQDFRHEVNLLVK 96
+F ++G G++G++ K ++L +L ++ R E N+L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 97 LRH-PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 155
+R P +V A L LI +Y+ GG++ +L ++ S ++ +I + +
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEH 120
Query: 156 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYM 215
LH I++RD+K N+LL S H+ + DFGLSK + Y G YM
Sbjct: 121 LHKLG--IVYRDIKLENILL--DSEGHVVLTDFGLSKEFLSEEKERTYSFCGTI---EYM 173
Query: 216 APEVFKHRK-YDKKVDVFSFAMILYEMLEGEPPL 248
APE+ + + + K VD +S ++++E+L G P
Sbjct: 174 APEIIRGKGGHGKAVDWWSLGILIFELLTGASPF 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 6e-13
Identities = 58/179 (32%), Positives = 90/179 (50%), Gaps = 19/179 (10%)
Query: 124 GGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHL 183
+ E ALS V F+ +A GM +L ++ V HRDL RNVL+ +
Sbjct: 223 RTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCV--HRDLAARNVLICEGKL--V 278
Query: 184 KVGDFGLSKLIKVQNSHDVYKMTGETG-SYRYMAPEVFKHRKYDKKVDVFSFAMILYEM- 241
K+ DFGL++ I +++S+ + K G T ++MAPE + Y DV+SF ++L+E+
Sbjct: 279 KICDFGLARDI-MRDSNYISK--GSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIF 335
Query: 242 -LEGEP----PLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSF 295
L G P P+ N + Y A K G+R + + E+ E+ +KCW RP F
Sbjct: 336 TLGGTPYPELPM-NEQFYNAIK---RGYR-MAKPAHASDEIYEIMQKCWEEKFEIRPDF 389
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 7e-13
Identities = 63/228 (27%), Positives = 102/228 (44%), Gaps = 45/228 (19%)
Query: 44 FSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN 101
F IG+G++G++ KA + G VA+K++ + I R E+ +L +L H N
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR-EIKILRQLNHRN 67
Query: 102 IVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA--------------LSPSTAVNFAL 147
IV VT+++ D + K+KGA L S V+F+
Sbjct: 68 IVNLKEIVTDKQ------------DALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSE 115
Query: 148 D--------IARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 199
D + G+ Y H + +HRD+K N+LL N +K+ DFGL++L NS
Sbjct: 116 DHIKSFMKQLLEGLNYCHKKN--FLHRDIKCSNILLNNKG--QIKLADFGLARLY---NS 168
Query: 200 HDVYKMTGETGSYRYMAPE-VFKHRKYDKKVDVFSFAMILYEMLEGEP 246
+ T + + Y PE + +Y +DV+S IL E+ +P
Sbjct: 169 EESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKP 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 3e-12
Identities = 63/215 (29%), Positives = 98/215 (45%), Gaps = 17/215 (7%)
Query: 43 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 100
DF +IG+G+FGE+ + T A+K + R FR E N+LV
Sbjct: 2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQ 61
Query: 101 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFAL-DIARGMAYLHNE 159
I A + L L+ +Y GGDL L + P F + ++ + +H
Sbjct: 62 WITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQL 121
Query: 160 PNVIIHRDLKPRNVLL-VNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPE 218
V HRD+KP NVLL +N H+++ DFG +K+ V + + G+ Y++PE
Sbjct: 122 HYV--HRDIKPDNVLLDMNG---HIRLADFG--SCLKMNQDGTV-QSSVAVGTPDYISPE 173
Query: 219 VFKHR-----KYDKKVDVFSFAMILYEMLEGEPPL 248
+ + KY + D +S + +YEML GE P
Sbjct: 174 ILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 1e-11
Identities = 57/247 (23%), Positives = 97/247 (39%), Gaps = 45/247 (18%)
Query: 50 IGKGSFGEILKAYWRGTPV--AIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 107
IG G+FGE+ T A+K + + R + E ++L + + +V+
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYY 68
Query: 108 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 167
+ ++ L + +Y+ GGD+ L G A + ++ + +H IHRD
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMG--FIHRD 126
Query: 168 LKPRNVLLVNSSADHLKVGDFGLS------------------------------------ 191
+KP N+L+ H+K+ DFGL
Sbjct: 127 IKPDNILI--DRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCR 184
Query: 192 -KLIKVQNSHDVYKMTGET--GSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPL 248
K ++ + + + G+ Y+APEV Y + D +S +ILYEML G+PP
Sbjct: 185 LKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPF 244
Query: 249 ANYEPYE 255
P E
Sbjct: 245 LADTPAE 251
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 1e-11
Identities = 68/218 (31%), Positives = 100/218 (45%), Gaps = 41/218 (18%)
Query: 49 IIGKGSFGEILKAYWRGTP--VAIKRIL--PSLSDDRLVIQDFRHEVNLL---------- 94
IIG GSFG + +A T VAIK++L P + L+I + +N++
Sbjct: 73 IIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTEC 132
Query: 95 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK----EKGALSPSTAVNFALDIA 150
K NI FL V E P + HKY+K AL ++ +
Sbjct: 133 FKKNEKNI--FLNVVMEFIPQTV----------HKYMKHYARNNHALPLFLVKLYSYQLC 180
Query: 151 RGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK-LIKVQNSHDVYKMTGET 209
R +AY+H++ I HRDLKP+N LL++ + LK+ DFG +K L+ Q S
Sbjct: 181 RALAYIHSK--FICHRDLKPQN-LLIDPNTHTLKLCDFGSAKNLLAGQRS------VSYI 231
Query: 210 GSYRYMAPEV-FKHRKYDKKVDVFSFAMILYEMLEGEP 246
S Y APE+ Y +D++S I+ EM+ G P
Sbjct: 232 CSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYP 269
|
Length = 440 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 3e-11
Identities = 54/186 (29%), Positives = 92/186 (49%), Gaps = 13/186 (6%)
Query: 125 GDLHKYLKEKGA--LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH 182
++ L + G+ L+ ++F +ARGM +L ++ V HRDL RNVLL +
Sbjct: 220 SEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCV--HRDLAARNVLL--AQGKI 275
Query: 183 LKVGDFGLSKLIKVQNSHDVYKMTGETG-SYRYMAPEVFKHRKYDKKVDVFSFAMILYEM 241
+K+ DFGL++ I ++ Y G T ++MAPE Y DV+S+ ++L+E+
Sbjct: 276 VKICDFGLARDIMHDSN---YVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEI 332
Query: 242 --LEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDIL 299
L G P + G+R + T E+ ++ KCW ++ +RPSFL +
Sbjct: 333 FSLGGTPYPGMIVDSTFYNKIKSGYR-MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLS 391
Query: 300 KRLEKI 305
+E +
Sbjct: 392 DIVESL 397
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 3e-11
Identities = 63/217 (29%), Positives = 96/217 (44%), Gaps = 23/217 (10%)
Query: 43 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 100
DF +IG+G+FGE+ + T A+K + R FR E ++LV
Sbjct: 2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRR 61
Query: 101 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFAL-DIARGMAYLHNE 159
I A + L L+ +Y GGDL L + P F L ++ + +H
Sbjct: 62 WITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQL 121
Query: 160 PNVIIHRDLKPRNVLLVNSSADHLKVGDFG----LSKLIKVQNSHDVYKMTGETGSYRYM 215
V HRD+KP NVLL H+++ DFG L VQ++ V G+ Y+
Sbjct: 122 GYV--HRDIKPDNVLL--DKNGHIRLADFGSCLRLLADGTVQSNVAV-------GTPDYI 170
Query: 216 APEVFKHR-----KYDKKVDVFSFAMILYEMLEGEPP 247
+PE+ + +Y + D +S + +YEML GE P
Sbjct: 171 SPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 3e-11
Identities = 59/206 (28%), Positives = 97/206 (47%), Gaps = 27/206 (13%)
Query: 50 IGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 107
IG G+ G + A+ G VA+K++ + + +R E+ LL + H NI+ L
Sbjct: 29 IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNIISLLN 87
Query: 108 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYL---------HN 158
T +K L E+ D++ ++ A + ++ LD R M+YL H
Sbjct: 88 VFTPQKSL---EEF---QDVYLVMELMDA-NLCQVIHMELDHER-MSYLLYQMLCGIKHL 139
Query: 159 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPE 218
IIHRDLKP N+++ + LK+ DFGL++ + MT + Y APE
Sbjct: 140 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTACTN-----FMMTPYVVTRYYRAPE 192
Query: 219 VFKHRKYDKKVDVFSFAMILYEMLEG 244
V Y + VD++S I+ E+++G
Sbjct: 193 VILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 4e-11
Identities = 63/213 (29%), Positives = 95/213 (44%), Gaps = 41/213 (19%)
Query: 50 IGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 107
IG G+ G + AY G VAIK++ + + +R E+ L+ + H NI+ L
Sbjct: 24 IGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYR-ELVLMKLVNHKNIIGLLN 82
Query: 108 AVTERKPL------MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIAR---------- 151
T +K L L+ E L +L + + LD R
Sbjct: 83 VFTPQKSLEEFQDVYLVME-LMDANLCQ------------VIQMDLDHERMSYLLYQMLC 129
Query: 152 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGS 211
G+ +LH+ IIHRDLKP N+ +V S LK+ DFGL++ + + MT +
Sbjct: 130 GIKHLHSAG--IIHRDLKPSNI-VVKSDCT-LKILDFGLAR-----TAGTSFMMTPYVVT 180
Query: 212 YRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEG 244
Y APEV Y + VD++S I+ EM+ G
Sbjct: 181 RYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG 213
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 5e-11
Identities = 71/279 (25%), Positives = 123/279 (44%), Gaps = 41/279 (14%)
Query: 50 IGKGSFGE-ILKAYWRGTPVA---IKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 105
IG G FG+ +L + T VA +K + + S +F + + L+HPNI+Q
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQ--NEFLQQGDPYRILQHPNILQC 60
Query: 106 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAV----NFALDIARGMAYLHNEPN 161
LG E P +L+ EY GDL YL ++ ++ + A +IA G+ ++H
Sbjct: 61 LGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN- 119
Query: 162 VIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSY--RYMAPEV 219
+H DL RN L +S +KVGD+G I + Y T + R++APE+
Sbjct: 120 -FLHSDLALRNCFL--TSDLTVKVGDYG----IGPSRYKEDYIETEDDKCVPLRWLAPEL 172
Query: 220 FKHR-------KYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAK 271
+ K +V++ + L+E+ E P ++ E +V + + K
Sbjct: 173 VGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQ----QVK 228
Query: 272 GFTPELR--------ELTEKCWAADMNQRPSFLDILKRL 302
F P+L E+ + CW + +R + ++ + L
Sbjct: 229 LFKPQLELPYSERWYEVLQFCWLSP-EKRATAEEVHRLL 266
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 9e-11
Identities = 63/227 (27%), Positives = 102/227 (44%), Gaps = 35/227 (15%)
Query: 96 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 155
KL+HPNIV+ +G K LI EY+ G +L + L+ LS A+ IA+ + +
Sbjct: 739 KLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRF 795
Query: 156 LHN--EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYR 213
LH P V++ +L P +++ HL++ L L+ + S
Sbjct: 796 LHCRCSPAVVVG-NLSPEKIIIDGKDEPHLRLS---LPGLLCTDTKCFI--------SSA 843
Query: 214 YMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPL-ANYEPYEA----AKYV-AEGH--- 264
Y+APE + + +K D++ F +IL E+L G+ P A + + + A+Y ++ H
Sbjct: 844 YVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDM 903
Query: 265 --RPFFRAKGFTPELRELTE------KCWAADMNQRPSFLDILKRLE 303
P R + E+ E C A D RP D+LK LE
Sbjct: 904 WIDPSIRGDVSVNQ-NEIVEVMNLALHCTATDPTARPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 1e-10
Identities = 62/279 (22%), Positives = 120/279 (43%), Gaps = 22/279 (7%)
Query: 37 IDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVK 96
I+ ++D +S +I + I K + V I+ +++I +E+ L +
Sbjct: 15 IESDDIDKYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRR 74
Query: 97 LRHPNIVQFLG----AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARG 152
+ NI++ G V + L LI EY G L + L ++ LS T ++ A+D +G
Sbjct: 75 IDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKG 134
Query: 153 MAYLH---NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET 209
+ L+ N+P +++L + L+ + LK+ GL K++ +V M
Sbjct: 135 LYNLYKYTNKP----YKNLTSVSFLVTENYK--LKIICHGLEKILSSPPFKNVNFMV--- 185
Query: 210 GSYRYMAPEVFKH--RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPF 267
Y + ++ +Y K D++S ++L+E+ G+ P N E + +
Sbjct: 186 ----YFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSL 241
Query: 268 FRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIK 306
E++ + E C + D +RP+ +IL L K
Sbjct: 242 KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280
|
Length = 283 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-10
Identities = 59/220 (26%), Positives = 95/220 (43%), Gaps = 27/220 (12%)
Query: 43 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 100
DF +IG+G+FGE+ + A+K + R FR E ++LV +
Sbjct: 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61
Query: 101 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNF-------ALDIARGM 153
I A + L L+ +Y GGDL L + P F A+D +
Sbjct: 62 WITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQL 121
Query: 154 AYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYR 213
Y +HRD+KP N+L+ H+++ DFG +K+ V + + G+
Sbjct: 122 HY--------VHRDIKPDNILM--DMNGHIRLADFG--SCLKLMEDGTV-QSSVAVGTPD 168
Query: 214 YMAPEVFKHR-----KYDKKVDVFSFAMILYEMLEGEPPL 248
Y++PE+ + KY + D +S + +YEML GE P
Sbjct: 169 YISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-10
Identities = 61/259 (23%), Positives = 104/259 (40%), Gaps = 53/259 (20%)
Query: 44 FSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQD----FRHEVNLLVKLRH 99
F +G G+FGE+ A R + +L +++++ + E ++L + +
Sbjct: 3 FVKIKTLGIGAFGEVCLA--RKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADN 60
Query: 100 PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE 159
+V+ + ++ L + +Y+ GGD+ L G A + ++ + +H
Sbjct: 61 EWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKM 120
Query: 160 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGL---------SKLIKV-----QNSHDVYKM 205
IHRD+KP N+L+ H+K+ DFGL SK + Q+S D
Sbjct: 121 G--FIHRDIKPDNILI--DRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNE 176
Query: 206 TGETGSYR-----------------------------YMAPEVFKHRKYDKKVDVFSFAM 236
G+ + R Y+APEV Y + D +S +
Sbjct: 177 WGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236
Query: 237 ILYEMLEGEPPLANYEPYE 255
ILYEML G+PP P E
Sbjct: 237 ILYEMLVGQPPFLAQTPLE 255
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 5e-10
Identities = 54/211 (25%), Positives = 99/211 (46%), Gaps = 19/211 (9%)
Query: 50 IGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIV---QFL 106
+G+G++G + KA + + L + + + R E+ LL +L+HPN++ +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACR-EIALLRELKHPNVIALQKVF 67
Query: 107 GAVTERKPLMLITEYLRGGDLH--------KYLKEKGALSPSTAVNFALDIARGMAYLHN 158
+ ++RK + L+ +Y H K K+ L S + I G+ YLH
Sbjct: 68 LSHSDRK-VWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH- 125
Query: 159 EPNVIIHRDLKPRNVLLVNSSAD--HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMA 216
N ++HRDLKP N+L++ + +K+ D G ++L + + ++ Y A
Sbjct: 126 -ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN-SPLKPLADLDPVVVTFWYRA 183
Query: 217 PE-VFKHRKYDKKVDVFSFAMILYEMLEGEP 246
PE + R Y K +D+++ I E+L EP
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSEP 214
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 6e-10
Identities = 66/293 (22%), Positives = 114/293 (38%), Gaps = 52/293 (17%)
Query: 44 FSSSAIIGKGSFGEILKAYWRGTPV--AIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN 101
F +G G+FGE+ A T A+K + +R + + E ++L + +
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 102 IVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPN 161
+V+ + ++ L + +Y+ GGD+ L A + ++ + +H
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMG- 121
Query: 162 VIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK----------------- 204
IHRD+KP N+L+ H+K+ DFGL + ++ Y+
Sbjct: 122 -FIHRDIKPDNILI--DLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWD 178
Query: 205 -----------MTGE---------------TGSYRYMAPEVFKHRKYDKKVDVFSFAMIL 238
T E G+ Y+APEV + Y + D +S +IL
Sbjct: 179 DVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL 238
Query: 239 YEMLEGEPPLANYEPYEAAKYVA--EGHRPFFRAKGFTPELREL-TEKCWAAD 288
+EML G+PP P E V E +PE +L T+ C +A+
Sbjct: 239 FEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAE 291
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 9e-10
Identities = 62/272 (22%), Positives = 121/272 (44%), Gaps = 36/272 (13%)
Query: 50 IGKGSFGEILKAYWR---------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 100
+G+G+F +I K R T V +K + S R + F +++ +L H
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS---HRNYSESFFEAASMMSQLSHK 59
Query: 101 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHN-- 158
++V G +++ EY++ G L YLK+ L + + L++A+ +A+ +
Sbjct: 60 HLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINIS---WKLEVAKQLAWALHFL 116
Query: 159 EPNVIIHRDLKPRNVLLVNSSADH------LKVGDFGLSKLIKVQNSHDVYKMTGETGSY 212
E + H ++ +NVLL+ +K+ D G+S I V ++
Sbjct: 117 EDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS--ITVL-PKEIL-----LERI 168
Query: 213 RYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEG-EPPLANYEPYEAAKYVAEGHRPFFRA 270
++ PE ++ + D +SF L+E+ G + PL+ + + ++ + H+ A
Sbjct: 169 PWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDRHQ--LPA 226
Query: 271 KGFTPELRELTEKCWAADMNQRPSFLDILKRL 302
+T EL L +C + + RPSF I++ L
Sbjct: 227 PKWT-ELANLINQCMDYEPDFRPSFRAIIRDL 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 1e-09
Identities = 40/153 (26%), Positives = 72/153 (47%), Gaps = 7/153 (4%)
Query: 90 EVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDI 149
E+++L + H I+ + A + + ++ + DL Y+ G L A+ +
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKC-DLFTYVDRSGPLPLEQAITIQRRL 194
Query: 150 ARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET 209
+AYLH IIHRD+K N+ L ++ +GDFG + K+ D + G +
Sbjct: 195 LEALAYLHGRG--IIHRDVKTENIFLDEP--ENAVLGDFGAA--CKLDAHPDTPQCYGWS 248
Query: 210 GSYRYMAPEVFKHRKYDKKVDVFSFAMILYEML 242
G+ +PE+ Y K D++S ++L+EM
Sbjct: 249 GTLETNSPELLALDPYCAKTDIWSAGLVLFEMS 281
|
Length = 392 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 5e-09
Identities = 51/210 (24%), Positives = 92/210 (43%), Gaps = 17/210 (8%)
Query: 50 IGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAV 109
+G+G++G + KA + L + + + R E+ LL +L+HPN++
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACR-EIALLRELKHPNVISLQKVF 67
Query: 110 TER--KPLMLITEYLRGGDLH--------KYLKEKGALSPSTAVNFALDIARGMAYLHNE 159
+ + L+ +Y H K K+ L + I G+ YLH
Sbjct: 68 LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH-- 125
Query: 160 PNVIIHRDLKPRNVLLVNSSAD--HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAP 217
N ++HRDLKP N+L++ + +K+ D G ++L + + ++ Y AP
Sbjct: 126 ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN-SPLKPLADLDPVVVTFWYRAP 184
Query: 218 E-VFKHRKYDKKVDVFSFAMILYEMLEGEP 246
E + R Y K +D+++ I E+L EP
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSEP 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 7e-09
Identities = 57/202 (28%), Positives = 95/202 (47%), Gaps = 19/202 (9%)
Query: 50 IGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 107
IG G+ G + AY VAIK++ + + +R E+ L+ + H NI+ L
Sbjct: 32 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLN 90
Query: 108 AVTERKPL-----MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNV 162
T +K L + I L +L + ++ + L + G+ +LH+
Sbjct: 91 VFTPQKSLEEFQDVYIVMELMDANLCQVIQME--LDHERMSYLLYQMLCGIKHLHSAG-- 146
Query: 163 IIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH 222
IIHRDLKP N+++ + LK+ DFGL++ + + MT + Y APEV
Sbjct: 147 IIHRDLKPSNIVVKSDCT--LKILDFGLAR-----TAGTSFMMTPYVVTRYYRAPEVILG 199
Query: 223 RKYDKKVDVFSFAMILYEMLEG 244
Y + VD++S I+ EM++G
Sbjct: 200 MGYKENVDIWSVGCIMGEMIKG 221
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 9e-09
Identities = 61/244 (25%), Positives = 109/244 (44%), Gaps = 26/244 (10%)
Query: 68 VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL-MLITEYLRGGD 126
V +K + PS D L F +L+ ++ H ++ F+ V R +++ E++ G
Sbjct: 47 VVLKVLDPSHRDIALA---FFETASLMSQVSHIHLA-FVHGVCVRGSENIMVEEFVEHGP 102
Query: 127 LHKYL-KEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLV-----NSSA 180
L L KEKG + + + A +A ++YL ++ ++H ++ +N+LL ++
Sbjct: 103 LDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKN--LVHGNVCAKNILLARLGLAEGTS 160
Query: 181 DHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILY 239
+K+ D G+S + V ++ ++APE D +SF L
Sbjct: 161 PFIKLSDPGVS-FTALSREERVERIP-------WIAPECVPGGNSLSTAADKWSFGTTLL 212
Query: 240 EM-LEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDI 298
E+ +GE PL P E ++ + HR + EL L +C + QRPSF I
Sbjct: 213 EICFDGEVPLKERTPSEKERFYEKKHR---LPEPSCKELATLISQCLTYEPTQRPSFRTI 269
Query: 299 LKRL 302
L+ L
Sbjct: 270 LRDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 2e-08
Identities = 48/158 (30%), Positives = 74/158 (46%), Gaps = 18/158 (11%)
Query: 89 HEVNLLVKLRHPNIVQFL-----GAVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTA 142
HE LL +L HP ++ L G +T +++ +Y DL+ YL L +
Sbjct: 209 HEARLLRRLSHPAVLALLDVRVVGGLT----CLVLPKY--RSDLYTYLGARLRPLGLAQV 262
Query: 143 VNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDV 202
A + + Y+H E IIHRD+K NV LVN D + +GDFG + + S
Sbjct: 263 TAVARQLLSAIDYIHGEG--IIHRDIKTENV-LVNGPED-ICLGDFGAACFARGSWSTPF 318
Query: 203 YKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYE 240
+ G G+ APEV Y VD++S ++++E
Sbjct: 319 H--YGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 7e-08
Identities = 57/201 (28%), Positives = 94/201 (46%), Gaps = 21/201 (10%)
Query: 50 IGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 107
IG G+ G + AY VAIK++ + + +R E+ L+ + H NI+ L
Sbjct: 25 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLN 83
Query: 108 AVTERKPL------MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPN 161
T +K L L+ E L +L + ++ + L + G+ +LH+
Sbjct: 84 VFTPQKSLEEFQDVYLVME-LMDANLCQVIQME--LDHERMSYLLYQMLCGIKHLHSAG- 139
Query: 162 VIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFK 221
IIHRDLKP N+++ + LK+ DFGL++ + + MT + Y APEV
Sbjct: 140 -IIHRDLKPSNIVVKSDCT--LKILDFGLAR-----TAGTSFMMTPYVVTRYYRAPEVIL 191
Query: 222 HRKYDKKVDVFSFAMILYEML 242
Y + VD++S I+ EM+
Sbjct: 192 GMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 2e-07
Identities = 40/118 (33%), Positives = 57/118 (48%), Gaps = 14/118 (11%)
Query: 26 PPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSL- 77
P LP WE + L F +G G+FG++++A G VA+K + PS
Sbjct: 21 PTQLPYDHKWEFPRNRLSFGK--TLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH 78
Query: 78 SDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK 134
+R + E+ +L L H NIV LGA T P ++ITEY GDL +L+ K
Sbjct: 79 LTER---EALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRK 133
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 2e-07
Identities = 38/145 (26%), Positives = 66/145 (45%), Gaps = 11/145 (7%)
Query: 100 PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE 159
PN+V + + L+ ++ GG L ++ + + +A ++ + LH E
Sbjct: 45 PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHRE 104
Query: 160 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV 219
I+ RDL P N+LL H+++ F + +V++S D GE Y APEV
Sbjct: 105 G--IVCRDLNPNNILL--DDRGHIQLTYFS--RWSEVEDSCD-----GEAVENMYCAPEV 153
Query: 220 FKHRKYDKKVDVFSFAMILYEMLEG 244
+ + D +S IL+E+L G
Sbjct: 154 GGISEETEACDWWSLGAILFELLTG 178
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 6e-07
Identities = 53/232 (22%), Positives = 91/232 (39%), Gaps = 50/232 (21%)
Query: 50 IGKGSFG----EILKAYWRGTPVAIKRI-LPSLSDDRLV-IQDFRHEVNLLVKLRHPNIV 103
IGK + K T VA+K+I L S S + L +Q E+ +L+HPNI+
Sbjct: 6 IGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQ---EIITSRQLQHPNIL 62
Query: 104 QFLGAVTERKPLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFAL-DIARGMAYLHNEP 160
++ + L +++ + G LK L P A+ F L D+ + Y+H+
Sbjct: 63 PYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGL-PELAIAFILKDVLNALDYIHS-- 119
Query: 161 NVIIHRDLKPRNVLL-----------------VNSSADHLKVGDFGLSKLIKVQNSHDVY 203
IHR +K ++LL + V DF S +K
Sbjct: 120 KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSS-VKNLP----- 173
Query: 204 KMTGETGSYRYMAPEVFKH--RKYDKKVDVFSFAMILYEMLEGEPPLANYEP 253
+++PEV + + Y++K D++S + E+ G P +
Sbjct: 174 ----------WLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPA 215
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 1e-06
Identities = 37/114 (32%), Positives = 53/114 (46%), Gaps = 12/114 (10%)
Query: 26 PPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLS 78
P LP WE+ L + +G G+FG +++A G VA+K + +
Sbjct: 23 PMQLPYDSAWEMPRDNLVLGRT--LGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR 80
Query: 79 DDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL 131
Q E+ ++ L H NIV LGA T+ P+ +ITEY R GDL YL
Sbjct: 81 SSE--KQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYL 132
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 47.2 bits (113), Expect = 2e-06
Identities = 39/155 (25%), Positives = 62/155 (40%), Gaps = 29/155 (18%)
Query: 49 IIGKGSFGEILKAYWRGTPVAIK-RI-----LPSLSDDRLVIQDFRHEVNLLVKLRH--- 99
+I KG+ I + G IK R+ P L D+R+ + R+E LL + R
Sbjct: 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPEL-DERIRRERTRNEARLLSRARKAGV 59
Query: 100 --PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLH 157
P + + ++ EY+ G L ++E +I R + LH
Sbjct: 60 NTPVVYDV-----DPDNKTIVMEYIEGKPLKDVIEEGN-------DELLREIGRLVGKLH 107
Query: 158 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 192
I+H DL N+++ D L + DFGL K
Sbjct: 108 K--AGIVHGDLTTSNIIV---RDDKLYLIDFGLGK 137
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 4e-06
Identities = 40/114 (35%), Positives = 55/114 (48%), Gaps = 12/114 (10%)
Query: 26 PPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILK--AYW--RGTPV---AIKRILPSLS 78
P LP WE L I+G G+FG++++ AY R PV A+K + P+
Sbjct: 23 PMQLPYDSRWEFPRDGLVLGR--ILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTAR 80
Query: 79 DDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL 131
Q E+ ++ L H NIV LGA T+ P+ +ITEY GDL YL
Sbjct: 81 SSEK--QALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYL 132
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 9e-06
Identities = 68/292 (23%), Positives = 110/292 (37%), Gaps = 67/292 (22%)
Query: 65 GTPVAIKRI-LPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLR 123
GT V ++ L + +++ L ++EV L RHPNI+ T L +I+ ++
Sbjct: 25 GTLVTVRITDLENCTEEHLKA--LQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82
Query: 124 GGDLHKYLKE--KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD 181
G + LK +S + N RG+ YLH N IHR++K ++L+ S D
Sbjct: 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQ--NGYIHRNIKASHILI---SGD 137
Query: 182 HLKVGDFGLSKLIKV----QNSHDVYKMTG-ETGSYRYMAPEVFKH--RKYDKKVDVFSF 234
L V GLS L + Q + VY T +++PE+ + Y+ K D++S
Sbjct: 138 GL-VSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSV 196
Query: 235 AMILYEMLEGEPPLAN---------------YEPYEAAKYVAEG---------------- 263
+ E+ G P + Y P + + E
Sbjct: 197 GITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGE 256
Query: 264 ----------------HRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDIL 299
P +K F+P + L E C D +RPS +L
Sbjct: 257 SVVAAGMTQTMTSERLRTP--SSKTFSPAFQNLVELCLQQDPEKRPSASSLL 306
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 1e-05
Identities = 15/33 (45%), Positives = 22/33 (66%)
Query: 215 MAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPP 247
MAPEV + + Y +K D++S + LYE L+ E P
Sbjct: 71 MAPEVIQGQSYTEKADIYSLGITLYEALDYELP 103
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 2e-05
Identities = 58/244 (23%), Positives = 101/244 (41%), Gaps = 30/244 (12%)
Query: 68 VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDL 127
V +K + PS D L F +++ ++ H +IV G +++ E++ G L
Sbjct: 35 VILKVLDPSHRDISLA---FFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPL 91
Query: 128 HKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH---- 182
++ K L+ A +A ++YL E ++H ++ +N+LL D
Sbjct: 92 DLFMHRKSDVLTTPWKFKVAKQLASALSYL--EDKDLVHGNVCTKNILLAREGIDGECGP 149
Query: 183 -LKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRK-YDKKVDVFSFAMILYE 240
+K+ D G+ I V + + + ++APE + K D +SF L+E
Sbjct: 150 FIKLSDPGIP--ITVLSRQECVERI------PWIAPECVEDSKNLSIAADKWSFGTTLWE 201
Query: 241 M-LEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTP---ELRELTEKCWAADMNQRPSFL 296
+ GE PL + E ++ TP EL +L C D NQRP F
Sbjct: 202 ICYNGEIPLKDKTLAEKERFYEGQCMLV------TPSCKELADLMTHCMNYDPNQRPFFR 255
Query: 297 DILK 300
I++
Sbjct: 256 AIMR 259
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.1 bits (105), Expect = 2e-05
Identities = 38/151 (25%), Positives = 67/151 (44%), Gaps = 20/151 (13%)
Query: 50 IGKGSFGEILKAYWRGTPVAIK-------RILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 102
I +G+ EI + G IK R P L D+R+ + R E ++ + R +
Sbjct: 4 IKRGAEAEIYLGDFLGIKAVIKWRIPKRYRH-PEL-DERIRRERTRREARIMSRARKAGV 61
Query: 103 -VQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPN 161
V + V + ++ EY+ G + LK+ + + + +I R + LH+
Sbjct: 62 NVPAVYFVDPENFI-IVMEYIEG----EPLKDLINSNGMEELELSREIGRLVGKLHS--A 114
Query: 162 VIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 192
IIH DL N++L S + + DFGL++
Sbjct: 115 GIIHGDLTTSNMIL---SGGKIYLIDFGLAE 142
|
Length = 211 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 7e-05
Identities = 41/153 (26%), Positives = 63/153 (41%), Gaps = 23/153 (15%)
Query: 48 AIIGKGSFGEILKAYWRGTPVAIK-RI-----LPSLSDDRLVIQDFRHEVNLLVKLRHPN 101
+I +G+ I + G P +K RI P L D++L + R E +L K R
Sbjct: 2 DLIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPEL-DEKLRRERTRREARILAKAREAG 60
Query: 102 I-VQFLGAVTERKPLMLIT-EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE 159
+ V + V LI EY+ G L L+E + ++ R + LH
Sbjct: 61 VPVPIVYDVDP--DNGLIVMEYIEGELLKDALEEA-------RPDLLREVGRLVGKLHK- 110
Query: 160 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 192
I+H DL N++L S + DFGL +
Sbjct: 111 -AGIVHGDLTTSNIIL---SGGRIYFIDFGLGE 139
|
Length = 204 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 1e-04
Identities = 53/241 (21%), Positives = 95/241 (39%), Gaps = 52/241 (21%)
Query: 36 EIDPSELDFSSSAIIGKGSFGEILKAYWRG----TPVAIKRILPSLSDDRLVIQDFRHEV 91
+ID S F +++G+G+FG++++A+ R V I R +P + +D + E+
Sbjct: 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYT------RDAKIEI 176
Query: 92 NLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLH------KY-------LKEKGALS 138
+ K+R + +R PLM I Y + H KY + + G S
Sbjct: 177 QFMEKVRQAD-------PADRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFS 229
Query: 139 PSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD--------------HLK 184
+ Y H E + ++H DLKP N+L+ S ++
Sbjct: 230 HRHLAQIIFQTGVALDYFHTELH-LMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVR 288
Query: 185 VGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEG 244
+ D G + + T + Y +PEV + D++S I+YE+ G
Sbjct: 289 ICDLG-------GCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTG 341
Query: 245 E 245
+
Sbjct: 342 K 342
|
Length = 467 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 2e-04
Identities = 31/111 (27%), Positives = 57/111 (51%), Gaps = 17/111 (15%)
Query: 35 WEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRIL--PSLSDDRLVIQ 85
WE L ++G G+FG++++A G VA+K + + S+ + ++
Sbjct: 2 WEFPRDRLRLGK--VLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMS 59
Query: 86 DFRHEVNLLVKL-RHPNIVQFLGAVTE-RKPLMLITEYLRGGDLHKYLKEK 134
E+ +L+ + H N+V LGA T+ PLM+I E+ + G+L +L+ K
Sbjct: 60 ----ELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAK 106
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Score = 39.9 bits (94), Expect = 0.001
Identities = 42/159 (26%), Positives = 64/159 (40%), Gaps = 38/159 (23%)
Query: 49 IIGKGSFGEILKAYWRGTPVAIK-RI-----LPSLSDDRLVIQDFRHEVNLLVKLRHPNI 102
+IGKG+ +I K + G IK R+ P L D+RL + R E LL + R +
Sbjct: 340 LIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPEL-DERLRTERTRAEARLLSEARRAGV 398
Query: 103 VQFLGAVTERKPLM---------LITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGM 153
P++ ++ EY+ G DL L+ + +
Sbjct: 399 ---------PTPVIYDVDPEEKTIVMEYIGGKDLKDVLEG--------NPELVRKVGEIV 441
Query: 154 AYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 192
A LH I+H DL N ++ + D L + DFGL K
Sbjct: 442 AKLHK--AGIVHGDLTTSNFIVRD---DRLYLIDFGLGK 475
|
Length = 535 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 320 | |||
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.98 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.98 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.95 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.92 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.92 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.92 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.91 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.91 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.9 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.9 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.9 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.88 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.87 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.85 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.84 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.84 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.83 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.82 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.81 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.8 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.79 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.78 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.77 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.74 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.74 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.71 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.7 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.67 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.66 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.61 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.6 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.57 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.51 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.47 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.47 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.46 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.43 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.41 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.39 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.35 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.35 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.27 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.25 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.24 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.13 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.12 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.11 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 99.05 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.99 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.85 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.72 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.66 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.64 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.61 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.49 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.48 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.41 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.37 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.37 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.26 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.26 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.24 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.22 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.22 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.05 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 98.02 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.97 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.94 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.8 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.78 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.77 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.64 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.55 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.51 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.45 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.4 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.23 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.19 | |
| PLN02236 | 344 | choline kinase | 97.18 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 97.04 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.99 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.94 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.9 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.85 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.83 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.79 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.67 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.58 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.24 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.15 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 95.88 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.75 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 95.43 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.27 | |
| PTZ00296 | 442 | choline kinase; Provisional | 95.13 |
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-51 Score=344.83 Aligned_cols=247 Identities=30% Similarity=0.511 Sum_probs=224.7
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCC-ceEEEE
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK-PLMLIT 119 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~iv~ 119 (320)
+.+.++.||+|..|+||++.++ ++.+|+|++.. ..+....+++.+|+++++..+||+|+++++.|.... ..+|+|
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~--~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~m 157 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILL--NIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICM 157 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecc--cCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeeh
Confidence 6778899999999999999997 78899998843 334555689999999999999999999999999888 499999
Q ss_pred ecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccC
Q 020888 120 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHN-EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 198 (320)
Q Consensus 120 e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~-~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~ 198 (320)
|||+||+|.+++.+.+++++.....++.++++||.|||+ ++ |+||||||+||++ +..|.|||||||.+..+...
T Consensus 158 EYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~--IIHRDIKPsNlLv--NskGeVKicDFGVS~~lvnS- 232 (364)
T KOG0581|consen 158 EYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERK--IIHRDIKPSNLLV--NSKGEVKICDFGVSGILVNS- 232 (364)
T ss_pred hhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccC--eeeccCCHHHeee--ccCCCEEeccccccHHhhhh-
Confidence 999999999999988899999999999999999999996 67 9999999999999 89999999999999877654
Q ss_pred ccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCC-----ChHHHHHHHHhCCCCCCCCCCC
Q 020888 199 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANY-----EPYEAAKYVAEGHRPFFRAKGF 273 (320)
Q Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~-----~~~~~~~~~~~~~~~~~~~~~~ 273 (320)
..++..||..|+|||.+.+..|+.++||||||++++|+.+|+.||... +..+....+..+..+......+
T Consensus 233 -----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~f 307 (364)
T KOG0581|consen 233 -----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEF 307 (364)
T ss_pred -----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccC
Confidence 345678999999999999999999999999999999999999999874 6677888888888777766679
Q ss_pred CHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 274 TPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 274 ~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
++++++||..||++||.+|||+.|+++|
T Consensus 308 S~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 308 SPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred CHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 9999999999999999999999999987
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-51 Score=361.81 Aligned_cols=258 Identities=28% Similarity=0.465 Sum_probs=235.7
Q ss_pred CCcCCCCCcccCccceecccCceEEEEEEE--CCCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEe
Q 020888 34 DWEIDPSELDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE 111 (320)
Q Consensus 34 ~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~--~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 111 (320)
+-..+.....|...+.||+|||+.+|.+.+ ++..||+|++.+.........+.+.+||++.+.|+||||++++++|++
T Consensus 10 ~~i~D~~~~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FED 89 (592)
T KOG0575|consen 10 EVIEDPRSKRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFED 89 (592)
T ss_pred CeeecCCcceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeec
Confidence 345666678899999999999999999998 389999999998877777777999999999999999999999999999
Q ss_pred CCceEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCc
Q 020888 112 RKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 191 (320)
Q Consensus 112 ~~~~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~ 191 (320)
.++.|||.|.|..++|.++++++.++++..+..++.||+.||.|||+++ |+|||||..|+|+ +.+.+|||+|||+|
T Consensus 90 s~nVYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~--IiHRDLKLGNlfL--~~~~~VKIgDFGLA 165 (592)
T KOG0575|consen 90 SNNVYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLG--IIHRDLKLGNLFL--NENMNVKIGDFGLA 165 (592)
T ss_pred CCceEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcC--ceecccchhheee--cCcCcEEeccccee
Confidence 9999999999999999999999889999999999999999999999999 9999999999999 88899999999999
Q ss_pred ccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCC
Q 020888 192 KLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAK 271 (320)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 271 (320)
..+..... ...+.+|||.|.|||++....++..+||||+||+||.|+.|+.||+...-.+.+..+...... .+.
T Consensus 166 t~le~~~E----rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~--~P~ 239 (592)
T KOG0575|consen 166 TQLEYDGE----RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYS--MPS 239 (592)
T ss_pred eeecCccc----ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcc--ccc
Confidence 99875533 334579999999999999999999999999999999999999999999888888877766533 334
Q ss_pred CCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 272 GFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 272 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
.++.+.++||.++|+.||.+|||+++++.+
T Consensus 240 ~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 240 HLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred ccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 689999999999999999999999999987
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-51 Score=350.30 Aligned_cols=254 Identities=30% Similarity=0.442 Sum_probs=219.1
Q ss_pred CcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHH----HHHHHHHHHHHHHhCCCCcccceeeeEEeCCc
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRL----VIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP 114 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 114 (320)
...|.+.+.||+|+||.|-++..+ ++.||+|++.+....... .-..+.+|+++|++++||+|++++++++..+.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 447888999999999999999875 899999999766544421 22346799999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeC-CCCcEEEecCCCccc
Q 020888 115 LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS-SADHLKVGDFGLSKL 193 (320)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~-~~~~~~L~dfg~~~~ 193 (320)
.|||+||++||.|.+.+-.++.+.+.....+++||+.|+.|||++| |+||||||+||++..+ .+..+||+|||+++.
T Consensus 251 ~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~G--I~HRDiKPeNILl~~~~e~~llKItDFGlAK~ 328 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQG--IIHRDIKPENILLSNDAEDCLLKITDFGLAKV 328 (475)
T ss_pred eEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcC--cccccCCcceEEeccCCcceEEEecccchhhc
Confidence 9999999999999999998889999999999999999999999999 9999999999999433 446899999999987
Q ss_pred ccccCccceeeccCCcccccccCccccCcCCCC---CchhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhCCCCCCC
Q 020888 194 IKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYD---KKVDVFSFAMILYEMLEGEPPLANYEPYE-AAKYVAEGHRPFFR 269 (320)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~---~~~Di~slG~~l~~ll~g~~p~~~~~~~~-~~~~~~~~~~~~~~ 269 (320)
.... ..+.+.||||.|.|||++.+.... .+.|+|||||+||-+++|..||.+..... ..+++.++......
T Consensus 329 ~g~~-----sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p 403 (475)
T KOG0615|consen 329 SGEG-----SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGP 403 (475)
T ss_pred cccc-----eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccC
Confidence 6533 256678999999999999776543 37799999999999999999998765444 77788887755443
Q ss_pred C--CCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 270 A--KGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 270 ~--~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
+ ..++++..++|.+||.+||++|||+.++|++
T Consensus 404 ~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 404 LQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred hhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 3 5689999999999999999999999999876
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-50 Score=327.12 Aligned_cols=254 Identities=30% Similarity=0.540 Sum_probs=221.6
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceee-eE-EeCCceEEE
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG-AV-TERKPLMLI 118 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~-~~-~~~~~~~iv 118 (320)
+|.++++||.|+||.||++.+. +..+|.|.+...... ....+....|+.+|++|+||||+++++ .+ ++...+++|
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md-~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMD-AKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhcc-HHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 7999999999999999999875 899999988754443 455688899999999999999999988 34 444448999
Q ss_pred EecCCCCCHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHhc--CCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcc
Q 020888 119 TEYLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLHN--EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 192 (320)
Q Consensus 119 ~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~~l~~~l~~lH~--~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~ 192 (320)
||+|.+|+|+++++. ...+++.++|+++.|++.||.+||. ..+.|.|+||||.|||+ +.+|.+||+|||+++
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl--~~~gvvKLGDfGL~r 176 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFL--TANGVVKLGDFGLGR 176 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEE--cCCCceeeccchhHh
Confidence 999999999999974 3468999999999999999999999 33459999999999999 999999999999998
Q ss_pred cccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCC
Q 020888 193 LIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKG 272 (320)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (320)
.+.... ....+.+|||.|++||.+.+..++.+||||||||++|||+.-+.||.+..-.+....+.++..++.....
T Consensus 177 ~l~s~~----tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~~~ 252 (375)
T KOG0591|consen 177 FLSSKT----TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPDEH 252 (375)
T ss_pred Hhcchh----HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcHHH
Confidence 876432 2344578999999999999999999999999999999999999999999999999999999877777677
Q ss_pred CCHHHHHHHHHHhhcCCCCCCCHHHHHHHHH
Q 020888 273 FTPELRELTEKCWAADMNQRPSFLDILKRLE 303 (320)
Q Consensus 273 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~ 303 (320)
++.+++.+|..|+.+||+.||+.-.++..++
T Consensus 253 YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 253 YSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred hhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 8999999999999999999998655544443
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-47 Score=336.34 Aligned_cols=276 Identities=44% Similarity=0.722 Sum_probs=236.0
Q ss_pred CCCCCcCCCCCcccCccceecccCceEEEEEEECCCc-eEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeE
Q 020888 31 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTP-VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAV 109 (320)
Q Consensus 31 ~~~~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~-~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 109 (320)
...+|.++.... ...+.+|+|+||+||++.+.++. ||+|.+......... .+.+.+|+.+|++++||||+++++++
T Consensus 32 ~~~~~~i~~~~l--~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~ 108 (362)
T KOG0192|consen 32 ELPEEEIDPDEL--PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGAC 108 (362)
T ss_pred cccceecChHHh--hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence 334555655443 44455999999999999999988 999988766555444 68999999999999999999999999
Q ss_pred EeCC-ceEEEEecCCCCCHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCC-cEEE
Q 020888 110 TERK-PLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD-HLKV 185 (320)
Q Consensus 110 ~~~~-~~~iv~e~~~~~~L~~~~~~--~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~-~~~L 185 (320)
.+.. .+++||||+++|+|.+++.. ...+++..++.++.+|+.|++|||+++. |+|+||||+||++ +.++ .+||
T Consensus 109 ~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~-iIHrDLK~~NiLv--~~~~~~~KI 185 (362)
T KOG0192|consen 109 TSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP-IIHRDLKSDNILV--DLKGKTLKI 185 (362)
T ss_pred cCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC-eeecccChhhEEE--cCCCCEEEE
Confidence 8887 79999999999999999987 5789999999999999999999999754 8999999999999 8887 9999
Q ss_pred ecCCCcccccccCccceeeccCCcccccccCccccC--cCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhC
Q 020888 186 GDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFK--HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEG 263 (320)
Q Consensus 186 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~ 263 (320)
+|||+++...... .......||+.|+|||++. ...++.++||||+|++++||+||+.||.+.........+...
T Consensus 186 ~DFGlsr~~~~~~----~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~ 261 (362)
T KOG0192|consen 186 ADFGLSREKVISK----TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVG 261 (362)
T ss_pred CCCccceeecccc----ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc
Confidence 9999998665432 1223367899999999999 568999999999999999999999999999987777777655
Q ss_pred CCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcCCCCCccc
Q 020888 264 HRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPTDHHWN 316 (320)
Q Consensus 264 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~~~~~ 316 (320)
...+..+..+++.+..++..||..||..||++.+++..|+.+.........++
T Consensus 262 ~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~~~~~~ 314 (362)
T KOG0192|consen 262 GLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISSAGPED 314 (362)
T ss_pred CCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcccCccc
Confidence 55555455589999999999999999999999999999999998877655543
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-48 Score=328.12 Aligned_cols=253 Identities=35% Similarity=0.594 Sum_probs=221.5
Q ss_pred CcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEE
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 118 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 118 (320)
..+|...+.||.|+|++||+++++ +..||+|.+..... ..+..+.+..|+++|+.++|+||+.+++++..++..|+|
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 347888899999999999999986 78899999876654 344557888999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeC-CC---CcEEEecCCCcccc
Q 020888 119 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS-SA---DHLKVGDFGLSKLI 194 (320)
Q Consensus 119 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~-~~---~~~~L~dfg~~~~~ 194 (320)
||||+||+|.+|+++.+.+++.++...+.||+.||++||+++ |+|+||||.||+++.. .+ -.+||.|||+++.+
T Consensus 88 MEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~--IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L 165 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENN--IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL 165 (429)
T ss_pred EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence 999999999999999999999999999999999999999988 9999999999999543 22 46999999999988
Q ss_pred cccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCC-CCCCCCCC
Q 020888 195 KVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHR-PFFRAKGF 273 (320)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~ 273 (320)
.... .....+|++.|+|||+.....|+.++|+||+|+++|++++|+.||+.....+....+.++.. .+..+..+
T Consensus 166 ~~~~-----~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~ 240 (429)
T KOG0595|consen 166 QPGS-----MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAEL 240 (429)
T ss_pred Cchh-----HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhc
Confidence 6433 45567899999999999999999999999999999999999999999999988887776653 33334556
Q ss_pred CHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 274 TPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 274 ~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
+..+.+++...+..++..|.+..+-..+
T Consensus 241 s~~~~~Ll~~ll~~~~~~~~~~~~~~~~ 268 (429)
T KOG0595|consen 241 SNPLRELLISLLQRNPKDRISFEDFFDH 268 (429)
T ss_pred cCchhhhhhHHHhcCccccCchHHhhhh
Confidence 7788899999999999999887775544
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-48 Score=324.45 Aligned_cols=252 Identities=33% Similarity=0.524 Sum_probs=226.4
Q ss_pred CcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEE
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 118 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 118 (320)
..+|.+.++||+|+||+|++++.+ ++-+|+|++.+....+....+....|..+|.+++||.|++++..|++.+.+|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 448999999999999999999975 788999999887776666678899999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccC
Q 020888 119 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 198 (320)
Q Consensus 119 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~ 198 (320)
+||+.||.|.-++++++.+++..+..++.+|+.||.|||++| |+|||+||+||++ |.+|.++|+|||++......+
T Consensus 104 ld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~g--IiyRDlKPENILL--d~~GHi~LtDFgL~k~~~~~~ 179 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKG--IIYRDLKPENILL--DEQGHIKLTDFGLCKEDLKDG 179 (357)
T ss_pred EeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHeee--cCCCcEEEeccccchhcccCC
Confidence 999999999999999999999999999999999999999999 9999999999999 999999999999998654433
Q ss_pred ccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHH
Q 020888 199 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 278 (320)
Q Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 278 (320)
. .....+||+.|+|||++.+..++..+|-||||+++|+|++|..||...+..+..+.+.++..... +..++.+.+
T Consensus 180 ~----~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~-p~~ls~~ar 254 (357)
T KOG0598|consen 180 D----ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLP-PGYLSEEAR 254 (357)
T ss_pred C----ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCC-CccCCHHHH
Confidence 2 23447899999999999999999999999999999999999999999999999999988874432 333799999
Q ss_pred HHHHHHhhcCCCCCC----CHHHHHHH
Q 020888 279 ELTEKCWAADMNQRP----SFLDILKR 301 (320)
Q Consensus 279 ~li~~~l~~dp~~Rp----s~~~ll~~ 301 (320)
++++.+|+.||+.|. +++++.+|
T Consensus 255 dll~~LL~rdp~~RLg~~~d~~~ik~H 281 (357)
T KOG0598|consen 255 DLLKKLLKRDPRQRLGGPGDAEEIKRH 281 (357)
T ss_pred HHHHHHhccCHHHhcCCCCChHHhhcC
Confidence 999999999999995 55555443
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-48 Score=337.12 Aligned_cols=256 Identities=28% Similarity=0.469 Sum_probs=230.1
Q ss_pred CCcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcccceeeeEEeCCceE
Q 020888 40 SELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLM 116 (320)
Q Consensus 40 ~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 116 (320)
...+|..++.||+|+|++|++|.+. ++.||+|++.+.........+.+..|-++|.+| .||+|++++-.|+++..+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 3458999999999999999999986 889999999887777776678888999999999 7999999999999999999
Q ss_pred EEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccc
Q 020888 117 LITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 196 (320)
Q Consensus 117 iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~ 196 (320)
+|+||+++|.|.+++...+.+++.....++.+|+.||+|||++| ||||||||+||++ |.++.++|.|||.+..+..
T Consensus 151 FvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~G--IIHRDlKPENILL--d~dmhikITDFGsAK~l~~ 226 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNG--IIHRDLKPENILL--DKDGHIKITDFGSAKILSP 226 (604)
T ss_pred EEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeE--cCCCcEEEeeccccccCCh
Confidence 99999999999999999999999999999999999999999999 9999999999999 9999999999999998865
Q ss_pred cCcc------ce-eec--cCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCC
Q 020888 197 QNSH------DV-YKM--TGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPF 267 (320)
Q Consensus 197 ~~~~------~~-~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~ 267 (320)
.... .. ... ...+||..|.+||.+.+...++.+|+|+|||++|+|+.|..||.+.+.....+.+..-...
T Consensus 227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~- 305 (604)
T KOG0592|consen 227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYE- 305 (604)
T ss_pred hhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhccc-
Confidence 3322 11 111 3467999999999999999999999999999999999999999999999888877765533
Q ss_pred CCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 268 FRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 268 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
.+.+.++..++||+++|..||.+|+|+++|.+|
T Consensus 306 -fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 306 -FPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred -CCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 346689999999999999999999999999887
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=321.32 Aligned_cols=256 Identities=29% Similarity=0.528 Sum_probs=212.3
Q ss_pred CcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCC--ceE
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK--PLM 116 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~ 116 (320)
..++...+.||+|+||.||++.+. +...|+|....... ...+.+.+|+.+|.+++||+|+++++...... .++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~---~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~ 92 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDS---PTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYN 92 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccc---hhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeE
Confidence 557888999999999999999986 58999997754421 11578999999999999999999999854444 699
Q ss_pred EEEecCCCCCHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCC-CCcEEEecCCCcccc
Q 020888 117 LITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS-ADHLKVGDFGLSKLI 194 (320)
Q Consensus 117 iv~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~-~~~~~L~dfg~~~~~ 194 (320)
+.|||+++|+|.+++++.+ ++++..+..+..|+++||+|||++| ++|+||||+||++ +. ++.+||+|||++...
T Consensus 93 i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g--~vH~DiK~~NiLl--~~~~~~~KlaDFG~a~~~ 168 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG--IVHCDIKPANILL--DPSNGDVKLADFGLAKKL 168 (313)
T ss_pred eeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCcccceEEE--eCCCCeEEeccCcccccc
Confidence 9999999999999999866 7999999999999999999999999 9999999999999 77 789999999998876
Q ss_pred cccCccceeeccCCcccccccCccccCcC-CCCCchhHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHHhCCCCCCCCCC
Q 020888 195 KVQNSHDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLAN-YEPYEAAKYVAEGHRPFFRAKG 272 (320)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~ 272 (320)
... ...........||+.|+|||++..+ ....++|||||||++.||+||+.||.. .......-.+......+..+..
T Consensus 169 ~~~-~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ 247 (313)
T KOG0198|consen 169 ESK-GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDS 247 (313)
T ss_pred ccc-cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcc
Confidence 641 1111123346789999999999853 444699999999999999999999998 4555544444433333344566
Q ss_pred CCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHH
Q 020888 273 FTPELRELTEKCWAADMNQRPSFLDILKRLEK 304 (320)
Q Consensus 273 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 304 (320)
++++.++|+..|+..||+.|||+.++|++--.
T Consensus 248 ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~ 279 (313)
T KOG0198|consen 248 LSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL 279 (313)
T ss_pred cCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence 99999999999999999999999999998443
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-46 Score=325.97 Aligned_cols=264 Identities=33% Similarity=0.597 Sum_probs=230.1
Q ss_pred CCCCcCCCCCcccCccceecccCceEEEEEEECCC-ceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEE
Q 020888 32 KCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGT-PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVT 110 (320)
Q Consensus 32 ~~~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~-~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 110 (320)
...|+++. ..+..++.||+|.||.||.+.++++ .||+|.+....... +.+.+|+.++++|+|++|+++++++.
T Consensus 198 ~d~wei~r--~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~----~~f~~Ea~iMk~L~H~~lV~l~gV~~ 271 (468)
T KOG0197|consen 198 RDPWEIPR--EELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSP----EAFLREAQIMKKLRHEKLVKLYGVCT 271 (468)
T ss_pred cCCeeecH--HHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccCh----hHHHHHHHHHHhCcccCeEEEEEEEe
Confidence 55666653 4567788999999999999999966 99999886653332 67779999999999999999999999
Q ss_pred eCCceEEEEecCCCCCHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecC
Q 020888 111 ERKPLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF 188 (320)
Q Consensus 111 ~~~~~~iv~e~~~~~~L~~~~~~--~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~df 188 (320)
.++.+||||||++.|+|.++++. ++.+...+.+.++.||++|++||.+++ +|||||.+.||+| +.+..+||+||
T Consensus 272 ~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~--~IHRDLAARNiLV--~~~~~vKIsDF 347 (468)
T KOG0197|consen 272 KQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN--YIHRDLAARNILV--DEDLVVKISDF 347 (468)
T ss_pred cCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC--ccchhhhhhheee--ccCceEEEccc
Confidence 98899999999999999999986 457999999999999999999999988 9999999999999 88899999999
Q ss_pred CCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCC
Q 020888 189 GLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPF 267 (320)
Q Consensus 189 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~ 267 (320)
|+++.+.+. ......+.--...|+|||.++-+.++.+|||||+|++|+|++| |+.||......+....+.++.+.+
T Consensus 348 GLAr~~~d~---~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp 424 (468)
T KOG0197|consen 348 GLARLIGDD---EYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLP 424 (468)
T ss_pred ccccccCCC---ceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCC
Confidence 999944322 1212222233557999999999999999999999999999999 999999999999999999999887
Q ss_pred CCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcC
Q 020888 268 FRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETL 309 (320)
Q Consensus 268 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 309 (320)
.+ ..+|+++-+++..||..+|++|||++.+...|+++....
T Consensus 425 ~P-~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~ 465 (468)
T KOG0197|consen 425 RP-EGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST 465 (468)
T ss_pred CC-CCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence 54 459999999999999999999999999999999887643
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-45 Score=323.96 Aligned_cols=253 Identities=33% Similarity=0.526 Sum_probs=219.3
Q ss_pred CCCcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCC-c-HHHHHHHHHHHHHHHhCC-CCcccceeeeEEeCC
Q 020888 39 PSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSD-D-RLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERK 113 (320)
Q Consensus 39 ~~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~-~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 113 (320)
.....|.+.+.||+|+||+|+.+.+. +..||+|++...... . ....+.+.+|+.+++.++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 44568999999999999999999875 799999976554221 1 123467778999999998 999999999999999
Q ss_pred ceEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCC-CcEEEecCCCcc
Q 020888 114 PLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSA-DHLKVGDFGLSK 192 (320)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~-~~~~L~dfg~~~ 192 (320)
.+|+||||+.||.|.+++.+.+++.+..+..++.|+++|++|||++| |+||||||+||++ +.+ +++||+|||++.
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~g--i~HRDLK~ENill--d~~~~~~Kl~DFG~s~ 169 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRG--IVHRDLKPENILL--DGNEGNLKLSDFGLSA 169 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEe--cCCCCCEEEecccccc
Confidence 99999999999999999999889999999999999999999999999 9999999999999 777 999999999998
Q ss_pred cccccCccceeeccCCcccccccCccccCcCC-CC-CchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCC
Q 020888 193 LIKVQNSHDVYKMTGETGSYRYMAPEVFKHRK-YD-KKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA 270 (320)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~-~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 270 (320)
.... ........+|++.|+|||++.+.. |+ .++||||+|++||.|++|..||++.+.......+..+.....
T Consensus 170 ~~~~----~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p-- 243 (370)
T KOG0583|consen 170 ISPG----EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIP-- 243 (370)
T ss_pred ccCC----CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCC--
Confidence 7631 112345678999999999999977 76 899999999999999999999999887777777777654433
Q ss_pred CCC-CHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 271 KGF-TPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 271 ~~~-~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
..+ +.+++.++.+||..||.+|+|+.+++.+
T Consensus 244 ~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h 275 (370)
T KOG0583|consen 244 SYLLSPEARSLIEKMLVPDPSTRITLLEILEH 275 (370)
T ss_pred CCcCCHHHHHHHHHHcCCCcccCCCHHHHhhC
Confidence 334 9999999999999999999999999943
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=313.52 Aligned_cols=260 Identities=22% Similarity=0.343 Sum_probs=221.0
Q ss_pred CCCCCcccCccceecccCceEEEEEEECCCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEe----C
Q 020888 37 IDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE----R 112 (320)
Q Consensus 37 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~ 112 (320)
++....+......+|+|+++.||++..+++.||+|.+...........+.+.+|+.++++++|+||+++++++.+ .
T Consensus 15 i~~~~i~~~~~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~ 94 (283)
T PHA02988 15 IESDDIDKYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94 (283)
T ss_pred cCHHHcCCCCCeEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCC
Confidence 343444444447899999999999999999999999877655555556788899999999999999999999866 4
Q ss_pred CceEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcC-CCCeEecCCCCCcEEEeeCCCCcEEEecCCCc
Q 020888 113 KPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE-PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 191 (320)
Q Consensus 113 ~~~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~-g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~ 191 (320)
...++||||+++|+|.+++.....+++.....++.+++.||.+||+. + ++|+||||+||++ +.++.++|+|||++
T Consensus 95 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--~~Hrdlkp~nill--~~~~~~kl~dfg~~ 170 (283)
T PHA02988 95 PRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTN--KPYKNLTSVSFLV--TENYKLKIICHGLE 170 (283)
T ss_pred CceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCC--CCCCcCChhhEEE--CCCCcEEEcccchH
Confidence 56899999999999999998877899999999999999999999985 7 8899999999999 88899999999998
Q ss_pred ccccccCccceeeccCCcccccccCccccCc--CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCC
Q 020888 192 KLIKVQNSHDVYKMTGETGSYRYMAPEVFKH--RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR 269 (320)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 269 (320)
....... ....++..|+|||...+ ..++.++||||||+++|+|++|..||...+..+....+.........
T Consensus 171 ~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~ 243 (283)
T PHA02988 171 KILSSPP-------FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKL 243 (283)
T ss_pred hhhcccc-------ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCC
Confidence 7653321 12356788999999976 67899999999999999999999999988877776666544433334
Q ss_pred CCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHh
Q 020888 270 AKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKE 307 (320)
Q Consensus 270 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 307 (320)
+..+++++++++.+||+.||++|||+.++++.|+.++.
T Consensus 244 ~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 244 PLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred CCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 44579999999999999999999999999999998864
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-45 Score=317.21 Aligned_cols=246 Identities=28% Similarity=0.496 Sum_probs=215.1
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEe
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 120 (320)
+|.+.+.||+|+||.||++.++ ++.+|+|.+...........+.+.+|+++++.++|+||+++++++.+++..++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 81 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLME 81 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEe
Confidence 6889999999999999999986 78899998865433333344678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCcc
Q 020888 121 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 200 (320)
Q Consensus 121 ~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~ 200 (320)
|+++++|.+++...+.+++..+..++.|++.||.|||++| ++|+||||+||++ +.++.++|+|||++......
T Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~NIli--~~~~~~kl~Dfg~~~~~~~~--- 154 (291)
T cd05612 82 YVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKE--IVYRDLKPENILL--DKEGHIKLTDFGFAKKLRDR--- 154 (291)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEE--CCCCCEEEEecCcchhccCC---
Confidence 9999999999998888999999999999999999999998 9999999999999 88899999999998765321
Q ss_pred ceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHH
Q 020888 201 DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELREL 280 (320)
Q Consensus 201 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 280 (320)
.....+++.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+....... +..++..++++
T Consensus 155 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~--~~~~~~~~~~l 228 (291)
T cd05612 155 ----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEF--PRHLDLYAKDL 228 (291)
T ss_pred ----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCC--CccCCHHHHHH
Confidence 122457899999999999999999999999999999999999999888777777766654332 34468999999
Q ss_pred HHHHhhcCCCCCCC-----HHHHHHH
Q 020888 281 TEKCWAADMNQRPS-----FLDILKR 301 (320)
Q Consensus 281 i~~~l~~dp~~Rps-----~~~ll~~ 301 (320)
+++||+.||.+|++ +++++++
T Consensus 229 i~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 229 IKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred HHHHcCCCHHHccCCccCCHHHHhcC
Confidence 99999999999995 8998877
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=312.52 Aligned_cols=248 Identities=27% Similarity=0.502 Sum_probs=228.9
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEe
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 120 (320)
+|.+.+.||.|++|+|-++... ++.||+|.+.++...+.+.+-.+.+|+++++.|+||||+.++++|++.+...+|||
T Consensus 54 RyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivME 133 (668)
T KOG0611|consen 54 RYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVME 133 (668)
T ss_pred HHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEE
Confidence 8999999999999999999873 89999999999988888888899999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCcc
Q 020888 121 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 200 (320)
Q Consensus 121 ~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~ 200 (320)
|..+|.|.||+.+.+.+++.....+++||.+|+.|||+++ ++|+|+|.+||++ |+++++||.|||++-.+....
T Consensus 134 YaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknr--VvHRDLKLENILL--D~N~NiKIADFGLSNly~~~k-- 207 (668)
T KOG0611|consen 134 YASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNR--VVHRDLKLENILL--DQNNNIKIADFGLSNLYADKK-- 207 (668)
T ss_pred ecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhcc--ceecccchhheee--cCCCCeeeeccchhhhhcccc--
Confidence 9999999999999999999999999999999999999988 9999999999999 999999999999987765443
Q ss_pred ceeeccCCcccccccCccccCcCCCC-CchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHH
Q 020888 201 DVYKMTGETGSYRYMAPEVFKHRKYD-KKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRE 279 (320)
Q Consensus 201 ~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 279 (320)
.....+|+|-|++||+.+|..|. +..|.||||++||.|+.|.+||++.+...+.+++..+..... . -|.....
T Consensus 208 ---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP--~-~PSdA~g 281 (668)
T KOG0611|consen 208 ---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREP--E-TPSDASG 281 (668)
T ss_pred ---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCC--C-CCchHHH
Confidence 45678999999999999999875 899999999999999999999999999999999988874432 2 3667899
Q ss_pred HHHHHhhcCCCCCCCHHHHHHHH
Q 020888 280 LTEKCWAADMNQRPSFLDILKRL 302 (320)
Q Consensus 280 li~~~l~~dp~~Rps~~~ll~~L 302 (320)
+|+.||.+||++|.|++++..++
T Consensus 282 LIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 282 LIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred HHHHHHhcCcccchhHHHHhhhh
Confidence 99999999999999999998874
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-45 Score=298.05 Aligned_cols=239 Identities=31% Similarity=0.557 Sum_probs=221.0
Q ss_pred CcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEE
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 118 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 118 (320)
-.+|+..+.||.|+||.|.+++.+ +..+|+|++.+...-.....+...+|..+|+.+.||.++++.+.+.+.+++|+|
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 348999999999999999999986 889999999777666666667888999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccC
Q 020888 119 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 198 (320)
Q Consensus 119 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~ 198 (320)
|||.+||-|..++++.+++++..+..++.|++.||+|||.++ |++||+||+||++ |++|.++|+|||+++.+...
T Consensus 123 meyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~--iiYRDLKPENiLl--D~~G~iKitDFGFAK~v~~r- 197 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLD--IIYRDLKPENLLL--DQNGHIKITDFGFAKRVSGR- 197 (355)
T ss_pred EeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcC--eeeccCChHHeee--ccCCcEEEEeccceEEecCc-
Confidence 999999999999999899999999999999999999999998 9999999999999 99999999999999987642
Q ss_pred ccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHH
Q 020888 199 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 278 (320)
Q Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 278 (320)
....||||.|+|||++.+..+..++|=||||+++|||+.|..||.+..+......+.++.... +..++.+++
T Consensus 198 ------T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~f--P~~fs~~~k 269 (355)
T KOG0616|consen 198 ------TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKF--PSYFSSDAK 269 (355)
T ss_pred ------EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccC--CcccCHHHH
Confidence 345789999999999999999999999999999999999999999999999999999887553 345799999
Q ss_pred HHHHHHhhcCCCCC
Q 020888 279 ELTEKCWAADMNQR 292 (320)
Q Consensus 279 ~li~~~l~~dp~~R 292 (320)
+||+.+|++|-.+|
T Consensus 270 dLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 270 DLLKKLLQVDLTKR 283 (355)
T ss_pred HHHHHHHhhhhHhh
Confidence 99999999999999
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=301.88 Aligned_cols=249 Identities=24% Similarity=0.435 Sum_probs=206.6
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEe
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 120 (320)
.|+.+..+|+|++|.||+|+++ |+-||+|.|..+.. +....+-..+|+++|++++|+|++.++++|.....+++|||
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esed-d~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESED-DPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCc-cHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 5888899999999999999986 88999999876543 34455777899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCc
Q 020888 121 YLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 199 (320)
Q Consensus 121 ~~~~~~L~~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~ 199 (320)
||+. |+.+-+++. ..++...+..+++|++.|+.|||+++ ++|+||||+||++ +.+|.+||||||+++.+..++.
T Consensus 82 ~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n--~IHRDIKPENILi--t~~gvvKLCDFGFAR~L~~pgd 156 (396)
T KOG0593|consen 82 YCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNN--CIHRDIKPENILI--TQNGVVKLCDFGFARTLSAPGD 156 (396)
T ss_pred ecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcC--eecccCChhheEE--ecCCcEEeccchhhHhhcCCcc
Confidence 9988 665556654 35899999999999999999999988 9999999999999 9999999999999998875332
Q ss_pred cceeeccCCcccccccCccccCc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCC--------------
Q 020888 200 HDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH-------------- 264 (320)
Q Consensus 200 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~-------------- 264 (320)
. -...+-|.+|.|||.+.| ..|....||||+||++.||++|..-|.+.+..+....+....
T Consensus 157 ~----YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N 232 (396)
T KOG0593|consen 157 N----YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSN 232 (396)
T ss_pred h----hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccC
Confidence 1 122456899999999988 579999999999999999999999998877665443332110
Q ss_pred ------CCCCC---------CCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 265 ------RPFFR---------AKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 265 ------~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
..+.. ...++.-+.++++.||..||.+|++.++++++
T Consensus 233 ~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 233 PFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred CceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 00000 02345668899999999999999999999876
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-44 Score=306.13 Aligned_cols=263 Identities=27% Similarity=0.455 Sum_probs=229.1
Q ss_pred CCCcCCCCCcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEE
Q 020888 33 CDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVT 110 (320)
Q Consensus 33 ~~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 110 (320)
.+..-......|.+...||.|..++||+++.. +..||+|++.-+... +..+.+.+|+..++.++||||++++..|.
T Consensus 17 ~~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~--~~ld~l~kE~~~msl~~HPNIv~~~~sFv 94 (516)
T KOG0582|consen 17 SEKEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCN--NDLDALRKEVQTMSLIDHPNIVTYHCSFV 94 (516)
T ss_pred ccccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhh--hhHHHHHHHHHHhhhcCCCCcceEEEEEE
Confidence 33344455678999999999999999999885 899999999655443 33689999999999999999999999999
Q ss_pred eCCceEEEEecCCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecC
Q 020888 111 ERKPLMLITEYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF 188 (320)
Q Consensus 111 ~~~~~~iv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~df 188 (320)
.+..+++||+||.+|++.+++... ..+++..+..|+++++.||.|||++| .+|||||+.||++ +.+|.|+|+||
T Consensus 95 v~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G--~IHRdvKAgnILi--~~dG~VkLadF 170 (516)
T KOG0582|consen 95 VDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG--HIHRDVKAGNILI--DSDGTVKLADF 170 (516)
T ss_pred ecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC--ceecccccccEEE--cCCCcEEEcCc
Confidence 999999999999999999999862 35999999999999999999999999 9999999999999 99999999999
Q ss_pred CCcccccccCccceeeccCCcccccccCccccC--cCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCC
Q 020888 189 GLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFK--HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRP 266 (320)
Q Consensus 189 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 266 (320)
|.+-.+...+......+....+++.|+|||++. ...|+.++||||||++..|+.+|..||..+.+.++.-.-.++..+
T Consensus 171 gvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp 250 (516)
T KOG0582|consen 171 GVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPP 250 (516)
T ss_pred eeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCC
Confidence 988877776666666667788999999999954 346899999999999999999999999999999887766666655
Q ss_pred CCCC--------CCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 267 FFRA--------KGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 267 ~~~~--------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
.... ..++.+++.++..||..||.+|||+.+++++
T Consensus 251 ~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 251 TLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred CcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 3222 3457789999999999999999999999876
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=319.50 Aligned_cols=248 Identities=32% Similarity=0.464 Sum_probs=214.3
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEe
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 120 (320)
+|.+.+.||+|++|.||++.+. ++.||+|++.............+.+|++++..++|+||+++++.+..++..|+|||
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 81 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME 81 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence 6899999999999999999985 78899999866543333445678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCcc
Q 020888 121 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 200 (320)
Q Consensus 121 ~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~ 200 (320)
|++|++|.+++...+.+++..+..++.|++.||.|||+.| ++|+||||+||++ +.++.++|+|||++.....
T Consensus 82 ~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~--~~~~~~kL~Dfg~a~~~~~---- 153 (333)
T cd05600 82 YVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG--YIHRDLKPENFLI--DASGHIKLTDFGLSKGIVT---- 153 (333)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEE--CCCCCEEEEeCcCCccccc----
Confidence 9999999999988788999999999999999999999998 9999999999999 8889999999999875533
Q ss_pred ceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCC------CCCC
Q 020888 201 DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA------KGFT 274 (320)
Q Consensus 201 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~------~~~~ 274 (320)
......+++.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+.........+ ..++
T Consensus 154 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s 230 (333)
T cd05600 154 ---YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLS 230 (333)
T ss_pred ---ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccC
Confidence 2234568999999999999999999999999999999999999999887776655554322111111 2468
Q ss_pred HHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 275 PELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 275 ~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
+++++++.+||..+|.+||++++++++
T Consensus 231 ~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 231 DEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred HHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 999999999999999999999999977
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=319.22 Aligned_cols=247 Identities=28% Similarity=0.493 Sum_probs=215.9
Q ss_pred cccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEE
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 119 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 119 (320)
.+|.+.+.||+|++|.||++.++ ++.+|+|++...........+.+.+|+.++++++|+||+++++.+..++..|+||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 47999999999999999999985 7889999886543333334567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCc
Q 020888 120 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 199 (320)
Q Consensus 120 e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~ 199 (320)
||+++++|.+++...+.+++..+..++.|++.||.|||++| ++|+||||+||++ +.++.++|+|||++.......
T Consensus 98 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~NIll--~~~~~~kl~Dfg~~~~~~~~~- 172 (329)
T PTZ00263 98 EFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKD--IIYRDLKPENLLL--DNKGHVKVTDFGFAKKVPDRT- 172 (329)
T ss_pred cCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEE--CCCCCEEEeeccCceEcCCCc-
Confidence 99999999999998888999999999999999999999998 9999999999999 889999999999987653321
Q ss_pred cceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHH
Q 020888 200 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRE 279 (320)
Q Consensus 200 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 279 (320)
....+++.|+|||++.+..++.++|+|||||++|+|++|..||......+....+..+... .+..++..+++
T Consensus 173 ------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~--~p~~~~~~~~~ 244 (329)
T PTZ00263 173 ------FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLK--FPNWFDGRARD 244 (329)
T ss_pred ------ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcC--CCCCCCHHHHH
Confidence 1246889999999999999999999999999999999999999988877777766665432 23447899999
Q ss_pred HHHHHhhcCCCCCCC-----HHHHHHH
Q 020888 280 LTEKCWAADMNQRPS-----FLDILKR 301 (320)
Q Consensus 280 li~~~l~~dp~~Rps-----~~~ll~~ 301 (320)
++.+||+.||.+|++ +++++.+
T Consensus 245 li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 245 LVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred HHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 999999999999986 7888866
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=315.98 Aligned_cols=259 Identities=29% Similarity=0.549 Sum_probs=209.0
Q ss_pred CcccCccceecccCceEEEEEEEC-------CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcccceeeeEEe-
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTE- 111 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~-------~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~- 111 (320)
..+|.+.+.||.|+||.||++.+. ++.||+|.+..... ......+.+|+++++.+ +|+||+++++.+..
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGAT--ASEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccc--hHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 357999999999999999999742 46799998864322 22346788999999999 89999999998765
Q ss_pred CCceEEEEecCCCCCHHHHHHHh---------------------------------------------------------
Q 020888 112 RKPLMLITEYLRGGDLHKYLKEK--------------------------------------------------------- 134 (320)
Q Consensus 112 ~~~~~iv~e~~~~~~L~~~~~~~--------------------------------------------------------- 134 (320)
+..++++|||+++|+|.+++...
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 44589999999999999998742
Q ss_pred -----CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCccceeeccCCc
Q 020888 135 -----GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET 209 (320)
Q Consensus 135 -----~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~ 209 (320)
.++++..+..++.|++.||.|||+.| |+|+||||+||++ +.++.++|+|||++..+..... ........
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDiKp~Nil~--~~~~~~kl~DfG~a~~~~~~~~--~~~~~~~~ 237 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASRK--CIHRDLAARNILL--SENNVVKICDFGLARDIYKDPD--YVRKGSAR 237 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCccceEEE--cCCCcEEEeecccccccccCcc--hhcccCCC
Confidence 23778889999999999999999988 9999999999999 7888999999999876543211 11112234
Q ss_pred ccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHH-HHHHhCCCCCCCCCCCCHHHHHHHHHHhhc
Q 020888 210 GSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAA-KYVAEGHRPFFRAKGFTPELRELTEKCWAA 287 (320)
Q Consensus 210 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 287 (320)
++..|+|||++.+..++.++||||||+++|++++ |..||......+.. ..+..+.. ...+..+++++++++.+||+.
T Consensus 238 ~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~ 316 (338)
T cd05102 238 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTR-MRAPENATPEIYRIMLACWQG 316 (338)
T ss_pred CCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCC-CCCCCCCCHHHHHHHHHHccC
Confidence 5678999999999999999999999999999997 99999876543333 33333332 233456789999999999999
Q ss_pred CCCCCCCHHHHHHHHHHHHhc
Q 020888 288 DMNQRPSFLDILKRLEKIKET 308 (320)
Q Consensus 288 dp~~Rps~~~ll~~L~~~~~~ 308 (320)
||.+|||+.++++.|+++...
T Consensus 317 dp~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 317 DPKERPTFSALVEILGDLLQE 337 (338)
T ss_pred ChhhCcCHHHHHHHHHHHHhc
Confidence 999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=323.93 Aligned_cols=248 Identities=30% Similarity=0.473 Sum_probs=224.5
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEe
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 120 (320)
-|.+++-||.|+.|.|-++++. |+.+|+|++.+...........+.+|+-+++-+.|||++.+++++++...+|+|.|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence 4777899999999999999974 99999999977644444445778999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCcc
Q 020888 121 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 200 (320)
Q Consensus 121 ~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~ 200 (320)
|++||-|.+++-+.+++++......++||+.|+.|||..+ |+|+|+||+|+++ +..+++||+|||+|..-..+.
T Consensus 93 yv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~--icHRDLKpENlLL--d~~~nIKIADFGMAsLe~~gk-- 166 (786)
T KOG0588|consen 93 YVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFN--ICHRDLKPENLLL--DVKNNIKIADFGMASLEVPGK-- 166 (786)
T ss_pred ecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhc--ceeccCCchhhhh--hcccCEeeeccceeecccCCc--
Confidence 9999999999999999999999999999999999999999 9999999999999 888889999999997544332
Q ss_pred ceeeccCCcccccccCccccCcCCCC-CchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHH
Q 020888 201 DVYKMTGETGSYRYMAPEVFKHRKYD-KKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRE 279 (320)
Q Consensus 201 ~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 279 (320)
-..+.||+|.|+|||++.|..|+ .++||||.|++||.|++|+.||++.+-......+.++.... +..++.+.++
T Consensus 167 ---lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~M--Ps~Is~eaQd 241 (786)
T KOG0588|consen 167 ---LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEM--PSNISSEAQD 241 (786)
T ss_pred ---cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccC--CCcCCHHHHH
Confidence 45567999999999999999986 79999999999999999999999998888888888888664 3668999999
Q ss_pred HHHHHhhcCCCCCCCHHHHHHH
Q 020888 280 LTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 280 li~~~l~~dp~~Rps~~~ll~~ 301 (320)
||.+||.+||++|.|++++++|
T Consensus 242 LLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 242 LLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred HHHHHhccCccccccHHHHhhC
Confidence 9999999999999999999988
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-44 Score=317.04 Aligned_cols=244 Identities=25% Similarity=0.425 Sum_probs=209.5
Q ss_pred ceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEecCCCC
Q 020888 48 AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGG 125 (320)
Q Consensus 48 ~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~ 125 (320)
+.||+|+||.||++.++ ++.+|+|++.............+.+|+++++.++|+||+++++.+...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999875 7889999886544333344467788999999999999999999999999999999999999
Q ss_pred CHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCccceeec
Q 020888 126 DLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKM 205 (320)
Q Consensus 126 ~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~~~~~~ 205 (320)
+|.+++...+.+++..+..++.||+.||+|||+.| |+|+||||+||++ +.++.++|+|||++........ ..
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--ivHrDlkp~NIll--~~~~~~kl~DfG~a~~~~~~~~----~~ 152 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCD--VVYRDLKLENLML--DKDGHIKITDFGLCKEGISDGA----TM 152 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEE--CCCCCEEEeeCCCCcccccCCC----cc
Confidence 99999988888999999999999999999999999 9999999999999 8889999999999865322111 12
Q ss_pred cCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHh
Q 020888 206 TGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCW 285 (320)
Q Consensus 206 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 285 (320)
....|++.|+|||++.+..++.++|+|||||++|+|++|..||...+.......+...... .+..++.+++++|.+||
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~--~p~~~~~~~~~li~~~L 230 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR--FPRTLSPEAKSLLAGLL 230 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCC--CCCCCCHHHHHHHHHHc
Confidence 2346899999999999999999999999999999999999999887776666655544322 23558999999999999
Q ss_pred hcCCCCCC-----CHHHHHHH
Q 020888 286 AADMNQRP-----SFLDILKR 301 (320)
Q Consensus 286 ~~dp~~Rp-----s~~~ll~~ 301 (320)
..||++|| ++.+++++
T Consensus 231 ~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 231 KKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred cCCHHHcCCCCCCCHHHHHcC
Confidence 99999999 79999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-45 Score=319.26 Aligned_cols=248 Identities=31% Similarity=0.518 Sum_probs=224.1
Q ss_pred cccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEE
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 119 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 119 (320)
.+|.+.+.||+|+||.||+++.+ .+.||+|.+.+....+ ..++.+.+|+++++.++||||+.++++|+.....++|.
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~-k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt 80 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNE-KELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT 80 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCch-HHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence 37899999999999999999976 6889999887765444 34588999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCc
Q 020888 120 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 199 (320)
Q Consensus 120 e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~ 199 (320)
||+.| +|..+++..+.++++.+..++.++..||.|||+.+ |.|+|+||.||++ +.++.+|+||||+++.....
T Consensus 81 e~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~r--ilhrd~kPqniLl--~~~~~~KlcdFg~Ar~m~~~-- 153 (808)
T KOG0597|consen 81 EYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNR--ILHRDMKPQNILL--EKGGTLKLCDFGLARAMSTN-- 153 (808)
T ss_pred hhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcC--cccccCCcceeee--cCCCceeechhhhhhhcccC--
Confidence 99977 99999999999999999999999999999999988 9999999999999 99999999999999977653
Q ss_pred cceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHH
Q 020888 200 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRE 279 (320)
Q Consensus 200 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 279 (320)
.......-|||.|+|||...+..++..+|+|||||++||+++|+.||....-....+.+..+...+. ...+..+.+
T Consensus 154 --t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p--~~~S~~f~n 229 (808)
T KOG0597|consen 154 --TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPP--STASSSFVN 229 (808)
T ss_pred --ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCc--ccccHHHHH
Confidence 2234556799999999999999999999999999999999999999998888888888877665543 467999999
Q ss_pred HHHHHhhcCCCCCCCHHHHHHH
Q 020888 280 LTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 280 li~~~l~~dp~~Rps~~~ll~~ 301 (320)
|+..+|..||..|.|..+++.|
T Consensus 230 fl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 230 FLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred HHHHHhhcChhhcccHHHHhcC
Confidence 9999999999999999999876
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=318.26 Aligned_cols=247 Identities=31% Similarity=0.561 Sum_probs=221.4
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEe
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 120 (320)
.|.....||+|..|.||.+... ++.||+|.+........ +.+.+|+.+++..+|+||+++++.+..++.+++|||
T Consensus 274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~k---eLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVME 350 (550)
T KOG0578|consen 274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKK---ELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVME 350 (550)
T ss_pred hhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCch---hhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEe
Confidence 7888999999999999999875 67899998865544443 788999999999999999999999988899999999
Q ss_pred cCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCcc
Q 020888 121 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 200 (320)
Q Consensus 121 ~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~ 200 (320)
|++||+|.|.+... .+++.++..|++++++||+|||.+| |+|+|||.+||++ +.+|.+||+|||+|..+.....
T Consensus 351 ym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~g--IiHrDIKSDnILL--~~~g~vKltDFGFcaqi~~~~~- 424 (550)
T KOG0578|consen 351 YMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARG--IIHRDIKSDNILL--TMDGSVKLTDFGFCAQISEEQS- 424 (550)
T ss_pred ecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcc--eeeeccccceeEe--ccCCcEEEeeeeeeeccccccC-
Confidence 99999999998764 5899999999999999999999999 9999999999999 8889999999999988866543
Q ss_pred ceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCC-CCCCCHHHHH
Q 020888 201 DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR-AKGFTPELRE 279 (320)
Q Consensus 201 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~ 279 (320)
.-....|||.|+|||+.....|.++.||||||++++||+.|+.||-..++......+..+-.+... +..++.++++
T Consensus 425 ---KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kd 501 (550)
T KOG0578|consen 425 ---KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKD 501 (550)
T ss_pred ---ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHH
Confidence 334568999999999999999999999999999999999999999988888777777766555444 4679999999
Q ss_pred HHHHHhhcCCCCCCCHHHHHHH
Q 020888 280 LTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 280 li~~~l~~dp~~Rps~~~ll~~ 301 (320)
|+.+||..|++.|+|+.+||+|
T Consensus 502 FL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 502 FLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred HHHHHhhcchhcCCCHHHHhcC
Confidence 9999999999999999999987
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=308.68 Aligned_cols=249 Identities=26% Similarity=0.446 Sum_probs=210.3
Q ss_pred CcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEE
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 118 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 118 (320)
..+|++.+.||+|++|.||++.+. +..+++|.+.... .......+.+|+++++.++|+||+++++++..++..++|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 468999999999999999999986 6779999876432 233447799999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcC-CCCeEecCCCCCcEEEeeCCCCcEEEecCCCccccccc
Q 020888 119 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE-PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 197 (320)
Q Consensus 119 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~-g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~ 197 (320)
|||+++++|.+++.....+++..+..++.|++.||.|||+. + ++|+||||+||++ +.++.++|+|||++......
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~--ivH~dlkp~Nil~--~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 82 MEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQ--IMHRDVKPSNILV--NSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred eecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCC--EEcCCCChhhEEE--cCCCcEEEccCccccccccc
Confidence 99999999999998877899999999999999999999985 6 9999999999999 88889999999998765432
Q ss_pred CccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH-----------------
Q 020888 198 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYV----------------- 260 (320)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~----------------- 260 (320)
. .....+++.|+|||++.+..++.++|+|||||++|++++|..||...+..+....+
T Consensus 158 ~------~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (331)
T cd06649 158 M------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISP 231 (331)
T ss_pred c------cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCc
Confidence 1 22346889999999999999999999999999999999999999766554432221
Q ss_pred -----------------------------HhCCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 261 -----------------------------AEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 261 -----------------------------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
.....+......++.++++|+.+||..||++|||+++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 232 RPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred ccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 11122222223468899999999999999999999999987
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-44 Score=319.46 Aligned_cols=254 Identities=30% Similarity=0.464 Sum_probs=216.3
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEe
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 120 (320)
+|.+.+.||+|++|+||++.+. ++.+|+|++.............+.+|++++..++|+||+++++.+.+++..++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVME 81 (350)
T ss_pred CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEc
Confidence 6899999999999999999986 88999999865443333344678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCcc
Q 020888 121 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 200 (320)
Q Consensus 121 ~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~ 200 (320)
|+++++|.+++...+.+++..++.++.|++.||.|||+.| ++|+||||+||++ +.++.++|+|||++.........
T Consensus 82 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--iiH~Dlkp~NIll--~~~~~~kL~Dfg~~~~~~~~~~~ 157 (350)
T cd05573 82 YMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLG--FIHRDIKPDNILI--DADGHIKLADFGLCKKMNKAKDR 157 (350)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEE--CCCCCEEeecCCCCccCcccCcc
Confidence 9999999999988788999999999999999999999998 9999999999999 88899999999998766543200
Q ss_pred -------------------------ceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 020888 201 -------------------------DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYE 255 (320)
Q Consensus 201 -------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~ 255 (320)
.........+++.|+|||++.+..++.++|||||||++|+|++|..||...+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~ 237 (350)
T cd05573 158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQE 237 (350)
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHH
Confidence 0011233468999999999999999999999999999999999999999888777
Q ss_pred HHHHHHhC--CCCCCCCCCCCHHHHHHHHHHhhcCCCCCCC-HHHHHHH
Q 020888 256 AAKYVAEG--HRPFFRAKGFTPELRELTEKCWAADMNQRPS-FLDILKR 301 (320)
Q Consensus 256 ~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-~~~ll~~ 301 (320)
....+... .........++++++++|.+|+. ||.+||+ +++++++
T Consensus 238 ~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 238 TYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 66666552 22222223479999999999997 9999999 9999986
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=312.69 Aligned_cols=248 Identities=27% Similarity=0.436 Sum_probs=204.4
Q ss_pred cccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCC-CCcccceeeeEEeCC-ceEE
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERK-PLML 117 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~-~~~i 117 (320)
.+|.+++.||.|+||.||+++.. +..||+|..++.... .+.+-. .+|++.|++++ |+||+++.+++-+.+ .+|+
T Consensus 10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~n-LREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMN-LREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHH-HHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 47999999999999999999875 788999988665544 333333 45999999998 999999999997766 8999
Q ss_pred EEecCCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccc
Q 020888 118 ITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 196 (320)
Q Consensus 118 v~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~ 196 (320)
||||| ..+|-++++.+ ..+++..+..|++||++||+|+|++| ++|||+||+||++ ..+..+||+|||+|+.+..
T Consensus 88 VfE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~G--fFHRDlKPENiLi--~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 88 VFEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHG--FFHRDLKPENILI--SGNDVIKIADFGLAREVRS 162 (538)
T ss_pred eHHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcC--cccccCChhheEe--cccceeEeccccccccccc
Confidence 99999 55999999865 46999999999999999999999999 9999999999999 7788999999999998765
Q ss_pred cCccceeeccCCcccccccCccccC-cCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhC------------
Q 020888 197 QNSHDVYKMTGETGSYRYMAPEVFK-HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEG------------ 263 (320)
Q Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~------------ 263 (320)
.+ +-...+.|.+|+|||++. .+.|+.+.||||+||+++|+.+-+..|.+.+..+....+.+-
T Consensus 163 kp-----PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg 237 (538)
T KOG0661|consen 163 KP-----PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEG 237 (538)
T ss_pred CC-----CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhH
Confidence 43 223457899999999875 567899999999999999999988888877654433222210
Q ss_pred ---------CCCCCCC-------CCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 264 ---------HRPFFRA-------KGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 264 ---------~~~~~~~-------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
..+...+ ..++.+..++|.+||..||.+|||+.+++++
T Consensus 238 ~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 238 YNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 0111111 2368899999999999999999999999987
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=312.01 Aligned_cols=244 Identities=25% Similarity=0.421 Sum_probs=208.9
Q ss_pred ceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEecCCCC
Q 020888 48 AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGG 125 (320)
Q Consensus 48 ~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~ 125 (320)
+.||+|+||.||++.+. ++.+|+|.+.............+.+|+++++.++||||+++++.+...+..|+||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46899999999999875 7889999886654333344567788999999999999999999999999999999999999
Q ss_pred CHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCccceeec
Q 020888 126 DLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKM 205 (320)
Q Consensus 126 ~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~~~~~~ 205 (320)
+|.+++...+.+++..++.++.||+.||.|||++| ++|+||||+||++ +.++.++|+|||++....... ...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll--~~~~~~kL~Dfg~~~~~~~~~----~~~ 152 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLML--DKDGHIKITDFGLCKEGISDG----ATM 152 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEE--cCCCCEEecccHHhccccCCC----Ccc
Confidence 99999988778999999999999999999999998 9999999999999 888999999999876432211 112
Q ss_pred cCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHh
Q 020888 206 TGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCW 285 (320)
Q Consensus 206 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 285 (320)
....+++.|+|||++.+..++.++|+|||||++|+|++|..||...+.......+...... .+..++++++++|.+||
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~--~p~~~~~~~~~li~~~L 230 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR--FPRTLSPEAKSLLAGLL 230 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC--CCCCCCHHHHHHHHHHc
Confidence 2346899999999999999999999999999999999999999888777666665544332 23458999999999999
Q ss_pred hcCCCCCC-----CHHHHHHH
Q 020888 286 AADMNQRP-----SFLDILKR 301 (320)
Q Consensus 286 ~~dp~~Rp-----s~~~ll~~ 301 (320)
..||.+|+ ++.+++++
T Consensus 231 ~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 231 KKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred cCCHHHhCCCCCCCHHHHHcC
Confidence 99999998 89998875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=315.50 Aligned_cols=248 Identities=27% Similarity=0.447 Sum_probs=215.4
Q ss_pred CcccCccceecccCceEEEEEEEC---CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEE
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR---GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLML 117 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~---~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 117 (320)
..+|.+.+.||+|+||.||++.+. +..+|+|.+.............+.+|+++++.++||||+++++++..++..|+
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 447999999999999999999864 25799998865433333345678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccccccc
Q 020888 118 ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 197 (320)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~ 197 (320)
||||+++++|.+++...+.+++..+..++.|++.||.|||+.| ++|+||||+||++ +.++.++|+|||++......
T Consensus 109 v~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl--~~~~~ikL~DFG~a~~~~~~ 184 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLN--IVYRDLKPENLLL--DKDGFIKMTDFGFAKVVDTR 184 (340)
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEE--CCCCCEEEecCCCCeecCCC
Confidence 9999999999999998888999999999999999999999998 9999999999999 88899999999998765321
Q ss_pred CccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHH
Q 020888 198 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPEL 277 (320)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 277 (320)
.....||+.|+|||++.+..++.++|+|||||++|+|++|..||...+.......+...... .+..+++.+
T Consensus 185 -------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~--~p~~~~~~~ 255 (340)
T PTZ00426 185 -------TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIY--FPKFLDNNC 255 (340)
T ss_pred -------cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC--CCCCCCHHH
Confidence 12346899999999999988999999999999999999999999988877777766665432 234579999
Q ss_pred HHHHHHHhhcCCCCCC-----CHHHHHHH
Q 020888 278 RELTEKCWAADMNQRP-----SFLDILKR 301 (320)
Q Consensus 278 ~~li~~~l~~dp~~Rp-----s~~~ll~~ 301 (320)
++++++||+.||++|+ |+++++++
T Consensus 256 ~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 256 KHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred HHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 9999999999999995 89999876
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=310.88 Aligned_cols=257 Identities=30% Similarity=0.466 Sum_probs=222.9
Q ss_pred CCcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEE
Q 020888 40 SELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLML 117 (320)
Q Consensus 40 ~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 117 (320)
...+|.+++.||+|+||.||+|+.+ |..+|+|++.++.-.....++-+..|-.+|...+.+.|++++..|++.+++|+
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 4568999999999999999999975 89999999988877776677788889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccccccc
Q 020888 118 ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 197 (320)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~ 197 (320)
||||++||++..++.+.+.|++..+..++.+++.|++.+|+.| ++|+||||+|+++ |..|.+||+|||++..+...
T Consensus 219 iMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~g--yIHRDIKPdNlLi--D~~GHiKLSDFGLs~gl~~~ 294 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLG--YIHRDIKPDNLLI--DAKGHIKLSDFGLSTGLDKK 294 (550)
T ss_pred EEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcC--cccccCChhheee--cCCCCEeeccccccchhhhh
Confidence 9999999999999999899999999999999999999999999 9999999999999 99999999999998755321
Q ss_pred Ccc------------------ceee-------------------------ccCCcccccccCccccCcCCCCCchhHHHH
Q 020888 198 NSH------------------DVYK-------------------------MTGETGSYRYMAPEVFKHRKYDKKVDVFSF 234 (320)
Q Consensus 198 ~~~------------------~~~~-------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 234 (320)
... .... ....+|||-|+|||++.+..++..+|.|||
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL 374 (550)
T KOG0605|consen 295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL 374 (550)
T ss_pred hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence 000 0000 012369999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHHhCCCC--CCCCCCCCHHHHHHHHHHhhcCCCCCC---CHHHHHHH
Q 020888 235 AMILYEMLEGEPPLANYEPYEAAKYVAEGHRP--FFRAKGFTPELRELTEKCWAADMNQRP---SFLDILKR 301 (320)
Q Consensus 235 G~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~~ll~~ 301 (320)
||++|||+.|..||...++.+..+.+..-... ......++++.++||.+||. ||+.|. +++||.+|
T Consensus 375 G~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~H 445 (550)
T KOG0605|consen 375 GCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKH 445 (550)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcC
Confidence 99999999999999999999988877755422 22234578999999999999 999995 67887665
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=304.37 Aligned_cols=250 Identities=24% Similarity=0.402 Sum_probs=205.2
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEe
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 120 (320)
.|...+.||+|+||.||++.+. ++.+|+|.+.............+.+|++++..++|++++++++.+..++..++++|
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 3778899999999999999874 78999998865443333333567789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccC
Q 020888 121 YLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 198 (320)
Q Consensus 121 ~~~~~~L~~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~ 198 (320)
|+++++|.+++... ..+++..+..++.|++.||.|||+.| ++|+||||+||++ +.++.++|+|||++.......
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nill--~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER--IVYRDLKPENILL--DDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEE--CCCCCEEEeeCCCcEEcCCCC
Confidence 99999999887643 36899999999999999999999998 9999999999999 888899999999987653221
Q ss_pred ccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhC--CCCCCCCCCCCHH
Q 020888 199 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEG--HRPFFRAKGFTPE 276 (320)
Q Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 276 (320)
......++..|+|||.+.+..++.++|||||||++|++++|..||...........+... ......+..++.+
T Consensus 157 -----~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 231 (285)
T cd05631 157 -----TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSED 231 (285)
T ss_pred -----eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHH
Confidence 112346899999999999999999999999999999999999999875432222111111 1111223457999
Q ss_pred HHHHHHHHhhcCCCCCCC-----HHHHHHH
Q 020888 277 LRELTEKCWAADMNQRPS-----FLDILKR 301 (320)
Q Consensus 277 l~~li~~~l~~dp~~Rps-----~~~ll~~ 301 (320)
+.+++++||+.||.+||+ +++++++
T Consensus 232 ~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 232 AKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred HHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 999999999999999997 8898886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=314.94 Aligned_cols=254 Identities=29% Similarity=0.472 Sum_probs=211.2
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEe
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 120 (320)
+|++.+.||+|+||+||++.+. ++.+|+|++.............+.+|+.++..++|++|+++++.+.++..+|+|||
T Consensus 2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E 81 (363)
T cd05628 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIME 81 (363)
T ss_pred CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEc
Confidence 6889999999999999999875 78899998865443334445678889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCcc
Q 020888 121 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 200 (320)
Q Consensus 121 ~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~ 200 (320)
|++|++|.+++..++.+++..+..++.|++.||.|||++| |+||||||+||++ +.++.++|+|||++..+......
T Consensus 82 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--ivHrDlKp~NILi--~~~~~vkL~DFGla~~~~~~~~~ 157 (363)
T cd05628 82 FLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLG--FIHRDIKPDNLLL--DSKGHVKLSDFGLCTGLKKAHRT 157 (363)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEE--CCCCCEEEeeccCcccccccccc
Confidence 9999999999988888999999999999999999999998 9999999999999 88899999999998755321110
Q ss_pred ce-------------------------------eeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCC
Q 020888 201 DV-------------------------------YKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLA 249 (320)
Q Consensus 201 ~~-------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~ 249 (320)
.. ......+||+.|+|||++.+..++.++|+|||||++|+|++|..||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~ 237 (363)
T cd05628 158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (363)
T ss_pred cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCC
Confidence 00 00123468999999999999999999999999999999999999999
Q ss_pred CCChHHHHHHHHhCCCCC-C-CCCCCCHHHHHHHHHHhhcCCC---CCCCHHHHHHH
Q 020888 250 NYEPYEAAKYVAEGHRPF-F-RAKGFTPELRELTEKCWAADMN---QRPSFLDILKR 301 (320)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~-~-~~~~~~~~l~~li~~~l~~dp~---~Rps~~~ll~~ 301 (320)
.....+....+....... . ....+++++++++.+|+. +|. .||++++++++
T Consensus 238 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 238 SETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCC
Confidence 888777766665432211 1 123468999999999774 344 46899999987
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=317.65 Aligned_cols=254 Identities=29% Similarity=0.507 Sum_probs=213.4
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEe
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 120 (320)
+|.+.+.||.|+||+||++.+. ++.+|+|++.............+.+|+++++.++|+||+++++.+..++..|+|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (364)
T cd05599 2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIME 81 (364)
T ss_pred CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEEC
Confidence 6899999999999999999985 78899999865433333444678889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCcc
Q 020888 121 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 200 (320)
Q Consensus 121 ~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~ 200 (320)
|++|++|.+++...+.+++..+..++.|++.||.|||+.| ++|+||||+||++ +.++.++|+|||++..+......
T Consensus 82 ~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~--~~~~~~kl~Dfg~~~~~~~~~~~ 157 (364)
T cd05599 82 YLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLG--YIHRDIKPDNLLL--DAKGHIKLSDFGLCTGLKKSHRT 157 (364)
T ss_pred CCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEE--CCCCCEEEeecccceeccccccc
Confidence 9999999999988788999999999999999999999998 9999999999999 88999999999998765322110
Q ss_pred cee----------------------------------eccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCC
Q 020888 201 DVY----------------------------------KMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEP 246 (320)
Q Consensus 201 ~~~----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~ 246 (320)
... ......||+.|+|||++.+..++.++|+|||||++|+|++|..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~ 237 (364)
T cd05599 158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYP 237 (364)
T ss_pred cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCC
Confidence 000 0112458999999999999999999999999999999999999
Q ss_pred CCCCCChHHHHHHHHhCCCCCC--CCCCCCHHHHHHHHHHhhcCCCCCCC---HHHHHHH
Q 020888 247 PLANYEPYEAAKYVAEGHRPFF--RAKGFTPELRELTEKCWAADMNQRPS---FLDILKR 301 (320)
Q Consensus 247 p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps---~~~ll~~ 301 (320)
||...+..+....+........ ....++++++++|.+|+. +|.+|++ +++++++
T Consensus 238 Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 238 PFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 9998887776665654332211 223578999999999996 9999987 9999885
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=311.19 Aligned_cols=244 Identities=25% Similarity=0.423 Sum_probs=209.1
Q ss_pred ceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEecCCCC
Q 020888 48 AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGG 125 (320)
Q Consensus 48 ~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~ 125 (320)
+.||+|+||.||++.+. ++.+|+|++.............+.+|+++++.++|+||+++.+.+..++..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999875 7889999987654444444577888999999999999999999999999999999999999
Q ss_pred CHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCccceeec
Q 020888 126 DLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKM 205 (320)
Q Consensus 126 ~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~~~~~~ 205 (320)
+|.+++.....+++..+..++.||+.||.|||++| |+|+||||+||++ +.++.++|+|||++....... ...
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~NIll--~~~~~~kL~DfG~~~~~~~~~----~~~ 152 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK--IVYRDLKLENLML--DKDGHIKITDFGLCKEGITDA----ATM 152 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeEE--CCCCcEEEecCcCCccCCCcc----ccc
Confidence 99999988778999999999999999999999998 9999999999999 888999999999986432211 112
Q ss_pred cCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHh
Q 020888 206 TGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCW 285 (320)
Q Consensus 206 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 285 (320)
....+++.|+|||.+.+..++.++|||||||++|+|++|..||...+..+....+...... .+..++.++.++|.+||
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~--~p~~~~~~~~~li~~~L 230 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIK--FPRTLSADAKSLLSGLL 230 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCcc--CCCCCCHHHHHHHHHHc
Confidence 2346899999999999999999999999999999999999999887776666555443322 23457999999999999
Q ss_pred hcCCCCCC-----CHHHHHHH
Q 020888 286 AADMNQRP-----SFLDILKR 301 (320)
Q Consensus 286 ~~dp~~Rp-----s~~~ll~~ 301 (320)
..||.+|+ ++.+++++
T Consensus 231 ~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 231 IKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCHHHcCCCCCCCHHHHhcC
Confidence 99999997 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=309.55 Aligned_cols=242 Identities=29% Similarity=0.442 Sum_probs=207.0
Q ss_pred ecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEecCCCCCH
Q 020888 50 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDL 127 (320)
Q Consensus 50 lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L 127 (320)
||+|+||.||++.+. ++.+|+|.+.............+.+|+++++.++|+||+++++.+...+..|+||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999985 678999988654333334456788899999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCccceeeccC
Q 020888 128 HKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG 207 (320)
Q Consensus 128 ~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~ 207 (320)
.+++...+.+++..+..++.|++.||.|||++| ++|+||||+||++ +.++.++|+|||++........ ....
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~HrDlkp~Nili--~~~~~~kl~Dfg~~~~~~~~~~----~~~~ 152 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFN--VIYRDLKPENILL--DYQGHIALCDFGLCKLNMKDDD----KTNT 152 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHeEE--CCCCcEEEEECcccccCccCCC----cccc
Confidence 999988788999999999999999999999998 9999999999999 8889999999999875332211 1233
Q ss_pred CcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHhhc
Q 020888 208 ETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAA 287 (320)
Q Consensus 208 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 287 (320)
..|++.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+...... .+..+++++++++.+||..
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~ 230 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLR--FPDGFDRDAKDLLIGLLSR 230 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCC--CCCcCCHHHHHHHHHHcCC
Confidence 46899999999999999999999999999999999999999988777766666554332 3355899999999999999
Q ss_pred CCCCCCC---HHHHHHH
Q 020888 288 DMNQRPS---FLDILKR 301 (320)
Q Consensus 288 dp~~Rps---~~~ll~~ 301 (320)
||.+||+ +.+++.+
T Consensus 231 dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 231 DPTRRLGYNGAQEIKNH 247 (312)
T ss_pred CHHHcCCCCCHHHHHcC
Confidence 9999974 6777665
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=316.17 Aligned_cols=255 Identities=25% Similarity=0.376 Sum_probs=210.6
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEe
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 120 (320)
.|.+++.||+|+||+||++.+. ++.+|+|++.............+.+|+++++.++|+||+++++.+.+.+..|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5889999999999999999885 78899999876544444555788999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCcc
Q 020888 121 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 200 (320)
Q Consensus 121 ~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~ 200 (320)
|++|++|.+++.+.+.+++..+..++.|++.||.|||+.| |+|+||||+||++ +.++.++|+|||++.........
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDlKp~Nili--~~~~~~kL~DFGl~~~~~~~~~~ 157 (381)
T cd05626 82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMG--FIHRDIKPDNILI--DLDGHIKLTDFGLCTGFRWTHNS 157 (381)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCcHHHEEE--CCCCCEEEeeCcCCccccccccc
Confidence 9999999999988888999999999999999999999998 9999999999999 88899999999987543211000
Q ss_pred c-------------------------------------------eeeccCCcccccccCccccCcCCCCCchhHHHHHHH
Q 020888 201 D-------------------------------------------VYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMI 237 (320)
Q Consensus 201 ~-------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~ 237 (320)
. ........||+.|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i 237 (381)
T cd05626 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237 (381)
T ss_pred ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence 0 000123468999999999999899999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHHhCC--CCCCCCCCCCHHHHHHHHHHh--hcCCCCCCCHHHHHHH
Q 020888 238 LYEMLEGEPPLANYEPYEAAKYVAEGH--RPFFRAKGFTPELRELTEKCW--AADMNQRPSFLDILKR 301 (320)
Q Consensus 238 l~~ll~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l--~~dp~~Rps~~~ll~~ 301 (320)
+|+|++|..||...+..+....+.... ........++++++++|.+|+ ..++..|+++++++++
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 238 LFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred HHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 999999999998877666555444322 122222357999999999965 4455569999999987
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=307.21 Aligned_cols=250 Identities=27% Similarity=0.458 Sum_probs=210.2
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeC--CceEEE
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER--KPLMLI 118 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~iv 118 (320)
.|+.+..||+|+||.||++++. ++-||+|.+..+....... ....+||.+|++|+||||+++.+++.+. ...|+|
T Consensus 118 ~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~-~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 118 SFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFP-ITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcch-HHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 7889999999999999999986 7889999887766544433 5667799999999999999999998765 789999
Q ss_pred EecCCCCCHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccccccc
Q 020888 119 TEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 197 (320)
Q Consensus 119 ~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~ 197 (320)
||||++ +|.-++...+ .+++.++.-++.||+.||+|||.+| +.|+|||.+||++ |++|.+||.|||+++.+...
T Consensus 197 FeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g--vlHRDIK~SNiLi--dn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG--VLHRDIKGSNILI--DNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred Eecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC--eeeccccccceEE--cCCCCEEeccccceeeccCC
Confidence 999988 9999888633 6999999999999999999999999 9999999999999 99999999999999877654
Q ss_pred CccceeeccCCcccccccCccccCcC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhC------------C
Q 020888 198 NSHDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEG------------H 264 (320)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~------------~ 264 (320)
... .....+.|++|.|||.+.|. .|+.+.|+||.||+|.||++|+..|.+.+..+-...+.+- .
T Consensus 272 ~~~---~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~k 348 (560)
T KOG0600|consen 272 GSA---PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSK 348 (560)
T ss_pred CCc---ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccccc
Confidence 332 24556789999999999886 5899999999999999999999999888766555444321 0
Q ss_pred CC---CCC------------CCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 265 RP---FFR------------AKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 265 ~~---~~~------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
.+ .+. ...++....+|+..||..||.+|.|+.++|+.
T Consensus 349 LP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 349 LPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred CCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 01 000 03457778899999999999999999998865
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-43 Score=303.34 Aligned_cols=251 Identities=24% Similarity=0.387 Sum_probs=204.6
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEe
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 120 (320)
+|.+.+.||+|++|.||++.++ ++.+|+|.+....... ...+.+.+|+++++.++|+||+++++.+..++..++|||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENE-EVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccc-cchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 6899999999999999999986 6789999886543332 234677889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCcc
Q 020888 121 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 200 (320)
Q Consensus 121 ~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~ 200 (320)
|++++.|..+.+....+++..++.++.|++.||.|||+.| ++|+||||+||++ +.++.++|+|||++..+......
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nill--~~~~~~kl~Dfg~~~~~~~~~~~ 156 (287)
T cd07848 81 YVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKND--IVHRDIKPENLLI--SHNDVLKLCDFGFARNLSEGSNA 156 (287)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEE--cCCCcEEEeeccCcccccccccc
Confidence 9988777665555557999999999999999999999998 9999999999999 88899999999998876432211
Q ss_pred ceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCC---------------
Q 020888 201 DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHR--------------- 265 (320)
Q Consensus 201 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~--------------- 265 (320)
......+++.|+|||++.+..++.++|+||||+++|+|++|+.||...+..+....+.....
T Consensus 157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07848 157 ---NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR 233 (287)
T ss_pred ---cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence 12234578899999999988999999999999999999999999987655443322221100
Q ss_pred ------CCCC---------CCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 266 ------PFFR---------AKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 266 ------~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
+... ...++.++.+++++||+.||++|||+++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000 01267889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=297.05 Aligned_cols=256 Identities=27% Similarity=0.481 Sum_probs=215.2
Q ss_pred CCcccCccceecccCceEEEEEEEC-----CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCc
Q 020888 40 SELDFSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP 114 (320)
Q Consensus 40 ~~~~y~~~~~lg~g~~~~vy~~~~~-----~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 114 (320)
+..+|.+.+.||+|+||.||++.++ +..+++|.+..... ......+.+|+..+++++|+||+++++++..++.
T Consensus 3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 80 (266)
T cd05064 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS--DKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNT 80 (266)
T ss_pred chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC--HHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCC
Confidence 4567999999999999999998753 46799998865422 2333678899999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccc
Q 020888 115 LMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 193 (320)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~ 193 (320)
.++||||+++++|.+++... +.+++..++.++.|++.||+|||+.| ++|+||||+||++ +.++.++++|||.+..
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--iiH~dikp~nili--~~~~~~~l~dfg~~~~ 156 (266)
T cd05064 81 MMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG--YVHKGLAAHKVLV--NSDLVCKISGFRRLQE 156 (266)
T ss_pred cEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeeccccHhhEEE--cCCCcEEECCCccccc
Confidence 99999999999999998763 57899999999999999999999998 9999999999999 8888999999997654
Q ss_pred ccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCC
Q 020888 194 IKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKG 272 (320)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (320)
..... ........++..|+|||.+.+..++.++||||||+++|++++ |..||......+....+..+...+ .+..
T Consensus 157 ~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~ 232 (266)
T cd05064 157 DKSEA---IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLP-APRN 232 (266)
T ss_pred ccccc---hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCC-CCCC
Confidence 32211 111112234568999999999999999999999999999775 999999888877777766655443 3456
Q ss_pred CCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHH
Q 020888 273 FTPELRELTEKCWAADMNQRPSFLDILKRLEKI 305 (320)
Q Consensus 273 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~ 305 (320)
++..+.+++.+||+.+|.+|||++++++.|.++
T Consensus 233 ~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 233 CPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred CCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 899999999999999999999999999998775
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-45 Score=311.28 Aligned_cols=252 Identities=32% Similarity=0.544 Sum_probs=225.1
Q ss_pred CCCcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceE
Q 020888 39 PSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLM 116 (320)
Q Consensus 39 ~~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 116 (320)
.....|+....||+|+||.||++.+. ++.||+|++.-+... ..++.+++|+.+|.+++++||.++++.+..+..++
T Consensus 10 ~~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~--deIediqqei~~Ls~~~~~~it~yygsyl~g~~Lw 87 (467)
T KOG0201|consen 10 DPELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAE--DEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLW 87 (467)
T ss_pred CcccccccchhccccccceeeeeeeccccceEEEEEechhhcc--hhhHHHHHHHHHHHhcCcchHHhhhhheeecccHH
Confidence 34557888899999999999999986 788999998655443 34588999999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccc
Q 020888 117 LITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 196 (320)
Q Consensus 117 iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~ 196 (320)
++|||+.||++.+.++..+.+++..+.-++++++.|+.|||.++ .+|+|||+.||++ ..+|.++|+|||.+..+..
T Consensus 88 iiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~--kiHrDIKaanil~--s~~g~vkl~DfgVa~ql~~ 163 (467)
T KOG0201|consen 88 IIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEK--KIHRDIKAANILL--SESGDVKLADFGVAGQLTN 163 (467)
T ss_pred HHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcc--eecccccccceeE--eccCcEEEEecceeeeeec
Confidence 99999999999999998877799999999999999999999998 9999999999999 6669999999999887654
Q ss_pred cCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHH
Q 020888 197 QNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPE 276 (320)
Q Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (320)
... ......|||.|+|||++.+..|+.++||||||++.+||.+|..|+.+.++..+...+.+...|.... .+++.
T Consensus 164 ~~~----rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~-~~S~~ 238 (467)
T KOG0201|consen 164 TVK----RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDG-DFSPP 238 (467)
T ss_pred hhh----ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCcccc-ccCHH
Confidence 332 2256789999999999999999999999999999999999999999999987777777766666555 78999
Q ss_pred HHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 277 LRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 277 l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
+++|+..||+.||+.|||+.+++++
T Consensus 239 ~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 239 FKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred HHHHHHHHhhcCcccCcCHHHHhhh
Confidence 9999999999999999999999987
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=310.70 Aligned_cols=251 Identities=28% Similarity=0.490 Sum_probs=224.9
Q ss_pred CcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCc-eEE
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP-LML 117 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~i 117 (320)
..+|..++.+|+|+||.++.+.++ +..+++|.+.-........ ....+|+.+++++.||||+.+.+.+..++. .+|
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r-~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~I 81 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPER-RSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCI 81 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhh-HHHHHHHHHHHhccCCCeeeeccchhcCCceEEE
Confidence 347999999999999999999887 6789999887777776665 477889999999999999999999998888 999
Q ss_pred EEecCCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccccc
Q 020888 118 ITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 195 (320)
Q Consensus 118 v~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~ 195 (320)
||+||+||+|.+.+.++. -+++..++.|+.|++.|+.|||++. |+|+|||+.|||+ +.++.|+|+|||+++.+.
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~--iLHRDlK~~Nifl--tk~~~VkLgDfGlaK~l~ 157 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR--VLHRDLKCANIFL--TKDKKVKLGDFGLAKILN 157 (426)
T ss_pred EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh--hhcccchhhhhhc--cccCceeecchhhhhhcC
Confidence 999999999999997643 5899999999999999999999877 9999999999999 888889999999999876
Q ss_pred ccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCH
Q 020888 196 VQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTP 275 (320)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (320)
... .......||+.|++||.+.+..|..++|+|||||++||+++-+.+|...+.......+.+....+ .+..++.
T Consensus 158 ~~~----~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~P-lp~~ys~ 232 (426)
T KOG0589|consen 158 PED----SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSP-LPSMYSS 232 (426)
T ss_pred Cch----hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCC-CCccccH
Confidence 543 13345679999999999999999999999999999999999999999999988888888877444 3455899
Q ss_pred HHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 276 ELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 276 ~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
+++.+|+.||..+|+.||++.++|.+
T Consensus 233 el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 233 ELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred HHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 99999999999999999999999988
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=299.52 Aligned_cols=254 Identities=32% Similarity=0.543 Sum_probs=215.3
Q ss_pred cccCccceecccCceEEEEEEECC-------CceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCc
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP 114 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~~-------~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 114 (320)
.+|.+.+.||+|++|.||++...+ ..+++|.+.... .......+.+|++.++.++|+||+++++++.....
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~ 82 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQP 82 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCc
Confidence 378999999999999999998753 458999875432 23344678999999999999999999999999899
Q ss_pred eEEEEecCCCCCHHHHHHHh----------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeC
Q 020888 115 LMLITEYLRGGDLHKYLKEK----------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS 178 (320)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~~----------------~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~ 178 (320)
.+++|||+++++|.+++... ..+++..++.++.|++.||.|||+.| ++|+||||+||++ +
T Consensus 83 ~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nil~--~ 158 (283)
T cd05048 83 TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH--FVHRDLAARNCLV--G 158 (283)
T ss_pred eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccccceEEE--c
Confidence 99999999999999999764 45788999999999999999999998 9999999999999 8
Q ss_pred CCCcEEEecCCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 020888 179 SADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAA 257 (320)
Q Consensus 179 ~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~ 257 (320)
+++.++|+|||++........ ........+++.|+|||.+.+..++.++|+||||+++|++++ |..||......+..
T Consensus 159 ~~~~~~L~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~ 236 (283)
T cd05048 159 EGLTVKISDFGLSRDIYSADY--YRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVI 236 (283)
T ss_pred CCCcEEECCCcceeecccccc--ccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 888999999999876543221 111223345778999999988899999999999999999998 99999988887777
Q ss_pred HHHHhCCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHH
Q 020888 258 KYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEK 304 (320)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 304 (320)
..+........ +..++.++.+++.+||+.||.+||++.+++++|+.
T Consensus 237 ~~i~~~~~~~~-~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 237 EMIRSRQLLPC-PEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHcCCcCCC-cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 77766654443 45689999999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=307.15 Aligned_cols=249 Identities=29% Similarity=0.443 Sum_probs=210.8
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCC-CcccceeeeEEeCCceEEEE
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH-PNIVQFLGAVTERKPLMLIT 119 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~iv~ 119 (320)
+|++.+.||+|+||.||++.++ ++.+|+|++...........+.+..|.+++..+.| ++++++++.+...+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 5889999999999999999886 57899998876543333445677889999999975 56888999999999999999
Q ss_pred ecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCc
Q 020888 120 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 199 (320)
Q Consensus 120 e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~ 199 (320)
||++|++|.+++...+.+++..+..++.|++.||.|||++| ++|+||||+||++ +.++.++|+|||++........
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill--~~~~~~kL~Dfg~~~~~~~~~~ 156 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVML--DAEGHIKIADFGMCKENIFGGK 156 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEE--cCCCCEEEeecCcceecCCCCC
Confidence 99999999999988788999999999999999999999998 9999999999999 8889999999998864322111
Q ss_pred cceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHH
Q 020888 200 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRE 279 (320)
Q Consensus 200 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 279 (320)
......|++.|+|||++.+..++.++|+|||||++|+|++|..||...+..+....+...... .+..++.++.+
T Consensus 157 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~~~ 230 (324)
T cd05587 157 ----TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVS--YPKSLSKEAVS 230 (324)
T ss_pred ----ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC--CCCCCCHHHHH
Confidence 122346899999999999999999999999999999999999999988877777766654432 23458999999
Q ss_pred HHHHHhhcCCCCCCCH-----HHHHHH
Q 020888 280 LTEKCWAADMNQRPSF-----LDILKR 301 (320)
Q Consensus 280 li~~~l~~dp~~Rps~-----~~ll~~ 301 (320)
++++||..||.+|++. ++++++
T Consensus 231 li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 231 ICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred HHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 9999999999999976 677654
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-43 Score=315.60 Aligned_cols=254 Identities=26% Similarity=0.424 Sum_probs=209.9
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEe
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 120 (320)
+|.+++.||.|+||+||++.+. ++.+|+|++.............+.+|+++++.++|+||+++++.+.+.+..|+|||
T Consensus 2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E 81 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIME 81 (377)
T ss_pred CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEe
Confidence 6889999999999999999875 78899998865433334445778899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCcc
Q 020888 121 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 200 (320)
Q Consensus 121 ~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~ 200 (320)
|++|++|.+++...+.+++..+..++.|++.||+|||+.| |+|+||||+||++ +.++.++|+|||++.........
T Consensus 82 ~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~g--ivHrDlkp~NIll--~~~~~~kl~DfGla~~~~~~~~~ 157 (377)
T cd05629 82 FLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLG--FIHRDIKPDNILI--DRGGHIKLSDFGLSTGFHKQHDS 157 (377)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEE--CCCCCEEEeeccccccccccccc
Confidence 9999999999988788999999999999999999999999 9999999999999 88899999999998643211000
Q ss_pred c----------e---------------------------------eeccCCcccccccCccccCcCCCCCchhHHHHHHH
Q 020888 201 D----------V---------------------------------YKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMI 237 (320)
Q Consensus 201 ~----------~---------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~ 237 (320)
. . .......||+.|+|||++.+..++.++|+|||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 237 (377)
T cd05629 158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAI 237 (377)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchh
Confidence 0 0 00012458999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHHhCCCCC--CCCCCCCHHHHHHHHHHhhcCCCCC---CCHHHHHHH
Q 020888 238 LYEMLEGEPPLANYEPYEAAKYVAEGHRPF--FRAKGFTPELRELTEKCWAADMNQR---PSFLDILKR 301 (320)
Q Consensus 238 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~R---ps~~~ll~~ 301 (320)
+|+|++|..||......+....+....... .....++.+++++|.+||. +|.+| +|+.+++.+
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 238 MFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred hhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence 999999999998877766665555422111 1123478999999999997 67765 599999887
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-44 Score=285.22 Aligned_cols=265 Identities=23% Similarity=0.368 Sum_probs=211.7
Q ss_pred CCCCCcccCccceecccCceEEEEEEE--CCCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeC--
Q 020888 37 IDPSELDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER-- 112 (320)
Q Consensus 37 ~~~~~~~y~~~~~lg~g~~~~vy~~~~--~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-- 112 (320)
+...+++|++.+.||+|||+.||+++. ++..+|+|.+.... .+..+...+|++..++++|||+++++++...+
T Consensus 16 v~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~---~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~ 92 (302)
T KOG2345|consen 16 VIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS---QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEK 92 (302)
T ss_pred EEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc---hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhc
Confidence 445678999999999999999999985 47889999886544 33457888999999999999999999886433
Q ss_pred ---CceEEEEecCCCCCHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEE
Q 020888 113 ---KPLMLITEYLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKV 185 (320)
Q Consensus 113 ---~~~~iv~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L 185 (320)
...|++++|+..|+|.+.+++ +..+++..++.|+.+++.||++||....+++|+||||+||++ +..+.++|
T Consensus 93 D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILl--s~~~~~vl 170 (302)
T KOG2345|consen 93 DGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILL--SDSGLPVL 170 (302)
T ss_pred cCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEe--cCCCceEE
Confidence 348999999999999999975 336999999999999999999999987789999999999999 77899999
Q ss_pred ecCCCcccccccCc--cce---eeccCCcccccccCccccCcC---CCCCchhHHHHHHHHHHHHhCCCCCCCCC-hH-H
Q 020888 186 GDFGLSKLIKVQNS--HDV---YKMTGETGSYRYMAPEVFKHR---KYDKKVDVFSFAMILYEMLEGEPPLANYE-PY-E 255 (320)
Q Consensus 186 ~dfg~~~~~~~~~~--~~~---~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~~l~~ll~g~~p~~~~~-~~-~ 255 (320)
.|||++....-.-. ... ...-....|..|+|||.++.. ..++++|||||||++|+|+.|..||+..- .. .
T Consensus 171 ~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgS 250 (302)
T KOG2345|consen 171 MDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGS 250 (302)
T ss_pred EeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCe
Confidence 99999876542111 010 011123468889999999755 56789999999999999999999997432 11 1
Q ss_pred HHHHHHhCCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHH
Q 020888 256 AAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIK 306 (320)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 306 (320)
..-.+..+.........+++.+.++|+.||++||..||++.+++..++.+.
T Consensus 251 laLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 251 LALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred EEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 111222223333344558999999999999999999999999999998764
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=307.05 Aligned_cols=244 Identities=25% Similarity=0.393 Sum_probs=207.5
Q ss_pred ceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcccceeeeEEeCCceEEEEecCCC
Q 020888 48 AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRG 124 (320)
Q Consensus 48 ~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~~ 124 (320)
+.||+|+||+||++.++ ++.+|+|++.+.........+.+..|.+++..+ +|+||+++++.+...+.+|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46899999999999986 678999988654333333446677888888877 699999999999999999999999999
Q ss_pred CCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCccceee
Q 020888 125 GDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK 204 (320)
Q Consensus 125 ~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~~~~~ 204 (320)
++|.+++.....+++..+..++.|++.||.|||++| ++||||||+||++ +.++.++|+|||++........ .
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~--ivH~dlkp~NIli--~~~~~~kL~DfG~~~~~~~~~~----~ 152 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKG--IIYRDLKLDNVLL--DHEGHCKLADFGMCKEGIFNGK----T 152 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEE--CCCCcEEEeeCCCCeecCcCCC----c
Confidence 999999988788999999999999999999999998 9999999999999 8889999999999865322211 2
Q ss_pred ccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHH
Q 020888 205 MTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKC 284 (320)
Q Consensus 205 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 284 (320)
.....|++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....+...... .+..++.++++++++|
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~~~li~~~ 230 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVV--YPTWLSQDAVDILKAF 230 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCC--CCCCCCHHHHHHHHHH
Confidence 23356899999999999999999999999999999999999999988887777777655432 2345799999999999
Q ss_pred hhcCCCCCCCH------HHHHHH
Q 020888 285 WAADMNQRPSF------LDILKR 301 (320)
Q Consensus 285 l~~dp~~Rps~------~~ll~~ 301 (320)
|+.||.+||++ ++++.+
T Consensus 231 L~~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 231 MTKNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred cccCHHHCCCCCCCCCHHHHHcC
Confidence 99999999998 666655
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-43 Score=309.53 Aligned_cols=244 Identities=25% Similarity=0.427 Sum_probs=208.1
Q ss_pred ceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEecCCCC
Q 020888 48 AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGG 125 (320)
Q Consensus 48 ~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~ 125 (320)
+.||+|+||.||++.+. ++.+|+|++.............+.+|+++++.++|+||+++.+.+...+..++||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999875 7889999987654444444567788999999999999999999999999999999999999
Q ss_pred CHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCccceee
Q 020888 126 DLHKYLKEKGALSPSTAVNFALDIARGMAYLHN-EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK 204 (320)
Q Consensus 126 ~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~-~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~~~~~ 204 (320)
+|.+++.....+++..+..++.||+.||.|||+ .| ++|+||||+||++ +.++.++|+|||++........ .
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~--ivHrDikp~NIll--~~~~~~kL~Dfg~~~~~~~~~~----~ 152 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLML--DKDGHIKITDFGLCKEGIKDGA----T 152 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCCCCeEEE--CCCCCEEEecCCCCeecCCCCc----c
Confidence 999999887789999999999999999999997 68 9999999999999 8889999999999864322111 1
Q ss_pred ccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHH
Q 020888 205 MTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKC 284 (320)
Q Consensus 205 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 284 (320)
.....+++.|+|||++.+..++.++||||||+++|+|++|..||...+.......+...... .+..+++++.+++.+|
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~--~p~~~~~~~~~li~~~ 230 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR--FPRTLSPEAKSLLSGL 230 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCC--CCCCCCHHHHHHHHHH
Confidence 22346899999999999999999999999999999999999999887776665555443322 2345799999999999
Q ss_pred hhcCCCCCC-----CHHHHHHH
Q 020888 285 WAADMNQRP-----SFLDILKR 301 (320)
Q Consensus 285 l~~dp~~Rp-----s~~~ll~~ 301 (320)
|+.||.+|+ ++.+++++
T Consensus 231 L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 231 LKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred hhcCHHHhCCCCCCCHHHHhcC
Confidence 999999996 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=304.34 Aligned_cols=249 Identities=25% Similarity=0.457 Sum_probs=207.8
Q ss_pred CcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEE
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 118 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 118 (320)
..+|++.+.||.|+||.||++.+. +..+++|.+.... .......+.+|+++++.++|+||+++++++..++..++|
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEE
Confidence 468999999999999999999986 6778888775432 233346788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcC-CCCeEecCCCCCcEEEeeCCCCcEEEecCCCccccccc
Q 020888 119 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE-PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 197 (320)
Q Consensus 119 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~-g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~ 197 (320)
|||+++++|.+++...+.+++..+..++.+++.||.|||+. + ++|+||||+||++ +.++.++|+|||++......
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~--ivH~dlkp~Nili--~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 82 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILV--NSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChhhEEE--cCCCCEEEeeCCcchhhhhh
Confidence 99999999999998877899999999999999999999974 6 9999999999999 88889999999998755332
Q ss_pred CccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHH-------------------
Q 020888 198 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAK------------------- 258 (320)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~------------------- 258 (320)
. .....++..|+|||.+.+..++.++|+|||||++|++++|..||..........
T Consensus 158 ~------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (333)
T cd06650 158 M------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRP 231 (333)
T ss_pred c------cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCccc
Confidence 1 123457889999999999899999999999999999999999997654332221
Q ss_pred -------------------------HHHhCCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 259 -------------------------YVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 259 -------------------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
.+.....+......++.++++++.+||..||++|||+.+++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 232 RPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299 (333)
T ss_pred CCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence 1112222222223467899999999999999999999999876
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=305.62 Aligned_cols=243 Identities=30% Similarity=0.468 Sum_probs=203.5
Q ss_pred ceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcccceeeeEEeCCceEEEEecCCC
Q 020888 48 AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRG 124 (320)
Q Consensus 48 ~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~~ 124 (320)
+.||+|+||.||++.+. ++.||+|++.............+..|.+++... +|+||+++++.+..++..|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46899999999999875 678999988654333333345556677777655 799999999999999999999999999
Q ss_pred CCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCccceee
Q 020888 125 GDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK 204 (320)
Q Consensus 125 ~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~~~~~ 204 (320)
++|.+++...+.+++..+..++.|++.||.|||+.| |+|+||||+||++ +.++.++|+|||++....... ..
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dlkp~Nill--~~~~~~kL~Dfg~a~~~~~~~----~~ 152 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG--IIYRDLKLDNVLL--DKDGHIKIADFGMCKENMNGE----GK 152 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHeEE--CCCCCEEEccCcCCeECCCCC----Cc
Confidence 999999988788999999999999999999999998 9999999999999 888999999999987543222 12
Q ss_pred ccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHH
Q 020888 205 MTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKC 284 (320)
Q Consensus 205 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 284 (320)
.....|++.|+|||.+.+..++.++|+|||||++|+|++|..||...+..+....+..... ..+..++.++++++.+|
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~ll~~~ 230 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRP--HFPRWISKEAKDCLSKL 230 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHH
Confidence 2345689999999999999999999999999999999999999998887776666554332 23345799999999999
Q ss_pred hhcCCCCCCCHH-HHHH
Q 020888 285 WAADMNQRPSFL-DILK 300 (320)
Q Consensus 285 l~~dp~~Rps~~-~ll~ 300 (320)
|..||.+||++. ++++
T Consensus 231 l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 231 FERDPTKRLGVDGDIRQ 247 (316)
T ss_pred ccCCHHHcCCChHHHHc
Confidence 999999999875 5654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=303.79 Aligned_cols=257 Identities=27% Similarity=0.424 Sum_probs=213.8
Q ss_pred CcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCc-----------HHHHHHHHHHHHHHHhCCCCcccceee
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDD-----------RLVIQDFRHEVNLLVKLRHPNIVQFLG 107 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~-----------~~~~~~~~~e~~~l~~l~h~~i~~~~~ 107 (320)
.++|++.+.||+|.+|.|-++++. ++.||+|++.+..... ...++...+||.+++++.|+||+++++
T Consensus 96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE 175 (576)
T KOG0585|consen 96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE 175 (576)
T ss_pred hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence 448999999999999999999986 8899999987653222 122468899999999999999999999
Q ss_pred eEEe--CCceEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEE
Q 020888 108 AVTE--RKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKV 185 (320)
Q Consensus 108 ~~~~--~~~~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L 185 (320)
+..+ .+.+|||+|||..|.+...-....-+++.+++.++..++.||+|||.+| |+||||||+|+++ +.+|.+||
T Consensus 176 vLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg--iiHRDIKPsNLLl--~~~g~VKI 251 (576)
T KOG0585|consen 176 VLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQG--IIHRDIKPSNLLL--SSDGTVKI 251 (576)
T ss_pred eecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEE--cCCCcEEe
Confidence 9864 6779999999987766543222222899999999999999999999999 9999999999999 88899999
Q ss_pred ecCCCcccccccCcc-ceeeccCCcccccccCccccCcCC----CCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 020888 186 GDFGLSKLIKVQNSH-DVYKMTGETGSYRYMAPEVFKHRK----YDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYV 260 (320)
Q Consensus 186 ~dfg~~~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~ 260 (320)
+|||.+.....+... ..-......|||.|.|||...++. .+.+.||||+|++||+|+.|+.||-+....+..+.+
T Consensus 252 sDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KI 331 (576)
T KOG0585|consen 252 SDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKI 331 (576)
T ss_pred eccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHH
Confidence 999998866433211 111233468999999999987743 347999999999999999999999998888888888
Q ss_pred HhCCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 261 AEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 261 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
............+.+.++++|++||..||+.|.++.++..|
T Consensus 332 vn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~H 372 (576)
T KOG0585|consen 332 VNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLH 372 (576)
T ss_pred hcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheec
Confidence 87765555555679999999999999999999999998776
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=293.34 Aligned_cols=254 Identities=30% Similarity=0.540 Sum_probs=215.1
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCc--HHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEE
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDD--RLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 118 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 118 (320)
+|.+.+.||.|++|.||++.+. ++.+++|.+....... ......+.+|++++++++|+||+++++++..++..+++
T Consensus 3 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 82 (263)
T cd06625 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIF 82 (263)
T ss_pred cccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEE
Confidence 6889999999999999999864 7899999886543222 22346788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccC
Q 020888 119 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 198 (320)
Q Consensus 119 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~ 198 (320)
+||+++++|.+++...+.+++..+..++.|++.||.+||+.| ++|+||+|+||++ +.++.++|+|||.+.......
T Consensus 83 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nilv--~~~~~~~l~dfg~~~~~~~~~ 158 (263)
T cd06625 83 MEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNM--IVHRDIKGANILR--DSAGNVKLGDFGASKRLQTIC 158 (263)
T ss_pred EEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEE--cCCCCEEEeecccceeccccc
Confidence 999999999999988778999999999999999999999998 9999999999999 888899999999987654321
Q ss_pred ccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHH
Q 020888 199 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 278 (320)
Q Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 278 (320)
... .......++..|+|||...+..++.++|+||||+++|++++|+.||...+.................+..++.++.
T Consensus 159 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (263)
T cd06625 159 SSG-TGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDAR 237 (263)
T ss_pred ccc-ccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHH
Confidence 111 1112345678899999999999999999999999999999999999887766655555554444444556899999
Q ss_pred HHHHHHhhcCCCCCCCHHHHHHH
Q 020888 279 ELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 279 ~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
+++.+||..+|.+|||+.+++++
T Consensus 238 ~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 238 NFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred HHHHHHhhcCcccCCCHHHHhhC
Confidence 99999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=316.17 Aligned_cols=255 Identities=24% Similarity=0.366 Sum_probs=210.3
Q ss_pred cccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEE
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 119 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 119 (320)
++|++++.||+|+||.||++.+. ++.+|+|++.............+.+|+++++.++|+||+++++.+.+++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36999999999999999999975 7889999886543322333467889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCc
Q 020888 120 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 199 (320)
Q Consensus 120 e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~ 199 (320)
||+++++|.+++...+.+++..+..++.||+.||+|||++| |+||||||+||++ +.++.++|+|||++..+.....
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill--~~~~~ikL~DFG~a~~~~~~~~ 156 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILI--DRDGHIKLTDFGLCTGFRWTHD 156 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHEEE--CCCCCEEEEeCCCCcccccccc
Confidence 99999999999988888999999999999999999999998 9999999999999 8889999999998753321000
Q ss_pred c---------------------------------------ceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHH
Q 020888 200 H---------------------------------------DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYE 240 (320)
Q Consensus 200 ~---------------------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ 240 (320)
. .........||+.|+|||++.+..++.++|||||||++|+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye 236 (376)
T cd05598 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236 (376)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence 0 0000112468999999999999999999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHhCCCC--CCCCCCCCHHHHHHHHHHhhcCCCCCC---CHHHHHHH
Q 020888 241 MLEGEPPLANYEPYEAAKYVAEGHRP--FFRAKGFTPELRELTEKCWAADMNQRP---SFLDILKR 301 (320)
Q Consensus 241 ll~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~~ll~~ 301 (320)
|++|..||......+....+...... ......++.++.++|.+|+ .+|.+|+ |+.+++++
T Consensus 237 ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 237 MLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred hhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 99999999988776665544432211 1122357899999999977 5999999 89999877
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=300.15 Aligned_cols=249 Identities=27% Similarity=0.439 Sum_probs=202.8
Q ss_pred cccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEE
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 119 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 119 (320)
.+|.+.+.||.|+||.||++.+. ++.+|+|.+....... ....+.+|+.+++.++|+||+++++++..++..++||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG--APCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVF 82 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCC--cchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence 47999999999999999999875 7889999886443221 1246678999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccC
Q 020888 120 EYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 198 (320)
Q Consensus 120 e~~~~~~L~~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~ 198 (320)
||+++ +|.+++...+ .+++..+..++.|++.||.|||++| ++|+||||+||++ +.++.++|+|||++.......
T Consensus 83 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nil~--~~~~~~kl~DfG~~~~~~~~~ 157 (288)
T cd07871 83 EYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK--ILHRDLKPQNLLI--NEKGELKLADFGLARAKSVPT 157 (288)
T ss_pred eCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEE--CCCCCEEECcCcceeeccCCC
Confidence 99975 9999887643 5799999999999999999999998 9999999999999 888999999999987543221
Q ss_pred ccceeeccCCcccccccCccccCc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCC------------
Q 020888 199 SHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHR------------ 265 (320)
Q Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~------------ 265 (320)
. ......+++.|+|||.+.+ ..++.++|+||||+++|++++|..||...+..+....+.....
T Consensus 158 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07871 158 K----TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITS 233 (288)
T ss_pred c----cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhcccc
Confidence 1 1223457889999999865 5688999999999999999999999987766554443322110
Q ss_pred ---------CC-------CCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 266 ---------PF-------FRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 266 ---------~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
+. .....++.+.+++|++||..||.+|||+++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 234 NEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred chhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00 0012467899999999999999999999999865
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=310.86 Aligned_cols=251 Identities=24% Similarity=0.397 Sum_probs=212.5
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEe
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 120 (320)
+|.+.+.||+|+||+||++.++ ++.+|+|.+.............+.+|+++++.++|++|+++++.+.+++..++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (330)
T cd05601 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVME 81 (330)
T ss_pred CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEEC
Confidence 6899999999999999999875 78899999876544344455778899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCc
Q 020888 121 YLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 199 (320)
Q Consensus 121 ~~~~~~L~~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~ 199 (320)
|+++++|.+++... +.+++..+..++.|++.||.|||+.| ++||||||+||++ +.++.++|+|||++..+.....
T Consensus 82 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--i~H~Dlkp~NIll--~~~~~~kL~Dfg~a~~~~~~~~ 157 (330)
T cd05601 82 YQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG--YVHRDIKPENVLI--DRTGHIKLADFGSAARLTANKM 157 (330)
T ss_pred CCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEcccCchHheEE--CCCCCEEeccCCCCeECCCCCc
Confidence 99999999999875 67999999999999999999999998 9999999999999 8889999999999876543221
Q ss_pred cceeeccCCcccccccCccccC------cCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCC--CCCC
Q 020888 200 HDVYKMTGETGSYRYMAPEVFK------HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPF--FRAK 271 (320)
Q Consensus 200 ~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~ 271 (320)
. ......+++.|+|||++. +..++.++||||||+++|+|++|..||...........+....... ....
T Consensus 158 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (330)
T cd05601 158 V---NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDP 234 (330)
T ss_pred e---eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCC
Confidence 1 122346789999999986 4567789999999999999999999998887776666555433221 1223
Q ss_pred CCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 272 GFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 272 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
.++.++++++..||. +|.+|||+++++.+
T Consensus 235 ~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 235 KVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred CCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 578999999999998 99999999999875
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=314.18 Aligned_cols=254 Identities=25% Similarity=0.386 Sum_probs=210.1
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEe
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 120 (320)
.|.+++.||+|+||+||++.+. ++.+|+|.+.............+.+|+++++.++|++|+++++.+.+++..|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5889999999999999999985 67899998865443334445778899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCcc
Q 020888 121 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 200 (320)
Q Consensus 121 ~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~ 200 (320)
|+++++|.+++.+.+.+++..+..++.|++.||.|||++| |+|+||||+||++ +.++.++|+|||++.........
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~--ivHrDlKp~NILl--~~~g~~kL~DFGla~~~~~~~~~ 157 (382)
T cd05625 82 YIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMG--FIHRDIKPDNILI--DRDGHIKLTDFGLCTGFRWTHDS 157 (382)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEE--CCCCCEEEeECCCCccccccccc
Confidence 9999999999988778999999999999999999999998 9999999999999 88999999999987533210000
Q ss_pred -------------------------------------------ceeeccCCcccccccCccccCcCCCCCchhHHHHHHH
Q 020888 201 -------------------------------------------DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMI 237 (320)
Q Consensus 201 -------------------------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~ 237 (320)
.........||+.|+|||++.+..++.++|+|||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi 237 (382)
T cd05625 158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 237 (382)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence 0000122468999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHHhCCCC--CCCCCCCCHHHHHHHHHHhhcCCCCCCC---HHHHHHH
Q 020888 238 LYEMLEGEPPLANYEPYEAAKYVAEGHRP--FFRAKGFTPELRELTEKCWAADMNQRPS---FLDILKR 301 (320)
Q Consensus 238 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~~ll~~ 301 (320)
+|+|++|..||...+..+....+...... ......+++++.++|.+|+ .+|++|++ +++++++
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 305 (382)
T cd05625 238 LYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAH 305 (382)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcC
Confidence 99999999999988776666555442221 1122457899999999987 59999987 8888775
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=303.46 Aligned_cols=244 Identities=27% Similarity=0.445 Sum_probs=208.0
Q ss_pred ceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcccceeeeEEeCCceEEEEecCCC
Q 020888 48 AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRG 124 (320)
Q Consensus 48 ~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~~ 124 (320)
+.||+|+||+||++.+. ++.+|+|++.+...........+.+|.++++.+ +|+||+++++++...+.+++||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46899999999999885 678999998765433334456777889999888 699999999999999999999999999
Q ss_pred CCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCccceee
Q 020888 125 GDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK 204 (320)
Q Consensus 125 ~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~~~~~ 204 (320)
++|.+++...+.+++..+..++.|++.||.|||+.| ++|+||||+||++ +.++.++|+|||++........ .
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill--~~~~~~kl~Dfg~~~~~~~~~~----~ 152 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERG--IIYRDLKLDNVLL--DSEGHIKIADFGMCKEGILGGV----T 152 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEccCCCHHHeEE--CCCCcEEecccCCCeecCcCCC----c
Confidence 999999988878999999999999999999999998 9999999999999 8889999999998864322111 1
Q ss_pred ccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHH
Q 020888 205 MTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKC 284 (320)
Q Consensus 205 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 284 (320)
.....+++.|+|||.+.+..++.++|+|||||++|+|++|..||...+.......+...... .+..++.++++++.+|
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~~~li~~~ 230 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVR--YPRWLSKEAKSILKSF 230 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCC--CCCcCCHHHHHHHHHH
Confidence 22345789999999999999999999999999999999999999988777766666554432 2345799999999999
Q ss_pred hhcCCCCCCCH-----HHHHHH
Q 020888 285 WAADMNQRPSF-----LDILKR 301 (320)
Q Consensus 285 l~~dp~~Rps~-----~~ll~~ 301 (320)
|..||.+|||+ .+++++
T Consensus 231 l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 231 LTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred ccCCHHHcCCCCCCCHHHHhcC
Confidence 99999999999 888775
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=309.68 Aligned_cols=256 Identities=31% Similarity=0.521 Sum_probs=207.8
Q ss_pred CcccCccceecccCceEEEEEEE-------CCCceEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcccceeeeEEeC
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYW-------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTER 112 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~-------~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 112 (320)
..+|++.+.||+|+||+||++.+ .+..+|+|++...... ...+.+.+|+.+++.+ +||||+++++++..+
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~ 111 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHL--TEREALMSELKVLSYLGNHINIVNLLGACTVG 111 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCc--HHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence 34799999999999999999864 2457999988643322 2236788899999999 899999999999999
Q ss_pred CceEEEEecCCCCCHHHHHHHhC---------------------------------------------------------
Q 020888 113 KPLMLITEYLRGGDLHKYLKEKG--------------------------------------------------------- 135 (320)
Q Consensus 113 ~~~~iv~e~~~~~~L~~~~~~~~--------------------------------------------------------- 135 (320)
+..++||||+++|+|.+++.+..
T Consensus 112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (375)
T cd05104 112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS 191 (375)
T ss_pred CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence 99999999999999999886421
Q ss_pred ------------------CCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccccccc
Q 020888 136 ------------------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 197 (320)
Q Consensus 136 ------------------~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~ 197 (320)
.+++..++.++.|++.||.|||+.| ++|+||||+||++ +.++.++|+|||++......
T Consensus 192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nill--~~~~~~kl~DfG~a~~~~~~ 267 (375)
T cd05104 192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN--CIHRDLAARNILL--THGRITKICDFGLARDIRND 267 (375)
T ss_pred ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCchhhEEE--ECCCcEEEecCccceeccCc
Confidence 4788899999999999999999988 9999999999999 77888999999998765432
Q ss_pred CccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHH-HHHHHHhCCCCCCCCCCCCH
Q 020888 198 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYE-AAKYVAEGHRPFFRAKGFTP 275 (320)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 275 (320)
... .......++..|+|||.+.+..++.++|+||||+++|++++ |..||....... ....+..+... ..+...+.
T Consensus 268 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 344 (375)
T cd05104 268 SNY--VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRM-LSPECAPS 344 (375)
T ss_pred ccc--cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccC-CCCCCCCH
Confidence 211 11122334567999999999999999999999999999998 899998765433 33334433322 23344689
Q ss_pred HHHHHHHHHhhcCCCCCCCHHHHHHHHHHH
Q 020888 276 ELRELTEKCWAADMNQRPSFLDILKRLEKI 305 (320)
Q Consensus 276 ~l~~li~~~l~~dp~~Rps~~~ll~~L~~~ 305 (320)
++++++.+||+.||++|||+.++++.|++.
T Consensus 345 ~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 345 EMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred HHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=305.26 Aligned_cols=247 Identities=27% Similarity=0.443 Sum_probs=206.6
Q ss_pred cCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHH---HhCCCCcccceeeeEEeCCceEEE
Q 020888 44 FSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLL---VKLRHPNIVQFLGAVTERKPLMLI 118 (320)
Q Consensus 44 y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l---~~l~h~~i~~~~~~~~~~~~~~iv 118 (320)
|.+.+.||+|++|.||++.+. ++.+|+|++...........+.+.+|++++ +.++|+||+++++++..++..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 678899999999999999875 788999998654333333345666666655 456799999999999999999999
Q ss_pred EecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccC
Q 020888 119 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 198 (320)
Q Consensus 119 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~ 198 (320)
|||++|++|..++.. +.+++..++.++.|++.||.|||+.| ++|+||||+||++ +.++.++|+|||++.......
T Consensus 81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrdlkp~Nill--~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05589 81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENK--IVYRDLKLDNLLL--DTEGFVKIADFGLCKEGMGFG 155 (324)
T ss_pred EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEE--CCCCcEEeCcccCCccCCCCC
Confidence 999999999988865 46999999999999999999999998 9999999999999 888999999999876432211
Q ss_pred ccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHH
Q 020888 199 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 278 (320)
Q Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 278 (320)
. ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....+...... .+..++.++.
T Consensus 156 ~----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~--~p~~~~~~~~ 229 (324)
T cd05589 156 D----RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVR--YPRFLSREAI 229 (324)
T ss_pred C----cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC--CCCCCCHHHH
Confidence 1 123356899999999999999999999999999999999999999988877776666555432 3345799999
Q ss_pred HHHHHHhhcCCCCCC-----CHHHHHHH
Q 020888 279 ELTEKCWAADMNQRP-----SFLDILKR 301 (320)
Q Consensus 279 ~li~~~l~~dp~~Rp-----s~~~ll~~ 301 (320)
++|.+||..||.+|| ++.+++++
T Consensus 230 ~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 230 SIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred HHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 999999999999999 67777775
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=279.56 Aligned_cols=255 Identities=30% Similarity=0.488 Sum_probs=225.6
Q ss_pred CCCCCcCCCCCcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeee
Q 020888 31 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGA 108 (320)
Q Consensus 31 ~~~~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 108 (320)
....|.++ +|.+.+.||.|-||.||+++.+ .--+|+|++.++.......-+++.+|+++.+.|+||||++++++
T Consensus 15 ~~~~~~l~----dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~ 90 (281)
T KOG0580|consen 15 ATKTWTLD----DFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGY 90 (281)
T ss_pred cccccchh----hccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhh
Confidence 34566666 7999999999999999999976 45699999877766555566899999999999999999999999
Q ss_pred EEeCCceEEEEecCCCCCHHHHHH--HhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEe
Q 020888 109 VTERKPLMLITEYLRGGDLHKYLK--EKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVG 186 (320)
Q Consensus 109 ~~~~~~~~iv~e~~~~~~L~~~~~--~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~ 186 (320)
+.+....|+++||.++|.|...++ ...++++.....++.|++.|+.|||..+ ++|+||||+|+++ +..+.++|.
T Consensus 91 fhd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~--VIhRdiKpenlLl--g~~~~lkiA 166 (281)
T KOG0580|consen 91 FHDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR--VIHRDIKPENLLL--GSAGELKIA 166 (281)
T ss_pred eeccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC--cccCCCCHHHhcc--CCCCCeecc
Confidence 999999999999999999999888 4457999999999999999999999988 9999999999999 999999999
Q ss_pred cCCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCC
Q 020888 187 DFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRP 266 (320)
Q Consensus 187 dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 266 (320)
|||.+..-..+ .-...+||.-|.|||...+..++...|+|++|++.||++.|..||......+.++.+.+-...
T Consensus 167 dfGwsV~~p~~------kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~ 240 (281)
T KOG0580|consen 167 DFGWSVHAPSN------KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLK 240 (281)
T ss_pred CCCceeecCCC------CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHcccc
Confidence 99988654321 234568999999999999999999999999999999999999999998888888877765533
Q ss_pred CCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 267 FFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 267 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
. +..++.+.+++|.+|+..+|.+|.+..+++++
T Consensus 241 ~--p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 241 F--PSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred C--CcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 3 36689999999999999999999999999887
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=291.75 Aligned_cols=256 Identities=34% Similarity=0.587 Sum_probs=215.8
Q ss_pred CcccCccceecccCceEEEEEEEC-----CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCce
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL 115 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~-----~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 115 (320)
..+|++.+.||+|+||.||++.+. ...+++|.+.... .......+.+|+.++++++|+||+++++.+...+..
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV 80 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence 347899999999999999999874 3468999875443 233346788899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccc
Q 020888 116 MLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 194 (320)
Q Consensus 116 ~iv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~ 194 (320)
+++|||+++++|.+++... +.+++..++.++.|++.||.+||+.| ++|+||+|+||++ +.++.++|+|||.+...
T Consensus 81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~di~p~nili--~~~~~~~l~dfg~~~~~ 156 (266)
T cd05033 81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN--YVHRDLAARNILV--NSNLVCKVSDFGLSRRL 156 (266)
T ss_pred EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEE--cCCCCEEECccchhhcc
Confidence 9999999999999998763 46899999999999999999999988 9999999999999 88889999999999877
Q ss_pred cccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCC
Q 020888 195 KVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGF 273 (320)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (320)
.... .........++..|+|||...+..++.++|+||||+++|++++ |..||......+....+........ +..+
T Consensus 157 ~~~~--~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~ 233 (266)
T cd05033 157 EDSE--ATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPP-PMDC 233 (266)
T ss_pred cccc--cceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCC-CCCC
Confidence 5211 1111222334678999999999999999999999999999998 9999988877777666665543332 3457
Q ss_pred CHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHH
Q 020888 274 TPELRELTEKCWAADMNQRPSFLDILKRLEKI 305 (320)
Q Consensus 274 ~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~ 305 (320)
++.+.+++.+|++.+|++||++.+++++|.++
T Consensus 234 ~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 234 PSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 99999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=305.05 Aligned_cols=245 Identities=29% Similarity=0.472 Sum_probs=207.6
Q ss_pred cceecccCceEEEEEEE-----CCCceEEEEccCCCC-CcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEe
Q 020888 47 SAIIGKGSFGEILKAYW-----RGTPVAIKRILPSLS-DDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120 (320)
Q Consensus 47 ~~~lg~g~~~~vy~~~~-----~~~~~~~K~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 120 (320)
++.||+|+||.||++.. .++.+|+|++..... ........+.+|+++++.++|+||+++++.+..++..|+|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 36899999999999985 367899998865322 112223567789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCcc
Q 020888 121 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 200 (320)
Q Consensus 121 ~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~ 200 (320)
|+++++|.+++...+.+++..+..++.|++.||.|||++| ++|+||||+||++ +.++.++|+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~--~~~~~~kl~Dfg~~~~~~~~~~- 155 (323)
T cd05584 81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG--IIYRDLKPENILL--DAQGHVKLTDFGLCKESIHEGT- 155 (323)
T ss_pred CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEE--CCCCCEEEeeCcCCeecccCCC-
Confidence 9999999999988888999999999999999999999998 9999999999999 8889999999999864432221
Q ss_pred ceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHH
Q 020888 201 DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELREL 280 (320)
Q Consensus 201 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 280 (320)
......+++.|+|||++.+..++.++||||||+++|+|++|..||...+.......+...... .+..++++++++
T Consensus 156 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l 230 (323)
T cd05584 156 ---VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLN--LPPYLTPEARDL 230 (323)
T ss_pred ---cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC--CCCCCCHHHHHH
Confidence 122346899999999999988999999999999999999999999988877766666655432 234579999999
Q ss_pred HHHHhhcCCCCCC-----CHHHHHHH
Q 020888 281 TEKCWAADMNQRP-----SFLDILKR 301 (320)
Q Consensus 281 i~~~l~~dp~~Rp-----s~~~ll~~ 301 (320)
+.+||..||++|| ++++++++
T Consensus 231 i~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 231 LKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred HHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 9999999999999 88988775
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=304.65 Aligned_cols=249 Identities=29% Similarity=0.439 Sum_probs=210.8
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcccceeeeEEeCCceEEEE
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLIT 119 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~iv~ 119 (320)
+|.+.+.||+|+||.||++.+. ++.+|+|++.+...........+..|..++..+ .|++++++++.+...+..|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 5888999999999999999886 678999988765433333345667788888877 5899999999999999999999
Q ss_pred ecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCc
Q 020888 120 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 199 (320)
Q Consensus 120 e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~ 199 (320)
||+++++|.+++...+.+++..+..++.|++.||.|||+.| ++|+||||+||++ +.++.++|+|||++........
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill--~~~~~~kL~DfG~~~~~~~~~~ 156 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVML--DSEGHIKIADFGMCKENMWDGV 156 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEecCCCHHHeEE--CCCCcEEEccCCCceecCCCCC
Confidence 99999999999988788999999999999999999999998 9999999999999 8889999999999875432111
Q ss_pred cceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHH
Q 020888 200 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRE 279 (320)
Q Consensus 200 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 279 (320)
......|++.|+|||++.+..++.++|+|||||++|+|++|..||...+.......+...... .+..++.++++
T Consensus 157 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~--~p~~~s~~~~~ 230 (323)
T cd05616 157 ----TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA--YPKSMSKEAVA 230 (323)
T ss_pred ----ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC--CCCcCCHHHHH
Confidence 122356899999999999999999999999999999999999999988887777766655433 23457999999
Q ss_pred HHHHHhhcCCCCCCCH-----HHHHHH
Q 020888 280 LTEKCWAADMNQRPSF-----LDILKR 301 (320)
Q Consensus 280 li~~~l~~dp~~Rps~-----~~ll~~ 301 (320)
++.+||+.||.+|++. .+++++
T Consensus 231 li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 231 ICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred HHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 9999999999999974 666554
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=294.71 Aligned_cols=259 Identities=29% Similarity=0.514 Sum_probs=217.9
Q ss_pred CcccCccceecccCceEEEEEEEC-------CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCC
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK 113 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~-------~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 113 (320)
..+|.+.+.||+|++|+||++.+. +..+++|.+... .....+.+.+|++++++++|++++++++++..++
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD 80 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 457899999999999999999752 345788877432 2334467899999999999999999999999999
Q ss_pred ceEEEEecCCCCCHHHHHHHhC-------------CCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCC
Q 020888 114 PLMLITEYLRGGDLHKYLKEKG-------------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSA 180 (320)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~~-------------~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~ 180 (320)
.+++++||+++++|.+++...+ .+++..++.++.|++.||+|||++| ++|+||||+||++ +.+
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~--i~H~dlkp~Nili--~~~ 156 (288)
T cd05093 81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLV--GEN 156 (288)
T ss_pred ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEE--ccC
Confidence 9999999999999999987543 3899999999999999999999998 9999999999999 888
Q ss_pred CcEEEecCCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 020888 181 DHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKY 259 (320)
Q Consensus 181 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~ 259 (320)
+.++|+|||.+..+..... ........++..|+|||.+.+..++.++|+||||+++|+|++ |..||......+....
T Consensus 157 ~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~ 234 (288)
T cd05093 157 LLVKIGDFGMSRDVYSTDY--YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIEC 234 (288)
T ss_pred CcEEeccCCccccccCCce--eecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 8999999999876543211 111122334678999999999999999999999999999998 9999988887777777
Q ss_pred HHhCCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcC
Q 020888 260 VAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETL 309 (320)
Q Consensus 260 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 309 (320)
+..+..... +..++.++.+++.+||+.||.+|||++++++.|+++....
T Consensus 235 i~~~~~~~~-~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~ 283 (288)
T cd05093 235 ITQGRVLQR-PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKAS 283 (288)
T ss_pred HHcCCcCCC-CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhc
Confidence 766654432 3457899999999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=305.47 Aligned_cols=244 Identities=23% Similarity=0.389 Sum_probs=208.3
Q ss_pred ceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcccceeeeEEeCCceEEEEecCCC
Q 020888 48 AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRG 124 (320)
Q Consensus 48 ~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~~ 124 (320)
+.||+|+||.||++.+. ++.+|+|++.............+..|.+++..+ +|++|+++++.+...+..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46899999999999886 678999988664333334446677888888876 799999999999999999999999999
Q ss_pred CCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCccceee
Q 020888 125 GDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK 204 (320)
Q Consensus 125 ~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~~~~~ 204 (320)
++|.+++...+.+++..+..++.|++.||.|||+.| ++|+||||+||++ +.++.++|+|||++........ .
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~Nill--~~~~~~kL~Dfg~~~~~~~~~~----~ 152 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG--VIYRDLKLDNILL--DAEGHCKLADFGMCKEGILNGV----T 152 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEE--CCCCCEEEeecccceecccCCc----c
Confidence 999999988788999999999999999999999998 9999999999999 8889999999998875432211 1
Q ss_pred ccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHH
Q 020888 205 MTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKC 284 (320)
Q Consensus 205 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 284 (320)
.....+++.|+|||++.+..++.++|+||||+++|+|++|..||...+..+....+...... .+..++.++.+++.+|
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~--~p~~~~~~~~~ll~~~ 230 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVL--YPVWLSKEAVSILKAF 230 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC--CCCCCCHHHHHHHHHH
Confidence 22346889999999999999999999999999999999999999988887777766655432 2344789999999999
Q ss_pred hhcCCCCCC-------CHHHHHHH
Q 020888 285 WAADMNQRP-------SFLDILKR 301 (320)
Q Consensus 285 l~~dp~~Rp-------s~~~ll~~ 301 (320)
|..||.+|+ ++++++++
T Consensus 231 L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 231 MTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred hccCHHHcCCCCCCCCCHHHHhcC
Confidence 999999999 88888866
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=292.89 Aligned_cols=257 Identities=26% Similarity=0.493 Sum_probs=215.0
Q ss_pred cccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEE
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 119 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 119 (320)
.+|.+.+.||+|++|.||++.+. ++.+++|.+.............+.+|+++++.++|+|++++++.+...+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 47899999999999999999874 7899999876544444555577889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccccc
Q 020888 120 EYLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 195 (320)
Q Consensus 120 e~~~~~~L~~~~~~----~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~ 195 (320)
||+++++|.+++.. ...+++..++.++.|++.||.|||+.| ++|+||+|+||++ +.++.++|+|||.+....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~nil~--~~~~~~~l~d~g~~~~~~ 157 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR--VMHRDIKPANVFI--TATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCCHHHEEE--cCCCCEEECccccceecc
Confidence 99999999988853 235899999999999999999999988 9999999999999 888899999999887654
Q ss_pred ccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHhCCCCCCCCCCC
Q 020888 196 VQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYE--PYEAAKYVAEGHRPFFRAKGF 273 (320)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~ 273 (320)
.... ......+++.|+|||.+.+..++.++|+||+|++++++++|..||.... .......+.....+......+
T Consensus 158 ~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (267)
T cd08228 158 SKTT----AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHY 233 (267)
T ss_pred chhH----HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhc
Confidence 3211 1123457888999999988889999999999999999999999986543 234444444444444444457
Q ss_pred CHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHH
Q 020888 274 TPELRELTEKCWAADMNQRPSFLDILKRLEKIK 306 (320)
Q Consensus 274 ~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 306 (320)
+..+++++.+||..+|.+|||+.++++.+++++
T Consensus 234 ~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 234 SEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred CHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 889999999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=307.97 Aligned_cols=258 Identities=28% Similarity=0.459 Sum_probs=209.9
Q ss_pred CcccCccceecccCceEEEEEEEC-------CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcccceeeeEEeC
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTER 112 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~-------~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 112 (320)
..+|.+.+.||+|+||.||++.+. ...||+|.+...... .....+.+|+++++.+ +|+||+++++.+...
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~ 114 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHT--DEREALMSELKILSHLGQHKNIVNLLGACTHG 114 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCH--HHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence 347999999999999999998752 247999988654322 2346788999999999 899999999999999
Q ss_pred CceEEEEecCCCCCHHHHHHHh----------------------------------------------------------
Q 020888 113 KPLMLITEYLRGGDLHKYLKEK---------------------------------------------------------- 134 (320)
Q Consensus 113 ~~~~iv~e~~~~~~L~~~~~~~---------------------------------------------------------- 134 (320)
+..++||||+++++|.+++...
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 9999999999999999988542
Q ss_pred ------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCccce
Q 020888 135 ------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDV 202 (320)
Q Consensus 135 ------------~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~~~ 202 (320)
.++++..++.++.|++.||.|||++| ++|+||||+||++ +.++.++|+|||++........ .
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--iiHrDLkp~Nil~--~~~~~~kL~DfGla~~~~~~~~--~ 268 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN--CIHRDVAARNVLL--TDGRVAKICDFGLARDIMNDSN--Y 268 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--EEeccCchheEEE--eCCCeEEEeeceeeeeccCCcc--e
Confidence 14788889999999999999999998 9999999999999 7788999999999876543221 1
Q ss_pred eeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHH
Q 020888 203 YKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELT 281 (320)
Q Consensus 203 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 281 (320)
.......++..|+|||++.+..++.++||||||+++|++++ |..||.....................+..++.++.+++
T Consensus 269 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 348 (374)
T cd05106 269 VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIM 348 (374)
T ss_pred eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHH
Confidence 11122234567999999988899999999999999999997 99999876554433333333223333445689999999
Q ss_pred HHHhhcCCCCCCCHHHHHHHHHHHH
Q 020888 282 EKCWAADMNQRPSFLDILKRLEKIK 306 (320)
Q Consensus 282 ~~~l~~dp~~Rps~~~ll~~L~~~~ 306 (320)
.+||+.||.+|||+.++++.|+++.
T Consensus 349 ~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 349 KMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred HHHcCCChhhCcCHHHHHHHHHHHh
Confidence 9999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=291.64 Aligned_cols=253 Identities=30% Similarity=0.601 Sum_probs=214.0
Q ss_pred CcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEE
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 118 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 118 (320)
..+|.+.+.||.|++|.||++.+. ++.+++|.+.... .....+.+|+++++.++|++++++++++..++..+++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 80 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc----hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEE
Confidence 346888899999999999999875 7889999875432 2236788899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccc
Q 020888 119 TEYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 196 (320)
Q Consensus 119 ~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~ 196 (320)
|||+++++|.+++... ..+++..++.++.|++.+|++||+.| ++|+||+|+||++ +.++.++|+|||.+.....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~nil~--~~~~~~kl~df~~~~~~~~ 156 (263)
T cd05052 81 TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLV--GENHLVKVADFGLSRLMTG 156 (263)
T ss_pred EEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEE--cCCCcEEeCCCcccccccc
Confidence 9999999999998753 35899999999999999999999988 9999999999999 8889999999999876543
Q ss_pred cCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCH
Q 020888 197 QNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTP 275 (320)
Q Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (320)
.... .......+..|+|||...+..++.++|+||||+++|++++ |..||...+..+....+....... .+..++.
T Consensus 157 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 232 (263)
T cd05052 157 DTYT---AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRME-RPEGCPP 232 (263)
T ss_pred ceee---ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCC-CCCCCCH
Confidence 2211 1111223567999999999999999999999999999998 999998887777666666554433 3455899
Q ss_pred HHHHHHHHHhhcCCCCCCCHHHHHHHHHHH
Q 020888 276 ELRELTEKCWAADMNQRPSFLDILKRLEKI 305 (320)
Q Consensus 276 ~l~~li~~~l~~dp~~Rps~~~ll~~L~~~ 305 (320)
++.+++.+||+.+|.+|||+.++++.|+.+
T Consensus 233 ~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 233 KVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred HHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=304.77 Aligned_cols=244 Identities=24% Similarity=0.404 Sum_probs=202.7
Q ss_pred ceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcccceeeeEEeCCceEEEEecCCC
Q 020888 48 AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRG 124 (320)
Q Consensus 48 ~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~~ 124 (320)
+.||+|+||.||++.+. ++.+|+|++.+...........+..|..++..+ +|+||+++++.+...+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46899999999999985 788999998765544444556788899999998 699999999999999999999999999
Q ss_pred CCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCccceee
Q 020888 125 GDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK 204 (320)
Q Consensus 125 ~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~~~~~ 204 (320)
++|.+++...+.+++..+..++.|++.||.|||++| ++|+||||+||++ +.++.++|+|||++........ .
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nili--~~~~~~kL~Dfg~~~~~~~~~~----~ 152 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG--IIYRDLKLDNVLL--DAEGHIKLTDYGMCKEGIRPGD----T 152 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEE--CCCCCEEECcCccccccccCCC----c
Confidence 999999988788999999999999999999999998 9999999999999 8889999999998864322111 1
Q ss_pred ccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh--------HH-HHHHHHhCCCCCCCCCCCCH
Q 020888 205 MTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEP--------YE-AAKYVAEGHRPFFRAKGFTP 275 (320)
Q Consensus 205 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~--------~~-~~~~~~~~~~~~~~~~~~~~ 275 (320)
.....|++.|+|||++.+..++.++|+||||+++|++++|..||..... .+ ....+..... ..+..++.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~--~~p~~~~~ 230 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI--RIPRSLSV 230 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC--CCCCCCCH
Confidence 2235689999999999999999999999999999999999999963221 11 2222333222 22345789
Q ss_pred HHHHHHHHHhhcCCCCCCC------HHHHHHH
Q 020888 276 ELRELTEKCWAADMNQRPS------FLDILKR 301 (320)
Q Consensus 276 ~l~~li~~~l~~dp~~Rps------~~~ll~~ 301 (320)
++.+++++||+.||.+|+| +++++++
T Consensus 231 ~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 231 KASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred HHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 9999999999999999987 6788765
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=305.26 Aligned_cols=252 Identities=28% Similarity=0.453 Sum_probs=201.0
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeC-----Cce
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER-----KPL 115 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~ 115 (320)
+|++.+.||+|++|.||++.++ +..||+|.+........ ....+.+|+++++.++|+||+++++++... ...
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVS-DATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccch-hHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 5889999999999999999875 78899998864332222 235678899999999999999999987532 347
Q ss_pred EEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccccc
Q 020888 116 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 195 (320)
Q Consensus 116 ~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~ 195 (320)
|+||||++ ++|.+++.....+++..+..++.|++.||.|||++| ++|+||||+||++ +.++.++|+|||++....
T Consensus 80 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll--~~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 80 YVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTAN--VFHRDLKPKNILA--NADCKLKICDFGLARVAF 154 (338)
T ss_pred EEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEE--CCCCcEEEccCccccccc
Confidence 99999995 599999988778999999999999999999999998 9999999999999 889999999999987653
Q ss_pred ccCccceeeccCCcccccccCccccCc--CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh-----------
Q 020888 196 VQNSHDVYKMTGETGSYRYMAPEVFKH--RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAE----------- 262 (320)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~----------- 262 (320)
...... .......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||...+.......+..
T Consensus 155 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (338)
T cd07859 155 NDTPTA-IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS 233 (338)
T ss_pred cccCcc-ccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 322111 11233568999999999876 6788999999999999999999999976654322211110
Q ss_pred ----------------CCCCCC--CCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 263 ----------------GHRPFF--RAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 263 ----------------~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
...... ....+++++.+++.+||..||++|||+++++++
T Consensus 234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 000000 012467889999999999999999999999987
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=291.16 Aligned_cols=252 Identities=33% Similarity=0.586 Sum_probs=213.0
Q ss_pred CcccCccceecccCceEEEEEEEC-CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEE
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 119 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~-~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 119 (320)
..+|++.+.||.|++|.||++.++ ++.+++|.+...... .+.+.+|++++++++|+|++++++++...+..+++|
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD----PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVT 80 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCccc----HHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeee
Confidence 456899999999999999999875 567999987654322 256888999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccccccc
Q 020888 120 EYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 197 (320)
Q Consensus 120 e~~~~~~L~~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~ 197 (320)
|++++++|.+++.... .+++..+..++.|++.||.+||+.| ++|+||+|+||++ +.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~--~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05068 81 ELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN--YIHRDLAARNVLV--GENNICKVADFGLARVIKED 156 (261)
T ss_pred ecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCcceEEE--cCCCCEEECCcceEEEccCC
Confidence 9999999999997643 6899999999999999999999988 9999999999999 88889999999998876532
Q ss_pred CccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHH
Q 020888 198 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPE 276 (320)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (320)
... .......+..|+|||...+..++.++|+||||++++++++ |+.||...........+....... .+..++..
T Consensus 157 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 232 (261)
T cd05068 157 IYE---AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMP-CPPGCPKE 232 (261)
T ss_pred ccc---ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC-CCCcCCHH
Confidence 111 1111223457999999999899999999999999999999 999999888777766665554332 33457899
Q ss_pred HHHHHHHHhhcCCCCCCCHHHHHHHHHH
Q 020888 277 LRELTEKCWAADMNQRPSFLDILKRLEK 304 (320)
Q Consensus 277 l~~li~~~l~~dp~~Rps~~~ll~~L~~ 304 (320)
+.+++.+|++.+|.+||++.+++..|+.
T Consensus 233 ~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 233 LYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred HHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 9999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=298.45 Aligned_cols=254 Identities=32% Similarity=0.516 Sum_probs=205.5
Q ss_pred cccCccceecccCceEEEEEEEC------------------CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCccc
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR------------------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 103 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~------------------~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~ 103 (320)
.+|.+.+.||+|+||.||++.+. +..+|+|.+.... .......+.+|++++.+++|+||+
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv 82 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDPNII 82 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCCCee
Confidence 47889999999999999999753 2359999886542 233446788999999999999999
Q ss_pred ceeeeEEeCCceEEEEecCCCCCHHHHHHHh-------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 020888 104 QFLGAVTERKPLMLITEYLRGGDLHKYLKEK-------------------GALSPSTAVNFALDIARGMAYLHNEPNVII 164 (320)
Q Consensus 104 ~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~-------------------~~l~~~~~~~i~~~l~~~l~~lH~~g~~iv 164 (320)
++++++.+.+..+++|||+++++|.+++... ..+++..++.++.|++.||.|||+.| ++
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--iv 160 (304)
T cd05096 83 RLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN--FV 160 (304)
T ss_pred EEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC--cc
Confidence 9999999999999999999999999998652 13677889999999999999999998 99
Q ss_pred ecCCCCCcEEEeeCCCCcEEEecCCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-
Q 020888 165 HRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE- 243 (320)
Q Consensus 165 H~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~- 243 (320)
|+||||+||++ +.++.++|+|||++..+..... ........++..|+|||.+.+..++.++|+||||+++|+|++
T Consensus 161 H~dlkp~Nill--~~~~~~kl~DfG~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~ 236 (304)
T cd05096 161 HRDLATRNCLV--GENLTIKIADFGMSRNLYAGDY--YRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILML 236 (304)
T ss_pred ccCcchhheEE--cCCccEEECCCccceecccCce--eEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHc
Confidence 99999999999 8888999999999876543321 111222345778999999988899999999999999999987
Q ss_pred -CCCCCCCCChHHHHHHHHhC------CCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHH
Q 020888 244 -GEPPLANYEPYEAAKYVAEG------HRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLE 303 (320)
Q Consensus 244 -g~~p~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~ 303 (320)
+..||......+........ ......+..++..+.+++.+||..||++|||++++.+.|+
T Consensus 237 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 237 CKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred cCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 66788877655544333221 1111223457899999999999999999999999988775
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=302.91 Aligned_cols=243 Identities=29% Similarity=0.464 Sum_probs=203.0
Q ss_pred ceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcccceeeeEEeCCceEEEEecCCC
Q 020888 48 AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRG 124 (320)
Q Consensus 48 ~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~~ 124 (320)
+.||+|+||.||++.++ +..+|+|.+.............+..|.+++... +|++|+++++.+...+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999985 778999988654322222335667788888765 899999999999999999999999999
Q ss_pred CCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCccceee
Q 020888 125 GDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK 204 (320)
Q Consensus 125 ~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~~~~~ 204 (320)
++|.+++...+.+++..+..++.|++.||+|||++| ++|+||||+||++ +.++.++|+|||++........ .
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nil~--~~~~~~kl~Dfg~~~~~~~~~~----~ 152 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG--IIYRDLKLDNVML--DRDGHIKIADFGMCKENVFGDN----R 152 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEE--CCCCCEEeCccCCCeecccCCC----c
Confidence 999999988778999999999999999999999998 9999999999999 8889999999998864322111 1
Q ss_pred ccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHH
Q 020888 205 MTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKC 284 (320)
Q Consensus 205 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 284 (320)
.....|++.|+|||++.+..++.++|+||||+++|+|++|..||...+..+....+..... ..+..++.++++++.+|
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~ 230 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTP--HYPRWITKESKDILEKL 230 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--CCCCCCCHHHHHHHHHH
Confidence 2335689999999999999999999999999999999999999998877766665554432 22345789999999999
Q ss_pred hhcCCCCCCCHH-HHHH
Q 020888 285 WAADMNQRPSFL-DILK 300 (320)
Q Consensus 285 l~~dp~~Rps~~-~ll~ 300 (320)
|..||++|+++. ++++
T Consensus 231 l~~dP~~R~~~~~~~~~ 247 (316)
T cd05620 231 FERDPTRRLGVVGNIRG 247 (316)
T ss_pred ccCCHHHcCCChHHHHc
Confidence 999999999984 6654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=294.61 Aligned_cols=248 Identities=40% Similarity=0.733 Sum_probs=205.9
Q ss_pred ccceecccCceEEEEEEEC------CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEE
Q 020888 46 SSAIIGKGSFGEILKAYWR------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 119 (320)
Q Consensus 46 ~~~~lg~g~~~~vy~~~~~------~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 119 (320)
+.+.||.|.||.||++... +..|++|.+... ...+..+.+.+|++.+++++|+||+++++++...+..++|+
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~ 80 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVM 80 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeecccccccccccccccccccccccccccccc
Confidence 4578999999999999987 577999988442 33334588999999999999999999999999888899999
Q ss_pred ecCCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccccccc
Q 020888 120 EYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 197 (320)
Q Consensus 120 e~~~~~~L~~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~ 197 (320)
||+++++|.+++... ..+++..++.++.|++.||.|||+++ ++|+||+++||++ +.++.+||+|||++......
T Consensus 81 e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~--iiH~~l~~~nill--~~~~~~Kl~~f~~~~~~~~~ 156 (259)
T PF07714_consen 81 EYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN--IIHGNLSPSNILL--DSNGQVKLSDFGLSRPISEK 156 (259)
T ss_dssp E--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT--EEEST-SGGGEEE--ETTTEEEEESTTTGEETTTS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccc--ccccccccccccc--cccccccccccccccccccc
Confidence 999999999999886 67999999999999999999999988 9999999999999 88889999999998766322
Q ss_pred CccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHH
Q 020888 198 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPE 276 (320)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (320)
. .............|.|||...+..++.++||||||++++|+++ |..||.+.+..+....+.++.... .+..++..
T Consensus 157 ~--~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 233 (259)
T PF07714_consen 157 S--KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLP-IPDNCPKD 233 (259)
T ss_dssp S--SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETT-SBTTSBHH
T ss_pred c--ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccce-eccchhHH
Confidence 1 1122233446778999999998889999999999999999999 789999998888777776665544 44568999
Q ss_pred HHHHHHHHhhcCCCCCCCHHHHHHHH
Q 020888 277 LRELTEKCWAADMNQRPSFLDILKRL 302 (320)
Q Consensus 277 l~~li~~~l~~dp~~Rps~~~ll~~L 302 (320)
+.+++.+||..+|++|||++++++.|
T Consensus 234 ~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 234 IYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 99999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=309.66 Aligned_cols=255 Identities=24% Similarity=0.369 Sum_probs=212.7
Q ss_pred CCCcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceE
Q 020888 39 PSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLM 116 (320)
Q Consensus 39 ~~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 116 (320)
....+|++.+.||+|+||.||++.+. ++.+|+|.+.............+.+|+++++.++|+||+++++.+..++..|
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 34568999999999999999999885 7889999886543333333456788999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccc
Q 020888 117 LITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 196 (320)
Q Consensus 117 iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~ 196 (320)
+||||++|++|.+++... .+++..+..++.|++.||+|||+.| |+|+||||+||++ +.++.++|+|||.+.....
T Consensus 120 lv~Ey~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl--~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 120 MVMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLL--DKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred EEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEE--cCCCCEEEEeccceeeccC
Confidence 999999999999998764 6899999999999999999999998 9999999999999 8899999999999876543
Q ss_pred cCccceeeccCCcccccccCccccCcC----CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCC--
Q 020888 197 QNSHDVYKMTGETGSYRYMAPEVFKHR----KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA-- 270 (320)
Q Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~-- 270 (320)
... .......|++.|+|||.+.+. .++.++|+|||||++|+|++|..||...+.......+.........+
T Consensus 195 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 271 (370)
T cd05596 195 NGM---VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDD 271 (370)
T ss_pred CCc---ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCc
Confidence 211 112345689999999998653 47889999999999999999999999888776666666543222222
Q ss_pred CCCCHHHHHHHHHHhhcCCCC--CCCHHHHHHH
Q 020888 271 KGFTPELRELTEKCWAADMNQ--RPSFLDILKR 301 (320)
Q Consensus 271 ~~~~~~l~~li~~~l~~dp~~--Rps~~~ll~~ 301 (320)
..++.+++++|++||+.+|.+ |+|+++++++
T Consensus 272 ~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 272 IEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 357999999999999998987 9999999877
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=305.17 Aligned_cols=272 Identities=34% Similarity=0.562 Sum_probs=216.5
Q ss_pred CCCCCCCCcCCCCCcccCccceecccCceEEEEEEECC-CceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCccccee
Q 020888 28 PLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 106 (320)
Q Consensus 28 ~~~~~~~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~-~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 106 (320)
+.+.++-.++..++.+|.....||+|+||+||++...+ ..||||.+....... ..+|.+|++++.+++|+|+++++
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~Ll 137 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLL 137 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEE
Confidence 45556666788888999999999999999999999875 889999775544432 25699999999999999999999
Q ss_pred eeEEeCC-ceEEEEecCCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHhcCC-CCeEecCCCCCcEEEeeCCCCc
Q 020888 107 GAVTERK-PLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEP-NVIIHRDLKPRNVLLVNSSADH 182 (320)
Q Consensus 107 ~~~~~~~-~~~iv~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~~g-~~ivH~di~p~nI~~~~~~~~~ 182 (320)
|+|.+++ ..++|+||+++|+|.+++.... +++|.++++|+.+++.||+|||... .+|+|+||||+||++ |.+..
T Consensus 138 GyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILL--D~~~~ 215 (361)
T KOG1187|consen 138 GYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILL--DEDFN 215 (361)
T ss_pred EEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeE--CCCCC
Confidence 9999988 4999999999999999997644 8999999999999999999999974 379999999999999 99999
Q ss_pred EEEecCCCcccccccCccceeeccCC-cccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCC---hHHHH-
Q 020888 183 LKVGDFGLSKLIKVQNSHDVYKMTGE-TGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYE---PYEAA- 257 (320)
Q Consensus 183 ~~L~dfg~~~~~~~~~~~~~~~~~~~-~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~---~~~~~- 257 (320)
.||+|||++........ ..... .||.+|++||+...+..+.++||||+|++++|++||+.+.+... .....
T Consensus 216 aKlsDFGLa~~~~~~~~----~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~ 291 (361)
T KOG1187|consen 216 AKLSDFGLAKLGPEGDT----SVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVE 291 (361)
T ss_pred EEccCccCcccCCcccc----ceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHH
Confidence 99999999954432110 11112 78999999999999999999999999999999999998877532 11111
Q ss_pred ---HHHHhC-----CCCCCCCCCCC-----HHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhc
Q 020888 258 ---KYVAEG-----HRPFFRAKGFT-----PELRELTEKCWAADMNQRPSFLDILKRLEKIKET 308 (320)
Q Consensus 258 ---~~~~~~-----~~~~~~~~~~~-----~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 308 (320)
..+..+ ..+.......+ ..+..+...|++.+|.+||++.++.+.|..+...
T Consensus 292 w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 292 WAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred HHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 111111 11111112233 2266788899999999999999999998665543
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=314.79 Aligned_cols=259 Identities=26% Similarity=0.402 Sum_probs=216.0
Q ss_pred CcCCCCCcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeC
Q 020888 35 WEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER 112 (320)
Q Consensus 35 ~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 112 (320)
-.......+|.+.+.||+|+||+||++.+. ++.||+|.+....... .....+.+|+..+..++|++++++++.+...
T Consensus 25 ~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~-~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~ 103 (496)
T PTZ00283 25 ATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSE-ADKNRAQAEVCCLLNCDFFSIVKCHEDFAKK 103 (496)
T ss_pred ccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCH-HHHHHHHHHHHHHhcCCCCcEEEeecceecc
Confidence 345555679999999999999999999874 8899999886554433 3346788899999999999999988876432
Q ss_pred C--------ceEEEEecCCCCCHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCC
Q 020888 113 K--------PLMLITEYLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSA 180 (320)
Q Consensus 113 ~--------~~~iv~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~ 180 (320)
+ ..++||||+++|+|.+++.. ...+++..+..++.|++.||.|||+.| |+|+||||+||++ +.+
T Consensus 104 ~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~--IiHrDLKP~NILl--~~~ 179 (496)
T PTZ00283 104 DPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH--MIHRDIKSANILL--CSN 179 (496)
T ss_pred cccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEE--eCC
Confidence 2 36899999999999999865 246899999999999999999999988 9999999999999 888
Q ss_pred CcEEEecCCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 020888 181 DHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYV 260 (320)
Q Consensus 181 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~ 260 (320)
+.++|+|||++.......... ......|++.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+
T Consensus 180 ~~vkL~DFGls~~~~~~~~~~--~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~ 257 (496)
T PTZ00283 180 GLVKLGDFGFSKMYAATVSDD--VGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKT 257 (496)
T ss_pred CCEEEEecccCeecccccccc--ccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 999999999987654322111 122356899999999999999999999999999999999999999988877776666
Q ss_pred HhCCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 261 AEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 261 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
..+..... +..+++++++++..||..||.+||++.+++++
T Consensus 258 ~~~~~~~~-~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 258 LAGRYDPL-PPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred hcCCCCCC-CCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 65554433 34579999999999999999999999999875
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=301.72 Aligned_cols=244 Identities=28% Similarity=0.449 Sum_probs=203.2
Q ss_pred ceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcccceeeeEEeCCceEEEEecCCC
Q 020888 48 AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRG 124 (320)
Q Consensus 48 ~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~~ 124 (320)
+.||+|+||+||++.++ ++.+|+|.+................|..++... +||+|+++++.+...+.+++||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46899999999999986 678999988654322222235566677787765 899999999999999999999999999
Q ss_pred CCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCccceee
Q 020888 125 GDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK 204 (320)
Q Consensus 125 ~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~~~~~ 204 (320)
++|.+++.....+++..+..++.|++.||.|||+.| ++|+||||+||++ +.++.++|+|||++........ .
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivHrdikp~Nil~--~~~~~~kl~Dfg~~~~~~~~~~----~ 152 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG--IVYRDLKLDNILL--DTDGHIKIADFGMCKENMLGDA----K 152 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEE--CCCCCEEEccCCcceECCCCCC----c
Confidence 999999988778999999999999999999999998 9999999999999 8889999999998865322211 1
Q ss_pred ccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHH
Q 020888 205 MTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKC 284 (320)
Q Consensus 205 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 284 (320)
.....+++.|+|||++.+..++.++|+||+||++|+|++|..||...+..+....+..... ..+..++.++++++.+|
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~li~~~ 230 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNP--CYPRWLTREAKDILVKL 230 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--CCCccCCHHHHHHHHHH
Confidence 2234688999999999999999999999999999999999999998887776665554432 22345789999999999
Q ss_pred hhcCCCCCCCHH-HHHHH
Q 020888 285 WAADMNQRPSFL-DILKR 301 (320)
Q Consensus 285 l~~dp~~Rps~~-~ll~~ 301 (320)
|..||.+||++. +++++
T Consensus 231 l~~~P~~R~~~~~~l~~h 248 (316)
T cd05619 231 FVREPERRLGVKGDIRQH 248 (316)
T ss_pred hccCHhhcCCChHHHHcC
Confidence 999999999997 66553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=291.72 Aligned_cols=253 Identities=31% Similarity=0.577 Sum_probs=214.0
Q ss_pred CcccCccceecccCceEEEEEEEC-CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEE
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 119 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~-~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 119 (320)
..+|.+.+.||+|++|.||++... +..+++|.+..... ..+.+.+|+.+++.++|+|++++++.+...+..++++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM----SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIIT 80 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch----hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEE
Confidence 457899999999999999999876 56799997754322 2367889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccccccc
Q 020888 120 EYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 197 (320)
Q Consensus 120 e~~~~~~L~~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~ 197 (320)
||+++++|.+++... ..+++..++.++.+++.||.|||+.| ++|+||+|+||++ +.++.++|+|||.+......
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nili--~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05072 81 EYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN--YIHRDLRAANVLV--SESLMCKIADFGLARVIEDN 156 (261)
T ss_pred ecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEe--cCCCcEEECCCccceecCCC
Confidence 999999999998753 46889999999999999999999988 9999999999999 88889999999999765432
Q ss_pred CccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHH
Q 020888 198 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPE 276 (320)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (320)
.. .......++..|+|||...+..++.++|+||||+++|++++ |..||...........+......+ ....++.+
T Consensus 157 ~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 232 (261)
T cd05072 157 EY---TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMP-RMENCPDE 232 (261)
T ss_pred ce---eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCC-CCCCCCHH
Confidence 11 11122334667999999998889999999999999999998 999998887777666666554433 23457999
Q ss_pred HHHHHHHHhhcCCCCCCCHHHHHHHHHHH
Q 020888 277 LRELTEKCWAADMNQRPSFLDILKRLEKI 305 (320)
Q Consensus 277 l~~li~~~l~~dp~~Rps~~~ll~~L~~~ 305 (320)
+.+++.+|+..+|++|||++++++.|+++
T Consensus 233 ~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 233 LYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred HHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 99999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=291.65 Aligned_cols=257 Identities=26% Similarity=0.375 Sum_probs=226.3
Q ss_pred CcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEE
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 118 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 118 (320)
-..|.+++.||+|.-|+||++... +..+|+|++.+......+.+.+..-|-++|+.++||.++.++..++.+...|++
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~ 155 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV 155 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence 347889999999999999999987 489999999888777788889999999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccc
Q 020888 119 TEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 196 (320)
Q Consensus 119 ~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~ 196 (320)
||||+||+|..++++++ .+++..+..++.+++-||+|||-.| ||+|||||+||+| .++|.+-|+||.++.....
T Consensus 156 meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG--ivYRDLKPENILv--redGHIMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG--IVYRDLKPENILV--REDGHIMLSDFDLSLRCPV 231 (459)
T ss_pred EecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc--eeeccCCcceeEE--ecCCcEEeeeccccccCCC
Confidence 99999999999998754 6999999999999999999999999 9999999999999 8999999999998765422
Q ss_pred cCc--------------------------------c--------------------ceeeccCCcccccccCccccCcCC
Q 020888 197 QNS--------------------------------H--------------------DVYKMTGETGSYRYMAPEVFKHRK 224 (320)
Q Consensus 197 ~~~--------------------------------~--------------------~~~~~~~~~~~~~y~aPE~~~~~~ 224 (320)
... . .....+..+||-.|+|||++.|..
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G 311 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG 311 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence 000 0 001122346899999999999999
Q ss_pred CCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCC----HHHHHH
Q 020888 225 YDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPS----FLDILK 300 (320)
Q Consensus 225 ~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps----~~~ll~ 300 (320)
++.+.|=|+||+++|||+.|..||.+.+..+....+............++..+++||+.+|..||.+|.. +.+|.+
T Consensus 312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKR 391 (459)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhc
Confidence 9999999999999999999999999999999988888777665555567899999999999999999987 888776
Q ss_pred H
Q 020888 301 R 301 (320)
Q Consensus 301 ~ 301 (320)
|
T Consensus 392 H 392 (459)
T KOG0610|consen 392 H 392 (459)
T ss_pred C
Confidence 5
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=312.82 Aligned_cols=252 Identities=25% Similarity=0.377 Sum_probs=212.3
Q ss_pred CCcccCccceecccCceEEEEEEEC---CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceE
Q 020888 40 SELDFSSSAIIGKGSFGEILKAYWR---GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLM 116 (320)
Q Consensus 40 ~~~~y~~~~~lg~g~~~~vy~~~~~---~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 116 (320)
....|.+.+.||+|++|.||++... +..+++|.+... .......+.+|+.+++.++|+||+++++++..++..|
T Consensus 65 ~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~ 141 (478)
T PTZ00267 65 REHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLL 141 (478)
T ss_pred cceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEE
Confidence 3446999999999999999999864 456888866332 2333467788999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcc
Q 020888 117 LITEYLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 192 (320)
Q Consensus 117 iv~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~ 192 (320)
+||||++|++|.+++.. ..++++..+..++.|++.||.|||+.| |+||||||+||++ +.++.++|+|||++.
T Consensus 142 lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll--~~~~~~kL~DFgla~ 217 (478)
T PTZ00267 142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK--MMHRDLKSANIFL--MPTGIIKLGDFGFSK 217 (478)
T ss_pred EEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCcCHHhEEE--CCCCcEEEEeCcCce
Confidence 99999999999988753 346899999999999999999999998 9999999999999 888999999999998
Q ss_pred cccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCC
Q 020888 193 LIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKG 272 (320)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (320)
........ .......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+..+..... +..
T Consensus 218 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~-~~~ 294 (478)
T PTZ00267 218 QYSDSVSL--DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPF-PCP 294 (478)
T ss_pred ecCCcccc--ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC-Ccc
Confidence 66432211 112335689999999999999999999999999999999999999998887777666665544332 345
Q ss_pred CCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 273 FTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 273 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
++.+++++|..||..||++|||+++++++
T Consensus 295 ~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 295 VSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 78999999999999999999999998754
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=293.49 Aligned_cols=261 Identities=30% Similarity=0.531 Sum_probs=217.5
Q ss_pred CcccCccceecccCceEEEEEEEC-------CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCC
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK 113 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~-------~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 113 (320)
..+|.+.+.||+|++|.||++.+. ...+++|.+.... ....+.+.+|++.+++++|+||+++++++..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT---LAARKDFQREAELLTNLQHEHIVKFYGVCGDGD 80 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc---HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 346888899999999999999753 3457788764322 233367889999999999999999999999999
Q ss_pred ceEEEEecCCCCCHHHHHHHhC----------------CCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEee
Q 020888 114 PLMLITEYLRGGDLHKYLKEKG----------------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN 177 (320)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~~----------------~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~ 177 (320)
..++||||+++++|.+++..++ .+++..++.++.|++.||.+||++| ++|+||||+||++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~Nil~-- 156 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLV-- 156 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEE--
Confidence 9999999999999999997542 3789999999999999999999998 9999999999999
Q ss_pred CCCCcEEEecCCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 020888 178 SSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEA 256 (320)
Q Consensus 178 ~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~ 256 (320)
+.++.++|+|||.+........ ........++..|+|||...+..++.++|+||||+++|+|++ |..||......+.
T Consensus 157 ~~~~~~~l~dfg~a~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 234 (291)
T cd05094 157 GANLLVKIGDFGMSRDVYSTDY--YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV 234 (291)
T ss_pred ccCCcEEECCCCcccccCCCce--eecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 8888999999999875543221 111222345778999999999999999999999999999999 9999988887777
Q ss_pred HHHHHhCCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcCCC
Q 020888 257 AKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPT 311 (320)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~ 311 (320)
...+..+.... .+...+..+++++.+||..+|++|||+.++++.|.++....+.
T Consensus 235 ~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~~~~ 288 (291)
T cd05094 235 IECITQGRVLE-RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKATPI 288 (291)
T ss_pred HHHHhCCCCCC-CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhhcCc
Confidence 76666554433 2344789999999999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=303.86 Aligned_cols=244 Identities=30% Similarity=0.462 Sum_probs=202.4
Q ss_pred ceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHH-HHHhCCCCcccceeeeEEeCCceEEEEecCCC
Q 020888 48 AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVN-LLVKLRHPNIVQFLGAVTERKPLMLITEYLRG 124 (320)
Q Consensus 48 ~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~ 124 (320)
+.||+|+||+||++.+. ++.+|+|.+.............+..|.. +++.++|+||+++++.+...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46899999999999985 7889999886543322222344444544 56778999999999999999999999999999
Q ss_pred CCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCccceee
Q 020888 125 GDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK 204 (320)
Q Consensus 125 ~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~~~~~ 204 (320)
++|.+++...+.+++..+..++.||+.||.|||++| ++|+||||+||++ +.++.++|+|||++........ .
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~g--ivH~dikp~NIll--~~~~~~kl~Dfg~~~~~~~~~~----~ 152 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLN--IIYRDLKPENILL--DSQGHVVLTDFGLCKEGIEHSK----T 152 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEE--CCCCcEEEeccCCCcccccCCC----c
Confidence 999999988788999999999999999999999998 9999999999999 8889999999998864322111 1
Q ss_pred ccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHH
Q 020888 205 MTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKC 284 (320)
Q Consensus 205 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 284 (320)
.....|++.|+|||++.+..++.++|+||||+++|+|++|..||...+..+....+...... ....++.++.++|.+|
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~~~li~~~ 230 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLR--LKPNISVSARHLLEGL 230 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCC--CCCCCCHHHHHHHHHH
Confidence 22346899999999999999999999999999999999999999988877776666654432 2334799999999999
Q ss_pred hhcCCCCCCCHH----HHHHH
Q 020888 285 WAADMNQRPSFL----DILKR 301 (320)
Q Consensus 285 l~~dp~~Rps~~----~ll~~ 301 (320)
|+.||.+||++. +++++
T Consensus 231 l~~~p~~R~~~~~~~~~il~~ 251 (323)
T cd05575 231 LQKDRTKRLGAKDDFLEIKNH 251 (323)
T ss_pred hhcCHHhCCCCCCCHHHHHcC
Confidence 999999999874 55543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-44 Score=284.63 Aligned_cols=252 Identities=28% Similarity=0.459 Sum_probs=218.5
Q ss_pred cccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEE
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 119 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 119 (320)
.+|++-..||+|.|+.||++.+. |+.+++|++........ ..+.+.+|+.+-+.|+||||+++++.+......|+||
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 47889999999999999998875 88999997754333322 4488999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE-eeCCCCcEEEecCCCcccccccC
Q 020888 120 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLL-VNSSADHLKVGDFGLSKLIKVQN 198 (320)
Q Consensus 120 e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~-~~~~~~~~~L~dfg~~~~~~~~~ 198 (320)
|+++|+.|..=+-.+.-+++..+-..+.||+.+|.|||.+| |||+|+||+|+++ +.+...-+||+|||++..+..+
T Consensus 90 e~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~--IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g- 166 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNG--IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDG- 166 (355)
T ss_pred ecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeeeeccCCCceeecccceEEEeCCc-
Confidence 99999998644433345788888999999999999999988 9999999999999 4455557999999999987632
Q ss_pred ccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCC--CCCCHH
Q 020888 199 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA--KGFTPE 276 (320)
Q Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 276 (320)
....+..|||.|+|||++....++..+|||+-|++||-++.|..||.+.+......++.++......+ ..++++
T Consensus 167 ----~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~ 242 (355)
T KOG0033|consen 167 ----EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPE 242 (355)
T ss_pred ----cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHH
Confidence 24566789999999999999999999999999999999999999999999999999999887544332 568999
Q ss_pred HHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 277 LRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 277 l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
.++++++||..||.+|.|+.|.|++
T Consensus 243 Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 243 AKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred HHHHHHHHhccChhhhccHHHHhCC
Confidence 9999999999999999999998865
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=318.98 Aligned_cols=267 Identities=21% Similarity=0.381 Sum_probs=219.0
Q ss_pred CcCCCCCcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCC-CCcccceeee-EE
Q 020888 35 WEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGA-VT 110 (320)
Q Consensus 35 ~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~-~~ 110 (320)
..+.....++++.+.|.+|||+.||++++. +..+|+|++. ..+++.++.+.+|+++++.|. |+|||.++|. ..
T Consensus 30 ~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~---~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~ 106 (738)
T KOG1989|consen 30 QTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMY---VNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAI 106 (738)
T ss_pred eEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeee---cCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccc
Confidence 346666778999999999999999999986 4899999874 346778899999999999996 9999999993 21
Q ss_pred ---eC---CceEEEEecCCCCCHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCc
Q 020888 111 ---ER---KPLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH 182 (320)
Q Consensus 111 ---~~---~~~~iv~e~~~~~~L~~~~~~--~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~ 182 (320)
.. -.++++||||.||.|-|+++. +..|++.++++|+.++++|+.+||....+|+|||||-+|||+ +.++.
T Consensus 107 ~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLl--s~~g~ 184 (738)
T KOG1989|consen 107 NRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLL--SADGN 184 (738)
T ss_pred cccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEE--cCCCC
Confidence 11 236899999999999999985 456999999999999999999999999899999999999999 88999
Q ss_pred EEEecCCCcccccccCcc-ce----eeccCCcccccccCcccc---CcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH
Q 020888 183 LKVGDFGLSKLIKVQNSH-DV----YKMTGETGSYRYMAPEVF---KHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPY 254 (320)
Q Consensus 183 ~~L~dfg~~~~~~~~~~~-~~----~~~~~~~~~~~y~aPE~~---~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~ 254 (320)
.||||||.+......... .. ...-....|+.|+|||.+ .+..+++++|||+|||+||-|+...+||+.....
T Consensus 185 ~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l 264 (738)
T KOG1989|consen 185 YKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL 264 (738)
T ss_pred EEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce
Confidence 999999998765443211 00 001112479999999976 5678999999999999999999999999987543
Q ss_pred HHHHHHHhCCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcCC
Q 020888 255 EAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLP 310 (320)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~ 310 (320)
.+ ..+.........++..+.+||+.||+.||++||++.+++.++.++...-.
T Consensus 265 aI----lng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~ 316 (738)
T KOG1989|consen 265 AI----LNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPC 316 (738)
T ss_pred eE----EeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCC
Confidence 32 22332222234589999999999999999999999999999999876544
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=284.50 Aligned_cols=250 Identities=25% Similarity=0.466 Sum_probs=221.5
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCC-----cHHHHHHHHHHHHHHHhC-CCCcccceeeeEEeCCc
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSD-----DRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKP 114 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~-----~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 114 (320)
.|.-.++||.|..+.|.++.++ +..+++|++...... ..+..+.-..|+.+|+++ .||+|+++.++++.+..
T Consensus 18 ~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF 97 (411)
T KOG0599|consen 18 KYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAF 97 (411)
T ss_pred hcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcch
Confidence 6777899999999999998875 788888877443222 234456677899999999 59999999999999999
Q ss_pred eEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccc
Q 020888 115 LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 194 (320)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~ 194 (320)
.++|||.++.|.|.|++.+.-.++++....|+.|++.+++|||.++ |||+|+||+||++ +++.+++|+|||+++.+
T Consensus 98 ~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~--IVHRDLKpENILl--ddn~~i~isDFGFa~~l 173 (411)
T KOG0599|consen 98 VFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARN--IVHRDLKPENILL--DDNMNIKISDFGFACQL 173 (411)
T ss_pred hhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhh--hhhcccChhheee--ccccceEEeccceeecc
Confidence 9999999999999999998888999999999999999999999998 9999999999999 89999999999999998
Q ss_pred cccCccceeeccCCcccccccCccccCc------CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCC
Q 020888 195 KVQNSHDVYKMTGETGSYRYMAPEVFKH------RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFF 268 (320)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 268 (320)
..+. .....+|||+|+|||.+.+ ..|+...|+|++|++||.++.|..||......-+...+.+++....
T Consensus 174 ~~Ge-----kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~ 248 (411)
T KOG0599|consen 174 EPGE-----KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFR 248 (411)
T ss_pred CCch-----hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccC
Confidence 7665 4566799999999999864 4678899999999999999999999999988889999998886655
Q ss_pred CC--CCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 269 RA--KGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 269 ~~--~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
.+ ..++.+.+++|.+||++||.+|.|++++|+|
T Consensus 249 speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 249 SPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred CcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 54 4578999999999999999999999999987
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=276.39 Aligned_cols=250 Identities=28% Similarity=0.433 Sum_probs=207.3
Q ss_pred cccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEE
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 119 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 119 (320)
.+|...+.+|+|.||.||++.++ ++.||+|.+......+.-. ....+|++.|+.++|+||+.++++|...+...+|+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~-~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGIN-RTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCcc-HHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence 36888999999999999999986 8999999987765543322 45667999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccC
Q 020888 120 EYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 198 (320)
Q Consensus 120 e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~ 198 (320)
||++- +|...++.. -.++...+..++.+++.||+|||.+. |.|+||||.|+++ +.+|.+||.|||+++.+..+.
T Consensus 81 Efm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~--IlHRDlKPnNLLi--s~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 81 EFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKW--ILHRDLKPNNLLI--SSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred Eeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhh--hhcccCCccceEE--cCCCcEEeecccchhccCCCC
Confidence 99954 999999864 46899999999999999999999988 9999999999999 999999999999999887654
Q ss_pred ccceeeccCCcccccccCccccCcC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCC-------------
Q 020888 199 SHDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH------------- 264 (320)
Q Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~------------- 264 (320)
.... ..+.|.+|.|||.+.|. .|+...||||.||++.||+-|..-|.+.+..+-...+....
T Consensus 156 ~~~~----~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~ 231 (318)
T KOG0659|consen 156 RIQT----HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTS 231 (318)
T ss_pred cccc----cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccc
Confidence 3222 23679999999998775 68999999999999999999987777666554443333211
Q ss_pred ---------CCCCC----CCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 265 ---------RPFFR----AKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 265 ---------~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
.+... ....+.+..+++..||..||.+|+|+.|++++
T Consensus 232 lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 232 LPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred cccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 00000 12246778999999999999999999999987
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=309.95 Aligned_cols=254 Identities=28% Similarity=0.462 Sum_probs=211.3
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEe
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 120 (320)
+|++.+.||+|+||+||++.++ ++.+|+|++.............+.+|+.++..++|++++++++.+.+++..|+|||
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E 81 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIME 81 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 6889999999999999999885 78899998865433334445778889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCcc
Q 020888 121 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 200 (320)
Q Consensus 121 ~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~ 200 (320)
|++|++|.+++.+.+.+++..+..++.|++.||.|||+.| |+|+||||+||++ +.++.++|+|||++..+......
T Consensus 82 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~g--ivHrDLkp~NIli--~~~~~vkL~DfG~~~~~~~~~~~ 157 (360)
T cd05627 82 FLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG--FIHRDIKPDNLLL--DAKGHVKLSDFGLCTGLKKAHRT 157 (360)
T ss_pred CCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEE--CCCCCEEEeeccCCccccccccc
Confidence 9999999999988888999999999999999999999999 9999999999999 88899999999998755321100
Q ss_pred c-------------------------------eeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCC
Q 020888 201 D-------------------------------VYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLA 249 (320)
Q Consensus 201 ~-------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~ 249 (320)
. ........||+.|+|||++.+..++.++|+|||||++|+|++|..||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~ 237 (360)
T cd05627 158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (360)
T ss_pred ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCC
Confidence 0 000113468999999999999999999999999999999999999999
Q ss_pred CCChHHHHHHHHhCCCCC--CCCCCCCHHHHHHHHHHhhcCCCCCC---CHHHHHHH
Q 020888 250 NYEPYEAAKYVAEGHRPF--FRAKGFTPELRELTEKCWAADMNQRP---SFLDILKR 301 (320)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~~ll~~ 301 (320)
..+..+....+....... .....++++++++|.+|+. ||.+|+ ++++++++
T Consensus 238 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 238 SETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence 888777666555422111 1122368999999999874 999998 47888877
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=295.38 Aligned_cols=250 Identities=27% Similarity=0.408 Sum_probs=206.0
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEe
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 120 (320)
.|++.+.||+|++|+||++.+. ++.+|+|.+.............+.+|+.+++.++|++|+++++.+..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4788999999999999999975 78899998865443333334567789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccC
Q 020888 121 YLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 198 (320)
Q Consensus 121 ~~~~~~L~~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~ 198 (320)
|+++++|.+++... ..+++..+..++.|++.||.|||+.| ++|+||+|+||++ +.++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~--~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER--IVYRDLKPENILL--DDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHEEE--CCCCCEEEeeCCCceecCCCC
Confidence 99999999888653 36899999999999999999999998 9999999999999 888899999999987653221
Q ss_pred ccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCC--CCCCCCCCCCHH
Q 020888 199 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH--RPFFRAKGFTPE 276 (320)
Q Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 276 (320)
......+++.|+|||.+.+..++.++|+||+|+++|++++|..||...........+.... .....+..+++.
T Consensus 157 -----~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (285)
T cd05605 157 -----TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEA 231 (285)
T ss_pred -----ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHH
Confidence 1123467899999999998899999999999999999999999998765433222221111 111223457999
Q ss_pred HHHHHHHHhhcCCCCCC-----CHHHHHHH
Q 020888 277 LRELTEKCWAADMNQRP-----SFLDILKR 301 (320)
Q Consensus 277 l~~li~~~l~~dp~~Rp-----s~~~ll~~ 301 (320)
+++++.+||..||.+|| ++++++++
T Consensus 232 ~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 232 ARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred HHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 99999999999999999 89999876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=288.53 Aligned_cols=249 Identities=30% Similarity=0.523 Sum_probs=214.2
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEe
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 120 (320)
+|.+.+.||+|++|.||++.+. +..+++|.+........ ....+.+|+++++.++|+|++++++.+...+..++++|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRR-EREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHH-HHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 4788899999999999999875 78899998865443333 34778899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccC
Q 020888 121 YLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 198 (320)
Q Consensus 121 ~~~~~~L~~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~ 198 (320)
|+++++|.+++... ..+++..++.++.+++.||.|||+.| ++|+||+|+||++ +.++.++|+|||++..+....
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~--i~h~dl~~~nili--~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK--ILHRDIKSLNLFL--DAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEE--eCCCCEEEcccccceeccCcc
Confidence 99999999999764 46899999999999999999999988 9999999999999 788899999999987664332
Q ss_pred ccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHH
Q 020888 199 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 278 (320)
Q Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 278 (320)
. ......+++.|.|||...+..++.++|+||||++++++++|..||...+.......+..+..+.... .++.+++
T Consensus 156 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 230 (256)
T cd08529 156 N----FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQ-MYSQQLA 230 (256)
T ss_pred c----hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcc-ccCHHHH
Confidence 1 1223457888999999999999999999999999999999999999888777666666665544333 5789999
Q ss_pred HHHHHHhhcCCCCCCCHHHHHHH
Q 020888 279 ELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 279 ~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
+++.+||+.+|++||++.+++++
T Consensus 231 ~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 231 QLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred HHHHHHccCCcccCcCHHHHhhC
Confidence 99999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=292.64 Aligned_cols=254 Identities=31% Similarity=0.529 Sum_probs=214.1
Q ss_pred CcccCccceecccCceEEEEEEEC-------CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCC
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK 113 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~-------~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 113 (320)
..+|.+.+.||+|++|.||++.+. +..+++|.+..... .+..+.+.+|+++++.++|+|++++++++..+.
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 81 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS--NDARKDFEREAELLTNFQHENIVKFYGVCTEGD 81 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC--HHHHHHHHHHHHHHHhcCCCCchheeeEEecCC
Confidence 457999999999999999999763 36799998865433 223478899999999999999999999999999
Q ss_pred ceEEEEecCCCCCHHHHHHHh--------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCC
Q 020888 114 PLMLITEYLRGGDLHKYLKEK--------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS 179 (320)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~--------------~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~ 179 (320)
..+++|||+++++|.+++... ..+++..+..++.|++.++.+||+.| ++|+||+|+||++ +.
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~h~dlkp~nili--~~ 157 (280)
T cd05049 82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH--FVHRDLATRNCLV--GY 157 (280)
T ss_pred CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eeccccccceEEE--cC
Confidence 999999999999999999753 24788899999999999999999998 9999999999999 88
Q ss_pred CCcEEEecCCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 020888 180 ADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAK 258 (320)
Q Consensus 180 ~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~ 258 (320)
++.++|+|||.+..+..... ........+++.|+|||.+.+..++.++|+||||+++|++++ |..||...+..+...
T Consensus 158 ~~~~kl~d~g~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~ 235 (280)
T cd05049 158 DLVVKIGDFGMSRDVYTTDY--YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIE 235 (280)
T ss_pred CCeEEECCcccceecccCcc--eecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 89999999999875432211 011122335678999999999999999999999999999998 999998888777777
Q ss_pred HHHhCCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHH
Q 020888 259 YVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLE 303 (320)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~ 303 (320)
.+..+..... +..++.++++++.+||..||.+|||++++++.|+
T Consensus 236 ~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 236 CITQGRLLQR-PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HHHcCCcCCC-CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 7765554433 3458999999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=304.69 Aligned_cols=271 Identities=30% Similarity=0.531 Sum_probs=217.3
Q ss_pred CCCCCCCCCCcCCCCCcccCccceecccCceEEEEEEEC-------CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCC
Q 020888 26 PPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR 98 (320)
Q Consensus 26 ~~~~~~~~~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~-------~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~ 98 (320)
+...|.-+.|..+ ..+|.+.+.||.|+||.||++.+. ...||+|.+..... ....+.+.+|+++++++.
T Consensus 23 ~~~~~~~~~~~~~--~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~~l~~l~ 98 (400)
T cd05105 23 PMQLPYDSRWEFP--RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTAR--SSEKQALMSELKIMTHLG 98 (400)
T ss_pred cccCCCCCceecc--ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhcC
Confidence 3345555666655 458899999999999999999863 23599998865432 233467889999999996
Q ss_pred -CCcccceeeeEEeCCceEEEEecCCCCCHHHHHHHh-------------------------------------------
Q 020888 99 -HPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK------------------------------------------- 134 (320)
Q Consensus 99 -h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~------------------------------------------- 134 (320)
||||+++++++...+..|+||||+++|+|.+++..+
T Consensus 99 ~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (400)
T cd05105 99 PHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYM 178 (400)
T ss_pred CCCCeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccc
Confidence 999999999999999999999999999999987542
Q ss_pred -----------------------------------------------------CCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 020888 135 -----------------------------------------------------GALSPSTAVNFALDIARGMAYLHNEPN 161 (320)
Q Consensus 135 -----------------------------------------------------~~l~~~~~~~i~~~l~~~l~~lH~~g~ 161 (320)
..+++..+..++.|++.||.|||+.|
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~- 257 (400)
T cd05105 179 DMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN- 257 (400)
T ss_pred ccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 13678888999999999999999988
Q ss_pred CeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHH
Q 020888 162 VIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEM 241 (320)
Q Consensus 162 ~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l 241 (320)
++|+||||+||++ +.++.++|+|||++........ ........++..|+|||.+.+..++.++||||||+++|++
T Consensus 258 -ivH~dikp~Nill--~~~~~~kL~DfGla~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~el 332 (400)
T cd05105 258 -CVHRDLAARNVLL--AQGKIVKICDFGLARDIMHDSN--YVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEI 332 (400)
T ss_pred -eeCCCCChHhEEE--eCCCEEEEEeCCcceecccccc--ccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHH
Confidence 9999999999999 7788999999999876543221 1112223456789999999988999999999999999999
Q ss_pred Hh-CCCCCCCCChHHH-HHHHHhCCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHh
Q 020888 242 LE-GEPPLANYEPYEA-AKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKE 307 (320)
Q Consensus 242 l~-g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 307 (320)
++ |..||........ ...+..+.. ...+..++.++.+++.+||+.||++|||+.++.+.|+++..
T Consensus 333 lt~g~~P~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 333 FSLGGTPYPGMIVDSTFYNKIKSGYR-MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred HHCCCCCCcccchhHHHHHHHhcCCC-CCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 97 9999987654333 333333332 33345689999999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=287.53 Aligned_cols=249 Identities=33% Similarity=0.641 Sum_probs=210.4
Q ss_pred cccCccceecccCceEEEEEEEC-CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEe
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~-~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 120 (320)
.+|.+.+.||+|+||.||++.++ +..+++|.+...... ...+.+|++++++++|+||+++++++...+..+++||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 79 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMS----EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTE 79 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCcc----HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEE
Confidence 46888999999999999999886 457999977543222 2567889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCc
Q 020888 121 YLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 199 (320)
Q Consensus 121 ~~~~~~L~~~~~~-~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~ 199 (320)
|+++++|.+++.. .+.+++..++.++.+++.||.|||+.| ++|+||+|+||++ +.++.++|+|||.+........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i--~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05114 80 FMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS--FIHRDLAARNCLV--SSTGVVKVSDFGMTRYVLDDEY 155 (256)
T ss_pred cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcceEEE--cCCCeEEECCCCCccccCCCce
Confidence 9999999999875 346899999999999999999999988 9999999999999 7888999999998876532211
Q ss_pred cceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHH
Q 020888 200 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 278 (320)
Q Consensus 200 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 278 (320)
.......++..|+|||...+..++.++|+||||+++|++++ |+.||...+..+....+..+.... .+...+.++.
T Consensus 156 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~-~~~~~~~~~~ 231 (256)
T cd05114 156 ---TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLY-RPKLASMTVY 231 (256)
T ss_pred ---eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCC-CCCCCCHHHH
Confidence 11112234567999999998889999999999999999999 999999888777777776655433 2344688999
Q ss_pred HHHHHHhhcCCCCCCCHHHHHHHH
Q 020888 279 ELTEKCWAADMNQRPSFLDILKRL 302 (320)
Q Consensus 279 ~li~~~l~~dp~~Rps~~~ll~~L 302 (320)
+++.+||..+|.+|||++++++.|
T Consensus 232 ~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 232 EVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred HHHHHHccCCcccCcCHHHHHHhh
Confidence 999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=305.03 Aligned_cols=243 Identities=29% Similarity=0.446 Sum_probs=205.8
Q ss_pred ceecccCceEEEEEEE-----CCCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEecC
Q 020888 48 AIIGKGSFGEILKAYW-----RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYL 122 (320)
Q Consensus 48 ~~lg~g~~~~vy~~~~-----~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~ 122 (320)
+.||+|+||.||++.+ .++.+|+|++........ ....+.+|++++++++|+||+++++.+...+..|+||||+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVR-DRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhh-hHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 6799999999999875 368899998865433222 2256678999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCccce
Q 020888 123 RGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDV 202 (320)
Q Consensus 123 ~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~~~ 202 (320)
++++|.+++.....+++..++.++.|++.||.|||+.| ++|+||||+||++ +.++.++|+|||++........
T Consensus 81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~--~~~~~~kL~Dfg~~~~~~~~~~--- 153 (318)
T cd05582 81 RGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILL--DEEGHIKLTDFGLSKESIDHEK--- 153 (318)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHeEE--CCCCcEEEeeccCCcccCCCCC---
Confidence 99999999988778999999999999999999999998 9999999999999 8889999999999875433211
Q ss_pred eeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHH
Q 020888 203 YKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTE 282 (320)
Q Consensus 203 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 282 (320)
......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+..+....+...... .+..+++++++++.
T Consensus 154 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~--~p~~~~~~~~~li~ 230 (318)
T cd05582 154 -KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLG--MPQFLSPEAQSLLR 230 (318)
T ss_pred -ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCC--CCCCCCHHHHHHHH
Confidence 122346889999999999988999999999999999999999999988877776666554432 23457999999999
Q ss_pred HHhhcCCCCCCC-----HHHHHHH
Q 020888 283 KCWAADMNQRPS-----FLDILKR 301 (320)
Q Consensus 283 ~~l~~dp~~Rps-----~~~ll~~ 301 (320)
+||+.||++||| +++++.+
T Consensus 231 ~~l~~~P~~R~~a~~~~~~~~~~~ 254 (318)
T cd05582 231 ALFKRNPANRLGAGPDGVEEIKRH 254 (318)
T ss_pred HHhhcCHhHcCCCCCCCHHHHhCC
Confidence 999999999999 5556544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=290.75 Aligned_cols=254 Identities=33% Similarity=0.598 Sum_probs=216.1
Q ss_pred CCcccCccceecccCceEEEEEEEC-CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEE
Q 020888 40 SELDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 118 (320)
Q Consensus 40 ~~~~y~~~~~lg~g~~~~vy~~~~~-~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 118 (320)
...+|++.+.||.|++|.||++.+. +..+++|.+..... .....+.+|+.+++.++|+|++++++++...+..+++
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDL---LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYII 80 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccch---hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEE
Confidence 3457999999999999999999986 67899998755432 2236788899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccc
Q 020888 119 TEYLRGGDLHKYLKE--KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 196 (320)
Q Consensus 119 ~e~~~~~~L~~~~~~--~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~ 196 (320)
|||+++++|.+++.. ...+++..++.++.|++.||.|||+.| ++|+||+|+||++ +.++.++|+|||.+.....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~h~dl~~~nilv--~~~~~~kl~d~g~~~~~~~ 156 (261)
T cd05148 81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN--SIHRDLAARNILV--GEDLVCKVADFGLARLIKE 156 (261)
T ss_pred EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccCcceEEE--cCCceEEEccccchhhcCC
Confidence 999999999999975 346899999999999999999999988 9999999999999 8888999999999876533
Q ss_pred cCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCH
Q 020888 197 QNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTP 275 (320)
Q Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (320)
.. .......++..|+|||...+..++.++|+||||+++|++++ |..||......+....+........ +..+++
T Consensus 157 ~~----~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 231 (261)
T cd05148 157 DV----YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPC-PAKCPQ 231 (261)
T ss_pred cc----ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCC-CCCCCH
Confidence 21 11112335667999999988889999999999999999998 8999988877777776665544433 356799
Q ss_pred HHHHHHHHHhhcCCCCCCCHHHHHHHHHHH
Q 020888 276 ELRELTEKCWAADMNQRPSFLDILKRLEKI 305 (320)
Q Consensus 276 ~l~~li~~~l~~dp~~Rps~~~ll~~L~~~ 305 (320)
++.+++.+||+.||.+|||+.++++.|+.+
T Consensus 232 ~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 232 EIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred HHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 999999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=287.00 Aligned_cols=249 Identities=28% Similarity=0.515 Sum_probs=207.7
Q ss_pred eecccCceEEEEEEE----CCCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEecCCC
Q 020888 49 IIGKGSFGEILKAYW----RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRG 124 (320)
Q Consensus 49 ~lg~g~~~~vy~~~~----~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~ 124 (320)
.||+|++|.||++.+ ++..+++|++..... .....+.+.+|+.+++.++|+||+++++++. ++..++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNN-DPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCC-cHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCC
Confidence 589999999999865 267899998754432 3334578889999999999999999999876 4567899999999
Q ss_pred CCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCccceee
Q 020888 125 GDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK 204 (320)
Q Consensus 125 ~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~~~~~ 204 (320)
++|.+++.....+++..+..++.|++.||.+||++| ++|+||||+||++ +.++.++|+|||.+.......... ..
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~nill--~~~~~~kl~Dfg~~~~~~~~~~~~-~~ 154 (257)
T cd05116 80 GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN--FVHRDLAARNVLL--VTQHYAKISDFGLSKALGADENYY-KA 154 (257)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchhhEEE--cCCCeEEECCCccccccCCCCCee-ee
Confidence 999999987778999999999999999999999998 9999999999999 788899999999987664332211 11
Q ss_pred ccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHH
Q 020888 205 MTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEK 283 (320)
Q Consensus 205 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 283 (320)
.....++..|+|||.+.+..++.++|+||||+++|++++ |..||......+....+..+..+. .+..++.+++++|.+
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~-~~~~~~~~l~~li~~ 233 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERME-CPQRCPPEMYDLMKL 233 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCC-CCCCCCHHHHHHHHH
Confidence 112234578999999988889999999999999999998 999999887777777666655433 344589999999999
Q ss_pred HhhcCCCCCCCHHHHHHHHHHH
Q 020888 284 CWAADMNQRPSFLDILKRLEKI 305 (320)
Q Consensus 284 ~l~~dp~~Rps~~~ll~~L~~~ 305 (320)
||+.||.+||++.++.+.|+.+
T Consensus 234 ~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 234 CWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred HhccCchhCcCHHHHHHHHhcc
Confidence 9999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=300.41 Aligned_cols=249 Identities=29% Similarity=0.448 Sum_probs=209.3
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCC-CCcccceeeeEEeCCceEEEE
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLMLIT 119 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~iv~ 119 (320)
+|+..+.||+|+||.||++.++ ++.||+|++...........+.+..|..+++.+. |++++++++.+...+..|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4778899999999999999875 7889999886543333334466778888988885 577888999999999999999
Q ss_pred ecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCc
Q 020888 120 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 199 (320)
Q Consensus 120 e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~ 199 (320)
||++|++|.+++...+.+++..+..++.|++.||.|||++| ++|+||||+||++ +.++.++|+|||++........
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivHrDikp~Nill--~~~~~ikL~Dfg~~~~~~~~~~ 156 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG--IIYRDLKLDNVML--DSEGHIKIADFGMCKEHMVDGV 156 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEE--CCCCCEEEeccccccccCCCCc
Confidence 99999999999988788999999999999999999999998 9999999999999 8889999999998875432211
Q ss_pred cceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHH
Q 020888 200 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRE 279 (320)
Q Consensus 200 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 279 (320)
......|++.|+|||++.+..++.++|+||||+++|+|++|..||...........+...... .+..++.++++
T Consensus 157 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~--~p~~~~~~~~~ 230 (323)
T cd05615 157 ----TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVS--YPKSLSKEAVS 230 (323)
T ss_pred ----cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC--CCccCCHHHHH
Confidence 122345889999999999999999999999999999999999999988877777766654433 23457899999
Q ss_pred HHHHHhhcCCCCCCCH-----HHHHHH
Q 020888 280 LTEKCWAADMNQRPSF-----LDILKR 301 (320)
Q Consensus 280 li~~~l~~dp~~Rps~-----~~ll~~ 301 (320)
++.+||..+|.+|++. ++++++
T Consensus 231 li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05615 231 ICKGLMTKHPSKRLGCGPEGERDIREH 257 (323)
T ss_pred HHHHHcccCHhhCCCCCCCCHHHHhcC
Confidence 9999999999999974 455554
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=288.24 Aligned_cols=247 Identities=38% Similarity=0.667 Sum_probs=212.8
Q ss_pred ceecccCceEEEEEEEC-----CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEecC
Q 020888 48 AIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYL 122 (320)
Q Consensus 48 ~~lg~g~~~~vy~~~~~-----~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~ 122 (320)
+.||+|+||.||++.+. +..+++|.+....... ....+.+|++.++.++|++++++++++..+...+++|||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence 46899999999999986 6789999886654433 3578899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHh---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccc
Q 020888 123 RGGDLHKYLKEK---------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 193 (320)
Q Consensus 123 ~~~~L~~~~~~~---------~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~ 193 (320)
++++|.++++.. ..+++..++.++.|++.||++||++| ++|+||+|+||++ +.++.++|+|||.+..
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~nili--~~~~~~~l~dfg~~~~ 154 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK--FVHRDLAARNCLV--GEDLVVKISDFGLSRD 154 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC--cccCccCcceEEE--CCCCcEEEcccccccc
Confidence 999999999875 67999999999999999999999988 9999999999999 8889999999999987
Q ss_pred ccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCC
Q 020888 194 IKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKG 272 (320)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (320)
...... ........++..|+|||.+.+..++.++|+||||+++|++++ |..||......+....+....... .+..
T Consensus 155 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~ 231 (262)
T cd00192 155 VYDDDY--YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLP-KPEY 231 (262)
T ss_pred cccccc--cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC-CCcc
Confidence 654321 112233456788999999988889999999999999999999 699999988777777666544333 3455
Q ss_pred CCHHHHHHHHHHhhcCCCCCCCHHHHHHHHH
Q 020888 273 FTPELRELTEKCWAADMNQRPSFLDILKRLE 303 (320)
Q Consensus 273 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~ 303 (320)
++.++.+++.+||+.+|.+|||+.+++++|+
T Consensus 232 ~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 232 CPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred CChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 7999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=290.58 Aligned_cols=256 Identities=27% Similarity=0.516 Sum_probs=213.7
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEe
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 120 (320)
+|.+.+.||.|++|.||++.+. ++.+++|.+.............+.+|+.+++.++|+|++++++.+..++..++++|
T Consensus 3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08229 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE 82 (267)
T ss_pred hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEE
Confidence 6889999999999999999964 78999998765444444445788899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccc
Q 020888 121 YLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 196 (320)
Q Consensus 121 ~~~~~~L~~~~~~----~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~ 196 (320)
|+++++|.+++.. ...+++..++.++.|++.+|.|||+.| ++|+||+|+||++ +.++.++|+|||.+.....
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili--~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 83 LADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFI--TATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEE--cCCCCEEECcchhhhcccc
Confidence 9999999998864 345899999999999999999999988 9999999999999 8888999999998876543
Q ss_pred cCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHhCCCCCCCCCCCC
Q 020888 197 QNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEP--YEAAKYVAEGHRPFFRAKGFT 274 (320)
Q Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 274 (320)
... ......++..|+|||...+..++.++|+||||++++++++|..||..... ......+.....+......++
T Consensus 159 ~~~----~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (267)
T cd08229 159 KTT----AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYS 234 (267)
T ss_pred CCc----ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCccccc
Confidence 221 11234578889999999988899999999999999999999999975433 233333333333333445578
Q ss_pred HHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHH
Q 020888 275 PELRELTEKCWAADMNQRPSFLDILKRLEKIK 306 (320)
Q Consensus 275 ~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 306 (320)
+++++++.+||..+|.+|||+.++++.+.++.
T Consensus 235 ~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 235 EELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred HHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 99999999999999999999999999998874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=297.76 Aligned_cols=250 Identities=26% Similarity=0.453 Sum_probs=198.7
Q ss_pred CcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEE
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 118 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 118 (320)
..+|.+.+.||+|++|.||++.++ ++.+|+|++........ ...+.+|+.+++.++|+||+++++++..+...++|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGT--PFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV 81 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccccc--chhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence 357999999999999999999985 78899998864432221 24567899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccccccc
Q 020888 119 TEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 197 (320)
Q Consensus 119 ~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~ 197 (320)
|||++ ++|.+++... +.++...+..++.|++.||.|||+.| ++|+||||+||++ +.++.++|+|||++......
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill--~~~~~~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 82 FEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY--ILHRDLKPQNLLI--SDTGELKLADFGLARAKSVP 156 (303)
T ss_pred EECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEE--CCCCCEEECCCCcceeccCC
Confidence 99995 5888877653 56899999999999999999999998 9999999999999 88899999999998654322
Q ss_pred CccceeeccCCcccccccCccccCc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhCC-C---------
Q 020888 198 NSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYE-AAKYVAEGH-R--------- 265 (320)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~-~~~~~~~~~-~--------- 265 (320)
.. ......+++.|+|||++.+ ..++.++|+|||||++|+|++|..||....... ....+.... .
T Consensus 157 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (303)
T cd07869 157 SH----TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGV 232 (303)
T ss_pred Cc----cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccch
Confidence 11 1233457889999999865 457889999999999999999999998754322 111111100 0
Q ss_pred ---CCC-----------------CCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 266 ---PFF-----------------RAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 266 ---~~~-----------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
+.. ....++.++++++.+||+.||.+|||+++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 233 HSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred hhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 000 001245788999999999999999999999975
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=301.26 Aligned_cols=244 Identities=25% Similarity=0.420 Sum_probs=201.3
Q ss_pred ceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcccceeeeEEeCCceEEEEecCCC
Q 020888 48 AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRG 124 (320)
Q Consensus 48 ~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~~ 124 (320)
+.||+|+||+||++.+. ++.+|+|++.+...........+.+|+.++.++ +|+||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999875 678999998765544444556788899988877 799999999999999999999999999
Q ss_pred CCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCccceee
Q 020888 125 GDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK 204 (320)
Q Consensus 125 ~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~~~~~ 204 (320)
++|.+++...+.+++..+..++.|++.||.|||++| ++|+||||+||++ +.++.++|+|||++........ .
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dikp~Nili--~~~~~~kL~DfG~~~~~~~~~~----~ 152 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLL--DSEGHIKLTDYGMCKEGLRPGD----T 152 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEE--CCCCCEEEeeCCccccccCCCC----c
Confidence 999999988788999999999999999999999998 9999999999999 8889999999999865322111 1
Q ss_pred ccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCC--------hHH-HHHHHHhCCCCCCCCCCCCH
Q 020888 205 MTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYE--------PYE-AAKYVAEGHRPFFRAKGFTP 275 (320)
Q Consensus 205 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~--------~~~-~~~~~~~~~~~~~~~~~~~~ 275 (320)
.....|++.|+|||++.+..++.++|+||||+++|+|++|..||.... ... ....+..... ..+..++.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~--~~p~~~~~ 230 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI--RIPRSLSV 230 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC--CCCCCCCH
Confidence 223468999999999999999999999999999999999999995321 111 2222222221 22345789
Q ss_pred HHHHHHHHHhhcCCCCCCC------HHHHHHH
Q 020888 276 ELRELTEKCWAADMNQRPS------FLDILKR 301 (320)
Q Consensus 276 ~l~~li~~~l~~dp~~Rps------~~~ll~~ 301 (320)
++++++++||+.||.+||+ +++++++
T Consensus 231 ~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 231 KAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred HHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 9999999999999999998 4677665
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=286.91 Aligned_cols=248 Identities=34% Similarity=0.645 Sum_probs=215.2
Q ss_pred CcccCccceecccCceEEEEEEECCCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEe
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 120 (320)
..+|.+.+.||.|++|.||++...++.+++|.+..... ..+++.+|+.+++.++|+|++++++++..+...++|+|
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 80 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTE 80 (256)
T ss_pred hhhccceeeeecCCCceEEEEEecCcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEE
Confidence 45789999999999999999999999999998865432 34788899999999999999999999998999999999
Q ss_pred cCCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccC
Q 020888 121 YLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 198 (320)
Q Consensus 121 ~~~~~~L~~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~ 198 (320)
|+++++|.+++.... .+++..++.++.|++.+|.|||+.| ++|+||+|+||++ +.++.++|+|||.+.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~Nili--~~~~~~~l~d~g~~~~~~~~~ 156 (256)
T cd05039 81 YMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN--FVHRDLAARNVLV--SEDLVAKVSDFGLAKEASQGQ 156 (256)
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccchhcccceEEE--eCCCCEEEccccccccccccc
Confidence 999999999998755 6899999999999999999999998 9999999999999 888899999999987663221
Q ss_pred ccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHH
Q 020888 199 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPEL 277 (320)
Q Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 277 (320)
. ....+..|.|||...+..++.++|+||||++++++++ |..||......+....+....... .+..+++++
T Consensus 157 ~-------~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 228 (256)
T cd05039 157 D-------SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRME-APEGCPPEV 228 (256)
T ss_pred c-------cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCC-CccCCCHHH
Confidence 1 1223557999999988889999999999999999997 999998887777666665554433 234578999
Q ss_pred HHHHHHHhhcCCCCCCCHHHHHHHHHH
Q 020888 278 RELTEKCWAADMNQRPSFLDILKRLEK 304 (320)
Q Consensus 278 ~~li~~~l~~dp~~Rps~~~ll~~L~~ 304 (320)
.+++.+||..+|.+|||+.++++.|+.
T Consensus 229 ~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 229 YKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred HHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=287.94 Aligned_cols=257 Identities=28% Similarity=0.514 Sum_probs=215.6
Q ss_pred cccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEE
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 119 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 119 (320)
.+|.+.+.||.|++|.||++.+. ++.+++|.+...........+.+.+|++++++++|++++++++.+..++..+++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 47899999999999999999985 8889999886544444444578899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccccc
Q 020888 120 EYLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 195 (320)
Q Consensus 120 e~~~~~~L~~~~~~----~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~ 195 (320)
||+++++|.+++.. ...+++..++.++.+++.+|.+||+.| ++|+||+|+||++ +.++.++|+|||.+....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~nil~--~~~~~~~l~d~~~~~~~~ 157 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR--IMHRDIKPANVFI--TATGVVKLGDLGLGRFFS 157 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecCCcChhhEEE--CCCCcEEEeccceeeecc
Confidence 99999999998864 345899999999999999999999998 9999999999999 888899999999887554
Q ss_pred ccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHhCCCCCCCCCCC
Q 020888 196 VQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYE--PYEAAKYVAEGHRPFFRAKGF 273 (320)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~ 273 (320)
.... ......++..|.|||.+.+..++.++|+||||++++++++|..||.... ..+....+..+..++.....+
T Consensus 158 ~~~~----~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (267)
T cd08224 158 SKTT----AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHY 233 (267)
T ss_pred CCCc----ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhc
Confidence 3211 1122356788999999998899999999999999999999999996543 233444444444444444467
Q ss_pred CHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHH
Q 020888 274 TPELRELTEKCWAADMNQRPSFLDILKRLEKIK 306 (320)
Q Consensus 274 ~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 306 (320)
+.++++++.+||..+|.+|||+.++++.|+.+.
T Consensus 234 ~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 234 SEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred CHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 889999999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=299.59 Aligned_cols=259 Identities=28% Similarity=0.510 Sum_probs=208.8
Q ss_pred CcccCccceecccCceEEEEEEEC-------CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcccceeeeEE-e
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVT-E 111 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~-------~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~-~ 111 (320)
..+|.+.+.||.|+||.||++... ++.|++|.+..... ....+.+..|+.++.++ +|+||+++++.+. .
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~ 83 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGAT--ASEYKALMTELKILIHIGHHLNVVNLLGACTKP 83 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCC--HHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence 347999999999999999998643 36799998864332 22346778899999999 7999999999875 4
Q ss_pred CCceEEEEecCCCCCHHHHHHHh---------------------------------------------------------
Q 020888 112 RKPLMLITEYLRGGDLHKYLKEK--------------------------------------------------------- 134 (320)
Q Consensus 112 ~~~~~iv~e~~~~~~L~~~~~~~--------------------------------------------------------- 134 (320)
+..+++++||+++++|.+++...
T Consensus 84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (337)
T cd05054 84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD 163 (337)
T ss_pred CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence 56789999999999999988531
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCccceeeccCCcc
Q 020888 135 ----GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETG 210 (320)
Q Consensus 135 ----~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~ 210 (320)
.++++..+..++.|++.||+|||+.| |+|+||||+||++ +.++.++|+|||++..+...... .......+
T Consensus 164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--ivHrDikp~Nill--~~~~~vkL~DfG~a~~~~~~~~~--~~~~~~~~ 237 (337)
T cd05054 164 ELYKEPLTLEDLISYSFQVARGMEFLASRK--CIHRDLAARNILL--SENNVVKICDFGLARDIYKDPDY--VRKGDARL 237 (337)
T ss_pred HHhhcCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEE--eCCCcEEEeccccchhcccCcch--hhccCCCC
Confidence 26789999999999999999999988 9999999999999 77889999999999876432211 11122344
Q ss_pred cccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHhhcCC
Q 020888 211 SYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADM 289 (320)
Q Consensus 211 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 289 (320)
+..|+|||.+.+..++.++|||||||++|++++ |..||......+..............+...++++.+++.+||+.+|
T Consensus 238 ~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p 317 (337)
T cd05054 238 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNP 317 (337)
T ss_pred CccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCCh
Confidence 667999999999999999999999999999998 9999987554443333333322223345578999999999999999
Q ss_pred CCCCCHHHHHHHHHHHHh
Q 020888 290 NQRPSFLDILKRLEKIKE 307 (320)
Q Consensus 290 ~~Rps~~~ll~~L~~~~~ 307 (320)
++||++.+++++|+++..
T Consensus 318 ~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 318 EDRPTFSELVEILGDLLQ 335 (337)
T ss_pred hhCcCHHHHHHHHHHHHh
Confidence 999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-42 Score=306.69 Aligned_cols=256 Identities=23% Similarity=0.375 Sum_probs=211.4
Q ss_pred CCCCcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCce
Q 020888 38 DPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL 115 (320)
Q Consensus 38 ~~~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 115 (320)
.....+|++.+.||+|+||.||++.+. ++.+|+|++.+...........+.+|+.+++.++||||+++++.+..+...
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL 118 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence 344568999999999999999999986 678999988543333333345678899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccccc
Q 020888 116 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 195 (320)
Q Consensus 116 ~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~ 195 (320)
|+||||++|++|.+++... .+++..+..++.||+.||+|||++| |+|+||||+||++ +.++.++|+|||++....
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~--IvHrDLKp~NILl--~~~~~~kL~DFG~a~~~~ 193 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMG--LIHRDVKPDNMLL--DKHGHLKLADFGTCMKMD 193 (370)
T ss_pred EEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEE--CCCCCEEEEecccceecc
Confidence 9999999999999999764 6899999999999999999999998 9999999999999 888999999999987654
Q ss_pred ccCccceeeccCCcccccccCccccCcCC----CCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCC--C
Q 020888 196 VQNSHDVYKMTGETGSYRYMAPEVFKHRK----YDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFF--R 269 (320)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~--~ 269 (320)
.... .......||+.|+|||++.+.. ++.++|+|||||++|+|++|..||...+.......+........ .
T Consensus 194 ~~~~---~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~ 270 (370)
T cd05621 194 ETGM---VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPE 270 (370)
T ss_pred cCCc---eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCC
Confidence 3221 1223456899999999987543 77899999999999999999999998877666666665432221 2
Q ss_pred CCCCCHHHHHHHHHHhhcCCCC--CCCHHHHHHH
Q 020888 270 AKGFTPELRELTEKCWAADMNQ--RPSFLDILKR 301 (320)
Q Consensus 270 ~~~~~~~l~~li~~~l~~dp~~--Rps~~~ll~~ 301 (320)
...++..+++++..||..++.+ |+|+++++++
T Consensus 271 ~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 271 DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred cccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 2357899999999999755543 8899999987
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=294.49 Aligned_cols=242 Identities=28% Similarity=0.425 Sum_probs=199.7
Q ss_pred ecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEecCCCCCH
Q 020888 50 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDL 127 (320)
Q Consensus 50 lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L 127 (320)
||+|+||+||++.+. ++.+|+|.+...........+.+..|+++++.++|++++++.+.+..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999875 788999988655444444456778899999999999999999999999999999999999999
Q ss_pred HHHHHH----hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCcccee
Q 020888 128 HKYLKE----KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 203 (320)
Q Consensus 128 ~~~~~~----~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~~~~ 203 (320)
.+++.. ...+++..++.++.|++.||.|||+.| ++|+||||+||++ +.++.++|+|||.+..+.....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili--~~~~~~~l~dfg~~~~~~~~~~---- 152 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR--IIYRDLKPENVLL--DNDGNVRISDLGLAVELKDGQS---- 152 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEE--CCCCCEEEeeCccceecCCCCc----
Confidence 987743 346899999999999999999999998 9999999999999 8888999999999876543321
Q ss_pred eccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHH----HHHHHHhCCCCCCCCCCCCHHHHH
Q 020888 204 KMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYE----AAKYVAEGHRPFFRAKGFTPELRE 279 (320)
Q Consensus 204 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~l~~ 279 (320)
......+++.|+|||.+.+..++.++|+||||+++|++++|+.||....... ....+... ....+..++.++++
T Consensus 153 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ 230 (280)
T cd05608 153 KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND--SVTYPDKFSPASKS 230 (280)
T ss_pred cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc--CCCCcccCCHHHHH
Confidence 1223467899999999999999999999999999999999999997654321 12222211 11223457999999
Q ss_pred HHHHHhhcCCCCCC-----CHHHHHHH
Q 020888 280 LTEKCWAADMNQRP-----SFLDILKR 301 (320)
Q Consensus 280 li~~~l~~dp~~Rp-----s~~~ll~~ 301 (320)
++.+||+.||++|| ++++++++
T Consensus 231 li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 231 FCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred HHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 99999999999999 77888876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=286.95 Aligned_cols=250 Identities=32% Similarity=0.607 Sum_probs=209.6
Q ss_pred CcccCccceecccCceEEEEEEEC-CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEE
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 119 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~-~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 119 (320)
..+|++.+.||+|++|.||++.+. +..+++|.+....... ..+.+|+++++.++|+|++++++++...+..++++
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~----~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSE----DDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVT 78 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCH----HHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEE
Confidence 346889999999999999999876 4579999875433222 46778999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccC
Q 020888 120 EYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 198 (320)
Q Consensus 120 e~~~~~~L~~~~~~-~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~ 198 (320)
||++|++|.+++.. .+.+++..++.++.|++.+|.+||+.| ++|+||+|+||++ +.++.++|+|||.+.......
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~ni~i--~~~~~~kl~dfg~~~~~~~~~ 154 (256)
T cd05059 79 EYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG--FIHRDLAARNCLV--GEDNVVKVSDFGLARYVLDDQ 154 (256)
T ss_pred ecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--cccccccHhhEEE--CCCCcEEECCcccceeccccc
Confidence 99999999999875 346899999999999999999999998 9999999999999 888899999999887553221
Q ss_pred ccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHH
Q 020888 199 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPEL 277 (320)
Q Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 277 (320)
. .......++..|+|||.+.+..++.++|+||||+++|++++ |..||...+..+....+........ +..++.++
T Consensus 155 ~---~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 230 (256)
T cd05059 155 Y---TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYR-PKLAPTEV 230 (256)
T ss_pred c---cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCC-CCCCCHHH
Confidence 1 01111223457999999999999999999999999999999 8999988777776666665544333 34579999
Q ss_pred HHHHHHHhhcCCCCCCCHHHHHHHH
Q 020888 278 RELTEKCWAADMNQRPSFLDILKRL 302 (320)
Q Consensus 278 ~~li~~~l~~dp~~Rps~~~ll~~L 302 (320)
.+++.+||..+|++|||+.++++.|
T Consensus 231 ~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 231 YTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred HHHHHHHhcCChhhCcCHHHHHHHh
Confidence 9999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=295.19 Aligned_cols=258 Identities=35% Similarity=0.563 Sum_probs=210.5
Q ss_pred cccCccceecccCceEEEEEEEC--CC--ceEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcccceeeeEEeCCceE
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLM 116 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~--~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 116 (320)
.+|++.+.||.|+||.||++.+. +. .+++|.+... ........+.+|++++.++ +|+||+++++++..++.+|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~ 84 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 84 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCce
Confidence 47889999999999999999875 33 3566655432 2233446788999999999 8999999999999999999
Q ss_pred EEEecCCCCCHHHHHHHhC----------------CCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCC
Q 020888 117 LITEYLRGGDLHKYLKEKG----------------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSA 180 (320)
Q Consensus 117 iv~e~~~~~~L~~~~~~~~----------------~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~ 180 (320)
+++||+++++|.+++...+ .+++..++.++.|++.||+|||++| ++|+||||+||++ +.+
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dlkp~Nili--~~~ 160 (303)
T cd05088 85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILV--GEN 160 (303)
T ss_pred EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEe--cCC
Confidence 9999999999999987532 4789999999999999999999998 9999999999999 888
Q ss_pred CcEEEecCCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 020888 181 DHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKY 259 (320)
Q Consensus 181 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~ 259 (320)
+.++|+|||++....... .......+..|+|||...+..++.++||||||++++++++ |..||...+..+....
T Consensus 161 ~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~ 235 (303)
T cd05088 161 YVAKIADFGLSRGQEVYV-----KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK 235 (303)
T ss_pred CcEEeCccccCcccchhh-----hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHH
Confidence 899999999886332111 0111223567999999988889999999999999999998 9999987777666655
Q ss_pred HHhCCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcCCC
Q 020888 260 VAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPT 311 (320)
Q Consensus 260 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~ 311 (320)
+....... .+..++.++.+++.+||+.+|.+||++++++..|.++...-.+
T Consensus 236 ~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~~ 286 (303)
T cd05088 236 LPQGYRLE-KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 286 (303)
T ss_pred HhcCCcCC-CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhhh
Confidence 54443222 2344789999999999999999999999999999887665543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=291.74 Aligned_cols=257 Identities=33% Similarity=0.583 Sum_probs=213.9
Q ss_pred ccCccceecccCceEEEEEEECC-------CceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCce
Q 020888 43 DFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL 115 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~~-------~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 115 (320)
+|++.+.||+|+||.||++.+.. ..+++|.+..... ......+.+|+.+++.++|+||+++++.+..++..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS--SSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC--HHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 47888999999999999998642 4588887754322 23346788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHHh------------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 020888 116 MLITEYLRGGDLHKYLKEK------------------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPR 171 (320)
Q Consensus 116 ~iv~e~~~~~~L~~~~~~~------------------------~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~ 171 (320)
++++||+++++|.+++... ..+++..++.++.|++.+|.+||+.| ++|+||+|+
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--ivH~dikp~ 156 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK--LVHRDLAAR 156 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC--eehhhhhhh
Confidence 9999999999999998642 24788999999999999999999988 999999999
Q ss_pred cEEEeeCCCCcEEEecCCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCC
Q 020888 172 NVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLAN 250 (320)
Q Consensus 172 nI~~~~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~ 250 (320)
||++ +.++.++|+|||++......... .......++..|+|||...+..++.++|+||||++++++++ |..||..
T Consensus 157 nill--~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 232 (290)
T cd05045 157 NVLV--AEGRKMKISDFGLSRDVYEEDSY--VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 232 (290)
T ss_pred eEEE--cCCCcEEeccccccccccCccch--hcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCC
Confidence 9999 77889999999998765432211 11122344668999999988889999999999999999998 9999988
Q ss_pred CChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhc
Q 020888 251 YEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKET 308 (320)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 308 (320)
....+............ .+..++.++++++.+||+.+|++||++.++++.|+++..+
T Consensus 233 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 233 IAPERLFNLLKTGYRME-RPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred CCHHHHHHHHhCCCCCC-CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 87777666665554333 3456789999999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=286.30 Aligned_cols=247 Identities=31% Similarity=0.556 Sum_probs=204.7
Q ss_pred ceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEecCCCC
Q 020888 48 AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGG 125 (320)
Q Consensus 48 ~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~ 125 (320)
+.||+|++|.||++.+. ++.+++|.+.... ..+....+.+|+++++.++|+||+++++++......++|+||++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence 36899999999999874 7889999875432 2334467889999999999999999999999999999999999999
Q ss_pred CHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCccceee
Q 020888 126 DLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK 204 (320)
Q Consensus 126 ~L~~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~~~~~ 204 (320)
+|.+++... ..+++..++.++.|++.||.|||+.| ++|+||+|+||++ +.++.++|+|||.+........ ...
T Consensus 79 ~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~--~~~~~~kl~dfg~~~~~~~~~~--~~~ 152 (252)
T cd05084 79 DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH--CIHRDLAARNCLV--TEKNVLKISDFGMSREEEDGVY--AST 152 (252)
T ss_pred cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEE--cCCCcEEECccccCcccccccc--ccc
Confidence 999998764 46899999999999999999999988 9999999999999 8888999999999875432110 000
Q ss_pred ccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHH
Q 020888 205 MTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEK 283 (320)
Q Consensus 205 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 283 (320)
......+..|+|||.+.+..++.++|+||||+++|++++ |..||...........+....... .+..++..+.+++.+
T Consensus 153 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~ 231 (252)
T cd05084 153 GGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLP-CPELCPDAVYRLMER 231 (252)
T ss_pred CCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCC-CcccCCHHHHHHHHH
Confidence 111123456999999999999999999999999999998 999998777666655555543333 344578999999999
Q ss_pred HhhcCCCCCCCHHHHHHHHH
Q 020888 284 CWAADMNQRPSFLDILKRLE 303 (320)
Q Consensus 284 ~l~~dp~~Rps~~~ll~~L~ 303 (320)
||..+|++|||+.++++.|+
T Consensus 232 ~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 232 CWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HcCCChhhCcCHHHHHHHHh
Confidence 99999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=293.25 Aligned_cols=260 Identities=33% Similarity=0.552 Sum_probs=215.2
Q ss_pred cccCccceecccCceEEEEEEEC---------CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcccceeeeEEe
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR---------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTE 111 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~---------~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 111 (320)
.+|.+.+.||+|+||.||++.+. ...+++|.+..... ......+.+|+++++.+ +|+||+++++.+..
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 95 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCC--hHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence 58999999999999999999753 24699998865422 23346788899999999 79999999999999
Q ss_pred CCceEEEEecCCCCCHHHHHHHhC----------------CCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE
Q 020888 112 RKPLMLITEYLRGGDLHKYLKEKG----------------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLL 175 (320)
Q Consensus 112 ~~~~~iv~e~~~~~~L~~~~~~~~----------------~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~ 175 (320)
.+..++|+||+++++|.+++..+. .+++..++.++.|++.||+|||+.| ++|+||||+||++
T Consensus 96 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp~Nill 173 (307)
T cd05098 96 DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLV 173 (307)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--cccccccHHheEE
Confidence 999999999999999999997532 4788999999999999999999988 9999999999999
Q ss_pred eeCCCCcEEEecCCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 020888 176 VNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPY 254 (320)
Q Consensus 176 ~~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~ 254 (320)
+.++.++|+|||.+.......... ......++..|+|||...+..++.++|+||||+++|++++ |..||......
T Consensus 174 --~~~~~~kL~dfg~a~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~ 249 (307)
T cd05098 174 --TEDNVMKIADFGLARDIHHIDYYK--KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 249 (307)
T ss_pred --cCCCcEEECCCcccccccccchhh--ccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH
Confidence 788899999999987654321110 1111223467999999998889999999999999999998 88999877766
Q ss_pred HHHHHHHhCCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcCC
Q 020888 255 EAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLP 310 (320)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~ 310 (320)
+....+....... .+..++.++.+++.+||..+|.+|||+.++++.|.++.....
T Consensus 250 ~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~ 304 (307)
T cd05098 250 ELFKLLKEGHRMD-KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTS 304 (307)
T ss_pred HHHHHHHcCCCCC-CCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHhh
Confidence 6666555554333 334578999999999999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-41 Score=285.66 Aligned_cols=250 Identities=29% Similarity=0.515 Sum_probs=208.9
Q ss_pred ceecccCceEEEEEEEC--C---CceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEecC
Q 020888 48 AIIGKGSFGEILKAYWR--G---TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYL 122 (320)
Q Consensus 48 ~~lg~g~~~~vy~~~~~--~---~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~ 122 (320)
+.||+|++|.||++... + ..+++|.+...... ...+.+.+|+.+++.+.|+|++++++++. ++..+++|||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeC
Confidence 46899999999999764 2 67999988655443 33467889999999999999999999876 45689999999
Q ss_pred CCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCccce
Q 020888 123 RGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDV 202 (320)
Q Consensus 123 ~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~~~ 202 (320)
++++|.+++...+.+++..++.++.|++.+|.+||..| ++|+||+|+||++ +.++.++|+|||.+...........
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~nili--~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 78 PLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKH--FVHRDLAARNVLL--VNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcC--eeccCcccceEEE--cCCCcEEeccccccceeecCCcccc
Confidence 99999999988778999999999999999999999988 9999999999999 8888999999999886644322111
Q ss_pred eeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHH
Q 020888 203 YKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELT 281 (320)
Q Consensus 203 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 281 (320)
......++..|+|||.+.+..++.++|+||||+++|++++ |..||...+..+....+...... ..+..++..+++++
T Consensus 154 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li 231 (257)
T cd05060 154 -ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERL-PRPEECPQEIYSIM 231 (257)
T ss_pred -cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcC-CCCCCCCHHHHHHH
Confidence 1111223457999999999999999999999999999998 99999988877776666655433 33456789999999
Q ss_pred HHHhhcCCCCCCCHHHHHHHHHHHH
Q 020888 282 EKCWAADMNQRPSFLDILKRLEKIK 306 (320)
Q Consensus 282 ~~~l~~dp~~Rps~~~ll~~L~~~~ 306 (320)
.+||..+|.+|||+.++++.|+++.
T Consensus 232 ~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 232 LSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred HHHhcCChhhCcCHHHHHHHHHhcc
Confidence 9999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=301.90 Aligned_cols=250 Identities=25% Similarity=0.413 Sum_probs=204.4
Q ss_pred ccCccceecccCceEEEEEEE-----CCCceEEEEccCCCC-CcHHHHHHHHHHHHHHHhC-CCCcccceeeeEEeCCce
Q 020888 43 DFSSSAIIGKGSFGEILKAYW-----RGTPVAIKRILPSLS-DDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPL 115 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~-----~~~~~~~K~~~~~~~-~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 115 (320)
+|++.+.||+|+||.||++.+ +++.+|+|++.+... ......+.+..|+.++..+ +|++|+++++.+..++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 488899999999999999876 367899998865322 2223346778899999999 599999999999999999
Q ss_pred EEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccccc
Q 020888 116 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 195 (320)
Q Consensus 116 ~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~ 195 (320)
++||||+++++|.+++..+..+++..+..++.|++.||.|||++| ++|+||||+||++ +.++.++|+|||++....
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nili--~~~~~~kl~DfG~~~~~~ 156 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLG--IVYRDIKLENILL--DSEGHVVLTDFGLSKEFL 156 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHeEE--CCCCCEEEeeCcCCcccc
Confidence 999999999999999988778999999999999999999999998 9999999999999 888999999999987653
Q ss_pred ccCccceeeccCCcccccccCccccCcC-CCCCchhHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHhCCCCCCCC
Q 020888 196 VQNSHDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYE----PYEAAKYVAEGHRPFFRA 270 (320)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~----~~~~~~~~~~~~~~~~~~ 270 (320)
..... ......|++.|+|||.+.+. .++.++||||||+++|+|++|..||.... .......+.... + ..+
T Consensus 157 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~-~-~~~ 231 (332)
T cd05614 157 SEEKE---RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCD-P-PFP 231 (332)
T ss_pred ccCCC---ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCC-C-CCC
Confidence 32211 11234689999999998875 47889999999999999999999996432 222222232222 2 223
Q ss_pred CCCCHHHHHHHHHHhhcCCCCCC-----CHHHHHHH
Q 020888 271 KGFTPELRELTEKCWAADMNQRP-----SFLDILKR 301 (320)
Q Consensus 271 ~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~ 301 (320)
..++..+++++.+||+.||++|| ++++++++
T Consensus 232 ~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 232 SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 45799999999999999999999 78888876
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=291.05 Aligned_cols=251 Identities=25% Similarity=0.431 Sum_probs=206.1
Q ss_pred CcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEE
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 118 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 118 (320)
..+|.+.+.||+|++|.||++.+. ++.+++|++...... ....+.+|+.+++.++|+|++++++.+..++..++|
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~---~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv 84 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGD---DFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWIC 84 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccc---hHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEE
Confidence 457999999999999999999974 678999988543222 235678899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccC
Q 020888 119 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 198 (320)
Q Consensus 119 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~ 198 (320)
+||+++++|.+++...+.+++..+..++.|++.||.|||+.| ++|+|++|+||++ +.++.++|+|||++.......
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nill--~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06646 85 MEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKG--KMHRDIKGANILL--TDNGDVKLADFGVAAKITATI 160 (267)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEE--CCCCCEEECcCccceeecccc
Confidence 999999999999987778999999999999999999999988 9999999999999 888899999999987664321
Q ss_pred ccceeeccCCcccccccCccccC---cCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCC---CCCCC
Q 020888 199 SHDVYKMTGETGSYRYMAPEVFK---HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPF---FRAKG 272 (320)
Q Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~ 272 (320)
. ......++..|+|||.+. ...++.++|+||+|++++++++|..||....+......+....... .....
T Consensus 161 ~----~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (267)
T cd06646 161 A----KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTK 236 (267)
T ss_pred c----ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccc
Confidence 1 112245778899999874 3457789999999999999999999997665444332222221111 11234
Q ss_pred CCHHHHHHHHHHhhcCCCCCCCHHHHHHHH
Q 020888 273 FTPELRELTEKCWAADMNQRPSFLDILKRL 302 (320)
Q Consensus 273 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 302 (320)
++.++++++++||..+|++|||+++++++|
T Consensus 237 ~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 237 WSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred cCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 689999999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=286.57 Aligned_cols=251 Identities=31% Similarity=0.604 Sum_probs=210.7
Q ss_pred CcccCccceecccCceEEEEEEECC-CceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEE
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWRG-TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 119 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~~-~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 119 (320)
..+|.+.+.||+|++|+||.+.+.+ ..+++|.+...... ...+.+|+.++++++|+||+++++++...+..+++|
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS----EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVT 78 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCccc----HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEE
Confidence 3478899999999999999998775 45999987543322 256888999999999999999999999888899999
Q ss_pred ecCCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccC
Q 020888 120 EYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 198 (320)
Q Consensus 120 e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~ 198 (320)
||+++++|.+++... ..+++..++.++.|++.||.|||+.| ++|+||+|+||++ +.++.++|+|||.+.......
T Consensus 79 e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~nili--~~~~~~kl~d~g~~~~~~~~~ 154 (256)
T cd05113 79 EYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ--FIHRDLAARNCLV--DDQGCVKVSDFGLSRYVLDDE 154 (256)
T ss_pred EcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEE--cCCCCEEECCCccceecCCCc
Confidence 999999999999763 46899999999999999999999988 9999999999999 788899999999887654322
Q ss_pred ccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHH
Q 020888 199 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPEL 277 (320)
Q Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 277 (320)
. .......++..|.|||...+..++.++|+||||+++|++++ |..||......+....+..+.... .+...+..+
T Consensus 155 ~---~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 230 (256)
T cd05113 155 Y---TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLY-RPHLASEKV 230 (256)
T ss_pred e---eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCC-CCCCCCHHH
Confidence 1 11112234567999999998889999999999999999998 999998887766666666554443 334468999
Q ss_pred HHHHHHHhhcCCCCCCCHHHHHHHHH
Q 020888 278 RELTEKCWAADMNQRPSFLDILKRLE 303 (320)
Q Consensus 278 ~~li~~~l~~dp~~Rps~~~ll~~L~ 303 (320)
++++.+||..+|.+|||+.++++.|+
T Consensus 231 ~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 231 YAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred HHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 99999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=305.97 Aligned_cols=261 Identities=32% Similarity=0.555 Sum_probs=218.0
Q ss_pred cccCccceecccCceEEEEEEECCCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEec
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY 121 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 121 (320)
.+..+...||+|+||+||++.+-| .||||++.-...... ..+.|++|+.++++-+|.||+-+.|++-.... .||+.|
T Consensus 392 ~ev~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~pt~~-qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqw 468 (678)
T KOG0193|consen 392 EEVLLGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDPTPE-QLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQW 468 (678)
T ss_pred HHhhccceeccccccceeeccccc-ceEEEEEecCCCCHH-HHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehh
Confidence 356788899999999999999876 499998876655554 67999999999999999999999999988776 899999
Q ss_pred CCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCcc
Q 020888 122 LRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 200 (320)
Q Consensus 122 ~~~~~L~~~~~~-~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~ 200 (320)
|+|.+|-.++.. ...++..+.+.|+.|+++|+.|||.++ |+|+|+|..|||+ .+++.|+|+|||++..-..-...
T Consensus 469 CeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~--IIHrDLKSnNIFl--~~~~kVkIgDFGLatvk~~w~g~ 544 (678)
T KOG0193|consen 469 CEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKN--IIHRDLKSNNIFL--HEDLKVKIGDFGLATVKTRWSGE 544 (678)
T ss_pred ccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhh--hhhhhccccceEE--ccCCcEEEecccceeeeeeeccc
Confidence 999999998864 347999999999999999999999998 9999999999999 77789999999998754332111
Q ss_pred ceeeccCCcccccccCccccCc---CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCC---CCCCCCCCCC
Q 020888 201 DVYKMTGETGSYRYMAPEVFKH---RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH---RPFFRAKGFT 274 (320)
Q Consensus 201 ~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 274 (320)
.......+...|+|||++.. ..+++.+||||+|+++|||++|..||....++..+..+-++. ........++
T Consensus 545 --~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~p 622 (678)
T KOG0193|consen 545 --QQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNCP 622 (678)
T ss_pred --cccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhccCH
Confidence 12233457778999999864 468899999999999999999999999666666666566662 2222335578
Q ss_pred HHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcCCC
Q 020888 275 PELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPT 311 (320)
Q Consensus 275 ~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~ 311 (320)
.++++|+..||..++++||++.+|+..|+.+..++++
T Consensus 623 k~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~pk 659 (678)
T KOG0193|consen 623 KAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSLPK 659 (678)
T ss_pred HHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcccc
Confidence 8999999999999999999999999998888876644
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=286.44 Aligned_cols=246 Identities=34% Similarity=0.634 Sum_probs=209.6
Q ss_pred cccCccceecccCceEEEEEEECCCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeE-EeCCceEEEEe
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAV-TERKPLMLITE 120 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~iv~e 120 (320)
.+|.+.+.||+|++|.||++...+..+++|.+.... ..+.+.+|+.++++++|++++++++++ ..++..++++|
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 80 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCc-----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEE
Confidence 478899999999999999999999999999875332 235788999999999999999999875 45667899999
Q ss_pred cCCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccC
Q 020888 121 YLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 198 (320)
Q Consensus 121 ~~~~~~L~~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~ 198 (320)
|+++++|.+++.... .+++..++.++.|++.+|.+||++| ++|+||+|+||++ +.++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~--~~~~~~kl~dfg~~~~~~~~~ 156 (256)
T cd05082 81 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN--FVHRDLAARNVLV--SEDNVAKVSDFGLTKEASSTQ 156 (256)
T ss_pred CCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccccchheEEE--cCCCcEEecCCccceeccccC
Confidence 999999999997643 4789999999999999999999998 9999999999999 888999999999887543321
Q ss_pred ccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHH
Q 020888 199 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPEL 277 (320)
Q Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 277 (320)
.....+..|+|||...+..++.++|+||||+++|++++ |+.||......+....+..+.... .+..++..+
T Consensus 157 -------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 228 (256)
T cd05082 157 -------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMD-APDGCPPVV 228 (256)
T ss_pred -------CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCC-CCCCCCHHH
Confidence 11233567999999998899999999999999999998 999998877776666665554433 335679999
Q ss_pred HHHHHHHhhcCCCCCCCHHHHHHHHHH
Q 020888 278 RELTEKCWAADMNQRPSFLDILKRLEK 304 (320)
Q Consensus 278 ~~li~~~l~~dp~~Rps~~~ll~~L~~ 304 (320)
++++.+|++.+|++|||+.++++.|+.
T Consensus 229 ~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 229 YDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred HHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-41 Score=287.17 Aligned_cols=254 Identities=32% Similarity=0.551 Sum_probs=211.7
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCc------HHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCc
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDD------RLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP 114 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 114 (320)
+|++.+.||.|++|.||++.+. ++.+++|.+....... ....+.+.+|+.++++++|+||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4778899999999999999874 6889999886543332 1234678899999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccc
Q 020888 115 LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 194 (320)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~ 194 (320)
.++++||+++++|.+++...+.+++..+..++.|++.||.+||+.| ++|+||+|+||++ +.++.++|+|||.+...
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~--ivH~di~p~nil~--~~~~~~~l~dfg~~~~~ 156 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG--IIHRDIKGANILV--DNKGGIKISDFGISKKL 156 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcC--cccccCCHHHEEE--cCCCCEEecccCCCccc
Confidence 9999999999999999988788999999999999999999999988 9999999999999 88899999999998877
Q ss_pred cccCccc--eeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCC
Q 020888 195 KVQNSHD--VYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKG 272 (320)
Q Consensus 195 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (320)
....... ........++..|+|||.+.+..++.++|+||||+++|++++|..||...+.......+.....+. .+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~ 235 (267)
T cd06628 157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPE-IPSN 235 (267)
T ss_pred ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCc-CCcc
Confidence 5321111 111122347788999999998889999999999999999999999998876655544444433333 2345
Q ss_pred CCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 273 FTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 273 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
++.++++++++||+.||.+||++.+++++
T Consensus 236 ~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 236 ISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred cCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 79999999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=299.84 Aligned_cols=246 Identities=24% Similarity=0.407 Sum_probs=199.3
Q ss_pred CcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEE
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 118 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 118 (320)
..+|...+.||+|+||+||++.+. ++.||+|++.... .......+.+|+++++.++|+||+++++++..++..++|
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 150 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVL 150 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEE
Confidence 347889999999999999999885 7899999885432 233446788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccC
Q 020888 119 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 198 (320)
Q Consensus 119 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~ 198 (320)
|||+++++|.+. ...++..+..++.||+.||.|||+.| ++|+||||+||++ +.++.++|+|||++..+....
T Consensus 151 ~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll--~~~~~~kL~DfG~~~~~~~~~ 222 (353)
T PLN00034 151 LEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRH--IVHRDIKPSNLLI--NSAKNVKIADFGVSRILAQTM 222 (353)
T ss_pred EecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEE--cCCCCEEEcccccceeccccc
Confidence 999999998653 24577888899999999999999998 9999999999999 888999999999987654321
Q ss_pred ccceeeccCCcccccccCccccCc-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHhCCCCCCCC
Q 020888 199 SHDVYKMTGETGSYRYMAPEVFKH-----RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYE---AAKYVAEGHRPFFRA 270 (320)
Q Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~---~~~~~~~~~~~~~~~ 270 (320)
. ......++..|+|||.+.. ...+.++|||||||++|+|++|+.||......+ ....+... ......
T Consensus 223 ~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~ 297 (353)
T PLN00034 223 D----PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMS-QPPEAP 297 (353)
T ss_pred c----cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhcc-CCCCCC
Confidence 1 1223468899999998743 234568999999999999999999997433222 11222222 222233
Q ss_pred CCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 271 KGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 271 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
..++.+++++|.+||..||++|||+.+++++
T Consensus 298 ~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 298 ATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred CccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 4578999999999999999999999999987
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=301.13 Aligned_cols=240 Identities=30% Similarity=0.452 Sum_probs=199.0
Q ss_pred ceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHH-HHHHhCCCCcccceeeeEEeCCceEEEEecCCC
Q 020888 48 AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEV-NLLVKLRHPNIVQFLGAVTERKPLMLITEYLRG 124 (320)
Q Consensus 48 ~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~ 124 (320)
+.||+|+||+||++.+. ++.+|+|++.............+..|. .+++.++|+||+++++.+...+..|+||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46899999999999986 677999988654322222223334343 456778999999999999999999999999999
Q ss_pred CCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCccceee
Q 020888 125 GDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK 204 (320)
Q Consensus 125 ~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~~~~~ 204 (320)
++|.+++...+.+++..+..++.||+.||.|||+.| ++|+||||+||++ +.++.++|+|||++........ .
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~g--iiHrDlkp~Nili--~~~~~~kl~DfG~a~~~~~~~~----~ 152 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILL--DSQGHIVLTDFGLCKENIEHNG----T 152 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEE--CCCCCEEEccCCCCcccccCCC----C
Confidence 999999988778999999999999999999999998 9999999999999 8889999999999875432211 1
Q ss_pred ccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHH
Q 020888 205 MTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKC 284 (320)
Q Consensus 205 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 284 (320)
.....|++.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+...... ....++.++++++.+|
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~~~li~~~ 230 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQ--LKPNITNSARHLLEGL 230 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcC--CCCCCCHHHHHHHHHH
Confidence 22346899999999999999999999999999999999999999988877776666554332 2235799999999999
Q ss_pred hhcCCCCCCCHHH
Q 020888 285 WAADMNQRPSFLD 297 (320)
Q Consensus 285 l~~dp~~Rps~~~ 297 (320)
|+.||.+|+++.+
T Consensus 231 l~~~p~~R~~~~~ 243 (325)
T cd05602 231 LQKDRTKRLGAKD 243 (325)
T ss_pred cccCHHHCCCCCC
Confidence 9999999998764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=304.47 Aligned_cols=258 Identities=24% Similarity=0.394 Sum_probs=211.5
Q ss_pred CCCCCcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCc
Q 020888 37 IDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP 114 (320)
Q Consensus 37 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 114 (320)
+.....+|++.+.||+|+||.||++.++ ++.+|+|++.............+.+|+.+++.++|+||+++++.+..++.
T Consensus 38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (371)
T cd05622 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 117 (371)
T ss_pred cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence 3444579999999999999999999986 67899998854333333334567889999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccc
Q 020888 115 LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 194 (320)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~ 194 (320)
.++||||++|++|.+++... .+++..+..++.||+.||.|||++| |+|+||||+||++ +.++.++|+|||++...
T Consensus 118 ~~lv~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NIll--~~~~~ikL~DfG~a~~~ 192 (371)
T cd05622 118 LYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLL--DKSGHLKLADFGTCMKM 192 (371)
T ss_pred EEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHEEE--CCCCCEEEEeCCceeEc
Confidence 99999999999999998764 5899999999999999999999998 9999999999999 88899999999998765
Q ss_pred cccCccceeeccCCcccccccCccccCcCC----CCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCC--CCC
Q 020888 195 KVQNSHDVYKMTGETGSYRYMAPEVFKHRK----YDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHR--PFF 268 (320)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~--~~~ 268 (320)
..... .......||+.|+|||++.+.. ++.++|+|||||++|+|++|..||...+.......+..... ...
T Consensus 193 ~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~ 269 (371)
T cd05622 193 NKEGM---VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFP 269 (371)
T ss_pred CcCCc---ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCC
Confidence 43221 1123456899999999986543 78899999999999999999999998887766666665432 222
Q ss_pred CCCCCCHHHHHHHHHHhhcCCCC--CCCHHHHHHHH
Q 020888 269 RAKGFTPELRELTEKCWAADMNQ--RPSFLDILKRL 302 (320)
Q Consensus 269 ~~~~~~~~l~~li~~~l~~dp~~--Rps~~~ll~~L 302 (320)
....++.+++++|..||..++.+ |+++++++++.
T Consensus 270 ~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 270 DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 23458999999999999843332 68999999873
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=295.68 Aligned_cols=255 Identities=26% Similarity=0.423 Sum_probs=213.8
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEe
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 120 (320)
+|.+.+.||+|++|.||++.+. ++.+++|.+...........+.+.+|+++++.++|++|+++++.+..+...+++||
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD 81 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence 6888999999999999999985 68999999876655544455788999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccC
Q 020888 121 YLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 198 (320)
Q Consensus 121 ~~~~~~L~~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~ 198 (320)
|+.|++|.+++... ..+++..+..++.|++.+|.|||+.| ++|+||||+||++ +.++.++|+|||++.......
T Consensus 82 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili--~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 82 YCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG--IVYRDLKPENILL--HESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred ecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChHHeEE--cCCCCEEEeecchhhcccccc
Confidence 99999999998763 46899999999999999999999998 9999999999999 888999999999887553321
Q ss_pred ccc-------------------------eeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 020888 199 SHD-------------------------VYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEP 253 (320)
Q Consensus 199 ~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~ 253 (320)
... ........++..|+|||...+..++.++|+||||+++|++++|..||...+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 110 0111223578889999999998999999999999999999999999988776
Q ss_pred HHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCC----HHHHHHH
Q 020888 254 YEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPS----FLDILKR 301 (320)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps----~~~ll~~ 301 (320)
......+............+++++++++.+||..||++||| +++++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 238 DETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred HHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 66555555433333333347999999999999999999999 8888875
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=289.71 Aligned_cols=255 Identities=29% Similarity=0.497 Sum_probs=210.0
Q ss_pred CCcccCccceecccCceEEEEEEEC-------CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeC
Q 020888 40 SELDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER 112 (320)
Q Consensus 40 ~~~~y~~~~~lg~g~~~~vy~~~~~-------~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 112 (320)
...+|++.+.||+|++|.||++.+. +..+++|.+.... .......+.+|+.+++.++|+||+++++++..+
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~ 81 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 81 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 4568999999999999999998764 3569999875432 222335688899999999999999999999999
Q ss_pred CceEEEEecCCCCCHHHHHHHh----------CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCc
Q 020888 113 KPLMLITEYLRGGDLHKYLKEK----------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH 182 (320)
Q Consensus 113 ~~~~iv~e~~~~~~L~~~~~~~----------~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~ 182 (320)
...++||||+++++|.+++... ..+++..+..++.|++.||.|||+.| ++|+||||+||++ +.++.
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~vH~dlkp~Nil~--~~~~~ 157 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMV--AEDFT 157 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCcchheEEE--cCCCC
Confidence 9999999999999999998752 13577889999999999999999988 9999999999999 78889
Q ss_pred EEEecCCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 020888 183 LKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVA 261 (320)
Q Consensus 183 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~ 261 (320)
++|+|||++......... .......++..|+|||.+.+..++.++|+||||+++|++++ |..||......+....+.
T Consensus 158 ~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~ 235 (277)
T cd05062 158 VKIGDFGMTRDIYETDYY--RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVM 235 (277)
T ss_pred EEECCCCCccccCCccee--ecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 999999998755432211 11112234678999999998899999999999999999999 789998887776666555
Q ss_pred hCCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHH
Q 020888 262 EGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLE 303 (320)
Q Consensus 262 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~ 303 (320)
...... .+..+++++++++.+||+.+|.+|||+.++++.|+
T Consensus 236 ~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 236 EGGLLD-KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred cCCcCC-CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 544333 33557899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=292.98 Aligned_cols=248 Identities=27% Similarity=0.447 Sum_probs=198.1
Q ss_pred ccCccceecccCceEEEEEEEC---CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhC---CCCcccceeeeEE-----e
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR---GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL---RHPNIVQFLGAVT-----E 111 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~---~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~-----~ 111 (320)
+|++.+.||+|+||.||++.+. ++.+|+|.+.......... ..+.+|+.+++.+ +|+||+++++++. .
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~-~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMP-LSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCch-HHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 6999999999999999999873 5779999886543332211 3445567666665 6999999999875 3
Q ss_pred CCceEEEEecCCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCC
Q 020888 112 RKPLMLITEYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFG 189 (320)
Q Consensus 112 ~~~~~iv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg 189 (320)
...+++||||++ ++|.+++... ..+++..++.++.|++.||.|||++| ++|+||||+||++ +.++.++|+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--iiH~dlkp~Nil~--~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILV--TSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEE--cCCCCEEEcccc
Confidence 456899999996 5999998753 35899999999999999999999998 9999999999999 888999999999
Q ss_pred CcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCC-
Q 020888 190 LSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFF- 268 (320)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~- 268 (320)
++....... ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||......+....+......+.
T Consensus 156 ~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~ 230 (290)
T cd07862 156 LARIYSFQM-----ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 230 (290)
T ss_pred ceEeccCCc-----ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCCh
Confidence 987654321 22334678999999999988999999999999999999999999988776655544432211000
Q ss_pred ------------------------CCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 269 ------------------------RAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 269 ------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
....++..+++++.+||+.||++|||+.+++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 231 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred hhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 012467889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-41 Score=286.93 Aligned_cols=255 Identities=28% Similarity=0.534 Sum_probs=211.4
Q ss_pred ccCccceecccCceEEEEEEEC-CCceEEEEccCCCCC---cHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEE
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSD---DRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 118 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~-~~~~~~K~~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 118 (320)
+|.+.+.||.|+||.||++... ++.+++|.+...... .......+.+|++.++.++|+|++++++++.+.+..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 4788899999999999999874 778999977543322 123346788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccC
Q 020888 119 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 198 (320)
Q Consensus 119 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~ 198 (320)
+||+++++|.+++.+.+++++..+..++.|++.+|++||+.| ++|+||+|+||++ +.++.++|+|||.+.......
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~--~~~~~~~l~dfg~~~~~~~~~ 156 (265)
T cd06631 81 MEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC--VVHRDIKGNNVML--MPNGIIKLIDFGCARRLAWVG 156 (265)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHhEEE--CCCCeEEeccchhhHhhhhcc
Confidence 999999999999988778999999999999999999999988 9999999999999 888999999999887653221
Q ss_pred cc--ceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhC-CCCCCCCCCCCH
Q 020888 199 SH--DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEG-HRPFFRAKGFTP 275 (320)
Q Consensus 199 ~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 275 (320)
.. .........++..|+|||.+.+..++.++|+||||++++++++|..||...+.......+... ...+..+..++.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (265)
T cd06631 157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSA 236 (265)
T ss_pred ccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCH
Confidence 11 111122345788999999999989999999999999999999999999877665544433332 122223456899
Q ss_pred HHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 276 ELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 276 ~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
++.+++++||..+|.+||++.+++++
T Consensus 237 ~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 237 AAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred HHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 99999999999999999999999864
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=289.83 Aligned_cols=254 Identities=30% Similarity=0.534 Sum_probs=210.7
Q ss_pred cccCccceecccCceEEEEEEE------CCCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCce
Q 020888 42 LDFSSSAIIGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL 115 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~------~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 115 (320)
.+|++.+.||+|+||+||++.. .+..+++|.+.... .......+.+|+++++.++|+||+++++++..+...
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 82 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPV 82 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCce
Confidence 4688889999999999999875 24679999876432 233446788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHHh-----------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeC
Q 020888 116 MLITEYLRGGDLHKYLKEK-----------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS 178 (320)
Q Consensus 116 ~iv~e~~~~~~L~~~~~~~-----------------~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~ 178 (320)
+++|||+++++|.+++... ..+++..++.++.|++.||+|||++| ++|+||||+||++ +
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~nili--~ 158 (283)
T cd05090 83 CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF--FVHKDLAARNILI--G 158 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC--eehhccccceEEE--c
Confidence 9999999999999998532 24788899999999999999999998 9999999999999 7
Q ss_pred CCCcEEEecCCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 020888 179 SADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAA 257 (320)
Q Consensus 179 ~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~ 257 (320)
.++.++|+|||++.......... ......++..|+|||.+.+..++.++|+||||+++|++++ |..||......+..
T Consensus 159 ~~~~~kl~dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~ 236 (283)
T cd05090 159 EQLHVKISDLGLSREIYSADYYR--VQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVI 236 (283)
T ss_pred CCCcEEeccccccccccCCccee--cccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 88899999999987664332111 1222345667999999998889999999999999999998 99999887766655
Q ss_pred HHHHhCCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHH
Q 020888 258 KYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEK 304 (320)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 304 (320)
..+....... .+..+++++++++.+|++.||.+||++.+++++|..
T Consensus 237 ~~~~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 237 EMVRKRQLLP-CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHcCCcCC-CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 5555544333 345579999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=305.54 Aligned_cols=251 Identities=28% Similarity=0.446 Sum_probs=222.4
Q ss_pred CCcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCC-CCcccceeeeEEeCCceE
Q 020888 40 SELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLM 116 (320)
Q Consensus 40 ~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 116 (320)
...+|..+++||+|+||+|+++..+ ++.+|+|++.+...-.....+..+.|.+++.... ||.++.++..++..+.+|
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 3458999999999999999999986 7899999999887777777789999999998885 999999999999999999
Q ss_pred EEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccc
Q 020888 117 LITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 196 (320)
Q Consensus 117 iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~ 196 (320)
+||||+.||++..+. ..+.+++..+..++..++.||.|||++| |++||||.+||++ |..|.+||+|||+++.-..
T Consensus 446 fvmey~~Ggdm~~~~-~~~~F~e~rarfyaAev~l~L~fLH~~~--IIYRDlKLdNiLL--D~eGh~kiADFGlcKe~m~ 520 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHHI-HTDVFSEPRARFYAAEVVLGLQFLHENG--IIYRDLKLDNLLL--DTEGHVKIADFGLCKEGMG 520 (694)
T ss_pred EEEEecCCCcEEEEE-ecccccHHHHHHHHHHHHHHHHHHHhcC--ceeeecchhheEE--cccCcEEecccccccccCC
Confidence 999999999954433 3357999999999999999999999998 9999999999999 9999999999999986543
Q ss_pred cCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHH
Q 020888 197 QNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPE 276 (320)
Q Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (320)
.+. ..++.+|||.|+|||++.+..|+.+.|=||||++||+|+.|+.||.+.+..+..+.+...... .+..++.+
T Consensus 521 ~g~----~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~--yP~~ls~e 594 (694)
T KOG0694|consen 521 QGD----RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVR--YPRFLSKE 594 (694)
T ss_pred CCC----ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCC--CCCcccHH
Confidence 322 456689999999999999999999999999999999999999999999999999988876644 45668999
Q ss_pred HHHHHHHHhhcCCCCCCC-----HHHHHHH
Q 020888 277 LRELTEKCWAADMNQRPS-----FLDILKR 301 (320)
Q Consensus 277 l~~li~~~l~~dp~~Rps-----~~~ll~~ 301 (320)
..++++++|..+|++|.. ++++.++
T Consensus 595 a~~il~~ll~k~p~kRLG~~e~d~~~i~~h 624 (694)
T KOG0694|consen 595 AIAIMRRLLRKNPEKRLGSGERDAEDIKKH 624 (694)
T ss_pred HHHHHHHHhccCcccccCCCCCCchhhhhC
Confidence 999999999999999964 4566554
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=291.99 Aligned_cols=246 Identities=30% Similarity=0.533 Sum_probs=213.5
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEe
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 120 (320)
+|++.+.||+|++|.||++.+. ++.+++|.+.............+.+|++++++++|+||+++++.+.+++.++++||
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVME 81 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEe
Confidence 6889999999999999999885 78899998865544444445778899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCcc
Q 020888 121 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 200 (320)
Q Consensus 121 ~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~ 200 (320)
|+++++|.+++...+.+++..+..++.|++.||.+||+.| ++|+||+|+||++ +.++.++|+|||++......
T Consensus 82 ~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~--i~H~dl~p~nili--~~~~~~kl~dfg~~~~~~~~--- 154 (290)
T cd05580 82 YVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLD--IVYRDLKPENLLL--DSDGYIKITDFGFAKRVKGR--- 154 (290)
T ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEE--CCCCCEEEeeCCCccccCCC---
Confidence 9999999999988888999999999999999999999988 9999999999999 88889999999998765433
Q ss_pred ceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHH
Q 020888 201 DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELREL 280 (320)
Q Consensus 201 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 280 (320)
.....+++.|+|||.+.+...+.++|+||||+++|++++|..||...+.......+..+... .+..++..++++
T Consensus 155 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~l 228 (290)
T cd05580 155 ----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVR--FPSFFSPDAKDL 228 (290)
T ss_pred ----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcc--CCccCCHHHHHH
Confidence 12345788999999998888899999999999999999999999888766666655544322 234468999999
Q ss_pred HHHHhhcCCCCCC-----CHHHHHHH
Q 020888 281 TEKCWAADMNQRP-----SFLDILKR 301 (320)
Q Consensus 281 i~~~l~~dp~~Rp-----s~~~ll~~ 301 (320)
+.+||..||.+|+ ++++++++
T Consensus 229 i~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 229 IRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred HHHHccCCHHHccCcccCCHHHHHcC
Confidence 9999999999998 78888765
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=293.70 Aligned_cols=259 Identities=29% Similarity=0.578 Sum_probs=212.8
Q ss_pred CcccCccceecccCceEEEEEEEC--CC----ceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCc
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--GT----PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP 114 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~~----~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 114 (320)
..+|+..+.||+|+||+||++.+. +. .+++|.+.... .....+.+.+|+.+++.++|+||+++++++..+ .
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~ 82 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 82 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-C
Confidence 457999999999999999999863 33 48999875432 233346788999999999999999999988765 5
Q ss_pred eEEEEecCCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccc
Q 020888 115 LMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 193 (320)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~ 193 (320)
.+++++|+++|+|.+++... ..+++..++.++.|++.||+|||+.| ++|+||||+||++ +.++.++|+|||++..
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--iiH~dlkp~Nill--~~~~~~kl~DfG~a~~ 158 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR--LVHRDLAARNVLV--KTPQHVKITDFGLAKL 158 (316)
T ss_pred ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEe--cCCCcEEEcccccccc
Confidence 67999999999999999864 46899999999999999999999998 9999999999999 8888999999999986
Q ss_pred ccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCC
Q 020888 194 IKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKG 272 (320)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (320)
...... .........+..|+|||.+.+..++.++|+||||+++|++++ |..||......+...........+ .+..
T Consensus 159 ~~~~~~--~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~ 235 (316)
T cd05108 159 LGADEK--EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP-QPPI 235 (316)
T ss_pred ccCCCc--ceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCC-CCCC
Confidence 653221 111222334668999999999999999999999999999998 999998877666554444443333 3345
Q ss_pred CCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcC
Q 020888 273 FTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETL 309 (320)
Q Consensus 273 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 309 (320)
++.++.+++.+||..+|.+|||+.+++..|.++....
T Consensus 236 ~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 236 CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 7899999999999999999999999999998887543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=291.19 Aligned_cols=240 Identities=28% Similarity=0.427 Sum_probs=195.4
Q ss_pred ecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEecCCCCCH
Q 020888 50 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDL 127 (320)
Q Consensus 50 lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L 127 (320)
||+|+||.||++.+. ++.+++|.+.............+..|++++++++|+||+++++.+..+...++||||++|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999875 789999988654333222334566799999999999999999999999999999999999999
Q ss_pred HHHHHHhC--CCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCccceeec
Q 020888 128 HKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKM 205 (320)
Q Consensus 128 ~~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~~~~~~ 205 (320)
.+++...+ .+++..+..++.|++.||.|||+.| ++|+||||+||++ +.++.++|+|||++....... ..
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili--~~~~~~~l~Dfg~~~~~~~~~-----~~ 151 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD--IVYRDMKPENVLL--DDQGNCRLSDLGLAVELKDGK-----TI 151 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EEEccCChHhEEE--cCCCCEEEeeceeeeecCCCc-----ee
Confidence 98886533 5899999999999999999999998 9999999999999 888899999999987654322 11
Q ss_pred cCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHhCCCCCCCCCCCCHHHHHHH
Q 020888 206 TGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEP----YEAAKYVAEGHRPFFRAKGFTPELRELT 281 (320)
Q Consensus 206 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~l~~li 281 (320)
....++..|+|||++.+..++.++|+||||+++|++++|..||..... ............ ......++.++++++
T Consensus 152 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li 230 (277)
T cd05607 152 TQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEV-KFEHQNFTEESKDIC 230 (277)
T ss_pred eccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcccc-ccccccCCHHHHHHH
Confidence 234578899999999988899999999999999999999999976432 122222222222 122345799999999
Q ss_pred HHHhhcCCCCCCCHHHHH
Q 020888 282 EKCWAADMNQRPSFLDIL 299 (320)
Q Consensus 282 ~~~l~~dp~~Rps~~~ll 299 (320)
.+||+.||++||++++++
T Consensus 231 ~~~L~~~P~~R~~~~~~~ 248 (277)
T cd05607 231 RLFLAKKPEDRLGSREKN 248 (277)
T ss_pred HHHhccCHhhCCCCccch
Confidence 999999999999996554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=290.12 Aligned_cols=257 Identities=33% Similarity=0.541 Sum_probs=211.3
Q ss_pred cccCccceecccCceEEEEEEEC--C--CceEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcccceeeeEEeCCceE
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--G--TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLM 116 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~--~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 116 (320)
.+|++.+.||.|++|.||++..+ + ..+++|.+... ......+.+.+|+++++++ +|+||+++++.+...+.++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF--ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc--CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 37889999999999999999875 2 24677766432 2223346788899999999 7999999999999999999
Q ss_pred EEEecCCCCCHHHHHHHhC----------------CCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCC
Q 020888 117 LITEYLRGGDLHKYLKEKG----------------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSA 180 (320)
Q Consensus 117 iv~e~~~~~~L~~~~~~~~----------------~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~ 180 (320)
+++||+++++|.+++.... .+++..++.++.|++.||++||+.| ++|+||||+||++ +.+
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nill--~~~ 155 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ--FIHRDLAARNVLV--GEN 155 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCcCCcceEEE--CCC
Confidence 9999999999999996532 4788999999999999999999988 9999999999999 888
Q ss_pred CcEEEecCCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 020888 181 DHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKY 259 (320)
Q Consensus 181 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~ 259 (320)
+.++|+|||++....... .......+..|+|||...+..++.++||||||+++|+|++ |..||......+....
T Consensus 156 ~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~ 230 (297)
T cd05089 156 LASKIADFGLSRGEEVYV-----KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEK 230 (297)
T ss_pred CeEEECCcCCCcccccee-----ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 899999999886432110 1111123456999999998889999999999999999997 9999998887776666
Q ss_pred HHhCCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcCC
Q 020888 260 VAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLP 310 (320)
Q Consensus 260 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~ 310 (320)
+..+.... .+..++.++++++.+||..+|.+|||++++++.|..+.....
T Consensus 231 ~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~ 280 (297)
T cd05089 231 LPQGYRME-KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARK 280 (297)
T ss_pred HhcCCCCC-CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 66554333 234589999999999999999999999999999988876543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=281.97 Aligned_cols=254 Identities=28% Similarity=0.390 Sum_probs=208.9
Q ss_pred CCCCcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEe--CC
Q 020888 38 DPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE--RK 113 (320)
Q Consensus 38 ~~~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~ 113 (320)
.-...+|..+..|++|+||.||+++++ +.-||+|.+.-+...+.-.+.. .+||.+|.+++|+||+.+-.+++. -+
T Consensus 72 Crsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPIts-LREIniLl~~~H~NIV~vkEVVvG~~~d 150 (419)
T KOG0663|consen 72 CRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITS-LREINILLKARHPNIVEVKEVVVGSNMD 150 (419)
T ss_pred cccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchh-HHHHHHHHhcCCCCeeeeEEEEeccccc
Confidence 334458999999999999999999987 7889999886654444333333 459999999999999999998864 35
Q ss_pred ceEEEEecCCCCCHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcc
Q 020888 114 PLMLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 192 (320)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~ 192 (320)
..|+||||++. +|..++...+ ++....+.-+..|++.|++|||.+. |+|+|+||+|+++ ...|.+|++|||+++
T Consensus 151 ~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~w--ilHRDLK~SNLLm--~~~G~lKiaDFGLAR 225 (419)
T KOG0663|consen 151 KIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNW--ILHRDLKTSNLLL--SHKGILKIADFGLAR 225 (419)
T ss_pred eeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhce--eEecccchhheee--ccCCcEEecccchhh
Confidence 58999999977 9999998754 7999999999999999999999988 9999999999999 999999999999999
Q ss_pred cccccCccceeeccCCcccccccCccccCcC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCC-------
Q 020888 193 LIKVQNSHDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH------- 264 (320)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~------- 264 (320)
.+..+. .+....+.|.+|.|||.+.|. .|+.+.||||+||++.|+++++.-|.+....+....+....
T Consensus 226 ~ygsp~----k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~i 301 (419)
T KOG0663|consen 226 EYGSPL----KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAI 301 (419)
T ss_pred hhcCCc----ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCcccc
Confidence 887653 345567789999999999876 58999999999999999999998888776555444333210
Q ss_pred -----------------------CCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 265 -----------------------RPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 265 -----------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
..-+....+++.-.+|+..+|..||.+|.|+++.|++
T Consensus 302 wpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 302 WPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred CCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 0000011256788899999999999999999999886
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=295.68 Aligned_cols=255 Identities=30% Similarity=0.479 Sum_probs=225.0
Q ss_pred CCCcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCC-CCcccceeeeEEeCCce
Q 020888 39 PSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPL 115 (320)
Q Consensus 39 ~~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 115 (320)
.....|.+.+.||.|.||.||++..+ ++.+|+|.+.+...........+.+|+.+|+++. ||||+.+.+.++....+
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~ 111 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV 111 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence 33447999999999999999999986 7889999998776655545678999999999998 99999999999999999
Q ss_pred EEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCC--CCcEEEecCCCccc
Q 020888 116 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS--ADHLKVGDFGLSKL 193 (320)
Q Consensus 116 ~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~--~~~~~L~dfg~~~~ 193 (320)
++|||++.||.|.+.+... .+++..+..++.|++.++.|||+.| ++|+|+||+|+++.... ++.++++|||++..
T Consensus 112 ~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~g--vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~ 188 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLG--VVHRDLKPENLLLASKDEGSGRIKLIDFGLAKF 188 (382)
T ss_pred EEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCHHHeeeccccCCCCcEEEeeCCCceE
Confidence 9999999999999999876 4999999999999999999999999 99999999999995443 35899999999987
Q ss_pred ccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCC--C
Q 020888 194 IKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA--K 271 (320)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~ 271 (320)
...+ ......+||+.|+|||+..+..++...||||+|+++|.|++|..||...........+..+......+ .
T Consensus 189 ~~~~-----~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~ 263 (382)
T KOG0032|consen 189 IKPG-----ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWD 263 (382)
T ss_pred ccCC-----ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCcc
Confidence 7652 24556789999999999999999999999999999999999999999988877777777775432222 4
Q ss_pred CCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 272 GFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 272 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
.++...+++|+.|+..||..|+|+.++|+|
T Consensus 264 ~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 264 DISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred ccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 579999999999999999999999999996
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=286.53 Aligned_cols=262 Identities=28% Similarity=0.488 Sum_probs=217.7
Q ss_pred CCCCcccCccceecccCceEEEEEEECC------CceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEe
Q 020888 38 DPSELDFSSSAIIGKGSFGEILKAYWRG------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE 111 (320)
Q Consensus 38 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~------~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 111 (320)
.....+|.+.+.||+|+||.||++.+.+ ..+++|.+... ........+.+|+.+++.++|+|++++++++..
T Consensus 2 ~~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~ 79 (280)
T cd05043 2 AISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGLSHQNILPILHVCIE 79 (280)
T ss_pred ccchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 4556789999999999999999998753 67888877532 233445778899999999999999999998765
Q ss_pred -CCceEEEEecCCCCCHHHHHHHh--------CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCc
Q 020888 112 -RKPLMLITEYLRGGDLHKYLKEK--------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH 182 (320)
Q Consensus 112 -~~~~~iv~e~~~~~~L~~~~~~~--------~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~ 182 (320)
+...+++++|+++++|.+++... ..+++..++.++.|++.||.|||+.| ++|+||+|+||++ +.++.
T Consensus 80 ~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--i~H~di~p~nil~--~~~~~ 155 (280)
T cd05043 80 DGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG--VIHKDIAARNCVI--DEELQ 155 (280)
T ss_pred CCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCHhhEEE--cCCCc
Confidence 56789999999999999998752 35899999999999999999999988 9999999999999 78889
Q ss_pred EEEecCCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 020888 183 LKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVA 261 (320)
Q Consensus 183 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~ 261 (320)
++|+|||+++.+....... ......++..|+|||.+.+..++.++||||||++++++++ |..||...+..+....+.
T Consensus 156 ~kl~d~g~~~~~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~ 233 (280)
T cd05043 156 VKITDNALSRDLFPMDYHC--LGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLK 233 (280)
T ss_pred EEECCCCCcccccCCceEE--eCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHH
Confidence 9999999987654322111 1112335667999999998889999999999999999999 999999888777766666
Q ss_pred hCCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhc
Q 020888 262 EGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKET 308 (320)
Q Consensus 262 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 308 (320)
.+..... ...+++++.+++.+||..+|++|||+.++++.|..+...
T Consensus 234 ~~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 234 DGYRLAQ-PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred cCCCCCC-CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 5544332 345789999999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=285.18 Aligned_cols=257 Identities=35% Similarity=0.630 Sum_probs=213.9
Q ss_pred CcccCccceecccCceEEEEEEEC--C---CceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCce
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--G---TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL 115 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~---~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 115 (320)
..+|+..+.||+|++|.||++... + ..+++|.+..... ......+.+|+++++.++|+|++++.+++...+..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYT--EKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPA 81 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCC--HHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCc
Confidence 457888999999999999999874 2 2688887754322 23346788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccc
Q 020888 116 MLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 194 (320)
Q Consensus 116 ~iv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~ 194 (320)
++||||+++++|.+++... +.+++..+..++.+++.||.+||+.| ++|+||+|+||++ +.++.++|+|||.+...
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nili--~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 82 MIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN--YVHRDLAARNILV--NSNLECKVSDFGLSRVL 157 (268)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEE--cCCCcEEECCCccceec
Confidence 9999999999999999763 57899999999999999999999998 9999999999999 78889999999998766
Q ss_pred cccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCC
Q 020888 195 KVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGF 273 (320)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (320)
....... ........+..|+|||.+.+..++.++|+||||+++|++++ |..||......+....+......+ ....+
T Consensus 158 ~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~-~~~~~ 235 (268)
T cd05063 158 EDDPEGT-YTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLP-APMDC 235 (268)
T ss_pred ccccccc-eeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCC-CCCCC
Confidence 4332111 11111223457999999998889999999999999999997 999998887777777666544332 33457
Q ss_pred CHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHH
Q 020888 274 TPELRELTEKCWAADMNQRPSFLDILKRLEKI 305 (320)
Q Consensus 274 ~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~ 305 (320)
+.++++++.+|+..+|.+||++.++++.|+++
T Consensus 236 ~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 236 PSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 89999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=297.89 Aligned_cols=244 Identities=24% Similarity=0.393 Sum_probs=201.9
Q ss_pred ceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcccceeeeEEeCCceEEEEecCCC
Q 020888 48 AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRG 124 (320)
Q Consensus 48 ~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~~ 124 (320)
+.||+|+||+||++.+. ++.+|+|++...........+.+.+|..++.++ +|++|+++++.+...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999875 678999998765544445557788999999888 599999999999999999999999999
Q ss_pred CCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCccceee
Q 020888 125 GDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK 204 (320)
Q Consensus 125 ~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~~~~~ 204 (320)
++|.+++...+.+++..+..++.||+.||.|||++| ++|+||||+||++ +.++.++|+|||++........ .
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nili--~~~~~~kl~Dfg~~~~~~~~~~----~ 152 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERG--IIYRDLKLDNVLL--DADGHIKLTDYGMCKEGLGPGD----T 152 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEE--eCCCCEEEeccccceeccCCCC----c
Confidence 999999988778999999999999999999999998 9999999999999 8888999999998864322111 1
Q ss_pred ccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCC------ChHH-HHHHHHhCCCCCCCCCCCCHHH
Q 020888 205 MTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANY------EPYE-AAKYVAEGHRPFFRAKGFTPEL 277 (320)
Q Consensus 205 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~------~~~~-~~~~~~~~~~~~~~~~~~~~~l 277 (320)
.....|++.|+|||.+.+..++.++|+||||+++|+|++|..||... ...+ ....+.... ...+..++..+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~p~~~~~~~ 230 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP--IRIPRFLSVKA 230 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC--CCCCCCCCHHH
Confidence 22356899999999999999999999999999999999999999632 2222 222232222 22344578999
Q ss_pred HHHHHHHhhcCCCCCCCH------HHHHHH
Q 020888 278 RELTEKCWAADMNQRPSF------LDILKR 301 (320)
Q Consensus 278 ~~li~~~l~~dp~~Rps~------~~ll~~ 301 (320)
.+++++||+.||.+|+++ ++++++
T Consensus 231 ~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 231 SHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred HHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 999999999999999984 576655
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=286.63 Aligned_cols=257 Identities=30% Similarity=0.535 Sum_probs=209.4
Q ss_pred CCcccCccceecccCceEEEEEEECC-------CceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeC
Q 020888 40 SELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER 112 (320)
Q Consensus 40 ~~~~y~~~~~lg~g~~~~vy~~~~~~-------~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 112 (320)
...+|.+.+.||+|++|.||++.+.+ ..+++|.+.... .......+.+|+.+++.++|+||+++++++.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFNHQNIVRLIGVSFER 81 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 34579999999999999999998853 568888765432 223335688899999999999999999999888
Q ss_pred CceEEEEecCCCCCHHHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCC-CCcEE
Q 020888 113 KPLMLITEYLRGGDLHKYLKEKG-------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS-ADHLK 184 (320)
Q Consensus 113 ~~~~iv~e~~~~~~L~~~~~~~~-------~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~-~~~~~ 184 (320)
+..+++|||++|++|.+++.... .+++..++.++.|++.+|.|||+.| ++|+||+|+||++..+. ...++
T Consensus 82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~nil~~~~~~~~~~k 159 (277)
T cd05036 82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH--FIHRDIAARNCLLTCKGPGRVAK 159 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchheEEEeccCCCcceE
Confidence 89999999999999999997643 4899999999999999999999998 99999999999994322 23699
Q ss_pred EecCCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhC
Q 020888 185 VGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEG 263 (320)
Q Consensus 185 L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~ 263 (320)
|+|||++..+..... .........+..|+|||++.+..++.++|||||||++|++++ |..||......+....+...
T Consensus 160 l~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~ 237 (277)
T cd05036 160 IADFGMARDIYRASY--YRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGG 237 (277)
T ss_pred eccCccccccCCccc--eecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 999999886632211 111112233567999999998899999999999999999997 99999987777766655554
Q ss_pred CCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHH
Q 020888 264 HRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLE 303 (320)
Q Consensus 264 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~ 303 (320)
.... .+..++.++.+++.+|++.+|.+|||+.+++++|+
T Consensus 238 ~~~~-~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 238 GRLD-PPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred CcCC-CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 4333 34567999999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=292.35 Aligned_cols=249 Identities=34% Similarity=0.575 Sum_probs=204.9
Q ss_pred cCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEec
Q 020888 44 FSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY 121 (320)
Q Consensus 44 y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 121 (320)
|++++.||+|+||+||++.+. ++.+|+|.+......... .....+|+..++.++|+||+++++++......+++||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEE-REENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHH-HHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccc-cchhhhhhhccccccccccccccccccccccccccccc
Confidence 678899999999999999987 457999998765433332 23445699999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCccc
Q 020888 122 LRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHD 201 (320)
Q Consensus 122 ~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~~ 201 (320)
+++++|.+++...+.+++..++.++.|++.||.+||+.| ++|+||||+||++ +.++.++|+|||.+..... .
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~--i~H~dikp~NIl~--~~~~~~~l~Dfg~~~~~~~----~ 151 (260)
T PF00069_consen 80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKG--IVHRDIKPENILL--DENGEVKLIDFGSSVKLSE----N 151 (260)
T ss_dssp ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTT--EEESSBSGGGEEE--STTSEEEESSGTTTEESTS----T
T ss_pred ccccccccccccccccccccccccccccccccccccccc--ccccccccccccc--ccccccccccccccccccc----c
Confidence 999899999997788999999999999999999999998 9999999999999 8899999999999875411 1
Q ss_pred eeeccCCcccccccCccccC-cCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH---hCCCCCC--CCCCCCH
Q 020888 202 VYKMTGETGSYRYMAPEVFK-HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA---EGHRPFF--RAKGFTP 275 (320)
Q Consensus 202 ~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~---~~~~~~~--~~~~~~~ 275 (320)
........++..|.|||... +...+.++|+||||+++++|++|..||......+....+. ....... .....+.
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (260)
T PF00069_consen 152 NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSE 231 (260)
T ss_dssp TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHH
Confidence 12334566889999999998 8889999999999999999999999999874333322222 1111110 0111248
Q ss_pred HHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 276 ELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 276 ~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
++++++.+||+.||++|||+.+++++
T Consensus 232 ~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 232 ELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp HHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcC
Confidence 99999999999999999999999864
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=285.02 Aligned_cols=252 Identities=32% Similarity=0.544 Sum_probs=212.8
Q ss_pred CcccCccceecccCceEEEEEEEC-CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEE
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 119 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~-~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 119 (320)
..+|++.+.||.|++|.||++.++ ++.+++|.+...... .+.+.+|+++++.++|++++++++++..+...++++
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS----PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVT 80 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccC----HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEE
Confidence 458999999999999999999876 577999987654332 257888999999999999999999999888999999
Q ss_pred ecCCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccccccc
Q 020888 120 EYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 197 (320)
Q Consensus 120 e~~~~~~L~~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~ 197 (320)
||+++++|.+++... ..+++..+..++.+++.|+.+||++| ++|+||+|+||++ +.++.++|+|||.+......
T Consensus 81 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~--i~h~di~p~nili--~~~~~~~l~d~g~~~~~~~~ 156 (261)
T cd05034 81 EYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN--YIHRDLAARNILV--GENLVCKIADFGLARLIEDD 156 (261)
T ss_pred eccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcchheEEE--cCCCCEEECccccceeccch
Confidence 999999999999764 36899999999999999999999988 9999999999999 88899999999998765431
Q ss_pred CccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHH
Q 020888 198 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPE 276 (320)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (320)
.. ........+..|+|||...+...+.++|+||||++++++++ |+.||...........+........ +...+.+
T Consensus 157 ~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 232 (261)
T cd05034 157 EY---TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPR-PPNCPEE 232 (261)
T ss_pred hh---hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC-CCCCCHH
Confidence 11 11112224567999999998899999999999999999998 9999988877777766665543333 3446899
Q ss_pred HHHHHHHHhhcCCCCCCCHHHHHHHHHH
Q 020888 277 LRELTEKCWAADMNQRPSFLDILKRLEK 304 (320)
Q Consensus 277 l~~li~~~l~~dp~~Rps~~~ll~~L~~ 304 (320)
+.+++.+|+..+|.+||+++++.+.|+.
T Consensus 233 ~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 233 LYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred HHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 9999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-41 Score=291.54 Aligned_cols=261 Identities=31% Similarity=0.549 Sum_probs=216.8
Q ss_pred CCCCCcccCccceecccCceEEEEEEEC-------CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcccceeee
Q 020888 37 IDPSELDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGA 108 (320)
Q Consensus 37 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~-------~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~ 108 (320)
......+|.+.+.||+|++|.||++... ...+++|.+..... ......+.+|++++.++ +|+||++++++
T Consensus 7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 84 (293)
T cd05053 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT--EKDLSDLVSEMEMMKMIGKHKNIINLLGV 84 (293)
T ss_pred cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC--HHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 3344568999999999999999999864 25689998765422 23346788899999999 79999999999
Q ss_pred EEeCCceEEEEecCCCCCHHHHHHHh----------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 020888 109 VTERKPLMLITEYLRGGDLHKYLKEK----------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRN 172 (320)
Q Consensus 109 ~~~~~~~~iv~e~~~~~~L~~~~~~~----------------~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~n 172 (320)
+..++..+++|||+++++|.++++.. ..+++..++.++.|++.||.|||+.| ++|+||||+|
T Consensus 85 ~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~N 162 (293)
T cd05053 85 CTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK--CIHRDLAARN 162 (293)
T ss_pred EcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--ccccccceee
Confidence 99999999999999999999998642 35889999999999999999999988 9999999999
Q ss_pred EEEeeCCCCcEEEecCCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCC
Q 020888 173 VLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANY 251 (320)
Q Consensus 173 I~~~~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~ 251 (320)
|++ +.++.++|+|||.+..+..... ........++..|+|||...+..++.++|+||||+++|++++ |..||...
T Consensus 163 il~--~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 238 (293)
T cd05053 163 VLV--TEDHVMKIADFGLARDIHHIDY--YRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI 238 (293)
T ss_pred EEE--cCCCeEEeCccccccccccccc--eeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCC
Confidence 999 8888999999999886543221 111112234567999999988999999999999999999998 99999988
Q ss_pred ChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHH
Q 020888 252 EPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIK 306 (320)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 306 (320)
...+....+........ +...+.++.+++.+||..||++|||++++++.|..+.
T Consensus 239 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 239 PVEELFKLLKEGYRMEK-PQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred CHHHHHHHHHcCCcCCC-CCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 87777776666554433 3457899999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=298.62 Aligned_cols=239 Identities=30% Similarity=0.435 Sum_probs=198.3
Q ss_pred ceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHH-HHHHhCCCCcccceeeeEEeCCceEEEEecCCC
Q 020888 48 AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEV-NLLVKLRHPNIVQFLGAVTERKPLMLITEYLRG 124 (320)
Q Consensus 48 ~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~ 124 (320)
+.||+|+||+||++.+. ++.+|+|++.+...........+..|. .+++.++|+||+++++.+...+..|+||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46899999999999985 788999988654332222234444454 467788999999999999999999999999999
Q ss_pred CCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCccceee
Q 020888 125 GDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK 204 (320)
Q Consensus 125 ~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~~~~~ 204 (320)
++|.+.+.....+++..+..++.||+.||.|||+.| ++|+||||+||++ +.++.++|+|||++........ .
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--ivH~Dlkp~NIll--~~~~~~kl~Dfg~~~~~~~~~~----~ 152 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLN--IIYRDLKPENILL--DSQGHVVLTDFGLCKEGVEPEE----T 152 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEE--CCCCCEEEccCCCCccCCCCCC----c
Confidence 999999987778999999999999999999999988 9999999999999 8889999999998864322111 1
Q ss_pred ccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHH
Q 020888 205 MTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKC 284 (320)
Q Consensus 205 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 284 (320)
.....+++.|+|||.+.+..++.++|+|||||++|+|++|..||...+.......+...... .+...+.++.+++.+|
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~~~li~~~ 230 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQ--LPGGKTVAACDLLVGL 230 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCC--CCCCCCHHHHHHHHHH
Confidence 22346889999999999989999999999999999999999999988777666666554322 2345789999999999
Q ss_pred hhcCCCCCCCHH
Q 020888 285 WAADMNQRPSFL 296 (320)
Q Consensus 285 l~~dp~~Rps~~ 296 (320)
|+.||.+|++..
T Consensus 231 l~~~p~~R~~~~ 242 (321)
T cd05603 231 LHKDQRRRLGAK 242 (321)
T ss_pred ccCCHhhcCCCC
Confidence 999999998754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=285.86 Aligned_cols=263 Identities=29% Similarity=0.415 Sum_probs=214.5
Q ss_pred cccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEe-----CCc
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE-----RKP 114 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 114 (320)
..|..++.||.|++|.|..+.++ +..||+|.+...+..... .++..+|+++|+.++|+||+.+.+++.. .+.
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~-akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQID-AKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHH-HHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 35666899999999999999886 889999988755544433 4778889999999999999999998854 455
Q ss_pred eEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccc
Q 020888 115 LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 194 (320)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~ 194 (320)
.|+|+|++ +.+|.+.++.+..++...+..+++|++.||+|+|+.| ++|+|+||+|+++ +.+..+||+|||+++..
T Consensus 101 vYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAn--ViHRDLKPsNll~--n~~c~lKI~DFGLAR~~ 175 (359)
T KOG0660|consen 101 VYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSAN--VIHRDLKPSNLLL--NADCDLKICDFGLARYL 175 (359)
T ss_pred eEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhccc--ccccccchhheee--ccCCCEEeccccceeec
Confidence 89999999 7799999999877999999999999999999999999 9999999999999 88889999999999987
Q ss_pred cccCccceeeccCCcccccccCccccC-cCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH------------
Q 020888 195 KVQNSHDVYKMTGETGSYRYMAPEVFK-HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA------------ 261 (320)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~------------ 261 (320)
... .........+.|.+|.|||+.. ...|+.+.||||+||++.||++|+.-|.+.+..+-...+.
T Consensus 176 ~~~--~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~ 253 (359)
T KOG0660|consen 176 DKF--FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQ 253 (359)
T ss_pred ccc--CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHH
Confidence 654 2222446677899999999874 5679999999999999999999999998776544333222
Q ss_pred ------------hCCCCCCC-----CCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH--HHHHHhcCCCC
Q 020888 262 ------------EGHRPFFR-----AKGFTPELRELTEKCWAADMNQRPSFLDILKR--LEKIKETLPTD 312 (320)
Q Consensus 262 ------------~~~~~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--L~~~~~~~~~~ 312 (320)
.....+.. ..+.++...+++.+||..||.+|+|++|+|+| |..+.+-..++
T Consensus 254 ~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP 323 (359)
T KOG0660|consen 254 KIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEP 323 (359)
T ss_pred HhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCC
Confidence 11111111 13567889999999999999999999999988 55555444333
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=289.73 Aligned_cols=257 Identities=29% Similarity=0.490 Sum_probs=211.3
Q ss_pred CcccCccceecccCceEEEEEEEC-------CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcccceeeeEEeC
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTER 112 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~-------~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 112 (320)
..+|.+.+.||+|++|.||++.+. +..+++|.+..... ....+.+.+|+++++++ +|+||+++++.+...
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 111 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH--SSEREALMSELKIMSHLGNHENIVNLLGACTIG 111 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC--hHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence 458999999999999999998752 34689998754422 23346789999999999 799999999999999
Q ss_pred CceEEEEecCCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCC
Q 020888 113 KPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGL 190 (320)
Q Consensus 113 ~~~~iv~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~ 190 (320)
+..++++||+++++|.+++.... .+++.++..++.+++.||.|||+.| ++|+||+|+||++ +.++.++|+|||.
T Consensus 112 ~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~--~~~~~~~l~dfg~ 187 (302)
T cd05055 112 GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNVLL--THGKIVKICDFGL 187 (302)
T ss_pred CceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eehhhhccceEEE--cCCCeEEECCCcc
Confidence 99999999999999999997533 3899999999999999999999988 9999999999999 7888999999999
Q ss_pred cccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCC
Q 020888 191 SKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFR 269 (320)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 269 (320)
+........ ........++..|+|||.+.+..++.++|+||||+++|++++ |..||......+..............
T Consensus 188 ~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~ 265 (302)
T cd05055 188 ARDIMNDSN--YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQ 265 (302)
T ss_pred cccccCCCc--eeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCC
Confidence 876543221 111222345678999999999999999999999999999998 99999876655443333333222233
Q ss_pred CCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHH
Q 020888 270 AKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKI 305 (320)
Q Consensus 270 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~ 305 (320)
+...+.++++++.+||..+|++|||+.++++.|.++
T Consensus 266 ~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 266 PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 345789999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=284.68 Aligned_cols=250 Identities=32% Similarity=0.552 Sum_probs=208.7
Q ss_pred cccCccceecccCceEEEEEEEC-CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEe
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~-~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 120 (320)
.+|++.+.||+|++|.||++.+. +..+++|.+...... .+.+.+|+.++++++|++++++++++.. ...+++||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e 80 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS----PESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTE 80 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC----HHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEE
Confidence 37899999999999999999876 567999988654332 2568899999999999999999998754 56789999
Q ss_pred cCCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccC
Q 020888 121 YLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 198 (320)
Q Consensus 121 ~~~~~~L~~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~ 198 (320)
|+++++|.+++... ..+++..++.++.+++.||.|||+.| ++|+||+|+||++ +.++.++|+|||.+.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~Nili--~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05070 81 YMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN--YIHRDLRSANILV--GDGLVCKIADFGLARLIEDNE 156 (260)
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEE--eCCceEEeCCceeeeeccCcc
Confidence 99999999998753 35899999999999999999999988 9999999999999 778899999999987654322
Q ss_pred ccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHH
Q 020888 199 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPEL 277 (320)
Q Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 277 (320)
.. ......++..|+|||...+..++.++|+||||+++|++++ |..||...+..+....+....... .+...+.++
T Consensus 157 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 232 (260)
T cd05070 157 YT---ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMP-CPQDCPISL 232 (260)
T ss_pred cc---cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC-CCCcCCHHH
Confidence 11 1112234567999999988889999999999999999999 899998887777766665543332 234578999
Q ss_pred HHHHHHHhhcCCCCCCCHHHHHHHHHH
Q 020888 278 RELTEKCWAADMNQRPSFLDILKRLEK 304 (320)
Q Consensus 278 ~~li~~~l~~dp~~Rps~~~ll~~L~~ 304 (320)
++++.+|+..+|.+|||++++.+.|+.
T Consensus 233 ~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 233 HELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred HHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 999999999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=290.80 Aligned_cols=263 Identities=31% Similarity=0.541 Sum_probs=217.1
Q ss_pred cccCccceecccCceEEEEEEEC---------CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcccceeeeEEe
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR---------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTE 111 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~---------~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 111 (320)
.+|.+.+.||+|++|.||++.+. ...+++|.+..... ......+.+|+++++.+ +|+||+++++++..
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT--DKDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCC--hHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 48899999999999999999752 34588898754322 33346788899999999 69999999999998
Q ss_pred CCceEEEEecCCCCCHHHHHHHh----------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE
Q 020888 112 RKPLMLITEYLRGGDLHKYLKEK----------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLL 175 (320)
Q Consensus 112 ~~~~~iv~e~~~~~~L~~~~~~~----------------~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~ 175 (320)
.+..++++||+++++|.+++... ..+++..+..++.|++.||.|||++| ++|+||||+||++
T Consensus 90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp~Nill 167 (314)
T cd05099 90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR--CIHRDLAARNVLV 167 (314)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeeccccceeEEE
Confidence 89999999999999999999753 24788999999999999999999988 9999999999999
Q ss_pred eeCCCCcEEEecCCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 020888 176 VNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPY 254 (320)
Q Consensus 176 ~~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~ 254 (320)
+.++.++|+|||.+.......... ......++..|+|||.+.+..++.++|+||||+++|++++ |..||......
T Consensus 168 --~~~~~~kL~Dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~ 243 (314)
T cd05099 168 --TEDNVMKIADFGLARGVHDIDYYK--KTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE 243 (314)
T ss_pred --cCCCcEEEcccccccccccccccc--ccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH
Confidence 788899999999997654321111 0111223457999999988889999999999999999999 89999888777
Q ss_pred HHHHHHHhCCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcCCCCC
Q 020888 255 EAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPTDH 313 (320)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~~ 313 (320)
+....+........ +..++.++++++.+||..+|++|||+.++++.|.++......+.
T Consensus 244 ~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~~~~ 301 (314)
T cd05099 244 ELFKLLREGHRMDK-PSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSEEY 301 (314)
T ss_pred HHHHHHHcCCCCCC-CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhcCCc
Confidence 77766665543332 34578999999999999999999999999999999987665543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=283.67 Aligned_cols=258 Identities=29% Similarity=0.572 Sum_probs=214.0
Q ss_pred CCcccCccceecccCceEEEEEEECC-----CceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCc
Q 020888 40 SELDFSSSAIIGKGSFGEILKAYWRG-----TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP 114 (320)
Q Consensus 40 ~~~~y~~~~~lg~g~~~~vy~~~~~~-----~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 114 (320)
...+|.+.+.||.|++|.||++.+.+ ..+++|....... ....+.+.+|+.+++++.|+|++++++++.+ +.
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~ 80 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS--PSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NP 80 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC--HHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CC
Confidence 34578899999999999999998642 3688887754322 3344788999999999999999999998875 45
Q ss_pred eEEEEecCCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccc
Q 020888 115 LMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 193 (320)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~ 193 (320)
.+++|||+++++|.+++... ..+++..++.++.+++.||.+||+.| ++|+||+|+||++ +.++.++|+|||++..
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~~H~dl~p~nili--~~~~~~~l~d~g~~~~ 156 (270)
T cd05056 81 VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR--FVHRDIAARNVLV--SSPDCVKLGDFGLSRY 156 (270)
T ss_pred cEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccChheEEE--ecCCCeEEccCceeee
Confidence 68999999999999999764 35899999999999999999999988 9999999999999 7888999999998876
Q ss_pred ccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCC
Q 020888 194 IKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKG 272 (320)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (320)
..... ........++..|+|||.+.+..++.++|+||||++++++++ |..||......+....+..+.... .+..
T Consensus 157 ~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~ 232 (270)
T cd05056 157 LEDES---YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLP-MPPN 232 (270)
T ss_pred ccccc---ceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCC-CCCC
Confidence 54331 111222334567999999988889999999999999999986 999998887776666665554443 3456
Q ss_pred CCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhc
Q 020888 273 FTPELRELTEKCWAADMNQRPSFLDILKRLEKIKET 308 (320)
Q Consensus 273 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 308 (320)
++.++.+++.+|+..+|.+|||+.++++.|..+...
T Consensus 233 ~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 233 CPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 899999999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=284.37 Aligned_cols=248 Identities=28% Similarity=0.497 Sum_probs=210.7
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEe
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 120 (320)
+|++.+.||.|++|.||++.+. ++.+++|.+..... ....+.+.+|+.+++.++|+|++++++.+..++..++++|
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS--SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc--hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 5788999999999999999885 78899998754322 2334778889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccC
Q 020888 121 YLRGGDLHKYLKE--KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 198 (320)
Q Consensus 121 ~~~~~~L~~~~~~--~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~ 198 (320)
|+++++|.+++.. ...+++..++.++.|++.||.+||+.| ++|+||+|+||++ +.++.++|+|||.+.......
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dl~p~nili--~~~~~~~l~dfg~~~~~~~~~ 154 (255)
T cd08219 79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR--VLHRDIKSKNIFL--TQNGKVKLGDFGSARLLTSPG 154 (255)
T ss_pred eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEE--CCCCcEEEcccCcceeecccc
Confidence 9999999998865 235899999999999999999999998 9999999999999 888899999999987654322
Q ss_pred ccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHH
Q 020888 199 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 278 (320)
Q Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 278 (320)
. ......+++.|+|||.+.+..++.++|+||||+++|++++|..||...+.......+..+..... +..++..++
T Consensus 155 ~----~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 229 (255)
T cd08219 155 A----YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPL-PSHYSYELR 229 (255)
T ss_pred c----ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCC-CcccCHHHH
Confidence 1 11234578889999999998999999999999999999999999998776666655555544433 345789999
Q ss_pred HHHHHHhhcCCCCCCCHHHHHHH
Q 020888 279 ELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 279 ~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
+++.+||+.||.+|||+.+++..
T Consensus 230 ~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 230 SLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHHHHHHhCCcccCCCHHHHhhc
Confidence 99999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=299.40 Aligned_cols=239 Identities=31% Similarity=0.467 Sum_probs=199.4
Q ss_pred ceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHH-HHHhCCCCcccceeeeEEeCCceEEEEecCCC
Q 020888 48 AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVN-LLVKLRHPNIVQFLGAVTERKPLMLITEYLRG 124 (320)
Q Consensus 48 ~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~ 124 (320)
+.||+|+||+||++.+. ++.+|+|++.............+..|.. +++.++|+||+++++.+..++..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46899999999999875 7889999886543332223344555554 46778999999999999999999999999999
Q ss_pred CCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCccceee
Q 020888 125 GDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK 204 (320)
Q Consensus 125 ~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~~~~~ 204 (320)
++|.+++...+.+++..+..++.||+.||.|||+.| ++|+||||+||++ +.++.++|+|||++........ .
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~g--ivH~Dlkp~NIll--~~~~~~kL~DfG~~~~~~~~~~----~ 152 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSIN--IVYRDLKPENILL--DSQGHVVLTDFGLCKEGIAQSD----T 152 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEE--CCCCCEEEeecCCcccCCCCCC----C
Confidence 999999988788999999999999999999999998 9999999999999 8889999999999864322111 1
Q ss_pred ccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHH
Q 020888 205 MTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKC 284 (320)
Q Consensus 205 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 284 (320)
.....+++.|+|||.+.+..++.++|+|||||++|+|++|..||...+..+....+....... ....+.++.+++.+|
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ll~~l 230 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVL--RPGASLTAWSILEEL 230 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccC--CCCCCHHHHHHHHHH
Confidence 223468999999999999999999999999999999999999999888777766665543222 234789999999999
Q ss_pred hhcCCCCCCCHH
Q 020888 285 WAADMNQRPSFL 296 (320)
Q Consensus 285 l~~dp~~Rps~~ 296 (320)
|..+|.+||++.
T Consensus 231 l~~~p~~R~~~~ 242 (325)
T cd05604 231 LEKDRQRRLGAK 242 (325)
T ss_pred hccCHHhcCCCC
Confidence 999999999875
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=300.84 Aligned_cols=246 Identities=26% Similarity=0.340 Sum_probs=198.1
Q ss_pred CCCcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceE
Q 020888 39 PSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLM 116 (320)
Q Consensus 39 ~~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 116 (320)
....+|.+.+.||+|+||.||++.+. ++.+|+|.... ..+.+|++++++++||||+++++++......+
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 159 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKFTC 159 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeE
Confidence 34457999999999999999999985 78899995421 35678999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccc
Q 020888 117 LITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 196 (320)
Q Consensus 117 iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~ 196 (320)
+++|++. ++|.+++.....+++..++.++.|++.||.|||++| |+|+||||+||++ +.++.++|+|||++.....
T Consensus 160 lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~--IvHrDiKP~NIll--~~~~~vkL~DFG~a~~~~~ 234 (391)
T PHA03212 160 LILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENR--IIHRDIKAENIFI--NHPGDVCLGDFGAACFPVD 234 (391)
T ss_pred EEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHhEEE--cCCCCEEEEeCCccccccc
Confidence 9999995 589999887778999999999999999999999998 9999999999999 8889999999999864332
Q ss_pred cCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh-------HHHHHHHH--------
Q 020888 197 QNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEP-------YEAAKYVA-------- 261 (320)
Q Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~-------~~~~~~~~-------- 261 (320)
... .......||+.|+|||++.+..++.++|||||||++|+|++|..||...+. ......+.
T Consensus 235 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~ 311 (391)
T PHA03212 235 INA---NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPN 311 (391)
T ss_pred ccc---cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChh
Confidence 111 112235689999999999999999999999999999999999987643210 01111110
Q ss_pred ------------------hCCC--CCCC-----CCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 262 ------------------EGHR--PFFR-----AKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 262 ------------------~~~~--~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
.... +... ...++.++.++|.+||+.||++|||+++++++
T Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 312 EFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred hcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0000 0000 01346789999999999999999999999975
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=287.08 Aligned_cols=248 Identities=33% Similarity=0.542 Sum_probs=213.5
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEe
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 120 (320)
+|.+.+.||.|++|.||++.+. ++.+++|.+..... ......+.+|+++++.++|+|++++.+.+.++...++|+|
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA--EDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME 79 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeecccc--chHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence 6889999999999999999875 78899998865432 2233678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCcc
Q 020888 121 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 200 (320)
Q Consensus 121 ~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~ 200 (320)
|+++++|.+++... ++++..++.++.|++.++.+||+.| ++|+||+|+||++ +.++.++|+|||.+..+.....
T Consensus 80 ~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i--~~~~~~~l~d~g~~~~~~~~~~- 153 (274)
T cd06609 80 YCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEG--KIHRDIKAANILL--SEEGDVKLADFGVSGQLTSTMS- 153 (274)
T ss_pred eeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEE--CCCCCEEEcccccceeeccccc-
Confidence 99999999999875 7899999999999999999999998 9999999999999 8889999999999877654321
Q ss_pred ceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHH
Q 020888 201 DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELREL 280 (320)
Q Consensus 201 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 280 (320)
......+++.|+|||.+.+..++.++|+||||+++|++++|..||...+.......+.....+......++.+++++
T Consensus 154 ---~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (274)
T cd06609 154 ---KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDF 230 (274)
T ss_pred ---ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHH
Confidence 12234567889999999988899999999999999999999999988777666655555554444433478999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHH
Q 020888 281 TEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 281 i~~~l~~dp~~Rps~~~ll~~ 301 (320)
+.+||..+|++|||+++++++
T Consensus 231 l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 231 VSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred HHHHhhCChhhCcCHHHHhhC
Confidence 999999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=289.21 Aligned_cols=255 Identities=28% Similarity=0.483 Sum_probs=213.4
Q ss_pred CcccCccceecccCceEEEEEEEC-------CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCC
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK 113 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~-------~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 113 (320)
..+|.+.+.||.|++|.||++.+. +..+++|.+..... ......+.+|+.++..++|+||+++++++...+
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~ 81 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAE--GPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ 81 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCC--HHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC
Confidence 346888999999999999999864 36799998864432 233467889999999999999999999999989
Q ss_pred ceEEEEecCCCCCHHHHHHH----------------hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEee
Q 020888 114 PLMLITEYLRGGDLHKYLKE----------------KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN 177 (320)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~----------------~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~ 177 (320)
..++++||+++++|.+++.. +..+++..++.++.|++.||.|||+.| ++|+||||+||++
T Consensus 82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g--i~H~dlkp~Nil~-- 157 (283)
T cd05091 82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH--VVHKDLATRNVLV-- 157 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC--ccccccchhheEe--
Confidence 99999999999999999853 134788899999999999999999998 9999999999999
Q ss_pred CCCCcEEEecCCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 020888 178 SSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEA 256 (320)
Q Consensus 178 ~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~ 256 (320)
+.++.++|+|||++........ ........+++.|+|||...+..++.++|+||||+++|++++ |..||......+.
T Consensus 158 ~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 235 (283)
T cd05091 158 FDKLNVKISDLGLFREVYAADY--YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV 235 (283)
T ss_pred cCCCceEecccccccccccchh--eeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 7788899999999876543221 112233345678999999988889999999999999999998 8889988887777
Q ss_pred HHHHHhCCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHH
Q 020888 257 AKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEK 304 (320)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 304 (320)
...+........ +..++.++.+++.+||+.+|.+||++.+++..|+.
T Consensus 236 ~~~i~~~~~~~~-~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 236 IEMIRNRQVLPC-PDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHHcCCcCCC-CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 776666654433 34689999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=283.67 Aligned_cols=253 Identities=31% Similarity=0.518 Sum_probs=209.7
Q ss_pred CcccCccceecccCceEEEEEEEC-CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEE
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 119 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~-~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 119 (320)
..+|++.+.||+|++|.||++.+. +..+++|.+...... .+.+.+|+.+++.++|+||+++++.+.. ...+++|
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~ 79 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 79 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccC----HHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEE
Confidence 346999999999999999999876 457999988653332 2567889999999999999999998754 5579999
Q ss_pred ecCCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccccccc
Q 020888 120 EYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 197 (320)
Q Consensus 120 e~~~~~~L~~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~ 197 (320)
||+++++|.+++... ..+++..+..++.|++.||.+||+.| ++|+||+|+||++ +.++.++|+|||.+..+...
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~Nill--~~~~~~~L~dfg~~~~~~~~ 155 (262)
T cd05071 80 EYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILV--GENLVCKVADFGLARLIEDN 155 (262)
T ss_pred EcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcccEEE--cCCCcEEeccCCceeecccc
Confidence 999999999999753 35799999999999999999999988 9999999999999 78889999999998765432
Q ss_pred CccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHH
Q 020888 198 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPE 276 (320)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (320)
... ......++..|+|||...+..++.++|+||||+++|++++ |..||......+....+........ ...++..
T Consensus 156 ~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 231 (262)
T cd05071 156 EYT---ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC-PPECPES 231 (262)
T ss_pred ccc---cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCC-ccccCHH
Confidence 211 1122345677999999988899999999999999999999 8889988776666655554433322 3457999
Q ss_pred HHHHHHHHhhcCCCCCCCHHHHHHHHHHHH
Q 020888 277 LRELTEKCWAADMNQRPSFLDILKRLEKIK 306 (320)
Q Consensus 277 l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 306 (320)
+.+++.+|++.+|.+|||+.++++.|+.+.
T Consensus 232 l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 232 LHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred HHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=282.46 Aligned_cols=248 Identities=29% Similarity=0.554 Sum_probs=205.6
Q ss_pred eecccCceEEEEEEEC----CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEecCCC
Q 020888 49 IIGKGSFGEILKAYWR----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRG 124 (320)
Q Consensus 49 ~lg~g~~~~vy~~~~~----~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~ 124 (320)
.||+|+||.||++.+. +..+++|.+..... ....+.+.+|+.++++++|+||+++++++.. +..++||||+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~--~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENE--KSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccC--hHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCC
Confidence 3899999999998764 34589998865432 3334678899999999999999999998764 568999999999
Q ss_pred CCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCcccee
Q 020888 125 GDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 203 (320)
Q Consensus 125 ~~L~~~~~~-~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~~~~ 203 (320)
++|.+++.. ...+++..++.++.|++.||.+||++| ++|+||||+||++ +.++.++|+|||.+...........
T Consensus 79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~--~~~~~~kl~dfg~~~~~~~~~~~~~- 153 (257)
T cd05115 79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN--FVHRDLAARNVLL--VNQHYAKISDFGLSKALGADDSYYK- 153 (257)
T ss_pred CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcC--eeecccchheEEE--cCCCcEEeccCCccccccCCcccee-
Confidence 999999875 457899999999999999999999998 9999999999999 8888999999999876543322111
Q ss_pred eccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHH
Q 020888 204 KMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTE 282 (320)
Q Consensus 204 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 282 (320)
......++..|+|||.+.+..++.++|+||||+++|++++ |..||......+....+..+..... +...++++.+++.
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~ 232 (257)
T cd05115 154 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDC-PAECPPEMYALMK 232 (257)
T ss_pred ccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCC-CCCCCHHHHHHHH
Confidence 1112233568999999988889999999999999999996 9999998888777776666654433 3457899999999
Q ss_pred HHhhcCCCCCCCHHHHHHHHHHH
Q 020888 283 KCWAADMNQRPSFLDILKRLEKI 305 (320)
Q Consensus 283 ~~l~~dp~~Rps~~~ll~~L~~~ 305 (320)
+||..+|++||++.++++.|+.+
T Consensus 233 ~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 233 DCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred HHcCCChhhCcCHHHHHHHHhhh
Confidence 99999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=284.10 Aligned_cols=257 Identities=33% Similarity=0.592 Sum_probs=214.3
Q ss_pred CcccCccceecccCceEEEEEEEC-----CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCce
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL 115 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~-----~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 115 (320)
..+|.+.+.||+|+||.||++.+. ...+++|.+..... ......+.+|+.++++++|+||+++++++..++..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT--EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV 80 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 347888999999999999999863 23688998754332 33347889999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccc
Q 020888 116 MLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 194 (320)
Q Consensus 116 ~iv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~ 194 (320)
+++|||+++++|.+++... +.+++..++.++.|++.||.+||+.| ++|+||+|+||++ +.++.++|+|||.+...
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~h~dlkp~nili--~~~~~~~l~dfg~~~~~ 156 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILV--NSNLVCKVSDFGLSRVL 156 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeehhhchhcEEE--CCCCeEEeCCCCccccc
Confidence 9999999999999999764 46899999999999999999999988 9999999999999 88889999999998876
Q ss_pred cccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCC
Q 020888 195 KVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGF 273 (320)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (320)
....... ........+..|.|||.+.+..++.++|+||||+++|++++ |..||......+....+.+....+ .+..+
T Consensus 157 ~~~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~ 234 (267)
T cd05066 157 EDDPEAA-YTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLP-APMDC 234 (267)
T ss_pred cccccee-eecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCC-CCCCC
Confidence 5432111 11112223567999999998899999999999999999887 999998887777666666554332 33457
Q ss_pred CHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHH
Q 020888 274 TPELRELTEKCWAADMNQRPSFLDILKRLEKI 305 (320)
Q Consensus 274 ~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~ 305 (320)
++++.+++.+|++.+|.+||++.++++.|+++
T Consensus 235 ~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 235 PAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred CHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 89999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=317.55 Aligned_cols=263 Identities=25% Similarity=0.374 Sum_probs=212.1
Q ss_pred cccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEE
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 119 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 119 (320)
.+|.+.+.||+|+||.||++.+. ++.||+|.+...........+++.+|++++++++|||++++++++.+++..+++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 37999999999999999999885 7889999987655444444577899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHHh-----------CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecC
Q 020888 120 EYLRGGDLHKYLKEK-----------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF 188 (320)
Q Consensus 120 e~~~~~~L~~~~~~~-----------~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~df 188 (320)
||++|++|.+++... ..++...++.++.|++.||.|||+.| ++||||||+||++ +.++.++|+||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G--IIHRDLKPeNILL--d~dg~vKLiDF 157 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG--VLHRDLKPDNILL--GLFGEVVILDW 157 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchheEEE--cCCCCEEEEec
Confidence 999999999988641 23566788999999999999999998 9999999999999 88899999999
Q ss_pred CCcccccccCc--------------cceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH
Q 020888 189 GLSKLIKVQNS--------------HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPY 254 (320)
Q Consensus 189 g~~~~~~~~~~--------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~ 254 (320)
|++........ ..........||+.|+|||...+..++.++|+|||||++|+|++|..||...+..
T Consensus 158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ 237 (932)
T PRK13184 158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR 237 (932)
T ss_pred CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence 99986622110 0011112346899999999999999999999999999999999999999875543
Q ss_pred HHHHHHH-hCCCCCCCCCCCCHHHHHHHHHHhhcCCCCCC-CHHHHHHHHHHHHhc
Q 020888 255 EAAKYVA-EGHRPFFRAKGFTPELRELTEKCWAADMNQRP-SFLDILKRLEKIKET 308 (320)
Q Consensus 255 ~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-s~~~ll~~L~~~~~~ 308 (320)
+...... ...........+++.+.+++.+|+..||.+|+ +++++++.|+.....
T Consensus 238 ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 238 KISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred hhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 3322111 11111111245789999999999999999996 778888888887654
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=298.21 Aligned_cols=247 Identities=28% Similarity=0.373 Sum_probs=198.4
Q ss_pred cccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCC------
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK------ 113 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------ 113 (320)
.+|.+.+.||+|+||.||++.+. ++.+|+|.+....... .....+.+|+.+++.++|+||+++++++....
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 21 KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQ-THAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccch-hHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 58999999999999999999875 7889999886543332 33467788999999999999999999886433
Q ss_pred ceEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccc
Q 020888 114 PLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 193 (320)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~ 193 (320)
..|+||||+++ +|.+.+.. .++...+..++.|++.||.|||+.| |+|+||||+||++ +.++.++|+|||++..
T Consensus 100 ~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~--ivHrDlkp~NIl~--~~~~~~kl~Dfg~a~~ 172 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIHM--ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVV--KSDCTLKILDFGLART 172 (359)
T ss_pred eeEEEEeCCCc-CHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEE--CCCCCEEEecCCCccc
Confidence 47999999965 77776643 5889999999999999999999998 9999999999999 8889999999999875
Q ss_pred ccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCC--------
Q 020888 194 IKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHR-------- 265 (320)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~-------- 265 (320)
..... ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....+.....
T Consensus 173 ~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (359)
T cd07876 173 ACTNF-----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMN 247 (359)
T ss_pred cccCc-----cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHH
Confidence 43221 12334678899999999999999999999999999999999999987654332221111000
Q ss_pred -------------CC-------------------CCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 266 -------------PF-------------------FRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 266 -------------~~-------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
+. ......+++++++|.+||..||++|||+.+++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 248 RLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00 0011236789999999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=283.77 Aligned_cols=254 Identities=31% Similarity=0.533 Sum_probs=209.9
Q ss_pred cCccceecccCceEEEEEEEC-----CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCc----
Q 020888 44 FSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP---- 114 (320)
Q Consensus 44 y~~~~~lg~g~~~~vy~~~~~-----~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---- 114 (320)
|.+.+.||+|+||.||++... +..+|+|.+...... ......+.+|++.++.++|+|++++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHT-YSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCC-HHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 567889999999999999864 266999988654333 3334678899999999999999999998765443
Q ss_pred --eEEEEecCCCCCHHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEe
Q 020888 115 --LMLITEYLRGGDLHKYLKEK------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVG 186 (320)
Q Consensus 115 --~~iv~e~~~~~~L~~~~~~~------~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~ 186 (320)
.++++||+++++|.+++... ..+++..++.++.|++.||.|||+.| ++|+||||+||++ +.++.++|+
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~--i~H~dlkp~Nil~--~~~~~~kl~ 155 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN--FIHRDLAARNCML--REDMTVCVA 155 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchheEEE--CCCCeEEEC
Confidence 79999999999999988532 25899999999999999999999988 9999999999999 888899999
Q ss_pred cCCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCC
Q 020888 187 DFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHR 265 (320)
Q Consensus 187 dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~ 265 (320)
|||.+.......... .......+..|.|||...+..++.++|+||||+++|++++ |..||......+....+..+..
T Consensus 156 dfg~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~ 233 (273)
T cd05035 156 DFGLSKKIYSGDYYR--QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNR 233 (273)
T ss_pred Cccceeecccccccc--ccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence 999988664432211 1111234567999999988889999999999999999999 9999988887777766665544
Q ss_pred CCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHH
Q 020888 266 PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKI 305 (320)
Q Consensus 266 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~ 305 (320)
.. .+..++.++.+++.+||+.||.+|||+.++++.|+++
T Consensus 234 ~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 234 LK-QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CC-CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 33 3456899999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=300.06 Aligned_cols=250 Identities=28% Similarity=0.436 Sum_probs=203.4
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCC-----ce
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK-----PL 115 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~ 115 (320)
+|++.+.||+|+||.||++.+. ++.||+|.+...... ....+.+.+|+++++.++|+||+++++++...+ ..
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQN-LVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccc-hHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 4788999999999999999974 789999988654322 233467889999999999999999999998766 78
Q ss_pred EEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccccc
Q 020888 116 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 195 (320)
Q Consensus 116 ~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~ 195 (320)
|+|+||+. ++|.+.+.....+++..+..++.|++.||.|||+.| ++|+||||+||++ +.++.++|+|||++....
T Consensus 80 ~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nili--~~~~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 80 YVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAG--ILHRDIKPGNLLV--NSNCVLKICDFGLARVEE 154 (372)
T ss_pred EEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHHEEE--CCCCCEEeccccceeecc
Confidence 99999995 589988887778999999999999999999999998 9999999999999 888999999999987543
Q ss_pred ccCccceeeccCCcccccccCccccCcC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh------------
Q 020888 196 VQNSHDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAE------------ 262 (320)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~------------ 262 (320)
.... .......+++.|+|||.+.+. .++.++|||||||++|+|++|+.||...+..+....+..
T Consensus 155 ~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 231 (372)
T cd07853 155 PDES---KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRS 231 (372)
T ss_pred cCcc---ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHH
Confidence 3211 112234578899999998875 478999999999999999999999987765544333221
Q ss_pred -----------CC-CCC------CCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 263 -----------GH-RPF------FRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 263 -----------~~-~~~------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
.. .+. ......++++.++|.+||+.||++|||+.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 232 ACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred hhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 11 000 0113358899999999999999999999999886
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=301.22 Aligned_cols=243 Identities=27% Similarity=0.426 Sum_probs=200.5
Q ss_pred ecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhC---CCCcccceeeeEEeCCceEEEEecCCC
Q 020888 50 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL---RHPNIVQFLGAVTERKPLMLITEYLRG 124 (320)
Q Consensus 50 lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~~~iv~e~~~~ 124 (320)
||+|+||+||++.++ ++.+|+|++................|..++... .|++|+++++.+...+.+|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999885 789999988554332222334455566666655 699999999999999999999999999
Q ss_pred CCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCccceee
Q 020888 125 GDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK 204 (320)
Q Consensus 125 ~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~~~~~ 204 (320)
++|.+++...+.+++..+..++.||+.||.|||++| |+|+||||+||++ +.++.++|+|||++........ .
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~--ivHrDlkp~Nili--~~~~~~kl~Dfg~a~~~~~~~~----~ 152 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD--IVYRDLKPENILL--DATGHIALCDFGLSKANLTDNK----T 152 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEE--CCCCCEEEecCCcCcCCCCCCC----C
Confidence 999999988888999999999999999999999998 9999999999999 8888999999999865432211 1
Q ss_pred ccCCcccccccCccccCcC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHH
Q 020888 205 MTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEK 283 (320)
Q Consensus 205 ~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 283 (320)
.....|++.|+|||++.+. .++.++||||||+++|+|++|..||...+..+....+..+.... ....+++++++++++
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~~~~li~~ 231 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRF-PKNVLSDEGRQFVKG 231 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCC-CCccCCHHHHHHHHH
Confidence 2335689999999998765 47899999999999999999999999888777766665544332 223479999999999
Q ss_pred HhhcCCCCCC----CHHHHHHH
Q 020888 284 CWAADMNQRP----SFLDILKR 301 (320)
Q Consensus 284 ~l~~dp~~Rp----s~~~ll~~ 301 (320)
||..||.+|| ++++++++
T Consensus 232 ~L~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 232 LLNRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred HcCCCHHHCCCCCCCHHHHhcC
Confidence 9999999998 67777764
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=288.90 Aligned_cols=262 Identities=31% Similarity=0.542 Sum_probs=217.1
Q ss_pred CCCcccCccceecccCceEEEEEEEC---------CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcccceeee
Q 020888 39 PSELDFSSSAIIGKGSFGEILKAYWR---------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGA 108 (320)
Q Consensus 39 ~~~~~y~~~~~lg~g~~~~vy~~~~~---------~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~ 108 (320)
....+|.+.+.||+|+||.||++... +..+++|.+..... ......+.+|+.+++.+ +|+||+++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 89 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDAT--EKDLSDLVSEMEMMKMIGKHKNIINLLGA 89 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccc--hHHHHHHHHHHHHHHhhccCCCchheeEE
Confidence 44678999999999999999999742 34688997754322 23347788999999999 79999999999
Q ss_pred EEeCCceEEEEecCCCCCHHHHHHHh----------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 020888 109 VTERKPLMLITEYLRGGDLHKYLKEK----------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRN 172 (320)
Q Consensus 109 ~~~~~~~~iv~e~~~~~~L~~~~~~~----------------~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~n 172 (320)
+......+++|||+++++|.+++... ..+++..+..++.|++.||.|||+.| ++|+||||+|
T Consensus 90 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g--ivH~dlkp~N 167 (304)
T cd05101 90 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK--CIHRDLAARN 167 (304)
T ss_pred EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC--eeecccccce
Confidence 99999999999999999999999753 24678889999999999999999998 9999999999
Q ss_pred EEEeeCCCCcEEEecCCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCC
Q 020888 173 VLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANY 251 (320)
Q Consensus 173 I~~~~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~ 251 (320)
|++ +.++.++|+|||.+.......... ......++..|+|||++.+..++.++||||||+++|++++ |..||...
T Consensus 168 ili--~~~~~~kl~D~g~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 243 (304)
T cd05101 168 VLV--TENNVMKIADFGLARDVNNIDYYK--KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 243 (304)
T ss_pred EEE--cCCCcEEECCCccceecccccccc--cccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC
Confidence 999 788899999999987664322111 1122334668999999988889999999999999999998 88899888
Q ss_pred ChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcC
Q 020888 252 EPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETL 309 (320)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 309 (320)
...+....+....... .+..++.++++++.+||..+|.+|||+.++++.|+++..-.
T Consensus 244 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~ 300 (304)
T cd05101 244 PVEELFKLLKEGHRMD-KPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLT 300 (304)
T ss_pred CHHHHHHHHHcCCcCC-CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhh
Confidence 7777766665554333 23457899999999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=285.99 Aligned_cols=252 Identities=33% Similarity=0.570 Sum_probs=209.7
Q ss_pred cccCccceecccCceEEEEEEEC-------CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCc
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP 114 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~-------~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 114 (320)
.+|...+.||+|+||.||++... +..+++|.+... .......+.+|+++++.++|+||+++++++..++.
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTVLQHQHIVRFYGVCTEGRP 81 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC---CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCc
Confidence 47888999999999999998642 456888876432 22334688999999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHHHHhC---------------CCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCC
Q 020888 115 LMLITEYLRGGDLHKYLKEKG---------------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS 179 (320)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~~~---------------~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~ 179 (320)
.++++||+++++|.+++...+ .+++..++.++.|++.|++|||+.| ++|+||||+||++ +.
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~nil~--~~ 157 (280)
T cd05092 82 LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH--FVHRDLATRNCLV--GQ 157 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC--eecccccHhhEEE--cC
Confidence 999999999999999987642 4789999999999999999999998 9999999999999 77
Q ss_pred CCcEEEecCCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 020888 180 ADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAK 258 (320)
Q Consensus 180 ~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~ 258 (320)
++.++|+|||++........ ........+++.|+|||...+..++.++|+||||+++|++++ |..||......+...
T Consensus 158 ~~~~kL~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 235 (280)
T cd05092 158 GLVVKIGDFGMSRDIYSTDY--YRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIE 235 (280)
T ss_pred CCCEEECCCCceeEcCCCce--eecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHH
Confidence 88999999999875533211 111122334678999999999999999999999999999998 999998877776666
Q ss_pred HHHhCCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHH
Q 020888 259 YVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLE 303 (320)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~ 303 (320)
.+....... .+..+++.+++++.+||+.||.+||+++++++.|+
T Consensus 236 ~~~~~~~~~-~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 236 CITQGRELE-RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HHHcCccCC-CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 665554333 34568999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=283.50 Aligned_cols=251 Identities=32% Similarity=0.544 Sum_probs=210.2
Q ss_pred CcccCccceecccCceEEEEEEEC-CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEE
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 119 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~-~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 119 (320)
..+|.++++||+|++|.||++..+ ++.+++|.+...... ...+.+|+.+++.++|+|++++++++. .+..++++
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~ 79 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS----PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIIT 79 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCc----HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEE
Confidence 357888999999999999999875 688999988654332 257888999999999999999999874 45689999
Q ss_pred ecCCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccccccc
Q 020888 120 EYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 197 (320)
Q Consensus 120 e~~~~~~L~~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~ 197 (320)
||+++++|.+++... ..+++..++.++.|++.+|++||+.| ++|+||+|+||++ +.++.++|+|||.+......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--i~H~dl~p~ni~i--~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05067 80 EYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN--YIHRDLRAANILV--SETLCCKIADFGLARLIEDN 155 (260)
T ss_pred EcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHHhEEE--cCCCCEEEccCcceeecCCC
Confidence 999999999998653 36899999999999999999999998 9999999999999 88889999999998765422
Q ss_pred CccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHH
Q 020888 198 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPE 276 (320)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (320)
.. .......++..|+|||.+.+..++.++|+||||+++|++++ |..||...+..+....+....... .+...+.+
T Consensus 156 ~~---~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 231 (260)
T cd05067 156 EY---TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMP-RPDNCPEE 231 (260)
T ss_pred Cc---ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCC-CCCCCCHH
Confidence 11 01112234568999999998899999999999999999999 999998887777766666554433 33457899
Q ss_pred HHHHHHHHhhcCCCCCCCHHHHHHHHHH
Q 020888 277 LRELTEKCWAADMNQRPSFLDILKRLEK 304 (320)
Q Consensus 277 l~~li~~~l~~dp~~Rps~~~ll~~L~~ 304 (320)
+++++.+||..+|++|||+++++..|+.
T Consensus 232 ~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 232 LYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred HHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 9999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=284.86 Aligned_cols=258 Identities=28% Similarity=0.573 Sum_probs=212.7
Q ss_pred CcccCccceecccCceEEEEEEEC--CC----ceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCc
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--GT----PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP 114 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~~----~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 114 (320)
..+|...+.||+|++|+||++.+. +. +||+|.+.... .......+.+|+.+++.+.|+|++++++++... .
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~ 82 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-T 82 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-C
Confidence 457899999999999999999863 33 48999875432 233346788999999999999999999988754 5
Q ss_pred eEEEEecCCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccc
Q 020888 115 LMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 193 (320)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~ 193 (320)
.+++++|+++|+|.+++.. .+.+++..++.++.|++.||.|||+.| ++|+||||+||++ ++++.++|+|||++..
T Consensus 83 ~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--iiH~dlkp~Nil~--~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 83 VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR--LVHRDLAARNVLV--KSPNHVKITDFGLARL 158 (279)
T ss_pred cEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccceEEE--cCCCcEEECCCCceee
Confidence 6789999999999999976 346899999999999999999999988 9999999999999 7788899999999876
Q ss_pred ccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCC
Q 020888 194 IKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKG 272 (320)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (320)
...... ........++..|+|||...+..++.++||||||+++|++++ |..||...........+........ +..
T Consensus 159 ~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~ 235 (279)
T cd05109 159 LDIDET--EYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQ-PPI 235 (279)
T ss_pred cccccc--eeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCC-Ccc
Confidence 643221 111222334678999999998999999999999999999998 9999988777766665555544433 345
Q ss_pred CCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhc
Q 020888 273 FTPELRELTEKCWAADMNQRPSFLDILKRLEKIKET 308 (320)
Q Consensus 273 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 308 (320)
++.++.+++.+||..||+.||++.++++.|.++...
T Consensus 236 ~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 236 CTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 799999999999999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=282.05 Aligned_cols=249 Identities=31% Similarity=0.519 Sum_probs=208.8
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEe-CCceEEEE
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE-RKPLMLIT 119 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~iv~ 119 (320)
+|++.+.||.|++|.||++.++ ++.+++|.+....... ...+.+.+|++++++++|+|++++.+.+.. +..+++++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASR-RERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCH-HHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 4889999999999999999875 6789999886543332 234678899999999999999999988764 44679999
Q ss_pred ecCCCCCHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccccccc
Q 020888 120 EYLRGGDLHKYLKE--KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 197 (320)
Q Consensus 120 e~~~~~~L~~~~~~--~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~ 197 (320)
||+++++|.+++.. ...+++.+++.++.+++.++.+||+.| ++|+||+|+||++ +.++.++|+|||.+......
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~--i~H~di~p~nil~--~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH--ILHRDLKTQNVFL--TRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCchhEEE--ecCCcEEEecccceEEeccc
Confidence 99999999999876 335899999999999999999999998 9999999999999 88889999999998765432
Q ss_pred CccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHH
Q 020888 198 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPEL 277 (320)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 277 (320)
.. ......+++.|+|||...+..++.++|+||||++++++++|..||...+.......+..+..+.. +..++.++
T Consensus 156 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 230 (257)
T cd08223 156 CD----MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPM-PKDYSPEL 230 (257)
T ss_pred CC----ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCC-ccccCHHH
Confidence 21 12234578899999999999999999999999999999999999987776665555555554333 34578999
Q ss_pred HHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 278 RELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 278 ~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
.+++.+|++.+|++|||+.+++++
T Consensus 231 ~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 231 GELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred HHHHHHHhccCcccCCCHHHHhcC
Confidence 999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=286.46 Aligned_cols=254 Identities=30% Similarity=0.528 Sum_probs=212.3
Q ss_pred CcccCccceecccCceEEEEEEECC-------CceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCC
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK 113 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~~-------~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 113 (320)
..+|.+.+.||+|++|.||++.+.+ ..+++|.+.... .......+.+|+.+++.++|+|++++++++..+.
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 82 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ 82 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC
Confidence 4578999999999999999988752 569999875432 2223357788999999999999999999999999
Q ss_pred ceEEEEecCCCCCHHHHHHHh----------CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcE
Q 020888 114 PLMLITEYLRGGDLHKYLKEK----------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHL 183 (320)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~----------~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~ 183 (320)
..++||||+++++|.+++... ..+++..++.++.|++.||.|||+.| ++|+||+|+||++ +.++.+
T Consensus 83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~di~p~nill--~~~~~~ 158 (277)
T cd05032 83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK--FVHRDLAARNCMV--AEDLTV 158 (277)
T ss_pred CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccChheEEE--cCCCCE
Confidence 999999999999999998642 23678899999999999999999988 9999999999999 888999
Q ss_pred EEecCCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHh
Q 020888 184 KVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAE 262 (320)
Q Consensus 184 ~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~ 262 (320)
+|+|||.+..+...... .......++..|.|||.+.+..++.++|+||||+++|++++ |..||...+..+....+..
T Consensus 159 kl~dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~ 236 (277)
T cd05032 159 KIGDFGMTRDIYETDYY--RKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVID 236 (277)
T ss_pred EECCcccchhhccCccc--ccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhc
Confidence 99999998765433211 11122345678999999988889999999999999999998 9999988887777776765
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHH
Q 020888 263 GHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLE 303 (320)
Q Consensus 263 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~ 303 (320)
..... .+..++.++.+++.+||+.+|++|||+.++++.|+
T Consensus 237 ~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 237 GGHLD-LPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred CCCCC-CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 44333 34557999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=282.26 Aligned_cols=248 Identities=31% Similarity=0.581 Sum_probs=208.3
Q ss_pred ceecccCceEEEEEEEC---C--CceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEecC
Q 020888 48 AIIGKGSFGEILKAYWR---G--TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYL 122 (320)
Q Consensus 48 ~~lg~g~~~~vy~~~~~---~--~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~ 122 (320)
+.||+|++|.||++.+. + ..+++|.+...... ...+.+.+|+..+++++|+||+++++.+.. ...++++||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence 36899999999999874 2 25899988665443 445789999999999999999999999888 8899999999
Q ss_pred CCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCcc
Q 020888 123 RGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 200 (320)
Q Consensus 123 ~~~~L~~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~ 200 (320)
++++|.+++.... .+++..++.++.|++.||.+||+.| ++|+||+|+||++ +.++.++|+|||.+..+......
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~di~p~nil~--~~~~~~kl~dfg~~~~~~~~~~~ 153 (257)
T cd05040 78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR--FIHRDLAARNILL--ASDDKVKIGDFGLMRALPQNEDH 153 (257)
T ss_pred CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC--ccccccCcccEEE--ecCCEEEeccccccccccccccc
Confidence 9999999997753 6899999999999999999999988 9999999999999 77899999999998876543221
Q ss_pred ceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHH
Q 020888 201 DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRE 279 (320)
Q Consensus 201 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 279 (320)
.. ......++..|+|||...+..++.++|+||||+++++|++ |..||......+....+.........+...+..+.+
T Consensus 154 ~~-~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (257)
T cd05040 154 YV-MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYN 232 (257)
T ss_pred ee-cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHH
Confidence 11 1112346678999999998899999999999999999999 999998887777666665443333344567899999
Q ss_pred HHHHHhhcCCCCCCCHHHHHHHHH
Q 020888 280 LTEKCWAADMNQRPSFLDILKRLE 303 (320)
Q Consensus 280 li~~~l~~dp~~Rps~~~ll~~L~ 303 (320)
++.+|+..+|.+|||+.++++.|.
T Consensus 233 li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 233 VMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred HHHHHCCCCcccCCCHHHHHHHhc
Confidence 999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=283.90 Aligned_cols=258 Identities=28% Similarity=0.553 Sum_probs=211.4
Q ss_pred cccCccceecccCceEEEEEEEC--CC----ceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCce
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GT----PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL 115 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~----~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 115 (320)
.+|.+.+.||.|+||+||++.+. +. .+++|.+... ........+..|+..++.++|+||+++++++. +...
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~ 83 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR--SGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASL 83 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc--cchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCcc
Confidence 47888999999999999999874 33 4777766432 22233467788888999999999999999875 4557
Q ss_pred EEEEecCCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccc
Q 020888 116 MLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 194 (320)
Q Consensus 116 ~iv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~ 194 (320)
++++|++++++|.+++.. .+.+++..++.++.|++.||.|||+.| ++|+||||+||++ +.++.++|+|||.+...
T Consensus 84 ~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~nili--~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 84 QLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR--MVHRNLAARNILL--KSDSIVQIADFGVADLL 159 (279)
T ss_pred EEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEE--cCCCcEEEcCCccceec
Confidence 889999999999999976 356899999999999999999999988 9999999999999 88889999999998765
Q ss_pred cccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCC
Q 020888 195 KVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGF 273 (320)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (320)
..... ........++..|+|||...+..++.++|+||||+++|++++ |..||...........+..+.... .+..+
T Consensus 160 ~~~~~--~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~ 236 (279)
T cd05111 160 YPDDK--KYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLA-QPQIC 236 (279)
T ss_pred cCCCc--ccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCC-CCCCC
Confidence 43221 111223345678999999998899999999999999999998 999998887766655555444333 34457
Q ss_pred CHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcC
Q 020888 274 TPELRELTEKCWAADMNQRPSFLDILKRLEKIKETL 309 (320)
Q Consensus 274 ~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 309 (320)
+.++.+++.+|+..||..|||+.++++.|..+....
T Consensus 237 ~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~ 272 (279)
T cd05111 237 TIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDP 272 (279)
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence 889999999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=283.51 Aligned_cols=254 Identities=30% Similarity=0.500 Sum_probs=206.9
Q ss_pred cCccceecccCceEEEEEEECC----CceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEe------CC
Q 020888 44 FSSSAIIGKGSFGEILKAYWRG----TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE------RK 113 (320)
Q Consensus 44 y~~~~~lg~g~~~~vy~~~~~~----~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~ 113 (320)
|.+.+.||+|++|.||++.+.+ ..+++|.+..... .....+.+.+|+++++.++|+||+++++++.. ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAIC-TRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence 3567899999999999998763 2588997765433 23345778889999999999999999987632 23
Q ss_pred ceEEEEecCCCCCHHHHHHH------hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEec
Q 020888 114 PLMLITEYLRGGDLHKYLKE------KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGD 187 (320)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~------~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~d 187 (320)
..++++||+++++|.+++.. ...+++..+..++.|++.||.|||+.| ++|+||||+||++ +.++.++|+|
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~--~~~~~~kl~D 155 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS--FIHRDLAARNCML--NENMNVCVAD 155 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhheEE--cCCCCEEECC
Confidence 46899999999999988742 124789999999999999999999988 9999999999999 8888999999
Q ss_pred CCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCC
Q 020888 188 FGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRP 266 (320)
Q Consensus 188 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~ 266 (320)
||.+..+...... .......+++.|++||...+..++.++|+||||+++|++++ |..||...........+..+...
T Consensus 156 fg~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~ 233 (272)
T cd05075 156 FGLSKKIYNGDYY--RQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRL 233 (272)
T ss_pred CCcccccCcccce--ecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 9998866432211 11112235668999999999999999999999999999999 89999888777777766665543
Q ss_pred CCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHH
Q 020888 267 FFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKI 305 (320)
Q Consensus 267 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~ 305 (320)
.. +..++..+++++.+||..||++|||+.++++.|+.+
T Consensus 234 ~~-~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 234 KQ-PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CC-CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 32 345789999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=288.97 Aligned_cols=251 Identities=26% Similarity=0.432 Sum_probs=210.1
Q ss_pred CCcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEE
Q 020888 40 SELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLML 117 (320)
Q Consensus 40 ~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 117 (320)
...+|++.+.||+|++|+||++.+. ++.+++|++..... ....+.+.+|+++++.++|+||+++++.+...+.+++
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAK--SSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICM 80 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCc--chHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEE
Confidence 4568999999999999999999986 78899998754322 2334788899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccc
Q 020888 118 ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHN-EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 196 (320)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~-~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~ 196 (320)
|+||+++++|.+++...+.+++..+..++.+++.+|.|||+ .| ++|+||+|+||++ +.++.++|+|||++.....
T Consensus 81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~--~~~~~~~l~d~gl~~~~~~ 156 (284)
T cd06620 81 CMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR--IMHRDIKPSNILV--NSRGQIKLCDFGVSGELIN 156 (284)
T ss_pred EEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcC--eeccCCCHHHEEE--CCCCcEEEccCCcccchhh
Confidence 99999999999999887789999999999999999999997 47 9999999999999 8888999999998765432
Q ss_pred cCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH-----------HHHHHHHhCCC
Q 020888 197 QNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPY-----------EAAKYVAEGHR 265 (320)
Q Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~-----------~~~~~~~~~~~ 265 (320)
.. .....++..|+|||.+.+..++.++|+|||||+++++++|..||...... +....+.....
T Consensus 157 ~~------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd06620 157 SI------ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPP 230 (284)
T ss_pred hc------cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccC
Confidence 21 12346788999999998889999999999999999999999999865442 22233333333
Q ss_pred CCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHH
Q 020888 266 PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRL 302 (320)
Q Consensus 266 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 302 (320)
+......++.++.+++.+|++.||.+|||+.+++++.
T Consensus 231 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 231 PRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred CCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 3333334788999999999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=286.42 Aligned_cols=249 Identities=27% Similarity=0.434 Sum_probs=206.1
Q ss_pred cccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEE
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 119 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 119 (320)
.+|.+.+.||+|++|.||++.+. ++.+++|.+..... .....+.+|+.+++.++|+|++++++.+..++..++++
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~ 85 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG---EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICM 85 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Confidence 48999999999999999999874 78899998754432 22356788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCc
Q 020888 120 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 199 (320)
Q Consensus 120 e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~ 199 (320)
||+++++|.+++...+.+++..++.++.|++.+|.|||+.| ++|+||+|+||++ +.++.++|+|||.+.......
T Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili--~~~~~~~l~dfg~~~~~~~~~- 160 (267)
T cd06645 86 EFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKG--KMHRDIKGANILL--TDNGHVKLADFGVSAQITATI- 160 (267)
T ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEE--CCCCCEEECcceeeeEccCcc-
Confidence 99999999999988888999999999999999999999998 9999999999999 888899999999987553221
Q ss_pred cceeeccCCcccccccCccccC---cCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCC-CCCC--CCCC
Q 020888 200 HDVYKMTGETGSYRYMAPEVFK---HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHR-PFFR--AKGF 273 (320)
Q Consensus 200 ~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~-~~~~--~~~~ 273 (320)
.......++..|+|||.+. ...++.++|+||||+++|++++|..||....+............ +... ...+
T Consensus 161 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T cd06645 161 ---AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKW 237 (267)
T ss_pred ---cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCC
Confidence 1122346788999999874 45578899999999999999999999976655444333322221 1111 1246
Q ss_pred CHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 274 TPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 274 ~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
+..+++++.+||..+|++|||+++++++
T Consensus 238 ~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 238 SNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred CHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 8899999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=281.36 Aligned_cols=250 Identities=25% Similarity=0.452 Sum_probs=213.7
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEe
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 120 (320)
+|+..+.||.|++|.||.+... ++.+++|.+....... .....+.+|++++++++|+|++++++++.+.+..+++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSE-KERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccch-hHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence 5889999999999999988875 7889999875544333 334678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccC
Q 020888 121 YLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 198 (320)
Q Consensus 121 ~~~~~~L~~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~ 198 (320)
|+++++|.+++... ..+++..+..++.|++.+|.+||+.| ++|+||+|+||++ +.++.++|+|||.+.......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~ni~~--~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG--ILHRDIKTLNIFL--TKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChHhEEE--eCCCCEEECcCcceEEccccc
Confidence 99999999999764 46899999999999999999999988 9999999999999 778899999999987654332
Q ss_pred ccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHH
Q 020888 199 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 278 (320)
Q Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 278 (320)
. ......+++.|.|||...+..++.++|+||||++++++++|..||......+....+..+..... ...++.++.
T Consensus 156 ~----~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 230 (256)
T cd08221 156 S----MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPV-VSVYSSELI 230 (256)
T ss_pred c----cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC-ccccCHHHH
Confidence 1 12334578899999999988899999999999999999999999988777776666665554433 355799999
Q ss_pred HHHHHHhhcCCCCCCCHHHHHHHH
Q 020888 279 ELTEKCWAADMNQRPSFLDILKRL 302 (320)
Q Consensus 279 ~li~~~l~~dp~~Rps~~~ll~~L 302 (320)
+++.+||..+|.+|||+.++++++
T Consensus 231 ~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 231 SLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred HHHHHHcccCcccCCCHHHHhhCc
Confidence 999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=295.17 Aligned_cols=252 Identities=25% Similarity=0.387 Sum_probs=206.5
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEe
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 120 (320)
+|++.+.||+|+||.||++.+. ++.+|+|++.+.........+.+.+|..+++.++|++|+++++.+..++..|+|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (331)
T cd05597 2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMD 81 (331)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEe
Confidence 6899999999999999999975 78899998864333333334668889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCc
Q 020888 121 YLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 199 (320)
Q Consensus 121 ~~~~~~L~~~~~~-~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~ 199 (320)
|++|++|.+++.+ ...+++..+..++.|++.||.|||++| ++|+||||+||++ +.++.++|+|||++..+.....
T Consensus 82 ~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill--~~~~~~kl~Dfg~~~~~~~~~~ 157 (331)
T cd05597 82 YYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG--YVHRDIKPDNVLL--DKNGHIRLADFGSCLRLLADGT 157 (331)
T ss_pred cCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEECCCCHHHEEE--CCCCCEEEEECCceeecCCCCC
Confidence 9999999999976 457899999999999999999999998 9999999999999 8889999999999876543221
Q ss_pred cceeeccCCcccccccCccccCc-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCC---CCCCCC
Q 020888 200 HDVYKMTGETGSYRYMAPEVFKH-----RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHR---PFFRAK 271 (320)
Q Consensus 200 ~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~ 271 (320)
. ......+++.|+|||++.+ ..++.++|+|||||++|+|++|..||......+....+..... ......
T Consensus 158 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 234 (331)
T cd05597 158 V---QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVT 234 (331)
T ss_pred c---cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccC
Confidence 1 1122458999999999863 4577899999999999999999999988776666555544321 111123
Q ss_pred CCCHHHHHHHHHHhhcCCC--CCCCHHHHHHH
Q 020888 272 GFTPELRELTEKCWAADMN--QRPSFLDILKR 301 (320)
Q Consensus 272 ~~~~~l~~li~~~l~~dp~--~Rps~~~ll~~ 301 (320)
.+++++++++++||..+++ .|+++++++++
T Consensus 235 ~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 235 DVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred CCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 4799999999999865443 37899999988
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=282.68 Aligned_cols=254 Identities=31% Similarity=0.537 Sum_probs=207.4
Q ss_pred cccCccceecccCceEEEEEEEC--CCceEEEEccCCCCC--cHHHHHHHHHHHHHHHhCCCCcccceeeeEEe--CCce
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSD--DRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE--RKPL 115 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 115 (320)
.+|...+.||+|++|.||++.+. +..+++|.+...... .......+.+|+.+++.++|+||+++++++.. +...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 47899999999999999999874 788999987544322 22334678899999999999999999998865 4567
Q ss_pred EEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccccc
Q 020888 116 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 195 (320)
Q Consensus 116 ~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~ 195 (320)
++++||+++++|.+++...+.+++...+.++.|++.+|++||+.| ++|+||+|+||++ +.++.++|+|||++....
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--i~H~~l~p~nil~--~~~~~~~l~dfg~~~~~~ 157 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM--IVHRDIKGANILR--DSAGNVKLGDFGASKRLQ 157 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEE--CCCCCEEEccCCCccccc
Confidence 899999999999999988778999999999999999999999988 9999999999999 888899999999987654
Q ss_pred ccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCH
Q 020888 196 VQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTP 275 (320)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (320)
....... ......++..|.|||.+.+..++.++|+||+|+++|++++|..||...+.................+..+++
T Consensus 158 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (266)
T cd06651 158 TICMSGT-GIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISE 236 (266)
T ss_pred cccccCC-ccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCH
Confidence 3211110 111234678899999999988999999999999999999999999887766555444433333333445788
Q ss_pred HHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 276 ELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 276 ~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
.+++++ +|+..+|++||++++++++
T Consensus 237 ~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 237 HARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred HHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 899999 5777899999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=281.47 Aligned_cols=250 Identities=32% Similarity=0.544 Sum_probs=207.7
Q ss_pred cccCccceecccCceEEEEEEEC-CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEe
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~-~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 120 (320)
.+|.+...||+|++|.||++.++ +..+++|.+...... .+.+.+|+.+++.++|++++++++++. ++..+++||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 80 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMM----PEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTE 80 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCcc----HHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEE
Confidence 35888899999999999999876 457999987544322 256788999999999999999998875 456789999
Q ss_pred cCCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccC
Q 020888 121 YLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 198 (320)
Q Consensus 121 ~~~~~~L~~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~ 198 (320)
|+++++|.+++... ..+++..+..++.|++.||.|||+.| ++|+||+|+||++ +.++.++|+|||.+.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dl~~~Nill--~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05069 81 FMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN--YIHRDLRAANILV--GDNLVCKIADFGLARLIEDNE 156 (260)
T ss_pred cCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEE--cCCCeEEECCCccceEccCCc
Confidence 99999999999763 24789999999999999999999988 9999999999999 888899999999987654322
Q ss_pred ccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHH
Q 020888 199 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPEL 277 (320)
Q Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 277 (320)
.. ......++..|+|||...+...+.++|+||||+++|++++ |..||......+....+....... .+...+..+
T Consensus 157 ~~---~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 232 (260)
T cd05069 157 YT---ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMP-CPQGCPESL 232 (260)
T ss_pred cc---ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-CCcccCHHH
Confidence 11 1112335667999999998899999999999999999999 999998877766666665554333 234578999
Q ss_pred HHHHHHHhhcCCCCCCCHHHHHHHHHH
Q 020888 278 RELTEKCWAADMNQRPSFLDILKRLEK 304 (320)
Q Consensus 278 ~~li~~~l~~dp~~Rps~~~ll~~L~~ 304 (320)
++++.+||..||.+||+++++++.|++
T Consensus 233 ~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 233 HELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred HHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=285.17 Aligned_cols=258 Identities=28% Similarity=0.473 Sum_probs=211.3
Q ss_pred CcccCccceecccCceEEEEEEEC-------CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCC
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK 113 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~-------~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 113 (320)
..+|++.+.||+|++|.||++..+ +..+++|.+..... ......+.+|+..++.++|+|++++++++...+
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS--LRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 458999999999999999998653 34799998754322 223356788999999999999999999999889
Q ss_pred ceEEEEecCCCCCHHHHHHHh----------CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcE
Q 020888 114 PLMLITEYLRGGDLHKYLKEK----------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHL 183 (320)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~----------~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~ 183 (320)
..+++|||+++++|.+++... ..++...+..++.|++.||.|||++| ++|+||||+||++ +.++.+
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dikp~nili--~~~~~~ 158 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK--FVHRDLAARNCMV--AHDFTV 158 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCCChheEEE--cCCCcE
Confidence 999999999999999999752 23466788999999999999999988 9999999999999 788899
Q ss_pred EEecCCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHh
Q 020888 184 KVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAE 262 (320)
Q Consensus 184 ~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~ 262 (320)
+|+|||++..+....... ......++..|+|||...+..++.++|+||||+++|++++ |..||......+....+..
T Consensus 159 ~L~Dfg~~~~~~~~~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~ 236 (288)
T cd05061 159 KIGDFGMTRDIYETDYYR--KGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMD 236 (288)
T ss_pred EECcCCcccccccccccc--ccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 999999987554322111 1111234567999999998899999999999999999998 7889988887777666655
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHh
Q 020888 263 GHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKE 307 (320)
Q Consensus 263 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 307 (320)
+..... +...++++++++.+||+.||.+|||+.++++.|+....
T Consensus 237 ~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~ 280 (288)
T cd05061 237 GGYLDQ-PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLH 280 (288)
T ss_pred CCCCCC-CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcC
Confidence 543332 34568999999999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=285.16 Aligned_cols=250 Identities=26% Similarity=0.416 Sum_probs=205.5
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEe
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 120 (320)
.|+..+.||.|+||+||++.+. ++.+|+|.+.............+.+|+++++.++|++++++.+.+..++..++++|
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 3677889999999999999885 78899998865443333334567789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccC
Q 020888 121 YLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 198 (320)
Q Consensus 121 ~~~~~~L~~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~ 198 (320)
|+++++|.+++... ..+++..+..++.|++.||.|||+.| |+|+||+|+||++ +.++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--iiH~dikp~Nili--~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN--TVYRDLKPENILL--DDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEE--CCCCCEEEecCCcceecCCCC
Confidence 99999999888653 36999999999999999999999998 9999999999999 788899999999886543221
Q ss_pred ccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCC--CCCCCCCCCHH
Q 020888 199 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHR--PFFRAKGFTPE 276 (320)
Q Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 276 (320)
......++..|+|||.+.+..++.++|+||||+++|++++|..||...........+..... .......++.+
T Consensus 157 -----~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (285)
T cd05632 157 -----SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEE 231 (285)
T ss_pred -----cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHH
Confidence 11234678999999999989999999999999999999999999987655433222222111 11223457899
Q ss_pred HHHHHHHHhhcCCCCCCC-----HHHHHHH
Q 020888 277 LRELTEKCWAADMNQRPS-----FLDILKR 301 (320)
Q Consensus 277 l~~li~~~l~~dp~~Rps-----~~~ll~~ 301 (320)
+.+++..||+.||++||+ +.+++.+
T Consensus 232 ~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 232 AKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred HHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 999999999999999999 7788876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=282.09 Aligned_cols=257 Identities=32% Similarity=0.568 Sum_probs=213.0
Q ss_pred cccCccceecccCceEEEEEEEC--C---CceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceE
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--G---TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLM 116 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~---~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 116 (320)
..|.+.+.||+|++|.||++.+. + ..+++|.+.... .......+..|+.+++.++|+||+++++++..+...+
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 81 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVM 81 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceE
Confidence 35788999999999999999875 2 359999876542 2334578999999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccccc
Q 020888 117 LITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 195 (320)
Q Consensus 117 iv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~ 195 (320)
+|+||+++++|.+++.. .+.+++..++.++.|++.||.+||+.| ++|+||+|+||++ +.++.++|+|||.+....
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g--~~H~dl~p~nili--~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 82 IITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN--YVHRDLAARNILV--NSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred EEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccChheEEE--cCCCcEEECCCccccccc
Confidence 99999999999999876 356899999999999999999999998 9999999999999 888899999999887654
Q ss_pred ccCccceeec-cCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCC
Q 020888 196 VQNSHDVYKM-TGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGF 273 (320)
Q Consensus 196 ~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (320)
.......... .....+..|+|||...+..++.++|+||||+++|++++ |..||...+..+....+......+. +..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~-~~~~ 236 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPP-PMDC 236 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCC-cccC
Confidence 3322111111 11112457999999998899999999999999999886 9999998887777666655433332 3457
Q ss_pred CHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHH
Q 020888 274 TPELRELTEKCWAADMNQRPSFLDILKRLEKI 305 (320)
Q Consensus 274 ~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~ 305 (320)
+..+.+++.+||..+|.+||++++++..|+++
T Consensus 237 ~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 237 PTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 89999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=287.04 Aligned_cols=253 Identities=30% Similarity=0.523 Sum_probs=213.2
Q ss_pred CCCCCcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCc
Q 020888 37 IDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP 114 (320)
Q Consensus 37 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 114 (320)
......+|++.+.||.|++|.||++.+. ++.+++|.+....... .+.+.+|++.++.++|+|++++++.+..++.
T Consensus 14 ~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 90 (296)
T cd06655 14 IGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPK---KELIINEILVMKELKNPNIVNFLDSFLVGDE 90 (296)
T ss_pred cCCCcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCch---HHHHHHHHHHHHhcCCCceeeeeeeEecCce
Confidence 4444567999999999999999999864 7889999885443322 3678889999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccc
Q 020888 115 LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 194 (320)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~ 194 (320)
.++|+||+++++|.+++... .+++..+..++.+++.+|.+||+.| ++|+||+|+||++ +.++.++|+|||++...
T Consensus 91 ~~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~~--i~H~dL~p~Nili--~~~~~~kl~dfg~~~~~ 165 (296)
T cd06655 91 LFVVMEYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQ--VIHRDIKSDNVLL--GMDGSVKLTDFGFCAQI 165 (296)
T ss_pred EEEEEEecCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEE--CCCCCEEEccCccchhc
Confidence 99999999999999988754 6899999999999999999999998 9999999999999 88889999999988765
Q ss_pred cccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCC-CCCCCCCC
Q 020888 195 KVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHR-PFFRAKGF 273 (320)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~ 273 (320)
..... ......++..|+|||.+.+..++.++|+||||+++|++++|..||...+.......+..... ....+..+
T Consensus 166 ~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (296)
T cd06655 166 TPEQS----KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKL 241 (296)
T ss_pred ccccc----cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccC
Confidence 43221 12234578889999999988899999999999999999999999988877655544443332 22234567
Q ss_pred CHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 274 TPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 274 ~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
+..+++++.+||..||.+|||+.+++++
T Consensus 242 ~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 242 SPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred CHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 8999999999999999999999999876
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=287.47 Aligned_cols=249 Identities=27% Similarity=0.453 Sum_probs=204.9
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEe
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 120 (320)
.|+..+.||+|+||.||++.+. ++.+|+|.+.............+.+|+.++++++|++++++++.+..++..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 3677889999999999999986 78899998865544444444567789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccC
Q 020888 121 YLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 198 (320)
Q Consensus 121 ~~~~~~L~~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~ 198 (320)
|++|++|.+++... ..+++..+..++.|++.||.|||+.| ++|+||||+||++ +.++.++|+|||++.......
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nil~--~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER--IVYRDLKPENILL--DDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEE--CCCCCEEEeeccceeecCCCc
Confidence 99999999988653 25899999999999999999999988 9999999999999 888899999999886543221
Q ss_pred ccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHhCCCCCCCCCCCCH
Q 020888 199 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPY---EAAKYVAEGHRPFFRAKGFTP 275 (320)
Q Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 275 (320)
......++..|+|||.+.+..++.++|+||+|+++|++++|..||...... +........... .....+++
T Consensus 157 -----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 230 (285)
T cd05630 157 -----TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQE-EYSEKFSP 230 (285)
T ss_pred -----cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhh-hcCccCCH
Confidence 112346789999999999999999999999999999999999999865421 112222221111 22345789
Q ss_pred HHHHHHHHHhhcCCCCCCC-----HHHHHHH
Q 020888 276 ELRELTEKCWAADMNQRPS-----FLDILKR 301 (320)
Q Consensus 276 ~l~~li~~~l~~dp~~Rps-----~~~ll~~ 301 (320)
++++++.+||+.||++||| +++++++
T Consensus 231 ~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 231 DARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred HHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 9999999999999999999 8899875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=286.61 Aligned_cols=256 Identities=31% Similarity=0.518 Sum_probs=212.1
Q ss_pred CCcccCccceecccCceEEEEEEEC-------CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeC
Q 020888 40 SELDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER 112 (320)
Q Consensus 40 ~~~~y~~~~~lg~g~~~~vy~~~~~-------~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 112 (320)
...+|.+.+.||.|+||.||++.+. +..+++|.+..... ......+.+|+.+++.++|+|++++++++..+
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~ 80 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--ADMQADFQREAALMAEFDHPNIVKLLGVCAVG 80 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcC--HHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence 3467999999999999999999863 46799998764332 33446788999999999999999999999999
Q ss_pred CceEEEEecCCCCCHHHHHHHh----------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 020888 113 KPLMLITEYLRGGDLHKYLKEK----------------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKP 170 (320)
Q Consensus 113 ~~~~iv~e~~~~~~L~~~~~~~----------------------~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p 170 (320)
...++++||+++++|.+++... ..+++..++.++.|++.||.+||+.| ++|+||+|
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~--i~H~dl~p 158 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK--FVHRDLAT 158 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--eecccccH
Confidence 9999999999999999998742 13678889999999999999999988 99999999
Q ss_pred CcEEEeeCCCCcEEEecCCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCC
Q 020888 171 RNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLA 249 (320)
Q Consensus 171 ~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~ 249 (320)
+||++ +.++.++|+|||.+..+..... .........+..|+|||...+..++.++|+||||+++|++++ |..||.
T Consensus 159 ~nil~--~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~ 234 (288)
T cd05050 159 RNCLV--GENMVVKIADFGLSRNIYSADY--YKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYY 234 (288)
T ss_pred hheEe--cCCCceEECccccceecccCcc--ccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 99999 8888999999998875432211 001112234567999999998899999999999999999998 888998
Q ss_pred CCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHH
Q 020888 250 NYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEK 304 (320)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 304 (320)
.....+....+........ +..++.++.+++.+||+.+|.+|||+.++++.|++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 235 GMAHEEVIYYVRDGNVLSC-PDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred CCCHHHHHHHHhcCCCCCC-CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 8877777666665554332 34578999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=296.13 Aligned_cols=268 Identities=30% Similarity=0.524 Sum_probs=215.3
Q ss_pred CCCCCCCCcCCCCCcccCccceecccCceEEEEEEEC-------CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCC-C
Q 020888 28 PLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-H 99 (320)
Q Consensus 28 ~~~~~~~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~-------~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-h 99 (320)
..+..++|+++. .+|.+.+.||+|+||.||++.+. +..||+|.+...... ...+.+.+|++++..+. |
T Consensus 25 ~~~~~~~~~~~~--~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~E~~~l~~l~~H 100 (401)
T cd05107 25 QLPYDSAWEMPR--DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARS--SEKQALMSELKIMSHLGPH 100 (401)
T ss_pred CCCCCCcceecH--HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCCh--hHHHHHHHHHHHHHhcCCC
Confidence 345555676664 46888999999999999999863 357999998654322 22357889999999997 9
Q ss_pred CcccceeeeEEeCCceEEEEecCCCCCHHHHHHHhC--------------------------------------------
Q 020888 100 PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG-------------------------------------------- 135 (320)
Q Consensus 100 ~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~-------------------------------------------- 135 (320)
+||+++++.+...+..++|+||+++|+|.+++...+
T Consensus 101 ~niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (401)
T cd05107 101 LNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMD 180 (401)
T ss_pred CCeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccc
Confidence 999999999999889999999999999999986421
Q ss_pred ------------------------------------------------------CCCHHHHHHHHHHHHHHHHHHhcCCC
Q 020888 136 ------------------------------------------------------ALSPSTAVNFALDIARGMAYLHNEPN 161 (320)
Q Consensus 136 ------------------------------------------------------~l~~~~~~~i~~~l~~~l~~lH~~g~ 161 (320)
.+++..++.++.|++.||.|||+.|
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~- 259 (401)
T cd05107 181 MSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN- 259 (401)
T ss_pred cCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC-
Confidence 2567778899999999999999988
Q ss_pred CeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHH
Q 020888 162 VIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEM 241 (320)
Q Consensus 162 ~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l 241 (320)
++|+||||+||++ +.++.++|+|||++......... .......++..|+|||.+.+..++.++|+||||++++++
T Consensus 260 -ivHrdlkp~NiLl--~~~~~~kL~DfGla~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~ 334 (401)
T cd05107 260 -CVHRDLAARNVLI--CEGKLVKICDFGLARDIMRDSNY--ISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEI 334 (401)
T ss_pred -cCcccCCcceEEE--eCCCEEEEEecCcceeccccccc--ccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHH
Confidence 9999999999999 77889999999998765332111 111223457789999999988899999999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHH-HHhCCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHH
Q 020888 242 LE-GEPPLANYEPYEAAKY-VAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIK 306 (320)
Q Consensus 242 l~-g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 306 (320)
++ |..||......+.... +..+... ..+..++.++.+++.+||..+|.+||++.++++.|+++.
T Consensus 335 l~~g~~P~~~~~~~~~~~~~~~~~~~~-~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 335 FTLGGTPYPELPMNEQFYNAIKRGYRM-AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred HHcCCCCCCCCCchHHHHHHHHcCCCC-CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 98 8999987665554333 3333322 234457899999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=287.02 Aligned_cols=255 Identities=27% Similarity=0.494 Sum_probs=212.0
Q ss_pred CcCCCCCcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeC
Q 020888 35 WEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER 112 (320)
Q Consensus 35 ~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 112 (320)
+.+.....+|++.+.||+|++|.||++.+. ++.+++|.+....... ...+.+|+.+++.+.|+|++++++.+..+
T Consensus 13 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~---~~~~~~e~~~l~~~~h~~v~~~~~~~~~~ 89 (296)
T cd06654 13 VSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVG 89 (296)
T ss_pred cccCCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcch---HHHHHHHHHHHHhCCCCCEeeEEEEEEeC
Confidence 344455568999999999999999999874 7889999876543332 36788899999999999999999999999
Q ss_pred CceEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcc
Q 020888 113 KPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 192 (320)
Q Consensus 113 ~~~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~ 192 (320)
...++||||+++++|.+++.. ..+++..+..++.|++.||.|||+.| ++|+||+|+||++ +.++.++|+|||.+.
T Consensus 90 ~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~g--i~H~dLkp~Nill--~~~~~~kl~dfg~~~ 164 (296)
T cd06654 90 DELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILL--GMDGSVKLTDFGFCA 164 (296)
T ss_pred CEEEEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEE--cCCCCEEECccccch
Confidence 999999999999999999875 46899999999999999999999998 9999999999999 888899999999887
Q ss_pred cccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCC-CCCCC
Q 020888 193 LIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRP-FFRAK 271 (320)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~ 271 (320)
....... ......+++.|+|||.+.+..++.++|+||||+++|++++|..||...+.............+ ...+.
T Consensus 165 ~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 240 (296)
T cd06654 165 QITPEQS----KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPE 240 (296)
T ss_pred hcccccc----ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCcc
Confidence 6543211 112345788999999999888999999999999999999999999877664443333332222 22234
Q ss_pred CCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 272 GFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 272 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
.++..+.+++.+||..+|++|||+.+++++
T Consensus 241 ~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 241 KLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred ccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 578999999999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=291.09 Aligned_cols=249 Identities=28% Similarity=0.445 Sum_probs=201.6
Q ss_pred cccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEE
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 119 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 119 (320)
.+|.+.+.||+|+||+||++.++ ++.+|+|.+........ ...+.+|++++++++|+||+++++++..++..++||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 83 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGA--PCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVF 83 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCc--chhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEE
Confidence 47999999999999999999875 67899998865433221 245678999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccC
Q 020888 120 EYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 198 (320)
Q Consensus 120 e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~ 198 (320)
||+++ +|.+++... ..+++..+..++.|++.||.|||+.| ++||||||+||++ +.++.++|+|||++.......
T Consensus 84 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~dlkp~Nill--~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 84 EYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK--VLHRDLKPQNLLI--NERGELKLADFGLARAKSVPT 158 (309)
T ss_pred eCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEE--CCCCCEEECccccceecCCCc
Confidence 99965 888888654 45899999999999999999999998 9999999999999 888999999999987543321
Q ss_pred ccceeeccCCcccccccCccccCc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCC-------------
Q 020888 199 SHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH------------- 264 (320)
Q Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~------------- 264 (320)
. ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...+..+....+....
T Consensus 159 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (309)
T cd07872 159 K----TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISS 234 (309)
T ss_pred c----ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcc
Confidence 1 1122356889999998865 458899999999999999999999998776554433332110
Q ss_pred --------CCCC-------CCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 265 --------RPFF-------RAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 265 --------~~~~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
.+.. ....++.+++++|.+||..||.+|||+++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 235 NDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred hhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 0000 012468899999999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=284.61 Aligned_cols=255 Identities=31% Similarity=0.508 Sum_probs=201.7
Q ss_pred ccCccceecccCceEEEEEEE------CCCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEe--CCc
Q 020888 43 DFSSSAIIGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE--RKP 114 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~------~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~ 114 (320)
.|.+.+.||.|+||+||++.. .+..+++|.+..... ......+.+|+++++.++|+|++++++++.. ...
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 5 YLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG--QQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred hceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 348899999999999988652 266799998865422 2234678889999999999999999998764 345
Q ss_pred eEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccc
Q 020888 115 LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 194 (320)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~ 194 (320)
.+++|||+++++|.+++... .+++..++.++.|++.||.|||++| ++|+||||+||++ +.++.++|+|||++...
T Consensus 83 ~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~--i~H~dlkp~Nili--~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQH--YIHRDLAARNVLL--DNDRLVKIGDFGLAKAV 157 (283)
T ss_pred EEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCC--eeccccChheEEE--cCCCcEEEeeccccccc
Confidence 79999999999999999764 5999999999999999999999988 9999999999999 88889999999998766
Q ss_pred cccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH---------------HHHHH
Q 020888 195 KVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPY---------------EAAKY 259 (320)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~---------------~~~~~ 259 (320)
........ ......++..|+|||...+..++.++|+||||++++++++|..||...... .....
T Consensus 158 ~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd05080 158 PEGHEYYR-VREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIEL 236 (283)
T ss_pred CCcchhhc-cCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhh
Confidence 43221100 011123456799999998888999999999999999999999998653311 01111
Q ss_pred HHhCCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHH
Q 020888 260 VAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIK 306 (320)
Q Consensus 260 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 306 (320)
...... ...+..++.++++++.+||+.+|.+|||++++++.|+.+.
T Consensus 237 ~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 237 LERGMR-LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhcCCC-CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 111111 1123457899999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=283.12 Aligned_cols=255 Identities=27% Similarity=0.512 Sum_probs=208.0
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCc---HHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEE
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDD---RLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLML 117 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 117 (320)
+|+..+.||+|++|.||++.+. ++.+++|.+....... ....+.+.+|++++++++|+|++++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 4788899999999999999874 7889999886443222 2235788999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCC-cEEEecCCCcccccc
Q 020888 118 ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD-HLKVGDFGLSKLIKV 196 (320)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~-~~~L~dfg~~~~~~~ 196 (320)
|+||+++++|.+++.+.+++++..++.++.|++.||.+||++| ++|+||+|+||++ +.++ .++|+|||.+.....
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~--i~H~~i~~~nil~--~~~~~~~~l~dfg~~~~~~~ 156 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQ--IIHRDVKGANLLI--DSTGQRLRIADFGAAARLAA 156 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEE--cCCCCEEEEccccccccccc
Confidence 9999999999999988788999999999999999999999998 9999999999999 6554 699999999877654
Q ss_pred cCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHhCCCCCCCCCCC
Q 020888 197 QNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEA---AKYVAEGHRPFFRAKGF 273 (320)
Q Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~ 273 (320)
.............++..|+|||.+.+..++.++|+||||++++++++|..||........ .............+..+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (268)
T cd06630 157 KGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHL 236 (268)
T ss_pred ccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhh
Confidence 322111112234578899999999888899999999999999999999999975543222 21222222222333457
Q ss_pred CHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 274 TPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 274 ~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
+.++.+++.+||..+|.+|||+.+++++
T Consensus 237 ~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 237 SPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 8999999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=286.64 Aligned_cols=255 Identities=31% Similarity=0.492 Sum_probs=209.1
Q ss_pred CcccCccceecccCceEEEEEEECC------------------CceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcc
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWRG------------------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 102 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~~------------------~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i 102 (320)
..+|.+++.||+|+||.||++.+.. ..+++|.+..... ....+.+.+|++++++++|+|+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i 81 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS--DNAREDFLKEVKILSRLSDPNI 81 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC--HHHHHHHHHHHHHHHhcCCCCE
Confidence 3579999999999999999988642 4588998764432 2345788899999999999999
Q ss_pred cceeeeEEeCCceEEEEecCCCCCHHHHHHHhC-----------CCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 020888 103 VQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG-----------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPR 171 (320)
Q Consensus 103 ~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~-----------~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~ 171 (320)
+++++++..++..++++|++++++|.+++.... .+++..++.++.|++.||.|||+.| ++|+||||+
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~--i~H~dlkp~ 159 (296)
T cd05051 82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN--FVHRDLATR 159 (296)
T ss_pred eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC--ccccccchh
Confidence 999999999999999999999999999997654 6899999999999999999999998 999999999
Q ss_pred cEEEeeCCCCcEEEecCCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh--CCCCCC
Q 020888 172 NVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE--GEPPLA 249 (320)
Q Consensus 172 nI~~~~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~--g~~p~~ 249 (320)
||++ +.++.++|+|||.+......... .......++..|+|||...+..++.++||||||+++|++++ |..||.
T Consensus 160 Nili--~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~ 235 (296)
T cd05051 160 NCLV--GKNYTIKIADFGMSRNLYSSDYY--RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYE 235 (296)
T ss_pred ceee--cCCCceEEccccceeecccCcce--eecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCC
Confidence 9999 78899999999998765432211 11222345678999999988889999999999999999998 778888
Q ss_pred CCChHHHHHHHHhC------CCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHH
Q 020888 250 NYEPYEAAKYVAEG------HRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLE 303 (320)
Q Consensus 250 ~~~~~~~~~~~~~~------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~ 303 (320)
.............. ......+..++.++.+++.+||+.||.+|||+.++++.|+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 236 HLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred CcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 77666555544432 1111123346789999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=281.37 Aligned_cols=254 Identities=28% Similarity=0.503 Sum_probs=208.2
Q ss_pred cccCccceecccCceEEEEEEEC--CCceEEEEccCCC--CCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEe--CCce
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSL--SDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE--RKPL 115 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~--~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 115 (320)
.+|.+.+.||+|++|.||.+.+. +..+++|.+.... .......+.+.+|+.+++++.|+||+++++.+.+ ...+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 36889999999999999999875 7889999875332 2223345788999999999999999999998865 3467
Q ss_pred EEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccccc
Q 020888 116 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 195 (320)
Q Consensus 116 ~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~ 195 (320)
++++||+++++|.+++.+...+++..++.++.|++.+|.+||+.| ++|+||+|+||++ +.++.++|+|||.+....
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~--~~~~~~~l~Dfg~~~~~~ 157 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM--IVHRDIKGANILR--DSVGNVKLGDFGASKRLQ 157 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEe--cCCCCEEECcCccccccc
Confidence 899999999999999988778899999999999999999999998 9999999999999 888899999999887654
Q ss_pred ccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCH
Q 020888 196 VQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTP 275 (320)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (320)
...... .......++..|+|||.+.+..++.++|+||||+++|++++|..||.....................+...+.
T Consensus 158 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (265)
T cd06652 158 TICLSG-TGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSD 236 (265)
T ss_pred cccccc-cccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCH
Confidence 321110 0112235788899999998888999999999999999999999999887666555444444333334455788
Q ss_pred HHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 276 ELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 276 ~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
.+.+++.+|+. +|+.||++++++++
T Consensus 237 ~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 237 HCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred HHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 89999999994 99999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=284.50 Aligned_cols=243 Identities=25% Similarity=0.463 Sum_probs=202.1
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEe
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 120 (320)
+|.+.+.||+|++|.||++.+. ++.+++|.+..... ......+.+|++++++++|+|++++++.+...+..++|+|
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDIT--VELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTE 79 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCC--hHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEe
Confidence 5788899999999999999874 78899998865422 2334678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCcc
Q 020888 121 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 200 (320)
Q Consensus 121 ~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~ 200 (320)
|+++++|..+ ..+++..+..++.|++.||.|||+.| ++|+||+|+||++ +.++.++|+|||++..+....
T Consensus 80 ~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nill--~~~~~~~l~dfg~~~~~~~~~-- 149 (279)
T cd06619 80 FMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLK--ILHRDVKPSNMLV--NTRGQVKLCDFGVSTQLVNSI-- 149 (279)
T ss_pred cCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCCHHHEEE--CCCCCEEEeeCCcceeccccc--
Confidence 9999999765 35788999999999999999999998 9999999999999 889999999999987654321
Q ss_pred ceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH-------HHHHHHHhCCCCCCCCCCC
Q 020888 201 DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPY-------EAAKYVAEGHRPFFRAKGF 273 (320)
Q Consensus 201 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~ 273 (320)
.....++..|+|||.+.+..++.++|+||||+++|++++|..||...... .....+.....+.......
T Consensus 150 ----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (279)
T cd06619 150 ----AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQF 225 (279)
T ss_pred ----ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcC
Confidence 22346788999999999999999999999999999999999999753321 2222222222333333457
Q ss_pred CHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 274 TPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 274 ~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
+.++++++.+|+..+|++||++++++++
T Consensus 226 ~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 226 SEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 8899999999999999999999999876
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=280.77 Aligned_cols=254 Identities=29% Similarity=0.532 Sum_probs=209.6
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEe
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 120 (320)
+|.+.+.||+|++|.||++.+. ++.+++|.+...... ......+.+|+.+++.++|+||+++++.+...+.+++|+|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 5888899999999999999874 788999988665443 3455889999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCcc
Q 020888 121 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 200 (320)
Q Consensus 121 ~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~ 200 (320)
|+++++|.+++.....+++..+..++.+++.||.+||+.| ++|+||+|+||++ +.++.++|+|||.+.........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~~~nil~--~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG--IVHRDIKPANIFL--DHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEE--CCCCCEEEcccccccccCCCCCc
Confidence 9999999999988777899999999999999999999998 9999999999999 78899999999998876543322
Q ss_pred ceeeccCCcccccccCccccCcCC---CCCchhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhCCCCCCCC-CCCCH
Q 020888 201 DVYKMTGETGSYRYMAPEVFKHRK---YDKKVDVFSFAMILYEMLEGEPPLANYEPYE-AAKYVAEGHRPFFRA-KGFTP 275 (320)
Q Consensus 201 ~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~-~~~~~~~~~~~~~~~-~~~~~ 275 (320)
.........++..|+|||.+.+.. .+.++|+||+|++++++++|..||...+... ....+.....+.... ..++.
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSP 235 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCH
Confidence 221122345788999999998766 8899999999999999999999997664332 222222222222211 23588
Q ss_pred HHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 276 ELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 276 ~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
.+.+++..||+.+|.+|||+.+++.+
T Consensus 236 ~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 236 EGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred HHHHHHHHHccCCcccCCCHHHHhcC
Confidence 99999999999999999999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=282.28 Aligned_cols=253 Identities=28% Similarity=0.509 Sum_probs=211.2
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEe
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 120 (320)
+|++.+.||.|++|+||++... +..+++|++....... ....+.+|++.++.++|+|++++++.+..++..++++|
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 79 (267)
T cd06610 2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP 79 (267)
T ss_pred cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence 6899999999999999999874 6789999886543332 45788999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccccccc
Q 020888 121 YLRGGDLHKYLKEK---GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 197 (320)
Q Consensus 121 ~~~~~~L~~~~~~~---~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~ 197 (320)
++++++|.+++... ..+++..+..++.|++.||.+||+.| ++|+||+|+||++ +.++.++|+|||.+......
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~--i~h~~l~p~ni~~--~~~~~~~l~df~~~~~~~~~ 155 (267)
T cd06610 80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG--QIHRDIKAGNILL--GEDGSVKIADFGVSASLADG 155 (267)
T ss_pred ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEE--cCCCCEEEcccchHHHhccC
Confidence 99999999999763 35899999999999999999999988 9999999999999 77889999999998877654
Q ss_pred CccceeeccCCcccccccCccccCcC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCC----CC
Q 020888 198 NSHDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA----KG 272 (320)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~----~~ 272 (320)
............++..|+|||..... .++.++|+||||++++++++|+.||...................... ..
T Consensus 156 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (267)
T cd06610 156 GDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKK 235 (267)
T ss_pred ccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCcccccc
Confidence 33221122334578899999998776 78899999999999999999999998877665554444443222222 25
Q ss_pred CCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 273 FTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 273 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
++.++.+++..||..||++|||+++++++
T Consensus 236 ~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 236 YSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred ccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 68899999999999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=282.26 Aligned_cols=243 Identities=28% Similarity=0.463 Sum_probs=208.7
Q ss_pred ecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEecCCCCCH
Q 020888 50 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDL 127 (320)
Q Consensus 50 lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L 127 (320)
||.|++|.||++.+. ++.+++|.+...........+.+.+|+++++.++|+||+++++.+.++...++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999987 889999998765554444557899999999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCccceeeccC
Q 020888 128 HKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG 207 (320)
Q Consensus 128 ~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~ 207 (320)
.+++.....+++..+..++.|++.||.+||+.| ++|+||+|+||++ +.++.++|+|||.+....... ....
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--~~h~dl~~~nilv--~~~~~~~l~df~~~~~~~~~~-----~~~~ 151 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRG--IIYRDLKPENLLL--DSNGYVKLVDFGFAKKLKSGQ-----KTWT 151 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEE--cCCCCEEEeeCCcccccCccc-----cccc
Confidence 999988778999999999999999999999988 9999999999999 888999999999988665432 1122
Q ss_pred CcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHh
Q 020888 208 ETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYE--PYEAAKYVAEGHRPFFRAKGFTPELRELTEKCW 285 (320)
Q Consensus 208 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 285 (320)
..+++.|+|||.+.+..++.++|+||+|+++|++++|..||.... ..+....+.........+...++++++++.+||
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 231 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLL 231 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHc
Confidence 356888999999988889999999999999999999999998776 555555555433334444556899999999999
Q ss_pred hcCCCCCCC-----HHHHHHH
Q 020888 286 AADMNQRPS-----FLDILKR 301 (320)
Q Consensus 286 ~~dp~~Rps-----~~~ll~~ 301 (320)
..+|.+||+ +++++++
T Consensus 232 ~~~p~~R~~~~~~~~~~l~~~ 252 (262)
T cd05572 232 RRNPEERLGNLKGGIKDIKKH 252 (262)
T ss_pred cCChhhCcCCcccCHHHHhcC
Confidence 999999999 7887764
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=281.70 Aligned_cols=249 Identities=31% Similarity=0.526 Sum_probs=209.1
Q ss_pred cccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEE
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 119 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 119 (320)
.+|.+.+.||.|++|.||++.+. +..+++|.+...... ..+.+.+|+++++.++|+|++++++.+..+..++++|
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~ 79 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD---DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM 79 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh---hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence 47889999999999999999875 678999988654332 3478889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccC
Q 020888 120 EYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 198 (320)
Q Consensus 120 e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~ 198 (320)
||+++++|.+++... ..+++..++.++.|++.+|.|||+.| ++|+||+|+||++ +.++.++|+|||.+..+....
T Consensus 80 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i--~~~~~~~l~d~g~~~~~~~~~ 155 (262)
T cd06613 80 EYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG--KIHRDIKGANILL--TEDGDVKLADFGVSAQLTATI 155 (262)
T ss_pred eCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCChhhEEE--CCCCCEEECccccchhhhhhh
Confidence 999999999999775 68999999999999999999999988 9999999999999 888899999999987654322
Q ss_pred ccceeeccCCcccccccCccccCcC---CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCC---CCCCC
Q 020888 199 SHDVYKMTGETGSYRYMAPEVFKHR---KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPF---FRAKG 272 (320)
Q Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~ 272 (320)
. ......++..|+|||...+. .++.++|+||||+++++|++|..||...+............... .....
T Consensus 156 ~----~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (262)
T cd06613 156 A----KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEK 231 (262)
T ss_pred h----ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhh
Confidence 1 11224567789999999776 78899999999999999999999998877665554444331111 11234
Q ss_pred CCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 273 FTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 273 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
++.++++++.+||..+|..|||+.+++.+
T Consensus 232 ~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 232 WSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred hhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 67889999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=280.02 Aligned_cols=250 Identities=28% Similarity=0.497 Sum_probs=211.1
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCC--CcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEE
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLS--DDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 118 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 118 (320)
+|+..+.||+|++|.||++.+. ++.+++|.+..... ...+..+.+.+|+.+++.++|+|++++++++..+..++++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4777899999999999999875 78899998754332 2234457889999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccC
Q 020888 119 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 198 (320)
Q Consensus 119 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~ 198 (320)
+||+++++|.+++...+.+++..++.++.|++.+|.+||+.| ++|+||+|+||++ +.++.++|+|||.+.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~~~ni~~--~~~~~~kl~d~~~~~~~~~~~ 156 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRN--TVHRDIKGANILV--DTNGVVKLADFGMAKQVVEFS 156 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEE--CCCCCEEEccCccceeccccc
Confidence 999999999999988777999999999999999999999998 9999999999999 888899999999887654332
Q ss_pred ccceeeccCCcccccccCccccCcCC-CCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHH
Q 020888 199 SHDVYKMTGETGSYRYMAPEVFKHRK-YDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPEL 277 (320)
Q Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 277 (320)
......++..|++||.+.... ++.++|+||||++++++++|..||......+..............+..+++++
T Consensus 157 -----~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (258)
T cd06632 157 -----FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEA 231 (258)
T ss_pred -----cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHH
Confidence 122345788899999987776 89999999999999999999999988775555444444233333345578999
Q ss_pred HHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 278 RELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 278 ~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
++++.+||..+|.+||++.+++.+
T Consensus 232 ~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 232 KDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred HHHHHHHhhcCcccCcCHHHHhcC
Confidence 999999999999999999999864
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=288.58 Aligned_cols=247 Identities=26% Similarity=0.468 Sum_probs=204.9
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEe
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 120 (320)
+|.+.+.||+|++|.||++.+. +..+++|.+.... .......+.+|++++++++|+||+++++.+..++.+++++|
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME 79 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence 6889999999999999999875 6678888775432 23344678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCc
Q 020888 121 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHN-EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 199 (320)
Q Consensus 121 ~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~-~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~ 199 (320)
|+++++|.+++...+.+++..+..++.|++.||.|||+ .+ ++|+||+|+||++ +.++.++|+|||.+.......
T Consensus 80 y~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dl~p~nil~--~~~~~~~l~dfg~~~~~~~~~- 154 (308)
T cd06615 80 HMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHK--IMHRDVKPSNILV--NSRGEIKLCDFGVSGQLIDSM- 154 (308)
T ss_pred ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC--EEECCCChHHEEE--ecCCcEEEccCCCcccccccc-
Confidence 99999999999887889999999999999999999997 47 9999999999999 788899999999886553321
Q ss_pred cceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh-----------------
Q 020888 200 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAE----------------- 262 (320)
Q Consensus 200 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~----------------- 262 (320)
.....++..|+|||...+..++.++|+||||++++++++|..||...+..........
T Consensus 155 -----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (308)
T cd06615 155 -----ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGH 229 (308)
T ss_pred -----cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCC
Confidence 1234578899999999888899999999999999999999999875543332221211
Q ss_pred -------------------CCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 263 -------------------GHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 263 -------------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
...+......++.++++++.+||..+|.+|||+++++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 230 PPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111111122367899999999999999999999999988
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=284.76 Aligned_cols=247 Identities=26% Similarity=0.420 Sum_probs=210.3
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEe
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 120 (320)
+|.+.+.||.|++|.||++.++ +..+++|.+...........+.+.+|++++++++|+|++++++.+.++...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4889999999999999999986 78899998876555444556889999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCcc
Q 020888 121 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 200 (320)
Q Consensus 121 ~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~ 200 (320)
|++|++|.+++....++++..+..++.|++++|.+||+.| ++|+||+|+||++ +.++.++|+|||.+.......
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~--~~~~~~~l~d~~~~~~~~~~~-- 154 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG--IIHRDIKPDNILL--DEQGHVHITDFNIATKVTPDT-- 154 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEE--cCCCCEEEeecccccccCCCc--
Confidence 9999999999988778999999999999999999999998 9999999999999 888999999999887664332
Q ss_pred ceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHhCCCCCCCCCCCCHHH
Q 020888 201 DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEP---YEAAKYVAEGHRPFFRAKGFTPEL 277 (320)
Q Consensus 201 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l 277 (320)
......++..|.|||.+.+..++.++|+||||+++|++++|..||..... ...... ... .....+..++..+
T Consensus 155 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~ 229 (258)
T cd05578 155 ---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAK-QET-ADVLYPATWSTEA 229 (258)
T ss_pred ---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHH-hcc-ccccCcccCcHHH
Confidence 12234577889999999988899999999999999999999999987763 322222 221 2223334578999
Q ss_pred HHHHHHHhhcCCCCCCCH--HHHHH
Q 020888 278 RELTEKCWAADMNQRPSF--LDILK 300 (320)
Q Consensus 278 ~~li~~~l~~dp~~Rps~--~~ll~ 300 (320)
.++|.+||..||.+||+. +++++
T Consensus 230 ~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 230 IDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred HHHHHHHccCChhHcCCccHHHHhc
Confidence 999999999999999999 66654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=286.08 Aligned_cols=255 Identities=28% Similarity=0.498 Sum_probs=205.9
Q ss_pred CcccCccceecccCceEEEEEEECC----------------CceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccc
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWRG----------------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQ 104 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~~----------------~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 104 (320)
..+|.+.+.||+|+||.||++.+.+ ..+++|.+.... .......+.+|++++++++|+|+++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~ 81 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNIIR 81 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCcCe
Confidence 4589999999999999999987632 248899886542 2334467889999999999999999
Q ss_pred eeeeEEeCCceEEEEecCCCCCHHHHHHHhC------------CCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 020888 105 FLGAVTERKPLMLITEYLRGGDLHKYLKEKG------------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRN 172 (320)
Q Consensus 105 ~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~------------~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~n 172 (320)
+++++...+..++||||+++++|.+++.... .+++..++.++.+++.||.|||+.| ++|+||||+|
T Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~N 159 (295)
T cd05097 82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN--FVHRDLATRN 159 (295)
T ss_pred EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC--eeccccChhh
Confidence 9999999999999999999999999986431 3688899999999999999999998 9999999999
Q ss_pred EEEeeCCCCcEEEecCCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh--CCCCCCC
Q 020888 173 VLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE--GEPPLAN 250 (320)
Q Consensus 173 I~~~~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~--g~~p~~~ 250 (320)
|++ +.++.++|+|||++........ ........++..|+|||...+..++.++|+||||++++++++ |..||..
T Consensus 160 ill--~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~ 235 (295)
T cd05097 160 CLV--GNHYTIKIADFGMSRNLYSGDY--YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSL 235 (295)
T ss_pred EEE--cCCCcEEecccccccccccCcc--eeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcc
Confidence 999 7788999999999876543221 111122334668999999998899999999999999999998 6778887
Q ss_pred CChHHHHHHHHh------CCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHH
Q 020888 251 YEPYEAAKYVAE------GHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLE 303 (320)
Q Consensus 251 ~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~ 303 (320)
....+....... .......+..++..+.+++.+|+..||++|||+.++++.|+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 236 LSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred cChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 766554443322 11112223446899999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=289.69 Aligned_cols=262 Identities=31% Similarity=0.541 Sum_probs=216.7
Q ss_pred CcccCccceecccCceEEEEEEEC---------CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcccceeeeEE
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR---------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVT 110 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~---------~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 110 (320)
..+|.+.+.||+|+||.||++.+. ...+++|.+.... .....+.+.+|+++++++ +|+||+++++.+.
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIINLLGACT 88 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc
Confidence 457999999999999999999753 1358899775432 233457888999999999 7999999999999
Q ss_pred eCCceEEEEecCCCCCHHHHHHHhC----------------CCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEE
Q 020888 111 ERKPLMLITEYLRGGDLHKYLKEKG----------------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVL 174 (320)
Q Consensus 111 ~~~~~~iv~e~~~~~~L~~~~~~~~----------------~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~ 174 (320)
.++..++++||+++++|.+++.... .+++..+..++.|++.||.|||+.| ++|+||||+||+
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--ivH~dlkp~Nil 166 (334)
T cd05100 89 QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK--CIHRDLAARNVL 166 (334)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccceEE
Confidence 9999999999999999999987532 4788899999999999999999988 999999999999
Q ss_pred EeeCCCCcEEEecCCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCh
Q 020888 175 LVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEP 253 (320)
Q Consensus 175 ~~~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~ 253 (320)
+ +.++.++|+|||.+......... .......++..|+|||.+.+..++.++|+||||+++|+|++ |..||.....
T Consensus 167 l--~~~~~~kL~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 242 (334)
T cd05100 167 V--TEDNVMKIADFGLARDVHNIDYY--KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV 242 (334)
T ss_pred E--cCCCcEEECCcccceeccccccc--ccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence 9 78889999999998765432111 11112233467999999999999999999999999999998 8899988877
Q ss_pred HHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcCCC
Q 020888 254 YEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPT 311 (320)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~ 311 (320)
.+....+........ +..++.++.+++.+||..+|++|||+.++++.|+++......
T Consensus 243 ~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~~ 299 (334)
T cd05100 243 EELFKLLKEGHRMDK-PANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTST 299 (334)
T ss_pred HHHHHHHHcCCCCCC-CCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcCC
Confidence 777766665544333 345789999999999999999999999999999999866544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=287.28 Aligned_cols=255 Identities=28% Similarity=0.426 Sum_probs=209.5
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEe
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 120 (320)
+|.+.+.||.|++|.||++.+. ++.+++|.+.............+.+|+++++.++|+||+++++.+..++..+++||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME 81 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence 6889999999999999999886 67899998865543333445678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCcc
Q 020888 121 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 200 (320)
Q Consensus 121 ~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~ 200 (320)
|++|++|.++++..+.+++..+..++.|++.||.|||+.| ++|+||+|+||++ +.++.++|+|||.+.........
T Consensus 82 ~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~NIll--~~~~~~~l~dfg~~~~~~~~~~~ 157 (305)
T cd05609 82 YVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYG--IVHRDLKPDNLLI--TSMGHIKLTDFGLSKIGLMSLTT 157 (305)
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHEEE--CCCCCEEEeeCCCccccCcCccc
Confidence 9999999999988788999999999999999999999988 9999999999999 88899999999987632111100
Q ss_pred -----------ceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCC-CC
Q 020888 201 -----------DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRP-FF 268 (320)
Q Consensus 201 -----------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~-~~ 268 (320)
.........++..|.|||.+.+..++.++|+||||+++|++++|..||......+........... +.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (305)
T cd05609 158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE 237 (305)
T ss_pred cccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCC
Confidence 001111234677899999998888999999999999999999999999887776666655544322 22
Q ss_pred CCCCCCHHHHHHHHHHhhcCCCCCCCH---HHHHHH
Q 020888 269 RAKGFTPELRELTEKCWAADMNQRPSF---LDILKR 301 (320)
Q Consensus 269 ~~~~~~~~l~~li~~~l~~dp~~Rps~---~~ll~~ 301 (320)
....++.++++++.+||+.+|++||+. .+++++
T Consensus 238 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 238 GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 223578999999999999999999984 555544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=277.09 Aligned_cols=246 Identities=32% Similarity=0.592 Sum_probs=204.9
Q ss_pred ceecccCceEEEEEEEC-CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEecCCCCC
Q 020888 48 AIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGD 126 (320)
Q Consensus 48 ~~lg~g~~~~vy~~~~~-~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~ 126 (320)
++||+|++|.||++... ++.+++|.+..... ......+.+|+++++.++|+|++++++++...+..++||||+++++
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLP--QELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGD 78 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCC--HHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCc
Confidence 36899999999999865 67899998765432 2233568899999999999999999999999999999999999999
Q ss_pred HHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCccceeec
Q 020888 127 LHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKM 205 (320)
Q Consensus 127 L~~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~~~~~~ 205 (320)
|.+++... ..+++..+..++.+++.+|.+||+.| ++|+||+|+||++ +.++.++|+|||++......... ..
T Consensus 79 L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~~H~dl~p~nili--~~~~~~~l~d~g~~~~~~~~~~~---~~ 151 (250)
T cd05085 79 FLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN--CIHRDLAARNCLV--GENNVLKISDFGMSRQEDDGIYS---SS 151 (250)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccChheEEE--cCCCeEEECCCccceeccccccc---cC
Confidence 99998753 46899999999999999999999988 9999999999999 88889999999988654322110 01
Q ss_pred cCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHH
Q 020888 206 TGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKC 284 (320)
Q Consensus 206 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 284 (320)
....++..|+|||.+.+..++.++|+||||+++|++++ |..||...........+........ +..++..+.+++.+|
T Consensus 152 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~ 230 (250)
T cd05085 152 GLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSC-PQKCPDDVYKVMQRC 230 (250)
T ss_pred CCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCC-CCCCCHHHHHHHHHH
Confidence 11233567999999998899999999999999999998 9999988877766666655544332 345789999999999
Q ss_pred hhcCCCCCCCHHHHHHHHH
Q 020888 285 WAADMNQRPSFLDILKRLE 303 (320)
Q Consensus 285 l~~dp~~Rps~~~ll~~L~ 303 (320)
+..+|++|||+.++++.|.
T Consensus 231 l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 231 WDYKPENRPKFSELQKELA 249 (250)
T ss_pred cccCcccCCCHHHHHHHhc
Confidence 9999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=295.16 Aligned_cols=248 Identities=26% Similarity=0.341 Sum_probs=200.9
Q ss_pred CcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeC------
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER------ 112 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------ 112 (320)
..+|.+.+.||+|+||.||++.+. ++.+|+|.+....... .....+.+|+.+++.++|+||+++++++...
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCc-hhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 358999999999999999999875 7889999886543332 2336778899999999999999999887533
Q ss_pred CceEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcc
Q 020888 113 KPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 192 (320)
Q Consensus 113 ~~~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~ 192 (320)
...|+||||+++ +|.+.+.. .+++..+..++.|++.||.|||++| |+|+||||+||++ +.++.++|+|||++.
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll--~~~~~~kL~DfG~a~ 174 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVV--KSDCTLKILDFGLAR 174 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEE--CCCCcEEEEeCCCcc
Confidence 357999999965 88887764 4789999999999999999999998 9999999999999 888999999999987
Q ss_pred cccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCC-----
Q 020888 193 LIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPF----- 267 (320)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~----- 267 (320)
...... ......++..|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+......+
T Consensus 175 ~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 249 (364)
T cd07875 175 TAGTSF-----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM 249 (364)
T ss_pred ccCCCC-----cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 553321 1233467899999999999999999999999999999999999998877655444333211100
Q ss_pred -----------------------------------CCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 268 -----------------------------------FRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 268 -----------------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
......+.+++++|.+||..||.+|||+++++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0001124678999999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=282.79 Aligned_cols=251 Identities=28% Similarity=0.513 Sum_probs=206.8
Q ss_pred CCCcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcccceeeeEEeC---
Q 020888 39 PSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTER--- 112 (320)
Q Consensus 39 ~~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--- 112 (320)
+.+..|.+.+.||+|++|.||++.+. ++.+++|.+...... ...+.+|+.+++++ +|+|++++++.+...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~----~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 78 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE----EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 78 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCcc----HHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCC
Confidence 44567999999999999999999875 778999988543222 25678899999998 699999999988642
Q ss_pred ---CceEEEEecCCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEec
Q 020888 113 ---KPLMLITEYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGD 187 (320)
Q Consensus 113 ---~~~~iv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~d 187 (320)
...++++||+++++|.+++... ..+++..+..++.|++.||.|||+.| ++|+||+|+||++ +.++.++|+|
T Consensus 79 ~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--ivh~dl~~~nili--~~~~~~~l~D 154 (272)
T cd06637 79 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLL--TENAEVKLVD 154 (272)
T ss_pred CCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHEEE--CCCCCEEEcc
Confidence 4589999999999999998863 36899999999999999999999998 9999999999999 8888999999
Q ss_pred CCCcccccccCccceeeccCCcccccccCccccC-----cCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh
Q 020888 188 FGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFK-----HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAE 262 (320)
Q Consensus 188 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~ 262 (320)
||++........ ......++..|+|||.+. +..++.++|+||+|+++|+|++|..||..............
T Consensus 155 fg~~~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~ 230 (272)
T cd06637 155 FGVSAQLDRTVG----RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR 230 (272)
T ss_pred CCCceecccccc----cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhc
Confidence 999876533211 122345788999999986 33578899999999999999999999987776655555554
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 263 GHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 263 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
..........++.++++++.+||..+|.+|||+.+++++
T Consensus 231 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 231 NPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred CCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 444444445678999999999999999999999999864
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=278.23 Aligned_cols=250 Identities=34% Similarity=0.650 Sum_probs=210.7
Q ss_pred CcccCccceecccCceEEEEEEEC-CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEE
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 119 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~-~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 119 (320)
..+|++.+.||.|++|.||++.+. +..+++|.+....... ..+.+|+++++.++|++++++++++......++++
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~----~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 78 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSE----EDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVF 78 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCH----HHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEE
Confidence 347888999999999999999876 7789999876543322 56788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccC
Q 020888 120 EYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 198 (320)
Q Consensus 120 e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~ 198 (320)
||+++++|.+++... +.+++..++.++.+++.++.+||+.| ++|+||+|+||++ +.++.++|+|||.+.......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~dl~p~ni~i--~~~~~~~l~d~g~~~~~~~~~ 154 (256)
T cd05112 79 EFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN--VIHRDLAARNCLV--GENQVVKVSDFGMTRFVLDDQ 154 (256)
T ss_pred EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccccceEEE--cCCCeEEECCCcceeecccCc
Confidence 999999999998763 46899999999999999999999988 9999999999999 788899999999887553321
Q ss_pred ccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHH
Q 020888 199 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPEL 277 (320)
Q Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 277 (320)
. ........+..|+|||...+..++.++|+||||+++|++++ |..||......+....+..+.... .+...+.++
T Consensus 155 ~---~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 230 (256)
T cd05112 155 Y---TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLY-KPRLASQSV 230 (256)
T ss_pred c---cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCC-CCCCCCHHH
Confidence 1 01112234567999999998899999999999999999998 999998887777776666554332 234468999
Q ss_pred HHHHHHHhhcCCCCCCCHHHHHHHH
Q 020888 278 RELTEKCWAADMNQRPSFLDILKRL 302 (320)
Q Consensus 278 ~~li~~~l~~dp~~Rps~~~ll~~L 302 (320)
.+++.+||+.+|++|||+.++++.|
T Consensus 231 ~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 231 YELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred HHHHHHHcccChhhCCCHHHHHHhh
Confidence 9999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=279.64 Aligned_cols=251 Identities=29% Similarity=0.543 Sum_probs=209.6
Q ss_pred CcccCccceecccCceEEEEEEEC-CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEE
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 119 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~-~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 119 (320)
..+|.+.+.||+|++|.||++.+. +..+++|.+... ....+.+.+|+++++.++|++++++++.+.. ...++++
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~ 79 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG----SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIIT 79 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC----hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEE
Confidence 357899999999999999999865 567999977543 2234678889999999999999999999877 7789999
Q ss_pred ecCCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccccccc
Q 020888 120 EYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 197 (320)
Q Consensus 120 e~~~~~~L~~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~ 197 (320)
||+++++|.+++... ..+++..+..++.|++.||.+||+.| ++|+||+|+||++ +..+.++|+|||.+..+...
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~ni~i--~~~~~~~l~d~~~~~~~~~~ 155 (260)
T cd05073 80 EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILV--SASLVCKIADFGLARVIEDN 155 (260)
T ss_pred EeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEE--cCCCcEEECCCcceeeccCC
Confidence 999999999999763 35788999999999999999999988 9999999999999 88899999999988765432
Q ss_pred CccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHH
Q 020888 198 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPE 276 (320)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (320)
... ......++..|+|||.+.+..++.++|+||||+++|++++ |..||...+.......+....... .....+.+
T Consensus 156 ~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 231 (260)
T cd05073 156 EYT---AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMP-RPENCPEE 231 (260)
T ss_pred Ccc---cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCC-CcccCCHH
Confidence 111 1112234567999999998889999999999999999999 999998877766666555554333 23457899
Q ss_pred HHHHHHHHhhcCCCCCCCHHHHHHHHHH
Q 020888 277 LRELTEKCWAADMNQRPSFLDILKRLEK 304 (320)
Q Consensus 277 l~~li~~~l~~dp~~Rps~~~ll~~L~~ 304 (320)
+.+++.+|+..+|++||++.++++.|+.
T Consensus 232 ~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 232 LYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred HHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 9999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=277.89 Aligned_cols=249 Identities=38% Similarity=0.690 Sum_probs=211.0
Q ss_pred cCccceecccCceEEEEEEECC------CceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEE
Q 020888 44 FSSSAIIGKGSFGEILKAYWRG------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLML 117 (320)
Q Consensus 44 y~~~~~lg~g~~~~vy~~~~~~------~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 117 (320)
+++.+.||.|++|.||++.+.. ..+++|.+...... ...+.+.+|++.+..++|+|++++++++...+..++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 78 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADE--QQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI 78 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCCh--HHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence 4567899999999999999864 77999988554332 234788899999999999999999999999899999
Q ss_pred EEecCCCCCHHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccccc
Q 020888 118 ITEYLRGGDLHKYLKEKGA--LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 195 (320)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~--l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~ 195 (320)
+|||+++++|.+++..... +++..+..++.|++.+|.+||+.| ++|+||+|+||++ +.++.++|+|||.+....
T Consensus 79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~--~~h~dl~~~nil~--~~~~~~~l~dfg~~~~~~ 154 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN--FIHRDLAARNCLV--GENLVVKISDFGLSRDLY 154 (258)
T ss_pred EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC--eeecccccceEEE--ccCCeEEEcccCCceecc
Confidence 9999999999999976443 899999999999999999999998 9999999999999 888899999999987665
Q ss_pred ccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCC
Q 020888 196 VQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFT 274 (320)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (320)
...... .....+++.|+|||...+..++.++|+||||++++++++ |..||...+.......+........ +..++
T Consensus 155 ~~~~~~---~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~ 230 (258)
T smart00219 155 DDDYYK---KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPK-PENCP 230 (258)
T ss_pred cccccc---cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCC-CCcCC
Confidence 432111 112235678999999988889999999999999999998 8889988777777766666554443 34489
Q ss_pred HHHHHHHHHHhhcCCCCCCCHHHHHHHH
Q 020888 275 PELRELTEKCWAADMNQRPSFLDILKRL 302 (320)
Q Consensus 275 ~~l~~li~~~l~~dp~~Rps~~~ll~~L 302 (320)
.++.+++.+|++.+|++|||+.++++.|
T Consensus 231 ~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 231 PEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred HHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 9999999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=295.96 Aligned_cols=269 Identities=32% Similarity=0.586 Sum_probs=229.9
Q ss_pred CCCcCCCCCcccCccceecccCceEEEEEEEC---C---CceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCccccee
Q 020888 33 CDWEIDPSELDFSSSAIIGKGSFGEILKAYWR---G---TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 106 (320)
Q Consensus 33 ~~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~---~---~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 106 (320)
..|++..+...+. +.||+|.||.||++..+ + ..||+|....+.......+..+.+|.+++++++|+||++++
T Consensus 150 ~~Wel~H~~v~l~--kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~y 227 (474)
T KOG0194|consen 150 QKWELSHSDIELG--KKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFY 227 (474)
T ss_pred cccEEeccCcccc--ceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEE
Confidence 4588888777777 99999999999999875 1 23788877654444456678999999999999999999999
Q ss_pred eeEEeCCceEEEEecCCCCCHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEE
Q 020888 107 GAVTERKPLMLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKV 185 (320)
Q Consensus 107 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L 185 (320)
|+......+++|||+|+||+|.++++..+ .++.......+.+.+.||+|||+++ ++||||-..|+++ +.++.+||
T Consensus 228 GVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~--~IHRDIAARNcL~--~~~~~vKI 303 (474)
T KOG0194|consen 228 GVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKN--CIHRDIAARNCLY--SKKGVVKI 303 (474)
T ss_pred EEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCC--CcchhHhHHHhee--cCCCeEEe
Confidence 99999999999999999999999999876 5999999999999999999999988 9999999999999 78778999
Q ss_pred ecCCCcccccccCccceeecc-CCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhC
Q 020888 186 GDFGLSKLIKVQNSHDVYKMT-GETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEG 263 (320)
Q Consensus 186 ~dfg~~~~~~~~~~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~ 263 (320)
+|||+++.-..-. ... ..--...|+|||.+....++.++||||+|++++|+++ |..||.+....+....+...
T Consensus 304 SDFGLs~~~~~~~-----~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~ 378 (474)
T KOG0194|consen 304 SDFGLSRAGSQYV-----MKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKN 378 (474)
T ss_pred CccccccCCccee-----eccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhc
Confidence 9999976432110 111 1123568999999999999999999999999999999 89999999999999999554
Q ss_pred CCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcCCCC
Q 020888 264 HRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPTD 312 (320)
Q Consensus 264 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~ 312 (320)
......+...|.++..++.+|+..+|+.|||+.++.+.|+.+......+
T Consensus 379 ~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~~ 427 (474)
T KOG0194|consen 379 GYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEAF 427 (474)
T ss_pred CccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccccc
Confidence 4444444567999999999999999999999999999999998876643
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=281.86 Aligned_cols=253 Identities=32% Similarity=0.553 Sum_probs=212.2
Q ss_pred cccCccceecccCceEEEEEEEC-------CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCc
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP 114 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~-------~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 114 (320)
.+|...+.||.|+||.||++..+ .+.+++|.+.... .......+.+|++++++++|+|++++++++.+.+.
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 82 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEP 82 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCc
Confidence 57889999999999999999864 3568888774322 22345778999999999999999999999999899
Q ss_pred eEEEEecCCCCCHHHHHHHhC---------CCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEE
Q 020888 115 LMLITEYLRGGDLHKYLKEKG---------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKV 185 (320)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~~~---------~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L 185 (320)
.++||||+++++|.+++.... .+++..+..++.|++.+|.|||+.| ++|+||||+||++ +.++.+++
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dlkp~Nili--~~~~~~~l 158 (275)
T cd05046 83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR--FVHRDLAARNCLV--SSQREVKV 158 (275)
T ss_pred ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC--cccCcCccceEEE--eCCCcEEE
Confidence 999999999999999998654 6899999999999999999999988 9999999999999 78889999
Q ss_pred ecCCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCC
Q 020888 186 GDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGH 264 (320)
Q Consensus 186 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~ 264 (320)
+|||.+....... ........++..|+|||...+..++.++|+||||++++++++ |..||..............+.
T Consensus 159 ~~~~~~~~~~~~~---~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~ 235 (275)
T cd05046 159 SLLSLSKDVYNSE---YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGK 235 (275)
T ss_pred cccccccccCccc---ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCC
Confidence 9999876443221 112223345677999999988889999999999999999999 888998777666666665555
Q ss_pred CCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHH
Q 020888 265 RPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLE 303 (320)
Q Consensus 265 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~ 303 (320)
........++..+.+++.+||+.+|.+|||+.++++.|.
T Consensus 236 ~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 236 LELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred cCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 444445568999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=294.27 Aligned_cols=252 Identities=25% Similarity=0.398 Sum_probs=207.0
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEe
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 120 (320)
+|.+.+.||+|+||.||++.++ ++.+|+|.+.+...........+.+|..++..++|++|+++++.+..++..|+|||
T Consensus 2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~E 81 (331)
T cd05624 2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMD 81 (331)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 6899999999999999999986 67899998865322223334567889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCc
Q 020888 121 YLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 199 (320)
Q Consensus 121 ~~~~~~L~~~~~~-~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~ 199 (320)
|++|++|.+++.. ...+++..+..++.|++.||.|||++| |+|+||||+||++ +.++.++|+|||++........
T Consensus 82 y~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~--iiHrDlkp~Nill--~~~~~~kl~DfG~a~~~~~~~~ 157 (331)
T cd05624 82 YYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH--YVHRDIKPDNVLL--DMNGHIRLADFGSCLKMNQDGT 157 (331)
T ss_pred CCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCchHHEEE--cCCCCEEEEeccceeeccCCCc
Confidence 9999999999986 457899999999999999999999998 9999999999999 8889999999999876543221
Q ss_pred cceeeccCCcccccccCccccCc-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCC---CCCC
Q 020888 200 HDVYKMTGETGSYRYMAPEVFKH-----RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPF---FRAK 271 (320)
Q Consensus 200 ~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~ 271 (320)
.......|++.|+|||++.+ ..++.++|+||||+++|+|++|..||...+..+....+....... ....
T Consensus 158 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~ 234 (331)
T cd05624 158 ---VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHIT 234 (331)
T ss_pred ---eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccc
Confidence 11223468999999999875 467889999999999999999999999887776666555433211 1123
Q ss_pred CCCHHHHHHHHHHhhcCCCC--CCCHHHHHHH
Q 020888 272 GFTPELRELTEKCWAADMNQ--RPSFLDILKR 301 (320)
Q Consensus 272 ~~~~~l~~li~~~l~~dp~~--Rps~~~ll~~ 301 (320)
.+++++++++.+||..++.+ |+++++++++
T Consensus 235 ~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 235 DVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred cCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 46899999999999865544 4688988876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=293.68 Aligned_cols=252 Identities=23% Similarity=0.387 Sum_probs=207.6
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEe
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 120 (320)
+|.+.+.||+|+||.||++.++ ++.+|+|.+.+...........+.+|+.++..++|++|+++++.+...+..++|||
T Consensus 2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (332)
T cd05623 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMD 81 (332)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEe
Confidence 6889999999999999999886 67799998754322223333567889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCc
Q 020888 121 YLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 199 (320)
Q Consensus 121 ~~~~~~L~~~~~~-~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~ 199 (320)
|+++++|.+++.+ ...+++..+..++.|++.||.|||+.| ++|+||||+||++ +.++.++|+|||++..+.....
T Consensus 82 y~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~--iiHrDlkp~Nili--~~~~~~kL~DfG~a~~~~~~~~ 157 (332)
T cd05623 82 YYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILM--DMNGHIRLADFGSCLKLMEDGT 157 (332)
T ss_pred ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEE--CCCCCEEEeecchheecccCCc
Confidence 9999999999976 457899999999999999999999998 9999999999999 8889999999999876533221
Q ss_pred cceeeccCCcccccccCccccC-----cCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCC---CCCCC
Q 020888 200 HDVYKMTGETGSYRYMAPEVFK-----HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRP---FFRAK 271 (320)
Q Consensus 200 ~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~ 271 (320)
.......|++.|+|||++. ...++.++|+||||+++|+|++|+.||...+..+....+...... +....
T Consensus 158 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~ 234 (332)
T cd05623 158 ---VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVT 234 (332)
T ss_pred ---ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccc
Confidence 1122346899999999986 345788999999999999999999999988877776666554322 11224
Q ss_pred CCCHHHHHHHHHHhhcCCCC--CCCHHHHHHH
Q 020888 272 GFTPELRELTEKCWAADMNQ--RPSFLDILKR 301 (320)
Q Consensus 272 ~~~~~l~~li~~~l~~dp~~--Rps~~~ll~~ 301 (320)
.++.++++++++|+..++.. |+++++++++
T Consensus 235 ~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 235 DVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred cCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 57999999999999664444 6899999988
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=294.43 Aligned_cols=248 Identities=26% Similarity=0.329 Sum_probs=199.6
Q ss_pred CcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeC------
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER------ 112 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------ 112 (320)
..+|.+.+.||+|+||.||++.+. ++.+|+|.+....... .....+.+|+.+++.++|+||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccCh-HHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 358999999999999999999875 7889999886544332 3346777899999999999999999987543
Q ss_pred CceEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcc
Q 020888 113 KPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 192 (320)
Q Consensus 113 ~~~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~ 192 (320)
...|++|||+++ +|.+.+.. .++...+..++.|++.||.|||+.| ++|+||||+||++ +.++.++|+|||++.
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDikp~Nill--~~~~~~kl~Dfg~~~ 167 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVV--KSDCTLKILDFGLAR 167 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEE--CCCCCEEEeeCcccc
Confidence 347999999965 78777754 4889999999999999999999998 9999999999999 888999999999987
Q ss_pred cccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCC------
Q 020888 193 LIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRP------ 266 (320)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~------ 266 (320)
...... ......+++.|+|||++.+..++.++|+|||||++|+|++|..||...+..+....+......
T Consensus 168 ~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (355)
T cd07874 168 TAGTSF-----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242 (355)
T ss_pred cCCCcc-----ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 543321 123346789999999999999999999999999999999999999876644332222111000
Q ss_pred ----------------------------------CCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 267 ----------------------------------FFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 267 ----------------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
.......+.+++++|.+||..||.+|||+.+++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 00011235678999999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=279.77 Aligned_cols=247 Identities=36% Similarity=0.584 Sum_probs=202.6
Q ss_pred ceecccCceEEEEEEEC--CC--ceEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcccceeeeEEeCCceEEEEecC
Q 020888 48 AIIGKGSFGEILKAYWR--GT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYL 122 (320)
Q Consensus 48 ~~lg~g~~~~vy~~~~~--~~--~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~iv~e~~ 122 (320)
+.||.|++|.||++.++ +. .+++|.+... ......+.+.+|+++++++ +|+||+++++++...+..+++|||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 78 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc--CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence 36899999999999875 22 4677766532 2223346788999999999 7999999999999999999999999
Q ss_pred CCCCHHHHHHHhC----------------CCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEe
Q 020888 123 RGGDLHKYLKEKG----------------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVG 186 (320)
Q Consensus 123 ~~~~L~~~~~~~~----------------~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~ 186 (320)
++++|.+++.... .+++..+..++.|++.||+|||+.| ++|+||||+||++ +.++.++|+
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nili--~~~~~~kl~ 154 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILV--GENYVAKIA 154 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccccceEEE--cCCCeEEEC
Confidence 9999999987532 4789999999999999999999988 9999999999999 888999999
Q ss_pred cCCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCC
Q 020888 187 DFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHR 265 (320)
Q Consensus 187 dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~ 265 (320)
|||++....... .......+..|.|||...+..++.++|+||||++++++++ |..||...+..+....+.....
T Consensus 155 dfgl~~~~~~~~-----~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~ 229 (270)
T cd05047 155 DFGLSRGQEVYV-----KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 229 (270)
T ss_pred CCCCccccchhh-----hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCC
Confidence 999875322110 0111223557999999988889999999999999999997 9999988777666666655443
Q ss_pred CCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHH
Q 020888 266 PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIK 306 (320)
Q Consensus 266 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 306 (320)
.. .+..++.++.+++.+|+..+|.+|||+.+++..|.++.
T Consensus 230 ~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 230 LE-KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CC-CCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 32 23447899999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=282.86 Aligned_cols=247 Identities=28% Similarity=0.487 Sum_probs=205.3
Q ss_pred cCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEec
Q 020888 44 FSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY 121 (320)
Q Consensus 44 y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 121 (320)
|++.+.||.|++|.||++.+. +..+++|.+... .....+.+.+|+++++.++|+|++++++.+..++..++|+||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK---SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC---CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 678899999999999999986 566788877432 233456788899999999999999999999999999999999
Q ss_pred CCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCcc
Q 020888 122 LRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 200 (320)
Q Consensus 122 ~~~~~L~~~~~~-~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~ 200 (320)
+++++|.+++.. ..++++..+..++.|++.||.|||+.| ++|+||+|+||++ +.++.++|+|||++........
T Consensus 84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~--i~H~dlkp~nili--~~~~~~kl~dfg~~~~~~~~~~- 158 (282)
T cd06643 84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK--IIHRDLKAGNILF--TLDGDIKLADFGVSAKNTRTIQ- 158 (282)
T ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEE--ccCCCEEEcccccccccccccc-
Confidence 999999988764 457899999999999999999999998 9999999999999 8888999999999875532211
Q ss_pred ceeeccCCcccccccCccccC-----cCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCC-CCCCCCCC
Q 020888 201 DVYKMTGETGSYRYMAPEVFK-----HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRP-FFRAKGFT 274 (320)
Q Consensus 201 ~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 274 (320)
......+++.|+|||.+. +..++.++|+||+|+++|++++|..||...+.......+.....+ ...+..++
T Consensus 159 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
T cd06643 159 ---RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWS 235 (282)
T ss_pred ---ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccC
Confidence 122345788999999873 445778999999999999999999999887766655544443322 22345578
Q ss_pred HHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 275 PELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 275 ~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
.++++++.+||+.+|.+|||+++++++
T Consensus 236 ~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 236 SEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 999999999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=279.33 Aligned_cols=258 Identities=30% Similarity=0.596 Sum_probs=214.3
Q ss_pred CcccCccceecccCceEEEEEEEC--C----CceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCc
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--G----TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP 114 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~----~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 114 (320)
..+|.+.+.||+|+||.||++.+. + ..+++|....... ......+.+|+..++.++|+|++++++++.. ..
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~ 82 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICLS-SQ 82 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cc
Confidence 457899999999999999999864 2 2588887755432 3344778899999999999999999999887 78
Q ss_pred eEEEEecCCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccc
Q 020888 115 LMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 193 (320)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~ 193 (320)
.++++||+++++|.+++... ..+++..++.++.|++.||+|||+.| ++|+||+|+||++ +.++.++|+|||.+..
T Consensus 83 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~di~p~nil~--~~~~~~kL~dfg~~~~ 158 (279)
T cd05057 83 VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR--LVHRDLAARNVLV--KTPQHVKITDFGLAKL 158 (279)
T ss_pred eEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecccCcceEEE--cCCCeEEECCCccccc
Confidence 89999999999999998763 46899999999999999999999988 9999999999999 7888999999999886
Q ss_pred ccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCC
Q 020888 194 IKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKG 272 (320)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (320)
+..... ........++..|+|||...+..++.++|+||||++++++++ |..||......+....+..+.... .+..
T Consensus 159 ~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~ 235 (279)
T cd05057 159 LDVDEK--EYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLP-QPPI 235 (279)
T ss_pred ccCccc--ceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCC-CCCC
Confidence 653221 111122233567999999988889999999999999999998 999999887777666565544333 2344
Q ss_pred CCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhc
Q 020888 273 FTPELRELTEKCWAADMNQRPSFLDILKRLEKIKET 308 (320)
Q Consensus 273 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 308 (320)
.+..+.+++.+||..+|..|||+.++++.|.++...
T Consensus 236 ~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 236 CTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 688999999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=282.68 Aligned_cols=257 Identities=30% Similarity=0.515 Sum_probs=204.6
Q ss_pred CcccCccceecccCceEEEEEEE------CCCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeC--
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER-- 112 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~------~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-- 112 (320)
..-|.+++.||+|++|.||++.. .+..+++|.+..... ......+.+|+++++.++|+|++++.+++...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (284)
T cd05079 3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG--GNHIADLKKEIEILRNLYHENIVKYKGICTEDGG 80 (284)
T ss_pred hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcccc--HHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence 45678999999999999999874 267899998764432 33346889999999999999999999988764
Q ss_pred CceEEEEecCCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCc
Q 020888 113 KPLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 191 (320)
Q Consensus 113 ~~~~iv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~ 191 (320)
...++||||++|++|.+++.+. ..+++..++.++.|++.+|.+||+.| ++|+||||+||++ +.++.++|+|||.+
T Consensus 81 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~g--i~H~dlkp~Nil~--~~~~~~~l~dfg~~ 156 (284)
T cd05079 81 NGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLV--ESEHQVKIGDFGLT 156 (284)
T ss_pred CceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccchheEEE--cCCCCEEECCCccc
Confidence 5689999999999999999764 35899999999999999999999988 9999999999999 78889999999998
Q ss_pred ccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCC---------------hHHH
Q 020888 192 KLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYE---------------PYEA 256 (320)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~---------------~~~~ 256 (320)
..+....... .......++..|+|||...+..++.++|+||||+++|+++++..|..... ....
T Consensus 157 ~~~~~~~~~~-~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05079 157 KAIETDKEYY-TVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRL 235 (284)
T ss_pred cccccCccce-eecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHH
Confidence 8765432211 11122345667999999988889999999999999999999776542210 1111
Q ss_pred HHHHHhCCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHH
Q 020888 257 AKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKI 305 (320)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~ 305 (320)
...+..+.... .+..++.++.+++.+||+.+|.+|||+.++++.|+++
T Consensus 236 ~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 236 VRVLEEGKRLP-RPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHHcCccCC-CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 12222222222 2345789999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=279.31 Aligned_cols=249 Identities=26% Similarity=0.497 Sum_probs=212.0
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEe
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 120 (320)
+|++.+.||.|++|.+|++.+. ++.+++|.+........ ....+.+|+.++++++|+|++++++.+...+..++|+|
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPK-EREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChH-HHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 5888999999999999999875 78899998865433322 33678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccC
Q 020888 121 YLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 198 (320)
Q Consensus 121 ~~~~~~L~~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~ 198 (320)
|+++++|.+++.... .+++..++.++.|++.++.+||+.| ++|+||+|+||++ +.++.++|+|||.+.......
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~l~~~nil~--~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFL--TKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEE--cCCCCEEEeeccceeecCcch
Confidence 999999999987632 5789999999999999999999988 9999999999999 888899999999887654322
Q ss_pred ccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHH
Q 020888 199 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 278 (320)
Q Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 278 (320)
. ......+++.|+|||...+..++.++|+||||++++++++|..||...+..+....+..+..+.. +..++.++.
T Consensus 156 ~----~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 230 (256)
T cd08218 156 E----LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPV-SSHYSYDLR 230 (256)
T ss_pred h----hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCC-cccCCHHHH
Confidence 1 11123467889999999998999999999999999999999999988877776666665554433 345799999
Q ss_pred HHHHHHhhcCCCCCCCHHHHHHH
Q 020888 279 ELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 279 ~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
+++.+||+.+|.+||++.+++++
T Consensus 231 ~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 231 NLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred HHHHHHhhCChhhCcCHHHHhhC
Confidence 99999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=302.22 Aligned_cols=250 Identities=26% Similarity=0.395 Sum_probs=197.0
Q ss_pred CcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEe-------
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE------- 111 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------- 111 (320)
..+|.+.+.||+|+||.||++.+. ++.||+|.+.... ....+|+.+++.++|+||+++++++..
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~ 137 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE 137 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence 457999999999999999999874 7889999775431 233469999999999999999887632
Q ss_pred -CCceEEEEecCCCCCHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCC-cEEE
Q 020888 112 -RKPLMLITEYLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD-HLKV 185 (320)
Q Consensus 112 -~~~~~iv~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~-~~~L 185 (320)
...+++||||+++ +|.+++.. ...+++..++.++.||+.||.|||+.| |+||||||+||++ +.++ .++|
T Consensus 138 ~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~--IiHrDLKp~NILl--~~~~~~vkL 212 (440)
T PTZ00036 138 KNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF--ICHRDLKPQNLLI--DPNTHTLKL 212 (440)
T ss_pred CceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCcCHHHEEE--cCCCCceee
Confidence 1246799999965 88777653 457899999999999999999999999 9999999999999 6544 6999
Q ss_pred ecCCCcccccccCccceeeccCCcccccccCccccCcC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCC
Q 020888 186 GDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH 264 (320)
Q Consensus 186 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~ 264 (320)
+|||++..+..... .....+++.|+|||++.+. .++.++|||||||++|+|++|..||......+....+.+..
T Consensus 213 ~DFGla~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~ 287 (440)
T PTZ00036 213 CDFGSAKNLLAGQR-----SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVL 287 (440)
T ss_pred eccccchhccCCCC-----cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence 99999986643321 2234678899999998764 68999999999999999999999998776554433332210
Q ss_pred C-------------------CCC--------CCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH--HHHHHh
Q 020888 265 R-------------------PFF--------RAKGFTPELRELTEKCWAADMNQRPSFLDILKR--LEKIKE 307 (320)
Q Consensus 265 ~-------------------~~~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--L~~~~~ 307 (320)
. +.. .+...++++++||.+||..||.+|||+.+++++ +..+.+
T Consensus 288 ~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~ 359 (440)
T PTZ00036 288 GTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD 359 (440)
T ss_pred CCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence 0 000 122367899999999999999999999999977 444443
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=277.56 Aligned_cols=253 Identities=28% Similarity=0.563 Sum_probs=203.1
Q ss_pred ceecccCceEEEEEEEC-----CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEE-eCCceEEEEec
Q 020888 48 AIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVT-ERKPLMLITEY 121 (320)
Q Consensus 48 ~~lg~g~~~~vy~~~~~-----~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~iv~e~ 121 (320)
+.||+|+||.||++.+. ...+++|.+... ......+.+.+|+.+++.++|+|++++++++. .++..++++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI--TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc--CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence 46899999999999863 246888976432 22334477888999999999999999999764 45668999999
Q ss_pred CCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCcc
Q 020888 122 LRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 200 (320)
Q Consensus 122 ~~~~~L~~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~ 200 (320)
+.+++|.+++... ..+++..+..++.|++.||.|||+.| ++|+||+|+||++ +.++.++|+|||++..+......
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlk~~nili--~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK--FVHRDLAARNCML--DESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEE--cCCCcEEECCccccccccCCcce
Confidence 9999999999764 34678888999999999999999988 9999999999999 88889999999998765432211
Q ss_pred ceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHH
Q 020888 201 DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRE 279 (320)
Q Consensus 201 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 279 (320)
.........++..|+|||...+..++.++||||||+++|++++ |..||...+..+....+....... .+..++..+.+
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 233 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLL-QPEYCPDPLYE 233 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCC-CCCcCCHHHHH
Confidence 1111122335668999999988899999999999999999999 566777777666666555544333 23456899999
Q ss_pred HHHHHhhcCCCCCCCHHHHHHHHHHHHh
Q 020888 280 LTEKCWAADMNQRPSFLDILKRLEKIKE 307 (320)
Q Consensus 280 li~~~l~~dp~~Rps~~~ll~~L~~~~~ 307 (320)
++.+||..+|++||++.++++.|+++..
T Consensus 234 li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 234 VMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred HHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 9999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=277.30 Aligned_cols=248 Identities=27% Similarity=0.488 Sum_probs=209.3
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEe
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 120 (320)
+|+..+.||+|++|.||++.+. ++.+++|.+....... .....+.+|+++++.++|++++++++.+..++..++|+|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTK-DERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccccc-HHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence 5888999999999999998875 7889999886544333 335788999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCC-CCcEEEecCCCccccccc
Q 020888 121 YLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS-ADHLKVGDFGLSKLIKVQ 197 (320)
Q Consensus 121 ~~~~~~L~~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~-~~~~~L~dfg~~~~~~~~ 197 (320)
|+++++|.+++... ..+++..++.++.+++.+|.+||++| ++|+||+|+||++ +. ++.++|+|||.+......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~--~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL--ILHRDLKTQNILL--DKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEE--cCCCCEEEEccCCCceecCCC
Confidence 99999999999763 35899999999999999999999988 9999999999999 54 346899999998876433
Q ss_pred CccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHH
Q 020888 198 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPEL 277 (320)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 277 (320)
. ......++..|+|||...+..++.++|+||+|++++++++|..||...+.......+........ +..++.++
T Consensus 156 ~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l 229 (256)
T cd08220 156 S-----KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPI-SDRYSPDL 229 (256)
T ss_pred c-----cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCC-CCCcCHHH
Confidence 2 11224578889999999988899999999999999999999999988776655555554443332 34579999
Q ss_pred HHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 278 RELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 278 ~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
++++.+||..+|.+|||+.+++.+
T Consensus 230 ~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 230 RQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred HHHHHHHccCChhhCCCHHHHhhC
Confidence 999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=285.31 Aligned_cols=248 Identities=28% Similarity=0.416 Sum_probs=194.7
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhC---CCCcccceeeeEEe-----C
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL---RHPNIVQFLGAVTE-----R 112 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~-----~ 112 (320)
+|++.+.||+|++|+||++.+. ++.+|+|.+......... ...+.+|+.+++.+ +|+||+++++++.. .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~-~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGL-PLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCC-chHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 5889999999999999999985 788999987654322211 12344566666555 69999999998754 3
Q ss_pred CceEEEEecCCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCC
Q 020888 113 KPLMLITEYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGL 190 (320)
Q Consensus 113 ~~~~iv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~ 190 (320)
...++++|++++ +|.+++... ..+++..+..++.|++.||.|||+.| ++|+||||+||++ +.++.++|+|||+
T Consensus 80 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili--~~~~~~kl~dfg~ 154 (288)
T cd07863 80 TKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILV--TSGGQVKLADFGL 154 (288)
T ss_pred ceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEE--CCCCCEEECccCc
Confidence 457999999975 899988763 34899999999999999999999999 9999999999999 8889999999999
Q ss_pred cccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCC-----
Q 020888 191 SKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHR----- 265 (320)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~----- 265 (320)
+....... ......++..|+|||++.+..++.++|+|||||++|+|++|..||......+....+.....
T Consensus 155 ~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~ 229 (288)
T cd07863 155 ARIYSCQM-----ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED 229 (288)
T ss_pred cccccCcc-----cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChh
Confidence 87654321 11234578899999999988999999999999999999999999977655443333221100
Q ss_pred -------------CC-------CCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 266 -------------PF-------FRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 266 -------------~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
.. .....+++++++++.+||+.||++|||+.+++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 230 DWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred hCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00 0012467889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=278.79 Aligned_cols=245 Identities=33% Similarity=0.630 Sum_probs=208.4
Q ss_pred cccCccceecccCceEEEEEEECCCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEec
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY 121 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 121 (320)
.+|++.+.||+|++|.||++...++.+++|.+.... ....+.+|+.+++.++|+|++++++.+..+ ..+++|||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~ 79 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMEL 79 (254)
T ss_pred HHceeeeeeccCCCCceEecccCCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEEC
Confidence 478999999999999999998889999999875432 125788899999999999999999988665 46899999
Q ss_pred CCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCc
Q 020888 122 LRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 199 (320)
Q Consensus 122 ~~~~~L~~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~ 199 (320)
+++++|.+++.... .+++..++.++.|++.||.+||+.| ++||||+|+||++ +.++.++|+|||.+.......
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--~~H~dl~p~nili--~~~~~~kl~Dfg~~~~~~~~~- 154 (254)
T cd05083 80 MSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK--LVHRDLAARNILV--SEDGVAKVSDFGLARVGSMGV- 154 (254)
T ss_pred CCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEE--cCCCcEEECCCccceeccccC-
Confidence 99999999997643 5799999999999999999999988 9999999999999 888899999999886543211
Q ss_pred cceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHH
Q 020888 200 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 278 (320)
Q Consensus 200 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 278 (320)
.....+..|.|||.+.+..++.++|+||||++++++++ |..||...+..+....+..+.... ....++.+++
T Consensus 155 ------~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 227 (254)
T cd05083 155 ------DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRME-PPEGCPADVY 227 (254)
T ss_pred ------CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCC-CCCcCCHHHH
Confidence 11223567999999988899999999999999999998 999999888777776666654433 2345799999
Q ss_pred HHHHHHhhcCCCCCCCHHHHHHHHHH
Q 020888 279 ELTEKCWAADMNQRPSFLDILKRLEK 304 (320)
Q Consensus 279 ~li~~~l~~dp~~Rps~~~ll~~L~~ 304 (320)
+++.+||+.+|+.||++++++..|++
T Consensus 228 ~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 228 VLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred HHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 99999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=314.88 Aligned_cols=255 Identities=27% Similarity=0.476 Sum_probs=203.7
Q ss_pred CCCcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEe--CCc
Q 020888 39 PSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE--RKP 114 (320)
Q Consensus 39 ~~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~ 114 (320)
....+|.+++.||.|+||+||++.+. +..+++|.+........ ....+..|+.+++.++|+||+++++++.. ...
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~-~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKER-EKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHH-HHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 33458999999999999999999986 67789998865443332 34678899999999999999999998854 456
Q ss_pred eEEEEecCCCCCHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHhcCC-----CCeEecCCCCCcEEEeeC-------
Q 020888 115 LMLITEYLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLHNEP-----NVIIHRDLKPRNVLLVNS------- 178 (320)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~~l~~~l~~lH~~g-----~~ivH~di~p~nI~~~~~------- 178 (320)
+|+||||+++++|.+++.. .+.+++..++.|+.||+.||.|||+.+ ..|+|+||||+|||+..+
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 8999999999999999875 357999999999999999999999843 239999999999999421
Q ss_pred --------CCCcEEEecCCCcccccccCccceeeccCCcccccccCccccCc--CCCCCchhHHHHHHHHHHHHhCCCCC
Q 020888 179 --------SADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH--RKYDKKVDVFSFAMILYEMLEGEPPL 248 (320)
Q Consensus 179 --------~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~ll~g~~p~ 248 (320)
..+.++|+|||++..+.... ......+++.|+|||++.+ ..++.++|||||||++|+|++|..||
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s-----~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF 243 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIES-----MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243 (1021)
T ss_pred cccccccCCCCceEEccCCccccccccc-----cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCC
Confidence 23458999999987654321 1223468999999999864 45889999999999999999999999
Q ss_pred CCCChHHHH-HHHHhCCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 249 ANYEPYEAA-KYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 249 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
......... ..+.... .......+.++.+||..||..+|.+|||+.+++.+
T Consensus 244 ~~~~~~~qli~~lk~~p--~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 244 HKANNFSQLISELKRGP--DLPIKGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred CcCCcHHHHHHHHhcCC--CCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 876544333 3333222 22234578999999999999999999999999864
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=289.57 Aligned_cols=258 Identities=29% Similarity=0.542 Sum_probs=205.9
Q ss_pred cccCccceecccCceEEEEEEE-------CCCceEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcccceeeeEEe-C
Q 020888 42 LDFSSSAIIGKGSFGEILKAYW-------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTE-R 112 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~-------~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-~ 112 (320)
.+|.+.+.||.|+||.||++.+ .++.||+|.+..... ......+.+|+.++.++ +|+||+++++++.. +
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC--hHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 4799999999999999999974 257899998865432 22346788899999999 68999999998754 4
Q ss_pred CceEEEEecCCCCCHHHHHHHh----------------------------------------------------------
Q 020888 113 KPLMLITEYLRGGDLHKYLKEK---------------------------------------------------------- 134 (320)
Q Consensus 113 ~~~~iv~e~~~~~~L~~~~~~~---------------------------------------------------------- 134 (320)
...+++|||+++++|.+++...
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 5679999999999999998642
Q ss_pred ---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCccceeec
Q 020888 135 ---------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKM 205 (320)
Q Consensus 135 ---------~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~~~~~~ 205 (320)
..+++..+..++.|++.||.|||++| ++|+||||+||++ +.++.++|+|||++........ ....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp~Nil~--~~~~~~kl~dfg~~~~~~~~~~--~~~~ 238 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK--CIHRDLAARNILL--SENNVVKICDFGLARDIYKDPD--YVRK 238 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCccCeEEE--cCCCcEEEEecccccccccCcc--hhhc
Confidence 13677888999999999999999998 9999999999999 7888999999999876532211 1111
Q ss_pred cCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHH-HHHHHHhCCCCCCCCCCCCHHHHHHHHH
Q 020888 206 TGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYE-AAKYVAEGHRPFFRAKGFTPELRELTEK 283 (320)
Q Consensus 206 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~ 283 (320)
....++..|+|||.+.+..++.++|+||||++++++++ |..||....... ....+..+... ..+...++++.+++..
T Consensus 239 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 317 (343)
T cd05103 239 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM-RAPDYTTPEMYQTMLD 317 (343)
T ss_pred CCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCC-CCCCCCCHHHHHHHHH
Confidence 22234567999999988899999999999999999997 999998765433 23333333322 2233468899999999
Q ss_pred HhhcCCCCCCCHHHHHHHHHHHHhc
Q 020888 284 CWAADMNQRPSFLDILKRLEKIKET 308 (320)
Q Consensus 284 ~l~~dp~~Rps~~~ll~~L~~~~~~ 308 (320)
||..||.+|||+.+++++|+.+...
T Consensus 318 cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 318 CWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred HccCChhhCcCHHHHHHHHHHHHhc
Confidence 9999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=281.91 Aligned_cols=249 Identities=29% Similarity=0.455 Sum_probs=206.6
Q ss_pred cccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEE
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 119 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 119 (320)
..|++.+.||.|++|.||++.+. +..+++|.+... .....+.+.+|+++++.++|+|++++++.+..+..+++||
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 88 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMI 88 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEE
Confidence 46999999999999999999885 688999987543 2334577888999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccC
Q 020888 120 EYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 198 (320)
Q Consensus 120 e~~~~~~L~~~~~~-~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~ 198 (320)
||+++++|..++.+ ...+++..++.++.|++.+|.+||+.| ++|+||+|+||++ +.++.++|+|||.+.......
T Consensus 89 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nili--~~~~~~kl~dfg~~~~~~~~~ 164 (292)
T cd06644 89 EFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK--IIHRDLKAGNVLL--TLDGDIKLADFGVSAKNVKTL 164 (292)
T ss_pred ecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC--eeecCCCcceEEE--cCCCCEEEccCccceeccccc
Confidence 99999999988754 456899999999999999999999988 9999999999999 788899999999876543221
Q ss_pred ccceeeccCCcccccccCccccC-----cCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCC-CCCCCC
Q 020888 199 SHDVYKMTGETGSYRYMAPEVFK-----HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRP-FFRAKG 272 (320)
Q Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~ 272 (320)
. ......+++.|+|||.+. ...++.++|+||||+++|++++|..||...+.......+.....+ ...+..
T Consensus 165 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (292)
T cd06644 165 Q----RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSK 240 (292)
T ss_pred c----ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcc
Confidence 1 112234678899999885 344678999999999999999999999887766555444443332 223356
Q ss_pred CCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 273 FTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 273 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
++.++.+++.+||..+|++||++++++++
T Consensus 241 ~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 241 WSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred cCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 78899999999999999999999999875
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=296.07 Aligned_cols=245 Identities=24% Similarity=0.385 Sum_probs=199.1
Q ss_pred cccCccceecccCceEEEEEEEC----CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEE
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLML 117 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~----~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 117 (320)
.+|.+++.||.|++|.||++... +..+++|.+... ....+|+++++.++|+||+++++.+......++
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 163 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------KTPGREIDILKTISHRAIINLIHAYRWKSTVCM 163 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence 36999999999999999998754 467888876432 234579999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccccccc
Q 020888 118 ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 197 (320)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~ 197 (320)
+||++. ++|.+++...+.+++..++.++.||+.||.|||++| |+|+||||+||++ +.++.++|+|||++......
T Consensus 164 v~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~g--ivHrDlkp~Nill--~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 164 VMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRG--IIHRDVKTENIFL--DEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred EehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEE--cCCCCEEEccCccccccCcc
Confidence 999995 589999977778999999999999999999999998 9999999999999 88899999999998765443
Q ss_pred CccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHh------------
Q 020888 198 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPY---EAAKYVAE------------ 262 (320)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~---~~~~~~~~------------ 262 (320)
... .......+++.|+|||++.+..++.++|||||||++|+|++|..||...... .....+.+
T Consensus 239 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~ 316 (392)
T PHA03207 239 PDT--PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQN 316 (392)
T ss_pred ccc--ccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCc
Confidence 211 1122456899999999999999999999999999999999999999654321 11111110
Q ss_pred --------------CCCCC------CCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 263 --------------GHRPF------FRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 263 --------------~~~~~------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
...+. .....++.+++++|++||..||++|||+.+++.+
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 317 GSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred cchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000 0112457789999999999999999999999987
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=281.15 Aligned_cols=247 Identities=30% Similarity=0.554 Sum_probs=208.3
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEe
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 120 (320)
+|...+.||.|++|.||++.+. ++.+++|.+...... .....+.+|++++++++|+|++++++.+..++.+++++|
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE--AIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICME 79 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccCh--HHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEE
Confidence 5788899999999999999986 788999988654332 344778899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccC
Q 020888 121 YLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHN-EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 198 (320)
Q Consensus 121 ~~~~~~L~~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~-~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~ 198 (320)
|+++++|.+++... ..+++..+..++.|++.+|.+||+ .| ++|+||+|+||++ +.++.++|+|||.+.......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~--i~H~dl~~~ni~~--~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 80 YMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK--IIHRDVKPSNILV--NSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred ecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCC--eecCCCCHHHEEE--CCCCCEEEeecccchhhHHHH
Confidence 99989999999875 678999999999999999999999 89 9999999999999 788899999999887654322
Q ss_pred ccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHhCCCCCCCCCCC
Q 020888 199 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYE-----PYEAAKYVAEGHRPFFRAKGF 273 (320)
Q Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~-----~~~~~~~~~~~~~~~~~~~~~ 273 (320)
.. ...++..|+|||...+..++.++|+||||++++++++|..||...+ ..+....+.....+......+
T Consensus 156 ~~------~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (265)
T cd06605 156 AK------TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKF 229 (265)
T ss_pred hh------cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhc
Confidence 11 1456788999999999999999999999999999999999997652 223333333433333333337
Q ss_pred CHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 274 TPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 274 ~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
+.+++++|.+||..+|++|||+.+++.+
T Consensus 230 ~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 230 SPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred CHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 8999999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=291.06 Aligned_cols=248 Identities=29% Similarity=0.483 Sum_probs=219.8
Q ss_pred ccCccceecccCceEEEEEEE--CCCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEe
Q 020888 43 DFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~--~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 120 (320)
-|.+.+-||+|.|..|-++++ +|..||||++.+........ ..+.+|++.++-++||||++++++......+|+|.|
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st-~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLST-GHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhh-hHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 588999999999999998886 69999999998877665544 567789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCc
Q 020888 121 YLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 199 (320)
Q Consensus 121 ~~~~~~L~~~~~~-~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~ 199 (320)
.-++|+|.||+-. ...+.+....+++.||+.|+.|||+.. +||+|+||+||.+. .+-|-|||.|||++-.+.++.
T Consensus 98 LGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLH--VVHRDLKPENVVFF-EKlGlVKLTDFGFSNkf~PG~- 173 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLH--VVHRDLKPENVVFF-EKLGLVKLTDFGFSNKFQPGK- 173 (864)
T ss_pred ecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhh--hhcccCCcceeEEe-eecCceEeeeccccccCCCcc-
Confidence 9989999999854 346999999999999999999999998 99999999999875 567899999999998776554
Q ss_pred cceeeccCCcccccccCccccCcCCCC-CchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHH
Q 020888 200 HDVYKMTGETGSYRYMAPEVFKHRKYD-KKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 278 (320)
Q Consensus 200 ~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 278 (320)
.....+|+..|.|||++.|..|+ ++.||||||++||+|++|+.||+..+..+..-.+...+... +..++.+++
T Consensus 174 ----kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtv--PshvS~eCr 247 (864)
T KOG4717|consen 174 ----KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTV--PSHVSKECR 247 (864)
T ss_pred ----hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccC--chhhhHHHH
Confidence 45668999999999999999997 68999999999999999999999988888877777766433 455899999
Q ss_pred HHHHHHhhcCCCCCCCHHHHHHH
Q 020888 279 ELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 279 ~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
++|..||..||.+|.|.+++...
T Consensus 248 dLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 248 DLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred HHHHHHHhcCchhhccHHHHhcc
Confidence 99999999999999999998654
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=298.85 Aligned_cols=245 Identities=32% Similarity=0.528 Sum_probs=217.6
Q ss_pred ccceecccCceEEEEEEECCCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEecCCCC
Q 020888 46 SSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGG 125 (320)
Q Consensus 46 ~~~~lg~g~~~~vy~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~ 125 (320)
-++-||.|++|.||+++..++.||||.+. +.-.-+|+.|++|+|+||+.+.++|.....++||||||..|
T Consensus 128 ELeWlGSGaQGAVF~Grl~netVAVKKV~----------elkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~G 197 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRLHNETVAVKKVR----------ELKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQG 197 (904)
T ss_pred hhhhhccCcccceeeeeccCceehhHHHh----------hhhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccc
Confidence 35568999999999999999999999663 22334789999999999999999999999999999999999
Q ss_pred CHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCccceeec
Q 020888 126 DLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKM 205 (320)
Q Consensus 126 ~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~~~~~~ 205 (320)
.|.+.++...++.......|..+|+.|+.|||.+. |+|+|||.-||+| .-+.-|||+|||-+.....- ...
T Consensus 198 qL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hK--IIHRDLKSPNiLI--s~~d~VKIsDFGTS~e~~~~-----STk 268 (904)
T KOG4721|consen 198 QLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHK--IIHRDLKSPNILI--SYDDVVKISDFGTSKELSDK-----STK 268 (904)
T ss_pred cHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhh--HhhhccCCCceEe--eccceEEeccccchHhhhhh-----hhh
Confidence 99999999888999999999999999999999987 9999999999999 77778999999977655432 123
Q ss_pred cCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHh
Q 020888 206 TGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCW 285 (320)
Q Consensus 206 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 285 (320)
...+||..|+|||++.....+++.||||+|++|+||+||..||.+.+...++..+-.+.....-+..+|+.++-|+++||
T Consensus 269 MSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw 348 (904)
T KOG4721|consen 269 MSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCW 348 (904)
T ss_pred hhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHHHH
Confidence 45689999999999999999999999999999999999999999998877777666666666667789999999999999
Q ss_pred hcCCCCCCCHHHHHHHHHHHHhcC
Q 020888 286 AADMNQRPSFLDILKRLEKIKETL 309 (320)
Q Consensus 286 ~~dp~~Rps~~~ll~~L~~~~~~~ 309 (320)
+..|.+|||+.+++.||+-+...+
T Consensus 349 ~sKpRNRPSFrqil~HldIa~pel 372 (904)
T KOG4721|consen 349 NSKPRNRPSFRQILLHLDIASPEL 372 (904)
T ss_pred hcCCCCCccHHHHHHHHhhcCHHH
Confidence 999999999999999998665443
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=278.03 Aligned_cols=249 Identities=29% Similarity=0.513 Sum_probs=209.7
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEE--eCCceEEE
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVT--ERKPLMLI 118 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~iv 118 (320)
+|++.+.||.|++|.||++.+. ++.+++|.+...... ....+.+.+|+++++.++|+|++++++.+. .+...+++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMT-EKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 4888999999999999999875 678999987654433 333477889999999999999999999775 34567999
Q ss_pred EecCCCCCHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHh-----cCCCCeEecCCCCCcEEEeeCCCCcEEEecCC
Q 020888 119 TEYLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLH-----NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFG 189 (320)
Q Consensus 119 ~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~~l~~~l~~lH-----~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg 189 (320)
+||+++++|.+++.. ..++++..++.++.|++.||.+|| +.+ ++|+||+|+||++ +.++.++|+|||
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~--i~h~dl~p~nili--~~~~~~kl~d~g 155 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT--VLHRDLKPANIFL--DANNNVKLGDFG 155 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc--ceecCCCHHHEEE--ecCCCEEEeccc
Confidence 999999999999875 357899999999999999999999 777 9999999999999 788999999999
Q ss_pred CcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCC
Q 020888 190 LSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR 269 (320)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 269 (320)
++........ ......+++.|+|||.+.+..++.++|+||||++++++++|..||...+.......+.....+. .
T Consensus 156 ~~~~~~~~~~----~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~ 230 (265)
T cd08217 156 LAKILGHDSS----FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRR-I 230 (265)
T ss_pred ccccccCCcc----cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCC-C
Confidence 9887654321 1223457889999999998889999999999999999999999999887666666555554433 3
Q ss_pred CCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 270 AKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 270 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
+..++.++.+++.+|+..+|.+|||+++++++
T Consensus 231 ~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 231 PYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 44578999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=278.05 Aligned_cols=249 Identities=29% Similarity=0.533 Sum_probs=213.6
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEe
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 120 (320)
+|.+.+.||.|++|.||++.+. ++.+++|.+...... .....+.+|++.++.++|+|++++++.+..++.+++++|
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE 79 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEE
Confidence 6888899999999999999986 788999988654332 344788999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCc
Q 020888 121 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHN-EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 199 (320)
Q Consensus 121 ~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~-~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~ 199 (320)
|+++++|.+++.....+++..++.++.|++.++.+||+ .| ++|+||+|+||++ +.++.++|+|||.+........
T Consensus 80 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~--~~H~~l~~~ni~~--~~~~~~~l~df~~~~~~~~~~~ 155 (264)
T cd06623 80 YMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH--IIHRDIKPSNLLI--NSKGEVKIADFGISKVLENTLD 155 (264)
T ss_pred ecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCC--CccCCCCHHHEEE--CCCCCEEEccCccceecccCCC
Confidence 99999999999887889999999999999999999999 99 9999999999999 8889999999999876644322
Q ss_pred cceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCC---ChHHHHHHHHhCCCCCCCCCCCCHH
Q 020888 200 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANY---EPYEAAKYVAEGHRPFFRAKGFTPE 276 (320)
Q Consensus 200 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (320)
.. ....++..|.|||...+..++.++|+||||+++|++++|..||... ...+....+.....+......++..
T Consensus 156 ~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (264)
T cd06623 156 QC----NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPE 231 (264)
T ss_pred cc----cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHH
Confidence 11 1234678899999999989999999999999999999999999877 3444555555444444433337999
Q ss_pred HHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 277 LRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 277 l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
+.+++.+||..+|.+|||+.+++++
T Consensus 232 l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 232 FRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred HHHHHHHHccCChhhCCCHHHHHhC
Confidence 9999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=286.29 Aligned_cols=253 Identities=27% Similarity=0.490 Sum_probs=210.3
Q ss_pred CCCCCcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCc
Q 020888 37 IDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP 114 (320)
Q Consensus 37 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 114 (320)
......+|++.+.||.|++|.||++.+. ++.+++|.+....... .+.+.+|+.+++.++|+|++++++.+..++.
T Consensus 14 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~ 90 (297)
T cd06656 14 VGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDE 90 (297)
T ss_pred cCChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccch---HHHHHHHHHHHHhCCCCCEeeEEEEEecCCE
Confidence 3445578999999999999999999874 7899999886443322 2667889999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccc
Q 020888 115 LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 194 (320)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~ 194 (320)
.++||||+++++|.+++.+ ..+++..+..++.|++.+|.+||+.| ++|+||+|+||++ +.++.++|+|||.+...
T Consensus 91 ~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~--i~H~dL~p~Nili--~~~~~~~l~Dfg~~~~~ 165 (297)
T cd06656 91 LWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQ--VIHRDIKSDNILL--GMDGSVKLTDFGFCAQI 165 (297)
T ss_pred EEEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEE--CCCCCEEECcCccceEc
Confidence 9999999999999999876 46899999999999999999999998 9999999999999 88889999999988765
Q ss_pred cccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCC-CCCCCCCCC
Q 020888 195 KVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH-RPFFRAKGF 273 (320)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~ 273 (320)
..... ......+++.|+|||...+..++.++|+||||+++|++++|..||...+............ .....+..+
T Consensus 166 ~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (297)
T cd06656 166 TPEQS----KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERL 241 (297)
T ss_pred cCCcc----CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCcccc
Confidence 33221 1223457888999999999889999999999999999999999997765543322222222 222234557
Q ss_pred CHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 274 TPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 274 ~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
+..+++++.+||..+|++||++++++++
T Consensus 242 ~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 242 SAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 8999999999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=281.07 Aligned_cols=251 Identities=29% Similarity=0.523 Sum_probs=206.2
Q ss_pred CCCcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcccceeeeEEeCC--
Q 020888 39 PSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERK-- 113 (320)
Q Consensus 39 ~~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~-- 113 (320)
....+|++.+.||.|++|.||++.++ ++.+++|.+..... ....+.+|+.+++++ .|+|++++++++....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 78 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED----EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPP 78 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch----hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCC
Confidence 34578999999999999999999985 67899998754432 236788999999999 6999999999986543
Q ss_pred ----ceEEEEecCCCCCHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEE
Q 020888 114 ----PLMLITEYLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKV 185 (320)
Q Consensus 114 ----~~~iv~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L 185 (320)
.+++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.| ++|+||+|+||++ +.++.++|
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~~l~p~ni~~--~~~~~~~l 154 (275)
T cd06608 79 GNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK--VIHRDIKGQNILL--TKNAEVKL 154 (275)
T ss_pred CcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEE--ccCCeEEE
Confidence 48999999999999998865 347899999999999999999999998 9999999999999 78889999
Q ss_pred ecCCCcccccccCccceeeccCCcccccccCccccCc-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 020888 186 GDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH-----RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYV 260 (320)
Q Consensus 186 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~ 260 (320)
+|||.+........ ......++..|+|||.+.+ ..++.++|+||||++++++++|..||...........+
T Consensus 155 ~d~~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~ 230 (275)
T cd06608 155 VDFGVSAQLDSTLG----RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKI 230 (275)
T ss_pred CCCccceecccchh----hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHh
Confidence 99998876543211 1223457888999998754 34678999999999999999999999877666555555
Q ss_pred HhCCCCCCCC-CCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 261 AEGHRPFFRA-KGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 261 ~~~~~~~~~~-~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
.......... ..++.++++++.+||..||++|||+++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 231 PRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred hccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 5544333322 3378899999999999999999999999864
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=279.70 Aligned_cols=257 Identities=30% Similarity=0.516 Sum_probs=202.4
Q ss_pred CcccCccceecccCceEEEEEEE------CCCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEE--eC
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVT--ER 112 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~------~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~ 112 (320)
...|.+.+.||+|+||.||++.. ++..+++|.+... .....+.+.+|+++++.++|+|++++++++. +.
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 79 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS---TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 79 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCC
Confidence 45788999999999999999874 2678999987543 2333467889999999999999999999764 34
Q ss_pred CceEEEEecCCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCc
Q 020888 113 KPLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 191 (320)
Q Consensus 113 ~~~~iv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~ 191 (320)
...++|+||+++++|.+++... ..+++..++.++.|++.||.|||+.| ++|+||||+||++ +.++.++|+|||++
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~--i~H~dlkp~nili--~~~~~~~l~dfg~~ 155 (284)
T cd05081 80 RNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR--YVHRDLATRNILV--ESENRVKIGDFGLT 155 (284)
T ss_pred CceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHhhEEE--CCCCeEEECCCccc
Confidence 5689999999999999999753 46899999999999999999999998 9999999999999 88889999999998
Q ss_pred ccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHH---------------H
Q 020888 192 KLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYE---------------A 256 (320)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~---------------~ 256 (320)
........... ......++..|+|||...+..++.++|+||||++++++++|..++....... .
T Consensus 156 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd05081 156 KVLPQDKEYYK-VREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYH 234 (284)
T ss_pred ccccCCCccee-ecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHH
Confidence 87643321111 0111223446999999998899999999999999999999877654322110 0
Q ss_pred HHHHHhCCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHH
Q 020888 257 AKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKI 305 (320)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~ 305 (320)
.............+..++.++.+++.+||..+|++|||++++++.|+.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 235 LIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 1111222222223355789999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=279.56 Aligned_cols=253 Identities=28% Similarity=0.486 Sum_probs=205.2
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCc-------HHHHHHHHHHHHHHHhCCCCcccceeeeEEeCC
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDD-------RLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK 113 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 113 (320)
+|.+.+.||.|++|.||++.+. ++.+++|.+....... ....+.+.+|+++++.++|+|++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 5788899999999999999864 7889999774321111 112356888999999999999999999999999
Q ss_pred ceEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccc
Q 020888 114 PLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 193 (320)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~ 193 (320)
..++|+||+++++|.+++...+.+++..+..++.|++.+|.+||+.| ++|+||+|+||++ +.++.++|+|||.+..
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~~~nil~--~~~~~~~l~d~~~~~~ 157 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKG--ILHRDLKADNLLV--DADGICKISDFGISKK 157 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC--eeecCCChhhEEE--cCCCeEEEeecccccc
Confidence 99999999999999999988788999999999999999999999988 9999999999999 8889999999999876
Q ss_pred ccccCccceeeccCCcccccccCccccCcCC--CCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCC-CC---C
Q 020888 194 IKVQNSHDVYKMTGETGSYRYMAPEVFKHRK--YDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH-RP---F 267 (320)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~-~~---~ 267 (320)
...... ........++..|+|||.+.+.. ++.++|+||||++++++++|..||...+............ .. .
T Consensus 158 ~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 235 (272)
T cd06629 158 SDDIYD--NDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPP 235 (272)
T ss_pred cccccc--ccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCc
Confidence 432211 11122345788899999987654 7899999999999999999999997665544333222221 11 1
Q ss_pred CCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 268 FRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 268 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
.....++.++++++.+||..+|.+|||+++++++
T Consensus 236 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 236 DVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred cccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 1123468999999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=282.60 Aligned_cols=250 Identities=24% Similarity=0.427 Sum_probs=203.6
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEe
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 120 (320)
+|++.+.||+|++|.||++.+. ++.+++|.+....... ...+.+.+|+++++.++|+|++++++++..+...++++|
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDP-VIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCc-cccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 6889999999999999999885 7889999886543222 122567789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCcc
Q 020888 121 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 200 (320)
Q Consensus 121 ~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~ 200 (320)
|+++++|..+......+++..++.++.|++.+|.|||+.| ++|+||+|+||++ +.++.++|+|||.+..+.....
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~--i~H~dl~p~nil~--~~~~~~~l~dfg~~~~~~~~~~- 155 (286)
T cd07847 81 YCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN--CIHRDVKPENILI--TKQGQIKLCDFGFARILTGPGD- 155 (286)
T ss_pred ccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCChhhEEE--cCCCcEEECccccceecCCCcc-
Confidence 9999888887776667999999999999999999999998 9999999999999 8888999999999887654321
Q ss_pred ceeeccCCcccccccCccccCc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCC--------------
Q 020888 201 DVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHR-------------- 265 (320)
Q Consensus 201 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~-------------- 265 (320)
......++..|+|||.+.+ ..++.++|+||||++++++++|..||......+....+.....
T Consensus 156 ---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07847 156 ---DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ 232 (286)
T ss_pred ---cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccc
Confidence 1122346778999999876 4578899999999999999999999987765544332221100
Q ss_pred -------CCC--------CCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 266 -------PFF--------RAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 266 -------~~~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
+.. ....++..+.+++.+||+.+|++|||+.+++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 000 012467889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=282.06 Aligned_cols=254 Identities=28% Similarity=0.466 Sum_probs=203.9
Q ss_pred cccCccceecccCceEEEEEEEC------------------CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCccc
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR------------------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 103 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~------------------~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~ 103 (320)
.+|++.+.||+|+||.||++.+. ...+++|.+.... .......+.+|+++++.++|+||+
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i~ 82 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNII 82 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcc
Confidence 46999999999999999998643 2358888875432 233346788999999999999999
Q ss_pred ceeeeEEeCCceEEEEecCCCCCHHHHHHHhC-----------CCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 020888 104 QFLGAVTERKPLMLITEYLRGGDLHKYLKEKG-----------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRN 172 (320)
Q Consensus 104 ~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~-----------~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~n 172 (320)
++++++..++..+++|||+++++|.+++.... .+++.+++.++.|++.||+|||+.| ++|+||||+|
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dlkp~N 160 (296)
T cd05095 83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN--FVHRDLATRN 160 (296)
T ss_pred eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--eecccCChhe
Confidence 99999999999999999999999999987532 3667889999999999999999998 9999999999
Q ss_pred EEEeeCCCCcEEEecCCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh--CCCCCCC
Q 020888 173 VLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE--GEPPLAN 250 (320)
Q Consensus 173 I~~~~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~--g~~p~~~ 250 (320)
|++ +.++.++|+|||++..+...... ........+..|++||...+..++.++|+||||+++|++++ |..||..
T Consensus 161 ili--~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~ 236 (296)
T cd05095 161 CLV--GKNYTIKIADFGMSRNLYSGDYY--RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQ 236 (296)
T ss_pred EEE--cCCCCEEeccCcccccccCCcce--eccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccc
Confidence 999 78889999999998765432211 11122234567999999888889999999999999999998 7789887
Q ss_pred CChHHHHHHHHh------CCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHH
Q 020888 251 YEPYEAAKYVAE------GHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLE 303 (320)
Q Consensus 251 ~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~ 303 (320)
....+....... .......+..++..+.+++.+||+.||.+|||+.++++.|+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 237 LSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred cChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 665554332211 01111223457899999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=305.21 Aligned_cols=259 Identities=34% Similarity=0.592 Sum_probs=227.8
Q ss_pred ccCccceecccCceEEEEEEEC-------CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCce
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL 115 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~-------~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 115 (320)
+-...+.||+|.||+||++.-. ...||||.++.... .+....|++|++++..++|+||++++|+|.+++..
T Consensus 487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~--~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAE--NQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccccc--HHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 4455678999999999998853 35699998765433 33558999999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHHhC--------------CCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCC
Q 020888 116 MLITEYLRGGDLHKYLKEKG--------------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD 181 (320)
Q Consensus 116 ~iv~e~~~~~~L~~~~~~~~--------------~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~ 181 (320)
+|||||+..|+|.+++...+ +++..+.+.|+.||+.|+.||.++. +||+||...|.+| +.+-
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~--FVHRDLATRNCLV--ge~l 640 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH--FVHRDLATRNCLV--GENL 640 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc--ccccchhhhhcee--ccce
Confidence 99999999999999997421 2788899999999999999999988 9999999999999 8899
Q ss_pred cEEEecCCCcccccccCccceeecc-CCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 020888 182 HLKVGDFGLSKLIKVQNSHDVYKMT-GETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKY 259 (320)
Q Consensus 182 ~~~L~dfg~~~~~~~~~~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~ 259 (320)
.|||+|||+++.+... ++|... ...-..+|+|||.+.-++++.+|||||+|++|+|+++ |..||.+....++...
T Consensus 641 ~VKIsDfGLsRdiYss---DYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~ 717 (774)
T KOG1026|consen 641 VVKISDFGLSRDIYSS---DYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIEC 717 (774)
T ss_pred EEEecccccchhhhhh---hhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHH
Confidence 9999999999988754 344444 3345668999999999999999999999999999999 9999999999999999
Q ss_pred HHhCCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcCCC
Q 020888 260 VAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPT 311 (320)
Q Consensus 260 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~ 311 (320)
+.++.. ...+..+|.++.+|+..||+.+|.+||++.+|-..|++.....+.
T Consensus 718 i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~~ 768 (774)
T KOG1026|consen 718 IRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASPK 768 (774)
T ss_pred HHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCcc
Confidence 999988 556677999999999999999999999999999999998776554
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=276.31 Aligned_cols=254 Identities=31% Similarity=0.548 Sum_probs=211.1
Q ss_pred cccCccceecccCceEEEEEEEC--CCceEEEEccCCC--CCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeC--Cce
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSL--SDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER--KPL 115 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~--~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 115 (320)
.+|.+.+.||+|++|.||++.+. +..+++|.+.... .........+.+|++++++++|+||+++++.+.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 36889999999999999999874 7889999875332 12234457889999999999999999999988653 458
Q ss_pred EEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccccc
Q 020888 116 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 195 (320)
Q Consensus 116 ~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~ 195 (320)
++++||+++++|.+++...+.+++..+..++.|++.||.+||+.| ++|+||+|+||++ +.++.++|+|||.+....
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~--i~H~dl~p~ni~i--~~~~~~~l~dfg~~~~~~ 157 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNM--IVHRDIKGANILR--DSAGNVKLGDFGASKRIQ 157 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEE--cCCCCEEECccccccccc
Confidence 899999999999999988778999999999999999999999998 9999999999999 788899999999988654
Q ss_pred ccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCH
Q 020888 196 VQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTP 275 (320)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (320)
...... .......++..|+|||.+.+..++.++|+||||++++++++|..||.....................+..+++
T Consensus 158 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~ 236 (264)
T cd06653 158 TICMSG-TGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSD 236 (264)
T ss_pred cccccC-ccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCH
Confidence 321111 1112345788899999999888999999999999999999999999887766665555544444555667899
Q ss_pred HHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 276 ELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 276 ~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
++.+++.+|+. ++..||++.+++.+
T Consensus 237 ~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 237 ACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred HHHHHHHHHhc-CcccCccHHHHhcC
Confidence 99999999999 57999999998865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=281.53 Aligned_cols=248 Identities=28% Similarity=0.478 Sum_probs=209.0
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEe
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 120 (320)
+|.+.+.||.|++|.||++.+. +..+++|.+... .......+.+|++++++++|+|++++++.+..+...++|||
T Consensus 6 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd06611 6 IWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE 82 (280)
T ss_pred HHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence 5999999999999999999875 788999987532 33344678889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCc
Q 020888 121 YLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 199 (320)
Q Consensus 121 ~~~~~~L~~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~ 199 (320)
|+++++|.+++... ..+++..+..++.|++.+|.|||+.| ++|+||+|+||++ +.++.++|+|||.+........
T Consensus 83 ~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~nili--~~~~~~~l~d~g~~~~~~~~~~ 158 (280)
T cd06611 83 FCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK--VIHRDLKAGNILL--TLDGDVKLADFGVSAKNKSTLQ 158 (280)
T ss_pred ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEE--CCCCCEEEccCccchhhccccc
Confidence 99999999998763 46999999999999999999999998 9999999999999 8889999999998765533221
Q ss_pred cceeeccCCcccccccCccccC-----cCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCC-CCCCC
Q 020888 200 HDVYKMTGETGSYRYMAPEVFK-----HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFF-RAKGF 273 (320)
Q Consensus 200 ~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~ 273 (320)
......+++.|.|||... +..++.++|+||||+++|++++|..||...+.......+.....+.. .+..+
T Consensus 159 ----~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (280)
T cd06611 159 ----KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKW 234 (280)
T ss_pred ----ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccC
Confidence 112235788899999874 34467899999999999999999999998877666555555443322 23467
Q ss_pred CHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 274 TPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 274 ~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
+.++.+++..||..+|.+||++++++++
T Consensus 235 ~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 235 SSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred CHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 8999999999999999999999999887
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=277.43 Aligned_cols=248 Identities=29% Similarity=0.537 Sum_probs=208.7
Q ss_pred CcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEE
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 118 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 118 (320)
..+|++.+.||.|++|.||++.+. ++.+++|.+..... .+.+.+|+++++.++|+|++++++.+..+...|++
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~ 76 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIV 76 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEE
Confidence 357999999999999999999986 68899998754321 47899999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccccccc
Q 020888 119 TEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 197 (320)
Q Consensus 119 ~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~ 197 (320)
+||+++++|.+++.. ...+++..++.++.|++.||.+||+.| ++|+||+|+||++ +.++.++|+|||.+..+...
T Consensus 77 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~ni~~--~~~~~~~l~dfg~~~~~~~~ 152 (256)
T cd06612 77 MEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK--KIHRDIKAGNILL--NEEGQAKLADFGVSGQLTDT 152 (256)
T ss_pred EecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEE--CCCCcEEEcccccchhcccC
Confidence 999999999999975 456899999999999999999999988 9999999999999 88889999999998876543
Q ss_pred CccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCC-CCCCCCHH
Q 020888 198 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFF-RAKGFTPE 276 (320)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 276 (320)
.. ......++..|+|||.+.+..++.++|+||+|++++++++|..||...........+........ .+..++.+
T Consensus 153 ~~----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (256)
T cd06612 153 MA----KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPE 228 (256)
T ss_pred cc----ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHH
Confidence 21 11223467889999999999999999999999999999999999987766544433332222221 12346789
Q ss_pred HHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 277 LRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 277 l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
+.+++.+||+.+|.+|||+.+++++
T Consensus 229 ~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 229 FNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred HHHHHHHHHhcChhhCcCHHHHhcC
Confidence 9999999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-41 Score=297.68 Aligned_cols=257 Identities=31% Similarity=0.565 Sum_probs=222.0
Q ss_pred cCCCCCcccCccceecccCceEEEEEEEC--CCceEEEEcc-CCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeC
Q 020888 36 EIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRIL-PSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER 112 (320)
Q Consensus 36 ~~~~~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~-~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 112 (320)
+.++.++-.....+||+|+|-+||++.++ |..||.-.+. .........++++..|+++|+.|+|+||+++++.+.+.
T Consensus 34 e~~p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~ 113 (632)
T KOG0584|consen 34 EKDPTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDT 113 (632)
T ss_pred ccCCCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecC
Confidence 45666665566789999999999999986 5555543322 22334455678999999999999999999999999776
Q ss_pred Cc--eEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCC
Q 020888 113 KP--LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGL 190 (320)
Q Consensus 113 ~~--~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~ 190 (320)
.. .-+|+|.+..|+|..|+++.++++...+..|++||+.||.|||++.++|+|+|||.+||||+ +..|.|||+|+|+
T Consensus 114 ~n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFin-G~~G~VKIGDLGL 192 (632)
T KOG0584|consen 114 DNKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVN-GNLGEVKIGDLGL 192 (632)
T ss_pred CCceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEc-CCcCceeecchhH
Confidence 55 78899999999999999999999999999999999999999999999999999999999985 6788999999999
Q ss_pred cccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHHhCCCCCCC
Q 020888 191 SKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLAN-YEPYEAAKYVAEGHRPFFR 269 (320)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~-~~~~~~~~~~~~~~~~~~~ 269 (320)
|.....+.. -...|||.|+|||.+. ..|++..||||||+||+||+|+..||.. .++...++.+..+..|...
T Consensus 193 Atl~r~s~a------ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl 265 (632)
T KOG0584|consen 193 ATLLRKSHA------KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAAL 265 (632)
T ss_pred HHHhhcccc------ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHh
Confidence 987754321 2257999999999987 8899999999999999999999999976 6788899999999988777
Q ss_pred CCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 270 AKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 270 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
..--++++++||..||.. ..+|+|+.+||++
T Consensus 266 ~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 266 SKVKDPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred hccCCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 765689999999999999 8999999999976
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=273.26 Aligned_cols=247 Identities=30% Similarity=0.561 Sum_probs=205.7
Q ss_pred ceecccCceEEEEEEEC-CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEecCCCCC
Q 020888 48 AIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGD 126 (320)
Q Consensus 48 ~~lg~g~~~~vy~~~~~-~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~ 126 (320)
++||.|++|.||++.+. ++.+++|.+...... .....+.+|++++++++|++|+++++++......++|+||+++++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 78 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGS 78 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCc
Confidence 46899999999999986 789999987654332 344788999999999999999999999999999999999999999
Q ss_pred HHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCccceeec
Q 020888 127 LHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKM 205 (320)
Q Consensus 127 L~~~~~~-~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~~~~~~ 205 (320)
|.+++.. ...+++..+..++.+++.+|.+||++| ++|+||+|+||++ +.++.++|+|||.+........ ....
T Consensus 79 l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~--i~h~di~p~nili--~~~~~~~l~d~g~~~~~~~~~~--~~~~ 152 (251)
T cd05041 79 LLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN--CIHRDLAARNCLV--GENNVLKISDFGMSREEEGGIY--TVSD 152 (251)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EehhhcCcceEEE--cCCCcEEEeeccccccccCCcc--eecc
Confidence 9999865 346899999999999999999999988 9999999999999 8888999999999875532110 0001
Q ss_pred cCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHH
Q 020888 206 TGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKC 284 (320)
Q Consensus 206 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 284 (320)
.....+..|+|||.+.+..++.++|+||||+++|++++ |..||...........+...... ..+..++.++.+++.+|
T Consensus 153 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~ 231 (251)
T cd05041 153 GLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRM-PAPQLCPEEIYRLMLQC 231 (251)
T ss_pred ccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCC-CCCccCCHHHHHHHHHH
Confidence 11223556999999998899999999999999999999 88999887766665555544322 23455789999999999
Q ss_pred hhcCCCCCCCHHHHHHHHH
Q 020888 285 WAADMNQRPSFLDILKRLE 303 (320)
Q Consensus 285 l~~dp~~Rps~~~ll~~L~ 303 (320)
|..+|.+|||+.++++.|+
T Consensus 232 l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 232 WAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred hccChhhCcCHHHHHHHhh
Confidence 9999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=281.13 Aligned_cols=249 Identities=28% Similarity=0.418 Sum_probs=199.3
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEe
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 120 (320)
+|++.+.||+|++|.||++.+. +..+++|.+....... .....+.+|+.+++.++|+|++++++++..++..++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEE-GVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccC-CchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 4888999999999999999875 7889999886543222 122567889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccccccc
Q 020888 121 YLRGGDLHKYLKEK---GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 197 (320)
Q Consensus 121 ~~~~~~L~~~~~~~---~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~ 197 (320)
|++ ++|.+++... ..+++..++.++.|++.||.|||+.| ++|+||+|+||++ +.++.++|+|||++......
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~--~~~~~~~l~dfg~~~~~~~~ 154 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR--VLHRDLKPQNLLI--DNKGVIKLADFGLARAFGIP 154 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEE--cCCCcEEECcccceeecCCC
Confidence 997 5898888642 46899999999999999999999998 9999999999999 88899999999998754322
Q ss_pred CccceeeccCCcccccccCccccCcC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCC------------
Q 020888 198 NSHDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH------------ 264 (320)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~------------ 264 (320)
. .......+++.|+|||.+.+. .++.++|+||||++++++++|+.||......+.........
T Consensus 155 ~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (285)
T cd07861 155 V----RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVT 230 (285)
T ss_pred c----ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcch
Confidence 1 111223567889999988654 47889999999999999999999998665433222111100
Q ss_pred ---------------CCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 265 ---------------RPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 265 ---------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
........++++++++|++||..||.+|||+.+++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 231 SLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred hhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0000113468899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=300.16 Aligned_cols=255 Identities=19% Similarity=0.282 Sum_probs=195.9
Q ss_pred CCCcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCC------CCcccceeeeEE
Q 020888 39 PSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR------HPNIVQFLGAVT 110 (320)
Q Consensus 39 ~~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~ 110 (320)
....+|.+.+.||+|+||+||++.+. ++.||+|++.... ........|+.++..+. |.+++++++++.
T Consensus 126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred cCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 34568999999999999999999875 7789999885321 11234556677766664 445888888886
Q ss_pred eC-CceEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCcEEEeeCCCC-------
Q 020888 111 ER-KPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHN-EPNVIIHRDLKPRNVLLVNSSAD------- 181 (320)
Q Consensus 111 ~~-~~~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~-~g~~ivH~di~p~nI~~~~~~~~------- 181 (320)
.+ ..+++||+++ |++|.+++...+.+++..+..++.||+.||.|||. .| |+|+||||+||++ +.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~g--IiHrDlKP~NILl--~~~~~~~~~~~ 276 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELH--LMHTDLKPENILM--ETSDTVVDPVT 276 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEE--ecCCccccccc
Confidence 54 5689999988 77999999887889999999999999999999997 58 9999999999999 4433
Q ss_pred ---------cEEEecCCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 020888 182 ---------HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYE 252 (320)
Q Consensus 182 ---------~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~ 252 (320)
.++|+|||.+..... ......+|+.|+|||++.+..++.++|||||||++|+|++|+.||...+
T Consensus 277 ~~~~~~~~~~vkl~DfG~~~~~~~-------~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~ 349 (467)
T PTZ00284 277 NRALPPDPCRVRICDLGGCCDERH-------SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHD 349 (467)
T ss_pred ccccCCCCceEEECCCCccccCcc-------ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 599999998754321 1234568999999999999999999999999999999999999998776
Q ss_pred hHHHHHHHHhCCC--------------------------CCCC--------------CCCCCHHHHHHHHHHhhcCCCCC
Q 020888 253 PYEAAKYVAEGHR--------------------------PFFR--------------AKGFTPELRELTEKCWAADMNQR 292 (320)
Q Consensus 253 ~~~~~~~~~~~~~--------------------------~~~~--------------~~~~~~~l~~li~~~l~~dp~~R 292 (320)
..+....+..... +... ....++.+.+||..||..||++|
T Consensus 350 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R 429 (467)
T PTZ00284 350 NLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKR 429 (467)
T ss_pred hHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhC
Confidence 5544333222110 0000 00114567899999999999999
Q ss_pred CCHHHHHHH--HHHHHhcC
Q 020888 293 PSFLDILKR--LEKIKETL 309 (320)
Q Consensus 293 ps~~~ll~~--L~~~~~~~ 309 (320)
||++|+++| +.+.....
T Consensus 430 ~ta~e~L~Hp~~~~~~~~~ 448 (467)
T PTZ00284 430 LNARQMTTHPYVLKYYPEC 448 (467)
T ss_pred CCHHHHhcCccccccCCcc
Confidence 999999986 55444333
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=281.76 Aligned_cols=247 Identities=33% Similarity=0.528 Sum_probs=208.3
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEe
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 120 (320)
.|+..+.||.|++|.||++.+. +..+++|.+..... ....+.+.+|+++++.++|+|++++++.+..++..++|+|
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc--hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence 5778899999999999999875 67899998754332 2334788999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCcc
Q 020888 121 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 200 (320)
Q Consensus 121 ~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~ 200 (320)
|+++++|.+++.. +.+++..+..++.+++.|+.|||+.| ++|+||+|+||++ +.++.++|+|||++..+.....
T Consensus 83 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--ivH~dl~p~ni~i--~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06642 83 YLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSER--KIHRDIKAANVLL--SEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred ccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCC--eeccCCChheEEE--eCCCCEEEccccccccccCcch-
Confidence 9999999998875 46899999999999999999999988 9999999999999 7788999999999876543221
Q ss_pred ceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHH
Q 020888 201 DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELREL 280 (320)
Q Consensus 201 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 280 (320)
......++..|+|||.+.+..++.++|+||||++++++++|..||...........+.....+. ....++.++.++
T Consensus 157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l 232 (277)
T cd06642 157 ---KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPT-LEGQYSKPFKEF 232 (277)
T ss_pred ---hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCC-CCcccCHHHHHH
Confidence 1122356788999999999899999999999999999999999998776655554444443332 234578899999
Q ss_pred HHHHhhcCCCCCCCHHHHHHH
Q 020888 281 TEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 281 i~~~l~~dp~~Rps~~~ll~~ 301 (320)
+.+||..+|.+|||+.+++++
T Consensus 233 i~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 233 VEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred HHHHccCCcccCcCHHHHHHh
Confidence 999999999999999999985
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=282.66 Aligned_cols=248 Identities=32% Similarity=0.487 Sum_probs=210.3
Q ss_pred CcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEE
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 118 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 118 (320)
...|...+.||+|++|+||++.+. ++.+++|.+.............+.+|+++++.++|+|++++.+++..++..++|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 356999999999999999999875 788999988655444455557788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccccccc
Q 020888 119 TEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 197 (320)
Q Consensus 119 ~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~ 197 (320)
+||++| +|.+++.. ...+++..+..++.|++.+|.|||+.| ++|+||+|+||++ +.++.++|+|||++......
T Consensus 94 ~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~--i~H~dl~p~nIl~--~~~~~~kL~dfg~~~~~~~~ 168 (307)
T cd06607 94 MEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE--RIHRDIKAGNILL--TEPGTVKLADFGSASLVSPA 168 (307)
T ss_pred HHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEE--CCCCCEEEeecCcceecCCC
Confidence 999965 88777754 457899999999999999999999988 9999999999999 88889999999988654322
Q ss_pred CccceeeccCCcccccccCccccC---cCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCC
Q 020888 198 NSHDVYKMTGETGSYRYMAPEVFK---HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFT 274 (320)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (320)
....++..|+|||.+. ...++.++|+||||+++|++++|..||...+.......+.....+......++
T Consensus 169 --------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (307)
T cd06607 169 --------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWS 240 (307)
T ss_pred --------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhC
Confidence 1235677899999874 45688899999999999999999999988777666555555555555555678
Q ss_pred HHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 275 PELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 275 ~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
.++++++.+||..+|.+||++.+++.+
T Consensus 241 ~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 241 DYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred HHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 999999999999999999999999875
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=280.41 Aligned_cols=248 Identities=31% Similarity=0.526 Sum_probs=209.7
Q ss_pred cccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEE
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 119 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 119 (320)
..|+..+.||.|++|.||++.+. +..+++|.+..... ......+.+|+++++.+.|++++++++.+.++...++||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIM 81 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 36888899999999999999875 67899998754322 234478889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCc
Q 020888 120 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 199 (320)
Q Consensus 120 e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~ 199 (320)
||++|++|.+++.. +++++..+..++.|++.+|.+||+.| ++|+||+|+||++ +.++.++|+|||.+........
T Consensus 82 e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~--ivH~dl~p~Nil~--~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 82 EYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEK--KIHRDIKAANVLL--SEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred ecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCcCCChhhEEE--cCCCCEEEcccccceeccCCcc
Confidence 99999999999875 46899999999999999999999988 9999999999999 7888999999999876543221
Q ss_pred cceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHH
Q 020888 200 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRE 279 (320)
Q Consensus 200 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 279 (320)
......++..|.|||.+.+..++.++|+||||+++|++++|..||....+......+.....+ .....++..+.+
T Consensus 157 ----~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 231 (277)
T cd06640 157 ----KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPP-TLTGEFSKPFKE 231 (277)
T ss_pred ----ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCC-CCchhhhHHHHH
Confidence 112235677899999999888999999999999999999999999887766555544333322 223347889999
Q ss_pred HHHHHhhcCCCCCCCHHHHHHH
Q 020888 280 LTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 280 li~~~l~~dp~~Rps~~~ll~~ 301 (320)
++.+||..+|..||++++++.+
T Consensus 232 li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 232 FIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred HHHHHcccCcccCcCHHHHHhC
Confidence 9999999999999999999887
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=279.78 Aligned_cols=258 Identities=29% Similarity=0.499 Sum_probs=207.8
Q ss_pred CcccCccceecccCceEEEEEEEC------CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEe--C
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE--R 112 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~------~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 112 (320)
...|...+.||+|++|.||++... +..+++|.+...... .....+.+|++.++.+.|+|++++++++.. .
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~ 80 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGG 80 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCC
Confidence 356888899999999999999853 568999988655433 345789999999999999999999998876 5
Q ss_pred CceEEEEecCCCCCHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCc
Q 020888 113 KPLMLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 191 (320)
Q Consensus 113 ~~~~iv~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~ 191 (320)
...+++|||+++++|.+++.... .+++..++.++.|++.||.+||+.| ++|+||+|+||++ +.++.++|+|||.+
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~nil~--~~~~~~~l~dfg~~ 156 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR--YIHRDLAARNILV--ESEDLVKISDFGLA 156 (284)
T ss_pred CceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEE--cCCCCEEEcccccc
Confidence 67899999999999999997644 5899999999999999999999988 9999999999999 78899999999998
Q ss_pred ccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHH--------------HH
Q 020888 192 KLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYE--------------AA 257 (320)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~--------------~~ 257 (320)
........... ......++..|+|||...+..++.++|+||||++++++++|..|+....... ..
T Consensus 157 ~~~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05038 157 KVLPEDKDYYY-VKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRL 235 (284)
T ss_pred cccccCCccee-ccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHH
Confidence 87653221111 1112234556999999988889999999999999999999999876532211 11
Q ss_pred HHHHhCCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHH
Q 020888 258 KYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKI 305 (320)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~ 305 (320)
............+..++.++.+++.+||+.+|..|||+.++++.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 236 LELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 112222222223345789999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=297.16 Aligned_cols=252 Identities=32% Similarity=0.479 Sum_probs=228.0
Q ss_pred CCCCCcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCc
Q 020888 37 IDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP 114 (320)
Q Consensus 37 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 114 (320)
-+.-+..|+-++.||.|+||.||.+++. +.-||+|....+.....+....+..|++.|++++|||.+.+-+.+..+.+
T Consensus 21 k~DPEklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~T 100 (948)
T KOG0577|consen 21 KDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHT 100 (948)
T ss_pred cCCHHHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccch
Confidence 3444557888999999999999999985 67799998866655566666889999999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccc
Q 020888 115 LMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 193 (320)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~ 193 (320)
.++|||||-| +-+|+++- ..++.+..+..|..+.++||.|||+.+ .+|+|||.-||++ +..|.|||.|||++..
T Consensus 101 aWLVMEYClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~--~IHRDiKAGNILL--se~g~VKLaDFGSAsi 175 (948)
T KOG0577|consen 101 AWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--RIHRDIKAGNILL--SEPGLVKLADFGSASI 175 (948)
T ss_pred HHHHHHHHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhh--HHhhhccccceEe--cCCCeeeeccccchhh
Confidence 9999999955 99999875 357999999999999999999999999 9999999999999 9999999999999876
Q ss_pred ccccCccceeeccCCcccccccCccccC---cCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCC
Q 020888 194 IKVQNSHDVYKMTGETGSYRYMAPEVFK---HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA 270 (320)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 270 (320)
..+ .++.+|||.|+|||++. .+.|+-+.||||||+++.++...+.|+-+.+.....-.+.++..|....
T Consensus 176 ~~P--------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs 247 (948)
T KOG0577|consen 176 MAP--------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQS 247 (948)
T ss_pred cCc--------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCC
Confidence 653 45678999999999884 5689999999999999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 271 KGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 271 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
+.|++.+++|+..||+.-|.+|||.++++++
T Consensus 248 ~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 248 NEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred chhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 9999999999999999999999999999887
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=272.83 Aligned_cols=247 Identities=33% Similarity=0.576 Sum_probs=210.1
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEe
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 120 (320)
+|+..+.||+|++|.||++.+. ++.+++|.+..... .....+.+|++.++.++|++++++++.+..+...++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence 4788899999999999999986 78899998865443 234788899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCc
Q 020888 121 YLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 199 (320)
Q Consensus 121 ~~~~~~L~~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~ 199 (320)
|+++++|.+++... ..+++..+..++.|++.+|.+||+.| ++||||+|+||++ +.++.++|+|||.+........
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--i~h~dl~p~ni~i--~~~~~~~l~d~~~~~~~~~~~~ 153 (253)
T cd05122 78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG--IIHRDIKAANILL--TSDGEVKLIDFGLSAQLSDTKA 153 (253)
T ss_pred cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC--EecCCCCHHHEEE--ccCCeEEEeecccccccccccc
Confidence 99999999999875 57899999999999999999999988 9999999999999 7788999999999877654321
Q ss_pred cceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCC-CCCCCHHHH
Q 020888 200 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR-AKGFTPELR 278 (320)
Q Consensus 200 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~ 278 (320)
.....++..|+|||...+...+.++|+||||++++++++|..||...+.............+... ...++.++.
T Consensus 154 -----~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (253)
T cd05122 154 -----RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFK 228 (253)
T ss_pred -----ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHH
Confidence 22345678899999999888999999999999999999999999887655554444433322222 223489999
Q ss_pred HHHHHHhhcCCCCCCCHHHHHHH
Q 020888 279 ELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 279 ~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
+++.+||+.||.+|||+.+++++
T Consensus 229 ~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 229 DFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred HHHHHHccCChhhCCCHHHHhcC
Confidence 99999999999999999999864
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=279.79 Aligned_cols=248 Identities=29% Similarity=0.567 Sum_probs=207.0
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCC---CCcccceeeeEEeCCceEE
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR---HPNIVQFLGAVTERKPLML 117 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~i 117 (320)
.|+..+.||.|++|.||++.+. ++.+++|.+...... .....+.+|+++++.+. |++++++++.+..+..+++
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPD--DDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCc--hhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 5788899999999999999974 788999988654322 23367888999999996 9999999999999999999
Q ss_pred EEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccccccc
Q 020888 118 ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 197 (320)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~ 197 (320)
+|||+++++|.++++. +.+++..++.++.|++.+|.+||+.| ++|+||+|+||++ +.++.++|+|||.+......
T Consensus 80 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~p~ni~i--~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 80 IMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVG--VIHRDIKAANILV--TNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred EEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHHEEE--cCCCCEEEccCCceeecCCC
Confidence 9999999999999876 47899999999999999999999998 9999999999999 77899999999998766543
Q ss_pred CccceeeccCCcccccccCccccCcC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHH
Q 020888 198 NSHDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPE 276 (320)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (320)
.. ......++..|+|||.+.++ .++.++|+||||+++|++++|..||...........+.....+......++.+
T Consensus 155 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (277)
T cd06917 155 SS----KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKL 230 (277)
T ss_pred cc----ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHH
Confidence 21 12234578889999988654 56899999999999999999999998877655544433333333333347899
Q ss_pred HHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 277 LRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 277 l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
+.+++.+||+.||.+||++.+++++
T Consensus 231 ~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 231 LREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred HHHHHHHHcCCCcccCcCHHHHhhC
Confidence 9999999999999999999999875
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=290.51 Aligned_cols=246 Identities=28% Similarity=0.468 Sum_probs=198.1
Q ss_pred cccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeC------C
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER------K 113 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~ 113 (320)
.+|.+.+.||.|+||+||++.+. ++.||+|.+....... .....+.+|+++++.++|+||+++++++... .
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07878 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSL-IHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN 93 (343)
T ss_pred hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhh-HHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence 47999999999999999999875 6789999886543222 2235677899999999999999999887532 4
Q ss_pred ceEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccc
Q 020888 114 PLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 193 (320)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~ 193 (320)
..|++++++ +++|.+++.. ..+++..+..++.|++.||.|||+.| |+|+||||+||++ +.++.++|+|||++..
T Consensus 94 ~~~~~~~~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrdikp~Nil~--~~~~~~kl~Dfg~~~~ 167 (343)
T cd07878 94 EVYLVTNLM-GADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAG--IIHRDLKPSNVAV--NEDCELRILDFGLARQ 167 (343)
T ss_pred cEEEEeecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecccCChhhEEE--CCCCCEEEcCCcccee
Confidence 478999988 7799988764 46999999999999999999999998 9999999999999 8889999999999876
Q ss_pred ccccCccceeeccCCcccccccCccccCc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCC--------
Q 020888 194 IKVQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH-------- 264 (320)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~-------- 264 (320)
.... .....+++.|+|||++.+ ..++.++|||||||++|+|++|..||...+..+....+....
T Consensus 168 ~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 240 (343)
T cd07878 168 ADDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVL 240 (343)
T ss_pred cCCC-------cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 5321 123467899999999877 568899999999999999999999998765443332222110
Q ss_pred --------------CCCCC-------CCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 265 --------------RPFFR-------AKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 265 --------------~~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
.+... ....++.+.+++.+||..||.+|||+.+++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 241 KKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000 12356778999999999999999999999987
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=285.93 Aligned_cols=251 Identities=18% Similarity=0.347 Sum_probs=196.5
Q ss_pred ccceeccc--CceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEec
Q 020888 46 SSAIIGKG--SFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY 121 (320)
Q Consensus 46 ~~~~lg~g--~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 121 (320)
++++||+| ++++||++.++ ++.||+|.+...... ......+.+|+++++.++||||+++++++..++..++|+||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACT-NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhcc-HHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 46789999 78899999875 788999988654333 23346788899999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCc
Q 020888 122 LRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 199 (320)
Q Consensus 122 ~~~~~L~~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~ 199 (320)
+++++|.+++... ..+++..++.++.|++.||.|||+.| ++|+||||+||++ +.++.+++.||+..........
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiH~dlkp~Nil~--~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILI--SVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCChhhEEE--ecCCcEEEcccchhhccccccc
Confidence 9999999999753 45899999999999999999999998 9999999999999 7888999999986554332111
Q ss_pred ccee---eccCCcccccccCccccCc--CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCC-------
Q 020888 200 HDVY---KMTGETGSYRYMAPEVFKH--RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPF------- 267 (320)
Q Consensus 200 ~~~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~------- 267 (320)
.... ......++..|+|||.+.+ ..++.++|||||||+++++++|..||.................+.
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTI 236 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccch
Confidence 0000 0111245677999999876 458899999999999999999999998655433222221111100
Q ss_pred -------------------------------------CCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 268 -------------------------------------FRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 268 -------------------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
.....+++++.+++.+||+.||++|||+++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred hhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 0012356789999999999999999999999875
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=273.08 Aligned_cols=249 Identities=30% Similarity=0.575 Sum_probs=213.4
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEe
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 120 (320)
+|++.+.||.|++|.||++.+. ++.+++|.+...... ......+.+|++++++++|++++++++++..++..++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 4788999999999999999875 678999988765443 2345789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCcc
Q 020888 121 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 200 (320)
Q Consensus 121 ~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~ 200 (320)
|+++++|.+++...+.+++..++.++.|++.+|.+||+.| ++|+||+|+||++ +.++.++|+|||.+.........
T Consensus 80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i--~~~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG--VIHRDIKAANILT--TKDGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEE--CCCCCEEEeccccceecCCCccc
Confidence 9999999999988788999999999999999999999988 9999999999999 77889999999999876543321
Q ss_pred ceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHH
Q 020888 201 DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELREL 280 (320)
Q Consensus 201 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 280 (320)
.....++..|+|||...+...+.++|+|+||++++++++|..||...+.............+. .+..++.+++++
T Consensus 156 ----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 230 (254)
T cd06627 156 ----DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPP-LPEGISPELKDF 230 (254)
T ss_pred ----ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCC-CCCCCCHHHHHH
Confidence 123456888999999988888999999999999999999999998877665555544443333 334578999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHH
Q 020888 281 TEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 281 i~~~l~~dp~~Rps~~~ll~~ 301 (320)
+.+||..+|++|||+.+++.+
T Consensus 231 i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 231 LMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred HHHHHhCChhhCcCHHHHhcC
Confidence 999999999999999999864
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=283.43 Aligned_cols=249 Identities=26% Similarity=0.440 Sum_probs=201.4
Q ss_pred cccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEE
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 119 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 119 (320)
.+|.+.+.||.|++|.||++.+. ++.+|+|.+........ ...+.+|+.+++.++|+||+++++++...+..++|+
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 83 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGA--PCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 83 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCc--hhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEE
Confidence 47999999999999999999875 78899998854432221 245678999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccC
Q 020888 120 EYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 198 (320)
Q Consensus 120 e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~ 198 (320)
||+++ +|.+++... ..+++..+..++.|++.||.+||+.| ++|+||+|+||++ +.++.++|+|||.+.......
T Consensus 84 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--i~H~dlkp~Nil~--~~~~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 84 EYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK--VLHRDLKPQNLLI--NERGELKLADFGLARAKSIPT 158 (301)
T ss_pred ecccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHHHEEE--CCCCcEEECcCcchhccCCCC
Confidence 99965 999888753 46899999999999999999999988 9999999999999 888899999999987543322
Q ss_pred ccceeeccCCcccccccCccccCcC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCC------------
Q 020888 199 SHDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHR------------ 265 (320)
Q Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~------------ 265 (320)
. ......+++.|+|||.+.+. .++.++|+||||+++|+|++|..||...+..+....+.....
T Consensus 159 ~----~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (301)
T cd07873 159 K----TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS 234 (301)
T ss_pred C----cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhc
Confidence 1 11223468889999988654 578899999999999999999999987765443332221100
Q ss_pred ---------CC-------CCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 266 ---------PF-------FRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 266 ---------~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
+. .....++.+++++|.+||..||.+|||+++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 235 NEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred cccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00 0012468899999999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=278.84 Aligned_cols=252 Identities=30% Similarity=0.538 Sum_probs=213.8
Q ss_pred CCCCcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCce
Q 020888 38 DPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL 115 (320)
Q Consensus 38 ~~~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 115 (320)
......|...+.||+|++|.||++.+. +..+++|.+..... ....+.+|++.++.++|+|++++++.+......
T Consensus 15 ~~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 90 (286)
T cd06614 15 GDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDEL 90 (286)
T ss_pred CCccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEE
Confidence 455667999999999999999999986 78899998864432 346788899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccc
Q 020888 116 MLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 194 (320)
Q Consensus 116 ~iv~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~ 194 (320)
++++||+++++|.+++.... .+++..+..++.+++.+|.+||+.| ++|+||+|+||++ +.++.++|+|||.+...
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~g--i~H~dl~p~ni~i--~~~~~~~l~d~~~~~~~ 166 (286)
T cd06614 91 WVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN--VIHRDIKSDNILL--SKDGSVKLADFGFAAQL 166 (286)
T ss_pred EEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCChhhEEE--cCCCCEEECccchhhhh
Confidence 99999999999999998866 7999999999999999999999988 9999999999999 88889999999987655
Q ss_pred cccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCC-CCCC
Q 020888 195 KVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR-AKGF 273 (320)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~ 273 (320)
..... ......++..|+|||...+..++.++|+||||+++|++++|..||...........+......... ...+
T Consensus 167 ~~~~~----~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (286)
T cd06614 167 TKEKS----KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKW 242 (286)
T ss_pred ccchh----hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhC
Confidence 43221 112234677899999998888999999999999999999999999887776555544443333222 2347
Q ss_pred CHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 274 TPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 274 ~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
+.++++++.+||+.+|.+|||+.+++++
T Consensus 243 ~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 243 SPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred CHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 8999999999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=277.53 Aligned_cols=247 Identities=32% Similarity=0.474 Sum_probs=208.0
Q ss_pred ecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEecCCCCCH
Q 020888 50 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDL 127 (320)
Q Consensus 50 lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L 127 (320)
||.|++|.||++.+. ++.+++|.+.............+.+|++++++++|+|++++++.+..+...|+++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 589999999999986 789999988665544445567899999999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCccc----ee
Q 020888 128 HKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHD----VY 203 (320)
Q Consensus 128 ~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~~----~~ 203 (320)
.+++.+.+.+++..+..++.|++.+|.+||+.| ++|+||+|+||++ +.++.++|+|||++.......... ..
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~di~~~nil~--~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 156 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNG--IIHRDLKPDNILI--DSNGHLKLTDFGLSKVGLVRRQINLNDDEK 156 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcC--eecCCCCHHHeEE--cCCCCEEEEecccchhcccCcccccccccc
Confidence 999988778999999999999999999999988 9999999999999 888999999999887654332110 11
Q ss_pred eccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHH
Q 020888 204 KMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEK 283 (320)
Q Consensus 204 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 283 (320)
......++..|+|||...+...+.++|+||||++++++++|..||......+....+..+.........++.++.+++.+
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 236 (265)
T cd05579 157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISK 236 (265)
T ss_pred cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHHHH
Confidence 12234567889999999888899999999999999999999999998887777666665443333333358999999999
Q ss_pred HhhcCCCCCCCH---HHHHH
Q 020888 284 CWAADMNQRPSF---LDILK 300 (320)
Q Consensus 284 ~l~~dp~~Rps~---~~ll~ 300 (320)
||+.+|..|||+ .++++
T Consensus 237 ~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 237 LLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred HhcCCHhhcCCCccHHHHhc
Confidence 999999999999 55554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=281.37 Aligned_cols=254 Identities=30% Similarity=0.477 Sum_probs=214.6
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEe
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 120 (320)
.|...+.||+|+||.||++.+. +..+++|.+.............+.+|+++++.++|+|++++++++..+...++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 4888999999999999999874 78899998866544444555788899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCc
Q 020888 121 YLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 199 (320)
Q Consensus 121 ~~~~~~L~~~~~~-~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~ 199 (320)
|++| +|.+++.. ..++++..+..++.+++.+|.+||+.| ++|+||+|+||++ +.++.++|+|||++......
T Consensus 106 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--i~H~dL~p~Nil~--~~~~~~kl~dfg~~~~~~~~-- 178 (317)
T cd06635 106 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILL--TEPGQVKLADFGSASIASPA-- 178 (317)
T ss_pred CCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcccEEE--CCCCCEEEecCCCccccCCc--
Confidence 9975 78777754 456899999999999999999999988 9999999999999 88889999999987644321
Q ss_pred cceeeccCCcccccccCccccC---cCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHH
Q 020888 200 HDVYKMTGETGSYRYMAPEVFK---HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPE 276 (320)
Q Consensus 200 ~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (320)
....++..|+|||.+. +..++.++|+||+|++++++++|..||...+.......+.....+......++..
T Consensus 179 ------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (317)
T cd06635 179 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDY 252 (317)
T ss_pred ------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHH
Confidence 2245778899999873 4568899999999999999999999998877766666666665555555668899
Q ss_pred HHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcC
Q 020888 277 LRELTEKCWAADMNQRPSFLDILKRLEKIKETL 309 (320)
Q Consensus 277 l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 309 (320)
+++++.+||+.+|.+||++.++++++-.+....
T Consensus 253 l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 285 (317)
T cd06635 253 FRNFVDSCLQKIPQDRPTSEELLKHMFVLRERP 285 (317)
T ss_pred HHHHHHHHccCCcccCcCHHHHHhChhhhccCc
Confidence 999999999999999999999999865554443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=280.58 Aligned_cols=259 Identities=28% Similarity=0.573 Sum_probs=211.4
Q ss_pred CcccCccceecccCceEEEEEEEC--CC----ceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCc
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--GT----PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP 114 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~~----~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 114 (320)
..+|...+.||+|++|.||++.+. +. .+++|.+..... ......+.+|+.+++.++|+||+++++++... .
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~ 82 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG--PKANVEFMDEALIMASMDHPHLVRLLGVCLSP-T 82 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-C
Confidence 457888999999999999999873 33 478887754332 23335688899999999999999999988654 4
Q ss_pred eEEEEecCCCCCHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccc
Q 020888 115 LMLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 193 (320)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~ 193 (320)
.+++++|+++|+|.+++.... .+++..++.++.|++.||.|||++| ++|+||||+||++ +.++.++|+|||.+..
T Consensus 83 ~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dikp~Nill--~~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 83 IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR--LVHRDLAARNVLV--KSPNHVKITDFGLARL 158 (303)
T ss_pred ceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcC--eeccccccceeee--cCCCceEEcccccccc
Confidence 678999999999999987643 6899999999999999999999988 9999999999999 7788999999999986
Q ss_pred ccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCC
Q 020888 194 IKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKG 272 (320)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (320)
...... ........++..|+|||...+..++.++||||||+++|++++ |..||...........+..+..... +..
T Consensus 159 ~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~ 235 (303)
T cd05110 159 LEGDEK--EYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQ-PPI 235 (303)
T ss_pred ccCccc--ccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCC-CCC
Confidence 643221 112223345678999999998999999999999999999997 9999988766666555555443332 345
Q ss_pred CCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcC
Q 020888 273 FTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETL 309 (320)
Q Consensus 273 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 309 (320)
++..+++++..|+..+|++||++.++++.|.++....
T Consensus 236 ~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 236 CTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence 7889999999999999999999999999999886543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=279.96 Aligned_cols=246 Identities=27% Similarity=0.496 Sum_probs=203.8
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEe
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 120 (320)
+|++.+.||+|++|.||++.+. +..+++|.+.... .......+.+|++++++++|+|++++++.+...+..++|+|
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME 79 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence 6889999999999999999986 7889999875432 23334678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccc
Q 020888 121 YLRGGDLHKYLKEK---GALSPSTAVNFALDIARGMAYLHN-EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 196 (320)
Q Consensus 121 ~~~~~~L~~~~~~~---~~l~~~~~~~i~~~l~~~l~~lH~-~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~ 196 (320)
|+++++|.+++... ..+++..+..++.+++.+|.|||+ .| ++|+||+|+||++ +.++.++|+|||.+..+..
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~--~~~~~~~l~dfg~~~~~~~ 155 (286)
T cd06622 80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIHRDVKPTNVLV--NGNGQVKLCDFGVSGNLVA 155 (286)
T ss_pred ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC--EeeCCCCHHHEEE--CCCCCEEEeecCCcccccC
Confidence 99999999988763 368999999999999999999996 47 9999999999999 7788999999998876532
Q ss_pred cCccceeeccCCcccccccCccccCcCC------CCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHhCCCCC
Q 020888 197 QNSHDVYKMTGETGSYRYMAPEVFKHRK------YDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKY---VAEGHRPF 267 (320)
Q Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~------~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~---~~~~~~~~ 267 (320)
.. .....+++.|+|||.+.+.. ++.++|+||||+++|++++|..||........... +.....+.
T Consensus 156 ~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd06622 156 SL------AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPT 229 (286)
T ss_pred Cc------cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCC
Confidence 21 12234677899999986543 47899999999999999999999976554443332 22333233
Q ss_pred CCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 268 FRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 268 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
. +..++.++++++.+||..+|.+||++++++.+
T Consensus 230 ~-~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 230 L-PSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred C-CcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 2 34489999999999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=288.02 Aligned_cols=257 Identities=26% Similarity=0.390 Sum_probs=205.4
Q ss_pred cCCCCCcccCccceecccCceEEEEEEEC-CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCC-CCcccceeeeEEeCC
Q 020888 36 EIDPSELDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERK 113 (320)
Q Consensus 36 ~~~~~~~~y~~~~~lg~g~~~~vy~~~~~-~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 113 (320)
.+...+..|++++.||+||-+.||++... .+-+|+|.+.. ...+...+.-+.+|++.|.+|+ |.+|++++|+-..++
T Consensus 355 ~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~-~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~ 433 (677)
T KOG0596|consen 355 IIKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVL-LEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDG 433 (677)
T ss_pred eEEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHH-hhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCc
Confidence 45667889999999999999999999976 34466664433 3345667789999999999995 999999999999999
Q ss_pred ceEEEEecCCCCCHHHHHHHhCC-CCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcc
Q 020888 114 PLMLITEYLRGGDLHKYLKEKGA-LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 192 (320)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~~~-l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~ 192 (320)
.+||||||= ..+|..+++.... ++...+..+..|++.++.++|+.| |||.||||.|+++ -.|++||+|||.+.
T Consensus 434 ~lYmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~g--IVHSDLKPANFLl---VkG~LKLIDFGIA~ 507 (677)
T KOG0596|consen 434 YLYMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHG--IVHSDLKPANFLL---VKGRLKLIDFGIAN 507 (677)
T ss_pred eEEEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhc--eeecCCCcccEEE---EeeeEEeeeechhc
Confidence 999999965 6699999987543 343488899999999999999999 9999999999998 45799999999998
Q ss_pred cccccCccceeeccCCcccccccCccccCcC-----------CCCCchhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHH
Q 020888 193 LIKVQNSHDVYKMTGETGSYRYMAPEVFKHR-----------KYDKKVDVFSFAMILYEMLEGEPPLANYEP-YEAAKYV 260 (320)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----------~~~~~~Di~slG~~l~~ll~g~~p~~~~~~-~~~~~~~ 260 (320)
.+......- -....+||+.|++||.+... +.+.++|||||||+||+|+.|+.||..+.. ......+
T Consensus 508 aI~~DTTsI--~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI 585 (677)
T KOG0596|consen 508 AIQPDTTSI--VKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAI 585 (677)
T ss_pred ccCccccce--eeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhh
Confidence 876543222 23456899999999998543 255799999999999999999999988763 3333333
Q ss_pred HhC-CCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 261 AEG-HRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 261 ~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
... -..++....-..++.++++.||..||.+|||+.++|++
T Consensus 586 ~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 586 TDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred cCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 322 11122222224569999999999999999999999986
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=278.22 Aligned_cols=247 Identities=32% Similarity=0.575 Sum_probs=202.2
Q ss_pred ceecccCceEEEEEEECC--------CceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEE
Q 020888 48 AIIGKGSFGEILKAYWRG--------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 119 (320)
Q Consensus 48 ~~lg~g~~~~vy~~~~~~--------~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 119 (320)
+.||.|++|.||++.+.+ ..+++|.+..... ......+.+|+.+++.++|+||+++++++...+..+++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT--DQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM 78 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccc--hhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence 368999999999998752 5688887754322 223467888999999999999999999999989999999
Q ss_pred ecCCCCCHHHHHHHh-------CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCC-----cEEEec
Q 020888 120 EYLRGGDLHKYLKEK-------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD-----HLKVGD 187 (320)
Q Consensus 120 e~~~~~~L~~~~~~~-------~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~-----~~~L~d 187 (320)
||+++++|.+++... ..+++..++.++.|++.+|.|||+.+ ++|+||+|+||++ +.++ .++|+|
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~--~~~~~~~~~~~~l~d 154 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH--FIHRDLAARNCLV--SEKGYDADRVVKIGD 154 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC--cccCCCChheEEE--ecCCCCCCcceEECC
Confidence 999999999998642 23788999999999999999999988 9999999999999 5555 799999
Q ss_pred CCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCC
Q 020888 188 FGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRP 266 (320)
Q Consensus 188 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~ 266 (320)
||++..+...... ........+..|+|||.+.+..++.++|+||||+++|++++ |..||......+....+......
T Consensus 155 fg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~ 232 (269)
T cd05044 155 FGLARDIYKSDYY--RKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRL 232 (269)
T ss_pred ccccccccccccc--ccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCcc
Confidence 9998765432211 11122345678999999999999999999999999999998 99999877766666555444333
Q ss_pred CCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHH
Q 020888 267 FFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLE 303 (320)
Q Consensus 267 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~ 303 (320)
. .+..++..+.+++.+||..+|.+||++.++++.|+
T Consensus 233 ~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 233 Q-KPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred C-CcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 2 23457899999999999999999999999999886
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=273.03 Aligned_cols=249 Identities=30% Similarity=0.542 Sum_probs=214.6
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEe
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 120 (320)
+|.+.+.||.|++|.||++.+. ++.+++|.+...... ......+.+|+++++.++|+|++++.+.+..+...++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS-EKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCC-hHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 5888899999999999999987 788999988654433 2334678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccc
Q 020888 121 YLRGGDLHKYLKEK----GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 196 (320)
Q Consensus 121 ~~~~~~L~~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~ 196 (320)
|+++++|.+++.+. ..+++..+..++.+++.||.+||+.| ++|+||+|+||++ +.++.++|+|||.+.....
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~~H~dl~~~nil~--~~~~~~~l~d~~~~~~~~~ 155 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK--ILHRDIKPQNIFL--TSNGLVKLGDFGISKVLSS 155 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHHeEE--cCCCcEEECCccceeeccc
Confidence 99999999999763 67999999999999999999999998 9999999999999 7888999999998876544
Q ss_pred cCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHH
Q 020888 197 QNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPE 276 (320)
Q Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (320)
.. .......+++.|+|||...+..++.++|+||+|++++++++|..||...+..+............. +..++.+
T Consensus 156 ~~----~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 230 (258)
T cd08215 156 TV----DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPI-PSQYSSE 230 (258)
T ss_pred Cc----ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCC-CCCCCHH
Confidence 32 112234578889999999888899999999999999999999999988887777666665544433 3468999
Q ss_pred HHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 277 LRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 277 l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
+.+++.+||..+|.+|||+.+++++
T Consensus 231 ~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 231 LRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred HHHHHHHHcCCChhhCcCHHHHhcC
Confidence 9999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=280.31 Aligned_cols=251 Identities=29% Similarity=0.491 Sum_probs=205.5
Q ss_pred CCCcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcccceeeeEE-----
Q 020888 39 PSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVT----- 110 (320)
Q Consensus 39 ~~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~----- 110 (320)
.....|++.+.||.|++|.||++.+. ++.+++|++.... .....+..|+.+++++ +|+|++++++++.
T Consensus 13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 88 (282)
T cd06636 13 DPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPP 88 (282)
T ss_pred ChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhccccc
Confidence 34568999999999999999999985 6889999874432 2235678899999998 6999999999874
Q ss_pred -eCCceEEEEecCCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEec
Q 020888 111 -ERKPLMLITEYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGD 187 (320)
Q Consensus 111 -~~~~~~iv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~d 187 (320)
....++++|||+++++|.+++... ..+++..++.++.|++.||.|||+.| ++|+||+|+||++ +.++.++|+|
T Consensus 89 ~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dl~~~nili--~~~~~~~l~d 164 (282)
T cd06636 89 GHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK--VIHRDIKGQNVLL--TENAEVKLVD 164 (282)
T ss_pred CCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEE--CCCCCEEEee
Confidence 345789999999999999998753 35889999999999999999999998 9999999999999 7888999999
Q ss_pred CCCcccccccCccceeeccCCcccccccCccccC-----cCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh
Q 020888 188 FGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFK-----HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAE 262 (320)
Q Consensus 188 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~ 262 (320)
||.+........ ......+++.|+|||.+. +..++.++|+||||+++|++++|..||....+......+..
T Consensus 165 fg~~~~~~~~~~----~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~ 240 (282)
T cd06636 165 FGVSAQLDRTVG----RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPR 240 (282)
T ss_pred Ccchhhhhcccc----CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhh
Confidence 998875542211 112345788999999875 34578899999999999999999999987766555544444
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 263 GHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 263 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
..........++.++.+++.+||..||.+|||+.+++++
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 241 NPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred CCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 444444455689999999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=272.92 Aligned_cols=252 Identities=29% Similarity=0.535 Sum_probs=211.2
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeC--CceEEE
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER--KPLMLI 118 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~iv 118 (320)
+|...+.||+|++|.||++.+. ++.+++|++...... ....+.+.+|++.+++++|++++++++.+... ..++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 4778899999999999999986 788999988655432 34457899999999999999999999999888 889999
Q ss_pred EecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccC
Q 020888 119 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 198 (320)
Q Consensus 119 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~ 198 (320)
+|++++++|.+++.+...+++..++.++.+++.+|.+||+.| ++|+||+|+||++ +.++.++|+|||.+.......
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~~h~dl~p~ni~i--~~~~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNG--IVHRDIKGANILV--DSDGVVKLADFGCAKRLGDIE 155 (260)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEE--cCCCCEEEcccccEEeccccc
Confidence 999999999999988778999999999999999999999988 9999999999999 778999999999988765543
Q ss_pred ccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHhCCCCCCCCCCCCHHH
Q 020888 199 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYE-PYEAAKYVAEGHRPFFRAKGFTPEL 277 (320)
Q Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l 277 (320)
.. .......++..|.|||...+...+.++|+||||++++++++|..||...+ .......+.........+..++.++
T Consensus 156 ~~--~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 233 (260)
T cd06606 156 TG--EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEA 233 (260)
T ss_pred cc--ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHH
Confidence 21 01223457888999999998889999999999999999999999998876 2222222222223333345568999
Q ss_pred HHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 278 RELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 278 ~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
++++.+|+..+|.+||++.+++.+
T Consensus 234 ~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 234 KDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred HHHHHHhCcCChhhCCCHHHHhhC
Confidence 999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=279.85 Aligned_cols=254 Identities=28% Similarity=0.508 Sum_probs=203.7
Q ss_pred CCCCCcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcccceeeeEE---
Q 020888 37 IDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVT--- 110 (320)
Q Consensus 37 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~--- 110 (320)
+.....+|++.+.||+|++|.||++.++ ++.+++|.+..... ....+.+|+.+++.+ +|+|++++++.+.
T Consensus 13 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 13 FPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD----IDEEIEAEYNILKALSDHPNVVKFYGMYYKKD 88 (286)
T ss_pred CCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc----hHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence 3445668999999999999999999885 68899997643221 125677899999999 6999999999873
Q ss_pred --eCCceEEEEecCCCCCHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEE
Q 020888 111 --ERKPLMLITEYLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLK 184 (320)
Q Consensus 111 --~~~~~~iv~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~ 184 (320)
.++..+++|||++|++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++ +.++.++
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili--~~~~~~k 164 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK--TIHRDVKGNNILL--TTEGGVK 164 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC--ccccCCCHHhEEE--CCCCCEE
Confidence 45678999999999999998753 346889999999999999999999988 9999999999999 7888899
Q ss_pred EecCCCcccccccCccceeeccCCcccccccCccccCc-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 020888 185 VGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH-----RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKY 259 (320)
Q Consensus 185 L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~ 259 (320)
|+|||.+..+..... ......+++.|+|||.+.+ ..++.++|+||+|++++++++|..||...........
T Consensus 165 l~dfg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~ 240 (286)
T cd06638 165 LVDFGVSAQLTSTRL----RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFK 240 (286)
T ss_pred EccCCceeecccCCC----ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhh
Confidence 999999876543211 1223457889999998753 4578899999999999999999999987765444333
Q ss_pred HHhCCCC-CCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHH
Q 020888 260 VAEGHRP-FFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRL 302 (320)
Q Consensus 260 ~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 302 (320)
......+ ...+..++.++.+++.+||+.||++|||+.+++++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 241 IPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred ccccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 3222211 222344678999999999999999999999999863
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=281.95 Aligned_cols=249 Identities=28% Similarity=0.463 Sum_probs=197.3
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEe
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 120 (320)
+|.+.+.||+|++|.||++.+. ++.+++|.+....... .....+.+|+++++.++|+|++++++++.+....++++|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~-~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccc-cCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 4888899999999999999985 7889999886543222 122467789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCc
Q 020888 121 YLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 199 (320)
Q Consensus 121 ~~~~~~L~~~~~~-~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~ 199 (320)
|+++ +|.+++.. .+.+++..++.++.|+++||.|||+.| ++|+||+|+||++ +.++.++|+|||.+........
T Consensus 80 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dl~~~nil~--~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 80 YCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN--VLHRDLKPQNLLI--NKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEE--cCCCcEEECccchhhccCCCCC
Confidence 9965 88887765 567999999999999999999999998 9999999999999 8889999999999875533211
Q ss_pred cceeeccCCcccccccCccccCcC-CCCCchhHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHHhCC-------------
Q 020888 200 HDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLAN-YEPYEAAKYVAEGH------------- 264 (320)
Q Consensus 200 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~-~~~~~~~~~~~~~~------------- 264 (320)
......+++.|+|||.+.+. .++.++|+||||+++|+|++|..|+.. .+..+....+.+..
T Consensus 155 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07839 155 ----CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSK 230 (284)
T ss_pred ----CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhh
Confidence 12234567889999998765 468999999999999999999888643 33322222221100
Q ss_pred ------CCCC--------CCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 265 ------RPFF--------RAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 265 ------~~~~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
.+.. ....++++++++|.+||..||.+|||+++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred cccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 0000 012367899999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=273.97 Aligned_cols=252 Identities=26% Similarity=0.505 Sum_probs=211.0
Q ss_pred ccCccceecccCceEEEEEEEC---CCceEEEEccCCCC-------CcHHHHHHHHHHHHHHHh-CCCCcccceeeeEEe
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR---GTPVAIKRILPSLS-------DDRLVIQDFRHEVNLLVK-LRHPNIVQFLGAVTE 111 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~---~~~~~~K~~~~~~~-------~~~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~ 111 (320)
.|++.+.||+|++|.||++.++ ++.+++|.+..... ........+.+|+.++.+ ++|+|++++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 4888999999999999999985 47799997753321 223344667788888875 689999999999999
Q ss_pred CCceEEEEecCCCCCHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCcEEEeeCCCCcEEEe
Q 020888 112 RKPLMLITEYLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLHN-EPNVIIHRDLKPRNVLLVNSSADHLKVG 186 (320)
Q Consensus 112 ~~~~~iv~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~~l~~~l~~lH~-~g~~ivH~di~p~nI~~~~~~~~~~~L~ 186 (320)
++..++++||+++++|.+++.. ...+++..++.++.|++.+|.+||+ .| ++|+||+|+||++ +.++.++|+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~--i~H~dl~~~nil~--~~~~~~~l~ 156 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR--IVHRDLTPNNIML--GEDDKVTIT 156 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc--eeecCCCHHHEEE--CCCCcEEEe
Confidence 9999999999999999988743 3468999999999999999999996 67 9999999999999 888999999
Q ss_pred cCCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCC
Q 020888 187 DFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRP 266 (320)
Q Consensus 187 dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 266 (320)
|||.+....... ......++..|+|||...+..++.++|+||||+++|++++|..||...........+......
T Consensus 157 dfg~~~~~~~~~-----~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 231 (269)
T cd08528 157 DFGLAKQKQPES-----KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYE 231 (269)
T ss_pred cccceeeccccc-----ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCC
Confidence 999987654322 223345788899999999888999999999999999999999999887776666666665555
Q ss_pred CCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHH
Q 020888 267 FFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLE 303 (320)
Q Consensus 267 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~ 303 (320)
+.....++.++.+++.+||+.||.+||++.++..++.
T Consensus 232 ~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 232 PLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred cCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 4444467899999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=277.64 Aligned_cols=250 Identities=27% Similarity=0.433 Sum_probs=203.9
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEe
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 120 (320)
+|.+.+.||.|++|.||++.+. ++.+++|.+....... .....+.+|+.++++++|+|++++++++..+...++|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEG-GIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccc-hhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 5888999999999999999975 7889999886654332 223678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCc
Q 020888 121 YLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 199 (320)
Q Consensus 121 ~~~~~~L~~~~~~-~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~ 199 (320)
|+ +++|.+++.. ...+++..++.++.|++.+|.|||+.| ++|+||+|+||++ +.++.++|+|||.+........
T Consensus 80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~~--~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG--IMHRDLKPANLLI--SADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCHHHEEE--cCCCcEEEeeeeecccccCCCC
Confidence 99 8999999865 456899999999999999999999998 9999999999999 7788999999999876654321
Q ss_pred cceeeccCCcccccccCccccCcC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCC-----------
Q 020888 200 HDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPF----------- 267 (320)
Q Consensus 200 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~----------- 267 (320)
.......++..|+|||.+.+. .++.++|+||||++++++++|..||...........+.......
T Consensus 155 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07832 155 ---RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSL 231 (286)
T ss_pred ---CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCc
Confidence 112234578899999998654 46899999999999999999988887665544433332211000
Q ss_pred -----------------CCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 268 -----------------FRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 268 -----------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
......+.++.++|.+||..+|++|||+++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 232 PDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred chhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0012357899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=278.94 Aligned_cols=253 Identities=28% Similarity=0.497 Sum_probs=213.7
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCC-CCcccceeeeEEeCCceEEEE
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLMLIT 119 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~iv~ 119 (320)
+|.+.+.||.|++|.||++.+. ++.+++|++.............+.+|.++++++. |+||+++++.+..++..+++|
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd05581 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVL 81 (280)
T ss_pred CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEE
Confidence 6889999999999999999884 7889999887654444444577889999999998 999999999999999999999
Q ss_pred ecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCc
Q 020888 120 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 199 (320)
Q Consensus 120 e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~ 199 (320)
|++++++|.+++...+.+++..++.++.|++.+|.+||+.| ++|+||+|+||++ +.++.++|+|||.+........
T Consensus 82 e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~--~~H~dl~~~ni~i--~~~~~~~l~df~~~~~~~~~~~ 157 (280)
T cd05581 82 EYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG--IIHRDLKPENILL--DKDMHIKITDFGTAKVLDPNSS 157 (280)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEE--CCCCCEEecCCccccccCCccc
Confidence 99999999999998878999999999999999999999998 9999999999999 8889999999999876644321
Q ss_pred cc----------------eeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhC
Q 020888 200 HD----------------VYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEG 263 (320)
Q Consensus 200 ~~----------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~ 263 (320)
.. ........++..|+|||...+..++.++|+||||++++++++|..||...+.......+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 237 (280)
T cd05581 158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKL 237 (280)
T ss_pred cccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhc
Confidence 10 01122335678899999998888999999999999999999999999988765555544432
Q ss_pred CCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCH----HHHHHH
Q 020888 264 HRPFFRAKGFTPELRELTEKCWAADMNQRPSF----LDILKR 301 (320)
Q Consensus 264 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~----~~ll~~ 301 (320)
.. ..+..+++.+.+++.+||+.+|.+|||+ ++++++
T Consensus 238 ~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 238 EY--SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred CC--CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 22 2234578999999999999999999999 887764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=276.95 Aligned_cols=247 Identities=27% Similarity=0.486 Sum_probs=207.9
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEe
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 120 (320)
.|...+.||.|++|.||++.+. ++.+++|.+.... ....+.+.+|+.+++.++|+|++++++.+..++..++++|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e 96 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK---QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME 96 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc---hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence 5666789999999999999875 6789999774322 2233568889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCcc
Q 020888 121 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 200 (320)
Q Consensus 121 ~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~ 200 (320)
|+++++|.+++.. +++++..+..++.|++.+|.+||+.| ++|+||+|+||++ +.++.++|+|||.+........
T Consensus 97 ~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~dl~p~Nil~--~~~~~~~l~d~g~~~~~~~~~~- 170 (285)
T cd06648 97 FLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQG--VIHRDIKSDSILL--TSDGRVKLSDFGFCAQVSKEVP- 170 (285)
T ss_pred ccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChhhEEE--cCCCcEEEcccccchhhccCCc-
Confidence 9999999999887 57899999999999999999999998 9999999999999 8889999999998765432211
Q ss_pred ceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCC-CCCCCHHHHH
Q 020888 201 DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR-AKGFTPELRE 279 (320)
Q Consensus 201 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~ 279 (320)
......+++.|+|||...+..++.++|+||+|++++++++|..||...+.......+.....+... ...++..+.+
T Consensus 171 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 247 (285)
T cd06648 171 ---RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRS 247 (285)
T ss_pred ---ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHH
Confidence 112245788999999999888999999999999999999999999887776666655555333322 2337899999
Q ss_pred HHHHHhhcCCCCCCCHHHHHHH
Q 020888 280 LTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 280 li~~~l~~dp~~Rps~~~ll~~ 301 (320)
++.+||..+|++|||+.+++++
T Consensus 248 li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 248 FLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred HHHHHcccChhhCcCHHHHccC
Confidence 9999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=273.58 Aligned_cols=247 Identities=30% Similarity=0.485 Sum_probs=211.4
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEe
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 120 (320)
+|++.+.||.|++|.||++.+. +..+++|.+....... .....+.+|+++++.++|+||+++.+.+..+...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQ-KEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccH-HHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 4788899999999999999875 6789999886544333 334677889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccc
Q 020888 121 YLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 196 (320)
Q Consensus 121 ~~~~~~L~~~~~~----~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~ 196 (320)
|+++++|.+++.. ...+++..++.++.+++.||.+||+.| ++|+||+|+||++ +.++.++|+|||++.....
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~--i~h~~l~~~ni~~--~~~~~~kl~d~g~~~~~~~ 155 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK--ILHRDLKSANILL--VANDLVKIGDLGISKVLKK 155 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEE--ecCCcEEEeeccchhhhcc
Confidence 9999999999865 346899999999999999999999998 9999999999999 6788999999999876644
Q ss_pred cCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHH
Q 020888 197 QNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPE 276 (320)
Q Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (320)
.. .....+++.|+|||...+..++.++|+||||++++++++|..||...+..+....+.....+... ..++.+
T Consensus 156 ~~------~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 228 (256)
T cd08530 156 NM------AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIP-PIYSQD 228 (256)
T ss_pred CC------cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCc-hhhCHH
Confidence 31 12245688899999999999999999999999999999999999988877666655555544433 357899
Q ss_pred HHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 277 LRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 277 l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
+++++.+||..+|++|||+.+++++
T Consensus 229 ~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 229 LQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred HHHHHHHHcCCCcccCCCHHHHhcC
Confidence 9999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=274.93 Aligned_cols=247 Identities=32% Similarity=0.541 Sum_probs=208.6
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEe
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 120 (320)
-|...+.||.|+||.||++.+. +..+++|.+..... ......+.+|++.+++++|+|++++++.+..++..++|+|
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 82 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 82 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence 4778899999999999999874 67899998754322 2334678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCcc
Q 020888 121 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 200 (320)
Q Consensus 121 ~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~ 200 (320)
|+++++|.+++.. +.+++..+..++.+++.++.+||+.| ++|+||+|+||++ +.++.++|+|||.+..+.....
T Consensus 83 ~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~Ni~i--~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06641 83 YLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLL--SEHGEVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred eCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCC--eecCCCCHHhEEE--CCCCCEEEeecccceecccchh-
Confidence 9999999999875 46899999999999999999999988 9999999999999 8888999999998875543211
Q ss_pred ceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHH
Q 020888 201 DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELREL 280 (320)
Q Consensus 201 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 280 (320)
......++..|+|||.+.+..++.++|+||||++++++++|..||...........+.....+. ....++.++.++
T Consensus 157 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 232 (277)
T cd06641 157 ---KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPT-LEGNYSKPLKEF 232 (277)
T ss_pred ---hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCC-CCcccCHHHHHH
Confidence 1122356788999999988889999999999999999999999998877666555554443332 234578999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHH
Q 020888 281 TEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 281 i~~~l~~dp~~Rps~~~ll~~ 301 (320)
+.+||..+|.+||++.+++++
T Consensus 233 i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 233 VEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred HHHHccCChhhCcCHHHHHhC
Confidence 999999999999999999996
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=279.94 Aligned_cols=250 Identities=28% Similarity=0.501 Sum_probs=202.8
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEe
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 120 (320)
+|++.+.||+|++|.||++.++ ++.+++|.+....... ...+.+.+|+++++.++|+|++++++++..++..++|+|
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 6888999999999999999985 7889999876543332 233677889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCcc
Q 020888 121 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 200 (320)
Q Consensus 121 ~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~ 200 (320)
|+++++|.++......+++..++.++.|++.+|.|||+.| ++|+||+|+||++ +.++.++|+|||++..+.....
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~h~~l~p~ni~~--~~~~~~~l~dfg~~~~~~~~~~- 155 (286)
T cd07846 81 FVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN--IIHRDIKPENILV--SQSGVVKLCDFGFARTLAAPGE- 155 (286)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEE--CCCCcEEEEeeeeeeeccCCcc-
Confidence 9999888887766667999999999999999999999998 9999999999999 8889999999999876544321
Q ss_pred ceeeccCCcccccccCccccCc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhC----------------
Q 020888 201 DVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEG---------------- 263 (320)
Q Consensus 201 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~---------------- 263 (320)
......++..|+|||...+ ..++.++|+||||++++++++|..||......+....+...
T Consensus 156 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07846 156 ---VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNP 232 (286)
T ss_pred ---ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccch
Confidence 1122346788999999875 34678999999999999999999998765543322222110
Q ss_pred ----C-CCCC--------CCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 264 ----H-RPFF--------RAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 264 ----~-~~~~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
. .+.. ....++..+++++.+||..+|++||++.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 0 0000 013468899999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=272.01 Aligned_cols=259 Identities=30% Similarity=0.473 Sum_probs=208.2
Q ss_pred cccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCc-ccceeeeEEeCC-----
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN-IVQFLGAVTERK----- 113 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~----- 113 (320)
..|..+++||+|++|+||+|... |+.||+|.+.-....+.- =....+|+.+++.++|+| |+.+++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~-P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGV-PSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCC-CchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 36888889999999999999986 889999988665442111 145567999999999999 999999998777
Q ss_pred -ceEEEEecCCCCCHHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecC
Q 020888 114 -PLMLITEYLRGGDLHKYLKEKG----ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF 188 (320)
Q Consensus 114 -~~~iv~e~~~~~~L~~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~df 188 (320)
.+++||||++- +|.+++...+ .++...+..+++||+.||+|||+++ |+||||||.||++ +.+|.+||+||
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~--IlHRDLKPQNlLi--~~~G~lKlaDF 164 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG--ILHRDLKPQNLLI--SSSGVLKLADF 164 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCcceEEE--CCCCcEeeecc
Confidence 79999999955 9999998744 4788899999999999999999999 9999999999999 88999999999
Q ss_pred CCcccccccCccceeeccCCcccccccCccccCcC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCC-
Q 020888 189 GLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRP- 266 (320)
Q Consensus 189 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~- 266 (320)
|+++....+.. ......+|.+|+|||++.|. .|+...||||+||++.||++++.-|.+....+....+.+-.-.
T Consensus 165 GlAra~~ip~~----~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP 240 (323)
T KOG0594|consen 165 GLARAFSIPMR----TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTP 240 (323)
T ss_pred chHHHhcCCcc----cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCC
Confidence 99996654322 13345689999999999987 6899999999999999999999999887765554444321100
Q ss_pred ----------------CCC----C-------CCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH--HHHHHhcCC
Q 020888 267 ----------------FFR----A-------KGFTPELRELTEKCWAADMNQRPSFLDILKR--LEKIKETLP 310 (320)
Q Consensus 267 ----------------~~~----~-------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--L~~~~~~~~ 310 (320)
.+. + ...+.+..+++..||+.+|.+|.|++.++.| +..+....+
T Consensus 241 ~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~~~ 313 (323)
T KOG0594|consen 241 NEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEKSS 313 (323)
T ss_pred CccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccchh
Confidence 000 0 1123478899999999999999999999998 555544433
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=277.24 Aligned_cols=243 Identities=30% Similarity=0.448 Sum_probs=198.5
Q ss_pred ecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEecCCCCCH
Q 020888 50 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDL 127 (320)
Q Consensus 50 lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L 127 (320)
||.|+||+||++.+. ++.+++|.+.............+.+|+++++.++|++++++++.+...+..|+|+||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999875 788999988654433333345667899999999999999999999999999999999999999
Q ss_pred HHHHHHhC--CCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCccceeec
Q 020888 128 HKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKM 205 (320)
Q Consensus 128 ~~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~~~~~~ 205 (320)
.+++.... .+++..++.++.|++.+|.+||+.| ++|+||+|+||++ +.++.++|+|||.+....... ..
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~Nil~--~~~~~~~l~dfg~~~~~~~~~-----~~ 151 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR--IVYRDLKPENVLL--DDHGNVRISDLGLAVELKGGK-----KI 151 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEE--CCCCCEEEccCcchhhhccCC-----cc
Confidence 99997655 6899999999999999999999998 9999999999999 888899999999887654321 11
Q ss_pred cCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhC--CCCCCCCCCCCHHHHHHHHH
Q 020888 206 TGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEG--HRPFFRAKGFTPELRELTEK 283 (320)
Q Consensus 206 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~ 283 (320)
....++..|+|||.+.+..++.++|+||||++++++++|+.||...........+... ......+..+++.+++++.+
T Consensus 152 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 231 (277)
T cd05577 152 KGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEA 231 (277)
T ss_pred ccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHH
Confidence 2335677899999998888999999999999999999999999776542222212211 11222334579999999999
Q ss_pred HhhcCCCCCC-----CHHHHHHH
Q 020888 284 CWAADMNQRP-----SFLDILKR 301 (320)
Q Consensus 284 ~l~~dp~~Rp-----s~~~ll~~ 301 (320)
||+.+|.+|| ++.+++.+
T Consensus 232 ~l~~~p~~R~~~~~~~~~~ll~h 254 (277)
T cd05577 232 LLQKDPEKRLGCRGGSADEVREH 254 (277)
T ss_pred HccCChhHccCCCcccHHHHHhC
Confidence 9999999999 77778764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=279.51 Aligned_cols=247 Identities=26% Similarity=0.454 Sum_probs=206.6
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEe
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 120 (320)
.|.....||.|+||.||++.+. ++.+++|.+...... ..+.+.+|+..+..++|+|++++++.+..++..++++|
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e 98 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQ---RRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLME 98 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccc---hHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEe
Confidence 3455568999999999999874 788999988543322 23567889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCcc
Q 020888 121 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 200 (320)
Q Consensus 121 ~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~ 200 (320)
|+++++|.+++.. ..+++..++.++.|++.||.+||+.| ++|+||+|+||++ +.++.++|+|||++..+.....
T Consensus 99 ~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dl~p~Nill--~~~~~~kL~dfg~~~~~~~~~~- 172 (297)
T cd06659 99 FLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQG--VIHRDIKSDSILL--TLDGRVKLSDFGFCAQISKDVP- 172 (297)
T ss_pred cCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHeEE--ccCCcEEEeechhHhhcccccc-
Confidence 9999999998765 46899999999999999999999988 9999999999999 8889999999998865433211
Q ss_pred ceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCC-CCCCCCCHHHHH
Q 020888 201 DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPF-FRAKGFTPELRE 279 (320)
Q Consensus 201 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~ 279 (320)
......++..|+|||.+.+..++.++|+||||++++++++|..||...+..+....+....... .....++..+.+
T Consensus 173 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 249 (297)
T cd06659 173 ---KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRD 249 (297)
T ss_pred ---cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHH
Confidence 1123457889999999998889999999999999999999999998777666655554433222 222457889999
Q ss_pred HHHHHhhcCCCCCCCHHHHHHH
Q 020888 280 LTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 280 li~~~l~~dp~~Rps~~~ll~~ 301 (320)
++.+||+.+|.+||++++++++
T Consensus 250 ~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 250 FLERMLTREPQERATAQELLDH 271 (297)
T ss_pred HHHHHhcCCcccCcCHHHHhhC
Confidence 9999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=271.99 Aligned_cols=252 Identities=30% Similarity=0.469 Sum_probs=200.1
Q ss_pred CCCcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceE
Q 020888 39 PSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLM 116 (320)
Q Consensus 39 ~~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 116 (320)
.+...+.....||+|++|.||++.+. +..+++|.+.... ....+.+.+|+++++.++|+||+++++++..++..+
T Consensus 5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (268)
T cd06624 5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD---SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK 81 (268)
T ss_pred cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence 34445555678999999999999875 5679999775432 223467889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHHh-CCC--CHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCC-CCcEEEecCCCcc
Q 020888 117 LITEYLRGGDLHKYLKEK-GAL--SPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS-ADHLKVGDFGLSK 192 (320)
Q Consensus 117 iv~e~~~~~~L~~~~~~~-~~l--~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~-~~~~~L~dfg~~~ 192 (320)
+++||+++++|.+++... ..+ ++..+..++.|++.||.|||+.| ++|+||+|+||++ +. .+.++|+|||.+.
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~h~dl~p~nil~--~~~~~~~~l~dfg~~~ 157 (268)
T cd06624 82 IFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLV--NTYSGVVKISDFGTSK 157 (268)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEE--cCCCCeEEEecchhhe
Confidence 999999999999998764 455 88899999999999999999988 9999999999999 54 5689999999887
Q ss_pred cccccCccceeeccCCcccccccCccccCcCC--CCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHhCCCCCCC
Q 020888 193 LIKVQNSHDVYKMTGETGSYRYMAPEVFKHRK--YDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAK-YVAEGHRPFFR 269 (320)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~-~~~~~~~~~~~ 269 (320)
....... ......+++.|+|||.+.+.. ++.++|+||+|++++++++|..||.......... ...........
T Consensus 158 ~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 233 (268)
T cd06624 158 RLAGINP----CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEI 233 (268)
T ss_pred ecccCCC----ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCC
Confidence 6543221 112234688999999986543 7889999999999999999999997654332211 11111111222
Q ss_pred CCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 270 AKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 270 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
+..+++++++++.+||..+|.+|||+.+++.+
T Consensus 234 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 234 PESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred CcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 34578999999999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=275.65 Aligned_cols=246 Identities=28% Similarity=0.443 Sum_probs=199.2
Q ss_pred CCcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeC-----
Q 020888 40 SELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER----- 112 (320)
Q Consensus 40 ~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 112 (320)
....|...+++|+|+||.||++... +..+|+|...++.... -+|+++++.++||||+++..++...
T Consensus 22 ~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k-------nrEl~im~~l~HpNIV~L~~~f~~~~~~d~ 94 (364)
T KOG0658|consen 22 VEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK-------NRELQIMRKLDHPNIVRLLYFFSSSTESDE 94 (364)
T ss_pred eEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC-------cHHHHHHHhcCCcCeeeEEEEEEecCCCch
Confidence 3457889999999999999998875 6899999775544322 2588999999999999998887421
Q ss_pred CceEEEEecCCCCCHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecC
Q 020888 113 KPLMLITEYLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF 188 (320)
Q Consensus 113 ~~~~iv~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~df 188 (320)
-...+||||+|. ||.+.++. +.+++...+.-+.+||+.||.|||..| |+||||||.|++++ ..+|.+|||||
T Consensus 95 ~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~--IcHRDIKPqNlLvD-~~tg~LKicDF 170 (364)
T KOG0658|consen 95 VYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG--ICHRDIKPQNLLVD-PDTGVLKICDF 170 (364)
T ss_pred hHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC--cccCCCChheEEEc-CCCCeEEeccC
Confidence 245789999977 99998874 457899999999999999999999999 99999999999993 34489999999
Q ss_pred CCcccccccCccceeeccCCcccccccCccccCcC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhC----
Q 020888 189 GLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEG---- 263 (320)
Q Consensus 189 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~---- 263 (320)
|+|+.+..+..... ...|..|+|||.+.|. .|+.+.||||.||++.||+-|+.-|.+.+..+....+.+-
T Consensus 171 GSAK~L~~~epniS-----YicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~P 245 (364)
T KOG0658|consen 171 GSAKVLVKGEPNIS-----YICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTP 245 (364)
T ss_pred CcceeeccCCCcee-----EEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCC
Confidence 99999887654333 3468889999998876 5899999999999999999999999887665544322211
Q ss_pred ---------------CCCC--------CCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 264 ---------------HRPF--------FRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 264 ---------------~~~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
..+. ......+++..+|+.++|..+|.+|.++.+++.+
T Consensus 246 t~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 246 TREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred CHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 0000 1124568999999999999999999999999876
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=272.81 Aligned_cols=245 Identities=26% Similarity=0.421 Sum_probs=192.7
Q ss_pred eecccCceEEEEEEEC----CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEecCCC
Q 020888 49 IIGKGSFGEILKAYWR----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRG 124 (320)
Q Consensus 49 ~lg~g~~~~vy~~~~~----~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~ 124 (320)
.||+|+||.||++... ...+++|.+.... .......+.+|++.++.++|+||+++++.+.....+++||||+++
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPL 79 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCC
Confidence 5899999999998653 3467888664332 233346778899999999999999999999999999999999999
Q ss_pred CCHHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCc
Q 020888 125 GDLHKYLKEKG-----ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 199 (320)
Q Consensus 125 ~~L~~~~~~~~-----~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~ 199 (320)
++|.+++.... ..++..+..++.|++.||.|||++| ++|+||||+||++ +.++.++|+|||++........
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill--~~~~~~kl~dfg~~~~~~~~~~ 155 (269)
T cd05042 80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD--FIHSDLALRNCQL--TADLSVKIGDYGLALEQYPEDY 155 (269)
T ss_pred CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC--EecccccHhheEe--cCCCcEEEeccccccccccchh
Confidence 99999997632 2467788999999999999999998 9999999999999 8888999999998865432211
Q ss_pred cceeeccCCcccccccCccccC-------cCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCC----C
Q 020888 200 HDVYKMTGETGSYRYMAPEVFK-------HRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRP----F 267 (320)
Q Consensus 200 ~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~----~ 267 (320)
.. ......++..|+|||... +..++.++|+||||+++|++++ |..||......+........... +
T Consensus 156 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 233 (269)
T cd05042 156 YI--TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKP 233 (269)
T ss_pred ee--ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCC
Confidence 10 112234567799999864 3456789999999999999999 88899887766555444433221 1
Q ss_pred CCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHH
Q 020888 268 FRAKGFTPELRELTEKCWAADMNQRPSFLDILKRL 302 (320)
Q Consensus 268 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 302 (320)
.....++..+.+++..|+ .||.+|||++++++.|
T Consensus 234 ~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 234 QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred cccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 122357889999999998 5999999999999886
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=292.61 Aligned_cols=245 Identities=31% Similarity=0.416 Sum_probs=202.3
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCC-C-----CcccceeeeEEeCCc
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-H-----PNIVQFLGAVTERKP 114 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-h-----~~i~~~~~~~~~~~~ 114 (320)
+|.+.+.||+|+||.|-+|.+. ++.||+|++.+... -..+...|+++|..++ | -|++++++++...+.
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~----f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H 262 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR----FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH 262 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH----HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence 7899999999999999999985 78999999865432 2366778999999996 3 399999999999999
Q ss_pred eEEEEecCCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcc
Q 020888 115 LMLITEYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 192 (320)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~ 192 (320)
.|||+|.+ ..+|.++++.+ ..++...+..++.||+.+|.+||+.| |+|+||||+|||+.+-....||++|||+++
T Consensus 263 lciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~--IIHcDLKPENILL~~~~r~~vKVIDFGSSc 339 (586)
T KOG0667|consen 263 LCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG--IIHCDLKPENILLKDPKRSRIKVIDFGSSC 339 (586)
T ss_pred eeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCChhheeeccCCcCceeEEeccccc
Confidence 99999999 55999999864 36899999999999999999999999 999999999999977777799999999998
Q ss_pred cccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCC--------
Q 020888 193 LIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH-------- 264 (320)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~-------- 264 (320)
.....- .....+..|+|||++.|..|+.+.|||||||++.||++|..-|.+.+..+-...+.+-.
T Consensus 340 ~~~q~v-------ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL 412 (586)
T KOG0667|consen 340 FESQRV-------YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKML 412 (586)
T ss_pred ccCCcc-------eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 654322 14567888999999999999999999999999999999988887766555443222100
Q ss_pred ------------------------------------------CCCCCC-----------CCCCHHHHHHHHHHhhcCCCC
Q 020888 265 ------------------------------------------RPFFRA-----------KGFTPELRELTEKCWAADMNQ 291 (320)
Q Consensus 265 ------------------------------------------~~~~~~-----------~~~~~~l~~li~~~l~~dp~~ 291 (320)
.....+ ..-...+.++|++||..||.+
T Consensus 413 ~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~ 492 (586)
T KOG0667|consen 413 DTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAE 492 (586)
T ss_pred HhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchh
Confidence 000000 011245789999999999999
Q ss_pred CCCHHHHHHH
Q 020888 292 RPSFLDILKR 301 (320)
Q Consensus 292 Rps~~~ll~~ 301 (320)
|+|..++++|
T Consensus 493 R~tp~qal~H 502 (586)
T KOG0667|consen 493 RITPAQALNH 502 (586)
T ss_pred cCCHHHHhcC
Confidence 9999999987
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=272.78 Aligned_cols=254 Identities=30% Similarity=0.529 Sum_probs=206.0
Q ss_pred cCccceecccCceEEEEEEEC-----CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCC-----
Q 020888 44 FSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK----- 113 (320)
Q Consensus 44 y~~~~~lg~g~~~~vy~~~~~-----~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----- 113 (320)
|.+.+.||+|++|.||++.+. ++.+++|.+....... ...+.+.+|+++++.++|+|++++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSS-SDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCCh-HHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 667889999999999999853 5789999886544333 33577889999999999999999999875432
Q ss_pred -ceEEEEecCCCCCHHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEe
Q 020888 114 -PLMLITEYLRGGDLHKYLKEK------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVG 186 (320)
Q Consensus 114 -~~~iv~e~~~~~~L~~~~~~~------~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~ 186 (320)
..+++++|+++++|.+++... ..++...++.++.|++.||+|||+.| ++|+||||+||++ +.++.++|+
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~nili--~~~~~~kl~ 155 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN--FIHRDLAARNCML--NENMTVCVA 155 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccchhhEEE--cCCCCEEEC
Confidence 247889999999999887431 14788999999999999999999988 9999999999999 788899999
Q ss_pred cCCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCC
Q 020888 187 DFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHR 265 (320)
Q Consensus 187 dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~ 265 (320)
|||.+........ ........+++.|++||...+..++.++|+||||+++|++++ |..||...+..+....+.....
T Consensus 156 dfg~~~~~~~~~~--~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~ 233 (273)
T cd05074 156 DFGLSKKIYSGDY--YRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNR 233 (273)
T ss_pred cccccccccCCcc--eecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCc
Confidence 9999886543221 111112234567999999988889999999999999999999 8999988877766666655443
Q ss_pred CCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHH
Q 020888 266 PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKI 305 (320)
Q Consensus 266 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~ 305 (320)
... +...+..+.+++.+||+.+|.+|||+.++++.|+.+
T Consensus 234 ~~~-~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 234 LKQ-PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCC-CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 322 234689999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=278.56 Aligned_cols=247 Identities=27% Similarity=0.465 Sum_probs=205.4
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEe
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 120 (320)
.|.....||.|++|.||++.+. +..+++|.+.... ....+.+.+|+..++.++|+|++++++.+..++..++|||
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e 99 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVME 99 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch---HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEe
Confidence 4555678999999999999874 7889999874422 2334678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCcc
Q 020888 121 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 200 (320)
Q Consensus 121 ~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~ 200 (320)
|+++++|.+++.. +.+++..++.++.|++.||.|||+.| ++|+||+|+||++ +.++.++|+|||++........
T Consensus 100 ~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill--~~~~~~kL~dfg~~~~~~~~~~- 173 (292)
T cd06658 100 FLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQG--VIHRDIKSDSILL--TSDGRIKLSDFGFCAQVSKEVP- 173 (292)
T ss_pred CCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEE--cCCCCEEEccCcchhhcccccc-
Confidence 9999999998865 46899999999999999999999998 9999999999999 8888999999998875532211
Q ss_pred ceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCC-CCCCCCHHHHH
Q 020888 201 DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFF-RAKGFTPELRE 279 (320)
Q Consensus 201 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~ 279 (320)
......++..|+|||.+.+..++.++|+||||+++|++++|..||...+.......+........ ....++..+.+
T Consensus 174 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (292)
T cd06658 174 ---KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRG 250 (292)
T ss_pred ---cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHH
Confidence 11224578899999999988899999999999999999999999987776655444443322221 22346889999
Q ss_pred HHHHHhhcCCCCCCCHHHHHHH
Q 020888 280 LTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 280 li~~~l~~dp~~Rps~~~ll~~ 301 (320)
++..||..||.+|||+++++++
T Consensus 251 li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 251 FLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred HHHHHccCChhHCcCHHHHhhC
Confidence 9999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=272.36 Aligned_cols=249 Identities=29% Similarity=0.506 Sum_probs=208.0
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEe
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 120 (320)
+|.+.+.||.|++|.||++.++ +..+++|.+........ ..+.+.+|+.+++.++|+|++++++.+..+...++++|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVK-EKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccch-hhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 4788899999999999999986 68899998865433222 23677889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCC-cEEEecCCCccccccc
Q 020888 121 YLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQ 197 (320)
Q Consensus 121 ~~~~~~L~~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~-~~~L~dfg~~~~~~~~ 197 (320)
|+++++|.+++.... .+++..+..++.|++.+|.|||+.+ ++|+||+|+||++ +.++ .++|+|||.+......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~nil~--~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK--ILHRDIKSQNIFL--SKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEE--cCCCCeEEecccccchhccCC
Confidence 999999999987643 4799999999999999999999988 9999999999999 6654 5699999988765432
Q ss_pred CccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHH
Q 020888 198 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPEL 277 (320)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 277 (320)
.. ......+++.|+|||...+..++.++|+||||++++++++|..||...+..+.............. ..++.++
T Consensus 156 ~~----~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 230 (257)
T cd08225 156 ME----LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPIS-PNFSRDL 230 (257)
T ss_pred cc----cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCC-CCCCHHH
Confidence 21 112235788899999998888999999999999999999999999877766666555554443332 3478999
Q ss_pred HHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 278 RELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 278 ~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
++++.+|+..+|.+|||+.+++++
T Consensus 231 ~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 231 RSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred HHHHHHHhccChhhCcCHHHHhhC
Confidence 999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=275.79 Aligned_cols=252 Identities=28% Similarity=0.492 Sum_probs=204.9
Q ss_pred CCCCcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcccceeeeEEeC--
Q 020888 38 DPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTER-- 112 (320)
Q Consensus 38 ~~~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~-- 112 (320)
.....+|.+.+.||+|++|.||++... ++.+++|.+..... ....+.+|+.+++++ +|+|++++++++...
T Consensus 18 ~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~ 93 (291)
T cd06639 18 GDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD----VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADK 93 (291)
T ss_pred CCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc----HHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccc
Confidence 344668999999999999999999885 78899998754321 125677899999999 799999999988643
Q ss_pred ---CceEEEEecCCCCCHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEE
Q 020888 113 ---KPLMLITEYLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKV 185 (320)
Q Consensus 113 ---~~~~iv~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L 185 (320)
+..++|+||+++++|.++++. ...+++..++.++.|++.||.+||+.| ++|+||+|+||++ +.++.++|
T Consensus 94 ~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~nili--~~~~~~kl 169 (291)
T cd06639 94 LVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR--IIHRDVKGNNILL--TTEGGVKL 169 (291)
T ss_pred cCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEE--cCCCCEEE
Confidence 358999999999999998863 356899999999999999999999988 9999999999999 88889999
Q ss_pred ecCCCcccccccCccceeeccCCcccccccCccccCcC-----CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 020888 186 GDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR-----KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYV 260 (320)
Q Consensus 186 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~ 260 (320)
+|||.+........ ......++..|+|||.+... .++.++|+||||+++|++++|..||...+.......+
T Consensus 170 ~dfg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~ 245 (291)
T cd06639 170 VDFGVSAQLTSTRL----RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKI 245 (291)
T ss_pred eecccchhcccccc----cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHH
Confidence 99999876543221 11234578889999987543 3678999999999999999999999887765555545
Q ss_pred HhCCCCCC-CCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 261 AEGHRPFF-RAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 261 ~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
.....+.. .+..++.++.+++.+||..+|++||++.+++++
T Consensus 246 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 246 PRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred hcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 44433222 234567899999999999999999999999875
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=276.89 Aligned_cols=251 Identities=27% Similarity=0.459 Sum_probs=203.6
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEe
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 120 (320)
+|++.+.||+|++|.||++.+. ++.+++|.+...... ....+.+.+|+++++.++|+|++++++++..++..++++|
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDD-EDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhccc-ccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 6889999999999999999885 678999987654332 2233678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCcc
Q 020888 121 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 200 (320)
Q Consensus 121 ~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~ 200 (320)
|++++.|..+......+++..++.++.+++.||.+||+.| ++|+||+|+||++ +.++.++|+|||.+........
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~ni~~--~~~~~~kl~d~g~~~~~~~~~~- 155 (288)
T cd07833 81 YVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN--IIHRDIKPENILV--SESGVLKLCDFGFARALRARPA- 155 (288)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEE--CCCCCEEEEeeecccccCCCcc-
Confidence 9988667666666567999999999999999999999988 9999999999999 8889999999999876654322
Q ss_pred ceeeccCCcccccccCccccCcC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCC---------------
Q 020888 201 DVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH--------------- 264 (320)
Q Consensus 201 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~--------------- 264 (320)
.......++..|+|||...+. .++.++|+||||++++++++|..||......+....+....
T Consensus 156 --~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07833 156 --SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNP 233 (288)
T ss_pred --ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCc
Confidence 111234567889999999888 78899999999999999999999998665444332221100
Q ss_pred -------CCC--------CCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 265 -------RPF--------FRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 265 -------~~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
... ..+..++.++++++++||..+|++|||+++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 000 0112248889999999999999999999998864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=271.65 Aligned_cols=242 Identities=28% Similarity=0.393 Sum_probs=197.5
Q ss_pred ceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHH-HhCCCCcccceeeeEEeCCceEEEEecCCC
Q 020888 48 AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLL-VKLRHPNIVQFLGAVTERKPLMLITEYLRG 124 (320)
Q Consensus 48 ~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l-~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~ 124 (320)
+.||.|++|.||++.+. ++.+|+|.+.............+..|..++ ...+|+|++++++.+..++.+|+++||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 57899999999999884 789999988654332222233444454444 444899999999999999999999999999
Q ss_pred CCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCccceee
Q 020888 125 GDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK 204 (320)
Q Consensus 125 ~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~~~~~ 204 (320)
++|.++++..+.+++..+..++.|++.||.|||+.| ++|+||+|+||++ +.++.++|+|||++.....
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--i~H~dl~p~nil~--~~~~~~~l~dfg~~~~~~~-------- 149 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG--IIHRDIKPENLLI--DQTGHLKLTDFGLSRNGLE-------- 149 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEE--CCCCcEEEeecccceeccc--------
Confidence 999999988778999999999999999999999988 9999999999999 7888999999998865432
Q ss_pred ccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCC--CCCCCCCCHHHHHHHH
Q 020888 205 MTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRP--FFRAKGFTPELRELTE 282 (320)
Q Consensus 205 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~ 282 (320)
.....++..|+|||...+..++.++|+||||+++|++++|..||...+.......+...... ......++.++.+++.
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 229 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLIN 229 (260)
T ss_pred cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHH
Confidence 12245678899999998888899999999999999999999999887776665555443322 1222357899999999
Q ss_pred HHhhcCCCCCCCH---HHHHHH
Q 020888 283 KCWAADMNQRPSF---LDILKR 301 (320)
Q Consensus 283 ~~l~~dp~~Rps~---~~ll~~ 301 (320)
+||..+|.+||++ ++++.+
T Consensus 230 ~~l~~~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 230 RLLCMDPAKRLGANGYQEIKSH 251 (260)
T ss_pred HHccCCHHHccCCCcHHHHHcC
Confidence 9999999999965 555544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=271.54 Aligned_cols=235 Identities=25% Similarity=0.469 Sum_probs=190.4
Q ss_pred ceecccCceEEEEEEECCC------------ceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCce
Q 020888 48 AIIGKGSFGEILKAYWRGT------------PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL 115 (320)
Q Consensus 48 ~~lg~g~~~~vy~~~~~~~------------~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 115 (320)
+.||+|+||.||++.+.+. .+++|.+...... ...+.+|+.+++.++|+|++++++++.. ...
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD----SLAFFETASLMSQLSHKHLVKLYGVCVR-DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh----HHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence 4689999999999998633 3777766443221 3788889999999999999999999887 778
Q ss_pred EEEEecCCCCCHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCC-------cEEEec
Q 020888 116 MLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD-------HLKVGD 187 (320)
Q Consensus 116 ~iv~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~-------~~~L~d 187 (320)
++|+||+++++|.+++...+ .+++..+..++.|++.||.|||+.| ++|+||||+||++ +.++ .++|+|
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dlkp~Nill--~~~~~~~~~~~~~kl~D 151 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK--LVHGNVCGKNILV--ARYGLNEGYVPFIKLSD 151 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC--eecccCccceEEE--ecCccccCCceeEEeCC
Confidence 99999999999999998755 7899999999999999999999988 9999999999999 5555 799999
Q ss_pred CCCcccccccCccceeeccCCcccccccCccccCcC--CCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCC
Q 020888 188 FGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR--KYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGH 264 (320)
Q Consensus 188 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~ 264 (320)
||.+...... ....++..|+|||.+.+. .++.++|+||||++++++++ |..||...+..+.........
T Consensus 152 fg~a~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~~ 223 (259)
T cd05037 152 PGIPITVLSR--------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQH 223 (259)
T ss_pred CCcccccccc--------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcCC
Confidence 9998765431 122355679999999876 78899999999999999999 688887775443333222221
Q ss_pred CCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHH
Q 020888 265 RPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRL 302 (320)
Q Consensus 265 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 302 (320)
.. +......+.+++.+||..+|.+|||+.++++.|
T Consensus 224 ~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 224 RL---PMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred CC---CCCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 11 111247999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=275.93 Aligned_cols=249 Identities=27% Similarity=0.448 Sum_probs=199.4
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEe
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 120 (320)
+|+.++.||.|++|.||++.++ ++.+++|.+....... .....+.+|++++++++|+|++++++++.+++..+++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccccc-ccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 4888999999999999999875 7889999876443222 223578889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccC
Q 020888 121 YLRGGDLHKYLKE--KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 198 (320)
Q Consensus 121 ~~~~~~L~~~~~~--~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~ 198 (320)
|++ ++|.+++.. ...+++..++.++.|++.||.|||+.| ++|+||+|+||++ +.++.++|+|||.+.......
T Consensus 80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~--i~H~~l~p~nill--~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLI--NTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEE--CCCCCEEEeeccchhhcccCc
Confidence 996 589998865 346899999999999999999999998 9999999999999 888899999999887553321
Q ss_pred ccceeeccCCcccccccCccccCcCC-CCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCC----------
Q 020888 199 SHDVYKMTGETGSYRYMAPEVFKHRK-YDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPF---------- 267 (320)
Q Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~---------- 267 (320)
. ......++..|.|||.+.+.. ++.++|+||||+++|++++|..||...+..+....+.......
T Consensus 155 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07860 155 R----TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 230 (284)
T ss_pred c----ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhH
Confidence 1 112234578899999887654 5889999999999999999999997765443332222111000
Q ss_pred ----------C-------CCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 268 ----------F-------RAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 268 ----------~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
. ....++.+++++|.+||+.||.+|||+++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 231 LPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 0 012367889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=278.53 Aligned_cols=250 Identities=33% Similarity=0.481 Sum_probs=210.2
Q ss_pred CCcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEE
Q 020888 40 SELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLML 117 (320)
Q Consensus 40 ~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 117 (320)
....|...+.||.|++|.||++.+. +..+++|.+.............+.+|+++++.++|+|++++.+++......++
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 92 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 92 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEE
Confidence 4456888999999999999999985 67899998865444444445678889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccc
Q 020888 118 ITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 196 (320)
Q Consensus 118 v~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~ 196 (320)
|+||+. ++|.+.+.. ...+++..+..++.|++.++.+||+.| ++|+||+|+||++ +.++.++|+|||.+.....
T Consensus 93 v~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nil~--~~~~~~kl~dfg~~~~~~~ 167 (308)
T cd06634 93 VMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILL--SEPGLVKLGDFGSASIMAP 167 (308)
T ss_pred EEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHhEEE--CCCCcEEECCcccceeecC
Confidence 999996 488877654 446899999999999999999999988 9999999999999 7888999999998865432
Q ss_pred cCccceeeccCCcccccccCccccC---cCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCC
Q 020888 197 QNSHDVYKMTGETGSYRYMAPEVFK---HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGF 273 (320)
Q Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (320)
. ....++..|+|||.+. ...++.++|+||||++++++++|..||...+..+..........+......+
T Consensus 168 ~--------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (308)
T cd06634 168 A--------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW 239 (308)
T ss_pred c--------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccc
Confidence 1 2235678899999874 3567889999999999999999999998877766666566655555555568
Q ss_pred CHHHHHHHHHHhhcCCCCCCCHHHHHHHH
Q 020888 274 TPELRELTEKCWAADMNQRPSFLDILKRL 302 (320)
Q Consensus 274 ~~~l~~li~~~l~~dp~~Rps~~~ll~~L 302 (320)
+..++++|.+||..+|.+||++++++++-
T Consensus 240 ~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 240 SEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred cHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 99999999999999999999999998873
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=275.11 Aligned_cols=247 Identities=28% Similarity=0.545 Sum_probs=199.0
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHH-HHhCCCCcccceeeeEEeCCceEEEE
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNL-LVKLRHPNIVQFLGAVTERKPLMLIT 119 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~~~~~~iv~ 119 (320)
+|++.+.||+|+||.||++.+. ++.||+|.+........ ...+..|+.. ++.++|+|++++++++..++..++++
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~ 79 (283)
T cd06617 2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE--QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM 79 (283)
T ss_pred CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHH--HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence 6889999999999999999985 78999998865433222 2345556655 55568999999999999999999999
Q ss_pred ecCCCCCHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHhcC-CCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccc
Q 020888 120 EYLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLHNE-PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 194 (320)
Q Consensus 120 e~~~~~~L~~~~~~----~~~l~~~~~~~i~~~l~~~l~~lH~~-g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~ 194 (320)
||++ ++|.+++.. ...+++..++.++.|++.||.|||++ + ++|+||+|+||++ +.++.++|+|||.+...
T Consensus 80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~--i~h~dlkp~nil~--~~~~~~kl~dfg~~~~~ 154 (283)
T cd06617 80 EVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS--VIHRDVKPSNVLI--NRNGQVKLCDFGISGYL 154 (283)
T ss_pred hhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEE--CCCCCEEEeeccccccc
Confidence 9996 488888764 23689999999999999999999997 7 9999999999999 88899999999998765
Q ss_pred cccCccceeeccCCcccccccCccccCc----CCCCCchhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHhCCCCCCC
Q 020888 195 KVQNSHDVYKMTGETGSYRYMAPEVFKH----RKYDKKVDVFSFAMILYEMLEGEPPLANYE-PYEAAKYVAEGHRPFFR 269 (320)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~l~~ll~g~~p~~~~~-~~~~~~~~~~~~~~~~~ 269 (320)
.... ......++..|+|||.+.+ ..++.++|+||||+++|++++|..||.... ..+..........+...
T Consensus 155 ~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd06617 155 VDSV-----AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLP 229 (283)
T ss_pred cccc-----ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCC
Confidence 3221 1122356788999998865 346789999999999999999999997643 33444444444444444
Q ss_pred CCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 270 AKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 270 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
...++.++.+++.+||..+|.+||++++++++
T Consensus 230 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 230 AEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 45689999999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=276.99 Aligned_cols=250 Identities=28% Similarity=0.503 Sum_probs=207.3
Q ss_pred CCcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEE
Q 020888 40 SELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLML 117 (320)
Q Consensus 40 ~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 117 (320)
...+|.+.+.||+|++|.||++.+. +..+++|.+..... ...+.+.+|+.+++.++|+|++++++.+..++..++
T Consensus 17 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~l 93 (293)
T cd06647 17 PKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ---PKKELIINEILVMRENKHPNIVNYLDSYLVGDELWV 93 (293)
T ss_pred chhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc---hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEE
Confidence 3468999999999999999999864 67899998743322 223678889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccccccc
Q 020888 118 ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 197 (320)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~ 197 (320)
|+||+++++|.+++.+. .+++..+..++.+++.||.+||+.| ++|+||+|+||++ +.++.++|+|||.+......
T Consensus 94 v~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~g--i~H~dL~p~Nili--~~~~~~kL~dfg~~~~~~~~ 168 (293)
T cd06647 94 VMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILL--GMDGSVKLTDFGFCAQITPE 168 (293)
T ss_pred EEecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC--EeeccCCHHHEEE--cCCCCEEEccCcceeccccc
Confidence 99999999999998764 5789999999999999999999998 9999999999999 78889999999987655432
Q ss_pred CccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCC-CCCCCCHH
Q 020888 198 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFF-RAKGFTPE 276 (320)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 276 (320)
.. ......+++.|+|||.+.+..++.++|+||||++++++++|..||...+.......+.....+.. ....++..
T Consensus 169 ~~----~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (293)
T cd06647 169 QS----KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAI 244 (293)
T ss_pred cc----ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHH
Confidence 21 12234577889999999888899999999999999999999999987665444333332222222 23346789
Q ss_pred HHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 277 LRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 277 l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
+++++.+||..+|++||++.+++.+
T Consensus 245 l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 245 FRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred HHHHHHHHccCChhhCcCHHHHhcC
Confidence 9999999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=290.79 Aligned_cols=245 Identities=24% Similarity=0.357 Sum_probs=194.9
Q ss_pred CcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEE
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 118 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 118 (320)
+..|.+.+.||+|+||.||++.+. ++.|++|.... ..+.+|++++++++|+||+++++++..++..+++
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv 238 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLV 238 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 447999999999999999999986 67899995321 3456799999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccccccc
Q 020888 119 TEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 197 (320)
Q Consensus 119 ~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~ 197 (320)
++++. ++|.+++... ..+++..++.++.|++.||.|||++| |+|+||||+||++ +.++.++|+|||+++.....
T Consensus 239 ~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDLKP~NILl--~~~~~vkL~DFGla~~~~~~ 313 (461)
T PHA03211 239 LPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG--IIHRDIKTENVLV--NGPEDICLGDFGAACFARGS 313 (461)
T ss_pred EEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEECcCCHHHEEE--CCCCCEEEcccCCceecccc
Confidence 99995 5888888653 46999999999999999999999998 9999999999999 88889999999998765432
Q ss_pred CccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCC--------hHHHHHHHHhCCC----
Q 020888 198 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYE--------PYEAAKYVAEGHR---- 265 (320)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~--------~~~~~~~~~~~~~---- 265 (320)
... .......||..|+|||++.+..++.++|||||||++|++++|..|+-... .......+.....
T Consensus 314 ~~~--~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~ 391 (461)
T PHA03211 314 WST--PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDE 391 (461)
T ss_pred ccc--ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcccccc
Confidence 111 11123568999999999999999999999999999999999876543221 1111221111110
Q ss_pred ----------------------CCCC------CCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 266 ----------------------PFFR------AKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 266 ----------------------~~~~------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
+... ...++.++.+||..||+.||.+|||+.|+|++
T Consensus 392 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 392 FPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred CCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0000 01345689999999999999999999999986
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=277.67 Aligned_cols=263 Identities=22% Similarity=0.369 Sum_probs=202.4
Q ss_pred CCCcCCCCCcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEE
Q 020888 33 CDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVT 110 (320)
Q Consensus 33 ~~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 110 (320)
.+|.....-.+|.+.+.||.|++|.||++.+. ++.+++|.+......... ...+.+|++++++++|+||+++++++.
T Consensus 3 ~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~ 81 (310)
T cd07865 3 YEFPFCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGF-PITALREIKILQLLKHENVVNLIEICR 81 (310)
T ss_pred ccCcccchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCc-hhHHHHHHHHHHhCCCCCccceEEEEe
Confidence 44555556668999999999999999999985 788999987544322221 135567999999999999999999886
Q ss_pred eCC--------ceEEEEecCCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCC
Q 020888 111 ERK--------PLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD 181 (320)
Q Consensus 111 ~~~--------~~~iv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~ 181 (320)
... ..++|+||+.+ +|.+++... ..+++..++.++.|++.||.|||+.| ++|+||+|+||++ +.++
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dl~p~nil~--~~~~ 156 (310)
T cd07865 82 TKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNK--ILHRDMKAANILI--TKDG 156 (310)
T ss_pred cccccccCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEE--CCCC
Confidence 543 35999999955 888887654 36899999999999999999999998 9999999999999 8889
Q ss_pred cEEEecCCCcccccccCccceeeccCCcccccccCccccCcC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 020888 182 HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYV 260 (320)
Q Consensus 182 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~ 260 (320)
.++|+|||.+..................++..|+|||.+.+. .++.++|+||||+++|++++|..||...+.......+
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~ 236 (310)
T cd07865 157 ILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLI 236 (310)
T ss_pred cEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 999999999987654332221122234567889999988665 3688999999999999999999999876654332222
Q ss_pred HhC---CCCCC---------------------------CCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 261 AEG---HRPFF---------------------------RAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 261 ~~~---~~~~~---------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
..- ..+.. .....+..+.++|.+||..||.+|||+++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 237 SQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred HHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 110 00000 001125678899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=277.10 Aligned_cols=250 Identities=29% Similarity=0.436 Sum_probs=202.1
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCC--cHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEE
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSD--DRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 118 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 118 (320)
+|.+.+.||.|++|.||++.+. ++.+++|.+...... .......+.+|+++++.++|+|++++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4788899999999999999875 789999988655433 122235677899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccccccc
Q 020888 119 TEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 197 (320)
Q Consensus 119 ~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~ 197 (320)
|||+ +++|.+++.... .+++..+..++.|+++||.|||++| ++|+||+|+||++ +.++.++|+|||++......
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nill--~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW--ILHRDLKPNNLLI--ASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCChhhEEE--cCCCCEEEccceeeeeccCC
Confidence 9999 889999998765 7999999999999999999999998 9999999999999 88899999999998766443
Q ss_pred CccceeeccCCcccccccCccccCc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCC---------
Q 020888 198 NSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPF--------- 267 (320)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~--------- 267 (320)
.. ......+++.|.|||.+.+ ..++.++|+||||++++++++|..+|...+..+....+.......
T Consensus 156 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (298)
T cd07841 156 NR----KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVT 231 (298)
T ss_pred Cc----cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcc
Confidence 21 1122345778999998865 457899999999999999999988787665544333332211000
Q ss_pred -----------------CCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 268 -----------------FRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 268 -----------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
......+.++.+++.+||..+|.+|||+.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0012347889999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=285.96 Aligned_cols=242 Identities=26% Similarity=0.392 Sum_probs=191.0
Q ss_pred CcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEE
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 118 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 118 (320)
..+|.+++.||+|+||.||++.+. +..+|+|..... ....|+.++++++|+||+++++++..+...++|
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 135 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV 135 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence 447999999999999999999986 568999965322 234589999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccccccc
Q 020888 119 TEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 197 (320)
Q Consensus 119 ~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~ 197 (320)
+|++. ++|.+++.. ...+++..++.++.|++.||.|||++| |+|+||||+||++ +.++.++|+|||.+......
T Consensus 136 ~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill--~~~~~~kl~DfG~a~~~~~~ 210 (357)
T PHA03209 136 LPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR--IIHRDVKTENIFI--NDVDQVCIGDLGAAQFPVVA 210 (357)
T ss_pred EEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEE--CCCCCEEEecCccccccccC
Confidence 99995 488888765 457899999999999999999999998 9999999999999 88899999999998643221
Q ss_pred CccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCC-CCCChH--H-------HHHHHHhC--CC
Q 020888 198 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPL-ANYEPY--E-------AAKYVAEG--HR 265 (320)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~-~~~~~~--~-------~~~~~~~~--~~ 265 (320)
. ......+++.|+|||++.+..++.++|+|||||++|+++++..++ ...... . ....+... ..
T Consensus 211 ~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 285 (357)
T PHA03209 211 P-----AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVH 285 (357)
T ss_pred c-----ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccC
Confidence 1 122345889999999999999999999999999999999865544 322110 0 00000000 00
Q ss_pred ----C--------------------------CCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 266 ----P--------------------------FFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 266 ----~--------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
+ ......++.++.++|.+||+.||.+|||+++++++
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h 351 (357)
T PHA03209 286 PEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY 351 (357)
T ss_pred hhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence 0 00112356778889999999999999999999976
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=270.16 Aligned_cols=247 Identities=28% Similarity=0.415 Sum_probs=193.0
Q ss_pred ceecccCceEEEEEEEC----CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEecCC
Q 020888 48 AIIGKGSFGEILKAYWR----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLR 123 (320)
Q Consensus 48 ~~lg~g~~~~vy~~~~~----~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 123 (320)
+.||+|+||.||++... +..+++|.+...... .....+.+|+.++++++|+|++++++.+.+....++||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASV--QEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP 78 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCCh--HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence 36899999999999764 356888877544322 223578889999999999999999999998889999999999
Q ss_pred CCCHHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccC
Q 020888 124 GGDLHKYLKEKG-----ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 198 (320)
Q Consensus 124 ~~~L~~~~~~~~-----~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~ 198 (320)
+++|.+++.... ..++..+..++.|++.|+.|||+.| ++|+||||+||++ +.++.++|+|||.+.......
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dlkp~nil~--~~~~~~kL~dfg~~~~~~~~~ 154 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN--FIHSDLALRNCLL--TADLTVKIGDYGLSHNKYKED 154 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEE--cCCCcEEECCccccccccCcc
Confidence 999999986422 3567788899999999999999988 9999999999999 778899999999886543221
Q ss_pred ccceeeccCCcccccccCccccCcC-------CCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCC-C---C
Q 020888 199 SHDVYKMTGETGSYRYMAPEVFKHR-------KYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGH-R---P 266 (320)
Q Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~~-------~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~-~---~ 266 (320)
. ........++..|+|||.+.+. .++.++|+||||++++++++ |..||......+......... . .
T Consensus 155 ~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 232 (269)
T cd05087 155 Y--YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPK 232 (269)
T ss_pred e--eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCC
Confidence 1 1111234467789999988642 35789999999999999996 999998776655433322221 1 1
Q ss_pred CCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHH
Q 020888 267 FFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLE 303 (320)
Q Consensus 267 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~ 303 (320)
.......++.+.+++.+|+ .+|++|||++++.+.|+
T Consensus 233 ~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 233 PRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 1112346788999999998 68999999999998764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=276.01 Aligned_cols=245 Identities=30% Similarity=0.490 Sum_probs=206.8
Q ss_pred cCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEec
Q 020888 44 FSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY 121 (320)
Q Consensus 44 y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 121 (320)
|...+.||+|++|+||++.+. +..+++|.+.............+.+|+++++.++|+|++++++++.++...|++|||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 677788999999999999874 788999988655444444556788899999999999999999999999999999999
Q ss_pred CCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCcc
Q 020888 122 LRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 200 (320)
Q Consensus 122 ~~~~~L~~~~~~-~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~ 200 (320)
+.+ +|.+++.. ..++++..+..++.|++.+|.|||+.| ++|+||+|+||++ +.++.++|+|||.+.....
T Consensus 103 ~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dl~p~nili--~~~~~~kL~dfg~~~~~~~---- 173 (313)
T cd06633 103 CLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILL--TEPGQVKLADFGSASKSSP---- 173 (313)
T ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChhhEEE--CCCCCEEEeecCCCcccCC----
Confidence 965 78877764 456899999999999999999999998 9999999999999 8888999999998753221
Q ss_pred ceeeccCCcccccccCccccC---cCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHH
Q 020888 201 DVYKMTGETGSYRYMAPEVFK---HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPEL 277 (320)
Q Consensus 201 ~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 277 (320)
.....++..|+|||.+. +..++.++|+||||++++++++|..||...+.......+.....+......++..+
T Consensus 174 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 249 (313)
T cd06633 174 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSF 249 (313)
T ss_pred ----CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHH
Confidence 22345788899999974 45688899999999999999999999988776666555555555544455678899
Q ss_pred HHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 278 RELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 278 ~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
++++.+||+.+|.+||++.+++++
T Consensus 250 ~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 250 RGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred HHHHHHHccCChhhCcCHHHHhcC
Confidence 999999999999999999999875
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=283.09 Aligned_cols=254 Identities=24% Similarity=0.407 Sum_probs=203.2
Q ss_pred cccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEE----eCCce
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVT----ERKPL 115 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~----~~~~~ 115 (320)
.+|++.+.||.|++|.||++.+. ++.+++|.+....... .....+.+|+.+++.++|+||+++++++. .....
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVP-TLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccc-cchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 68999999999999999999875 7889999886543322 23467778999999999999999998875 34568
Q ss_pred EEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccccc
Q 020888 116 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 195 (320)
Q Consensus 116 ~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~ 195 (320)
++|+||+. ++|.+++...+.+++..+..++.|++.||.|||+.| ++|+||+|+||++ +.++.++|+|||.+....
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~Nil~--~~~~~~kl~dfg~~~~~~ 158 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLV--NEDCELRIGDFGMARGLS 158 (334)
T ss_pred EEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEE--cCCCcEEecccccceeec
Confidence 99999995 599999987778999999999999999999999988 9999999999999 888999999999987665
Q ss_pred ccCccceeeccCCcccccccCccccCc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh------------
Q 020888 196 VQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAE------------ 262 (320)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~------------ 262 (320)
..............++..|.|||.+.+ ..++.++|+||||+++|++++|..||...+.......+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~ 238 (334)
T cd07855 159 SSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNR 238 (334)
T ss_pred ccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhh
Confidence 433222222334567889999998765 4588999999999999999999999977654322211111
Q ss_pred -----------CC--CCCC----CCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 263 -----------GH--RPFF----RAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 263 -----------~~--~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
.. .... .....+.+++++|++||+.+|.+|||+.+++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 239 IGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00 0000 013368899999999999999999999999886
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=274.09 Aligned_cols=248 Identities=29% Similarity=0.457 Sum_probs=200.1
Q ss_pred cCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEec
Q 020888 44 FSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY 121 (320)
Q Consensus 44 y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 121 (320)
|++.+.||.|++|.||++.++ +..+++|.+........ ....+.+|++.++.++|++++++++++.+++..++++||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEG-VPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccccc-chhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 678899999999999999875 88899998865432221 225677899999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCc
Q 020888 122 LRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 199 (320)
Q Consensus 122 ~~~~~L~~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~ 199 (320)
++ ++|.+++.... .+++..++.++.|++.+|.+||+.+ ++|+||+|+||++ +.++.++|+|||.+........
T Consensus 80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~--~~H~dl~p~nil~--~~~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR--VLHRDLKPQNLLI--DREGALKLADFGLARAFGVPVR 154 (283)
T ss_pred cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEE--cCCCcEEEeecccccccCCCcc
Confidence 95 59999998755 6899999999999999999999988 9999999999999 7789999999999875533211
Q ss_pred cceeeccCCcccccccCccccCcC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCC-------------
Q 020888 200 HDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHR------------- 265 (320)
Q Consensus 200 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~------------- 265 (320)
......++..|+|||.+.+. .++.++|+||||+++|++++|+.||...+..+....+.+...
T Consensus 155 ----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd07835 155 ----TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSL 230 (283)
T ss_pred ----ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhc
Confidence 11223457889999988664 568899999999999999999999987665443322221100
Q ss_pred --------------CCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 266 --------------PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 266 --------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
.......++.++.+++.+||+.+|.+|||+++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 231 PDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000123467899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=271.03 Aligned_cols=237 Identities=23% Similarity=0.407 Sum_probs=189.3
Q ss_pred ceecccCceEEEEEEEC--------------CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCC
Q 020888 48 AIIGKGSFGEILKAYWR--------------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK 113 (320)
Q Consensus 48 ~~lg~g~~~~vy~~~~~--------------~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 113 (320)
+.||+|++|.||++... ...+++|.+.... ......+.+|+.+++.++||||+++++++....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~ 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVRDV 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 36899999999999742 2358888765432 223357888999999999999999999999988
Q ss_pred ceEEEEecCCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCC-------cEEE
Q 020888 114 PLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD-------HLKV 185 (320)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~-------~~~L 185 (320)
..+++|||+++++|..++.. .+.+++..++.++.|+++||.|||++| ++|+||||+||++ +.++ .+++
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nill--~~~~~~~~~~~~~~l 153 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKD--LVHGNVCTKNILL--AREGIDGECGPFIKL 153 (262)
T ss_pred CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC--eECCCCCcccEEE--ecCCccCCCCceeEe
Confidence 99999999999999998875 356899999999999999999999988 9999999999999 4433 3899
Q ss_pred ecCCCcccccccCccceeeccCCcccccccCccccC-cCCCCCchhHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHhC
Q 020888 186 GDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFK-HRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKYVAEG 263 (320)
Q Consensus 186 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~ll-~g~~p~~~~~~~~~~~~~~~~ 263 (320)
+|||.+...... ....++..|+|||... +..++.++||||||+++|+++ +|..||......+... ....
T Consensus 154 ~d~g~~~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-~~~~ 224 (262)
T cd05077 154 SDPGIPITVLSR--------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-FYEG 224 (262)
T ss_pred CCCCCCccccCc--------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-HHhc
Confidence 999987654321 2234677899999886 566889999999999999997 5888887655443322 2222
Q ss_pred CCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHH
Q 020888 264 HRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRL 302 (320)
Q Consensus 264 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 302 (320)
.... ....++++++++.+||+.||++||++.++++++
T Consensus 225 ~~~~--~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 225 QCML--VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred CccC--CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 2221 122468899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=273.45 Aligned_cols=242 Identities=28% Similarity=0.412 Sum_probs=192.4
Q ss_pred eecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHh---CCCCcccceeeeEEeCCceEEEEecCC
Q 020888 49 IIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVK---LRHPNIVQFLGAVTERKPLMLITEYLR 123 (320)
Q Consensus 49 ~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~---l~h~~i~~~~~~~~~~~~~~iv~e~~~ 123 (320)
+||+|+||.||++.+. ++.+|+|.+.+.............++..++.. .+|++++.+++.+..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999875 78899998866543322222333444443333 469999999999998899999999999
Q ss_pred CCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCcccee
Q 020888 124 GGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 203 (320)
Q Consensus 124 ~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~~~~ 203 (320)
+++|.+++..++.+++..+..++.|++.||.|||+.| ++|+||||+||++ +.++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dikp~Nil~--~~~~~~~l~dfg~~~~~~~~~----- 151 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRF--VVYRDLKPANILL--DEHGHVRISDLGLACDFSKKK----- 151 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cCCCCCCHHHEEE--CCCCCEEEccCCcceeccccC-----
Confidence 9999999988788999999999999999999999998 9999999999999 888899999999986553321
Q ss_pred eccCCcccccccCccccC-cCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHhCCCCCCCCCCCCHHHHHH
Q 020888 204 KMTGETGSYRYMAPEVFK-HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPY--EAAKYVAEGHRPFFRAKGFTPELREL 280 (320)
Q Consensus 204 ~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~l 280 (320)
.....++..|+|||.+. +..++.++|+||+|+++|++++|..||...... ......... .....+..++.+++++
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l 229 (279)
T cd05633 152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT-VNVELPDSFSPELKSL 229 (279)
T ss_pred -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhc-CCcCCccccCHHHHHH
Confidence 12245788999999986 456889999999999999999999999754322 222222211 1222334578999999
Q ss_pred HHHHhhcCCCCCC-----CHHHHHHH
Q 020888 281 TEKCWAADMNQRP-----SFLDILKR 301 (320)
Q Consensus 281 i~~~l~~dp~~Rp-----s~~~ll~~ 301 (320)
+.+||..||.+|| |+++++++
T Consensus 230 i~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 230 LEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred HHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 9999999999999 69999886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=282.48 Aligned_cols=247 Identities=27% Similarity=0.354 Sum_probs=199.2
Q ss_pred cccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeC------C
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER------K 113 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~ 113 (320)
.+|.+.+.||+|++|.||++.+. ++.+|+|.+....... .....+.+|+++++.++|+|++++++++... .
T Consensus 16 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNV-THAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred cceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccCh-hHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 57999999999999999999975 7889999886543332 2335677899999999999999999987533 3
Q ss_pred ceEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccc
Q 020888 114 PLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 193 (320)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~ 193 (320)
..|+|+||+++ +|.+.+... ++...+..++.|++.||++||+.| ++|+||||+||++ +.++.++|+|||.+..
T Consensus 95 ~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nil~--~~~~~~kL~Dfg~~~~ 167 (353)
T cd07850 95 DVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVV--KSDCTLKILDFGLART 167 (353)
T ss_pred cEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEE--CCCCCEEEccCcccee
Confidence 57999999955 899888754 899999999999999999999998 9999999999999 8889999999999876
Q ss_pred ccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCC------
Q 020888 194 IKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPF------ 267 (320)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~------ 267 (320)
..... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+......+
T Consensus 168 ~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (353)
T cd07850 168 AGTSF-----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMS 242 (353)
T ss_pred CCCCC-----CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 53321 1223456888999999999999999999999999999999999998766443332221110000
Q ss_pred --------------------------------C---CCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 268 --------------------------------F---RAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 268 --------------------------------~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
. .....+..++++|.+||..||.+|||+.+++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 243 RLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 011246678999999999999999999999977
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=267.70 Aligned_cols=241 Identities=33% Similarity=0.510 Sum_probs=206.3
Q ss_pred ecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEecCCCCCH
Q 020888 50 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDL 127 (320)
Q Consensus 50 lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L 127 (320)
||.|++|.||++.+. ++.+++|.+.............+.+|+++++.++|++++++++.+..+...+++|||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999986 788999988766555444567889999999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCccceeeccC
Q 020888 128 HKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG 207 (320)
Q Consensus 128 ~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~ 207 (320)
.+++.....+++..+..++.|++.+|.+||+.| ++|+||+|+||++ +.++.++|+|||.+........ ....
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~--~~H~~l~p~ni~~--~~~~~~~l~d~~~~~~~~~~~~----~~~~ 152 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLG--IIYRDLKPENILL--DADGHIKLTDFGLAKELSSEGS----RTNT 152 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcceEEE--cCCCcEEEeecCcceecccCCC----cccC
Confidence 999998778999999999999999999999988 9999999999999 7888999999999876643321 1223
Q ss_pred CcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHhhc
Q 020888 208 ETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAA 287 (320)
Q Consensus 208 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 287 (320)
..++..|.|||...+...+.++|+||||++++++++|..||...+.......+.... ...+...+.++.+++++||..
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~~i~~~l~~ 230 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDP--LRFPEFLSPEARDLISGLLQK 230 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCC--CCCCCCCCHHHHHHHHHHhcC
Confidence 456788999999988889999999999999999999999998877666555555432 223344689999999999999
Q ss_pred CCCCCCCH---HHHHH
Q 020888 288 DMNQRPSF---LDILK 300 (320)
Q Consensus 288 dp~~Rps~---~~ll~ 300 (320)
||++||++ +++++
T Consensus 231 ~p~~R~~~~~~~~l~~ 246 (250)
T cd05123 231 DPTKRLGSGGAEEIKA 246 (250)
T ss_pred CHhhCCCcccHHHHHh
Confidence 99999999 56554
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=272.54 Aligned_cols=245 Identities=26% Similarity=0.395 Sum_probs=194.9
Q ss_pred cCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCC-CCcccceeeeEEeC--CceEEE
Q 020888 44 FSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTER--KPLMLI 118 (320)
Q Consensus 44 y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~~~iv 118 (320)
|++.+.||+|++|.||++.+. ++.+++|.+......... ....+|+..++++. |+|++++++++.+. +..++|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~--~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQ--VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchh--hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 678899999999999999875 788999988654333222 23346888888885 99999999999877 889999
Q ss_pred EecCCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccccccc
Q 020888 119 TEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 197 (320)
Q Consensus 119 ~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~ 197 (320)
+||+++ +|.+.+.. ...+++..++.++.|++.||.+||+.| ++|+||+|+||++ +. +.++|+|||.+..+...
T Consensus 79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~p~ni~l--~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 79 FELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG--IFHRDIKPENILI--KD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred EecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEE--cC-CCeEEEecccccccccC
Confidence 999965 88877765 357899999999999999999999998 9999999999999 66 89999999998766432
Q ss_pred CccceeeccCCcccccccCccccC-cCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCC----------
Q 020888 198 NSHDVYKMTGETGSYRYMAPEVFK-HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRP---------- 266 (320)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~---------- 266 (320)
.. .....++..|+|||... +..++.++|+||||+++|++++|..||...+..+....+......
T Consensus 153 ~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (282)
T cd07831 153 PP-----YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFR 227 (282)
T ss_pred CC-----cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhc
Confidence 21 12234678899999764 455788999999999999999999999877655443333211100
Q ss_pred -----C--C----------CCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 267 -----F--F----------RAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 267 -----~--~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
. . ....++.++++++.+||..+|++|||+++++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 228 KSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred ccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 0 0 012468999999999999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=277.73 Aligned_cols=246 Identities=22% Similarity=0.363 Sum_probs=185.8
Q ss_pred cceecccCceEEEEEEEC----CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEe--CCceEEEEe
Q 020888 47 SAIIGKGSFGEILKAYWR----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE--RKPLMLITE 120 (320)
Q Consensus 47 ~~~lg~g~~~~vy~~~~~----~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~iv~e 120 (320)
.+.||+|+||.||++.+. ++.+|+|.+...... ..+.+|+++++.++|+||+++++.+.. +...++++|
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS-----MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCc-----HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 368999999999999864 467999987543221 456789999999999999999998853 456899999
Q ss_pred cCCCCCHHHHHHHh---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEee--CCCCcEEEecCC
Q 020888 121 YLRGGDLHKYLKEK---------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN--SSADHLKVGDFG 189 (320)
Q Consensus 121 ~~~~~~L~~~~~~~---------~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~--~~~~~~~L~dfg 189 (320)
|+++ +|.+++... ..+++..+..++.|++.||.|||+.| ++|+||||+||++.. +.++.++|+|||
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivHrDlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07868 81 YAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred ccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence 9954 898887531 24899999999999999999999998 999999999999942 345689999999
Q ss_pred CcccccccCccceeeccCCcccccccCccccCcC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChH---------HHHHH
Q 020888 190 LSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPY---------EAAKY 259 (320)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~---------~~~~~ 259 (320)
++........ .........+|+.|+|||++.+. .++.++|+||+||++++|++|..||...... +....
T Consensus 158 ~a~~~~~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~ 236 (317)
T cd07868 158 FARLFNSPLK-PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR 236 (317)
T ss_pred ceeccCCCCc-cccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHH
Confidence 9976543221 11122345678999999998774 5889999999999999999999999643210 10000
Q ss_pred HHhC----------------------------CCC--------CCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 260 VAEG----------------------------HRP--------FFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 260 ~~~~----------------------------~~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
+... ... .......+.++.++|.+||+.||.+|||+++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~h 314 (317)
T cd07868 237 IFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 314 (317)
T ss_pred HHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000 000 00001235678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=271.05 Aligned_cols=239 Identities=25% Similarity=0.428 Sum_probs=190.1
Q ss_pred ceecccCceEEEEEEEC--------------------------CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCc
Q 020888 48 AIIGKGSFGEILKAYWR--------------------------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN 101 (320)
Q Consensus 48 ~~lg~g~~~~vy~~~~~--------------------------~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~ 101 (320)
..||+|+||.||++... ...+++|.+.... ......+.+|+.+++.++|+|
T Consensus 1 ~~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~h~n 77 (274)
T cd05076 1 AHLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVSHIH 77 (274)
T ss_pred CCcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCCCCC
Confidence 36899999999998631 1347888774322 223357788999999999999
Q ss_pred ccceeeeEEeCCceEEEEecCCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCC-
Q 020888 102 IVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS- 179 (320)
Q Consensus 102 i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~- 179 (320)
|+++++++..+...++||||+++++|.+++.. .+.+++..+..++.|++.||+|||++| ++|+||||+||++....
T Consensus 78 iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 78 LAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKN--LVHGNVCAKNILLARLGL 155 (274)
T ss_pred eeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC--ccCCCCCcccEEEeccCc
Confidence 99999999999999999999999999999865 457899999999999999999999988 99999999999994221
Q ss_pred ----CCcEEEecCCCcccccccCccceeeccCCcccccccCccccCc-CCCCCchhHHHHHHHHHHHH-hCCCCCCCCCh
Q 020888 180 ----ADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEML-EGEPPLANYEP 253 (320)
Q Consensus 180 ----~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll-~g~~p~~~~~~ 253 (320)
...++++|||.+...... ....++..|+|||.+.+ ..++.++|+||||+++|+++ +|..||....+
T Consensus 156 ~~~~~~~~kl~d~g~~~~~~~~--------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~ 227 (274)
T cd05076 156 AEGTSPFIKLSDPGVSFTALSR--------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP 227 (274)
T ss_pred ccCccceeeecCCccccccccc--------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh
Confidence 224899999987543221 12245677999998865 56889999999999999985 69999987766
Q ss_pred HHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHH
Q 020888 254 YEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRL 302 (320)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 302 (320)
.+........... +...+..+.+++.+||+.+|++|||+.++++.|
T Consensus 228 ~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 228 SEKERFYEKKHRL---PEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HHHHHHHHhccCC---CCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 5544333322211 123467899999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=316.48 Aligned_cols=253 Identities=30% Similarity=0.483 Sum_probs=215.8
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEe
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 120 (320)
++.....||.|.||.||.+.+. |...|+|.+.--... ......+.+|.+++..++|||+++++++-...+..+|.||
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence 5566778999999999999864 788999966432222 5556889999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCcc
Q 020888 121 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 200 (320)
Q Consensus 121 ~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~ 200 (320)
||.||+|++.++..+..++.....+..|++.|+.|||+.| |||+||||.||++ +.+|.+|++|||.+..+...-..
T Consensus 1315 yC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~g--IVHRDIK~aNI~L--d~~g~iK~~DFGsa~ki~~~~~~ 1390 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHG--IVHRDIKPANILL--DFNGLIKYGDFGSAVKIKNNAQT 1390 (1509)
T ss_pred HhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcC--ceecCCCccceee--ecCCcEEeecccceeEecCchhc
Confidence 9999999999998777888888899999999999999999 9999999999999 89999999999999988776434
Q ss_pred ceeeccCCcccccccCccccCcCC---CCCchhHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHhCCCCCCCCCCCCHH
Q 020888 201 DVYKMTGETGSYRYMAPEVFKHRK---YDKKVDVFSFAMILYEMLEGEPPLANYEPYEAA-KYVAEGHRPFFRAKGFTPE 276 (320)
Q Consensus 201 ~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 276 (320)
.....+...||+.|+|||++.+.. ..-++|||||||++.||+||+.||...+..=.+ -.+..+-.|.+ +..++.+
T Consensus 1391 ~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~-P~~ls~~ 1469 (1509)
T KOG4645|consen 1391 MPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQI-PERLSSE 1469 (1509)
T ss_pred CCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCC-chhhhHh
Confidence 444556678999999999997654 567999999999999999999999988755433 33444444444 4449999
Q ss_pred HHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 277 LRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 277 l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
-++||..||..||+.|.++.|++++
T Consensus 1470 g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1470 GRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred HHHHHHHHHhcCchhhhHHHHHHHh
Confidence 9999999999999999999988876
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=271.29 Aligned_cols=247 Identities=27% Similarity=0.481 Sum_probs=200.5
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEe--CCceEEE
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE--RKPLMLI 118 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~iv 118 (320)
+|...+.||.|++|.||++.+. ++.+++|.+...... .....+.+|++++++++|+||+++++++.. ...+++|
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNP--DLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCch--HHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence 5788899999999999999985 688999988654322 334778999999999999999999998854 3468999
Q ss_pred EecCCCCCHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccc
Q 020888 119 TEYLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 194 (320)
Q Consensus 119 ~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~ 194 (320)
|||+++++|.+++.. ...++...+..++.|++.+|.|||+.| ++|+||+|+||++ +.++.++|+|||++...
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~--i~H~dl~~~nil~--~~~~~~~l~dfg~~~~~ 155 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK--IIHRDIKPSNILL--TRKGQVKLCDFGVSGEL 155 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEE--ecCCeEEEeeccccccc
Confidence 999999999988753 345899999999999999999999998 9999999999999 77888999999998655
Q ss_pred cccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCC-----ChHHHHHHHHhCCCCCCC
Q 020888 195 KVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANY-----EPYEAAKYVAEGHRPFFR 269 (320)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~-----~~~~~~~~~~~~~~~~~~ 269 (320)
..... ....++..|.|||...+..++.++|+||||+++|++++|..||... ...+....+.....+...
T Consensus 156 ~~~~~------~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (287)
T cd06621 156 VNSLA------GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELK 229 (287)
T ss_pred ccccc------ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhc
Confidence 43211 1234677899999999999999999999999999999999999865 223333333332211111
Q ss_pred C-----CCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 270 A-----KGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 270 ~-----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
. ..+++++++++.+||..+|.+|||+.+++++
T Consensus 230 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 230 DEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred cCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 1 2356889999999999999999999999885
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=273.08 Aligned_cols=249 Identities=29% Similarity=0.491 Sum_probs=196.5
Q ss_pred cccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEE
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 119 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 119 (320)
.+|++.+.||.|++|.||++.++ ++.+++|.+........ ...+.+|++++++++|+||+++++++..++..++||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGA--PFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVF 82 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCC--chhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEE
Confidence 57999999999999999999975 78899998865432221 134567999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccC
Q 020888 120 EYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 198 (320)
Q Consensus 120 e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~ 198 (320)
||+++ +|.+++... ..+++..+..++.|+++||.|||+.| ++|+||+|+||++ +.++.++|+|||.+.......
T Consensus 83 e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~dl~p~nil~--~~~~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 83 EYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR--VLHRDLKPQNLLI--SERGELKLADFGLARAKSVPS 157 (291)
T ss_pred ecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCHHHEEE--cCCCCEEECccccccccCCCC
Confidence 99975 999988763 46899999999999999999999998 9999999999999 888999999999886543221
Q ss_pred ccceeeccCCcccccccCccccCc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHhCCC-----------
Q 020888 199 SHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYE-PYEAAKYVAEGHR----------- 265 (320)
Q Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~p~~~~~-~~~~~~~~~~~~~----------- 265 (320)
. ......++..|.|||.+.+ ..++.++|+||+|+++|++++|..||.... ..+....+.....
T Consensus 158 ~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07844 158 K----TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVS 233 (291)
T ss_pred c----cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhh
Confidence 1 1112245778999999876 457899999999999999999999997655 2222211111000
Q ss_pred ----------CCC-------CCCCCC--HHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 266 ----------PFF-------RAKGFT--PELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 266 ----------~~~-------~~~~~~--~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
... ....++ .++.+++.+||+.+|++|||+.+++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 234 SNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred hccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 000 001233 788999999999999999999998864
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=272.84 Aligned_cols=250 Identities=28% Similarity=0.472 Sum_probs=195.7
Q ss_pred CcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEE
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 118 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 118 (320)
..+|.+.+.||+|++|.||++.+. +..+++|.+........ ...+.+|+.+++.++|+||+++.+++..++..++|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~--~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 81 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGV--PFTAIREASLLKGLKHANIVLLHDIIHTKETLTFV 81 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCC--cHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEE
Confidence 468999999999999999999875 78899998865432221 24567899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccccccc
Q 020888 119 TEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 197 (320)
Q Consensus 119 ~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~ 197 (320)
+||++ ++|.+++.. ...+++..+..++.|++.||.|||+.| ++|+||||+||++ +.++.++|+|||++......
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nil~--~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 82 FEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH--ILHRDLKPQNLLI--SYLGELKLADFGLARAKSIP 156 (291)
T ss_pred Eeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEE--cCCCcEEEeccccccccCCC
Confidence 99995 577776654 346788899999999999999999998 9999999999999 88889999999988754332
Q ss_pred CccceeeccCCcccccccCccccCcC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHh-------------
Q 020888 198 NSHDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPY-EAAKYVAE------------- 262 (320)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~-~~~~~~~~------------- 262 (320)
.. ......+++.|+|||.+.+. .++.++|+||||++++++++|..||...... +.......
T Consensus 157 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (291)
T cd07870 157 SQ----TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGV 232 (291)
T ss_pred CC----CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhh
Confidence 11 11223468889999998764 5788999999999999999999999865432 11111100
Q ss_pred ----CCCCCC-------------CCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 263 ----GHRPFF-------------RAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 263 ----~~~~~~-------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
...... .....+.++.+++.+|+..||.+|||+.+++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 233 SKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred hhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 000000 001236789999999999999999999998864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=285.07 Aligned_cols=250 Identities=31% Similarity=0.472 Sum_probs=221.1
Q ss_pred CCcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEE
Q 020888 40 SELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLML 117 (320)
Q Consensus 40 ~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 117 (320)
....|.+.+.||.|.|++|.++.+. +..||+|.+.++....... ..+.+|++++..++||||++++.+.+....+|+
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~-~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKR-QKLGREVDIMKSLNHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHH-HHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence 3447899999999999999999985 8899999998877665544 558999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccccccc
Q 020888 118 ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 197 (320)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~ 197 (320)
||||+.+|.+.+++..++++.+.....++.|+.+|++|||+++ |||+|||+.||++ +.+.+++|+|||++..+...
T Consensus 133 V~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~--ivHrdLk~eNilL--~~~mnikIaDfgfS~~~~~~ 208 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKN--IVHRDLKAENILL--DENMNIKIADFGFSTFFDYG 208 (596)
T ss_pred EEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcc--eeccccchhhccc--ccccceeeeccccceeeccc
Confidence 9999999999999999999999999999999999999999998 9999999999999 89989999999999887644
Q ss_pred CccceeeccCCcccccccCccccCcCCCC-CchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHH
Q 020888 198 NSHDVYKMTGETGSYRYMAPEVFKHRKYD-KKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPE 276 (320)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (320)
. .....+|++.|+|||++.|..++ +..|+||||+++|.++.|..||++..-.+.......++.... ..++.+
T Consensus 209 ~-----~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp--~~ms~d 281 (596)
T KOG0586|consen 209 L-----MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIP--FYMSCD 281 (596)
T ss_pred c-----cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeeccc--ceeech
Confidence 3 45668999999999999998865 899999999999999999999998776665555555543322 336889
Q ss_pred HHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 277 LRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 277 l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
+.++|+++|..+|.+|++.++++++
T Consensus 282 ce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 282 CEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred hHHHHHHhhccCccccCCHHHhhhh
Confidence 9999999999999999999999876
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=279.39 Aligned_cols=258 Identities=26% Similarity=0.405 Sum_probs=205.5
Q ss_pred cccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeC-----Cc
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER-----KP 114 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~ 114 (320)
.+|.+.+.||.|++|+||++.+. +..+++|.+........ ....+.+|+.+++.++|+|++++++++... ..
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRI-DAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccc-hhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 47999999999999999999975 78899998865433322 235677899999999999999999987543 34
Q ss_pred eEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccc
Q 020888 115 LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 194 (320)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~ 194 (320)
.|+++||+. ++|.+++...+.+++..++.++.|++.||.+||+.| ++|+||+|+||++ +.++.++|+|||++...
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dlkp~Nil~--~~~~~~kL~Dfg~~~~~ 158 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSAN--VLHRDLKPSNLLL--NANCDLKICDFGLARTT 158 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEE--cCCCCEEECcCcccccc
Confidence 799999995 699999988788999999999999999999999988 9999999999999 88889999999998765
Q ss_pred cccCccceeeccCCcccccccCccccCc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhC----------
Q 020888 195 KVQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEG---------- 263 (320)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~---------- 263 (320)
..... ......++..|+|||.+.+ ..++.++|+||||+++|++++|..||...+..+....+...
T Consensus 159 ~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (337)
T cd07858 159 SEKGD----FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLG 234 (337)
T ss_pred CCCcc----cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhh
Confidence 43221 1223456788999998765 46889999999999999999999999765433222211110
Q ss_pred -----------------CCC--CCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH--HHHHHhcC
Q 020888 264 -----------------HRP--FFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR--LEKIKETL 309 (320)
Q Consensus 264 -----------------~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--L~~~~~~~ 309 (320)
... ......+++++++++.+||+.+|++|||+++++++ +..+.+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~ 301 (337)
T cd07858 235 FIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPS 301 (337)
T ss_pred hcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcc
Confidence 000 00113478899999999999999999999999998 76665444
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=277.96 Aligned_cols=264 Identities=29% Similarity=0.438 Sum_probs=212.8
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCC-----ce
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK-----PL 115 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~ 115 (320)
+|.+.+.||.|++|.||++.+. +..+++|.+...... ....+.+.+|+++++.++|+|++++.+++.... ..
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDD-LIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccccc-chhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 5888999999999999999975 688999988654322 223367888999999999999999999987665 78
Q ss_pred EEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccccc
Q 020888 116 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 195 (320)
Q Consensus 116 ~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~ 195 (320)
|++++|+++ +|.+++.+...+++..++.++.+++.||.+||+.| ++|+||||+||++ +.++.++|+|||.+....
T Consensus 80 ~lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~g--i~H~dlkp~nili--~~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 80 YIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSAN--VIHRDLKPSNILV--NSNCDLKICDFGLARGVD 154 (330)
T ss_pred EEEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEE--cCCCCEEEcccCceEeec
Confidence 999999964 89999987778999999999999999999999998 9999999999999 888999999999988765
Q ss_pred ccCccceeeccCCcccccccCccccCcC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCC------
Q 020888 196 VQNSHDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFF------ 268 (320)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~------ 268 (320)
...... .......++..|+|||.+.+. .++.++|+||||++++++++|..||......+....+........
T Consensus 155 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 233 (330)
T cd07834 155 PDEDEK-GFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF 233 (330)
T ss_pred cccccc-ccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhh
Confidence 432110 112234568889999999887 789999999999999999999999987766554443332111000
Q ss_pred -----------------------CCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH--HHHHHhcCCCCC
Q 020888 269 -----------------------RAKGFTPELRELTEKCWAADMNQRPSFLDILKR--LEKIKETLPTDH 313 (320)
Q Consensus 269 -----------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--L~~~~~~~~~~~ 313 (320)
....++.++.+++.+||+.+|.+|||+++++.+ ++.+........
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~~~~ 303 (330)
T cd07834 234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDEPV 303 (330)
T ss_pred ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccccCCC
Confidence 012367889999999999999999999999987 666665544333
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=293.80 Aligned_cols=253 Identities=20% Similarity=0.307 Sum_probs=187.7
Q ss_pred CcccCccceecccCceEEEEEEECC---CceEEE--------------EccCCCCCcHHHHHHHHHHHHHHHhCCCCccc
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWRG---TPVAIK--------------RILPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 103 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~~---~~~~~K--------------~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~ 103 (320)
..+|.+++.||+|+||+||++..+. ...+.| .+.+...........+.+|+++++.++|+||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 3579999999999999999987531 111111 11111111222346788999999999999999
Q ss_pred ceeeeEEeCCceEEEEecCCCCCHHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeC
Q 020888 104 QFLGAVTERKPLMLITEYLRGGDLHKYLKEK-----GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS 178 (320)
Q Consensus 104 ~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~ 178 (320)
++++++...+..|++++++. ++|.+++... .......+..++.||+.||.|||++| |+|+||||+||++ +
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g--IiHrDLKP~NILl--~ 301 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK--LIHRDIKLENIFL--N 301 (501)
T ss_pred cEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEE--C
Confidence 99999999999999999995 4787776532 22345677889999999999999998 9999999999999 8
Q ss_pred CCCcEEEecCCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCC-CCCCC--hHH
Q 020888 179 SADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPP-LANYE--PYE 255 (320)
Q Consensus 179 ~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p-~~~~~--~~~ 255 (320)
.++.++|+|||++..+..... .......|+..|+|||++.+..++.++|||||||++|+|++|..+ +.... ...
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~ 378 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKERE---AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK 378 (501)
T ss_pred CCCCEEEEeCCCceecCcccc---cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHH
Confidence 889999999999976643221 112235689999999999999999999999999999999998754 43221 111
Q ss_pred HHHHHHhCC------------------------------CCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 256 AAKYVAEGH------------------------------RPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 256 ~~~~~~~~~------------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
....+.... ........++.++.++|.+||+.||.+|||+.|++.+
T Consensus 379 ~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 379 QLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 111111100 0001112356778889999999999999999999875
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=272.35 Aligned_cols=250 Identities=26% Similarity=0.374 Sum_probs=201.0
Q ss_pred cccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeC--CceEE
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER--KPLML 117 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~i 117 (320)
.+|.+.+.||.|++|.||++.+. ++.+++|.+........ ....+.+|+.++++++|+|++++.+++... ...|+
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEG-FPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccccc-chhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 47999999999999999999986 67899998865433321 224567899999999999999999998877 88999
Q ss_pred EEecCCCCCHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccc
Q 020888 118 ITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 196 (320)
Q Consensus 118 v~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~ 196 (320)
++||+++ +|.+++.... .+++..++.++.|++.||+|||+.| ++|+||+|+||++ +.++.++|+|||.+.....
T Consensus 84 v~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili--~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 84 VMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW--ILHRDLKTSNLLL--NNRGILKICDFGLAREYGS 158 (293)
T ss_pred EehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEE--CCCCcEEEeecCceeeccC
Confidence 9999965 9999887643 5899999999999999999999998 9999999999999 8889999999998886654
Q ss_pred cCccceeeccCCcccccccCccccCcCC-CCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCC----------
Q 020888 197 QNSHDVYKMTGETGSYRYMAPEVFKHRK-YDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHR---------- 265 (320)
Q Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~---------- 265 (320)
... ......+++.|+|||.+.+.. ++.++|+||||++++++++|..||...........+.....
T Consensus 159 ~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (293)
T cd07843 159 PLK----PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGF 234 (293)
T ss_pred Ccc----ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHh
Confidence 321 122344678899999987654 68899999999999999999999987665444332221100
Q ss_pred --------------------CCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 266 --------------------PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 266 --------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
..+....+++.+.++|++||+.+|++|||+.+++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 235 SELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred hccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 001111158889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=270.58 Aligned_cols=258 Identities=16% Similarity=0.218 Sum_probs=192.0
Q ss_pred CCCCCcccCccceecccCceEEEEEEECC-----CceEEEEccCCCCCcHHHH--------HHHHHHHHHHHhCCCCccc
Q 020888 37 IDPSELDFSSSAIIGKGSFGEILKAYWRG-----TPVAIKRILPSLSDDRLVI--------QDFRHEVNLLVKLRHPNIV 103 (320)
Q Consensus 37 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~-----~~~~~K~~~~~~~~~~~~~--------~~~~~e~~~l~~l~h~~i~ 103 (320)
++....+|.+.+.||+|+||+||++.+.+ ..+++|............. .....+...+..+.|++++
T Consensus 7 ~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~ 86 (294)
T PHA02882 7 IDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIP 86 (294)
T ss_pred eccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCC
Confidence 34455789999999999999999998753 3566665432221110000 1112233445566899999
Q ss_pred ceeeeEEeCC----ceEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCC
Q 020888 104 QFLGAVTERK----PLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS 179 (320)
Q Consensus 104 ~~~~~~~~~~----~~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~ 179 (320)
++++.+.... ..+++++++ ..++.+.+......++..+..++.|++.||.|||+.| ++||||||+||++ +.
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiHrDiKp~Nill--~~ 161 (294)
T PHA02882 87 KYYGCGSFKRCRMYYRFILLEKL-VENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHG--ISHGDIKPENIMV--DG 161 (294)
T ss_pred cEEEeeeEecCCceEEEEEEehh-ccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEE--cC
Confidence 9998765443 347788877 4488888876556788999999999999999999998 9999999999999 78
Q ss_pred CCcEEEecCCCcccccccCccce---eeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh-HH
Q 020888 180 ADHLKVGDFGLSKLIKVQNSHDV---YKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEP-YE 255 (320)
Q Consensus 180 ~~~~~L~dfg~~~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~-~~ 255 (320)
++.++|+|||++..+........ .......+|+.|+|||++.+..++.++|||||||+++++++|..||..... ..
T Consensus 162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~ 241 (294)
T PHA02882 162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN 241 (294)
T ss_pred CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH
Confidence 88999999999987643221111 111224689999999999999999999999999999999999999987732 22
Q ss_pred H--------HHHHHhCCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHH
Q 020888 256 A--------AKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRL 302 (320)
Q Consensus 256 ~--------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 302 (320)
. ...+..+. .....++.++.+++..|++.+|++||+++++++.|
T Consensus 242 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 242 LIHAAKCDFIKRLHEGK---IKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHHhHHHHHHHhhhhh---hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 1 12222221 12345689999999999999999999999999876
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=274.46 Aligned_cols=251 Identities=28% Similarity=0.418 Sum_probs=201.1
Q ss_pred CcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeC--CceE
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER--KPLM 116 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 116 (320)
..+|.+.+.||.|++|.||++.+. ++.||+|.+......... .....+|+.++++++|+|++++++++.+. +..+
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGI-PISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCC-cchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 457999999999999999999985 788999988644332211 13456799999999999999999998654 5689
Q ss_pred EEEecCCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccccc
Q 020888 117 LITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 195 (320)
Q Consensus 117 iv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~ 195 (320)
+|+||+++ +|.+++.. ...+++..++.++.|++.||.+||+.| ++|+||+|+||++ +.++.++|+|||.+....
T Consensus 85 lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~--~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 85 LVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF--IIHRDLKVSNLLL--TDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEE--CCCCCEEECccceeeecC
Confidence 99999965 89888875 357899999999999999999999998 9999999999999 888899999999987664
Q ss_pred ccCccceeeccCCcccccccCccccCc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCC-------
Q 020888 196 VQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPF------- 267 (320)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~------- 267 (320)
.... ......+++.|+|||.+.+ ..++.++|+||||+++|++++|..||...+..+....+.......
T Consensus 160 ~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
T cd07845 160 LPAK----PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPG 235 (309)
T ss_pred CccC----CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchh
Confidence 3221 1122335778999999865 457899999999999999999999998877666555444321100
Q ss_pred -----------CC----------CCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 268 -----------FR----------AKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 268 -----------~~----------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
.. ....++++.++|.+||..||++|||+++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 236 FSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred hhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00 01247889999999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=263.28 Aligned_cols=244 Identities=28% Similarity=0.492 Sum_probs=202.7
Q ss_pred ccCc-cceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcccceeeeEEe----CCc
Q 020888 43 DFSS-SAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTE----RKP 114 (320)
Q Consensus 43 ~y~~-~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~----~~~ 114 (320)
+|.+ -++||-|-.|+|-.|.++ ++++|+|++... ...++|+++.-.. .|+||+.+++++++ ...
T Consensus 62 dY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 62 DYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred hheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 5655 468999999999999886 889999988543 5667888877666 59999999999853 455
Q ss_pred eEEEEecCCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEe-eCCCCcEEEecCCCc
Q 020888 115 LMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLV-NSSADHLKVGDFGLS 191 (320)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~-~~~~~~~~L~dfg~~ 191 (320)
+.+|||+++||.|...+++++ ++++..+..|+.||..|+.|||+.+ |+|+||||+|++.. ...+..+||+|||++
T Consensus 134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n--IAHRDlKpENLLyt~t~~na~lKLtDfGFA 211 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN--IAHRDLKPENLLYTTTSPNAPLKLTDFGFA 211 (400)
T ss_pred eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc--hhhccCChhheeeecCCCCcceEecccccc
Confidence 789999999999999999866 4999999999999999999999999 99999999999994 334557999999999
Q ss_pred ccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH----HHHHHHHhCCCCC
Q 020888 192 KLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPY----EAAKYVAEGHRPF 267 (320)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~----~~~~~~~~~~~~~ 267 (320)
+....+. .....+-||.|.|||++....++..+|+||||+++|-|++|..||...... .+...+..+....
T Consensus 212 K~t~~~~-----~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~F 286 (400)
T KOG0604|consen 212 KETQEPG-----DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEF 286 (400)
T ss_pred cccCCCc-----cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccC
Confidence 8765432 355678899999999999999999999999999999999999999766432 2334444444332
Q ss_pred CCC--CCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 268 FRA--KGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 268 ~~~--~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
..+ ..+++..+++|+.+|..+|.+|.|+++++++
T Consensus 287 P~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 287 PEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred CChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 222 3578999999999999999999999999876
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=290.55 Aligned_cols=243 Identities=33% Similarity=0.518 Sum_probs=204.1
Q ss_pred eecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEecCCCCC
Q 020888 49 IIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGD 126 (320)
Q Consensus 49 ~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~ 126 (320)
+||+|++|+||-+++. ..+.|+|.++...... .+.+.+|+.+.++++|.||+++++.+.++++.-|.||-.+||+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~---~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSRE---VQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchh---hccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 7999999999999986 5568888886544332 3778899999999999999999999999999999999999999
Q ss_pred HHHHHHH-hCCC--CHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCcccee
Q 020888 127 LHKYLKE-KGAL--SPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 203 (320)
Q Consensus 127 L~~~~~~-~~~l--~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~~~~ 203 (320)
|+++++. ++++ .+.++-.+.+||++||.|||++. |||+|||-+||+++ +-.|-+||+|||-++++..-+ +
T Consensus 659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~--IVHRDIKGDNVLvN-TySGvlKISDFGTsKRLAgin--P-- 731 (1226)
T KOG4279|consen 659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK--IVHRDIKGDNVLVN-TYSGVLKISDFGTSKRLAGIN--P-- 731 (1226)
T ss_pred HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc--eeeccccCCcEEEe-eccceEEecccccchhhccCC--c--
Confidence 9999985 6787 89999999999999999999977 99999999999985 456799999999988876432 1
Q ss_pred eccCCcccccccCccccCcC--CCCCchhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhCCCCCCCCCCCCHHHHHH
Q 020888 204 KMTGETGSYRYMAPEVFKHR--KYDKKVDVFSFAMILYEMLEGEPPLANYEPYE-AAKYVAEGHRPFFRAKGFTPELREL 280 (320)
Q Consensus 204 ~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~l 280 (320)
-.....||..|+|||++..+ .|..++|||||||++.||.||+.||....... ....+--.+.++..+..++.+.++|
T Consensus 732 ~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~F 811 (1226)
T KOG4279|consen 732 CTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNF 811 (1226)
T ss_pred cccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHH
Confidence 12335689999999999765 48899999999999999999999998765332 2222222334455566789999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHH
Q 020888 281 TEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 281 i~~~l~~dp~~Rps~~~ll~~ 301 (320)
|.+|+.+||.+||++.++|..
T Consensus 812 ilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 812 ILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred HHHHcCCCcccCccHHHhccC
Confidence 999999999999999999865
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=264.97 Aligned_cols=247 Identities=25% Similarity=0.407 Sum_probs=191.0
Q ss_pred ceecccCceEEEEEEEC-C---CceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEecCC
Q 020888 48 AIIGKGSFGEILKAYWR-G---TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLR 123 (320)
Q Consensus 48 ~~lg~g~~~~vy~~~~~-~---~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 123 (320)
+.||+|+||.||++... + ..+++|.+..... ....+.+.+|+..++.++|+|++++++.+......++||||++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS--SKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCE 78 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCC--hHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCC
Confidence 36899999999998753 2 3456666543322 2334788899999999999999999999999999999999999
Q ss_pred CCCHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCc
Q 020888 124 GGDLHKYLKEK----GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 199 (320)
Q Consensus 124 ~~~L~~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~ 199 (320)
+++|.+++.+. ...+...++.++.|++.||.|||+.+ ++|+||||+||++ +.++.++|+|||++........
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nil~--~~~~~~~l~Dfg~~~~~~~~~~ 154 (268)
T cd05086 79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN--FLHSDLALRNCFL--TSDLTVKVGDYGIGPSRYKEDY 154 (268)
T ss_pred CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--eeccCCccceEEE--cCCccEEecccccccccCcchh
Confidence 99999998753 24577788899999999999999988 9999999999999 8888999999998754321110
Q ss_pred cceeeccCCcccccccCccccCc-------CCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCC-C---CC
Q 020888 200 HDVYKMTGETGSYRYMAPEVFKH-------RKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGH-R---PF 267 (320)
Q Consensus 200 ~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~-~---~~ 267 (320)
........++..|+|||...+ ..++.++|+||||+++|++++ |..||...+..+....+.... . .+
T Consensus 155 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 232 (268)
T cd05086 155 --IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKP 232 (268)
T ss_pred --hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCC
Confidence 011123456788999998743 235789999999999999997 577887776655544433332 1 11
Q ss_pred CCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHH
Q 020888 268 FRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLE 303 (320)
Q Consensus 268 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~ 303 (320)
.....+++.+.+++..|+ .+|.+||+++++++.|.
T Consensus 233 ~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 233 QLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred ccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 122347889999999999 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=270.59 Aligned_cols=246 Identities=25% Similarity=0.460 Sum_probs=205.2
Q ss_pred cCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEec
Q 020888 44 FSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY 121 (320)
Q Consensus 44 y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 121 (320)
|.....||+|++|.||++... +..+++|.+.... ......+.+|+.+++.++|+|++++++.+..++..+++|||
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 98 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 98 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc---hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEec
Confidence 444578999999999999874 7889999774322 23346788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCccc
Q 020888 122 LRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHD 201 (320)
Q Consensus 122 ~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~~ 201 (320)
+++++|.+++.. +.+++..+..++.|++.+|++||+.| ++|+||+|+||++ +.++.++|+|||.+........
T Consensus 99 ~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~g--ivH~dl~p~Nilv--~~~~~~~l~dfg~~~~~~~~~~-- 171 (292)
T cd06657 99 LEGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQG--VIHRDIKSDSILL--THDGRVKLSDFGFCAQVSKEVP-- 171 (292)
T ss_pred CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEE--CCCCCEEEcccccceecccccc--
Confidence 999999998764 46899999999999999999999998 9999999999999 7888999999998875543211
Q ss_pred eeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCC-CCCCCCHHHHHH
Q 020888 202 VYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFF-RAKGFTPELREL 280 (320)
Q Consensus 202 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l 280 (320)
......++..|+|||.+.+..++.++|+||+|+++|++++|..||......+....+........ ....++..+.++
T Consensus 172 --~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 249 (292)
T cd06657 172 --RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGF 249 (292)
T ss_pred --cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHH
Confidence 11234578889999999888899999999999999999999999987776665555544433222 224578999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHH
Q 020888 281 TEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 281 i~~~l~~dp~~Rps~~~ll~~ 301 (320)
+.+||..+|.+||++.+++++
T Consensus 250 i~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 250 LDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred HHHHHhCCcccCcCHHHHhcC
Confidence 999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=277.99 Aligned_cols=259 Identities=27% Similarity=0.446 Sum_probs=202.3
Q ss_pred CcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeC-----C
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER-----K 113 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~ 113 (320)
+.+|.+.+.||+|++|.||++.+. ++.|++|.+.... .......+.+|+.+++.++|+|++++++++... .
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 81 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE--HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFN 81 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccc
Confidence 357999999999999999999875 7889999875322 222346677899999999999999999887543 3
Q ss_pred ceEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccc
Q 020888 114 PLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 193 (320)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~ 193 (320)
..++++||+++ +|.+++.. ..+++..+..++.|++.||.+||+.| ++|+||||+||++ +.++.++|+|||++..
T Consensus 82 ~~~lv~e~~~~-~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~--ivH~dlkp~Nill--~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 82 DVYIVQELMET-DLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSAN--VLHRDLKPSNLLL--NTNCDLKICDFGLARI 155 (336)
T ss_pred eEEEEehhccc-CHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEE--CCCCCEEECcccceee
Confidence 47999999965 88888765 46899999999999999999999998 9999999999999 8889999999999876
Q ss_pred ccccCccceeeccCCcccccccCccccCc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCC-------
Q 020888 194 IKVQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHR------- 265 (320)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~------- 265 (320)
......... ......+++.|+|||...+ ..++.++|+||||+++|++++|+.||...+.......+.....
T Consensus 156 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 234 (336)
T cd07849 156 ADPEHDHTG-FLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDL 234 (336)
T ss_pred ccccccccC-CcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence 543322111 1223467889999998654 5688999999999999999999999976554332221111000
Q ss_pred -----------------CCC-----CCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH--HHHHHhc
Q 020888 266 -----------------PFF-----RAKGFTPELRELTEKCWAADMNQRPSFLDILKR--LEKIKET 308 (320)
Q Consensus 266 -----------------~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--L~~~~~~ 308 (320)
... .....++++.+++.+||+.+|++|||+.+++++ +..+.+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~ 301 (336)
T cd07849 235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDP 301 (336)
T ss_pred HHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCC
Confidence 000 012357889999999999999999999999998 6666554
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=298.25 Aligned_cols=258 Identities=34% Similarity=0.618 Sum_probs=221.6
Q ss_pred ccCccceecccCceEEEEEEEC---CC----ceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCce
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR---GT----PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL 115 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~---~~----~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 115 (320)
.-+....||+|.||.||.+... +. .|++|.+.+ ..+.+....|.+|..+++.++||||+++++++-+...+
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~--~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKR--LSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccc--cCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 4456789999999999998864 22 377776644 34556668999999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHHh-------CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecC
Q 020888 116 MLITEYLRGGDLHKYLKEK-------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF 188 (320)
Q Consensus 116 ~iv~e~~~~~~L~~~~~~~-------~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~df 188 (320)
+|++|||+||+|..++++. ..++....+.++.++++|++||++++ +||+||...|+|+ +....|||+||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~--fvHRDLAaRNCLL--~~~r~VKIaDF 846 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH--FVHRDLAARNCLL--DERRVVKIADF 846 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC--CcCcchhhhheee--cccCcEEEccc
Confidence 9999999999999999864 35899999999999999999999988 9999999999999 77899999999
Q ss_pred CCcccccccCccceeeccCC-cccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCC
Q 020888 189 GLSKLIKVQNSHDVYKMTGE-TGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRP 266 (320)
Q Consensus 189 g~~~~~~~~~~~~~~~~~~~-~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~ 266 (320)
|+++.+... +.+..... .-...|+|||.+..+.++.++||||||+++||++| |..||.+.+..+.......+- .
T Consensus 847 GlArDiy~~---~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg-R 922 (1025)
T KOG1095|consen 847 GLARDIYDK---DYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG-R 922 (1025)
T ss_pred chhHhhhhc---hheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC-c
Confidence 999966543 23333333 34568999999999999999999999999999999 999999999999988666665 4
Q ss_pred CCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcCC
Q 020888 267 FFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLP 310 (320)
Q Consensus 267 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~ 310 (320)
..++..+|+.+.+++.+||+.+|++||++..+++.+..+....-
T Consensus 923 L~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~ 966 (1025)
T KOG1095|consen 923 LDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAAL 966 (1025)
T ss_pred cCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhc
Confidence 45567799999999999999999999999999998887765543
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=270.07 Aligned_cols=249 Identities=29% Similarity=0.432 Sum_probs=198.1
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEe
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 120 (320)
+|++.+.||.|++|+||++.++ ++.+++|.+....... .....+.+|+++++.++|+|++++++++..+..+++|+|
T Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDE-GVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred ceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccc-cchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 6889999999999999999875 7889999886543322 223567889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeC-CCCcEEEecCCCccccccc
Q 020888 121 YLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS-SADHLKVGDFGLSKLIKVQ 197 (320)
Q Consensus 121 ~~~~~~L~~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~-~~~~~~L~dfg~~~~~~~~ 197 (320)
|+++ +|.+++.... .+++..++.++.||+.||++||++| ++|+||+|+||++ + .++.++|+|||.+......
T Consensus 82 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dl~p~nill--~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR--VLHRDLKPQNLLI--DRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred cccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCcceEEE--ECCCCEEEEcccccccccCCC
Confidence 9964 8888876543 3578889999999999999999988 9999999999999 5 3457999999998755332
Q ss_pred CccceeeccCCcccccccCccccCcC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCC----------
Q 020888 198 NSHDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRP---------- 266 (320)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~---------- 266 (320)
.. ......+++.|+|||.+.+. .++.++|+||||+++|++++|..||...+..+....+......
T Consensus 157 ~~----~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (294)
T PLN00009 157 VR----TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVT 232 (294)
T ss_pred cc----ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccc
Confidence 11 11223467889999988664 5789999999999999999999999876655444333211000
Q ss_pred ----------C-------CCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 267 ----------F-------FRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 267 ----------~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
. .....+++++++++.+|++.+|++||++.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 233 SLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred cchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 0012468889999999999999999999999875
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=269.21 Aligned_cols=248 Identities=28% Similarity=0.495 Sum_probs=199.7
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEe
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 120 (320)
+|++.+.||.|++|.||++.+. +..+++|.+....... ....+.+|+++++.++|+|++++++.+...+..++|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEG--TPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccccc--chHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence 5888999999999999999985 7889999886543322 22566789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccccccc
Q 020888 121 YLRGGDLHKYLKEK---GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 197 (320)
Q Consensus 121 ~~~~~~L~~~~~~~---~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~ 197 (320)
|+++ +|.+++... ..+++..+..++.|++.||.|||+.| ++|+||+|+||++ +.++.++|+|||.+......
T Consensus 79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~h~dl~p~ni~~--~~~~~~~l~d~g~~~~~~~~ 153 (284)
T cd07836 79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR--VLHRDLKPQNLLI--NKRGELKLADFGLARAFGIP 153 (284)
T ss_pred cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEE--CCCCcEEEeecchhhhhcCC
Confidence 9975 899888753 35899999999999999999999998 9999999999999 88889999999998755432
Q ss_pred CccceeeccCCcccccccCccccCcC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCC-----------
Q 020888 198 NSHDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHR----------- 265 (320)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~----------- 265 (320)
.. ......++..|+|||.+.+. .++.++|+||||++++++++|..||...+..+....+.....
T Consensus 154 ~~----~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd07836 154 VN----TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGIS 229 (284)
T ss_pred cc----ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHh
Confidence 11 11233467889999988664 568899999999999999999999987665544332221100
Q ss_pred ------CCC----------CCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 266 ------PFF----------RAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 266 ------~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
... .....+..+++++..|++.||.+||++.+++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 230 QLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred cCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 000 002357889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=268.28 Aligned_cols=237 Identities=24% Similarity=0.417 Sum_probs=189.6
Q ss_pred ceecccCceEEEEEEEC---------CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEE
Q 020888 48 AIIGKGSFGEILKAYWR---------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 118 (320)
Q Consensus 48 ~~lg~g~~~~vy~~~~~---------~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 118 (320)
+.||.|+||.||++.+. ...+++|.+... .....+.+.+|+.+++.+.|+|++++++++..++..++|
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 77 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS---HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV 77 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch---hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence 36899999999999864 224777766332 223346788899999999999999999999998999999
Q ss_pred EecCCCCCHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCc--------EEEecCC
Q 020888 119 TEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH--------LKVGDFG 189 (320)
Q Consensus 119 ~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~--------~~L~dfg 189 (320)
|||+++++|.+++...+ .+++..++.++.|++.||+|||++| ++|+||||+||++ +.++. ++++|||
T Consensus 78 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dlkp~nili--~~~~~~~~~~~~~~~l~d~g 153 (258)
T cd05078 78 QEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG--LTHGNVCAKNVLL--IREEDRKTGNPPFIKLSDPG 153 (258)
T ss_pred EecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCccceEEE--ecccccccCCCceEEecccc
Confidence 99999999999997643 5899999999999999999999998 9999999999999 44433 7999999
Q ss_pred CcccccccCccceeeccCCcccccccCccccCcC-CCCCchhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHhCCCCC
Q 020888 190 LSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEG-EPPLANYEPYEAAKYVAEGHRPF 267 (320)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g-~~p~~~~~~~~~~~~~~~~~~~~ 267 (320)
.+...... ....++..|+|||.+.+. .++.++|+||||+++|++++| ..|+...+............ .
T Consensus 154 ~~~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~--~ 223 (258)
T cd05078 154 ISITVLPK--------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDRH--Q 223 (258)
T ss_pred cccccCCc--------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHHccc--c
Confidence 87654321 123467789999998764 578999999999999999998 56666665554433222211 1
Q ss_pred CCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHH
Q 020888 268 FRAKGFTPELRELTEKCWAADMNQRPSFLDILKRL 302 (320)
Q Consensus 268 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 302 (320)
.+...+.++.+++.+||+.||++|||++++++.|
T Consensus 224 -~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 224 -LPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred -CCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 2233568899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=266.98 Aligned_cols=239 Identities=24% Similarity=0.396 Sum_probs=190.3
Q ss_pred ccCcccee--cccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcccceeeeEEeCCceEE
Q 020888 43 DFSSSAII--GKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLML 117 (320)
Q Consensus 43 ~y~~~~~l--g~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~i 117 (320)
+|.+.+.+ |+|+||.||++..+ +..+++|.+........ |+.....+ +|+|++++++.+...+..++
T Consensus 15 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--------e~~~~~~~~~h~~iv~~~~~~~~~~~~~i 86 (267)
T PHA03390 15 NCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI--------EPMVHQLMKDNPNFIKLYYSVTTLKGHVL 86 (267)
T ss_pred hhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh--------hHHHHHHhhcCCCEEEEEEEEecCCeeEE
Confidence 56666665 99999999999875 77899998754432211 22222222 69999999999999999999
Q ss_pred EEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCC-cEEEecCCCcccccc
Q 020888 118 ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD-HLKVGDFGLSKLIKV 196 (320)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~-~~~L~dfg~~~~~~~ 196 (320)
||||+++++|.+++.....+++..++.++.|++.||.+||+.| ++|+||+|+||++ +.++ .++|+|||.+.....
T Consensus 87 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~--~~~~~~~~l~dfg~~~~~~~ 162 (267)
T PHA03390 87 IMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHN--IIHNDIKLENVLY--DRAKDRIYLCDYGLCKIIGT 162 (267)
T ss_pred EEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEE--eCCCCeEEEecCccceecCC
Confidence 9999999999999988778999999999999999999999998 9999999999999 6666 899999998875532
Q ss_pred cCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHH-HhCCCCCCCCCCCC
Q 020888 197 QNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEA-AKYV-AEGHRPFFRAKGFT 274 (320)
Q Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~-~~~~-~~~~~~~~~~~~~~ 274 (320)
. ....++..|+|||.+.+..++.++|+||+|++++++++|..||........ .... ............++
T Consensus 163 ~--------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (267)
T PHA03390 163 P--------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVS 234 (267)
T ss_pred C--------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccC
Confidence 2 123468889999999988899999999999999999999999975433221 1111 11122222334689
Q ss_pred HHHHHHHHHHhhcCCCCCCC-HHHHHHH
Q 020888 275 PELRELTEKCWAADMNQRPS-FLDILKR 301 (320)
Q Consensus 275 ~~l~~li~~~l~~dp~~Rps-~~~ll~~ 301 (320)
..++++|.+||+.+|.+||+ +++++++
T Consensus 235 ~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 235 KNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred HHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 99999999999999999995 6998864
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=274.00 Aligned_cols=253 Identities=26% Similarity=0.407 Sum_probs=196.3
Q ss_pred ccCccceecccCceEEEEEEEC----CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeC--CceE
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER--KPLM 116 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~----~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 116 (320)
+|.+.+.||+|++|.||++.+. ++.+|+|.+.............+.+|+.+++.++|+|++++++++... ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4788899999999999999984 588999988764322222235677899999999999999999999877 7899
Q ss_pred EEEecCCCCCHHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCC----CCcEEEec
Q 020888 117 LITEYLRGGDLHKYLKEK-----GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS----ADHLKVGD 187 (320)
Q Consensus 117 iv~e~~~~~~L~~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~----~~~~~L~d 187 (320)
+|+||+++ +|.+.+... ..+++..++.++.|++.||.|||+.| ++|+||+|+||++ +. ++.++|+|
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~h~dlkp~Nil~--~~~~~~~~~~kl~D 155 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW--VLHRDLKPANILV--MGEGPERGVVKIGD 155 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEE--cCCCCccceEEECC
Confidence 99999965 777776531 26899999999999999999999998 9999999999999 66 88999999
Q ss_pred CCCcccccccCccceeeccCCcccccccCccccCcC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHH---------HH
Q 020888 188 FGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPYE---------AA 257 (320)
Q Consensus 188 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~---------~~ 257 (320)
||++......... ........++..|+|||...+. .++.++|+||||++++++++|..||....... ..
T Consensus 156 fg~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (316)
T cd07842 156 LGLARLFNAPLKP-LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQL 234 (316)
T ss_pred CccccccCCCccc-ccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHH
Confidence 9998866443221 1122334578889999988764 57899999999999999999999997554321 00
Q ss_pred HHHHh------------------------CCCCCCCC-----------CCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 258 KYVAE------------------------GHRPFFRA-----------KGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 258 ~~~~~------------------------~~~~~~~~-----------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
..+.. ........ ...+.++.+++.+||..||++|||+.+++++
T Consensus 235 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 235 ERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00000 00000000 1456789999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=267.41 Aligned_cols=242 Identities=29% Similarity=0.429 Sum_probs=192.1
Q ss_pred eecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHH---HHHHhCCCCcccceeeeEEeCCceEEEEecCC
Q 020888 49 IIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEV---NLLVKLRHPNIVQFLGAVTERKPLMLITEYLR 123 (320)
Q Consensus 49 ~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~---~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 123 (320)
+||+|++|.||++.+. ++.+|+|.+................|. +.++...|++++++.+.+...+..++|+||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4799999999999875 688999988664433222212233333 34444579999999999999999999999999
Q ss_pred CCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCcccee
Q 020888 124 GGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 203 (320)
Q Consensus 124 ~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~~~~ 203 (320)
|++|.+++...+.+++..+..++.|++.||.|||+.+ ++|+||+|+||++ +.++.++|+|||.+.......
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~nili--~~~~~~kl~dfg~~~~~~~~~----- 151 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRF--VVYRDLKPANILL--DEHGHVRISDLGLACDFSKKK----- 151 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCCCCHHHEEE--CCCCCEEEccCcCccccCccC-----
Confidence 9999999988778999999999999999999999988 9999999999999 888899999999987553221
Q ss_pred eccCCcccccccCccccCcC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHhCCCCCCCCCCCCHHHHHH
Q 020888 204 KMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPYE--AAKYVAEGHRPFFRAKGFTPELREL 280 (320)
Q Consensus 204 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~l 280 (320)
.....++..|+|||.+.+. .++.++|+||+|+++|++++|..||....... ............ .+..++.++.++
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~~l 229 (278)
T cd05606 152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE-LPDSFSPELRSL 229 (278)
T ss_pred -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCC-CCCcCCHHHHHH
Confidence 1224578899999998754 68899999999999999999999998763221 111122222222 234468999999
Q ss_pred HHHHhhcCCCCCC-----CHHHHHHH
Q 020888 281 TEKCWAADMNQRP-----SFLDILKR 301 (320)
Q Consensus 281 i~~~l~~dp~~Rp-----s~~~ll~~ 301 (320)
+.+||..+|.+|| ++.+++++
T Consensus 230 i~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 230 LEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred HHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 9999999999999 99999865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=269.90 Aligned_cols=247 Identities=28% Similarity=0.548 Sum_probs=197.4
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCC-CCcccceeeeEEeCCceEEEE
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLMLIT 119 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~iv~ 119 (320)
+|...+.||+|++|.||++.+. ++.+++|.+...... .....+.+|+.++.++. |+||+++++++..++..++++
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~ 82 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICM 82 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEE
Confidence 5777889999999999999885 788999988654332 33467888999999996 999999999998888999999
Q ss_pred ecCCCCCHHHHHH-----HhCCCCHHHHHHHHHHHHHHHHHHhcC-CCCeEecCCCCCcEEEeeCCCCcEEEecCCCccc
Q 020888 120 EYLRGGDLHKYLK-----EKGALSPSTAVNFALDIARGMAYLHNE-PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 193 (320)
Q Consensus 120 e~~~~~~L~~~~~-----~~~~l~~~~~~~i~~~l~~~l~~lH~~-g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~ 193 (320)
|++++ +|.++.. ....+++..+..++.+++.||+|||+. | ++|+||+|+||++ +.++.++|+|||++..
T Consensus 83 e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~--~~~~~~kl~dfg~~~~ 157 (288)
T cd06616 83 ELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK--IIHRDVKPSNILL--DRNGNIKLCDFGISGQ 157 (288)
T ss_pred ecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC--eeccCCCHHHEEE--ccCCcEEEeecchhHH
Confidence 99854 6665432 235689999999999999999999975 7 9999999999999 7888999999999876
Q ss_pred ccccCccceeeccCCcccccccCccccCcC---CCCCchhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHhCCCCCCC
Q 020888 194 IKVQNSHDVYKMTGETGSYRYMAPEVFKHR---KYDKKVDVFSFAMILYEMLEGEPPLANYEP-YEAAKYVAEGHRPFFR 269 (320)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~~l~~ll~g~~p~~~~~~-~~~~~~~~~~~~~~~~ 269 (320)
+..... .....++..|+|||.+.+. .++.++|+||||++++++++|+.||..... .+..........+...
T Consensus 158 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd06616 158 LVDSIA-----KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILS 232 (288)
T ss_pred hccCCc-----cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCC
Confidence 543221 1223567889999998776 688999999999999999999999976542 1222222222222222
Q ss_pred C---CCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 270 A---KGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 270 ~---~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
. ..++.++.+++.+||+.+|.+|||+++++++
T Consensus 233 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 233 NSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 2 2478999999999999999999999999886
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=285.95 Aligned_cols=247 Identities=28% Similarity=0.482 Sum_probs=210.5
Q ss_pred cCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEec
Q 020888 44 FSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY 121 (320)
Q Consensus 44 y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 121 (320)
+.++..||.|+||+||++..+ +-..|.|++ .....+.++.+.-||++|..++||+|+++++.|-.++.++|+.||
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvI---etkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF 110 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVI---ETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF 110 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhh---cccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence 567789999999999999876 344566766 334455678889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCcc
Q 020888 122 LRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 200 (320)
Q Consensus 122 ~~~~~L~~~~~~-~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~ 200 (320)
|+||....++-+ ...+.+.++..+++|++.||.|||+++ |+|+|+|..||++ +.+|.++|.|||.+-....
T Consensus 111 C~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~--iIHRDLKAGNiL~--TldGdirLADFGVSAKn~~---- 182 (1187)
T KOG0579|consen 111 CGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQN--IIHRDLKAGNILL--TLDGDIRLADFGVSAKNKS---- 182 (1187)
T ss_pred cCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcc--hhhhhccccceEE--EecCcEeeecccccccchh----
Confidence 999988877654 567999999999999999999999988 9999999999999 8899999999998754321
Q ss_pred ceeeccCCcccccccCcccc-----CcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCC-CCCCCCCC
Q 020888 201 DVYKMTGETGSYRYMAPEVF-----KHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRP-FFRAKGFT 274 (320)
Q Consensus 201 ~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 274 (320)
....-....|||.|+|||+. ....|+.++||||||++|.+|..+..|-...++..+.-.+.+...+ ...+..|+
T Consensus 183 t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws 262 (1187)
T KOG0579|consen 183 TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWS 262 (1187)
T ss_pred HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhh
Confidence 11123456799999999976 4567999999999999999999999999999888877666655544 45567899
Q ss_pred HHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 275 PELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 275 ~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
..+.+|++.||..||..||++.++++|
T Consensus 263 ~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 263 RSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred hHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 999999999999999999999999876
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=268.94 Aligned_cols=249 Identities=27% Similarity=0.416 Sum_probs=196.5
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCC-CCcccceeeeEEeCCc-----
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKP----- 114 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~----- 114 (320)
+|++.+.||+|++|.||++.+. ++.+++|.+........ ....+.+|+.+++.+. |+|++++++++...+.
T Consensus 2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEG-IPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccC-CchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 6889999999999999999975 78899998755432221 2256778999999995 6999999999877665
Q ss_pred eEEEEecCCCCCHHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCC-CCcEEEecC
Q 020888 115 LMLITEYLRGGDLHKYLKEK-----GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS-ADHLKVGDF 188 (320)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~-~~~~~L~df 188 (320)
.|++|||+++ +|.+++... ..+++..++.++.|++.||.|||+.| ++|+||+|+||++ +. ++.++|+||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~~~nil~--~~~~~~~kl~df 155 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG--VMHRDLKPQNLLV--DKQKGLLKIADL 155 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEE--ecCCCeEEEeec
Confidence 8999999976 898887642 35799999999999999999999998 9999999999999 66 789999999
Q ss_pred CCcccccccCccceeeccCCcccccccCccccCc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCC--
Q 020888 189 GLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHR-- 265 (320)
Q Consensus 189 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~-- 265 (320)
|.+........ ......+++.|.|||.+.+ ..++.++|+||||+++|+|++|..||...+..+....+.....
T Consensus 156 g~~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~ 231 (295)
T cd07837 156 GLGRAFSIPVK----SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTP 231 (295)
T ss_pred ccceecCCCcc----ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 98875533211 1112345778999998865 4578999999999999999999999987665544333222110
Q ss_pred -----------------CC-------CCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 266 -----------------PF-------FRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 266 -----------------~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
+. .....++.++.++|.+||..||.+|||+.+++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 232 TEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred ChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00 0012468899999999999999999999999865
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=274.86 Aligned_cols=245 Identities=23% Similarity=0.377 Sum_probs=184.7
Q ss_pred ceecccCceEEEEEEEC----CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEE--eCCceEEEEec
Q 020888 48 AIIGKGSFGEILKAYWR----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVT--ERKPLMLITEY 121 (320)
Q Consensus 48 ~~lg~g~~~~vy~~~~~----~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~iv~e~ 121 (320)
+.||+|+||+||++... +..+|+|.+..... ...+.+|+++++.++|+|++++++++. .+...++++||
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 68999999999999864 46799998754322 145678999999999999999999884 35668999999
Q ss_pred CCCCCHHHHHHHh---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEee--CCCCcEEEecCCC
Q 020888 122 LRGGDLHKYLKEK---------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN--SSADHLKVGDFGL 190 (320)
Q Consensus 122 ~~~~~L~~~~~~~---------~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~--~~~~~~~L~dfg~ 190 (320)
+++ +|.+++... ..+++..+..++.|++.||.|||+.| ++|+||||+||++.. +.++.++|+|||+
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07867 82 AEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred eCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence 965 888877521 24789999999999999999999998 999999999999932 3456899999999
Q ss_pred cccccccCccceeeccCCcccccccCccccCcC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChH---------HHHHHH
Q 020888 191 SKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPY---------EAAKYV 260 (320)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~---------~~~~~~ 260 (320)
+........ .........+++.|+|||.+.+. .++.++||||||+++|+|++|..||...... .....+
T Consensus 159 a~~~~~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~ 237 (317)
T cd07867 159 ARLFNSPLK-PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRI 237 (317)
T ss_pred eeccCCCcc-cccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHH
Confidence 986643321 11122344678899999998764 5789999999999999999999998643211 000000
Q ss_pred Hh------------------------CCC------------CCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 261 AE------------------------GHR------------PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 261 ~~------------------------~~~------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
.. ... ........+..+.+++.+||..||.+|||++|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~h 314 (317)
T cd07867 238 FSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQD 314 (317)
T ss_pred HHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcC
Confidence 00 000 000011235678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=271.54 Aligned_cols=257 Identities=23% Similarity=0.357 Sum_probs=198.9
Q ss_pred ceeccc--CceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEecCC
Q 020888 48 AIIGKG--SFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLR 123 (320)
Q Consensus 48 ~~lg~g--~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 123 (320)
..||.| ++++||++.+. ++.||+|.+....... ...+.+.+|+.+++.++|+||+++++++..++..++|+||+.
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTE-EHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 456766 89999999984 8999999886543333 345788999999999999999999999999999999999999
Q ss_pred CCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCccc
Q 020888 124 GGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHD 201 (320)
Q Consensus 124 ~~~L~~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~~ 201 (320)
+++|.+++.+. ..+++..+..++.|++.||+|||+.| ++|+||||+||++ +.++.++++||+.+..........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivHrDlkp~Nill--~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG--YIHRNIKASHILI--SGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEE--eCCCcEEEechHHHhhhhccCccc
Confidence 99999998764 35899999999999999999999988 9999999999999 778899999998654433221111
Q ss_pred ee--e-ccCCcccccccCccccCcC--CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCC-----------
Q 020888 202 VY--K-MTGETGSYRYMAPEVFKHR--KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHR----------- 265 (320)
Q Consensus 202 ~~--~-~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~----------- 265 (320)
.. . .....++..|+|||++.+. .++.++|+|||||++|++++|..||.................
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPC 238 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccch
Confidence 10 0 0112245679999998764 478999999999999999999999987654443322221110
Q ss_pred ----------------------------------CCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH--HHHHHhcC
Q 020888 266 ----------------------------------PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR--LEKIKETL 309 (320)
Q Consensus 266 ----------------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--L~~~~~~~ 309 (320)
.......+++.+.+++++||..||++|||+.+++++ +..+..+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~~~ 318 (328)
T cd08226 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKEQT 318 (328)
T ss_pred hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHHhc
Confidence 000112356789999999999999999999999877 55555543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=267.19 Aligned_cols=250 Identities=26% Similarity=0.497 Sum_probs=200.7
Q ss_pred CCcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCC-CCcccceeeeEEeCCceE
Q 020888 40 SELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLM 116 (320)
Q Consensus 40 ~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 116 (320)
...+|.+.+.||.|++|.||++.+. ++.+++|.+...... .....+..|++++.... |+||+++++++..+...|
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 90 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVF 90 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh--HHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEE
Confidence 3457899999999999999999987 788999988654322 22355666777777774 999999999999999999
Q ss_pred EEEecCCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccc
Q 020888 117 LITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHN-EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 194 (320)
Q Consensus 117 iv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~~l~~~l~~lH~-~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~ 194 (320)
++|||+++ +|.+++.. .+.+++..+..++.|++.++.|||+ .| ++|+||+|+||++ +.++.++|+|||.+..+
T Consensus 91 ~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~--i~H~dl~p~nill--~~~~~~kL~dfg~~~~~ 165 (296)
T cd06618 91 ICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG--VIHRDVKPSNILL--DASGNVKLCDFGISGRL 165 (296)
T ss_pred EEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC--EecCCCcHHHEEE--cCCCCEEECccccchhc
Confidence 99999854 78877765 4578999999999999999999997 47 9999999999999 88899999999998765
Q ss_pred cccCccceeeccCCcccccccCccccCcCC----CCCchhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHhCCCCCCC
Q 020888 195 KVQNSHDVYKMTGETGSYRYMAPEVFKHRK----YDKKVDVFSFAMILYEMLEGEPPLANYEP-YEAAKYVAEGHRPFFR 269 (320)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~Di~slG~~l~~ll~g~~p~~~~~~-~~~~~~~~~~~~~~~~ 269 (320)
..... .....++..|+|||.+.+.. ++.++|+||||+++|++++|+.||..... .+....+.....+...
T Consensus 166 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 240 (296)
T cd06618 166 VDSKA-----KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLP 240 (296)
T ss_pred cCCCc-----ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCC
Confidence 43221 12234677899999987654 78899999999999999999999976433 2333334433333222
Q ss_pred C-CCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 270 A-KGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 270 ~-~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
. ..++.++++++.+||..||.+||++++++++
T Consensus 241 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 241 PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 2 2478999999999999999999999999877
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=273.28 Aligned_cols=254 Identities=25% Similarity=0.347 Sum_probs=200.8
Q ss_pred ccC-ccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHH-----------HHHHHHHHHHHHHhCCCCcccceeee
Q 020888 43 DFS-SSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRL-----------VIQDFRHEVNLLVKLRHPNIVQFLGA 108 (320)
Q Consensus 43 ~y~-~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~-----------~~~~~~~e~~~l~~l~h~~i~~~~~~ 108 (320)
+|. +.+.||.|++|+||++.+. ++.+|+|.+......... ....+.+|+++++.++|+||++++++
T Consensus 9 ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 88 (335)
T PTZ00024 9 RYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDV 88 (335)
T ss_pred chhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEE
Confidence 454 5678999999999999875 788999987544322210 01246789999999999999999999
Q ss_pred EEeCCceEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecC
Q 020888 109 VTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF 188 (320)
Q Consensus 109 ~~~~~~~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~df 188 (320)
+..++..+++||+++ ++|.+++.....+++..+..++.|++.||.+||+.| ++|+||+|+||++ +.++.++|+||
T Consensus 89 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~--i~H~dl~~~nill--~~~~~~kl~df 163 (335)
T PTZ00024 89 YVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWY--FMHRDLSPANIFI--NSKGICKIADF 163 (335)
T ss_pred EecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHeEE--CCCCCEEECCc
Confidence 999999999999996 599999988778999999999999999999999998 9999999999999 88889999999
Q ss_pred CCcccccccCcc----------ceeeccCCcccccccCccccCcC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 020888 189 GLSKLIKVQNSH----------DVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAA 257 (320)
Q Consensus 189 g~~~~~~~~~~~----------~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~ 257 (320)
|.+......... .........+++.|+|||.+.+. .++.++|+||||++++++++|..||...+..+..
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~ 243 (335)
T PTZ00024 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL 243 (335)
T ss_pred cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 988765421100 01111223467789999998765 4689999999999999999999999887765544
Q ss_pred HHHHhCCCCC--------------------------CCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 258 KYVAEGHRPF--------------------------FRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 258 ~~~~~~~~~~--------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
..+......+ ......++++.++|.+||+.+|.+|||+++++.+
T Consensus 244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 244 GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 3332211000 0012357889999999999999999999999975
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=272.60 Aligned_cols=265 Identities=31% Similarity=0.464 Sum_probs=208.6
Q ss_pred CCcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEe-CCceE
Q 020888 40 SELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE-RKPLM 116 (320)
Q Consensus 40 ~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 116 (320)
.+.+|++.+.||.|++|.||++.+. ++.+++|.+....... ...+.+.+|+++++.++|||++++.+++.. +...+
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTP-VLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccccc-chhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 4568999999999999999999875 7889999876543322 223677789999999999999999998865 56789
Q ss_pred EEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccc
Q 020888 117 LITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 196 (320)
Q Consensus 117 iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~ 196 (320)
+++||+ +++|.+++.. .++++..+..++.|+++||.+||+.| ++|+||+|+||++ +.++.++|+|||.+.....
T Consensus 87 lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~--iiH~dl~p~Nili--~~~~~~~l~dfg~~~~~~~ 160 (328)
T cd07856 87 FVTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAG--VVHRDLKPSNILI--NENCDLKICDFGLARIQDP 160 (328)
T ss_pred EEeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEeE--CCCCCEEeCccccccccCC
Confidence 999998 5699988875 46888999999999999999999998 9999999999999 8888999999998875422
Q ss_pred cCccceeeccCCcccccccCccccCc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhC------------
Q 020888 197 QNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEG------------ 263 (320)
Q Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~------------ 263 (320)
. .....++..|+|||.+.+ ..++.++|+||||+++|++++|..||...........+.+.
T Consensus 161 ~-------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (328)
T cd07856 161 Q-------MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI 233 (328)
T ss_pred C-------cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 1 122346778999998765 56889999999999999999999999776543322111110
Q ss_pred ------------CCCC-----CCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH--HHHHHhcCCCCCccccc
Q 020888 264 ------------HRPF-----FRAKGFTPELRELTEKCWAADMNQRPSFLDILKR--LEKIKETLPTDHHWNIF 318 (320)
Q Consensus 264 ------------~~~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--L~~~~~~~~~~~~~~~~ 318 (320)
.... .....+++++++++++||+.+|++|||+++++.+ +.+..+....+...+.|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~~~~~~~~~~ 307 (328)
T cd07856 234 CSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTDEPVAEEKF 307 (328)
T ss_pred cchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCccccCchhhc
Confidence 0000 0012467899999999999999999999999988 66666665555554444
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=266.67 Aligned_cols=249 Identities=29% Similarity=0.438 Sum_probs=200.8
Q ss_pred cCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeC--CceEEEE
Q 020888 44 FSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER--KPLMLIT 119 (320)
Q Consensus 44 y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~iv~ 119 (320)
|.+.+.||.|++|.||++.+. ++.+++|.+...... ......+.+|+++++.++|+|++++++++... +..++|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEK-EGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccccc-ccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 678899999999999999886 688999998765422 22235677899999999999999999999887 8899999
Q ss_pred ecCCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccC
Q 020888 120 EYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 198 (320)
Q Consensus 120 e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~ 198 (320)
||+++ +|.+++... ..+++..++.++.|++.||++||+.| ++|+||+|+||++ +.++.++|+|||.+.......
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--~~h~dl~p~nil~--~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 80 EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG--ILHRDIKGSNILI--NNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEE--cCCCCEEEccccceeeccCCC
Confidence 99975 899888764 57999999999999999999999998 9999999999999 888999999999987665432
Q ss_pred ccceeeccCCcccccccCccccCc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCC----------
Q 020888 199 SHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPF---------- 267 (320)
Q Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~---------- 267 (320)
. .......++..|+|||.+.+ ..++.++|+||||++++++++|..||...+.......+.......
T Consensus 155 ~---~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07840 155 S---ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSK 231 (287)
T ss_pred c---ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhcccccc
Confidence 1 11222346778999998765 457899999999999999999999998776554443333211000
Q ss_pred -------------------CCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 268 -------------------FRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 268 -------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
.....++.++.+++.+||..+|.+||++++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 232 LPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred chhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0001137889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=263.45 Aligned_cols=249 Identities=31% Similarity=0.497 Sum_probs=202.8
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCC--cHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEE
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSD--DRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 118 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 118 (320)
+|.+.+.||.|++|.||++.+. +..+++|........ .......+..|+.+++.++|+|++++++.+.+....+++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 5888899999999999999876 344556655432221 111224566789999999999999999999988999999
Q ss_pred EecCCCCCHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccc
Q 020888 119 TEYLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 194 (320)
Q Consensus 119 ~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~ 194 (320)
+||+++++|.+++.. ...+++..++.++.|++.||.+||+.| ++|+||+|+||++ +. +.++|+|||.+...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~~l~~~nili--~~-~~~~l~d~g~~~~~ 155 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR--ILHRDLKAKNIFL--KN-NLLKIGDFGVSRLL 155 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC--ccccCCChhheEe--ec-CCEeecccCceeec
Confidence 999999999988753 346899999999999999999999998 9999999999999 43 56999999988765
Q ss_pred cccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCC
Q 020888 195 KVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFT 274 (320)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (320)
..... ......+++.|+|||.+.+..++.++|+||+|++++++++|..||...........+..+..+.. +..++
T Consensus 156 ~~~~~----~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 230 (260)
T cd08222 156 MGSCD----LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSL-PETYS 230 (260)
T ss_pred CCCcc----cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCC-cchhc
Confidence 43221 12234567889999999888889999999999999999999999987776666666655544433 44578
Q ss_pred HHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 275 PELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 275 ~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
.++.+++.+||..+|.+||++.+++++
T Consensus 231 ~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 231 RQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred HHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=266.31 Aligned_cols=248 Identities=27% Similarity=0.415 Sum_probs=202.3
Q ss_pred cCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEec
Q 020888 44 FSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY 121 (320)
Q Consensus 44 y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 121 (320)
|.+.+.||.|++|.||++.+. ++.+++|.+....... .....+.+|++++++++|++++++++++..++..++++||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESE-GIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccc-hhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 677889999999999999875 7889999886554332 2346788899999999999999999999999999999999
Q ss_pred CCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCcc
Q 020888 122 LRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 200 (320)
Q Consensus 122 ~~~~~L~~~~~~-~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~ 200 (320)
+++ +|.+++.. ...+++..++.++.|++.+|.+||+.| ++|+||+|+||++ +.++.++|+|||.+........
T Consensus 80 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili--~~~~~~~l~df~~~~~~~~~~~- 153 (283)
T cd05118 80 MDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG--ILHRDLKPENLLI--NTEGVLKLADFGLARSFGSPVR- 153 (283)
T ss_pred cCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCC--eeecCcCHHHEEE--CCCCcEEEeeeeeeEecCCCcc-
Confidence 965 88888876 357899999999999999999999998 9999999999999 7888999999998876644321
Q ss_pred ceeeccCCcccccccCccccCcC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCC------------
Q 020888 201 DVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPF------------ 267 (320)
Q Consensus 201 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~------------ 267 (320)
......++..|.|||...+. .++.++|+||||+++|++++|+.||...+..+....+.......
T Consensus 154 ---~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd05118 154 ---PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLA 230 (283)
T ss_pred ---cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhh
Confidence 11223467789999998776 78899999999999999999999998776554433322110000
Q ss_pred ----------------CCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 268 ----------------FRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 268 ----------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
.....++.++++++.+||..||.+||++.+++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 231 RNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 0012367899999999999999999999999864
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=254.19 Aligned_cols=247 Identities=27% Similarity=0.513 Sum_probs=202.4
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCC-CCcccceeeeEEeCCceEEEE
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLMLIT 119 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~iv~ 119 (320)
+...+..||.|+.|+|+++... +.-.|||..... ...+..+++...+.+..... .|+|++++++|-.+...++.|
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt--~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcM 170 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRT--GNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICM 170 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeeccc--CCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHH
Confidence 3456778999999999999886 588999988654 33445578888888877764 899999999999998899999
Q ss_pred ecCCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHhcC-CCCeEecCCCCCcEEEeeCCCCcEEEecCCCccccccc
Q 020888 120 EYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNE-PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 197 (320)
Q Consensus 120 e~~~~~~L~~~~~~-~~~l~~~~~~~i~~~l~~~l~~lH~~-g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~ 197 (320)
|.+ ..-+..++.+ .+++++..+-.+...++.||.||.++ | |+|+|+||+||++ |..|++||||||.+.++..+
T Consensus 171 elM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~--viHRDvKPSNILl--De~GniKlCDFGIsGrlvdS 245 (391)
T KOG0983|consen 171 ELM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILL--DERGNIKLCDFGISGRLVDS 245 (391)
T ss_pred HHH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcc--eeecccCccceEE--ccCCCEEeecccccceeecc
Confidence 987 4356666654 56799999999999999999999777 5 9999999999999 99999999999999888765
Q ss_pred CccceeeccCCcccccccCccccCc---CCCCCchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHhCCCCCCCC-CC
Q 020888 198 NSHDVYKMTGETGSYRYMAPEVFKH---RKYDKKVDVFSFAMILYEMLEGEPPLANYEPY-EAAKYVAEGHRPFFRA-KG 272 (320)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~-~~~~~~~~~~~~~~~~-~~ 272 (320)
.. .....|-+.|+|||.+.- ..|+.++||||||++++||.||+.||...+.. +....+.....+.... .+
T Consensus 246 kA-----htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~g 320 (391)
T KOG0983|consen 246 KA-----HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMG 320 (391)
T ss_pred cc-----cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccC
Confidence 42 334567888999999854 46888999999999999999999999985543 4444444444433333 45
Q ss_pred CCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 273 FTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 273 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
+++.+.+|+..||..|+.+||.+.+++++
T Consensus 321 FSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 321 FSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred cCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 89999999999999999999999999876
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=271.38 Aligned_cols=253 Identities=26% Similarity=0.384 Sum_probs=198.6
Q ss_pred ccCccceecccCceEEEEEEEC----CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcccceeeeEEe----CC
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTE----RK 113 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~----~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~----~~ 113 (320)
+|.+.+.||+|+||.||++.+. +..+|+|.+...... ....+.+.+|+++++++ +|+||+++++.... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSK-KILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccccc-chhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 4788899999999999999986 457999987643322 22235677899999999 59999999986532 24
Q ss_pred ceEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccc
Q 020888 114 PLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 193 (320)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~ 193 (320)
..++++++++ ++|.+++.....+++..++.++.|++.||.|||+.| ++|+||||+||++ +.++.++|+|||.+..
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivH~dlkp~Nili--~~~~~~kl~Dfg~a~~ 154 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSAN--VLHRDLKPGNLLV--NADCELKICDFGLARG 154 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHeEE--cCCCCEEeCcCCCcee
Confidence 5788999885 599999987778999999999999999999999998 9999999999999 8888999999999987
Q ss_pred ccccCccceeeccCCcccccccCccccCc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCC--------
Q 020888 194 IKVQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH-------- 264 (320)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~-------- 264 (320)
+...............++..|+|||...+ ..++.++|+||+|++++++++|..||...+..+....+....
T Consensus 155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 234 (332)
T cd07857 155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETL 234 (332)
T ss_pred cccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 65433222222233467889999998765 468899999999999999999999998765443322211110
Q ss_pred -------------------CC--CCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 265 -------------------RP--FFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 265 -------------------~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
.. .......+..+++++.+||+.||.+|||+.+++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 235 SRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00 00112357899999999999999999999999876
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=269.82 Aligned_cols=253 Identities=19% Similarity=0.291 Sum_probs=197.4
Q ss_pred cCccceecccCceEEEEEEECCCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEecCC
Q 020888 44 FSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLR 123 (320)
Q Consensus 44 y~~~~~lg~g~~~~vy~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 123 (320)
|.+.+.+|.|+++.++++..+++.+|+|.+...... ......+.+|+++++.++|+||+++++.+...+..+++|||++
T Consensus 4 ~~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~ 82 (314)
T cd08216 4 TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCS-KEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA 82 (314)
T ss_pred hhhhHhhcCCceEEEEEecCCCCEEEEEEEeccccc-hhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccC
Confidence 455566666777777777667899999988654322 3345789999999999999999999999999999999999999
Q ss_pred CCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCcc-
Q 020888 124 GGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH- 200 (320)
Q Consensus 124 ~~~L~~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~- 200 (320)
+++|.+++... ..+++..+..++.|++.||.|||++| |+|+||+|+||++ +.++.++|+||+.+.........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~--ivH~dlk~~Nili--~~~~~~kl~d~~~~~~~~~~~~~~ 158 (314)
T cd08216 83 YGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG--FIHRSVKASHILL--SGDGKVVLSGLRYSVSMIKHGKRQ 158 (314)
T ss_pred CCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCcceEEE--ecCCceEEecCccceeeccccccc
Confidence 99999999763 35899999999999999999999998 9999999999999 78889999999988765432211
Q ss_pred --ceeeccCCcccccccCccccCcC--CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCC-----------
Q 020888 201 --DVYKMTGETGSYRYMAPEVFKHR--KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHR----------- 265 (320)
Q Consensus 201 --~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~----------- 265 (320)
.........++..|.|||.+.+. .++.++|+||+|++++++++|..||..............+..
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (314)
T cd08216 159 RVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPL 238 (314)
T ss_pred cccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhh
Confidence 00111223467789999998663 578899999999999999999999987654433221111100
Q ss_pred ---------------------CCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 266 ---------------------PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 266 ---------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
.......++.++.+++.+||..||.+|||+++++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 239 YEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred hcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 000011234678999999999999999999999987
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=266.04 Aligned_cols=250 Identities=24% Similarity=0.405 Sum_probs=201.4
Q ss_pred ccCccceecccCceEEEEEEE-----CCCceEEEEccCCCCC-cHHHHHHHHHHHHHHHhC-CCCcccceeeeEEeCCce
Q 020888 43 DFSSSAIIGKGSFGEILKAYW-----RGTPVAIKRILPSLSD-DRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPL 115 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~-----~~~~~~~K~~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 115 (320)
+|++.+.||.|++|.||.+.+ ++..+++|.+...... .....+.+.+|+.+++++ +|++|+++++.+..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 478889999999999999986 4688999988653322 222336678899999999 599999999999999999
Q ss_pred EEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccccc
Q 020888 116 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 195 (320)
Q Consensus 116 ~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~ 195 (320)
++|+||+++++|.+++.....+++..+..++.|++.||.+||+.| ++|+||+|+||++ +.++.++|+|||.+....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nil~--~~~~~~kl~dfg~~~~~~ 156 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLG--IIYRDIKLENILL--DSNGHVVLTDFGLSKEFH 156 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEE--CCCCCEEEeeCccceecc
Confidence 999999999999999988778999999999999999999999998 9999999999999 888999999999887653
Q ss_pred ccCccceeeccCCcccccccCccccCcC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHhCCCCCCC
Q 020888 196 VQNSHDVYKMTGETGSYRYMAPEVFKHR--KYDKKVDVFSFAMILYEMLEGEPPLANYEP----YEAAKYVAEGHRPFFR 269 (320)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~ll~g~~p~~~~~~----~~~~~~~~~~~~~~~~ 269 (320)
..... ......++..|+|||...+. .++.++|+||||+++|++++|..||..... .+....+.... +. .
T Consensus 157 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~-~~-~ 231 (290)
T cd05613 157 EDEVE---RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE-PP-Y 231 (290)
T ss_pred ccccc---ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccC-CC-C
Confidence 32211 11234578889999998753 467899999999999999999999974322 22222222222 22 2
Q ss_pred CCCCCHHHHHHHHHHhhcCCCCCC-----CHHHHHHH
Q 020888 270 AKGFTPELRELTEKCWAADMNQRP-----SFLDILKR 301 (320)
Q Consensus 270 ~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~ 301 (320)
+..++..+.+++.+||..||.+|| ++++++.+
T Consensus 232 ~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 232 PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred CccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 345789999999999999999997 77888775
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=272.57 Aligned_cols=251 Identities=26% Similarity=0.433 Sum_probs=196.7
Q ss_pred CcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeC------
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER------ 112 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------ 112 (320)
..+|.+.+.||.|++|.||++.++ +..+++|.+..... ...+.+.+|+++++.++|+|++++++.+...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTE 80 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccc
Confidence 468999999999999999999885 78899998755433 2336788899999999999999999776543
Q ss_pred --------CceEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeC-CCCcE
Q 020888 113 --------KPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS-SADHL 183 (320)
Q Consensus 113 --------~~~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~-~~~~~ 183 (320)
...++++||++ ++|.+++.. +.+++..++.++.|++.||.|||+.| ++|+||||+||++ + .++.+
T Consensus 81 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g--ivH~dikp~Nili--~~~~~~~ 154 (342)
T cd07854 81 DVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANVFI--NTEDLVL 154 (342)
T ss_pred ccccccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEE--cCCCceE
Confidence 35799999996 499888865 46899999999999999999999998 9999999999999 5 34578
Q ss_pred EEecCCCcccccccCccceeeccCCcccccccCccccCc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh
Q 020888 184 KVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAE 262 (320)
Q Consensus 184 ~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~ 262 (320)
+|+|||.+........... ......++..|+|||.+.+ ..++.++|+|||||+++++++|..||......+.......
T Consensus 155 kl~dfg~~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~ 233 (342)
T cd07854 155 KIGDFGLARIVDPHYSHKG-YLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILE 233 (342)
T ss_pred EECCcccceecCCcccccc-ccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9999999876532211111 1122346788999998754 4678899999999999999999999987665444333222
Q ss_pred CCC-----------------------CCC-----CCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 263 GHR-----------------------PFF-----RAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 263 ~~~-----------------------~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
... ... ....++.++++++.+||..||++|||+.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 234 SVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred hcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 110 000 012467899999999999999999999999876
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=268.60 Aligned_cols=246 Identities=26% Similarity=0.502 Sum_probs=217.5
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEe
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 120 (320)
-|.++.+||+|++|.||++.++ |+-+|+|..+.+ ..++.+..|+.++++++.++++++++.+-....+++|||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME 108 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME 108 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence 5889999999999999999886 888999976432 345888899999999999999999999888888999999
Q ss_pred cCCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCc
Q 020888 121 YLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 199 (320)
Q Consensus 121 ~~~~~~L~~~~~~-~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~ 199 (320)
||..|+.+|+++. +.++++..+..++...+.||+|||... =+|+|||.-||++ +.+|..+|.|||.+..+...
T Consensus 109 YCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~--KIHRDIKAGNILL--NT~G~AKLADFGVAGQLTDT-- 182 (502)
T KOG0574|consen 109 YCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLK--KIHRDIKAGNILL--NTDGIAKLADFGVAGQLTDT-- 182 (502)
T ss_pred hcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHH--HHHhhcccccEEE--cccchhhhhhccccchhhhh--
Confidence 9998999999975 568999999999999999999999987 7899999999999 88899999999998766542
Q ss_pred cceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCC-CCCCHHHH
Q 020888 200 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA-KGFTPELR 278 (320)
Q Consensus 200 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~ 278 (320)
-..-+...|||.|+|||++..-.|+..+||||||++..+|..|+.||.+..+.....-+.....+.+.. ..++.++.
T Consensus 183 --MAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~ 260 (502)
T KOG0574|consen 183 --MAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFN 260 (502)
T ss_pred --HHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHH
Confidence 223456789999999999999999999999999999999999999999999887776666666666553 56899999
Q ss_pred HHHHHHhhcCCCCCCCHHHHHHH
Q 020888 279 ELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 279 ~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
+|+++||-..|++|.|+-++++|
T Consensus 261 DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 261 DFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred HHHHHHhcCCHHHHHHHHHHhhh
Confidence 99999999999999999999876
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=266.43 Aligned_cols=253 Identities=26% Similarity=0.379 Sum_probs=202.1
Q ss_pred ccCccceecccCceEEEEEEEC-----CCceEEEEccCCCCC-cHHHHHHHHHHHHHHHhC-CCCcccceeeeEEeCCce
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSD-DRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPL 115 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~-----~~~~~~K~~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 115 (320)
+|.+.+.||.|++|.||++.+. +..+++|.+...... .......+.+|++++.++ +|++++++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4788899999999999998753 577999988644322 223346678899999999 599999999999999999
Q ss_pred EEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccccc
Q 020888 116 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 195 (320)
Q Consensus 116 ~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~ 195 (320)
++||||+++++|.+++.....+++..+..++.|++.+|.+||+.| ++|+||+|+||++ +.++.++|+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--~~H~dl~p~nil~--~~~~~~~l~dfg~~~~~~ 156 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLG--IIYRDIKLENILL--DSEGHVVLTDFGLSKEFL 156 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEE--CCCCCEEEEECccccccc
Confidence 999999999999999987778999999999999999999999988 9999999999999 788899999999887654
Q ss_pred ccCccceeeccCCcccccccCccccCcCC--CCCchhHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHhCCCCCCC
Q 020888 196 VQNSHDVYKMTGETGSYRYMAPEVFKHRK--YDKKVDVFSFAMILYEMLEGEPPLANYEP----YEAAKYVAEGHRPFFR 269 (320)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~~ll~g~~p~~~~~~----~~~~~~~~~~~~~~~~ 269 (320)
..... ......++..|+|||...+.. .+.++|+||||++++++++|..||..... .+....+..... ..
T Consensus 157 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~ 231 (288)
T cd05583 157 AEEEE---RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKP--PF 231 (288)
T ss_pred ccccc---ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCC--CC
Confidence 32211 112245788999999987765 78899999999999999999999964322 222222222222 22
Q ss_pred CCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHH
Q 020888 270 AKGFTPELRELTEKCWAADMNQRPSFLDILKRLEK 304 (320)
Q Consensus 270 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 304 (320)
+..++.++++++.+||+.||++|||+.++.+.|..
T Consensus 232 ~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 232 PKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred CcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 34478999999999999999999997766555443
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=263.18 Aligned_cols=247 Identities=29% Similarity=0.465 Sum_probs=197.2
Q ss_pred cCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhC---CCCcccceeeeEEeCCc----
Q 020888 44 FSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL---RHPNIVQFLGAVTERKP---- 114 (320)
Q Consensus 44 y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~---- 114 (320)
|.+.+.||+|++|.||++.++ ++.+++|.+........ ....+.+|+.+++++ +|+|++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEG-IPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccch-hhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 677899999999999999986 78899998865443322 224555677776665 59999999999987776
Q ss_pred -eEEEEecCCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCc
Q 020888 115 -LMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 191 (320)
Q Consensus 115 -~~iv~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~ 191 (320)
.+++|||+++ +|.+++.... .+++..++.++.|++.||.+||+.| ++|+||+|+||++ +.++.++|+|||.+
T Consensus 80 ~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~--i~h~~l~~~nili--~~~~~~~l~dfg~~ 154 (287)
T cd07838 80 KLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR--IVHRDLKPQNILV--TSDGQVKIADFGLA 154 (287)
T ss_pred eeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhEEE--ccCCCEEEeccCcc
Confidence 9999999965 8999887643 5899999999999999999999998 9999999999999 77899999999998
Q ss_pred ccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCC-----
Q 020888 192 KLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRP----- 266 (320)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~----- 266 (320)
....... ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||......+....+.+....
T Consensus 155 ~~~~~~~-----~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (287)
T cd07838 155 RIYSFEM-----ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEE 229 (287)
T ss_pred eeccCCc-----ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHh
Confidence 7654322 112234678899999999999999999999999999999999999877665544433321100
Q ss_pred -------------CC-------CCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 267 -------------FF-------RAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 267 -------------~~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
.. ....++..+.+++.+||+.||.+||++++++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 230 WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred cCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 00 001346788999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=277.98 Aligned_cols=258 Identities=26% Similarity=0.397 Sum_probs=234.4
Q ss_pred CcCCCCCcccCccceecccCceEEEEEEECCCc--eEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeC
Q 020888 35 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER 112 (320)
Q Consensus 35 ~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~--~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 112 (320)
+.-+..-.++.++.-||-|+||-|-++..+++. +|+|.+.+...-+....+-+..|-.++..++.+.|++++..+.+.
T Consensus 413 e~a~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~ 492 (732)
T KOG0614|consen 413 EFAQVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDS 492 (732)
T ss_pred hhcccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccc
Confidence 334455567888889999999999999887555 899988777666655557788899999999999999999999999
Q ss_pred CceEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcc
Q 020888 113 KPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 192 (320)
Q Consensus 113 ~~~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~ 192 (320)
.+.|++||-|-||.|+.+++.++.++..+...++..+++|++|||.+| |+++|+||+|.++ +.+|.+||.|||+++
T Consensus 493 kyvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~--iIYRDLKPENllL--d~~Gy~KLVDFGFAK 568 (732)
T KOG0614|consen 493 KYVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKG--IIYRDLKPENLLL--DNRGYLKLVDFGFAK 568 (732)
T ss_pred hhhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcC--ceeccCChhheee--ccCCceEEeehhhHH
Confidence 999999999999999999999999999999999999999999999999 9999999999999 999999999999999
Q ss_pred cccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCC
Q 020888 193 LIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKG 272 (320)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (320)
.+..+. ...+.+|||.|.|||++.+..++.+.|.||||+++|||++|..||...++...+..+.++......+..
T Consensus 569 ki~~g~-----KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~ 643 (732)
T KOG0614|consen 569 KIGSGR-----KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRR 643 (732)
T ss_pred HhccCC-----ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccc
Confidence 987665 455679999999999999999999999999999999999999999999999999999999988888888
Q ss_pred CCHHHHHHHHHHhhcCCCCCCC-----HHHHHHH
Q 020888 273 FTPELRELTEKCWAADMNQRPS-----FLDILKR 301 (320)
Q Consensus 273 ~~~~l~~li~~~l~~dp~~Rps-----~~~ll~~ 301 (320)
++....+++++++..+|.+|.. +.++.+|
T Consensus 644 I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH 677 (732)
T KOG0614|consen 644 ITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH 677 (732)
T ss_pred cchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence 9999999999999999999964 6777766
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=267.33 Aligned_cols=252 Identities=25% Similarity=0.392 Sum_probs=199.3
Q ss_pred CcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCC-----
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK----- 113 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----- 113 (320)
..+|.+.+.||.|++|.||++.++ ++.+++|.+........ ....+.+|+++++.++|+|++++++++....
T Consensus 6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~-~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEG-FPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccC-chHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 357999999999999999999985 78899998865432222 2246678999999999999999999886544
Q ss_pred -----ceEEEEecCCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEec
Q 020888 114 -----PLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGD 187 (320)
Q Consensus 114 -----~~~iv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~d 187 (320)
.+++++||+++ +|.+.+... ..+++..+..++.|++.||.|||+.| ++|+||+|+||++ ++++.++|+|
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili--~~~~~~kl~d 159 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKN--FLHRDIKCSNILL--NNKGQIKLAD 159 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEE--CCCCcEEeCc
Confidence 78999999976 787777653 46899999999999999999999988 9999999999999 8889999999
Q ss_pred CCCcccccccCccceeeccCCcccccccCccccCcC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhC---
Q 020888 188 FGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEG--- 263 (320)
Q Consensus 188 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~--- 263 (320)
||.+......... ......++..|+|||.+.+. .++.++|+||||++++++++|+.||...+..+....+.+.
T Consensus 160 fg~~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~ 236 (302)
T cd07864 160 FGLARLYNSEESR---PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGS 236 (302)
T ss_pred ccccccccCCccc---ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence 9998766433211 11122356789999988653 5788999999999999999999999876655444333321
Q ss_pred CCCC-------------------------CCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 264 HRPF-------------------------FRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 264 ~~~~-------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
..+. .....++..+.+++.+||..+|.+|||+++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 237 PCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred CChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1000 0112468999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=269.37 Aligned_cols=258 Identities=27% Similarity=0.415 Sum_probs=202.3
Q ss_pred cccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcccceeeeEEe--CCceE
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTE--RKPLM 116 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~ 116 (320)
.+|++.+.||+|++|.||++.+. ++.+++|.+........ ....+..|+.+++++ +|+||+++++++.. ...++
T Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~-~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNAT-DAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcch-hhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 47999999999999999999875 78899998765433222 235677899999999 99999999998864 34589
Q ss_pred EEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccc
Q 020888 117 LITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 196 (320)
Q Consensus 117 iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~ 196 (320)
+|+||+++ +|.+++..+ .+++...+.++.|++.||.+||+.| ++|+||+|+||++ +.++.++|+|||.+.....
T Consensus 86 lv~e~~~~-~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~--i~H~dl~p~nill--~~~~~~kl~d~g~~~~~~~ 159 (337)
T cd07852 86 LVFEYMET-DLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGN--VIHRDLKPSNILL--NSDCRVKLADFGLARSLSE 159 (337)
T ss_pred EEeccccc-CHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEE--cCCCcEEEeeccchhcccc
Confidence 99999964 999998775 7899999999999999999999988 9999999999999 8899999999999887654
Q ss_pred cCccc-eeeccCCcccccccCccccCc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCC---------
Q 020888 197 QNSHD-VYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHR--------- 265 (320)
Q Consensus 197 ~~~~~-~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~--------- 265 (320)
..... ........++..|+|||.+.+ ..++.++|+||||+++|++++|+.||......+....+.....
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd07852 160 LEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIES 239 (337)
T ss_pred ccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 32210 011222357888999998755 4578899999999999999999999976654433222211100
Q ss_pred --------------------CCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH--HHHHH
Q 020888 266 --------------------PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR--LEKIK 306 (320)
Q Consensus 266 --------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--L~~~~ 306 (320)
.......++.++.+++..||+.||.+|||+.+++++ ++.+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~ 302 (337)
T cd07852 240 IKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFH 302 (337)
T ss_pred HHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhc
Confidence 000112368899999999999999999999999987 55543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=259.26 Aligned_cols=249 Identities=26% Similarity=0.433 Sum_probs=217.5
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEe
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 120 (320)
+|..+++||+|.||+|.+|+.+ ++.+|+|++.+.-.-......--.-|-++|++.+||.+..+...++..+.+++|||
T Consensus 169 dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMe 248 (516)
T KOG0690|consen 169 DFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVME 248 (516)
T ss_pred hhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEE
Confidence 7888999999999999999986 88999999987766555555555668899999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCcc
Q 020888 121 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 200 (320)
Q Consensus 121 ~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~ 200 (320)
|..||.|.-++++...+++.....+...|+.||.|||+++ ||.+|+|.+|.++ |.+|.+||.|||+++.-...+
T Consensus 249 yanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~--ivYRDlKLENLlL--DkDGHIKitDFGLCKE~I~~g-- 322 (516)
T KOG0690|consen 249 YANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRN--IVYRDLKLENLLL--DKDGHIKITDFGLCKEEIKYG-- 322 (516)
T ss_pred EccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCC--eeeeechhhhhee--ccCCceEeeecccchhccccc--
Confidence 9999999988888778999999999999999999999988 9999999999999 999999999999997543322
Q ss_pred ceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHH
Q 020888 201 DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELREL 280 (320)
Q Consensus 201 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 280 (320)
......+|||.|+|||++....|..+.|-|.+|+++|+|++|+.||.+.+.......+....... +..++++.+.+
T Consensus 323 --~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kF--Pr~ls~eAktL 398 (516)
T KOG0690|consen 323 --DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKF--PRTLSPEAKTL 398 (516)
T ss_pred --ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccC--CccCCHHHHHH
Confidence 23456799999999999999999999999999999999999999999998888877776655432 45689999999
Q ss_pred HHHHhhcCCCCCC-----CHHHHHHH
Q 020888 281 TEKCWAADMNQRP-----SFLDILKR 301 (320)
Q Consensus 281 i~~~l~~dp~~Rp-----s~~~ll~~ 301 (320)
+..+|..||.+|. .+.++.++
T Consensus 399 LsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 399 LSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred HHHHhhcChHhhcCCCchhHHHHHhh
Confidence 9999999999994 34555443
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=261.43 Aligned_cols=246 Identities=27% Similarity=0.419 Sum_probs=196.8
Q ss_pred cCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCC-CCcccceeeeEEeCCceEEEEe
Q 020888 44 FSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLMLITE 120 (320)
Q Consensus 44 y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~iv~e 120 (320)
|.+.+.||+|++|+||++... ++.+++|.+........ .....+|+..+++++ |++++++++++..++..++|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~--~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE--ECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchh--HHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 677899999999999999985 67899998765433221 134456899999998 9999999999999999999999
Q ss_pred cCCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccC
Q 020888 121 YLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 198 (320)
Q Consensus 121 ~~~~~~L~~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~ 198 (320)
|+ +++|.+++.... .+++..+..++.|++.+|.+||+.| ++|+||+|+||++ +.++.++|+|||.+.......
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~dl~~~ni~i--~~~~~~~l~d~~~~~~~~~~~ 153 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG--FFHRDLKPENLLV--SGPEVVKIADFGLAREIRSRP 153 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEE--cCCCCEEEeecccceeccCCC
Confidence 99 779999887654 7899999999999999999999988 9999999999999 888999999999987654322
Q ss_pred ccceeeccCCcccccccCccccC-cCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCC----------
Q 020888 199 SHDVYKMTGETGSYRYMAPEVFK-HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPF---------- 267 (320)
Q Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~---------- 267 (320)
. .....++..|+|||.+. +..++.++|+||||++++++++|+.||......+....+.......
T Consensus 154 ~-----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (283)
T cd07830 154 P-----YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYK 228 (283)
T ss_pred C-----cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhh
Confidence 1 12245678899999874 4557899999999999999999999997765544332222110000
Q ss_pred ------------------CCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 268 ------------------FRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 268 ------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
......+..+++++..||..+|++|||+++++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 229 LASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred hhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0001236789999999999999999999999764
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=286.19 Aligned_cols=264 Identities=31% Similarity=0.567 Sum_probs=231.5
Q ss_pred CCCCcccCccceecccCceEEEEEEEC-----CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeC
Q 020888 38 DPSELDFSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER 112 (320)
Q Consensus 38 ~~~~~~y~~~~~lg~g~~~~vy~~~~~-----~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 112 (320)
+.+.....+.++||.|.||.|+++..+ ...||+|.++...... ....|..|..++-+++||||+++.+++...
T Consensus 625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gytek--qrrdFL~EAsIMGQFdHPNIIrLEGVVTks 702 (996)
T KOG0196|consen 625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEK--QRRDFLSEASIMGQFDHPNIIRLEGVVTKS 702 (996)
T ss_pred hcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHH--HHhhhhhhhhhcccCCCCcEEEEEEEEecC
Confidence 333445578899999999999999875 4569999887655433 347889999999999999999999999999
Q ss_pred CceEEEEecCCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCc
Q 020888 113 KPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 191 (320)
Q Consensus 113 ~~~~iv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~ 191 (320)
....||+|||++|+|..+++. .+.++..++...++.|+.|++||.+.| +||+||...||++ +.+=-.|++|||++
T Consensus 703 ~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~--YVHRDLAARNILV--NsnLvCKVsDFGLS 778 (996)
T KOG0196|consen 703 KPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMN--YVHRDLAARNILV--NSNLVCKVSDFGLS 778 (996)
T ss_pred ceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcC--chhhhhhhhheee--ccceEEEeccccce
Confidence 999999999999999999986 467999999999999999999999999 9999999999999 88889999999999
Q ss_pred ccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCC
Q 020888 192 KLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRA 270 (320)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 270 (320)
+.+.+.. ...+...+.-...+|.|||.+.-.+++.+|||||+|++|+|.++ |..||.+....+.++.+.++...+..
T Consensus 779 Rvledd~-~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpP- 856 (996)
T KOG0196|consen 779 RVLEDDP-EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPP- 856 (996)
T ss_pred eecccCC-CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCC-
Confidence 9776554 33333344444678999999999999999999999999999988 99999999999999999999877654
Q ss_pred CCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcC
Q 020888 271 KGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETL 309 (320)
Q Consensus 271 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 309 (320)
..+|..|.+|+..||+.|-..||.+.|+...|+++..+-
T Consensus 857 mDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP 895 (996)
T KOG0196|consen 857 MDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP 895 (996)
T ss_pred CCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence 459999999999999999999999999999999997653
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=269.25 Aligned_cols=251 Identities=28% Similarity=0.454 Sum_probs=200.3
Q ss_pred CcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCC-----
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK----- 113 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----- 113 (320)
..+|.+.+.||+|++|.||++.+. +..||+|.+..... .......+.+|+++++.++|+||+++++++..+.
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 447999999999999999999875 78899998754332 2233356889999999999999999999886543
Q ss_pred -ceEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcc
Q 020888 114 -PLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 192 (320)
Q Consensus 114 -~~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~ 192 (320)
..++|++++ +++|.+++.. ..+++..++.++.|++.||.|||+.| ++|+||+|+||++ +.++.++|+|||.+.
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~g--i~H~dlkp~Nill--~~~~~~kl~dfg~~~ 166 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAG--IIHRDLKPGNLAV--NEDCELKILDFGLAR 166 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEE--cCCCCEEEeeccccc
Confidence 358999999 7799988875 47899999999999999999999998 9999999999999 888899999999987
Q ss_pred cccccCccceeeccCCcccccccCccccCc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCC-----
Q 020888 193 LIKVQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRP----- 266 (320)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~----- 266 (320)
..... .....+++.|+|||.+.+ ..++.++|+||||++++++++|..||...+.......+......
T Consensus 167 ~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (343)
T cd07880 167 QTDSE-------MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEF 239 (343)
T ss_pred ccccC-------ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 55321 122346788999998876 45789999999999999999999999876544333222211100
Q ss_pred -----------------CC-------CCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH--HHHH
Q 020888 267 -----------------FF-------RAKGFTPELRELTEKCWAADMNQRPSFLDILKR--LEKI 305 (320)
Q Consensus 267 -----------------~~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--L~~~ 305 (320)
.. ....++.++.++|.+||..||.+|||+.+++++ ++..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~ 304 (343)
T cd07880 240 VQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF 304 (343)
T ss_pred HHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence 00 013467889999999999999999999999965 4444
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=271.14 Aligned_cols=248 Identities=27% Similarity=0.441 Sum_probs=200.8
Q ss_pred CCcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCc---
Q 020888 40 SELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP--- 114 (320)
Q Consensus 40 ~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--- 114 (320)
...+|.+.+.||+|++|.||++.+. ++.+++|.+....... .....+.+|+.+++.++|+|++++.+++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSA-IHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchh-hHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 3457999999999999999999985 6889999876543222 233667789999999999999999988765544
Q ss_pred ---eEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCc
Q 020888 115 ---LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 191 (320)
Q Consensus 115 ---~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~ 191 (320)
.++|+||+ +++|.+++.. ..+++..++.++.|++.||.+||+.| ++|+||+|+||++ +.++.++|+|||.+
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nill--~~~~~~kL~dfg~~ 165 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAG--IIHRDLKPSNIAV--NEDCELKILDFGLA 165 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEE--CCCCCEEEcccccc
Confidence 89999999 6699999876 46899999999999999999999998 9999999999999 88899999999998
Q ss_pred ccccccCccceeeccCCcccccccCccccCc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCC--
Q 020888 192 KLIKVQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFF-- 268 (320)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~-- 268 (320)
...... .....++..|.|||...+ ..++.++|+||||+++|++++|..||......+....+........
T Consensus 166 ~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 238 (343)
T cd07851 166 RHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEE 238 (343)
T ss_pred cccccc-------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHH
Confidence 765332 123356788999998765 3678899999999999999999999987765544433322111000
Q ss_pred ---------------------------CCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 269 ---------------------------RAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 269 ---------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
.....+.++.+++.+||+.+|.+|||+.+++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 239 LLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred HHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 012358899999999999999999999999876
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=267.59 Aligned_cols=255 Identities=27% Similarity=0.421 Sum_probs=196.9
Q ss_pred CcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeC------
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER------ 112 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------ 112 (320)
..+|++.+.||.|++|.||++.+. ++.+++|.+......... ...+.+|+++++.++|+||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 85 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGF-PITALREIKILKKLKHPNVVPLIDMAVERPDKSKR 85 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCc-chhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence 458999999999999999999975 788999988554332221 13567899999999999999999887433
Q ss_pred --CceEEEEecCCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCC
Q 020888 113 --KPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFG 189 (320)
Q Consensus 113 --~~~~iv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg 189 (320)
...+++++|+++ +|.+.+.. ...+++..+..++.|+++||.|||+.| ++|+||+|+||++ +.++.++|+|||
T Consensus 86 ~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~--i~H~dl~p~nil~--~~~~~~~l~dfg 160 (311)
T cd07866 86 KRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENH--ILHRDIKAANILI--DNQGILKIADFG 160 (311)
T ss_pred cCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEE--CCCCCEEECcCc
Confidence 346999999965 77776654 447999999999999999999999999 9999999999999 888999999999
Q ss_pred CcccccccCccce-------eeccCCcccccccCccccCcC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 020888 190 LSKLIKVQNSHDV-------YKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA 261 (320)
Q Consensus 190 ~~~~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~ 261 (320)
++........... .......+++.|+|||...+. .++.++|+||||+++|+|++|..||...........+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~ 240 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF 240 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9876543321111 011223457789999987654 57899999999999999999999998766554433322
Q ss_pred hCCCC-------------CC--------C-------CCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 262 EGHRP-------------FF--------R-------AKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 262 ~~~~~-------------~~--------~-------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
..... .. . ...++.++++++.+||..||.+|||+.+++.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 21000 00 0 02245789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=262.44 Aligned_cols=248 Identities=31% Similarity=0.494 Sum_probs=200.8
Q ss_pred cCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEec
Q 020888 44 FSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY 121 (320)
Q Consensus 44 y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 121 (320)
|+..+.||+|++|.||++... ++.+++|.+....... .....+.+|+++++.++|++++++++++...+..++|+|+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEE-GIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccc-cccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 567789999999999999986 7889999887654222 2235677899999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCcc
Q 020888 122 LRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 200 (320)
Q Consensus 122 ~~~~~L~~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~ 200 (320)
+++ +|.+++.+. ..+++..++.++.+++.+|.+||+.| ++|+||+|+||++ +.++.++|+|||.+........
T Consensus 80 ~~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~~l~~~ni~~--~~~~~~~l~d~g~~~~~~~~~~- 153 (282)
T cd07829 80 CDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR--ILHRDLKPQNILI--NRDGVLKLADFGLARAFGIPLR- 153 (282)
T ss_pred cCc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChheEEE--cCCCCEEEecCCcccccCCCcc-
Confidence 974 999999876 57999999999999999999999998 9999999999999 8889999999998876543221
Q ss_pred ceeeccCCcccccccCccccCcC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCC---------------
Q 020888 201 DVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH--------------- 264 (320)
Q Consensus 201 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~--------------- 264 (320)
.......+..|+|||.+.+. .++.++|+||||++++++++|..||......+....+....
T Consensus 154 ---~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07829 154 ---TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLP 230 (282)
T ss_pred ---ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccc
Confidence 12223456789999998776 78899999999999999999999998766544333222110
Q ss_pred -----CCC-------CCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 265 -----RPF-------FRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 265 -----~~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
.+. ......+..+.+++.+||..+|++||++++++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 231 DYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred cccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 000 0011347889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=290.49 Aligned_cols=250 Identities=31% Similarity=0.523 Sum_probs=198.1
Q ss_pred cccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEe--------
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE-------- 111 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-------- 111 (320)
.+|..+.+||+||||.||+++.+ |+.||+|.++... .......+.+|++.+++|+|||+++++..+.+
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 36888999999999999999987 9999999987655 45556889999999999999999998742100
Q ss_pred ----------------------------------------------------------------------C---------
Q 020888 112 ----------------------------------------------------------------------R--------- 112 (320)
Q Consensus 112 ----------------------------------------------------------------------~--------- 112 (320)
+
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence 0
Q ss_pred --------------------------------CceEEEEecCCCCCHHHHHHHhCCC-CHHHHHHHHHHHHHHHHHHhcC
Q 020888 113 --------------------------------KPLMLITEYLRGGDLHKYLKEKGAL-SPSTAVNFALDIARGMAYLHNE 159 (320)
Q Consensus 113 --------------------------------~~~~iv~e~~~~~~L~~~~~~~~~l-~~~~~~~i~~~l~~~l~~lH~~ 159 (320)
..+||-||||+..+|.+++.++... .....|+++++|++||.|+|++
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~ 716 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQ 716 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhC
Confidence 1268999999997777877765433 5778899999999999999999
Q ss_pred CCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccc--------------cCccceeeccCCcccccccCccccCcCC-
Q 020888 160 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV--------------QNSHDVYKMTGETGSYRYMAPEVFKHRK- 224 (320)
Q Consensus 160 g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~--------------~~~~~~~~~~~~~~~~~y~aPE~~~~~~- 224 (320)
| ++||||||.|||+ +..+.|||+|||++..... ....+.....+..||.-|+|||++.+..
T Consensus 717 g--iIHRDLKP~NIFL--d~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~ 792 (1351)
T KOG1035|consen 717 G--IIHRDLKPRNIFL--DSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSS 792 (1351)
T ss_pred c--eeeccCCcceeEE--cCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccc
Confidence 9 9999999999999 8999999999999987320 0011111334567999999999997654
Q ss_pred --CCCchhHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHHhCCCCCC---CCCCCCHHHHHHHHHHhhcCCCCCCCHHHH
Q 020888 225 --YDKKVDVFSFAMILYEMLEGEPPLAN-YEPYEAAKYVAEGHRPFF---RAKGFTPELRELTEKCWAADMNQRPSFLDI 298 (320)
Q Consensus 225 --~~~~~Di~slG~~l~~ll~g~~p~~~-~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l 298 (320)
|+.++||||||++++||+. ||.. .++......+..+..+.. .... -+.-+.+|+.|++.||.+|||+.++
T Consensus 793 ~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~-~~~e~slI~~Ll~hdP~kRPtA~eL 868 (1351)
T KOG1035|consen 793 NKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPE-HPEEASLIRWLLSHDPSKRPTATEL 868 (1351)
T ss_pred ccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCccccccc-chHHHHHHHHHhcCCCccCCCHHHH
Confidence 9999999999999999995 5653 455566666665555544 2222 3456789999999999999999999
Q ss_pred HHH
Q 020888 299 LKR 301 (320)
Q Consensus 299 l~~ 301 (320)
|+.
T Consensus 869 L~s 871 (1351)
T KOG1035|consen 869 LNS 871 (1351)
T ss_pred hhc
Confidence 874
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=267.76 Aligned_cols=252 Identities=27% Similarity=0.475 Sum_probs=199.5
Q ss_pred cccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeC------C
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER------K 113 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~ 113 (320)
.+|.+.+.||.|++|.||++.+. ++.+|+|.+....... .....+.+|+.+++.++|+||+++++++... .
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSE-IFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccc-cchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 47999999999999999999874 7899999886543322 2235677899999999999999999988644 2
Q ss_pred ceEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccc
Q 020888 114 PLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 193 (320)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~ 193 (320)
.+++|+||+.. +|.++.. ..+++..+..++.|++.||.+||+.| ++|+||+|+||++ +.++.++|+|||++..
T Consensus 94 ~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dlkp~NIll--~~~~~~kL~dfg~~~~ 166 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG--HPLSEDKVQYLVYQMLCGLKYIHSAG--IIHRDLKPGNLAV--NEDCELKILDFGLARH 166 (342)
T ss_pred eEEEEeccccc-CHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEE--CCCCCEEEeeCCCCcC
Confidence 46999999954 7777653 36899999999999999999999998 9999999999999 8889999999999875
Q ss_pred ccccCccceeeccCCcccccccCccccCc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCC--------
Q 020888 194 IKVQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH-------- 264 (320)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~-------- 264 (320)
.... .....++..|+|||.+.+ ..++.++|+||||++++++++|+.||...+.......+....
T Consensus 167 ~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (342)
T cd07879 167 ADAE-------MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFV 239 (342)
T ss_pred CCCC-------CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 4321 122356788999999876 458899999999999999999999998766444332222110
Q ss_pred --------------CCCCC-------CCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH--HHHHHhc
Q 020888 265 --------------RPFFR-------AKGFTPELRELTEKCWAADMNQRPSFLDILKR--LEKIKET 308 (320)
Q Consensus 265 --------------~~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--L~~~~~~ 308 (320)
.+... ....+.++.+++.+||+.||++||++++++.+ ++.+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~ 306 (342)
T cd07879 240 QKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA 306 (342)
T ss_pred HHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccc
Confidence 00000 12357889999999999999999999999977 7776653
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=285.45 Aligned_cols=148 Identities=31% Similarity=0.509 Sum_probs=135.5
Q ss_pred CcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEE
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 118 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 118 (320)
..+|.+.+.||+|+||+||++.+. ++.||+|++.............+..|+.+++.++|+||+++++.+...+..|+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 357999999999999999999987 789999998765555555567889999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcc
Q 020888 119 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 192 (320)
Q Consensus 119 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~ 192 (320)
|||++|++|.+++...+.+++..++.++.||+.||.|||..| |+|+||||+||++ +.++.++|+|||+++
T Consensus 83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~g--IiHrDLKP~NILl--~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHG--IIHRDLKPDNMLI--SNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCccHHHEEE--cCCCCEEEEeCCCCc
Confidence 999999999999988778999999999999999999999998 9999999999999 788899999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=266.60 Aligned_cols=248 Identities=27% Similarity=0.460 Sum_probs=197.2
Q ss_pred CCcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeC-----
Q 020888 40 SELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER----- 112 (320)
Q Consensus 40 ~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 112 (320)
...+|.+.+.||+|++|.||++.+. ++.||+|.+....... ...+.+.+|+.+++.++|+||+++.+++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (345)
T cd07877 15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 93 (345)
T ss_pred ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhh-HHHHHHHHHHHHHHHcCCCcccceeeeeeecccccc
Confidence 4468999999999999999999864 7889999886543222 2235678899999999999999999987532
Q ss_pred -CceEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCc
Q 020888 113 -KPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 191 (320)
Q Consensus 113 -~~~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~ 191 (320)
...+++++++ +++|.++++.. .+++..++.++.|++.||.|||+.| ++|+||+|+||++ +.++.++|+|||++
T Consensus 94 ~~~~~lv~~~~-~~~L~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll--~~~~~~kl~dfg~~ 167 (345)
T cd07877 94 FNDVYLVTHLM-GADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAV--NEDCELKILDFGLA 167 (345)
T ss_pred cccEEEEehhc-ccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEE--cCCCCEEEeccccc
Confidence 3468888877 77999888653 6899999999999999999999998 9999999999999 88889999999998
Q ss_pred ccccccCccceeeccCCcccccccCccccCc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCC-----
Q 020888 192 KLIKVQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHR----- 265 (320)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~----- 265 (320)
...... .....++..|+|||.+.+ ..++.++|+||||+++|++++|..||...+.......+.....
T Consensus 168 ~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (345)
T cd07877 168 RHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 240 (345)
T ss_pred cccccc-------ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 754321 123456888999998866 4678899999999999999999999976654433222211100
Q ss_pred --------------------C--CC--CCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 266 --------------------P--FF--RAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 266 --------------------~--~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
+ .. .....+.++.++|..||..||.+|||+.+++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 241 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0 00 011357889999999999999999999999987
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=291.94 Aligned_cols=253 Identities=27% Similarity=0.410 Sum_probs=216.5
Q ss_pred CcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEE
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 118 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 118 (320)
-.+|.++++||+|+||.|.+++.+ ++-||+|++.+-.--....-..|+.|-.++..-+.+=|+.++..|+++.++|+|
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlV 153 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLV 153 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEE
Confidence 448999999999999999999986 778999988552111112226788888999888899999999999999999999
Q ss_pred EecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccC
Q 020888 119 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 198 (320)
Q Consensus 119 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~ 198 (320)
|||++||+|-.++...+++++..+..++..|..||..+|+.| +|||||||+||++ |..|.++|.|||.|..+...+
T Consensus 154 MdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mg--yVHRDiKPDNvLl--d~~GHikLADFGsClkm~~dG 229 (1317)
T KOG0612|consen 154 MDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMG--YVHRDIKPDNVLL--DKSGHIKLADFGSCLKMDADG 229 (1317)
T ss_pred EecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhcc--ceeccCCcceeEe--cccCcEeeccchhHHhcCCCC
Confidence 999999999999999889999999999999999999999999 9999999999999 999999999999998886443
Q ss_pred ccceeeccCCcccccccCccccC----c-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCC--C
Q 020888 199 SHDVYKMTGETGSYRYMAPEVFK----H-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA--K 271 (320)
Q Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~----~-~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~ 271 (320)
. -.....+|||-|.+||++. + +.|...+|-||+|+++|||+.|..||....-.+.+..|...+.....| .
T Consensus 230 ~---V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~ 306 (1317)
T KOG0612|consen 230 T---VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDET 306 (1317)
T ss_pred c---EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCccc
Confidence 2 2345678999999999984 3 568899999999999999999999999998888888777764333333 5
Q ss_pred CCCHHHHHHHHHHhhcCCCCCCC---HHHHHHH
Q 020888 272 GFTPELRELTEKCWAADMNQRPS---FLDILKR 301 (320)
Q Consensus 272 ~~~~~l~~li~~~l~~dp~~Rps---~~~ll~~ 301 (320)
.+|++.++||..++. +|+.|.. ++++..|
T Consensus 307 ~VSeeakdLI~~ll~-~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 307 DVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH 338 (1317)
T ss_pred ccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC
Confidence 689999999999985 4777876 9988776
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=265.59 Aligned_cols=255 Identities=31% Similarity=0.539 Sum_probs=214.2
Q ss_pred ccCccceecccCceEEEEEEECC-CceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEec
Q 020888 43 DFSSSAIIGKGSFGEILKAYWRG-TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY 121 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~~-~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 121 (320)
...++++||+|.||.|.+|...+ ..||+|.++..... +....|..|+++|.+++||||+.++++|..++.+++++||
T Consensus 539 ~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~--~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 539 RLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATK--NARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred heehhhhhcCcccceeEEEEecCceEEEEeecCcccch--hHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 44678999999999999999886 89999988765433 3348899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCc
Q 020888 122 LRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 199 (320)
Q Consensus 122 ~~~~~L~~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~ 199 (320)
++.|+|.+++.++. ...-.....|+.||++|++||.+.+ +|||||.+.|+++ +.++++||+|||+++.+..+..
T Consensus 617 mEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n--fVHrd~a~rNcLv--~~e~~iKiadfgmsR~lysg~y 692 (807)
T KOG1094|consen 617 MENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN--FVHRDLATRNCLV--DGEFTIKIADFGMSRNLYSGDY 692 (807)
T ss_pred HhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc--hhhccccccceee--cCcccEEecCcccccccccCCc
Confidence 99999999998763 3355566789999999999999998 9999999999999 9999999999999997765432
Q ss_pred cceeeccC-CcccccccCccccCcCCCCCchhHHHHHHHHHHHHh--CCCCCCCCChHHHHHHHHhCC------CCCCCC
Q 020888 200 HDVYKMTG-ETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE--GEPPLANYEPYEAAKYVAEGH------RPFFRA 270 (320)
Q Consensus 200 ~~~~~~~~-~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~--g~~p~~~~~~~~~~~~~~~~~------~~~~~~ 270 (320)
+...+ ..-..+|+|+|.+..++++.++|+|++|+++||+++ ...||.........+....-. .-...+
T Consensus 693 ---y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P 769 (807)
T KOG1094|consen 693 ---YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRP 769 (807)
T ss_pred ---eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCC
Confidence 23332 234568999999999999999999999999999766 889999887776654433222 112234
Q ss_pred CCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHH
Q 020888 271 KGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIK 306 (320)
Q Consensus 271 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 306 (320)
.-++.++.+++..||..|.++|||++++-..|++..
T Consensus 770 ~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 770 PACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred CcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence 558999999999999999999999999998887653
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=268.42 Aligned_cols=252 Identities=28% Similarity=0.564 Sum_probs=215.9
Q ss_pred CccceecccCceEEEEEEEC----CC--ceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEE
Q 020888 45 SSSAIIGKGSFGEILKAYWR----GT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 118 (320)
Q Consensus 45 ~~~~~lg~g~~~~vy~~~~~----~~--~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 118 (320)
+..++||.|.||.||++... |. .||+|.-..+-.. +..+.|..|.-++++++||||++++|++.+.. .++|
T Consensus 392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~--d~tekflqEa~iMrnfdHphIikLIGv~~e~P-~Wiv 468 (974)
T KOG4257|consen 392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTP--DDTEKFLQEASIMRNFDHPHIIKLIGVCVEQP-MWIV 468 (974)
T ss_pred cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCCh--hhHHHHHHHHHHHHhCCCcchhheeeeeeccc-eeEE
Confidence 35678999999999998753 33 4777755443222 23488999999999999999999999998764 6899
Q ss_pred EecCCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccccccc
Q 020888 119 TEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 197 (320)
Q Consensus 119 ~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~ 197 (320)
||.++.|-|..|++.+ ..++..+..-++.||+.+|.|||+.. .||+||...||++ ....-|||+|||+++-+...
T Consensus 469 mEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkr--fVHRDIAaRNiLV--sSp~CVKLaDFGLSR~~ed~ 544 (974)
T KOG4257|consen 469 MELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKR--FVHRDIAARNILV--SSPQCVKLADFGLSRYLEDD 544 (974)
T ss_pred EecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhc--hhhhhhhhhheee--cCcceeeecccchhhhcccc
Confidence 9999999999999864 46999999999999999999999988 9999999999999 78888999999999877653
Q ss_pred CccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHH
Q 020888 198 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPE 276 (320)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (320)
..|..+...-...|+|||.++-..++.++|||.||++++|++. |..||......+....+..+.+.+..+. +|+.
T Consensus 545 ---~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~n-CPp~ 620 (974)
T KOG4257|consen 545 ---AYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPN-CPPA 620 (974)
T ss_pred ---chhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCC-CChH
Confidence 3344443344567999999999999999999999999999988 9999999999888888888887776655 9999
Q ss_pred HHHHHHHHhhcCCCCCCCHHHHHHHHHHHHh
Q 020888 277 LRELTEKCWAADMNQRPSFLDILKRLEKIKE 307 (320)
Q Consensus 277 l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 307 (320)
+..+..+||..+|.+||.+.++...|..+..
T Consensus 621 LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 621 LYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred HHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 9999999999999999999999998888766
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=270.18 Aligned_cols=244 Identities=28% Similarity=0.469 Sum_probs=204.3
Q ss_pred cceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEecCCC
Q 020888 47 SAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRG 124 (320)
Q Consensus 47 ~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~ 124 (320)
.+.||+|.||+||-+.+. |+.||+|++.+........ .++++|+.+|+++.||+|+.+.-.++..+..++|||-+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqe-sqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQE-SQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchH-HHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc
Confidence 678999999999998875 8999999997765554443 8999999999999999999999999999999999999955
Q ss_pred CCHHHHH--HHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeC-CCCcEEEecCCCcccccccCccc
Q 020888 125 GDLHKYL--KEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS-SADHLKVGDFGLSKLIKVQNSHD 201 (320)
Q Consensus 125 ~~L~~~~--~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~-~~~~~~L~dfg~~~~~~~~~~~~ 201 (320)
+..+++ .+.+++++..-..++.||+.||.|||-+| |+|+|+||+||++... .=..+||||||+++.+....
T Consensus 648 -DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn--IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks--- 721 (888)
T KOG4236|consen 648 -DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN--IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS--- 721 (888)
T ss_pred -hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc--eeeccCCchheeeccCCCCCceeeccccceeecchhh---
Confidence 666665 34678999999999999999999999999 9999999999999422 22379999999999886543
Q ss_pred eeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCC--CCCCCCCCCCHHHHH
Q 020888 202 VYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH--RPFFRAKGFTPELRE 279 (320)
Q Consensus 202 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~ 279 (320)
.-....|||.|+|||++....|...-||||.|+++|--++|..||...+. ..+++.... .++..=..++.+..+
T Consensus 722 --FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd--IndQIQNAaFMyPp~PW~eis~~Aid 797 (888)
T KOG4236|consen 722 --FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED--INDQIQNAAFMYPPNPWSEISPEAID 797 (888)
T ss_pred --hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc--hhHHhhccccccCCCchhhcCHHHHH
Confidence 23346899999999999999999999999999999999999999987654 333343333 222222568899999
Q ss_pred HHHHHhhcCCCCCCCHHHHHHH
Q 020888 280 LTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 280 li~~~l~~dp~~Rps~~~ll~~ 301 (320)
+|..+|++.-.+|.|+++.+.+
T Consensus 798 lIn~LLqVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 798 LINNLLQVKMRKRYSVDKSLSH 819 (888)
T ss_pred HHHHHHHHHHHHhcchHhhccc
Confidence 9999999999999999876543
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=251.65 Aligned_cols=218 Identities=20% Similarity=0.280 Sum_probs=177.9
Q ss_pred cCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEecCCCCCHHHH
Q 020888 53 GSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKY 130 (320)
Q Consensus 53 g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~ 130 (320)
|.+|.||++.+. ++.+|+|.+.... ...+|...+....|+|++++++++...+..+++|||++|++|.++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 889999999985 7889999886542 222344555556799999999999999999999999999999999
Q ss_pred HHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCccceeeccCCcc
Q 020888 131 LKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETG 210 (320)
Q Consensus 131 ~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~ 210 (320)
+.....+++..+..++.|++.||.|||+.| ++|+||||+||++ +.++.++++|||.+....... ....+
T Consensus 76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nil~--~~~~~~~l~df~~~~~~~~~~-------~~~~~ 144 (237)
T cd05576 76 ISKFLNIPEECVKRWAAEMVVALDALHREG--IVCRDLNPNNILL--DDRGHIQLTYFSRWSEVEDSC-------DGEAV 144 (237)
T ss_pred HHHhcCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEE--cCCCCEEEecccchhcccccc-------ccCCc
Confidence 987778999999999999999999999998 9999999999999 888899999999776543321 12335
Q ss_pred cccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHhhcCCC
Q 020888 211 SYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMN 290 (320)
Q Consensus 211 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 290 (320)
+..|+|||...+..++.++|+||+|+++|++++|..|+...... .... .....+..+++.+++++.+||+.||.
T Consensus 145 ~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~~~~-~~~~~~~~~~~~~~~li~~~l~~dp~ 218 (237)
T cd05576 145 ENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-----INTH-TTLNIPEWVSEEARSLLQQLLQFNPT 218 (237)
T ss_pred CccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----cccc-cccCCcccCCHHHHHHHHHHccCCHH
Confidence 66799999998888999999999999999999999887543211 0111 11112345789999999999999999
Q ss_pred CCCCH
Q 020888 291 QRPSF 295 (320)
Q Consensus 291 ~Rps~ 295 (320)
+||++
T Consensus 219 ~R~~~ 223 (237)
T cd05576 219 ERLGA 223 (237)
T ss_pred HhcCC
Confidence 99986
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=262.56 Aligned_cols=254 Identities=28% Similarity=0.440 Sum_probs=213.4
Q ss_pred CCCCCcccCccceecccCceEEEEEEE--CCCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCc
Q 020888 37 IDPSELDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP 114 (320)
Q Consensus 37 ~~~~~~~y~~~~~lg~g~~~~vy~~~~--~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 114 (320)
.......|+.-++||+|+||.|+-|+. +|+-+|+|.+.+.............+|-.+|.+++.+.|+.+-..++..+.
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~ 259 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDA 259 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCc
Confidence 344456788999999999999998775 488899998866665555555778899999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcc
Q 020888 115 LMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 192 (320)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~ 192 (320)
+++|+..|+||+|.=++-+.+ .++++.+..++.+|+.||++||+.+ ||++|+||+||++ |+.|.+.|+|+|++.
T Consensus 260 LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~--iVYRDLKPeNILL--Dd~GhvRISDLGLAv 335 (591)
T KOG0986|consen 260 LCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR--IVYRDLKPENILL--DDHGHVRISDLGLAV 335 (591)
T ss_pred eEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc--eeeccCChhheee--ccCCCeEeeccceEE
Confidence 999999999999998886644 7999999999999999999999999 9999999999999 999999999999999
Q ss_pred cccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh---H-HHHHHHHhCCCCCC
Q 020888 193 LIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEP---Y-EAAKYVAEGHRPFF 268 (320)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~---~-~~~~~~~~~~~~~~ 268 (320)
.+..+. +..+.+||.+|+|||++.+..|+...|-|||||++|+|+.|+.||..... . +.-+.+......
T Consensus 336 ei~~g~-----~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~e-- 408 (591)
T KOG0986|consen 336 EIPEGK-----PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEE-- 408 (591)
T ss_pred ecCCCC-----ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhh--
Confidence 887654 34445899999999999999999999999999999999999999976532 2 222223332222
Q ss_pred CCCCCCHHHHHHHHHHhhcCCCCCC-----CHHHHHHH
Q 020888 269 RAKGFTPELRELTEKCWAADMNQRP-----SFLDILKR 301 (320)
Q Consensus 269 ~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~ 301 (320)
.+...+++.+++...+|..||++|. +++++.+|
T Consensus 409 y~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~H 446 (591)
T KOG0986|consen 409 YSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEH 446 (591)
T ss_pred cccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhC
Confidence 2366899999999999999999995 34455544
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=269.90 Aligned_cols=256 Identities=26% Similarity=0.431 Sum_probs=201.8
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeC------Cc
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER------KP 114 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~ 114 (320)
.+.....||+|+||.||+++++ |+.+|+|.+.+...... .++.-+|++++++++|+|||+++++=+.. ..
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~--~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~ 91 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRP--RERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRL 91 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccch--HHHHHHHHHHHHHcCchhhhhhcccCCccccCccccc
Confidence 3445579999999999999975 99999999977553332 37788999999999999999999976543 35
Q ss_pred eEEEEecCCCCCHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCC--cEEEecCC
Q 020888 115 LMLITEYLRGGDLHKYLKE---KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD--HLKVGDFG 189 (320)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~---~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~--~~~L~dfg 189 (320)
..++||||.||+|...+++ ...+++..++.++..+..||.|||++| |+||||||.||++..+.+| .-||+|||
T Consensus 92 ~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~--IvHRDlKP~NIvl~~Gedgq~IyKLtDfG 169 (732)
T KOG4250|consen 92 PVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG--IVHRDLKPGNIVLQIGEDGQSIYKLTDFG 169 (732)
T ss_pred ceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEEeecCCCceEEeeeccc
Confidence 7899999999999999975 346999999999999999999999988 9999999999999544444 68899999
Q ss_pred CcccccccCccceeeccCCcccccccCccccC-cCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH----HHHHHHHhCC
Q 020888 190 LSKLIKVQNSHDVYKMTGETGSYRYMAPEVFK-HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPY----EAAKYVAEGH 264 (320)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~----~~~~~~~~~~ 264 (320)
.++.+..+. .+.+..||+.|++||.+. ...++...|+||+||++|+++||..||...... +....+...+
T Consensus 170 ~Arel~d~s-----~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkk 244 (732)
T KOG4250|consen 170 AARELDDNS-----LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKK 244 (732)
T ss_pred ccccCCCCC-----eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccC
Confidence 999887654 567788999999999998 588999999999999999999999999665433 1222222111
Q ss_pred CCC-------------------CCCCCCC----HHHHHHHHHHhhcCCCCCC--CHHHHHHHHHHHHh
Q 020888 265 RPF-------------------FRAKGFT----PELRELTEKCWAADMNQRP--SFLDILKRLEKIKE 307 (320)
Q Consensus 265 ~~~-------------------~~~~~~~----~~l~~li~~~l~~dp~~Rp--s~~~ll~~L~~~~~ 307 (320)
... ..+..++ ..+-..+..+|..+|.+|. ...+.-..+..+..
T Consensus 245 p~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~ 312 (732)
T KOG4250|consen 245 PSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN 312 (732)
T ss_pred CCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence 100 0011122 3355778888999999998 77777777766654
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=247.27 Aligned_cols=250 Identities=28% Similarity=0.454 Sum_probs=204.2
Q ss_pred cceecccCceEEEEEEE--CCCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCC-CCcccceeeeEEeCCceEEEEecCC
Q 020888 47 SAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLMLITEYLR 123 (320)
Q Consensus 47 ~~~lg~g~~~~vy~~~~--~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~iv~e~~~ 123 (320)
..+||+|+++.|-.+.. ++..+|||++.+- ......++.+|++++.+.+ |+||++++++|++++..|+|||-+.
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq---~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~ 159 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ---PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMR 159 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcC---CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEeccc
Confidence 56899999999998875 4899999988654 3344578899999999995 9999999999999999999999999
Q ss_pred CCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEe-eCCCCcEEEecCCCcccccccCccce
Q 020888 124 GGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLV-NSSADHLKVGDFGLSKLIKVQNSHDV 202 (320)
Q Consensus 124 ~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~-~~~~~~~~L~dfg~~~~~~~~~~~~~ 202 (320)
||+|...++++..+++..+.++...|+.||.+||.+| |+|+|+||+||+.. .+.-.-||||||.+...+.....-.+
T Consensus 160 GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kg--IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp 237 (463)
T KOG0607|consen 160 GGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKG--IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP 237 (463)
T ss_pred CchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcC--cccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence 9999999998888999999999999999999999999 99999999999982 22223589999998776654332222
Q ss_pred e---eccCCcccccccCccccC---c--CCCCCchhHHHHHHHHHHHHhCCCCCCCC-------C--------hHHHHHH
Q 020888 203 Y---KMTGETGSYRYMAPEVFK---H--RKYDKKVDVFSFAMILYEMLEGEPPLANY-------E--------PYEAAKY 259 (320)
Q Consensus 203 ~---~~~~~~~~~~y~aPE~~~---~--~~~~~~~Di~slG~~l~~ll~g~~p~~~~-------~--------~~~~~~~ 259 (320)
. ...+.+|+..|+|||+.. + ..|+.++|+||||+++|-|++|..||.+. + .......
T Consensus 238 astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFes 317 (463)
T KOG0607|consen 238 ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFES 317 (463)
T ss_pred CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHH
Confidence 1 223457888999999863 2 35889999999999999999999999654 1 2234556
Q ss_pred HHhCCCCCCCC--CCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 260 VAEGHRPFFRA--KGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 260 ~~~~~~~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
+.++....... ..++.+.+++++.+|..|+..|.++.+++.+
T Consensus 318 IQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnh 361 (463)
T KOG0607|consen 318 IQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNH 361 (463)
T ss_pred HhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence 66665433222 3578999999999999999999999998873
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=263.13 Aligned_cols=267 Identities=30% Similarity=0.577 Sum_probs=227.7
Q ss_pred CCCCCCcCCCCCcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceee
Q 020888 30 PNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 107 (320)
Q Consensus 30 ~~~~~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 107 (320)
|....|+++- .+.+...+||.|.+|.||.+.|+ ...||||.+..+.- .+++|..|..+++.++|||++++++
T Consensus 257 Pn~DkWEmeR--tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM----eveEFLkEAAvMKeikHpNLVqLLG 330 (1157)
T KOG4278|consen 257 PNADKWEMER--TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLG 330 (1157)
T ss_pred CCcchhhccc--hheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch----hHHHHHHHHHHHHhhcCccHHHHhh
Confidence 4456676653 45567789999999999999998 67899997755432 3488999999999999999999999
Q ss_pred eEEeCCceEEEEecCCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEE
Q 020888 108 AVTERKPLMLITEYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKV 185 (320)
Q Consensus 108 ~~~~~~~~~iv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L 185 (320)
+|..+...|||+|||..|+|.||+++- .-++--..+..+.||.+|++||..++ ++|+||...|.++ +.+..||+
T Consensus 331 VCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn--FIHRDLAARNCLV--gEnhiVKv 406 (1157)
T KOG4278|consen 331 VCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLV--GENHIVKV 406 (1157)
T ss_pred hhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh--hhhhhhhhhhccc--cccceEEe
Confidence 999999999999999999999999863 34677788899999999999999988 9999999999999 99999999
Q ss_pred ecCCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCC
Q 020888 186 GDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGH 264 (320)
Q Consensus 186 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~ 264 (320)
.|||+++.+..... ...-+.--...|.|||-+.-..++.++|||+||++|+|+.| |-.||.+.+....+..+.++.
T Consensus 407 ADFGLsRlMtgDTY---TAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgy 483 (1157)
T KOG4278|consen 407 ADFGLSRLMTGDTY---TAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGY 483 (1157)
T ss_pred eccchhhhhcCCce---ecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccc
Confidence 99999987753211 11111112446999999999999999999999999999999 999999999999998888877
Q ss_pred CCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcCC
Q 020888 265 RPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLP 310 (320)
Q Consensus 265 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~ 310 (320)
+.. .+.+|++.+..|+++||+..|.+||++.++-+.++.+..+.+
T Consensus 484 RM~-~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~sS 528 (1157)
T KOG4278|consen 484 RMD-GPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSSS 528 (1157)
T ss_pred ccc-CCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcccc
Confidence 664 456799999999999999999999999999999999876654
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=265.86 Aligned_cols=239 Identities=27% Similarity=0.414 Sum_probs=198.6
Q ss_pred CcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcccceeeeEEeCCceEE
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLML 117 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~i 117 (320)
..+|.....+|.|+|+.|..+.+. ++..++|++.+.. ..-.+|+.++... +|+|+++..+.+.++...|+
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~ 393 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYL 393 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc-------cccccccchhhhhcCCCcceeecceecCCceeee
Confidence 447888888999999999999885 7889999886652 2233466666555 69999999999999999999
Q ss_pred EEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccccccc
Q 020888 118 ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 197 (320)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~ 197 (320)
|||.+.|+-|.+.+....... ..+..|+.+|+.++.|||.+| ++|||+||+||++. ++.+.++|+|||.++.....
T Consensus 394 v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~g--vvhRDLkp~NIL~~-~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 394 VMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQG--VVHRDLKPGNILLD-GSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred eehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcC--eeecCCChhheeec-CCCCcEEEEEechhhhCchh
Confidence 999999988877776654444 667789999999999999999 99999999999994 47788999999999876543
Q ss_pred CccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHhCCCCCCCCCCCCHH
Q 020888 198 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPY-EAAKYVAEGHRPFFRAKGFTPE 276 (320)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 276 (320)
....+-|..|+|||+.....+++++|+||||++||+|++|+.||...... +....+..+... ..+|++
T Consensus 470 -------~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s----~~vS~~ 538 (612)
T KOG0603|consen 470 -------CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFS----ECVSDE 538 (612)
T ss_pred -------hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccc----cccCHH
Confidence 23346688999999999999999999999999999999999999876555 333333332222 568999
Q ss_pred HHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 277 LRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 277 l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
.++||.+||++||.+|+++.+++.+
T Consensus 539 AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 539 AKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred HHHHHHHhccCChhhCcChhhhccC
Confidence 9999999999999999999999876
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=268.74 Aligned_cols=253 Identities=30% Similarity=0.588 Sum_probs=217.0
Q ss_pred ccCccceecccCceEEEEEEEC-----CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEE
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLML 117 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~-----~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 117 (320)
+....++||+|+||.|+++.|+ ...||||.+....... ....|.+|+.++.+|+|+|++++++++.+ ....|
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mM 187 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMM 187 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeeeecc-chhhH
Confidence 5667789999999999999997 2469999887655443 45889999999999999999999999887 66789
Q ss_pred EEecCCCCCHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccccc
Q 020888 118 ITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 195 (320)
Q Consensus 118 v~e~~~~~~L~~~~~~--~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~ 195 (320)
|||.++.|+|.+.+.. ...+-......++.||+.|+.||-.++ +||+|+...|+++ .....|||+|||+.+.+.
T Consensus 188 V~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr--lvHRDLAARNlll--asprtVKI~DFGLmRaLg 263 (1039)
T KOG0199|consen 188 VFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR--LVHRDLAARNLLL--ASPRTVKICDFGLMRALG 263 (1039)
T ss_pred HhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh--hhhhhhhhhhhee--cccceeeeecccceeccC
Confidence 9999999999999876 446888899999999999999999998 9999999999999 667799999999999876
Q ss_pred ccCccceeeccCC-cccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCC
Q 020888 196 VQNSHDVYKMTGE-TGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGF 273 (320)
Q Consensus 196 ~~~~~~~~~~~~~-~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (320)
.+.. .|-+... -....|||||.++-..++.++|+|++|+++|||++ |+.||.+.....+.+.+.++... ..+.-+
T Consensus 264 ~ned--~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erL-pRPk~c 340 (1039)
T KOG0199|consen 264 ENED--MYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERL-PRPKYC 340 (1039)
T ss_pred CCCc--ceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccC-CCCCCC
Confidence 5543 3333333 34557999999999999999999999999999999 99999999999999888855444 455669
Q ss_pred CHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHH
Q 020888 274 TPELRELTEKCWAADMNQRPSFLDILKRLEKI 305 (320)
Q Consensus 274 ~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~ 305 (320)
++.+.++++.||..+|.+|||+..|.+.+-..
T Consensus 341 sedIY~imk~cWah~paDRptFsair~~~~l~ 372 (1039)
T KOG0199|consen 341 SEDIYQIMKNCWAHNPADRPTFSAIREDLVLA 372 (1039)
T ss_pred hHHHHHHHHHhccCCccccccHHHHHHhHHHH
Confidence 99999999999999999999999997554433
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=243.69 Aligned_cols=236 Identities=37% Similarity=0.606 Sum_probs=199.6
Q ss_pred CceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEecCCCCCHHHHH
Q 020888 54 SFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL 131 (320)
Q Consensus 54 ~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~ 131 (320)
++|.||++.+. ++.+++|++........ .+.+.+|++.+++++|++++++++.+..+...++++|++++++|.+++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence 57899999986 58899998866544332 478899999999999999999999999999999999999989999999
Q ss_pred HHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCccceeeccCCccc
Q 020888 132 KEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGS 211 (320)
Q Consensus 132 ~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~ 211 (320)
.....+++..++.++.+++.++.+||+.| ++|+||+|+||++ +.++.++|+|||.+....... ......++
T Consensus 79 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~i~~~ni~~--~~~~~~~l~d~~~~~~~~~~~-----~~~~~~~~ 149 (244)
T smart00220 79 KKRGRLSEDEARFYARQILSALEYLHSNG--IIHRDLKPENILL--DEDGHVKLADFGLARQLDPGG-----LLTTFVGT 149 (244)
T ss_pred HhccCCCHHHHHHHHHHHHHHHHHHHHcC--eecCCcCHHHeEE--CCCCcEEEccccceeeecccc-----ccccccCC
Confidence 87666899999999999999999999998 9999999999999 777899999999988765432 22334567
Q ss_pred ccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHHhCCCCCCCCCC-CCHHHHHHHHHHhhcCC
Q 020888 212 YRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLAN-YEPYEAAKYVAEGHRPFFRAKG-FTPELRELTEKCWAADM 289 (320)
Q Consensus 212 ~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~dp 289 (320)
..|.+||...+..++.++|+|+||++++++++|..||.. .+.................... ++.++.+++.+|+..+|
T Consensus 150 ~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p 229 (244)
T smart00220 150 PEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDP 229 (244)
T ss_pred cCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCc
Confidence 889999999988899999999999999999999999987 4444444444444333322222 78999999999999999
Q ss_pred CCCCCHHHHHH
Q 020888 290 NQRPSFLDILK 300 (320)
Q Consensus 290 ~~Rps~~~ll~ 300 (320)
.+||++.++++
T Consensus 230 ~~Rp~~~~~~~ 240 (244)
T smart00220 230 EKRLTAEEALQ 240 (244)
T ss_pred hhccCHHHHhh
Confidence 99999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=268.88 Aligned_cols=280 Identities=29% Similarity=0.542 Sum_probs=236.1
Q ss_pred CCCCCCCCCCCCCCCCCcCCCCCcccCccceecccCceEEEEEEEC------CCceEEEEccCCCCCcHHHHHHHHHHHH
Q 020888 19 HFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR------GTPVAIKRILPSLSDDRLVIQDFRHEVN 92 (320)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~------~~~~~~K~~~~~~~~~~~~~~~~~~e~~ 92 (320)
..+|...+.+.++..-..|.. +......+.||+|+||+||++.+- ..+|++|++........ -.++.+|+-
T Consensus 674 l~eplapS~~~~n~~~lrI~k-Etelkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~--s~e~LdeAl 750 (1177)
T KOG1025|consen 674 LVEPLAPSGFAANLALLRILK-ETELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKA--SIELLDEAL 750 (1177)
T ss_pred ccCccccccccchhhheeech-hhhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchh--hHHHHHHHH
Confidence 345555555666655555554 445677889999999999998872 57899999876544433 378889999
Q ss_pred HHHhCCCCcccceeeeEEeCCceEEEEecCCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 020888 93 LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPR 171 (320)
Q Consensus 93 ~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~ 171 (320)
++.+++|+|++++++++.... +.+|++|+++|+|.|+++. ++.+..+..+.|..||++|+.|||.+. ++||||-..
T Consensus 751 ~masldHpnl~RLLgvc~~s~-~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qr--lVHrdLaaR 827 (1177)
T KOG1025|consen 751 RMASLDHPNLLRLLGVCMLST-LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQR--LVHRDLAAR 827 (1177)
T ss_pred HHhcCCCchHHHHhhhcccch-HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcc--hhhhhhhhh
Confidence 999999999999999997765 8899999999999999986 457899999999999999999999988 999999999
Q ss_pred cEEEeeCCCCcEEEecCCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCC
Q 020888 172 NVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLAN 250 (320)
Q Consensus 172 nI~~~~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~ 250 (320)
||+| ..-..+++.|||+++.+.... ..+...+.-....|+|-|.+.-..++.++||||+|+++||++| |..|++.
T Consensus 828 NVLV--ksP~hvkitdfgla~ll~~d~--~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~g 903 (1177)
T KOG1025|consen 828 NVLV--KSPNHVKITDFGLAKLLAPDE--KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDG 903 (1177)
T ss_pred heee--cCCCeEEEEecchhhccCccc--ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCC
Confidence 9999 788899999999998876543 2333334445667899999999999999999999999999999 9999999
Q ss_pred CChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcC
Q 020888 251 YEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETL 309 (320)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 309 (320)
....+.-+.+..+.+ ..++..++.++..++.+||..|+..||+++++...+.++....
T Consensus 904 i~~~eI~dlle~geR-LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardp 961 (1177)
T KOG1025|consen 904 IPAEEIPDLLEKGER-LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDP 961 (1177)
T ss_pred CCHHHhhHHHhcccc-CCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCc
Confidence 999888888887777 5566679999999999999999999999999999988877654
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=244.92 Aligned_cols=255 Identities=25% Similarity=0.423 Sum_probs=194.7
Q ss_pred CcccCccceecccCceEEEEEEEC------CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEe-CC
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE-RK 113 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~------~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~ 113 (320)
...|+.+..||+|++|.||++..+ +..+|+|.|........-. ...-+|+.+++.++|+|++.+..++.. +.
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS-~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGIS-MSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcC-HHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 347999999999999999999543 2368999885542221111 345579999999999999999998866 88
Q ss_pred ceEEEEecCCCCCHHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCC----CcEE
Q 020888 114 PLMLITEYLRGGDLHKYLKE-----KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSA----DHLK 184 (320)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~-----~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~----~~~~ 184 (320)
..++++||.+. +|.+++.- ...++..++..|++||+.|+.|||++= |.|+|+||.||++ ..+ |.||
T Consensus 102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW--vlHRDLKPaNIlv--mgdgperG~VK 176 (438)
T KOG0666|consen 102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW--VLHRDLKPANILV--MGDGPERGRVK 176 (438)
T ss_pred eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh--eeeccCCcceEEE--eccCCccCeeE
Confidence 89999999988 99998863 235899999999999999999999966 9999999999999 444 8999
Q ss_pred EecCCCcccccccCccceeeccCCcccccccCccccCcCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCh-------H--
Q 020888 185 VGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRK-YDKKVDVFSFAMILYEMLEGEPPLANYEP-------Y-- 254 (320)
Q Consensus 185 L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~g~~p~~~~~~-------~-- 254 (320)
|.|+|+++.+..+.. ..+.....+.|.+|.|||.+.|.. |+.+.|||++||++.||++-...|...+. .
T Consensus 177 IaDlGlaR~~~~plk-pl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~ 255 (438)
T KOG0666|consen 177 IADLGLARLFNNPLK-PLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQH 255 (438)
T ss_pred eecccHHHHhhcccc-ccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchH
Confidence 999999988765532 333455667899999999998875 89999999999999999997766643210 0
Q ss_pred HHHH-------------------------HHHhCCCCCCCC----------CCCCHHHHHHHHHHhhcCCCCCCCHHHHH
Q 020888 255 EAAK-------------------------YVAEGHRPFFRA----------KGFTPELRELTEKCWAADMNQRPSFLDIL 299 (320)
Q Consensus 255 ~~~~-------------------------~~~~~~~~~~~~----------~~~~~~l~~li~~~l~~dp~~Rps~~~ll 299 (320)
+-.. .+.......... ..-++...+++..||+.||-+|.|+++.+
T Consensus 256 dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAl 335 (438)
T KOG0666|consen 256 DQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQAL 335 (438)
T ss_pred HHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHh
Confidence 0000 000000000000 11244577999999999999999999999
Q ss_pred HHH
Q 020888 300 KRL 302 (320)
Q Consensus 300 ~~L 302 (320)
++.
T Consensus 336 eh~ 338 (438)
T KOG0666|consen 336 EHP 338 (438)
T ss_pred ccc
Confidence 874
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=246.70 Aligned_cols=243 Identities=30% Similarity=0.467 Sum_probs=212.1
Q ss_pred CcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcccceeeeEEeCCceEE
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLML 117 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~i 117 (320)
..+|..+.+||.|+||+|-++..+ ...+|+|++.++-.-.....+--..|-++|+-. +-|.+++++..++.-+.+|+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 458899999999999999999887 567999988776444333335556677777766 46788899999999999999
Q ss_pred EEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccccccc
Q 020888 118 ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 197 (320)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~ 197 (320)
||||+.||+|--.+++-+++.+..+..++.+|+-||-+||++| |+++|+|.+||++ +..|.++|.|||++..-...
T Consensus 428 VMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kg--IiYRDLKLDNvmL--d~eGHiKi~DFGmcKEni~~ 503 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVML--DSEGHIKIADFGMCKENIFD 503 (683)
T ss_pred EEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCC--eeeeeccccceEe--ccCCceEeeecccccccccC
Confidence 9999999999999999899999999999999999999999999 9999999999999 99999999999999754433
Q ss_pred CccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHH
Q 020888 198 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPEL 277 (320)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 277 (320)
.. .....+|||.|+|||++.-..|..+.|-||+|++||||+.|+.||++.+..+....+.+..... +..++.+.
T Consensus 504 ~~----TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsy--PKslSkEA 577 (683)
T KOG0696|consen 504 GV----TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSY--PKSLSKEA 577 (683)
T ss_pred Cc----ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcC--cccccHHH
Confidence 22 2335689999999999999999999999999999999999999999999999999998877554 45689999
Q ss_pred HHHHHHHhhcCCCCCC
Q 020888 278 RELTEKCWAADMNQRP 293 (320)
Q Consensus 278 ~~li~~~l~~dp~~Rp 293 (320)
.++.+.+|...|.+|.
T Consensus 578 v~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 578 VAICKGLLTKHPGKRL 593 (683)
T ss_pred HHHHHHHhhcCCcccc
Confidence 9999999999999994
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=265.20 Aligned_cols=249 Identities=31% Similarity=0.542 Sum_probs=216.5
Q ss_pred CcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcccceeeeEE-----eC
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVT-----ER 112 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~-----~~ 112 (320)
...|+++..+|.|.+|.||++... ++..|+|+.......+ +++..|.++++.+ .|||++.+++++- .+
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d----eEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~ 93 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE----EEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNG 93 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc----HHHHHHHHHHHhccCCCCcceEEEEEEEecCCCC
Confidence 346888899999999999998864 8889999776544433 6778899999998 5999999999883 57
Q ss_pred CceEEEEecCCCCCHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCC
Q 020888 113 KPLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGL 190 (320)
Q Consensus 113 ~~~~iv~e~~~~~~L~~~~~~--~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~ 190 (320)
+++++|||||.||+..|+++. ..++.|..+..|++.++.|+.+||+.. ++|+|||-.||++ +.++.|||+|||.
T Consensus 94 DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk--viHRDikG~NiLL--T~e~~VKLvDFGv 169 (953)
T KOG0587|consen 94 DQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK--VIHRDIKGQNVLL--TENAEVKLVDFGV 169 (953)
T ss_pred CeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc--eeeecccCceEEE--eccCcEEEeeeee
Confidence 889999999999999999986 457999999999999999999999966 9999999999999 8999999999998
Q ss_pred cccccccCccceeeccCCcccccccCccccCcC-----CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCC
Q 020888 191 SKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR-----KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHR 265 (320)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~ 265 (320)
+..+...- ..-+...|||.|+|||++.+. .++..+|+||||++.+||.-|..|+-+..+....-.+..++.
T Consensus 170 SaQldsT~----grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPP 245 (953)
T KOG0587|consen 170 SAQLDSTV----GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPP 245 (953)
T ss_pred eeeeeccc----ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCC
Confidence 87665432 234557899999999998654 577899999999999999999999999999988888888877
Q ss_pred CCCC-CCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 266 PFFR-AKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 266 ~~~~-~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
+... +..++.++.++|..||..|.+.||++.+++++
T Consensus 246 PkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 246 PKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred ccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 6665 57899999999999999999999999999876
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=252.40 Aligned_cols=260 Identities=26% Similarity=0.415 Sum_probs=206.6
Q ss_pred cccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHH----HHHHHHHHHHHHhCCCCcccceeeeEE-eCCc
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLV----IQDFRHEVNLLVKLRHPNIVQFLGAVT-ERKP 114 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~ 114 (320)
.+|..+.+||+|||+.||++.+- .++||+|+-.....+..+. .+-.-+|..+.+.|+|+.|+++++++. +.+.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 37889999999999999999874 7889999665444443322 133457889999999999999999996 4566
Q ss_pred eEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE-eeCCCCcEEEecCCCccc
Q 020888 115 LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLL-VNSSADHLKVGDFGLSKL 193 (320)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~-~~~~~~~~~L~dfg~~~~ 193 (320)
.+-|.|||+|.+|.=|++.+..+++..+..|+.||+.||.||.+...+|+|.|+||.||++ +.+..|.++|.|||++..
T Consensus 543 FCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKI 622 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKI 622 (775)
T ss_pred ceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhh
Confidence 8899999999999999998888999999999999999999999998899999999999999 445567999999999987
Q ss_pred ccccCccc---eeeccCCcccccccCccccCcC----CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHhC
Q 020888 194 IKVQNSHD---VYKMTGETGSYRYMAPEVFKHR----KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEA---AKYVAEG 263 (320)
Q Consensus 194 ~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~----~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~---~~~~~~~ 263 (320)
+....... ..-.+...||.+|+|||.+..+ ..+.+.||||+|+++|.++-|+.||.....-.. ...+...
T Consensus 623 MdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkA 702 (775)
T KOG1151|consen 623 MDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKA 702 (775)
T ss_pred ccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhcc
Confidence 76533221 1112335799999999998644 577899999999999999999999987643221 1222222
Q ss_pred CCCCCC-CCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 264 HRPFFR-AKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 264 ~~~~~~-~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
....+. ...++.+.++||++||...-++|..+.++..+
T Consensus 703 tEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~d 741 (775)
T KOG1151|consen 703 TEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACD 741 (775)
T ss_pred eeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccC
Confidence 222222 24579999999999999999999999998654
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=263.36 Aligned_cols=267 Identities=35% Similarity=0.615 Sum_probs=220.0
Q ss_pred CCCCCCcCCCCCcccCccceecccCceEEEEEEEC---------CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CC
Q 020888 30 PNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR---------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RH 99 (320)
Q Consensus 30 ~~~~~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~---------~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h 99 (320)
|....|+++.+.. .+.+.||+|.||+|+++... ...||||........ ...+.+..|+++++.+ .|
T Consensus 286 ~~~~~~e~~~~~l--~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H 361 (609)
T KOG0200|consen 286 PEDPKWEIPRENL--KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKH 361 (609)
T ss_pred CcCCceeechhhc--cccceeecccccceEeEEEeecccccccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCC
Confidence 4444777777665 44459999999999998743 345899977665444 4458999999999999 59
Q ss_pred CcccceeeeEEeCCceEEEEecCCCCCHHHHHHHhC----------------CCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 020888 100 PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG----------------ALSPSTAVNFALDIARGMAYLHNEPNVI 163 (320)
Q Consensus 100 ~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~----------------~l~~~~~~~i~~~l~~~l~~lH~~g~~i 163 (320)
+|++.+++.+...+.+++|.||+..|+|.++++..+ .++....+.+++||+.|++||++.. +
T Consensus 362 ~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~--~ 439 (609)
T KOG0200|consen 362 PNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP--C 439 (609)
T ss_pred cchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC--c
Confidence 999999999999999999999999999999998654 3889999999999999999999988 9
Q ss_pred EecCCCCCcEEEeeCCCCcEEEecCCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh
Q 020888 164 IHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE 243 (320)
Q Consensus 164 vH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~ 243 (320)
+|||+...||++ ..+..++|+|||+++................ -...|+|||.+....++.++||||+|++|||++|
T Consensus 440 vHRDLAaRNVLi--~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~-LP~kWmApEsl~~~~ft~kSDVWSfGI~L~Eifs 516 (609)
T KOG0200|consen 440 VHRDLAARNVLI--TKNKVIKIADFGLARDHYNKDYYRTKSSAGT-LPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFT 516 (609)
T ss_pred cchhhhhhhEEe--cCCCEEEEccccceeccCCCCceEecCCCCc-cceeecCHHHhccCcccccchhhHHHHHHHHHhh
Confidence 999999999999 7888999999999987654332211111111 2346999999999999999999999999999999
Q ss_pred -CCCCCCCCC-hHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHH
Q 020888 244 -GEPPLANYE-PYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIK 306 (320)
Q Consensus 244 -g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 306 (320)
|..||.+.. ..+....+.++.+.. .+..+++++.++++.||+.+|++||++.++.+.+....
T Consensus 517 LG~~PYp~~~~~~~l~~~l~~G~r~~-~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 517 LGGTPYPGIPPTEELLEFLKEGNRME-QPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred CCCCCCCCCCcHHHHHHHHhcCCCCC-CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 999999866 555556566666544 45558999999999999999999999999999998854
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=284.50 Aligned_cols=245 Identities=27% Similarity=0.413 Sum_probs=188.2
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEe
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 120 (320)
.|.....||+|+||.||++.+. +..||+|.+...... ...|++.+++++||||+++++++...+..++|||
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E 763 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE 763 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence 4666789999999999999974 788999987543221 1235888999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHh---cCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccccccc
Q 020888 121 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLH---NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 197 (320)
Q Consensus 121 ~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH---~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~ 197 (320)
|+++++|.++++. +++..+..++.+++.|++||| +.+ ++|+||||+||++ +.++..++. ++.......
T Consensus 764 y~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~--iiH~dlkp~Nil~--~~~~~~~~~-~~~~~~~~~- 834 (968)
T PLN00113 764 YIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPA--VVVGNLSPEKIII--DGKDEPHLR-LSLPGLLCT- 834 (968)
T ss_pred CCCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCC--eecCCCCHHhEEE--CCCCceEEE-ecccccccc-
Confidence 9999999999963 799999999999999999999 546 9999999999999 666666654 443322211
Q ss_pred CccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh--HHHHH---HHHhC------CCC
Q 020888 198 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEP--YEAAK---YVAEG------HRP 266 (320)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~--~~~~~---~~~~~------~~~ 266 (320)
.....+++.|+|||+..+..++.++||||+|+++||+++|+.||+.... ..... ..... ..+
T Consensus 835 -------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 907 (968)
T PLN00113 835 -------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDP 907 (968)
T ss_pred -------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCc
Confidence 1123567899999999999999999999999999999999999854211 01111 00000 000
Q ss_pred CCCC-----CCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcCC
Q 020888 267 FFRA-----KGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLP 310 (320)
Q Consensus 267 ~~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~ 310 (320)
.... .....++.+++.+|++.||++|||+.++++.|+++....+
T Consensus 908 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~ 956 (968)
T PLN00113 908 SIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSS 956 (968)
T ss_pred cccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcccc
Confidence 0000 0112357789999999999999999999999999877554
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=240.10 Aligned_cols=247 Identities=28% Similarity=0.460 Sum_probs=199.2
Q ss_pred cCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcccceeeeEEeCCceEEEEe
Q 020888 44 FSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITE 120 (320)
Q Consensus 44 y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~iv~e 120 (320)
.+-+..||.|.||+|++..++ ++..|||.+........ -+++..|.+...+- +.|+|+++++..-.++-.+|.||
T Consensus 66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~ke--q~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME 143 (361)
T KOG1006|consen 66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKE--QKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME 143 (361)
T ss_pred HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHH--HHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence 344668999999999998886 89999999976655333 26778888877776 68999999999877788999999
Q ss_pred cCCCCCHHHHHH-----HhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccccc
Q 020888 121 YLRGGDLHKYLK-----EKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 195 (320)
Q Consensus 121 ~~~~~~L~~~~~-----~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~ 195 (320)
.+ ..+|..+.. .+..++++.+-.|......||.||-.. -.|+|+|+||+||++ +..|.+||||||.+..+.
T Consensus 144 LM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~-lkiIHRDvKPSNILl--dr~G~vKLCDFGIcGqLv 219 (361)
T KOG1006|consen 144 LM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE-LKIIHRDVKPSNILL--DRHGDVKLCDFGICGQLV 219 (361)
T ss_pred HH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH-hhhhhccCChhheEE--ecCCCEeeecccchHhHH
Confidence 98 558776544 245799999999999999999999776 239999999999999 999999999999988765
Q ss_pred ccCccceeeccCCcccccccCccccCc--CCCCCchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHhCCCCCCCC--
Q 020888 196 VQNSHDVYKMTGETGSYRYMAPEVFKH--RKYDKKVDVFSFAMILYEMLEGEPPLANYEPY-EAAKYVAEGHRPFFRA-- 270 (320)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~-~~~~~~~~~~~~~~~~-- 270 (320)
.+- ......|-..|+|||.+.. ..++.+||+||||++|||+.||+.||...+.. +...+++.+..+....
T Consensus 220 ~Si-----AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~ 294 (361)
T KOG1006|consen 220 DSI-----AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDK 294 (361)
T ss_pred HHH-----HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcc
Confidence 432 1223456667999999853 35889999999999999999999999887543 4445555555444333
Q ss_pred --CCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 271 --KGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 271 --~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
..++..+..+|..||..|-..||.+.++++.
T Consensus 295 ~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 295 ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred cccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 2378999999999999999999999998764
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=247.20 Aligned_cols=249 Identities=24% Similarity=0.339 Sum_probs=195.5
Q ss_pred CCCcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCC-C-C----cccceeeeEE
Q 020888 39 PSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-H-P----NIVQFLGAVT 110 (320)
Q Consensus 39 ~~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-h-~----~i~~~~~~~~ 110 (320)
....+|.+++.+|+|.||.|-.+.+. +..+|+|++.... ...++..-|+++|+++. + | -++++.++++
T Consensus 86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~----kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFd 161 (415)
T KOG0671|consen 86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD----KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFD 161 (415)
T ss_pred ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH----HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhh
Confidence 33669999999999999999999986 6789999875432 22356677999999994 2 2 3566677799
Q ss_pred eCCceEEEEecCCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeC----------
Q 020888 111 ERKPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS---------- 178 (320)
Q Consensus 111 ~~~~~~iv~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~---------- 178 (320)
..+..++|+|.+ |.++.+++.+++ +++...+..+++||++++++||+.+ ++|.|+||+||++..+
T Consensus 162 yrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k--l~HTDLKPENILfvss~~~~~~~~k~ 238 (415)
T KOG0671|consen 162 YRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK--LTHTDLKPENILFVSSEYFKTYNPKK 238 (415)
T ss_pred ccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc--eeecCCChheEEEeccceEEEeccCC
Confidence 999999999988 779999998754 7899999999999999999999988 9999999999999311
Q ss_pred --------CCCcEEEecCCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 020888 179 --------SADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLAN 250 (320)
Q Consensus 179 --------~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~ 250 (320)
.+-.|+++|||.+..... ..+..+.|..|.|||++.|-.|+.++||||+||+|+|+++|..-|+.
T Consensus 239 ~~~~~r~~ks~~I~vIDFGsAtf~~e-------~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqt 311 (415)
T KOG0671|consen 239 KVCFIRPLKSTAIKVIDFGSATFDHE-------HHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQT 311 (415)
T ss_pred ccceeccCCCcceEEEecCCcceecc-------CcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceeccc
Confidence 133689999999875432 23456789999999999999999999999999999999999999988
Q ss_pred CChHHHHHHHHhC--CCCC----------------------------------CCC--------CCCCHHHHHHHHHHhh
Q 020888 251 YEPYEAAKYVAEG--HRPF----------------------------------FRA--------KGFTPELRELTEKCWA 286 (320)
Q Consensus 251 ~~~~~~~~~~~~~--~~~~----------------------------------~~~--------~~~~~~l~~li~~~l~ 286 (320)
.+..+....+..- +.|. ..+ ..-..+|-+|++.||.
T Consensus 312 Hen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~ 391 (415)
T KOG0671|consen 312 HENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLE 391 (415)
T ss_pred CCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHc
Confidence 7765533211110 0000 000 0001347899999999
Q ss_pred cCCCCCCCHHHHHHH
Q 020888 287 ADMNQRPSFLDILKR 301 (320)
Q Consensus 287 ~dp~~Rps~~~ll~~ 301 (320)
.||.+|+|+.|++.+
T Consensus 392 fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 392 FDPARRITLREALSH 406 (415)
T ss_pred cCccccccHHHHhcC
Confidence 999999999999876
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=218.36 Aligned_cols=249 Identities=28% Similarity=0.460 Sum_probs=201.2
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEe
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 120 (320)
+|.-.++||+|.+|+||+++.. ..-||+|...-+...+.-. ....+|+-+++.++|.||+++++....+..+.+|+|
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvp-ssalreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVP-SSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCc-HHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 4666788999999999999875 6779999876554333222 456679999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCc
Q 020888 121 YLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 199 (320)
Q Consensus 121 ~~~~~~L~~~~~~-~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~ 199 (320)
||.. .|..++.. ++-++.+.+...+.|++.||.+||+++ +.|+|+||.|.++ +.+|.++|.|||+++.+..+-
T Consensus 82 ~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshn--vlhrdlkpqnlli--n~ngelkladfglarafgipv- 155 (292)
T KOG0662|consen 82 FCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHN--VLHRDLKPQNLLI--NRNGELKLADFGLARAFGIPV- 155 (292)
T ss_pred HhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhh--hhhccCCcceEEe--ccCCcEEecccchhhhcCCce-
Confidence 9955 99999976 677999999999999999999999998 9999999999999 999999999999998765432
Q ss_pred cceeeccCCcccccccCccccCcCC-CCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCC--------
Q 020888 200 HDVYKMTGETGSYRYMAPEVFKHRK-YDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFR-------- 269 (320)
Q Consensus 200 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~-------- 269 (320)
.-.+....|.+|.+|.++.|.+ ++...|+||.||++.|+.. |..-|.+.+-.+..+.+....-.+..
T Consensus 156 ---rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~ 232 (292)
T KOG0662|consen 156 ---RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTK 232 (292)
T ss_pred ---EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCcccc
Confidence 1123456799999999998865 7899999999999999998 66667777766665555432111000
Q ss_pred ----------C---------CCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 270 ----------A---------KGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 270 ----------~---------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
+ ..++..-+++++.+|.-+|..|.+++..+++
T Consensus 233 lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 233 LPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 0 1123446799999999999999999998875
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=241.97 Aligned_cols=257 Identities=29% Similarity=0.428 Sum_probs=205.6
Q ss_pred ccCccceecccCceEEEEEEECCCceEEEEccCCCCCcHHHHHHHHHHHHHHHhC--CCCcccceeeeEEeCC----ceE
Q 020888 43 DFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL--RHPNIVQFLGAVTERK----PLM 116 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l--~h~~i~~~~~~~~~~~----~~~ 116 (320)
......++|+|.||+||+++.+++.||||+|+.. ..+.+.+|-++.... +|+||+++++.-..++ .+.
T Consensus 211 pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~~------~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw 284 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPEQ------EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW 284 (534)
T ss_pred chhhHHHhhcCccceeehhhccCceeEEEecCHH------HHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence 4566789999999999999999999999998542 236677777776665 7999999999876655 799
Q ss_pred EEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCC-------CCeEecCCCCCcEEEeeCCCCcEEEecCC
Q 020888 117 LITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP-------NVIIHRDLKPRNVLLVNSSADHLKVGDFG 189 (320)
Q Consensus 117 iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g-------~~ivH~di~p~nI~~~~~~~~~~~L~dfg 189 (320)
+|++|.+.|+|.+|+..+ .++|....+++..++.||+|||+.- +.|+|||||..||++ .++....|+|||
T Consensus 285 LVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLv--K~DlTccIaDFG 361 (534)
T KOG3653|consen 285 LVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLV--KNDLTCCIADFG 361 (534)
T ss_pred EEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEE--ccCCcEEeeccc
Confidence 999999999999999985 7899999999999999999999862 359999999999999 888999999999
Q ss_pred CcccccccCccceeeccCCcccccccCccccCcCCC------CCchhHHHHHHHHHHHHhCCCC------------CC--
Q 020888 190 LSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKY------DKKVDVFSFAMILYEMLEGEPP------------LA-- 249 (320)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~------~~~~Di~slG~~l~~ll~g~~p------------~~-- 249 (320)
++.++..+.... ..-+.+||.+|+|||++.|... -.+.||||+|.+|+|+++...- |.
T Consensus 362 LAl~~~p~~~~~--d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~e 439 (534)
T KOG3653|consen 362 LALRLEPGKPQG--DTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAE 439 (534)
T ss_pred eeEEecCCCCCc--chhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHH
Confidence 999887543222 2334789999999999876532 2589999999999999996432 32
Q ss_pred ---CCChHHHHHHHHhCCCCCCCCC-----CCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcCC
Q 020888 250 ---NYEPYEAAKYVAEGHRPFFRAK-----GFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLP 310 (320)
Q Consensus 250 ---~~~~~~~~~~~~~~~~~~~~~~-----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~ 310 (320)
.-.-.+++..++..+..+..+. .-..-+++.+..||+.|++.|.|+.=+.+.+..+....+
T Consensus 440 vG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~ 508 (534)
T KOG3653|consen 440 VGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE 508 (534)
T ss_pred hcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence 1123455666666554443332 224568999999999999999999988888888776654
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=243.05 Aligned_cols=257 Identities=30% Similarity=0.487 Sum_probs=205.2
Q ss_pred ccCccceecccCceEEEEEEECCCceEEEEccCCCCCcHHHHHHHHHHHHHHHhC--CCCcccceeeeEE----eCCceE
Q 020888 43 DFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL--RHPNIVQFLGAVT----ERKPLM 116 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l--~h~~i~~~~~~~~----~~~~~~ 116 (320)
+..+.+.||+|.||.||++.+.|..||||+|..... ..+.+|.++.+.. +|+||+.+++.-- .-.+++
T Consensus 212 qI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srdE------~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw 285 (513)
T KOG2052|consen 212 QIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRDE------RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW 285 (513)
T ss_pred eeEEEEEecCccccceeeccccCCceEEEEecccch------hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence 667889999999999999999999999999954322 5667788887765 8999999988652 234589
Q ss_pred EEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcC-----C-CCeEecCCCCCcEEEeeCCCCcEEEecCCC
Q 020888 117 LITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE-----P-NVIIHRDLKPRNVLLVNSSADHLKVGDFGL 190 (320)
Q Consensus 117 iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~-----g-~~ivH~di~p~nI~~~~~~~~~~~L~dfg~ 190 (320)
+|++|.+.|+|.||+++ ..++-...++++..+++||+|||.. | +.|+|||||..||+| .+++...|.|+|+
T Consensus 286 LvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILV--Kkn~~C~IADLGL 362 (513)
T KOG2052|consen 286 LVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV--KKNGTCCIADLGL 362 (513)
T ss_pred EeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEE--ccCCcEEEeecee
Confidence 99999999999999998 5799999999999999999999975 2 459999999999999 8999999999999
Q ss_pred cccccccCccceeeccCCcccccccCccccCcCC----C--CCchhHHHHHHHHHHHHhC----------CCCCCCCC--
Q 020888 191 SKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRK----Y--DKKVDVFSFAMILYEMLEG----------EPPLANYE-- 252 (320)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~--~~~~Di~slG~~l~~ll~g----------~~p~~~~~-- 252 (320)
+.+.......-....+..+||.+|+|||++...- + -..+||||+|.+++|+... +.||.+.-
T Consensus 363 Av~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~ 442 (513)
T KOG2052|consen 363 AVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPS 442 (513)
T ss_pred eEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCC
Confidence 9988766544455677789999999999986542 1 2589999999999998763 46776543
Q ss_pred ---hHHHHHHHHhCCCCCCCCCCCC-----HHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhc
Q 020888 253 ---PYEAAKYVAEGHRPFFRAKGFT-----PELRELTEKCWAADMNQRPSFLDILKRLEKIKET 308 (320)
Q Consensus 253 ---~~~~~~~~~~~~~~~~~~~~~~-----~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 308 (320)
..++.+.+......+..++.+. ..+..+++.||..+|..|.|+-.+.+.|.++...
T Consensus 443 DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~ 506 (513)
T KOG2052|consen 443 DPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNS 506 (513)
T ss_pred CCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcC
Confidence 2334443333333333333222 3366889999999999999999999999998863
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=235.75 Aligned_cols=257 Identities=24% Similarity=0.374 Sum_probs=196.7
Q ss_pred CCCcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEe-----
Q 020888 39 PSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE----- 111 (320)
Q Consensus 39 ~~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----- 111 (320)
.+.+.|....++|+|.||.||+++.+ ++.|++|...-+...+.-.+ ...+|+++|..++|+|++.++++|..
T Consensus 14 ~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpi-talreikiL~~lkHenv~nliEic~tk~Tp~ 92 (376)
T KOG0669|consen 14 DEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPI-TALREIKILQLLKHENVVNLIEICRTKATPT 92 (376)
T ss_pred ecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcH-HHHHHHHHHHHhcchhHHHHHHHHhhccCCc
Confidence 34567888899999999999998875 77888875533333322222 34459999999999999999998742
Q ss_pred ---CCceEEEEecCCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEec
Q 020888 112 ---RKPLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGD 187 (320)
Q Consensus 112 ---~~~~~iv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~d 187 (320)
....|+||++|+. +|.-++... -+++...+..++.+++.||.|+|... |+|+|+||.|+++ +.+|.++|.|
T Consensus 93 ~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k--ilHRDmKaaNvLI--t~dgilklAD 167 (376)
T KOG0669|consen 93 NRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNK--ILHRDMKAANVLI--TKDGILKLAD 167 (376)
T ss_pred ccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhh--HHhhcccHhhEEE--cCCceEEeec
Confidence 3448999999977 899888764 47999999999999999999999977 9999999999999 9999999999
Q ss_pred CCCcccccccCccceeeccCCcccccccCccccCcC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH---hC
Q 020888 188 FGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA---EG 263 (320)
Q Consensus 188 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~---~~ 263 (320)
||+++.+..+.......-...+.|.+|.+||.+.|. .++++.|+|..||++.+|++|.+.+.+...-.....+. ..
T Consensus 168 FGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs 247 (376)
T KOG0669|consen 168 FGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGS 247 (376)
T ss_pred cccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhcc
Confidence 999987765432211112234569999999999876 58999999999999999999988877654333222111 00
Q ss_pred C------------------CCCCC------------CCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 264 H------------------RPFFR------------AKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 264 ~------------------~~~~~------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
. .++.. +-.-+++..+++.+++..||.+|+++.+++++
T Consensus 248 ~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 248 ITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred CCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 0 00000 01124577899999999999999999999876
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=249.44 Aligned_cols=246 Identities=25% Similarity=0.343 Sum_probs=202.2
Q ss_pred cccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCC------CCcccceeeeEEeCC
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR------HPNIVQFLGAVTERK 113 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~ 113 (320)
.+|.+..-.|.|.|++|-+|.+. ++.||||++......- +.=..|+++|++|+ -.|+++++..|...+
T Consensus 432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~----KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hkn 507 (752)
T KOG0670|consen 432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMH----KTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKN 507 (752)
T ss_pred ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHh----hhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcc
Confidence 47888888999999999999986 7899999997654433 44556999999995 348999999999999
Q ss_pred ceEEEEecCCCCCHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCC
Q 020888 114 PLMLITEYLRGGDLHKYLKEKG---ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGL 190 (320)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~ 190 (320)
.+|+|||-+ ..+|.+.++..+ .|....+..++.||+.||..|-+.| ++|.||||+||+|++ ....++|||||.
T Consensus 508 HLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~--vlHaDIKPDNiLVNE-~k~iLKLCDfGS 583 (752)
T KOG0670|consen 508 HLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG--VLHADIKPDNILVNE-SKNILKLCDFGS 583 (752)
T ss_pred eeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC--eeecccCccceEecc-CcceeeeccCcc
Confidence 999999988 559999998754 4888999999999999999999999 999999999999964 445899999999
Q ss_pred cccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCC-
Q 020888 191 SKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR- 269 (320)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~- 269 (320)
+.....+.. .+...+..|.|||++.|-.|+...|+||.||+||||+||+..|.+.....+....+..+-+...
T Consensus 584 A~~~~enei------tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~K 657 (752)
T KOG0670|consen 584 ASFASENEI------TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNK 657 (752)
T ss_pred ccccccccc------cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHH
Confidence 987765543 2234567899999999999999999999999999999999999988877776544422111000
Q ss_pred ---------------------------------------C-----------CCCC-------HHHHHHHHHHhhcCCCCC
Q 020888 270 ---------------------------------------A-----------KGFT-------PELRELTEKCWAADMNQR 292 (320)
Q Consensus 270 ---------------------------------------~-----------~~~~-------~~l~~li~~~l~~dp~~R 292 (320)
+ ..++ ..+++|+..||..||++|
T Consensus 658 mlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KR 737 (752)
T KOG0670|consen 658 MLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKR 737 (752)
T ss_pred HhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhc
Confidence 0 0011 348899999999999999
Q ss_pred CCHHHHHHH
Q 020888 293 PSFLDILKR 301 (320)
Q Consensus 293 ps~~~ll~~ 301 (320)
.|+.++|+|
T Consensus 738 it~nqAL~H 746 (752)
T KOG0670|consen 738 ITVNQALKH 746 (752)
T ss_pred CCHHHHhcC
Confidence 999999876
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=261.48 Aligned_cols=247 Identities=28% Similarity=0.486 Sum_probs=198.6
Q ss_pred ccCccceecccCce-EEEEEEECCCceEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcccceeeeEEeCCceEEEEe
Q 020888 43 DFSSSAIIGKGSFG-EILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITE 120 (320)
Q Consensus 43 ~y~~~~~lg~g~~~-~vy~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~iv~e 120 (320)
-|.-.+++|.|+.| .||++...++.||||.+..+. .....+|+..|+.- +|+||++++..-.+..+.||..|
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e~------~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalE 583 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGVYEGREVAVKRLLEEF------FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALE 583 (903)
T ss_pred eeccHHHcccCCCCcEEEEEeeCCceehHHHHhhHh------HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEeh
Confidence 46667889999876 689999999999999875432 25778899999998 59999999999999999999999
Q ss_pred cCCCCCHHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEee---CCCCcEEEecCCCccc
Q 020888 121 YLRGGDLHKYLKEKG----ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN---SSADHLKVGDFGLSKL 193 (320)
Q Consensus 121 ~~~~~~L~~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~---~~~~~~~L~dfg~~~~ 193 (320)
.| ..+|.|+++..+ .......+.++.|+++||++||+.+ |||+|+||.||+|.. +...+++|+|||+++.
T Consensus 584 LC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~--iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKk 660 (903)
T KOG1027|consen 584 LC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK--IVHRDLKPQNILISVPSADGTLRAKISDFGLSKK 660 (903)
T ss_pred Hh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc--cccccCCCceEEEEccCCCcceeEEecccccccc
Confidence 99 559999998631 1122445788999999999999999 999999999999953 3345899999999999
Q ss_pred ccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCC
Q 020888 194 IKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKG 272 (320)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (320)
+..+.+.-. ...+..||.+|.|||++....-+.+.|||||||++|+.++ |.+||.+.-.. ...+..+.........
T Consensus 661 l~~~~sS~~-r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R--~~NIl~~~~~L~~L~~ 737 (903)
T KOG1027|consen 661 LAGGKSSFS-RLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER--QANILTGNYTLVHLEP 737 (903)
T ss_pred cCCCcchhh-cccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh--hhhhhcCccceeeecc
Confidence 987654433 3667789999999999999998999999999999999999 59999865433 2334444433332221
Q ss_pred -CCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 273 -FTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 273 -~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
-..+.++||.+|++++|..||++.++|.|
T Consensus 738 ~~d~eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 738 LPDCEAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred CchHHHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 12288999999999999999999999654
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=245.82 Aligned_cols=248 Identities=25% Similarity=0.408 Sum_probs=203.4
Q ss_pred CcccCccceecccCceEEEEEEE--CCCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEE
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 118 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~--~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 118 (320)
.+-|..++.||-|+||.|-++.. +...+|+|.+.+..+-..+...-.+.|-.+|...+.+-|++++..|++++.+|+|
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV 707 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 707 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence 34567789999999999999875 3678999988877666666666778889999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccC
Q 020888 119 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 198 (320)
Q Consensus 119 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~ 198 (320)
|||++||++-.++-+.+.+.+..+..++.++.+|+++.|..| ++|+||||+||+| |.+|.+||.|||+|..+.=.-
T Consensus 708 MdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmG--FIHRDiKPDNILI--DrdGHIKLTDFGLCTGfRWTH 783 (1034)
T KOG0608|consen 708 MDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILI--DRDGHIKLTDFGLCTGFRWTH 783 (1034)
T ss_pred EeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhcc--ceecccCccceEE--ccCCceeeeeccccccceecc
Confidence 999999999999988889999999999999999999999999 9999999999999 999999999999998663110
Q ss_pred ccceee--------------------------------------ccCCcccccccCccccCcCCCCCchhHHHHHHHHHH
Q 020888 199 SHDVYK--------------------------------------MTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYE 240 (320)
Q Consensus 199 ~~~~~~--------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ 240 (320)
....|. .-..+||+.|+|||++....++..+|-||.|++||+
T Consensus 784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~e 863 (1034)
T KOG0608|consen 784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYE 863 (1034)
T ss_pred ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHH
Confidence 000000 012259999999999999999999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHH--hCCCCCCCCCCCCHHHHHHHHHHhhcCCCCCC
Q 020888 241 MLEGEPPLANYEPYEAAKYVA--EGHRPFFRAKGFTPELRELTEKCWAADMNQRP 293 (320)
Q Consensus 241 ll~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 293 (320)
|+.|+.||-...+.+.+..+. +..........++.++.++|.+++. +++.|.
T Consensus 864 m~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RL 917 (1034)
T KOG0608|consen 864 MLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRL 917 (1034)
T ss_pred HhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-Chhhhh
Confidence 999999998877665443222 2223333446689999999988774 355563
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-32 Score=252.91 Aligned_cols=248 Identities=19% Similarity=0.198 Sum_probs=166.4
Q ss_pred CCCcccCccceecccCceEEEEEEEC------CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeee----
Q 020888 39 PSELDFSSSAIIGKGSFGEILKAYWR------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGA---- 108 (320)
Q Consensus 39 ~~~~~y~~~~~lg~g~~~~vy~~~~~------~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~---- 108 (320)
....+|.+.+.||+|+||.||++.+. +..+|+|.+...... +...++ .+....+.++..+...
T Consensus 129 ~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-----e~~~~e--~l~~~~~~~~~~~~~~~~~~ 201 (566)
T PLN03225 129 FKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-----EIWMNE--RVRRACPNSCADFVYGFLEP 201 (566)
T ss_pred CccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-----HHHHHH--HHHhhchhhHHHHHHhhhcc
Confidence 34568999999999999999999875 468999976432211 111111 1122222222222111
Q ss_pred --EEeCCceEEEEecCCCCCHHHHHHHhCC--------------------CCHHHHHHHHHHHHHHHHHHhcCCCCeEec
Q 020888 109 --VTERKPLMLITEYLRGGDLHKYLKEKGA--------------------LSPSTAVNFALDIARGMAYLHNEPNVIIHR 166 (320)
Q Consensus 109 --~~~~~~~~iv~e~~~~~~L~~~~~~~~~--------------------l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~ 166 (320)
...+...++|+||+++++|.+++..... .....+..++.|++.||.|||+.| |+|+
T Consensus 202 ~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g--IiHR 279 (566)
T PLN03225 202 VSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG--IVHR 279 (566)
T ss_pred cccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC--EEeC
Confidence 2456778999999999999999875321 123446689999999999999998 9999
Q ss_pred CCCCCcEEEeeCC-CCcEEEecCCCcccccccCccceeeccCCcccccccCccccCcCC---------------------
Q 020888 167 DLKPRNVLLVNSS-ADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRK--------------------- 224 (320)
Q Consensus 167 di~p~nI~~~~~~-~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--------------------- 224 (320)
||||+||++ +. ++.++|+|||++..+..... +......+++.|+|||.+....
T Consensus 280 DLKP~NILl--~~~~~~~KL~DFGlA~~l~~~~~---~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~ 354 (566)
T PLN03225 280 DVKPQNIIF--SEGSGSFKIIDLGAAADLRVGIN---YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQL 354 (566)
T ss_pred cCCHHHEEE--eCCCCcEEEEeCCCccccccccc---cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccc
Confidence 999999999 54 57899999999976543221 1223456789999999764322
Q ss_pred -CCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCC----------CCCCC---------CCCCCHHHHHHHHHH
Q 020888 225 -YDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH----------RPFFR---------AKGFTPELRELTEKC 284 (320)
Q Consensus 225 -~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~----------~~~~~---------~~~~~~~l~~li~~~ 284 (320)
++.++|||||||++|+|+++..+++.. .......+.... ..... ....+...++||.+|
T Consensus 355 ~~~~k~DVwSlGviL~el~~~~~~~~~~-~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~m 433 (566)
T PLN03225 355 NLPDRFDIYSAGLIFLQMAFPNLRSDSN-LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSM 433 (566)
T ss_pred cCCCCcccHHHHHHHHHHHhCcCCCchH-HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHH
Confidence 334569999999999999987664422 111111111100 00000 011234466999999
Q ss_pred hhcCCCCCCCHHHHHHH
Q 020888 285 WAADMNQRPSFLDILKR 301 (320)
Q Consensus 285 l~~dp~~Rps~~~ll~~ 301 (320)
|+.||++|||+.++++|
T Consensus 434 L~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 434 MRFKGRQRISAKAALAH 450 (566)
T ss_pred ccCCcccCCCHHHHhCC
Confidence 99999999999999987
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-31 Score=242.13 Aligned_cols=255 Identities=20% Similarity=0.240 Sum_probs=178.7
Q ss_pred CCcccCccceecccCceEEEEEEE------------------CCCceEEEEccCCCCCcHH-----------HHHHHHHH
Q 020888 40 SELDFSSSAIIGKGSFGEILKAYW------------------RGTPVAIKRILPSLSDDRL-----------VIQDFRHE 90 (320)
Q Consensus 40 ~~~~y~~~~~lg~g~~~~vy~~~~------------------~~~~~~~K~~~~~~~~~~~-----------~~~~~~~e 90 (320)
...+|.+.++||+|+||+||++.. .++.||+|.+......... ..+....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 456899999999999999999863 2457999987543221110 01223346
Q ss_pred HHHHHhCCCCc-----ccceeeeEEe--------CCceEEEEecCCCCCHHHHHHHh-----------------------
Q 020888 91 VNLLVKLRHPN-----IVQFLGAVTE--------RKPLMLITEYLRGGDLHKYLKEK----------------------- 134 (320)
Q Consensus 91 ~~~l~~l~h~~-----i~~~~~~~~~--------~~~~~iv~e~~~~~~L~~~~~~~----------------------- 134 (320)
+.++.+++|.+ ++++++++.. .+..++|+||+++++|.+++...
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 66777776554 3566666542 35689999999999999987631
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCccceeeccCCccccc
Q 020888 135 -GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYR 213 (320)
Q Consensus 135 -~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~ 213 (320)
..+++..+..++.|++.+|.|||+.+ ++|+||||+||++ +.++.++|+|||++........ .......+++.
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~--ivHrDLKp~NILl--~~~~~~kL~DFGla~~~~~~~~---~~~~~g~~tp~ 375 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG--IVHRDIKPENLLV--TVDGQVKIIDFGAAVDMCTGIN---FNPLYGMLDPR 375 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCchHhEEE--CCCCcEEEEeCcCccccccCCc---cCccccCCCcc
Confidence 12456788999999999999999988 9999999999999 7788999999999865533211 11112234789
Q ss_pred ccCccccCcCCC----------------------CCchhHHHHHHHHHHHHhCCC-CCCCCChHHH-----------HHH
Q 020888 214 YMAPEVFKHRKY----------------------DKKVDVFSFAMILYEMLEGEP-PLANYEPYEA-----------AKY 259 (320)
Q Consensus 214 y~aPE~~~~~~~----------------------~~~~Di~slG~~l~~ll~g~~-p~~~~~~~~~-----------~~~ 259 (320)
|+|||.+..... ....|+||+||++|+|++|.. |+........ ...
T Consensus 376 Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~ 455 (507)
T PLN03224 376 YSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM 455 (507)
T ss_pred eeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh
Confidence 999998754321 124699999999999999875 6654321111 111
Q ss_pred HHhCCCCCCCCCCCCHHHHHHHHHHhhcCC---CCCCCHHHHHHH
Q 020888 260 VAEGHRPFFRAKGFTPELRELTEKCWAADM---NQRPSFLDILKR 301 (320)
Q Consensus 260 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp---~~Rps~~~ll~~ 301 (320)
..............++..++++.+||..+| .+|+|++++|+|
T Consensus 456 ~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 456 YKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred hcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 111111122224568999999999999766 689999999976
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=228.46 Aligned_cols=244 Identities=23% Similarity=0.384 Sum_probs=204.6
Q ss_pred CcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcccceeeeEEeCCceEE
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLML 117 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~i 117 (320)
-.+|.+.++||+|++.+|-++..+ .+-+|+|++.+....+.+.+.-.+-|-.+..+. +||.++-++..++.+..+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 348999999999999999998875 788999999888777666556666666666666 69999999999999999999
Q ss_pred EEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccccccc
Q 020888 118 ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 197 (320)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~ 197 (320)
|.||.+||+|-=.++++.+++++.+..+...|+-||.|||++| |+.+|+|.+|+++ +..|.+||.|+|+++.-..+
T Consensus 329 vieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rg--iiyrdlkldnvll--daeghikltdygmcke~l~~ 404 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERG--IIYRDLKLDNVLL--DAEGHIKLTDYGMCKEGLGP 404 (593)
T ss_pred EEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcC--eeeeeccccceEE--ccCCceeecccchhhcCCCC
Confidence 9999999999988999889999999999999999999999999 9999999999999 99999999999999754333
Q ss_pred CccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCC-------ChHHHHHHHHhCCCCCCCC
Q 020888 198 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANY-------EPYEAAKYVAEGHRPFFRA 270 (320)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~-------~~~~~~~~~~~~~~~~~~~ 270 (320)
+. ..+..+|||.|.|||++.|..|....|-|+||++++||+.|+.||+-. +..+...++.-....- -+
T Consensus 405 gd----~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqir-ip 479 (593)
T KOG0695|consen 405 GD----TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIR-IP 479 (593)
T ss_pred Cc----ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccc-cc
Confidence 22 234578999999999999999999999999999999999999999643 2334433333222111 23
Q ss_pred CCCCHHHHHHHHHHhhcCCCCCC
Q 020888 271 KGFTPELRELTEKCWAADMNQRP 293 (320)
Q Consensus 271 ~~~~~~l~~li~~~l~~dp~~Rp 293 (320)
..++-....+++..|+.||.+|.
T Consensus 480 rslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 480 RSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred ceeehhhHHHHHHhhcCCcHHhc
Confidence 44677788999999999999994
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-32 Score=243.38 Aligned_cols=199 Identities=28% Similarity=0.438 Sum_probs=173.2
Q ss_pred cccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHH-----HHHHHHHHHHHhCC---CCcccceeeeEEe
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVI-----QDFRHEVNLLVKLR---HPNIVQFLGAVTE 111 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~-----~~~~~e~~~l~~l~---h~~i~~~~~~~~~ 111 (320)
.+|+..+.+|.|+||.|++|.++ ...|++|.+.++..-...+. -.+--|+.+|..++ |+||+|++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 37999999999999999999987 45588898766544333222 23457899999997 9999999999999
Q ss_pred CCceEEEEecC-CCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCC
Q 020888 112 RKPLMLITEYL-RGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGL 190 (320)
Q Consensus 112 ~~~~~iv~e~~-~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~ 190 (320)
++++|++||.. +|.+|.++++..+.+++.....|++|+..|+++||+.| |+|||||-+|+.+ +.+|.++|+|||.
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~--ivhrdikdenviv--d~~g~~klidfgs 716 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQG--IVHRDIKDENVIV--DSNGFVKLIDFGS 716 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccC--ceecccccccEEE--ecCCeEEEeeccc
Confidence 99999999975 56789999999899999999999999999999999999 9999999999999 9999999999999
Q ss_pred cccccccCccceeeccCCcccccccCccccCcCCC-CCchhHHHHHHHHHHHHhCCCCCCC
Q 020888 191 SKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKY-DKKVDVFSFAMILYEMLEGEPPLAN 250 (320)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~ll~g~~p~~~ 250 (320)
+..+..+ ++....||..|+|||++.|..| ...-|||+||++||.++....||.+
T Consensus 717 aa~~ksg------pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 717 AAYTKSG------PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hhhhcCC------CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 8766544 3556789999999999999876 5789999999999999999999865
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.3e-32 Score=235.11 Aligned_cols=129 Identities=29% Similarity=0.411 Sum_probs=109.5
Q ss_pred cccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCC--------CCcccceeeeEE-
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR--------HPNIVQFLGAVT- 110 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~--------h~~i~~~~~~~~- 110 (320)
.+|.+.++||.|-|+|||++.++ .+.||+|+....... .+....||++|++++ ..+|+++++.|.
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhY----tEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkh 153 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHY----TEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKH 153 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHH----HHHHHHHHHHHHHHHhcCCCCCCCceeeeeecccee
Confidence 38899999999999999999997 788999987544222 256677999999984 238999999985
Q ss_pred ---eCCceEEEEecCCCCCHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEe
Q 020888 111 ---ERKPLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLV 176 (320)
Q Consensus 111 ---~~~~~~iv~e~~~~~~L~~~~~~--~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~ 176 (320)
.+...+||+|++ |.+|..++.. ...++...+..|++|++.||.|||.. .+|+|.||||+||++.
T Consensus 154 sGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~e-cgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 154 SGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRE-CGIIHTDLKPENVLLC 222 (590)
T ss_pred cCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHh-cCccccCCCcceeeee
Confidence 567799999999 7799999875 34699999999999999999999998 3399999999999994
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.2e-31 Score=216.57 Aligned_cols=210 Identities=42% Similarity=0.721 Sum_probs=183.2
Q ss_pred ecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEecCCCCCH
Q 020888 50 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDL 127 (320)
Q Consensus 50 lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L 127 (320)
||+|++|.||++... ++.+++|.+....... ....+.+|++.++.+.|++++++++++......++++|+++|++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 689999999999987 8899999886554332 346889999999999999999999999998999999999998999
Q ss_pred HHHHHHh-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCC-CCcEEEecCCCcccccccCccceeec
Q 020888 128 HKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS-ADHLKVGDFGLSKLIKVQNSHDVYKM 205 (320)
Q Consensus 128 ~~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~-~~~~~L~dfg~~~~~~~~~~~~~~~~ 205 (320)
.+++... ..++...++.++.+++.++.+||+.| ++|+||+|.||++ +. ++.++|+||+.+........ ..
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~~H~dl~~~ni~~--~~~~~~~~l~d~~~~~~~~~~~~----~~ 150 (215)
T cd00180 79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNG--IIHRDLKPENILL--DSDNGKVKLADFGLSKLLTSDKS----LL 150 (215)
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHhhEEE--eCCCCcEEEecCCceEEccCCcc----hh
Confidence 9999875 46899999999999999999999998 9999999999999 66 78999999999876544321 12
Q ss_pred cCCcccccccCccccCcC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHH
Q 020888 206 TGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKC 284 (320)
Q Consensus 206 ~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 284 (320)
....+...|.+||..... ..+.++|+|++|++++++ ..+.+++..|
T Consensus 151 ~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------~~~~~~l~~~ 197 (215)
T cd00180 151 KTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------PELKDLIRKM 197 (215)
T ss_pred hcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------HHHHHHHHHH
Confidence 224467789999999887 888999999999999999 6889999999
Q ss_pred hhcCCCCCCCHHHHHHHH
Q 020888 285 WAADMNQRPSFLDILKRL 302 (320)
Q Consensus 285 l~~dp~~Rps~~~ll~~L 302 (320)
+..+|.+||++.++++++
T Consensus 198 l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 198 LQKDPEKRPSAKEILEHL 215 (215)
T ss_pred hhCCcccCcCHHHHhhCC
Confidence 999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-32 Score=213.64 Aligned_cols=244 Identities=23% Similarity=0.417 Sum_probs=190.8
Q ss_pred CcccCccceecccCceEEEEEEE--CCCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCC-CCcccceeeeEEe--CCce
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTE--RKPL 115 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~--~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~ 115 (320)
..+|++++.+|+|-++.||.+.. ++.++++|++.+. ..+.+.+|+++|++|. ++||+++++++.+ ...+
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV------kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp 110 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV------KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP 110 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH------HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence 44899999999999999999884 5889999988543 2378999999999996 9999999999864 5668
Q ss_pred EEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccccc
Q 020888 116 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 195 (320)
Q Consensus 116 ~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~ 195 (320)
.++|||.++.+...+.. .++...+..++.+++.||.|||++| |.|+|+||.|++++ .....++|+|||++...-
T Consensus 111 aLiFE~v~n~Dfk~ly~---tl~d~dIryY~~elLkALdyCHS~G--ImHRDVKPhNvmId-h~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 111 SLIFEYVNNTDFKQLYP---TLTDYDIRYYIYELLKALDYCHSMG--IMHRDVKPHNVMID-HELRKLRLIDWGLAEFYH 184 (338)
T ss_pred hhHhhhhccccHHHHhh---hhchhhHHHHHHHHHHHHhHHHhcC--cccccCCcceeeec-hhhceeeeeecchHhhcC
Confidence 99999998877776654 5788899999999999999999999 99999999999983 334579999999997665
Q ss_pred ccCccceeeccCCcccccccCccccCc-CCCCCchhHHHHHHHHHHHHhCCCCCCCC-ChHH-------------HHHHH
Q 020888 196 VQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANY-EPYE-------------AAKYV 260 (320)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~p~~~~-~~~~-------------~~~~~ 260 (320)
++...+. ..-+..|.-||.+-. ..++.+-|+|||||++..|+..+.||-.. +..+ ....+
T Consensus 185 p~~eYnV-----RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl 259 (338)
T KOG0668|consen 185 PGKEYNV-----RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYL 259 (338)
T ss_pred CCceeee-----eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHH
Confidence 4433222 234556788998765 45889999999999999999999887432 2111 11111
Q ss_pred HhC----------------------CCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 261 AEG----------------------HRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 261 ~~~----------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
.+- ........-.+++..+++..+|..|..+|+|+.|++.+
T Consensus 260 ~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 260 NKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 111 01111112346899999999999999999999999887
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-31 Score=222.38 Aligned_cols=258 Identities=26% Similarity=0.469 Sum_probs=213.5
Q ss_pred ccCccceecccCceEEEEEEEC-------CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeE-EeCCc
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAV-TERKP 114 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~-------~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~ 114 (320)
+++...++-+|.||.||.+.+. .+.+.+|....... .-....+..|...+..+.|+|++.+.++. ++...
T Consensus 285 Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS--~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~ 362 (563)
T KOG1024|consen 285 RVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHAS--QIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYAT 362 (563)
T ss_pred heechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhccc--HHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCc
Confidence 5677778889999999999653 24466675543222 22246778888999999999999999987 56677
Q ss_pred eEEEEecCCCCCHHHHHHH--------hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEe
Q 020888 115 LMLITEYLRGGDLHKYLKE--------KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVG 186 (320)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~--------~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~ 186 (320)
+++++.+..-|+|..++.. ...++-.+....+.|++.|++|||++| ++|.||...|.++ ++.-+++|+
T Consensus 363 P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~--ViHkDiAaRNCvI--dd~LqVklt 438 (563)
T KOG1024|consen 363 PFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG--VIHKDIAARNCVI--DDQLQVKLT 438 (563)
T ss_pred ceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC--cccchhhhhccee--hhheeEEec
Confidence 8999999988999999972 123666777788999999999999999 9999999999999 777899999
Q ss_pred cCCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCC
Q 020888 187 DFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHR 265 (320)
Q Consensus 187 dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~ 265 (320)
|=.+++.+-+...+ .. -....+...|++||.+....++.++|+||||++|+|++| |+.|+.+.++.++...+.++.+
T Consensus 439 DsaLSRDLFP~DYh-cL-GDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyR 516 (563)
T KOG1024|consen 439 DSALSRDLFPGDYH-CL-GDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYR 516 (563)
T ss_pred cchhccccCccccc-cc-CCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccce
Confidence 99988876543321 11 111235668999999999999999999999999999999 9999999999999999988886
Q ss_pred CCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcC
Q 020888 266 PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETL 309 (320)
Q Consensus 266 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 309 (320)
.. ++..+|+++-.++..||..+|++||+++|+..-|.++..++
T Consensus 517 la-QP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ql 559 (563)
T KOG1024|consen 517 LA-QPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQL 559 (563)
T ss_pred ec-CCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHH
Confidence 54 55669999999999999999999999999999999887765
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=203.99 Aligned_cols=221 Identities=26% Similarity=0.484 Sum_probs=176.3
Q ss_pred cccCccceecccCceEEEEEEE--CCCceEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcccceeeeEEeCCceEEE
Q 020888 42 LDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLI 118 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~--~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~iv 118 (320)
.....+..||+|++|.|-+.++ +|.-.|+|.+....... .-+++.+|+.+..+. .+|.++.+++..-.+...++.
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q--~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIc 123 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQ--EQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWIC 123 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChH--HHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEe
Confidence 3445677899999998877776 48889999886654432 236777788887776 689999999988888889999
Q ss_pred EecCCCCCHHHHHH----HhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccc
Q 020888 119 TEYLRGGDLHKYLK----EKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 194 (320)
Q Consensus 119 ~e~~~~~~L~~~~~----~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~ 194 (320)
||.+ ..+|..+-. .++.+++..+-+|+..+.+||.|||++ -.++|+|+||+||++ +..|++|+||||.+--+
T Consensus 124 ME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k-L~vIHRDvKPsNiLI--n~~GqVKiCDFGIsG~L 199 (282)
T KOG0984|consen 124 MELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK-LSVIHRDVKPSNILI--NYDGQVKICDFGISGYL 199 (282)
T ss_pred HHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH-hhhhhccCCcceEEE--ccCCcEEEcccccceee
Confidence 9998 558877654 466899999999999999999999998 339999999999999 99999999999998765
Q ss_pred cccCccceeeccCCcccccccCccccCc----CCCCCchhHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHhCCCCCCC
Q 020888 195 KVQNSHDVYKMTGETGSYRYMAPEVFKH----RKYDKKVDVFSFAMILYEMLEGEPPLANY-EPYEAAKYVAEGHRPFFR 269 (320)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~l~~ll~g~~p~~~~-~~~~~~~~~~~~~~~~~~ 269 (320)
.++- ......|-..|+|||.++. ..|+-++||||||+++.||.+++.||+.. .+....+++.+...+...
T Consensus 200 ~dSi-----Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~P~Lp 274 (282)
T KOG0984|consen 200 VDSI-----AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPSPQLP 274 (282)
T ss_pred hhhh-----HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCCCCCc
Confidence 4432 1122345667999998854 36888999999999999999999999875 566777788877666544
Q ss_pred CCCC
Q 020888 270 AKGF 273 (320)
Q Consensus 270 ~~~~ 273 (320)
...+
T Consensus 275 ~~~F 278 (282)
T KOG0984|consen 275 ADTF 278 (282)
T ss_pred cccc
Confidence 4333
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-29 Score=210.20 Aligned_cols=212 Identities=35% Similarity=0.618 Sum_probs=178.6
Q ss_pred cCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEec
Q 020888 44 FSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY 121 (320)
Q Consensus 44 y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 121 (320)
|.+.+.||.|++|.||++... ++.+++|.+...... ...+.+.+|++.+++++|++++++++.+......++++|+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence 567789999999999999986 588999988655433 2357889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHhCC-CCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCcc
Q 020888 122 LRGGDLHKYLKEKGA-LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 200 (320)
Q Consensus 122 ~~~~~L~~~~~~~~~-l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~ 200 (320)
+++++|.+++..... +++..+..++.+++.++.+||+.+ ++|+|++|+||++ +.++.++|+|||.+.........
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~di~~~ni~v--~~~~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLG--IVHRDLKPENILL--GMDGLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEE--cCCCCEEEeeCceeeEecCcccc
Confidence 999999999987666 899999999999999999999998 9999999999999 77799999999988876543200
Q ss_pred ceeeccCCcccccccCcccc-CcCCCCCchhHHHHHHHHHHHHhCCCCCCC-CC-hHHHHHHHHhCC
Q 020888 201 DVYKMTGETGSYRYMAPEVF-KHRKYDKKVDVFSFAMILYEMLEGEPPLAN-YE-PYEAAKYVAEGH 264 (320)
Q Consensus 201 ~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~~ll~g~~p~~~-~~-~~~~~~~~~~~~ 264 (320)
......++..|++||.+ ....++.++|+|+||++++++++|+.||.. .+ .....+.+..+.
T Consensus 155 ---~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 218 (225)
T smart00221 155 ---LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGV 218 (225)
T ss_pred ---cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCC
Confidence 11223467789999998 667788899999999999999999999977 33 335555555544
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-31 Score=217.02 Aligned_cols=247 Identities=26% Similarity=0.365 Sum_probs=195.5
Q ss_pred CcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEe------C
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE------R 112 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~ 112 (320)
..+|--.+.+|.|.. .|-.+.+. +++|++|......... ...++..+|..++..++|+|+++++.++.- -
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~-~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~ 93 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQ-THAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF 93 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccC-ccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence 458888899999998 55555554 8999999876664443 334788899999999999999999999853 3
Q ss_pred CceEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcc
Q 020888 113 KPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 192 (320)
Q Consensus 113 ~~~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~ 192 (320)
...|+|||++.. +|.+.+.. .++=.++..+++|++.|++|||+.| |+|+||||+||++ ..++.+|++|||+++
T Consensus 94 ~e~y~v~e~m~~-nl~~vi~~--elDH~tis~i~yq~~~~ik~lhs~~--IihRdLkPsnivv--~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 94 QEVYLVMELMDA-NLCQVILM--ELDHETISYILYQMLCGIKHLHSAG--IIHRDLKPSNIVV--NSDCTLKILDFGLAR 166 (369)
T ss_pred HhHHHHHHhhhh-HHHHHHHH--hcchHHHHHHHHHHHHHHHHHHhcc--eeecccCccccee--cchhheeeccchhhc
Confidence 347999999955 99998874 4688899999999999999999999 9999999999999 888999999999997
Q ss_pred cccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhC---------
Q 020888 193 LIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEG--------- 263 (320)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~--------- 263 (320)
.-... ...+....+..|.|||+..+-.+.+..||||+||++.||++|..-|.+.+..+.+..+.+.
T Consensus 167 ~e~~~-----~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~ 241 (369)
T KOG0665|consen 167 TEDTD-----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFM 241 (369)
T ss_pred ccCcc-----cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHH
Confidence 54332 3455567888999999999999999999999999999999999888766543332211111
Q ss_pred -------------------------CCCCCC------CCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 264 -------------------------HRPFFR------AKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 264 -------------------------~~~~~~------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
...... ...-....++++.+||..||++|.|++++|+|
T Consensus 242 ~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 242 KQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 000000 00113458899999999999999999999987
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-31 Score=212.17 Aligned_cols=238 Identities=21% Similarity=0.358 Sum_probs=186.1
Q ss_pred cccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcccceeee-EEeCCceEE
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGA-VTERKPLML 117 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~-~~~~~~~~i 117 (320)
..|.+.+.||+|.||.+-++.++ ++.+++|.++..... ...|.+|..---.| .|.||+.-++. |+..+.+++
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt----~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF 99 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTT----QADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVF 99 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhh----HHHHHHHhccceeeccchhhhHHHHHHhhcCceEEE
Confidence 37999999999999999999997 577999988776554 36788888766666 48999987664 677889999
Q ss_pred EEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccccccc
Q 020888 118 ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 197 (320)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~ 197 (320)
++||+|-|+|..-+... .+.+.....++.|+++||.|+|+++ +||+|||.+||++.+.+..+|||||||........
T Consensus 100 ~qE~aP~gdL~snv~~~-GigE~~~K~v~~ql~SAi~fMHskn--lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t 176 (378)
T KOG1345|consen 100 VQEFAPRGDLRSNVEAA-GIGEANTKKVFAQLLSAIEFMHSKN--LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT 176 (378)
T ss_pred eeccCccchhhhhcCcc-cccHHHHHHHHHHHHHHHHHhhccc--hhhcccccceEEEecCCccEEEeeecccccccCce
Confidence 99999999999988764 4789999999999999999999999 99999999999997777779999999998755432
Q ss_pred CccceeeccCCcccccccCccccCcC-----CCCCchhHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHhCCC--C
Q 020888 198 NSHDVYKMTGETGSYRYMAPEVFKHR-----KYDKKVDVFSFAMILYEMLEGEPPLANYE----PYEAAKYVAEGHR--P 266 (320)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~~l~~ll~g~~p~~~~~----~~~~~~~~~~~~~--~ 266 (320)
-.. .-....|.+||..... ...+.+|+|.||++++.++||+.||+... +.-...+..+++. .
T Consensus 177 V~~-------~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~ 249 (378)
T KOG1345|consen 177 VKY-------LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPAL 249 (378)
T ss_pred ehh-------hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccC
Confidence 111 1124458899876432 35689999999999999999999998542 1112222222222 2
Q ss_pred CCCCCCCCHHHHHHHHHHhhcCCCCCC
Q 020888 267 FFRAKGFTPELRELTEKCWAADMNQRP 293 (320)
Q Consensus 267 ~~~~~~~~~~l~~li~~~l~~dp~~Rp 293 (320)
+-..+.+++.+..+.++-|..++++|=
T Consensus 250 P~~F~~fs~~a~r~Fkk~lt~~~~drc 276 (378)
T KOG1345|consen 250 PKKFNPFSEKALRLFKKSLTPRFKDRC 276 (378)
T ss_pred chhhcccCHHHHHHHHHhcCCcccccc
Confidence 222355788899999999999999993
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-28 Score=214.42 Aligned_cols=261 Identities=21% Similarity=0.297 Sum_probs=204.7
Q ss_pred ccCccceecccCceEEEEEEECC---CceEEEEccCCCCCcHHHHHHHHHHHHHHHhCC----CCcccceeeeE-EeCCc
Q 020888 43 DFSSSAIIGKGSFGEILKAYWRG---TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR----HPNIVQFLGAV-TERKP 114 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~~---~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~----h~~i~~~~~~~-~~~~~ 114 (320)
+|.+.+.||+|+||.||.+.+.. ..+|+|.......... ..+..|..++..+. ..++..+++.+ ..+..
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 79999999999999999999864 3689997765433322 25667888888886 36899999999 57888
Q ss_pred eEEEEecCCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCC-C--CcEEEecCC
Q 020888 115 LMLITEYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS-A--DHLKVGDFG 189 (320)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~-~--~~~~L~dfg 189 (320)
.|+||+.+ |.+|.++.... +.++..+++.++.|++.+|+++|+.| ++||||||.|+.+.... . ..+.|+|||
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G--~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG--FIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC--cccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 99999988 88999998654 47999999999999999999999999 99999999999993221 1 479999999
Q ss_pred Cccccc--ccCcc---ceee-ccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhC
Q 020888 190 LSKLIK--VQNSH---DVYK-MTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEG 263 (320)
Q Consensus 190 ~~~~~~--~~~~~---~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~ 263 (320)
+++... ..... .... .....||..|+++..+.+...+.+.|+||+++++.+++.|..||...........+.+.
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~ 252 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKD 252 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHH
Confidence 999433 22211 1111 22355999999999999999999999999999999999999999877643322222222
Q ss_pred CCCCC---CCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcC
Q 020888 264 HRPFF---RAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETL 309 (320)
Q Consensus 264 ~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 309 (320)
..... .....+.++..+...+-..+..++|.+..+...|..+....
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 253 PRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred hhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 21111 22335788999999888999999999999999998887765
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=203.79 Aligned_cols=263 Identities=22% Similarity=0.309 Sum_probs=216.4
Q ss_pred CcccCccceecccCceEEEEEEE--CCCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCC-CCcccceeeeEEeCCceEE
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLML 117 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~--~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~i 117 (320)
+..|.+.++||+|+||.++.+.. ++++||+|.-+.... ..+++.|.+..+.|. .++|..++.+..++....+
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~-----APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiL 101 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE-----APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNIL 101 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEeccccCC-----cchHHHHHHHHHHHcCCCCCCceeeeccccchhhh
Confidence 45799999999999999999986 499999996643322 267888999998885 7999999999999999999
Q ss_pred EEecCCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEe---eCCCCcEEEecCCCccc
Q 020888 118 ITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLV---NSSADHLKVGDFGLSKL 193 (320)
Q Consensus 118 v~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~---~~~~~~~~L~dfg~~~~ 193 (320)
|+|.+ |.+|.|++.- ..+++..++..++.|++.-++++|+++ +|.+||||+|++|. ......+.++|||+++.
T Consensus 102 VidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~--LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 102 VIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKD--LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred hhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcc--eeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 99988 8899999974 457999999999999999999999999 99999999999991 11223689999999998
Q ss_pred ccccCccce---eeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHhCCCC-
Q 020888 194 IKVQNSHDV---YKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPY---EAAKYVAEGHRP- 266 (320)
Q Consensus 194 ~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~---~~~~~~~~~~~~- 266 (320)
..++....- ...-...||.+|++-..+.|..-+.+.|+-|||-++++++-|..||.+.... +....+-+.+..
T Consensus 179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T 258 (449)
T KOG1165|consen 179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRST 258 (449)
T ss_pred hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccC
Confidence 877654432 2233457999999999999999999999999999999999999999887432 222223222222
Q ss_pred --CCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcCCC
Q 020888 267 --FFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPT 311 (320)
Q Consensus 267 --~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~ 311 (320)
.....++|.++...+...=..+-.+-|.++-+...+..+.+++..
T Consensus 259 ~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~ 305 (449)
T KOG1165|consen 259 PIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGE 305 (449)
T ss_pred CHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCC
Confidence 222356899999999999999999999999999998888887754
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.4e-31 Score=212.64 Aligned_cols=251 Identities=29% Similarity=0.445 Sum_probs=196.3
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeC-----Cce
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER-----KPL 115 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~ 115 (320)
+.+-.+.||-|.||.||.+.+. ++.+++|.+...... -...+++.+|+++|+-++|.|++..+++.+.. ...
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~-L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi 132 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQN-LASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL 132 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHH-HHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence 4556789999999999999885 899999987654332 34457888999999999999999999887532 235
Q ss_pred EEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccccc
Q 020888 116 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 195 (320)
Q Consensus 116 ~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~ 195 (320)
|+++|.+ ..+|..++-.-.+++...+.-.++||+.||+|||+.| |.|+||||.|.++ +.+..+||||||+++.-.
T Consensus 133 YV~TELm-QSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~--ILHRDIKPGNLLV--NSNCvLKICDFGLARvee 207 (449)
T KOG0664|consen 133 YVLTELM-QSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTAN--ILHRDIKPGNLLV--NSNCILKICDFGLARTWD 207 (449)
T ss_pred HHHHHHH-HhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcc--hhhccCCCccEEe--ccCceEEecccccccccc
Confidence 7788877 4488888776667899999999999999999999999 9999999999999 999999999999998654
Q ss_pred ccCccceeeccCCcccccccCccccCcC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh------------
Q 020888 196 VQNSHDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAE------------ 262 (320)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~------------ 262 (320)
.... ..+.....|..|.|||++.|. .|+.+.||||.||++.|++..+..|...++.+-...+.+
T Consensus 208 ~d~~---~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ 284 (449)
T KOG0664|consen 208 QRDR---LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKY 284 (449)
T ss_pred hhhh---hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHH
Confidence 4322 223334578889999999876 588999999999999999999988877766544332221
Q ss_pred -----------CC-CCCCCC--------CCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHH
Q 020888 263 -----------GH-RPFFRA--------KGFTPELRELTEKCWAADMNQRPSFLDILKRL 302 (320)
Q Consensus 263 -----------~~-~~~~~~--------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 302 (320)
+. ..+..+ ..-..+...++.+++..||.+|.+.++.+.++
T Consensus 285 ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 285 ACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred HhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 11 111111 12234567888999999999999999987764
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-30 Score=231.17 Aligned_cols=249 Identities=27% Similarity=0.455 Sum_probs=211.2
Q ss_pred cccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEE
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 119 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 119 (320)
.+|..+..+|.|++|.||++++. +...|+|++.-....+ +.-+.+|+-+++..+|+||+.+++.+...+..++.|
T Consensus 15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd---~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM 91 (829)
T KOG0576|consen 15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD---FSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM 91 (829)
T ss_pred cchhheeeecCCcccchhhhcccccCchhhheeeeccCCcc---ccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence 37999999999999999999986 8899999886554444 367889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCc
Q 020888 120 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 199 (320)
Q Consensus 120 e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~ 199 (320)
|||.||+|.+.-.--+++++.++....+..+++++|||+.| =+|||||-.||++ +..|.++|.|||.+-.+...-
T Consensus 92 EycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~g--k~hRdiKGanill--td~gDvklaDfgvsaqitati- 166 (829)
T KOG0576|consen 92 EYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQG--KIHRDIKGANILL--TDEGDVKLADFGVSAQITATI- 166 (829)
T ss_pred EecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCC--cccccccccceee--cccCceeecccCchhhhhhhh-
Confidence 99999999998887788999999999999999999999998 7899999999999 888999999999887664321
Q ss_pred cceeeccCCcccccccCccccC---cCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCC---CCCC
Q 020888 200 HDVYKMTGETGSYRYMAPEVFK---HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR---AKGF 273 (320)
Q Consensus 200 ~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~ 273 (320)
.+.-...||+.|+|||+.. .+.+...+|+|++|++..|+-.-+.|..+..+......+.+....+.. ...+
T Consensus 167 ---~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kw 243 (829)
T KOG0576|consen 167 ---AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKW 243 (829)
T ss_pred ---hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccc
Confidence 1223356899999999863 457889999999999999999888887777766666555544332222 2568
Q ss_pred CHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 274 TPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 274 ~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
++.+.+|++.+|..+|.+|||++.+|.+
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~h 271 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQH 271 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhheec
Confidence 9999999999999999999999998764
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-28 Score=193.88 Aligned_cols=265 Identities=22% Similarity=0.283 Sum_probs=215.1
Q ss_pred CcccCccceecccCceEEEEEEE--CCCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCC-CCcccceeeeEEeCCceEE
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLML 117 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~--~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~i 117 (320)
...|.+++.||+|+||.+|.+.. .+..||+|+-...... .++..|.++...++ ..+|+.+..+..+...-.+
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h-----pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvl 88 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH-----PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVL 88 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC-----cchhHHHHHHHHhccCCCCchhhhhcccccccee
Confidence 45899999999999999999886 4899999987554333 45667888888886 4788888888999999999
Q ss_pred EEecCCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEe-eCCCCcEEEecCCCccccc
Q 020888 118 ITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLV-NSSADHLKVGDFGLSKLIK 195 (320)
Q Consensus 118 v~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~-~~~~~~~~L~dfg~~~~~~ 195 (320)
|||.+ |.+|.++++- ...++..+++.++-|++.-++|+|.++ ++|+||||+|+++- ..-...+.|+|||+++...
T Consensus 89 VMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~--fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 89 VMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRN--FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred eeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhc--cccccCCccceeeccccccceEEEEeccchhhhc
Confidence 99988 8899999873 346999999999999999999999999 99999999999992 2223379999999999876
Q ss_pred ccCcc---ceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHhCC---CC
Q 020888 196 VQNSH---DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEA---AKYVAEGH---RP 266 (320)
Q Consensus 196 ~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~---~~~~~~~~---~~ 266 (320)
+..+. +........||.+|++-..+.|...+.+.|+-|+|++|+++--|..||++..+... ...+.+.+ ..
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~i 245 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPI 245 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCH
Confidence 64322 22223345799999999999999999999999999999999999999998754322 22233322 22
Q ss_pred CCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcCCCCC
Q 020888 267 FFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPTDH 313 (320)
Q Consensus 267 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~~ 313 (320)
.....++|.|+...+..|=...-++-|...-+.+.++-+...+....
T Consensus 246 e~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~ 292 (341)
T KOG1163|consen 246 EVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQY 292 (341)
T ss_pred HHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccC
Confidence 23347889999999999999999999999999999888888776554
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-28 Score=209.21 Aligned_cols=250 Identities=24% Similarity=0.363 Sum_probs=191.9
Q ss_pred CcccCccceecccCceEEEEEEE-----CCCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCC-CCcccceeeeEEeCCc
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYW-----RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKP 114 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~-----~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 114 (320)
...|.++.+||.|+|++||++.+ +++.||+|.+...... .++.+|+++|..+. +.||+++.+.+...++
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p-----~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP-----SRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc-----hHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 34789999999999999999875 3678999988654333 57899999999995 9999999999999999
Q ss_pred eEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccc
Q 020888 115 LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 194 (320)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~ 194 (320)
..+|+||+++..-.++... ++...+..+++.++.||+++|..| |+|+||||.|++.+ ...+.-.|+|||++...
T Consensus 110 v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~G--IvHRDiKpsNFL~n-~~t~rg~LvDFgLA~~~ 183 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNG--IVHRDIKPSNFLYN-RRTQRGVLVDFGLAQRY 183 (418)
T ss_pred eEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccC--ccccCCCccccccc-cccCCceEEechhHHHH
Confidence 9999999999999998864 678999999999999999999999 99999999999984 45668899999999832
Q ss_pred cccC------c------------------------ccee----------eccCCcccccccCccccCc-CCCCCchhHHH
Q 020888 195 KVQN------S------------------------HDVY----------KMTGETGSYRYMAPEVFKH-RKYDKKVDVFS 233 (320)
Q Consensus 195 ~~~~------~------------------------~~~~----------~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~s 233 (320)
.... . ...+ ..-...||++|.|||++.. +..+.+.||||
T Consensus 184 d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws 263 (418)
T KOG1167|consen 184 DGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWS 263 (418)
T ss_pred HhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceee
Confidence 1100 0 0000 0012259999999998854 56788999999
Q ss_pred HHHHHHHHHhCCCCCCCCC----h----------HHHHHH--------------------HHhCC--------CC-----
Q 020888 234 FAMILYEMLEGEPPLANYE----P----------YEAAKY--------------------VAEGH--------RP----- 266 (320)
Q Consensus 234 lG~~l~~ll~g~~p~~~~~----~----------~~~~~~--------------------~~~~~--------~~----- 266 (320)
.|++++.++++.+||-... . .++.+. ....+ ..
T Consensus 264 ~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n 343 (418)
T KOG1167|consen 264 AGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPN 343 (418)
T ss_pred ccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccc
Confidence 9999999999999983221 0 000000 00000 00
Q ss_pred ---CCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 267 ---FFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 267 ---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
.......+..+.+++.+||..||.+|.|+++.|++
T Consensus 344 ~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 344 TEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred eeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 00012234578899999999999999999999876
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.9e-27 Score=189.28 Aligned_cols=163 Identities=20% Similarity=0.273 Sum_probs=129.2
Q ss_pred CCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCcccee
Q 020888 125 GDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 203 (320)
Q Consensus 125 ~~L~~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~~~~ 203 (320)
|+|.+++..+ ..+++..++.++.|++.||.|||+.+ ||+||++ +.++.+++ ||.+......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--------kp~Nil~--~~~~~~~~--fG~~~~~~~~------ 62 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA--------KSGNILL--TWDGLLKL--DGSVAFKTPE------ 62 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC--------CcccEeE--cCccceee--ccceEeeccc------
Confidence 5899999864 46999999999999999999999975 9999999 88888998 9988754332
Q ss_pred eccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHhCCCCCC-----CCCCCCH--
Q 020888 204 KMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPY-EAAKYVAEGHRPFF-----RAKGFTP-- 275 (320)
Q Consensus 204 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~-~~~~~~~~~~~~~~-----~~~~~~~-- 275 (320)
...+++.|+|||++.+..++.++||||||+++|+|++|..||...... .....+........ ....++.
T Consensus 63 ---~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 139 (176)
T smart00750 63 ---QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAAR 139 (176)
T ss_pred ---cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhh
Confidence 125789999999999999999999999999999999999999765432 22222222222111 1112333
Q ss_pred HHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhc
Q 020888 276 ELRELTEKCWAADMNQRPSFLDILKRLEKIKET 308 (320)
Q Consensus 276 ~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 308 (320)
++++++.+||..+|.+|||+.++++++..+..+
T Consensus 140 ~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~ 172 (176)
T smart00750 140 SFADFMRVCASRLPQRREAANHYLAHCRALFAE 172 (176)
T ss_pred hHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence 699999999999999999999999998877654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=233.65 Aligned_cols=196 Identities=13% Similarity=0.155 Sum_probs=138.9
Q ss_pred CcccceeeeE-------EeCCceEEEEecCCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 020888 100 PNIVQFLGAV-------TERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPR 171 (320)
Q Consensus 100 ~~i~~~~~~~-------~~~~~~~iv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~ 171 (320)
.||.++++.+ ......+.++||+ +++|.+++.. ...+++..++.++.||+.||.|||++| |+|+||||+
T Consensus 33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g--IvHrDlKP~ 109 (793)
T PLN00181 33 DYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQG--IVVHNVRPS 109 (793)
T ss_pred HHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCC--eeeccCCch
Confidence 4666677765 2334577788988 5599999975 346999999999999999999999998 999999999
Q ss_pred cEEEee-----------------CCCCcEEEecCCCcccccccCcc------------ceeeccCCcccccccCccccCc
Q 020888 172 NVLLVN-----------------SSADHLKVGDFGLSKLIKVQNSH------------DVYKMTGETGSYRYMAPEVFKH 222 (320)
Q Consensus 172 nI~~~~-----------------~~~~~~~L~dfg~~~~~~~~~~~------------~~~~~~~~~~~~~y~aPE~~~~ 222 (320)
||++.. +.++.++++|||+++........ .........+|+.|+|||++.+
T Consensus 110 NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~ 189 (793)
T PLN00181 110 CFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNG 189 (793)
T ss_pred hEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhcc
Confidence 999921 22334556666655432110000 0000112357888999999999
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 223 RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 223 ~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
..++.++|||||||+||||++|..|+..... ....+.....+..... .......++..||..+|.+|||+.+++++
T Consensus 190 ~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~~~~~~~~-~~~~~~~~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 190 SSSNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRVLPPQILL-NWPKEASFCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred CCCCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhhcChhhhh-cCHHHHHHHHHhCCCChhhCcChHHHhhc
Confidence 9999999999999999999999887654321 1222222222211111 24567789999999999999999999875
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.3e-23 Score=181.55 Aligned_cols=253 Identities=33% Similarity=0.490 Sum_probs=205.6
Q ss_pred cCccceecccCceEEEEEEECCCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCC-cccceeeeEEeCCceEEEEecC
Q 020888 44 FSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP-NIVQFLGAVTERKPLMLITEYL 122 (320)
Q Consensus 44 y~~~~~lg~g~~~~vy~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~~iv~e~~ 122 (320)
|.+.+.||.|+|+.||.+.+. ..+++|.+.............+.+|+..++.+.|+ +++++.+.+......+++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 80 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV 80 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence 778899999999999999887 78899988776665543457889999999999887 7999999997777789999999
Q ss_pred CCCCHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCC-cEEEecCCCcccccccC
Q 020888 123 RGGDLHKYLKEKG---ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQN 198 (320)
Q Consensus 123 ~~~~L~~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~-~~~L~dfg~~~~~~~~~ 198 (320)
.+++|.+++.... .++......++.|++.++.++|..| ++|+|+||+||++ +..+ .++++|||.+.......
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~--~~hrd~kp~nil~--~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 81 DGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG--IIHRDIKPENILL--DRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeee--cCCCCeEEEeccCcceecCCCC
Confidence 9999998877654 6899999999999999999999999 9999999999999 7777 79999999988554433
Q ss_pred ccce--eeccCCcccccccCccccCc---CCCCCchhHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHhCCCC-CC
Q 020888 199 SHDV--YKMTGETGSYRYMAPEVFKH---RKYDKKVDVFSFAMILYEMLEGEPPLANYEP----YEAAKYVAEGHRP-FF 268 (320)
Q Consensus 199 ~~~~--~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~----~~~~~~~~~~~~~-~~ 268 (320)
.... .......++..|.+||...+ .......|+|++|++++++++|..||..... ......+...... ..
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA 236 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccc
Confidence 2211 12355678999999999988 5788999999999999999999999877663 4444444444433 11
Q ss_pred CCCCC------CHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 269 RAKGF------TPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 269 ~~~~~------~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
..... ...+.+++..++..+|..|.+..+....
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 237 SPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 11111 1579999999999999999988877665
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.1e-26 Score=216.06 Aligned_cols=245 Identities=20% Similarity=0.243 Sum_probs=190.1
Q ss_pred ccCccceecccCceEEEEEEECCCceEEEEccCCCC-CcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEec
Q 020888 43 DFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLS-DDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY 121 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~K~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 121 (320)
+|...+-||++.|-+|.++++..-.+++|+|.+... -.-....+..+|++ ...+++||++++.-+.+.+...|+|-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 678889999999999999998866699999855432 22222233333444 4445899999999888888889999999
Q ss_pred CCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccccccc---C
Q 020888 122 LRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ---N 198 (320)
Q Consensus 122 ~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~---~ 198 (320)
..+ +|.|.+..++-+...+.+.|+.||+.||+.||..| |+|||||.+||++ +..+.+.|+||...+...-+ +
T Consensus 103 vkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~g--VcHGDIKsENILi--TSWNW~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 103 VKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLG--VCHGDIKSENILI--TSWNWLYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred Hhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcC--ccccccccceEEE--eeechhhhhcccccCCccCCCCCc
Confidence 956 99999998777888889999999999999999999 9999999999999 89999999999987655432 3
Q ss_pred ccceeeccCCcccccccCccccCcC-----------CCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHH-------HH
Q 020888 199 SHDVYKMTGETGSYRYMAPEVFKHR-----------KYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAA-------KY 259 (320)
Q Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~~-----------~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~-------~~ 259 (320)
..-.+.+.+..+-..|.|||.+... ..+++.||||+||++.||++ |..+|.-..-..+. ..
T Consensus 178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~ 257 (1431)
T KOG1240|consen 178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQ 257 (1431)
T ss_pred ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHH
Confidence 3344556666677789999988542 15689999999999999999 77777522111111 11
Q ss_pred HHhCCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 260 VAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 260 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
..+.. -+..++.+|..|++.||..|.|+++.|+.
T Consensus 258 ~Le~I--------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 258 LLEKI--------EDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HHHhC--------cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 11110 14579999999999999999999999987
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.3e-24 Score=187.72 Aligned_cols=170 Identities=22% Similarity=0.299 Sum_probs=127.7
Q ss_pred CCCCcccCccceecccCceEEEEEEEC---CCceEEEEccCCCC--CcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeC
Q 020888 38 DPSELDFSSSAIIGKGSFGEILKAYWR---GTPVAIKRILPSLS--DDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER 112 (320)
Q Consensus 38 ~~~~~~y~~~~~lg~g~~~~vy~~~~~---~~~~~~K~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 112 (320)
..-..+|.+.+.||+|+||+||++.+. ++.+|+|.+..... ......+.+.+|+++++.++|+++++.+.. .
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~ 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---T 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---c
Confidence 334457999999999999999999874 56679997643211 123345679999999999999998853322 2
Q ss_pred CceEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCC-CCCcEEEeeCCCCcEEEecCCCc
Q 020888 113 KPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDL-KPRNVLLVNSSADHLKVGDFGLS 191 (320)
Q Consensus 113 ~~~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di-~p~nI~~~~~~~~~~~L~dfg~~ 191 (320)
+..|+||||++|++|... . ... ...++.+++++|.+||+.| |+|||| ||+||++ +.++.++|+|||++
T Consensus 91 ~~~~LVmE~~~G~~L~~~-~---~~~---~~~~~~~i~~aL~~lH~~g--IiHrDL~KP~NILv--~~~~~ikLiDFGlA 159 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLA-R---PHG---DPAWFRSAHRALRDLHRAG--ITHNDLAKPQNWLM--GPDGEAAVIDFQLA 159 (365)
T ss_pred CCcEEEEEccCCCCHHHh-C---ccc---hHHHHHHHHHHHHHHHHCC--CeeCCCCCcceEEE--cCCCCEEEEECccc
Confidence 457999999999999732 1 111 1467889999999999999 999999 9999999 77889999999999
Q ss_pred ccccccCccceee----ccCCcccccccCccccC
Q 020888 192 KLIKVQNSHDVYK----MTGETGSYRYMAPEVFK 221 (320)
Q Consensus 192 ~~~~~~~~~~~~~----~~~~~~~~~y~aPE~~~ 221 (320)
+.+.......... .....+++.|.+||...
T Consensus 160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT 193 (365)
T ss_pred eecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence 9776543222211 12345778899999874
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.3e-25 Score=205.72 Aligned_cols=252 Identities=27% Similarity=0.380 Sum_probs=193.7
Q ss_pred CccceecccCceEEEEEEEC--CCceEEEEccC---CCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEE
Q 020888 45 SSSAIIGKGSFGEILKAYWR--GTPVAIKRILP---SLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 119 (320)
Q Consensus 45 ~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~---~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 119 (320)
....++|.|.+|.++.+... ......|.+.. ...........+..|+.+-..+.|++++..+..+.+....+-.|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 35678999999977776653 33344443321 11122222222666777777889999988888777666655669
Q ss_pred ecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCc
Q 020888 120 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 199 (320)
Q Consensus 120 e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~ 199 (320)
|||++ +|..++.+.+.+....+.-.+.|++.|+.|+|..| +.|+|+||+|+++ ..+|.++|+|||.+.....+..
T Consensus 401 E~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~G--iahrdlK~enll~--~~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMG--LAHRDLKLENLLV--TENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred hcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcC--ceeccCccccEEE--ecCCceEEeecCcceeeccCcc
Confidence 99999 99999988777888999999999999999999999 9999999999999 8889999999999988877766
Q ss_pred cceeeccCCcccccccCccccCcCCCCC-chhHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHh-C-----CCCCCCCC
Q 020888 200 HDVYKMTGETGSYRYMAPEVFKHRKYDK-KVDVFSFAMILYEMLEGEPPLANYEPYEAA-KYVAE-G-----HRPFFRAK 271 (320)
Q Consensus 200 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~~l~~ll~g~~p~~~~~~~~~~-~~~~~-~-----~~~~~~~~ 271 (320)
.......+.+|+..|.|||.+.+..|++ ..||||.|++++.|++|+.||......+.. ..... . ..+.....
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~ 555 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLS 555 (601)
T ss_pred hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHH
Confidence 5555667788999999999999999985 799999999999999999999765444322 11110 0 01111114
Q ss_pred CCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 272 GFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 272 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
.++.+.+.++.+||++||.+|.|++++++.
T Consensus 556 ~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 556 LLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred hchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 478889999999999999999999999874
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.6e-24 Score=180.57 Aligned_cols=235 Identities=19% Similarity=0.305 Sum_probs=156.1
Q ss_pred CCcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCC----------CCcccceee
Q 020888 40 SELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR----------HPNIVQFLG 107 (320)
Q Consensus 40 ~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~----------h~~i~~~~~ 107 (320)
....+.....||.|+++.||.+.+. ++.+++|++..........++.+++|.-....+. |-.++..++
T Consensus 10 ~~r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d 89 (288)
T PF14531_consen 10 RPRTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLD 89 (288)
T ss_dssp -EEEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SE
T ss_pred CceEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeE
Confidence 3446677889999999999999996 6999999887666555556778887776665532 234555555
Q ss_pred eEE---------eCC--------ceEEEEecCCCCCHHHHHHH---hC----CCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 020888 108 AVT---------ERK--------PLMLITEYLRGGDLHKYLKE---KG----ALSPSTAVNFALDIARGMAYLHNEPNVI 163 (320)
Q Consensus 108 ~~~---------~~~--------~~~iv~e~~~~~~L~~~~~~---~~----~l~~~~~~~i~~~l~~~l~~lH~~g~~i 163 (320)
... ... +.+++|+-+ .++|.++++. .. .+.....+.+..|++..+++||..| +
T Consensus 90 ~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G--l 166 (288)
T PF14531_consen 90 LLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG--L 166 (288)
T ss_dssp EEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--E
T ss_pred EEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc--e
Confidence 442 111 246788877 4599888653 21 1334445666789999999999999 9
Q ss_pred EecCCCCCcEEEeeCCCCcEEEecCCCcccccccCccceeeccCCcccccccCccccCcC--------CCCCchhHHHHH
Q 020888 164 IHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR--------KYDKKVDVFSFA 235 (320)
Q Consensus 164 vH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--------~~~~~~Di~slG 235 (320)
+|+||+|+|+++ +.+|.+.|+||+...+..... .. ...+..|.|||..... .++.+.|.|+||
T Consensus 167 VHgdi~~~nfll--~~~G~v~Lg~F~~~~r~g~~~-----~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG 237 (288)
T PF14531_consen 167 VHGDIKPENFLL--DQDGGVFLGDFSSLVRAGTRY-----RC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLG 237 (288)
T ss_dssp EEST-SGGGEEE---TTS-EEE--GGGEEETTEEE-----EG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHH
T ss_pred EecccceeeEEE--cCCCCEEEcChHHHeecCcee-----ec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHH
Confidence 999999999999 999999999998776544321 11 2335678999976442 467899999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHhhcCCCCC
Q 020888 236 MILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQR 292 (320)
Q Consensus 236 ~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 292 (320)
+++|.+++|..||........... .......+|+.++.+|..+|+.||++|
T Consensus 238 ~~ly~lWC~~lPf~~~~~~~~~~~------~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 238 ITLYSLWCGRLPFGLSSPEADPEW------DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHHHSS-STCCCGGGSTSGG------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHHHHccCCCCCCCccccccc------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 999999999999986543211111 111223689999999999999999987
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.3e-24 Score=174.28 Aligned_cols=174 Identities=11% Similarity=0.181 Sum_probs=135.0
Q ss_pred CcccCccceecccCceEEEEEEECCCceEEEEccCCCCCcHHHHHH------HHHHHHHHHhCCCCcccceeeeEEeC--
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQD------FRHEVNLLVKLRHPNIVQFLGAVTER-- 112 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~K~~~~~~~~~~~~~~~------~~~e~~~l~~l~h~~i~~~~~~~~~~-- 112 (320)
..+|.+++++|.|+||.||++..++..+|+|++............. +.+|+..+.++.|++|..+.+++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~ 109 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAER 109 (232)
T ss_pred hCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeeccc
Confidence 3489999999999999999988778899999997766555443333 57899999999999999998885532
Q ss_pred ------CceEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEe
Q 020888 113 ------KPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVG 186 (320)
Q Consensus 113 ------~~~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~ 186 (320)
+..+++|||++|.+|.++.. ++. ....+++.++..||+.| ++|||++|+||++ +.++ ++|+
T Consensus 110 ~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~g--i~H~Dikp~Nili--~~~g-i~li 176 (232)
T PRK10359 110 KTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQHG--MVSGDPHKGNFIV--SKNG-LRII 176 (232)
T ss_pred ccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHcC--CccCCCChHHEEE--eCCC-EEEE
Confidence 45899999999999988732 333 24569999999999999 9999999999999 6667 9999
Q ss_pred cCCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh
Q 020888 187 DFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE 243 (320)
Q Consensus 187 dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~ 243 (320)
|||........... ........+..++|+|+||+++..+..
T Consensus 177 Dfg~~~~~~e~~a~----------------d~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 177 DLSGKRCTAQRKAK----------------DRIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred ECCCcccccchhhH----------------HHHHHHhHhcccccccceeEeehHHHH
Confidence 99987644221110 012233445678999999999876543
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.3e-23 Score=196.48 Aligned_cols=255 Identities=22% Similarity=0.283 Sum_probs=197.9
Q ss_pred CCCCCcccCccceecccCceEEEEEEEC-CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCce
Q 020888 37 IDPSELDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL 115 (320)
Q Consensus 37 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~-~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 115 (320)
....+..|.+.+.+|.|++|+||.|... ++.+|+|+-.+...++.....++...++ ++ --+.|+.+...+...+.-
T Consensus 693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~~q~~~RLk-~~--~~~~~~~~~~a~~~~~~S 769 (974)
T KOG1166|consen 693 FEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYICLQVMERLK-PQ--MLPSIMHISSAHVFQNAS 769 (974)
T ss_pred eeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeeehHHHHHhhc-hh--hhcchHHHHHHHccCCcc
Confidence 4556779999999999999999999875 8899999999888888776666665444 11 134566666666666778
Q ss_pred EEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEe-----eCCCCcEEEecCCC
Q 020888 116 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLV-----NSSADHLKVGDFGL 190 (320)
Q Consensus 116 ~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~-----~~~~~~~~L~dfg~ 190 (320)
++|++|.+.|||.++++..+.+++..+..+..|++..+++||..+ ||||||||+|+++. +...--++|+|||.
T Consensus 770 ~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~--IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~ 847 (974)
T KOG1166|consen 770 VLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMG--IIHGDIKPDNFLLRREICADSDSKGLYLIDFGR 847 (974)
T ss_pred eeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcc--eecccCCcceeEeecccCCCCcccceEEEeccc
Confidence 999999999999999998778999999999999999999999999 99999999999992 22334699999999
Q ss_pred cccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCC
Q 020888 191 SKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA 270 (320)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 270 (320)
+..+.... +...+...++|..|-++|...|..|++..|.|.|+.+++-|+.|++.- ...+.......
T Consensus 848 siDm~lfp--~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q-----------~~~g~~~~~~~ 914 (974)
T KOG1166|consen 848 SIDMKLFP--DGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME-----------VKNGSSWMVKT 914 (974)
T ss_pred ceeeeEcC--CCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH-----------hcCCcceeccc
Confidence 88776543 224566678899999999999999999999999999999999997421 11111111111
Q ss_pred ---CCCCHH-HHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcC
Q 020888 271 ---KGFTPE-LRELTEKCWAADMNQRPSFLDILKRLEKIKETL 309 (320)
Q Consensus 271 ---~~~~~~-l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 309 (320)
.-+..+ .-.|+..+|+.|...=|...+|...|+....+.
T Consensus 915 ~~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~~ 957 (974)
T KOG1166|consen 915 NFPRYWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLAEH 957 (974)
T ss_pred cchhhhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHHHH
Confidence 111222 347788888866655588888888888776653
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.8e-24 Score=172.79 Aligned_cols=251 Identities=30% Similarity=0.500 Sum_probs=201.8
Q ss_pred ccCccceecccCceEEEEEEECCCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEecC
Q 020888 43 DFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYL 122 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~ 122 (320)
+.....+|.+...|..|++++.+..++.|++......... -+.|..|.-.|+-+.||||+.+++.+.....+.++..|+
T Consensus 191 ~lnl~tkl~e~hsgelwrgrwqgndivakil~vr~~t~ri-srdfneefp~lrifshpnilpvlgacnsppnlv~isq~m 269 (448)
T KOG0195|consen 191 SLNLITKLAESHSGELWRGRWQGNDIVAKILNVREVTARI-SRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYM 269 (448)
T ss_pred hhhhhhhhccCCCcccccccccCcchhhhhhhhhhcchhh-cchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeec
Confidence 4456678899999999999999999999987554444332 267888888898889999999999999999999999999
Q ss_pred CCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCcc
Q 020888 123 RGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 200 (320)
Q Consensus 123 ~~~~L~~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~ 200 (320)
+.|+|...+.++. ..+-.+..+.+..++.|++|||+...-|----++...++++++-..++.+.|-.++.
T Consensus 270 p~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf-------- 341 (448)
T KOG0195|consen 270 PFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF-------- 341 (448)
T ss_pred cchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee--------
Confidence 9999999998754 367778889999999999999999654555578889999955555555555544332
Q ss_pred ceeeccCCcccccccCccccCcCCCC---CchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH-HhCCCCCCCCCCCCHH
Q 020888 201 DVYKMTGETGSYRYMAPEVFKHRKYD---KKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYV-AEGHRPFFRAKGFTPE 276 (320)
Q Consensus 201 ~~~~~~~~~~~~~y~aPE~~~~~~~~---~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 276 (320)
...+....|.|++||.+.....+ .++|+||++++++|+.|...||.+..+.+-...+ .++..... +.+++..
T Consensus 342 ---qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~i-ppgis~h 417 (448)
T KOG0195|consen 342 ---QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHI-PPGISRH 417 (448)
T ss_pred ---eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccC-CCCccHH
Confidence 23344568889999998766544 6899999999999999999999999888765444 44444444 4568999
Q ss_pred HHHHHHHHhhcCCCCCCCHHHHHHHHHHHH
Q 020888 277 LRELTEKCWAADMNQRPSFLDILKRLEKIK 306 (320)
Q Consensus 277 l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 306 (320)
+..+++-|.+.||.+||.+.++.-.|+++.
T Consensus 418 m~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 418 MNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred HHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 999999999999999999999998888764
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.6e-22 Score=164.21 Aligned_cols=142 Identities=21% Similarity=0.162 Sum_probs=109.8
Q ss_pred cceecccCceEEEEEEEC-CCceEEEEccCCCCCcHH-----------------------HHHHHHHHHHHHHhCCCCcc
Q 020888 47 SAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRL-----------------------VIQDFRHEVNLLVKLRHPNI 102 (320)
Q Consensus 47 ~~~lg~g~~~~vy~~~~~-~~~~~~K~~~~~~~~~~~-----------------------~~~~~~~e~~~l~~l~h~~i 102 (320)
...||+|++|.||++.+. +++||+|++......... ......+|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 468999999999999975 899999998665322111 01223459999999988777
Q ss_pred cceeeeEEeCCceEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHH-hcCCCCeEecCCCCCcEEEeeCCCC
Q 020888 103 VQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYL-HNEPNVIIHRDLKPRNVLLVNSSAD 181 (320)
Q Consensus 103 ~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~l-H~~g~~ivH~di~p~nI~~~~~~~~ 181 (320)
.....+.. . ..++||||++|++|.......++++...+..++.|++.+|.++ |+.| |+|+||||+||++ + ++
T Consensus 82 ~~p~~~~~-~-~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~g--iiHrDlkP~NIli--~-~~ 154 (190)
T cd05147 82 PCPEPILL-K-SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCR--LVHADLSEYNLLY--H-DG 154 (190)
T ss_pred CCCcEEEe-c-CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEE--E-CC
Confidence 44333222 2 2389999998877766544456789999999999999999999 7988 9999999999999 4 46
Q ss_pred cEEEecCCCccccc
Q 020888 182 HLKVGDFGLSKLIK 195 (320)
Q Consensus 182 ~~~L~dfg~~~~~~ 195 (320)
.++|+|||++....
T Consensus 155 ~v~LiDFG~a~~~~ 168 (190)
T cd05147 155 KLYIIDVSQSVEHD 168 (190)
T ss_pred cEEEEEccccccCC
Confidence 89999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.8e-21 Score=156.07 Aligned_cols=143 Identities=17% Similarity=0.135 Sum_probs=111.4
Q ss_pred cceecccCceEEEEEEEC-CCceEEEEccCCCCCcH-----------------------HHHHHHHHHHHHHHhCCCCcc
Q 020888 47 SAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDR-----------------------LVIQDFRHEVNLLVKLRHPNI 102 (320)
Q Consensus 47 ~~~lg~g~~~~vy~~~~~-~~~~~~K~~~~~~~~~~-----------------------~~~~~~~~e~~~l~~l~h~~i 102 (320)
...||+|++|.||++.+. ++.||+|++........ .....+..|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 468999999999999875 89999999876532110 001234678999999988887
Q ss_pred cceeeeEEeCCceEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCcEEEeeCCCC
Q 020888 103 VQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHN-EPNVIIHRDLKPRNVLLVNSSAD 181 (320)
Q Consensus 103 ~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~-~g~~ivH~di~p~nI~~~~~~~~ 181 (320)
.....+... ..++||||++|+++....-...+++......++.|++.++.++|. .| ++|+||||.||++ + ++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~g--ivHrDlkP~NIll--~-~~ 154 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAG--LVHGDLSEYNILY--H-DG 154 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCChhhEEE--E-CC
Confidence 554444332 248999999887654433334568889999999999999999999 89 9999999999999 5 68
Q ss_pred cEEEecCCCcccccc
Q 020888 182 HLKVGDFGLSKLIKV 196 (320)
Q Consensus 182 ~~~L~dfg~~~~~~~ 196 (320)
.++|+|||++..+..
T Consensus 155 ~~~liDFG~a~~~~~ 169 (190)
T cd05145 155 KPYIIDVSQAVELDH 169 (190)
T ss_pred CEEEEEcccceecCC
Confidence 899999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.9e-20 Score=150.92 Aligned_cols=190 Identities=16% Similarity=0.090 Sum_probs=137.9
Q ss_pred CccceecccCceEEEEEEECCCceEEEEccCCCCCcH-HHHHHHHHHHHHHHhCC-CCcccceeeeEEeCCceEEEEecC
Q 020888 45 SSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDR-LVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLMLITEYL 122 (320)
Q Consensus 45 ~~~~~lg~g~~~~vy~~~~~~~~~~~K~~~~~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~iv~e~~ 122 (320)
.+...|++|+||+||.+...+.+++.+.+........ -....+.+|+++|+++. ++++++++++ +..+++|+|+
T Consensus 5 ~~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred ccceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 4567899999999998887788888877755443322 11236789999999995 5889999886 3468999999
Q ss_pred CCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCC-CCCcEEEeeCCCCcEEEecCCCcccccccCcc-
Q 020888 123 RGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDL-KPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH- 200 (320)
Q Consensus 123 ~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di-~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~- 200 (320)
.|.+|.+..... ...++.|++.+|.++|++| |+|+|| ||.||++ +.++.++|+|||++.........
T Consensus 81 ~G~~L~~~~~~~-------~~~~~~qi~~~L~~lH~~G--IvHrDL~kp~NILv--~~~g~i~LIDFG~A~~~~~~~~~~ 149 (218)
T PRK12274 81 AGAAMYQRPPRG-------DLAYFRAARRLLQQLHRCG--VAHNDLAKEANWLV--QEDGSPAVIDFQLAVRGNPRARWM 149 (218)
T ss_pred cCccHHhhhhhh-------hHHHHHHHHHHHHHHHHCc--CccCCCCCcceEEE--cCCCCEEEEECCCceecCCcchHH
Confidence 999987654221 1357789999999999999 999999 7999999 77889999999999854432210
Q ss_pred ---c---eee--ccCCcccccccCccccCcC-CCC-CchhHHHHHHHHHHHHhCCCCCC
Q 020888 201 ---D---VYK--MTGETGSYRYMAPEVFKHR-KYD-KKVDVFSFAMILYEMLEGEPPLA 249 (320)
Q Consensus 201 ---~---~~~--~~~~~~~~~y~aPE~~~~~-~~~-~~~Di~slG~~l~~ll~g~~p~~ 249 (320)
. ... ......++.++.|+...-- ..+ ...+-++.|+-+|.++|+..+..
T Consensus 150 r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 150 RLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred HHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 0 000 0001245556666654332 334 57788899999999999887754
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.8e-20 Score=160.23 Aligned_cols=272 Identities=24% Similarity=0.290 Sum_probs=182.5
Q ss_pred CCCCCCCCCCCCcCCCCCcccCccceecccCceEEEEEEECC------------------------------C-------
Q 020888 24 PVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG------------------------------T------- 66 (320)
Q Consensus 24 ~~~~~~~~~~~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~------------------------------~------- 66 (320)
+.+-+-..-+.|.++ +|.+...||+|....||.+...+ +
T Consensus 143 hDei~~r~dskFtid----dyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aF 218 (598)
T KOG4158|consen 143 HDEIPNRIDSKFTID----DYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAF 218 (598)
T ss_pred CCcCcchhhcccchh----hhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCcccccc
Confidence 334455555667777 79999999999999999876310 0
Q ss_pred ceEEEEccCC--CCCcHHHHHHHHHHHH-------H-------HHh--------CCCCcccceeeeEE------------
Q 020888 67 PVAIKRILPS--LSDDRLVIQDFRHEVN-------L-------LVK--------LRHPNIVQFLGAVT------------ 110 (320)
Q Consensus 67 ~~~~K~~~~~--~~~~~~~~~~~~~e~~-------~-------l~~--------l~h~~i~~~~~~~~------------ 110 (320)
+.|+|..-.- .......++...+|.- . .+. -+||||+.+++.|-
T Consensus 219 PLAiKmMfN~~~~s~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~ 298 (598)
T KOG4158|consen 219 PLAIKMMFNFEHDSGDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIER 298 (598)
T ss_pred chHHHHhcccccCCchHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhh
Confidence 1344432111 1122233344444331 1 111 24999999887652
Q ss_pred ---------------eCCceEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE
Q 020888 111 ---------------ERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLL 175 (320)
Q Consensus 111 ---------------~~~~~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~ 175 (320)
...++|+||..++. ||.+++..+. .+--+..-++.|+++|+.|||++| +.|+|+|.+||++
T Consensus 299 YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~-~s~r~~~~~laQlLEav~hL~~hg--vAhRDlKSDNiL~ 374 (598)
T KOG4158|consen 299 YPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH-RSYRTGRVILAQLLEAVTHLHKHG--VAHRDLKSDNILL 374 (598)
T ss_pred CcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC-CchHHHHHHHHHHHHHHHHHHHcc--chhhcccccceEE
Confidence 23458999999966 9999998754 455566778999999999999999 9999999999999
Q ss_pred eeCCC--CcEEEecCCCcccccccCccceee--ccCCcccccccCccccCcCC------CCCchhHHHHHHHHHHHHhCC
Q 020888 176 VNSSA--DHLKVGDFGLSKLIKVQNSHDVYK--MTGETGSYRYMAPEVFKHRK------YDKKVDVFSFAMILYEMLEGE 245 (320)
Q Consensus 176 ~~~~~--~~~~L~dfg~~~~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~------~~~~~Di~slG~~l~~ll~g~ 245 (320)
.-+++ ..+++.|||.+-.-..-+-.-.+. .-...|+-.-+|||+.+... .-.++|.|+.|.+.||+++..
T Consensus 375 ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~ 454 (598)
T KOG4158|consen 375 ELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRS 454 (598)
T ss_pred EecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccC
Confidence 44443 468899999875433211111111 11223667789999986432 225899999999999999999
Q ss_pred CCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHH
Q 020888 246 PPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLE 303 (320)
Q Consensus 246 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~ 303 (320)
.||............-+....+..+..+++.+++++..+|+.||.+|++..=....|+
T Consensus 455 NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 455 NPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred CcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHHhHHH
Confidence 9998743222111112222333445668999999999999999999998766655544
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.9e-22 Score=178.44 Aligned_cols=224 Identities=27% Similarity=0.409 Sum_probs=187.1
Q ss_pred ecccCceEEEEEEE-----CCCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCC-CCcccceeeeEEeCCceEEEEecCC
Q 020888 50 IGKGSFGEILKAYW-----RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLMLITEYLR 123 (320)
Q Consensus 50 lg~g~~~~vy~~~~-----~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~iv~e~~~ 123 (320)
+|+|++|.|+++.. .+.-+++|+..+........- ....|-.++...+ |+.+++++..++.+...+++.++..
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 68999999998653 367799998866544433222 4445667777776 9999999999999999999999999
Q ss_pred CCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCcccee
Q 020888 124 GGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 203 (320)
Q Consensus 124 ~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~~~~ 203 (320)
|+.|...+.....++......+...++-+++++|+.| ++|+|+|++||++ +..|.+++.|||.++.......
T Consensus 81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~--iiyrd~k~enill--d~~Ghi~~tdfglske~v~~~~---- 152 (612)
T KOG0603|consen 81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLG--IAYRDYKLENVLL--LLEGHIKLTDFGLSKEAVKEKI---- 152 (612)
T ss_pred cchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhH--HHHhcccccceee--cccCccccCCchhhhHhHhhhh----
Confidence 9999988887778888889999999999999999988 9999999999999 9999999999999886654332
Q ss_pred eccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHH
Q 020888 204 KMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEK 283 (320)
Q Consensus 204 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 283 (320)
.+|+..|+|||+++ ....+.|-||+|++++++++|..||.. +....+.+.... .+..++.+.++++.+
T Consensus 153 ----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~--~p~~l~~~a~~~~~~ 220 (612)
T KOG0603|consen 153 ----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELE--MPRELSAEARSLFRQ 220 (612)
T ss_pred ----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccC--CchhhhHHHHHHHHH
Confidence 27899999999998 778899999999999999999999988 555555554433 345578999999999
Q ss_pred HhhcCCCCCCC
Q 020888 284 CWAADMNQRPS 294 (320)
Q Consensus 284 ~l~~dp~~Rps 294 (320)
++..+|.+|..
T Consensus 221 l~~r~p~nrLg 231 (612)
T KOG0603|consen 221 LFKRNPENRLG 231 (612)
T ss_pred HHhhCHHHHhc
Confidence 99999999953
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=1e-18 Score=144.93 Aligned_cols=136 Identities=24% Similarity=0.406 Sum_probs=114.3
Q ss_pred ceecccCceEEEEEEECCCceEEEEccCCCCCcH-----HHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEecC
Q 020888 48 AIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDR-----LVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYL 122 (320)
Q Consensus 48 ~~lg~g~~~~vy~~~~~~~~~~~K~~~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~ 122 (320)
+.||+|++|.||++.+.+..+++|.......... .....+.+|++++..+.|+++.....++...+..+++|||+
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 81 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI 81 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence 5789999999999999999999997654332221 12246778999999999998887777777777889999999
Q ss_pred CCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcc
Q 020888 123 RGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 192 (320)
Q Consensus 123 ~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~ 192 (320)
+|++|.+++.... . ....++.+++.+|.++|+.| ++|+|++|.||++ + ++.++|+|||.+.
T Consensus 82 ~G~~L~~~~~~~~---~-~~~~i~~~i~~~l~~lH~~~--i~H~Dl~p~Nil~--~-~~~~~liDf~~a~ 142 (211)
T PRK14879 82 EGEPLKDLINSNG---M-EELELSREIGRLVGKLHSAG--IIHGDLTTSNMIL--S-GGKIYLIDFGLAE 142 (211)
T ss_pred CCcCHHHHHHhcc---H-HHHHHHHHHHHHHHHHHhCC--cccCCCCcccEEE--E-CCCEEEEECCccc
Confidence 9999999987542 2 77899999999999999998 9999999999999 5 6789999999875
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.1e-19 Score=146.35 Aligned_cols=139 Identities=18% Similarity=0.217 Sum_probs=105.2
Q ss_pred cCccceecccCceEEEEEEECCCceEEEEccCCCCCcHHHHHHHHHHHHHHHhC-----CCCcccceeeeEEeCC---ce
Q 020888 44 FSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-----RHPNIVQFLGAVTERK---PL 115 (320)
Q Consensus 44 y~~~~~lg~g~~~~vy~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~---~~ 115 (320)
+.-.+.||+|+++.||.....+.. ++|++...... ..+.+.+|++.++.+ .|+||++++++++.+. ..
T Consensus 4 L~~~~~LG~G~~~~Vy~hp~~~~k-~IKv~~~~~~~---~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v 79 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYAHPEDAQR-CIKIVYHRGDG---GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV 79 (210)
T ss_pred cCCcceecCCCceEEEECCCCcCe-EEEEEeccccc---hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence 455689999999999963223444 68877553322 236789999999999 5799999999998763 33
Q ss_pred E-EEEec--CCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHH-HHHhcCCCCeEecCCCCCcEEEeeC--CCCcEEEecCC
Q 020888 116 M-LITEY--LRGGDLHKYLKEKGALSPSTAVNFALDIARGM-AYLHNEPNVIIHRDLKPRNVLLVNS--SADHLKVGDFG 189 (320)
Q Consensus 116 ~-iv~e~--~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l-~~lH~~g~~ivH~di~p~nI~~~~~--~~~~~~L~dfg 189 (320)
+ +|+|| +++++|.+++++. .+++. ..++.+++.++ +|||+++ |+|+||||+||++... .++.++|+|++
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~--IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNR--IVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred EEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 3 78999 4468999999764 46655 35677888777 9999998 9999999999999422 33489999954
Q ss_pred Cc
Q 020888 190 LS 191 (320)
Q Consensus 190 ~~ 191 (320)
.+
T Consensus 155 G~ 156 (210)
T PRK10345 155 GE 156 (210)
T ss_pred CC
Confidence 33
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.1e-19 Score=171.98 Aligned_cols=215 Identities=31% Similarity=0.465 Sum_probs=163.0
Q ss_pred CcCCCCCcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeC
Q 020888 35 WEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER 112 (320)
Q Consensus 35 ~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 112 (320)
+...+...+|..++.+..|++|.||.++++ .+++|+| +.+.. . +++ ||+.+ .
T Consensus 76 s~~~p~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~--------l------ilR-----nilt~------a 129 (1205)
T KOG0606|consen 76 SRRAPSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQN--------L------ILR-----NILTF------A 129 (1205)
T ss_pred cccCCCccccceeEeeccCCCCceeeeeccccccchhhc-ccccc--------h------hhh-----ccccc------c
Confidence 366777889999999999999999999887 7889996 32211 1 111 12221 1
Q ss_pred CceEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcc
Q 020888 113 KPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 192 (320)
Q Consensus 113 ~~~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~ 192 (320)
+..++| |+=...++.-++++... +.+++|+|+.| |+|+|+||+|.++ ..-|.+|+.|||+.+
T Consensus 130 ~npfvv------gDc~tllk~~g~lPvdm--------vla~Eylh~yg--ivhrdlkpdnllI--T~mGhiKlTDfgLsk 191 (1205)
T KOG0606|consen 130 GNPFVV------GDCATLLKNIGPLPVDM--------VLAVEYLHSYG--IVHRDLKPDNLLI--TSMGHIKLTDFGLSK 191 (1205)
T ss_pred CCccee------chhhhhcccCCCCcchh--------hHHhHhhccCC--eecCCCCCCccee--eecccccccchhhhh
Confidence 233343 23344455545555443 77899999988 9999999999999 999999999999987
Q ss_pred cccccCcccee-----------eccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 020888 193 LIKVQNSHDVY-----------KMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA 261 (320)
Q Consensus 193 ~~~~~~~~~~~-----------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~ 261 (320)
........+.+ ..-..++|+.|.|||+.....|....|=|++|+++|+++-|..||.+..+.+...++.
T Consensus 192 ~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~vi 271 (1205)
T KOG0606|consen 192 KGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI 271 (1205)
T ss_pred hhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhh
Confidence 55332221111 1123479999999999999999999999999999999999999999999999988877
Q ss_pred hCCCCCCC-CCCCCHHHHHHHHHHhhcCCCCCC
Q 020888 262 EGHRPFFR-AKGFTPELRELTEKCWAADMNQRP 293 (320)
Q Consensus 262 ~~~~~~~~-~~~~~~~l~~li~~~l~~dp~~Rp 293 (320)
........ ..-++.+.++++.++|..+|..|-
T Consensus 272 sd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 272 SDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred hhhccccccCcCCCHHHHHHHHHHHHhChHhhc
Confidence 66543333 345789999999999999999994
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=6.1e-19 Score=158.73 Aligned_cols=210 Identities=31% Similarity=0.490 Sum_probs=165.6
Q ss_pred HhCCCCcccceeeeEEeCCceEEEEecCCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcE
Q 020888 95 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNV 173 (320)
Q Consensus 95 ~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI 173 (320)
+.+.|.|+.++++.+.++...++|.+||.-|+|.|.+... -.+++.......+.++.||.|+|.-. ..+||.++..|.
T Consensus 2 ~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~-i~~hg~l~s~nC 80 (484)
T KOG1023|consen 2 RQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSP-IGYHGALKSSNC 80 (484)
T ss_pred cccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCc-ceeeeeeccccc
Confidence 5678999999999999999999999999999999999873 46899999999999999999999974 239999999999
Q ss_pred EEeeCCCCcEEEecCCCcccccccCccceeeccCCcccccccCccccCcCC-------CCCchhHHHHHHHHHHHHhCCC
Q 020888 174 LLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRK-------YDKKVDVFSFAMILYEMLEGEP 246 (320)
Q Consensus 174 ~~~~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~Di~slG~~l~~ll~g~~ 246 (320)
++ +....+||.|||+........ .........-..-|.|||.+.+.. .+.+.|+||+|++++|+++...
T Consensus 81 lv--d~~w~lklt~~Gl~~~~~~~~--~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 81 LV--DSRWVLKLTDFGLNSLLEETA--EPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred ee--eeeEEEEechhhhcccccccc--cccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 99 999999999999887664310 111111122345689999987642 4678999999999999999999
Q ss_pred CCCCC----ChHHHHHHHHhCCCCCCCC-----CCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcC
Q 020888 247 PLANY----EPYEAAKYVAEGHRPFFRA-----KGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETL 309 (320)
Q Consensus 247 p~~~~----~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 309 (320)
||... ++.+....+..+...++.+ ...++++..++.+||..+|+.||+++++...+..+....
T Consensus 157 ~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~ 228 (484)
T KOG1023|consen 157 PFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGG 228 (484)
T ss_pred ccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcccc
Confidence 99763 2333444444423332332 245668999999999999999999999999888877654
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.6e-18 Score=141.23 Aligned_cols=133 Identities=26% Similarity=0.398 Sum_probs=108.1
Q ss_pred eecccCceEEEEEEECCCceEEEEccCCCCCc-----HHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEecCC
Q 020888 49 IIGKGSFGEILKAYWRGTPVAIKRILPSLSDD-----RLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLR 123 (320)
Q Consensus 49 ~lg~g~~~~vy~~~~~~~~~~~K~~~~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 123 (320)
.||+|++|.||++...+..+++|......... .....++.+|++++..+.++++....-++...+..+++|||++
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~ 80 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE 80 (199)
T ss_pred CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence 47999999999999889999999865432211 1223667889999999988876655555556667799999999
Q ss_pred CCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccc
Q 020888 124 GGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 193 (320)
Q Consensus 124 ~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~ 193 (320)
|++|.+.+..... .++.+++.+|.+||+.| ++|+|++|.||++ + ++.++++|||.+..
T Consensus 81 g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~g--i~H~Dl~~~Nil~--~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 81 GKPLKDVIEEGND-------ELLREIGRLVGKLHKAG--IVHGDLTTSNIIV--R-DDKLYLIDFGLGKY 138 (199)
T ss_pred CccHHHHHhhcHH-------HHHHHHHHHHHHHHHCC--eecCCCCcceEEE--E-CCcEEEEECCCCcC
Confidence 9999998765321 78899999999999999 9999999999999 5 78999999998753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.5e-18 Score=145.70 Aligned_cols=148 Identities=19% Similarity=0.181 Sum_probs=112.7
Q ss_pred CCCcccCccceecccCceEEEEEE-E--CCCceEEEEccCCCCCc---------------------HHHHHHHHHHHHHH
Q 020888 39 PSELDFSSSAIIGKGSFGEILKAY-W--RGTPVAIKRILPSLSDD---------------------RLVIQDFRHEVNLL 94 (320)
Q Consensus 39 ~~~~~y~~~~~lg~g~~~~vy~~~-~--~~~~~~~K~~~~~~~~~---------------------~~~~~~~~~e~~~l 94 (320)
..+.-|.+.+.||+|++|.||++. + +++.||+|.+....... ......+..|++.+
T Consensus 25 ~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L 104 (237)
T smart00090 25 NRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNL 104 (237)
T ss_pred hcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHH
Confidence 345568899999999999999998 3 48999999886543211 00123467899999
Q ss_pred HhCCCC--cccceeeeEEeCCceEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 020888 95 VKLRHP--NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRN 172 (320)
Q Consensus 95 ~~l~h~--~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~n 172 (320)
.++.+. .++++++. . ..++||||++|.+|.........+.......++.|++.++.+||+.| .++|+||||+|
T Consensus 105 ~~L~~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g-~iiH~Dikp~N 179 (237)
T smart00090 105 QRLYEAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEG-ELVHGDLSEYN 179 (237)
T ss_pred HHHHhcCCCCCeeeEe---c-CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcC-CEEeCCCChhh
Confidence 999753 33444432 2 35899999999888776544445677778899999999999999953 39999999999
Q ss_pred EEEeeCCCCcEEEecCCCcccc
Q 020888 173 VLLVNSSADHLKVGDFGLSKLI 194 (320)
Q Consensus 173 I~~~~~~~~~~~L~dfg~~~~~ 194 (320)
|++ + ++.++|+|||.+...
T Consensus 180 Ili--~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 180 ILV--H-DGKVVIIDVSQSVEL 198 (237)
T ss_pred EEE--E-CCCEEEEEChhhhcc
Confidence 999 5 678999999987644
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.7e-17 Score=153.70 Aligned_cols=147 Identities=27% Similarity=0.384 Sum_probs=116.6
Q ss_pred CCcCCCCC-cccCccceecccCceEEEEEEECCCceEEEEccCCCCC-----cHHHHHHHHHHHHHHHhCCCCcccceee
Q 020888 34 DWEIDPSE-LDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSD-----DRLVIQDFRHEVNLLVKLRHPNIVQFLG 107 (320)
Q Consensus 34 ~~~~~~~~-~~y~~~~~lg~g~~~~vy~~~~~~~~~~~K~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 107 (320)
.|...... ..|...+.||+|++|+||++.+.+..+++|........ .....+.+.+|+++++.++|++++.+..
T Consensus 324 ~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~ 403 (535)
T PRK09605 324 TWIKEEEVKRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVI 403 (535)
T ss_pred eeccccccccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEE
Confidence 34444433 34577899999999999999888777776654322111 1122356889999999999999988777
Q ss_pred eEEeCCceEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEec
Q 020888 108 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGD 187 (320)
Q Consensus 108 ~~~~~~~~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~d 187 (320)
+.......++||||++|++|.+++. ....++.+++.+|.+||+.| ++|||+||+||++ + ++.++|+|
T Consensus 404 ~~~~~~~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~g--iiHrDlkp~NILl--~-~~~~~liD 470 (535)
T PRK09605 404 YDVDPEEKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAG--IVHGDLTTSNFIV--R-DDRLYLID 470 (535)
T ss_pred EEEeCCCCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCC--CccCCCChHHEEE--E-CCcEEEEe
Confidence 7777777899999999999999886 34678999999999999998 9999999999999 3 56899999
Q ss_pred CCCccc
Q 020888 188 FGLSKL 193 (320)
Q Consensus 188 fg~~~~ 193 (320)
||++..
T Consensus 471 FGla~~ 476 (535)
T PRK09605 471 FGLGKY 476 (535)
T ss_pred Cccccc
Confidence 998864
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.74 E-value=7.8e-19 Score=155.57 Aligned_cols=173 Identities=27% Similarity=0.434 Sum_probs=133.7
Q ss_pred CceEEEEecCCCCCHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCC
Q 020888 113 KPLMLITEYLRGGDLHKYLKEK---GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFG 189 (320)
Q Consensus 113 ~~~~iv~e~~~~~~L~~~~~~~---~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg 189 (320)
..+||.|++|...+|.+++... ...++...+.++.|+..+++| +| .+|+|+||.||++ ..+..++|.|||
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~--~ihrdlkp~nif~--~~d~q~kIgDFg 401 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG--LIHRDLKPSNIFF--SDDDQLKIGDFG 401 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc--chhhhcccccccc--ccchhhhhhhhh
Confidence 4579999999999999999753 246888999999999999999 77 9999999999999 677789999999
Q ss_pred CcccccccC--ccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCC
Q 020888 190 LSKLIKVQN--SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRP 266 (320)
Q Consensus 190 ~~~~~~~~~--~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~ 266 (320)
+........ ...........+|+.|++||++.+..++.++|||+||++++|++. =...+. .......+..+..+
T Consensus 402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e---r~~t~~d~r~g~ip 478 (516)
T KOG1033|consen 402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE---RIATLTDIRDGIIP 478 (516)
T ss_pred heeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH---HHHhhhhhhcCCCC
Confidence 988766543 112234556789999999999999999999999999999999998 222222 22333334444444
Q ss_pred CCCCCCCCHHHHHHHHHHhhcCCCCCCCHH
Q 020888 267 FFRAKGFTPELRELTEKCWAADMNQRPSFL 296 (320)
Q Consensus 267 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ 296 (320)
+..... .+.-.+|+.+|+...|.+||++.
T Consensus 479 ~~~~~d-~p~e~~ll~~lls~~p~~RP~~~ 507 (516)
T KOG1033|consen 479 PEFLQD-YPEEYTLLQQLLSPSPEERPSAI 507 (516)
T ss_pred hHHhhc-CcHHHHHHHHhcCCCcccCchHH
Confidence 222222 33456999999999999999443
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.2e-17 Score=135.49 Aligned_cols=141 Identities=20% Similarity=0.177 Sum_probs=108.0
Q ss_pred cccCccceecccCceEEEEEEEC-CCceEEEEccCCCCCcH-------------------HHHHHHHHHHHHHHhCCCCc
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDR-------------------LVIQDFRHEVNLLVKLRHPN 101 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~-~~~~~~K~~~~~~~~~~-------------------~~~~~~~~e~~~l~~l~h~~ 101 (320)
..|.+.+.||.|++|.||++... ++.+++|++........ ........|+..+..+.+.+
T Consensus 15 ~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 15 VVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred chhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 35888899999999999999874 89999998754321100 11123667888888887663
Q ss_pred --ccceeeeEEeCCceEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCC
Q 020888 102 --IVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS 179 (320)
Q Consensus 102 --i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~ 179 (320)
++++++ ....+++|||++|++|.+.... .....++.+++.++.++|+.| ++|+||+|+||++ +.
T Consensus 95 i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~g--i~H~Dl~p~Nill--~~ 160 (198)
T cd05144 95 FPVPKPID----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHG--IIHGDLSEFNILV--DD 160 (198)
T ss_pred CCCCceee----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCC--CCcCCCCcccEEE--cC
Confidence 444443 2345899999999999876431 235678899999999999998 9999999999999 77
Q ss_pred CCcEEEecCCCcccccc
Q 020888 180 ADHLKVGDFGLSKLIKV 196 (320)
Q Consensus 180 ~~~~~L~dfg~~~~~~~ 196 (320)
++.++|+|||.+.....
T Consensus 161 ~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 161 DEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CCcEEEEECCccccCCC
Confidence 88999999999865543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.71 E-value=2e-16 Score=133.05 Aligned_cols=138 Identities=22% Similarity=0.237 Sum_probs=106.5
Q ss_pred cceec-ccCceEEEEEEECCCceEEEEccCCCC----------CcHHHHHHHHHHHHHHHhCCCCcc--cceeeeEEeC-
Q 020888 47 SAIIG-KGSFGEILKAYWRGTPVAIKRILPSLS----------DDRLVIQDFRHEVNLLVKLRHPNI--VQFLGAVTER- 112 (320)
Q Consensus 47 ~~~lg-~g~~~~vy~~~~~~~~~~~K~~~~~~~----------~~~~~~~~~~~e~~~l~~l~h~~i--~~~~~~~~~~- 112 (320)
...|| .|+.|+||.+...+..+++|.+..... ........+.+|++++..+.|+++ ++++++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred CceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 45787 899999999998899999998743211 111233678889999999988775 6667664332
Q ss_pred Cc---eEEEEecCCC-CCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecC
Q 020888 113 KP---LMLITEYLRG-GDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF 188 (320)
Q Consensus 113 ~~---~~iv~e~~~~-~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~df 188 (320)
.. .++|+|+++| .+|.+++.. .+++... +.+++.+|.+||+.| |+|+||||.||++ +.++.++|+||
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~G--I~HrDlkp~NILv--~~~~~v~LIDf 186 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAG--VYHADLNAHNILL--DPDGKFWLIDF 186 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCC--CCCCCCCchhEEE--cCCCCEEEEEC
Confidence 22 2599999987 699998875 3455543 568999999999999 9999999999999 77778999999
Q ss_pred CCccc
Q 020888 189 GLSKL 193 (320)
Q Consensus 189 g~~~~ 193 (320)
|.+..
T Consensus 187 g~~~~ 191 (239)
T PRK01723 187 DRGEL 191 (239)
T ss_pred CCccc
Confidence 98764
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.4e-16 Score=129.58 Aligned_cols=139 Identities=20% Similarity=0.219 Sum_probs=98.1
Q ss_pred cceecccCceEEEEEEEC-CCceEEEEccCCCCCcHHHHHH---------------------HHHHHHHHHhCCCC--cc
Q 020888 47 SAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQD---------------------FRHEVNLLVKLRHP--NI 102 (320)
Q Consensus 47 ~~~lg~g~~~~vy~~~~~-~~~~~~K~~~~~~~~~~~~~~~---------------------~~~e~~~l~~l~h~--~i 102 (320)
.+.||+|++|+||++.+. ++.||+|++............. ...|...+..+.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 468999999999999987 8999999886543322211111 13556666666433 24
Q ss_pred cceeeeEEeCCceEEEEecCCCCCHHH-HHHHhCCCCHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCcEEEeeCCC
Q 020888 103 VQFLGAVTERKPLMLITEYLRGGDLHK-YLKEKGALSPSTAVNFALDIARGMAYLHN-EPNVIIHRDLKPRNVLLVNSSA 180 (320)
Q Consensus 103 ~~~~~~~~~~~~~~iv~e~~~~~~L~~-~~~~~~~l~~~~~~~i~~~l~~~l~~lH~-~g~~ivH~di~p~nI~~~~~~~ 180 (320)
.++++. ...+++|||++++++.. .+.... .. .....++.+++.++.++|. .| ++|+||+|+||++ + +
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-~~-~~~~~~~~~~~~~l~~lh~~~~--ivH~Dl~p~Nili--~-~ 150 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-LL-EDPEELYDQILELMRKLYREAG--LVHGDLSEYNILV--D-D 150 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh-hc-ccHHHHHHHHHHHHHHHhhccC--cCcCCCChhhEEE--E-C
Confidence 444432 24689999998844321 122111 11 5678899999999999999 89 9999999999999 5 7
Q ss_pred CcEEEecCCCcccccc
Q 020888 181 DHLKVGDFGLSKLIKV 196 (320)
Q Consensus 181 ~~~~L~dfg~~~~~~~ 196 (320)
+.++|+|||.+.....
T Consensus 151 ~~~~liDfg~a~~~~~ 166 (187)
T cd05119 151 GKVYIIDVPQAVEIDH 166 (187)
T ss_pred CcEEEEECcccccccC
Confidence 8999999999875543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.67 E-value=8.2e-16 Score=120.14 Aligned_cols=133 Identities=22% Similarity=0.242 Sum_probs=110.6
Q ss_pred ccceecccCceEEEEEEECCCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCC--CcccceeeeEEeCCceEEEEecCC
Q 020888 46 SSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH--PNIVQFLGAVTERKPLMLITEYLR 123 (320)
Q Consensus 46 ~~~~lg~g~~~~vy~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~iv~e~~~ 123 (320)
+++.+|.|.++.||++...+..+++|....... ...+.+|+..+..+.+ .++++++.+....+..++++||++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~ 76 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIE 76 (155)
T ss_pred cceecccccccceEEEEecCCeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecC
Confidence 457899999999999999888999998755433 2567889999999965 588888888887788999999998
Q ss_pred CCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCC-CCeEecCCCCCcEEEeeCCCCcEEEecCCCcc
Q 020888 124 GGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP-NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 192 (320)
Q Consensus 124 ~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g-~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~ 192 (320)
|..+..+ +......++.++++++..+|... ..++|+|++|.||++ ++.+.++++||+.+.
T Consensus 77 g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~--~~~~~~~l~Df~~~~ 137 (155)
T cd05120 77 GETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILV--DDGKILGIIDWEYAG 137 (155)
T ss_pred CeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEE--ECCcEEEEEeccccc
Confidence 8777654 45566778899999999999951 129999999999999 667899999999875
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.1e-17 Score=157.10 Aligned_cols=253 Identities=25% Similarity=0.362 Sum_probs=195.4
Q ss_pred CcccCccceecccCceEEEEEEEC---CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCC-CCcccceeeeEEeCCceE
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR---GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLM 116 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~---~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 116 (320)
...|.+.+-||+|+++.|-..... ...+++|.+.... ........+..|..+-..+. |.|++.+++...+.+..+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 446778888999999999887764 3446666554332 22333466677888888886 999999999999999999
Q ss_pred EEEecCCCCCHHHHH-HHhC-CCCHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEEeeCCCC-cEEEecCCCcc
Q 020888 117 LITEYLRGGDLHKYL-KEKG-ALSPSTAVNFALDIARGMAYLH-NEPNVIIHRDLKPRNVLLVNSSAD-HLKVGDFGLSK 192 (320)
Q Consensus 117 iv~e~~~~~~L~~~~-~~~~-~l~~~~~~~i~~~l~~~l~~lH-~~g~~ivH~di~p~nI~~~~~~~~-~~~L~dfg~~~ 192 (320)
+..++..|+++.+.+ .... ..+....-.++.|+..++.|+| ..+ +.|+|++|+|.++ +..+ .+++.|||++.
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~--~~h~~ikP~n~~l--~~s~~~l~~~df~~At 173 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG--VTHRDIKPSNSLL--DESGSALKIADFGLAT 173 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc--cccCCCCCccchh--ccCCCcccCCCchhhc
Confidence 999999999999888 4433 5677777889999999999999 877 9999999999999 7777 99999999999
Q ss_pred cccc-cCccceeeccCCcc-cccccCccccCcC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHhCC--CC
Q 020888 193 LIKV-QNSHDVYKMTGETG-SYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAA-KYVAEGH--RP 266 (320)
Q Consensus 193 ~~~~-~~~~~~~~~~~~~~-~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~-~~~~~~~--~~ 266 (320)
.... .+.. ......+| ++.|.|||...+. ...+..|+||.|+++..+++|..||......... ....... ..
T Consensus 174 ~~~~~~g~~--~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 251 (601)
T KOG0590|consen 174 AYRNKNGAE--RSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFT 251 (601)
T ss_pred cccccCCcc--eeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccc
Confidence 8876 3322 23334566 9999999999885 4568999999999999999999999765433211 1111111 12
Q ss_pred CCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 020888 267 FFRAKGFTPELRELTEKCWAADMNQRPSFLDILK 300 (320)
Q Consensus 267 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 300 (320)
......++....+++..++..+|..|.+.+++-.
T Consensus 252 ~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 252 QLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred cCccccCChhhhhcccccccCCchhccccccccc
Confidence 2333567888999999999999999999988744
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.61 E-value=2.2e-15 Score=126.50 Aligned_cols=204 Identities=24% Similarity=0.309 Sum_probs=142.6
Q ss_pred HHHHHhCCCCcccceeeeEEeC-----CceEEEEecCCCCCHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 020888 91 VNLLVKLRHPNIVQFLGAVTER-----KPLMLITEYLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLHNEPN 161 (320)
Q Consensus 91 ~~~l~~l~h~~i~~~~~~~~~~-----~~~~iv~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~~l~~~l~~lH~~g~ 161 (320)
+..|.++.|.|+++++.++.+. ....++.||+.-|+|..++++ +..+......+|+-||+.||.|||...+
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~P 197 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCC
Confidence 4555666799999999998543 446888999999999999975 4468888899999999999999999999
Q ss_pred CeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHH
Q 020888 162 VIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEM 241 (320)
Q Consensus 162 ~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l 241 (320)
+++||++..+.|++ ..++-+++.--.....-...............+.++|.+||.=.....+-++|||++|.+..++
T Consensus 198 piihgnlTc~tifi--q~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem 275 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFI--QHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM 275 (458)
T ss_pred ccccCCcchhheee--cCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence 99999999999999 7888888753221111000000001111112356789999986666777899999999999999
Q ss_pred HhCCCCCCC-CChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 242 LEGEPPLAN-YEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 242 l~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
..+..--.+ .........+..-.... . +.-=++++..|++..|..||++..++.|
T Consensus 276 ailEiq~tnseS~~~~ee~ia~~i~~l--e---n~lqr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 276 AILEIQSTNSESKVEVEENIANVIIGL--E---NGLQRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred HHheeccCCCcceeehhhhhhhheeec--c---CccccCcCcccccCCCCCCcchhhhhcC
Confidence 887643221 12222221121111111 1 1223688999999999999999998766
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.3e-15 Score=137.46 Aligned_cols=249 Identities=24% Similarity=0.273 Sum_probs=190.9
Q ss_pred ccCccceecc--cCceEEEEEEE----CCCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCC-CCcccceeeeEEeCCce
Q 020888 43 DFSSSAIIGK--GSFGEILKAYW----RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPL 115 (320)
Q Consensus 43 ~y~~~~~lg~--g~~~~vy~~~~----~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 115 (320)
.+.+.+.+|. |.+|.+|.+.. .+..+++|.-.......... ..-.+|+...+.++ |.+.++.+..+..++..
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~-~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDS-KRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCcccc-ccccchhhcccccCccccccccCcccccCCcc
Confidence 5678889999 99999998776 26778888654444333322 23334666777774 89999999999999999
Q ss_pred EEEEecCCCCCHHHHHHHhCC-CCHHHHHHHHHHHHH----HHHHHhcCCCCeEecCCCCCcEEEeeCCC-CcEEEecCC
Q 020888 116 MLITEYLRGGDLHKYLKEKGA-LSPSTAVNFALDIAR----GMAYLHNEPNVIIHRDLKPRNVLLVNSSA-DHLKVGDFG 189 (320)
Q Consensus 116 ~iv~e~~~~~~L~~~~~~~~~-l~~~~~~~i~~~l~~----~l~~lH~~g~~ivH~di~p~nI~~~~~~~-~~~~L~dfg 189 (320)
|+-+|.+ +.+|..+...... ++...++..+.+..+ ||.++|..+ ++|.|++|+||+. ..+ ...+++|||
T Consensus 194 fiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~--~~~~~~kp~~i~~--~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 194 FIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN--IVHDDLKPANIFT--TSDWTSCKLTDFG 268 (524)
T ss_pred eeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCc--ccccccchhheec--ccccceeecCCcc
Confidence 9999988 5699998876444 888999999999999 999999988 9999999999999 555 789999999
Q ss_pred CcccccccCccceeeccCC-cccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCC--ChHHHHHHHHhCCCC
Q 020888 190 LSKLIKVQNSHDVYKMTGE-TGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANY--EPYEAAKYVAEGHRP 266 (320)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~-~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~--~~~~~~~~~~~~~~~ 266 (320)
+...+..+.....+..... .+...|++||..+ +.++..+|+|+||.++.+..+|..+.... ..+.. +.....+
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~---~r~~~ip 344 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQ---LRQGYIP 344 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCCCccc---cccccCc
Confidence 9998887765444443322 5778899999865 56788899999999999998887665433 22222 2222233
Q ss_pred CCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 267 FFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 267 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
.......+.+++..+.+|++.++..|++.+.+..+
T Consensus 345 ~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 345 LEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred hhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 33334567888899999999999999998887653
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.57 E-value=2.4e-13 Score=124.41 Aligned_cols=163 Identities=23% Similarity=0.335 Sum_probs=123.2
Q ss_pred CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEecCCCCCHHHHHHHhCCCCHHHHHH
Q 020888 65 GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVN 144 (320)
Q Consensus 65 ~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~ 144 (320)
+.++.+........ .....+.+.++.++.++||+|+++++.++.++..|+|+|.+ . .|..++++.+ ...+..
T Consensus 37 ~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV-~-Pl~~~lk~l~---~~~v~~ 108 (690)
T KOG1243|consen 37 GGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV-R-PLETVLKELG---KEEVCL 108 (690)
T ss_pred CCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc-c-cHHHHHHHhH---HHHHHH
Confidence 66677665544333 34467888999999999999999999999999999999987 3 7888888743 666777
Q ss_pred HHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCccceeeccCCcccccccCccccCcCC
Q 020888 145 FALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRK 224 (320)
Q Consensus 145 i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 224 (320)
-++||+.||.+||+. ..++||||.-+.|+| +..|.++|++|..+......+. +.........|..|+......
T Consensus 109 Gl~qIl~AL~FL~~d-~~lvHgNv~~~SVfV--n~~GeWkLggle~v~~~~~~~~----~~~~~~~~~s~~~P~~~~~s~ 181 (690)
T KOG1243|consen 109 GLFQILAALSFLNDD-CNLVHGNVCKDSVFV--NESGEWKLGGLELVSKASGFNA----PAKSLYLIESFDDPEEIDPSE 181 (690)
T ss_pred HHHHHHHHHHHHhcc-CCeeeccEeeeeEEE--cCCCcEEEeeeEEEeccccCCc----ccccchhhhcccChhhcCccc
Confidence 789999999999855 239999999999999 9999999999998865543221 001111122355555443222
Q ss_pred CCCchhHHHHHHHHHHHHhC
Q 020888 225 YDKKVDVFSFAMILYEMLEG 244 (320)
Q Consensus 225 ~~~~~Di~slG~~l~~ll~g 244 (320)
-..|.|.|||++++++.|
T Consensus 182 --~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 --WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred --cchhhhhHHHHHHHHhCc
Confidence 346999999999999999
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.51 E-value=3.3e-12 Score=116.71 Aligned_cols=142 Identities=20% Similarity=0.283 Sum_probs=95.8
Q ss_pred cceecccCceEEEEEEEC-CCceEEEEccCCCCCcHHH---------------------------HH----------HHH
Q 020888 47 SAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLV---------------------------IQ----------DFR 88 (320)
Q Consensus 47 ~~~lg~g~~~~vy~~~~~-~~~~~~K~~~~~~~~~~~~---------------------------~~----------~~~ 88 (320)
.+.||.|+.|+||++... |+.||||+..+........ .+ .+.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 468999999999999875 8999999986643211100 00 133
Q ss_pred HHHHHHHhCC----CCcccceeeeE-EeCCceEEEEecCCCCCHHHHHHHh-CCCCHHHHHHHHHHHHH-HHHHHhcCCC
Q 020888 89 HEVNLLVKLR----HPNIVQFLGAV-TERKPLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIAR-GMAYLHNEPN 161 (320)
Q Consensus 89 ~e~~~l~~l~----h~~i~~~~~~~-~~~~~~~iv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~l~~-~l~~lH~~g~ 161 (320)
+|.+.+.++. +..-+.+-.++ ......++||||++|++|.++.... ...+ ...++..++. .+..+|..|
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g- 277 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDG- 277 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCC-
Confidence 3444444442 22222222222 2344578999999999999876532 1222 2345556655 467899988
Q ss_pred CeEecCCCCCcEEEeeCCCCcEEEecCCCccccc
Q 020888 162 VIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 195 (320)
Q Consensus 162 ~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~ 195 (320)
++|+|++|.||++ +.++.++++|||++..+.
T Consensus 278 -~~H~D~hPgNilv--~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 278 -FFHADLHPGNIFV--LKDGKIIALDFGIVGRLS 308 (437)
T ss_pred -ceeCCCCcccEEE--CCCCcEEEEeCCCeeECC
Confidence 9999999999999 788899999999987553
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.47 E-value=3.4e-13 Score=107.71 Aligned_cols=129 Identities=19% Similarity=0.167 Sum_probs=94.9
Q ss_pred cceecccCceEEEEEEECCCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcc-cceeeeEEeCCceEEEEecCCCC
Q 020888 47 SAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI-VQFLGAVTERKPLMLITEYLRGG 125 (320)
Q Consensus 47 ~~~lg~g~~~~vy~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~iv~e~~~~~ 125 (320)
++.++.|..+.||++...+..+++|........ ...+..|++.++.+.+.++ ++++.... ...++||||++|.
T Consensus 3 ~~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~~----~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~ 76 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVANKKYVVRIPGNGTEL----LINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGS 76 (170)
T ss_pred eeecCCcccCceEEEEECCeEEEEEeCCCCccc----ccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCC
Confidence 467899999999999988999999987544321 1345678888888854443 44554432 3458999999998
Q ss_pred CHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCC---CeEecCCCCCcEEEeeCCCCcEEEecCCCcc
Q 020888 126 DLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPN---VIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 192 (320)
Q Consensus 126 ~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~---~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~ 192 (320)
++.+. . .. ...++.+++.+|..||..+. .++|||++|.||++ + ++.++++||+.+.
T Consensus 77 ~l~~~-~----~~---~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~--~-~~~~~liDf~~a~ 135 (170)
T cd05151 77 ELLTE-D----FS---DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLL--D-DGRLWLIDWEYAG 135 (170)
T ss_pred ccccc-c----cc---CHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEE--E-CCeEEEEeccccc
Confidence 87653 1 11 12456789999999999861 14999999999999 5 5679999999764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.47 E-value=9.6e-13 Score=106.22 Aligned_cols=141 Identities=19% Similarity=0.163 Sum_probs=101.6
Q ss_pred cceecccCceEEEEEEEC--------CCceEEEEccCCCCCc-------------------HHHHHHHH----HHHHHHH
Q 020888 47 SAIIGKGSFGEILKAYWR--------GTPVAIKRILPSLSDD-------------------RLVIQDFR----HEVNLLV 95 (320)
Q Consensus 47 ~~~lg~g~~~~vy~~~~~--------~~~~~~K~~~~~~~~~-------------------~~~~~~~~----~e~~~l~ 95 (320)
...||.|-.+.||.+... +..+|+|++......- .+....+. +|++.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 357899999999999754 3689999876432110 11123344 8999999
Q ss_pred hCCC--CcccceeeeEEeCCceEEEEecCCCCCHH-HHHHHhCCCCHHHHHHHHHHHHHHHHHH-hcCCCCeEecCCCCC
Q 020888 96 KLRH--PNIVQFLGAVTERKPLMLITEYLRGGDLH-KYLKEKGALSPSTAVNFALDIARGMAYL-HNEPNVIIHRDLKPR 171 (320)
Q Consensus 96 ~l~h--~~i~~~~~~~~~~~~~~iv~e~~~~~~L~-~~~~~~~~l~~~~~~~i~~~l~~~l~~l-H~~g~~ivH~di~p~ 171 (320)
++.. -.+++++++ ..-++||||+.++.+. ..++. ..++......+..+++.++..+ |+.| ++|||+++.
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-~~~~~~~~~~i~~~i~~~l~~l~H~~g--lVHGDLs~~ 154 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-AKLNDEEMKNAYYQVLSMMKQLYKECN--LVHADLSEY 154 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-cccCHHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHH
Confidence 9853 456667764 4568999999764342 22322 2455666778889999999998 8988 999999999
Q ss_pred cEEEeeCCCCcEEEecCCCccccccc
Q 020888 172 NVLLVNSSADHLKVGDFGLSKLIKVQ 197 (320)
Q Consensus 172 nI~~~~~~~~~~~L~dfg~~~~~~~~ 197 (320)
||++ . ++.+.|+||+.+.....+
T Consensus 155 NIL~--~-~~~v~iIDF~qav~~~hp 177 (197)
T cd05146 155 NMLW--H-DGKVWFIDVSQSVEPTHP 177 (197)
T ss_pred HEEE--E-CCcEEEEECCCceeCCCC
Confidence 9999 3 467999999998866543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.46 E-value=2e-12 Score=101.05 Aligned_cols=133 Identities=24% Similarity=0.363 Sum_probs=103.5
Q ss_pred ceecccCceEEEEEEECCCceEEEEc-cCCCCCc----HHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEecC
Q 020888 48 AIIGKGSFGEILKAYWRGTPVAIKRI-LPSLSDD----RLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYL 122 (320)
Q Consensus 48 ~~lg~g~~~~vy~~~~~~~~~~~K~~-~~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~ 122 (320)
..+++|+.+.+|.+.+.+.++++|.- ++..... .-...+-.+|.+++.++.-.++.-..=+..+.+...|+|||+
T Consensus 2 ~~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred chhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 35789999999999888888888844 3332222 223456778999999998767766666666667778999999
Q ss_pred CCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcc
Q 020888 123 RGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 192 (320)
Q Consensus 123 ~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~ 192 (320)
+|..|.+.+... ...++..+-..+.-||..| |+|||+.++||++ .. +.+.++|||++.
T Consensus 82 ~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~g--ivHGDLTtsNiIl--~~-~~i~~IDfGLg~ 139 (204)
T COG3642 82 EGELLKDALEEA-------RPDLLREVGRLVGKLHKAG--IVHGDLTTSNIIL--SG-GRIYFIDFGLGE 139 (204)
T ss_pred CChhHHHHHHhc-------chHHHHHHHHHHHHHHhcC--eecCCCccceEEE--eC-CcEEEEECCccc
Confidence 999999999875 1456667777788999999 9999999999999 33 359999999986
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.43 E-value=5.9e-12 Score=116.57 Aligned_cols=141 Identities=18% Similarity=0.256 Sum_probs=89.4
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCc---------------------------H----HHHHH---
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDD---------------------------R----LVIQD--- 86 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~---------------------------~----~~~~~--- 86 (320)
.|.. +.||+|+.|+||++..+ |+.||||+..+..... . +-.+.
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ 199 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD 199 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence 4666 79999999999999974 7999999997653110 0 01112
Q ss_pred ---HHHHHHHHHhCC----CCcccceeeeEE-eCCceEEEEecCCCCCHHHHH--HHhC----CCCHHHHHHHHHHHHHH
Q 020888 87 ---FRHEVNLLVKLR----HPNIVQFLGAVT-ERKPLMLITEYLRGGDLHKYL--KEKG----ALSPSTAVNFALDIARG 152 (320)
Q Consensus 87 ---~~~e~~~l~~l~----h~~i~~~~~~~~-~~~~~~iv~e~~~~~~L~~~~--~~~~----~l~~~~~~~i~~~l~~~ 152 (320)
+.+|...+.++. +...+.+-.++. -....++||||++|+.|.++- ...+ .+....+..++.
T Consensus 200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~----- 274 (537)
T PRK04750 200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFT----- 274 (537)
T ss_pred hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHH-----
Confidence 223333333331 222233323332 245568999999999998753 3322 122223333333
Q ss_pred HHHHhcCCCCeEecCCCCCcEEEeeCCCC----cEEEecCCCccccc
Q 020888 153 MAYLHNEPNVIIHRDLKPRNVLLVNSSAD----HLKVGDFGLSKLIK 195 (320)
Q Consensus 153 l~~lH~~g~~ivH~di~p~nI~~~~~~~~----~~~L~dfg~~~~~~ 195 (320)
.+...| ++|+|++|.||++ +.++ .++++|||++..+.
T Consensus 275 --Qif~~G--ffHaDpHPGNIlv--~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 275 --QVFRDG--FFHADMHPGNIFV--SYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred --HHHhCC--eeeCCCChHHeEE--ecCCCCCCeEEEEecceEEECC
Confidence 345678 9999999999999 6666 89999999887553
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.41 E-value=5.1e-12 Score=98.42 Aligned_cols=146 Identities=22% Similarity=0.293 Sum_probs=108.8
Q ss_pred ccceecccCceEEEEEEECCCceEEEE-ccCCCCCc----HHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEe
Q 020888 46 SSAIIGKGSFGEILKAYWRGTPVAIKR-ILPSLSDD----RLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120 (320)
Q Consensus 46 ~~~~lg~g~~~~vy~~~~~~~~~~~K~-~~~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 120 (320)
...++.+|+.+.|+++.+.++..++|. +.+..... .-..++..+|++.|.++.--+|.-..=++.+...-.+.||
T Consensus 11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME 90 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME 90 (229)
T ss_pred cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence 567889999999999999999988883 33333322 2334678899999999876566655555555556678899
Q ss_pred cCCC-CCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCC-CcEEEecCCCccc
Q 020888 121 YLRG-GDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSA-DHLKVGDFGLSKL 193 (320)
Q Consensus 121 ~~~~-~~L~~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~-~~~~L~dfg~~~~ 193 (320)
|++| .++.+++... ..........++..+-+.+.-||..+ |+|||+..+||++..+.+ -.+.|+|||++..
T Consensus 91 ~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd--iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 91 FIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND--IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred eccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC--eecccccccceEEecCCCcCceEEEeecchhc
Confidence 9977 5888888753 22333333678889999999999988 999999999999943333 2468999998753
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.39 E-value=3.8e-11 Score=104.73 Aligned_cols=249 Identities=16% Similarity=0.213 Sum_probs=168.3
Q ss_pred CccceecccCceEEEEEEECCCceEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcccc----eeeeE---EeCCceE
Q 020888 45 SSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQ----FLGAV---TERKPLM 116 (320)
Q Consensus 45 ~~~~~lg~g~~~~vy~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~----~~~~~---~~~~~~~ 116 (320)
.....||+|+.+.+|..-.- ...+.|+++....... .+-++.|... .||-+-. ..... ..+...-
T Consensus 14 ~~gr~LgqGgea~ly~l~e~-~d~VAKIYh~Pppa~~------aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iG 86 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEV-RDQVAKIYHAPPPAAQ------AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIG 86 (637)
T ss_pred CCCccccCCccceeeecchh-hchhheeecCCCchHH------HHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeE
Confidence 44578999999999976432 3345576755433211 1123444444 4553322 11111 1222366
Q ss_pred EEEecCCCC-CHHHHHH------HhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCC
Q 020888 117 LITEYLRGG-DLHKYLK------EKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFG 189 (320)
Q Consensus 117 iv~e~~~~~-~L~~~~~------~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg 189 (320)
++|+.++|. .+..+.+ ..+..+|...++.++.|+.+...||..| .+-||+.++|+++ ++++.|.|+|-.
T Consensus 87 flmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G--h~vGDVn~~~~lV--sd~~~V~LVdsD 162 (637)
T COG4248 87 FLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG--HVVGDVNQNSFLV--SDDSKVVLVDSD 162 (637)
T ss_pred EecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC--CcccccCccceee--ecCceEEEEccc
Confidence 778877663 3333332 2235799999999999999999999999 9999999999999 778889999876
Q ss_pred CcccccccCccceeeccCCcccccccCccccC-----cCCCCCchhHHHHHHHHHHHHhC-CCCCCCCC-------hHHH
Q 020888 190 LSKLIKVQNSHDVYKMTGETGSYRYMAPEVFK-----HRKYDKKVDVFSFAMILYEMLEG-EPPLANYE-------PYEA 256 (320)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~ll~g-~~p~~~~~-------~~~~ 256 (320)
....-. +..-.-...+...|.+||..+ +-.-+...|.|.||+++++++.| .+||.+.. +.+
T Consensus 163 sfqi~~-----ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E- 236 (637)
T COG4248 163 SFQINA-----NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLE- 236 (637)
T ss_pred ceeecc-----CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcch-
Confidence 544322 122344567889999999875 33456789999999999998885 99997652 222
Q ss_pred HHHHH-----------hCCCCCCC---CCCCCHHHHHHHHHHhhc--CCCCCCCHHHHHHHHHHHHhcCCC
Q 020888 257 AKYVA-----------EGHRPFFR---AKGFTPELRELTEKCWAA--DMNQRPSFLDILKRLEKIKETLPT 311 (320)
Q Consensus 257 ~~~~~-----------~~~~~~~~---~~~~~~~l~~li~~~l~~--dp~~Rps~~~ll~~L~~~~~~~~~ 311 (320)
..+. .+..+... ..-+++++..+..+|+.. ++.-|||++-++..|..+.+++.+
T Consensus 237 -~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~ 306 (637)
T COG4248 237 -TDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKK 306 (637)
T ss_pred -hhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhh
Confidence 1111 11111111 134688999999999965 467899999999999999988753
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.35 E-value=6.6e-11 Score=105.63 Aligned_cols=210 Identities=14% Similarity=0.208 Sum_probs=151.6
Q ss_pred CceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEE----eCCceEEEEecCCC-CC
Q 020888 54 SFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVT----ERKPLMLITEYLRG-GD 126 (320)
Q Consensus 54 ~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~----~~~~~~iv~e~~~~-~~ 126 (320)
--.+.|++..+ |..|++|+++-....... ..-.-++.|+++.|.|++++.+++. .+..+++|++|+|+ ++
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~n---k~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~T 364 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTN---KDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPT 364 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcc---cchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCch
Confidence 34678888875 889999988433222221 1222468999999999999998876 45668999999986 47
Q ss_pred HHHHHH---------------HhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCc
Q 020888 127 LHKYLK---------------EKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 191 (320)
Q Consensus 127 L~~~~~---------------~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~ 191 (320)
|-++.- ++...++..+|.++.||..||.++|+.| +..+-+.|.+|++ +++.+++|...|..
T Consensus 365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG--LAck~L~~~kIlv--~G~~RIriS~C~i~ 440 (655)
T KOG3741|consen 365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG--LACKTLDLKKILV--TGKMRIRISGCGIM 440 (655)
T ss_pred HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC--ceeecccHhHeEe--eCcceEEEecccce
Confidence 766531 1234688999999999999999999999 9999999999999 88889999888876
Q ss_pred ccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCC-CCCChHHH-HHHHHhCCCCCCC
Q 020888 192 KLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPL-ANYEPYEA-AKYVAEGHRPFFR 269 (320)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~-~~~~~~~~-~~~~~~~~~~~~~ 269 (320)
..+..... + . -.-..+.|.=.||.++..|.||..-- ......+. ...+
T Consensus 441 Dvl~~d~~----------------~--~---le~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I--------- 490 (655)
T KOG3741|consen 441 DVLQEDPT----------------E--P---LESQQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRI--------- 490 (655)
T ss_pred eeecCCCC----------------c--c---hhHHhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHh---------
Confidence 55433210 0 0 01135689999999999999995431 11111111 1111
Q ss_pred CCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 270 AKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 270 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
...++.+++++|..+...++++ -++++++.+
T Consensus 491 ~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 491 TTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred hhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 1347899999999999998887 688888765
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.35 E-value=1.5e-12 Score=117.94 Aligned_cols=251 Identities=22% Similarity=0.261 Sum_probs=182.6
Q ss_pred CcccCccceecccCceEEEEEEEC---CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcccceeeeEEeCCceE
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR---GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLM 116 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~---~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 116 (320)
..+|..+..||.|.++.|+.+... +..+++|...+........+..+ .|+-+...+ .|.+++.+...+...+..|
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl-~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSL-GEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcch-hhhhHhhHhhcccccCCCCCCcccccccc
Confidence 347889999999999999987643 67889988877666655443333 366666666 4888888888888888888
Q ss_pred EEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCC-CcEEEecCCCccccc
Q 020888 117 LITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSA-DHLKVGDFGLSKLIK 195 (320)
Q Consensus 117 iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~-~~~~L~dfg~~~~~~ 195 (320)
+--||++++++.....-...+++...+++..|++.++.++|+.. ++|.|++|+||++ ..+ +.-++.||+...++.
T Consensus 343 ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~--~~~~d~~psni~i--~~~~~~~~~~~~~~~t~~~ 418 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKL--FVHLDVKPSNILI--SNDGFFSKLGDFGCWTRLA 418 (524)
T ss_pred CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchh--hhcccccccceee--ccchhhhhccccccccccc
Confidence 99999999888776654446788889999999999999999988 9999999999999 443 788899999887543
Q ss_pred ccCccceeeccCCccccccc--CccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCC
Q 020888 196 VQNSHDVYKMTGETGSYRYM--APEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGF 273 (320)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~--aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (320)
... .......++. ++.......+..+.|+++||..+.+.++|..--...... ..+..+..+.. .+.
T Consensus 419 ~~~-------~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~---~~i~~~~~p~~--~~~ 486 (524)
T KOG0601|consen 419 FSS-------GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS---LTIRSGDTPNL--PGL 486 (524)
T ss_pred eec-------ccccccccccccchhhccccccccccccccccccccccccCcccCcccccc---eeeecccccCC--Cch
Confidence 211 1112233333 555556667889999999999999999986432222211 11223322222 233
Q ss_pred CHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhc
Q 020888 274 TPELRELTEKCWAADMNQRPSFLDILKRLEKIKET 308 (320)
Q Consensus 274 ~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 308 (320)
..++..+.+.+...++..||++.++..+.....+.
T Consensus 487 ~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~~~ 521 (524)
T KOG0601|consen 487 KLQLQVLLKVMINPDRKRRPSAVELSLHSEFYRDS 521 (524)
T ss_pred HHhhhhhhhhhcCCccccchhhhhhcccchhhhhc
Confidence 47888999999999999999999987776655443
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.27 E-value=5.6e-12 Score=120.49 Aligned_cols=276 Identities=23% Similarity=0.301 Sum_probs=186.3
Q ss_pred CCCCCCCCCCCCCCCCCCCCcCCCCCcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHH
Q 020888 16 NGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNL 93 (320)
Q Consensus 16 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~ 93 (320)
++.+..|.......|+-... -......+.+.+.+.+|+++.++.+.-. +...+.++......-....++.+..+-.+
T Consensus 779 eS~pgdp~~sls~sP~sp~~-yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~ 857 (1205)
T KOG0606|consen 779 ESLPGDPTRSLSASPRSPTK-YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNI 857 (1205)
T ss_pred ccCCCCcccccccCCCCccc-ccCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCc
Confidence 33334455444444443332 2223446778888899999999877643 32223332211110001111112211111
Q ss_pred HHhCCCCcccceeeeEEeCCceEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcE
Q 020888 94 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNV 173 (320)
Q Consensus 94 l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI 173 (320)
+-...+|-++....-+......+++++++.+++|...+..-+..+..........+.+++++||... +.|+|++|+|+
T Consensus 858 ~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~--r~h~~~~p~~~ 935 (1205)
T KOG0606|consen 858 LITPRSPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSL--RKHRDLKPDSL 935 (1205)
T ss_pred cccCCCCceecccCCCCCCCCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccch--hhcccccccch
Confidence 1111234444443344556778999999999999999887776777777778888999999999987 89999999999
Q ss_pred EEeeCCCCcEEEecCCCccccccc---------------------Cccc------eeeccCCcccccccCccccCcCCCC
Q 020888 174 LLVNSSADHLKVGDFGLSKLIKVQ---------------------NSHD------VYKMTGETGSYRYMAPEVFKHRKYD 226 (320)
Q Consensus 174 ~~~~~~~~~~~L~dfg~~~~~~~~---------------------~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~ 226 (320)
+. ..++..++.||+....+..- .... ........+|+.|.+||...+....
T Consensus 936 l~--~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hg 1013 (1205)
T KOG0606|consen 936 LI--AYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHG 1013 (1205)
T ss_pred hh--cccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCC
Confidence 99 77888999998733322110 0000 0112234589999999999999999
Q ss_pred CchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCC-CCCCCHHHHHHHHHHhhcCCCCCCCHH
Q 020888 227 KKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR-AKGFTPELRELTEKCWAADMNQRPSFL 296 (320)
Q Consensus 227 ~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~dp~~Rps~~ 296 (320)
..+|.|+.|+++++.++|..||....+......+.....+... +...+++.++++..++..++..|..+.
T Consensus 1014 s~ad~~~~g~~l~e~l~g~pp~na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1014 SAADWWSSGVCLFEVLTGIPPFNAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CcchhhhhhhhhhhhhcCCCCCCCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 9999999999999999999999999888887777666544433 456789999999999999999997654
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.25 E-value=7.2e-11 Score=98.43 Aligned_cols=140 Identities=21% Similarity=0.229 Sum_probs=103.0
Q ss_pred ceecccCceEEEEEEECC-CceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCC--cccceeeeEEeC---CceEEEEec
Q 020888 48 AIIGKGSFGEILKAYWRG-TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP--NIVQFLGAVTER---KPLMLITEY 121 (320)
Q Consensus 48 ~~lg~g~~~~vy~~~~~~-~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~--~i~~~~~~~~~~---~~~~iv~e~ 121 (320)
+.++.|..+.+|++...+ ..+++|........ .....+..|.++++.+.+. .+++++.+.... +..++||||
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~ 81 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMER 81 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence 568999999999998875 89999987544321 1225678899999998653 456777776653 367899999
Q ss_pred CCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCC-----------------------------------------
Q 020888 122 LRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP----------------------------------------- 160 (320)
Q Consensus 122 ~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g----------------------------------------- 160 (320)
++|.++.+.+.. ..++......++.+++.+|..||+..
T Consensus 82 i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 82 VDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred eCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 999888775432 34566666667777777777777421
Q ss_pred -------------CCeEecCCCCCcEEEeeCC--CCcEEEecCCCcc
Q 020888 161 -------------NVIIHRDLKPRNVLLVNSS--ADHLKVGDFGLSK 192 (320)
Q Consensus 161 -------------~~ivH~di~p~nI~~~~~~--~~~~~L~dfg~~~ 192 (320)
..++|||+.|.||++ +. ++.+.|+||+.+.
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~--~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLF--HPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEE--cCCCCcEEEEEeccccc
Confidence 127999999999999 55 5668999999764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.24 E-value=3.8e-10 Score=96.16 Aligned_cols=143 Identities=16% Similarity=0.096 Sum_probs=101.9
Q ss_pred ceecccCceEEEEEEECCCceEEEEccCCCCCc-H-------HHHHHHHHHHHHHHhCCCCccc--ceeeeEEe-----C
Q 020888 48 AIIGKGSFGEILKAYWRGTPVAIKRILPSLSDD-R-------LVIQDFRHEVNLLVKLRHPNIV--QFLGAVTE-----R 112 (320)
Q Consensus 48 ~~lg~g~~~~vy~~~~~~~~~~~K~~~~~~~~~-~-------~~~~~~~~e~~~l~~l~h~~i~--~~~~~~~~-----~ 112 (320)
+.+.......|.++...|+.+.+|......... . .....+.+|...+..+...+|. +++.+.+. .
T Consensus 28 e~v~~~~~rrvvr~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 28 EVFRELEGRRTLRFELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred cEEecCCCceEEEEEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 444444444566777788999999764332110 0 0011367889888888544443 45556543 2
Q ss_pred CceEEEEecCCCC-CHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEee-----CCCCcEE
Q 020888 113 KPLMLITEYLRGG-DLHKYLKE--KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN-----SSADHLK 184 (320)
Q Consensus 113 ~~~~iv~e~~~~~-~L~~~~~~--~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~-----~~~~~~~ 184 (320)
...++|+|++++. +|.+++.. ..+.+......++.+++..+..||+.| ++|+|+++.||++.. +.+..+.
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G--i~HgDL~~~NiLl~~~~~~~~~~~~~~ 185 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG--INHRDCYICHFLLHLPFPGREEDLKLS 185 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc--CccCCCChhhEEEeccccCCCCCceEE
Confidence 3468999999885 89999864 234566777899999999999999999 999999999999943 2356899
Q ss_pred EecCCCcc
Q 020888 185 VGDFGLSK 192 (320)
Q Consensus 185 L~dfg~~~ 192 (320)
|+||+.+.
T Consensus 186 LIDl~r~~ 193 (268)
T PRK15123 186 VIDLHRAQ 193 (268)
T ss_pred EEECCccc
Confidence 99999774
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.13 E-value=7.8e-10 Score=89.01 Aligned_cols=128 Identities=22% Similarity=0.279 Sum_probs=81.8
Q ss_pred EEEEEEEC-CCceEEEEccCCCCC-----------------------cHHHHHHHHHHHHHHHhCCCC--cccceeeeEE
Q 020888 57 EILKAYWR-GTPVAIKRILPSLSD-----------------------DRLVIQDFRHEVNLLVKLRHP--NIVQFLGAVT 110 (320)
Q Consensus 57 ~vy~~~~~-~~~~~~K~~~~~~~~-----------------------~~~~~~~~~~e~~~l~~l~h~--~i~~~~~~~~ 110 (320)
.||.+... +..+|+|+....... .........+|.+.|.++... ++++++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 37888764 778999977553211 112234577899999999755 456666542
Q ss_pred eCCceEEEEecCC--CCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHH-HhcCCCCeEecCCCCCcEEEeeCCCCcEEEec
Q 020888 111 ERKPLMLITEYLR--GGDLHKYLKEKGALSPSTAVNFALDIARGMAY-LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGD 187 (320)
Q Consensus 111 ~~~~~~iv~e~~~--~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~-lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~d 187 (320)
.-++||||++ |..+..+.... ++......++.+++..+.. +|..| ++|||+++.||++ +.+ .+.++|
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~g--ivHGDLs~~NIlv--~~~-~~~iID 149 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAG--IVHGDLSEYNILV--DDG-KVYIID 149 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTT--EEESS-STTSEEE--ETT-CEEE--
T ss_pred ---CCEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcC--ceecCCChhhEEe--ecc-eEEEEe
Confidence 3479999998 66666544432 2234456677888885555 68988 9999999999999 444 899999
Q ss_pred CCCccccc
Q 020888 188 FGLSKLIK 195 (320)
Q Consensus 188 fg~~~~~~ 195 (320)
||.+....
T Consensus 150 f~qav~~~ 157 (188)
T PF01163_consen 150 FGQAVDSS 157 (188)
T ss_dssp GTTEEETT
T ss_pred cCcceecC
Confidence 99887554
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.12 E-value=2.8e-11 Score=111.42 Aligned_cols=148 Identities=20% Similarity=0.346 Sum_probs=105.6
Q ss_pred HHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCccc--eee---ccCCcccccccCccccCcC
Q 020888 149 IARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHD--VYK---MTGETGSYRYMAPEVFKHR 223 (320)
Q Consensus 149 l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~~--~~~---~~~~~~~~~y~aPE~~~~~ 223 (320)
...|+.++|+. ..+||++|.|++|.+ +.++.+||+.|+++.....+.... .+. .........|.|||+..+.
T Consensus 108 v~dgl~flh~s-Ak~VH~ni~p~~i~~--na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 108 VADGLAFLHRS-AKVVHGNIQPEAIVV--NANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred ccchhhhhccC-cceeecccchhheee--ccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 33899999998 449999999999999 999999999999887655422210 011 1111346679999999998
Q ss_pred CCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHH--HHhCCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHH
Q 020888 224 KYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKY--VAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDIL 299 (320)
Q Consensus 224 ~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll 299 (320)
..+.++|+||||+++|.+.. |+.-+........... ...+.........+|.++++-+.+++..++..||++..+.
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLL 263 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhh
Confidence 89999999999999999995 4444443322222111 1111111222356899999999999999999999777764
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.11 E-value=4.8e-10 Score=93.04 Aligned_cols=140 Identities=19% Similarity=0.167 Sum_probs=104.9
Q ss_pred cCccceecccCceEEEEEEEC-CCceEEEEccCCCCCc--------------------HHHHHHHHHHHHHHHhCCCC--
Q 020888 44 FSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDD--------------------RLVIQDFRHEVNLLVKLRHP-- 100 (320)
Q Consensus 44 y~~~~~lg~g~~~~vy~~~~~-~~~~~~K~~~~~~~~~--------------------~~~~~~~~~e~~~l~~l~h~-- 100 (320)
+.+...||-|-.+.||.+.+. +.++++|. +..-... ........+|++.|++|...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKf-HR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKF-HRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEE-eecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 346788999999999999986 89999994 3221111 12234567899999999644
Q ss_pred cccceeeeEEeCCceEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCC
Q 020888 101 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSA 180 (320)
Q Consensus 101 ~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~ 180 (320)
.+++.+++ +.-.+|||+++|..|...- ++....-.++..|+..+..+-..| ++|||+++-||++ +.+
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~G--iVHGDlSefNIlV--~~d 238 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRG--IVHGDLSEFNILV--TED 238 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcC--ccccCCchheEEE--ecC
Confidence 77777765 3457999999987776642 244555667778888888877888 9999999999999 888
Q ss_pred CcEEEecCCCccccccc
Q 020888 181 DHLKVGDFGLSKLIKVQ 197 (320)
Q Consensus 181 ~~~~L~dfg~~~~~~~~ 197 (320)
|.+.++||=.+.....+
T Consensus 239 g~~~vIDwPQ~v~~~hp 255 (304)
T COG0478 239 GDIVVIDWPQAVPISHP 255 (304)
T ss_pred CCEEEEeCcccccCCCC
Confidence 99999999887655443
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.05 E-value=5.7e-09 Score=84.61 Aligned_cols=139 Identities=13% Similarity=0.134 Sum_probs=102.8
Q ss_pred cccCceEEEEEEECCCceEEEEccCCCCCc---HHHHHHHHHHHHHHHhCCCC--cccceeeeEE-e----CCceEEEEe
Q 020888 51 GKGSFGEILKAYWRGTPVAIKRILPSLSDD---RLVIQDFRHEVNLLVKLRHP--NIVQFLGAVT-E----RKPLMLITE 120 (320)
Q Consensus 51 g~g~~~~vy~~~~~~~~~~~K~~~~~~~~~---~~~~~~~~~e~~~l~~l~h~--~i~~~~~~~~-~----~~~~~iv~e 120 (320)
|+||.+.|++....+..+-+|....-.... +.....+.+|+..++.+... .++++. ++. . .-..++|+|
T Consensus 27 ~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVTe 105 (216)
T PRK09902 27 RRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVTE 105 (216)
T ss_pred CCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEEE
Confidence 568889999998888888888664211111 22347889999999998532 355555 332 1 222589999
Q ss_pred cCCC-CCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCc--EEEecCCCcccc
Q 020888 121 YLRG-GDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH--LKVGDFGLSKLI 194 (320)
Q Consensus 121 ~~~~-~~L~~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~--~~L~dfg~~~~~ 194 (320)
-++| .+|.+++.+. .+.+......++.+++.++..||+.| +.|+|+.+.||++ +.++. +.++||.-++..
T Consensus 106 ~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G--v~Hgdly~khIll--~~~g~~~v~lIDlEk~r~~ 180 (216)
T PRK09902 106 DMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN--RQHGCCYVRHIYV--KTEGKAEAGFLDLEKSRRR 180 (216)
T ss_pred eCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHhheee--cCCCCeeEEEEEhhccchh
Confidence 8754 5899988763 34677878899999999999999999 9999999999999 43445 999999976543
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.99 E-value=5.6e-09 Score=86.04 Aligned_cols=107 Identities=28% Similarity=0.335 Sum_probs=83.7
Q ss_pred HHHHHHHHHHHhCCCC--cccceeeeEEeC----CceEEEEecCCCC-CHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHh
Q 020888 85 QDFRHEVNLLVKLRHP--NIVQFLGAVTER----KPLMLITEYLRGG-DLHKYLKEKGALSPSTAVNFALDIARGMAYLH 157 (320)
Q Consensus 85 ~~~~~e~~~l~~l~h~--~i~~~~~~~~~~----~~~~iv~e~~~~~-~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH 157 (320)
.+..+|...+..+... ..++++.+.+.. ...++|+|++++. +|.++++....++......++.+++..+.-||
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH 135 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH 135 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH
Confidence 5677788888887533 345667776542 2358999999874 89999987555777888899999999999999
Q ss_pred cCCCCeEecCCCCCcEEEeeCC-CCcEEEecCCCccc
Q 020888 158 NEPNVIIHRDLKPRNVLLVNSS-ADHLKVGDFGLSKL 193 (320)
Q Consensus 158 ~~g~~ivH~di~p~nI~~~~~~-~~~~~L~dfg~~~~ 193 (320)
..| ++|+|+++.||++..+. ...+.|+||+-+..
T Consensus 136 ~~g--i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 136 DAG--IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HCc--CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 999 99999999999993332 23899999997653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.85 E-value=2.2e-08 Score=81.49 Aligned_cols=139 Identities=16% Similarity=0.221 Sum_probs=92.6
Q ss_pred CcccCccceecccCceEEEEEEECCCceEEEEccCCCCCcHHHHHH------HHHHHHHHHhCCCCcccceee---eE--
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQD------FRHEVNLLVKLRHPNIVQFLG---AV-- 109 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~K~~~~~~~~~~~~~~~------~~~e~~~l~~l~h~~i~~~~~---~~-- 109 (320)
..+|...+++.......|.+..-++..+++|.......-....... ..+.+..+..+...++..+.+ ..
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ek 109 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEK 109 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeee
Confidence 3478888889988899999998899999999876543222111111 123333333333222222222 21
Q ss_pred ---EeCCceEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEe
Q 020888 110 ---TERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVG 186 (320)
Q Consensus 110 ---~~~~~~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~ 186 (320)
......+++|||++|..|.++.. +++ .+...+.+++..+|+.| ++|||..|.|+++ + ++.++++
T Consensus 110 k~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G--~~HGD~hpgNFlv--~-~~~i~iI 176 (229)
T PF06176_consen 110 KIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHG--FYHGDPHPGNFLV--S-NNGIRII 176 (229)
T ss_pred eeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcC--CccCCCCcCcEEE--E-CCcEEEE
Confidence 12234568999999998888643 232 24456778899999999 9999999999999 4 3459999
Q ss_pred cCCCcc
Q 020888 187 DFGLSK 192 (320)
Q Consensus 187 dfg~~~ 192 (320)
||+...
T Consensus 177 D~~~k~ 182 (229)
T PF06176_consen 177 DTQGKR 182 (229)
T ss_pred ECcccc
Confidence 998553
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.72 E-value=3.3e-07 Score=76.50 Aligned_cols=72 Identities=21% Similarity=0.219 Sum_probs=54.8
Q ss_pred ceecccCceEEEEEEECCCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCC--cccceeeeEEeCCceEEEEecCCCC
Q 020888 48 AIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP--NIVQFLGAVTERKPLMLITEYLRGG 125 (320)
Q Consensus 48 ~~lg~g~~~~vy~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~--~i~~~~~~~~~~~~~~iv~e~~~~~ 125 (320)
..+|.|..+.||+. .+..+++|...... . ...+.+|.++++.+... .+.+++++...++...++|++++|.
T Consensus 7 ~~i~~G~t~~~y~~--~~~~~VlR~~~~~~--~---~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~ 79 (226)
T TIGR02172 7 TQTGEGGNGESYTH--KTGKWMLKLYNPGF--D---KETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGK 79 (226)
T ss_pred eeecCCCCcceeEe--cCCCEEEEeCCCCC--C---HHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCc
Confidence 56899999999985 36678899875432 1 14568899999988643 3577888888888889999999886
Q ss_pred C
Q 020888 126 D 126 (320)
Q Consensus 126 ~ 126 (320)
+
T Consensus 80 ~ 80 (226)
T TIGR02172 80 R 80 (226)
T ss_pred c
Confidence 3
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.66 E-value=2.3e-07 Score=76.48 Aligned_cols=136 Identities=20% Similarity=0.174 Sum_probs=93.7
Q ss_pred ceecccCceEEEEEEEC-CCceEEEEccCCCCCcHHHHH---------------------HHHHHHHHHHhCC--CCccc
Q 020888 48 AIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQ---------------------DFRHEVNLLVKLR--HPNIV 103 (320)
Q Consensus 48 ~~lg~g~~~~vy~~~~~-~~~~~~K~~~~~~~~~~~~~~---------------------~~~~e~~~l~~l~--h~~i~ 103 (320)
..|++|-.+.||++... +..+|+|++......-..... =...|+..|.++. +-.++
T Consensus 54 g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP 133 (268)
T COG1718 54 GCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP 133 (268)
T ss_pred eeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence 37788999999998764 889999988654333221100 0235666666663 33445
Q ss_pred ceeeeEEeCCceEEEEecCCCC-----CHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCcEEEee
Q 020888 104 QFLGAVTERKPLMLITEYLRGG-----DLHKYLKEKGALSPSTAVNFALDIARGMAYLHN-EPNVIIHRDLKPRNVLLVN 177 (320)
Q Consensus 104 ~~~~~~~~~~~~~iv~e~~~~~-----~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~-~g~~ivH~di~p~nI~~~~ 177 (320)
+.+.+.. ..+||||++.. .|.|. ++.......+..++++.+.-|-. .| +||||++.-||++
T Consensus 134 ~Pi~~~~----nVLvMEfIg~~g~pAP~LkDv-----~~e~~e~~~~~~~~v~~~~~l~~~a~--LVHgDLSEyNiL~-- 200 (268)
T COG1718 134 EPIAFRN----NVLVMEFIGDDGLPAPRLKDV-----PLELEEAEGLYEDVVEYMRRLYKEAG--LVHGDLSEYNILV-- 200 (268)
T ss_pred CceeecC----CeEEEEeccCCCCCCCCcccC-----CcCchhHHHHHHHHHHHHHHHHHhcC--cccccchhhheEE--
Confidence 5555433 46899998542 23332 22333567788899999988876 78 9999999999999
Q ss_pred CCCCcEEEecCCCccccccc
Q 020888 178 SSADHLKVGDFGLSKLIKVQ 197 (320)
Q Consensus 178 ~~~~~~~L~dfg~~~~~~~~ 197 (320)
. ++.+.++||+.+....++
T Consensus 201 ~-~~~p~iID~~QaV~~~hp 219 (268)
T COG1718 201 H-DGEPYIIDVSQAVTIDHP 219 (268)
T ss_pred E-CCeEEEEECccccccCCC
Confidence 5 778999999998876544
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.64 E-value=6.7e-07 Score=74.94 Aligned_cols=78 Identities=17% Similarity=0.169 Sum_probs=56.8
Q ss_pred cceecccCceEEEEEEECCCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCC--cccceeeeE---EeCCceEEEEec
Q 020888 47 SAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP--NIVQFLGAV---TERKPLMLITEY 121 (320)
Q Consensus 47 ~~~lg~g~~~~vy~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~--~i~~~~~~~---~~~~~~~iv~e~ 121 (320)
++.++.|..+.||++...+..+++|..... .....+.+|..+++.+... .+++++... ......+++|++
T Consensus 2 i~~l~~G~~n~~~~v~~~~~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~ 76 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDDGRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEY 76 (239)
T ss_dssp EEEEEESSSSEEEEEEETTSEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECCcEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEE
Confidence 467899999999999998889999986443 3346777888888888532 356666643 233447899999
Q ss_pred CCCCCHHH
Q 020888 122 LRGGDLHK 129 (320)
Q Consensus 122 ~~~~~L~~ 129 (320)
++|.++.+
T Consensus 77 i~g~~~~~ 84 (239)
T PF01636_consen 77 IPGRPLDD 84 (239)
T ss_dssp ESSEEHHH
T ss_pred eccccccc
Confidence 99987776
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.61 E-value=8.6e-07 Score=75.09 Aligned_cols=75 Identities=11% Similarity=0.077 Sum_probs=53.6
Q ss_pred ecccC-ceEEEEEEECCCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCC-CCcccceeeeEEeCCceEEEEecCCCCCH
Q 020888 50 IGKGS-FGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLMLITEYLRGGDL 127 (320)
Q Consensus 50 lg~g~-~~~vy~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~iv~e~~~~~~L 127 (320)
|..|. .+.||++...+..+++|...... ...+..|+++++.+. +--+++++++...++..++||++++|.+|
T Consensus 6 ~~~g~~~~~v~~~~~~~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l 79 (244)
T cd05150 6 VTEGQSGATVYRLDGKNPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPA 79 (244)
T ss_pred cCCCCCcCeEEEEcCCCCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccH
Confidence 33444 47899998777789999775432 135567888887773 44566788887776778999999999877
Q ss_pred HHH
Q 020888 128 HKY 130 (320)
Q Consensus 128 ~~~ 130 (320)
.+.
T Consensus 80 ~~~ 82 (244)
T cd05150 80 AAL 82 (244)
T ss_pred hHh
Confidence 643
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.49 E-value=1.1e-06 Score=81.48 Aligned_cols=140 Identities=20% Similarity=0.314 Sum_probs=90.2
Q ss_pred ceecccCceEEEEEEEC-CCceEEEEccCCCCCcHHH-HHH------------------------------------HHH
Q 020888 48 AIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLV-IQD------------------------------------FRH 89 (320)
Q Consensus 48 ~~lg~g~~~~vy~~~~~-~~~~~~K~~~~~~~~~~~~-~~~------------------------------------~~~ 89 (320)
..|+.++-|+||++... |+.||||+.++.....-.. +.. +.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 68899999999999987 8999999987754322100 000 112
Q ss_pred HHHHHHhC----C-CCcccceeee-EEeCCceEEEEecCCCCCHHHHH--HHhCCCCHHHHHHHHHHHHHH-HHHHhcCC
Q 020888 90 EVNLLVKL----R-HPNIVQFLGA-VTERKPLMLITEYLRGGDLHKYL--KEKGALSPSTAVNFALDIARG-MAYLHNEP 160 (320)
Q Consensus 90 e~~~l~~l----~-h~~i~~~~~~-~~~~~~~~iv~e~~~~~~L~~~~--~~~~~l~~~~~~~i~~~l~~~-l~~lH~~g 160 (320)
|...+.++ . .+. +++=.+ ++-.+.-.++|||++|..+.+.. +. ...+...+ +..++.+ +..+-..|
T Consensus 211 EA~n~~~~~~nf~~~~~-v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~i---a~~~~~~f~~q~~~dg 285 (517)
T COG0661 211 EAANAERFRENFKDDPD-VYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKEL---AELLVRAFLRQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHcCCCCC-eEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHH---HHHHHHHHHHHHHhcC
Confidence 22222222 1 111 111112 23345568999999999998874 44 34564433 3333333 34455567
Q ss_pred CCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccc
Q 020888 161 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 196 (320)
Q Consensus 161 ~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~ 196 (320)
++|+|..|-||++ +.+|.+.+.|||+...+..
T Consensus 286 --ffHaDpHpGNi~v--~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 286 --FFHADPHPGNILV--RSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred --ccccCCCccceEE--ecCCcEEEEcCcceecCCH
Confidence 9999999999999 8889999999999876643
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.48 E-value=5.2e-06 Score=67.02 Aligned_cols=153 Identities=23% Similarity=0.296 Sum_probs=103.2
Q ss_pred CCCCCCCCCCCCCCCCCCCcCCC---CCcccCccceecccCc-eEEEEEEECCCceEEEEccC---CCC--------CcH
Q 020888 17 GSHFEPKPVPPPLPNKCDWEIDP---SELDFSSSAIIGKGSF-GEILKAYWRGTPVAIKRILP---SLS--------DDR 81 (320)
Q Consensus 17 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~y~~~~~lg~g~~-~~vy~~~~~~~~~~~K~~~~---~~~--------~~~ 81 (320)
..+.+|...+.|.|+...-.+.. .+.+++.++.||.|.- |.||++...++.+|+|++.. ... ...
T Consensus 9 ~~~~~~~~~~~plp~~~gPKL~~F~~h~~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~ 88 (207)
T PF13095_consen 9 PLDQPPRKPPKPLPQCPGPKLEPFTHHGDDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHE 88 (207)
T ss_pred cccCCCCCCCcccccCCCCCcCCcCCCCCcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccc
Confidence 34444555555555554444322 3467888999999999 99999999999999999322 110 000
Q ss_pred -------HHHHHHHHHHHHHHhCC---CCcc--cceeeeEEeC------------------CceEEEEecCCCCCHHHHH
Q 020888 82 -------LVIQDFRHEVNLLVKLR---HPNI--VQFLGAVTER------------------KPLMLITEYLRGGDLHKYL 131 (320)
Q Consensus 82 -------~~~~~~~~e~~~l~~l~---h~~i--~~~~~~~~~~------------------~~~~iv~e~~~~~~L~~~~ 131 (320)
.-...|..|.+...+|+ +.++ ++++++..-. ....||.||.+...
T Consensus 89 ~~~~~~~~y~~PF~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----- 163 (207)
T PF13095_consen 89 TSLSTPAHYADPFNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----- 163 (207)
T ss_pred cccchhhhhcChHHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----
Confidence 12245778888777774 4566 8999987322 12467888776543
Q ss_pred HHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCc
Q 020888 132 KEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 191 (320)
Q Consensus 132 ~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~ 191 (320)
.+... -+.+|.+-+..+|..| |+-+|+++.|..= =+|+|||.+
T Consensus 164 ----~~~~~----~~~~~~~dl~~~~k~g--I~~~Dv~~~ny~~-------G~lvDfs~~ 206 (207)
T PF13095_consen 164 ----PLQIR----DIPQMLRDLKILHKLG--IVPRDVKPRNYRG-------GKLVDFSSS 206 (207)
T ss_pred ----ccchh----HHHHHHHHHHHHHHCC--eeeccCccccccC-------CEEEecccC
Confidence 12222 3457777888999999 9999999999882 478999864
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.41 E-value=3.5e-06 Score=65.93 Aligned_cols=130 Identities=18% Similarity=0.246 Sum_probs=92.9
Q ss_pred ccCccceecccCceEEEEEEECCCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCccc-ceeeeEEeCCceEEEEec
Q 020888 43 DFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIV-QFLGAVTERKPLMLITEY 121 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~-~~~~~~~~~~~~~iv~e~ 121 (320)
.-.+.+.|+.|+.|.||++.+.+..+++|+-..+.. ...+..|.++|..+.-.++- +++.+..+ ++.|||
T Consensus 23 ~~~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds~-----r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~ 93 (201)
T COG2112 23 ELRVEKELAKGTTSVVYLGEWRGGEVALKVRRRDSP-----RRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEY 93 (201)
T ss_pred hhhhhhhhhcccccEEEEeeccCceEEEEEecCCcc-----hhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhh
Confidence 446688999999999999999999999997644322 26788899999988765554 45544443 345999
Q ss_pred CCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC-CCcEEEeeCCCCcEEEecCCCcc
Q 020888 122 LRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLK-PRNVLLVNSSADHLKVGDFGLSK 192 (320)
Q Consensus 122 ~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~-p~nI~~~~~~~~~~~L~dfg~~~ 192 (320)
+.|..|.+..... +...+. .+++.---|-..| |-|+.|+ |..+++ .+++.+.|+||..+.
T Consensus 94 i~G~~L~~~~~~~---~rk~l~----~vlE~a~~LD~~G--I~H~El~~~~k~vl--v~~~~~~iIDFd~At 154 (201)
T COG2112 94 IDGRPLGKLEIGG---DRKHLL----RVLEKAYKLDRLG--IEHGELSRPWKNVL--VNDRDVYIIDFDSAT 154 (201)
T ss_pred hcCcchhhhhhcc---cHHHHH----HHHHHHHHHHHhc--cchhhhcCCceeEE--ecCCcEEEEEccchh
Confidence 9998998876532 344444 3444434466778 9999997 544444 355589999999886
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.37 E-value=8e-06 Score=80.35 Aligned_cols=232 Identities=21% Similarity=0.248 Sum_probs=151.9
Q ss_pred ecccCceEEEEEEEC------CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCc----eEEEE
Q 020888 50 IGKGSFGEILKAYWR------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP----LMLIT 119 (320)
Q Consensus 50 lg~g~~~~vy~~~~~------~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~~iv~ 119 (320)
+..-.+|+++...+. .+++-++.-..........+....-|.+.+.++.|+|+..++.+...... ..+..
T Consensus 186 ls~~~~~~l~l~k~~~~~qs~~~~~~~s~~~~~~~~~k~~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~ 265 (1351)
T KOG1035|consen 186 LSHLTQGTLLLVKWVEQAQSLSEPIEISHDYESTPCGKKEIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQ 265 (1351)
T ss_pred eccccCceEEEEehhhhHHhhcCcccccCcccCccchHHHHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHH
Confidence 667778888888764 22333321111111112333445567778888899999999888754433 23456
Q ss_pred ecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC---cEEEeeCCCCcEEEe--cCCCcccc
Q 020888 120 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPR---NVLLVNSSADHLKVG--DFGLSKLI 194 (320)
Q Consensus 120 e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~---nI~~~~~~~~~~~L~--dfg~~~~~ 194 (320)
+++.+.++...++.-+..+..+.+.+..++.+||.++|... +.|.-+..+ +..+ +..+.+.+. ||+.+...
T Consensus 266 ~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~--l~~v~L~~s~~~~~~~--~~e~~~~~sl~~~~ss~~l 341 (1351)
T KOG1035|consen 266 EICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLS--LEHVVLSASSSKESTV--DGEGVVAISLSDFDSSKPL 341 (1351)
T ss_pred hhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhc--cceeEEeccccccccc--CccceeecchhhhcccccC
Confidence 78888899999998888999999999999999999999975 555544444 2222 444455555 88877765
Q ss_pred cccCccceeeccCCcccccccCccccCcCCCC--CchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCC
Q 020888 195 KVQNSHDVYKMTGETGSYRYMAPEVFKHRKYD--KKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKG 272 (320)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~--~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (320)
..... .........+.++|........ ...|+|++|.+...+..|..+-...... . ......
T Consensus 342 ~d~~~-----~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~~~~-------~----~~l~~~ 405 (1351)
T KOG1035|consen 342 PDNEK-----SFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKSAVP-------V----SLLDVL 405 (1351)
T ss_pred CCccc-----chhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcCcccccccch-------h----hhhccc
Confidence 54321 1112234446667766555544 4589999999999999986542221110 0 111111
Q ss_pred CCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 273 FTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 273 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
...+..+.+..|+..++++|+++.+++.+
T Consensus 406 ~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~ 434 (1351)
T KOG1035|consen 406 STSELLDALPKCLDEDSEERLSALELLTH 434 (1351)
T ss_pred cchhhhhhhhhhcchhhhhccchhhhhhc
Confidence 22278899999999999999999998876
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.37 E-value=7e-06 Score=81.46 Aligned_cols=78 Identities=17% Similarity=0.210 Sum_probs=56.0
Q ss_pred cceecccCceEEEEEEECC----CceEEEEccCCCCCcHHHHHHHHHHHHHHHhCC-CCcc--cceeeeEEeC---CceE
Q 020888 47 SAIIGKGSFGEILKAYWRG----TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNI--VQFLGAVTER---KPLM 116 (320)
Q Consensus 47 ~~~lg~g~~~~vy~~~~~~----~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i--~~~~~~~~~~---~~~~ 116 (320)
++.++.|..+.+|++...+ ..+++|..+....... ...+.+|+++++.+. |.++ ++++.++.+. +..|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~--~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~f 120 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQS--AHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAF 120 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCcc--HHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCce
Confidence 5678999999999987663 4688887654332211 256788999999985 6554 6777776553 4689
Q ss_pred EEEecCCCCC
Q 020888 117 LITEYLRGGD 126 (320)
Q Consensus 117 iv~e~~~~~~ 126 (320)
+||||++|..
T Consensus 121 lVME~v~G~~ 130 (822)
T PLN02876 121 YIMEYLEGRI 130 (822)
T ss_pred EEEEecCCcc
Confidence 9999998864
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.26 E-value=4.5e-05 Score=62.04 Aligned_cols=134 Identities=25% Similarity=0.349 Sum_probs=92.4
Q ss_pred ccceecccCceEEEEEEECCCceEEEEccCCCCC-------------cHHHHHHHHHHHHHHHhCC------CCccccee
Q 020888 46 SSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSD-------------DRLVIQDFRHEVNLLVKLR------HPNIVQFL 106 (320)
Q Consensus 46 ~~~~lg~g~~~~vy~~~~~~~~~~~K~~~~~~~~-------------~~~~~~~~~~e~~~l~~l~------h~~i~~~~ 106 (320)
-...||+|+.-.||..-+ +...++|+....... .....++..+|+.....+. +.+|.+++
T Consensus 5 ~~~~i~~G~~R~cy~HP~-dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQHPD-DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CCcccccCCCceEEECCC-CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 346899999999987642 455778877665500 0112355556665555554 78999999
Q ss_pred eeEEeCCceEEEEecCC------CCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCC
Q 020888 107 GAVTERKPLMLITEYLR------GGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSA 180 (320)
Q Consensus 107 ~~~~~~~~~~iv~e~~~------~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~ 180 (320)
|+.+.+.-.-+|+|.+. ..||.+++++. .++. ... ..+-.-..+|-+.+ |+.+|++|+||++....+
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~-~~~~-~~~---~~L~~f~~~l~~~~--Iv~~dl~~~NIv~~~~~~ 156 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEG-GLTE-ELR---QALDEFKRYLLDHH--IVIRDLNPHNIVVQRRDS 156 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHcC-CccH-HHH---HHHHHHHHHHHHcC--CeecCCCcccEEEEecCC
Confidence 99999888899998752 23788988664 4555 333 34445566778877 999999999999965554
Q ss_pred Cc--EEEec
Q 020888 181 DH--LKVGD 187 (320)
Q Consensus 181 ~~--~~L~d 187 (320)
+. +.|+|
T Consensus 157 ~~~~lvlID 165 (199)
T PF10707_consen 157 GEFRLVLID 165 (199)
T ss_pred CceEEEEEe
Confidence 44 67776
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.26 E-value=1.1e-05 Score=68.05 Aligned_cols=73 Identities=14% Similarity=0.145 Sum_probs=45.9
Q ss_pred ceecccCce-EEEEEEECCCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCC---cccceeeeEEeC---CceEEEEe
Q 020888 48 AIIGKGSFG-EILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP---NIVQFLGAVTER---KPLMLITE 120 (320)
Q Consensus 48 ~~lg~g~~~-~vy~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~---~i~~~~~~~~~~---~~~~iv~e 120 (320)
..++.|+.. .||++ +..+++|...... ....+.+|.+.+..+... .+.++++..... ...+++|+
T Consensus 3 ~~~~~gG~~n~vy~~---~~~~VlR~~~~~~-----~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~ 74 (235)
T cd05155 3 EPVDSGGTDNATFRL---GDDMSVRLPSAAG-----YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYR 74 (235)
T ss_pred eeccCCCcccceEEc---CCceEEEcCCccc-----hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEE
Confidence 456766655 58987 3457888654311 125788899999888532 344555544332 24588999
Q ss_pred cCCCCCHH
Q 020888 121 YLRGGDLH 128 (320)
Q Consensus 121 ~~~~~~L~ 128 (320)
+++|.++.
T Consensus 75 ~i~G~~l~ 82 (235)
T cd05155 75 WLEGETAT 82 (235)
T ss_pred eecCCCCC
Confidence 99987763
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.24 E-value=1.3e-05 Score=74.28 Aligned_cols=142 Identities=18% Similarity=0.303 Sum_probs=89.9
Q ss_pred cceecccCceEEEEEEEC-CCceEEEEccCCCCCcH----------------------------HHHHHHHH------HH
Q 020888 47 SAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDR----------------------------LVIQDFRH------EV 91 (320)
Q Consensus 47 ~~~lg~g~~~~vy~~~~~-~~~~~~K~~~~~~~~~~----------------------------~~~~~~~~------e~ 91 (320)
.+.||.-+.+.||+++.. |+.||||+.++...... +..+.+.. |.
T Consensus 166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 368899999999999987 88899999877644331 00111111 22
Q ss_pred ----HHHHhCCCCc------ccceeeeEEeCCceEEEEecCCCCCHHHH--HHHhCCCCHHHHHHHHHHHHHHH-HHHhc
Q 020888 92 ----NLLVKLRHPN------IVQFLGAVTERKPLMLITEYLRGGDLHKY--LKEKGALSPSTAVNFALDIARGM-AYLHN 158 (320)
Q Consensus 92 ----~~l~~l~h~~------i~~~~~~~~~~~~~~iv~e~~~~~~L~~~--~~~~~~l~~~~~~~i~~~l~~~l-~~lH~ 158 (320)
+....+.|.+ |++++- .-.....++|||++|..+.|. +++. .++...+. ..+.++. +.+=.
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i~~~-gi~~~~i~---~~l~~~~~~qIf~ 319 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAIDKR-GISPHDIL---NKLVEAYLEQIFK 319 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHHHHc-CCCHHHHH---HHHHHHHHHHHHh
Confidence 2222233433 222222 223456899999999877654 4443 35655443 3444432 33445
Q ss_pred CCCCeEecCCCCCcEEEeeC--CCCcEEEecCCCcccccc
Q 020888 159 EPNVIIHRDLKPRNVLLVNS--SADHLKVGDFGLSKLIKV 196 (320)
Q Consensus 159 ~g~~ivH~di~p~nI~~~~~--~~~~~~L~dfg~~~~~~~ 196 (320)
.| .+|+|=.|-||++..+ .++.+.+.|||+...+..
T Consensus 320 ~G--ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 320 TG--FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred cC--CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 56 9999999999999533 467899999999887654
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.22 E-value=4.4e-05 Score=66.57 Aligned_cols=78 Identities=19% Similarity=0.164 Sum_probs=57.8
Q ss_pred CccceecccCceEEEEEEECCCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCC---CcccceeeeEEe---CCceEEE
Q 020888 45 SSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH---PNIVQFLGAVTE---RKPLMLI 118 (320)
Q Consensus 45 ~~~~~lg~g~~~~vy~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h---~~i~~~~~~~~~---~~~~~iv 118 (320)
...+.||.|..+.||.....+..+++|.... .... ..+..|.+.++.+.. -.++++++.+.. .+..++|
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~~~~~~k~~~~-~~~~----~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV 91 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQGNPMPLMARS-FSTP----GVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL 91 (297)
T ss_pred heeeecCCccceeEEEEEcCCCCEEEEEecc-cccc----hHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence 4456899999999999987666788887432 1111 577889999988842 367888887754 4668999
Q ss_pred EecCCCCCH
Q 020888 119 TEYLRGGDL 127 (320)
Q Consensus 119 ~e~~~~~~L 127 (320)
||+++|.++
T Consensus 92 mE~i~G~~~ 100 (297)
T PRK10593 92 LERLRGVSV 100 (297)
T ss_pred EeccCCEec
Confidence 999988765
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.22 E-value=4.1e-05 Score=61.89 Aligned_cols=102 Identities=21% Similarity=0.237 Sum_probs=78.4
Q ss_pred HHHHHHHHhCCC-CcccceeeeEEeCCceEEEEecCCCCCHHHH---HHHhCCCCHHHHHHHHHHHHHHHHHHhcCC-CC
Q 020888 88 RHEVNLLVKLRH-PNIVQFLGAVTERKPLMLITEYLRGGDLHKY---LKEKGALSPSTAVNFALDIARGMAYLHNEP-NV 162 (320)
Q Consensus 88 ~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~---~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g-~~ 162 (320)
.+|.-+++.+++ +++++++|.|.. +++.|+.+.+++... +...-..+|..+.+|+.+++..+++++... ..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 347788888865 699999999842 578899876655321 112224599999999999999999998841 12
Q ss_pred eEecCCCCCcEEEeeCCCCcEEEecCCCccccc
Q 020888 163 IIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 195 (320)
Q Consensus 163 ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~ 195 (320)
+.-.|++|+|+-+ +.++.++++|...+....
T Consensus 83 ~~lcDv~~~nfgv--~~~~~lk~iDld~v~~~~ 113 (188)
T PF12260_consen 83 FYLCDVSPDNFGV--NDDGRLKLIDLDDVFVED 113 (188)
T ss_pred EEEeecchHHeEE--eCCCcEEEEechhcchhH
Confidence 8889999999999 788899999999776553
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.05 E-value=8.2e-05 Score=62.56 Aligned_cols=73 Identities=15% Similarity=0.136 Sum_probs=47.2
Q ss_pred cceecccCceEEEEEEEC---CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcc-cceeeeEEeCCceEEEEecC
Q 020888 47 SAIIGKGSFGEILKAYWR---GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI-VQFLGAVTERKPLMLITEYL 122 (320)
Q Consensus 47 ~~~lg~g~~~~vy~~~~~---~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~iv~e~~ 122 (320)
++.|..|-.+.+|++... +..+++|+........ ....+|+.+++.+...++ ++++.... + .++|||+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~----~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i 74 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELI----IDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFI 74 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccce----ecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEee
Confidence 456788888999999865 4689999765432211 223468888888753333 44444332 1 3799999
Q ss_pred CCCCH
Q 020888 123 RGGDL 127 (320)
Q Consensus 123 ~~~~L 127 (320)
+|.++
T Consensus 75 ~G~~l 79 (235)
T cd05157 75 PGRTL 79 (235)
T ss_pred CCCcC
Confidence 88765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=98.02 E-value=4.7e-05 Score=64.95 Aligned_cols=134 Identities=18% Similarity=0.207 Sum_probs=75.8
Q ss_pred eecccCceEEEEEEECCCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcc-cceeeeEEeCCceEEEEecCCCCCH
Q 020888 49 IIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI-VQFLGAVTERKPLMLITEYLRGGDL 127 (320)
Q Consensus 49 ~lg~g~~~~vy~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~iv~e~~~~~~L 127 (320)
.+..|-.+.+|++...+..+++|........- . -...+|.++++.+...++ ++++.... -++|+||++|.++
T Consensus 3 ~~~~G~tn~~y~~~~~~~~~vlR~~~~~~~~~--~-~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~ 75 (256)
T TIGR02721 3 TLSGGLTNRSWRIEHPGISFVWRPQSPVCKAL--G-VDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVI 75 (256)
T ss_pred cCCCcCcCCeEEEEeCCccEEEeeCCcccccc--c-CcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccc
Confidence 35567788999998778889999754332111 0 123568888888854333 44444432 2689999988665
Q ss_pred HH--------------HHHH-h------CCCCHH-HHHHHHHHH---------HHHHHHHhcC------CCCeEecCCCC
Q 020888 128 HK--------------YLKE-K------GALSPS-TAVNFALDI---------ARGMAYLHNE------PNVIIHRDLKP 170 (320)
Q Consensus 128 ~~--------------~~~~-~------~~l~~~-~~~~i~~~l---------~~~l~~lH~~------g~~ivH~di~p 170 (320)
.. .+.+ + .+++.. .+..+..++ ...+..+-.. ...++|+|+.|
T Consensus 76 ~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~ 155 (256)
T TIGR02721 76 TLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHA 155 (256)
T ss_pred ccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCc
Confidence 31 1111 1 011211 111111111 1112222111 12389999999
Q ss_pred CcEEEeeCCCCcEEEecCCCcc
Q 020888 171 RNVLLVNSSADHLKVGDFGLSK 192 (320)
Q Consensus 171 ~nI~~~~~~~~~~~L~dfg~~~ 192 (320)
.||++ ++++ +.++||+.+.
T Consensus 156 ~Nil~--~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 156 YNLVV--TPQG-LKLIDWEYAS 174 (256)
T ss_pred CcEEE--eCCC-CEEEeccccC
Confidence 99999 5554 7899999764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.97 E-value=1.5e-06 Score=80.30 Aligned_cols=190 Identities=22% Similarity=0.193 Sum_probs=133.1
Q ss_pred CCCCCcccCccceecccCceEEEEEEECCC-ceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCc-ccceeeeEEeCCc
Q 020888 37 IDPSELDFSSSAIIGKGSFGEILKAYWRGT-PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN-IVQFLGAVTERKP 114 (320)
Q Consensus 37 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~-~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~ 114 (320)
+...+..|......++++.+++++.+.... ....+++... ....-++++|.+++||| .+..++-++.++.
T Consensus 237 lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~--------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~ 308 (829)
T KOG0576|consen 237 LKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT--------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDY 308 (829)
T ss_pred ccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc--------hhhHHHHHHHHHccCCCCcccccccCCcccc
Confidence 444455666677889999999999887643 3334444322 34456889999999999 6666666777888
Q ss_pred eEEEEecCCCC-CHHHHH-HHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcc
Q 020888 115 LMLITEYLRGG-DLHKYL-KEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 192 (320)
Q Consensus 115 ~~iv~e~~~~~-~L~~~~-~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~ 192 (320)
..++++++.++ +-..-+ ...-.+...+...+.+.-+.+++++|+.- -+|+| ||+. .++..+..+|+...
T Consensus 309 ~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~--~~~~d----~~l~---s~~~~~~~~~~v~~ 379 (829)
T KOG0576|consen 309 LWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSY--KVHRD----NILG---SEEEVKLLDFAVPP 379 (829)
T ss_pred cchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhccccccccccc--ccCcc----cccc---cccccccccccCCc
Confidence 89999998765 222111 11112344455566667777899999963 36777 7775 45788999999876
Q ss_pred cccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCC
Q 020888 193 LIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPL 248 (320)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~ 248 (320)
.+...- ......+++.+.|||+.....+....|.|++|.--.++.-|..|-
T Consensus 380 ~L~~~~-----~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 380 QLTRTM-----KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred ccCccc-----ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 554332 334456889999999999999999999999998766777776654
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.94 E-value=0.00022 Score=62.15 Aligned_cols=138 Identities=17% Similarity=0.106 Sum_probs=80.9
Q ss_pred cceecccCceEEEEEEECCCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCc--ccceeee------EEeCCceEEE
Q 020888 47 SAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN--IVQFLGA------VTERKPLMLI 118 (320)
Q Consensus 47 ~~~lg~g~~~~vy~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~------~~~~~~~~iv 118 (320)
.+.+..|....+|++...+..+++|++.. ... ..+..|++++..+...+ +.+++.. ...++..+++
T Consensus 19 i~~i~~G~~n~~y~v~~~~~~~vLr~~~~---~~~---~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l 92 (296)
T cd05153 19 FEGISAGIENTNYFVTTDSGRYVLTLFEK---VSA---EELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAAL 92 (296)
T ss_pred eecccCccccceEEEEeCCCcEEEEEcCC---CCh---HhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEE
Confidence 56777888889999987777899998754 111 45566777777764222 4444432 2335567899
Q ss_pred EecCCCCCHHH-----------HHHH----hCCC----------CHHHHH----------HHHHHHHHHHHHHhc-----
Q 020888 119 TEYLRGGDLHK-----------YLKE----KGAL----------SPSTAV----------NFALDIARGMAYLHN----- 158 (320)
Q Consensus 119 ~e~~~~~~L~~-----------~~~~----~~~l----------~~~~~~----------~i~~~l~~~l~~lH~----- 158 (320)
++|++|..+.. .+.+ ...+ .+.... .....+..++..+..
T Consensus 93 ~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~ 172 (296)
T cd05153 93 VEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSD 172 (296)
T ss_pred EEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhc
Confidence 99998866421 1111 0000 110000 001112223333332
Q ss_pred CCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcc
Q 020888 159 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 192 (320)
Q Consensus 159 ~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~ 192 (320)
....++|||+.|.||++ +.++.+.|+||+.+.
T Consensus 173 ~~~~l~HgD~~~~Nil~--~~~~~~~iIDfe~a~ 204 (296)
T cd05153 173 LPRGVIHADLFRDNVLF--DGDELSGVIDFYFAC 204 (296)
T ss_pred CCCcCCccCcCcccEEE--eCCceEEEeehhhhc
Confidence 11239999999999999 666567899999764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00036 Score=61.25 Aligned_cols=141 Identities=17% Similarity=0.152 Sum_probs=79.9
Q ss_pred CccceecccCceEEEEEEECCCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCC--cccceeee------EEeCCceE
Q 020888 45 SSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP--NIVQFLGA------VTERKPLM 116 (320)
Q Consensus 45 ~~~~~lg~g~~~~vy~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~--~i~~~~~~------~~~~~~~~ 116 (320)
..++.++.|....+|++...+..+++|....... . ..+..|++++..|... .+++++.. ...++..+
T Consensus 25 ~~i~~~~~G~~n~~y~v~t~~~~~vLK~~~~~~~--~---~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~ 99 (307)
T TIGR00938 25 LSLKGIAEGVENSNYLLTTDVGRYILTLYEKRVK--A---EELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPA 99 (307)
T ss_pred eeccccCCccccceEEEEeCCCcEEEEEecCCCC--H---HHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEE
Confidence 3456777888889999987777889997644211 1 3344566666666322 23444432 12346678
Q ss_pred EEEecCCCCCHH-----------HHHHH----hCCC--------CHH---HHH------------HHHHHHHHHHHHHhc
Q 020888 117 LITEYLRGGDLH-----------KYLKE----KGAL--------SPS---TAV------------NFALDIARGMAYLHN 158 (320)
Q Consensus 117 iv~e~~~~~~L~-----------~~~~~----~~~l--------~~~---~~~------------~i~~~l~~~l~~lH~ 158 (320)
++++|++|..+. ..+.. ...+ ... ... .....+...++++..
T Consensus 100 ~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~ 179 (307)
T TIGR00938 100 CLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDK 179 (307)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHh
Confidence 999999885431 11111 0001 001 000 001112234444432
Q ss_pred -----CCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcc
Q 020888 159 -----EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 192 (320)
Q Consensus 159 -----~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~ 192 (320)
....++|||+.+.||++ ++++.+.++||+.+.
T Consensus 180 ~~~~~~~~~l~HgD~~~~Nvl~--~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 180 FWPRDLPRGVIHADLFPDNVLF--DGDSVKGVIDFYFAC 216 (307)
T ss_pred hhhhcCCCccCCCCCCcCcEEE--ECCceEEEeeccccc
Confidence 11339999999999999 666667899999763
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.78 E-value=0.0015 Score=57.71 Aligned_cols=74 Identities=11% Similarity=-0.039 Sum_probs=45.1
Q ss_pred cceecccCceEEEEEEECCCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCC--Ccccceee------eEEeCCceEEE
Q 020888 47 SAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH--PNIVQFLG------AVTERKPLMLI 118 (320)
Q Consensus 47 ~~~lg~g~~~~vy~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~------~~~~~~~~~iv 118 (320)
.+.++.|....+|++..++..+++|++. . ... ..+..++..+..|.. -.+++++. +...++..+++
T Consensus 27 ~~~l~~G~~n~~y~v~t~~g~~vLK~~~-~--~~~---~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l 100 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTTQGEYVLTLFE-R--LTA---EDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAI 100 (319)
T ss_pred cchhccccccceEEEEeCCCcEEEEEec-c--CCh---HHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEE
Confidence 4567778888999998777789999874 1 112 233334455544421 12334442 12335668999
Q ss_pred EecCCCCC
Q 020888 119 TEYLRGGD 126 (320)
Q Consensus 119 ~e~~~~~~ 126 (320)
++|++|..
T Consensus 101 ~~~l~G~~ 108 (319)
T PRK05231 101 VTFLEGKW 108 (319)
T ss_pred EEecCCCC
Confidence 99998864
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.77 E-value=0.0011 Score=59.92 Aligned_cols=77 Identities=17% Similarity=0.190 Sum_probs=52.4
Q ss_pred cceecccCceEEEEEEECC--CceEEEEccCCCC--Cc--HHHHHHHHHHHHHHHhCC---CCcccceeeeEEeCCceEE
Q 020888 47 SAIIGKGSFGEILKAYWRG--TPVAIKRILPSLS--DD--RLVIQDFRHEVNLLVKLR---HPNIVQFLGAVTERKPLML 117 (320)
Q Consensus 47 ~~~lg~g~~~~vy~~~~~~--~~~~~K~~~~~~~--~~--~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~i 117 (320)
.+.||.|..+.||++...+ +.+++|.-.+... .. .-..++...|.+.|+.+. ..++++++.+.. +..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~--~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE--ELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC--CCCEE
Confidence 3678999999999999874 3899997532211 01 123467777888888763 245667777633 45789
Q ss_pred EEecCCCC
Q 020888 118 ITEYLRGG 125 (320)
Q Consensus 118 v~e~~~~~ 125 (320)
||||+++.
T Consensus 109 VME~L~~~ 116 (401)
T PRK09550 109 VMEDLSDH 116 (401)
T ss_pred EEecCCCc
Confidence 99998763
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.00051 Score=60.10 Aligned_cols=74 Identities=18% Similarity=0.188 Sum_probs=47.4
Q ss_pred cceecccCceEEEEEEEC--------CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCc-ccceeeeEEeCCceEE
Q 020888 47 SAIIGKGSFGEILKAYWR--------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN-IVQFLGAVTERKPLML 117 (320)
Q Consensus 47 ~~~lg~g~~~~vy~~~~~--------~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~i 117 (320)
++.+..|-...+|++... ++.+++|+....... .....+|.+++..+...+ ..+++..+.+ ..
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~----~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~ 74 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVEL----LIDRERELVVFARLSERNLGPKLYGIFPN----GR 74 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcc----eechHHHHHHHHHHHhCCCCCceEEEeCC----Cc
Confidence 345677777899998765 378999986543221 134566888887775333 3455655542 25
Q ss_pred EEecCCCCCHH
Q 020888 118 ITEYLRGGDLH 128 (320)
Q Consensus 118 v~e~~~~~~L~ 128 (320)
|++|++|.++.
T Consensus 75 v~e~i~G~~l~ 85 (302)
T cd05156 75 IEEFIPSRTLT 85 (302)
T ss_pred hhheeCCCcCC
Confidence 78998887653
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.00047 Score=60.50 Aligned_cols=145 Identities=22% Similarity=0.188 Sum_probs=93.3
Q ss_pred ccceecccCceEEEEEEEC-CCceEEEEccCCCCCcH----------------------HHHH-HHHHHHHHHHhCCCCc
Q 020888 46 SSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDR----------------------LVIQ-DFRHEVNLLVKLRHPN 101 (320)
Q Consensus 46 ~~~~lg~g~~~~vy~~~~~-~~~~~~K~~~~~~~~~~----------------------~~~~-~~~~e~~~l~~l~h~~ 101 (320)
+..+|..|-.+.||.+..+ |..+|+|++..+...-. ..++ =...|++.|.+++..+
T Consensus 148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 4567888999999999876 78899998755422111 0011 1345777777776665
Q ss_pred ccceeeeEEeCCceEEEEecCCCCCHH-HHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCC
Q 020888 102 IVQFLGAVTERKPLMLITEYLRGGDLH-KYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSA 180 (320)
Q Consensus 102 i~~~~~~~~~~~~~~iv~e~~~~~~L~-~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~ 180 (320)
|+-.--+.. . .-.+||+|+.+.... -.++. -.++...+...-.+++..+.-|.+. ..+||.||+--|+++ .+
T Consensus 228 IP~PePIlL-k-~hVLVM~FlGrdgw~aPkLKd-~~ls~~ka~~~Y~~~v~~MR~lY~~-c~LVHADLSEfN~Ly---hd 300 (520)
T KOG2270|consen 228 IPCPEPILL-K-NHVLVMEFLGRDGWAAPKLKD-ASLSTSKARELYQQCVRIMRRLYQK-CRLVHADLSEFNLLY---HD 300 (520)
T ss_pred CCCCCceee-e-cceEeeeeccCCCCcCccccc-ccCChHHHHHHHHHHHHHHHHHHHH-hceeccchhhhhheE---EC
Confidence 433222222 1 236899998532221 12221 2466666777777788888777554 339999999999998 56
Q ss_pred CcEEEecCCCccccccc
Q 020888 181 DHLKVGDFGLSKLIKVQ 197 (320)
Q Consensus 181 ~~~~L~dfg~~~~~~~~ 197 (320)
|.++++|.+.+.....+
T Consensus 301 G~lyiIDVSQSVE~DHP 317 (520)
T KOG2270|consen 301 GKLYIIDVSQSVEHDHP 317 (520)
T ss_pred CEEEEEEccccccCCCh
Confidence 78999999877655443
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.0016 Score=56.80 Aligned_cols=138 Identities=21% Similarity=0.264 Sum_probs=84.7
Q ss_pred cceecccCceEEEEEEECCCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCC--CcccceeeeEEeCC--ceEEEEecC
Q 020888 47 SAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH--PNIVQFLGAVTERK--PLMLITEYL 122 (320)
Q Consensus 47 ~~~lg~g~~~~vy~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~--~~~iv~e~~ 122 (320)
++....|.-..+|....++++++++ .+. ........+...+|+++++.+.- --+...++.+.++. ..|.||+|.
T Consensus 30 v~~~~~G~sn~t~~~~~~~~~~vlR-~P~-~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~v 107 (321)
T COG3173 30 VEEISGGWSNDTFRLGDTGQKYVLR-KPP-RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWV 107 (321)
T ss_pred eeeccCCcccceEEEecCCceEEEe-cCC-ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEe
Confidence 3344445555666666668889998 432 33334445778888998888853 23345566665544 679999999
Q ss_pred CCCCHHHHHHHhCCCCHHHHHHHH-HHHHHHHHHHhcCC-----------------------------------------
Q 020888 123 RGGDLHKYLKEKGALSPSTAVNFA-LDIARGMAYLHNEP----------------------------------------- 160 (320)
Q Consensus 123 ~~~~L~~~~~~~~~l~~~~~~~i~-~~l~~~l~~lH~~g----------------------------------------- 160 (320)
+|..+.+..... +.. .+.+ ..+...|..||+-.
T Consensus 108 eGe~~~~~~~~~---~~~--~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~ 182 (321)
T COG3173 108 EGEVVWSALPPE---SLG--RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADR 182 (321)
T ss_pred cceeccCcCCcc---cch--HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHH
Confidence 884333221110 000 1111 24444444444431
Q ss_pred ---------------CCeEecCCCCCcEEEeeCCCCcEEEecCCCccc
Q 020888 161 ---------------NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 193 (320)
Q Consensus 161 ---------------~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~ 193 (320)
..++|||+.+.|+++ ++.+-+-++||+.+..
T Consensus 183 ~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii--~~~~~~gVlDwe~~~l 228 (321)
T COG3173 183 LIKWLEANRPPWAGPPVLVHGDYRPGNLII--DPGRPTGVLDWELATL 228 (321)
T ss_pred HHHHHHhcCCCcCCCceeeeCCcccCCEEE--eCCCeeEEEecccccc
Confidence 029999999999999 6666699999998753
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.00023 Score=61.33 Aligned_cols=142 Identities=19% Similarity=0.160 Sum_probs=97.1
Q ss_pred ccCccceecccCceEEEEEEEC-CCceEEEEccCCCCCc-----------------H--HHHHHHHHHHHHHHhCCC--C
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDD-----------------R--LVIQDFRHEVNLLVKLRH--P 100 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~-~~~~~~K~~~~~~~~~-----------------~--~~~~~~~~e~~~l~~l~h--~ 100 (320)
-+.+...||-|-.+.||.+.+. |++.++|.=.-....- . -..-...+|+..++.|.. .
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 3567788999999999999886 8888888422111000 0 001123457777777742 4
Q ss_pred cccceeeeEEeCCceEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCC
Q 020888 101 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSA 180 (320)
Q Consensus 101 ~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~ 180 (320)
-+++.+++. .-++|||.+.|-+|.+...-. +. ..+...++..+--|...| ++|||+.--||++ ..+
T Consensus 173 pVPkpiD~~----RH~Vvmelv~g~Pl~~v~~v~---d~---~~ly~~lm~~Iv~la~~G--lIHgDFNEFNimv--~dd 238 (465)
T KOG2268|consen 173 PVPKPIDHN----RHCVVMELVDGYPLRQVRHVE---DP---PTLYDDLMGLIVRLANHG--LIHGDFNEFNIMV--KDD 238 (465)
T ss_pred CCCCccccc----ceeeHHHhhcccceeeeeecC---Ch---HHHHHHHHHHHHHHHHcC--ceecccchheeEE--ecC
Confidence 455666643 357899999887877654321 22 234556677778889989 9999999999999 677
Q ss_pred CcEEEecCCCcccccccC
Q 020888 181 DHLKVGDFGLSKLIKVQN 198 (320)
Q Consensus 181 ~~~~L~dfg~~~~~~~~~ 198 (320)
+.++++||=.+..+..++
T Consensus 239 ~~i~vIDFPQmvS~sh~n 256 (465)
T KOG2268|consen 239 DKIVVIDFPQMVSTSHPN 256 (465)
T ss_pred CCEEEeechHhhccCCCc
Confidence 889999998777665544
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.003 Score=57.00 Aligned_cols=77 Identities=13% Similarity=0.116 Sum_probs=52.1
Q ss_pred ccceecccCceEEEEEEECCCceEEEEccCCCCCc-H---HHHHHHHHHHHHHHhCC---CCcccceeeeEEeCCceEEE
Q 020888 46 SSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDD-R---LVIQDFRHEVNLLVKLR---HPNIVQFLGAVTERKPLMLI 118 (320)
Q Consensus 46 ~~~~lg~g~~~~vy~~~~~~~~~~~K~~~~~~~~~-~---~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~iv 118 (320)
..+.+|.|....||++.+.+..++||.-....... . ....+-..|.+.|+.+. ...+++++.++. +..+++
T Consensus 36 ~~~eiggGn~N~VyrV~~~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSSSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred eEEEcCCCceeeEEEEEcCCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 35678999999999998877789999765222100 0 12344455677776663 347778888777 345788
Q ss_pred EecCCC
Q 020888 119 TEYLRG 124 (320)
Q Consensus 119 ~e~~~~ 124 (320)
||++++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999966
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.0021 Score=55.55 Aligned_cols=75 Identities=19% Similarity=0.144 Sum_probs=48.2
Q ss_pred CccceecccCceEEEEEEECCCceEEEEccCCCCCcHHHHHHHHHHHHHHHhC---CCCcccceeeeEEeCCceEEEEec
Q 020888 45 SSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL---RHPNIVQFLGAVTERKPLMLITEY 121 (320)
Q Consensus 45 ~~~~~lg~g~~~~vy~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~~~iv~e~ 121 (320)
+..+.++.|..+.+|++...++.+.+|.-..... ..+..|.+-|+.| .--.+++++.+...++..|+++||
T Consensus 20 ~~~~~v~GG~i~~a~~~~~~~~~~FvK~~~~~~~------~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~ 93 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLDTDGGSYFVKVNSESGR------DMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEF 93 (288)
T ss_dssp -EEEEE--SSSSEEEEEETTS-EEEEEEEEGGGC------CHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-
T ss_pred eeeEecCCCChhheEEEECCCccEEEEecChhhH------HHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEe
Confidence 3456788899999999997789999997642211 4566777777777 345678899998887778999999
Q ss_pred CCCC
Q 020888 122 LRGG 125 (320)
Q Consensus 122 ~~~~ 125 (320)
++.+
T Consensus 94 l~~~ 97 (288)
T PF03881_consen 94 LEMG 97 (288)
T ss_dssp ----
T ss_pred ecCC
Confidence 8765
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.19 E-value=0.0073 Score=52.08 Aligned_cols=45 Identities=18% Similarity=0.064 Sum_probs=29.9
Q ss_pred eecccCceEEEEEEEC-CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCC
Q 020888 49 IIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR 98 (320)
Q Consensus 49 ~lg~g~~~~vy~~~~~-~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~ 98 (320)
..++|....|+.+... +..+++|.-+. ......+.+|.++++.+.
T Consensus 18 ~~~~g~~~~v~~i~~~~g~~~VlR~p~~-----~~~~~~l~rE~~vL~~L~ 63 (276)
T cd05152 18 LNESGLDFQVVFAKDTDGVPWVLRIPRR-----PDVSERAAAEKRVLALVR 63 (276)
T ss_pred ecCCcceeEEEEEEcCCCCeEEEEecCC-----HHHHHHHHHHHHHHHHHH
Confidence 3355666677777553 78888885532 222356788999998884
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.0062 Score=54.33 Aligned_cols=136 Identities=14% Similarity=0.223 Sum_probs=77.5
Q ss_pred cceecccCceEEEEEEEC------CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcc-cceeeeEEeCCceEEEE
Q 020888 47 SAIIGKGSFGEILKAYWR------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI-VQFLGAVTERKPLMLIT 119 (320)
Q Consensus 47 ~~~lg~g~~~~vy~~~~~------~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~iv~ 119 (320)
++.+..|-...+|++... ++.+++|+........ +. -.+|..+++.+...++ .++++.+..+ .|.
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~---id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~ 112 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELF---FD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVE 112 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCee---ec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEE
Confidence 345666888899998753 3678999775532211 12 2568888888754333 4566665443 578
Q ss_pred ecCCCCCHHH-----------H---HHH-h--C------CCCHHHHHHHHHHHH-----------------HH---HHH-
Q 020888 120 EYLRGGDLHK-----------Y---LKE-K--G------ALSPSTAVNFALDIA-----------------RG---MAY- 155 (320)
Q Consensus 120 e~~~~~~L~~-----------~---~~~-~--~------~l~~~~~~~i~~~l~-----------------~~---l~~- 155 (320)
+|+++.+|.. + +.+ + . ...+..+..++.++. .. |..
T Consensus 113 efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~ 192 (344)
T PLN02236 113 EFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKE 192 (344)
T ss_pred EeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHH
Confidence 8887766531 1 111 0 0 011223333322211 11 111
Q ss_pred HhcC--CCCeEecCCCCCcEEEeeCC-CCcEEEecCCCcc
Q 020888 156 LHNE--PNVIIHRDLKPRNVLLVNSS-ADHLKVGDFGLSK 192 (320)
Q Consensus 156 lH~~--g~~ivH~di~p~nI~~~~~~-~~~~~L~dfg~~~ 192 (320)
+... ...++|+|+++.||++ ++ ++.+.++||+.+.
T Consensus 193 ~~~~~~~~~~cH~Dl~~~Nil~--~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 193 LSGDDQEIGFCHNDLQYGNIMI--DEETRAITIIDYEYAS 230 (344)
T ss_pred hcccCCCceEEeCCCCcCcEEE--eCCCCcEEEEeehhcc
Confidence 1111 1238999999999999 44 4679999999774
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=97.04 E-value=0.035 Score=48.70 Aligned_cols=65 Identities=20% Similarity=0.247 Sum_probs=39.1
Q ss_pred eEEEEEEECCCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCC--cccceeee------EEeCCceEEEEecCCCCCH
Q 020888 56 GEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP--NIVQFLGA------VTERKPLMLITEYLRGGDL 127 (320)
Q Consensus 56 ~~vy~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~--~i~~~~~~------~~~~~~~~iv~e~~~~~~L 127 (320)
-.||++...+..+++|.+... . ..+..++..+..|... .+++++.. ...++..+++++|++|.++
T Consensus 10 ~~v~~v~t~~g~~~LK~~~~~----~---~~~~~~~~~~~~L~~~g~~vp~~i~t~~g~~~~~~~~~~~~l~~~i~G~~~ 82 (313)
T TIGR02906 10 RNVYKVETDSGNKCLKKINYP----P---ERLLFILGAQEHLRKNGFNIPKILKTKDGELYVKYNGDLYVLTEWIEGREC 82 (313)
T ss_pred ccEEEEEeCCCCeEEEEcCCC----H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEehhccCcCC
Confidence 359998876668999987421 1 2344455555555322 33444432 2335678999999988543
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.99 E-value=0.0079 Score=53.35 Aligned_cols=73 Identities=18% Similarity=0.254 Sum_probs=45.4
Q ss_pred cceecccCceEEEEEEECC-----CceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcc-cceeeeEEeCCceEEEEe
Q 020888 47 SAIIGKGSFGEILKAYWRG-----TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI-VQFLGAVTERKPLMLITE 120 (320)
Q Consensus 47 ~~~lg~g~~~~vy~~~~~~-----~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~iv~e 120 (320)
++.|..|-...+|++...+ ..+++|+........ -.-.+|..+++.+...++ +++++++..+ +|.+
T Consensus 19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~----IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~ 90 (330)
T PLN02421 19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYV----IDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQS 90 (330)
T ss_pred EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeE----echHHHHHHHHHHHhcCCCCceeEEeCCc----Eeeh
Confidence 3456667888899987543 378899775432211 123457888887754444 4566655332 5888
Q ss_pred cCCCCCH
Q 020888 121 YLRGGDL 127 (320)
Q Consensus 121 ~~~~~~L 127 (320)
|++|.+|
T Consensus 91 fi~g~~l 97 (330)
T PLN02421 91 FINARTL 97 (330)
T ss_pred hhcCCCC
Confidence 8877665
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.94 E-value=0.032 Score=48.96 Aligned_cols=29 Identities=17% Similarity=0.208 Sum_probs=25.9
Q ss_pred CeEecCCCCCcEEEeeCCCCcEEEecCCCcc
Q 020888 162 VIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 192 (320)
Q Consensus 162 ~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~ 192 (320)
.+||||+.++||++ ++++.+.++||..+.
T Consensus 197 ~lcHgD~~~~Nvl~--~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLY--DETRGGYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEE--cCCCCEEEEEhhhcc
Confidence 39999999999999 777889999999775
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.90 E-value=0.0065 Score=53.48 Aligned_cols=112 Identities=22% Similarity=0.308 Sum_probs=73.6
Q ss_pred eCCceEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCC
Q 020888 111 ERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGL 190 (320)
Q Consensus 111 ~~~~~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~ 190 (320)
+..+.|++|++- |++|.-. . .-.++++..++++.+..+.-+... .+.-|+|+.-+||++ + +|+|.|+||.+
T Consensus 297 e~~y~yl~~kdh-gt~is~i-k---~~~~~e~lsff~s~~sil~~lekk-f~fehrnlt~~niLI--d-~GnvtLIDfkl 367 (488)
T COG5072 297 ETLYLYLHFKDH-GTPISII-K---ADRSEEELSFFWSCISILDILEKK-FPFEHRNLTLDNILI--D-EGNVTLIDFKL 367 (488)
T ss_pred CceEEEEEEecC-Cceeeee-e---cccHHHHHHHHHHHHHHHhhhhhc-CCcccccccccceee--e-cCceEEEEeee
Confidence 344567788866 6666543 2 236778889999988887777665 668999999999999 6 89999999999
Q ss_pred cccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhC
Q 020888 191 SKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEG 244 (320)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g 244 (320)
++.-..++. .....+--|..+.|.. +.+=+||-+ |--++.|
T Consensus 368 sRl~~~q~~---------isy~rldhp~lF~G~d-d~QFeIYrl---Mr~l~~g 408 (488)
T COG5072 368 SRLSYSQGI---------ISYNRLDHPDLFNGVD-DYQFEIYRL---MRRLLKG 408 (488)
T ss_pred eecccCCce---------eeccccCchhhhcCcc-ceeeeHHHH---HHHHhcC
Confidence 984332221 1112233444555433 555666663 4444444
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.85 E-value=0.011 Score=52.14 Aligned_cols=137 Identities=20% Similarity=0.209 Sum_probs=79.1
Q ss_pred ceecccCceEEEEEEECCCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCC---CCcccc---e----eeeEEeCCceEE
Q 020888 48 AIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR---HPNIVQ---F----LGAVTERKPLML 117 (320)
Q Consensus 48 ~~lg~g~~~~vy~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~---~----~~~~~~~~~~~i 117 (320)
..|.+ ....+|++..++..+++|+.... ... ..+.-|...+..+. .+-.++ . +.........+.
T Consensus 32 ~~l~s-~eN~~f~~~~~~g~~iLki~~~~-~~~----~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~ 105 (331)
T COG2334 32 RGLNS-EENSNFRVQTEDGRYILKIYRPG-WTR----AEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAA 105 (331)
T ss_pred ccccc-ccCceEEEEecCCCeEEEEecCC-CCH----HHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEE
Confidence 34445 66789999988777799988665 322 56666777777773 221112 1 111222247889
Q ss_pred EEecCCCCCHHH------------HHHH-------hC--------CCCHHH-------------HHHHHHHHHHHHHHHh
Q 020888 118 ITEYLRGGDLHK------------YLKE-------KG--------ALSPST-------------AVNFALDIARGMAYLH 157 (320)
Q Consensus 118 v~e~~~~~~L~~------------~~~~-------~~--------~l~~~~-------------~~~i~~~l~~~l~~lH 157 (320)
+++|++|..+.. ++.+ .. ...|.. ......++...+..+.
T Consensus 106 lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~ 185 (331)
T COG2334 106 LFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLL 185 (331)
T ss_pred EEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHH
Confidence 999999877662 1110 10 112210 0111223333333333
Q ss_pred cC--------CCCeEecCCCCCcEEEeeCCCC-cEEEecCCCcc
Q 020888 158 NE--------PNVIIHRDLKPRNVLLVNSSAD-HLKVGDFGLSK 192 (320)
Q Consensus 158 ~~--------g~~ivH~di~p~nI~~~~~~~~-~~~L~dfg~~~ 192 (320)
.. +..+||+|+.|+||++ +.+. -+-++||+.+.
T Consensus 186 ~~~~~~lp~~~~~iIH~D~~~~NVl~--d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 186 ARLPAHLPALGDQIIHGDLHPDNVLF--DDDTDVSGFIDFDDAG 227 (331)
T ss_pred hhchhhCCcccceeeecCCCccceeE--cCCCCeeeEEEccccc
Confidence 32 1128999999999999 5555 38899999775
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.83 E-value=0.053 Score=48.01 Aligned_cols=71 Identities=14% Similarity=0.046 Sum_probs=42.8
Q ss_pred ccCceEEEEEEEC-CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCc--cccee---e--eEEeCCceEEEEecCC
Q 020888 52 KGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN--IVQFL---G--AVTERKPLMLITEYLR 123 (320)
Q Consensus 52 ~g~~~~vy~~~~~-~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~---~--~~~~~~~~~iv~e~~~ 123 (320)
.+....||++..+ +..+++|+....... ...+..|++.+..+...+ ++... + +...++..+.++++++
T Consensus 35 ~s~eN~vy~v~~~~~~~~vlKv~r~~~~~----~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~ 110 (325)
T PRK11768 35 NSYENRVYQFGDEDGRRVVAKFYRPERWS----DAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRG 110 (325)
T ss_pred ccccceEEEEecCCCCEEEEEEcCcccCC----HHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeC
Confidence 3455679998875 668999977533222 255666777776663211 22222 1 2233567889999997
Q ss_pred CCC
Q 020888 124 GGD 126 (320)
Q Consensus 124 ~~~ 126 (320)
|..
T Consensus 111 G~~ 113 (325)
T PRK11768 111 GRA 113 (325)
T ss_pred CCC
Confidence 753
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.79 E-value=0.018 Score=51.11 Aligned_cols=74 Identities=19% Similarity=0.299 Sum_probs=45.0
Q ss_pred eecccCceEEEEEEECC--CceEEEEccCCCC--C-c-HHHHHHHHHHHHHHHhCC--CC-cccceeeeEEeCCceEEEE
Q 020888 49 IIGKGSFGEILKAYWRG--TPVAIKRILPSLS--D-D-RLVIQDFRHEVNLLVKLR--HP-NIVQFLGAVTERKPLMLIT 119 (320)
Q Consensus 49 ~lg~g~~~~vy~~~~~~--~~~~~K~~~~~~~--~-~-~~~~~~~~~e~~~l~~l~--h~-~i~~~~~~~~~~~~~~iv~ 119 (320)
.+|.|....||++...+ +.++||.-..... . . .-...+..-|.+.|+... .| .+++++.+-. +...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D~--e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFDT--EMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEcc--ccceehH
Confidence 57999999999998764 5799985432111 0 0 122355566778887763 34 3444444332 3456889
Q ss_pred ecCCC
Q 020888 120 EYLRG 124 (320)
Q Consensus 120 e~~~~ 124 (320)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 98854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.67 E-value=0.00018 Score=73.11 Aligned_cols=154 Identities=17% Similarity=0.108 Sum_probs=110.7
Q ss_pred HHHHHHhCCCCcccceeeeEE--eCCceEEEEecCCCCCHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHhcC---C
Q 020888 90 EVNLLVKLRHPNIVQFLGAVT--ERKPLMLITEYLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLHNE---P 160 (320)
Q Consensus 90 e~~~l~~l~h~~i~~~~~~~~--~~~~~~iv~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~~l~~~l~~lH~~---g 160 (320)
|...++...|+++.....-.. .....+..++++.+|.+.+.+-. .+.++...+.....+.+....-+|.. |
T Consensus 1279 e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg 1358 (2724)
T KOG1826|consen 1279 ERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLG 1358 (2724)
T ss_pred hhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCC
Confidence 333444556777666544442 33445788899889999888743 34566666666666656666666555 4
Q ss_pred CCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHH
Q 020888 161 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYE 240 (320)
Q Consensus 161 ~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ 240 (320)
+..+|.++++.|.++ ..+.++++.++|+.+...+ .....+...+++-|+.|++.+.-.++.++|+|.+|+.+|.
T Consensus 1359 ~T~v~~~Lkf~lpmI--Vtny~v~~gk~gLdKIknp----~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~ 1432 (2724)
T KOG1826|consen 1359 NTNVSKSLKFTLPMI--VTNYNVKLGKGGLDKIKNP----VLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYL 1432 (2724)
T ss_pred ccchhhhhhhhccce--ecCCcccccccccccccCc----hHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHH
Confidence 568999999999999 8888999999999872111 1123344567778888999888889999999999999999
Q ss_pred HHhCCCCCC
Q 020888 241 MLEGEPPLA 249 (320)
Q Consensus 241 ll~g~~p~~ 249 (320)
...|..+|-
T Consensus 1433 rs~~n~~fi 1441 (2724)
T KOG1826|consen 1433 RSDGNAYFI 1441 (2724)
T ss_pred HhcccHHHH
Confidence 888877664
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.58 E-value=0.0085 Score=55.05 Aligned_cols=155 Identities=19% Similarity=0.225 Sum_probs=93.7
Q ss_pred HHHHHHHHHHHhCCCCcccceeeeEEeC-CceEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 020888 85 QDFRHEVNLLVKLRHPNIVQFLGAVTER-KPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVI 163 (320)
Q Consensus 85 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~i 163 (320)
.++.-....++.+.|++...++++.... .+..+|+|++ +.+|.++...+. +-..... -.| +
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~-l~~~s~~--------------~~~--~ 88 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN-LKDESLL--------------AHG--V 88 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc-cchhhhc--------------ccc--c
Confidence 4566678889999999999999987543 3478899999 669999987653 2111111 111 2
Q ss_pred EecCCCCCcEEEeeCCCCcEEEecCCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh
Q 020888 164 IHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE 243 (320)
Q Consensus 164 vH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~ 243 (320)
.| -||+. .+| -++. |. | ....+++|||++|.++.++.-
T Consensus 89 ~~-----~~~~~---------~td-~~~t---------------------~~-~-----~~~~pKsdVwsl~~i~~el~L 126 (725)
T KOG1093|consen 89 LH-----LNIIY---------ITD-HFLT---------------------KY-P-----SPIGPKSDVWSLGFIILELYL 126 (725)
T ss_pred ce-----ehhhh---------ccc-cccc---------------------cC-C-----CCCCcchhhhhHHHHHHHHHH
Confidence 22 22222 222 0000 00 0 001148999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHhCCCCCCC----------CCCCCHHHHHHHHHHhhcCCCCCCCHHHHH
Q 020888 244 GEPPLANYEPYEAAKYVAEGHRPFFR----------AKGFTPELRELTEKCWAADMNQRPSFLDIL 299 (320)
Q Consensus 244 g~~p~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll 299 (320)
|..-+......+....+.+-...... ...++.-+..+...|+-..|..||...++.
T Consensus 127 ~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~ 192 (725)
T KOG1093|consen 127 GISLEAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELS 192 (725)
T ss_pred hhHHHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHh
Confidence 87766655544444333332211111 123566678889999999998888655543
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.24 E-value=0.037 Score=49.82 Aligned_cols=76 Identities=17% Similarity=0.181 Sum_probs=48.1
Q ss_pred cceecccCceEEEEEEEC--CCceEEEEccCCC-CCc--HHHHHHHHHHHHHHHhCC--CC-cccceeeeEEeCCceEEE
Q 020888 47 SAIIGKGSFGEILKAYWR--GTPVAIKRILPSL-SDD--RLVIQDFRHEVNLLVKLR--HP-NIVQFLGAVTERKPLMLI 118 (320)
Q Consensus 47 ~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~-~~~--~~~~~~~~~e~~~l~~l~--h~-~i~~~~~~~~~~~~~~iv 118 (320)
.+.||.|.-+.||++.+. ++.++||.-.... ... .-..++..-|.+.|+... .| ++++++.+-. +...+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D~--e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFDS--VMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEECc--HHhhHH
Confidence 468899999999999975 5679988542211 111 122466677888888763 34 4444554333 345688
Q ss_pred EecCCC
Q 020888 119 TEYLRG 124 (320)
Q Consensus 119 ~e~~~~ 124 (320)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 888853
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.15 E-value=0.041 Score=45.24 Aligned_cols=88 Identities=16% Similarity=0.172 Sum_probs=57.8
Q ss_pred HHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 020888 85 QDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVII 164 (320)
Q Consensus 85 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~iv 164 (320)
.-+.++..+++++. +|+++..= ++-.+-++.|.|-.... ... .+...=+.+|.-.|+.+...+
T Consensus 103 ~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i---------~~~----N~i~agi~~L~~fH~~~~~~l 165 (308)
T PF07387_consen 103 ALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI---------NFS----NFITAGIKDLMDFHSENQHCL 165 (308)
T ss_pred hhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc---------chh----HHHHHhHHHHHHhhccCCCee
Confidence 45677888887654 35555421 34446788888733110 111 111111456777896655599
Q ss_pred ecCCCCCcEEEeeCCCCcEEEecCCCc
Q 020888 165 HRDLKPRNVLLVNSSADHLKVGDFGLS 191 (320)
Q Consensus 165 H~di~p~nI~~~~~~~~~~~L~dfg~~ 191 (320)
|||..|+|||. |+.|.+||.|-+..
T Consensus 166 HGD~np~NiM~--D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 166 HGDCNPDNIMC--DKFGYLKLVDPVCL 190 (308)
T ss_pred cCCCChhheee--cCCCCEEecChhhh
Confidence 99999999999 99999999998754
|
The function of this family is unknown. |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=95.88 E-value=0.15 Score=42.35 Aligned_cols=74 Identities=20% Similarity=0.226 Sum_probs=53.7
Q ss_pred ceecccCceEEEEEEECCCceEEEEccCCCCCcHHHHHHHHHHHHHHHhC---CCCcccceeeeEEeCCceEEEEecCCC
Q 020888 48 AIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL---RHPNIVQFLGAVTERKPLMLITEYLRG 124 (320)
Q Consensus 48 ~~lg~g~~~~vy~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~~~iv~e~~~~ 124 (320)
+.+..|.-...|.+.+...++.+|+-... ....+..|+.-|..+ +.-.+.+++.+....+..|+|+||++-
T Consensus 22 ~~v~gG~inea~~v~dg~~~~FvK~n~~~------~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~ 95 (286)
T COG3001 22 EEVSGGDINEAWRLRDGTDPFFVKCNQRE------QLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPT 95 (286)
T ss_pred cccCCccccceeEeecCCcceEEEecchh------hHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccC
Confidence 45566667778888877889999964322 235566677666665 345678889888999999999999976
Q ss_pred CCH
Q 020888 125 GDL 127 (320)
Q Consensus 125 ~~L 127 (320)
+.+
T Consensus 96 ~~~ 98 (286)
T COG3001 96 GPL 98 (286)
T ss_pred CCC
Confidence 544
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.75 E-value=0.43 Score=48.94 Aligned_cols=31 Identities=26% Similarity=0.452 Sum_probs=23.9
Q ss_pred CeEecCCCCCcEEEeeCCCCcEE-EecCCCcc
Q 020888 162 VIIHRDLKPRNVLLVNSSADHLK-VGDFGLSK 192 (320)
Q Consensus 162 ~ivH~di~p~nI~~~~~~~~~~~-L~dfg~~~ 192 (320)
.++|+|+.++||++..+..+.+. |+|||.+.
T Consensus 204 ~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 204 QVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred ceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 49999999999999433322555 99999775
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.43 E-value=0.3 Score=44.06 Aligned_cols=59 Identities=25% Similarity=0.336 Sum_probs=44.3
Q ss_pred eEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcC-CCCeEecCCCCCcEEEe
Q 020888 115 LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE-PNVIIHRDLKPRNVLLV 176 (320)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~-g~~ivH~di~p~nI~~~ 176 (320)
..++-+|..|.++..+++..+ .++..+..++.-...|+-.+--. + .+|.|+.|.||++.
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~~~-~pe~l~kkva~lg~~AllkMl~vDN--FvHaDlHPGNVlir 379 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKWKS-QPEALVKKVAKLGVNALLKMLIVDN--FVHADLHPGNVLIR 379 (565)
T ss_pred ceeeeeccccccHHhhhhccc-ChHHHHHHHHHHHHHHHHHHHHhhc--ceecccCCCcEEEE
Confidence 455566778889998887643 46667777777777777765544 4 99999999999993
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.27 E-value=0.24 Score=44.80 Aligned_cols=74 Identities=20% Similarity=0.241 Sum_probs=43.4
Q ss_pred cceecccCceEEEEEEECC---Cc-----eEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcc-cceeeeEEeCCceEE
Q 020888 47 SAIIGKGSFGEILKAYWRG---TP-----VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI-VQFLGAVTERKPLML 117 (320)
Q Consensus 47 ~~~lg~g~~~~vy~~~~~~---~~-----~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~i 117 (320)
++.+..|-.+.+|++...+ .. |+++........ . -.-.+|+++++.+...++ .++++.+.+ ++
T Consensus 55 i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l---~-IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~ 126 (383)
T PTZ00384 55 IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSL---V-IDNDLQYNIAKLLGDNNFGPKIIGRFGD----FT 126 (383)
T ss_pred EEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCce---E-eccHHHHHHHHHHHhCCCCCeEEEecCC----EE
Confidence 4566678888999987542 12 444432111111 1 122457888888864444 456666653 48
Q ss_pred EEecCCCCCHH
Q 020888 118 ITEYLRGGDLH 128 (320)
Q Consensus 118 v~e~~~~~~L~ 128 (320)
+.||++|.+|.
T Consensus 127 l~efIeGr~l~ 137 (383)
T PTZ00384 127 IQEWVEGNTMG 137 (383)
T ss_pred EEEEeccccCC
Confidence 99999887653
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.13 E-value=0.38 Score=44.43 Aligned_cols=74 Identities=16% Similarity=0.165 Sum_probs=44.5
Q ss_pred ccceecccCceEEEEEEEC----------CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCccc-ceeeeEEeCCc
Q 020888 46 SSAIIGKGSFGEILKAYWR----------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIV-QFLGAVTERKP 114 (320)
Q Consensus 46 ~~~~lg~g~~~~vy~~~~~----------~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~-~~~~~~~~~~~ 114 (320)
.++.|..|-...+|++... ++.|++++.-.....- -.-.+|..+++.+...++- ++++.+.+
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~l----IdR~~E~~v~~~ls~~gi~P~l~~~f~g--- 181 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDEL----YNPISEFEVYKTMSKYRIAPQLLNTFSG--- 181 (442)
T ss_pred EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccce----eCHHHHHHHHHHHHHCCCCCceEEEeCC---
Confidence 4567777888899998754 3578888764432211 1223466666666533333 45555432
Q ss_pred eEEEEecCCCCCH
Q 020888 115 LMLITEYLRGGDL 127 (320)
Q Consensus 115 ~~iv~e~~~~~~L 127 (320)
..+.+|++|.+|
T Consensus 182 -g~I~efi~g~~l 193 (442)
T PTZ00296 182 -GRIEEWLYGDPL 193 (442)
T ss_pred -CEEEEeeCCccC
Confidence 357899987644
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 320 | ||||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-40 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-39 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 5e-39 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 9e-38 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 7e-37 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-36 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-36 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-36 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 5e-36 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 5e-36 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-35 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-35 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 6e-35 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-34 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-34 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 6e-34 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-33 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 4e-32 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 5e-32 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-31 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-31 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-31 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-31 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-30 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-30 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-30 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-30 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-30 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-30 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-30 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-30 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-30 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-30 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-30 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-30 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 4e-30 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-30 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 5e-30 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 5e-30 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-30 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 7e-30 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-30 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 9e-30 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-30 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 9e-30 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 9e-30 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 9e-30 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 9e-30 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-29 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-29 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-29 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-29 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-29 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-29 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-29 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-29 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-29 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-29 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-29 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-29 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-29 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-29 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-29 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-29 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-29 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 4e-29 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 5e-29 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 5e-29 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 5e-29 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 5e-29 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-29 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 5e-29 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 6e-29 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 7e-29 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 8e-29 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 8e-29 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-29 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-28 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-28 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-28 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-28 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-28 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-28 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-28 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-28 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-28 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-28 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 4e-28 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-28 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-28 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 5e-28 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 6e-28 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 6e-28 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 6e-28 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 9e-28 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-27 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-27 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-27 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 4e-27 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-27 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 6e-27 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-27 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-27 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 7e-27 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-27 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 7e-27 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 7e-27 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 7e-27 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-27 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 8e-27 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 8e-27 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 8e-27 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 8e-27 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 8e-27 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 9e-27 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 9e-27 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 9e-27 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-26 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-26 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-26 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-26 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-26 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-26 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-26 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-26 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-26 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-26 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-26 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-26 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-26 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-26 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-26 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-26 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-26 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-26 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-26 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-26 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-26 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-26 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-26 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-26 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-26 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-26 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-26 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-26 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-26 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-26 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-26 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-26 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-26 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-26 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-26 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-26 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-26 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-26 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-26 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-26 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-26 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-26 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 4e-26 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-26 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 4e-26 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 5e-26 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-26 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 5e-26 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 5e-26 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 5e-26 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-26 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-26 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 5e-26 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-26 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 6e-26 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 6e-26 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 6e-26 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 6e-26 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 6e-26 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 6e-26 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 6e-26 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 6e-26 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-26 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 7e-26 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-26 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 8e-26 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-25 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-25 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-25 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-25 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-25 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-25 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-25 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-25 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-25 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-25 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-25 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-25 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-25 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-25 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-25 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-25 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-25 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-25 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-25 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-25 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-25 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-25 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-25 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-25 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-25 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-25 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 4e-25 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 4e-25 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-25 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-25 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 4e-25 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-25 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-25 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-25 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 5e-25 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 5e-25 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 5e-25 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-25 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 6e-25 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 6e-25 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 7e-25 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 7e-25 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 7e-25 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 7e-25 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 9e-25 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 9e-25 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-24 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-24 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-24 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-24 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-24 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-24 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-24 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-24 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-24 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-24 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-24 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-24 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-24 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-24 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-24 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-24 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-24 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-24 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-24 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-24 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-24 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-24 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-24 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-24 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-24 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-24 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-24 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-24 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-24 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-24 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-24 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-24 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 4e-24 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-24 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 4e-24 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 4e-24 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 4e-24 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-24 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 4e-24 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 4e-24 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 4e-24 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-24 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 4e-24 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 4e-24 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 4e-24 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-24 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-24 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 4e-24 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 4e-24 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-24 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 4e-24 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-24 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-24 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 4e-24 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-24 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-24 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 5e-24 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 5e-24 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 5e-24 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-24 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 5e-24 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 6e-24 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 6e-24 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 6e-24 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 7e-24 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 7e-24 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 7e-24 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 8e-24 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 8e-24 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 8e-24 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 8e-24 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 9e-24 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 9e-24 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-23 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-23 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-23 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-23 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-23 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-23 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-23 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-23 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-23 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-23 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-23 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-23 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-23 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-23 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-23 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-23 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-23 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-23 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-23 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-23 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-23 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-23 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-23 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-23 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-23 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-23 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-23 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-23 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-23 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-23 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-23 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-23 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-23 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-23 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-23 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-23 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-23 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-23 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-23 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-23 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-23 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 4e-23 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-23 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 4e-23 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 4e-23 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-23 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 5e-23 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 5e-23 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 5e-23 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 5e-23 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 6e-23 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 6e-23 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 6e-23 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 7e-23 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 8e-23 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 8e-23 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 9e-23 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 9e-23 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 9e-23 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-22 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-22 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-22 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-22 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-22 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-22 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-22 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-22 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-22 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-22 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-22 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-22 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-22 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-22 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-22 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-22 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-22 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-22 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-22 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-22 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-22 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-22 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-22 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-22 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-22 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-22 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 4e-22 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 5e-22 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 5e-22 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 5e-22 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 5e-22 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 5e-22 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 5e-22 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 6e-22 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-22 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-22 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 7e-22 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 8e-22 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-22 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-22 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 8e-22 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 9e-22 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 9e-22 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-21 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-21 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-21 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-21 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-21 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-21 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-21 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-21 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-21 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-21 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-21 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-21 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-21 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-21 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-21 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-21 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-21 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-21 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-21 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-21 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-21 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-21 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-21 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-21 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-21 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 4e-21 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 4e-21 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-21 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 4e-21 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 5e-21 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 5e-21 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 5e-21 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-21 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 5e-21 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 5e-21 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-21 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-21 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 6e-21 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-21 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 6e-21 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 7e-21 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-21 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 7e-21 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 7e-21 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-21 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 9e-21 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-20 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-20 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-20 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-20 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-20 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-20 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-20 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-20 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-20 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-20 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-20 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-20 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-20 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-20 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-20 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-20 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-20 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-20 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-20 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-20 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-20 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-20 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-20 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-20 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 4e-20 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 4e-20 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 5e-20 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 5e-20 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 5e-20 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-20 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 5e-20 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 5e-20 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 5e-20 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 6e-20 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 6e-20 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 6e-20 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 6e-20 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 6e-20 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 6e-20 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 6e-20 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 6e-20 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 6e-20 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 6e-20 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 6e-20 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-20 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-20 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-20 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 7e-20 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 7e-20 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 7e-20 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 7e-20 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 7e-20 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 7e-20 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 7e-20 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 7e-20 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-20 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 8e-20 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 8e-20 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-20 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 8e-20 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 8e-20 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 8e-20 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 9e-20 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 9e-20 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 9e-20 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 9e-20 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-19 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-19 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-19 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-19 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-19 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-19 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-19 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-19 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-19 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-19 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-19 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-19 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-19 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-19 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-19 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-19 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-19 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-19 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-19 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-19 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-19 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-19 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-19 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-19 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-19 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-19 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-19 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-19 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-19 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-19 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-19 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-19 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-19 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-19 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-19 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-19 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-19 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-19 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-19 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-19 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-19 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-19 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-19 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-19 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-19 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-19 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-19 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-19 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-19 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-19 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-19 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 4e-19 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-19 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-19 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-19 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-19 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 6e-19 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 6e-19 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 6e-19 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 6e-19 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 6e-19 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 6e-19 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 6e-19 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 7e-19 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 7e-19 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 7e-19 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 7e-19 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 7e-19 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 7e-19 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 8e-19 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 8e-19 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-19 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 8e-19 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 8e-19 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 8e-19 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 8e-19 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-19 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 9e-19 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 9e-19 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 9e-19 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 9e-19 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-18 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-18 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-18 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-18 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-18 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-18 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-18 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-18 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-18 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-18 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-18 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-18 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-18 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-18 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-18 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-18 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-18 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-18 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-18 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-18 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-18 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-18 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-18 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-18 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-18 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-18 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-18 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-18 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-18 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-18 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-18 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-18 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-18 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-18 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-18 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-18 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-18 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-18 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-18 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-18 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-18 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-18 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-18 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-18 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-18 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-18 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 3e-18 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 4e-18 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-18 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-18 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-18 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-18 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-18 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-18 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-18 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 5e-18 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 5e-18 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 5e-18 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 6e-18 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-18 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 6e-18 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 8e-18 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-17 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-17 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-17 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-17 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-17 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-17 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-17 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-17 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-17 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-17 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-17 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-17 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-17 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-17 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-17 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-17 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-17 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-17 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-17 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-17 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-17 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-17 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-17 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-17 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-17 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-17 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-17 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-17 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-17 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-17 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-17 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-17 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-17 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-17 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-17 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-17 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-17 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-17 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-17 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-17 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-17 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-17 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 5e-17 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-17 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-17 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 6e-17 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 6e-17 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 8e-17 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-17 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 9e-17 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 9e-17 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 9e-17 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-16 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-16 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-16 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-16 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-16 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-16 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-16 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-16 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-16 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-16 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-16 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-16 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-16 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-16 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-16 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-16 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 4e-16 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-16 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-16 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 4e-16 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-16 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 4e-16 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-16 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 5e-16 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 5e-16 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 5e-16 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 5e-16 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 5e-16 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 5e-16 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 5e-16 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 5e-16 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-16 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-16 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-16 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 5e-16 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 5e-16 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 5e-16 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 5e-16 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 5e-16 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 6e-16 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-16 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 6e-16 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 6e-16 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 7e-16 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 7e-16 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 7e-16 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 7e-16 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 7e-16 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 7e-16 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 7e-16 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-16 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 7e-16 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 7e-16 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 7e-16 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 7e-16 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 8e-16 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 8e-16 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 8e-16 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 8e-16 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 8e-16 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 8e-16 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 8e-16 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 8e-16 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 8e-16 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-16 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 8e-16 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 8e-16 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 8e-16 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 8e-16 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 8e-16 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 8e-16 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 9e-16 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 9e-16 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 9e-16 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 9e-16 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 9e-16 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 9e-16 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 9e-16 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 9e-16 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 9e-16 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 9e-16 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 9e-16 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 9e-16 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 9e-16 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 9e-16 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 9e-16 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 9e-16 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-15 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-15 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-15 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-15 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-15 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-15 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-15 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-15 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-15 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-15 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-15 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-15 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-15 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-15 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-15 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-15 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-15 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-15 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-15 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-15 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-15 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-15 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-15 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-15 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-15 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-15 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-15 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-15 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-15 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-15 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-15 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-15 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-15 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-15 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-15 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-15 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-15 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-15 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-15 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-15 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-15 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-15 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-15 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-15 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-15 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-15 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 5e-15 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-15 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 5e-15 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 5e-15 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 5e-15 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 5e-15 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 5e-15 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 5e-15 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-15 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 6e-15 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 6e-15 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 6e-15 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 6e-15 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-15 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 6e-15 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 7e-15 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 7e-15 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 7e-15 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 8e-15 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-15 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 8e-15 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-15 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 8e-15 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 8e-15 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 8e-15 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 9e-15 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 9e-15 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-14 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-14 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-14 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-14 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-14 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-14 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-14 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-14 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-14 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-14 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-14 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-14 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-14 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-14 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-14 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-14 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-14 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-14 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-14 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 4e-14 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-14 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-14 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 5e-14 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 5e-14 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-14 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-14 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 6e-14 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 6e-14 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-14 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 6e-14 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 7e-14 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 7e-14 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 7e-14 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-14 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 7e-14 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 7e-14 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 8e-14 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 8e-14 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 8e-14 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 8e-14 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 8e-14 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 8e-14 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 8e-14 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 8e-14 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 8e-14 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 9e-14 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 9e-14 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-13 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-13 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-13 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 1e-13 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-13 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-13 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-13 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-13 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-13 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-13 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-13 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 3e-13 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 3e-13 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 3e-13 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-13 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 3e-13 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 3e-13 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-13 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 4e-13 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 4e-13 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-13 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-13 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 4e-13 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-13 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 4e-13 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-13 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 4e-13 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-13 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 4e-13 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 4e-13 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 4e-13 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 4e-13 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 4e-13 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-13 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 4e-13 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 4e-13 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 5e-13 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 5e-13 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 7e-13 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 7e-13 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 7e-13 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-13 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 7e-13 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 8e-13 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 9e-13 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 9e-13 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-12 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-12 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-12 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-12 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-12 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-12 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-12 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 4e-12 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 5e-12 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 7e-12 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 8e-12 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-11 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-11 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 2e-11 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-11 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-11 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-11 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 4e-11 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 6e-11 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 6e-11 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 6e-11 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 7e-11 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 7e-11 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 9e-11 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-10 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-10 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-10 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 4e-10 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 6e-10 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 6e-10 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 7e-10 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-10 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-10 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-10 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 8e-10 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 9e-10 |
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 353 bits (908), Expect = e-122
Identities = 96/301 (31%), Positives = 153/301 (50%), Gaps = 15/301 (4%)
Query: 22 PKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDR 81
+ D +I +L+ IG GSFG + +A W G+ VA+K ++
Sbjct: 19 ENLYFQGAMDGDDMDIPWCDLNIKE--KIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAE 76
Query: 82 LVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA---LS 138
+ +F EV ++ +LRHPNIV F+GAVT+ L ++TEYL G L++ L + GA L
Sbjct: 77 R-VNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLD 135
Query: 139 PSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 198
++ A D+A+GM YLHN I+HR+LK N+L+ +KV DFGLS+L
Sbjct: 136 ERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLV--DKKYTVKVCDFGLSRLK---- 189
Query: 199 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAK 258
+ G+ +MAPEV + ++K DV+SF +IL+E+ + P N P +
Sbjct: 190 ASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVA 249
Query: 259 YVA-EGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKI-KETLPTDHHWN 316
V + R + P++ + E CW + +RPSF I+ L + K +P + +
Sbjct: 250 AVGFKCKRLEIP-RNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPNRSD 308
Query: 317 I 317
+
Sbjct: 309 L 309
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 337 bits (866), Expect = e-117
Identities = 101/279 (36%), Positives = 144/279 (51%), Gaps = 17/279 (6%)
Query: 35 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDR-LVIQDFRHEVNL 93
EID +EL IIG G FG++ +A+W G VA+K +D I++ R E L
Sbjct: 2 LEIDFAELTLEE--IIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKL 59
Query: 94 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGM 153
L+HPNI+ G + L L+ E+ RGG L++ L K + P VN+A+ IARGM
Sbjct: 60 FAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK-RIPPDILVNWAVQIARGM 118
Query: 154 AYLHNE-PNVIIHRDLKPRNVLLVNSSADH------LKVGDFGLSKLIKVQNSHDVYKMT 206
YLH+E IIHRDLK N+L++ + LK+ DFGL++ H KM+
Sbjct: 119 NYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW-----HRTTKMS 173
Query: 207 GETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRP 266
G+Y +MAPEV + + K DV+S+ ++L+E+L GE P + A VA
Sbjct: 174 A-AGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLA 232
Query: 267 FFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKI 305
+L E CW D + RPSF +IL +L I
Sbjct: 233 LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 333 bits (856), Expect = e-115
Identities = 84/309 (27%), Positives = 136/309 (44%), Gaps = 21/309 (6%)
Query: 22 PKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDR 81
P+ +W+I +L+ +IGKG FG++ W G VAI+ I D+
Sbjct: 15 PRKASQTSIFLQEWDIPFEQLEIGE--LIGKGRFGQVYHGRWHGE-VAIRLIDIE-RDNE 70
Query: 82 LVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL-KEKGALSPS 140
++ F+ EV + RH N+V F+GA L +IT +G L+ + K L +
Sbjct: 71 DQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVN 130
Query: 141 TAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV-QNS 199
A +I +GM YLH + I+H+DLK +NV N + + DFGL + V Q
Sbjct: 131 KTRQIAQEIVKGMGYLHAKG--ILHKDLKSKNVFYDN---GKVVITDFGLFSISGVLQAG 185
Query: 200 HDVYKMTGETGSYRYMAPEVFKHRK---------YDKKVDVFSFAMILYEMLEGEPPLAN 250
K+ + G ++APE+ + + K DVF+ I YE+ E P
Sbjct: 186 RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT 245
Query: 251 YEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKI-KETL 309
+ G +P G E+ ++ CWA + +RP+F ++ LEK+ K
Sbjct: 246 QPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNR 305
Query: 310 PTDHHWNIF 318
H + +
Sbjct: 306 RLSHPGHFW 314
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 331 bits (852), Expect = e-114
Identities = 92/293 (31%), Positives = 144/293 (49%), Gaps = 27/293 (9%)
Query: 28 PLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRL--- 82
P + +E+++ IGKG FG + K + VAIK ++ S+
Sbjct: 7 EFPKSRLPTLADNEIEYEK--QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMI 64
Query: 83 -VIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL-KEKGALSPS 140
Q+F+ EV ++ L HPNIV+ G + P ++ E++ GDL+ L + + S
Sbjct: 65 EKFQEFQREVFIMSNLNHPNIVKLYGLMH--NPPRMVMEFVPCGDLYHRLLDKAHPIKWS 122
Query: 141 TAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD---HLKVGDFGLSKLIKVQ 197
+ LDIA G+ Y+ N+ I+HRDL+ N+ L + + KV DFGLS+
Sbjct: 123 VKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ---- 178
Query: 198 NSHDVYKMTGETGSYRYMAPEVF--KHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYE 255
V+ ++G G++++MAPE + Y +K D +SFAMILY +L GE P Y +
Sbjct: 179 ---SVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK 235
Query: 256 AAKYVA---EGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKI 305
EG RP + P LR + E CW+ D +RP F I+K L ++
Sbjct: 236 IKFINMIREEGLRPTI-PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 331 bits (851), Expect = e-114
Identities = 95/282 (33%), Positives = 146/282 (51%), Gaps = 24/282 (8%)
Query: 35 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLL 94
ID E++ ++G+G+FG + KA WR VAIK+I S+ + F E+ L
Sbjct: 3 HMIDYKEIEVEE--VVGRGAFGVVCKAKWRAKDVAIKQIE---SES--ERKAFIVELRQL 55
Query: 95 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL---KEKGALSPSTAVNFALDIAR 151
++ HPNIV+ GA P+ L+ EY GG L+ L + + + A+++ L ++
Sbjct: 56 SRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQ 113
Query: 152 GMAYLHN-EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETG 210
G+AYLH+ +P +IHRDLKP N LL+ + LK+ DFG + I+ MT G
Sbjct: 114 GVAYLHSMQPKALIHRDLKPPN-LLLVAGGTVLKICDFGTACDIQTH-------MTNNKG 165
Query: 211 SYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYE--PYEAAKYVAEGHRPFF 268
S +MAPEVF+ Y +K DVFS+ +IL+E++ P + V G RP
Sbjct: 166 SAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPL 225
Query: 269 RAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLP 310
K + L +CW+ D +QRPS +I+K + + P
Sbjct: 226 -IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFP 266
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 322 bits (827), Expect = e-111
Identities = 78/282 (27%), Positives = 129/282 (45%), Gaps = 23/282 (8%)
Query: 34 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNL 93
ID +L+F + + + GE+ K W+G + +K + R +DF E
Sbjct: 4 HSGIDFKQLNFLT--KLNENHSGELWKGRWQGNDIVVKVLKVRDWSTR-KSRDFNEECPR 60
Query: 94 LVKLRHPNIVQFLGAVTE--RKPLMLITEYLRGGDLHKYL--KEKGALSPSTAVNFALDI 149
L HPN++ LGA LIT ++ G L+ L + S AV FALD+
Sbjct: 61 LRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDM 120
Query: 150 ARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET 209
ARGMA+LH +I L R+V++ ++ + ++ G
Sbjct: 121 ARGMAFLHTLEPLIPRHALNSRSVMIDED--MTARISMADVKF---------SFQSPGRM 169
Query: 210 GSYRYMAPEVFKHRKYD---KKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA-EGHR 265
+ ++APE + + D + D++SFA++L+E++ E P A+ E VA EG R
Sbjct: 170 YAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLR 229
Query: 266 PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKE 307
P G +P + +L + C D +RP F I+ LEK+++
Sbjct: 230 PTI-PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 298 bits (764), Expect = e-101
Identities = 91/293 (31%), Positives = 141/293 (48%), Gaps = 25/293 (8%)
Query: 35 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVN 92
PS+L ++GKG FG+ +K R T + +K ++ + + + F EV
Sbjct: 5 RIFRPSDLIHGE--VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQ---RTFLKEVK 59
Query: 93 LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIAR 151
++ L HPN+++F+G + + K L ITEY++GG L + S V+FA DIA
Sbjct: 60 VMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIAS 119
Query: 152 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI----------KVQNSHD 201
GMAYLH+ IIHRDL N LV + ++ V DFGL++L+ + D
Sbjct: 120 GMAYLHSMN--IIHRDLNSHN-CLVREN-KNVVVADFGLARLMVDEKTQPEGLRSLKKPD 175
Query: 202 VYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPY--EAAKY 259
K G+ +MAPE+ R YD+KVDVFSF ++L E++ +Y P +
Sbjct: 176 RKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN 235
Query: 260 VAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPTD 312
V + P +T +C D +RPSF+ + LE ++ L
Sbjct: 236 VRGFLDR-YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGH 287
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 292 bits (749), Expect = 7e-99
Identities = 86/280 (30%), Positives = 139/280 (49%), Gaps = 19/280 (6%)
Query: 34 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNL 93
DWEI ++ IG GSFG + K W G VA+K + + + +Q F++EV +
Sbjct: 18 DWEIPDGQITVGQ--RIGSGSFGTVYKGKWHGD-VAVKMLNVTAPTPQQ-LQAFKNEVGV 73
Query: 94 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARG 152
L K RH NI+ F+G T L ++T++ G L+ +L + ++ A ARG
Sbjct: 74 LRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARG 132
Query: 153 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSY 212
M YLH + IIHRDLK N+ L + +K+GDFGL+ + + +GS
Sbjct: 133 MDYLHAKS--IIHRDLKSNNIFL--HEDNTVKIGDFGLATEKSRWSGSH--QFEQLSGSI 186
Query: 213 RYMAPEVFKHR---KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKY-VAEGHRPFF 268
+MAPEV + + Y + DV++F ++LYE++ G+ P +N + V G
Sbjct: 187 LWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPD 246
Query: 269 RAK---GFTPELRELTEKCWAADMNQRPSFLDILKRLEKI 305
+K ++ L +C ++RPSF IL +E++
Sbjct: 247 LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 286
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 287 bits (735), Expect = 4e-96
Identities = 76/312 (24%), Positives = 119/312 (38%), Gaps = 45/312 (14%)
Query: 34 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNL 93
++ IGKG +GE+ WRG VA+K + E+
Sbjct: 31 VQRTIAKQIQMVK--QIGKGRYGEVWMGKWRGEKVAVKVFFTTEEASWF----RETEIYQ 84
Query: 94 LVKLRHPNIVQFLGAVTE----RKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDI 149
V +RH NI+ F+ A + L LIT+Y G L+ YLK L + + A
Sbjct: 85 TVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSS 143
Query: 150 ARGMAYLHNEP------NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 203
G+ +LH E I HRDLK +N+L+ + D GL+ +
Sbjct: 144 VSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV--KKNGTCCIADLGLAVKFISDTNEVDI 201
Query: 204 KMTGETGSYRYMAPEV------FKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAA 257
G+ RYM PEV H + D++SF +IL+E+ E Y+
Sbjct: 202 PPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP 261
Query: 258 KY----------------VAEGHRPFF----RAKGFTPELRELTEKCWAADMNQRPSFLD 297
+ + RP F + ++ +L +CWA + R + L
Sbjct: 262 YHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALR 321
Query: 298 ILKRLEKIKETL 309
+ K L K+ E+
Sbjct: 322 VKKTLAKMSESQ 333
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 274 bits (702), Expect = 1e-91
Identities = 78/295 (26%), Positives = 123/295 (41%), Gaps = 47/295 (15%)
Query: 49 IIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHE--VNLLVKLRHPNIVQFL 106
+GKG +GE+ + W+G VA+K + + E + V LRH NI+ F+
Sbjct: 15 CVGKGRYGEVWRGSWQGENVAVKIFSSRDE------KSWFRETELYNTVMLRHENILGFI 68
Query: 107 GAVT----ERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP-- 160
+ L LIT Y G L+ YL+ L + + L IA G+A+LH E
Sbjct: 69 ASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT-TLDTVSCLRIVLSIASGLAHLHIEIFG 127
Query: 161 ----NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMA 216
I HRDLK +N+L+ + + D GL+ + + G+ RYMA
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKN--GQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 217 PEVFKHR------KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKY----------- 259
PEV K+VD+++F ++L+E+ E Y+ Y
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFED 245
Query: 260 -----VAEGHRPFFRAKGFT----PELRELTEKCWAADMNQRPSFLDILKRLEKI 305
+ RP + F+ L +L ++CW + + R + L I K L KI
Sbjct: 246 MRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 274 bits (703), Expect = 3e-91
Identities = 74/311 (23%), Positives = 119/311 (38%), Gaps = 45/311 (14%)
Query: 34 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNL 93
+ IGKG FGE+ + WRG VA+K E+
Sbjct: 36 VQRTIARTIVLQE--SIGKGRFGEVWRGKWRGEEVAVKIFSSREERS----WFREAEIYQ 89
Query: 94 LVKLRHPNIVQFLGAVT----ERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDI 149
V LRH NI+ F+ A L L+++Y G L YL + ++ + AL
Sbjct: 90 TVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN-RYTVTVEGMIKLALST 148
Query: 150 ARGMAYLHNEPN------VIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 203
A G+A+LH E I HRDLK +N+L+ + D GL+
Sbjct: 149 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV--KKNGTCCIADLGLAVRHDSATDTIDI 206
Query: 204 KMTGETGSYRYMAPEV------FKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAA 257
G+ RYMAPEV KH + K+ D+++ ++ +E+ +E Y+
Sbjct: 207 APNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 266
Query: 258 KY----------------VAEGHRPFFRAKGFT----PELRELTEKCWAADMNQRPSFLD 297
Y + RP + + + ++ +CW A+ R + L
Sbjct: 267 YYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALR 326
Query: 298 ILKRLEKIKET 308
I K L ++ +
Sbjct: 327 IKKTLSQLSQQ 337
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 250 bits (640), Expect = 7e-82
Identities = 86/339 (25%), Positives = 130/339 (38%), Gaps = 67/339 (19%)
Query: 34 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVN- 92
+ +D L +IG+G +G + K PVA+K + + Q+F +E N
Sbjct: 7 EPSLDLDNLKLLE--LIGRGRYGAVYKGSLDERPVAVK-VFSFANR-----QNFINEKNI 58
Query: 93 -LLVKLRHPNIVQFLGAVTE-----RKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFA 146
+ + H NI +F+ R +L+ EY G L KYL ++ A
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLA 117
Query: 147 LDIARGMAYLHNEPN-------VIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI----K 195
+ RG+AYLH E I HRDL RNVL+ N + DFGLS +
Sbjct: 118 HSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDG--TCVISDFGLSMRLTGNRL 175
Query: 196 VQNSHDVYKMTGETGSYRYMAPEVFK-------HRKYDKKVDVFSFAMILYEML---EGE 245
V+ + E G+ RYMAPEV + K+VD+++ +I +E+
Sbjct: 176 VRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235
Query: 246 PPLANYEPYEAAKY----------------VAEGHRPFFRA-----KGFTPELRELTEKC 284
P + Y+ A E RP F L+E E C
Sbjct: 236 FPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDC 295
Query: 285 WAADMNQRPSFLDILKRLEKI-------KETLPTDHHWN 316
W D R + +R+ ++ K PT HH +
Sbjct: 296 WDQDAEARLTAQXAEERMAELMMIWERNKSVSPTAHHHH 334
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 241 bits (617), Expect = 9e-78
Identities = 88/293 (30%), Positives = 145/293 (49%), Gaps = 22/293 (7%)
Query: 22 PKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG--TPVAIKRILPSLSD 79
+ +P W ++ +L IG+G+FGE+ R T VA+K +L
Sbjct: 97 GVVLHRAVPKD-KWVLNHEDLVLGE--QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPP 153
Query: 80 DRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG-ALS 138
D + F E +L + HPNIV+ +G T+++P+ ++ E ++GGD +L+ +G L
Sbjct: 154 D--LKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLR 211
Query: 139 PSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 198
T + D A GM YL ++ IHRDL RN L+ + + LK+ DFG+S+
Sbjct: 212 VKTLLQMVGDAAAGMEYLESKC--CIHRDLAARNCLV--TEKNVLKISDFGMSREEA--- 264
Query: 199 SHDVYKMTGETGS--YRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYE 255
VY +G ++ APE + +Y + DV+SF ++L+E G P N +
Sbjct: 265 -DGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ 323
Query: 256 AAKYVAEGHR-PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKE 307
++V +G R P + + L E+CWA + QRPSF I + L+ I++
Sbjct: 324 TREFVEKGGRLP--CPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 238 bits (610), Expect = 1e-77
Identities = 80/314 (25%), Positives = 125/314 (39%), Gaps = 51/314 (16%)
Query: 34 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNL 93
+ L + +G FG + KA VA+K I P +EV
Sbjct: 18 NLYFQSMPLQLLE--VKARGRFGCVWKAQLLNEYVAVK-IFPIQDKQS---WQNEYEVYS 71
Query: 94 LVKLRHPNIVQFLGAVTE----RKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDI 149
L ++H NI+QF+GA L LIT + G L +LK +S + + A +
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK-ANVVSWNELCHIAETM 130
Query: 150 ARGMAYLHNEPN--------VIIHRDLKPRNVLL-VNSSADHLKVGDFGLSKLIKVQNSH 200
ARG+AYLH + I HRD+K +NVLL N +A + DFGL+ + S
Sbjct: 131 ARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTA---CIADFGLALKFEAGKSA 187
Query: 201 DVYKMTGETGSYRYMAPEVFKH-----RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYE 255
G+ G+ RYMAPEV + R ++D+++ ++L+E+
Sbjct: 188 GD--THGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245
Query: 256 AAKY-----------------VAEGHRPFFRAK----GFTPELRELTEKCWAADMNQRPS 294
+ V + RP R L E E+CW D R S
Sbjct: 246 MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLS 305
Query: 295 FLDILKRLEKIKET 308
+ +R+ +++
Sbjct: 306 AGCVGERITQMQRL 319
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 230 bits (590), Expect = 6e-75
Identities = 82/292 (28%), Positives = 131/292 (44%), Gaps = 26/292 (8%)
Query: 30 PNKCD-WEIDPSELDFSSSAIIGKGSFGEILKAYWRG-----TPVAIKRILPSLSDDRLV 83
P + I +L +G GSFG + + W VA+K + P +
Sbjct: 7 PLQSLTCLIGEKDLRLLE--KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEA 64
Query: 84 IQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTA 142
+ DF EVN + L H N+++ G V P+ ++TE G L L++ +G T
Sbjct: 65 MDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTL 123
Query: 143 VNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDV 202
+A+ +A GM YL E IHRDL RN+LL ++ D +K+GDFGL + + + D
Sbjct: 124 SRYAVQVAEGMGYL--ESKRFIHRDLAARNLLL--ATRDLVKIGDFGLMRALPQND--DH 177
Query: 203 YKMTGETGS---YRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAK 258
Y M + + APE K R + D + F + L+EM G+ P +
Sbjct: 178 YVMQ--EHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILH 235
Query: 259 YV-AEGHR-PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKET 308
+ EG R P R + ++ + +CWA RP+F+ + L + + T
Sbjct: 236 KIDKEGERLP--RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 230 bits (588), Expect = 7e-75
Identities = 94/281 (33%), Positives = 145/281 (51%), Gaps = 25/281 (8%)
Query: 35 WEIDPSELDFSSSAIIGKGSFGEILKAYWRG-TPVAIKRILPSLSDDRLVIQDFRHEVNL 93
W IDPSEL F IG G FG + YW VAIK I + +DF E +
Sbjct: 3 WVIDPSELTFVQ--EIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE----EDFIEEAEV 56
Query: 94 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARG 152
++KL HP +VQ G E+ P+ L+TE++ G L YL+ +G + T + LD+ G
Sbjct: 57 MMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEG 116
Query: 153 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGS- 211
MAYL E +IHRDL RN L+ +KV DFG+++ + D Y T TG+
Sbjct: 117 MAYL--EEACVIHRDLAARNCLV--GENQVIKVSDFGMTRFVL----DDQY--TSSTGTK 166
Query: 212 --YRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKYVAEGHR-PF 267
++ +PEVF +Y K DV+SF ++++E+ EG+ P N E + ++ G R
Sbjct: 167 FPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY- 225
Query: 268 FRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKET 308
+ + + + ++ CW RP+F +L++L +I E+
Sbjct: 226 -KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 230 bits (589), Expect = 8e-75
Identities = 86/293 (29%), Positives = 139/293 (47%), Gaps = 26/293 (8%)
Query: 22 PKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-TPVAIKRILPSLSDD 80
P L WEIDP +L F +G G FG + WRG VAIK I +
Sbjct: 7 NAPSTAGLG-YGSWEIDPKDLTFLK--ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE 63
Query: 81 RLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSP 139
+F E +++ L H +VQ G T+++P+ +ITEY+ G L YL+E +
Sbjct: 64 ----DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQT 119
Query: 140 STAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 199
+ D+ M YL E +HRDL RN L+ + +KV DFGLS+ +
Sbjct: 120 QQLLEMCKDVCEAMEYL--ESKQFLHRDLAARNCLV--NDQGVVKVSDFGLSRYVL---- 171
Query: 200 HDVYKMTGETGS---YRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYE 255
D Y T GS R+ PEV + K+ K D+++F ++++E+ G+ P + E
Sbjct: 172 DDEY--TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE 229
Query: 256 AAKYVAEGHR-PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKE 307
A+++A+G R R + ++ + CW ++RP+F +L + + +
Sbjct: 230 TAEHIAQGLRLY--RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 229 bits (587), Expect = 1e-74
Identities = 92/291 (31%), Positives = 142/291 (48%), Gaps = 31/291 (10%)
Query: 26 PPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQ 85
+ W ++ EL IGKG FG+++ +RG VA+K I + Q
Sbjct: 7 AQDEFYRSGWALNMKELKLLQ--TIGKGEFGDVMLGDYRGNKVAVKCIKNDATA-----Q 59
Query: 86 DFRHEVNLLVKLRHPNIVQFLGAVTERKP-LMLITEYLRGGDLHKYLKEKG--ALSPSTA 142
F E +++ +LRH N+VQ LG + E K L ++TEY+ G L YL+ +G L
Sbjct: 60 AFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL 119
Query: 143 VNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDV 202
+ F+LD+ M YL E N +HRDL RNVL+ S + KV DFGL+K +
Sbjct: 120 LKFSLDVCEAMEYL--EGNNFVHRDLAARNVLV--SEDNVAKVSDFGLTK--------EA 167
Query: 203 YKMTGETGS---YRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAK 258
+ + ++ APE + +K+ K DV+SF ++L+E+ G P +
Sbjct: 168 S--STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP 225
Query: 259 YVAEGHR-PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKET 308
V +G++ G P + E+ + CW D RPSFL + ++LE IK
Sbjct: 226 RVEKGYKMD--APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 229 bits (586), Expect = 1e-74
Identities = 84/280 (30%), Positives = 137/280 (48%), Gaps = 25/280 (8%)
Query: 35 WEIDPSELDFSSSAIIGKGSFGEILKAYWRG-TPVAIKRILPSLSDDRLVIQDFRHEVNL 93
E+ E+ +G G FG + W+G VA+K I + +F E
Sbjct: 3 MELKREEITLLK--ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE----DEFFQEAQT 56
Query: 94 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARG 152
++KL HP +V+F G ++ P+ ++TEY+ G L YL+ G L PS + D+ G
Sbjct: 57 MMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEG 116
Query: 153 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGS- 211
MA+L E + IHRDL RN L+ +KV DFG+++ + D Y G+
Sbjct: 117 MAFL--ESHQFIHRDLAARNCLV--DRDLCVKVSDFGMTRYVL----DDQY--VSSVGTK 166
Query: 212 --YRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKYVAEGHR-PF 267
++ APEVF + KY K DV++F ++++E+ G+ P Y E V++GHR
Sbjct: 167 FPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLY- 225
Query: 268 FRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKE 307
R + + ++ CW +RP+F +L +E ++E
Sbjct: 226 -RPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 229 bits (587), Expect = 2e-74
Identities = 81/298 (27%), Positives = 138/298 (46%), Gaps = 23/298 (7%)
Query: 28 PLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG----TPVAIKRILPSLSDDRLV 83
+ K + +D L +G G+FG + K Y++ VA+K IL + ++D +
Sbjct: 5 EIRPK-EVYLDRKLLTLEDK-ELGSGNFGTVKKGYYQMKKVVKTVAVK-ILKNEANDPAL 61
Query: 84 IQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAV 143
+ E N++ +L +P IV+ +G + ML+ E G L+KYL++ + +
Sbjct: 62 KDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNII 120
Query: 144 NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 203
++ GM YL E + +HRDL RNVLL + + K+ DFGLSK ++ + Y
Sbjct: 121 ELVHQVSMGMKYL--EESNFVHRDLAARNVLL--VTQHYAKISDFGLSKALRADE--NYY 174
Query: 204 KMTGETGS---YRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKY 259
K T ++ APE + K+ K DV+SF ++++E G+ P + E
Sbjct: 175 KAQ--THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM 232
Query: 260 VAEGHR-PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPTDHHWN 316
+ +G R G E+ +L CW D+ RP F + RL + + H +
Sbjct: 233 LEKGERMG--CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEGHHH 288
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 229 bits (585), Expect = 3e-74
Identities = 82/289 (28%), Positives = 142/289 (49%), Gaps = 27/289 (9%)
Query: 29 LPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG--TPVAIKRILPSLSDDRLVIQD 86
PN WE++ +++ +G G +GE+ + W+ VA+K + + ++
Sbjct: 2 SPNYDKWEMERTDITMKH--KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV----EE 55
Query: 87 FRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK--EKGALSPSTAVN 144
F E ++ +++HPN+VQ LG T P +ITE++ G+L YL+ + +S +
Sbjct: 56 FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLY 115
Query: 145 FALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK 204
A I+ M YL E IHRDL RN L+ +KV DFGLS+L+ D Y
Sbjct: 116 MATQISSAMEYL--EKKNFIHRDLAARNCLV--GENHLVKVADFGLSRLMT----GDTY- 166
Query: 205 MTGETGS---YRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKYV 260
T G+ ++ APE + K+ K DV++F ++L+E+ G P + + + +
Sbjct: 167 -TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 225
Query: 261 AEGHR-PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKET 308
+ +R R +G ++ EL CW + + RPSF +I + E + +
Sbjct: 226 EKDYRME--RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 229 bits (587), Expect = 5e-74
Identities = 84/313 (26%), Positives = 142/313 (45%), Gaps = 40/313 (12%)
Query: 24 PVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG------TPVAIKRILPSL 77
+ ++ + + L F +GKG+FG + + VA+K++ S
Sbjct: 25 AMGSAFEDRDPTQFEERHLKFLQ--QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST 82
Query: 78 SDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE--RKPLMLITEYLRGGDLHKYLKE-K 134
+ +DF E+ +L L+H NIV++ G R+ L LI EYL G L YL++ K
Sbjct: 83 EEHL---RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK 139
Query: 135 GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 194
+ + + I +GM YL IHRDL RN+L+ + + +K+GDFGL+K++
Sbjct: 140 ERIDHIKLLQYTSQICKGMEYL--GTKRYIHRDLATRNILV--ENENRVKIGDFGLTKVL 195
Query: 195 KVQNSHDVYKMTGETGS-YRYMAPEVFKHRKYDKKVDVFSFAMILYEML----------- 242
+ YK+ S + APE K+ DV+SF ++LYE+
Sbjct: 196 P--QDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA 253
Query: 243 -----EGEPPLANYEPYEAAKYVAEGHR-PFFRAKGFTPELRELTEKCWAADMNQRPSFL 296
G + + + R P R G E+ + +CW ++NQRPSF
Sbjct: 254 EFMRMIGNDKQGQMIVFHLIELLKNNGRLP--RPDGCPDEIYMIMTECWNNNVNQRPSFR 311
Query: 297 DILKRLEKIKETL 309
D+ R+++I++ +
Sbjct: 312 DLALRVDQIRDQM 324
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 227 bits (582), Expect = 3e-73
Identities = 78/288 (27%), Positives = 135/288 (46%), Gaps = 27/288 (9%)
Query: 30 PNKCDWE-IDPSELDFSSSAIIGKGSFGEILKAYWRG------TPVAIKRILPSLSDDRL 82
PN+ + +E ++G G+FG + K W PVAIK + + S
Sbjct: 4 PNQALLRILKETEFKKIK--VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK-- 59
Query: 83 VIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPST 141
++ E ++ + +P++ + LG + LIT+ + G L Y++E K +
Sbjct: 60 ANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQY 118
Query: 142 AVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHD 201
+N+ + IA+GM YL E ++HRDL RNVL+ + H+K+ DFGL+KL+
Sbjct: 119 LLNWCVQIAKGMNYL--EDRRLVHRDLAARNVLV--KTPQHVKITDFGLAKLL--GAEEK 172
Query: 202 VYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKYV 260
Y G ++MA E HR Y + DV+S+ + ++E++ G P E + +
Sbjct: 173 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232
Query: 261 AEGHR---PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKI 305
+G R P T ++ + KCW D + RP F +++ K+
Sbjct: 233 EKGERLPQP----PICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKM 276
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 232 bits (594), Expect = 4e-73
Identities = 79/294 (26%), Positives = 140/294 (47%), Gaps = 21/294 (7%)
Query: 21 EPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG--TPVAIKRILPSLS 78
+ PN WE++ +++ +G G +GE+ + W+ VA+K +
Sbjct: 201 NKPTIYGVSPNYDKWEMERTDITMKH--KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM 258
Query: 79 DDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK--EKGA 136
+ ++F E ++ +++HPN+VQ LG T P +ITE++ G+L YL+ +
Sbjct: 259 EV----EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE 314
Query: 137 LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 196
+S + A I+ M YL E IHR+L RN L+ +KV DFGLS+L+
Sbjct: 315 VSAVVLLYMATQISSAMEYL--EKKNFIHRNLAARNCLV--GENHLVKVADFGLSRLMT- 369
Query: 197 QNSHDVYKMTGETG-SYRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPY 254
D Y ++ APE + K+ K DV++F ++L+E+ G P +
Sbjct: 370 ---GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS 426
Query: 255 EAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKET 308
+ + + + +R R +G ++ EL CW + + RPSF +I + E + +
Sbjct: 427 QVYELLEKDYR-MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 226 bits (578), Expect = 4e-73
Identities = 83/300 (27%), Positives = 138/300 (46%), Gaps = 40/300 (13%)
Query: 35 WEIDPSELDFSSSAIIGKGSFGEILKAYWRG------TPVAIKRILPSLSDDRLVIQDFR 88
+ + L F +GKG+FG + + VA+K++ S + +DF
Sbjct: 5 TQFEERHLKFLQ--QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL---RDFE 59
Query: 89 HEVNLLVKLRHPNIVQFLGAVTE--RKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNF 145
E+ +L L+H NIV++ G R+ L LI EYL G L YL++ K + + +
Sbjct: 60 REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY 119
Query: 146 ALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKM 205
I +GM YL IHRDL RN+L+ + + +K+GDFGL+K++ + +K+
Sbjct: 120 TSQICKGMEYL--GTKRYIHRDLATRNILV--ENENRVKIGDFGLTKVLP--QDKEFFKV 173
Query: 206 TGETGS-YRYMAPEVFKHRKYDKKVDVFSFAMILYEML----------------EGEPPL 248
S + APE K+ DV+SF ++LYE+ G
Sbjct: 174 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQ 233
Query: 249 ANYEPYEAAKYVAEGHR-PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKE 307
+ + + R P R G E+ + +CW ++NQRPSF D+ R+++I++
Sbjct: 234 GQMIVFHLIELLKNNGRLP--RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 226 bits (578), Expect = 6e-73
Identities = 80/308 (25%), Positives = 130/308 (42%), Gaps = 38/308 (12%)
Query: 24 PVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR------GTPVAIKRILPSL 77
P + L +G+G FG++ + G VA+K + P
Sbjct: 5 SEKKPATEVDPTHFEKRFLKRIR--DLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES 62
Query: 78 SDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE--RKPLMLITEYLRGGDLHKYLKE-K 134
+ + D + E+ +L L H NIV++ G TE + LI E+L G L +YL + K
Sbjct: 63 GGNHI--ADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNK 120
Query: 135 GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 194
++ + +A+ I +GM YL +HRDL RNVL+ S +K+GDFGL+K I
Sbjct: 121 NKINLKQQLKYAVQICKGMDYL--GSRQYVHRDLAARNVLV--ESEHQVKIGDFGLTKAI 176
Query: 195 KVQNSHDVYKMTGETGS-YRYMAPEVFKHRKYDKKVDVFSFAMILYEML---------EG 244
+ + Y + + S + APE K+ DV+SF + L+E+L
Sbjct: 177 --ETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMA 234
Query: 245 EPPLANYEPY------EAAKYVAEGHR-PFFRAKGFTPELRELTEKCWAADMNQRPSFLD 297
+ + EG R P E+ +L KCW + R SF +
Sbjct: 235 LFLKMIGPTHGQMTVTRLVNTLKEGKRLP--CPPNCPDEVYQLMRKCWEFQPSNRTSFQN 292
Query: 298 ILKRLEKI 305
+++ E +
Sbjct: 293 LIEGFEAL 300
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 231 bits (590), Expect = 7e-73
Identities = 90/294 (30%), Positives = 143/294 (48%), Gaps = 29/294 (9%)
Query: 21 EPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDD 80
E + W ++ EL IGKG FG+++ +RG VA+K I +
Sbjct: 174 EGTVAAQDEFYRSGWALNMKELKLLQ--TIGKGEFGDVMLGDYRGNKVAVKCIKNDATA- 230
Query: 81 RLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP-LMLITEYLRGGDLHKYLKEKG--AL 137
Q F E +++ +LRH N+VQ LG + E K L ++TEY+ G L YL+ +G L
Sbjct: 231 ----QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVL 286
Query: 138 SPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 197
+ F+LD+ M YL E N +HRDL RNVL+ S + KV DFGL+K
Sbjct: 287 GGDCLLKFSLDVCEAMEYL--EGNNFVHRDLAARNVLV--SEDNVAKVSDFGLTK----- 337
Query: 198 NSHDVYKMTGETGS---YRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEP 253
+ + + ++ APE + +K+ K DV+SF ++L+E+ G P
Sbjct: 338 ---EAS--STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL 392
Query: 254 YEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKE 307
+ V +G++ G P + ++ + CW D RP+FL + ++LE I+
Sbjct: 393 KDVVPRVEKGYK-MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT 445
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 224 bits (574), Expect = 1e-72
Identities = 85/282 (30%), Positives = 139/282 (49%), Gaps = 22/282 (7%)
Query: 34 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-----TPVAIKRILPSLSDDRLVIQDFR 88
D+EI ++ IG+G FG++ + + VAIK SD V + F
Sbjct: 9 DYEIQRERIELGR--CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDS--VREKFL 64
Query: 89 HEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFAL 147
E + + HP+IV+ +G +TE P+ +I E G+L +L+ K +L ++ + +A
Sbjct: 65 QEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAY 123
Query: 148 DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG 207
++ +AYL E +HRD+ RNVL+ SS D +K+GDFGLS+ ++ YK +
Sbjct: 124 QLSTALAYL--ESKRFVHRDIAARNVLV--SSNDCVKLGDFGLSRYME---DSTYYKASK 176
Query: 208 ETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKYVAEGHR- 265
++MAPE R++ DV+ F + ++E+L G P + + + G R
Sbjct: 177 GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL 236
Query: 266 PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKE 307
P P L L KCWA D ++RP F ++ +L I E
Sbjct: 237 P--MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 276
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 224 bits (573), Expect = 2e-72
Identities = 82/283 (28%), Positives = 141/283 (49%), Gaps = 22/283 (7%)
Query: 34 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-----TPVAIKRILPSLSDDRLVIQDFR 88
+ I ++ + I+G+G FGE+ + + VA+K + D + F
Sbjct: 6 QYGIAREDVVLNR--ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLD--NKEKFM 61
Query: 89 HEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFAL 147
E ++ L HP+IV+ +G + E +P +I E G+L YL+ K +L T V ++L
Sbjct: 62 SEAVIMKNLDHPHIVKLIGIIEE-EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSL 120
Query: 148 DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG 207
I + MAYL E +HRD+ RN+L+ +S + +K+GDFGLS+ I+ D YK +
Sbjct: 121 QICKAMAYL--ESINCVHRDIAVRNILV--ASPECVKLGDFGLSRYIE---DEDYYKASV 173
Query: 208 ETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKYVAEGHR- 265
++M+PE R++ DV+ FA+ ++E+L G+ P E + + +G R
Sbjct: 174 TRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRL 233
Query: 266 PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKET 308
P + P L L +CW D + RP F +++ L + +
Sbjct: 234 P--KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 225 bits (575), Expect = 3e-72
Identities = 90/288 (31%), Positives = 133/288 (46%), Gaps = 19/288 (6%)
Query: 26 PPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-----TPVAIKRILPSLSDD 80
P EI+ S + IIG G GE+ R PVAIK + ++
Sbjct: 35 PGRAGRSFTREIEASRIHIEK--IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTER 92
Query: 81 RLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSP 139
+ +DF E +++ + HPNI++ G VT + M++TEY+ G L +L+ G +
Sbjct: 93 QR--RDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTI 150
Query: 140 STAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 199
V + GM YL +HRDL RNVL+ S KV DFGLS++++ +
Sbjct: 151 MQLVGMLRGVGAGMRYL--SDLGYVHRDLAARNVLV--DSNLVCKVSDFGLSRVLE-DDP 205
Query: 200 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAK 258
Y TG R+ APE R + DV+SF ++++E+L GE P N +
Sbjct: 206 DAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVIS 265
Query: 259 YVAEGHR-PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKI 305
V EG+R P G L +L CW D QRP F I+ L+ +
Sbjct: 266 SVEEGYRLP--APMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDAL 311
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 225 bits (575), Expect = 4e-72
Identities = 82/315 (26%), Positives = 135/315 (42%), Gaps = 41/315 (13%)
Query: 17 GSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG------TPVAI 70
G H + + L + S +GKG+FG + + VA+
Sbjct: 2 GHHHHHHAQLYACQDP--TIFEERHLKYIS--QLGKGNFGSVELCRYDPLGDNTGALVAV 57
Query: 71 KRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE--RKPLMLITEYLRGGDLH 128
K++ S D + +DF+ E+ +L L IV++ G R+ L L+ EYL G L
Sbjct: 58 KQLQHSGPDQQ---RDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLR 114
Query: 129 KYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGD 187
+L+ + L S + ++ I +GM YL +HRDL RN+L+ S H+K+ D
Sbjct: 115 DFLQRHRARLDASRLLLYSSQICKGMEYL--GSRRCVHRDLAARNILV--ESEAHVKIAD 170
Query: 188 FGLSKLIKVQNSHDVYKMTGETGS-YRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGE 245
FGL+KL+ D Y + S + APE + ++ DV+SF ++LYE+ +
Sbjct: 171 FGLAKLL--PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCD 228
Query: 246 PPLANYEPY--------------EAAKYVAEGHR-PFFRAKGFTPELRELTEKCWAADMN 290
+ + + + EG R P E+ EL + CWA
Sbjct: 229 KSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLP--APPACPAEVHELMKLCWAPSPQ 286
Query: 291 QRPSFLDILKRLEKI 305
RPSF + +L+ +
Sbjct: 287 DRPSFSALGPQLDML 301
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 223 bits (571), Expect = 7e-72
Identities = 82/311 (26%), Positives = 142/311 (45%), Gaps = 28/311 (9%)
Query: 19 HFEPKPVPPPLPNK-CDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-----TPVAIKR 72
H + + P L I PS L + +IG+G FG + A+K
Sbjct: 1 HIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVK- 59
Query: 73 ILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK-PLMLITEYLRGGDLHKYL 131
L ++D + F E ++ HPN++ LG + +++ Y++ GDL ++
Sbjct: 60 SLNRITDIG-EVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 118
Query: 132 -KEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGL 190
E + + F L +A+GM YL +HRDL RN +L +KV DFGL
Sbjct: 119 RNETHNPTVKDLIGFGLQVAKGMKYL--ASKKFVHRDLAARNCML--DEKFTVKVADFGL 174
Query: 191 SKLIKVQNSHDVYKMTGETGS---YRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEP 246
++ + + Y + +TG+ ++MA E + +K+ K DV+SF ++L+E++ G P
Sbjct: 175 ARDM---YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 231
Query: 247 PLANYEPYEAAKYVAEGHR---PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLE 303
P + ++ Y+ +G R P + L E+ KCW RPSF +++ R+
Sbjct: 232 PYPDVNTFDITVYLLQGRRLLQP----EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 287
Query: 304 KIKETLPTDHH 314
I T +H+
Sbjct: 288 AIFSTFIGEHY 298
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 224 bits (572), Expect = 1e-71
Identities = 92/292 (31%), Positives = 144/292 (49%), Gaps = 20/292 (6%)
Query: 23 KPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG------TPVAIKRILPS 76
P K EI PS + +IG G FGE+ K + PVAIK +
Sbjct: 27 GSDPNQAVLKFTTEIHPSCVTRQK--VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG 84
Query: 77 LSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KG 135
++ + DF E ++ + H NI++ G +++ KP+M+ITEY+ G L K+L+E G
Sbjct: 85 YTEKQR--VDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG 142
Query: 136 ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 195
S V IA GM YL +HRDL RN+L+ +S KV DFGLS++++
Sbjct: 143 EFSVLQLVGMLRGIAAGMKYL--ANMNYVHRDLAARNILV--NSNLVCKVSDFGLSRVLE 198
Query: 196 VQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPY 254
+ Y +G R+ APE +RK+ DV+SF ++++E++ GE P +
Sbjct: 199 -DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH 257
Query: 255 EAAKYVAEGHR-PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKI 305
E K + +G R P + +L +CW + +RP F DI+ L+K+
Sbjct: 258 EVMKAINDGFRLP--TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 307
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 222 bits (568), Expect = 2e-71
Identities = 86/309 (27%), Positives = 142/309 (45%), Gaps = 44/309 (14%)
Query: 30 PNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRL 82
I ++ +G+G+FG++ A VA+K + R
Sbjct: 5 SGIHVQHIKRRDIVLKR--ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAAR- 61
Query: 83 VIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK---------- 132
+DF+ E LL L+H +IV+F G + PL+++ EY++ GDL+K+L+
Sbjct: 62 --KDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILV 119
Query: 133 ------EKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVG 186
KG L S ++ A IA GM YL +HRDL RN L+ + +K+G
Sbjct: 120 DGQPRQAKGELGLSQMLHIASQIASGMVYL--ASQHFVHRDLATRNCLV--GANLLVKIG 175
Query: 187 DFGLSKLIKVQNSHDVYKMTGETG-SYRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EG 244
DFG+S+ + S D Y++ G T R+M PE +RK+ + DV+SF +IL+E+ G
Sbjct: 176 DFGMSRDV---YSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYG 232
Query: 245 EPPLANYEPYEAAKYVAEGHR---PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301
+ P E + + +G P + E+ ++ CW + QR + +I K
Sbjct: 233 KQPWFQLSNTEVIECITQGRVLERP----RVCPKEVYDVMLGCWQREPQQRLNIKEIYKI 288
Query: 302 LEKIKETLP 310
L + + P
Sbjct: 289 LHALGKATP 297
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 222 bits (567), Expect = 6e-71
Identities = 80/286 (27%), Positives = 132/286 (46%), Gaps = 24/286 (8%)
Query: 35 WEIDPSELDFSSSAIIGKGSFGEILKAYWRG------TPVAIKRILPSLSDDRLVIQDFR 88
+EL ++G G FG + K W PV IK I Q
Sbjct: 8 RIFKETELRKLK--VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQ--SFQAVT 63
Query: 89 HEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFAL 147
+ + L H +IV+ LG L L+T+YL G L ++++ +GAL P +N+ +
Sbjct: 64 DHMLAIGSLDHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGV 122
Query: 148 DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG 207
IA+GM YL E + ++HR+L RNVLL S ++V DFG++ L+ D +
Sbjct: 123 QIAKGMYYL--EEHGMVHRNLAARNVLL--KSPSQVQVADFGVADLL---PPDDKQLLYS 175
Query: 208 ETGS-YRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKYVAEGHR 265
E + ++MA E KY + DV+S+ + ++E++ G P A E + +G R
Sbjct: 176 EAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGER 235
Query: 266 -PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLP 310
+ + T ++ + KCW D N RP+F ++ ++ P
Sbjct: 236 LA--QPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDPP 279
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 221 bits (566), Expect = 7e-71
Identities = 79/297 (26%), Positives = 127/297 (42%), Gaps = 35/297 (11%)
Query: 30 PNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRL 82
E+ + +G G+FGE+ + G VA+K + S+
Sbjct: 20 SISDLKEVPRKNITLIR--GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE 77
Query: 83 VIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK-------EKG 135
DF E ++ K H NIV+ +G + P ++ E + GGDL +L+ +
Sbjct: 78 --LDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPS 135
Query: 136 ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHL--KVGDFGLSKL 193
+L+ ++ A DIA G YL E N IHRD+ RN L+ K+GDFG+++
Sbjct: 136 SLAMLDLLHVARDIACGCQYL--EENHFIHRDIAARNC-LLTCPGPGRVAKIGDFGMARD 192
Query: 194 IKVQNSHDVYKMTGETGS-YRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANY 251
I Y+ G ++M PE F + K D +SF ++L+E+ G P +
Sbjct: 193 I---YRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK 249
Query: 252 EPYEAAKYVAEGHR---PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKI 305
E ++V G R P K + + +CW RP+F IL+R+E
Sbjct: 250 SNQEVLEFVTSGGRMDPP----KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 223 bits (570), Expect = 8e-71
Identities = 85/288 (29%), Positives = 140/288 (48%), Gaps = 19/288 (6%)
Query: 26 PPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-----TPVAIKRILPSLSDD 80
P ++ E+D + + ++G G FGE+ + VAIK + ++
Sbjct: 31 PTQTVHEFAKELDATNISIDK--VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK 88
Query: 81 RLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSP 139
+ +DF E +++ + HPNI++ G VT+ KP+M++TEY+ G L +L++ +
Sbjct: 89 QR--RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV 146
Query: 140 STAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 199
V IA GM YL +HRDL RN+L+ +S KV DFGL ++++ +
Sbjct: 147 IQLVGMLRGIASGMKYL--SDMGYVHRDLAARNILI--NSNLVCKVSDFGLGRVLE-DDP 201
Query: 200 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAK 258
Y G R+ +PE +RK+ DV+S+ ++L+E++ GE P + K
Sbjct: 202 EAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIK 261
Query: 259 YVAEGHR-PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKI 305
V EG+R P L +L CW D N RP F I+ L+K+
Sbjct: 262 AVDEGYRLP--PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 219 bits (560), Expect = 2e-70
Identities = 86/280 (30%), Positives = 133/280 (47%), Gaps = 27/280 (9%)
Query: 34 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-TPVAIKRILPSLSDDRLVIQDFRHEVN 92
+WE+ L +G G FGE+ Y+ G T VA+K SL + F E N
Sbjct: 7 EWEVPRETLKLVE--RLGAGQFGEVWMGYYNGHTKVAVK----SLKQGSMSPDAFLAEAN 60
Query: 93 LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIA 150
L+ +L+H +V+ VT+ P+ +ITEY+ G L +LK L+ + ++ A IA
Sbjct: 61 LMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 119
Query: 151 RGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETG 210
GMA++ E IHRDL+ N+L+ S K+ DFGL++LI+ + Y T G
Sbjct: 120 EGMAFI--EERNYIHRDLRAANILV--SDTLSCKIADFGLARLIE----DNEY--TAREG 169
Query: 211 S---YRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKYVAEGHR- 265
+ ++ APE + + K DV+SF ++L E++ G P E + + G+R
Sbjct: 170 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM 229
Query: 266 PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKI 305
R EL +L CW RP+F + LE
Sbjct: 230 V--RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 219 bits (561), Expect = 2e-70
Identities = 76/286 (26%), Positives = 125/286 (43%), Gaps = 20/286 (6%)
Query: 34 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRG----TPVAIKRILPSLSDDRLVIQDFRH 89
+ L + +G G+FG + + +R VAIK + ++
Sbjct: 3 KLFLKRDNLLIAD-IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA--DTEEMMR 59
Query: 90 EVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALD 148
E ++ +L +P IV+ +G + LML+ E GG LHK+L ++ + S
Sbjct: 60 EAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQ 118
Query: 149 IARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGE 208
++ GM YL E +HRDL RNVLL + + K+ DFGLSK + + Y
Sbjct: 119 VSMGMKYL--EEKNFVHRDLAARNVLL--VNRHYAKISDFGLSKALGADD--SYYTARSA 172
Query: 209 TGS-YRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKYVAEGHR- 265
++ APE RK+ + DV+S+ + ++E L G+ P + E ++ +G R
Sbjct: 173 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM 232
Query: 266 PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPT 311
PEL L CW RP FL + +R+ +L +
Sbjct: 233 E--CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 276
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 220 bits (563), Expect = 2e-70
Identities = 91/312 (29%), Positives = 145/312 (46%), Gaps = 43/312 (13%)
Query: 26 PPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLS 78
P + C I ++ +G+G+FG++ A VA+K + +
Sbjct: 27 PQYFSDACVHHIKRRDIVLKW--ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE 84
Query: 79 DDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE----- 133
R QDF+ E LL L+H +IV+F G TE +PL+++ EY+R GDL+++L+
Sbjct: 85 SAR---QDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDA 141
Query: 134 ----------KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHL 183
G L + A +A GM YL +HRDL RN L+ +
Sbjct: 142 KLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL--AGLHFVHRDLATRNCLV--GQGLVV 197
Query: 184 KVGDFGLSKLIKVQNSHDVYKMTGETG-SYRYMAPEVFKHRKYDKKVDVFSFAMILYEML 242
K+GDFG+S+ I S D Y++ G T R+M PE +RK+ + DV+SF ++L+E+
Sbjct: 198 KIGDFGMSRDI---YSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIF 254
Query: 243 -EGEPPLANYEPYEAAKYVAEGHR---PFFRAKGFTPELRELTEKCWAADMNQRPSFLDI 298
G+ P EA + +G P + PE+ + CW + QR S D+
Sbjct: 255 TYGKQPWYQLSNTEAIDCITQGRELERP----RACPPEVYAIMRGCWQREPQQRHSIKDV 310
Query: 299 LKRLEKIKETLP 310
RL+ + + P
Sbjct: 311 HARLQALAQAPP 322
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 3e-70
Identities = 91/319 (28%), Positives = 140/319 (43%), Gaps = 35/319 (10%)
Query: 13 YGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-----TP 67
+ + S P+ D ID + L I+G+G FG +++ +
Sbjct: 7 HHHHSSGLVPRGSEELQNKLEDVVIDRNLLILGK--ILGEGEFGSVMEGNLKQEDGTSLK 64
Query: 68 VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP-----LMLITEYL 122
VA+K + S R + ++F E + HPN+++ LG E M+I ++
Sbjct: 65 VAVKTMKLDNSSQREI-EEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFM 123
Query: 123 RGGDLHKYLK------EKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLV 176
+ GDLH YL + T + F +DIA GM YL +HRDL RN +L
Sbjct: 124 KYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYL--SNRNFLHRDLAARNCML- 180
Query: 177 NSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGS-YRYMAPEVFKHRKYDKKVDVFSFA 235
+ V DFGLSK I S D Y+ +++A E R Y K DV++F
Sbjct: 181 -RDDMTVCVADFGLSKKI---YSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFG 236
Query: 236 MILYEMLE-GEPPLANYEPYEAAKYVAEGHR---PFFRAKGFTPELRELTEKCWAADMNQ 291
+ ++E+ G P + +E Y+ GHR P + EL E+ CW D
Sbjct: 237 VTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQP----EDCLDELYEIMYSCWRTDPLD 292
Query: 292 RPSFLDILKRLEKIKETLP 310
RP+F + +LEK+ E+LP
Sbjct: 293 RPTFSVLRLQLEKLLESLP 311
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 221 bits (565), Expect = 4e-70
Identities = 79/303 (26%), Positives = 139/303 (45%), Gaps = 21/303 (6%)
Query: 26 PPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-----TPVAIKRILPSLSDD 80
P + I PS L + +IG+G FG + A+K L ++D
Sbjct: 73 PELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVK-SLNRITDI 131
Query: 81 RLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK-PLMLITEYLRGGDLHKYL-KEKGALS 138
+ F E ++ HPN++ LG + +++ Y++ GDL ++ E +
Sbjct: 132 G-EVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPT 190
Query: 139 PSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 198
+ F L +A+GM +L +HRDL RN +L +KV DFGL++ + +
Sbjct: 191 VKDLIGFGLQVAKGMKFL--ASKKFVHRDLAARNCML--DEKFTVKVADFGLARDMYDKE 246
Query: 199 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAA 257
V+ TG ++MA E + +K+ K DV+SF ++L+E++ G PP + ++
Sbjct: 247 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT 306
Query: 258 KYVAEGHR---PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPTDHH 314
Y+ +G R P + L E+ KCW RPSF +++ R+ I T +H+
Sbjct: 307 VYLLQGRRLLQP----EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHY 362
Query: 315 WNI 317
++
Sbjct: 363 VHV 365
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 221 bits (564), Expect = 4e-70
Identities = 79/301 (26%), Positives = 127/301 (42%), Gaps = 35/301 (11%)
Query: 26 PPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLS 78
E+ + +G G+FGE+ + G VA+K + S
Sbjct: 57 GKTSSISDLKEVPRKNITLIR--GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS 114
Query: 79 DDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK------ 132
+ DF E ++ K H NIV+ +G + P ++ E + GGDL +L+
Sbjct: 115 EQDE--LDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRP 172
Query: 133 -EKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHL--KVGDFG 189
+ +L+ ++ A DIA G YL E N IHRD+ RN L+ K+GDFG
Sbjct: 173 SQPSSLAMLDLLHVARDIACGCQYL--EENHFIHRDIAARNC-LLTCPGPGRVAKIGDFG 229
Query: 190 LSKLIKVQNSHDVYKMTGETGS-YRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPP 247
+++ I Y+ G ++M PE F + K D +SF ++L+E+ G P
Sbjct: 230 MARDIY---RAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286
Query: 248 LANYEPYEAAKYVAEGHR---PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEK 304
+ E ++V G R P K + + +CW RP+F IL+R+E
Sbjct: 287 YPSKSNQEVLEFVTSGGRMDPP----KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY 342
Query: 305 I 305
Sbjct: 343 C 343
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 218 bits (558), Expect = 6e-70
Identities = 79/303 (26%), Positives = 141/303 (46%), Gaps = 27/303 (8%)
Query: 26 PPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-----TPVAIKRILPSLSDD 80
L D I + S +IGKG FG + + AIK +
Sbjct: 5 SALLAEVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQ 64
Query: 81 RLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP-LMLITEYLRGGDLHKYLK-EKGALS 138
++ F E L+ L HPN++ +G + + ++ Y+ GDL ++++ + +
Sbjct: 65 --QVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPT 122
Query: 139 PSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 198
++F L +ARGM YL +HRDL RN +L + +KV DFGL++ I
Sbjct: 123 VKDLISFGLQVARGMEYL--AEQKFVHRDLAARNCML--DESFTVKVADFGLARDI---L 175
Query: 199 SHDVYKMTGETGS---YRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPY 254
+ Y + + ++ A E + ++ K DV+SF ++L+E+L G PP + +P+
Sbjct: 176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF 235
Query: 255 EAAKYVAEGHR---PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPT 311
+ ++A+G R P + L ++ ++CW AD RP+F ++ +E+I L
Sbjct: 236 DLTHFLAQGRRLPQP----EYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG 291
Query: 312 DHH 314
DH+
Sbjct: 292 DHY 294
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 219 bits (560), Expect = 6e-70
Identities = 88/314 (28%), Positives = 146/314 (46%), Gaps = 41/314 (13%)
Query: 16 NGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPV 68
N +F V P +WE+ ++ S +G+GSFG + + +G T V
Sbjct: 5 NPEYFSAADVYVPD----EWEVAREKITMSR--ELGQGSFGMVYEGVAKGVVKDEPETRV 58
Query: 69 AIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLH 128
AIK + + S +F +E +++ + ++V+ LG V++ +P ++I E + GDL
Sbjct: 59 AIKTVNEAASMR--ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLK 116
Query: 129 KYLKEK----------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS 178
YL+ S S + A +IA GMAYL N +HRDL RN ++ +
Sbjct: 117 SYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYL--NANKFVHRDLAARNCMV--A 172
Query: 179 SADHLKVGDFGLSKLIKVQNSHDVYKMTGETG-SYRYMAPEVFKHRKYDKKVDVFSFAMI 237
+K+GDFG+++ I D Y+ G+ R+M+PE K + DV+SF ++
Sbjct: 173 EDFTVKIGDFGMTRDI---YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVV 229
Query: 238 LYEMLE-GEPPLANYEPYEAAKYVAEGHR---PFFRAKGFTPELRELTEKCWAADMNQRP 293
L+E+ E P + ++V EG P L EL CW + RP
Sbjct: 230 LWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKP----DNCPDMLFELMRMCWQYNPKMRP 285
Query: 294 SFLDILKRLEKIKE 307
SFL+I+ +++ E
Sbjct: 286 SFLEIISSIKEEME 299
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 228 bits (582), Expect = 7e-70
Identities = 86/307 (28%), Positives = 145/307 (47%), Gaps = 24/307 (7%)
Query: 9 GGLSYGQNGSHFEPKPVPPP--LPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG- 65
+S + + E +P+ D+EI ++ IG+G FG++ + +
Sbjct: 357 HTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQRERIELGR--CIGEGQFGDVHQGIYMSP 414
Query: 66 ----TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY 121
VAIK SD + F E + + HP+IV+ +G +TE P+ +I E
Sbjct: 415 ENPAMAVAIKTCKNCTSDSVR--EKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMEL 471
Query: 122 LRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSA 180
G+L +L+ K +L ++ + +A ++ +AYL E +HRD+ RNVL+ SS
Sbjct: 472 CTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYL--ESKRFVHRDIAARNVLV--SSN 527
Query: 181 DHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYE 240
D +K+GDFGLS+ ++ YK + ++MAPE R++ DV+ F + ++E
Sbjct: 528 DCVKLGDFGLSRYME---DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWE 584
Query: 241 ML-EGEPPLANYEPYEAAKYVAEGHR-PFFRAKGFTPELRELTEKCWAADMNQRPSFLDI 298
+L G P + + + G R P P L L KCWA D ++RP F ++
Sbjct: 585 ILMHGVKPFQGVKNNDVIGRIENGERLP--MPPNCPPTLYSLMTKCWAYDPSRRPRFTEL 642
Query: 299 LKRLEKI 305
+L I
Sbjct: 643 KAQLSTI 649
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 222 bits (567), Expect = 2e-69
Identities = 86/287 (29%), Positives = 131/287 (45%), Gaps = 19/287 (6%)
Query: 26 PPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-TPVAIKRILPSLSDDRLVI 84
K WEI L +G+G FGE+ W G T VAIK +L +
Sbjct: 170 QTQGLAKDAWEIPRESLRLEV--KLGQGCFGEVWMGTWNGTTRVAIK----TLKPGTMSP 223
Query: 85 QDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG--ALSPSTA 142
+ F E ++ KLRH +VQ V+E +P+ ++TEY+ G L +LK + L
Sbjct: 224 EAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQL 282
Query: 143 VNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDV 202
V+ A IA GMAY+ E +HRDL+ N+L+ KV DFGL++LI ++
Sbjct: 283 VDMAAQIASGMAYV--ERMNYVHRDLRAANILV--GENLVCKVADFGLARLI---EDNEY 335
Query: 203 YKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKYVA 261
G ++ APE + ++ K DV+SF ++L E+ +G P E V
Sbjct: 336 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 395
Query: 262 EGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKET 308
G+R L +L +CW + +RP+F + LE +
Sbjct: 396 RGYR-MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 217 bits (554), Expect = 4e-69
Identities = 80/287 (27%), Positives = 136/287 (47%), Gaps = 25/287 (8%)
Query: 30 PNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG------TPVAIKRILPSLSDDRLV 83
PN+ I E +F ++G G+FG + K W PVAIK + + S
Sbjct: 4 PNQALLRILK-ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK--A 60
Query: 84 IQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTA 142
++ E ++ + +P++ + LG + LIT+ + G L Y++E K +
Sbjct: 61 NKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYL 119
Query: 143 VNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDV 202
+N+ + IA+GM YL E ++HRDL RNVL+ + H+K+ DFGL+KL+
Sbjct: 120 LNWCVQIAKGMNYL--EDRRLVHRDLAARNVLV--KTPQHVKITDFGLAKLL--GAEEKE 173
Query: 203 YKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKYVA 261
Y G ++MA E HR Y + DV+S+ + ++E++ G P E + +
Sbjct: 174 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233
Query: 262 EGHR---PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKI 305
+G R P T ++ + KCW D + RP F +++ K+
Sbjct: 234 KGERLPQP----PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 223 bits (569), Expect = 6e-69
Identities = 88/292 (30%), Positives = 133/292 (45%), Gaps = 20/292 (6%)
Query: 22 PKPVPPP-LPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-TPVAIKRILPSLSD 79
P P K WEI L +G+G FGE+ W G T VAIK +L
Sbjct: 248 PTSKPQTQGLAKDAWEIPRESLRLEV--KLGQGCFGEVWMGTWNGTTRVAIK----TLKP 301
Query: 80 DRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG--AL 137
+ + F E ++ KLRH +VQ V+E +P+ ++TEY+ G L +LK + L
Sbjct: 302 GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYL 360
Query: 138 SPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 197
V+ A IA GMAY+ E +HRDL+ N+L+ KV DFGL++LI
Sbjct: 361 RLPQLVDMAAQIASGMAYV--ERMNYVHRDLRAANILV--GENLVCKVADFGLARLI--- 413
Query: 198 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEA 256
++ G ++ APE + ++ K DV+SF ++L E+ +G P E
Sbjct: 414 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV 473
Query: 257 AKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKET 308
V G+R L +L +CW + +RP+F + LE +
Sbjct: 474 LDQVERGYR-MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 216 bits (552), Expect = 7e-69
Identities = 78/318 (24%), Positives = 131/318 (41%), Gaps = 39/318 (12%)
Query: 16 NGSHFEPKPVPPPLPNKCD-WEIDPSELDFSSSAIIGKGSFGEILKAYWRG------TPV 68
+ H + D L +G+G FG++ + V
Sbjct: 6 HHHHHHHGALEVLFQGPGDPTVFHKRYLKKIR--DLGEGHFGKVSLYCYDPTNDGTGEMV 63
Query: 69 AIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE--RKPLMLITEYLRGGD 126
A+K + ++ E+++L L H +I+++ G + L L+ EY+ G
Sbjct: 64 AVKALKADAGPQ--HRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGS 121
Query: 127 LHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVG 186
L YL + ++ + + FA I GMAYL IHRDL RNVLL + +K+G
Sbjct: 122 LRDYLP-RHSIGLAQLLLFAQQICEGMAYL--HAQHYIHRDLAARNVLL--DNDRLVKIG 176
Query: 187 DFGLSKLIKVQNSHDVYKMTGETGS-YRYMAPEVFKHRKYDKKVDVFSFAMILYEML--- 242
DFGL+K + H+ Y++ + S + APE K K+ DV+SF + LYE+L
Sbjct: 177 DFGLAKAVP--EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHC 234
Query: 243 ------EGEPPLANYEPY------EAAKYVAEGHR-PFFRAKGFTPELRELTEKCWAADM 289
+ + + G R P R E+ L + CW +
Sbjct: 235 DSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLP--RPDKCPAEVYHLMKNCWETEA 292
Query: 290 NQRPSFLDILKRLEKIKE 307
+ RP+F +++ L+ + E
Sbjct: 293 SFRPTFENLIPILKTVHE 310
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 9e-69
Identities = 82/292 (28%), Positives = 133/292 (45%), Gaps = 21/292 (7%)
Query: 22 PKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-TPVAIKRILPSLSDD 80
P K WEI L +G G FGE+ A + T VA+K + P
Sbjct: 170 MSSKPQKPWEKDAWEIPRESLKLEK--KLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSV 227
Query: 81 RLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK--EKGALS 138
+ F E N++ L+H +V+ VT+ +P+ +ITE++ G L +LK E
Sbjct: 228 ----EAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQP 282
Query: 139 PSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 198
++F+ IA GMA++ E IHRDL+ N+L+ S++ K+ DFGL+++I
Sbjct: 283 LPKLIDFSAQIAEGMAFI--EQRNYIHRDLRAANILV--SASLVCKIADFGLARVI---E 335
Query: 199 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAA 257
++ G ++ APE + K DV+SF ++L E++ G P E
Sbjct: 336 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI 395
Query: 258 KYVAEGHR-PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKET 308
+ + G+R P R + EL + +CW +RP+F I L+
Sbjct: 396 RALERGYRMP--RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 2e-68
Identities = 79/273 (28%), Positives = 127/273 (46%), Gaps = 18/273 (6%)
Query: 36 EIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRI-LPSLSDDRLVIQDFRHEVN 92
+ IG+GSF + K VA + L+ Q F+ E
Sbjct: 20 GMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSER--QRFKEEAE 77
Query: 93 LLVKLRHPNIVQFLGA----VTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALD 148
+L L+HPNIV+F + V +K ++L+TE + G L YLK + ++
Sbjct: 78 MLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQ 137
Query: 149 IARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGE 208
I +G+ +LH IIHRDLK N+ + +K+GD GL+ L + + V
Sbjct: 138 ILKGLQFLHTRTPPIIHRDLKCDNI-FITGPTGSVKIGDLGLATLKRASFAKAV------ 190
Query: 209 TGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAA-KYVAEGHRPF 267
G+ +MAPE+++ KYD+ VDV++F M + EM E P + + + V G +P
Sbjct: 191 IGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA 249
Query: 268 FRAKGFTPELRELTEKCWAADMNQRPSFLDILK 300
K PE++E+ E C + ++R S D+L
Sbjct: 250 SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 213 bits (545), Expect = 3e-68
Identities = 65/290 (22%), Positives = 124/290 (42%), Gaps = 38/290 (13%)
Query: 35 WEIDPSELDFSSSAIIGKGSFGEILKAYWRG---------TPVAIKRILPSLSDDRLVIQ 85
+I +L F+ +G+G+F +I K R T V +K + + + +
Sbjct: 3 HKIRNEDLIFNE--SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYS---E 57
Query: 86 DFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVN 144
F +++ KL H ++V G +L+ E+++ G L YLK+ K ++ +
Sbjct: 58 SFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLE 117
Query: 145 FALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHL------KVGDFGLSKLIKVQN 198
A +A M +L E N +IH ++ +N+LL+ K+ D G+S +
Sbjct: 118 VAKQLAAAMHFL--EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVL--- 172
Query: 199 SHDVYKMTGETGSYRYMAPEVFKHRK-YDKKVDVFSFAMILYEML-EGEPPLANYEPYEA 256
D+ + ++ PE ++ K + D +SF L+E+ G+ PL+ +
Sbjct: 173 PKDILQE-----RIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRK 227
Query: 257 AKYVAEGHR-PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKI 305
++ + H+ P EL L C + + RPSF I++ L +
Sbjct: 228 LQFYEDRHQLP----APKAAELANLINNCMDYEPDHRPSFRAIIRDLNSL 273
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 1e-67
Identities = 89/321 (27%), Positives = 141/321 (43%), Gaps = 51/321 (15%)
Query: 23 KPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILP 75
+ P E + +++ IG+G+FG + +A G T VA+K +L
Sbjct: 30 RMPLLLNPKLLSLEYPRNNIEYVR--DIGEGAFGRVFQARAPGLLPYEPFTMVAVK-MLK 86
Query: 76 SLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK- 134
+ + DF+ E L+ + +PNIV+ LG KP+ L+ EY+ GDL+++L+
Sbjct: 87 EEASADM-QADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMS 145
Query: 135 -----------------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPR 171
LS + + A +A GMAYL +HRDL R
Sbjct: 146 PHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYL--SERKFVHRDLATR 203
Query: 172 NVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETG-SYRYMAPEVFKHRKYDKKVD 230
N L+ +K+ DFGLS+ I S D YK G R+M PE + +Y + D
Sbjct: 204 NCLV--GENMVVKIADFGLSRNI---YSADYYKADGNDAIPIRWMPPESIFYNRYTTESD 258
Query: 231 VFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHR---PFFRAKGFTPELRELTEKCWA 286
V+++ ++L+E+ G P E YV +G+ P + EL L CW+
Sbjct: 259 VWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACP----ENCPLELYNLMRLCWS 314
Query: 287 ADMNQRPSFLDILKRLEKIKE 307
RPSF I + L+++ E
Sbjct: 315 KLPADRPSFCSIHRILQRMCE 335
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 1e-67
Identities = 86/299 (28%), Positives = 133/299 (44%), Gaps = 45/299 (15%)
Query: 35 WEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQDF 87
EI S + F +G+ FG++ K + G VAIK + ++F
Sbjct: 4 KEISLSAVRFME--ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLR--EEF 59
Query: 88 RHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-------------- 133
RHE L +L+HPN+V LG VT+ +PL +I Y GDLH++L
Sbjct: 60 RHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDR 119
Query: 134 --KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 191
K AL P V+ IA GM YL + ++H+DL RNVL+ ++K+ D GL
Sbjct: 120 TVKSALEPPDFVHLVAQIAAGMEYL--SSHHVVHKDLATRNVLV--YDKLNVKISDLGLF 175
Query: 192 KLIKVQNSHDVYKMTGETGSY--RYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPL 248
+ + + D YK+ G R+MAPE + K+ D++S+ ++L+E+ G P
Sbjct: 176 REV---YAADYYKLLGN-SLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY 231
Query: 249 ANYEPYEAAKYVAEGHR---PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEK 304
Y + + + P + L +CW ++RP F DI RL
Sbjct: 232 CGYSNQDVVEMIRNRQVLPCP----DDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRA 286
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 2e-67
Identities = 85/302 (28%), Positives = 133/302 (44%), Gaps = 36/302 (11%)
Query: 34 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-----TPVAIKRILPSLSDDRLVIQDFR 88
D I + ++GKG FG + +A + VA+K +L + I++F
Sbjct: 17 DVLIPEQQFTLGR--MLGKGEFGSVREAQLKQEDGSFVKVAVK-MLKADIIASSDIEEFL 73
Query: 89 HEVNLLVKLRHPNIVQFLGAVTERKP------LMLITEYLRGGDLHKYLK------EKGA 136
E + + HP++ + +G + M+I +++ GDLH +L
Sbjct: 74 REAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFN 133
Query: 137 LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 196
L T V F +DIA GM YL IHRDL RN +L + + V DFGLS+ I
Sbjct: 134 LPLQTLVRFMVDIACGMEYL--SSRNFIHRDLAARNCML--AEDMTVCVADFGLSRKI-- 187
Query: 197 QNSHDVYKMTGETGS-YRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPY 254
S D Y+ + +++A E Y DV++F + ++E++ G+ P A E
Sbjct: 188 -YSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA 246
Query: 255 EAAKYVAEGHR---PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPT 311
E Y+ G+R P E+ +L +CW+AD QRPSF + LE I L
Sbjct: 247 EIYNYLIGGNRLKQP----PECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSV 302
Query: 312 DH 313
Sbjct: 303 LS 304
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 5e-67
Identities = 97/324 (29%), Positives = 143/324 (44%), Gaps = 49/324 (15%)
Query: 16 NGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG----TPVAIK 71
H P P +D +++ F +IG+G+FG++LKA + AIK
Sbjct: 2 KKHHHHHHGKNNPDPTI-YPVLDWNDIKFQD--VIGEGNFGQVLKARIKKDGLRMDAAIK 58
Query: 72 RILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKY 130
R+ S D +DF E+ +L KL HPNI+ LGA R L L EY G+L +
Sbjct: 59 RMKEYASKDDH--RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDF 116
Query: 131 LKEK----------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVL 174
L++ LS ++FA D+ARGM YL IHRDL RN+L
Sbjct: 117 LRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL--SQKQFIHRDLAARNIL 174
Query: 175 LVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGS---YRYMAPEVFKHRKYDKKVDV 231
+ K+ DFGLS+ +VY T R+MA E + Y DV
Sbjct: 175 V--GENYVAKIADFGLSR------GQEVYVKK--TMGRLPVRWMAIESLNYSVYTTNSDV 224
Query: 232 FSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHR---PFFRAKGFTPELRELTEKCWAA 287
+S+ ++L+E++ G P E + + +G+R P E+ +L +CW
Sbjct: 225 WSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKP----LNCDDEVYDLMRQCWRE 280
Query: 288 DMNQRPSFLDILKRLEKIKETLPT 311
+RPSF IL L ++ E T
Sbjct: 281 KPYERPSFAQILVSLNRMLEERKT 304
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 212 bits (543), Expect = 8e-67
Identities = 92/312 (29%), Positives = 145/312 (46%), Gaps = 48/312 (15%)
Query: 29 LPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG---------TPVAIKRILPSLSD 79
LP WE +L +G+G FG+++ A G VA+K + ++
Sbjct: 70 LPEDPKWEFPRDKLTLGK--PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATE 127
Query: 80 DRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK------ 132
L D E+ ++ + +H NI+ LGA T+ PL +I EY G+L +YL+
Sbjct: 128 KDL--SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPG 185
Query: 133 ----------EKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH 182
+ ++ V+ +ARGM YL IHRDL RNVL+ + ++
Sbjct: 186 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL--ASQKCIHRDLAARNVLV---TENN 240
Query: 183 -LKVGDFGLSKLIKVQNSHDVYKMTGETG-SYRYMAPEVFKHRKYDKKVDVFSFAMILYE 240
+K+ DFGL++ I N+ D YK T ++MAPE R Y + DV+SF ++++E
Sbjct: 241 VMKIADFGLARDI---NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWE 297
Query: 241 MLE-GEPPLANYEPYEAAKYVAEGHR---PFFRAKGFTPELRELTEKCWAADMNQRPSFL 296
+ G P E K + EGHR P T EL + CW A +QRP+F
Sbjct: 298 IFTLGGSPYPGIPVEELFKLLKEGHRMDKP----ANCTNELYMMMRDCWHAVPSQRPTFK 353
Query: 297 DILKRLEKIKET 308
+++ L++I
Sbjct: 354 QLVEDLDRILTL 365
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 210 bits (536), Expect = 2e-66
Identities = 87/315 (27%), Positives = 142/315 (45%), Gaps = 53/315 (16%)
Query: 28 PLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDD 80
+ WE L +G+G FG+++KA T VA+K + + S
Sbjct: 11 KILEDPKWEFPRKNLVLGK--TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPS 68
Query: 81 RLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK------ 134
L +D E N+L ++ HP++++ GA ++ PL+LI EY + G L +L+E
Sbjct: 69 EL--RDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPG 126
Query: 135 ------------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLV 176
AL+ ++FA I++GM YL ++HRDL RN+L+
Sbjct: 127 YLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL--AEMKLVHRDLAARNILV- 183
Query: 177 NSSADH-LKVGDFGLSKLIKVQNSHDVYKMTGETG-SYRYMAPEVFKHRKYDKKVDVFSF 234
+ +K+ DFGLS+ + D Y + ++MA E Y + DV+SF
Sbjct: 184 --AEGRKMKISDFGLSRDV---YEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSF 238
Query: 235 AMILYEMLE-GEPPLANYEPYEAAKYVAEGHR---PFFRAKGFTPELRELTEKCWAADMN 290
++L+E++ G P P + GHR P + E+ L +CW + +
Sbjct: 239 GVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRMERP----DNCSEEMYRLMLQCWKQEPD 294
Query: 291 QRPSFLDILKRLEKI 305
+RP F DI K LEK+
Sbjct: 295 KRPVFADISKDLEKM 309
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 209 bits (535), Expect = 2e-66
Identities = 93/325 (28%), Positives = 147/325 (45%), Gaps = 53/325 (16%)
Query: 14 GQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------T 66
G N + +P +P WE + L F +G G+FG++++A G
Sbjct: 1 GNNYVYIDPTQLPYDH----KWEFPRNRLSFGK--TLGAGAFGKVVEATAYGLIKSDAAM 54
Query: 67 PVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGG 125
VA+K + PS + E+ +L L H NIV LGA T P ++ITEY G
Sbjct: 55 TVAVKMLKPSAHLTER--EALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYG 112
Query: 126 DLHKYLKEK------------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 167
DL +L+ K AL ++F+ +A+GMA+L IHRD
Sbjct: 113 DLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL--ASKNCIHRD 170
Query: 168 LKPRNVLLVNSSADHL-KVGDFGLSKLIKVQNSHDVYKMTGETG-SYRYMAPEVFKHRKY 225
L RN+LL + + K+ DFGL++ I + Y + G ++MAPE + Y
Sbjct: 171 LAARNILL---THGRITKICDFGLARDI---KNDSNYVVKGNARLPVKWMAPESIFNCVY 224
Query: 226 DKKVDVFSFAMILYEMLE-GEPPLANYEP-YEAAKYVAEGHR---PFFRAKGFTPELREL 280
+ DV+S+ + L+E+ G P + K + EG R P + E+ ++
Sbjct: 225 TFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSP----EHAPAEMYDI 280
Query: 281 TEKCWAADMNQRPSFLDILKRLEKI 305
+ CW AD +RP+F I++ +EK
Sbjct: 281 MKTCWDADPLKRPTFKQIVQLIEKQ 305
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 209 bits (534), Expect = 6e-66
Identities = 94/330 (28%), Positives = 150/330 (45%), Gaps = 50/330 (15%)
Query: 8 HGGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-- 65
H + Q+ P K WE +L +G+G+FG+++ A G
Sbjct: 5 HHHHHHSQDPMLAGVSEYELPEDPK--WEFPRDKLTLGK--PLGEGAFGQVVMAEAVGID 60
Query: 66 -------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLML 117
VA+K + ++ L D E+ ++ + +H NI+ LGA T+ PL +
Sbjct: 61 KDKPKEAVTVAVKMLKDDATEKDL--SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYV 118
Query: 118 ITEYLRGGDLHKYLK----------------EKGALSPSTAVNFALDIARGMAYLHNEPN 161
I EY G+L +YL+ + ++ V+ +ARGM YL
Sbjct: 119 IVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL--ASQ 176
Query: 162 VIIHRDLKPRNVLLVNSSADH-LKVGDFGLSKLIKVQNSHDVYKMTGETG-SYRYMAPEV 219
IHRDL RNVL+ + ++ +K+ DFGL++ I N+ D YK T ++MAPE
Sbjct: 177 KCIHRDLAARNVLV---TENNVMKIADFGLARDI---NNIDYYKKTTNGRLPVKWMAPEA 230
Query: 220 FKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHR---PFFRAKGFTP 275
R Y + DV+SF ++++E+ G P E K + EGHR P T
Sbjct: 231 LFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKP----ANCTN 286
Query: 276 ELRELTEKCWAADMNQRPSFLDILKRLEKI 305
EL + CW A +QRP+F +++ L++I
Sbjct: 287 ELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 3e-64
Identities = 99/342 (28%), Positives = 153/342 (44%), Gaps = 53/342 (15%)
Query: 1 MMELLNAHGGLSYGQNGSHFEPKPVPPP-----LPNKCDWEIDPSELDFSSSAIIGKGSF 55
M + H + + + LP WE+ L +G+G+F
Sbjct: 25 MGYYHHHHHHDYDIPTTENLYFQGMLAGVSEYELPEDPRWELPRDRLVLGK--PLGEGAF 82
Query: 56 GEILKAYWRG---------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQF 105
G+++ A G T VA+K + ++ L D E+ ++ + +H NI+
Sbjct: 83 GQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDL--SDLISEMEMMKMIGKHKNIINL 140
Query: 106 LGAVTERKPLMLITEYLRGGDLHKYLKEK----------------GALSPSTAVNFALDI 149
LGA T+ PL +I EY G+L +YL+ + LS V+ A +
Sbjct: 141 LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQV 200
Query: 150 ARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH-LKVGDFGLSKLIKVQNSHDVYKMTGE 208
ARGM YL IHRDL RNVL+ + D+ +K+ DFGL++ I + D YK T
Sbjct: 201 ARGMEYL--ASKKCIHRDLAARNVLV---TEDNVMKIADFGLARDI---HHIDYYKKTTN 252
Query: 209 TG-SYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHR- 265
++MAPE R Y + DV+SF ++L+E+ G P E K + EGHR
Sbjct: 253 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRM 312
Query: 266 --PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKI 305
P T EL + CW A +QRP+F +++ L++I
Sbjct: 313 DKP----SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 350
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 3e-64
Identities = 90/312 (28%), Positives = 144/312 (46%), Gaps = 51/312 (16%)
Query: 26 PPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLS 78
P LP WE + L F +G G+FG++++A G VA+K + +
Sbjct: 32 PTQLPYNEKWEFPRNNLQFGK--TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAH 89
Query: 79 DDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG-- 135
D + E+ ++ L +H NIV LGA T P+++ITEY GDL +L+ K
Sbjct: 90 ADEK--EALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRV 147
Query: 136 ------------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHL 183
S ++F+ +A+GMA+L IHRD+ RNVLL + H+
Sbjct: 148 LETDPAFAIANSTASTRDLLHFSSQVAQGMAFL--ASKNCIHRDVAARNVLL---TNGHV 202
Query: 184 -KVGDFGLSKLIKVQNSHDVYKMTGETG-SYRYMAPEVFKHRKYDKKVDVFSFAMILYEM 241
K+GDFGL++ I + Y + G ++MAPE Y + DV+S+ ++L+E+
Sbjct: 203 AKIGDFGLARDI---MNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 259
Query: 242 LE-GEPP----LANYEPYEAAKYVAEGHR---PFFRAKGFTPELRELTEKCWAADMNQRP 293
G P L N + Y K V +G++ P + + + CWA + RP
Sbjct: 260 FSLGLNPYPGILVNSKFY---KLVKDGYQMAQP----AFAPKNIYSIMQACWALEPTHRP 312
Query: 294 SFLDILKRLEKI 305
+F I L++
Sbjct: 313 TFQQICSFLQEQ 324
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 7e-63
Identities = 80/301 (26%), Positives = 130/301 (43%), Gaps = 25/301 (8%)
Query: 22 PKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG----TPVAIKRILPSL 77
P P L +K + L + +G G+FG + + +R VAIK +
Sbjct: 318 PFSDPEELKDK-KLFLKRDNLLIAD-IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT 375
Query: 78 SDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGA 136
++ E ++ +L +P IV+ +G + LML+ E GG LHK+L +
Sbjct: 376 EKA--DTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREE 432
Query: 137 LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 196
+ S ++ GM YL E +HR+L RNVLL + + K+ DFGLSK +
Sbjct: 433 IPVSNVAELLHQVSMGMKYL--EEKNFVHRNLAARNVLL--VNRHYAKISDFGLSKALGA 488
Query: 197 QNSHDVYKMTGETGS-YRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPY 254
+ Y ++ APE RK+ + DV+S+ + ++E L G+ P +
Sbjct: 489 DD--SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP 546
Query: 255 EAAKYVAEGHR---PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPT 311
E ++ +G R P PEL L CW RP FL + +R+ +L +
Sbjct: 547 EVMAFIEQGKRMECP----PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 602
Query: 312 D 312
Sbjct: 603 K 603
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 200 bits (512), Expect = 1e-62
Identities = 86/318 (27%), Positives = 131/318 (41%), Gaps = 54/318 (16%)
Query: 26 PPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLS 78
WE L+F ++G G+FG+++ A G VA+K +
Sbjct: 31 FREYEYDLKWEFPRENLEFGK--VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD 88
Query: 79 DDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK--- 134
+ E+ ++ +L H NIV LGA T P+ LI EY GDL YL+ K
Sbjct: 89 SSER--EALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREK 146
Query: 135 --------------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVL 174
L+ + FA +A+GM +L E +HRDL RNVL
Sbjct: 147 FSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFL--EFKSCVHRDLAARNVL 204
Query: 175 LVNSSADHL-KVGDFGLSKLIKVQNSHDVYKMTGETG-SYRYMAPEVFKHRKYDKKVDVF 232
+ + + K+ DFGL++ I S Y + G ++MAPE Y K DV+
Sbjct: 205 V---THGKVVKICDFGLARDI---MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVW 258
Query: 233 SFAMILYEMLE-GEPPLANYEP-YEAAKYVAEGHR---PFFRAKGFTPELRELTEKCWAA 287
S+ ++L+E+ G P K + G + P T E+ + + CWA
Sbjct: 259 SYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQP----FYATEEIYIIMQSCWAF 314
Query: 288 DMNQRPSFLDILKRLEKI 305
D +RPSF ++ L
Sbjct: 315 DSRKRPSFPNLTSFLGCQ 332
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 4e-62
Identities = 87/320 (27%), Positives = 144/320 (45%), Gaps = 56/320 (17%)
Query: 21 EPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRI 73
E P +K WE L +G+G+FG++++A G VA+K +
Sbjct: 10 EHCERLPYDASK--WEFPRDRLKLGK--PLGRGAFGQVIEADAFGIDKTATCRTVAVKML 65
Query: 74 LPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTER-KPLMLITEYLRGGDLHKYL 131
+ + E+ +L+ + H N+V LGA T+ PLM+I E+ + G+L YL
Sbjct: 66 KEGATHSEH--RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 123
Query: 132 KE----------------KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLL 175
+ K L+ + ++ +A+GM +L IHRDL RN+LL
Sbjct: 124 RSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAARNILL 181
Query: 176 VNSSADH-LKVGDFGLSKLIKVQNSHDVYKMTGETG-SYRYMAPEVFKHRKYDKKVDVFS 233
S + +K+ DFGL++ I Y G+ ++MAPE R Y + DV+S
Sbjct: 182 ---SEKNVVKICDFGLARDI---YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWS 235
Query: 234 FAMILYEMLE-GEPPLANY----EPYEAAKYVAEGHR---PFFRAKGFTPELRELTEKCW 285
F ++L+E+ G P Y E + + EG R P TPE+ + CW
Sbjct: 236 FGVLLWEIFSLGASP---YPGVKIDEEFCRRLKEGTRMRAP----DYTTPEMYQTMLDCW 288
Query: 286 AADMNQRPSFLDILKRLEKI 305
+ +QRP+F ++++ L +
Sbjct: 289 HGEPSQRPTFSELVEHLGNL 308
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 1e-58
Identities = 76/276 (27%), Positives = 126/276 (45%), Gaps = 22/276 (7%)
Query: 39 PSELD-FSSSAIIGKGSFGEILKAYWR--GTPVAIKRI-LPSLSDDRLVIQDFRHEVNLL 94
PS + + IG GS+G K + G + K + S+++ Q EVNLL
Sbjct: 2 PSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEK--QMLVSEVNLL 59
Query: 95 VKLRHPNIVQFLGAVTERKP--LMLITEYLRGGDLHKYLKE----KGALSPSTAVNFALD 148
+L+HPNIV++ + +R L ++ EY GGDL + + + L +
Sbjct: 60 RELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQ 119
Query: 149 IARGMAYLHNE---PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKM 205
+ + H + ++HRDLKP NV L ++K+GDFGL++++ +HD
Sbjct: 120 LTLALKECHRRSDGGHTVLHRDLKPANVFL--DGKQNVKLGDFGLARIL----NHDTSFA 173
Query: 206 TGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHR 265
G+ YM+PE Y++K D++S +LYE+ PP + E A + EG
Sbjct: 174 KTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF 233
Query: 266 PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301
++ EL E+ + RPS +IL+
Sbjct: 234 RRI-PYRYSDELNEIITRMLNLKDYHRPSVEEILEN 268
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 2e-58
Identities = 64/258 (24%), Positives = 124/258 (48%), Gaps = 16/258 (6%)
Query: 49 IIGKGSFGEILKAYWR--GTPVAIKRI-LPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 105
IG+GSFG+ + G IK I + +S ++ R EV +L ++HPNIVQ+
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKER--EESRREVAVLANMKHPNIVQY 88
Query: 106 LGAVTERKPLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIARGMAYLHNEPNVI 163
+ E L ++ +Y GGDL K + +++ + I + ++H+ I
Sbjct: 89 RESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD--RKI 146
Query: 164 IHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR 223
+HRD+K +N+ L + +++GDFG+++++ NS G+ Y++PE+ +++
Sbjct: 147 LHRDIKSQNIFL--TKDGTVQLGDFGIARVL---NSTVELARA-CIGTPYYLSPEICENK 200
Query: 224 KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEK 283
Y+ K D+++ +LYE+ + + G P ++ +LR L +
Sbjct: 201 PYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVS-LHYSYDLRSLVSQ 259
Query: 284 CWAADMNQRPSFLDILKR 301
+ + RPS IL++
Sbjct: 260 LFKRNPRDRPSVNSILEK 277
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 4e-58
Identities = 73/305 (23%), Positives = 131/305 (42%), Gaps = 18/305 (5%)
Query: 16 NGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRI 73
G P P P + +F IG+G F E+ +A G PVA+K++
Sbjct: 6 QGMQGPPVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKV 65
Query: 74 -LPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK 132
+ L D + D E++LL +L HPN++++ + E L ++ E GDL + +K
Sbjct: 66 QIFDLMDAKA-RADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIK 124
Query: 133 EKGA----LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF 188
+ T + + + + ++H+ ++HRD+KP NV + ++ +K+GD
Sbjct: 125 HFKKQKRLIPERTVWKYFVQLCSALEHMHS--RRVMHRDIKPANVFI--TATGVVKLGDL 180
Query: 189 GLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPL 248
GL + S G+ YM+PE Y+ K D++S +LYEM + P
Sbjct: 181 GLGRFF----SSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF 236
Query: 249 A--NYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIK 306
Y K + + P + ++ ELR+L C D +RP + +++
Sbjct: 237 YGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMH 296
Query: 307 ETLPT 311
+
Sbjct: 297 ACTAS 301
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 8e-58
Identities = 78/288 (27%), Positives = 128/288 (44%), Gaps = 45/288 (15%)
Query: 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 100
DF +IG G FG++ KA R G IKR+ + + EV L KL H
Sbjct: 12 DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV-------KYNNEKAEREVKALAKLDHV 64
Query: 101 NIVQFLGA----------------VTERKPLMLITEYLRGGDLHKYLKEKGA--LSPSTA 142
NIV + G ++ K L + E+ G L ++++++ L A
Sbjct: 65 NIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLA 124
Query: 143 VNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDV 202
+ I +G+ Y+H+ +I+RDLKP N+ L +K+GDFGL +K
Sbjct: 125 LELFEQITKGVDYIHS--KKLINRDLKPSNIFL--VDTKQVKIGDFGLVTSLKNDG---- 176
Query: 203 YKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAE 262
K T G+ RYM+PE + Y K+VD+++ +IL E+L +E +K+ +
Sbjct: 177 -KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT-----AFETSKFFTD 230
Query: 263 GHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRL---EKIKE 307
+ F + + L +K + RP+ +IL+ L +K E
Sbjct: 231 LRDGII-SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 2e-57
Identities = 68/262 (25%), Positives = 110/262 (41%), Gaps = 19/262 (7%)
Query: 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RH 99
F + +G GS+GE+ K + G A+KR + + EV K+ +H
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDR-ARKLAEVGSHEKVGQH 116
Query: 100 PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA-LSPSTAVNFALDIARGMAYLHN 158
P V+ A E L L TE G L ++ + GA L + + D +A+LH+
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS 175
Query: 159 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPE 218
++H D+KP N+ L K+GDFGL + + +V + G RYMAPE
Sbjct: 176 --QGLVHLDVKPANIFL--GPRGRCKLGDFGLLVELGTAGAGEVQE-----GDPRYMAPE 226
Query: 219 VFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 278
+ + Y DVFS + + E+ E ++ + +G+ P G + ELR
Sbjct: 227 LLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQ---LRQGYLPPEFTAGLSSELR 282
Query: 279 ELTEKCWAADMNQRPSFLDILK 300
+ D R + +L
Sbjct: 283 SVLVMMLEPDPKLRATAEALLA 304
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 1e-56
Identities = 67/311 (21%), Positives = 127/311 (40%), Gaps = 40/311 (12%)
Query: 6 NAHGGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR- 64
+ G+ G +F+ V + I IG G ++ +
Sbjct: 6 HHSSGVDLGTENLYFQSMSV-----KGRIYSIL---------KQIGSGGSSKVFQVLNEK 51
Query: 65 GTPVAIKRILPSLSD-DRLVIQDFRHEVNLLVKLRHPN--IVQFLGAVTERKPLMLITEY 121
AIK + +L + D + +R+E+ L KL+ + I++ + + ++ E
Sbjct: 52 KQIYAIKYV--NLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC 109
Query: 122 LRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD 181
DL+ +LK+K ++ P ++ ++ + +H + I+H DLKP N L+V+
Sbjct: 110 -GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ--HGIVHSDLKPANFLIVDGM-- 164
Query: 182 HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFK-----------HRKYDKKVD 230
LK+ DFG++ ++ ++ V K + + G+ YM PE K K K D
Sbjct: 165 -LKLIDFGIANQMQ-PDTTSVVKDS-QVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSD 221
Query: 231 VFSFAMILYEMLEGEPPLANY-EPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADM 289
V+S ILY M G+ P + + + +L+++ + C D
Sbjct: 222 VWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDP 281
Query: 290 NQRPSFLDILK 300
QR S ++L
Sbjct: 282 KQRISIPELLA 292
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 1e-56
Identities = 75/285 (26%), Positives = 121/285 (42%), Gaps = 36/285 (12%)
Query: 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRI-LPSLSDDRLVIQDFRHEVNLLVKLRH 99
DF +G+G FG + +A + AIKRI LP+ R + EV L KL H
Sbjct: 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAR---EKVMREVKALAKLEH 62
Query: 100 PNIVQFLGAVTERKP------------LMLITEYLRGGDLHKYLKEKGALSP---STAVN 144
P IV++ A E+ L + + R +L ++ + + S ++
Sbjct: 63 PGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLH 122
Query: 145 FALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK--------V 196
L IA + +LH+ ++HRDLKP N+ + D +KVGDFGL + +
Sbjct: 123 IFLQIAEAVEFLHS--KGLMHRDLKPSNIFF--TMDDVVKVGDFGLVTAMDQDEEEQTVL 178
Query: 197 QNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEA 256
+ TG+ G+ YM+PE Y KVD+FS +IL+E+L P E
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL--YPFSTQMERVRT 236
Query: 257 AKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301
V P + P + + + +RP ++I++
Sbjct: 237 LTDVRNLKFPPLFTQ-KYPCEYVMVQDMLSPSPMERPEAINIIEN 280
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 2e-56
Identities = 61/266 (22%), Positives = 117/266 (43%), Gaps = 24/266 (9%)
Query: 50 IGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN--IVQFL 106
IG G ++ + AIK + +D++ + +R+E+ L KL+ + I++
Sbjct: 17 IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQ-TLDSYRNEIAYLNKLQQHSDKIIRLY 75
Query: 107 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 166
+ + ++ E DL+ +LK+K ++ P ++ ++ + +H + I+H
Sbjct: 76 DYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ--HGIVHS 132
Query: 167 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFK----- 221
DLKP N L+V+ LK+ DFG++ ++ ++ V K + + G+ YM PE K
Sbjct: 133 DLKPANFLIVD---GMLKLIDFGIANQMQ-PDTTSVVKDS-QVGTVNYMPPEAIKDMSSS 187
Query: 222 ------HRKYDKKVDVFSFAMILYEMLEGEPPLANY-EPYEAAKYVAEGHRPFFRAKGFT 274
K K DV+S ILY M G+ P + + +
Sbjct: 188 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPE 247
Query: 275 PELRELTEKCWAADMNQRPSFLDILK 300
+L+++ + C D QR S ++L
Sbjct: 248 KDLQDVLKCCLKRDPKQRISIPELLA 273
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 183 bits (465), Expect = 1e-55
Identities = 70/288 (24%), Positives = 115/288 (39%), Gaps = 18/288 (6%)
Query: 34 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRGT--PVAIKRI-LPSLSDDRLVIQDFRHE 90
D+E + +G+GSFGE+ + + T A+K++ L + E
Sbjct: 50 DYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE---------E 100
Query: 91 VNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIA 150
+ L P IV GAV E + + E L GG L + +K+ G L A+ +
Sbjct: 101 LVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQAL 160
Query: 151 RGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK-LIKVQNSHDVYKMTGET 209
G+ YLH I+H D+K NVLL +S + DFG + L +
Sbjct: 161 EGLEYLHT--RRILHGDVKADNVLL-SSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP 217
Query: 210 GSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR 269
G+ +MAPEV + D KVD++S ++ ML G P Y +A P
Sbjct: 218 GTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIRE 277
Query: 270 AK-GFTPELRELTEKCWAADMNQRPSFLDILK-RLEKIKETLPTDHHW 315
P + ++ + R S +++ + + ++E W
Sbjct: 278 IPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPW 325
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 2e-55
Identities = 67/318 (21%), Positives = 119/318 (37%), Gaps = 26/318 (8%)
Query: 15 QNGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKR 72
+ H + + +G+G F + G A+KR
Sbjct: 2 GSSHHHHHHSSGRENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKR 61
Query: 73 ILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP----LMLITEYLRGGDLH 128
IL DR ++ + E ++ HPNI++ + + L+ + + G L
Sbjct: 62 ILCHEQQDR---EEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLW 118
Query: 129 KYLKE----KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLK 184
++ L+ + L I RG+ +H + HRDLKP N+LL
Sbjct: 119 NEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG--YAHRDLKPTNILL--GDEGQPV 174
Query: 185 VGDFGLSKL--IKVQNSHDVYKM---TGETGSYRYMAPEVF---KHRKYDKKVDVFSFAM 236
+ D G I V+ S + + + Y APE+F H D++ DV+S
Sbjct: 175 LMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGC 234
Query: 237 ILYEMLEGEPP-LANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSF 295
+LY M+ GE P ++ ++ + ++ + L +L D +QRP
Sbjct: 235 VLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHI 294
Query: 296 LDILKRLEKIKETLPTDH 313
+L +LE ++ P H
Sbjct: 295 PLLLSQLEALQPPAPGQH 312
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 3e-55
Identities = 67/284 (23%), Positives = 111/284 (39%), Gaps = 42/284 (14%)
Query: 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRI-LPSLSDDRLVIQDFRHEVNLLVKL-R 98
+F IG G FG + K R G AIKR P Q+ EV L +
Sbjct: 12 EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVD--EQNALREVYAHAVLGQ 69
Query: 99 HPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMA 154
H ++V++ A E +++ EY GG L + E + + L + RG+
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 155 YLHNEPNVIIHRDLKPRNVLL-----------------VNSSADHLKVGDFGLSKLIKVQ 197
Y+H+ ++H D+KP N+ + S+ K+GD G I
Sbjct: 130 YIHS--MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP 187
Query: 198 NSHDVYKMTGETGSYRYMAPEVFKHRK-YDKKVDVFSFAMILYEMLEGEPPLANYEPYEA 256
E G R++A EV + + K D+F+ A+ + EP N + +
Sbjct: 188 QV--------EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHE 239
Query: 257 AKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILK 300
+ +G P + + E EL + D +RPS + ++K
Sbjct: 240 ---IRQGRLPRI-PQVLSQEFTELLKVMIHPDPERRPSAMALVK 279
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 3e-55
Identities = 62/267 (23%), Positives = 117/267 (43%), Gaps = 26/267 (9%)
Query: 50 IGKGSFGEILKAYWR-GTPVAIKRILPSLSD-DRLVIQDFRHEVNLLVKLRHPN--IVQF 105
IG G ++ + AIK + +L + D + +R+E+ L KL+ + I++
Sbjct: 64 IGSGGSSKVFQVLNEKKQIYAIKYV--NLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 106 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 165
+ + ++ E DL+ +LK+K ++ P ++ ++ + +H + I+H
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ--HGIVH 178
Query: 166 RDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFK---- 221
DLKP N L+V+ LK+ DFG++ ++ ++ V K + + G+ YM PE K
Sbjct: 179 SDLKPANFLIVDGM---LKLIDFGIANQMQ-PDTTSVVKDS-QVGAVNYMPPEAIKDMSS 233
Query: 222 -------HRKYDKKVDVFSFAMILYEMLEGEPPLANY-EPYEAAKYVAEGHRPFFRAKGF 273
K K DV+S ILY M G+ P + + +
Sbjct: 234 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIP 293
Query: 274 TPELRELTEKCWAADMNQRPSFLDILK 300
+L+++ + C D QR S ++L
Sbjct: 294 EKDLQDVLKCCLKRDPKQRISIPELLA 320
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 1e-53
Identities = 69/287 (24%), Positives = 119/287 (41%), Gaps = 39/287 (13%)
Query: 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 100
DF A++G+G+FG+++KA AIK+I ++++ + EV LL L H
Sbjct: 7 DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI--RHTEEK--LSTILSEVMLLASLNHQ 62
Query: 101 NIVQFLGAVTERKP-------------LMLITEYLRGGDLHKYLKEKGA-LSPSTAVNFA 146
+V++ A ER+ L + EY G L+ + +
Sbjct: 63 YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122
Query: 147 LDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY--- 203
I ++Y+H+ IIHRDLKP N+ + + ++K+GDFGL+K +
Sbjct: 123 RQILEALSYIHS--QGIIHRDLKPMNIFI--DESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 204 -------KMTGETGSYRYMAPEVFKHRK-YDKKVDVFSFAMILYEMLEGEPPLANYEPYE 255
+T G+ Y+A EV Y++K+D++S +I +EM+ P E
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGMERVN 236
Query: 256 AAKYVAEGHRPF--FRAKGFTPELRELTEKCWAADMNQRPSFLDILK 300
K + F +++ D N+RP +L
Sbjct: 237 ILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 5e-53
Identities = 75/289 (25%), Positives = 121/289 (41%), Gaps = 24/289 (8%)
Query: 26 PPPLPNKCDWE---IDPSELDFSSSAIIGKGSFGEILKA-YWRGTPVAIKRILPSLSDDR 81
P + D E + ++ F ++G G+ G I+ + VA+KRILP
Sbjct: 5 PSLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---- 60
Query: 82 LVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG-ALSP 139
EV LL + HPN++++ +R+ + E L +Y+++K A
Sbjct: 61 --FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLG 117
Query: 140 STAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH---LKVGDFGLSKLIKV 196
+ G+A+LH+ I+HRDLKP N+L+ +A + DFGL K +
Sbjct: 118 LEPITLLQQTTSGLAHLHS--LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA- 174
Query: 197 QNSHDVYKMTGETGSYRYMAPEVFK---HRKYDKKVDVFSFAMILYEML-EGEPPLANYE 252
H + +G G+ ++APE+ VD+FS + Y ++ EG P
Sbjct: 175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL 234
Query: 253 PYEAAKYVAEGHRPFFRA-KGFTPELRELTEKCWAADMNQRPSFLDILK 300
+A + K REL EK A D +RPS +LK
Sbjct: 235 QRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 3e-50
Identities = 80/260 (30%), Positives = 120/260 (46%), Gaps = 18/260 (6%)
Query: 49 IIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 106
++GKG++G + +AIK I D R Q E+ L L+H NIVQ+L
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEI--PERDSRY-SQPLHEEIALHKHLKHKNIVQYL 85
Query: 107 GAVTERKPLMLITEYLRGGDLHKYLKEK-GALSPSTAV--NFALDIARGMAYLHNEPNVI 163
G+ +E + + E + GG L L+ K G L + + I G+ YLH+ N I
Sbjct: 86 GSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD--NQI 143
Query: 164 IHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR 223
+HRD+K NV L+N+ + LK+ DFG SK + N TG+ +YMAPE+
Sbjct: 144 VHRDIKGDNV-LINTYSGVLKISDFGTSKRLAGINP----CTETFTGTLQYMAPEIIDKG 198
Query: 224 K--YDKKVDVFSFAMILYEMLEGEPPLANY-EPYEAAKYVAEGHRPFFRAKGFTPELREL 280
Y K D++S + EM G+PP EP A V + + E +
Sbjct: 199 PRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAF 258
Query: 281 TEKCWAADMNQRPSFLDILK 300
KC+ D ++R D+L
Sbjct: 259 ILKCFEPDPDKRACANDLLV 278
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 2e-48
Identities = 81/257 (31%), Positives = 122/257 (47%), Gaps = 13/257 (5%)
Query: 49 IIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 106
++GKGSFGE++ + T A+K I + + EV LL +L HPNI++
Sbjct: 33 VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 92
Query: 107 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 166
++ L+ E GG+L + + S A + G+ Y+H N I+HR
Sbjct: 93 EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHK--NKIVHR 150
Query: 167 DLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKY 225
DLKP N+LL + S D ++++ DFGLS + KM + G+ Y+APEV Y
Sbjct: 151 DLKPENLLLESKSKDANIRIIDFGLSTHFEASK-----KMKDKIGTAYYIAPEVLH-GTY 204
Query: 226 DKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA--KGFTPELRELTEK 283
D+K DV+S +ILY +L G PP Y+ K V +G F K + ++L K
Sbjct: 205 DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRK 264
Query: 284 CWAADMNQRPSFLDILK 300
+ R S D L
Sbjct: 265 MLTYVPSMRISARDALD 281
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 2e-48
Identities = 63/203 (31%), Positives = 101/203 (49%), Gaps = 13/203 (6%)
Query: 49 IIGKGSFGEILKAYWRGT--PVAIKRIL-PSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 105
+GKG+F + + + T A K I LS Q E + KL+HPNIV+
Sbjct: 13 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD--FQKLEREARICRKLQHPNIVRL 70
Query: 106 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 165
++ E L+ + + GG+L + + + S + A + I +AY H+ N I+H
Sbjct: 71 HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS--NGIVH 128
Query: 166 RDLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRK 224
R+LKP N+LL + + +K+ DFGL+ + G G+ Y++PEV K
Sbjct: 129 RNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE-----AWHGFAGTPGYLSPEVLKKDP 183
Query: 225 YDKKVDVFSFAMILYEMLEGEPP 247
Y K VD+++ +ILY +L G PP
Sbjct: 184 YSKPVDIWACGVILYILLVGYPP 206
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 2e-48
Identities = 90/281 (32%), Positives = 136/281 (48%), Gaps = 17/281 (6%)
Query: 23 KPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGT--PVAIKRI-LPSLSD 79
PV LP + + DP EL F+ IGKGSFGE+ K T VAIK I L D
Sbjct: 4 SPVQSGLPGMQNLKADPEEL-FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED 62
Query: 80 DRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSP 139
+ I+D + E+ +L + P + ++ G+ + L +I EYL GG L+
Sbjct: 63 E---IEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDET 119
Query: 140 STAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 199
A +I +G+ YLH+E IHRD+K NVLL S +K+ DFG++ Q +
Sbjct: 120 QIAT-ILREILKGLDYLHSEK--KIHRDIKAANVLL--SEHGEVKLADFGVAG----QLT 170
Query: 200 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKY 259
K G+ +MAPEV K YD K D++S + E+ GEPP + P +
Sbjct: 171 DTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFL 230
Query: 260 VAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILK 300
+ + + P ++ L+E E C + + RP+ ++LK
Sbjct: 231 IPKNNPPTLEGN-YSKPLKEFVEACLNKEPSFRPTAKELLK 270
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 8e-48
Identities = 61/202 (30%), Positives = 96/202 (47%), Gaps = 14/202 (6%)
Query: 49 IIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 106
++G G+F E+ R T A+K I S + +E+ +L K++H NIV
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRD---SSLENEIAVLKKIKHENIVTLE 72
Query: 107 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 166
L+ + + GG+L + E+G + A + + YLH N I+HR
Sbjct: 73 DIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHE--NGIVHR 130
Query: 167 DLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKY 225
DLKP N+L + + + + DFGLSK+ + M+ G+ Y+APEV + Y
Sbjct: 131 DLKPENLLYLTPEENSKIMITDFGLSKMEQNG------IMSTACGTPGYVAPEVLAQKPY 184
Query: 226 DKKVDVFSFAMILYEMLEGEPP 247
K VD +S +I Y +L G PP
Sbjct: 185 SKAVDCWSIGVITYILLCGYPP 206
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 161 bits (411), Expect = 1e-47
Identities = 85/284 (29%), Positives = 129/284 (45%), Gaps = 35/284 (12%)
Query: 43 DFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN 101
+F +IG G FG++ K R G VA+KR P + I++F E+ L RHP+
Sbjct: 40 NFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTP---ESSQGIEEFETEIETLSFCRHPH 96
Query: 102 IVQFLGAVTERKPLMLITEYLRGGDLHKYL----KEKGALSPSTAVNFALDIARGMAYLH 157
+V +G ER ++LI +Y+ G+L ++L ++S + + ARG+ YLH
Sbjct: 97 LVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH 156
Query: 158 NEPNVIIHRDLKPRNVLL-VNSSADHLKVGDFGLSKLIKVQ-NSHDVYKMTGETGSYRYM 215
IIHRD+K N+LL N K+ DFG+SK +H + T G+ Y+
Sbjct: 157 TRA--IIHRDVKSINILLDENFVP---KITDFGISKKGTELDQTH-L--STVVKGTLGYI 208
Query: 216 APEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFT- 274
PE F + +K DV+SF ++L+E+L + P E +AE
Sbjct: 209 DPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPRE-MVNLAEWAVESHNNGQLEQ 267
Query: 275 ---PELR------------ELTEKCWAADMNQRPSFLDILKRLE 303
P L + KC A RPS D+L +LE
Sbjct: 268 IVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 1e-47
Identities = 68/290 (23%), Positives = 123/290 (42%), Gaps = 44/290 (15%)
Query: 44 FSSSAIIGKGSFGEILKAY-WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPN 101
S I+G GS G ++ ++G PVA+KR+L E+ LL + HPN
Sbjct: 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID------FCDIALMEIKLLTESDDHPN 70
Query: 102 IVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPST-------AVNFALDIARGMA 154
++++ + T + L + E +L ++ K + ++ IA G+A
Sbjct: 71 VIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129
Query: 155 YLHNEPNVIIHRDLKPRNVLLVNSSADH-----------LKVGDFGLSKLIKVQNSHDVY 203
+LH+ IIHRDLKP+N+L+ SS + + DFGL K + S
Sbjct: 130 HLHS--LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187
Query: 204 KMTGETGSYRYMAPEVFK-------HRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYE 255
+ +G+ + APE+ + R+ + +D+FS + Y +L +G+ P + Y
Sbjct: 188 NLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF--GDKYS 245
Query: 256 AAKYVAEG-----HRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILK 300
+ G + E +L + D +RP+ + +L+
Sbjct: 246 RESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 2e-47
Identities = 62/202 (30%), Positives = 99/202 (49%), Gaps = 14/202 (6%)
Query: 49 IIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 106
IG+GS+GE+ A +GT A K+I +D + F+ E+ ++ L HPNI++
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED---VDRFKQEIEIMKSLDHPNIIRLY 72
Query: 107 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 166
+ + L+ E GG+L + + K S A D+ +AY H + HR
Sbjct: 73 ETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHK--LNVAHR 130
Query: 167 DLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKY 225
DLKP N L + S D LK+ DFGL+ K M + G+ Y++P+V + Y
Sbjct: 131 DLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK-----MMRTKVGTPYYVSPQVLE-GLY 184
Query: 226 DKKVDVFSFAMILYEMLEGEPP 247
+ D +S +++Y +L G PP
Sbjct: 185 GPECDEWSAGVMMYVLLCGYPP 206
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 2e-47
Identities = 74/241 (30%), Positives = 115/241 (47%), Gaps = 20/241 (8%)
Query: 15 QNGSHFEPKPVPPPLPNKCDWEIDPSELD-----FSSSAIIGKGSFGEILKAYWRGT--P 67
Q+ S P D+ ID S D F + +G+G+ + + +GT P
Sbjct: 21 QSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKP 80
Query: 68 VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDL 127
A+K + + + R E+ +L++L HPNI++ + L+ E + GG+L
Sbjct: 81 YALKVL-----KKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGEL 135
Query: 128 HKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD-HLKVG 186
+ EKG S A + I +AYLH N I+HRDLKP N+L + D LK+
Sbjct: 136 FDRIVEKGYYSERDAADAVKQILEAVAYLHE--NGIVHRDLKPENLLYATPAPDAPLKIA 193
Query: 187 DFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEP 246
DFGLSK+++ Q M G+ Y APE+ + Y +VD++S +I Y +L G
Sbjct: 194 DFGLSKIVEHQV-----LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFE 248
Query: 247 P 247
P
Sbjct: 249 P 249
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 3e-47
Identities = 67/238 (28%), Positives = 111/238 (46%), Gaps = 16/238 (6%)
Query: 17 GSHFEPKPVPPPLPNKCDWEIDPSELDFSSS----AIIGKGSFGEILKAYWRGT--PVAI 70
G H + ++ ++ S FS + +GKG+F + + + T A
Sbjct: 1 GPHMASMTGGQQMGRGSEFMMNAST-KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAA 59
Query: 71 KRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKY 130
K I R Q E + KL+HPNIV+ ++ E L+ + + GG+L +
Sbjct: 60 KIINTKKLSARDF-QKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFED 118
Query: 131 LKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD-HLKVGDFG 189
+ + S + A + I +AY H+ N I+HR+LKP N+LL + + +K+ DFG
Sbjct: 119 IVAREFYSEADASHCIQQILESIAYCHS--NGIVHRNLKPENLLLASKAKGAAVKLADFG 176
Query: 190 LSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPP 247
L+ + G G+ Y++PEV K Y K VD+++ +ILY +L G PP
Sbjct: 177 LAIEVNDSE-----AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 229
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 3e-47
Identities = 52/216 (24%), Positives = 89/216 (41%), Gaps = 26/216 (12%)
Query: 49 IIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 106
I+G+G+ + + + G AIK + E +L KL H NIV+
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPV--DVQMREFEVLKKLNHKNIVKLF 73
Query: 107 GAVTERKP--LMLITEYLRGGDLHKYLKEKG---ALSPSTAVNFALDIARGMAYLHNEPN 161
E +LI E+ G L+ L+E L S + D+ GM +L N
Sbjct: 74 AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE--N 131
Query: 162 VIIHRDLKPRNVLLVNSSADH--LKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV 219
I+HR++KP N++ V K+ DFG ++ ++ + G+ Y+ P++
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-----QFVSLYGTEEYLHPDM 186
Query: 220 FK--------HRKYDKKVDVFSFAMILYEMLEGEPP 247
++ +KY VD++S + Y G P
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 4e-47
Identities = 65/212 (30%), Positives = 96/212 (45%), Gaps = 21/212 (9%)
Query: 49 IIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 106
+G G FG +L+ + G VAIK+ LS + + E+ ++ KL HPN+V
Sbjct: 21 RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNR--ERWCLEIQIMKKLNHPNVVSAR 78
Query: 107 ------GAVTERKPLMLITEYLRGGDLHKYLKEKG---ALSPSTAVNFALDIARGMAYLH 157
+ +L EY GGDL KYL + L DI+ + YLH
Sbjct: 79 EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH 138
Query: 158 NEPNVIIHRDLKPRNVLLV-NSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMA 216
N IIHRDLKP N++L K+ D G +K + T G+ +Y+A
Sbjct: 139 E--NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE-----LCTEFVGTLQYLA 191
Query: 217 PEVFKHRKYDKKVDVFSFAMILYEMLEGEPPL 248
PE+ + +KY VD +SF + +E + G P
Sbjct: 192 PELLEQKKYTVTVDYWSFGTLAFECITGFRPF 223
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 4e-47
Identities = 71/265 (26%), Positives = 114/265 (43%), Gaps = 22/265 (8%)
Query: 50 IGKGSFGEILKAYWRGT--PVAIKRI-----LPSLSDDRLVIQDFRHEVNLLVKLRHPNI 102
+G G+ GE+ A+ R T VAI+ I + + + E+ +L KL HP I
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 103 VQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNV 162
++ ++ E + GG+L + L +T + + + YLH N
Sbjct: 203 IKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHE--NG 259
Query: 163 IIHRDLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF- 220
IIHRDLKP NVLL + D +K+ DFG SK++ + M G+ Y+APEV
Sbjct: 260 IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-----ETSLMRTLCGTPTYLAPEVLV 314
Query: 221 --KHRKYDKKVDVFSFAMILYEMLEGEPP-LANYEPYEAAKYVAEGHRPFFRA--KGFTP 275
Y++ VD +S +IL+ L G PP + + G F +
Sbjct: 315 SVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSE 374
Query: 276 ELRELTEKCWAADMNQRPSFLDILK 300
+ +L +K D R + + L+
Sbjct: 375 KALDLVKKLLVVDPKARFTTEEALR 399
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 5e-47
Identities = 82/300 (27%), Positives = 132/300 (44%), Gaps = 28/300 (9%)
Query: 19 HFEPKPVPPPLPNKCDWEIDPSELDFSSSA------------IIGKGSFGEILKAYWRGT 66
H ++ + F +S +G G++GE+L + T
Sbjct: 2 HHHHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVT 61
Query: 67 --PVAIKRI-LPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLR 123
AIK I S+S EV +L L HPNI++ +++ L+ E +
Sbjct: 62 HVERAIKIIRKTSVSTSS--NSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYK 119
Query: 124 GGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD-H 182
GG+L + + + A + G+ YLH + I+HRDLKP N+LL + D
Sbjct: 120 GGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHK--HNIVHRDLKPENLLLESKEKDAL 177
Query: 183 LKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEML 242
+K+ DFGLS + + Q KM G+ Y+APEV + +KYD+K DV+S +IL+ +L
Sbjct: 178 IKIVDFGLSAVFENQK-----KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILL 231
Query: 243 EGEPPLANYEPYEAAKYVAEGHRPFFRA--KGFTPELRELTEKCWAADMNQRPSFLDILK 300
G PP E + V +G F K + ++L ++ D +R S L+
Sbjct: 232 AGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 1e-46
Identities = 72/266 (27%), Positives = 126/266 (47%), Gaps = 16/266 (6%)
Query: 38 DPSELDFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLV 95
DP + ++ IG+G+ G + A T VAI+++ + +I + E+ ++
Sbjct: 17 DPKKK-YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN---EILVMR 72
Query: 96 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 155
+ ++PNIV +L + L ++ EYL GG L + E A + + + +
Sbjct: 73 ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA-VCRECLQALEF 131
Query: 156 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYM 215
LH+ +IHRD+K N+LL +K+ DFG Q + + K + G+ +M
Sbjct: 132 LHSNQ--VIHRDIKSDNILL--GMDGSVKLTDFGFCA----QITPEQSKRSTMVGTPYWM 183
Query: 216 APEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKG-FT 274
APEV + Y KVD++S ++ EM+EGEPP N P A +A P + +
Sbjct: 184 APEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLS 243
Query: 275 PELRELTEKCWAADMNQRPSFLDILK 300
R+ +C D+ +R S ++L+
Sbjct: 244 AIFRDFLNRCLEMDVEKRGSAKELLQ 269
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 2e-46
Identities = 81/258 (31%), Positives = 122/258 (47%), Gaps = 16/258 (6%)
Query: 49 IIGKGSFGEILKAYWRGT--PVAIKRI-LPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 105
++GKGSFGE+LK R T A+K I S + EV LL KL HPNI++
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD--TSTILREVELLKKLDHPNIMKL 86
Query: 106 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 165
+ + ++ E GG+L + ++ S A + G+ Y+H + I+H
Sbjct: 87 FEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHK--HNIVH 144
Query: 166 RDLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRK 224
RDLKP N+LL + D +K+ DFGLS + KM G+ Y+APEV +
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT-----KMKDRIGTAYYIAPEVLR-GT 198
Query: 225 YDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA--KGFTPELRELTE 282
YD+K DV+S +ILY +L G PP Y+ K V G F + + + ++L
Sbjct: 199 YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIR 258
Query: 283 KCWAADMNQRPSFLDILK 300
K + R + L+
Sbjct: 259 KMLTFHPSLRITATQCLE 276
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 3e-46
Identities = 71/202 (35%), Positives = 106/202 (52%), Gaps = 12/202 (5%)
Query: 49 IIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 106
++GKGSFGE+LK R T A+K I + + ++ EV LL KL HPNI++
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKKLDHPNIMKLF 87
Query: 107 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 166
+ + ++ E GG+L + ++ S A + G+ Y+H + I+HR
Sbjct: 88 EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHK--HNIVHR 145
Query: 167 DLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKY 225
DLKP N+LL + D +K+ DFGLS + KM G+ Y+APEV + Y
Sbjct: 146 DLKPENILLESKEKDCDIKIIDFGLSTCFQQNT-----KMKDRIGTAYYIAPEVLR-GTY 199
Query: 226 DKKVDVFSFAMILYEMLEGEPP 247
D+K DV+S +ILY +L G PP
Sbjct: 200 DEKCDVWSAGVILYILLSGTPP 221
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 3e-46
Identities = 73/266 (27%), Positives = 129/266 (48%), Gaps = 16/266 (6%)
Query: 38 DPSELDFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLV 95
DP L S IG+GS G + A + + VA+K + R ++ + EV ++
Sbjct: 42 DPRLL-LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFN---EVVIMR 97
Query: 96 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 155
+H N+V+ + + L ++ E+L+GG L + + L+ + + +AY
Sbjct: 98 DYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAY 156
Query: 156 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYM 215
LH + +IHRD+K ++LL + +K+ DFG Q S DV K G+ +M
Sbjct: 157 LHAQG--VIHRDIKSDSILL--TLDGRVKLSDFGFCA----QISKDVPKRKSLVGTPYWM 208
Query: 216 APEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKG-FT 274
APEV Y +VD++S +++ EM++GEPP + P +A K + + P + +
Sbjct: 209 APEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVS 268
Query: 275 PELRELTEKCWAADMNQRPSFLDILK 300
P LR+ E+ D +R + ++L
Sbjct: 269 PVLRDFLERMLVRDPQERATAQELLD 294
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 3e-46
Identities = 56/203 (27%), Positives = 96/203 (47%), Gaps = 12/203 (5%)
Query: 49 IIGKGSFGEILKAYWRGT--PVAIKRIL-PSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 105
+GKG+F + + A I LS Q E + L+HPNIV+
Sbjct: 18 ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARD--HQKLEREARICRLLKHPNIVRL 75
Query: 106 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 165
+++E LI + + GG+L + + + S + A + I + + H ++H
Sbjct: 76 HDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQ--MGVVH 133
Query: 166 RDLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRK 224
R+LKP N+LL + +K+ DFGL+ ++ + G G+ Y++PEV +
Sbjct: 134 RNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ----AWFGFAGTPGYLSPEVLRKDP 189
Query: 225 YDKKVDVFSFAMILYEMLEGEPP 247
Y K VD+++ +ILY +L G PP
Sbjct: 190 YGKPVDLWACGVILYILLVGYPP 212
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 4e-46
Identities = 79/267 (29%), Positives = 128/267 (47%), Gaps = 23/267 (8%)
Query: 49 IIGKGSFGEILKAYWRGT--PVAIKRI----------LPSLSDDRLVIQDFRHEVNLLVK 96
+G G++GE+L + AIK I + ++ +E++LL
Sbjct: 43 KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKS 102
Query: 97 LRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYL 156
L HPNI++ ++K L+TE+ GG+L + + + A N I G+ YL
Sbjct: 103 LDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYL 162
Query: 157 HNEPNVIIHRDLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYM 215
H + I+HRD+KP N+LL N ++ ++K+ DFGLS K+ G+ Y+
Sbjct: 163 HK--HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY-----KLRDRLGTAYYI 215
Query: 216 APEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA--KGF 273
APEV K +KY++K DV+S +I+Y +L G PP + K V +G F K
Sbjct: 216 APEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNI 274
Query: 274 TPELRELTEKCWAADMNQRPSFLDILK 300
+ E +EL + D N+R + + L
Sbjct: 275 SDEAKELIKLMLTYDYNKRCTAEEALN 301
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 6e-46
Identities = 62/205 (30%), Positives = 103/205 (50%), Gaps = 14/205 (6%)
Query: 50 IGKGSFGEILKAYWRGT--PVAIKRIL---PSLSDDRLVIQDFRHEVNLLVKLRHPNIVQ 104
+G G F + K +GT A K I S S + ++ EVN+L ++RHPNI+
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 105 FLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVII 164
+ ++LI E + GG+L +L EK +L+ A F I G+ YLH+ I
Sbjct: 73 LHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHS--KRIA 130
Query: 165 HRDLKPRNVLLVNSSAD--HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH 222
H DLKP N++L++ + +K+ DFG++ I+ N + G+ ++APE+ +
Sbjct: 131 HFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN-----EFKNIFGTPEFVAPEIVNY 185
Query: 223 RKYDKKVDVFSFAMILYEMLEGEPP 247
+ D++S +I Y +L G P
Sbjct: 186 EPLGLEADMWSIGVITYILLSGASP 210
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 6e-46
Identities = 60/205 (29%), Positives = 100/205 (48%), Gaps = 14/205 (6%)
Query: 50 IGKGSFGEILKAYWRGT--PVAIKRI---LPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQ 104
+G G F + K + T A K I S + ++ EV++L ++ HPNI+
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 105 FLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVII 164
R ++LI E + GG+L +L +K +LS A +F I G+ YLH I
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT--KKIA 137
Query: 165 HRDLKPRNVLLVNSSAD--HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH 222
H DLKP N++L++ + H+K+ DFGL+ I+ + G+ ++APE+ +
Sbjct: 138 HFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV-----EFKNIFGTPEFVAPEIVNY 192
Query: 223 RKYDKKVDVFSFAMILYEMLEGEPP 247
+ D++S +I Y +L G P
Sbjct: 193 EPLGLEADMWSIGVITYILLSGASP 217
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 6e-46
Identities = 55/217 (25%), Positives = 91/217 (41%), Gaps = 28/217 (12%)
Query: 49 IIGKGSFGEILKAYWR--GTPVAIKRI-LPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 105
I+G+G+ + + + G AIK S V E +L KL H NIV+
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQ---MREFEVLKKLNHKNIVKL 72
Query: 106 LGAVTERKP--LMLITEYLRGGDLHKYLKEKG---ALSPSTAVNFALDIARGMAYLHNEP 160
E +LI E+ G L+ L+E L S + D+ GM +L
Sbjct: 73 FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE-- 130
Query: 161 NVIIHRDLKPRNVLLVNSSADH--LKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPE 218
N I+HR++KP N++ V K+ DFG ++ ++ D + G+ Y+ P+
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-----DDEQFVSLYGTEEYLHPD 185
Query: 219 VFK--------HRKYDKKVDVFSFAMILYEMLEGEPP 247
+++ +KY VD++S + Y G P
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 1e-45
Identities = 71/268 (26%), Positives = 122/268 (45%), Gaps = 30/268 (11%)
Query: 43 DFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 100
DF +GKG FG + A + + +A+K + + + V R EV + LRHP
Sbjct: 10 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 69
Query: 101 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP 160
NI++ G + + LI EY G +++ L++ + ++A ++Y H+
Sbjct: 70 NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS-- 127
Query: 161 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET--GSYRYMAPE 218
+IHRD+KP N+LL SA LK+ DFG S + G+ Y+ PE
Sbjct: 128 KRVIHRDIKPENLLL--GSAGELKIADFGWSVHAP-SSRRT-------DLCGTLDYLPPE 177
Query: 219 VFKHRKYDKKVDVFSFAMILYEMLEGEPP------LANYEPYEAAKYVAEGHRPFFRAKG 272
+ + R +D+KVD++S ++ YE L G+PP Y+ ++
Sbjct: 178 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF-------- 229
Query: 273 FTPELRELTEKCWAADMNQRPSFLDILK 300
T R+L + + +QRP ++L+
Sbjct: 230 VTEGARDLISRLLKHNPSQRPMLREVLE 257
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 1e-45
Identities = 65/210 (30%), Positives = 98/210 (46%), Gaps = 19/210 (9%)
Query: 49 IIGKGSFGEILKAYWRGT--PVAIKRI-----LPSLSDDRLVIQDFRHEVNLLVKLRHPN 101
+G G+ GE+ A+ R T VAIK I + + + E+ +L KL HP
Sbjct: 17 TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 102 IVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPN 161
I++ ++ E + GG+L + L +T + + + YLH N
Sbjct: 77 IIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHE--N 133
Query: 162 VIIHRDLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF 220
IIHRDLKP NVLL + D +K+ DFG SK++ + M G+ Y+APEV
Sbjct: 134 GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS-----LMRTLCGTPTYLAPEVL 188
Query: 221 ---KHRKYDKKVDVFSFAMILYEMLEGEPP 247
Y++ VD +S +IL+ L G PP
Sbjct: 189 VSVGTAGYNRAVDCWSLGVILFICLSGYPP 218
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 1e-45
Identities = 58/206 (28%), Positives = 99/206 (48%), Gaps = 14/206 (6%)
Query: 49 IIGKGSFGEILKAYWRGT--PVAIKRIL---PSLSDDRLVIQDFRHEVNLLVKLRHPNIV 103
+G G F + K + T A K I S + ++ EV++L ++ H N++
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 104 QFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVI 163
R ++LI E + GG+L +L +K +LS A +F I G+ YLH I
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT--KKI 136
Query: 164 IHRDLKPRNVLLVNSSAD--HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFK 221
H DLKP N++L++ + H+K+ DFGL+ I+ + G+ ++APE+
Sbjct: 137 AHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV-----EFKNIFGTPEFVAPEIVN 191
Query: 222 HRKYDKKVDVFSFAMILYEMLEGEPP 247
+ + D++S +I Y +L G P
Sbjct: 192 YEPLGLEADMWSIGVITYILLSGASP 217
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 4e-45
Identities = 55/203 (27%), Positives = 98/203 (48%), Gaps = 16/203 (7%)
Query: 49 IIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQF 105
+G+GSF K + + A+K I + + + + E+ L HPNIV+
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKII------SKRMEANTQKEITALKLCEGHPNIVKL 71
Query: 106 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 165
++ L+ E L GG+L + +K+K S + A + ++++H+ ++H
Sbjct: 72 HEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHD--VGVVH 129
Query: 166 RDLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRK 224
RDLKP N+L + + + +K+ DFG ++L N + + Y APE+
Sbjct: 130 RDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ----PLKTPCFTLHYAAPELLNQNG 185
Query: 225 YDKKVDVFSFAMILYEMLEGEPP 247
YD+ D++S +ILY ML G+ P
Sbjct: 186 YDESCDLWSLGVILYTMLSGQVP 208
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 4e-45
Identities = 59/205 (28%), Positives = 97/205 (47%), Gaps = 17/205 (8%)
Query: 50 IGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 107
+G G+FG++ R + IK I S ++ E+ +L L HPNI++
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVP--MEQIEAEIEVLKSLDHPNIIKIFE 87
Query: 108 AVTERKPLMLITEYLRGGDLHKYLKEK----GALSPSTAVNFALDIARGMAYLHNEPNVI 163
+ + ++ E GG+L + + ALS + +AY H+ +
Sbjct: 88 VFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS--QHV 145
Query: 164 IHRDLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH 222
+H+DLKP N+L ++S +K+ DFGL++L K T G+ YMAPEVFK
Sbjct: 146 VHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE-----HSTNAAGTALYMAPEVFK- 199
Query: 223 RKYDKKVDVFSFAMILYEMLEGEPP 247
R K D++S +++Y +L G P
Sbjct: 200 RDVTFKCDIWSAGVVMYFLLTGCLP 224
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 4e-45
Identities = 65/287 (22%), Positives = 112/287 (39%), Gaps = 33/287 (11%)
Query: 50 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFL 106
+ +G F + +A G A+KR+L + + + EV + KL HPNIVQF
Sbjct: 36 LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKN---RAIIQEVCFMKKLSGHPNIVQFC 92
Query: 107 GAVTERKPLM-------LITEYLRGGDLHKYLKE---KGALSPSTAVNFALDIARGMAYL 156
A + K L+ L G L ++LK+ +G LS T + R + ++
Sbjct: 93 SAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHM 152
Query: 157 HNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET------- 209
H + IIHRDLK N+LL S+ +K+ DFG + I +
Sbjct: 153 HRQKPPIIHRDLKVENLLL--SNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITR 210
Query: 210 -GSYRYMAPEVF---KHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHR 265
+ Y PE+ + +K D+++ ILY + + P + A + G
Sbjct: 211 NTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED----GAKLRIVNGKY 266
Query: 266 PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPTD 312
L + +R S +++ +L++I +
Sbjct: 267 SIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVN 313
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 4e-45
Identities = 57/236 (24%), Positives = 106/236 (44%), Gaps = 13/236 (5%)
Query: 15 QNGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGT--PVAIKR 72
N ++ P + + D + +G G+FG + + R T A K
Sbjct: 130 SNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKF 189
Query: 73 ILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDL-HKYL 131
++ D+ + R E+ + LRHP +V A + +++I E++ GG+L K
Sbjct: 190 VMTPHESDK---ETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVA 246
Query: 132 KEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 191
E +S AV + + +G+ ++H N +H DLKP N++ ++ LK+ DFGL+
Sbjct: 247 DEHNKMSEDEAVEYMRQVCKGLCHMHE--NNYVHLDLKPENIMFTTKRSNELKLIDFGLT 304
Query: 192 KLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPP 247
+ + + TG+ + APEV + + D++S ++ Y +L G P
Sbjct: 305 AHLDPKQ-----SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 355
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 5e-45
Identities = 59/205 (28%), Positives = 100/205 (48%), Gaps = 14/205 (6%)
Query: 50 IGKGSFGEILKAYWRGT--PVAIKRIL---PSLSDDRLVIQDFRHEVNLLVKLRHPNIVQ 104
+G G F + K + T A K I S + +D EV++L +++HPN++
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 105 FLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVII 164
+ ++LI E + GG+L +L EK +L+ A F I G+ YLH+ I
Sbjct: 79 LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS--LQIA 136
Query: 165 HRDLKPRNVLLVNSSAD--HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH 222
H DLKP N++L++ + +K+ DFGL+ I N + G+ ++APE+ +
Sbjct: 137 HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN-----EFKNIFGTPEFVAPEIVNY 191
Query: 223 RKYDKKVDVFSFAMILYEMLEGEPP 247
+ D++S +I Y +L G P
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASP 216
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 5e-45
Identities = 72/277 (25%), Positives = 121/277 (43%), Gaps = 26/277 (9%)
Query: 30 PNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDF 87
K + ID DF +GKG FG + A + +A+K + S + V
Sbjct: 6 MPKRKFTID----DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQL 61
Query: 88 RHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFAL 147
R E+ + LRHPNI++ +RK + L+ E+ G+L+K L++ G + F
Sbjct: 62 RREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFME 121
Query: 148 DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG 207
++A + Y H +IHRD+KP N+L+ LK+ DFG S
Sbjct: 122 ELADALHYCHE--RKVIHRDIKPENLLM--GYKGELKIADFGWSVHAPSLRRR------- 170
Query: 208 ET--GSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEG-- 263
T G+ Y+ PE+ + + +D+KVD++ ++ YE L G PP + E + +
Sbjct: 171 -TMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDL 229
Query: 264 HRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILK 300
P F + ++L K QR +++
Sbjct: 230 KFPPF----LSDGSKDLISKLLRYHPPQRLPLKGVME 262
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 2e-44
Identities = 88/298 (29%), Positives = 126/298 (42%), Gaps = 25/298 (8%)
Query: 15 QNGSHFEPKPVPPPLPNKCDWEI-------DPSELDFSSSAIIGKGSFGEILKAYWRGT- 66
+P P + D ++ DP +L FS IG GSFG + A
Sbjct: 21 YFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKL-FSDLREIGHGSFGAVYFARDVRNS 79
Query: 67 -PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGG 125
VAIK++ S QD EV L KLRHPN +Q+ G L+ EY G
Sbjct: 80 EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGS 139
Query: 126 DLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKV 185
K L +G+AYLH+ +IHRD+K N+LL S +K+
Sbjct: 140 ASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILL--SEPGLVKL 195
Query: 186 GDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRK---YDKKVDVFSFAMILYEML 242
GDFG + ++ NS G+ +MAPEV YD KVDV+S + E+
Sbjct: 196 GDFGSASIMAPANSF--------VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 247
Query: 243 EGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILK 300
E +PPL N A ++A+ P ++ ++ R + C RP+ +LK
Sbjct: 248 ERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 305
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 2e-44
Identities = 57/204 (27%), Positives = 100/204 (49%), Gaps = 18/204 (8%)
Query: 49 IIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQF 105
IG GS+ + + T A+K I D D E+ +L++ +HPNI+
Sbjct: 29 DIGVGSYSVCKRCIHKATNMEFAVKII-----DKSKR--DPTEEIEILLRYGQHPNIITL 81
Query: 106 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 165
+ K + ++TE ++GG+L + + S A I + + YLH ++H
Sbjct: 82 KDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHA--QGVVH 139
Query: 166 RDLKPRNVLLVNSSADH--LKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR 223
RDLKP N+L V+ S + +++ DFG +K ++ +N + + ++APEV + +
Sbjct: 140 RDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG----LLMTPCYTANFVAPEVLERQ 195
Query: 224 KYDKKVDVFSFAMILYEMLEGEPP 247
YD D++S ++LY ML G P
Sbjct: 196 GYDAACDIWSLGVLLYTMLTGYTP 219
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-44
Identities = 42/201 (20%), Positives = 90/201 (44%), Gaps = 14/201 (6%)
Query: 50 IGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 107
+G+G FG + + + K + +D + E+++L RH NI+
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD----QVLVKKEISILNIARHRNILHLHE 68
Query: 108 AVTERKPLMLITEYLRGGDLHKYLKEKGA-LSPSTAVNFALDIARGMAYLHNEPNVIIHR 166
+ + L++I E++ G D+ + + L+ V++ + + +LH+ + I H
Sbjct: 69 SFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS--HNIGHF 126
Query: 167 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYD 226
D++P N++ + +K+ +FG ++ +K + + Y APEV +H
Sbjct: 127 DIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-----NFRLLFTAPEYYAPEVHQHDVVS 181
Query: 227 KKVDVFSFAMILYEMLEGEPP 247
D++S ++Y +L G P
Sbjct: 182 TATDMWSLGTLVYVLLSGINP 202
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 2e-44
Identities = 74/283 (26%), Positives = 125/283 (44%), Gaps = 21/283 (7%)
Query: 27 PPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVI 84
++DP+E+ + +G G+FG++ KA + T A K I ++ +
Sbjct: 5 SREYEHVRRDLDPNEV-WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE---L 60
Query: 85 QDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAV 143
+D+ E+ +L HP IV+ LGA L ++ E+ GG + + E L+
Sbjct: 61 EDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQ 120
Query: 144 NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 203
+ + +LH+ IIHRDLK NVL+ + +++ DFG+S +N +
Sbjct: 121 VVCRQMLEALNFLHS--KRIIHRDLKAGNVLM--TLEGDIRLADFGVS----AKNLKTLQ 172
Query: 204 KMTGETGSYRYMAPEV-----FKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAK 258
K G+ +MAPEV K YD K D++S + L EM + EPP P
Sbjct: 173 KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLL 232
Query: 259 YVAEGHRPFFRAKG-FTPELRELTEKCWAADMNQRPSFLDILK 300
+A+ P ++ E R+ + + RPS +L+
Sbjct: 233 KIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 3e-44
Identities = 62/208 (29%), Positives = 101/208 (48%), Gaps = 15/208 (7%)
Query: 49 IIGKGSFGEILKAYWRGT--PVAIKRILPS--LSDDRLVIQDFRHEVNLLVKLRHPNIVQ 104
+IGKG F + + R T A+K + + S L +D + E ++ L+HP+IV+
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 105 FLGAVTERKPLMLITEYLRGGDLHKYLKEKG----ALSPSTAVNFALDIARGMAYLHNEP 160
L + L ++ E++ G DL + ++ S + A ++ I + Y H+
Sbjct: 91 LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD-- 148
Query: 161 NVIIHRDLKPRNVLLVNSSADH-LKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV 219
N IIHRD+KP VLL + +K+G FG++ + G G+ +MAPEV
Sbjct: 149 NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL----VAGGRVGTPHFMAPEV 204
Query: 220 FKHRKYDKKVDVFSFAMILYEMLEGEPP 247
K Y K VDV+ +IL+ +L G P
Sbjct: 205 VKREPYGKPVDVWGCGVILFILLSGCLP 232
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 4e-44
Identities = 41/242 (16%), Positives = 91/242 (37%), Gaps = 30/242 (12%)
Query: 27 PPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTP-------VAIKRILPSLSD 79
P + K ++++ + ++G+G+F ++ +A +K P+
Sbjct: 52 PAIKPKTEFQLGSKLVYVHH--LLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPW 109
Query: 80 DRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA--- 136
+ + + L ++F A + +L+ E G L +
Sbjct: 110 EFYIG---TQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPE 166
Query: 137 --LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD---------HLKV 185
+ ++FA+ + + +H+ IIH D+KP N +L N + L +
Sbjct: 167 KVMPQGLVISFAMRMLYMIEQVHD--CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLAL 224
Query: 186 GDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGE 245
D G S +K+ + T + + + E+ ++ ++ ++D F A +Y ML G
Sbjct: 225 IDLGQSIDMKLFPKGTI--FTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
Query: 246 PP 247
Sbjct: 283 YM 284
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 5e-44
Identities = 70/269 (26%), Positives = 126/269 (46%), Gaps = 22/269 (8%)
Query: 38 DPSELDFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLV 95
P E+ F +G+GS+G + KA + T VAIK++ + D +Q+ E++++
Sbjct: 26 QPEEV-FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV--PVESD---LQEIIKEISIMQ 79
Query: 96 KLRHPNIVQFLGAVTERKPLMLITEYLRGG---DLHKYLKEKGALSPSTAVNFALDIARG 152
+ P++V++ G+ + L ++ EY G D+ + L+ +G
Sbjct: 80 QCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRN--KTLTEDEIATILQSTLKG 137
Query: 153 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSY 212
+ YLH IHRD+K N+LL ++ H K+ DFG++ Q + + K G+
Sbjct: 138 LEYLHFMR--KIHRDIKAGNILL--NTEGHAKLADFGVAG----QLTDTMAKRNTVIGTP 189
Query: 213 RYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKG 272
+MAPEV + Y+ D++S + EM EG+PP A+ P A + P FR
Sbjct: 190 FWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPE 249
Query: 273 -FTPELRELTEKCWAADMNQRPSFLDILK 300
++ + ++C QR + +L+
Sbjct: 250 LWSDNFTDFVKQCLVKSPEQRATATQLLQ 278
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 6e-44
Identities = 59/208 (28%), Positives = 106/208 (50%), Gaps = 13/208 (6%)
Query: 43 DFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 100
S + I+G G FG++ K T +A K I D+ ++ ++E++++ +L H
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDK---EEVKNEISVMNQLDHA 146
Query: 101 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNE 159
N++Q A + ++L+ EY+ GG+L + ++ L+ + F I G+ ++H
Sbjct: 147 NLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQ- 205
Query: 160 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV 219
I+H DLKP N+L VN A +K+ DFGL++ K + K+ G+ ++APEV
Sbjct: 206 -MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE-----KLKVNFGTPEFLAPEV 259
Query: 220 FKHRKYDKKVDVFSFAMILYEMLEGEPP 247
+ D++S +I Y +L G P
Sbjct: 260 VNYDFVSFPTDMWSVGVIAYMLLSGLSP 287
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 1e-43
Identities = 59/211 (27%), Positives = 97/211 (45%), Gaps = 17/211 (8%)
Query: 49 IIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQF 105
++G+G+ + T A+K I R EV +L + + H N+++
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIR---SRVFREVEMLYQCQGHRNVLEL 76
Query: 106 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 165
+ E L+ E +RGG + ++ ++ + A D+A + +LHN I H
Sbjct: 77 IEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHN--KGIAH 134
Query: 166 RDLKPRNVLLVNSSADH-LKVGDFGLSKLIKVQNSH---DVYKMTGETGSYRYMAPEVFK 221
RDLKP N+L + + +K+ DF L IK+ ++ GS YMAPEV +
Sbjct: 135 RDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVE 194
Query: 222 -----HRKYDKKVDVFSFAMILYEMLEGEPP 247
YDK+ D++S +ILY +L G PP
Sbjct: 195 AFSEEASIYDKRCDLWSLGVILYILLSGYPP 225
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 4e-43
Identities = 45/201 (22%), Positives = 94/201 (46%), Gaps = 13/201 (6%)
Query: 50 IGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 107
+G G+FG + + + T K I D+ ++E++++ +L HP ++
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK---YTVKNEISIMNQLHHPKLINLHD 115
Query: 108 AVTERKPLMLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHR 166
A ++ ++LI E+L GG+L + + +S + +N+ G+ ++H + I+H
Sbjct: 116 AFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE--HSIVHL 173
Query: 167 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYD 226
D+KP N++ A +K+ DFGL+ + + T + + APE+
Sbjct: 174 DIKPENIMCETKKASSVKIIDFGLATKLNPDE-----IVKVTTATAEFAAPEIVDREPVG 228
Query: 227 KKVDVFSFAMILYEMLEGEPP 247
D+++ ++ Y +L G P
Sbjct: 229 FYTDMWAIGVLGYVLLSGLSP 249
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 6e-43
Identities = 77/292 (26%), Positives = 122/292 (41%), Gaps = 40/292 (13%)
Query: 35 WEIDPSELDFSSSAIIGKGSFGEILKAY--WRGTPVAIKRI-LPSLSDDRLVIQDFRHEV 91
W I+ D+ +IG G+ + AY + VAIKRI L + + E+
Sbjct: 10 WSINRD--DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTS---MDELLKEI 64
Query: 92 NLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGG---DLHKYLKEKGALSPSTAVNFALD 148
+ + HPNIV + + + L L+ + L GG D+ K++ KG LD
Sbjct: 65 QAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGV-----LD 119
Query: 149 ---IA-------RGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS-KLIKVQ 197
IA G+ YLH N IHRD+K N+LL +++ DFG+S L
Sbjct: 120 ESTIATILREVLEGLEYLHK--NGQIHRDVKAGNILL--GEDGSVQIADFGVSAFLATGG 175
Query: 198 NSHDVYKMTGETGSYRYMAPEVFKHRK-YDKKVDVFSFAMILYEMLEGEPPLANYEPYEA 256
+ G+ +MAPEV + + YD K D++SF + E+ G P Y P +
Sbjct: 176 DITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV 235
Query: 257 AKYVA--------EGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILK 300
G + K + R++ C D +RP+ ++L+
Sbjct: 236 LMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 7e-43
Identities = 63/244 (25%), Positives = 96/244 (39%), Gaps = 48/244 (19%)
Query: 50 IGKGSFGEILKAYWRGT--PVAIKRILPS--LSDDRLVIQDFRHEVNLLVKLRHPNIVQF 105
IG+GS+G + A T AIK + + + ++ + EV L+ KL HPNI +
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 106 LGAVTERKPLMLITEYLRGGDLHKYLKEKG------------------------------ 135
+ + + L+ E GG L L
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 136 ----------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKV 185
N I + YLHN I HRD+KP N L + + +K+
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHN--QGICHRDIKPENFLFSTNKSFEIKL 211
Query: 186 GDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFK--HRKYDKKVDVFSFAMILYEMLE 243
DFGLSK N+ + Y MT + G+ ++APEV + Y K D +S ++L+ +L
Sbjct: 212 VDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLM 271
Query: 244 GEPP 247
G P
Sbjct: 272 GAVP 275
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 8e-43
Identities = 61/214 (28%), Positives = 100/214 (46%), Gaps = 24/214 (11%)
Query: 49 IIGKGSFGEILKAYWRGT--PVAIKRI------LPSLSDDRLVIQDFRHEVNLLVKL-RH 99
I+G+G + + + T A+K I S + + + + EV++L K+ H
Sbjct: 24 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83
Query: 100 PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE 159
PNI+Q L+ + ++ G+L YL EK LS + + LH
Sbjct: 84 PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHK- 142
Query: 160 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV 219
I+HRDLKP N+LL + ++K+ DFG S + K+ G+ Y+APE+
Sbjct: 143 -LNIVHRDLKPENILLDDDM--NIKLTDFGFSCQLDPGE-----KLREVCGTPSYLAPEI 194
Query: 220 FK------HRKYDKKVDVFSFAMILYEMLEGEPP 247
+ H Y K+VD++S +I+Y +L G PP
Sbjct: 195 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 8e-43
Identities = 80/280 (28%), Positives = 133/280 (47%), Gaps = 31/280 (11%)
Query: 38 DPSELDFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLV 95
DP+ + F ++G G++G++ K T AIK ++ D+ ++ + E+N+L
Sbjct: 21 DPAGI-FELVELVGNGTYGQVYKGRHVKTGQLAAIK-VMDVTGDE---EEEIKQEINMLK 75
Query: 96 KL-RHPNIVQFLGAVTERKP------LMLITEYLRGG---DLHKYLKEKGALSPSTAVNF 145
K H NI + GA ++ P L L+ E+ G DL K K A
Sbjct: 76 KYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY-I 134
Query: 146 ALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKM 205
+I RG+++LH + +IHRD+K +NVLL + +K+ DFG+S Q V +
Sbjct: 135 CREILRGLSHLHQ--HKVIHRDIKGQNVLL--TENAEVKLVDFGVSA----QLDRTVGRR 186
Query: 206 TGETGSYRYMAPEVFKHRK-----YDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYV 260
G+ +MAPEV + YD K D++S + EM EG PPL + P A +
Sbjct: 187 NTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI 246
Query: 261 AEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILK 300
P ++K ++ + + E C + +QRP+ ++K
Sbjct: 247 PRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 2e-42
Identities = 70/261 (26%), Positives = 111/261 (42%), Gaps = 28/261 (10%)
Query: 50 IGKGSFGEILKAYWRGT--PVAIKRILP--SLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 105
+GKG F + + T A K I+P L + E+++ L H ++V F
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGK-IVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGF 80
Query: 106 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 165
G + + ++ E R L + K + AL+ A + I G YLH N +IH
Sbjct: 81 HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR--NRVIH 138
Query: 166 RDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKY 225
RDLK N+ L + +K+GDFGL+ ++ K G+ Y+APEV + +
Sbjct: 139 RDLKLGNLFL--NEDLEVKIGDFGLATKVEYDGE---RKKV-LCGTPNYIAPEVLSKKGH 192
Query: 226 DKKVDVFSFAMILYEMLEGEPP------LANYEPYEAAKYVAEGHRPFFRAKGFTPELRE 279
+VDV+S I+Y +L G+PP Y + +Y P P
Sbjct: 193 SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY----SIPKH----INPVAAS 244
Query: 280 LTEKCWAADMNQRPSFLDILK 300
L +K D RP+ ++L
Sbjct: 245 LIQKMLQTDPTARPTINELLN 265
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 2e-42
Identities = 74/286 (25%), Positives = 118/286 (41%), Gaps = 29/286 (10%)
Query: 26 PPPLPNKCDWEIDPSEL-DFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILP--SLSDD 80
PP + +DP + +GKG F + + T A K I+P L
Sbjct: 24 APPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGK-IVPKSLLLKP 82
Query: 81 RLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPS 140
+ E+++ L H ++V F G + + ++ E R L + K + AL+
Sbjct: 83 HQREK-MSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEP 141
Query: 141 TAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 200
A + I G YLH N +IHRDLK N+ L + +K+GDFGL+ ++
Sbjct: 142 EARYYLRQIVLGCQYLHR--NRVIHRDLKLGNLFL--NEDLEVKIGDFGLATKVEYDGE- 196
Query: 201 DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPP------LANYEPY 254
K G+ Y+APEV + + +VDV+S I+Y +L G+PP Y
Sbjct: 197 --RKKV-LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI 253
Query: 255 EAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILK 300
+ +Y P P L +K D RP+ ++L
Sbjct: 254 KKNEY----SIPKH----INPVAASLIQKMLQTDPTARPTINELLN 291
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 6e-42
Identities = 61/213 (28%), Positives = 106/213 (49%), Gaps = 23/213 (10%)
Query: 49 IIGKGSFGEILKAYWRGT--PVAIKRI-----LPSLSDDRLVIQDFRHEVNLLVKLR-HP 100
+IG+G + + R T A+K + S V + R E ++L ++ HP
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160
Query: 101 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP 160
+I+ + + + L+ + +R G+L YL EK ALS + + +++LH
Sbjct: 161 HIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHA-- 218
Query: 161 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF 220
N I+HRDLKP N+LL ++ +++ DFG S ++ K+ G+ Y+APE+
Sbjct: 219 NNIVHRDLKPENILLDDNM--QIRLSDFGFSCHLEPGE-----KLRELCGTPGYLAPEIL 271
Query: 221 K------HRKYDKKVDVFSFAMILYEMLEGEPP 247
K H Y K+VD+++ +IL+ +L G PP
Sbjct: 272 KCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 7e-42
Identities = 49/222 (22%), Positives = 93/222 (41%), Gaps = 33/222 (14%)
Query: 50 IGKGSFGEILKAYWRGTPVAIK--------------RILPSLSDDRLVIQDFRHEVNLLV 95
+ +G F +I+ A+K + + DF++E+ ++
Sbjct: 39 LNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIIT 98
Query: 96 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIAR---- 151
+++ + G +T + +I EY+ + K+ + L + + + +
Sbjct: 99 DIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIK 158
Query: 152 ----GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG 207
+Y+HNE N I HRD+KP N+L+ +K+ DFG S+ + + K+ G
Sbjct: 159 SVLNSFSYIHNEKN-ICHRDVKPSNILM--DKNGRVKLSDFGESEY--MVDK----KIKG 209
Query: 208 ETGSYRYMAPEVFKHRK--YDKKVDVFSFAMILYEMLEGEPP 247
G+Y +M PE F + KVD++S + LY M P
Sbjct: 210 SRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 8e-42
Identities = 78/256 (30%), Positives = 119/256 (46%), Gaps = 19/256 (7%)
Query: 50 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 107
IGKG+F ++ A G VAIK I+ + +Q EV ++ L HPNIV+
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIK-IIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFE 81
Query: 108 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 167
+ K L LI EY GG++ YL G + A + I + Y H I+HRD
Sbjct: 82 VIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQ--KRIVHRD 139
Query: 168 LKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYD- 226
LK N+LL + ++K+ DFG S K+ G+ Y APE+F+ +KYD
Sbjct: 140 LKAENLLL--DADMNIKIADFGFSNEFT-----VGGKLDAFCGAPPYAAPELFQGKKYDG 192
Query: 227 KKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEG--HRPFFRAKGFTPELRELTEKC 284
+VDV+S +ILY ++ G P E + V G PF+ + + L ++
Sbjct: 193 PEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFY----MSTDCENLLKRF 248
Query: 285 WAADMNQRPSFLDILK 300
+ +R + I+K
Sbjct: 249 LVLNPIKRGTLEQIMK 264
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 1e-41
Identities = 62/209 (29%), Positives = 100/209 (47%), Gaps = 26/209 (12%)
Query: 49 IIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQF 105
++G G G++L+ + R T A+K + D R EV+ + P+IV
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLL-----YDS---PKARQEVDHHWQASGGPHIVCI 87
Query: 106 LGA----VTERKPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNE 159
L ++ L++I E + GG+L ++E+G A + A DI + +LH+
Sbjct: 88 LDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS- 146
Query: 160 PNVIIHRDLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPE 218
+ I HRD+KP N+L + D LK+ DFG +K + + Y+APE
Sbjct: 147 -HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN------ALQTPCYTPYYVAPE 199
Query: 219 VFKHRKYDKKVDVFSFAMILYEMLEGEPP 247
V KYDK D++S +I+Y +L G PP
Sbjct: 200 VLGPEKYDKSCDMWSLGVIMYILLCGFPP 228
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 1e-41
Identities = 77/289 (26%), Positives = 132/289 (45%), Gaps = 40/289 (13%)
Query: 43 DFSSSAIIGKGSFGEILKAY-WRGTPVAIKRILPSLSDDRL--VIQDFRHEVNLLVKLRH 99
+FS+ I+G+G FG++ K GT VA+KR L ++R F+ EV ++ H
Sbjct: 31 NFSNKNILGRGGFGKVYKGRLADGTLVAVKR----LKEERTQGGELQFQTEVEMISMAVH 86
Query: 100 PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSP----STAVNFALDIARGMAY 155
N+++ G +L+ Y+ G + L+E+ P AL ARG+AY
Sbjct: 87 RNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAY 146
Query: 156 LHNEPNV-IIHRDLKPRNVLLVNSSAD---HLKVGDFGLSKLIKVQNSHDVYKMTGETGS 211
LH+ + IIHRD+K N+LL D VGDFGL+KL+ +++H + G G
Sbjct: 147 LHDHCDPKIIHRDVKAANILL-----DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIG- 200
Query: 212 YRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPL-ANYEPYEAAKYVAEGHRPFFRA 270
++APE K +K DVF + ++L E++ G+ + + + + +
Sbjct: 201 --HIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 258
Query: 271 KGFT----PEL------RELTE------KCWAADMNQRPSFLDILKRLE 303
K +L E+ + C + +RP ++++ LE
Sbjct: 259 KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 5e-41
Identities = 71/305 (23%), Positives = 120/305 (39%), Gaps = 28/305 (9%)
Query: 6 NAHGGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR- 64
+ H GSH P E +P E + ++G G FG +
Sbjct: 7 HHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVS 66
Query: 65 -GTPVAIKRI----LPSLSDDRLVIQDFRHEVNLLVKLRH--PNIVQFLGAVTERKPLML 117
PVAIK + + + + EV LL K+ +++ L +L
Sbjct: 67 DNLPVAIKHVEKDRISDWGELPNGTRVPM-EVVLLKKVSSGFSGVIRLLDWFERPDSFVL 125
Query: 118 ITEYLRG-GDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLV 176
I E DL ++ E+GAL A +F + + + HN ++HRD+K N +L+
Sbjct: 126 ILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN--CGVLHRDIKDEN-ILI 182
Query: 177 NSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYD-KKVDVFSFA 235
+ + LK+ DFG L+K D G+ Y PE ++ +Y + V+S
Sbjct: 183 DLNRGELKLIDFGSGALLKDTVYTDF------DGTRVYSPPEWIRYHRYHGRSAAVWSLG 236
Query: 236 MILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSF 295
++LY+M+ G+ P + E + + E + L C A + RP+F
Sbjct: 237 ILLYDMVCGDIPFEHDEEIIRGQV----FFRQR----VSSECQHLIRWCLALRPSDRPTF 288
Query: 296 LDILK 300
+I
Sbjct: 289 EEIQN 293
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 5e-41
Identities = 66/298 (22%), Positives = 117/298 (39%), Gaps = 48/298 (16%)
Query: 40 SELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQ---DFRHEVNLLVK 96
+G+G FG + K Y T VA+K+ + D + F E+ ++ K
Sbjct: 29 ERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKK--LAAMVDITTEELKQQFDQEIKVMAK 86
Query: 97 LRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSP---STAVNFALDIARGM 153
+H N+V+ LG ++ L L+ Y+ G L L P A A G+
Sbjct: 87 CQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGI 146
Query: 154 AYLHNEPNVIIHRDLKPRNVLLVNSSAD---HLKVGDFGLSKLIKV-QNSHDVYKMTGET 209
+LH IHRD+K N+LL D K+ DFGL++ + + MT +
Sbjct: 147 NFLHENH--HIHRDIKSANILL-----DEAFTAKISDFGLARASEKFAQTV----MT--S 193
Query: 210 ---GSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRP 266
G+ YMAPE + K D++SF ++L E++ G P + + + + +
Sbjct: 194 RIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQ---LLLDIKEE 249
Query: 267 FFRAKG-FT----PELRELTEK-----------CWAADMNQRPSFLDILKRLEKIKET 308
+ ++ + C N+RP + + L+++ +
Sbjct: 250 IEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 307
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 146 bits (369), Expect = 7e-41
Identities = 63/209 (30%), Positives = 102/209 (48%), Gaps = 25/209 (11%)
Query: 49 IIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQF 105
++G G G++L+ + + T A+K + D R EV L + + P+IV+
Sbjct: 69 VLGLGINGKVLQIFNKRTQEKFALKML-----QDC---PKARREVELHWRASQCPHIVRI 120
Query: 106 LGA----VTERKPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNE 159
+ RK L+++ E L GG+L ++++G A + A I + YLH+
Sbjct: 121 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS- 179
Query: 160 PNVIIHRDLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPE 218
I HRD+KP N+L + + LK+ DFG +K N +T + Y+APE
Sbjct: 180 -INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN-----SLTTPCYTPYYVAPE 233
Query: 219 VFKHRKYDKKVDVFSFAMILYEMLEGEPP 247
V KYDK D++S +I+Y +L G PP
Sbjct: 234 VLGPEKYDKSCDMWSLGVIMYILLCGYPP 262
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-40
Identities = 68/263 (25%), Positives = 110/263 (41%), Gaps = 30/263 (11%)
Query: 50 IGKGSFGEILKAYWR--GTPVAIKRI----LPSLSDDRLVIQDFRHEVNLLVKLR----H 99
+GKG FG + + VAIK I + S + EV LL K+ H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPL-EVALLWKVGAGGGH 97
Query: 100 PNIVQFLGAVTERKPLMLITEY-LRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHN 158
P +++ L ++ ML+ E L DL Y+ EKG L + F + + + H+
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHS 157
Query: 159 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPE 218
++HRD+K N +L++ K+ DFG L+ + D G+ Y PE
Sbjct: 158 --RGVVHRDIKDEN-ILIDLRRGCAKLIDFGSGALLHDEPYTDF------DGTRVYSPPE 208
Query: 219 VFKHRKYD-KKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPEL 277
+Y V+S ++LY+M+ G+ P + A+ H P +P+
Sbjct: 209 WISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAEL----HFPAH----VSPDC 260
Query: 278 RELTEKCWAADMNQRPSFLDILK 300
L +C A + RPS +IL
Sbjct: 261 CALIRRCLAPKPSSRPSLEEILL 283
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 1e-40
Identities = 75/265 (28%), Positives = 116/265 (43%), Gaps = 18/265 (6%)
Query: 48 AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 105
+G G + A VAIK I + ++ F EV+ +L H NIV
Sbjct: 17 DKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 106 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 165
+ E L+ EY+ G L +Y++ G LS TA+NF I G+ + H+ I+H
Sbjct: 77 IDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHD--MRIVH 134
Query: 166 RDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET-GSYRYMAPEVFKHRK 224
RD+KP+N+L+ S LK+ DFG++K + S T G+ +Y +PE K
Sbjct: 135 RDIKPQNILI--DSNKTLKIFDFGIAKAL----SETSLTQTNHVLGTVQYFSPEQAKGEA 188
Query: 225 YDKKVDVFSFAMILYEMLEGEPPLANYEPYE-AAKYVAEG--HRPFFRAKGFTPELRELT 281
D+ D++S ++LYEML GEPP A K++ + + K L +
Sbjct: 189 TDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVI 248
Query: 282 EKCWAADMNQRPS----FLDILKRL 302
+ D R D L +
Sbjct: 249 LRATEKDKANRYKTIQEMKDDLSSV 273
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 1e-40
Identities = 50/206 (24%), Positives = 90/206 (43%), Gaps = 18/206 (8%)
Query: 50 IGKGSFGEILKAYWRGT--PVAIKRILPSL--SDDRLVIQDFRHEVNLLVKLRH-PNIVQ 104
+G+G F + + + T A K + D R + HE+ +L + P ++
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCR---AEILHEIAVLELAKSCPRVIN 93
Query: 105 FLGAVTERKPLMLITEYLRGGDLHKYL--KEKGALSPSTAVNFALDIARGMAYLHNEPNV 162
++LI EY GG++ + +S + + I G+ YLH N
Sbjct: 94 LHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ--NN 151
Query: 163 IIHRDLKPRNVLLVNSSADH-LKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFK 221
I+H DLKP+N+LL + +K+ DFG+S+ I ++ G+ Y+APE+
Sbjct: 152 IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC-----ELREIMGTPEYLAPEILN 206
Query: 222 HRKYDKKVDVFSFAMILYEMLEGEPP 247
+ D+++ +I Y +L P
Sbjct: 207 YDPITTATDMWNIGIIAYMLLTHTSP 232
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 2e-40
Identities = 64/286 (22%), Positives = 113/286 (39%), Gaps = 17/286 (5%)
Query: 34 DWEIDPSELDFSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEV 91
+ + DF + +G G+ G + K G +A K I L + E+
Sbjct: 25 QKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLI--HLEIKPAIRNQIIREL 82
Query: 92 NLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIAR 151
+L + P IV F GA + + E++ GG L + LK+ G + ++ + +
Sbjct: 83 QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIK 142
Query: 152 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS-KLIK-VQNSHDVYKMTGET 209
G+ YL + I+HRD+KP N+L+ +S +K+ DFG+S +LI + NS
Sbjct: 143 GLTYLREKHK-IMHRDVKPSNILV--NSRGEIKLCDFGVSGQLIDSMANSF--------V 191
Query: 210 GSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR 269
G+ YM+PE + Y + D++S + L EM G P+ + E
Sbjct: 192 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAA 251
Query: 270 AKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPTDHHW 315
P + D + ++L + +
Sbjct: 252 ETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVF 297
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 3e-40
Identities = 66/257 (25%), Positives = 107/257 (41%), Gaps = 26/257 (10%)
Query: 48 AIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 105
++G+G G++ +A R VA+K + +LS D + + E +L+ P++V
Sbjct: 40 RLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPI 99
Query: 106 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 165
L + + G DL L+ +G L+P AV I + H H
Sbjct: 100 HDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHA--AGATH 157
Query: 166 RDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMT--GET-GSYRYMAPEVFKH 222
RD+KP N+L+ S+ D + DFG++ K+T G T G+ YMAPE F
Sbjct: 158 RDVKPENILV--SADDFAYLVDFGIASAT------TDEKLTQLGNTVGTLYYMAPERFSE 209
Query: 223 RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH------RPFFRAKGFTPE 276
+ D+++ +LYE L G PP Y+ + + V H RP G
Sbjct: 210 SHATYRADIYALTCVLYECLTGSPP---YQGDQLS--VMGAHINQAIPRPSTVRPGIPVA 264
Query: 277 LRELTEKCWAADMNQRP 293
+ + A + R
Sbjct: 265 FDAVIARGMAKNPEDRY 281
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 3e-40
Identities = 60/203 (29%), Positives = 108/203 (53%), Gaps = 15/203 (7%)
Query: 50 IGKGSFGEILKAYWRGT--PVAIKRILP--SLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 105
+GKGSF + +A T VAIK ++ ++ +V + ++EV + +L+HP+I++
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIK-MIDKKAMYKAGMVQR-VQNEVKIHCQLKHPSILEL 76
Query: 106 LGAVTERKPLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVII 164
+ + L+ E G++++YLK + S + A +F I GM YLH+ + I+
Sbjct: 77 YNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHS--HGIL 134
Query: 165 HRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRK 224
HRDL N+LL + ++K+ DFGL+ +K+ + T G+ Y++PE+
Sbjct: 135 HRDLTLSNLLL--TRNMNIKIADFGLATQLKMPHE---KHYT-LCGTPNYISPEIATRSA 188
Query: 225 YDKKVDVFSFAMILYEMLEGEPP 247
+ + DV+S + Y +L G PP
Sbjct: 189 HGLESDVWSLGCMFYTLLIGRPP 211
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 4e-40
Identities = 62/276 (22%), Positives = 126/276 (45%), Gaps = 23/276 (8%)
Query: 36 EIDPSELDFSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNL 93
E+ +L+ +G+G++G + K G +A+KRI + + + ++++
Sbjct: 3 EVKADDLEPIME--LGRGAYGVVEKMRHVPSGQIMAVKRI--RATVNSQEQKRLLMDLDI 58
Query: 94 LVKL-RHPNIVQFLGAVTERKPLMLITEYLRGG---DLHKYLKEKGALSPSTAVNFALDI 149
++ P V F GA+ + + E + + + + + A+ I
Sbjct: 59 SMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSI 118
Query: 150 ARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET 209
+ + +LH++ + +IHRD+KP NVL+ ++ +K+ DFG+S DV K +
Sbjct: 119 VKALEHLHSKLS-VIHRDVKPSNVLI--NALGQVKMCDFGISG----YLVDDVAKDI-DA 170
Query: 210 GSYRYMAPEVFK----HRKYDKKVDVFSFAMILYEMLEGEPPLANYE-PYEAAKYVAEGH 264
G YMAPE + Y K D++S + + E+ P ++ P++ K V E
Sbjct: 171 GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEP 230
Query: 265 RPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILK 300
P A F+ E + T +C + +RP++ ++++
Sbjct: 231 SPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 6e-40
Identities = 65/326 (19%), Positives = 113/326 (34%), Gaps = 75/326 (23%)
Query: 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKR------------------ILPSLSDDRL 82
DF +G+G FG + +A + AIKR L L +
Sbjct: 7 DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 66
Query: 83 V-------------------------------------IQDFRHEVNLLVKLRHPNIVQF 105
V + ++ + N V
Sbjct: 67 VRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQ 126
Query: 106 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSP---STAVNFALDIARGMAYLHNEPNV 162
L + + L + + R +L ++ + +L ++ + IA + +LH+
Sbjct: 127 LQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS--KG 184
Query: 163 IIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK--------VQNSHDVYKMTGETGSYRY 214
++HRDLKP N+ + D +KVGDFGL + + TG+ G+ Y
Sbjct: 185 LMHRDLKPSNIFF--TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242
Query: 215 MAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFT 274
M+PE Y KVD+FS +IL+E+L E V P + +
Sbjct: 243 MSPEQIHGNNYSHKVDIFSLGLILFELL--YSFSTQMERVRIITDVRNLKFPLLFTQKY- 299
Query: 275 PELRELTEKCWAADMNQRPSFLDILK 300
P+ + + + +RP DI++
Sbjct: 300 PQEHMMVQDMLSPSPTERPEATDIIE 325
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 9e-40
Identities = 62/279 (22%), Positives = 114/279 (40%), Gaps = 22/279 (7%)
Query: 33 CDWEIDPSELDFSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHE 90
D + +G G+ G++ K G +A+K++ S ++ + +
Sbjct: 16 GGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQM--RRSGNKEENKRILMD 73
Query: 91 VNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDI 149
+++++K P IVQ G + + E + + +G + + I
Sbjct: 74 LDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAI 133
Query: 150 ARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS-KLIKVQNSHDVYKMTGE 208
+ + YL + +IHRD+KP N+LL +K+ DFG+S +L+ D
Sbjct: 134 VKALYYLKEKHG-VIHRDVKPSNILL--DERGQIKLCDFGISGRLV------DDKAKDRS 184
Query: 209 TGSYRYMAPEVFKHRK-----YDKKVDVFSFAMILYEMLEGEPPLANYEP-YEAAKYVAE 262
G YMAPE YD + DV+S + L E+ G+ P N + +E V +
Sbjct: 185 AGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ 244
Query: 263 GHRPFFRAK-GFTPELRELTEKCWAADMNQRPSFLDILK 300
P GF+ + + + C D +RP + +L+
Sbjct: 245 EEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 5e-39
Identities = 54/260 (20%), Positives = 102/260 (39%), Gaps = 26/260 (10%)
Query: 50 IGKGSFGEILKAYWR--GTPVAIK-----RILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 102
+G G+FG + A + V +K ++L + + E+ +L ++ H NI
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 103 VQFLGAVTERKPLMLITE-YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPN 161
++ L + L+ E + G DL ++ L A + + YL
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRL--K 149
Query: 162 VIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFK 221
IIHRD+K N+++ + +K+ DFG + ++ + G+ Y APEV
Sbjct: 150 DIIHRDIKDENIVI--AEDFTIKLIDFGSAAYLERGKLFYTF-----CGTIEYCAPEVLM 202
Query: 222 HRKYD-KKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELREL 280
Y +++++S + LY ++ E P E A H P+ + EL L
Sbjct: 203 GNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAI----HPPYL----VSKELMSL 254
Query: 281 TEKCWAADMNQRPSFLDILK 300
+R + ++
Sbjct: 255 VSGLLQPVPERRTTLEKLVT 274
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-38
Identities = 73/279 (26%), Positives = 125/279 (44%), Gaps = 24/279 (8%)
Query: 48 AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 105
I+G G E+ A VA+K + L+ D FR E L HP IV
Sbjct: 18 EILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 106 L--GAVTERKPLM--LITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPN 161
G + ++ EY+ G L + +G ++P A+ D + + + H N
Sbjct: 78 YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQ--N 135
Query: 162 VIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET-GSYRYMAPEVF 220
IIHRD+KP N+++ S+ + +KV DFG+++ + +S + T G+ +Y++PE
Sbjct: 136 GIIHRDVKPANIMI--SATNAVKVMDFGIARA--IADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 221 KHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH------RPFFRAKGFT 274
+ D + DV+S +LYE+L GEPP ++ VA H P R +G +
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEPPFTG----DSPVSVAYQHVREDPIPPSARHEGLS 247
Query: 275 PELRELTEKCWAADMNQRP-SFLDILKRLEKIKETLPTD 312
+L + K A + R + ++ L ++ P +
Sbjct: 248 ADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPE 286
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-38
Identities = 68/286 (23%), Positives = 123/286 (43%), Gaps = 35/286 (12%)
Query: 34 DWEIDPSELDFSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEV 91
W+ +L IG+G++G + K G +A+KRI ++ + + ++
Sbjct: 16 HWDFTAEDLKDLG--EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEK--EQKQLLMDL 71
Query: 92 NLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPST------AVN 144
+++++ P IVQF GA+ + E + K+ K ++
Sbjct: 72 DVVMRSSDCPYIVQFYGALFREGDCWICMELMSTS-FDKFYKYVYSVLDDVIPEEILGK- 129
Query: 145 FALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS-KLIK-VQNSHDV 202
L + + +L IIHRD+KP N+LL + ++K+ DFG+S +L+ + + D
Sbjct: 130 ITLATVKALNHLKENLK-IIHRDIKPSNILL--DRSGNIKLCDFGISGQLVDSIAKTRDA 186
Query: 203 YKMTGETGSYRYMAPEVFK----HRKYDKKVDVFSFAMILYEMLEGEPPLANYEP-YEAA 257
G YMAPE + YD + DV+S + LYE+ G P + ++
Sbjct: 187 -------GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQL 239
Query: 258 KYVAEGHRPFFRA---KGFTPELRELTEKCWAADMNQRPSFLDILK 300
V +G P + F+P C D ++RP + ++LK
Sbjct: 240 TQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 1e-38
Identities = 71/201 (35%), Positives = 97/201 (48%), Gaps = 14/201 (6%)
Query: 50 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 107
IG G+FG + VA+K I + ++ + E+ LRHPNIV+F
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYI----ERGAAIDENVQREIINHRSLRHPNIVRFKE 83
Query: 108 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 167
+ L +I EY GG+L++ + G S A F + G++Y H+ I HRD
Sbjct: 84 VILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHS--MQICHRD 141
Query: 168 LKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYD- 226
LK N LL S A LK+ DFG SK H K T G+ Y+APEV ++YD
Sbjct: 142 LKLENTLLDGSPAPRLKICDFGYSKSSV---LHSQPKST--VGTPAYIAPEVLLRQEYDG 196
Query: 227 KKVDVFSFAMILYEMLEGEPP 247
K DV+S + LY ML G P
Sbjct: 197 KIADVWSCGVTLYVMLVGAYP 217
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-38
Identities = 71/257 (27%), Positives = 116/257 (45%), Gaps = 16/257 (6%)
Query: 50 IGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 107
+G+G++GE+ A R T VA+K I+ + E+ + L H N+V+F G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKK-EICINKMLNHENVVKFYG 72
Query: 108 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 167
E L EY GG+L ++ + A F + G+ YLH I HRD
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG--IGITHRD 130
Query: 168 LKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYD- 226
+KP N+LL D+LK+ DFGL+ + + N + G+ Y+APE+ K R++
Sbjct: 131 IKPENLLL--DERDNLKISDFGLATVFRYNNRERLLNKM--CGTLPYVAPELLKRREFHA 186
Query: 227 KKVDVFSFAMILYEMLEGEPP---LANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEK 283
+ VDV+S ++L ML GE P ++ + + + ++ L K
Sbjct: 187 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKK--IDSAPLALLHK 244
Query: 284 CWAADMNQRPSFLDILK 300
+ + R + DI K
Sbjct: 245 ILVENPSARITIPDIKK 261
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 1e-37
Identities = 70/257 (27%), Positives = 115/257 (44%), Gaps = 16/257 (6%)
Query: 50 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 107
+G+G++GE+ A R VA+K I+ + E+ + L H N+V+F G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKK-EICINKMLNHENVVKFYG 72
Query: 108 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 167
E L EY GG+L ++ + A F + G+ YLH I HRD
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG--IGITHRD 130
Query: 168 LKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYD- 226
+KP N+LL D+LK+ DFGL+ + + N + G+ Y+APE+ K R++
Sbjct: 131 IKPENLLL--DERDNLKISDFGLATVFRYNNRERLLNKM--CGTLPYVAPELLKRREFHA 186
Query: 227 KKVDVFSFAMILYEMLEGEPP---LANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEK 283
+ VDV+S ++L ML GE P ++ + + + ++ L K
Sbjct: 187 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKK--IDSAPLALLHK 244
Query: 284 CWAADMNQRPSFLDILK 300
+ + R + DI K
Sbjct: 245 ILVENPSARITIPDIKK 261
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 135 bits (340), Expect = 4e-37
Identities = 32/321 (9%), Positives = 69/321 (21%), Gaps = 54/321 (16%)
Query: 23 KPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDD 80
P D + E + G + A+K +
Sbjct: 43 TVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENS 102
Query: 81 RLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP-------------------------- 114
R ++ +L + + P
Sbjct: 103 RSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVAN 162
Query: 115 LMLITEYLRG------GDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDL 168
+L+ L +G + R A L + ++H
Sbjct: 163 YLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQS--KGLVHGHF 220
Query: 169 KPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRK--YD 226
P N+ + L +GD + + Y E +
Sbjct: 221 TPDNLFI--MPDGRLMLGDVSALW-------KVGTRGPASSVPVTYAPREFLNASTATFT 271
Query: 227 KKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHR-------PFFRAKGFTPELRE 279
++ + + +Y + P P + R F ++
Sbjct: 272 HALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKT 331
Query: 280 LTEKCWAADMNQRPSFLDILK 300
L + D +R L+ ++
Sbjct: 332 LIGRFLNFDRRRRLLPLEAME 352
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-35
Identities = 64/203 (31%), Positives = 102/203 (50%), Gaps = 16/203 (7%)
Query: 50 IGKGSFGEILKAYWR--GTPVAIKRILP--SLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 105
+G G+FG++ + G VA+K IL + +V + R E+ L RHP+I++
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVK-ILNRQKIRSLDVVGKIKR-EIQNLKLFRHPHIIKL 76
Query: 106 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 165
++ ++ EY+ GG+L Y+ + G + A I + Y H ++++H
Sbjct: 77 YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHR--HMVVH 134
Query: 166 RDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKY 225
RDLKP NVLL + + K+ DFGLS ++ D + GS Y APEV R Y
Sbjct: 135 RDLKPENVLL--DAHMNAKIADFGLSNMMS-----DGEFLRTSCGSPNYAAPEVISGRLY 187
Query: 226 D-KKVDVFSFAMILYEMLEGEPP 247
+VD++S +ILY +L G P
Sbjct: 188 AGPEVDIWSCGVILYALLCGTLP 210
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-35
Identities = 62/229 (27%), Positives = 99/229 (43%), Gaps = 41/229 (17%)
Query: 50 IGKGSFGEILKAYWR--GTPVAIK-----------------------RILPSLSDDRLVI 84
IGKGS+G + AY T A+K R I
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 85 QDFRHEVNLLVKLRHPNIVQF---LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPST 141
+ E+ +L KL HPN+V+ L E L ++ E + G + + LS
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDH-LYMVFELVNQGPVMEVPT-LKPLSEDQ 138
Query: 142 AVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHD 201
A + D+ +G+ YLH IIHRD+KP N+L+ H+K+ DFG+S K ++
Sbjct: 139 ARFYFQDLIKGIEYLHY--QKIIHRDIKPSNLLV--GEDGHIKIADFGVSNEFKGSDAL- 193
Query: 202 VYKMTGETGSYRYMAPEVF--KHRKYD-KKVDVFSFAMILYEMLEGEPP 247
++ G+ +MAPE + + K +DV++ + LY + G+ P
Sbjct: 194 ---LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 6e-35
Identities = 58/226 (25%), Positives = 106/226 (46%), Gaps = 38/226 (16%)
Query: 38 DPSELDFSSSAIIGKGSFGEILKAYWRGT-PVAIKRILPSLSDDRLVIQDFRH---EVNL 93
+ E+ +++ +IG GSFG + +A + VAIK++L QD R E+ +
Sbjct: 36 EQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVL----------QDKRFKNRELQI 85
Query: 94 LVKLRHPNIVQFLGAVTERKP------LMLITEYLRGGDLHKYL----KEKGALSPSTAV 143
+ ++HPN+V L L+ EY+ +++ K K +
Sbjct: 86 MRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPMLLIK 144
Query: 144 NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 203
+ + R +AY+H+ I HRD+KP+N LL++ + LK+ DFG +K++
Sbjct: 145 LYMYQLLRSLAYIHS--IGICHRDIKPQN-LLLDPPSGVLKLIDFGSAKILIAGEP---- 197
Query: 204 KMTGE--TGSYRYMAPEV-FKHRKYDKKVDVFSFAMILYEMLEGEP 246
+ YR APE+ F Y +D++S ++ E+++G+P
Sbjct: 198 -NVSYICSRYYR--APELIFGATNYTTNIDIWSTGCVMAELMQGQP 240
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 6e-35
Identities = 66/203 (32%), Positives = 104/203 (51%), Gaps = 17/203 (8%)
Query: 50 IGKGSFGEILKAYWR--GTPVAIKRILP--SLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 105
+G+GSFG++ A VA+K + L + ++ R E++ L LRHP+I++
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALK-FISRQLLKKSDMHMRVER-EISYLKLLRHPHIIKL 74
Query: 106 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 165
+T ++++ EY GG+L Y+ EK ++ F I + Y H + I+H
Sbjct: 75 YDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHR--HKIVH 131
Query: 166 RDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKY 225
RDLKP N+LL ++K+ DFGLS ++ D + GS Y APEV + Y
Sbjct: 132 RDLKPENLLL--DDNLNVKIADFGLSNIMT-----DGNFLKTSCGSPNYAAPEVINGKLY 184
Query: 226 D-KKVDVFSFAMILYEMLEGEPP 247
+VDV+S ++LY ML G P
Sbjct: 185 AGPEVDVWSCGIVLYVMLVGRLP 207
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-34
Identities = 77/295 (26%), Positives = 135/295 (45%), Gaps = 34/295 (11%)
Query: 9 GGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGT-- 66
G + + G+ PPP P K E DF I+G+GSF ++ A T
Sbjct: 3 GTAAEPRPGAGSLQHAQPPPQPRKKRPE------DFKFGKILGEGSFSTVVLARELATSR 56
Query: 67 PVAIKRILPSLSDDRLVIQD-----FRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY 121
AIK IL + R +I++ E +++ +L HP V+ + + L Y
Sbjct: 57 EYAIK-IL----EKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY 111
Query: 122 LRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD 181
+ G+L KY+++ G+ + + +I + YLH IIHRDLKP N+LL +
Sbjct: 112 AKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG--KGIIHRDLKPENILL--NEDM 167
Query: 182 HLKVGDFGLSKLIKVQNSHDVYKMTGETGSY----RYMAPEVFKHRKYDKKVDVFSFAMI 237
H+++ DFG +K++ ++ S+ +Y++PE+ + K D+++ I
Sbjct: 168 HIQITDFGTAKVLSPESK------QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCI 221
Query: 238 LYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQR 292
+Y+++ G PP Y + + + F + F P+ R+L EK D +R
Sbjct: 222 IYQLVAGLPPFRAGNEYLIFQKIIKLEYDF--PEKFFPKARDLVEKLLVLDATKR 274
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 1e-34
Identities = 42/230 (18%), Positives = 86/230 (37%), Gaps = 23/230 (10%)
Query: 38 DPSELDFSSSAIIGKG--SFGEILKAY--WRGTPVAIKRI-LPSLSDDRLVIQDFRHEVN 92
+ +IGKG + A G V ++RI L + S++ + + E++
Sbjct: 22 PEGG-CYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEM--VTFLQGELH 78
Query: 93 LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGG---DLHKYLKEKGALSPSTAVNFALDI 149
+ HPNIV + L ++T ++ G DL G ++ +
Sbjct: 79 VSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDG-MNELAIAYILQGV 137
Query: 150 ARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFG----LSKLIKVQNSHDVYKM 205
+ + Y+H+ +HR +K ++L+ S + + + + Q +
Sbjct: 138 LKALDYIHH--MGYVHRSVKASHILI--SVDGKVYLSGLRSNLSMISHGQRQRVVHDFPK 193
Query: 206 TGETGSYRYMAPEVFKHRK--YDKKVDVFSFAMILYEMLEGEPPLANYEP 253
+++PEV + YD K D++S + E+ G P +
Sbjct: 194 Y-SVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPA 242
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-34
Identities = 63/213 (29%), Positives = 98/213 (46%), Gaps = 21/213 (9%)
Query: 43 DFSSSAIIGKGSFGEILKAYWRGTPV--AIKRILPSLSDDRLVIQD----FRHEVNLLVK 96
F ++GKG FGE+ R T A K L R+ + +E +L K
Sbjct: 185 TFRQYRVLGKGGFGEVCACQVRATGKMYACK----KLEKKRIKKRKGEAMALNEKQILEK 240
Query: 97 LRHPNIVQFLGAVTERKPLMLITEYLRGGDL--HKYLKEKGALSPSTAVNFALDIARGMA 154
+ +V A + L L+ + GGDL H Y + + AV +A +I G+
Sbjct: 241 VNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLE 300
Query: 155 YLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRY 214
LH I++RDLKP N+LL H+++ D GL+ + + + G G+ Y
Sbjct: 301 DLHR--ERIVYRDLKPENILL--DDHGHIRISDLGLAVHVP-----EGQTIKGRVGTVGY 351
Query: 215 MAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPP 247
MAPEV K+ +Y D ++ +LYEM+ G+ P
Sbjct: 352 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-34
Identities = 72/241 (29%), Positives = 111/241 (46%), Gaps = 21/241 (8%)
Query: 15 QNGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGT--PVAIKR 72
G+ P + + + +G+G++GE+ KA T VAIKR
Sbjct: 8 HMGTLEAQTQGPGSMSVSAAPSATSID-RYRRITKLGEGTYGEVYKAIDTVTNETVAIKR 66
Query: 73 ILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK 132
I ++ + R EV+LL +L+H NI++ + L LI EY DL KY+
Sbjct: 67 IRLEHEEEGVPGTAIR-EVSLLKELQHRNIIELKSVIHHNHRLHLIFEYA-ENDLKKYMD 124
Query: 133 EKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD----HLKVGDF 188
+ +S +F + G+ + H+ +HRDLKP+N LL++ S LK+GDF
Sbjct: 125 KNPDVSMRVIKSFLYQLINGVNFCHS--RRCLHRDLKPQN-LLLSVSDASETPVLKIGDF 181
Query: 189 GLSKLIKVQNSHDVYKMTGE--TGSYRYMAPEV-FKHRKYDKKVDVFSFAMILYEMLEGE 245
GL++ + + + T E T YR PE+ R Y VD++S A I EML
Sbjct: 182 GLARAFGIP----IRQFTHEIITLWYR--PPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235
Query: 246 P 246
P
Sbjct: 236 P 236
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-34
Identities = 59/215 (27%), Positives = 93/215 (43%), Gaps = 22/215 (10%)
Query: 43 DFSSSAIIGKGSFGEILKAYWRGTPV--AIKRILPSLSDDRLVIQD----FRHEVNLLVK 96
F ++G+G FGE+ + T A K L+ RL + E +L K
Sbjct: 186 WFLDFRVLGRGGFGEVFACQMKATGKLYACK----KLNKKRLKKRKGYQGAMVEKKILAK 241
Query: 97 LRHPNIVQFLGAVTERKPLMLITEYLRGGDL----HKYLKEKGALSPSTAVNFALDIARG 152
+ IV A + L L+ + GGD+ + ++ A+ + I G
Sbjct: 242 VHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG 301
Query: 153 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSY 212
+ +LH II+RDLKP NVLL ++++ D GL+ + K G G+
Sbjct: 302 LEHLHQ--RNIIYRDLKPENVLL--DDDGNVRISDLGLAV----ELKAGQTKTKGYAGTP 353
Query: 213 RYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPP 247
+MAPE+ +YD VD F+ + LYEM+ P
Sbjct: 354 GFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 4e-34
Identities = 67/226 (29%), Positives = 103/226 (45%), Gaps = 26/226 (11%)
Query: 36 EIDPSELD-FSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVN 92
E E+D F + G+G+FG + + G VAIK+++ D R ++ + +
Sbjct: 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVI---QDPRFRNRELQ-IMQ 71
Query: 93 LLVKLRHPNIVQ---FLGAVTERKP----LMLITEYLRGGDLHKYLK----EKGALSPST 141
L L HPNIVQ + + ER L ++ EY+ LH+ + + A P
Sbjct: 72 DLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVAPPPIL 130
Query: 142 AVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHD 201
F + R + LH + HRD+KP N +LVN + LK+ DFG +K +
Sbjct: 131 IKVFLFQLIRSIGCLHLPSVNVCHRDIKPHN-VLVNEADGTLKLCDFGSAKKLSPSEP-- 187
Query: 202 VYKMTGETGSYRYMAPEV-FKHRKYDKKVDVFSFAMILYEMLEGEP 246
S Y APE+ F ++ Y VD++S I EM+ GEP
Sbjct: 188 ---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEP 230
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 6e-34
Identities = 66/208 (31%), Positives = 103/208 (49%), Gaps = 26/208 (12%)
Query: 50 IGKGSFGEILKAYWR--GTPVAIKRILP--SLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 105
+G G+FG++ G VA+K IL + +V + R E+ L RHP+I++
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVK-ILNRQKIRSLDVVGKIRR-EIQNLKLFRHPHIIKL 81
Query: 106 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 165
++ + ++ EY+ GG+L Y+ + G L + I G+ Y H ++++H
Sbjct: 82 YQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHR--HMVVH 139
Query: 166 RDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET-----GSYRYMAPEVF 220
RDLKP NVLL + + K+ DFGLS ++ GE GS Y APEV
Sbjct: 140 RDLKPENVLL--DAHMNAKIADFGLSNMMS----------DGEFLRTSCGSPNYAAPEVI 187
Query: 221 KHRKYD-KKVDVFSFAMILYEMLEGEPP 247
R Y +VD++S +ILY +L G P
Sbjct: 188 SGRLYAGPEVDIWSSGVILYALLCGTLP 215
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 6e-34
Identities = 64/203 (31%), Positives = 100/203 (49%), Gaps = 18/203 (8%)
Query: 50 IGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 107
+G+GS+G ++K + T VAIK+ L S D + R E+ LL +LRH N+V L
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR-EIKLLKQLRHENLVNLLE 91
Query: 108 AVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 166
++K L+ E++ + L+ L + I G+ + H+ + IIHR
Sbjct: 92 VCKKKKRWYLVFEFVD-HTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHS--HNIIHR 148
Query: 167 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGE--TGSYRYMAPEV-FKHR 223
D+KP N +LV+ S +K+ DFG ++ + E T YR APE+
Sbjct: 149 DIKPEN-ILVSQS-GVVKLCDFGFARTLAAP----GEVYDDEVATRWYR--APELLVGDV 200
Query: 224 KYDKKVDVFSFAMILYEMLEGEP 246
KY K VDV++ ++ EM GEP
Sbjct: 201 KYGKAVDVWAIGCLVTEMFMGEP 223
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 6e-34
Identities = 57/203 (28%), Positives = 94/203 (46%), Gaps = 18/203 (8%)
Query: 50 IGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 107
IG+GS+G + K R T VAIK+ L S D + R E+ +L +L+HPN+V L
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR-EIRMLKQLKHPNLVNLLE 69
Query: 108 AVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 166
++ L L+ EY + L + + + + + + H + IHR
Sbjct: 70 VFRRKRRLHLVFEYCD-HTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHK--HNCIHR 126
Query: 167 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGE--TGSYRYMAPEV-FKHR 223
D+KP N +L+ +K+ DFG ++L+ + E T YR +PE+
Sbjct: 127 DVKPEN-ILITKH-SVIKLCDFGFARLLTGPSD----YYDDEVATRWYR--SPELLVGDT 178
Query: 224 KYDKKVDVFSFAMILYEMLEGEP 246
+Y VDV++ + E+L G P
Sbjct: 179 QYGPPVDVWAIGCVFAELLSGVP 201
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 7e-34
Identities = 64/226 (28%), Positives = 103/226 (45%), Gaps = 39/226 (17%)
Query: 39 PSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRH---EVNL 93
P E+ ++ + +IG GSFG + +A G VAIK++L QD R E+ +
Sbjct: 51 PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----------QDKRFKNRELQI 100
Query: 94 LVKLRHPNIVQFLGAVTERKP------LMLITEYLRGGDLHKYLK----EKGALSPSTAV 143
+ KL H NIV+ L L+ +Y+ +++ + K L
Sbjct: 101 MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVK 159
Query: 144 NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 203
+ + R +AY+H+ I HRD+KP+N LL++ LK+ DFG +K +
Sbjct: 160 LYMYQLFRSLAYIHS--FGICHRDIKPQN-LLLDPDTAVLKLCDFGSAKQLVRGE----- 211
Query: 204 KMTGE--TGSYRYMAPEV-FKHRKYDKKVDVFSFAMILYEMLEGEP 246
+ YR APE+ F Y +DV+S +L E+L G+P
Sbjct: 212 PNVSYICSRYYR--APELIFGATDYTSSIDVWSAGCVLAELLLGQP 255
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 1e-33
Identities = 52/256 (20%), Positives = 89/256 (34%), Gaps = 42/256 (16%)
Query: 50 IGKGSFGEILKAYWRGT-------PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 102
I G G I + PV +K ++ S D E L ++ HP+I
Sbjct: 88 IAHGGLGWI----YLALDRNVNGRPVVLKGLVHS--GDAEAQAMAMAERQFLAEVVHPSI 141
Query: 103 VQFLGAVTERKPLM-----LITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLH 157
VQ V ++ EY+ G L + L + A+ + L+I ++YLH
Sbjct: 142 VQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG--QKLPVAEAIAYLLEILPALSYLH 199
Query: 158 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAP 217
+ +++ DLKP N++L + + LK+ D G I +Y G+ + AP
Sbjct: 200 SIG--LVYNDLKPENIML---TEEQLKLIDLGAVSRINSFGY--LY------GTPGFQAP 246
Query: 218 EVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPEL 277
E+ + D+++ L + P + E
Sbjct: 247 EIVRTGP-TVATDIYTVGRTLAALTLDLPTRNG----RYVDGLPEDDPVLKTY----DSY 297
Query: 278 RELTEKCWAADMNQRP 293
L + D QR
Sbjct: 298 GRLLRRAIDPDPRQRF 313
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-33
Identities = 41/324 (12%), Positives = 85/324 (26%), Gaps = 64/324 (19%)
Query: 23 KPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDD 80
P + + E+ ++G+ L+A + G + +
Sbjct: 54 SLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPP 113
Query: 81 RLVIQDFRHEVNLLVKLR-------------------------HPNIVQFLGAVTERK-- 113
I+ + EV L LR +++ +
Sbjct: 114 SNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVL 173
Query: 114 ------PLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 167
P M G L + +L + L + R +A LH+ ++H
Sbjct: 174 SRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH--YGLVHTY 231
Query: 168 LKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR---- 223
L+P +++L + + F + S + PE+ R
Sbjct: 232 LRPVDIVL--DQRGGVFLTGFEHLVRDG--------ARVVSSVSRGFEPPELEARRATIS 281
Query: 224 -------KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPE 276
D ++ +++Y + + P + F K
Sbjct: 282 YHRDRRTLMTFSFDAWALGLVIYWIWCADL------PITKDAALGGSEWIFRSCKNIPQP 335
Query: 277 LRELTEKCWAADMNQRPSFLDILK 300
+R L E R L ++
Sbjct: 336 VRALLEGFLRYPKEDRLLPLQAME 359
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 4e-33
Identities = 62/211 (29%), Positives = 102/211 (48%), Gaps = 17/211 (8%)
Query: 43 DFSSSAIIGKGSFGEILKAYWRGTPV--AIKRILPSLSDDRLVIQD-FRH---EVNLLVK 96
+F ++GKG+FG+++ + T A+K L + +V +D H E +L
Sbjct: 149 EFEYLKLLGKGTFGKVILVKEKATGRYYAMK----ILKKEVIVAKDEVAHTLTENRVLQN 204
Query: 97 LRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYL 156
RHP + + L + EY GG+L +L + S A + +I + YL
Sbjct: 205 SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYL 264
Query: 157 HNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMA 216
H+E N +++RDLK N++L H+K+ DFGL K + D M G+ Y+A
Sbjct: 265 HSEKN-VVYRDLKLENLML--DKDGHIKITDFGLCK----EGIKDGATMKTFCGTPEYLA 317
Query: 217 PEVFKHRKYDKKVDVFSFAMILYEMLEGEPP 247
PEV + Y + VD + +++YEM+ G P
Sbjct: 318 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 5e-33
Identities = 57/209 (27%), Positives = 92/209 (44%), Gaps = 46/209 (22%)
Query: 49 IIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQF 105
++G G G++L+ + + T A+K + D R EV L + + P+IV+
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKML-----QDC---PKARREVELHWRASQCPHIVRI 76
Query: 106 LGA----VTERKPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNE 159
+ RK L+++ E L GG+L ++++G A + A I + YLH+
Sbjct: 77 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS- 135
Query: 160 PNVIIHRDLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPE 218
I HRD+KP N+L + + LK+ DFG A E
Sbjct: 136 -INIAHRDVKPENLLYTSKRPNAILKLTDFGF-------------------------AKE 169
Query: 219 VFKHRKYDKKVDVFSFAMILYEMLEGEPP 247
KYDK D++S +I+Y +L G PP
Sbjct: 170 TTG-EKYDKSCDMWSLGVIMYILLCGYPP 197
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 5e-33
Identities = 60/212 (28%), Positives = 102/212 (48%), Gaps = 20/212 (9%)
Query: 43 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQD-FRH---EVNLLVK 96
DF ++GKG+FG+++ + T A+K L + ++ +D H E +L
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMK----ILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 97 LRHPNIVQFLGAV-TERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 155
RHP + A T + L + EY GG+L +L + + A + +I + Y
Sbjct: 62 TRHPFLTALKYAFQTHDR-LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 156 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYM 215
LH+ +++RD+K N++L H+K+ DFGL K + D M G+ Y+
Sbjct: 121 LHS--RDVVYRDIKLENLML--DKDGHIKITDFGLCK----EGISDGATMKTFCGTPEYL 172
Query: 216 APEVFKHRKYDKKVDVFSFAMILYEMLEGEPP 247
APEV + Y + VD + +++YEM+ G P
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 7e-33
Identities = 71/221 (32%), Positives = 109/221 (49%), Gaps = 36/221 (16%)
Query: 43 DFSSSAIIGKGSFGEIL---KAYWRGTPV--AIKRILPSLSDDRLVIQDFRH---EVNLL 94
F ++G+GSFG++ K A+K L L ++D E ++L
Sbjct: 25 QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMK----VLKKATLKVRDRVRTKMERDIL 80
Query: 95 VKLRHPNIVQFLGAV-TERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGM 153
V++ HP IV+ A TE K L LI ++LRGGDL L ++ + + ++A +
Sbjct: 81 VEVNHPFIVKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALAL 139
Query: 154 AYLHNEPNVIIHRDLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVYKMTGETGSY 212
+LH+ II+RDLKP N+LL + H+K+ DFGLSK + E +Y
Sbjct: 140 DHLHS--LGIIYRDLKPENILL---DEEGHIKLTDFGLSKE----------SIDHEKKAY 184
Query: 213 ------RYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPP 247
YMAPEV R + + D +SF ++++EML G P
Sbjct: 185 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 9e-33
Identities = 65/232 (28%), Positives = 107/232 (46%), Gaps = 26/232 (11%)
Query: 25 VPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPV--AIKRILPSLSDDRL 82
+PP D D F IGKGSFG++ T A+K ++ +
Sbjct: 2 MPPVFDENEDVNFD----HFEILRAIGKGSFGKVCIVQKNDTKKMYAMK----YMNKQKC 53
Query: 83 VIQD-FRH---EVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALS 138
V ++ R+ E+ ++ L HP +V + + + + ++ + L GGDL +L++
Sbjct: 54 VERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFK 113
Query: 139 PSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 198
T F ++ + YL N IIHRD+KP N+LL H+ + DF ++ ++
Sbjct: 114 EETVKLFICELVMALDYLQN--QRIIHRDMKPDNILL--DEHGHVHITDFNIAAMLP--- 166
Query: 199 SHDVYKMTGETGSYRYMAPEVFKHRK---YDKKVDVFSFAMILYEMLEGEPP 247
++T G+ YMAPE+F RK Y VD +S + YE+L G P
Sbjct: 167 --RETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-32
Identities = 73/202 (36%), Positives = 111/202 (54%), Gaps = 17/202 (8%)
Query: 50 IGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGA 108
IG+G++G + KA G A+K+I D+ + R E+++L +L+H NIV+
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR-EISILKELKHSNIVKLYDV 68
Query: 109 VTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 167
+ +K L+L+ E+L DL K L +G L TA +F L + G+AY H+ ++HRD
Sbjct: 69 IHTKKRLVLVFEHLD-QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD--RRVLHRD 125
Query: 168 LKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGE--TGSYRYMAPEV-FKHRK 224
LKP+N LL+N LK+ DFGL++ + V K T E T YR AP+V +K
Sbjct: 126 LKPQN-LLINREG-ELKIADFGLARAFGIP----VRKYTHEIVTLWYR--APDVLMGSKK 177
Query: 225 YDKKVDVFSFAMILYEMLEGEP 246
Y +D++S I EM+ G P
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGTP 199
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 124 bits (311), Expect = 1e-32
Identities = 40/331 (12%), Positives = 89/331 (26%), Gaps = 57/331 (17%)
Query: 23 KPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDD 80
P + + E+ ++G+ L+A + G + +
Sbjct: 59 SLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPP 118
Query: 81 RLVIQDFRHEVNLLVKLR----------------------HPNIVQFLGAVTERKPLMLI 118
I+ + EV L LR P + + + + + ++
Sbjct: 119 SNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVL 178
Query: 119 TEYL-----------RGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 167
+ + G L + +L + L + R +A LH+ ++H
Sbjct: 179 SRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTY 236
Query: 168 LKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET-GSYRYMAPEVFK----- 221
L+P +++L + + F G A +
Sbjct: 237 LRPVDIVL--DQRGGVFLTGFEHLVRD----GASAVSPIGRGFAPPETTAERMLPFGQHH 290
Query: 222 HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELT 281
D ++ + +Y + + P + F K +R L
Sbjct: 291 PTLMTFAFDTWTLGLAIYWIWCADL------PNTDDAALGGSEWIFRSCKNIPQPVRALL 344
Query: 282 EKCWAADMNQRPSFLDILKR--LEKIKETLP 310
E R L ++ E+++ L
Sbjct: 345 EGFLRYPKEDRLLPLQAMETPEYEQLRTELS 375
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 1e-32
Identities = 64/233 (27%), Positives = 110/233 (47%), Gaps = 29/233 (12%)
Query: 31 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFR 88
N +++ + +G G G + A VAIK+I L+D + V R
Sbjct: 3 NIHGFDLGS---RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKI--VLTDPQSVKHALR 57
Query: 89 HEVNLLVKLRHPNIVQFL--------------GAVTERKPLMLITEYLRGGDLHKYLKEK 134
E+ ++ +L H NIV+ G++TE + ++ EY+ DL L+ +
Sbjct: 58 -EIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLE-Q 114
Query: 135 GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 194
G L A F + RG+ Y+H+ ++HRDLKP N L +N+ LK+GDFGL++++
Sbjct: 115 GPLLEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPAN-LFINTEDLVLKIGDFGLARIM 171
Query: 195 KVQNSHDVYKMTGETGSYRYMAPEV-FKHRKYDKKVDVFSFAMILYEMLEGEP 246
SH + ++ + Y +P + Y K +D+++ I EML G+
Sbjct: 172 DPHYSHKGH-LSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKT 223
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-32
Identities = 74/202 (36%), Positives = 109/202 (53%), Gaps = 17/202 (8%)
Query: 50 IGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGA 108
+G+G++G + KA G VA+KRI D+ + R E++LL +L HPNIV +
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIR-EISLLKELHHPNIVSLIDV 87
Query: 109 VTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 167
+ + L L+ E++ DL K L E K L S + + RG+A+ H + I+HRD
Sbjct: 88 IHSERCLTLVFEFME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQ--HRILHRD 144
Query: 168 LKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGE--TGSYRYMAPEV-FKHRK 224
LKP+N LL+NS LK+ DFGL++ + V T E T YR AP+V +K
Sbjct: 145 LKPQN-LLINSDG-ALKLADFGLARAFGIP----VRSYTHEVVTLWYR--APDVLMGSKK 196
Query: 225 YDKKVDVFSFAMILYEMLEGEP 246
Y VD++S I EM+ G+P
Sbjct: 197 YSTSVDIWSIGCIFAEMITGKP 218
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 4e-32
Identities = 71/222 (31%), Positives = 108/222 (48%), Gaps = 36/222 (16%)
Query: 43 DFSSSAIIGKGSFGEIL---KAYWRGTPV--AIKRILPSLSDDRLV--IQDFRH---EVN 92
F ++GKG +G++ K T A+K L +V +D H E N
Sbjct: 18 CFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMK----VLKKAMIVRNAKDTAHTKAERN 73
Query: 93 LLVKLRHPNIVQFLGAV-TERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIAR 151
+L +++HP IV + A T K L LI EYL GG+L L+ +G TA + +I+
Sbjct: 74 ILEEVKHPFIVDLIYAFQTGGK-LYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISM 132
Query: 152 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET-- 209
+ +LH II+RDLKP N++L + H+K+ DFGL K + T
Sbjct: 133 ALGHLHQ--KGIIYRDLKPENIML--NHQGHVKLTDFGLCKE----------SIHDGTVT 178
Query: 210 ----GSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPP 247
G+ YMAPE+ +++ VD +S ++Y+ML G PP
Sbjct: 179 HTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 119 bits (302), Expect = 5e-32
Identities = 66/205 (32%), Positives = 103/205 (50%), Gaps = 18/205 (8%)
Query: 50 IGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 107
IG+G++G + KA R T VA+KR+ D+ + R E+ LL +L+H NIV+
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKHKNIVRLHD 68
Query: 108 AVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 166
+ K L L+ E+ DL KY G L P +F + +G+ + H+ ++HR
Sbjct: 69 VLHSDKKLTLVFEFCD-QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS--RNVLHR 125
Query: 167 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGE--TGSYRYMAPEV-FKHR 223
DLKP+N LL+N + LK+ +FGL++ V + E T YR P+V F +
Sbjct: 126 DLKPQN-LLINRNG-ELKLANFGLARAF----GIPVRCYSAEVVTLWYR--PPDVLFGAK 177
Query: 224 KYDKKVDVFSFAMILYEMLEGEPPL 248
Y +D++S I E+ PL
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPL 202
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 6e-32
Identities = 70/222 (31%), Positives = 109/222 (49%), Gaps = 39/222 (17%)
Query: 43 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVN-------- 92
DF ++GKGSFG++ A ++ T AIK +L D +++ D +V
Sbjct: 18 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIK----ALKKDVVLMDD---DVECTMVEKRV 70
Query: 93 LLVKLRHPNIVQFLGAV-TERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIAR 151
L + HP + T+ L + EYL GGDL +++ S A +A +I
Sbjct: 71 LSLAWEHPFLTHMFCTFQTKEN-LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIIL 129
Query: 152 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET-- 209
G+ +LH+ I++RDLK N+LL H+K+ DFG+ K M G+
Sbjct: 130 GLQFLHS--KGIVYRDLKLDNILL--DKDGHIKIADFGMCKE----------NMLGDAKT 175
Query: 210 ----GSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPP 247
G+ Y+APE+ +KY+ VD +SF ++LYEML G+ P
Sbjct: 176 NTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 7e-32
Identities = 66/260 (25%), Positives = 121/260 (46%), Gaps = 31/260 (11%)
Query: 43 DFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLV----IQDFRHEVNLLVK 96
F +G GSFG ++ + + A+K L ++V I+ +E +L
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMK----ILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 97 LRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYL 156
+ P +V+ + + L ++ EY+ GG++ +L+ G S A +A I YL
Sbjct: 98 VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 157 HNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET----GSY 212
H+ +I+RDLKP N+L+ +++V DFG +K ++ G T G+
Sbjct: 158 HS--LDLIYRDLKPENLLI--DQQGYIQVTDFGFAK-----------RVKGRTWTLCGTP 202
Query: 213 RYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKG 272
+APE+ + Y+K VD ++ +++YEM G PP +P + + + G F
Sbjct: 203 EALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF--PSH 260
Query: 273 FTPELRELTEKCWAADMNQR 292
F+ +L++L D+ +R
Sbjct: 261 FSSDLKDLLRNLLQVDLTKR 280
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 8e-32
Identities = 68/222 (30%), Positives = 111/222 (50%), Gaps = 39/222 (17%)
Query: 43 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVN-------- 92
DF+ ++GKGSFG+++ + +GT A+K L D ++ D +V
Sbjct: 21 DFNFLMVLGKGSFGKVMLSERKGTDELYAVK----ILKKDVVIQDD---DVECTMVEKRV 73
Query: 93 LLVKLRHPNIVQFLGAV-TERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIAR 151
L + + P + Q T + L + EY+ GGDL ++++ G AV +A +IA
Sbjct: 74 LALPGKPPFLTQLHSCFQTMDR-LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAI 132
Query: 152 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET-- 209
G+ +L + II+RDLK NV+L S H+K+ DFG+ K +
Sbjct: 133 GLFFLQS--KGIIYRDLKLDNVML--DSEGHIKIADFGMCKE----------NIWDGVTT 178
Query: 210 ----GSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPP 247
G+ Y+APE+ ++ Y K VD ++F ++LYEML G+ P
Sbjct: 179 KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 9e-32
Identities = 68/212 (32%), Positives = 103/212 (48%), Gaps = 33/212 (15%)
Query: 50 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRH---------EVNLLVKLR 98
+G+G F + KA + VAIK+I +L + E+ LL +L
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKI-------KLGHRSEAKDGINRTALREIKLLQELS 70
Query: 99 HPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLH 157
HPNI+ L A + + L+ +++ DL +K+ L+PS + L +G+ YLH
Sbjct: 71 HPNIIGLLDAFGHKSNISLVFDFME-TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH 129
Query: 158 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGE--TGSYRYM 215
+ I+HRDLKP N LL++ + LK+ DFGL+K N T + T YR
Sbjct: 130 Q--HWILHRDLKPNN-LLLDENG-VLKLADFGLAKSFGSPNR----AYTHQVVTRWYR-- 179
Query: 216 APEV-FKHRKYDKKVDVFSFAMILYEMLEGEP 246
APE+ F R Y VD+++ IL E+L P
Sbjct: 180 APELLFGARMYGVGVDMWAVGCILAELLLRVP 211
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-31
Identities = 67/215 (31%), Positives = 99/215 (46%), Gaps = 24/215 (11%)
Query: 43 DFSSSAIIGKGSFGEILKAYWRGTPV--AIKRILPSLSDDRLVI-QDFRH---EVNLLVK 96
DFS IIG+G FGE+ T A+K L R+ + Q E +L
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMK----CLDKKRIKMKQGETLALNERIMLSL 245
Query: 97 L---RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGM 153
+ P IV A L I + + GGDLH +L + G S + +A +I G+
Sbjct: 246 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 305
Query: 154 AYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYR 213
++HN +++RDLKP N+LL H+++ D GL+ + K G++
Sbjct: 306 EHMHN--RFVVYRDLKPANILL--DEHGHVRISDLGLACDFSKK------KPHASVGTHG 355
Query: 214 YMAPEVF-KHRKYDKKVDVFSFAMILYEMLEGEPP 247
YMAPEV K YD D FS +L+++L G P
Sbjct: 356 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-31
Identities = 57/219 (26%), Positives = 102/219 (46%), Gaps = 33/219 (15%)
Query: 43 DFSSSAIIGKGSFGEILKAYWRGTPV--AIKRILPSLSDDRLVIQD----FRHEVNLLVK 96
DF +IG+GS+ ++L + T A+K + + + + + E ++ +
Sbjct: 10 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMK----VVKKELVNDDEDIDWVQTEKHVFEQ 65
Query: 97 -LRHPNIVQFLGAV-TERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMA 154
HP +V TE + L + EY+ GGDL +++ + L A ++ +I+ +
Sbjct: 66 ASNHPFLVGLHSCFQTESR-LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALN 124
Query: 155 YLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET----- 209
YLH II+RDLK NVLL S H+K+ D+G+ K +
Sbjct: 125 YLHE--RGIIYRDLKLDNVLL--DSEGHIKLTDYGMCKE----------GLRPGDTTSTF 170
Query: 210 -GSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPP 247
G+ Y+APE+ + Y VD ++ ++++EM+ G P
Sbjct: 171 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-31
Identities = 55/217 (25%), Positives = 94/217 (43%), Gaps = 23/217 (10%)
Query: 43 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQD----FRHEVNLLVK 96
DF +IG+G+FGE+ + A+K L+ ++ + FR E ++LV
Sbjct: 75 DFEILKVIGRGAFGEVAVVKLKNADKVFAMK----ILNKWEMLKRAETACFREERDVLVN 130
Query: 97 LRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARGMAY 155
I A + L L+ +Y GGDL L K + L A + ++ +
Sbjct: 131 GDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDS 190
Query: 156 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYM 215
+H +HRD+KP N+L+ H+++ DFG + + G Y+
Sbjct: 191 VHQ--LHYVHRDIKPDNILM--DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTP---DYI 243
Query: 216 APEVFK-----HRKYDKKVDVFSFAMILYEMLEGEPP 247
+PE+ + +Y + D +S + +YEML GE P
Sbjct: 244 SPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 2e-31
Identities = 67/221 (30%), Positives = 109/221 (49%), Gaps = 37/221 (16%)
Query: 43 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVN-------- 92
DF+ ++GKGSFG+++ + +GT A+K L D ++ D +V
Sbjct: 342 DFNFLMVLGKGSFGKVMLSERKGTDELYAVK----ILKKDVVIQDD---DVECTMVEKRV 394
Query: 93 LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARG 152
L + + P + Q L + EY+ GGDL ++++ G AV +A +IA G
Sbjct: 395 LALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIG 454
Query: 153 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET--- 209
+ +L + II+RDLK NV+L S H+K+ DFG+ K +
Sbjct: 455 LFFLQS--KGIIYRDLKLDNVML--DSEGHIKIADFGMCKE----------NIWDGVTTK 500
Query: 210 ---GSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPP 247
G+ Y+APE+ ++ Y K VD ++F ++LYEML G+ P
Sbjct: 501 TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-31
Identities = 80/261 (30%), Positives = 121/261 (46%), Gaps = 46/261 (17%)
Query: 10 GLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSEL------DFSSSAIIGKGSFGEILKAYW 63
G+S Q P PPP P++ + PS DF +IGKGSFG++L A
Sbjct: 1 GISQPQEPELMNANPAPPPAPSQ-QINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARH 59
Query: 64 RGTPV--AIKRILPSLSDDRLVIQDFRHEVN--------LLVKLRHPNIVQFLGAV-TER 112
+ V A+K L +++ + E LL ++HP +V + T
Sbjct: 60 KAEEVFYAVK----VLQKK-AILK--KKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD 112
Query: 113 KPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRN 172
K L + +Y+ GG+L +L+ + A +A +IA + YLH+ I++RDLKP N
Sbjct: 113 K-LYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHS--LNIVYRDLKPEN 169
Query: 173 VLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET------GSYRYMAPEVFKHRKYD 226
+LL S H+ + DFGL K + + G+ Y+APEV + YD
Sbjct: 170 ILL--DSQGHIVLTDFGLCKE----------NIEHNSTTSTFCGTPEYLAPEVLHKQPYD 217
Query: 227 KKVDVFSFAMILYEMLEGEPP 247
+ VD + +LYEML G PP
Sbjct: 218 RTVDWWCLGAVLYEMLYGLPP 238
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 3e-31
Identities = 56/219 (25%), Positives = 102/219 (46%), Gaps = 33/219 (15%)
Query: 43 DFSSSAIIGKGSFGEILKAYWRGTPV--AIKRILPSLSDDRLVIQD----FRHEVNLLVK 96
DF +IG+GS+ ++L + T A++ + + + + + E ++ +
Sbjct: 53 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMR----VVKKELVNDDEDIDWVQTEKHVFEQ 108
Query: 97 -LRHPNIVQFLGAV-TERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMA 154
HP +V TE + L + EY+ GGDL +++ + L A ++ +I+ +
Sbjct: 109 ASNHPFLVGLHSCFQTESR-LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALN 167
Query: 155 YLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET----- 209
YLH II+RDLK NVLL S H+K+ D+G+ K +
Sbjct: 168 YLHE--RGIIYRDLKLDNVLL--DSEGHIKLTDYGMCKE----------GLRPGDTTSTF 213
Query: 210 -GSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPP 247
G+ Y+APE+ + Y VD ++ ++++EM+ G P
Sbjct: 214 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 3e-31
Identities = 65/225 (28%), Positives = 106/225 (47%), Gaps = 27/225 (12%)
Query: 31 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFR 88
NK WE+ + + S +G G++G + A + G VAIK++ + + +R
Sbjct: 16 NKTAWELPKT---YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR 72
Query: 89 HEVNLLVKLRHPNIVQFLGAVTERKPLM------LITEYLRGGDLHKYLKEKGALSPSTA 142
E+ LL ++H N++ L T L L+ ++ DL K + K S
Sbjct: 73 -ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIMGLK--FSEEKI 128
Query: 143 VNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDV 202
+ +G+ Y+H+ ++HRDLKP N L VN + LK+ DFGL++ +
Sbjct: 129 QYLVYQMLKGLKYIHSAG--VVHRDLKPGN-LAVNEDCE-LKILDFGLARHADAE----- 179
Query: 203 YKMTGETGSYRYMAPEV-FKHRKYDKKVDVFSFAMILYEMLEGEP 246
MTG + Y APEV Y++ VD++S I+ EML G+
Sbjct: 180 --MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKT 222
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 5e-31
Identities = 62/222 (27%), Positives = 101/222 (45%), Gaps = 39/222 (17%)
Query: 43 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVN-------- 92
+F ++GKGSFG+++ A + T A+K L D ++ D +V
Sbjct: 24 NFEFIRVLGKGSFGKVMLARVKETGDLYAVK----VLKKDVILQDD---DVECTMTEKRI 76
Query: 93 LLVKLRHPNIVQFLGAV-TERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIAR 151
L + HP + Q T + L + E++ GGDL ++++ + A +A +I
Sbjct: 77 LSLARNHPFLTQLFCCFQTPDR-LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIIS 135
Query: 152 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET-- 209
+ +LH+ II+RDLK NVLL H K+ DFG+ K +
Sbjct: 136 ALMFLHD--KGIIYRDLKLDNVLL--DHEGHCKLADFGMCKE----------GICNGVTT 181
Query: 210 ----GSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPP 247
G+ Y+APE+ + Y VD ++ ++LYEML G P
Sbjct: 182 ATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 6e-31
Identities = 37/259 (14%), Positives = 71/259 (27%), Gaps = 54/259 (20%)
Query: 48 AIIGKGSFGEILKAYWRGT------PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN 101
G + W+ VA+ + P V+Q+ L ++ P
Sbjct: 37 IFHGGVPPLQF----WQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG 92
Query: 102 IVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPN 161
+ + L V R +++ E++RGG L + + SP A+ +A H
Sbjct: 93 VARVLDVVHTRAGGLVVAEWIRGGSLQEVA--DTSPSPVGAIRAMQSLAAAADAAHRAG- 149
Query: 162 VIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFK 221
+ P V + S + + M
Sbjct: 150 -VALSIDHPSRVRV--SIDGDVVLAYPA------------------------TMPDA--- 179
Query: 222 HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH------RPFFRAKGFTP 275
+ + D+ LY +L PL + AE P +
Sbjct: 180 ----NPQDDIRGIGASLYALLVNRWPLPE-AGVRSGLAPAERDTAGQPIEPADIDRDIPF 234
Query: 276 ELRELTEKCWAADMNQRPS 294
++ + + D R +
Sbjct: 235 QISAVAARSVQGDGGIRSA 253
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 9e-31
Identities = 58/224 (25%), Positives = 98/224 (43%), Gaps = 24/224 (10%)
Query: 31 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFR 88
+ + + + IG G+ G + AY VAIK++ + + +R
Sbjct: 17 GDSTFTVLK---RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR 73
Query: 89 HEVNLLVKLRHPNIVQFLGAVTERKPLM------LITEYLRGGDLHKYLKEKGALSPSTA 142
E+ L+ + H NI+ L T +K L ++ E + +L + ++ + L
Sbjct: 74 -ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME--LDHERM 129
Query: 143 VNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDV 202
+ G+ +LH+ IIHRDLKP N ++V S LK+ DFGL++
Sbjct: 130 SYLLYQMLCGIKHLHS--AGIIHRDLKPSN-IVVKSDCT-LKILDFGLARTAGTSFM--- 182
Query: 203 YKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEP 246
MT + Y APEV Y + VD++S I+ EM++G
Sbjct: 183 --MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGV 224
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 1e-30
Identities = 66/210 (31%), Positives = 101/210 (48%), Gaps = 33/210 (15%)
Query: 50 IGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQD------FRHEVNLLVKLRHPN 101
+G+G++ + K + T VA+K I RL ++ R EV+LL L+H N
Sbjct: 10 LGEGTYATVYKGKSKLTDNLVALKEI-------RLEHEEGAPCTAIR-EVSLLKDLKHAN 61
Query: 102 IVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA-LSPSTAVNFALDIARGMAYLHNEP 160
IV + K L L+ EYL DL +YL + G ++ F + RG+AY H
Sbjct: 62 IVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHR-- 118
Query: 161 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN---SHDVYKMTGETGSYRYMAP 217
++HRDLKP+N LL+N LK+ DFGL++ + ++V T YR P
Sbjct: 119 QKVLHRDLKPQN-LLINERG-ELKLADFGLARAKSIPTKTYDNEVV-----TLWYR--PP 169
Query: 218 EV-FKHRKYDKKVDVFSFAMILYEMLEGEP 246
++ Y ++D++ I YEM G P
Sbjct: 170 DILLGSTDYSTQIDMWGVGCIFYEMATGRP 199
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-30
Identities = 56/219 (25%), Positives = 96/219 (43%), Gaps = 25/219 (11%)
Query: 43 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQD----FRHEVNLLVK 96
DF +IG+G+F E+ + T A+K ++ ++ + FR E ++LV
Sbjct: 62 DFEILKVIGRGAFSEVAVVKMKQTGQVYAMK----IMNKWDMLKRGEVSCFREERDVLVN 117
Query: 97 LRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA-LSPSTAVNFALDIARGMAY 155
I Q A + L L+ EY GGDL L + G + A + +I +
Sbjct: 118 GDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDS 177
Query: 156 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYM 215
+H +HRD+KP N+LL H+++ DFG K++ V + G+ Y+
Sbjct: 178 VHR--LGYVHRDIKPDNILL--DRCGHIRLADFGSCL--KLRADGTVRSLVA-VGTPDYL 230
Query: 216 APEVFK-------HRKYDKKVDVFSFAMILYEMLEGEPP 247
+PE+ + Y + D ++ + YEM G+ P
Sbjct: 231 SPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-30
Identities = 66/225 (29%), Positives = 104/225 (46%), Gaps = 26/225 (11%)
Query: 31 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFR 88
K WE+ + +G G++G + A G VAIK++ + + +R
Sbjct: 17 TKTAWEVRA---VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR 73
Query: 89 HEVNLLVKLRHPNIVQFLGAVTERKPLM------LITEYLRGGDLHKYLKEKGALSPSTA 142
E+ LL +RH N++ L T + L L+ ++ G DL K +K + L
Sbjct: 74 -ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHE-KLGEDRI 130
Query: 143 VNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDV 202
+ +G+ Y+H IIHRDLKP N L VN + LK+ DFGL++ +
Sbjct: 131 QFLVYQMLKGLRYIHAAG--IIHRDLKPGN-LAVNEDCE-LKILDFGLARQADSE----- 181
Query: 203 YKMTGETGSYRYMAPEV-FKHRKYDKKVDVFSFAMILYEMLEGEP 246
MTG + Y APEV +Y + VD++S I+ EM+ G+
Sbjct: 182 --MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKT 224
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-30
Identities = 69/260 (26%), Positives = 118/260 (45%), Gaps = 31/260 (11%)
Query: 43 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQD----FRHEVNLLVK 96
DF +G GSFG + R A+K L + +V E +L
Sbjct: 7 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMK----VLKKEIVVRLKQVEHTNDERLMLSI 62
Query: 97 LRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYL 156
+ HP I++ G + + + +I +Y+ GG+L L++ A +A ++ + YL
Sbjct: 63 VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYL 122
Query: 157 HNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET----GSY 212
H+ II+RDLKP N+LL H+K+ DFG +K + T G+
Sbjct: 123 HS--KDIIYRDLKPENILL--DKNGHIKITDFGFAK-----------YVPDVTYTLCGTP 167
Query: 213 RYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKG 272
Y+APEV + Y+K +D +SF +++YEML G P + + + + F
Sbjct: 168 DYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF--PPF 225
Query: 273 FTPELRELTEKCWAADMNQR 292
F ++++L + D++QR
Sbjct: 226 FNEDVKDLLSRLITRDLSQR 245
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 2e-30
Identities = 60/226 (26%), Positives = 98/226 (43%), Gaps = 28/226 (12%)
Query: 31 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFR 88
+ + + + IG G+ G + AY VAIK++ + + +R
Sbjct: 54 GDSTFTVLK---RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR 110
Query: 89 HEVNLLVKLRHPNIVQFLGAVTERKPLM------LITEYLRGGDLHKYLKEKGALSPSTA 142
E+ L+ + H NI+ L T +K L L+ E + +L + ++ + L
Sbjct: 111 -ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME--LDHERM 166
Query: 143 VNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDV 202
+ G+ +LH+ IIHRDLKP N ++V S LK+ DFGL++
Sbjct: 167 SYLLYQMLCGIKHLHSAG--IIHRDLKPSN-IVVKSDCT-LKILDFGLARTAGTSFM--- 219
Query: 203 YKMTGE--TGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEP 246
MT T YR APEV Y + VD++S I+ EM+ +
Sbjct: 220 --MTPYVVTRYYR--APEVILGMGYKENVDIWSVGCIMGEMVRHKI 261
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-30
Identities = 57/211 (27%), Positives = 95/211 (45%), Gaps = 14/211 (6%)
Query: 43 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 100
D+ +IG+G+FGE+ + T A+K + R F E +++ P
Sbjct: 70 DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 129
Query: 101 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP 160
+VQ A + + L ++ EY+ GGDL + + A + ++ + +H+
Sbjct: 130 WVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMS-NYDVPEKWARFYTAEVVLALDAIHS-- 186
Query: 161 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF 220
IHRD+KP N+LL + HLK+ DFG + + G Y++PEV
Sbjct: 187 MGFIHRDVKPDNMLL--DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTP---DYISPEVL 241
Query: 221 K----HRKYDKKVDVFSFAMILYEMLEGEPP 247
K Y ++ D +S + LYEML G+ P
Sbjct: 242 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-30
Identities = 62/264 (23%), Positives = 117/264 (44%), Gaps = 26/264 (9%)
Query: 50 IGKGSFGEILKAYWR--GTPVAIKRILP--SLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 105
+G+GS+G++ + A+K IL L + + E+ LL +LRH N++Q
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVK-ILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 106 ---LGAVTERKPLMLITEYLRGG--DLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP 160
L ++K + ++ EY G ++ + EK A + + G+ YLH+
Sbjct: 72 VDVLYNEEKQK-MYMVMEYCVCGMQEMLDSVPEKR-FPVCQAHGYFCQLIDGLEYLHS-- 127
Query: 161 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF 220
I+H+D+KP N+LL ++ LK+ G+++ + + D + + GS + PE+
Sbjct: 128 QGIVHKDIKPGNLLL--TTGGTLKISALGVAEALHPFAADDTCRTS--QGSPAFQPPEIA 183
Query: 221 KHRK-YD-KKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEG--HRPFFRAKGFTPE 276
+ KVD++S + LY + G P Y+ + + +G P P
Sbjct: 184 NGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGD----CGPP 239
Query: 277 LRELTEKCWAADMNQRPSFLDILK 300
L +L + + +R S I +
Sbjct: 240 LSDLLKGMLEYEPAKRFSIRQIRQ 263
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-30
Identities = 70/246 (28%), Positives = 115/246 (46%), Gaps = 34/246 (13%)
Query: 19 HFEPKPVPPPLP------NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAI 70
H + +++ P +++ + IG+G++G + AY VAI
Sbjct: 1 HHHHHHMAAAAAAGPEMVRGQVFDVGP---RYTNLSYIGEGAYGMVCSAYDNLNKVRVAI 57
Query: 71 KRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP-----LMLITEYLRGG 125
K+I P + R E+ +L++ RH NI+ + + ++ + +
Sbjct: 58 KKISP-FEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ET 114
Query: 126 DLHKYLKEKGALSPSTAVNFALDIARGMAYLH--NEPNVIIHRDLKPRNVLLVNSSADHL 183
DL+K LK LS F I RG+ Y+H N ++HRDLKP N LL+N++ D L
Sbjct: 115 DLYKLLK-TQHLSNDHICYFLYQILRGLKYIHSAN----VLHRDLKPSN-LLLNTTCD-L 167
Query: 184 KVGDFGLSKLIKVQNSHDVYKMTGE--TGSYRYMAPEV-FKHRKYDKKVDVFSFAMILYE 240
K+ DFGL+++ + H + +T T YR APE+ + Y K +D++S IL E
Sbjct: 168 KICDFGLARVADPDHDHTGF-LTEYVATRWYR--APEIMLNSKGYTKSIDIWSVGCILAE 224
Query: 241 MLEGEP 246
ML P
Sbjct: 225 MLSNRP 230
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-30
Identities = 54/233 (23%), Positives = 91/233 (39%), Gaps = 31/233 (13%)
Query: 31 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRH 89
+ ++ I GS+G + G PVAIKR+ + D +
Sbjct: 14 IAELHAMQS---PYTVQRFISSGSYGAVCAGVDSEGIPVAIKRV-FNTVSDGRTVNILSD 69
Query: 90 ---------EVNLLVKLRHPNIVQFLGAVTERKP-----LMLITEYLRGGDLHKYLK-EK 134
E+ LL HPNI+ + L L+TE + DL + + ++
Sbjct: 70 SFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQR 128
Query: 135 GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 194
+SP F I G+ LH ++HRDL P N +L+ + D + + DF L++
Sbjct: 129 IVISPQHIQYFMYHILLGLHVLHE--AGVVHRDLHPGN-ILLADNND-ITICDFNLARED 184
Query: 195 KVQNSHDVYKMTGETGSYRYMAPEV-FKHRKYDKKVDVFSFAMILYEMLEGEP 246
T Y APE+ + + + K VD++S ++ EM +
Sbjct: 185 TADA-----NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKA 232
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 4e-30
Identities = 53/182 (29%), Positives = 88/182 (48%), Gaps = 23/182 (12%)
Query: 133 EKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 192
K L+ + ++ +A+GM +L IHRDL RN+LL S + +K+ DFGL++
Sbjct: 186 YKDFLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAARNILL--SEKNVVKICDFGLAR 241
Query: 193 LIKVQNSHDVYKMTGETG-SYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPP--- 247
I Y G+ ++MAPE R Y + DV+SF ++L+E+ G P
Sbjct: 242 DI---YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 298
Query: 248 -LANYEPYEAAKYVAEGHR---PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLE 303
+ E + + EG R P TPE+ + CW + +QRP+F ++++ L
Sbjct: 299 VKIDEEFC---RRLKEGTRMRAP----DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 351
Query: 304 KI 305
+
Sbjct: 352 NL 353
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 86.5 bits (214), Expect = 2e-19
Identities = 41/161 (25%), Positives = 67/161 (41%), Gaps = 20/161 (12%)
Query: 29 LPNKCD-WEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDD 80
LP WE L +G+G+FG++++A G VA+K + +
Sbjct: 10 LPYDASKWEFPRDRLKLGK--PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 67
Query: 81 RLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERK-PLMLITEYLRGGDLHKYLKEKGALS 138
+ E+ +L+ + H N+V LGA T+ PLM+I E+ + G+L YL+ K
Sbjct: 68 --EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK-RNE 124
Query: 139 PSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS 179
+G Y+ I DLK R + +S
Sbjct: 125 FVPYKTKGARFRQGKDYVGA-----IPVDLKRRLDSITSSQ 160
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-29
Identities = 73/330 (22%), Positives = 113/330 (34%), Gaps = 58/330 (17%)
Query: 15 QNGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKR 72
Q H KP DW+I + +IG GS+G + +AY + VAIK+
Sbjct: 29 QRKQHHSSKPTASMPRPHSDWQIPD---RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKK 85
Query: 73 ILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL-----GAVTERKPLMLITEYLRGGDL 127
IL D + R E+ +L +L H ++V+ L V + L ++ E D
Sbjct: 86 ILRVFEDLIDCKRILR-EIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDF 143
Query: 128 HKYLKEKGALSPSTAVNFALDIARGMAYLH--NEPNVIIHRDLKPRNVLLVNSSADHLKV 185
K + L+ ++ G+ Y+H I+HRDLKP N LVN +KV
Sbjct: 144 KKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAG----ILHRDLKPAN-CLVNQDCS-VKV 197
Query: 186 GDFGLSKLIKVQNSHDVYKMTGETGSYR-----------------------YMAPEV-FK 221
DFGL++ + + + Y APE+
Sbjct: 198 CDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILL 257
Query: 222 HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELT 281
Y + +DV+S I E+L Y P F P +
Sbjct: 258 QENYTEAIDVWSIGCIFAELLNMIKENVAYHA---------DRGPLFPGSSCFPLSPDQK 308
Query: 282 EKCWAADMNQRPSFLDILKRLEKIKETLPT 311
+ + +L I L T
Sbjct: 309 AG-----NDFKFHTRGNRDQLNVIFNILGT 333
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-29
Identities = 64/306 (20%), Positives = 107/306 (34%), Gaps = 56/306 (18%)
Query: 34 DWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEV 91
+ + ++ +IG+GS+G + AY + VAIK++ D + R E+
Sbjct: 21 NVHVPD---NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILR-EI 76
Query: 92 NLLVKLRHPNIVQFLGAVT-----ERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFA 146
+L +L+ I++ + + L ++ E DL K K L+
Sbjct: 77 TILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTIL 135
Query: 147 LDIARGMAYLH--NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK 204
++ G ++H IIHRDLKP N L+N +KV DFGL++ I + ++
Sbjct: 136 YNLLLGENFIHESG----IIHRDLKPAN-CLLNQDCS-VKVCDFGLARTINSEKDTNIVN 189
Query: 205 MTGETGSYR------------------YMAPEV-FKHRKYDKKVDVFSFAMILYEMLEGE 245
E Y APE+ Y K +D++S I E+L
Sbjct: 190 DLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNML 249
Query: 246 PPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKI 305
N P F P + K + +L I
Sbjct: 250 QSHINDPT---------NRFPLFPGSSCFPLSPDRNSK--------KVHEKSNRDQLNII 292
Query: 306 KETLPT 311
+ T
Sbjct: 293 FNIIGT 298
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-29
Identities = 66/215 (30%), Positives = 104/215 (48%), Gaps = 38/215 (17%)
Query: 50 IGKGSFGEILKAYWRGT--PVAIKRI-------LPSLSDDRLVIQDFRHEVNLLVKLRHP 100
+G G++ + K + T VA+K + PS + R E++L+ +L+H
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTA--------IR-EISLMKELKHE 63
Query: 101 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE------KGALSPSTAVNFALDIARGMA 154
NIV+ + L L+ E++ DL KY+ L + F + +G+A
Sbjct: 64 NIVRLYDVIHTENKLTLVFEFM-DNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLA 122
Query: 155 YLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGE--TGSY 212
+ H N I+HRDLKP+N LL+N LK+GDFGL++ + V + E T Y
Sbjct: 123 FCHE--NKILHRDLKPQN-LLINKRG-QLKLGDFGLARAFGIP----VNTFSSEVVTLWY 174
Query: 213 RYMAPEV-FKHRKYDKKVDVFSFAMILYEMLEGEP 246
R AP+V R Y +D++S IL EM+ G+P
Sbjct: 175 R--APDVLMGSRTYSTSIDIWSCGCILAEMITGKP 207
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 3e-29
Identities = 66/225 (29%), Positives = 108/225 (48%), Gaps = 26/225 (11%)
Query: 31 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFR 88
NK WE+ + + + +G G++G + A+ G VA+K++ + +R
Sbjct: 21 NKTIWEVPE---RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 77
Query: 89 HEVNLLVKLRHPNIVQFLGAVTERKPLM------LITEYLRGGDLHKYLKEKGALSPSTA 142
E+ LL ++H N++ L T + L L+T + G DL+ +K + L+
Sbjct: 78 -ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ-KLTDDHV 134
Query: 143 VNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDV 202
I RG+ Y+H+ IIHRDLKP N L VN + LK+ DFGL++ +
Sbjct: 135 QFLIYQILRGLKYIHSAD--IIHRDLKPSN-LAVNEDCE-LKILDFGLARHTADE----- 185
Query: 203 YKMTGETGSYRYMAPEV-FKHRKYDKKVDVFSFAMILYEMLEGEP 246
MTG + Y APE+ Y++ VD++S I+ E+L G
Sbjct: 186 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 228
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 5e-29
Identities = 71/236 (30%), Positives = 108/236 (45%), Gaps = 33/236 (13%)
Query: 29 LPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQD 86
+P + + I DF +++G+G++G + A + G VAIK+I P ++
Sbjct: 1 MPKRIVYNISS---DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP-FDKPLFALRT 56
Query: 87 FRHEVNLLVKLRHPNIVQFLGAVT-----ERKPLMLITEYLRGGDLHKYLKEKGALSPST 141
R E+ +L +H NI+ + +I E + DLH+ + + LS
Sbjct: 57 LR-EIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVISTQ-MLSDDH 113
Query: 142 AVNFALDIARGMAYLH--NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI----- 194
F R + LH N +IHRDLKP N LL+NS+ D LKV DFGL+++I
Sbjct: 114 IQYFIYQTLRAVKVLHGSN----VIHRDLKPSN-LLINSNCD-LKVCDFGLARIIDESAA 167
Query: 195 -KVQNSHDVYKMTGE--TGSYRYMAPEV-FKHRKYDKKVDVFSFAMILYEMLEGEP 246
+ + M T YR APEV KY + +DV+S IL E+ P
Sbjct: 168 DNSEPTGQQSGMVEFVATRWYR--APEVMLTSAKYSRAMDVWSCGCILAELFLRRP 221
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 9e-29
Identities = 58/211 (27%), Positives = 93/211 (44%), Gaps = 22/211 (10%)
Query: 50 IGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 107
IG+G+FGE+ KA R T VA+K++L + I R E+ +L L+H N+V +
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQLLKHENVVNLIE 83
Query: 108 AVTERKP--------LMLITEYLRGGDLHKYLKEKGA-LSPSTAVNFALDIARGMAYLHN 158
+ + L+ ++ DL L + S + G+ Y+H
Sbjct: 84 ICRTKASPYNRCKGSIYLVFDFCE-HDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR 142
Query: 159 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGE--TGSYRYMA 216
N I+HRD+K NVL+ LK+ DFGL++ + + + T T YR
Sbjct: 143 --NKILHRDMKAANVLITRDG--VLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYR--P 196
Query: 217 PEV-FKHRKYDKKVDVFSFAMILYEMLEGEP 246
PE+ R Y +D++ I+ EM P
Sbjct: 197 PELLLGERDYGPPIDLWGAGCIMAEMWTRSP 227
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-28
Identities = 56/246 (22%), Positives = 102/246 (41%), Gaps = 67/246 (27%)
Query: 49 IIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRH---EVNLLVKLRHPNIV 103
+G GSFG + + + G A+K++L QD R+ E++++ L H NI+
Sbjct: 14 TLGTGSFGIVCEVFDIESGKRFALKKVL----------QDPRYKNRELDIMKVLDHVNII 63
Query: 104 QFL--------------------------------------GAVTERKPLMLITEYLRGG 125
+ + ++ K L +I EY+
Sbjct: 64 KLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV-PD 122
Query: 126 DLHK----YLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD 181
LHK +++ ++ + + + R + ++H+ I HRD+KP+N LLVNS +
Sbjct: 123 TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS--LGICHRDIKPQN-LLVNSKDN 179
Query: 182 HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV-FKHRKYDKKVDVFSFAMILYE 240
LK+ DFG +K + S Y APE+ +Y +D++S + E
Sbjct: 180 TLKLCDFGSAKKLIPSEP-----SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGE 234
Query: 241 MLEGEP 246
++ G+P
Sbjct: 235 LILGKP 240
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-28
Identities = 47/224 (20%), Positives = 97/224 (43%), Gaps = 26/224 (11%)
Query: 31 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFR 88
+ +W D+ +G+G + E+ +A V +K + P + ++ R
Sbjct: 28 HVVEWGNQD---DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-VKKKKI----KR 79
Query: 89 HEVNLLVKLR-HPNIVQFLGAVT--ERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNF 145
E+ +L LR PNI+ V + L+ E++ D + + L+ +
Sbjct: 80 -EIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ---TLTDYDIRFY 135
Query: 146 ALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKM 205
+I + + Y H+ I+HRD+KP N ++++ L++ D+GL++ H +
Sbjct: 136 MYEILKALDYCHS--MGIMHRDVKPHN-VMIDHEHRKLRLIDWGLAEFY-----HPGQEY 187
Query: 206 TGETGSYRYMAPEV-FKHRKYDKKVDVFSFAMILYEMLEGEPPL 248
S + PE+ ++ YD +D++S +L M+ + P
Sbjct: 188 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 1e-27
Identities = 66/212 (31%), Positives = 105/212 (49%), Gaps = 28/212 (13%)
Query: 50 IGKGSFGEILKAYWR---GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR---HPNIV 103
IG+G++G++ KA G VA+KR+ ++ + + R EV +L L HPN+V
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR-EVAVLRHLETFEHPNVV 77
Query: 104 QFLGAVTERKP-----LMLITEYLRGGDLHKYLKEKGA--LSPSTAVNFALDIARGMAYL 156
+ T + L L+ E++ DL YL + + T + + RG+ +L
Sbjct: 78 RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 136
Query: 157 HNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGE--TGSYRY 214
H+ + ++HRDLKP+N +LV SS +K+ DFGL+++ Q +T T YR
Sbjct: 137 HS--HRVVHRDLKPQN-ILVTSSG-QIKLADFGLARIYSFQM-----ALTSVVVTLWYR- 186
Query: 215 MAPEVFKHRKYDKKVDVFSFAMILYEMLEGEP 246
APEV Y VD++S I EM +P
Sbjct: 187 -APEVLLQSSYATPVDLWSVGCIFAEMFRRKP 217
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-27
Identities = 67/214 (31%), Positives = 96/214 (44%), Gaps = 30/214 (14%)
Query: 50 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLV---IQDFRHEVNLLVKLR---HPN 101
IG G++G + KA G VA+K + I R EV LL +L HPN
Sbjct: 17 IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVR-EVALLRRLEAFEHPN 75
Query: 102 IVQFLGAVTERKP-----LMLITEYLRGGDLHKYLKEKGA--LSPSTAVNFALDIARGMA 154
+V+ + + + L+ E++ DL YL + L T + RG+
Sbjct: 76 VVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLD 134
Query: 155 YLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGE--TGSY 212
+LH N I+HRDLKP N +LV S +K+ DFGL+++ Q +T T Y
Sbjct: 135 FLHA--NCIVHRDLKPEN-ILVTSGG-TVKLADFGLARIYSYQM-----ALTPVVVTLWY 185
Query: 213 RYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEP 246
R APEV Y VD++S I EM +P
Sbjct: 186 R--APEVLLQSTYATPVDMWSVGCIFAEMFRRKP 217
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-27
Identities = 62/222 (27%), Positives = 105/222 (47%), Gaps = 32/222 (14%)
Query: 43 DFSSSAIIGKGSFGEIL---KAYWRGTPV--AIKRILPSLSDDRLVIQ--DFRH---EVN 92
+F ++G G++G++ K T A+K L +V + H E
Sbjct: 55 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMK----VLKKATIVQKAKTTEHTRTERQ 110
Query: 93 LLVKLRH-PNIVQFLGAV-TERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIA 150
+L +R P +V A TE K L LI +Y+ GG+L +L ++ + + +I
Sbjct: 111 VLEHIRQSPFLVTLHYAFQTETK-LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIV 169
Query: 151 RGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVYKMTGET 209
+ +LH II+RD+K N+LL ++ H+ + DFGLSK + D +
Sbjct: 170 LALEHLHK--LGIIYRDIKLENILL---DSNGHVVLTDFGLSK----EFVADETERAY-D 219
Query: 210 --GSYRYMAPEVFKHRK--YDKKVDVFSFAMILYEMLEGEPP 247
G+ YMAP++ + +DK VD +S +++YE+L G P
Sbjct: 220 FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-26
Identities = 62/240 (25%), Positives = 104/240 (43%), Gaps = 37/240 (15%)
Query: 32 KCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRH 89
+ D + + +GKG++G + K+ R G VA+K+I + + + FR
Sbjct: 2 RVDRHVLR---KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR- 57
Query: 90 EVNLLVKLR-HPNIVQFLGAVT--ERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFA 146
E+ +L +L H NIV L + + + L+ +Y+ DLH ++ L P
Sbjct: 58 EIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYM-ETDLHAVIRAN-ILEPVHKQYVV 115
Query: 147 LDIARGMAYLH--NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK 204
+ + + YLH ++HRD+KP N +L+N+ +KV DFGLS+
Sbjct: 116 YQLIKVIKYLHSGG----LLHRDMKPSN-ILLNAECH-VKVADFGLSRSFVNIRRVTNNI 169
Query: 205 MTGETGSYR-----------------YMAPEV-FKHRKYDKKVDVFSFAMILYEMLEGEP 246
+ Y APE+ KY K +D++S IL E+L G+P
Sbjct: 170 PLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKP 229
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-26
Identities = 56/221 (25%), Positives = 93/221 (42%), Gaps = 39/221 (17%)
Query: 50 IGKGSFGEILKAYWR----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 105
+G+G++G + KA + A+K+I + + R E+ LL +L+HPN++
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQI----EGTGISMSACR-EIALLRELKHPNVISL 83
Query: 106 LGAVTER--KPLMLITEYLRGGDLHKYLKEKGA---------LSPSTAVNFALDIARGMA 154
+ + L+ +Y DL +K A L + I G+
Sbjct: 84 QKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 142
Query: 155 YLHNEPNVIIHRDLKPRNVLLVNSSADH---LKVGDFGLSKLIKVQNSHDVYKMTGETGS 211
YLH N ++HRDLKP N +LV +K+ D G ++L + +
Sbjct: 143 YLHA--NWVLHRDLKPAN-ILVMGEGPERGRVKIADMGFARLFNS----PLKPLADLDPV 195
Query: 212 -----YRYMAPEV-FKHRKYDKKVDVFSFAMILYEMLEGEP 246
YR APE+ R Y K +D+++ I E+L EP
Sbjct: 196 VVTFWYR--APELLLGARHYTKAIDIWAIGCIFAELLTSEP 234
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-24
Identities = 65/217 (29%), Positives = 98/217 (45%), Gaps = 40/217 (18%)
Query: 48 AIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVI---QDFRH----EVNLLVKLR 98
+IGKGSFG+++KAY VA+K ++ + F E+ +L LR
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALK-----------MVRNEKRFHRQAAEEIRILEHLR 151
Query: 99 H------PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE---KGALSPSTAVNFALDI 149
N++ L T R + + E L +L++ +K+ +G S FA I
Sbjct: 152 KQDKDNTMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQG-FSLPLVRKFAHSI 209
Query: 150 ARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET 209
+ + LH N IIH DLKP N+LL +KV DFG S ++ ++
Sbjct: 210 LQCLDALHK--NRIIHCDLKPENILLKQQGRSGIKVIDFGSS-------CYEHQRVYTYI 260
Query: 210 GSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEP 246
S Y APEV +Y +D++S IL E+L G P
Sbjct: 261 QSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYP 297
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 6e-24
Identities = 67/216 (31%), Positives = 96/216 (44%), Gaps = 36/216 (16%)
Query: 48 AIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVI---QDFRH----EVNLLVKLR 98
++IGKGSFG+++KAY R VAIK +I + F + EV LL +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIK-----------IIKNKKAFLNQAQIEVRLLELMN 108
Query: 99 HP------NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIA 150
IV R L L+ E L +L+ L+ +S + FA +
Sbjct: 109 KHDTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMC 167
Query: 151 RGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETG 210
+ +L IIH DLKP N+LL N +K+ DFG S ++ Y ++
Sbjct: 168 TALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS--CQLGQRIYQYI---QSR 222
Query: 211 SYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEP 246
YR +PEV YD +D++S IL EM GEP
Sbjct: 223 FYR--SPEVLLGMPYDLAIDMWSLGCILVEMHTGEP 256
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 7e-21
Identities = 46/222 (20%), Positives = 84/222 (37%), Gaps = 36/222 (16%)
Query: 48 AIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR------- 98
+G G F + A T VA+K I+ + E+ LL ++
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMK-IVRGDKVYT---EAAEDEIKLLQRVNDADNTKE 80
Query: 99 ----HPNIVQFLGAVTERKPLM----LITEYLRGGDLHKYLK--EKGALSPSTAVNFALD 148
+I++ L + P ++ E L G +L +K E + +
Sbjct: 81 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQ 139
Query: 149 IARGMAYLHNEPNVIIHRDLKPRNVLL----VNSSADHLKVGDFGLSKLIKVQNSHDVYK 204
+ G+ Y+H IIH D+KP NVL+ + +K+ D G +
Sbjct: 140 LLLGLDYMHRRCG-IIHTDIKPENVLMEIVDSPENLIQIKIADLGNA-------CWYDEH 191
Query: 205 MTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEP 246
T + Y +PEV + D++S A +++E++ G+
Sbjct: 192 YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDF 233
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 4e-18
Identities = 54/231 (23%), Positives = 85/231 (36%), Gaps = 50/231 (21%)
Query: 48 AIIGKGSFGEILKAYWRGT---PVAIKRILPSLSDDRLVIQDFRH----EVNLLVKLRHP 100
+G+G+FG++++ VA+K I+ + + + E+ +L L
Sbjct: 20 DTLGEGAFGKVVECIDHKAGGRHVAVK-IVKN-------VDRYCEAARSEIQVLEHLNTT 71
Query: 101 ------NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARG 152
VQ L + ++ E L G + ++KE G A I +
Sbjct: 72 DPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKS 130
Query: 153 MAYLHNEPNVIIHRDLKPRNVLLVNSSADH-----------------LKVGDFGLSKLIK 195
+ +LH+ N + H DLKP N+L V S +KV DFG +
Sbjct: 131 VNFLHS--NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA--TY 186
Query: 196 VQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEP 246
H T YR APEV + + DV+S IL E G
Sbjct: 187 DDEHHSTLV---STRHYR--APEVILALGWSQPCDVWSIGCILIEYYLGFT 232
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 5e-18
Identities = 51/231 (22%), Positives = 88/231 (38%), Gaps = 50/231 (21%)
Query: 48 AIIGKGSFGEILKAYWRGT---PVAIKRILPSLSDDRLVIQDFRH----EVNLLVKLRHP 100
+G+G+FG++++ VA+K I+ + + +R E+N+L K++
Sbjct: 25 GNLGEGTFGKVVECLDHARGKSQVALK-IIRN-------VGKYREAARLEINVLKKIKEK 76
Query: 101 ------NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARG 152
V + + E L G + ++LKE + A +
Sbjct: 77 DKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHA 135
Query: 153 MAYLHNEPNVIIHRDLKPRNVLLVNSSADH-----------------LKVGDFGLSKLIK 195
+ +LH N + H DLKP N+L VNS + ++V DFG +
Sbjct: 136 LRFLHE--NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA---- 189
Query: 196 VQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEP 246
+ + T YR PEV + + DV+S IL+E G
Sbjct: 190 TFDHEHHTTIV-ATRHYR--PPEVILELGWAQPCDVWSIGCILFEYYRGFT 237
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 1e-17
Identities = 51/235 (21%), Positives = 90/235 (38%), Gaps = 54/235 (22%)
Query: 48 AIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRH----EVNLLVKLRH-- 99
+G G+FG +L A+K ++ + I+ + E ++L K+++
Sbjct: 41 RKMGDGTFGRVLLCQHIDNKKYYAVK-VVRN-------IKKYTRSAKIEADILKKIQNDD 92
Query: 100 ---PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMA 154
NIV++ G + LI E L G L++ + + ++I + +
Sbjct: 93 INNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALN 151
Query: 155 YLHNEPNVIIHRDLKPRNVLLVNSSADH-----------------------LKVGDFGLS 191
YL + H DLKP N+LL + + +K+ DFG +
Sbjct: 152 YLRK--MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA 209
Query: 192 KLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEP 246
+ H T YR APEV + +D D++SF +L E+ G
Sbjct: 210 --TFKSDYHGSII---NTRQYR--APEVILNLGWDVSSDMWSFGCVLAELYTGSL 257
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 5e-13
Identities = 43/186 (23%), Positives = 70/186 (37%), Gaps = 23/186 (12%)
Query: 50 IGKGSFGEILKAY--WRGTPVAIKRI------LPSLSD-----DRLVIQDFRHEVNLLVK 96
IG G FG I A+ + A + L R+ +D + +
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104
Query: 97 LRHPNIVQFLG----AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARG 152
L + I F G R ++ E L G DL K + G ST + + +
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDV 163
Query: 153 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKM---TGET 209
+ Y+H N +H D+K N+LL + D + + D+GLS +H Y+ G
Sbjct: 164 LEYIHE--NEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHN 221
Query: 210 GSYRYM 215
G+ +
Sbjct: 222 GTIEFT 227
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 66.8 bits (162), Expect = 9e-13
Identities = 39/210 (18%), Positives = 62/210 (29%), Gaps = 50/210 (23%)
Query: 35 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDD-----RLVIQDFRH 89
+ IG+G FGE+ + TPVAIK I D + ++
Sbjct: 13 FSHCLPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILP 72
Query: 90 EVNLLVKL---------RHPNIVQFLGA--VTERKP------------------------ 114
E+ + +L R + V P
Sbjct: 73 EIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFF 132
Query: 115 ----LMLITEYLRGG-DLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLK 169
L ++ E+ GG DL + + S +TA + + +A HRDL
Sbjct: 133 KDDQLFIVLEFEFGGIDLEQMRTKL--SSLATAKSILHQLTASLAVAEASLR-FEHRDLH 189
Query: 170 PRNVLLVNSSADHLKVGDFGLSKLIKVQNS 199
NVLL K+ K + +
Sbjct: 190 WGNVLL--KKTSLKKLHYTLNGKSSTIPSC 217
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 65.0 bits (158), Expect = 7e-12
Identities = 44/174 (25%), Positives = 69/174 (39%), Gaps = 16/174 (9%)
Query: 50 IGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFL 106
IG GSFGEI VAIK +L +E + L+ I
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQL-----LYESKIYRILQGGTGIPNVR 69
Query: 107 GAVTERKPLMLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIH 165
E +L+ + L G L LS T + A + + ++H+ +H
Sbjct: 70 WFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS--KSFLH 126
Query: 166 RDLKPRNVLL-VNSSADHLKVGDFGLSKLIKVQNSHDVYKMT---GETGSYRYM 215
RD+KP N L+ + A+ + + DFGL+K + ++H TG+ RY
Sbjct: 127 RDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 7e-12
Identities = 26/189 (13%), Positives = 55/189 (29%), Gaps = 26/189 (13%)
Query: 50 IGKGSFGEI----------LKAYWRGTPVAIK-------RILPSLSDDRLVIQDFRHEVN 92
+ + G + + + ++K R ++
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 93 LLVKLRHPNIVQFLG-AVTERKPLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDI 149
L I +G V + K L+ L G L L K LS + + A +
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRL 168
Query: 150 ARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKM---T 206
+ +LH N +H ++ N+ + + + +G + H Y +
Sbjct: 169 LDALEFLHE--NEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRS 226
Query: 207 GETGSYRYM 215
G ++
Sbjct: 227 PHEGDLEFI 235
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 63.0 bits (153), Expect = 3e-11
Identities = 51/261 (19%), Positives = 89/261 (34%), Gaps = 76/261 (29%)
Query: 50 IGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-----HPN- 101
+G G F + ++ VA+K ++ S + E+ LL +R PN
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYT---ETALDEIRLLKSVRNSDPNDPNR 100
Query: 102 --IVQFLGAVTERKP----LMLITEYLRGGDLHKYLK--EKGALSPSTAVNFALDIARGM 153
+VQ L + ++ E L G L K++ L + +G+
Sbjct: 101 EMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGL 159
Query: 154 AYLHNEPNVIIHRDLKPRNVLLV------------------------------------- 176
YLH + IIH D+KP N+LL
Sbjct: 160 DYLHTKCR-IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAG 218
Query: 177 ----------NSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYD 226
N+ +K+ D G + + + D+ +T YR + EV Y+
Sbjct: 219 NFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDI-----QTRQYR--SLEVLIGSGYN 271
Query: 227 KKVDVFSFAMILYEMLEGEPP 247
D++S A + +E+ G+
Sbjct: 272 TPADIWSTACMAFELATGDYL 292
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 4e-11
Identities = 44/179 (24%), Positives = 66/179 (36%), Gaps = 26/179 (14%)
Query: 50 IGKGSFGEILKAY--WRGTPVAIKR-----ILPSLSDDRLVIQDFRHEVNLLVKLRH-PN 101
IG GSFG+I G VAIK P L E + ++
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQL----------HIESKIYKMMQGGVG 66
Query: 102 IVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEP 160
I E +++ E L G L S T + A + + Y+H+
Sbjct: 67 IPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS-- 123
Query: 161 NVIIHRDLKPRNVLL-VNSSADHLKVGDFGLSKLIKVQNSHDVYKMT---GETGSYRYM 215
IHRD+KP N L+ + + + + DFGL+K + +H TG+ RY
Sbjct: 124 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 182
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 9e-11
Identities = 43/176 (24%), Positives = 66/176 (37%), Gaps = 18/176 (10%)
Query: 50 IGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH-PNIVQFL 106
IG G+FGE+ + VAIK L + E +L I Q
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIK-----LEPMKSRAPQLHLEYRFYKQLGSGDGIPQVY 71
Query: 107 GAVTERKPLMLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIH 165
K ++ E L G L S T + A+ + M Y+H++ +I+
Sbjct: 72 YFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSK--NLIY 128
Query: 166 RDLKPRNVLL---VNSSADHLKVGDFGLSKLIKVQNSHDVYKMT---GETGSYRYM 215
RD+KP N L+ N + + + DF L+K + TG+ RYM
Sbjct: 129 RDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYM 184
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 60.6 bits (147), Expect = 1e-10
Identities = 39/196 (19%), Positives = 66/196 (33%), Gaps = 40/196 (20%)
Query: 50 IGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 102
IG+G FG I A P +K + + L E+ + P
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVK--VEPSDNGPL-----FTELKFYQRAAKPEQ 95
Query: 103 VQFLGAVTERKPL-------------------MLITEYLRGGDLHKYLKEKG-ALSPSTA 142
+Q + K L +I + G DL K + S T
Sbjct: 96 IQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTV 154
Query: 143 VNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDV 202
+ +L I + Y+H + +H D+K N+LL + D + + D+GL+ + H
Sbjct: 155 LQLSLRILDILEYIHE--HEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKA 212
Query: 203 YKM---TGETGSYRYM 215
Y G+ +
Sbjct: 213 YAADPKRCHDGTIEFT 228
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 1e-09
Identities = 43/176 (24%), Positives = 65/176 (36%), Gaps = 18/176 (10%)
Query: 50 IGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH-PNIVQFL 106
IG+GSFG I + VAIK R R E L I
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKF-----EPRRSDAPQLRDEYRTYKLLAGCTGIPNVY 72
Query: 107 GAVTERKPLMLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIH 165
E +L+ + L G L L G S T A + + +H +++
Sbjct: 73 YFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE--KSLVY 129
Query: 166 RDLKPRNVLL---VNSSADHLKVGDFGLSKLIKVQNSHDVYKMT---GETGSYRYM 215
RD+KP N L+ + +A+ + V DFG+ K + + +G+ RYM
Sbjct: 130 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 185
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 50.2 bits (119), Expect = 5e-07
Identities = 58/371 (15%), Positives = 106/371 (28%), Gaps = 95/371 (25%)
Query: 17 GSHFEPKPVPPPLPNKCDWEIDP---SELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRI 73
+ P+ V L ++IDP S D SS+ + S L+ + P +
Sbjct: 190 KNCNSPETVLEMLQKLL-YQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKP--YENC 246
Query: 74 LPSLSD--DRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLM-----LITEYLRGGD 126
L L + + F +L+ R + FL A T + +T
Sbjct: 247 LLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSL 306
Query: 127 LHKYLKEKGALSPSTAVN---FALD-IARGMAYLHNEPN--------------------- 161
L KYL + P + L IA + +
Sbjct: 307 LLKYLDCRPQDLPREVLTTNPRRLSIIA---ESIRDGLATWDNWKHVNCDKLTTIIESSL 363
Query: 162 ---------------VIIHRDLK-PRNVLLV-----NSSADHLKVGDFGLSKLIKVQNS- 199
+ P +L + S + V L++ Q
Sbjct: 364 NVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKE 423
Query: 200 -----HDVY-----KMTGETGSYRYMAPEVFKHRKYDK------KVDVFSFAMILYEMLE 243
+Y K+ E +R + + +D +D + ++ I + +
Sbjct: 424 STISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKN 483
Query: 244 GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLE 303
E + E + V R F K +R + N S L+ L++L+
Sbjct: 484 IE----HPERMTLFRMVFLDFR-FLEQK-----IRHDSTAW-----NASGSILNTLQQLK 528
Query: 304 KIKETLPTDHH 314
K + D+
Sbjct: 529 FYKPYI-CDND 538
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 2e-05
Identities = 32/165 (19%), Positives = 56/165 (33%), Gaps = 22/165 (13%)
Query: 35 WEIDPSELDFSS-SAIIGKGSFGEILKAYWRGTPVAIKRIL------PSLSDDRLVIQDF 87
W + +IGKG+ +I + + V IK + L D+ +
Sbjct: 328 WIKEIKGKKRKIPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERL-DENIRKSRT 386
Query: 88 RHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFAL 147
E L ++ I + ++ Y+ G +++ ++ A
Sbjct: 387 AREARYLALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIEDN--------LDIAY 438
Query: 148 DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 192
I + LH N +IH DL N + L + DFGL K
Sbjct: 439 KIGEIVGKLHK--NDVIHNDLTTSNFIF----DKDLYIIDFGLGK 477
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 320 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.9 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.82 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.73 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.47 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.27 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.21 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.01 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.92 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.76 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.73 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.64 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.44 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.35 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.34 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.21 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 98.19 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.14 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 98.1 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.79 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.62 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.59 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.58 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.57 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.47 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.33 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.28 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.23 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.05 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.82 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.66 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.6 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 92.9 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 92.39 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-58 Score=400.56 Aligned_cols=252 Identities=25% Similarity=0.434 Sum_probs=223.6
Q ss_pred cccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEE
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 119 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 119 (320)
.+|.+++.||+|+||+||++.+. ++.||+|++.+.........+.+.+|++++++++||||+++++++++++.+|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 47999999999999999999986 8899999986543322333478999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCc
Q 020888 120 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 199 (320)
Q Consensus 120 e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~ 199 (320)
||++||+|.+++++.+.+++..+..++.||+.||+|||++| |+||||||+||++ +.++.+||+|||+++.+.....
T Consensus 112 Ey~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDlKPeNILl--~~~g~vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILL--NEDMHIQITDFGTAKVLSPESK 187 (311)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--CTTSCEEECCCTTCEECCTTTT
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEE--cCCCCEEEEEcCCceecCCCCC
Confidence 99999999999999889999999999999999999999999 9999999999999 8899999999999987654322
Q ss_pred cceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHH
Q 020888 200 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRE 279 (320)
Q Consensus 200 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 279 (320)
.......+||+.|+|||++.+..++.++|+|||||++|+|++|..||...+..+....+....... +..+++++++
T Consensus 188 --~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~--p~~~s~~~~d 263 (311)
T 4aw0_A 188 --QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDF--PEKFFPKARD 263 (311)
T ss_dssp --CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC--CTTCCHHHHH
T ss_pred --cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC--CcccCHHHHH
Confidence 123445689999999999999999999999999999999999999999988888888887766432 3568999999
Q ss_pred HHHHHhhcCCCCCCCHHHHHHH
Q 020888 280 LTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 280 li~~~l~~dp~~Rps~~~ll~~ 301 (320)
||.+||..||++|||++|++.+
T Consensus 264 li~~lL~~dp~~R~t~~e~~~~ 285 (311)
T 4aw0_A 264 LVEKLLVLDATKRLGCEEMEGY 285 (311)
T ss_dssp HHHHHSCSSGGGSTTSGGGTCH
T ss_pred HHHHHccCCHhHCcChHHHcCC
Confidence 9999999999999999987544
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-57 Score=399.69 Aligned_cols=250 Identities=25% Similarity=0.469 Sum_probs=216.7
Q ss_pred cccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEE
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 119 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 119 (320)
.+|++++.||+|+||+||++.+. ++.||+|++....... ...+.+.+|++++++++||||+++++++.+++.+|+||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSS-KEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCH-HHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 37999999999999999999986 8899999987655443 34578999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccccccc
Q 020888 120 EYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 197 (320)
Q Consensus 120 e~~~~~~L~~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~ 197 (320)
||++||+|.+++..+ ..+++..++.++.||+.||.|||++| |+||||||+|||+ +.++.+||+|||+++.+...
T Consensus 103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl--~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFL--TKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CEETTCCGGGEEE--CTTCCEEECSTTEESCCCHH
T ss_pred eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEE--CCCCCEEEcccccceeecCC
Confidence 999999999999754 35799999999999999999999999 9999999999999 88999999999999866432
Q ss_pred CccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHH
Q 020888 198 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPEL 277 (320)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 277 (320)
.. .....+||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+..+..+.. +..+++++
T Consensus 179 ~~----~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~-~~~~s~~~ 253 (350)
T 4b9d_A 179 VE----LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPV-SLHYSYDL 253 (350)
T ss_dssp HH----HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC-CTTSCHHH
T ss_pred cc----cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCC-CccCCHHH
Confidence 11 12345799999999999999999999999999999999999999999998888888888776544 34589999
Q ss_pred HHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 278 RELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 278 ~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
++||.+||+.||.+|||+++++++
T Consensus 254 ~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 254 RSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHccCChhHCcCHHHHhcC
Confidence 999999999999999999999875
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-57 Score=384.37 Aligned_cols=248 Identities=29% Similarity=0.496 Sum_probs=206.7
Q ss_pred cccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEE
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 119 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 119 (320)
.+|++.+.||+|+||+||++.+. ++.||+|++.+...........+.+|+++++.++||||+++++++.+.+.+|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 37999999999999999999975 8899999997765555444578999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCc
Q 020888 120 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 199 (320)
Q Consensus 120 e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~ 199 (320)
||+ +|+|.+++.+++++++..+..++.||+.||+|||++| |+||||||+||++ +.++.+||+|||+++......
T Consensus 93 Ey~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDiKP~NILl--~~~~~vkl~DFGla~~~~~~~- 166 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK--IVHRDLKPENLLL--DEHLNVKIADFGLSNIMTDGN- 166 (275)
T ss_dssp ECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEE--CTTCCEEECCSSCC--------
T ss_pred eCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCChHHeEE--CCCCCEEEeecCCCeecCCCC-
Confidence 999 6799999998889999999999999999999999999 9999999999999 888999999999997654332
Q ss_pred cceeeccCCcccccccCccccCcCCC-CCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHH
Q 020888 200 HDVYKMTGETGSYRYMAPEVFKHRKY-DKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 278 (320)
Q Consensus 200 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 278 (320)
.....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...+.......+..+.... +..++++++
T Consensus 167 ----~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~--p~~~s~~~~ 240 (275)
T 3hyh_A 167 ----FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTL--PKFLSPGAA 240 (275)
T ss_dssp ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC--CTTSCHHHH
T ss_pred ----ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCC--CCCCCHHHH
Confidence 2334679999999999998876 579999999999999999999999988888777777765432 356899999
Q ss_pred HHHHHHhhcCCCCCCCHHHHHHH
Q 020888 279 ELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 279 ~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
++|.+||+.||++|||++|++++
T Consensus 241 ~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 241 GLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHHC
T ss_pred HHHHHHccCChhHCcCHHHHHcC
Confidence 99999999999999999999986
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-57 Score=394.87 Aligned_cols=261 Identities=25% Similarity=0.352 Sum_probs=222.3
Q ss_pred CCCCcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCce
Q 020888 38 DPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL 115 (320)
Q Consensus 38 ~~~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 115 (320)
......|.+.+.||+|+||+||++.++ ++.||+|++..... ..+|+++++.++||||+++++++.+++.+
T Consensus 54 ~~~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~--------~~~E~~il~~l~HpnIV~l~~~~~~~~~~ 125 (336)
T 4g3f_A 54 REEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF--------RVEELVACAGLSSPRIVPLYGAVREGPWV 125 (336)
T ss_dssp CBTTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--------CTHHHHTTTTCCCTTBCCEEEEEEETTEE
T ss_pred hcchhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh--------HHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 334457888999999999999999986 88999999865432 23599999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCC-cEEEecCCCcccc
Q 020888 116 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD-HLKVGDFGLSKLI 194 (320)
Q Consensus 116 ~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~-~~~L~dfg~~~~~ 194 (320)
|+||||++||+|.+++++.+++++..+..++.|++.||.|||++| |+||||||+||++ +.++ .+||+|||+++.+
T Consensus 126 ~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl--~~~g~~vKl~DFGla~~~ 201 (336)
T 4g3f_A 126 NIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR--ILHGDVKADNVLL--SSDGSRAALCDFGHALCL 201 (336)
T ss_dssp EEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCCGGGEEE--CTTSCCEEECCCTTCEEC
T ss_pred EEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEE--eCCCCEEEEeeCCCCeEc
Confidence 999999999999999998889999999999999999999999999 9999999999999 7776 6999999999877
Q ss_pred cccCccce-eeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCC-CCCCC
Q 020888 195 KVQNSHDV-YKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPF-FRAKG 272 (320)
Q Consensus 195 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~ 272 (320)
........ ......+||+.|+|||++.+..++.++|||||||++|+|++|..||......+....+.....+. ..+..
T Consensus 202 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 281 (336)
T 4g3f_A 202 QPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPS 281 (336)
T ss_dssp ------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTT
T ss_pred cCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCcc
Confidence 54332211 12234579999999999999999999999999999999999999999877766666666655432 23456
Q ss_pred CCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcCC
Q 020888 273 FTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLP 310 (320)
Q Consensus 273 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~ 310 (320)
++++++++|.+||..||.+|||+.|++++|........
T Consensus 282 ~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~ 319 (336)
T 4g3f_A 282 CAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVG 319 (336)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred CCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhh
Confidence 89999999999999999999999999999998877654
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-56 Score=393.10 Aligned_cols=248 Identities=26% Similarity=0.468 Sum_probs=220.9
Q ss_pred cccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEE
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 119 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 119 (320)
..|.+.+.||+|+||+||+|.++ ++.||+|++........ +.+.+|+++++.++||||+++++++.+++.+|+||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~---~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm 150 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRR---ELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 150 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSG---GGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHH---HHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 46999999999999999999986 88999999865443332 56789999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCc
Q 020888 120 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 199 (320)
Q Consensus 120 e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~ 199 (320)
||++||+|.+++.. +++++..+..++.||+.||+|||++| |+||||||+|||+ +.++.+||+|||++..+.....
T Consensus 151 Ey~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl--~~~g~vKl~DFGla~~~~~~~~ 225 (346)
T 4fih_A 151 EFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILL--THDGRVKLSDFGFCAQVSKEVP 225 (346)
T ss_dssp CCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--CTTCCEEECCCTTCEECCSSSC
T ss_pred eCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEE--CCCCCEEEecCcCceecCCCCC
Confidence 99999999999976 57999999999999999999999999 9999999999999 8899999999999987654321
Q ss_pred cceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCC-CCCCCHHHH
Q 020888 200 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR-AKGFTPELR 278 (320)
Q Consensus 200 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~ 278 (320)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+.....+... ...++++++
T Consensus 226 ----~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~ 301 (346)
T 4fih_A 226 ----RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLK 301 (346)
T ss_dssp ----CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHH
T ss_pred ----cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHH
Confidence 234568999999999999999999999999999999999999999999888888878776544332 346899999
Q ss_pred HHHHHHhhcCCCCCCCHHHHHHH
Q 020888 279 ELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 279 ~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
+||.+||..||++|||++|+++|
T Consensus 302 dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 302 GFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHHHcCCChhHCcCHHHHhcC
Confidence 99999999999999999999886
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-56 Score=383.63 Aligned_cols=269 Identities=32% Similarity=0.546 Sum_probs=219.8
Q ss_pred CCCCcCCCCCcccCccceecccCceEEEEEEECCCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEe
Q 020888 32 KCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE 111 (320)
Q Consensus 32 ~~~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 111 (320)
...|+++. .++.+.+.||+|+||+||++.+.+ .+|+|++..... ..+..+.+.+|++++++++||||+++++++.+
T Consensus 28 ~~~Wei~~--~~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~ 103 (307)
T 3omv_A 28 SYYWEIEA--SEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDP-TPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK 103 (307)
T ss_dssp -CCCBCCT--TSCCEEEECCCCSSSEEEEEESSS-EEEEEECCCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred CcCcEEcH--HHeEEeeEEeeCCCcEEEEEEECC-cEEEEEEEecCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC
Confidence 34677775 467788999999999999998654 599998865433 34456889999999999999999999998765
Q ss_pred CCceEEEEecCCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCC
Q 020888 112 RKPLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGL 190 (320)
Q Consensus 112 ~~~~~iv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~ 190 (320)
+.+++||||++||+|.+++... +++++..+..++.|++.||.|||++| |+||||||+||++ +.++.+||+|||+
T Consensus 104 -~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~--IiHRDlKp~NILl--~~~~~~Ki~DFGl 178 (307)
T 3omv_A 104 -DNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKN--IIHRDMKSNNIFL--HEGLTVKIGDFGL 178 (307)
T ss_dssp -SSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCSSSEEE--ETTEEEEECCCSS
T ss_pred -CeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCccCHHHEEE--CCCCcEEEeeccC
Confidence 5689999999999999999764 57999999999999999999999988 9999999999999 8889999999999
Q ss_pred cccccccCccceeeccCCcccccccCccccCc---CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHhCCCC
Q 020888 191 SKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH---RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAK-YVAEGHRP 266 (320)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~-~~~~~~~~ 266 (320)
++....... .......+||+.|+|||++.+ ..++.++|||||||++|||+||+.||...+...... .+..+...
T Consensus 179 a~~~~~~~~--~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~ 256 (307)
T 3omv_A 179 ATVKSRWSG--SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYAS 256 (307)
T ss_dssp CBC--------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCC
T ss_pred ceecccCCc--ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCC
Confidence 986543221 112344679999999999864 358999999999999999999999999876654443 34444332
Q ss_pred C---CCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcCCC
Q 020888 267 F---FRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPT 311 (320)
Q Consensus 267 ~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~ 311 (320)
+ ..+..+++++++++.+||+.||++|||+.+++++|+.++..+++
T Consensus 257 p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lpk 304 (307)
T 3omv_A 257 PDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPK 304 (307)
T ss_dssp CCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCCC
T ss_pred CCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCCC
Confidence 2 22356899999999999999999999999999999999988765
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-56 Score=386.14 Aligned_cols=260 Identities=29% Similarity=0.512 Sum_probs=226.8
Q ss_pred cccCccceecccCceEEEEEEEC-------CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCc
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP 114 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~-------~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 114 (320)
.+|.+.+.||+|+||+||++.+. +..||+|.+... .....+.+.+|++++++++||||+++++++.+++.
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~ 89 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP 89 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE
Confidence 47889999999999999999863 567999988643 34455789999999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHHHHh-------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCC
Q 020888 115 LMLITEYLRGGDLHKYLKEK-------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD 181 (320)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~~-------------~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~ 181 (320)
.|+||||+++|+|.+++... ..+++..++.++.|++.||.|||+++ |+||||||+||++ +.++
T Consensus 90 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDlKp~NILl--~~~~ 165 (299)
T 4asz_A 90 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLV--GENL 165 (299)
T ss_dssp EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE--CGGG
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccCHhhEEE--CCCC
Confidence 99999999999999999753 25999999999999999999999988 9999999999999 8889
Q ss_pred cEEEecCCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 020888 182 HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYV 260 (320)
Q Consensus 182 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~ 260 (320)
.+||+|||+++....... ........+|+.|+|||++.+..++.++|||||||++|||+| |+.||...+..+....+
T Consensus 166 ~~Ki~DFGla~~~~~~~~--~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i 243 (299)
T 4asz_A 166 LVKIGDFGMSRDVYSTDY--YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI 243 (299)
T ss_dssp CEEECCCSCHHHHTGGGC--EEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH
T ss_pred cEEECCcccceecCCCCc--eeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 999999999986644321 112233468999999999999999999999999999999999 99999999999988888
Q ss_pred HhCCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcCCC
Q 020888 261 AEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPT 311 (320)
Q Consensus 261 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~ 311 (320)
..+..+.. +..+|+++.+++.+||+.||++|||++++.+.|+.+....+.
T Consensus 244 ~~~~~~~~-p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~p~ 293 (299)
T 4asz_A 244 TQGRVLQR-PRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKASPV 293 (299)
T ss_dssp HHTCCCCC-CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCC
T ss_pred HcCCCCCC-CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCCc
Confidence 88776543 456899999999999999999999999999999999887654
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-56 Score=382.47 Aligned_cols=251 Identities=30% Similarity=0.500 Sum_probs=213.1
Q ss_pred CcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEe----CCc
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE----RKP 114 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~ 114 (320)
++.|...+.||+|+||+||+|.+. ++.||+|.+....... ...+.+.+|++++++++||||+++++++.. ++.
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~ 103 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEE
T ss_pred CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCH-HHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcE
Confidence 333467788999999999999986 7889999886654443 345789999999999999999999999865 355
Q ss_pred eEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCC-CCcEEEecCCCccc
Q 020888 115 LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS-ADHLKVGDFGLSKL 193 (320)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~-~~~~~L~dfg~~~~ 193 (320)
+|+||||++||+|.+++.+.+.+++..+..++.||+.||.|||++|.+|+||||||+|||+ +. ++.+||+|||+++.
T Consensus 104 ~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl--~~~~g~vKl~DFGla~~ 181 (290)
T 3fpq_A 104 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFI--TGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEE--SSTTSCEEECCTTGGGG
T ss_pred EEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeE--ECCCCCEEEEeCcCCEe
Confidence 8999999999999999999889999999999999999999999986669999999999999 64 68999999999975
Q ss_pred ccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHhCCCCCCCCCC
Q 020888 194 IKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEP-YEAAKYVAEGHRPFFRAKG 272 (320)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~ 272 (320)
.... .....+||+.|+|||++.+ .++.++|||||||++|+|+||..||..... ......+..+..+...+..
T Consensus 182 ~~~~------~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~ 254 (290)
T 3fpq_A 182 KRAS------FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKV 254 (290)
T ss_dssp CCTT------SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGC
T ss_pred CCCC------ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCcc
Confidence 3321 2234679999999999875 599999999999999999999999987554 4455555555555555566
Q ss_pred CCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 273 FTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 273 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
+++++++||.+||..||++|||++++++|
T Consensus 255 ~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 255 AIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp CCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 78999999999999999999999999875
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-55 Score=385.43 Aligned_cols=260 Identities=32% Similarity=0.557 Sum_probs=220.7
Q ss_pred CcccCccceecccCceEEEEEEEC-------CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCC
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK 113 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~-------~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 113 (320)
..+|.+.+.||+|+||+||++.+. ++.||||.+... .....+.+.+|++++++++||||+++++++.+.+
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~ 116 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQHQHIVRFFGVCTEGR 116 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 357888899999999999999863 567999998543 3445578999999999999999999999999999
Q ss_pred ceEEEEecCCCCCHHHHHHHh---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeC
Q 020888 114 PLMLITEYLRGGDLHKYLKEK---------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS 178 (320)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~---------------~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~ 178 (320)
.+|+||||+++|+|.+++... +++++..++.++.|++.||.|||+++ |+||||||+||++ +
T Consensus 117 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLKp~NILl--~ 192 (329)
T 4aoj_A 117 PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLV--G 192 (329)
T ss_dssp SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE--E
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHhhEEE--C
Confidence 999999999999999998753 35899999999999999999999988 9999999999999 8
Q ss_pred CCCcEEEecCCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 020888 179 SADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAA 257 (320)
Q Consensus 179 ~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~ 257 (320)
.++.+||+|||+++.+..... ........+|+.|+|||++.+..++.++|||||||++|||+| |+.||...+..+..
T Consensus 193 ~~~~~Ki~DFGla~~~~~~~~--~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~ 270 (329)
T 4aoj_A 193 QGLVVKIGDFGMSRDIYSTDY--YRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAI 270 (329)
T ss_dssp TTTEEEECCCC------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHH
T ss_pred CCCcEEEcccccceeccCCCc--ceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 899999999999986644321 112234568999999999999999999999999999999999 99999999998888
Q ss_pred HHHHhCCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcCC
Q 020888 258 KYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLP 310 (320)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~ 310 (320)
..+..+..+.. +..+++++.+++.+||+.||++|||+.+++++|+.+.+..+
T Consensus 271 ~~i~~g~~~~~-p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~pp 322 (329)
T 4aoj_A 271 DCITQGRELER-PRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPP 322 (329)
T ss_dssp HHHHHTCCCCC-CTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSCC
T ss_pred HHHHcCCCCCC-cccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCCc
Confidence 88888765543 45689999999999999999999999999999999987643
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-55 Score=395.02 Aligned_cols=248 Identities=26% Similarity=0.464 Sum_probs=221.4
Q ss_pred cccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEE
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 119 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 119 (320)
..|.+.+.||+|+||+||+|.+. ++.||+|++........ +.+.+|+++++.++||||+++++++..++.+|+||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~---~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVm 227 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRR---ELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 227 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSG---GGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHH---HHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEE
Confidence 46999999999999999999986 88999999865544333 56889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCc
Q 020888 120 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 199 (320)
Q Consensus 120 e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~ 199 (320)
|||+||+|.+++.. +.+++..+..++.||+.||+|||++| |+||||||+|||+ +.+|.+||+|||++..+.....
T Consensus 228 Ey~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~--IiHRDiKp~NILl--~~~g~vKl~DFGla~~~~~~~~ 302 (423)
T 4fie_A 228 EFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILL--THDGRVKLSDFGFCAQVSKEVP 302 (423)
T ss_dssp ECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSTTTEEE--CTTCCEEECCCTTCEECCSSCC
T ss_pred eCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEE--cCCCCEEEecCccceECCCCCc
Confidence 99999999999976 57999999999999999999999999 9999999999999 8899999999999987654321
Q ss_pred cceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCC-CCCCCCHHHH
Q 020888 200 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFF-RAKGFTPELR 278 (320)
Q Consensus 200 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~ 278 (320)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+.....+.. ....++++++
T Consensus 303 ----~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~ 378 (423)
T 4fie_A 303 ----RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLK 378 (423)
T ss_dssp ----CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHH
T ss_pred ----cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHH
Confidence 23456899999999999999999999999999999999999999999988888888877654433 2356899999
Q ss_pred HHHHHHhhcCCCCCCCHHHHHHH
Q 020888 279 ELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 279 ~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
+||.+||..||++|||++|+++|
T Consensus 379 dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 379 GFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHHHcCCChhHCcCHHHHhcC
Confidence 99999999999999999999886
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-56 Score=387.05 Aligned_cols=249 Identities=29% Similarity=0.430 Sum_probs=212.8
Q ss_pred cccCccceecccCceEEEEEEEC-----CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceE
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLM 116 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~-----~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 116 (320)
.+|++++.||+|+||+||+|.+. ++.||+|++.+....... ...+.+|++++++++||||+++++++.+++.+|
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~-~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 102 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD-RVRTKMERDILVEVNHPFIVKLHYAFQTEGKLY 102 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEE-CC------CCCCCCCCTTEECEEEEEEETTEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHH-HHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence 58999999999999999999872 577999998654332222 146778999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccc
Q 020888 117 LITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 196 (320)
Q Consensus 117 iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~ 196 (320)
+||||++||+|.+++.+.+.+++..+..++.|++.||+|||++| |+||||||+||++ +.++.+||+|||+++....
T Consensus 103 ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl--~~~g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 103 LILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILL--DEEGHIKLTDFGLSKESID 178 (304)
T ss_dssp EEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEE--CTTSCEEEESSEEEEC---
T ss_pred EEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHeEE--cCCCCEEecccccceeccC
Confidence 99999999999999999889999999999999999999999999 9999999999999 8899999999999986543
Q ss_pred cCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHH
Q 020888 197 QNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPE 276 (320)
Q Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (320)
... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+....... +..++++
T Consensus 179 ~~~----~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~--p~~~s~~ 252 (304)
T 3ubd_A 179 HEK----KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGM--PQFLSPE 252 (304)
T ss_dssp --C----CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC--CTTSCHH
T ss_pred CCc----cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCC--CCcCCHH
Confidence 321 2345689999999999999999999999999999999999999999999888888887766443 4568999
Q ss_pred HHHHHHHHhhcCCCCCCC-----HHHHHHH
Q 020888 277 LRELTEKCWAADMNQRPS-----FLDILKR 301 (320)
Q Consensus 277 l~~li~~~l~~dp~~Rps-----~~~ll~~ 301 (320)
+++||.+||+.||++||| ++|+++|
T Consensus 253 ~~~li~~~L~~dP~~R~ta~~~~~~eil~H 282 (304)
T 3ubd_A 253 AQSLLRMLFKRNPANRLGAGPDGVEEIKRH 282 (304)
T ss_dssp HHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred HHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence 999999999999999998 5788775
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-55 Score=379.82 Aligned_cols=255 Identities=29% Similarity=0.504 Sum_probs=221.2
Q ss_pred cccCccceecccCceEEEEEEEC-------CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCc
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP 114 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~-------~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 114 (320)
.++.+.+.||+|+||+||++... ++.||||.+...... ...+.+.+|+.++++++||||+++++++..++.
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~--~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~ 103 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEG--PLREEFRHEAMLRARLQHPNVVCLLGVVTKDQP 103 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccCh--HHHHHHHHHHHHHHhCCCCCCCCcceEEEECCE
Confidence 35667789999999999999862 578999998654332 223789999999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHHHHh----------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeC
Q 020888 115 LMLITEYLRGGDLHKYLKEK----------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS 178 (320)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~~----------------~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~ 178 (320)
+++||||+++|+|.+++..+ ..+++..++.++.|++.||.|||+++ |+||||||+||++ +
T Consensus 104 ~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLK~~NILl--~ 179 (308)
T 4gt4_A 104 LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVLV--Y 179 (308)
T ss_dssp CEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE--C
T ss_pred EEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCccccceEE--C
Confidence 99999999999999999642 35899999999999999999999998 9999999999999 8
Q ss_pred CCCcEEEecCCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 020888 179 SADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAA 257 (320)
Q Consensus 179 ~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~ 257 (320)
.++.+||+|||+++.+..... ........||+.|+|||++.+..++.++|||||||++|||+| |..||.+.+..+..
T Consensus 180 ~~~~~Ki~DFGlar~~~~~~~--~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~ 257 (308)
T 4gt4_A 180 DKLNVKISDLGLFREVYAADY--YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVV 257 (308)
T ss_dssp GGGCEEECCSCCBCGGGGGGC--BCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHH
T ss_pred CCCCEEECCcccceeccCCCc--eeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 889999999999987654321 122344678999999999999999999999999999999998 89999999998888
Q ss_pred HHHHhCCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHH
Q 020888 258 KYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKI 305 (320)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~ 305 (320)
..+..+..++. +..+|+++.+++.+||+.||.+|||+.+++++|+.+
T Consensus 258 ~~i~~~~~~~~-p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 258 EMIRNRQVLPC-PDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHHHTTCCCCC-CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHHcCCCCCC-cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 88887765543 456899999999999999999999999999999753
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-53 Score=377.94 Aligned_cols=265 Identities=30% Similarity=0.549 Sum_probs=221.8
Q ss_pred CCcCCCCCcccCccceecccCceEEEEEEECC-------CceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCC-Ccccce
Q 020888 34 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH-PNIVQF 105 (320)
Q Consensus 34 ~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~-------~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~ 105 (320)
.|+++. .+|.+.+.||+|+||+||+|.+.+ +.||+|.+..... ....+.+.+|+++++++.| |||+++
T Consensus 58 ~wEi~~--~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~--~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 58 KWEFPR--DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp HHBCCG--GGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccEecH--HHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccC--hHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 455553 578999999999999999998753 4699998865432 3345789999999999965 899999
Q ss_pred eeeEEe-CCceEEEEecCCCCCHHHHHHHh----------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 020888 106 LGAVTE-RKPLMLITEYLRGGDLHKYLKEK----------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDL 168 (320)
Q Consensus 106 ~~~~~~-~~~~~iv~e~~~~~~L~~~~~~~----------------~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di 168 (320)
++++.. ++.+++|||||++|+|.++++.. ..+++..+..++.|++.||.|||+++ |+||||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~--iiHRDL 211 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDL 211 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC--eecCcc
Confidence 999865 45689999999999999999752 34899999999999999999999998 999999
Q ss_pred CCCcEEEeeCCCCcEEEecCCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCC
Q 020888 169 KPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPP 247 (320)
Q Consensus 169 ~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p 247 (320)
||+||++ +.++.+||+|||+++.+..... ........+|+.|+|||++.+..++.++|||||||++|||+| |..|
T Consensus 212 K~~NILl--~~~~~vKi~DFGlar~~~~~~~--~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~P 287 (353)
T 4ase_A 212 AARNILL--SEKNVVKICDFGLARDIYKDPD--YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 287 (353)
T ss_dssp SGGGEEE--CGGGCEEECCCGGGSCTTTCTT--SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred Cccceee--CCCCCEEECcchhhhhcccCCC--ceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCC
Confidence 9999999 8889999999999987654322 222344568999999999999999999999999999999998 9999
Q ss_pred CCCCChH-HHHHHHHhCCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcC
Q 020888 248 LANYEPY-EAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETL 309 (320)
Q Consensus 248 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 309 (320)
|.+.... .....+..+..+. .+..+++++.+++.+||+.||++|||+.+++++|+.+.+..
T Consensus 288 f~~~~~~~~~~~~i~~g~~~~-~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~ 349 (353)
T 4ase_A 288 YPGVKIDEEFCRRLKEGTRMR-APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 349 (353)
T ss_dssp STTCCCSHHHHHHHHHTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred CCCCCHHHHHHHHHHcCCCCC-CCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence 9887644 4455555655444 34568999999999999999999999999999999987643
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-52 Score=374.06 Aligned_cols=254 Identities=24% Similarity=0.378 Sum_probs=212.3
Q ss_pred cccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEe------CC
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE------RK 113 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~ 113 (320)
.+|.+++.||+|+||+||+|.+. ++.||+|++....... ...+.+.+|+++|+.++||||+++++++.. .+
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVV-TNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSH-HHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccch-HHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 47999999999999999999986 8899999987654433 334778899999999999999999998753 46
Q ss_pred ceEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccc
Q 020888 114 PLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 193 (320)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~ 193 (320)
.+|+||||++ |+|.+++...+++++..+..++.||+.||.|||++| |+||||||+||++ +.++.+||+|||+++.
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NIl~--~~~~~~Ki~DFGla~~ 207 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQ--VIHRDLKPSNLLV--NENCELKIGDFGMARG 207 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEE--CTTCCEEECCCTTCBC
T ss_pred EEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc--CcCCCcCcccccc--CCCCCEEEeecceeee
Confidence 7899999996 589999988889999999999999999999999999 9999999999999 8899999999999987
Q ss_pred ccccCccceeeccCCcccccccCccccCcC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCC-----
Q 020888 194 IKVQNSHDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPF----- 267 (320)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~----- 267 (320)
+..............+||+.|+|||++.+. .++.++||||+||++|+|++|..||.+.+..+....+......+
T Consensus 208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~ 287 (398)
T 4b99_A 208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVI 287 (398)
T ss_dssp C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGT
T ss_pred cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHh
Confidence 755443333345567899999999998875 56899999999999999999999999888777665554321110
Q ss_pred -----------------CC-------CCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 268 -----------------FR-------AKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 268 -----------------~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
.. ...+++++.+||.+||..||.+|||++|+|+|
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 288 QAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp C-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred hhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00 12468999999999999999999999999987
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-52 Score=363.33 Aligned_cols=249 Identities=29% Similarity=0.493 Sum_probs=192.7
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCC-------
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK------- 113 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------- 113 (320)
+|++++.||+|+||+||+|.++ ++.||+|.+.... .....+.+.+|++++++++||||+++++++.+.+
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 6899999999999999999986 8899999886543 3344578899999999999999999999986544
Q ss_pred -----ceEEEEecCCCCCHHHHHHHhCC---CCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEE
Q 020888 114 -----PLMLITEYLRGGDLHKYLKEKGA---LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKV 185 (320)
Q Consensus 114 -----~~~iv~e~~~~~~L~~~~~~~~~---l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L 185 (320)
..|+||||++||+|.++++..+. .++..++.++.||+.||+|||++| |+||||||+||++ +.++.+||
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~--IiHRDlKp~NILl--~~~~~vKl 159 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG--LMHRDLKPSNIFF--TMDDVVKV 159 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE--CTTCCEEE
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc--CccccCcHHHeEE--CCCCcEEE
Confidence 36999999999999999987544 456778999999999999999999 9999999999999 88899999
Q ss_pred ecCCCcccccccCccce--------eeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-hHHH
Q 020888 186 GDFGLSKLIKVQNSHDV--------YKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYE-PYEA 256 (320)
Q Consensus 186 ~dfg~~~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~-~~~~ 256 (320)
+|||+++.+........ ......+||+.|+|||++.+..++.++|||||||++|+|++ ||.... ....
T Consensus 160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~ 236 (299)
T 4g31_A 160 GDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRT 236 (299)
T ss_dssp CCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHH
T ss_pred ccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHH
Confidence 99999987754332211 12234579999999999999999999999999999999996 776432 2222
Q ss_pred HHHHHhCCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 257 AKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
...+.....+.. ....++.++++|.+||+.||.+|||+.+++++
T Consensus 237 ~~~~~~~~~p~~-~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 237 LTDVRNLKFPPL-FTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp HHHHHTTCCCHH-HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHhcCCCCCC-CcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 333333333322 12346678899999999999999999999875
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-52 Score=362.53 Aligned_cols=259 Identities=28% Similarity=0.419 Sum_probs=201.3
Q ss_pred cccCccceecccCceEEEEEEECCCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCC----ceEE
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK----PLML 117 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~i 117 (320)
++|.+.+.||+|+||+||++.++++.||||++.... ........|+..+.+++||||+++++++..++ .+|+
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~----~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~l 78 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc----hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEE
Confidence 468888999999999999999999999999885431 11123345666667889999999999997654 4799
Q ss_pred EEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcC--------CCCeEecCCCCCcEEEeeCCCCcEEEecCC
Q 020888 118 ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE--------PNVIIHRDLKPRNVLLVNSSADHLKVGDFG 189 (320)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~--------g~~ivH~di~p~nI~~~~~~~~~~~L~dfg 189 (320)
||||+++|+|.++++.. ++++..+..++.|++.||.|||++ + |+||||||+||++ +.++.+||+|||
T Consensus 79 V~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~--IiHRDlKp~NILl--~~~~~~Ki~DFG 153 (303)
T 3hmm_A 79 VSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA--IAHRDLKSKNILV--KKNGTCCIADLG 153 (303)
T ss_dssp EEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCC--EECSCCCGGGEEE--CTTSCEEECCCT
T ss_pred EecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC--EeeccCCcccEEE--CCCCCEEEEeCC
Confidence 99999999999999864 689999999999999999999986 6 9999999999999 899999999999
Q ss_pred CcccccccCccceeeccCCcccccccCccccCcC------CCCCchhHHHHHHHHHHHHhCCCCCC----------CC--
Q 020888 190 LSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR------KYDKKVDVFSFAMILYEMLEGEPPLA----------NY-- 251 (320)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~~l~~ll~g~~p~~----------~~-- 251 (320)
+++.................||+.|+|||++.+. .++.++|||||||++|||+||..||. ..
T Consensus 154 la~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~ 233 (303)
T 3hmm_A 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233 (303)
T ss_dssp TCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred CCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccc
Confidence 9987765433222233445799999999998765 35679999999999999999976543 21
Q ss_pred ---ChHHHHHHHHhCCC-CCCCC----CCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcC
Q 020888 252 ---EPYEAAKYVAEGHR-PFFRA----KGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETL 309 (320)
Q Consensus 252 ---~~~~~~~~~~~~~~-~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 309 (320)
........+..... +.... ...++.+.+++.+||+.||++|||+.++++.|+++.++.
T Consensus 234 ~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~ 299 (303)
T 3hmm_A 234 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred ccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHc
Confidence 11223333333322 22211 113457899999999999999999999999999998753
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=352.41 Aligned_cols=249 Identities=19% Similarity=0.286 Sum_probs=198.5
Q ss_pred CcccCccceecccCceEEEEEEEC-----CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcccceeeeEEeCCc
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKP 114 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~-----~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 114 (320)
..+|.+.+.||+|+||+||+|.++ ++.||+|.+..... ..++.+|+++++.+ +||||+++++++...+.
T Consensus 20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~-----~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~ 94 (361)
T 4f9c_A 20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH-----PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH 94 (361)
T ss_dssp GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC-----HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC-----HHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence 357999999999999999999863 56799998855321 25678899999998 69999999999999999
Q ss_pred eEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCC-CcEEEecCCCccc
Q 020888 115 LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSA-DHLKVGDFGLSKL 193 (320)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~-~~~~L~dfg~~~~ 193 (320)
+|+||||++|++|.++++ .+++..+..++.||+.||+|||++| |+||||||+||++ +.+ +.++|+|||+++.
T Consensus 95 ~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~g--IiHRDiKPeNiLl--~~~~~~~kl~DFGla~~ 167 (361)
T 4f9c_A 95 VVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFG--IVHRDVKPSNFLY--NRRLKKYALVDFGLAQG 167 (361)
T ss_dssp EEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--ETTTTEEEECCCTTCEE
T ss_pred EEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCcCCHHHeEE--eCCCCeEEECcCCCCcc
Confidence 999999999999999984 5899999999999999999999999 9999999999999 554 7999999999976
Q ss_pred ccccCcc------------------------ceeeccCCcccccccCccccCcC-CCCCchhHHHHHHHHHHHHhCCCCC
Q 020888 194 IKVQNSH------------------------DVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPL 248 (320)
Q Consensus 194 ~~~~~~~------------------------~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~ 248 (320)
....... ........+||+.|+|||++.+. .++.++||||+||++|+|++|+.||
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf 247 (361)
T 4f9c_A 168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF 247 (361)
T ss_dssp CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence 5432111 00112345799999999999775 5899999999999999999999999
Q ss_pred CCCCh-HHHHHHHHh----------------------------------------------------CCCCCCCCCCCCH
Q 020888 249 ANYEP-YEAAKYVAE----------------------------------------------------GHRPFFRAKGFTP 275 (320)
Q Consensus 249 ~~~~~-~~~~~~~~~----------------------------------------------------~~~~~~~~~~~~~ 275 (320)
...+. .+....+.. ..........+++
T Consensus 248 ~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~ 327 (361)
T 4f9c_A 248 YKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPD 327 (361)
T ss_dssp SCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCH
T ss_pred CCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCH
Confidence 65432 222211110 0000011235789
Q ss_pred HHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 276 ELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 276 ~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
++++||++||..||.+|+|++|+++|
T Consensus 328 ~a~DLl~~lL~~dP~~R~ta~eaL~H 353 (361)
T 4f9c_A 328 EAYDLLDKLLDLNPASRITAEEALLH 353 (361)
T ss_dssp HHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred HHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 99999999999999999999999876
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-50 Score=374.99 Aligned_cols=250 Identities=24% Similarity=0.437 Sum_probs=220.2
Q ss_pred cccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEE
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 119 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 119 (320)
.+|.+.+.||+|+||+||+|.++ ++.||+|.+.... ....+.+.+|+++|+.++||||+++++++.+.+.+|+||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~---~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~ 233 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 233 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc---hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 47999999999999999999986 8899999886543 233467889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccC
Q 020888 120 EYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 198 (320)
Q Consensus 120 e~~~~~~L~~~~~~-~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~ 198 (320)
||++||+|.+++.. .+.+++..+..++.||+.||.|||++| |+|+||||+||++..+..+.+||+|||+++.+....
T Consensus 234 E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~ 311 (573)
T 3uto_A 234 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311 (573)
T ss_dssp ECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred eecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence 99999999999864 467999999999999999999999999 999999999999954456899999999998775432
Q ss_pred ccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCC--CCCCCCCHH
Q 020888 199 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPF--FRAKGFTPE 276 (320)
Q Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 276 (320)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+....... .....++++
T Consensus 312 -----~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 386 (573)
T 3uto_A 312 -----SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISED 386 (573)
T ss_dssp -----EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHH
T ss_pred -----ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHH
Confidence 2234579999999999999999999999999999999999999999999888888877765332 223568999
Q ss_pred HHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 277 LRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 277 l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
+++||.+||..||.+|||++|+++|
T Consensus 387 ~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 387 GKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHccCChhHCcCHHHHhcC
Confidence 9999999999999999999999985
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=342.43 Aligned_cols=268 Identities=34% Similarity=0.590 Sum_probs=222.8
Q ss_pred CCCCcccCccceecccCceEEEEEEECCCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEE
Q 020888 38 DPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLML 117 (320)
Q Consensus 38 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 117 (320)
+....+|.+.+.||+|+||+||++.++++.+|+|++...... ....+.+.+|++++++++|+||+++++++...+..++
T Consensus 33 ~i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 3p86_A 33 DIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFH-AERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSI 111 (309)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCS-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEE
T ss_pred cCChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEE
Confidence 334568999999999999999999999999999988665433 4445788999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccc
Q 020888 118 ITEYLRGGDLHKYLKEKG---ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 194 (320)
Q Consensus 118 v~e~~~~~~L~~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~ 194 (320)
||||+++++|.+++...+ .+++..++.++.|++.||.|||+.|.+++|+||||+||++ +.++.++|+|||++...
T Consensus 112 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll--~~~~~~kL~Dfg~a~~~ 189 (309)
T 3p86_A 112 VTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLV--DKKYTVKVCDFGLSRLK 189 (309)
T ss_dssp EEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEE--CTTCCEEECCCC-----
T ss_pred EEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEE--eCCCcEEECCCCCCccc
Confidence 999999999999998654 3899999999999999999999976669999999999999 88899999999998754
Q ss_pred cccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCC
Q 020888 195 KVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFT 274 (320)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (320)
.... .......+++.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+.........+..++
T Consensus 190 ~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (309)
T 3p86_A 190 ASTF----LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLN 265 (309)
T ss_dssp ----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSC
T ss_pred cccc----cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCC
Confidence 3321 122345689999999999999999999999999999999999999999988887777765555555566789
Q ss_pred HHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcCCCC
Q 020888 275 PELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPTD 312 (320)
Q Consensus 275 ~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~ 312 (320)
+++.+++.+||..||.+|||++++++.|+.+..+...+
T Consensus 266 ~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~ 303 (309)
T 3p86_A 266 PQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPP 303 (309)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-----
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999999999998765443
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=373.43 Aligned_cols=252 Identities=29% Similarity=0.442 Sum_probs=211.9
Q ss_pred CCCCcccCccceecccCceEEEEEEEC--CCceEEEEccCCCC---CcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeC
Q 020888 38 DPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLS---DDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER 112 (320)
Q Consensus 38 ~~~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 112 (320)
...-.+|.+++.||+|+||+||+|.+. ++.||+|++.+... ..........+++.+++.++||||+++++.+++.
T Consensus 185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~ 264 (689)
T 3v5w_A 185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP 264 (689)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS
T ss_pred CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEEC
Confidence 444568999999999999999999986 88999999864321 1122223334456777788999999999999999
Q ss_pred CceEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcc
Q 020888 113 KPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 192 (320)
Q Consensus 113 ~~~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~ 192 (320)
+.+|+||||++||+|.+++.+.+.+++..+..++.||+.||+|||++| |+||||||+||++ +.+|.+||+|||++.
T Consensus 265 ~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~g--IiHRDLKPeNILl--d~~G~vKL~DFGlA~ 340 (689)
T 3v5w_A 265 DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILL--DEHGHVRISDLGLAC 340 (689)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEE--CTTSCEEECCCTTCE
T ss_pred CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHeEE--eCCCCEEecccceee
Confidence 999999999999999999999899999999999999999999999999 9999999999999 899999999999998
Q ss_pred cccccCccceeeccCCcccccccCccccC-cCCCCCchhHHHHHHHHHHHHhCCCCCCCC---ChHHHHHHHHhCCCCCC
Q 020888 193 LIKVQNSHDVYKMTGETGSYRYMAPEVFK-HRKYDKKVDVFSFAMILYEMLEGEPPLANY---EPYEAAKYVAEGHRPFF 268 (320)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~ll~g~~p~~~~---~~~~~~~~~~~~~~~~~ 268 (320)
.+.... ....+||+.|+|||++. +..++.++|+|||||++|+|++|..||... +..+....+......
T Consensus 341 ~~~~~~------~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~-- 412 (689)
T 3v5w_A 341 DFSKKK------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE-- 412 (689)
T ss_dssp ECSSCC------CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCC--
T ss_pred ecCCCC------CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCC--
Confidence 764332 34568999999999996 457999999999999999999999999753 333444445444433
Q ss_pred CCCCCCHHHHHHHHHHhhcCCCCCCC-----HHHHHHH
Q 020888 269 RAKGFTPELRELTEKCWAADMNQRPS-----FLDILKR 301 (320)
Q Consensus 269 ~~~~~~~~l~~li~~~l~~dp~~Rps-----~~~ll~~ 301 (320)
.+..+++++++||.+||..||.+|++ ++++++|
T Consensus 413 ~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 413 LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp CCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred CCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 24568999999999999999999997 6888876
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-48 Score=339.76 Aligned_cols=249 Identities=31% Similarity=0.494 Sum_probs=221.8
Q ss_pred CcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEE
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 118 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 118 (320)
..+|.+.+.||+|+||.||++.+. ++.||+|++...... ....+.+.+|+++++.++||||+++++++...+..|+|
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLN-PTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 448999999999999999999984 889999998665443 34457888999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccC
Q 020888 119 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 198 (320)
Q Consensus 119 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~ 198 (320)
|||++|++|.+++...+.+++..+..++.|++.||.|||++| ++|+||||+||++ +.++.++|+|||++.......
T Consensus 93 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~NIll--~~~~~~kl~DFG~a~~~~~~~ 168 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR--IVHRDLKAENLLL--DADMNIKIADFGFSNEFTVGG 168 (328)
T ss_dssp ECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE--CTTSCEEECSTTCCGGGSSSC
T ss_pred EECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCCHHHEEE--cCCCCEEEeeccCceecCCCC
Confidence 999999999999988889999999999999999999999998 9999999999999 889999999999997665432
Q ss_pred ccceeeccCCcccccccCccccCcCCCC-CchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHH
Q 020888 199 SHDVYKMTGETGSYRYMAPEVFKHRKYD-KKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPEL 277 (320)
Q Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 277 (320)
.....++|+.|+|||++.+..++ .++||||||+++|+|++|..||...+..+....+..+.... +..+++++
T Consensus 169 -----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~--p~~~s~~~ 241 (328)
T 3fe3_A 169 -----KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRI--PFYMSTDC 241 (328)
T ss_dssp -----GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC--CTTSCHHH
T ss_pred -----ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC--CCCCCHHH
Confidence 23456799999999999888875 79999999999999999999999998888888777765443 34579999
Q ss_pred HHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 278 RELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 278 ~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
.+++.+||..||.+|||+++++++
T Consensus 242 ~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 242 ENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp HHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred HHHHHHHCCCChhHCcCHHHHhcC
Confidence 999999999999999999999886
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=333.46 Aligned_cols=264 Identities=27% Similarity=0.429 Sum_probs=225.1
Q ss_pred CcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEE
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 118 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 118 (320)
..+|.+.+.||+|+||.||++.+. ++.+|+|.+...........+.+.+|+.+++.++||||+++++++..++..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 458999999999999999999976 788999998776666667778999999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccC
Q 020888 119 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 198 (320)
Q Consensus 119 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~ 198 (320)
|||++|++|.+++...+++++..++.++.|++.||.|||++| ++|+||||+||++ +.++.++|+|||++.......
T Consensus 90 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~--~~~~~~kl~Dfg~~~~~~~~~ 165 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR--IVHRDIKPQNILI--DSNKTLKIFDFGIAKALSETS 165 (294)
T ss_dssp EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE--CTTSCEEECCCSSSTTC----
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEE--CCCCCEEEEeCCCcccccccc
Confidence 999999999999998888999999999999999999999999 9999999999999 888999999999998664322
Q ss_pred ccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCC---CCCCCCH
Q 020888 199 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFF---RAKGFTP 275 (320)
Q Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 275 (320)
. .......+|+.|+|||++.+..++.++|+||||+++|+|++|..||......+..........+.. ....+++
T Consensus 166 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (294)
T 4eqm_A 166 L---TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQ 242 (294)
T ss_dssp ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCH
T ss_pred c---cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCH
Confidence 1 122335689999999999999999999999999999999999999998887766555555544332 1345899
Q ss_pred HHHHHHHHHhhcCCCCCC-CHHHHHHHHHHHHhcCCC
Q 020888 276 ELRELTEKCWAADMNQRP-SFLDILKRLEKIKETLPT 311 (320)
Q Consensus 276 ~l~~li~~~l~~dp~~Rp-s~~~ll~~L~~~~~~~~~ 311 (320)
.+.+++.+||..||.+|| +++++++.|..+......
T Consensus 243 ~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~ 279 (294)
T 4eqm_A 243 SLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRA 279 (294)
T ss_dssp HHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSST
T ss_pred HHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccC
Confidence 999999999999999998 999999999887654433
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=337.81 Aligned_cols=268 Identities=32% Similarity=0.533 Sum_probs=227.7
Q ss_pred cCCCCCcccCccceecccCceEEEEEEEC-----CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEE
Q 020888 36 EIDPSELDFSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVT 110 (320)
Q Consensus 36 ~~~~~~~~y~~~~~lg~g~~~~vy~~~~~-----~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 110 (320)
..+....+|.+.+.||+|+||+||++.+. +..||+|.+.... .....+.+.+|+++++.++|+||+++++++.
T Consensus 43 ~~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 120 (325)
T 3kul_A 43 TREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFDHPNIIRLEGVVT 120 (325)
T ss_dssp CCBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred ccccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 34445678999999999999999999984 3459999886543 3344578899999999999999999999999
Q ss_pred eCCceEEEEecCCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCC
Q 020888 111 ERKPLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFG 189 (320)
Q Consensus 111 ~~~~~~iv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg 189 (320)
.++..++||||+++++|.+++... +.+++..++.++.|++.||.|||+.| |+|+||||+||++ +.++.++|+|||
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll--~~~~~~kl~Dfg 196 (325)
T 3kul_A 121 RGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG--YVHRDLAARNVLV--DSNLVCKVSDFG 196 (325)
T ss_dssp GGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--CTTCCEEECCCS
T ss_pred eCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEE--CCCCCEEECCCC
Confidence 999999999999999999999754 57999999999999999999999999 9999999999999 888999999999
Q ss_pred CcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCC
Q 020888 190 LSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFF 268 (320)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~ 268 (320)
++......... ........+++.|+|||++.+..++.++||||||+++|+|++ |..||......+....+........
T Consensus 197 ~a~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~ 275 (325)
T 3kul_A 197 LSRVLEDDPDA-AYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPA 275 (325)
T ss_dssp SCEECC----C-CEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCC
T ss_pred cccccccCccc-eeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCC
Confidence 99876543222 122233456778999999999999999999999999999999 9999999998888887777654443
Q ss_pred CCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcCCC
Q 020888 269 RAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPT 311 (320)
Q Consensus 269 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~ 311 (320)
+..+++++.+++..||..||.+|||+.++++.|+.+......
T Consensus 276 -~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~ 317 (325)
T 3kul_A 276 -PMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPES 317 (325)
T ss_dssp -CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC-
T ss_pred -CCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCccc
Confidence 345899999999999999999999999999999999887654
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=331.27 Aligned_cols=252 Identities=27% Similarity=0.495 Sum_probs=218.2
Q ss_pred CCCCcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCce
Q 020888 38 DPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL 115 (320)
Q Consensus 38 ~~~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 115 (320)
.....+|++.+.||+|+||+||++.+. ++.||+|.+........ +.+.+|+.+++.++||||+++++++..++..
T Consensus 16 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 92 (297)
T 3fxz_A 16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK---ELIINEILVMRENKNPNIVNYLDSYLVGDEL 92 (297)
T ss_dssp SCGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCH---HHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred CChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHH---HHHHHHHHHHhcCCCCCCCeEeEEEEECCEE
Confidence 344568999999999999999999874 78999998865544332 6788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccccc
Q 020888 116 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 195 (320)
Q Consensus 116 ~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~ 195 (320)
++||||++|++|.+++... .+++..+..++.|++.||.|||++| ++|+||||+||++ +.++.++|+|||++....
T Consensus 93 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~--~~~~~~kl~Dfg~~~~~~ 167 (297)
T 3fxz_A 93 WVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILL--GMDGSVKLTDFGFCAQIT 167 (297)
T ss_dssp EEEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--CTTCCEEECCCTTCEECC
T ss_pred EEEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEE--CCCCCEEEeeCCCceecC
Confidence 9999999999999999874 6899999999999999999999999 9999999999999 888999999999987665
Q ss_pred ccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCC-CCCCCCCCCC
Q 020888 196 VQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH-RPFFRAKGFT 274 (320)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 274 (320)
.... ......+++.|+|||++.+..++.++||||||+++|+|++|..||...+.......+.... .....+..++
T Consensus 168 ~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (297)
T 3fxz_A 168 PEQS----KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLS 243 (297)
T ss_dssp STTC----CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSC
T ss_pred Cccc----ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccC
Confidence 4322 2334578999999999999999999999999999999999999999888766655554433 3333345689
Q ss_pred HHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 275 PELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 275 ~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
..+++++.+||+.||++|||+++++++
T Consensus 244 ~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 244 AIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 999999999999999999999999875
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=337.89 Aligned_cols=262 Identities=31% Similarity=0.545 Sum_probs=224.5
Q ss_pred CcccCccceecccCceEEEEEEEC---------CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcccceeeeEE
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR---------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVT 110 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~---------~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 110 (320)
..+|.+.+.||+|+||+||++.+. +..||+|.+... ......+.+.+|+++++.+ +||||+++++++.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 157 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 157 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT--CBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC--cCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc
Confidence 458999999999999999999863 345999988654 2344557899999999999 8999999999999
Q ss_pred eCCceEEEEecCCCCCHHHHHHHhC----------------CCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEE
Q 020888 111 ERKPLMLITEYLRGGDLHKYLKEKG----------------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVL 174 (320)
Q Consensus 111 ~~~~~~iv~e~~~~~~L~~~~~~~~----------------~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~ 174 (320)
..+.+|+||||+++++|.+++.... .+++..++.++.|++.||.|||++| |+|+||||+||+
T Consensus 158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIl 235 (370)
T 2psq_A 158 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVL 235 (370)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEE
T ss_pred cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchhhEE
Confidence 9999999999999999999998643 4789999999999999999999999 999999999999
Q ss_pred EeeCCCCcEEEecCCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCh
Q 020888 175 LVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEP 253 (320)
Q Consensus 175 ~~~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~ 253 (320)
+ +.++.++|+|||++..+...... .......+++.|+|||++.+..++.++||||||+++|+|++ |..||.....
T Consensus 236 l--~~~~~~kl~DFG~a~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~ 311 (370)
T 2psq_A 236 V--TENNVMKIADFGLARDINNIDYY--KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 311 (370)
T ss_dssp E--CTTCCEEECCCSSCEETTCCCTT--CTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred E--CCCCCEEEccccCCcccCcccce--ecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 9 88899999999999866433211 11223456788999999999999999999999999999999 9999999888
Q ss_pred HHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcCCC
Q 020888 254 YEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPT 311 (320)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~ 311 (320)
.+....+..+.... .+..++.++.+++.+||..||.+|||+.+++++|+++......
T Consensus 312 ~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~~ 368 (370)
T 2psq_A 312 EELFKLLKEGHRMD-KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 368 (370)
T ss_dssp GGHHHHHHTTCCCC-CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred HHHHHHHhcCCCCC-CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhcc
Confidence 77777776665443 3456899999999999999999999999999999998876543
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-47 Score=327.72 Aligned_cols=264 Identities=28% Similarity=0.558 Sum_probs=224.8
Q ss_pred CCCCcCCCCCcccCccceecccCceEEEEEEEC-CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEE
Q 020888 32 KCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVT 110 (320)
Q Consensus 32 ~~~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~-~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 110 (320)
...|.+ ...+|.+.+.||+|+||.||++.+. +..||+|.+....... +.+.+|+++++.++|+||+++++++.
T Consensus 16 ~~~~~~--~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~ 89 (283)
T 3gen_A 16 YGSWEI--DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEKLVQLYGVCT 89 (283)
T ss_dssp CCTTBC--CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCH----HHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred CCCccC--CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCH----HHHHHHHHHHhcCCCCCEeeEEEEEe
Confidence 345554 4678999999999999999999887 5579999887544332 56889999999999999999999999
Q ss_pred eCCceEEEEecCCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCC
Q 020888 111 ERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFG 189 (320)
Q Consensus 111 ~~~~~~iv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg 189 (320)
..+..++||||+++++|.+++.. ...+++..++.++.|++.||.|||++| ++|+||||+||++ +.++.++|+|||
T Consensus 90 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nili--~~~~~~kl~Dfg 165 (283)
T 3gen_A 90 KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLV--NDQGVVKVSDFG 165 (283)
T ss_dssp SSSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEE--CTTSCEEECSTT
T ss_pred cCCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCccceEEE--cCCCCEEEcccc
Confidence 99999999999999999999986 457999999999999999999999999 9999999999999 888999999999
Q ss_pred CcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCC
Q 020888 190 LSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFF 268 (320)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~ 268 (320)
.+....... ........+++.|+|||++.+..++.++|+||||+++|+|++ |..||......+....+........
T Consensus 166 ~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~ 242 (283)
T 3gen_A 166 LSRYVLDDE---YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR 242 (283)
T ss_dssp GGGGBCCHH---HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCC
T ss_pred ccccccccc---cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCC
Confidence 987654321 112233456788999999999999999999999999999998 9999999988888777776654433
Q ss_pred CCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcC
Q 020888 269 RAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETL 309 (320)
Q Consensus 269 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 309 (320)
+..+++.+.+++.+||+.||.+|||+++++++|.++.+..
T Consensus 243 -~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~e 282 (283)
T 3gen_A 243 -PHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEE 282 (283)
T ss_dssp -CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred -CCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhcc
Confidence 4557999999999999999999999999999999988653
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=336.58 Aligned_cols=251 Identities=25% Similarity=0.418 Sum_probs=219.2
Q ss_pred CcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEE
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 118 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 118 (320)
..+|.+.+.||+|+||+||++.++ ++.||+|++.+...........+.+|+++++.++||||+++++++...+..|+|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 358999999999999999999986 789999988653221222236788899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccC
Q 020888 119 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 198 (320)
Q Consensus 119 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~ 198 (320)
|||++|++|.+++...+.+++..+..++.||+.||.|||++| |+|+||||+||++ +.++.++|+|||++.......
T Consensus 84 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll--~~~g~vkL~DFG~a~~~~~~~ 159 (337)
T 1o6l_A 84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLML--DKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEE--CTTSCEEECCCTTCBCSCCTT
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCCHHHEEE--CCCCCEEEeeccchhhcccCC
Confidence 999999999999998888999999999999999999999999 9999999999999 889999999999987543222
Q ss_pred ccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHH
Q 020888 199 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 278 (320)
Q Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 278 (320)
. .....+||+.|+|||++.+..++.++|+||||+++|+|++|..||...+.......+...... .+..++++++
T Consensus 160 ~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~--~p~~~s~~~~ 233 (337)
T 1o6l_A 160 A----TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR--FPRTLSPEAK 233 (337)
T ss_dssp C----CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC--CCTTSCHHHH
T ss_pred C----cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC--CCCCCCHHHH
Confidence 1 233457899999999999999999999999999999999999999988887777777665433 2346899999
Q ss_pred HHHHHHhhcCCCCCC-----CHHHHHHH
Q 020888 279 ELTEKCWAADMNQRP-----SFLDILKR 301 (320)
Q Consensus 279 ~li~~~l~~dp~~Rp-----s~~~ll~~ 301 (320)
++|.+||..||.+|| ++++++++
T Consensus 234 ~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 234 SLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp HHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 999999999999999 89999886
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-47 Score=337.76 Aligned_cols=254 Identities=26% Similarity=0.418 Sum_probs=220.1
Q ss_pred CCCcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcH---HHHHHHHHHHHHHHhCCCCcccceeeeEEeCC
Q 020888 39 PSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDR---LVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK 113 (320)
Q Consensus 39 ~~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 113 (320)
.-..+|.+.+.||+|+||+||++.+. ++.+|+|++........ ...+.+.+|+.+++.++||||+++++++...+
T Consensus 9 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 88 (361)
T 2yab_A 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRT 88 (361)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCC
Confidence 33457999999999999999999986 78999999876543221 12367889999999999999999999999999
Q ss_pred ceEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCC----cEEEecCC
Q 020888 114 PLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD----HLKVGDFG 189 (320)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~----~~~L~dfg 189 (320)
.+++||||++|++|.+++...+.+++..+..++.|++.||.|||+.| |+|+||||+||++ +.++ .++|+|||
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll--~~~~~~~~~vkl~DFG 164 (361)
T 2yab_A 89 DVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIML--LDKNIPIPHIKLIDFG 164 (361)
T ss_dssp EEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--SCTTSSSCCEEECCCS
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEE--eCCCCCccCEEEEecC
Confidence 99999999999999999988788999999999999999999999999 9999999999999 5555 79999999
Q ss_pred CcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCC
Q 020888 190 LSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR 269 (320)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 269 (320)
++..+.... ......||+.|+|||++.+..++.++|+||||+++|+|++|..||...+..+....+.........
T Consensus 165 ~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~ 239 (361)
T 2yab_A 165 LAHEIEDGV-----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDE 239 (361)
T ss_dssp SCEECCTTC-----CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCH
T ss_pred CceEcCCCC-----ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCc
Confidence 998765432 223457899999999999999999999999999999999999999998888887777765543221
Q ss_pred --CCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 270 --AKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 270 --~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
...++++++++|.+||..||.+|||+++++++
T Consensus 240 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 240 EFFSQTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 24679999999999999999999999999864
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-47 Score=324.15 Aligned_cols=256 Identities=31% Similarity=0.632 Sum_probs=223.5
Q ss_pred CcccCccceecccCceEEEEEEEC-CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEE
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 119 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~-~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 119 (320)
..+|.+.+.||+|+||.||++.+. ++.+|+|.+....... +.+.+|++++++++|+||+++++++.+.+..++||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF 84 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCH----HHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCH----HHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEE
Confidence 468999999999999999999985 7789999987544332 57889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccC
Q 020888 120 EYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 198 (320)
Q Consensus 120 e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~ 198 (320)
||+++++|.+++... +.+++..++.++.|++.||.+||+.| ++|+||||+||++ +.++.++|+|||++.......
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~--~~~~~~kl~Dfg~~~~~~~~~ 160 (269)
T 4hcu_A 85 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLV--GENQVIKVSDFGMTRFVLDDQ 160 (269)
T ss_dssp ECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE--CGGGCEEECCTTGGGGBCCHH
T ss_pred EeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCC--eecCCcchheEEE--cCCCCEEeccccccccccccc
Confidence 999999999999763 46899999999999999999999999 9999999999999 888899999999987654321
Q ss_pred ccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHH
Q 020888 199 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPEL 277 (320)
Q Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 277 (320)
........+++.|+|||.+.+..++.++|+||||+++|++++ |..||......+....+....... .+..+++++
T Consensus 161 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 236 (269)
T 4hcu_A 161 ---YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY-KPRLASTHV 236 (269)
T ss_dssp ---HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC-CCTTSCHHH
T ss_pred ---cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCC-CCCcCCHHH
Confidence 112233456778999999999999999999999999999999 999999988888887777765443 344579999
Q ss_pred HHHHHHHhhcCCCCCCCHHHHHHHHHHHHhc
Q 020888 278 RELTEKCWAADMNQRPSFLDILKRLEKIKET 308 (320)
Q Consensus 278 ~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 308 (320)
.+++.+||+.||++|||+.+++++|+++.++
T Consensus 237 ~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 237 YQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 9999999999999999999999999998764
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=326.85 Aligned_cols=269 Identities=25% Similarity=0.480 Sum_probs=216.6
Q ss_pred CCCCcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCce
Q 020888 38 DPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL 115 (320)
Q Consensus 38 ~~~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 115 (320)
.....+|.+.+.||+|+||.||++.+. ++.+|+|.+.............+.+|+++++.++|+||+++++++..++..
T Consensus 28 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 107 (310)
T 2wqm_A 28 YNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNEL 107 (310)
T ss_dssp TSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred cccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcE
Confidence 344568999999999999999999974 889999998765555566668899999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCc
Q 020888 116 MLITEYLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 191 (320)
Q Consensus 116 ~iv~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~ 191 (320)
++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.| ++|+||+|+||++ +.++.++|+|||++
T Consensus 108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIl~--~~~~~~kl~Dfg~~ 183 (310)
T 2wqm_A 108 NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFI--TATGVVKLGDLGLG 183 (310)
T ss_dssp EEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE--CTTSCEEECCC---
T ss_pred EEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCcHHHEEE--cCCCCEEEEeccce
Confidence 999999999999999874 356899999999999999999999998 9999999999999 88899999999998
Q ss_pred ccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCC--ChHHHHHHHHhCCCCCCC
Q 020888 192 KLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANY--EPYEAAKYVAEGHRPFFR 269 (320)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~--~~~~~~~~~~~~~~~~~~ 269 (320)
........ ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||... ........+.....+...
T Consensus 184 ~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 259 (310)
T 2wqm_A 184 RFFSSKTT----AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLP 259 (310)
T ss_dssp -------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCC
T ss_pred eeecCCCc----cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCc
Confidence 76543221 122346789999999999999999999999999999999999999754 334445555555555555
Q ss_pred CCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcCCCCCc
Q 020888 270 AKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPTDHH 314 (320)
Q Consensus 270 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~~~ 314 (320)
...+++++++++.+||..||.+|||+.++++.|+++........+
T Consensus 260 ~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~~ 304 (310)
T 2wqm_A 260 SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLE 304 (310)
T ss_dssp TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC----
T ss_pred ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhhh
Confidence 567899999999999999999999999999999999887766543
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-47 Score=324.24 Aligned_cols=259 Identities=30% Similarity=0.592 Sum_probs=223.4
Q ss_pred CCCcccCccceecccCceEEEEEEEC-CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEE
Q 020888 39 PSELDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLML 117 (320)
Q Consensus 39 ~~~~~y~~~~~lg~g~~~~vy~~~~~-~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 117 (320)
....+|.+.+.||+|+||.||++.++ +..+|+|.+....... +.+.+|++++++++|+||+++++++..++..++
T Consensus 5 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (268)
T 3sxs_A 5 LKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE----DEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYI 80 (268)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCH----HHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEE
T ss_pred echhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcH----HHHHHHHHHHHhCCCCCEeeEEEEEccCCceEE
Confidence 34678999999999999999999887 4579999886544332 568899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccc
Q 020888 118 ITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 196 (320)
Q Consensus 118 v~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~ 196 (320)
||||+++++|.+++...+ .+++..++.++.|++.||.+||+.| ++|+||||+||++ +.++.++|+|||.+.....
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~--~~~~~~~l~Dfg~~~~~~~ 156 (268)
T 3sxs_A 81 VTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ--FIHRDLAARNCLV--DRDLCVKVSDFGMTRYVLD 156 (268)
T ss_dssp EEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCSGGGEEE--CTTCCEEECCTTCEEECCT
T ss_pred EEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCcceEEE--CCCCCEEEccCccceecch
Confidence 999999999999998754 5999999999999999999999999 9999999999999 8889999999999876543
Q ss_pred cCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCH
Q 020888 197 QNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTP 275 (320)
Q Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (320)
.. ........+++.|+|||.+.+..++.++|+||||+++|++++ |..||......+....+....... .+..+++
T Consensus 157 ~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 232 (268)
T 3sxs_A 157 DQ---YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLY-RPHLASD 232 (268)
T ss_dssp TC---EEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCC-CCTTSCH
T ss_pred hh---hhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCC-CCCcChH
Confidence 32 122334456778999999999899999999999999999999 999999988887777766655443 3445799
Q ss_pred HHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcC
Q 020888 276 ELRELTEKCWAADMNQRPSFLDILKRLEKIKETL 309 (320)
Q Consensus 276 ~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 309 (320)
++.+++.+||+.||.+|||+.+++++|+.+.++-
T Consensus 233 ~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~ 266 (268)
T 3sxs_A 233 TIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD 266 (268)
T ss_dssp HHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC--
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhcc
Confidence 9999999999999999999999999999886543
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=335.72 Aligned_cols=274 Identities=33% Similarity=0.554 Sum_probs=232.7
Q ss_pred CCCCCCCcCCCCCcccCccceecccCceEEEEEEEC---------CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhC-C
Q 020888 29 LPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR---------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-R 98 (320)
Q Consensus 29 ~~~~~~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~---------~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~ 98 (320)
.+....|.+. ..+|.+.+.||+|+||+||++.+. +..+|+|++.... .......+.+|+++++.+ +
T Consensus 58 ~~~~~~~~i~--~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~ 133 (382)
T 3tt0_A 58 LPEDPRWELP--RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGK 133 (382)
T ss_dssp CCCCTTTBCC--GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCC
T ss_pred cccCcccccc--hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc--CHHHHHHHHHHHHHHHHhcC
Confidence 3343444443 568999999999999999999863 2469999886542 344457889999999999 8
Q ss_pred CCcccceeeeEEeCCceEEEEecCCCCCHHHHHHHhC----------------CCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 020888 99 HPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG----------------ALSPSTAVNFALDIARGMAYLHNEPNV 162 (320)
Q Consensus 99 h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~----------------~l~~~~~~~i~~~l~~~l~~lH~~g~~ 162 (320)
|+||+++++++..++..++||||+++++|.+++.... .+++..++.++.|++.||.|||+.|
T Consensus 134 hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-- 211 (382)
T 3tt0_A 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK-- 211 (382)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred CchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 9999999999999999999999999999999998753 4899999999999999999999998
Q ss_pred eEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHH
Q 020888 163 IIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEML 242 (320)
Q Consensus 163 ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll 242 (320)
|+|+||||+||++ +.++.++|+|||++......... .......+++.|+|||++.+..++.++||||||+++++|+
T Consensus 212 ivH~Dlkp~NIll--~~~~~~kL~DFG~a~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ell 287 (382)
T 3tt0_A 212 CIHRDLAARNVLV--TEDNVMKIADFGLARDIHHIDYY--KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 287 (382)
T ss_dssp CCCSCCCGGGEEE--CTTCCEEECSCSCCCCSSCCCTT--CCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHH
T ss_pred EecCCCCcceEEE--cCCCcEEEcccCccccccccccc--ccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHH
Confidence 9999999999999 88899999999999866443211 1223345678999999999999999999999999999999
Q ss_pred h-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcCCCCC
Q 020888 243 E-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPTDH 313 (320)
Q Consensus 243 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~~ 313 (320)
+ |..||......+....+........ +..+++++.+++.+||+.||.+|||+++++++|+++......+.
T Consensus 288 t~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~ 358 (382)
T 3tt0_A 288 TLGGSPYPGVPVEELFKLLKEGHRMDK-PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE 358 (382)
T ss_dssp TTSCCSSTTCCHHHHHHHHHTTCCCCC-CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC
T ss_pred hCCCCCCCCCCHHHHHHHHHcCCCCCC-CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCC
Confidence 9 9999999888888777776655443 45589999999999999999999999999999999988776543
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=343.23 Aligned_cols=254 Identities=26% Similarity=0.408 Sum_probs=220.4
Q ss_pred CcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEE
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 118 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 118 (320)
..+|.+.+.||+|+||+||++.+. ++.+|+|.+....... ...+.+.+|+++++.++||||+++++++.+++..|+|
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSA-RDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHH-HHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCH-HHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 347999999999999999999885 7889999887654433 3347789999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeC-CCCcEEEecCCCccccccc
Q 020888 119 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS-SADHLKVGDFGLSKLIKVQ 197 (320)
Q Consensus 119 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~-~~~~~~L~dfg~~~~~~~~ 197 (320)
|||++|++|.+.+...+.+++..+..++.||+.||.|||++| |+|+||||+||++..+ .++.++|+|||++......
T Consensus 89 ~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~g--ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~ 166 (444)
T 3soa_A 89 FDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG--VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE 166 (444)
T ss_dssp ECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT
T ss_pred EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC
Confidence 999999999999998888999999999999999999999999 9999999999999322 5678999999999766433
Q ss_pred CccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCC--CCCCH
Q 020888 198 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA--KGFTP 275 (320)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 275 (320)
.. ......||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+..+......+ ..+++
T Consensus 167 ~~----~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 242 (444)
T 3soa_A 167 QQ----AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTP 242 (444)
T ss_dssp CC----BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCH
T ss_pred Cc----eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCH
Confidence 21 2234578999999999999999999999999999999999999999998888888887776443332 46899
Q ss_pred HHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 276 ELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 276 ~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
+++++|.+||..||.+|||+.+++++
T Consensus 243 ~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 243 EAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 99999999999999999999999986
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=327.73 Aligned_cols=263 Identities=31% Similarity=0.553 Sum_probs=226.0
Q ss_pred CCCCCcccCccceecccCceEEEEEEEC-------CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeE
Q 020888 37 IDPSELDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAV 109 (320)
Q Consensus 37 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~-------~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 109 (320)
.+....+|.+.+.||+|+||.||++.+. ++.+|+|.+.... .....+.+.+|+++++.++||||+++++++
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 95 (314)
T 2ivs_A 18 WEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLYGAC 95 (314)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCceeeEEEEE
Confidence 3445679999999999999999999873 3679999886443 344557899999999999999999999999
Q ss_pred EeCCceEEEEecCCCCCHHHHHHHhCC------------------------CCHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 020888 110 TERKPLMLITEYLRGGDLHKYLKEKGA------------------------LSPSTAVNFALDIARGMAYLHNEPNVIIH 165 (320)
Q Consensus 110 ~~~~~~~iv~e~~~~~~L~~~~~~~~~------------------------l~~~~~~~i~~~l~~~l~~lH~~g~~ivH 165 (320)
...+..++||||+++++|.+++..... +++..++.++.|++.||.|||++| ++|
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH 173 (314)
T 2ivs_A 96 SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK--LVH 173 (314)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT--EEC
T ss_pred ecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC--Ccc
Confidence 999999999999999999999986433 899999999999999999999998 999
Q ss_pred cCCCCCcEEEeeCCCCcEEEecCCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-C
Q 020888 166 RDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-G 244 (320)
Q Consensus 166 ~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g 244 (320)
+||||+||++ +.++.++|+|||++........ ........+++.|+|||.+.+..++.++||||||+++|+|++ |
T Consensus 174 ~dikp~NIli--~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g 249 (314)
T 2ivs_A 174 RDLAARNILV--AEGRKMKISDFGLSRDVYEEDS--YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLG 249 (314)
T ss_dssp CCCSGGGEEE--ETTTEEEECCCTTCEECTTTSC--EECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTS
T ss_pred cccchheEEE--cCCCCEEEcccccccccccccc--ceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCC
Confidence 9999999999 7888999999999986644321 112233456788999999999889999999999999999999 9
Q ss_pred CCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhc
Q 020888 245 EPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKET 308 (320)
Q Consensus 245 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 308 (320)
..||...........+....... .+..+++++.+++.+||+.||.+|||+.+++++|+++...
T Consensus 250 ~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 250 GNPYPGIPPERLFNLLKTGHRME-RPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp CCSSTTCCGGGHHHHHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCCCCCHHHHHHHhhcCCcCC-CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 99999888877777666655443 3456899999999999999999999999999999998765
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-47 Score=323.78 Aligned_cols=260 Identities=36% Similarity=0.642 Sum_probs=212.1
Q ss_pred CCCcccCccceecccCceEEEEEEECCCceEEEEccCCCCCc-HHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEE
Q 020888 39 PSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDD-RLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLML 117 (320)
Q Consensus 39 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~K~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 117 (320)
....+|.+.+.||+|+||.||++.++++.+|+|++....... ....+.+.+|+++++.++|+||+++++++..++..++
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (271)
T 3dtc_A 4 IDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL 83 (271)
T ss_dssp CCTTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred cchhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence 345689999999999999999999999999999886543332 2334678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCC-CeEecCCCCCcEEEeeC------CCCcEEEecCCC
Q 020888 118 ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPN-VIIHRDLKPRNVLLVNS------SADHLKVGDFGL 190 (320)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~-~ivH~di~p~nI~~~~~------~~~~~~L~dfg~ 190 (320)
||||+++++|.++++. ..+++..++.++.|++.||.|||++|. +++|+||||+||++..+ .++.++|+|||+
T Consensus 84 v~e~~~~~~L~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~ 162 (271)
T 3dtc_A 84 VMEFARGGPLNRVLSG-KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGL 162 (271)
T ss_dssp EEECCTTEEHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC
T ss_pred EEEcCCCCCHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCc
Confidence 9999999999999864 579999999999999999999999862 27899999999999321 267899999999
Q ss_pred cccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCC
Q 020888 191 SKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA 270 (320)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 270 (320)
+....... .....+++.|+|||.+.+..++.++|+||||++++++++|..||...+.................+
T Consensus 163 ~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 236 (271)
T 3dtc_A 163 AREWHRTT------KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIP 236 (271)
T ss_dssp -------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCC
T ss_pred cccccccc------ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCC
Confidence 97654322 123468999999999999999999999999999999999999999988877777777666655566
Q ss_pred CCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHH
Q 020888 271 KGFTPELRELTEKCWAADMNQRPSFLDILKRLEKI 305 (320)
Q Consensus 271 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~ 305 (320)
..+++++.+++.+||+.||.+|||+.+++++|+++
T Consensus 237 ~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 237 STCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred cccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 77899999999999999999999999999999754
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=336.15 Aligned_cols=270 Identities=30% Similarity=0.541 Sum_probs=217.6
Q ss_pred CCCCcCCCCCcccCccceecccCceEEEEEEEC-----CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCccccee
Q 020888 32 KCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 106 (320)
Q Consensus 32 ~~~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~-----~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 106 (320)
..++.-+....+|.+.+.||+|+||.||++.+. +..||+|.+.... .....+.+.+|++++++++|+||++++
T Consensus 35 ~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~ 112 (373)
T 2qol_A 35 VHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLE 112 (373)
T ss_dssp CTTTSCBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred HHHHHhhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 334445556679999999999999999999864 5679999886543 334457899999999999999999999
Q ss_pred eeEEeCCceEEEEecCCCCCHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEE
Q 020888 107 GAVTERKPLMLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKV 185 (320)
Q Consensus 107 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L 185 (320)
+++...+..++||||+++++|.+++...+ .+++..++.++.|++.||.|||++| |+|+||||+||++ +.++.++|
T Consensus 113 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll--~~~~~~kl 188 (373)
T 2qol_A 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILI--NSNLVCKV 188 (373)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE--CTTCCEEE
T ss_pred EEEeeCCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEE--cCCCCEEE
Confidence 99999999999999999999999998654 6999999999999999999999998 9999999999999 88899999
Q ss_pred ecCCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCC
Q 020888 186 GDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGH 264 (320)
Q Consensus 186 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~ 264 (320)
+|||++.......... .......+++.|+|||++.+..++.++||||||+++|++++ |..||......+....+..+.
T Consensus 189 ~Dfg~a~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~ 267 (373)
T 2qol_A 189 SDFGLGRVLEDDPEAA-YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY 267 (373)
T ss_dssp CCC-----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTE
T ss_pred CcCccccccccCCccc-eeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 9999998765432111 11222345678999999999999999999999999999998 999999988888777777664
Q ss_pred CCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcC
Q 020888 265 RPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETL 309 (320)
Q Consensus 265 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 309 (320)
.... +..++.++.+++.+||+.||.+|||+.++++.|+++....
T Consensus 268 ~~~~-~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 268 RLPP-PMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp ECCC-CTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred CCCC-CccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 4333 3458999999999999999999999999999999997653
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=333.89 Aligned_cols=254 Identities=31% Similarity=0.421 Sum_probs=205.0
Q ss_pred CCCCCcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCc
Q 020888 37 IDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP 114 (320)
Q Consensus 37 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 114 (320)
+.....+|.+.+.||+|+||+||++.+. ++.||+|.+....... +.+.+|+.+++.++|+||+++++++...+.
T Consensus 15 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 90 (361)
T 3uc3_A 15 IMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID----ENVQREIINHRSLRHPNIVRFKEVILTPTH 90 (361)
T ss_dssp CCCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC----HHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred CCCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc----HHHHHHHHHHHhCCCCCCCcEEEEEeeCCE
Confidence 3444568999999999999999999985 7889999987654433 567889999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccc
Q 020888 115 LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 194 (320)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~ 194 (320)
.++||||+++++|.+++...+.+++..++.++.|++.||.|||++| |+||||||+||++..+..+.++|+|||++...
T Consensus 91 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~--ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~ 168 (361)
T 3uc3_A 91 LAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSS 168 (361)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCSCCCCGGGEEECSSSSCCEEECCCCCC---
T ss_pred EEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCceEEEeecCccccc
Confidence 9999999999999999988888999999999999999999999999 99999999999994334445999999998743
Q ss_pred cccCccceeeccCCcccccccCccccCcCCCCCc-hhHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHhCCCCCCC
Q 020888 195 KVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKK-VDVFSFAMILYEMLEGEPPLANYEP----YEAAKYVAEGHRPFFR 269 (320)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~ll~g~~p~~~~~~----~~~~~~~~~~~~~~~~ 269 (320)
.... ......+|+.|+|||++.+..++.+ +||||||+++|+|++|..||..... ......+.........
T Consensus 169 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (361)
T 3uc3_A 169 VLHS-----QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPD 243 (361)
T ss_dssp -----------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCT
T ss_pred cccC-----CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCC
Confidence 3221 1233568999999999988887655 8999999999999999999986533 3344444444444334
Q ss_pred CCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 270 AKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 270 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
...++++++++|.+||..||.+|||+.+++++
T Consensus 244 ~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 244 DIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred cCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 44689999999999999999999999999987
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=322.10 Aligned_cols=256 Identities=27% Similarity=0.419 Sum_probs=222.1
Q ss_pred CCcccCccceecccCceEEEEEEECCCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeC--CceEE
Q 020888 40 SELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER--KPLML 117 (320)
Q Consensus 40 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~i 117 (320)
...+|.+.+.||+|++|+||++.++++.+|+|++...... ....+.+.+|++++++++|+||+++++++... +..++
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (271)
T 3kmu_A 8 DFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWS-TRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL 86 (271)
T ss_dssp CGGGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCC-HHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred CHHHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccC-HHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence 3458999999999999999999999999999998765433 33447899999999999999999999999876 78899
Q ss_pred EEecCCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccccc
Q 020888 118 ITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 195 (320)
Q Consensus 118 v~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~ 195 (320)
||||+++++|.+++.... .+++..++.++.|++.||.|||++|..++|+||||+||++ +.++.++|.||++.....
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~--~~~~~~~l~~~~~~~~~~ 164 (271)
T 3kmu_A 87 ITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMI--DEDMTARISMADVKFSFQ 164 (271)
T ss_dssp EEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEE--CTTSCEEEEGGGSCCTTS
T ss_pred eecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEE--cCCcceeEEeccceeeec
Confidence 999999999999998754 4899999999999999999999976669999999999999 888889999888765432
Q ss_pred ccCccceeeccCCcccccccCccccCcCCCCC---chhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCC
Q 020888 196 VQNSHDVYKMTGETGSYRYMAPEVFKHRKYDK---KVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKG 272 (320)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~---~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (320)
. ....+|+.|+|||.+.+...+. ++||||||+++|++++|..||......+..............+..
T Consensus 165 ~---------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (271)
T 3kmu_A 165 S---------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPG 235 (271)
T ss_dssp C---------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTT
T ss_pred c---------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCC
Confidence 2 2346789999999998765544 799999999999999999999998888777666666555555667
Q ss_pred CCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHh
Q 020888 273 FTPELRELTEKCWAADMNQRPSFLDILKRLEKIKE 307 (320)
Q Consensus 273 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 307 (320)
+++++.+++..||+.||++|||++++++.|+++.+
T Consensus 236 ~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 236 ISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 89999999999999999999999999999998864
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=335.59 Aligned_cols=252 Identities=27% Similarity=0.444 Sum_probs=219.5
Q ss_pred cccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEE
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 119 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 119 (320)
.+|.+.+.||+|+||.||++.+. ++.+|+|++...... ....+.+.+|+++++.++||||+++++++.+.+..|+||
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 47999999999999999999986 789999998765443 334578899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeC-CCCcEEEecCCCcccccccC
Q 020888 120 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS-SADHLKVGDFGLSKLIKVQN 198 (320)
Q Consensus 120 e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~-~~~~~~L~dfg~~~~~~~~~ 198 (320)
||++|++|.+++...+.+++..++.++.|++.||.|||++| |+|+||||+||++..+ .++.++|+|||++.......
T Consensus 108 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~ 185 (362)
T 2bdw_A 108 DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE 185 (362)
T ss_dssp CCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCC
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEeecCcceEecCCc
Confidence 99999999999988778999999999999999999999999 9999999999999322 23469999999997665332
Q ss_pred ccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCC--CCCCHH
Q 020888 199 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA--KGFTPE 276 (320)
Q Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 276 (320)
......+|+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+..+......+ ..++++
T Consensus 186 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 260 (362)
T 2bdw_A 186 -----AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPE 260 (362)
T ss_dssp -----SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHH
T ss_pred -----ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHH
Confidence 1234578999999999999999999999999999999999999999988888877777765433222 457999
Q ss_pred HHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 277 LRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 277 l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
++++|.+||..||.+|||+.+++++
T Consensus 261 ~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 261 AKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred HHHHHHHHcCCChhhCcCHHHHhcC
Confidence 9999999999999999999999876
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-47 Score=338.17 Aligned_cols=250 Identities=24% Similarity=0.386 Sum_probs=216.1
Q ss_pred cccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcccceeeeEEeCCceEEE
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLI 118 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~iv 118 (320)
.+|.+.+.||+|+||+||++.++ ++.||+|++.+.........+.+.+|.++++.+ +||||+++++++...+.+|+|
T Consensus 23 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv 102 (353)
T 3txo_A 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFV 102 (353)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEE
Confidence 48999999999999999999986 788999998654332333346788899999998 699999999999999999999
Q ss_pred EecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccC
Q 020888 119 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 198 (320)
Q Consensus 119 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~ 198 (320)
|||++|++|.+++...+.+++..++.++.||+.||.|||++| |+||||||+||++ +.++.++|+|||++.......
T Consensus 103 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NILl--~~~g~ikL~DFG~a~~~~~~~ 178 (353)
T 3txo_A 103 MEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKG--IIYRDLKLDNVLL--DHEGHCKLADFGMCKEGICNG 178 (353)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEE--CTTSCEEECCCTTCBCSCC--
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCHHHEEE--CCCCCEEEccccceeecccCC
Confidence 999999999999998889999999999999999999999999 9999999999999 889999999999987533221
Q ss_pred ccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHH
Q 020888 199 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 278 (320)
Q Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 278 (320)
......+||+.|+|||++.+..++.++|+||||+++|+|++|..||...+..+....+....... +..++++++
T Consensus 179 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~--p~~~~~~~~ 252 (353)
T 3txo_A 179 ----VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVY--PTWLHEDAT 252 (353)
T ss_dssp -----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC--CTTSCHHHH
T ss_pred ----ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC--CCCCCHHHH
Confidence 12334578999999999999999999999999999999999999999999888888887766443 345899999
Q ss_pred HHHHHHhhcCCCCCCCH------HHHHHH
Q 020888 279 ELTEKCWAADMNQRPSF------LDILKR 301 (320)
Q Consensus 279 ~li~~~l~~dp~~Rps~------~~ll~~ 301 (320)
++|++||..||.+||++ +++++|
T Consensus 253 ~li~~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 253 GILKSFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp HHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred HHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence 99999999999999998 788765
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=324.60 Aligned_cols=273 Identities=28% Similarity=0.533 Sum_probs=227.9
Q ss_pred CCcCCCCCcccCccceecccCceEEEEEEEC-----CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeee
Q 020888 34 DWEIDPSELDFSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGA 108 (320)
Q Consensus 34 ~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~-----~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 108 (320)
.+.+.....+|.+.+.||+|+||+||++.+. ...+++|.+... ......+.+.+|++++++++|+||++++++
T Consensus 17 ~~~i~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 94 (298)
T 3f66_A 17 HVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGI 94 (298)
T ss_dssp GGBCCGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCCCTTBCCCCEE
T ss_pred heecCccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC--CCHHHHHHHHHHHHHHHhCCCCCEeeeeeE
Confidence 4557778889999999999999999999864 224788877542 334455789999999999999999999998
Q ss_pred E-EeCCceEEEEecCCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEe
Q 020888 109 V-TERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVG 186 (320)
Q Consensus 109 ~-~~~~~~~iv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~ 186 (320)
+ ..++..++||||+++++|.+++.. ...+++..++.++.|++.||.|||++| ++|+||||+||++ +.++.++|+
T Consensus 95 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~--i~H~dikp~Nil~--~~~~~~kl~ 170 (298)
T 3f66_A 95 CLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK--FVHRDLAARNCML--DEKFTVKVA 170 (298)
T ss_dssp ECCSSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE--CTTCCEEEC
T ss_pred EEcCCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEE--CCCCCEEEC
Confidence 5 556778999999999999999976 346899999999999999999999999 9999999999999 888999999
Q ss_pred cCCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCC
Q 020888 187 DFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHR 265 (320)
Q Consensus 187 dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~ 265 (320)
|||++..................+++.|+|||.+.+..++.++|+||||+++|++++ |..||......+....+.....
T Consensus 171 Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (298)
T 3f66_A 171 DFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR 250 (298)
T ss_dssp SCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCC
T ss_pred cccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCC
Confidence 999998765543333333444567889999999999999999999999999999999 6667777766666666665554
Q ss_pred CCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcCCCCC
Q 020888 266 PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPTDH 313 (320)
Q Consensus 266 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~~ 313 (320)
.. .+..+++++.+++.+||..||.+|||+.++++.|+++..+...++
T Consensus 251 ~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~~~ 297 (298)
T 3f66_A 251 LL-QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 297 (298)
T ss_dssp CC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCCSC
T ss_pred CC-CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhccCC
Confidence 33 345589999999999999999999999999999999999887765
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=331.99 Aligned_cols=265 Identities=30% Similarity=0.505 Sum_probs=226.4
Q ss_pred CCCCCcccCccceecccCceEEEEEEECC-------CceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeE
Q 020888 37 IDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAV 109 (320)
Q Consensus 37 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~-------~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 109 (320)
.+....+|.+.+.||+|+||.||++.+.+ +.||+|.+.... .....+.+.+|+++++.++|+||+++++++
T Consensus 42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 119 (343)
T 1luf_A 42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVC 119 (343)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 34456799999999999999999999864 779999886543 334457899999999999999999999999
Q ss_pred EeCCceEEEEecCCCCCHHHHHHHh------------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 020888 110 TERKPLMLITEYLRGGDLHKYLKEK------------------------GALSPSTAVNFALDIARGMAYLHNEPNVIIH 165 (320)
Q Consensus 110 ~~~~~~~iv~e~~~~~~L~~~~~~~------------------------~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH 165 (320)
..++..++||||+++++|.+++... ..+++..++.++.|++.||.|||++| ++|
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--ivH 197 (343)
T 1luf_A 120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVH 197 (343)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCC
T ss_pred ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eec
Confidence 9999999999999999999999763 56899999999999999999999999 999
Q ss_pred cCCCCCcEEEeeCCCCcEEEecCCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-C
Q 020888 166 RDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-G 244 (320)
Q Consensus 166 ~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g 244 (320)
+||||+||++ +.++.++|+|||++........ ........+++.|+|||++.+..++.++|+||||+++|+|++ |
T Consensus 198 ~Dlkp~NIl~--~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g 273 (343)
T 1luf_A 198 RDLATRNCLV--GENMVVKIADFGLSRNIYSADY--YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 273 (343)
T ss_dssp SCCSGGGEEE--CGGGCEEECCCSCHHHHTGGGC--BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTT
T ss_pred CCCCcceEEE--CCCCeEEEeecCCCcccccCcc--ccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcC
Confidence 9999999999 8888999999999986643321 112233467889999999999999999999999999999999 9
Q ss_pred CCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcCC
Q 020888 245 EPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLP 310 (320)
Q Consensus 245 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~ 310 (320)
..||......+....+..+..... +..++.++.+++.+||+.||.+|||+.+++++|+++.++..
T Consensus 274 ~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~ 338 (343)
T 1luf_A 274 LQPYYGMAHEEVIYYVRDGNILAC-PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE 338 (343)
T ss_dssp CCTTTTSCHHHHHHHHHTTCCCCC-CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred CCcCCCCChHHHHHHHhCCCcCCC-CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence 999999888888777776655433 45689999999999999999999999999999999877654
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=330.35 Aligned_cols=253 Identities=26% Similarity=0.438 Sum_probs=218.2
Q ss_pred CCcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcH---HHHHHHHHHHHHHHhCCCCcccceeeeEEeCCc
Q 020888 40 SELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDR---LVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP 114 (320)
Q Consensus 40 ~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 114 (320)
-..+|.+.+.||+|+||.||++.+. ++.+|+|++........ ...+.+.+|+.+++.++||||+++++++.....
T Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 88 (326)
T 2y0a_A 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 88 (326)
T ss_dssp HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 3457999999999999999999986 78999998865433211 123678899999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCC----cEEEecCCC
Q 020888 115 LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD----HLKVGDFGL 190 (320)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~----~~~L~dfg~ 190 (320)
.++||||+++++|.+++...+.+++..++.++.|++.||.|||+.| ++|+||||+||++ +.++ .++|+|||+
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIll--~~~~~~~~~~kl~Dfg~ 164 (326)
T 2y0a_A 89 VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIML--LDRNVPKPRIKIIDFGL 164 (326)
T ss_dssp EEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEE--SCSSSSSCCEEECCCTT
T ss_pred EEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCC--eEcCCCCHHHEEE--ecCCCCCCCEEEEECCC
Confidence 9999999999999999988788999999999999999999999998 9999999999999 5555 799999999
Q ss_pred cccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCC-
Q 020888 191 SKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR- 269 (320)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~- 269 (320)
+....... ......+|+.|+|||++.+..++.++||||||+++|+|++|..||......+....+.........
T Consensus 165 a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 239 (326)
T 2y0a_A 165 AHKIDFGN-----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDE 239 (326)
T ss_dssp CEECCTTS-----CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHH
T ss_pred CeECCCCC-----ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCcc
Confidence 98765332 123456899999999999999999999999999999999999999988877777666654433221
Q ss_pred -CCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 270 -AKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 270 -~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
...++.+++++|.+||..||.+|||+++++++
T Consensus 240 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 240 YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp HHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 24579999999999999999999999999975
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=329.90 Aligned_cols=248 Identities=27% Similarity=0.488 Sum_probs=218.4
Q ss_pred CcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEE
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 118 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 118 (320)
..+|.+.+.||+|+||+||++.+. ++.+|+|++.+.........+.+.+|..+++.++||||+++++++.+....|+|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 358999999999999999999985 789999988654222222346778899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccC
Q 020888 119 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 198 (320)
Q Consensus 119 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~ 198 (320)
|||++|++|.+++...+.+++..+..++.|++.||.|||++| |+|+||||+||++ +.++.++|+|||++......
T Consensus 85 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll--~~~g~~kL~Dfg~a~~~~~~- 159 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILL--DKNGHIKITDFGFAKYVPDV- 159 (318)
T ss_dssp ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEE--CTTSCEEECCCSSCEECSSC-
T ss_pred EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChheEEE--cCCCCEEEeecCcceecCCc-
Confidence 999999999999998888999999999999999999999999 9999999999999 88999999999999765321
Q ss_pred ccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHH
Q 020888 199 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 278 (320)
Q Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 278 (320)
....+||+.|+|||++.+..++.++|+||||+++|+|++|..||...+..+....+...... .+..++++++
T Consensus 160 ------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~--~p~~~~~~~~ 231 (318)
T 1fot_A 160 ------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELR--FPPFFNEDVK 231 (318)
T ss_dssp ------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCC--CCTTSCHHHH
T ss_pred ------cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC--CCCCCCHHHH
Confidence 23457899999999999999999999999999999999999999998888877777766533 2345899999
Q ss_pred HHHHHHhhcCCCCCC-----CHHHHHHH
Q 020888 279 ELTEKCWAADMNQRP-----SFLDILKR 301 (320)
Q Consensus 279 ~li~~~l~~dp~~Rp-----s~~~ll~~ 301 (320)
++|.+||..||.+|| ++++++++
T Consensus 232 ~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 232 DLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp HHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 999999999999999 89999876
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=334.41 Aligned_cols=248 Identities=26% Similarity=0.442 Sum_probs=219.7
Q ss_pred CcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEE
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 118 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 118 (320)
..+|.+.+.||+|+||.||++.+. ++.||+|++.+.........+.+.+|+++++.++||||+++++++.+.+..|+|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 458999999999999999999985 789999988554322222346788899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccC
Q 020888 119 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 198 (320)
Q Consensus 119 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~ 198 (320)
|||++|++|.+++...+.+++..++.++.||+.||.|||++| |+|+||||+||++ +.++.++|+|||++......
T Consensus 120 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll--~~~g~~kL~DFg~a~~~~~~- 194 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLI--DQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--CTTSCEEECCCTTCEECSSC-
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCccceEEE--CCCCCEEEcccccceeccCC-
Confidence 999999999999998888999999999999999999999999 9999999999999 88999999999999865432
Q ss_pred ccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHH
Q 020888 199 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 278 (320)
Q Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 278 (320)
....+||+.|+|||++.+..++.++|+||||+++|+|++|..||...+..+....+..+... .+..++.+++
T Consensus 195 ------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~--~p~~~~~~~~ 266 (350)
T 1rdq_E 195 ------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLK 266 (350)
T ss_dssp ------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC--CCTTCCHHHH
T ss_pred ------cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCC--CCCCCCHHHH
Confidence 22456899999999999999999999999999999999999999998888888878776543 2356899999
Q ss_pred HHHHHHhhcCCCCCCC-----HHHHHHH
Q 020888 279 ELTEKCWAADMNQRPS-----FLDILKR 301 (320)
Q Consensus 279 ~li~~~l~~dp~~Rps-----~~~ll~~ 301 (320)
++|.+||..||.+||+ +++++++
T Consensus 267 ~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 267 DLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp HHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 9999999999999998 8998876
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=321.67 Aligned_cols=275 Identities=28% Similarity=0.509 Sum_probs=229.7
Q ss_pred CCCcCCCCCcccCccceecccCceEEEEEEEC--C---CceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceee
Q 020888 33 CDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--G---TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 107 (320)
Q Consensus 33 ~~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~--~---~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 107 (320)
.++.++.....|.+.+.||+|+||+||++.+. + ..+|+|.+... ......+.+.+|+++++.++|+||+++++
T Consensus 12 ~~~~i~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 89 (298)
T 3pls_A 12 KDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI--TEMQQVEAFLREGLLMRGLNHPNVLALIG 89 (298)
T ss_dssp GGGBCCGGGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCCCTTBCCCCE
T ss_pred hheEccccceEEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc--ccHHHHHHHHHHHHHHHhCCCCCeeeEEE
Confidence 34556777778888999999999999999863 2 26999987542 34445678899999999999999999999
Q ss_pred eEEeCCce-EEEEecCCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEE
Q 020888 108 AVTERKPL-MLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKV 185 (320)
Q Consensus 108 ~~~~~~~~-~iv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L 185 (320)
++...+.. ++++||+.+++|.+++.. ...+++..++.++.|++.||.|||+.| ++|+||||+||++ +.++.++|
T Consensus 90 ~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nili--~~~~~~kl 165 (298)
T 3pls_A 90 IMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK--FVHRDLAARNCML--DESFTVKV 165 (298)
T ss_dssp EECCSSSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE--CTTCCEEE
T ss_pred EEecCCCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEE--cCCCcEEe
Confidence 99766554 999999999999999986 456899999999999999999999998 9999999999999 88899999
Q ss_pred ecCCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHhCC
Q 020888 186 GDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEG-EPPLANYEPYEAAKYVAEGH 264 (320)
Q Consensus 186 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g-~~p~~~~~~~~~~~~~~~~~ 264 (320)
+|||++..................+++.|.|||.+.+..++.++||||||+++|+|++| ..||...+..+....+....
T Consensus 166 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~ 245 (298)
T 3pls_A 166 ADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGR 245 (298)
T ss_dssp CCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTC
T ss_pred CcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCC
Confidence 99999986654433233333445678899999999999999999999999999999994 55566666666666666555
Q ss_pred CCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcCCCCCc
Q 020888 265 RPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPTDHH 314 (320)
Q Consensus 265 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~~~ 314 (320)
... .+..+++++.+++.+||+.||.+|||+.++++.|+++...+..+..
T Consensus 246 ~~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~~~ 294 (298)
T 3pls_A 246 RLP-QPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDHY 294 (298)
T ss_dssp CCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSCCB
T ss_pred CCC-CCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhccch
Confidence 433 3455899999999999999999999999999999999999876654
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-47 Score=336.11 Aligned_cols=253 Identities=28% Similarity=0.439 Sum_probs=217.1
Q ss_pred CCCcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcccceeeeEEeCCce
Q 020888 39 PSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPL 115 (320)
Q Consensus 39 ~~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 115 (320)
....+|.+.+.||+|+||+||++.++ ++.||+|++.+...........+..|.+++..+ +||||+++++++...+..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 34568999999999999999999986 788999988654221112235677889998877 899999999999999999
Q ss_pred EEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccccc
Q 020888 116 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 195 (320)
Q Consensus 116 ~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~ 195 (320)
|+||||++|++|.+++...+.+++..+..++.|++.||.|||++| |+||||||+||++ +.++.++|+|||++....
T Consensus 94 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll--~~~g~vkL~DFG~a~~~~ 169 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILL--DKDGHIKIADFGMCKENM 169 (345)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEE--CTTSCEEECCCTTCBCCC
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCChhhEEE--CCCCCEEEeEChhhhhcc
Confidence 999999999999999998888999999999999999999999999 9999999999999 889999999999987543
Q ss_pred ccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCH
Q 020888 196 VQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTP 275 (320)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (320)
.... .....+||+.|+|||++.+..++.++|+||||+++|+|++|..||...+..+....+...... .+..+++
T Consensus 170 ~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~--~p~~~s~ 243 (345)
T 1xjd_A 170 LGDA----KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPF--YPRWLEK 243 (345)
T ss_dssp CTTC----CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC--CCTTSCH
T ss_pred cCCC----cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCC--CCcccCH
Confidence 2221 234467899999999999999999999999999999999999999998888887777766533 2345899
Q ss_pred HHHHHHHHHhhcCCCCCCCHH-HHHHH
Q 020888 276 ELRELTEKCWAADMNQRPSFL-DILKR 301 (320)
Q Consensus 276 ~l~~li~~~l~~dp~~Rps~~-~ll~~ 301 (320)
+++++|.+||..||.+||++. +++++
T Consensus 244 ~~~~li~~lL~~dp~~R~~~~~~i~~h 270 (345)
T 1xjd_A 244 EAKDLLVKLFVREPEKRLGVRGDIRQH 270 (345)
T ss_dssp HHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred HHHHHHHHHhcCCHhHcCCChHHHHcC
Confidence 999999999999999999997 76643
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=332.23 Aligned_cols=266 Identities=28% Similarity=0.432 Sum_probs=218.0
Q ss_pred CCcccCccceecccCceEEEEEEE-------CCCceEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcccceeeeEEe
Q 020888 40 SELDFSSSAIIGKGSFGEILKAYW-------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTE 111 (320)
Q Consensus 40 ~~~~y~~~~~lg~g~~~~vy~~~~-------~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 111 (320)
...+|.+.+.||+|+||.||++.+ .+..||+|.+..... ....+.+.+|+++++++ +||||+++++++..
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 120 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD--SSEREALMSELKMMTQLGSHENIVNLLGACTL 120 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccC--HHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence 356899999999999999999997 245799998865432 22347889999999999 89999999999999
Q ss_pred CCceEEEEecCCCCCHHHHHHHhC-----------------------CCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 020888 112 RKPLMLITEYLRGGDLHKYLKEKG-----------------------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDL 168 (320)
Q Consensus 112 ~~~~~iv~e~~~~~~L~~~~~~~~-----------------------~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di 168 (320)
.+..++||||+++++|.+++.... .+++..++.++.|++.||.|||+.| ++|+||
T Consensus 121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Di 198 (344)
T 1rjb_A 121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHRDL 198 (344)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--EEETTC
T ss_pred CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCC
Confidence 999999999999999999998643 3799999999999999999999999 999999
Q ss_pred CCCcEEEeeCCCCcEEEecCCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCC
Q 020888 169 KPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPP 247 (320)
Q Consensus 169 ~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p 247 (320)
||+||++ +.++.++|+|||++......... .......+++.|+|||.+.+..++.++||||||+++|+|++ |..|
T Consensus 199 kp~NIll--~~~~~~kL~Dfg~~~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 274 (344)
T 1rjb_A 199 AARNVLV--THGKVVKICDFGLARDIMSDSNY--VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274 (344)
T ss_dssp SGGGEEE--ETTTEEEECCCGGGSCGGGCTTS--EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred ChhhEEE--cCCCcEEeCCCccCcccccCccc--eeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCC
Confidence 9999999 88889999999999876543221 12233456888999999999999999999999999999998 9999
Q ss_pred CCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcCCCCC
Q 020888 248 LANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPTDH 313 (320)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~~ 313 (320)
|.....................+..+++++.+++.+||..||.+|||+.+++++|+.+......+.
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~ 340 (344)
T 1rjb_A 275 YPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEEAM 340 (344)
T ss_dssp STTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-------
T ss_pred cccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHHHHH
Confidence 988765554444444444444455689999999999999999999999999999999988876654
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=334.97 Aligned_cols=248 Identities=30% Similarity=0.450 Sum_probs=207.3
Q ss_pred CCCcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHH-HHhCCCCcccceeeeEEeCCce
Q 020888 39 PSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNL-LVKLRHPNIVQFLGAVTERKPL 115 (320)
Q Consensus 39 ~~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~~~~~ 115 (320)
....+|.+.+.||+|+||+||++.++ ++.+|+|++.+...........+..|..+ ++.++|+||+++++.+...+..
T Consensus 35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~ 114 (373)
T 2r5t_A 35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKL 114 (373)
T ss_dssp CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEE
Confidence 34568999999999999999999986 67899999876654444344566667766 4667999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccccc
Q 020888 116 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 195 (320)
Q Consensus 116 ~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~ 195 (320)
|+||||++|++|.+++...+.+++..++.++.||+.||.|||++| |+||||||+||++ +.++.++|+|||++....
T Consensus 115 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll--~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 115 YFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILL--DSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE--CTTSCEEECCCCBCGGGB
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEE--CCCCCEEEeeCccccccc
Confidence 999999999999999998888999999999999999999999999 9999999999999 889999999999987643
Q ss_pred ccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCH
Q 020888 196 VQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTP 275 (320)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (320)
.... .....+||+.|+|||++.+..++.++|+||||+++|+|++|..||...+..+....+....... +..++.
T Consensus 191 ~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~--~~~~~~ 264 (373)
T 2r5t_A 191 EHNS----TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQL--KPNITN 264 (373)
T ss_dssp CCCC----CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCC--CSSSCH
T ss_pred cCCC----ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCC--CCCCCH
Confidence 3221 2344678999999999999999999999999999999999999999988888887777664332 345899
Q ss_pred HHHHHHHHHhhcCCCCCCCHH
Q 020888 276 ELRELTEKCWAADMNQRPSFL 296 (320)
Q Consensus 276 ~l~~li~~~l~~dp~~Rps~~ 296 (320)
+++++|.+||..||.+||++.
T Consensus 265 ~~~~li~~lL~~dp~~R~~~~ 285 (373)
T 2r5t_A 265 SARHLLEGLLQKDRTKRLGAK 285 (373)
T ss_dssp HHHHHHHHHTCSSGGGSTTTT
T ss_pred HHHHHHHHHcccCHHhCCCCC
Confidence 999999999999999999874
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-46 Score=326.47 Aligned_cols=264 Identities=30% Similarity=0.478 Sum_probs=223.2
Q ss_pred CCcccCccceecccCceEEEEEEE-------CCCceEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcccceeeeEEe
Q 020888 40 SELDFSSSAIIGKGSFGEILKAYW-------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTE 111 (320)
Q Consensus 40 ~~~~y~~~~~lg~g~~~~vy~~~~-------~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 111 (320)
...+|.+.+.||+|+||.||++.+ .++.||+|.+.... .....+.+.+|+++++++ +|+||+++++++..
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 98 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch--hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence 356899999999999999999985 25789999886543 233457899999999999 89999999999999
Q ss_pred CCceEEEEecCCCCCHHHHHHHhC------------------CCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcE
Q 020888 112 RKPLMLITEYLRGGDLHKYLKEKG------------------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNV 173 (320)
Q Consensus 112 ~~~~~iv~e~~~~~~L~~~~~~~~------------------~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI 173 (320)
++..++||||+++++|.+++.... .+++..++.++.|++.||.|||++| ++|+||||+||
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Ni 176 (313)
T 1t46_A 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNI 176 (313)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGE
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCccceE
Confidence 999999999999999999998643 4899999999999999999999998 99999999999
Q ss_pred EEeeCCCCcEEEecCCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q 020888 174 LLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYE 252 (320)
Q Consensus 174 ~~~~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~ 252 (320)
++ +.++.++|+|||++........ ........+++.|+|||.+.+..++.++||||||+++|+|++ |..||....
T Consensus 177 l~--~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 252 (313)
T 1t46_A 177 LL--THGRITKICDFGLARDIKNDSN--YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (313)
T ss_dssp EE--ETTTEEEECCCGGGSCTTSCTT--SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred EE--cCCCCEEEcccccccccccccc--ceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence 99 8889999999999887654322 112233456788999999999999999999999999999999 999998876
Q ss_pred hHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcCCC
Q 020888 253 PYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPT 311 (320)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~ 311 (320)
.................+..++.++.+++.+||..||.+|||+.+++++|+++..+...
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 311 (313)
T 1t46_A 253 VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISESTN 311 (313)
T ss_dssp SSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTCC
T ss_pred chhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhhc
Confidence 54444333333333334456899999999999999999999999999999999887654
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=329.23 Aligned_cols=258 Identities=34% Similarity=0.588 Sum_probs=215.3
Q ss_pred CcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEE
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 118 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 118 (320)
..+|.+.+.||+|+||+||++.+. ++.+|+|.+.. ......+.+.+|++++++++|+||+++++++.+++..++|
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~---~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 85 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR---FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFI 85 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC---CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc---CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEE
Confidence 458999999999999999999986 78899998743 3345568899999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccccccc
Q 020888 119 TEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 197 (320)
Q Consensus 119 ~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~ 197 (320)
|||+++++|.++++. ...+++..++.++.|++.||.|||++| ++|+||||+||++ +.++.++|+|||++......
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nil~--~~~~~~kl~Dfg~~~~~~~~ 161 (310)
T 3s95_A 86 TEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN--IIHRDLNSHNCLV--RENKNVVVADFGLARLMVDE 161 (310)
T ss_dssp EECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEE--CTTSCEEECCCTTCEECC--
T ss_pred EEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCcCeEEE--CCCCCEEEeecccceecccc
Confidence 999999999999987 457999999999999999999999999 9999999999999 88899999999999876443
Q ss_pred Cccce----------eeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHH
Q 020888 198 NSHDV----------YKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYE------AAKYVA 261 (320)
Q Consensus 198 ~~~~~----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~------~~~~~~ 261 (320)
..... .......||+.|+|||++.+..++.++||||||+++|+|++|..||....... ......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~ 241 (310)
T 3s95_A 162 KTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD 241 (310)
T ss_dssp ------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH
T ss_pred cccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc
Confidence 22111 01114568999999999999999999999999999999999999987543211 111111
Q ss_pred hCCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcCC
Q 020888 262 EGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLP 310 (320)
Q Consensus 262 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~ 310 (320)
. . .+..+++++.+++.+||+.||++|||+.++++.|+++...+.
T Consensus 242 ~-~----~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~ 285 (310)
T 3s95_A 242 R-Y----CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLA 285 (310)
T ss_dssp H-T----CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred c-c----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcc
Confidence 1 1 124578899999999999999999999999999999987653
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-46 Score=328.89 Aligned_cols=254 Identities=26% Similarity=0.393 Sum_probs=223.8
Q ss_pred CCCCcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCce
Q 020888 38 DPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL 115 (320)
Q Consensus 38 ~~~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 115 (320)
.....+|.+.+.||+|+||.||++.+. ++.+++|++...........+.+.+|+.+++.++|+||+++++++.+.+..
T Consensus 37 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 116 (335)
T 2owb_A 37 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFV 116 (335)
T ss_dssp TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred cccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeE
Confidence 345668999999999999999999986 678999998776655666668899999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccccc
Q 020888 116 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 195 (320)
Q Consensus 116 ~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~ 195 (320)
++||||+++++|.+++.....+++..++.++.|++.||.|||++| ++|+||||+||++ +.++.++|+|||++....
T Consensus 117 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~--~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 117 FVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFL--NEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp EEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEE--CTTCCEEECCCTTCEECC
T ss_pred EEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CEecCCCchhEEE--cCCCCEEEeeccCceecc
Confidence 999999999999999998888999999999999999999999998 9999999999999 888999999999998764
Q ss_pred ccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCH
Q 020888 196 VQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTP 275 (320)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (320)
.... ......+++.|+|||++.+..++.++||||||+++|+|++|..||......+....+...... .+..++.
T Consensus 193 ~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~ 266 (335)
T 2owb_A 193 YDGE----RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS--IPKHINP 266 (335)
T ss_dssp STTC----CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC--CCTTSCH
T ss_pred cCcc----cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCC--CCccCCH
Confidence 3321 123356899999999999999999999999999999999999999988777766666655433 2345799
Q ss_pred HHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 276 ELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 276 ~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
++.+++.+||..||++|||+++++++
T Consensus 267 ~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 267 VAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp HHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcC
Confidence 99999999999999999999999986
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=330.87 Aligned_cols=249 Identities=18% Similarity=0.324 Sum_probs=216.5
Q ss_pred cccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEE
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 119 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 119 (320)
.+|.+.+.||+|+||+||++.+. ++.+|+|.+... ......+.+|+++++.++||||+++++++.+.+..++||
T Consensus 5 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 80 (321)
T 1tki_A 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK----GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIF 80 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC----THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred hceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC----cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEE
Confidence 57999999999999999999986 778999987533 123367889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccC
Q 020888 120 EYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 198 (320)
Q Consensus 120 e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~ 198 (320)
||++|++|.+++... ..+++..++.++.|++.||.|||++| ++|+||||+||++..+.++.++|+|||++.......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g--ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~ 158 (321)
T 1tki_A 81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred EeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC
Confidence 999999999999764 36999999999999999999999998 999999999999943337899999999998765432
Q ss_pred ccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCC--CCCCCHH
Q 020888 199 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR--AKGFTPE 276 (320)
Q Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 276 (320)
......+++.|+|||++.+..++.++||||||+++|+|++|..||......+....+......... ...++.+
T Consensus 159 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 233 (321)
T 1tki_A 159 -----NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIE 233 (321)
T ss_dssp -----EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHH
T ss_pred -----ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHH
Confidence 122346899999999999988999999999999999999999999998888877777766544322 1468999
Q ss_pred HHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 277 LRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 277 l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
+++++.+||..||.+|||+.+++++
T Consensus 234 ~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 234 AMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHcCCChhHCcCHHHHhcC
Confidence 9999999999999999999999986
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=328.04 Aligned_cols=265 Identities=26% Similarity=0.449 Sum_probs=215.7
Q ss_pred CcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCc----
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP---- 114 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---- 114 (320)
..+|.+.+.||+|+||.||++.+. ++.||+|++.............+.+|+++++.++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 357999999999999999999975 78899999987766666667889999999999999999999999876544
Q ss_pred eEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccc
Q 020888 115 LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 194 (320)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~ 194 (320)
.|+||||++|++|.+++...+.+++..++.++.|++.||.|||++| ++|+||||+||++ +.++.++|+|||++..+
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~--~~~~~~kl~Dfg~a~~~ 166 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMI--SATNAVKVMDFGIARAI 166 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE--ETTSCEEECCCSCC---
T ss_pred cEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEE--cCCCCEEEeeccCcccc
Confidence 4999999999999999998888999999999999999999999998 9999999999999 78889999999999876
Q ss_pred cccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCC--CCCC
Q 020888 195 KVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFF--RAKG 272 (320)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~ 272 (320)
...... ........+++.|+|||++.+..++.++||||||+++|+|++|..||......+............. ....
T Consensus 167 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (311)
T 3ork_A 167 ADSGNS-VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEG 245 (311)
T ss_dssp ----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTT
T ss_pred cccccc-cccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCC
Confidence 543221 1122335689999999999999999999999999999999999999998887776655555443322 1245
Q ss_pred CCHHHHHHHHHHhhcCCCCCCCH-HHHHHHHHHHHhcCC
Q 020888 273 FTPELRELTEKCWAADMNQRPSF-LDILKRLEKIKETLP 310 (320)
Q Consensus 273 ~~~~l~~li~~~l~~dp~~Rps~-~~ll~~L~~~~~~~~ 310 (320)
++.++.+++.+||..||++||+. +.+.+.|.++....+
T Consensus 246 ~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~~ 284 (311)
T 3ork_A 246 LSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEP 284 (311)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTTCC
T ss_pred CCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcCCC
Confidence 89999999999999999999954 555566777655443
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-46 Score=328.66 Aligned_cols=251 Identities=25% Similarity=0.400 Sum_probs=216.0
Q ss_pred CcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcccceeeeEEeCCceEE
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLML 117 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~i 117 (320)
..+|.+.+.||+|+||.||++.++ ++.+|+|++.+.........+.+.+|..+++++ +||||+++++++...+..|+
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 458999999999999999999986 788999999877666666667889999999998 89999999999999999999
Q ss_pred EEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccccccc
Q 020888 118 ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 197 (320)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~ 197 (320)
||||++|++|.+++...+.+++..++.++.|++.||.|||++| |+|+||||+||++ +.++.++|+|||++......
T Consensus 88 v~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll--~~~g~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLL--DSEGHIKLTDYGMCKEGLRP 163 (345)
T ss_dssp EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEE--CTTSCEEECCGGGCBCSCCT
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEE--CCCCCEEEEeccccccccCC
Confidence 9999999999999998888999999999999999999999999 9999999999999 88999999999998754322
Q ss_pred CccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCC---------ChHHHHHHHHhCCCCCC
Q 020888 198 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANY---------EPYEAAKYVAEGHRPFF 268 (320)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~---------~~~~~~~~~~~~~~~~~ 268 (320)
.. .....+||+.|+|||++.+..++.++|+|||||++|+|++|..||... ........+......
T Consensus 164 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~-- 237 (345)
T 3a8x_A 164 GD----TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR-- 237 (345)
T ss_dssp TC----CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCC--
T ss_pred CC----cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCC--
Confidence 21 233457899999999999999999999999999999999999999752 222333444444322
Q ss_pred CCCCCCHHHHHHHHHHhhcCCCCCCCH------HHHHHH
Q 020888 269 RAKGFTPELRELTEKCWAADMNQRPSF------LDILKR 301 (320)
Q Consensus 269 ~~~~~~~~l~~li~~~l~~dp~~Rps~------~~ll~~ 301 (320)
.+..++.+++++|.+||+.||.+||++ ++++++
T Consensus 238 ~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 238 IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp CCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred CCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 235689999999999999999999985 677765
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-46 Score=321.80 Aligned_cols=267 Identities=27% Similarity=0.491 Sum_probs=223.0
Q ss_pred CCCCCcccCccc-eecccCceEEEEEEEC----CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEe
Q 020888 37 IDPSELDFSSSA-IIGKGSFGEILKAYWR----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE 111 (320)
Q Consensus 37 ~~~~~~~y~~~~-~lg~g~~~~vy~~~~~----~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 111 (320)
+.....+|.+.+ .||+|+||+||++.+. ++.+|+|.+....... ...+.+.+|+++++.++|+||+++++++ .
T Consensus 11 ~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~ 88 (291)
T 1xbb_A 11 VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDP-ALKDELLAEANVMQQLDNPYIVRMIGIC-E 88 (291)
T ss_dssp CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----C-HHHHHHHHHHHHHHTCCCTTBCCEEEEE-E
T ss_pred eeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCH-HHHHHHHHHHHHHHhCCCCCEEEEEEEE-C
Confidence 334456888888 9999999999999653 5779999886654332 3357899999999999999999999999 5
Q ss_pred CCceEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCc
Q 020888 112 RKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 191 (320)
Q Consensus 112 ~~~~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~ 191 (320)
.+..++||||+++++|.+++...+.+++..++.++.|++.||.+||+.| ++|+||||+||++ +.++.++|+|||++
T Consensus 89 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nil~--~~~~~~kl~Dfg~~ 164 (291)
T 1xbb_A 89 AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLL--VTQHYAKISDFGLS 164 (291)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--EETTEEEECCCTTC
T ss_pred CCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCC--eEcCCCCcceEEE--eCCCcEEEccCCcc
Confidence 6778999999999999999998888999999999999999999999998 9999999999999 77889999999999
Q ss_pred ccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCC
Q 020888 192 KLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRA 270 (320)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 270 (320)
.......... .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||......+....+........ +
T Consensus 165 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~-~ 242 (291)
T 1xbb_A 165 KALRADENYY-KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC-P 242 (291)
T ss_dssp EECCTTCSEE-EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC-C
T ss_pred eeeccCCCcc-cccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC-C
Confidence 8765432211 11222345788999999998889999999999999999999 9999999888887777776654443 4
Q ss_pred CCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcCCC
Q 020888 271 KGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPT 311 (320)
Q Consensus 271 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~ 311 (320)
..+++++.+++.+||+.||.+|||+.++++.|+.+..+...
T Consensus 243 ~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~ 283 (291)
T 1xbb_A 243 AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN 283 (291)
T ss_dssp TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhh
Confidence 56899999999999999999999999999999999876543
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=318.49 Aligned_cols=251 Identities=27% Similarity=0.448 Sum_probs=219.5
Q ss_pred CcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEE
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 118 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 118 (320)
..+|.+.+.||+|++|.||++.+. ++.+|+|++...... ....+.+.+|++++++++|+||+++++++..++..++|
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCC-HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 358999999999999999999986 788999988665443 33457888999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCC---cEEEecCCCccccc
Q 020888 119 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD---HLKVGDFGLSKLIK 195 (320)
Q Consensus 119 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~---~~~L~dfg~~~~~~ 195 (320)
|||+++++|.+.+...+.+++..+..++.|++.||.|||+.| ++|+||||+||++ +.++ .++|+|||.+....
T Consensus 84 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~--~~~~~~~~~kl~Dfg~~~~~~ 159 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLL--ASKAKGAAVKLADFGLAIEVN 159 (284)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEE--SSSSTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cCcCCCCHHHEEE--ecCCCCCcEEEeeceeeEEcc
Confidence 999999999999988888999999999999999999999999 9999999999999 5444 49999999997664
Q ss_pred ccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCC--CCC
Q 020888 196 VQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA--KGF 273 (320)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~ 273 (320)
... ......+++.|+|||.+.+..++.++||||||+++|+|++|..||...........+.........+ ..+
T Consensus 160 ~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T 3kk8_A 160 DSE-----AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTV 234 (284)
T ss_dssp SSC-----BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTS
T ss_pred cCc-----cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhccc
Confidence 332 2234568999999999999999999999999999999999999999988888777777665433322 468
Q ss_pred CHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 274 TPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 274 ~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
++++++++.+||+.||.+|||+++++++
T Consensus 235 ~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 235 TPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred CHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 9999999999999999999999999986
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-46 Score=317.20 Aligned_cols=256 Identities=32% Similarity=0.638 Sum_probs=222.8
Q ss_pred CcccCccceecccCceEEEEEEEC-CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEE
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 119 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~-~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 119 (320)
..+|.+.+.||+|++|.||++.+. ++.+|+|.+....... +.+.+|+++++.++|+||+++++++...+..++||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVT 82 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCH----HHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCH----HHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEE
Confidence 468999999999999999999985 6789999987644322 57889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccC
Q 020888 120 EYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 198 (320)
Q Consensus 120 e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~ 198 (320)
||+++++|.+++... +.+++..++.++.|++.||.+||++| ++|+||||+||++ +.++.++|+|||++.......
T Consensus 83 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nili--~~~~~~kl~dfg~~~~~~~~~ 158 (267)
T 3t9t_A 83 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLV--GENQVIKVSDFGMTRFVLDDQ 158 (267)
T ss_dssp CCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEE--CGGGCEEECCTTGGGGBCCHH
T ss_pred eCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEE--CCCCCEEEccccccccccccc
Confidence 999999999999864 46899999999999999999999999 9999999999999 888899999999987654321
Q ss_pred ccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHH
Q 020888 199 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPEL 277 (320)
Q Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 277 (320)
........+++.|+|||++.+..++.++|+||||+++|+|++ |..||......+....+..+.... .+..++.++
T Consensus 159 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~-~~~~~~~~l 234 (267)
T 3t9t_A 159 ---YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY-KPRLASTHV 234 (267)
T ss_dssp ---HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC-CCTTSCHHH
T ss_pred ---ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCC-CCccCcHHH
Confidence 112233456788999999998999999999999999999999 899999988887777777665443 344579999
Q ss_pred HHHHHHHhhcCCCCCCCHHHHHHHHHHHHhc
Q 020888 278 RELTEKCWAADMNQRPSFLDILKRLEKIKET 308 (320)
Q Consensus 278 ~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 308 (320)
.+++.+||+.||++|||+.+++++|+++.++
T Consensus 235 ~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 235 YQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 9999999999999999999999999999764
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-46 Score=334.63 Aligned_cols=252 Identities=24% Similarity=0.397 Sum_probs=212.4
Q ss_pred CCcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcccceeeeEEeCCceE
Q 020888 40 SELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLM 116 (320)
Q Consensus 40 ~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 116 (320)
...+|.+.+.||+|+||+||++.++ ++.+|+|++.+...........+.+|..++.++ +||||+++++++...+.+|
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 129 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 129 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence 3458999999999999999999986 678999999776555554556788899999887 8999999999999999999
Q ss_pred EEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccc
Q 020888 117 LITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 196 (320)
Q Consensus 117 iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~ 196 (320)
+||||++|++|.+++...+.+++..+..++.||+.||.|||++| |+||||||+||++ +.++.++|+|||++.....
T Consensus 130 lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl--~~~g~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLL--DSEGHIKLTDYGMCKEGLR 205 (396)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEE--CTTSCEEECCCTTCBCCCC
T ss_pred EEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEE--CCCCCEEEeecceeeeccc
Confidence 99999999999999998889999999999999999999999999 9999999999999 8999999999999975332
Q ss_pred cCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCC---------hHHHHHHHHhCCCCC
Q 020888 197 QNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYE---------PYEAAKYVAEGHRPF 267 (320)
Q Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~---------~~~~~~~~~~~~~~~ 267 (320)
... .....+||+.|+|||++.+..++.++|+|||||++|+|++|..||.... .......+......
T Consensus 206 ~~~----~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~- 280 (396)
T 4dc2_A 206 PGD----TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR- 280 (396)
T ss_dssp TTC----CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCC-
T ss_pred CCC----ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccC-
Confidence 211 2345679999999999999999999999999999999999999996432 22234444444332
Q ss_pred CCCCCCCHHHHHHHHHHhhcCCCCCCCH------HHHHHH
Q 020888 268 FRAKGFTPELRELTEKCWAADMNQRPSF------LDILKR 301 (320)
Q Consensus 268 ~~~~~~~~~l~~li~~~l~~dp~~Rps~------~~ll~~ 301 (320)
.+..++.+++++|++||+.||.+||++ ++++++
T Consensus 281 -~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 281 -IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp -CCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred -CCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 234589999999999999999999985 677765
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=320.01 Aligned_cols=270 Identities=27% Similarity=0.507 Sum_probs=228.6
Q ss_pred CCcccCccc-eecccCceEEEEEEE----CCCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCc
Q 020888 40 SELDFSSSA-IIGKGSFGEILKAYW----RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP 114 (320)
Q Consensus 40 ~~~~y~~~~-~lg~g~~~~vy~~~~----~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 114 (320)
...+|.+.. .||+|+||.||++.+ ++..||+|.+.... .....+.+.+|+++++.++|+||+++++++ ..+.
T Consensus 7 ~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~ 83 (287)
T 1u59_A 7 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEA 83 (287)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSS
T ss_pred cHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCC
Confidence 345677766 999999999999985 36779999886542 344557899999999999999999999999 5567
Q ss_pred eEEEEecCCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccc
Q 020888 115 LMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 193 (320)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~ 193 (320)
.++||||+++++|.+++.. ...+++..++.++.|++.||.+||+.| ++|+||||+||++ +.++.++|+|||++..
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili--~~~~~~kl~Dfg~~~~ 159 (287)
T 1u59_A 84 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLL--VNRHYAKISDFGLSKA 159 (287)
T ss_dssp EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--EETTEEEECCCTTCEE
T ss_pred cEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCchheEEE--cCCCCEEECcccceee
Confidence 8999999999999999965 346999999999999999999999998 9999999999999 7788999999999987
Q ss_pred ccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCC
Q 020888 194 IKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKG 272 (320)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (320)
....... ........+++.|+|||++.+..++.++|+||||+++|+|++ |..||......+....+..+..... +..
T Consensus 160 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~-~~~ 237 (287)
T 1u59_A 160 LGADDSY-YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC-PPE 237 (287)
T ss_dssp CTTCSCE-ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCC-CTT
T ss_pred eccCcce-eeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCC-CCC
Confidence 6543221 112223456889999999998889999999999999999998 9999999888887777776654443 346
Q ss_pred CCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcCCCCCccccc
Q 020888 273 FTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPTDHHWNIF 318 (320)
Q Consensus 273 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~~~~~~~ 318 (320)
+++++.+++.+||..||.+|||+.+++++|+.+..+...+...+.+
T Consensus 238 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~~~~~ 283 (287)
T 1u59_A 238 CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGHHH 283 (287)
T ss_dssp CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCSSCCC
T ss_pred cCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcccCCcc
Confidence 8999999999999999999999999999999999988777665544
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=325.11 Aligned_cols=274 Identities=31% Similarity=0.554 Sum_probs=229.9
Q ss_pred CCCCCCCcCCCCCcccCccceecccCceEEEEEEEC---------CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhC-C
Q 020888 29 LPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR---------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-R 98 (320)
Q Consensus 29 ~~~~~~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~---------~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~ 98 (320)
++....|.+. ..+|.+.+.||+|+||+||++.+. +..||+|.+.... .......+.+|+++++.+ +
T Consensus 24 ~~~~~~~~~~--~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~ 99 (334)
T 2pvf_A 24 LPEDPKWEFP--RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGK 99 (334)
T ss_dssp CCCCTTTBCC--GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCC
T ss_pred CCCCccccCC--HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhc
Confidence 3444445443 568999999999999999999863 4679999886543 334457889999999999 8
Q ss_pred CCcccceeeeEEeCCceEEEEecCCCCCHHHHHHHhC----------------CCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 020888 99 HPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG----------------ALSPSTAVNFALDIARGMAYLHNEPNV 162 (320)
Q Consensus 99 h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~----------------~l~~~~~~~i~~~l~~~l~~lH~~g~~ 162 (320)
|+||+++++++...+..++||||+++++|.+++.... .+++..++.++.|++.||.|||+.|
T Consensus 100 hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-- 177 (334)
T 2pvf_A 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK-- 177 (334)
T ss_dssp CTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred CCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 9999999999999999999999999999999998643 3899999999999999999999998
Q ss_pred eEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHH
Q 020888 163 IIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEML 242 (320)
Q Consensus 163 ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll 242 (320)
++|+||||+||++ +.++.++|+|||++........ ........+++.|+|||++.+..++.++||||||+++|+|+
T Consensus 178 ivH~Dlkp~NIll--~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell 253 (334)
T 2pvf_A 178 CIHRDLAARNVLV--TENNVMKIADFGLARDINNIDY--YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253 (334)
T ss_dssp EECSCCSGGGEEE--CTTCCEEECCCTTCEECTTTSS--EECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHH
T ss_pred eeCCCCccceEEE--cCCCCEEEcccccccccccccc--ccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHH
Confidence 9999999999999 8889999999999986654321 11223345678899999999888999999999999999999
Q ss_pred h-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcCCCCC
Q 020888 243 E-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPTDH 313 (320)
Q Consensus 243 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~~ 313 (320)
+ |..||......+....+........ +..++.++++++.+||..||.+|||+.+++++|+++......+.
T Consensus 254 t~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~~~ 324 (334)
T 2pvf_A 254 TLGGSPYPGIPVEELFKLLKEGHRMDK-PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEE 324 (334)
T ss_dssp TTSCCSSTTCCHHHHHHHHHHTCCCCC-CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC---
T ss_pred hCCCCCcCcCCHHHHHHHHhcCCCCCC-CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccccCc
Confidence 9 9999999888887777776654433 34589999999999999999999999999999999988766544
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=335.06 Aligned_cols=265 Identities=31% Similarity=0.558 Sum_probs=225.2
Q ss_pred CCcCCCCCcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEe
Q 020888 34 DWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE 111 (320)
Q Consensus 34 ~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 111 (320)
.|.++ ..+|.+.+.||+|+||.||++.+. ++.||+|.+.... .......+.+|++++++++||||+++++++..
T Consensus 108 ~~~~~--~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 183 (377)
T 3cbl_A 108 KWVLN--HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ 183 (377)
T ss_dssp TTBCC--GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS--CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECS
T ss_pred ccEEc--hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEec
Confidence 45444 468999999999999999999985 7889999886542 23344678899999999999999999999999
Q ss_pred CCceEEEEecCCCCCHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCC
Q 020888 112 RKPLMLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGL 190 (320)
Q Consensus 112 ~~~~~iv~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~ 190 (320)
.+..++||||+++++|.+++...+ .+++..++.++.|++.||.|||++| ++|+||||+||++ +.++.++|+|||+
T Consensus 184 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nil~--~~~~~~kl~DfG~ 259 (377)
T 3cbl_A 184 KQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC--CIHRDLAARNCLV--TEKNVLKISDFGM 259 (377)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--CTTCCEEECCGGG
T ss_pred CCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cCCcccCHHHEEE--cCCCcEEECcCCC
Confidence 999999999999999999998643 6999999999999999999999998 9999999999999 8889999999999
Q ss_pred cccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCC
Q 020888 191 SKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFR 269 (320)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 269 (320)
+........ ........+++.|+|||.+.+..++.++||||||+++|++++ |..||......+....+..+.....
T Consensus 260 s~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~- 336 (377)
T 3cbl_A 260 SREEADGVY--AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPC- 336 (377)
T ss_dssp CEECTTSEE--ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCC-
T ss_pred ceecCCCce--eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC-
Confidence 875432210 001111234678999999998889999999999999999998 9999999888877777766654443
Q ss_pred CCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcC
Q 020888 270 AKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETL 309 (320)
Q Consensus 270 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 309 (320)
+..+++++.+++.+||+.||++|||++++++.|+++..+.
T Consensus 337 ~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~~ 376 (377)
T 3cbl_A 337 PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRH 376 (377)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhhc
Confidence 4558999999999999999999999999999999998653
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-46 Score=321.67 Aligned_cols=265 Identities=30% Similarity=0.570 Sum_probs=228.2
Q ss_pred CCCCCcCCCCCcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeee
Q 020888 31 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGA 108 (320)
Q Consensus 31 ~~~~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 108 (320)
....|++ ...+|.+.+.||+|++|+||++.+. +..+|+|.+..... ..+.+.+|+++++.++|+||++++++
T Consensus 4 ~~~~~~~--~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~ 77 (288)
T 3kfa_A 4 NYDKWEM--ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGV 77 (288)
T ss_dssp TCCTTBC--CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST----HHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred chhcccc--cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHH----HHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 4445555 4678999999999999999999987 78899998864322 34778899999999999999999999
Q ss_pred EEeCCceEEEEecCCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEe
Q 020888 109 VTERKPLMLITEYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVG 186 (320)
Q Consensus 109 ~~~~~~~~iv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~ 186 (320)
+..++..++||||+++++|.+++... ..+++..++.++.|++.||.+||+.| ++|+||||+||++ +.++.++|+
T Consensus 78 ~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~--~~~~~~~l~ 153 (288)
T 3kfa_A 78 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLV--GENHLVKVA 153 (288)
T ss_dssp ECSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT--CCCSCCSGGGEEE--CGGGCEEEC
T ss_pred EccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC--ccCCCCCcceEEE--cCCCCEEEc
Confidence 99999999999999999999999863 35899999999999999999999999 9999999999999 888899999
Q ss_pred cCCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCC
Q 020888 187 DFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHR 265 (320)
Q Consensus 187 dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~ 265 (320)
|||.+........ .......+++.|+|||.+.+..++.++|+||||+++|+|++ |..||...+.......+.....
T Consensus 154 Dfg~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~ 230 (288)
T 3kfa_A 154 DFGLSRLMTGDTY---TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR 230 (288)
T ss_dssp CCCGGGTSCSSSS---EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC
T ss_pred cCccceeccCCcc---ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCC
Confidence 9999876543321 22233456788999999999999999999999999999999 9999998888777776666544
Q ss_pred CCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcC
Q 020888 266 PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETL 309 (320)
Q Consensus 266 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 309 (320)
.. .+..+++++.+++.+||..||.+|||+.++++.|+.+....
T Consensus 231 ~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~ 273 (288)
T 3kfa_A 231 ME-RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273 (288)
T ss_dssp CC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CC-CCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence 43 34568999999999999999999999999999999987754
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-46 Score=323.92 Aligned_cols=266 Identities=22% Similarity=0.339 Sum_probs=214.6
Q ss_pred CcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEE
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 118 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 118 (320)
..+|.+.+.||+|+||.||++.+. ++.||+|++...........+.+.+|+.+++.++|+||+++++++..++..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 348999999999999999999975 788999998766555556668899999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccC
Q 020888 119 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 198 (320)
Q Consensus 119 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~ 198 (320)
+||+++++|.+++...+.+++..++.++.|++.||.|||+.| ++|+||+|+||++ +.++.++|+|||++.......
T Consensus 113 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~NIl~--~~~~~~kl~Dfg~~~~~~~~~ 188 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG--ATHRDVKPENILV--SADDFAYLVDFGIASATTDEK 188 (309)
T ss_dssp EECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE--CTTSCEEECSCCC--------
T ss_pred EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc--CCcCCCChHHEEE--cCCCCEEEecCccCccccccc
Confidence 999999999999998888999999999999999999999998 9999999999999 888999999999987654322
Q ss_pred ccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCC-CCCCCCCHHH
Q 020888 199 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPF-FRAKGFTPEL 277 (320)
Q Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l 277 (320)
. .......+++.|+|||.+.+..++.++|+||||+++|+|++|..||...........+....... .....++.++
T Consensus 189 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 265 (309)
T 2h34_A 189 L---TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAF 265 (309)
T ss_dssp -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHH
T ss_pred c---ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHH
Confidence 1 12234568899999999999999999999999999999999999998876655444444433222 2345689999
Q ss_pred HHHHHHHhhcCCCCCC-CHHHHHHHHHHHHhcCCCCC
Q 020888 278 RELTEKCWAADMNQRP-SFLDILKRLEKIKETLPTDH 313 (320)
Q Consensus 278 ~~li~~~l~~dp~~Rp-s~~~ll~~L~~~~~~~~~~~ 313 (320)
++++.+||+.||++|| |++++++.|+++......+.
T Consensus 266 ~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~~~ 302 (309)
T 2h34_A 266 DAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQDR 302 (309)
T ss_dssp HHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC------
T ss_pred HHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhcccc
Confidence 9999999999999999 99999999998876665443
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=324.11 Aligned_cols=269 Identities=32% Similarity=0.570 Sum_probs=220.6
Q ss_pred CCcCCCCCcccCccceecccCceEEEEEEECC------CceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceee
Q 020888 34 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRG------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 107 (320)
Q Consensus 34 ~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~------~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 107 (320)
.+..+....+|.+.+.||+|+||+||++.+.. ..||+|.+.... .......+.+|+++++.++|+||+++++
T Consensus 36 ~~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 113 (333)
T 1mqb_A 36 KFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEG 113 (333)
T ss_dssp --CCBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred hccccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEE
Confidence 33345556789999999999999999998752 349999886543 2334467889999999999999999999
Q ss_pred eEEeCCceEEEEecCCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEe
Q 020888 108 AVTERKPLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVG 186 (320)
Q Consensus 108 ~~~~~~~~~iv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~ 186 (320)
++...+..++||||+++++|.+++... +.+++..++.++.|++.||.|||++| ++|+||||+||++ +.++.++|+
T Consensus 114 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~--~~~~~~kl~ 189 (333)
T 1mqb_A 114 VISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILV--NSNLVCKVS 189 (333)
T ss_dssp EECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE--CTTCCEEEC
T ss_pred EEecCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChheEEE--CCCCcEEEC
Confidence 999999999999999999999999864 57999999999999999999999998 9999999999999 888999999
Q ss_pred cCCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCC
Q 020888 187 DFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHR 265 (320)
Q Consensus 187 dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~ 265 (320)
|||++......... ........+++.|+|||.+.+..++.++||||||+++|+|++ |..||......+....+..+..
T Consensus 190 Dfg~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~ 268 (333)
T 1mqb_A 190 DFGLSRVLEDDPEA-TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR 268 (333)
T ss_dssp CCCC------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC
T ss_pred CCCcchhhcccccc-ccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCc
Confidence 99999876543221 111223345778999999999999999999999999999999 9999999888888777776654
Q ss_pred CCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcCC
Q 020888 266 PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLP 310 (320)
Q Consensus 266 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~ 310 (320)
... +..++.++.+++.+||+.||.+|||+.++++.|+++.....
T Consensus 269 ~~~-~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~ 312 (333)
T 1mqb_A 269 LPT-PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 312 (333)
T ss_dssp CCC-CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred CCC-cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence 433 34589999999999999999999999999999999876544
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-46 Score=322.16 Aligned_cols=263 Identities=30% Similarity=0.549 Sum_probs=211.3
Q ss_pred CCCcccCccceecccCceEEEEEEE------CCCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEe-
Q 020888 39 PSELDFSSSAIIGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE- 111 (320)
Q Consensus 39 ~~~~~y~~~~~lg~g~~~~vy~~~~------~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 111 (320)
....+|++.+.||+|+||+||++.. +++.||+|.+... .....+.+.+|+++++.++|+||+++++++..
T Consensus 7 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 83 (295)
T 3ugc_A 7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 83 (295)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH
T ss_pred CCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 3467899999999999999999984 3788999988543 34455789999999999999999999998854
Q ss_pred -CCceEEEEecCCCCCHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCC
Q 020888 112 -RKPLMLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFG 189 (320)
Q Consensus 112 -~~~~~iv~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg 189 (320)
....++||||+++++|.+++...+ .+++..++.++.|++.||.|||+.| ++|+||||+||++ +.++.++|+|||
T Consensus 84 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~--~~~~~~kl~Dfg 159 (295)
T 3ugc_A 84 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILV--ENENRVKIGDFG 159 (295)
T ss_dssp HHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE--EETTEEEECCCC
T ss_pred CCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHhhEEE--cCCCeEEEccCc
Confidence 456899999999999999998743 5999999999999999999999998 9999999999999 778899999999
Q ss_pred CcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH---------------
Q 020888 190 LSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPY--------------- 254 (320)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~--------------- 254 (320)
++......... ........++..|+|||.+.+..++.++||||||+++|++++|..|+......
T Consensus 160 ~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (295)
T 3ugc_A 160 LTKVLPQDKEF-FKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 238 (295)
T ss_dssp SCC--------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHH
T ss_pred ccccccCCcce-eeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhH
Confidence 99876543211 11222344677899999999999999999999999999999999887643211
Q ss_pred -HHHHHHHhCCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcCC
Q 020888 255 -EAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLP 310 (320)
Q Consensus 255 -~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~ 310 (320)
.....+..... ...+..+++++.+++.+||+.||++|||+.++++.|+++.++++
T Consensus 239 ~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l~ 294 (295)
T 3ugc_A 239 FHLIELLKNNGR-LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 294 (295)
T ss_dssp HHHHHHHHTTCC-CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred HHHHHHHhccCc-CCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhcc
Confidence 12222333332 33345689999999999999999999999999999999998764
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-46 Score=320.51 Aligned_cols=250 Identities=30% Similarity=0.495 Sum_probs=216.1
Q ss_pred CCcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEE
Q 020888 40 SELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLML 117 (320)
Q Consensus 40 ~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 117 (320)
...+|.+.+.||+|++|+||++.+. +..+|+|++.............+.+|+++++.++|+||+++++++.+.+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 4458999999999999999999986 66799998855332222234678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccccccc
Q 020888 118 ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 197 (320)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~ 197 (320)
||||+++++|.+++...+.+++..++.++.|++.||.|||+.| ++|+||||+||++ +.++.++|+|||++......
T Consensus 87 v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~dlkp~Nili--~~~~~~~l~Dfg~~~~~~~~ 162 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLL--GSAGELKIADFGWSVHAPSS 162 (279)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT--CEECCCCGGGEEE--CTTSCEEECSCCEESCC---
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHhEEE--cCCCCEEEEeccccccCCcc
Confidence 9999999999999998888999999999999999999999998 9999999999999 88999999999987544322
Q ss_pred CccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHH
Q 020888 198 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPEL 277 (320)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 277 (320)
. .....+++.|+|||.+.+..++.++||||||+++|+|++|..||......+....+....... +..+++++
T Consensus 163 ~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 234 (279)
T 3fdn_A 163 R------RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF--PDFVTEGA 234 (279)
T ss_dssp -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCC--CTTSCHHH
T ss_pred c------ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCC--CCcCCHHH
Confidence 1 223468999999999999999999999999999999999999999988887777776654432 34579999
Q ss_pred HHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 278 RELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 278 ~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
++++.+||+.||.+|||+++++++
T Consensus 235 ~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 235 RDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp HHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred HHHHHHHhccChhhCCCHHHHhhC
Confidence 999999999999999999999987
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-46 Score=325.74 Aligned_cols=264 Identities=30% Similarity=0.519 Sum_probs=208.6
Q ss_pred CCCcccCccceecccCceEEEEEEECC-----CceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCC
Q 020888 39 PSELDFSSSAIIGKGSFGEILKAYWRG-----TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK 113 (320)
Q Consensus 39 ~~~~~y~~~~~lg~g~~~~vy~~~~~~-----~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 113 (320)
....+|.+.+.||+|+||+||++.+.. ..||+|.+........ ..+.+.+|++++++++|+||+++++++....
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 98 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASS-DIEEFLREAACMKEFDHPHVAKLVGVSLRSR 98 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CH-HHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHH-HHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence 345689999999999999999998752 2799998866543433 3578999999999999999999999997765
Q ss_pred ce------EEEEecCCCCCHHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCC
Q 020888 114 PL------MLITEYLRGGDLHKYLKEKG------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD 181 (320)
Q Consensus 114 ~~------~iv~e~~~~~~L~~~~~~~~------~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~ 181 (320)
.. ++||||+++++|.+++.... .+++..++.++.|++.||.|||++| ++|+||||+||++ +.++
T Consensus 99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--ivH~Dikp~NIli--~~~~ 174 (323)
T 3qup_A 99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN--FIHRDLAARNCML--AEDM 174 (323)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE--CTTS
T ss_pred cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC--cccCCCCcceEEE--cCCC
Confidence 54 99999999999999986532 5899999999999999999999999 9999999999999 8889
Q ss_pred cEEEecCCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 020888 182 HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYV 260 (320)
Q Consensus 182 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~ 260 (320)
.++|+|||++.......... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+
T Consensus 175 ~~kl~Dfg~a~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~ 252 (323)
T 3qup_A 175 TVCVADFGLSRKIYSGDYYR--QGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYL 252 (323)
T ss_dssp CEEECCCCC-------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH
T ss_pred CEEEeecccccccccccccc--ccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHH
Confidence 99999999998664432111 1223346778999999999999999999999999999999 99999998888887777
Q ss_pred HhCCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcCC
Q 020888 261 AEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLP 310 (320)
Q Consensus 261 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~ 310 (320)
........ +..+++++.+++.+||+.||.+|||+.++++.|+++.....
T Consensus 253 ~~~~~~~~-~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~ 301 (323)
T 3qup_A 253 IGGNRLKQ-PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLS 301 (323)
T ss_dssp HTTCCCCC-CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred hcCCCCCC-CCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhh
Confidence 76654443 34589999999999999999999999999999999987653
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=338.74 Aligned_cols=266 Identities=29% Similarity=0.524 Sum_probs=226.7
Q ss_pred CCCCcCCCCCcccCccceecccCceEEEEEEEC-CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEE
Q 020888 32 KCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVT 110 (320)
Q Consensus 32 ~~~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~-~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 110 (320)
...|++. ..+|.+.+.||+|+||+||++.++ +..||+|.+...... .+.+.+|++++++++|+||+++++++.
T Consensus 180 ~~~~~i~--~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~l~~~~~ 253 (454)
T 1qcf_A 180 KDAWEIP--RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS----VEAFLAEANVMKTLQHDKLVKLHAVVT 253 (454)
T ss_dssp TTCSBCC--GGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBC----HHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred ccceeec--hHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCcc----HHHHHHHHHHHhhCCCCCEeeEEEEEe
Confidence 3445544 568999999999999999999986 678999988654322 378899999999999999999999886
Q ss_pred eCCceEEEEecCCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecC
Q 020888 111 ERKPLMLITEYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF 188 (320)
Q Consensus 111 ~~~~~~iv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~df 188 (320)
.+..++||||+++++|.+++... ..+++..++.++.|++.||.|||++| ++|+||||+||++ +.++.++|+||
T Consensus 254 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill--~~~~~~kl~DF 328 (454)
T 1qcf_A 254 -KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILV--SASLVCKIADF 328 (454)
T ss_dssp -SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEE--CTTCCEEECST
T ss_pred -CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHHHEEE--CCCCcEEEeeC
Confidence 56789999999999999999753 36899999999999999999999998 9999999999999 88899999999
Q ss_pred CCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCC
Q 020888 189 GLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPF 267 (320)
Q Consensus 189 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~ 267 (320)
|++....... ........++..|+|||++.+..++.++||||||+++|+|++ |..||...+..+....+..+....
T Consensus 329 G~a~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~ 405 (454)
T 1qcf_A 329 GLARVIEDNE---YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMP 405 (454)
T ss_dssp TGGGGBCCHH---HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCC
T ss_pred CCceEcCCCc---eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 9998654321 111123345778999999999999999999999999999999 999999998888888777776544
Q ss_pred CCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcCCCC
Q 020888 268 FRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPTD 312 (320)
Q Consensus 268 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~ 312 (320)
. +..+++++.+++.+||..||++|||++++++.|+.+......+
T Consensus 406 ~-~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~~~ 449 (454)
T 1qcf_A 406 R-PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQ 449 (454)
T ss_dssp C-CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSCCS
T ss_pred C-CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhccccc
Confidence 3 4568999999999999999999999999999999987765544
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=334.38 Aligned_cols=261 Identities=28% Similarity=0.500 Sum_probs=217.4
Q ss_pred CCcccCccceecccCceEEEEEEEC-------CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcccceeeeEEe
Q 020888 40 SELDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTE 111 (320)
Q Consensus 40 ~~~~y~~~~~lg~g~~~~vy~~~~~-------~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 111 (320)
...+|.+.+.||+|+||.||++.+. ++.||+|.+.... .....+.+.+|+++++++ +||||+++++++..
T Consensus 20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~ 97 (359)
T 3vhe_A 20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTK 97 (359)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeeeeeeeec
Confidence 3568999999999999999999842 4779999886542 233457889999999999 79999999999876
Q ss_pred CC-ceEEEEecCCCCCHHHHHHHhCC------------------------------------------------------
Q 020888 112 RK-PLMLITEYLRGGDLHKYLKEKGA------------------------------------------------------ 136 (320)
Q Consensus 112 ~~-~~~iv~e~~~~~~L~~~~~~~~~------------------------------------------------------ 136 (320)
.+ ..++||||+++++|.+++.....
T Consensus 98 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (359)
T 3vhe_A 98 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVE 177 (359)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------
T ss_pred CCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhh
Confidence 54 48999999999999999986432
Q ss_pred ------------CCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCccceee
Q 020888 137 ------------LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK 204 (320)
Q Consensus 137 ------------l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~~~~~ 204 (320)
+++..++.++.|++.||.|||++| |+|+||||+||++ +.++.++|+|||++........ ...
T Consensus 178 ~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~--ivH~Dikp~NIll--~~~~~~kl~Dfg~a~~~~~~~~--~~~ 251 (359)
T 3vhe_A 178 EEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILL--SEKNVVKICDFGLARDIYKDPD--YVR 251 (359)
T ss_dssp ------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE--CGGGCEEECCCGGGSCTTSCTT--CEE
T ss_pred hcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEE--cCCCcEEEEeccceeeeccccc--chh
Confidence 899999999999999999999998 9999999999999 8888999999999986644322 122
Q ss_pred ccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHH
Q 020888 205 MTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEK 283 (320)
Q Consensus 205 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 283 (320)
.....+|+.|+|||++.+..++.++||||||+++|+|++ |..||......+..............+..+++++.+++.+
T Consensus 252 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 331 (359)
T 3vhe_A 252 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLD 331 (359)
T ss_dssp C--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHH
T ss_pred ccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHH
Confidence 334567889999999999999999999999999999998 9999988765444333333333333445689999999999
Q ss_pred HhhcCCCCCCCHHHHHHHHHHHHhc
Q 020888 284 CWAADMNQRPSFLDILKRLEKIKET 308 (320)
Q Consensus 284 ~l~~dp~~Rps~~~ll~~L~~~~~~ 308 (320)
||..||.+|||+.+++++|+.+...
T Consensus 332 ~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 332 CWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp HTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HccCChhhCCCHHHHHHHHHHHHHH
Confidence 9999999999999999999998764
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=331.69 Aligned_cols=251 Identities=27% Similarity=0.424 Sum_probs=217.7
Q ss_pred CcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcccceeeeEEeCCceEE
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLML 117 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~i 117 (320)
..+|.+.+.||+|+||+||++.++ ++.||+|++.+.........+.+..|..++..+ +|++|+++++.+...+..|+
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 348999999999999999999986 678999988654222222236678899999988 79999999999999999999
Q ss_pred EEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccccccc
Q 020888 118 ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 197 (320)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~ 197 (320)
||||++|++|.+++...+.+++..++.++.|++.||.|||++| |+|+||||+||++ +.++.++|+|||++......
T Consensus 99 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll--~~~g~vkL~DFG~a~~~~~~ 174 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVML--DSEGHIKIADFGMCKENIWD 174 (353)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEE--CTTSCEEECCCTTCBCCCCT
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEE--cCCCcEEEEeCCcccccccC
Confidence 9999999999999998888999999999999999999999999 9999999999999 88999999999998754322
Q ss_pred CccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHH
Q 020888 198 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPEL 277 (320)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 277 (320)
.. .....+||+.|+|||++.+..++.++|+||||+++|+|++|..||...+..+....+....... +..++.++
T Consensus 175 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~--p~~~s~~~ 248 (353)
T 2i0e_A 175 GV----TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY--PKSMSKEA 248 (353)
T ss_dssp TC----CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC--CTTSCHHH
T ss_pred Cc----ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCC--CCCCCHHH
Confidence 21 2334678999999999999999999999999999999999999999988888887777765432 35689999
Q ss_pred HHHHHHHhhcCCCCCCC-----HHHHHHH
Q 020888 278 RELTEKCWAADMNQRPS-----FLDILKR 301 (320)
Q Consensus 278 ~~li~~~l~~dp~~Rps-----~~~ll~~ 301 (320)
+++|.+||..||.+||+ +++++++
T Consensus 249 ~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 249 VAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp HHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred HHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 99999999999999995 5888776
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-46 Score=323.31 Aligned_cols=251 Identities=26% Similarity=0.424 Sum_probs=209.3
Q ss_pred cccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCc-----------------------HHHHHHHHHHHHHHHh
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDD-----------------------RLVIQDFRHEVNLLVK 96 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~-----------------------~~~~~~~~~e~~~l~~ 96 (320)
.+|.+.+.||+|+||.||++.+. ++.||+|++....... ....+.+.+|+++++.
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 48999999999999999999875 7889999986543221 1123568899999999
Q ss_pred CCCCcccceeeeEEe--CCceEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEE
Q 020888 97 LRHPNIVQFLGAVTE--RKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVL 174 (320)
Q Consensus 97 l~h~~i~~~~~~~~~--~~~~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~ 174 (320)
++|+||+++++++.. ++..++||||+++++|.++... ..+++..++.++.|++.||.|||++| ++|+||||+||+
T Consensus 93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil 169 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-KPLSEDQARFYFQDLIKGIEYLHYQK--IIHRDIKPSNLL 169 (298)
T ss_dssp CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEE
T ss_pred CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEE
Confidence 999999999999986 5678999999999999886543 57999999999999999999999998 999999999999
Q ss_pred EeeCCCCcEEEecCCCcccccccCccceeeccCCcccccccCccccCcCC---CCCchhHHHHHHHHHHHHhCCCCCCCC
Q 020888 175 LVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRK---YDKKVDVFSFAMILYEMLEGEPPLANY 251 (320)
Q Consensus 175 ~~~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~~l~~ll~g~~p~~~~ 251 (320)
+ +.++.++|+|||++........ ......+|+.|+|||++.+.. .+.++||||||+++|+|++|..||...
T Consensus 170 ~--~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 243 (298)
T 2zv2_A 170 V--GEDGHIKIADFGVSNEFKGSDA----LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE 243 (298)
T ss_dssp E--CTTSCEEECCCTTCEECSSSSC----EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred E--CCCCCEEEecCCCccccccccc----cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence 9 8889999999999986653321 223457899999999998765 367899999999999999999999988
Q ss_pred ChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 252 EPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
........+............++++++++|.+||..||++|||+.+++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 244 RIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp SHHHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred cHHHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 87777666666655544455689999999999999999999999999865
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-46 Score=330.24 Aligned_cols=251 Identities=27% Similarity=0.436 Sum_probs=199.5
Q ss_pred CCCcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceE
Q 020888 39 PSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLM 116 (320)
Q Consensus 39 ~~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 116 (320)
....+|.+.+.||+|+||+||++.+. ++.||+|++.... ..+.+.+|++++++++|+||+++++++...+..+
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 124 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEIS 124 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEE
Confidence 34457999999999999999999986 6789999886542 1256788999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEee-CCCCcEEEecCCCccccc
Q 020888 117 LITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN-SSADHLKVGDFGLSKLIK 195 (320)
Q Consensus 117 iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~-~~~~~~~L~dfg~~~~~~ 195 (320)
+||||+++++|.+++...+.+++..++.++.|++.||.|||+.| ++|+||||+||++.. +.++.++|+|||++....
T Consensus 125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 125 LVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG--IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp EEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 99999999999999988778999999999999999999999998 999999999999932 237899999999987654
Q ss_pred ccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhCCCCCCC--CCC
Q 020888 196 VQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYE-AAKYVAEGHRPFFR--AKG 272 (320)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~-~~~~~~~~~~~~~~--~~~ 272 (320)
... ......+++.|+|||++.+..++.++||||||+++|+|++|..||....... ....+......... ...
T Consensus 203 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~ 277 (349)
T 2w4o_A 203 HQV-----LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDE 277 (349)
T ss_dssp ---------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTT
T ss_pred ccc-----ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhh
Confidence 321 1233568999999999999999999999999999999999999998766544 44445544332222 246
Q ss_pred CCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 273 FTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 273 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
++.+++++|.+||..||++|||+.+++++
T Consensus 278 ~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 278 VSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 89999999999999999999999999885
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=317.88 Aligned_cols=260 Identities=29% Similarity=0.554 Sum_probs=211.1
Q ss_pred CCCCcccCccceecccCceEEEEEEEC-----CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeC
Q 020888 38 DPSELDFSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER 112 (320)
Q Consensus 38 ~~~~~~y~~~~~lg~g~~~~vy~~~~~-----~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 112 (320)
+....+|.+.+.||+|+||+||++.+. +..+++|.+... ......+.+.+|+.++++++||||+++++++. +
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~ 87 (281)
T 1mp8_A 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 87 (281)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-S
T ss_pred EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-c
Confidence 344678999999999999999999874 345899987543 23445578999999999999999999999885 4
Q ss_pred CceEEEEecCCCCCHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCc
Q 020888 113 KPLMLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 191 (320)
Q Consensus 113 ~~~~iv~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~ 191 (320)
+..++||||+++++|.+++.... .+++..++.++.|++.||.|||+.| ++|+||||+||++ +.++.++|+|||++
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~--~~~~~~kl~Dfg~~ 163 (281)
T 1mp8_A 88 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLV--SSNDCVKLGDFGLS 163 (281)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE--EETTEEEECC----
T ss_pred CccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHEEE--CCCCCEEECccccc
Confidence 56899999999999999998654 6999999999999999999999998 9999999999999 77789999999999
Q ss_pred ccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCC
Q 020888 192 KLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRA 270 (320)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 270 (320)
........ .......+++.|+|||.+.+..++.++||||||+++|++++ |..||......+....+........ +
T Consensus 164 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~-~ 239 (281)
T 1mp8_A 164 RYMEDSTY---YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM-P 239 (281)
T ss_dssp ------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCC-C
T ss_pred cccCcccc---cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCC-C
Confidence 87644321 11223346778999999999999999999999999999997 9999998887777777766654433 3
Q ss_pred CCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhc
Q 020888 271 KGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKET 308 (320)
Q Consensus 271 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 308 (320)
..+++++.+++.+||..||++|||+.+++++|+++.+.
T Consensus 240 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 240 PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 45899999999999999999999999999999998765
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-46 Score=332.31 Aligned_cols=278 Identities=27% Similarity=0.513 Sum_probs=220.8
Q ss_pred CCCCcCCCCCcccCccceecccCceEEEEEEEC-----CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCccccee
Q 020888 32 KCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 106 (320)
Q Consensus 32 ~~~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~-----~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 106 (320)
...+.+......|.+.+.||+|+||+||++.+. ...+|+|.+... ......+.+.+|+.++++++||||++++
T Consensus 79 ~~~~~i~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~~~ 156 (373)
T 3c1x_A 79 VQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLL 156 (373)
T ss_dssp TTTTBCCSTTEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC--SCSHHHHHHHHHHTTSTTCCCTTBCCCC
T ss_pred ccccccChhhceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCCCcceEE
Confidence 345567777788999999999999999999864 235888987543 2334457899999999999999999999
Q ss_pred eeEE-eCCceEEEEecCCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEE
Q 020888 107 GAVT-ERKPLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLK 184 (320)
Q Consensus 107 ~~~~-~~~~~~iv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~ 184 (320)
+++. .++..++||||+++++|.+++... ..+++..++.++.|++.||.|||++| ++|+||||+||++ +.++.++
T Consensus 157 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll--~~~~~~k 232 (373)
T 3c1x_A 157 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCML--DEKFTVK 232 (373)
T ss_dssp EEECCCSSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE--CTTCCEE
T ss_pred EEEEcCCCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCccchheEEE--CCCCCEE
Confidence 9864 556789999999999999999864 45899999999999999999999998 9999999999999 8889999
Q ss_pred EecCCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhC
Q 020888 185 VGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEG 263 (320)
Q Consensus 185 L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~ 263 (320)
|+|||++..................+++.|+|||.+.+..++.++||||||+++|+|++ |..||......+....+..+
T Consensus 233 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~ 312 (373)
T 3c1x_A 233 VADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG 312 (373)
T ss_dssp ECCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTT
T ss_pred EeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcC
Confidence 99999998765433222222334456788999999999999999999999999999999 78888877766666666655
Q ss_pred CCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcCCCCCccc
Q 020888 264 HRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPTDHHWN 316 (320)
Q Consensus 264 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~~~~~ 316 (320)
... ..+..++.++.+++.+||..||++|||+.++++.|+++..+...+...+
T Consensus 313 ~~~-~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~~~~~ 364 (373)
T 3c1x_A 313 RRL-LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVH 364 (373)
T ss_dssp CCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCCBCC
T ss_pred CCC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccccceee
Confidence 543 3345689999999999999999999999999999999999998776443
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-46 Score=332.37 Aligned_cols=259 Identities=29% Similarity=0.477 Sum_probs=221.2
Q ss_pred CcccCccceecccCceEEEEEEEC-------CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCC
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK 113 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~-------~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 113 (320)
..+|.+.+.||+|+||.||++.+. ++.||+|.+.... .......+.+|+.++++++|+||+++++++....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 147 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 147 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc--ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 458999999999999999999843 4579999886432 2334467889999999999999999999999999
Q ss_pred ceEEEEecCCCCCHHHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCC---CCcE
Q 020888 114 PLMLITEYLRGGDLHKYLKEKG-------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS---ADHL 183 (320)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~~-------~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~---~~~~ 183 (320)
..++||||+++++|.+++.... .+++..++.++.|++.||.|||++| |+||||||+||++ +. +..+
T Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll--~~~~~~~~~ 223 (367)
T 3l9p_A 148 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLL--TCPGPGRVA 223 (367)
T ss_dssp SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE--SCSSTTCCE
T ss_pred CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEE--ecCCCCceE
Confidence 9999999999999999998643 4899999999999999999999999 9999999999999 53 3459
Q ss_pred EEecCCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHh
Q 020888 184 KVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAE 262 (320)
Q Consensus 184 ~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~ 262 (320)
+|+|||++..+....... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||......+....+..
T Consensus 224 kL~DFG~a~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~ 301 (367)
T 3l9p_A 224 KIGDFGMARDIYRAGYYR--KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS 301 (367)
T ss_dssp EECCCHHHHHHHHHSSCT--TCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT
T ss_pred EECCCccccccccccccc--cCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 999999998664432111 1223456889999999999999999999999999999998 9999999988888877777
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhc
Q 020888 263 GHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKET 308 (320)
Q Consensus 263 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 308 (320)
+..... +..++.++.+++.+||+.||.+|||+.+++++|+.+...
T Consensus 302 ~~~~~~-~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 302 GGRMDP-PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp TCCCCC-CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCCCC-CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 664443 445899999999999999999999999999999988764
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=343.79 Aligned_cols=252 Identities=28% Similarity=0.468 Sum_probs=219.8
Q ss_pred CCCcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceE
Q 020888 39 PSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLM 116 (320)
Q Consensus 39 ~~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 116 (320)
....+|.+.+.||+|+||.||++.+. ++.||+|++.............+.+|+++++.++||||+++++++...+..|
T Consensus 13 ~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~ 92 (476)
T 2y94_A 13 VKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIF 92 (476)
T ss_dssp CEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred ceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 33458999999999999999999986 8899999886432222223467889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccc
Q 020888 117 LITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 196 (320)
Q Consensus 117 iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~ 196 (320)
+||||++|++|.+++...+.+++..++.++.|++.||.|||+.| |+|+||||+||++ +.++.++|+|||++.....
T Consensus 93 lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDLkp~NIll--~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 93 MVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM--VVHRDLKPENVLL--DAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp EEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEE--CTTCCEEECCCSSCEECCT
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcccccHHHEEE--ecCCCeEEEeccchhhccc
Confidence 99999999999999988788999999999999999999999999 9999999999999 8889999999999986643
Q ss_pred cCccceeeccCCcccccccCccccCcCCC-CCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCH
Q 020888 197 QNSHDVYKMTGETGSYRYMAPEVFKHRKY-DKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTP 275 (320)
Q Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (320)
.. .....+|++.|+|||++.+..+ +.++||||||+++|+|++|..||...+.......+..+... .+..+++
T Consensus 169 ~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~--~p~~~s~ 241 (476)
T 2y94_A 169 GE-----FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFY--TPQYLNP 241 (476)
T ss_dssp TC-----CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCC--CCTTCCH
T ss_pred cc-----cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcC--CCccCCH
Confidence 32 2234578999999999988765 68999999999999999999999988877777777766543 2345799
Q ss_pred HHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 276 ELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 276 ~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
+++++|.+||..||.+|||+++++++
T Consensus 242 ~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 242 SVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred HHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 99999999999999999999999986
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=331.80 Aligned_cols=251 Identities=22% Similarity=0.408 Sum_probs=216.2
Q ss_pred CcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEE
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 118 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 118 (320)
..+|.+.+.||+|+||.||++.+. ++.+|+|++.... ......+.+|+++++.++|+||+++++++.+....++|
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 126 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 126 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc---hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEE
Confidence 458999999999999999999986 7889999885432 22346788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccccccc
Q 020888 119 TEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 197 (320)
Q Consensus 119 ~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~ 197 (320)
|||++|++|.+++...+ .+++..++.++.|++.||.|||++| |+|+||||+||++..+..+.++|+|||++......
T Consensus 127 ~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 127 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred EEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 99999999999987643 6999999999999999999999998 99999999999994445678999999999876443
Q ss_pred CccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCC--CCCCCCCH
Q 020888 198 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPF--FRAKGFTP 275 (320)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 275 (320)
.. .....+|+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+....... .....+++
T Consensus 205 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 279 (387)
T 1kob_A 205 EI-----VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSP 279 (387)
T ss_dssp SC-----EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCH
T ss_pred cc-----eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCH
Confidence 21 123468999999999999999999999999999999999999999988777777666654322 22246899
Q ss_pred HHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 276 ELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 276 ~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
+++++|.+||..||.+|||+.+++++
T Consensus 280 ~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 280 EAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 99999999999999999999999986
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=318.26 Aligned_cols=250 Identities=27% Similarity=0.432 Sum_probs=205.7
Q ss_pred cccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEE
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 119 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 119 (320)
.+|++.+.||+|+||+||++.+. ++.||+|.+....... .....+.+|++++++++|+||+++++++..++..++||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSST-THHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcC-CcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEE
Confidence 37999999999999999999985 7889999987654433 33467889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccC
Q 020888 120 EYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 198 (320)
Q Consensus 120 e~~~~~~L~~~~~~-~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~ 198 (320)
||+++ +|.+.+.. .+.+++..++.++.|++.||.|||++| ++|+||||+||++ +.++.++|+|||++.......
T Consensus 81 e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--ivH~dikp~Nil~--~~~~~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 81 EFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLI--NRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp ECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--CTTSCEEECCCTTCEECCSCC
T ss_pred ecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEE--cCCCCEEEeecccceecCCcc
Confidence 99976 66665554 668999999999999999999999999 9999999999999 888999999999997654322
Q ss_pred ccceeeccCCcccccccCccccCcCC-CCCchhHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHhCCCCC---------
Q 020888 199 SHDVYKMTGETGSYRYMAPEVFKHRK-YDKKVDVFSFAMILYEMLEGEPPL-ANYEPYEAAKYVAEGHRPF--------- 267 (320)
Q Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~g~~p~-~~~~~~~~~~~~~~~~~~~--------- 267 (320)
. ......+|+.|+|||++.+.. ++.++||||||+++|+|++|..|| ...+..+....+.......
T Consensus 156 ~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 231 (292)
T 3o0g_A 156 R----CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp S----CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred c----cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhc
Confidence 1 223456799999999997765 799999999999999999988884 5555555444443211000
Q ss_pred ------------------CCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 268 ------------------FRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 268 ------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
.....++++++++|.+||+.||++|||+++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0112478999999999999999999999999875
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=319.31 Aligned_cols=261 Identities=21% Similarity=0.277 Sum_probs=216.5
Q ss_pred CcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcccceeeeEEeCCceEE
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLML 117 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~i 117 (320)
..+|.+.+.||+|++|.||++.+. ++.||+|++...... ..+.+|++.++.+ +|++++++++++..+...++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~l 83 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 83 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc-----HHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEE
Confidence 458999999999999999999964 889999988654322 4577899999999 79999999999999999999
Q ss_pred EEecCCCCCHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCc-----EEEecCCCc
Q 020888 118 ITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH-----LKVGDFGLS 191 (320)
Q Consensus 118 v~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~-----~~L~dfg~~ 191 (320)
||||+ +++|.+++...+ ++++..++.++.|++.||.|||++| ++|+||||+||++ +.++. ++|+|||++
T Consensus 84 v~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~--~~~~~~~~~~~kl~Dfg~~ 158 (298)
T 1csn_A 84 VIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLI--GRPNSKNANMIYVVDFGMV 158 (298)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEE--CCSSSTTTTCEEECCCTTC
T ss_pred EEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEe--ccCCCCCCCeEEEEECccc
Confidence 99999 889999998744 5999999999999999999999998 9999999999999 55554 999999999
Q ss_pred ccccccCccce---eeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHhCC-
Q 020888 192 KLIKVQNSHDV---YKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYE---PYEAAKYVAEGH- 264 (320)
Q Consensus 192 ~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~---~~~~~~~~~~~~- 264 (320)
........... .......+|+.|+|||++.+..++.++||||||+++|+|++|..||.... .......+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (298)
T 1csn_A 159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ 238 (298)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred cccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhcc
Confidence 87765432211 12344568999999999999999999999999999999999999998753 223222222211
Q ss_pred --CCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcCCC
Q 020888 265 --RPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPT 311 (320)
Q Consensus 265 --~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~ 311 (320)
........+++++++++.+||+.||.+|||++++++.|+++..+...
T Consensus 239 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~ 287 (298)
T 1csn_A 239 STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT 287 (298)
T ss_dssp HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred CccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCC
Confidence 11111235899999999999999999999999999999999988654
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-46 Score=332.36 Aligned_cols=250 Identities=26% Similarity=0.425 Sum_probs=211.6
Q ss_pred CcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEE
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 118 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 118 (320)
..+|.+.+.||+|+||.||++.+. ++.||+|++.............+.+|+++++.++||||+++++++...+..|+|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 458999999999999999999986 678999988654322222346788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccC
Q 020888 119 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 198 (320)
Q Consensus 119 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~ 198 (320)
|||++|++|.+++...+.+++..+..++.|++.||.|||+.| |+|+||||+||++ +.++.++|+|||++..+....
T Consensus 94 ~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll--~~~g~vkL~DFG~a~~~~~~~ 169 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQR--IIHRDMKPDNILL--DEHGHVHITDFNIAAMLPRET 169 (384)
T ss_dssp ECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--CTTSCEEECCCTTCEECCTTC
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEE--CCCCCEEEeccceeeeccCCC
Confidence 999999999999998888999999999999999999999999 9999999999999 889999999999998664322
Q ss_pred ccceeeccCCcccccccCccccCc---CCCCCchhHHHHHHHHHHHHhCCCCCCCC---ChHHHHHHHHhCCCCCCCCCC
Q 020888 199 SHDVYKMTGETGSYRYMAPEVFKH---RKYDKKVDVFSFAMILYEMLEGEPPLANY---EPYEAAKYVAEGHRPFFRAKG 272 (320)
Q Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~~ll~g~~p~~~~---~~~~~~~~~~~~~~~~~~~~~ 272 (320)
.....+||+.|+|||++.+ ..++.++|+|||||++|+|++|..||... ...+....+...... .+..
T Consensus 170 -----~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~--~p~~ 242 (384)
T 4fr4_A 170 -----QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVT--YPSA 242 (384)
T ss_dssp -----CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCC--CCTT
T ss_pred -----ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccC--CCCc
Confidence 2344679999999999864 45889999999999999999999999743 333444444443332 2345
Q ss_pred CCHHHHHHHHHHhhcCCCCCCC-HHHHHHH
Q 020888 273 FTPELRELTEKCWAADMNQRPS-FLDILKR 301 (320)
Q Consensus 273 ~~~~l~~li~~~l~~dp~~Rps-~~~ll~~ 301 (320)
++.++.++|.+||..||.+||+ +++++++
T Consensus 243 ~s~~~~~li~~lL~~dP~~R~s~~~~l~~h 272 (384)
T 4fr4_A 243 WSQEMVSLLKKLLEPNPDQRFSQLSDVQNF 272 (384)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCSHHHHHTS
T ss_pred CCHHHHHHHHHHhcCCHhHhcccHHHHHcC
Confidence 8999999999999999999998 7777653
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=329.52 Aligned_cols=252 Identities=29% Similarity=0.439 Sum_probs=210.5
Q ss_pred cccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEE
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 119 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 119 (320)
.+|++.+.||+|+||+||++.+. ++.||+|++....... ..+.+.+|+.+++.++|+||+++++++..++..|+||
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 84 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccc--hHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 47999999999999999999986 7889999885443322 2367889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCc
Q 020888 120 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 199 (320)
Q Consensus 120 e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~ 199 (320)
||+++++|.+++.....+++..++.++.|++.||.|||+.| ++|+||||+||++ +.++.++|+|||++........
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll--~~~~~~kl~Dfg~a~~~~~~~~ 160 (323)
T 3tki_A 85 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLL--DERDNLKISDFGLATVFRYNNR 160 (323)
T ss_dssp ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--CTTCCEEECCCTTCEECEETTE
T ss_pred EcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccchHHEEE--eCCCCEEEEEeeccceeccCCc
Confidence 99999999999988778999999999999999999999999 9999999999999 8889999999999986643321
Q ss_pred cceeeccCCcccccccCccccCcCCC-CCchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHhCCCCCCCCCCCCHHH
Q 020888 200 HDVYKMTGETGSYRYMAPEVFKHRKY-DKKVDVFSFAMILYEMLEGEPPLANYEPY-EAAKYVAEGHRPFFRAKGFTPEL 277 (320)
Q Consensus 200 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~ll~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l 277 (320)
........+++.|+|||++.+..+ +.++||||||+++|+|++|..||...... ..................++.++
T Consensus 161 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (323)
T 3tki_A 161 --ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 238 (323)
T ss_dssp --ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHH
T ss_pred --ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHH
Confidence 112334578999999999987775 77999999999999999999999876543 22333333333333335689999
Q ss_pred HHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 278 RELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 278 ~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
.+++.+||..||.+|||+++++++
T Consensus 239 ~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 239 LALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHHHHccCChhhCcCHHHHhhC
Confidence 999999999999999999999876
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=323.75 Aligned_cols=251 Identities=27% Similarity=0.441 Sum_probs=208.5
Q ss_pred CcccCccceecccCceEEEEEEE-----CCCceEEEEccCCCCC-cHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCc
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYW-----RGTPVAIKRILPSLSD-DRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP 114 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~-----~~~~~~~K~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 114 (320)
..+|.+.+.||+|+||.||++.+ +++.+|+|++...... .......+.+|+++++.++|+||+++++++..++.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 45899999999999999999987 3788999998765332 22234667889999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccc
Q 020888 115 LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 194 (320)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~ 194 (320)
.|+||||++|++|.+++...+.+++..++.++.|++.||.|||++| |+|+||||+||++ +.++.++|+|||++...
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~Nill--~~~~~~kl~Dfg~~~~~ 171 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKG--IIYRDLKPENIML--NHQGHVKLTDFGLCKES 171 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEE--CTTSCEEECCCSCC---
T ss_pred EEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEcccCCHHHeEE--CCCCcEEEEeCCccccc
Confidence 9999999999999999998888999999999999999999999999 9999999999999 88899999999998754
Q ss_pred cccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCC
Q 020888 195 KVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFT 274 (320)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (320)
..... ......|++.|+|||++.+..++.++|+||||+++|+|++|..||...+..+....+....... +..++
T Consensus 172 ~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~--p~~~~ 245 (327)
T 3a62_A 172 IHDGT----VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNL--PPYLT 245 (327)
T ss_dssp -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC--CTTSC
T ss_pred ccCCc----cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC--CCCCC
Confidence 33221 2234568999999999999999999999999999999999999999988887777777654332 34579
Q ss_pred HHHHHHHHHHhhcCCCCCC-----CHHHHHHH
Q 020888 275 PELRELTEKCWAADMNQRP-----SFLDILKR 301 (320)
Q Consensus 275 ~~l~~li~~~l~~dp~~Rp-----s~~~ll~~ 301 (320)
.+++++|.+||..||.+|| ++++++++
T Consensus 246 ~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 246 QEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp HHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred HHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 9999999999999999999 78898876
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=317.86 Aligned_cols=253 Identities=26% Similarity=0.395 Sum_probs=223.3
Q ss_pred CCCcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceE
Q 020888 39 PSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLM 116 (320)
Q Consensus 39 ~~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 116 (320)
....+|.+.+.||+|+||.||++.+. ++.+++|++...........+.+.+|+.+++.++|+||+++++++...+..+
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 91 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEE
Confidence 34568999999999999999999986 7789999987766555666688999999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccc
Q 020888 117 LITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 196 (320)
Q Consensus 117 iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~ 196 (320)
+||||+++++|.+++...+.+++..++.++.|++.||.|||++| ++|+||+|+||++ +.++.++|+|||.+.....
T Consensus 92 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~--~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 92 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFL--NEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp EEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEE--CTTCCEEECCCTTCEECCS
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEE--cCCCCEEEEeccCceeccc
Confidence 99999999999999998888999999999999999999999998 9999999999999 8889999999999987643
Q ss_pred cCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHH
Q 020888 197 QNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPE 276 (320)
Q Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (320)
... ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||......+....+...... .+..++.+
T Consensus 168 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 241 (294)
T 2rku_A 168 DGE----RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS--IPKHINPV 241 (294)
T ss_dssp TTC----CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCC--CCTTSCHH
T ss_pred Ccc----ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCC--CccccCHH
Confidence 221 123356899999999999999999999999999999999999999988877766666655432 23468999
Q ss_pred HHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 277 LRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 277 l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
+.+++.+||+.||++|||+++++++
T Consensus 242 ~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 242 AASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp HHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred HHHHHHHHcccChhhCcCHHHHhhC
Confidence 9999999999999999999999986
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=324.01 Aligned_cols=253 Identities=25% Similarity=0.406 Sum_probs=218.7
Q ss_pred CCcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcH---HHHHHHHHHHHHHHhCCCCcccceeeeEEeCCc
Q 020888 40 SELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDR---LVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP 114 (320)
Q Consensus 40 ~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 114 (320)
-..+|.+.+.||+|+||.||++.+. ++.+|+|.+........ ...+.+.+|+++++.++|+||+++++++...+.
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 3458999999999999999999986 78899998866543321 123678899999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCC----cEEEecCCC
Q 020888 115 LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD----HLKVGDFGL 190 (320)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~----~~~L~dfg~ 190 (320)
.++||||+++++|.+++...+.+++..++.++.|++.||.|||+.| ++|+||||+||++ +.++ .++|+|||+
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--ivH~dikp~NIl~--~~~~~~~~~~kl~Dfg~ 165 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIML--LDKNIPIPHIKLIDFGL 165 (321)
T ss_dssp EEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--SCTTSSSCCEEECCCTT
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChHHEEE--ecCCCCcCCEEEccCcc
Confidence 9999999999999999998778999999999999999999999998 9999999999999 6666 799999999
Q ss_pred cccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCC-
Q 020888 191 SKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR- 269 (320)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~- 269 (320)
+....... ......+++.|+|||++.+..++.++|+||||+++|+|++|..||......+....+.........
T Consensus 166 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 240 (321)
T 2a2a_A 166 AHEIEDGV-----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEE 240 (321)
T ss_dssp CEECCTTC-----CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHH
T ss_pred ceecCccc-----cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChh
Confidence 98665432 123456899999999999999999999999999999999999999988887777766655433221
Q ss_pred -CCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 270 -AKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 270 -~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
...++..++++|.+||..||.+|||+++++++
T Consensus 241 ~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 241 FFSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp HHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred hhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 14579999999999999999999999999875
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=328.01 Aligned_cols=245 Identities=27% Similarity=0.424 Sum_probs=207.5
Q ss_pred cceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEecCCC
Q 020888 47 SAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRG 124 (320)
Q Consensus 47 ~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~ 124 (320)
.+.||+|+||.||++.+. ++.||+|++.... ....+.+.+|++++++++|+||+++++++...+..++||||+++
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~ 170 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRG---MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDG 170 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc---cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCC
Confidence 568999999999999985 7899999886532 23447889999999999999999999999999999999999999
Q ss_pred CCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCcccee
Q 020888 125 GDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 203 (320)
Q Consensus 125 ~~L~~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~~~~ 203 (320)
++|.+++... ..+++..++.++.|++.||.|||+.| |+|+||||+||++..+.++.++|+|||++.......
T Consensus 171 ~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~----- 243 (373)
T 2x4f_A 171 GELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY--ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE----- 243 (373)
T ss_dssp CEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC-----
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc-----
Confidence 9999988653 46999999999999999999999999 999999999999976677899999999998765432
Q ss_pred eccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCC--CCCCCCHHHHHHH
Q 020888 204 KMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFF--RAKGFTPELRELT 281 (320)
Q Consensus 204 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li 281 (320)
......+|+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+........ ....++++++++|
T Consensus 244 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 323 (373)
T 2x4f_A 244 KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFI 323 (373)
T ss_dssp BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHH
T ss_pred ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHH
Confidence 12234689999999999999999999999999999999999999999888777776666543322 2246899999999
Q ss_pred HHHhhcCCCCCCCHHHHHHH
Q 020888 282 EKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 282 ~~~l~~dp~~Rps~~~ll~~ 301 (320)
.+||..||.+|||+++++++
T Consensus 324 ~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 324 SKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp HTTSCSSGGGSCCHHHHHHS
T ss_pred HHHcCCChhhCCCHHHHhcC
Confidence 99999999999999999985
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=315.10 Aligned_cols=264 Identities=30% Similarity=0.536 Sum_probs=222.9
Q ss_pred CCcCCCCCcccCccceecccCceEEEEEEEC-CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeC
Q 020888 34 DWEIDPSELDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER 112 (320)
Q Consensus 34 ~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~-~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 112 (320)
+|++. ..+|.+.+.||+|++|+||++.++ +..+|+|.+...... .+.+.+|+++++.++|+||+++++++..
T Consensus 7 ~~~v~--~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~- 79 (279)
T 1qpc_A 7 EWEVP--RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVTQ- 79 (279)
T ss_dssp TTBCC--GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred hcccC--HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCccc----HHHHHHHHHHHHhCCCcCcceEEEEEcC-
Confidence 34443 468999999999999999999987 568999988654332 2678899999999999999999998864
Q ss_pred CceEEEEecCCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCC
Q 020888 113 KPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGL 190 (320)
Q Consensus 113 ~~~~iv~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~ 190 (320)
+..++||||+++++|.+++.... .+++..++.++.|++.||.+||++| ++|+||||+||++ +.++.++|+|||.
T Consensus 80 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~--~~~~~~kl~Dfg~ 155 (279)
T 1qpc_A 80 EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILV--SDTLSCKIADFGL 155 (279)
T ss_dssp SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--CTTSCEEECCCTT
T ss_pred CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHhhEEE--cCCCCEEECCCcc
Confidence 45899999999999999987532 6999999999999999999999999 9999999999999 8889999999999
Q ss_pred cccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCC
Q 020888 191 SKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFR 269 (320)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 269 (320)
+....... ........++..|+|||.+.+..++.++||||||+++++|++ |..||......+....+....... .
T Consensus 156 ~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~-~ 231 (279)
T 1qpc_A 156 ARLIEDNE---YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV-R 231 (279)
T ss_dssp CEECSSSC---EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC-C
T ss_pred cccccCcc---cccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCC-C
Confidence 98664322 112233456778999999998889999999999999999999 999999988887777776665443 3
Q ss_pred CCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcCCCC
Q 020888 270 AKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPTD 312 (320)
Q Consensus 270 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~ 312 (320)
+..+++++.+++.+||..||++|||+.++++.|+.+.......
T Consensus 232 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~ 274 (279)
T 1qpc_A 232 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQ 274 (279)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC---
T ss_pred cccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccCC
Confidence 4568999999999999999999999999999999998876543
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=335.50 Aligned_cols=251 Identities=33% Similarity=0.628 Sum_probs=219.1
Q ss_pred CcccCccceecccCceEEEEEEECCCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCC-ceEEEE
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK-PLMLIT 119 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~iv~ 119 (320)
..+|.+.+.||+|+||.||++.++++.||+|.+.... ..+.+.+|++++++++|+||+++++++.... ..++||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~ 266 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 266 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEE
T ss_pred hHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEE
Confidence 5689999999999999999999999999999986543 1267889999999999999999999986654 789999
Q ss_pred ecCCCCCHHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccccccc
Q 020888 120 EYLRGGDLHKYLKEKGA--LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 197 (320)
Q Consensus 120 e~~~~~~L~~~~~~~~~--l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~ 197 (320)
||+++++|.+++...+. +++..++.++.|++.||.|||++| ++|+||||+||++ +.++.++|+|||++......
T Consensus 267 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill--~~~~~~kl~DfG~a~~~~~~ 342 (450)
T 1k9a_A 267 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLV--SEDNVAKVSDFGLTKEASST 342 (450)
T ss_dssp ECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEE--CTTSCEEECCCTTCEECC--
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEE--CCCCCEEEeeCCCccccccc
Confidence 99999999999987543 799999999999999999999998 9999999999999 88899999999998754321
Q ss_pred CccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHH
Q 020888 198 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPE 276 (320)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (320)
.....++..|+|||++.+..++.++||||||+++|+|++ |..||......+....+..+.... .+..++++
T Consensus 343 -------~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~-~p~~~~~~ 414 (450)
T 1k9a_A 343 -------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMD-APDGCPPA 414 (450)
T ss_dssp -----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCC-CCTTCCHH
T ss_pred -------ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-CCCcCCHH
Confidence 112346788999999999999999999999999999998 999999888777777777665444 34568999
Q ss_pred HHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhc
Q 020888 277 LRELTEKCWAADMNQRPSFLDILKRLEKIKET 308 (320)
Q Consensus 277 l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 308 (320)
+.+++.+||..||.+|||+.++++.|+.+...
T Consensus 415 l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 415 VYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 99999999999999999999999999998764
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=328.03 Aligned_cols=269 Identities=30% Similarity=0.472 Sum_probs=217.7
Q ss_pred CCCCcCCCCCcccCccceecccCceEEEEEEEC-CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEE
Q 020888 32 KCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVT 110 (320)
Q Consensus 32 ~~~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~-~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 110 (320)
.....+.....+|.+.+.||+|+||+||++.+. ++.||+|.+..... ...+.+.+|+++++.++|+||+++++++.
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 105 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESS---QGIEEFETEIETLSFCRHPHLVSLIGFCD 105 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCS---SHHHHHHHHHHGGGSCCCTTBCCEEEECC
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccCh---HHHHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence 334456777889999999999999999999976 78999998765432 23478899999999999999999999999
Q ss_pred eCCceEEEEecCCCCCHHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEe
Q 020888 111 ERKPLMLITEYLRGGDLHKYLKEKG----ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVG 186 (320)
Q Consensus 111 ~~~~~~iv~e~~~~~~L~~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~ 186 (320)
..+..++||||+++++|.+++.... .+++..++.++.|++.||.|||++| ++|+||||+||++ +.++.++|+
T Consensus 106 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~--~~~~~~kl~ 181 (321)
T 2qkw_B 106 ERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA--IIHRDVKSINILL--DENFVPKIT 181 (321)
T ss_dssp CTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCSTTEEE--CTTCCEEEC
T ss_pred CCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC--eecCCCCHHHEEE--CCCCCEEEe
Confidence 9999999999999999999986532 5899999999999999999999998 9999999999999 889999999
Q ss_pred cCCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHH-------HH
Q 020888 187 DFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAA-------KY 259 (320)
Q Consensus 187 dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~-------~~ 259 (320)
|||++........ ........+++.|+|||++.+..++.++||||||+++|+|++|..||....+.+.. ..
T Consensus 182 Dfg~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~ 259 (321)
T 2qkw_B 182 DFGISKKGTELDQ--THLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVES 259 (321)
T ss_dssp CCTTCEECSSSSC--CCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHH
T ss_pred ecccccccccccc--cccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhc
Confidence 9999876543221 11123345799999999999899999999999999999999999999764332110 01
Q ss_pred HHhCCCCC--------CCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcC
Q 020888 260 VAEGHRPF--------FRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETL 309 (320)
Q Consensus 260 ~~~~~~~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 309 (320)
........ ......+..+.+++.+||..||++|||+.+++++|+.+....
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~ 317 (321)
T 2qkw_B 260 HNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ 317 (321)
T ss_dssp HTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred cccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcc
Confidence 11111000 011224567999999999999999999999999999987643
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=332.65 Aligned_cols=260 Identities=18% Similarity=0.342 Sum_probs=212.7
Q ss_pred CCCCCcccCccceeccc--CceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeC
Q 020888 37 IDPSELDFSSSAIIGKG--SFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER 112 (320)
Q Consensus 37 ~~~~~~~y~~~~~lg~g--~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 112 (320)
+.....+|++++.||+| +||+||++.+. ++.||+|.+...... ....+.+.+|+++++.++|+||+++++++..+
T Consensus 20 ~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 98 (389)
T 3gni_B 20 FLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACS-NEMVTFLQGELHVSKLFNHPNIVPYRATFIAD 98 (389)
T ss_dssp CCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred ccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccC-hHHHHHHHHHHHHHHhCCCCCCCcEeEEEEEC
Confidence 44557799999999999 99999999986 889999998765433 34557889999999999999999999999999
Q ss_pred CceEEEEecCCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCC
Q 020888 113 KPLMLITEYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGL 190 (320)
Q Consensus 113 ~~~~iv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~ 190 (320)
+..++||||+++++|.+++... ..+++..+..++.||+.||.|||++| |+|+||||+||++ +.++.++|+|||.
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~NIll--~~~~~~kl~dfg~ 174 (389)
T 3gni_B 99 NELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILI--SVDGKVYLSGLRS 174 (389)
T ss_dssp TEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--CTTCCEEECCGGG
T ss_pred CEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEE--cCCCCEEEccccc
Confidence 9999999999999999999875 67999999999999999999999999 9999999999999 8889999999998
Q ss_pred cccccccCccce---eeccCCcccccccCccccCc--CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCC
Q 020888 191 SKLIKVQNSHDV---YKMTGETGSYRYMAPEVFKH--RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHR 265 (320)
Q Consensus 191 ~~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~ 265 (320)
+........... .......+++.|+|||++.+ ..++.++|||||||++|+|++|..||..............+..
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 254 (389)
T 3gni_B 175 NLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTV 254 (389)
T ss_dssp CEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----
T ss_pred ceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC
Confidence 876543321111 11122468899999999987 5789999999999999999999999987654433322211110
Q ss_pred C--------------------------------------------CCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 266 P--------------------------------------------FFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 266 ~--------------------------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
+ ......+++++++||.+||+.||.+|||+++++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 255 PCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp ---------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 0 01124478899999999999999999999999976
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=326.81 Aligned_cols=248 Identities=33% Similarity=0.489 Sum_probs=219.0
Q ss_pred CcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEE
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 118 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 118 (320)
...|...+.||+|+||+||++.+. ++.||+|.+...........+.+.+|++++++++|+||+++++++..++..++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 456999999999999999999974 788999998766555555667899999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccccccc
Q 020888 119 TEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 197 (320)
Q Consensus 119 ~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~ 197 (320)
|||++| +|.+++.. ...+++..++.++.|++.||.|||+.| ++|+||||+||++ +.++.++|+|||++......
T Consensus 133 ~e~~~g-~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll--~~~~~~kL~DfG~a~~~~~~ 207 (348)
T 1u5q_A 133 MEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILL--SEPGLVKLGDFGSASIMAPA 207 (348)
T ss_dssp EECCSE-EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEE--ETTTEEEECCCTTCBSSSSB
T ss_pred EecCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEE--CCCCCEEEeeccCceecCCC
Confidence 999975 88888764 567999999999999999999999998 9999999999999 88899999999998765422
Q ss_pred CccceeeccCCcccccccCccccC---cCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCC
Q 020888 198 NSHDVYKMTGETGSYRYMAPEVFK---HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFT 274 (320)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (320)
....+|+.|+|||++. +..++.++||||||+++|+|++|..||...+..+....+.....+......++
T Consensus 208 --------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (348)
T 1u5q_A 208 --------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWS 279 (348)
T ss_dssp --------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSC
T ss_pred --------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCC
Confidence 2356899999999984 56789999999999999999999999998888777777777776666667789
Q ss_pred HHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 275 PELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 275 ~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
+.+++++.+||+.||.+|||+++++++
T Consensus 280 ~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 280 EYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred HHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 999999999999999999999999875
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=315.05 Aligned_cols=250 Identities=28% Similarity=0.471 Sum_probs=217.5
Q ss_pred CcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEE
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 118 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 118 (320)
..+|.+.+.||+|+||+||++.+. +..+++|.+....... .+.+.+|+++++.++|+||+++++++..++..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED---VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLV 84 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch---HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEE
Confidence 357999999999999999999986 5679999886654443 36788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEee-CCCCcEEEecCCCccccccc
Q 020888 119 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN-SSADHLKVGDFGLSKLIKVQ 197 (320)
Q Consensus 119 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~-~~~~~~~L~dfg~~~~~~~~ 197 (320)
|||+++++|.+++...+.+++..++.++.|++.||.|||++| ++|+||||+||++.. +.++.++|+|||++......
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~ 162 (277)
T 3f3z_A 85 MELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG 162 (277)
T ss_dssp EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT
T ss_pred EeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc
Confidence 999999999999988888999999999999999999999999 999999999999932 45678999999999766543
Q ss_pred CccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCC--CCCCH
Q 020888 198 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA--KGFTP 275 (320)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 275 (320)
. ......+++.|+|||.+.+. ++.++|+||||+++|+|++|..||......+....+..+....... ..+++
T Consensus 163 ~-----~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (277)
T 3f3z_A 163 K-----MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSP 236 (277)
T ss_dssp S-----CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCH
T ss_pred c-----chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCH
Confidence 2 22345689999999998765 8999999999999999999999999988888877777765443332 25799
Q ss_pred HHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 276 ELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 276 ~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
++++++.+||+.||.+|||+.+++++
T Consensus 237 ~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 237 QAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcC
Confidence 99999999999999999999999876
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-45 Score=320.65 Aligned_cols=247 Identities=27% Similarity=0.459 Sum_probs=215.5
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEe
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 120 (320)
.|...+.||+|+||.||++.+. ++.||+|++....... .+.+.+|+.+++.++|+||+++++++...+..++|||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 122 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQR---RELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME 122 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCS---HHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhH---HHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 4777789999999999999985 8899999986554333 3678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCcc
Q 020888 121 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 200 (320)
Q Consensus 121 ~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~ 200 (320)
|+++++|.+++.. ..+++..+..++.|++.||.|||+.| ++|+||||+||++ +.++.++|+|||++........
T Consensus 123 ~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll--~~~~~~kl~Dfg~~~~~~~~~~- 196 (321)
T 2c30_A 123 FLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQG--VIHRDIKSDSILL--TLDGRVKLSDFGFCAQISKDVP- 196 (321)
T ss_dssp CCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--CTTCCEEECCCTTCEECCSSSC-
T ss_pred cCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEE--CCCCcEEEeeeeeeeecccCcc-
Confidence 9999999998875 46999999999999999999999998 9999999999999 8889999999999876643321
Q ss_pred ceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCC-CCCCCHHHHH
Q 020888 201 DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR-AKGFTPELRE 279 (320)
Q Consensus 201 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~ 279 (320)
......+|+.|+|||++.+..++.++||||||+++|+|++|..||...........+.....+... ...+++++++
T Consensus 197 ---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 273 (321)
T 2c30_A 197 ---KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRD 273 (321)
T ss_dssp ---CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHH
T ss_pred ---ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHH
Confidence 123456899999999999999999999999999999999999999988887777777666544322 3457999999
Q ss_pred HHHHHhhcCCCCCCCHHHHHHH
Q 020888 280 LTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 280 li~~~l~~dp~~Rps~~~ll~~ 301 (320)
++.+||..||++|||+++++++
T Consensus 274 li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 274 FLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp HHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHccCChhhCcCHHHHhcC
Confidence 9999999999999999999886
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=320.54 Aligned_cols=267 Identities=31% Similarity=0.498 Sum_probs=215.0
Q ss_pred CCCCCcccCccceecccCceEEEEEEEC-----CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEe
Q 020888 37 IDPSELDFSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE 111 (320)
Q Consensus 37 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~-----~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 111 (320)
+.....+|.+.+.||+|+||+||++.+. +..+|+|.+...... ....+.+.+|+.++++++|+||+++++++..
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 107 (313)
T 3brb_A 29 VVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSS-QREIEEFLSEAACMKDFSHPNVIRLLGVCIE 107 (313)
T ss_dssp TBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCC-HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC
T ss_pred cccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccc-hhHHHHHHHHHHHHhcCCCCCeeeeeEEEee
Confidence 4445678999999999999999999764 247999988655433 3445788999999999999999999999876
Q ss_pred CC-----ceEEEEecCCCCCHHHHHHH------hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCC
Q 020888 112 RK-----PLMLITEYLRGGDLHKYLKE------KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSA 180 (320)
Q Consensus 112 ~~-----~~~iv~e~~~~~~L~~~~~~------~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~ 180 (320)
.+ ..++||||+++++|.+++.. ...+++..++.++.|++.||.|||++| ++|+||||+||++ +.+
T Consensus 108 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli--~~~ 183 (313)
T 3brb_A 108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN--FLHRDLAARNCML--RDD 183 (313)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCSGGGEEE--CTT
T ss_pred ccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEE--cCC
Confidence 44 45999999999999999853 346999999999999999999999998 9999999999999 888
Q ss_pred CcEEEecCCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 020888 181 DHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKY 259 (320)
Q Consensus 181 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~ 259 (320)
+.++|+|||++......... .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||...........
T Consensus 184 ~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 261 (313)
T 3brb_A 184 MTVCVADFGLSKKIYSGDYY--RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDY 261 (313)
T ss_dssp SCEEECSCSCC------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH
T ss_pred CcEEEeecCcceeccccccc--CcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHH
Confidence 99999999999866443211 11223346788999999999999999999999999999999 9999998888777777
Q ss_pred HHhCCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcCCC
Q 020888 260 VAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPT 311 (320)
Q Consensus 260 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~ 311 (320)
+........ +..+++++.+++.+||..||.+|||+.+++++|+++..++++
T Consensus 262 ~~~~~~~~~-~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp~ 312 (313)
T 3brb_A 262 LLHGHRLKQ-PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLPD 312 (313)
T ss_dssp HHTTCCCCC-BTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC--
T ss_pred HHcCCCCCC-CccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence 776654443 455899999999999999999999999999999999988764
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-45 Score=315.52 Aligned_cols=255 Identities=35% Similarity=0.592 Sum_probs=211.7
Q ss_pred CCcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHH----HHHHHHHHHHHhCCCCcccceeeeEEeCC
Q 020888 40 SELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVI----QDFRHEVNLLVKLRHPNIVQFLGAVTERK 113 (320)
Q Consensus 40 ~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 113 (320)
...+|.+.+.||+|+||+||++.+. ++.||+|.+........... +.+.+|++++++++|+||+++++++.+..
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 96 (287)
T 4f0f_A 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP 96 (287)
T ss_dssp CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT
T ss_pred hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC
Confidence 3468999999999999999999985 78899998866544432221 67889999999999999999999986554
Q ss_pred ceEEEEecCCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCc-----EEEec
Q 020888 114 PLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH-----LKVGD 187 (320)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~-----~~L~d 187 (320)
++||||+++++|.+++... ..+++..++.++.|++.||.|||+.|.+++|+||||+||++ +.++. ++|+|
T Consensus 97 --~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~--~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 97 --RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFL--QSLDENAPVCAKVAD 172 (287)
T ss_dssp --EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEE--SCCCTTCSCCEEECC
T ss_pred --eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEE--eccCCCCceeEEeCC
Confidence 7999999999999888654 47999999999999999999999976669999999999999 66555 99999
Q ss_pred CCCcccccccCccceeeccCCcccccccCccccC--cCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHhC
Q 020888 188 FGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFK--HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEA--AKYVAEG 263 (320)
Q Consensus 188 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~--~~~~~~~ 263 (320)
||++..... ......+++.|+|||++. +..++.++||||||+++|+|++|..||........ ...+...
T Consensus 173 fg~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 245 (287)
T 4f0f_A 173 FGLSQQSVH-------SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREE 245 (287)
T ss_dssp CTTCBCCSS-------CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHS
T ss_pred CCccccccc-------cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhcc
Confidence 999874332 123456899999999984 45578899999999999999999999987654333 4444555
Q ss_pred CCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHH
Q 020888 264 HRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKI 305 (320)
Q Consensus 264 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~ 305 (320)
......+..+++++++++.+||+.||.+|||++++++.|+++
T Consensus 246 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 246 GLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred CCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 544455567899999999999999999999999999998753
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-46 Score=327.85 Aligned_cols=262 Identities=27% Similarity=0.379 Sum_probs=210.7
Q ss_pred CCCCCcccCccceecccCceEEEEEEECCCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCc--
Q 020888 37 IDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP-- 114 (320)
Q Consensus 37 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-- 114 (320)
+.....+|.+.+.||+|+||+||++.+.++.||+|++.... .......+|+.++++++||||+++++++.....
T Consensus 19 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 94 (322)
T 3soc_A 19 LYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQD----KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVD 94 (322)
T ss_dssp EEETTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSS
T ss_pred cccchhhchhhheecccCceEEEEEEECCCEEEEEEeecCc----hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCC
Confidence 44456799999999999999999999999999999885431 222455668899999999999999999987543
Q ss_pred --eEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcC----------CCCeEecCCCCCcEEEeeCCCCc
Q 020888 115 --LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE----------PNVIIHRDLKPRNVLLVNSSADH 182 (320)
Q Consensus 115 --~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~----------g~~ivH~di~p~nI~~~~~~~~~ 182 (320)
+++||||+++++|.++++.. .+++..++.++.|++.||.|||+. | ++|+||||+||++ +.++.
T Consensus 95 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~--ivH~Dlkp~Nill--~~~~~ 169 (322)
T 3soc_A 95 VDLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA--ISHRDIKSKNVLL--KNNLT 169 (322)
T ss_dssp EEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE--EECSCCSGGGEEE--CTTCC
T ss_pred ceEEEEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC--EEeCCCChHhEEE--CCCCe
Confidence 69999999999999999874 699999999999999999999998 8 9999999999999 88899
Q ss_pred EEEecCCCcccccccCccceeeccCCcccccccCccccCcC-----CCCCchhHHHHHHHHHHHHhCCCCCCCCC-----
Q 020888 183 LKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR-----KYDKKVDVFSFAMILYEMLEGEPPLANYE----- 252 (320)
Q Consensus 183 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~~l~~ll~g~~p~~~~~----- 252 (320)
++|+|||++......... .......+|+.|+|||++.+. .++.++||||||+++|+|++|..||....
T Consensus 170 ~kL~DFg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~ 247 (322)
T 3soc_A 170 ACIADFGLALKFEAGKSA--GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247 (322)
T ss_dssp EEECCCTTCEEECTTSCC--CCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCC
T ss_pred EEEccCCcccccccccCc--cccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhcc
Confidence 999999999876543321 122335689999999999874 45568899999999999999999996532
Q ss_pred -----------hHHHHHHHHhCCCCCCCC-----CCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcC
Q 020888 253 -----------PYEAAKYVAEGHRPFFRA-----KGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETL 309 (320)
Q Consensus 253 -----------~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 309 (320)
..............+... ...++++.+++.+||+.||++|||+.++++.|+++.+..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~ 320 (322)
T 3soc_A 248 PFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT 320 (322)
T ss_dssp TTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred chhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 122222222222222111 122456999999999999999999999999999998754
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-46 Score=340.71 Aligned_cols=251 Identities=25% Similarity=0.422 Sum_probs=210.5
Q ss_pred CcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEE
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 118 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 118 (320)
..+|.+.+.||+|+||.||++.+. ++.||+|++.............+.+|+++++.++|+||+++++++...+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 458999999999999999999985 789999988654333333446778899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccccccc
Q 020888 119 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHN-EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 197 (320)
Q Consensus 119 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~-~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~ 197 (320)
|||+++++|.+++...+.+++..+..++.|++.||.|||+ .| |+|+||||+||++ +.++.++|+|||++......
T Consensus 227 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~g--iiHrDlkp~NIll--~~~~~~kl~DFG~a~~~~~~ 302 (446)
T 4ejn_A 227 MEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLML--DKDGHIKITDFGLCKEGIKD 302 (446)
T ss_dssp ECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTC--CCCCCCCGGGEEE--CSSSCEEECCCCCCCTTCC-
T ss_pred EeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC--EEECCCCHHHEEE--CCCCCEEEccCCCceeccCC
Confidence 9999999999999988889999999999999999999998 89 9999999999999 88899999999998754322
Q ss_pred CccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHH
Q 020888 198 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPEL 277 (320)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 277 (320)
. .......||+.|+|||++.+..++.++||||||+++|+|++|..||...+.......+....... +..+++++
T Consensus 303 ~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~--p~~~~~~~ 376 (446)
T 4ejn_A 303 G----ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRF--PRTLGPEA 376 (446)
T ss_dssp --------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC--CTTSCHHH
T ss_pred C----cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCC--CccCCHHH
Confidence 2 12334678999999999999999999999999999999999999999988888877777665432 34589999
Q ss_pred HHHHHHHhhcCCCCCC-----CHHHHHHH
Q 020888 278 RELTEKCWAADMNQRP-----SFLDILKR 301 (320)
Q Consensus 278 ~~li~~~l~~dp~~Rp-----s~~~ll~~ 301 (320)
+++|.+||..||.+|| |+++++++
T Consensus 377 ~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 377 KSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp HHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 9999999999999999 99999875
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-45 Score=320.47 Aligned_cols=260 Identities=29% Similarity=0.483 Sum_probs=222.4
Q ss_pred CCCcccCccceecccCceEEEEEEEC-------CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEe
Q 020888 39 PSELDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE 111 (320)
Q Consensus 39 ~~~~~y~~~~~lg~g~~~~vy~~~~~-------~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 111 (320)
....+|.+.+.||+|+||.||++.+. ++.+|+|.+.... .......+.+|+++++.++|+||+++++++..
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 99 (322)
T 1p4o_A 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 99 (322)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhcCCCCEeeeEEEEcc
Confidence 34578999999999999999999864 5779999886443 23344678899999999999999999999999
Q ss_pred CCceEEEEecCCCCCHHHHHHHh----------CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCC
Q 020888 112 RKPLMLITEYLRGGDLHKYLKEK----------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD 181 (320)
Q Consensus 112 ~~~~~iv~e~~~~~~L~~~~~~~----------~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~ 181 (320)
++..++||||+++++|.+++... ..+++..++.++.|++.||.|||++| ++|+||||+||++ +.++
T Consensus 100 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~NIli--~~~~ 175 (322)
T 1p4o_A 100 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMV--AEDF 175 (322)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEE--CTTC
T ss_pred CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--CccCCCccceEEE--cCCC
Confidence 99999999999999999998752 35699999999999999999999998 9999999999999 8889
Q ss_pred cEEEecCCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 020888 182 HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYV 260 (320)
Q Consensus 182 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~ 260 (320)
.++|+|||++........ ........+++.|+|||.+.+..++.++||||||+++|+|++ |..||......+....+
T Consensus 176 ~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 253 (322)
T 1p4o_A 176 TVKIGDFGMTRDIYETDY--YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 253 (322)
T ss_dssp CEEECCTTCCCGGGGGGC--EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH
T ss_pred eEEECcCccccccccccc--cccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHH
Confidence 999999999986644321 112233456889999999999999999999999999999999 89999998888877777
Q ss_pred HhCCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHh
Q 020888 261 AEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKE 307 (320)
Q Consensus 261 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 307 (320)
........ +..++.++.+++.+||..||.+|||+.+++++|+++..
T Consensus 254 ~~~~~~~~-~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 254 MEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp HTTCCCCC-CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HcCCcCCC-CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 76654433 35689999999999999999999999999999987644
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=323.86 Aligned_cols=271 Identities=28% Similarity=0.480 Sum_probs=223.9
Q ss_pred CCCCCCCcCCCCCcccCccceecccCceEEEEEEECC-------CceEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCC
Q 020888 29 LPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHP 100 (320)
Q Consensus 29 ~~~~~~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~-------~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ 100 (320)
.+....|++. ..+|.+.+.||+|+||+||++.+.+ ..+++|.+.... .....+.+.+|+++++.+ +||
T Consensus 35 ~~~~~~~~~~--~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~ 110 (333)
T 2i1m_A 35 LPYNEKWEFP--RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHE 110 (333)
T ss_dssp SCCCGGGBCC--TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCT
T ss_pred ccccccccCC--HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCC
Confidence 3333344443 5689999999999999999999752 369999886543 234457899999999999 899
Q ss_pred cccceeeeEEeCCceEEEEecCCCCCHHHHHHHh--------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEec
Q 020888 101 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK--------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHR 166 (320)
Q Consensus 101 ~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~--------------~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~ 166 (320)
||+++++++..++..++||||+++++|.+++... ..+++..++.++.|++.||.|||+.| ++|+
T Consensus 111 ~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~ 188 (333)
T 2i1m_A 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN--CIHR 188 (333)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT--EECS
T ss_pred CeeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC--cccC
Confidence 9999999999999999999999999999998752 35799999999999999999999998 9999
Q ss_pred CCCCCcEEEeeCCCCcEEEecCCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CC
Q 020888 167 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GE 245 (320)
Q Consensus 167 di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~ 245 (320)
||||+||++ +.++.++|+|||++........ ........+++.|+|||++.+..++.++||||||+++|+|++ |.
T Consensus 189 Dlkp~NIl~--~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~ 264 (333)
T 2i1m_A 189 DVAARNVLL--TNGHVAKIGDFGLARDIMNDSN--YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGL 264 (333)
T ss_dssp CCSGGGCEE--EGGGEEEBCCCGGGCCGGGCTT--SEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSC
T ss_pred CcccceEEE--CCCCeEEECccccccccccccc--eeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCC
Confidence 999999999 7788999999999986654321 112233456788999999999999999999999999999998 99
Q ss_pred CCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcC
Q 020888 246 PPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETL 309 (320)
Q Consensus 246 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 309 (320)
.||.....................+..+++++.+++.+||+.||.+|||+.++++.|+++....
T Consensus 265 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 328 (333)
T 2i1m_A 265 NPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQED 328 (333)
T ss_dssp CSSTTCCSSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCcccchhHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhh
Confidence 9998876555444444433333445567999999999999999999999999999999987653
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-45 Score=314.84 Aligned_cols=261 Identities=30% Similarity=0.530 Sum_probs=218.0
Q ss_pred CCCCCcccCccceecccCceEEEEEEECC-----CceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEe
Q 020888 37 IDPSELDFSSSAIIGKGSFGEILKAYWRG-----TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE 111 (320)
Q Consensus 37 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~-----~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 111 (320)
......+|.+.+.||+|+||+||++.+.+ ..+|+|.+.... .....+.+.+|+++++.++||||+++++++.+
T Consensus 7 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 84 (281)
T 3cc6_A 7 YGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE 84 (281)
T ss_dssp CSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS
T ss_pred ceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC
Confidence 34456789999999999999999998642 249999886543 33445789999999999999999999999875
Q ss_pred CCceEEEEecCCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCC
Q 020888 112 RKPLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGL 190 (320)
Q Consensus 112 ~~~~~iv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~ 190 (320)
+ ..++||||+++++|.+++... ..+++..++.++.|++.||.+||++| ++|+||||+||++ +.++.++|+|||.
T Consensus 85 ~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~--~~~~~~kl~Dfg~ 159 (281)
T 3cc6_A 85 E-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN--CVHRDIAVRNILV--ASPECVKLGDFGL 159 (281)
T ss_dssp S-SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEE--EETTEEEECCCCG
T ss_pred C-CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEE--CCCCcEEeCccCC
Confidence 4 568999999999999999765 45999999999999999999999999 9999999999999 7788999999999
Q ss_pred cccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCC
Q 020888 191 SKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFR 269 (320)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 269 (320)
+........ .......+++.|+|||.+.+..++.++|+||||+++|+|++ |..||......+....+........
T Consensus 160 ~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~- 235 (281)
T 3cc6_A 160 SRYIEDEDY---YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPK- 235 (281)
T ss_dssp GGCC------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCC-
T ss_pred Ccccccccc---cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCC-
Confidence 876644321 11233456788999999999999999999999999999998 9999988777777666666554433
Q ss_pred CCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhc
Q 020888 270 AKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKET 308 (320)
Q Consensus 270 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 308 (320)
+..+++.+.+++.+||..||.+|||+.+++++|+.+...
T Consensus 236 ~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 236 PDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 345899999999999999999999999999999998764
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=317.05 Aligned_cols=252 Identities=34% Similarity=0.629 Sum_probs=211.8
Q ss_pred CCcccCccceecccCceEEEEEEECCCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEE-eCCceEEE
Q 020888 40 SELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVT-ERKPLMLI 118 (320)
Q Consensus 40 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~iv 118 (320)
...+|.+.+.||+|++|+||++.++++.+|+|.+.... ..+.+.+|+++++.++|+||+++++++. ..+..++|
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv 93 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 93 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred ChhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEE
Confidence 35689999999999999999999999999999886432 2367889999999999999999999864 44578999
Q ss_pred EecCCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccc
Q 020888 119 TEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 196 (320)
Q Consensus 119 ~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~ 196 (320)
|||+++++|.+++...+ .+++..++.++.|++.||.+||++| ++|+||||+||++ +.++.++|+|||++.....
T Consensus 94 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~--~~~~~~~l~Dfg~~~~~~~ 169 (278)
T 1byg_A 94 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLV--SEDNVAKVSDFGLTKEASS 169 (278)
T ss_dssp ECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE--CTTSCEEECCCCC------
T ss_pred EecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCcceEEE--eCCCcEEEeeccccccccc
Confidence 99999999999998654 3899999999999999999999998 9999999999999 8889999999999875543
Q ss_pred cCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCH
Q 020888 197 QNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTP 275 (320)
Q Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (320)
.. ....+++.|+|||.+.+..++.++|+||||+++|+|++ |..||......+....+..+.... .+..+++
T Consensus 170 ~~-------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 241 (278)
T 1byg_A 170 TQ-------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMD-APDGCPP 241 (278)
T ss_dssp -------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCC-CCTTCCH
T ss_pred cc-------cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCC-CcccCCH
Confidence 21 12346788999999999999999999999999999998 999999887777766665554333 3456899
Q ss_pred HHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhc
Q 020888 276 ELRELTEKCWAADMNQRPSFLDILKRLEKIKET 308 (320)
Q Consensus 276 ~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 308 (320)
++++++.+||..||.+|||+.++++.|+.+...
T Consensus 242 ~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 242 AVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 999999999999999999999999999998764
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-47 Score=335.06 Aligned_cols=248 Identities=30% Similarity=0.474 Sum_probs=208.4
Q ss_pred cccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEE
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 119 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 119 (320)
.+|.+.+.||+|+||+||++.+. ++.||+|++.............+.+|+++++.++||||+++++++...+..++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 48999999999999999999984 7899999885432211122257889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCc
Q 020888 120 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 199 (320)
Q Consensus 120 e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~ 199 (320)
||+ +|+|.+++...+.+++..++.++.|++.||.|||+.| ++|+||||+||++ +.++.++|+|||++.......
T Consensus 89 E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll--~~~~~~kl~DFG~s~~~~~~~- 162 (336)
T 3h4j_B 89 EYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK--IVHRDLKPENLLL--DDNLNVKIADFGLSNIMTDGN- 162 (336)
T ss_dssp CCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT--CCCCCCSTTTEEE--CTTCCEEECCSSCTBTTTTSB-
T ss_pred ECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCchhhEEE--cCCCCEEEEEeccceeccCCc-
Confidence 999 6799999988888999999999999999999999999 9999999999999 888999999999987654332
Q ss_pred cceeeccCCcccccccCccccCcCCC-CCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHH
Q 020888 200 HDVYKMTGETGSYRYMAPEVFKHRKY-DKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 278 (320)
Q Consensus 200 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 278 (320)
.....+||+.|+|||++.+..+ +.++||||||+++|+|++|..||...........+... ....+..++++++
T Consensus 163 ----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~ 236 (336)
T 3h4j_B 163 ----FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSC--VYVMPDFLSPGAQ 236 (336)
T ss_dssp ----TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSS--CCCCCTTSCHHHH
T ss_pred ----ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcC--CCCCcccCCHHHH
Confidence 2234578999999999988876 68999999999999999999999865433222211111 1122345799999
Q ss_pred HHHHHHhhcCCCCCCCHHHHHHH
Q 020888 279 ELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 279 ~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
+++.+||..||.+|||+++++++
T Consensus 237 ~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 237 SLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp HHHHTTSCSSGGGSCCHHHHTTC
T ss_pred HHHHHHcCCChhHCcCHHHHHhC
Confidence 99999999999999999999886
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-45 Score=321.41 Aligned_cols=259 Identities=27% Similarity=0.491 Sum_probs=214.2
Q ss_pred CCCCCcCCCCCcccCccceecccCceEEEEEEE--CCCceEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcccceee
Q 020888 31 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLG 107 (320)
Q Consensus 31 ~~~~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~--~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~ 107 (320)
....-.+.....+|.+.+.||+|+||.||++.+ +++.||+|++....... ..+.+|+.+++++ +|+||+++++
T Consensus 13 ~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~----~~~~~e~~~l~~l~~h~~i~~~~~ 88 (326)
T 2x7f_A 13 EIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE----EEIKQEINMLKKYSHHRNIATYYG 88 (326)
T ss_dssp ---CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTT----HHHHHHHHHHHHHCCSTTBCCEEE
T ss_pred hccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccH----HHHHHHHHHHHhccCCCCeeeeee
Confidence 333345666778999999999999999999998 48899999886543322 6788899999999 7999999999
Q ss_pred eEEe------CCceEEEEecCCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCC
Q 020888 108 AVTE------RKPLMLITEYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS 179 (320)
Q Consensus 108 ~~~~------~~~~~iv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~ 179 (320)
++.. .+..++||||+++++|.+++... ..+++..++.++.|++.||.|||+.| ++|+||+|+||++ +.
T Consensus 89 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~--~~ 164 (326)
T 2x7f_A 89 AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLL--TE 164 (326)
T ss_dssp EEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEE--CT
T ss_pred EEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCcHHHEEE--cC
Confidence 9976 56789999999999999999863 47999999999999999999999998 9999999999999 88
Q ss_pred CCcEEEecCCCcccccccCccceeeccCCcccccccCccccC-----cCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH
Q 020888 180 ADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFK-----HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPY 254 (320)
Q Consensus 180 ~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~ 254 (320)
++.++|+|||++........ ......+++.|+|||++. +..++.++||||||+++|+|++|..||......
T Consensus 165 ~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~ 240 (326)
T 2x7f_A 165 NAEVKLVDFGVSAQLDRTVG----RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM 240 (326)
T ss_dssp TCCEEECCCTTTC-----------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH
T ss_pred CCCEEEeeCcCceecCcCcc----ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH
Confidence 89999999999876543211 123346899999999987 567889999999999999999999999988887
Q ss_pred HHHHHHHhCCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 255 EAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
.....+.....+......++..++++|.+||..||.+|||+++++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 241 RALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp HHHHHHHHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHHHhhcCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 77777777776666667789999999999999999999999999885
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=321.63 Aligned_cols=252 Identities=31% Similarity=0.457 Sum_probs=205.8
Q ss_pred CCcccCccceecccCceEEEEEEEC-CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEE
Q 020888 40 SELDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 118 (320)
Q Consensus 40 ~~~~y~~~~~lg~g~~~~vy~~~~~-~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 118 (320)
-..+|.+.+.||+|+||+||++.+. ++.+|+|.+...... ......+.+|++++++++|+||+++++++..++..++|
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 97 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAED-EGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLV 97 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEeccccc-chhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEE
Confidence 3458999999999999999999985 788999988654332 22346788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccccccc
Q 020888 119 TEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 197 (320)
Q Consensus 119 ~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~ 197 (320)
|||+++ +|.+++... ..+++..++.++.|++.||.|||+.| |+|+||||+||++ +.++.++|+|||++......
T Consensus 98 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIl~--~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 98 FEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR--ILHRDLKPQNLLI--NSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp EECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEE--CTTCCEEECCCTTCEETTSC
T ss_pred EcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCchHhEEE--CCCCCEEEccCcCceecCCC
Confidence 999975 888888764 45999999999999999999999998 9999999999999 88899999999999866432
Q ss_pred CccceeeccCCcccccccCccccCc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhC---CCCCC-----
Q 020888 198 NSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEG---HRPFF----- 268 (320)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~---~~~~~----- 268 (320)
.. ......+++.|+|||++.+ ..++.++||||||+++|+|++|..||......+....+... ..+..
T Consensus 173 ~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 248 (311)
T 3niz_A 173 VR----SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQ 248 (311)
T ss_dssp CC-------CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGT
T ss_pred cc----cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhh
Confidence 21 2233567999999999876 56899999999999999999999999877655554444321 11000
Q ss_pred --------------------CCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 269 --------------------RAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 269 --------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
....+++++.++|.+||..||.+|||+++++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp TSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred ccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 012467899999999999999999999999975
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-46 Score=331.23 Aligned_cols=273 Identities=18% Similarity=0.238 Sum_probs=211.9
Q ss_pred CCCCCcccCccceecccCceEEEEEEEC-------CCceEEEEccCCCCCcHHHH--------HHHHHHHHHHHhCCCCc
Q 020888 37 IDPSELDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVI--------QDFRHEVNLLVKLRHPN 101 (320)
Q Consensus 37 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~-------~~~~~~K~~~~~~~~~~~~~--------~~~~~e~~~l~~l~h~~ 101 (320)
.+....+|.+.+.||+|+||.||++.+. ++.||+|++........... ..+..|+..+..++|+|
T Consensus 30 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~ 109 (364)
T 3op5_A 30 TDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLG 109 (364)
T ss_dssp ECTTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCC
T ss_pred eccCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCC
Confidence 3456679999999999999999999885 36899998865432111111 12334555677778999
Q ss_pred ccceeeeEEeC----CceEEEEecCCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEe
Q 020888 102 IVQFLGAVTER----KPLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLV 176 (320)
Q Consensus 102 i~~~~~~~~~~----~~~~iv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~ 176 (320)
|+++++++... ...++||||+ |++|.+++... +.+++..++.++.|++.||.|||++| |+|+||||+||++.
T Consensus 110 iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~--iiHrDlkp~Nill~ 186 (364)
T 3op5_A 110 VPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE--YVHGDIKASNLLLN 186 (364)
T ss_dssp SCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEE
T ss_pred CCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eEEecCCHHHEEEe
Confidence 99999998764 4589999999 88999999875 57999999999999999999999998 99999999999994
Q ss_pred eCCCCcEEEecCCCcccccccCcccee---eccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-
Q 020888 177 NSSADHLKVGDFGLSKLIKVQNSHDVY---KMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYE- 252 (320)
Q Consensus 177 ~~~~~~~~L~dfg~~~~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~- 252 (320)
.+.++.++|+|||++..+......... ......+|+.|+|||++.+..++.++||||||+++|+|++|..||....
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~ 266 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK 266 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 338889999999999876544322211 1233458999999999999999999999999999999999999998532
Q ss_pred hHHHHHHHHhC--------CCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcCCCC
Q 020888 253 PYEAAKYVAEG--------HRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPTD 312 (320)
Q Consensus 253 ~~~~~~~~~~~--------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~ 312 (320)
........... .........+++++.+++..||..||.+||++.++++.|+.+.......
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~ 334 (364)
T 3op5_A 267 DPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSK 334 (364)
T ss_dssp CHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred CHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCC
Confidence 21111111100 0011112457999999999999999999999999999999998876543
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=323.35 Aligned_cols=259 Identities=29% Similarity=0.584 Sum_probs=213.9
Q ss_pred CCcccCccceecccCceEEEEEEEC--CC----ceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCC
Q 020888 40 SELDFSSSAIIGKGSFGEILKAYWR--GT----PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK 113 (320)
Q Consensus 40 ~~~~y~~~~~lg~g~~~~vy~~~~~--~~----~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 113 (320)
...+|.+.+.||+|+||+||++.+. ++ ++++|.+..... ....+.+.+|++++++++|+||+++++++..+.
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 90 (327)
T 3poz_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVMASVDNPHVCRLLGICLTST 90 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS
T ss_pred CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccC--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC
Confidence 3568999999999999999999874 33 357887754322 223378899999999999999999999998764
Q ss_pred ceEEEEecCCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcc
Q 020888 114 PLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 192 (320)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~ 192 (320)
.+++++++++++|.+++.. .+.+++..++.++.|++.||.|||++| ++|+||||+||++ +.++.++|+|||++.
T Consensus 91 -~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIll--~~~~~~kl~Dfg~a~ 165 (327)
T 3poz_A 91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLV--KTPQHVKITDFGLAK 165 (327)
T ss_dssp -EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE--EETTEEEECCTTHHH
T ss_pred -eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCChheEEE--CCCCCEEEccCccee
Confidence 7889999999999999987 457999999999999999999999998 9999999999999 778899999999998
Q ss_pred cccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCC
Q 020888 193 LIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAK 271 (320)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 271 (320)
....... ........+++.|+|||.+.+..++.++||||||+++|++++ |..||......+....+........ +.
T Consensus 166 ~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~-~~ 242 (327)
T 3poz_A 166 LLGAEEK--EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ-PP 242 (327)
T ss_dssp HHTTTCC---------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCC-CT
T ss_pred EccCCcc--cccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCC-Cc
Confidence 7654322 112233456789999999999999999999999999999999 9999998888777776666654443 44
Q ss_pred CCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhc
Q 020888 272 GFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKET 308 (320)
Q Consensus 272 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 308 (320)
.++.++.+++.+||..||.+|||+.+++++|+.+...
T Consensus 243 ~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 243 ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp TBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 5799999999999999999999999999999998753
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=323.77 Aligned_cols=260 Identities=20% Similarity=0.260 Sum_probs=214.9
Q ss_pred CcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcccceeeeEEeCCceEE
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLML 117 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~i 117 (320)
+.+|.+.+.||+|+||+||++.+. ++.||+|++...... ..+.+|+++++.+ +|+||+++++++..++..++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l 82 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA-----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAM 82 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS-----CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch-----HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEE
Confidence 458999999999999999999974 889999988654322 3577899999999 89999999999999999999
Q ss_pred EEecCCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCc-----EEEecCCCc
Q 020888 118 ITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH-----LKVGDFGLS 191 (320)
Q Consensus 118 v~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~-----~~L~dfg~~ 191 (320)
||||+ +++|.+++.. .+.+++..++.++.|++.||.|||+.| |+|+||||+||++ +.++. ++|+|||++
T Consensus 83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--iiHrDlkp~Nill--~~~~~~~~~~~kl~DFg~a 157 (330)
T 2izr_A 83 VLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN--LIYRDVKPENFLI--GRPGNKTQQVIHIIDFALA 157 (330)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEE--CCGGGTCTTSEEECCCTTC
T ss_pred EEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeee--ccCCCCCCceEEEEEcccc
Confidence 99999 8899999986 467999999999999999999999998 9999999999999 66666 999999999
Q ss_pred ccccccCccce---eeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHhCCC
Q 020888 192 KLIKVQNSHDV---YKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEP---YEAAKYVAEGHR 265 (320)
Q Consensus 192 ~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~---~~~~~~~~~~~~ 265 (320)
........... .......||+.|+|||++.+..++.++||||||+++|+|++|..||..... .+....+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~ 237 (330)
T 2izr_A 158 KEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKR 237 (330)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHH
T ss_pred eeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhc
Confidence 87654432211 112356789999999999999999999999999999999999999987543 222332222111
Q ss_pred ---CCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcCCC
Q 020888 266 ---PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPT 311 (320)
Q Consensus 266 ---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~ 311 (320)
.......++ ++++++..||+.||.+||+++++.+.|+++..+...
T Consensus 238 ~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~ 285 (330)
T 2izr_A 238 ATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGY 285 (330)
T ss_dssp HSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred cCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCC
Confidence 111123345 999999999999999999999999999999988654
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=327.39 Aligned_cols=253 Identities=26% Similarity=0.427 Sum_probs=208.4
Q ss_pred cccCccceecccCceEEEEEEEC--CCceEEEEccCCCC--CcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEE
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLS--DDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLML 117 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 117 (320)
.+|.+.+.||+|+||+||++.+. ++.||+|++..... ......+.+.+|+.+++.++||||+++++++..++..|+
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 47999999999999999999985 78999998753211 111123678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeC-CCCcEEEecCCCcc
Q 020888 118 ITEYLRGGDLHKYLKEK----GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS-SADHLKVGDFGLSK 192 (320)
Q Consensus 118 v~e~~~~~~L~~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~-~~~~~~L~dfg~~~ 192 (320)
||||++|++|.+++... ..+++..++.++.|++.||.|||++| |+|+||||+||++..+ ..+.++|+|||++.
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~ 181 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAI 181 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECSSSTTCCEEECCCTTCE
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChHHeEEecCCCCCcEEEecCccee
Confidence 99999999999887542 25899999999999999999999998 9999999999999322 22349999999998
Q ss_pred cccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCC--C
Q 020888 193 LIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR--A 270 (320)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~--~ 270 (320)
....... ......+|+.|+|||++.+..++.++||||||+++|+|++|..||.... ......+..+...... .
T Consensus 182 ~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~~~ 256 (351)
T 3c0i_A 182 QLGESGL----VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQW 256 (351)
T ss_dssp ECCTTSC----BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHHHH
T ss_pred EecCCCe----eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCcccc
Confidence 7654321 2234578999999999999999999999999999999999999998753 3444445544432221 1
Q ss_pred CCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 271 KGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 271 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
..++++++++|.+||..||++|||+.+++++
T Consensus 257 ~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 257 SHISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 4579999999999999999999999999875
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-45 Score=314.65 Aligned_cols=256 Identities=30% Similarity=0.495 Sum_probs=214.5
Q ss_pred cCCCCCcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEe--
Q 020888 36 EIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE-- 111 (320)
Q Consensus 36 ~~~~~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 111 (320)
.....+..|.+.+.||+|+||+||++.+. +..+++|.+...... ....+.+.+|+++++.++|+||+++++++..
T Consensus 20 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 98 (290)
T 1t4h_A 20 GMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV 98 (290)
T ss_dssp EECTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES
T ss_pred hcccCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeecccc
Confidence 34556677999999999999999999986 677999988654443 3345788999999999999999999998865
Q ss_pred --CCceEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeC-CCCcEEEecC
Q 020888 112 --RKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS-SADHLKVGDF 188 (320)
Q Consensus 112 --~~~~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~-~~~~~~L~df 188 (320)
....++||||+++++|.+++...+.+++..++.++.|++.||.|||+.|.+++|+||||+||++ + .++.++|+||
T Consensus 99 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~--~~~~~~~kl~Df 176 (290)
T 1t4h_A 99 KGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFI--TGPTGSVKIGDL 176 (290)
T ss_dssp SSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEE--SSTTSCEEECCT
T ss_pred CCCceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEE--ECCCCCEEEeeC
Confidence 4558999999999999999998888999999999999999999999976569999999999999 6 6789999999
Q ss_pred CCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHhCCCCC
Q 020888 189 GLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPY-EAAKYVAEGHRPF 267 (320)
Q Consensus 189 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~-~~~~~~~~~~~~~ 267 (320)
|++....... .....+++.|+|||.+.+ .++.++|+||||+++|+|++|..||...... .....+.....+.
T Consensus 177 g~~~~~~~~~------~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 249 (290)
T 1t4h_A 177 GLATLKRASF------AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA 249 (290)
T ss_dssp TGGGGCCTTS------BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCG
T ss_pred CCcccccccc------cccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCcc
Confidence 9986543221 223468999999998874 5899999999999999999999999885444 4444455554554
Q ss_pred CCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 268 FRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 268 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
......++++.+++.+||..||.+|||+++++++
T Consensus 250 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 250 SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 4455678999999999999999999999999875
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=322.30 Aligned_cols=261 Identities=35% Similarity=0.546 Sum_probs=218.8
Q ss_pred CcccCccceecccCceEEEEEEEC--CCc--eEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcccceeeeEEeCCce
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--GTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPL 115 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~~~--~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 115 (320)
..+|.+.+.||+|+||.||++.+. +.. +++|.+..... ....+.+.+|+++++++ +||||+++++++...+..
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 101 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS--KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 101 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccc--hHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCce
Confidence 358999999999999999999875 443 48887754322 22346788999999999 899999999999999999
Q ss_pred EEEEecCCCCCHHHHHHHhC----------------CCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCC
Q 020888 116 MLITEYLRGGDLHKYLKEKG----------------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS 179 (320)
Q Consensus 116 ~iv~e~~~~~~L~~~~~~~~----------------~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~ 179 (320)
++||||+++++|.+++...+ .+++..++.++.|++.||.|||++| ++|+||||+||++ +.
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~--~~ 177 (327)
T 1fvr_A 102 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILV--GE 177 (327)
T ss_dssp EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--CG
T ss_pred EEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCccceEEE--cC
Confidence 99999999999999997643 6899999999999999999999999 9999999999999 88
Q ss_pred CCcEEEecCCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 020888 180 ADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAK 258 (320)
Q Consensus 180 ~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~ 258 (320)
++.++|+|||++....... ......+++.|+|||++.+..++.++||||||+++|+|++ |..||......+...
T Consensus 178 ~~~~kL~Dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~ 252 (327)
T 1fvr_A 178 NYVAKIADFGLSRGQEVYV-----KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE 252 (327)
T ss_dssp GGCEEECCTTCEESSCEEC-----CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH
T ss_pred CCeEEEcccCcCccccccc-----cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHH
Confidence 8899999999987433221 1222346788999999998889999999999999999998 999999988887777
Q ss_pred HHHhCCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcCCCCC
Q 020888 259 YVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPTDH 313 (320)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~~ 313 (320)
.+..+.... .+..+++++++++.+||..||.+|||+++++++|.++......-.
T Consensus 253 ~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~ 306 (327)
T 1fvr_A 253 KLPQGYRLE-KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYV 306 (327)
T ss_dssp HGGGTCCCC-CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCSB
T ss_pred HhhcCCCCC-CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcCcc
Confidence 666654433 334589999999999999999999999999999999988765443
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=318.42 Aligned_cols=264 Identities=28% Similarity=0.525 Sum_probs=213.4
Q ss_pred CCcccCccceecccCceEEEEEEEC---CC--ceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCc
Q 020888 40 SELDFSSSAIIGKGSFGEILKAYWR---GT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP 114 (320)
Q Consensus 40 ~~~~y~~~~~lg~g~~~~vy~~~~~---~~--~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 114 (320)
...+|.+.+.||+|++|+||++.+. ++ .|++|.+...........+.+.+|++++++++|+||+++++++....
T Consensus 16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 94 (291)
T 1u46_A 16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP- 94 (291)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-
Confidence 4568999999999999999999863 22 58999887655444556688999999999999999999999988765
Q ss_pred eEEEEecCCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccc
Q 020888 115 LMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 193 (320)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~ 193 (320)
.++|+||+++++|.+++... +.+++..++.++.|++.||.+||++| ++|+||||+||++ +.++.++|+|||++..
T Consensus 95 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nili--~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 95 MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLL--ATRDLVKIGDFGLMRA 170 (291)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEE--EETTEEEECCCTTCEE
T ss_pred ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEE--cCCCCEEEcccccccc
Confidence 78999999999999999764 56999999999999999999999998 9999999999999 7788999999999987
Q ss_pred ccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCC
Q 020888 194 IKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKG 272 (320)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (320)
....... ........++..|+|||++.+..++.++|+||||+++|+|++ |..||......+....+.........+..
T Consensus 171 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (291)
T 1u46_A 171 LPQNDDH-YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPED 249 (291)
T ss_dssp CCC-CCE-EEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTT
T ss_pred ccccccc-hhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcC
Confidence 6543221 112223456778999999998889999999999999999999 99999999888887777766655555667
Q ss_pred CCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcC
Q 020888 273 FTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETL 309 (320)
Q Consensus 273 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 309 (320)
++.++++++.+||..||.+|||+.++++.|+++....
T Consensus 250 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 286 (291)
T 1u46_A 250 CPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTD 286 (291)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred cCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccc
Confidence 8999999999999999999999999999999886543
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=316.91 Aligned_cols=258 Identities=31% Similarity=0.555 Sum_probs=203.2
Q ss_pred CcccCccceecccCceEEEEEEECCCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEe
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 120 (320)
..+|++.+.||+|+||+||++.+.+ .+|+|++..... .....+.+.+|+++++.++|+||++++++. ..+..++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 6689999999999999999998655 599998865543 344557899999999999999999999955 5566899999
Q ss_pred cCCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCc
Q 020888 121 YLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 199 (320)
Q Consensus 121 ~~~~~~L~~~~~~-~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~ 199 (320)
|+++++|.+++.. ...+++..++.++.|++.||.|||+.| ++|+||||+||++ +.++.++|+|||++........
T Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~Dlkp~Nil~--~~~~~~kl~Dfg~~~~~~~~~~ 175 (289)
T 3og7_A 100 WCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS--IIHRDLKSNNIFL--HEDNTVKIGDFGLATEKSRWSG 175 (289)
T ss_dssp CCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE--ETTTEEEECCCC----------
T ss_pred ecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccccCccceEEE--CCCCCEEEccceeccccccccc
Confidence 9999999999964 356999999999999999999999998 9999999999999 7888999999999876543221
Q ss_pred cceeeccCCcccccccCccccC---cCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHhCCCCCC---CCCC
Q 020888 200 HDVYKMTGETGSYRYMAPEVFK---HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEA-AKYVAEGHRPFF---RAKG 272 (320)
Q Consensus 200 ~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~-~~~~~~~~~~~~---~~~~ 272 (320)
........+++.|+|||.+. +..++.++||||||+++|+|++|..||......+. ...+........ ....
T Consensus 176 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (289)
T 3og7_A 176 --SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSN 253 (289)
T ss_dssp ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTT
T ss_pred --cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhcccc
Confidence 11223456899999999986 56788899999999999999999999988655443 333333332221 2246
Q ss_pred CCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHh
Q 020888 273 FTPELRELTEKCWAADMNQRPSFLDILKRLEKIKE 307 (320)
Q Consensus 273 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 307 (320)
+++++++++.+||+.||.+|||+.++++.|+++..
T Consensus 254 ~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 254 CPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 78999999999999999999999999999998754
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=327.35 Aligned_cols=259 Identities=27% Similarity=0.391 Sum_probs=212.5
Q ss_pred CcccCccceecccCceEEEEEEEC--CCceEEEEccCCCC--CcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceE
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLS--DDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLM 116 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 116 (320)
..+|.+.+.||+|+||+||++.+. ++.+|+|++..... ......+.+.+|+++++.++||||+++++++.+.+..+
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 104 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC 104 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence 458999999999999999999985 67899998854321 12233478999999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHH----------------------------------------hCCCCHHHHHHHHHHHHHHHHHH
Q 020888 117 LITEYLRGGDLHKYLKE----------------------------------------KGALSPSTAVNFALDIARGMAYL 156 (320)
Q Consensus 117 iv~e~~~~~~L~~~~~~----------------------------------------~~~l~~~~~~~i~~~l~~~l~~l 156 (320)
+||||++|++|.+++.. ...+++..++.++.|++.||.||
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L 184 (345)
T 3hko_A 105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL 184 (345)
T ss_dssp EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 99999999999998842 01236778899999999999999
Q ss_pred hcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCccceeeccCCcccccccCccccCc--CCCCCchhHHHH
Q 020888 157 HNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH--RKYDKKVDVFSF 234 (320)
Q Consensus 157 H~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~sl 234 (320)
|++| ++|+||||+||++..+..+.++|+|||++..+...............+++.|+|||.+.+ ..++.++|||||
T Consensus 185 H~~~--ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diwsl 262 (345)
T 3hko_A 185 HNQG--ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSA 262 (345)
T ss_dssp HHTT--EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHH
T ss_pred HHCC--ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHH
Confidence 9998 999999999999943333489999999998776544434334455678999999999975 678899999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCC--CCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 235 AMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA--KGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 235 G~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
|+++|+|++|..||......+....+.........+ ..++++++++|.+||+.||.+|||+.+++++
T Consensus 263 G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h 331 (345)
T 3hko_A 263 GVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQH 331 (345)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHS
T ss_pred HHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 999999999999999988888777777666443332 3479999999999999999999999999986
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=315.26 Aligned_cols=258 Identities=29% Similarity=0.502 Sum_probs=210.2
Q ss_pred CcccCccceecccCceEEEEEEE------CCCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeC--
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER-- 112 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~------~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-- 112 (320)
..+|.+.+.||+|+||.||++.. +++.||+|.+....... ....+.+|+++++.++|+||+++++++...
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 97 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGN--HIADLKKEIEILRNLYHENIVKYKGICTEDGG 97 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----C--CHHHHHHHHHHHHTCCCTTBCCEEEEEEC---
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccch--hHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence 45799999999999999999983 37889999986543222 236788999999999999999999999766
Q ss_pred CceEEEEecCCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCc
Q 020888 113 KPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 191 (320)
Q Consensus 113 ~~~~iv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~ 191 (320)
...++||||+++++|.+++.. ...+++..++.++.|++.||.+||+.| ++|+||||+||++ +.++.++|+|||++
T Consensus 98 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~--~~~~~~kl~Dfg~~ 173 (302)
T 4e5w_A 98 NGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLV--ESEHQVKIGDFGLT 173 (302)
T ss_dssp CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--EETTEEEECCCTTC
T ss_pred ceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCC--cccCCCchheEEE--cCCCCEEECccccc
Confidence 668999999999999999955 457999999999999999999999998 9999999999999 77889999999999
Q ss_pred ccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCC--------------Ch-HHH
Q 020888 192 KLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANY--------------EP-YEA 256 (320)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~--------------~~-~~~ 256 (320)
......... ........++..|+|||.+.+..++.++|+||||+++|+|++|..|+... .. ...
T Consensus 174 ~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (302)
T 4e5w_A 174 KAIETDKEY-YTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRL 252 (302)
T ss_dssp EECCTTCCE-EECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHH
T ss_pred ccccCCCcc-eeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHH
Confidence 876543321 12233456788899999999999999999999999999999998875322 11 122
Q ss_pred HHHHHhCCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHH
Q 020888 257 AKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIK 306 (320)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 306 (320)
...+.... ....+..+++++.+++.+||+.||.+|||+.++++.|+++.
T Consensus 253 ~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 253 VNTLKEGK-RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHHTTC-CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHhccC-CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 23333333 33334568999999999999999999999999999999875
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=316.23 Aligned_cols=249 Identities=27% Similarity=0.447 Sum_probs=216.2
Q ss_pred CcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEE
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 118 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 118 (320)
..+|.+.+.||+|++|.||++.+. ++.+|+|.+...........+.+.+|+++++.++|+||+++++++...+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 458999999999999999999986 677999988543222222236788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccC
Q 020888 119 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 198 (320)
Q Consensus 119 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~ 198 (320)
|||+++++|.+++...+.+++..++.++.|++.||.|||+.| ++|+||+|+||++ +.++.++|+|||++.......
T Consensus 93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~--~~~~~~kl~Dfg~~~~~~~~~ 168 (284)
T 2vgo_A 93 LEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK--VIHRDIKPENLLM--GYKGELKIADFGWSVHAPSLR 168 (284)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEE--CTTCCEEECCCTTCEECSSSC
T ss_pred EEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEE--cCCCCEEEecccccccCcccc
Confidence 999999999999998888999999999999999999999998 9999999999999 888999999999986543321
Q ss_pred ccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHH
Q 020888 199 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 278 (320)
Q Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 278 (320)
.....+++.|+|||.+.+..++.++|+||||+++|++++|..||......+....+...... .+..++.+++
T Consensus 169 ------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 240 (284)
T 2vgo_A 169 ------RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLK--FPPFLSDGSK 240 (284)
T ss_dssp ------BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCC--CCTTSCHHHH
T ss_pred ------cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccC--CCCcCCHHHH
Confidence 23356899999999999999999999999999999999999999988877776666654432 2345799999
Q ss_pred HHHHHHhhcCCCCCCCHHHHHHH
Q 020888 279 ELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 279 ~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
++|.+||..||.+|||+++++++
T Consensus 241 ~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 241 DLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHTC
T ss_pred HHHHHHhhcCHhhCCCHHHHhhC
Confidence 99999999999999999999986
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-45 Score=333.95 Aligned_cols=265 Identities=31% Similarity=0.513 Sum_probs=221.0
Q ss_pred CCCcCCCCCcccCccceecccCceEEEEEEEC-CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEe
Q 020888 33 CDWEIDPSELDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE 111 (320)
Q Consensus 33 ~~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~-~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 111 (320)
..|++. ..+|.+.+.||+|+||.||++.++ +..||+|.+...... .+.+.+|++++++++|+||+++++++.+
T Consensus 177 ~~~~i~--~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 250 (452)
T 1fmk_A 177 DAWEIP--RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE 250 (452)
T ss_dssp TCSBCC--GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccccC--hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence 445544 568999999999999999999987 467999988654432 2678899999999999999999999876
Q ss_pred CCceEEEEecCCCCCHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCC
Q 020888 112 RKPLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFG 189 (320)
Q Consensus 112 ~~~~~iv~e~~~~~~L~~~~~~--~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg 189 (320)
+..++||||+++++|.+++.. ...+++..++.++.|++.||.|||++| ++|+||||+||++ +.++.++|+|||
T Consensus 251 -~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~Nill--~~~~~~kl~DfG 325 (452)
T 1fmk_A 251 -EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILV--GENLVCKVADFG 325 (452)
T ss_dssp -SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE--CGGGCEEECCCC
T ss_pred -CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEE--CCCCCEEECCCc
Confidence 678999999999999999964 356999999999999999999999998 9999999999999 888899999999
Q ss_pred CcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCC
Q 020888 190 LSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFF 268 (320)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~ 268 (320)
++........ .......++..|+|||.+.+..++.++||||||+++|+|++ |..||......+....+..+.....
T Consensus 326 ~a~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~ 402 (452)
T 1fmk_A 326 LARLIEDNEY---TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC 402 (452)
T ss_dssp TTC-----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC
T ss_pred cceecCCCce---ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 9986643211 11223346778999999999999999999999999999999 9999999988888887777655443
Q ss_pred CCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcCCCC
Q 020888 269 RAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPTD 312 (320)
Q Consensus 269 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~ 312 (320)
+..+++++.+++.+||..||++|||++++++.|+.+......+
T Consensus 403 -~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~~ 445 (452)
T 1fmk_A 403 -PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 445 (452)
T ss_dssp -CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCC
T ss_pred -CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCcc
Confidence 3468999999999999999999999999999999987765443
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-45 Score=338.18 Aligned_cols=251 Identities=32% Similarity=0.541 Sum_probs=214.5
Q ss_pred CcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcH----------HHHHHHHHHHHHHHhCCCCcccceeee
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDR----------LVIQDFRHEVNLLVKLRHPNIVQFLGA 108 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~----------~~~~~~~~e~~~l~~l~h~~i~~~~~~ 108 (320)
..+|.+++.||+|+||+||+|.+. ++.+|+|++........ ...+.+.+|+++++.++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 458999999999999999999986 68899999866543211 224678899999999999999999999
Q ss_pred EEeCCceEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCC---cEEE
Q 020888 109 VTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD---HLKV 185 (320)
Q Consensus 109 ~~~~~~~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~---~~~L 185 (320)
+.+....++||||++|++|.+++...+.+++..++.++.|++.||.|||+.| |+|+||||+||++ +.++ .++|
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~--~~~~~~~~~kl 190 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHN--IVHRDIKPENILL--ENKNSLLNIKI 190 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--SSTTCCSSEEE
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCcHHHEEE--ecCCCCccEEE
Confidence 9999999999999999999999988888999999999999999999999999 9999999999999 5444 6999
Q ss_pred ecCCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCC
Q 020888 186 GDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHR 265 (320)
Q Consensus 186 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~ 265 (320)
+|||++....... ......+|+.|+|||++. ..++.++||||||+++|+|++|..||......+....+..+..
T Consensus 191 ~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~ 264 (504)
T 3q5i_A 191 VDFGLSSFFSKDY-----KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKY 264 (504)
T ss_dssp CCCTTCEECCTTS-----CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC
T ss_pred EECCCCEEcCCCC-----ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC
Confidence 9999998664432 233456899999999987 4689999999999999999999999999988888888877664
Q ss_pred CCCCC--CCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 266 PFFRA--KGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 266 ~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
....+ ..++++++++|.+||..||.+|||+++++++
T Consensus 265 ~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 265 YFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 43222 4689999999999999999999999999886
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-45 Score=319.35 Aligned_cols=251 Identities=24% Similarity=0.404 Sum_probs=207.5
Q ss_pred cccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEE
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 119 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 119 (320)
.+|.+.+.||+|++|+||++.+. ++.+|+|.+..... .....+.+.+|++++++++|+||+++++++...+..++||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESED-DPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeecccc-chHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 47999999999999999999986 78899998866543 3344577889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCc
Q 020888 120 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 199 (320)
Q Consensus 120 e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~ 199 (320)
||+++++|.+++...+.+++..+..++.|++.||.|||++| ++|+||||+||++ +.++.++|+|||.+........
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~--ivH~dlkp~Nil~--~~~~~~kl~Dfg~~~~~~~~~~ 157 (311)
T 4agu_A 82 EYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN--CIHRDVKPENILI--TKHSVIKLCDFGFARLLTGPSD 157 (311)
T ss_dssp ECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--CTTSCEEECCCTTCEECC----
T ss_pred EeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCChhhEEE--cCCCCEEEeeCCCchhccCccc
Confidence 99999999999888778999999999999999999999999 9999999999999 8889999999999976543221
Q ss_pred cceeeccCCcccccccCccccCc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCC------------
Q 020888 200 HDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRP------------ 266 (320)
Q Consensus 200 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~------------ 266 (320)
......+++.|+|||.+.+ ..++.++|+||||+++|++++|..||......+....+......
T Consensus 158 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
T 4agu_A 158 ----YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTN 233 (311)
T ss_dssp ------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTC
T ss_pred ----ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccc
Confidence 1233468899999999876 56899999999999999999999999988776655443321100
Q ss_pred ---------CC--------CCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 267 ---------FF--------RAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 267 ---------~~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
.. ....++.++.+++.+||..||.+|||+++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 234 QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp GGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00 013578899999999999999999999999876
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=315.03 Aligned_cols=254 Identities=35% Similarity=0.632 Sum_probs=209.1
Q ss_pred CcccCccceecccCceEEEEEEECCCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEe
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 120 (320)
..+|.+.+.||+|+||+||++.+.++.+|+|.+... ...+.+.+|++++++++|+||+++++++. +..++|||
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e 79 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESE-----SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVME 79 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEETTEEEEEEECSST-----THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEE
T ss_pred HhHeeeeeEeecCCCceEEEEEECCeeEEEEEecCh-----hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEE
Confidence 458999999999999999999999999999988532 23477889999999999999999999887 44799999
Q ss_pred cCCCCCHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHhc---CCCCeEecCCCCCcEEEeeCCCCc-EEEecCCCccc
Q 020888 121 YLRGGDLHKYLKEKG---ALSPSTAVNFALDIARGMAYLHN---EPNVIIHRDLKPRNVLLVNSSADH-LKVGDFGLSKL 193 (320)
Q Consensus 121 ~~~~~~L~~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~---~g~~ivH~di~p~nI~~~~~~~~~-~~L~dfg~~~~ 193 (320)
|+++++|.+++.... .++...++.++.|++.||.|||+ +| ++|+||||+||++ +.++. ++|+|||++..
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~--ivH~dlkp~NIll--~~~~~~~kl~Dfg~~~~ 155 (307)
T 2eva_A 80 YAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA--LIHRDLKPPNLLL--VAGGTVLKICDFGTACD 155 (307)
T ss_dssp CCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSC--CCCCCCSGGGEEE--ETTTTEEEECCCCC---
T ss_pred cCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCC--eecCCCChhHEEE--eCCCCEEEEcccccccc
Confidence 999999999998654 37899999999999999999999 77 9999999999999 66665 79999999875
Q ss_pred ccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHhCCCCCCCCC
Q 020888 194 IKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPY--EAAKYVAEGHRPFFRAK 271 (320)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~ 271 (320)
.... .....+++.|+|||++.+..++.++||||||+++|+|++|..||...... ...........+. ...
T Consensus 156 ~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~ 227 (307)
T 2eva_A 156 IQTH-------MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPP-LIK 227 (307)
T ss_dssp ----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCC-CBT
T ss_pred cccc-------cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCC-ccc
Confidence 5432 12235899999999999999999999999999999999999999865432 2333333433333 345
Q ss_pred CCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcCCCCC
Q 020888 272 GFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPTDH 313 (320)
Q Consensus 272 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~~ 313 (320)
.++..+.+++.+||+.||.+|||++++++.|+.+....+...
T Consensus 228 ~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~ 269 (307)
T 2eva_A 228 NLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGAD 269 (307)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTT
T ss_pred ccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCC
Confidence 689999999999999999999999999999999998876543
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-45 Score=319.93 Aligned_cols=259 Identities=29% Similarity=0.580 Sum_probs=212.2
Q ss_pred CCcccCccceecccCceEEEEEEEC--CCc----eEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCC
Q 020888 40 SELDFSSSAIIGKGSFGEILKAYWR--GTP----VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK 113 (320)
Q Consensus 40 ~~~~y~~~~~lg~g~~~~vy~~~~~--~~~----~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 113 (320)
...+|.+.+.||+|+||+||++.+. ++. +++|.+....... ..+.+.+|+.+++.++|+||+++++++..+.
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 90 (327)
T 3lzb_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK--ANKEILDEAYVMASVDNPHVCRLLGICLTST 90 (327)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCC--CHHHHHHHHHHHTTCCBTTBCCCCEEEESSS
T ss_pred CHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHH--HHHHHHHHHHHHHhCCCCCeeEEEEEEecCC
Confidence 3568999999999999999999975 444 4777665433222 2378889999999999999999999998765
Q ss_pred ceEEEEecCCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcc
Q 020888 114 PLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 192 (320)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~ 192 (320)
.+++++++++++|.+++.. .+.+++..++.++.|++.||.|||++| ++|+||||+||++ +.++.++|+|||++.
T Consensus 91 -~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~--~~~~~~kL~DfG~a~ 165 (327)
T 3lzb_A 91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLV--KTPQHVKITDFGLAK 165 (327)
T ss_dssp -EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE--EETTEEEECCTTC--
T ss_pred -ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC--CcCCCCCHHHEEE--cCCCCEEEccCccee
Confidence 7889999999999999986 457999999999999999999999999 9999999999999 778899999999998
Q ss_pred cccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCC
Q 020888 193 LIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAK 271 (320)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 271 (320)
....... ........+++.|+|||.+.+..++.++||||||+++|+|++ |..||......+....+........ +.
T Consensus 166 ~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~ 242 (327)
T 3lzb_A 166 LLGAEEK--EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ-PP 242 (327)
T ss_dssp ----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCC-CT
T ss_pred EccCccc--cccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC-Cc
Confidence 7644322 112233456788999999999999999999999999999999 9999999888877777766654443 44
Q ss_pred CCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhc
Q 020888 272 GFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKET 308 (320)
Q Consensus 272 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 308 (320)
.++.++.+++..||..||.+|||+.++++.|+++...
T Consensus 243 ~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 243 ICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 5899999999999999999999999999999998754
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=313.12 Aligned_cols=259 Identities=25% Similarity=0.437 Sum_probs=217.9
Q ss_pred cccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcH---HHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceE
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDR---LVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLM 116 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 116 (320)
.+|.+.+.||+|+||+||++.+. ++.+|+|.+........ ...+.+.+|+++++.++|+||+++++++...+..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 47999999999999999999986 78999998865433221 12467889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCC----cEEEecCCCcc
Q 020888 117 LITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD----HLKVGDFGLSK 192 (320)
Q Consensus 117 iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~----~~~L~dfg~~~ 192 (320)
+||||+++++|.+++.....+++..++.++.|++.||.+||+.| ++|+||+|+||++ +.++ .++|+|||.+.
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~--~~~~~~~~~~kl~dfg~~~ 160 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKR--IAHFDLKPENIML--LDKNVPNPRIKLIDFGIAH 160 (283)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--SCSSSSSCCEEECCCTTCE
T ss_pred EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChHHEEE--ecCCCCCCceEEEecccce
Confidence 99999999999999988888999999999999999999999998 9999999999999 5555 89999999998
Q ss_pred cccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCC--C
Q 020888 193 LIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR--A 270 (320)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~--~ 270 (320)
...... ......+++.|+|||.+.+..++.++|+||||+++++|++|..||......+....+......... .
T Consensus 161 ~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T 3bhy_A 161 KIEAGN-----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYF 235 (283)
T ss_dssp ECC-------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHH
T ss_pred eccCCC-----cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhc
Confidence 664332 123346889999999999999999999999999999999999999988877776666554432221 2
Q ss_pred CCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH--HHHHHhcC
Q 020888 271 KGFTPELRELTEKCWAADMNQRPSFLDILKR--LEKIKETL 309 (320)
Q Consensus 271 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--L~~~~~~~ 309 (320)
..+++.+++++.+||..||.+|||+.+++++ ++.+....
T Consensus 236 ~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~ 276 (283)
T 3bhy_A 236 SNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRN 276 (283)
T ss_dssp TTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHCC
T ss_pred ccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHHh
Confidence 4578999999999999999999999999985 55555443
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=317.09 Aligned_cols=250 Identities=30% Similarity=0.465 Sum_probs=205.5
Q ss_pred cccCccceecccCceEEEEEEEC-CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEe
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~-~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 120 (320)
.+|.+.+.||+|+||+||++.+. ++.+|+|.+....... .....+.+|+++++.++||||+++++++...+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDE-GIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGG-CCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEecccccc-ccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence 37999999999999999999986 7889999886543222 122567889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCc
Q 020888 121 YLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 199 (320)
Q Consensus 121 ~~~~~~L~~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~ 199 (320)
|+++ +|.+++... +.+++..+..++.|++.||.|||++| ++|+||||+||++ +.++.++|+|||++........
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~--~~~~~~kl~Dfg~~~~~~~~~~ 155 (288)
T 1ob3_A 81 HLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLI--NREGELKIADFGLARAFGIPVR 155 (288)
T ss_dssp CCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE--CTTSCEEECCTTHHHHHCC---
T ss_pred ecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEE--cCCCCEEEeECccccccCcccc
Confidence 9976 999998763 57999999999999999999999998 9999999999999 8889999999999876543211
Q ss_pred cceeeccCCcccccccCccccCcC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCC------------
Q 020888 200 HDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRP------------ 266 (320)
Q Consensus 200 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~------------ 266 (320)
......+|+.|+|||++.+. .++.++||||||+++|+|++|..||......+....+......
T Consensus 156 ----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T 1ob3_A 156 ----KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL 231 (288)
T ss_dssp ----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred ----ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcc
Confidence 12234679999999999764 5899999999999999999999999988776655544321000
Q ss_pred -----C----------CCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 267 -----F----------FRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 267 -----~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
. .....++++++++|.+||..||.+|||+++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0 0113578999999999999999999999999875
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-45 Score=319.16 Aligned_cols=250 Identities=25% Similarity=0.455 Sum_probs=195.4
Q ss_pred CcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEE
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 118 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 118 (320)
..+|.+.+.||+|+||+||++.+. ++.||+|.+....... ....+.+|+++++.++||||+++++++..++..++|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 81 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEG--TPSTAIREISLMKELKHENIVRLYDVIHTENKLTLV 81 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTC--SCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccc--cHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEE
Confidence 357999999999999999999875 7889999886543222 125678899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcc
Q 020888 119 TEYLRGGDLHKYLKEK------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 192 (320)
Q Consensus 119 ~e~~~~~~L~~~~~~~------~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~ 192 (320)
|||+++ +|.+++... ..+++..+..++.|++.||.|||++| |+|+||||+||++ +.++.++|+|||++.
T Consensus 82 ~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~--~~~~~~kl~Dfg~~~ 156 (317)
T 2pmi_A 82 FEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK--ILHRDLKPQNLLI--NKRGQLKLGDFGLAR 156 (317)
T ss_dssp EECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEE--CTTCCEEECCCSSCE
T ss_pred EEecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCChHHeEE--cCCCCEEECcCccce
Confidence 999975 999998753 35899999999999999999999998 9999999999999 888999999999997
Q ss_pred cccccCccceeeccCCcccccccCccccCcC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCC-----
Q 020888 193 LIKVQNSHDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRP----- 266 (320)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~----- 266 (320)
....... ......+|+.|+|||++.+. .++.++||||||+++|+|++|..||...+..+....+......
T Consensus 157 ~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 232 (317)
T 2pmi_A 157 AFGIPVN----TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESL 232 (317)
T ss_dssp ETTSCCC----CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTT
T ss_pred ecCCCcc----cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhH
Confidence 6643221 12345689999999999764 6899999999999999999999999988877666555431000
Q ss_pred ---------------------------CCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 267 ---------------------------FFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 267 ---------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
......++.+++++|.+||+.||.+|||+++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 233 WPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp CGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 00112478899999999999999999999999875
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=312.35 Aligned_cols=250 Identities=28% Similarity=0.479 Sum_probs=208.0
Q ss_pred cccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEE
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 119 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 119 (320)
.+|.+.+.||+|+||+||++.+. +..+|+|.+........ .+.+.+|+++++.++|+||+++++++......++||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 99 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVP--MEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM 99 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSC--HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchh--HHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence 47999999999999999999985 78899998866543322 367889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEee-CCCCcEEEecCCCcccc
Q 020888 120 EYLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN-SSADHLKVGDFGLSKLI 194 (320)
Q Consensus 120 e~~~~~~L~~~~~~----~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~-~~~~~~~L~dfg~~~~~ 194 (320)
||+++++|.+++.. ...+++..++.++.|++.||.|||+.| ++|+||||+||++.+ +.++.++|+|||++...
T Consensus 100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH--VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 99999999998854 357999999999999999999999998 999999999999943 33568999999999765
Q ss_pred cccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCC-CCCCCC
Q 020888 195 KVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPF-FRAKGF 273 (320)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~ 273 (320)
.... ......+++.|+|||++. ..++.++||||||+++|+|++|..||......+............ .....+
T Consensus 178 ~~~~-----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (285)
T 3is5_A 178 KSDE-----HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPL 251 (285)
T ss_dssp --------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCC
T ss_pred CCcc-----cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcC
Confidence 4332 123456899999999986 568899999999999999999999999888777766555444332 223457
Q ss_pred CHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 274 TPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 274 ~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
++++.+++.+||+.||.+|||+.+++++
T Consensus 252 ~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 252 TPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp CHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 9999999999999999999999999874
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-46 Score=335.01 Aligned_cols=256 Identities=24% Similarity=0.387 Sum_probs=215.7
Q ss_pred CCCCcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCce
Q 020888 38 DPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL 115 (320)
Q Consensus 38 ~~~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 115 (320)
.....+|.+.+.||+|+||+||++.+. ++.+|+|++.+...........+.+|+.+++.++||||+++++++.+++.+
T Consensus 65 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 144 (410)
T 3v8s_A 65 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL 144 (410)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence 345568999999999999999999986 788999988542111111113477899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccccc
Q 020888 116 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 195 (320)
Q Consensus 116 ~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~ 195 (320)
|+||||++||+|.++++. ..+++..+..++.|++.||.|||++| |+||||||+||++ +.++.++|+|||++....
T Consensus 145 ~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl--~~~g~ikL~DFG~a~~~~ 219 (410)
T 3v8s_A 145 YMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLL--DKSGHLKLADFGTCMKMN 219 (410)
T ss_dssp EEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--CTTSCEEECCCTTCEECC
T ss_pred EEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeeE--CCCCCEEEeccceeEeec
Confidence 999999999999999976 46899999999999999999999999 9999999999999 899999999999997654
Q ss_pred ccCccceeeccCCcccccccCccccCcCC----CCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCC--CCCCC
Q 020888 196 VQNSHDVYKMTGETGSYRYMAPEVFKHRK----YDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH--RPFFR 269 (320)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~--~~~~~ 269 (320)
... .......+||+.|+|||++.+.. ++.++|+||||+++|+|++|..||...+..+....+.... .....
T Consensus 220 ~~~---~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~ 296 (410)
T 3v8s_A 220 KEG---MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPD 296 (410)
T ss_dssp TTS---EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCT
T ss_pred cCC---cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCC
Confidence 332 12234567999999999997665 7889999999999999999999999988887777776532 12222
Q ss_pred CCCCCHHHHHHHHHHhhcCCCC--CCCHHHHHHH
Q 020888 270 AKGFTPELRELTEKCWAADMNQ--RPSFLDILKR 301 (320)
Q Consensus 270 ~~~~~~~l~~li~~~l~~dp~~--Rps~~~ll~~ 301 (320)
...++.+++++|++||..+|.+ ||+++++++|
T Consensus 297 ~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 297 DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred cccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 3458999999999999998988 9999999987
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=323.80 Aligned_cols=251 Identities=25% Similarity=0.454 Sum_probs=215.7
Q ss_pred CCCcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceE
Q 020888 39 PSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLM 116 (320)
Q Consensus 39 ~~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 116 (320)
....+|.+.+.||+|+||+||++.+. ++.+|+|++.... .....+.+.+|+++++.++|+||+++++++..++..+
T Consensus 30 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 107 (360)
T 3eqc_A 30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 107 (360)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEE
T ss_pred cccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEE
Confidence 34568999999999999999999986 7889999886543 3444578999999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcC-CCCeEecCCCCCcEEEeeCCCCcEEEecCCCccccc
Q 020888 117 LITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE-PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 195 (320)
Q Consensus 117 iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~-g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~ 195 (320)
+||||+++++|.+++...+.+++..+..++.|++.||.|||+. | ++|+||||+||++ +.++.++|+|||++....
T Consensus 108 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~--~~~~~~kl~Dfg~~~~~~ 183 (360)
T 3eqc_A 108 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILV--NSRGEIKLCDFGVSGQLI 183 (360)
T ss_dssp EEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEE--CTTCCEEECCCCCCHHHH
T ss_pred EEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCC--EEcCCccHHHEEE--CCCCCEEEEECCCCcccc
Confidence 9999999999999999888899999999999999999999996 8 9999999999999 888999999999987654
Q ss_pred ccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHH-------------------
Q 020888 196 VQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEA------------------- 256 (320)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~------------------- 256 (320)
... .....+++.|+|||++.+..++.++||||||+++|+|++|..||...+..+.
T Consensus 184 ~~~------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (360)
T 3eqc_A 184 DSM------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP 257 (360)
T ss_dssp HHC----------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------
T ss_pred ccc------ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCc
Confidence 322 2234689999999999999999999999999999999999999987654432
Q ss_pred -----------------------HHHHHhCCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 257 -----------------------AKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 257 -----------------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
...+.....+......++.+++++|.+||..||.+|||+++++++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 258 RTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp ----------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 223333444444445679999999999999999999999999986
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=318.60 Aligned_cols=254 Identities=30% Similarity=0.500 Sum_probs=203.4
Q ss_pred CcccCccceecccCceEEEEEEECCCceEEEEccCCCCCcHHHHHHHHHHHHHHHh--CCCCcccceeeeEEe----CCc
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVK--LRHPNIVQFLGAVTE----RKP 114 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~~----~~~ 114 (320)
..+|.+.+.||+|+||+||++.++++.||+|++.... ...+..|.+++.. ++|+||+++++++.. ...
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~ 80 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRD------EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQ 80 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGGG------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEECCEEEEEEEecccc------chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCce
Confidence 5689999999999999999999999999999885421 2455566777666 789999999998643 345
Q ss_pred eEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHh--------cCCCCeEecCCCCCcEEEeeCCCCcEEEe
Q 020888 115 LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLH--------NEPNVIIHRDLKPRNVLLVNSSADHLKVG 186 (320)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH--------~~g~~ivH~di~p~nI~~~~~~~~~~~L~ 186 (320)
.++||||+++++|.++++. ..+++..++.++.|++.||.||| +.| ++|+||||+||++ +.++.++|+
T Consensus 81 ~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~Nill--~~~~~~kl~ 155 (301)
T 3q4u_A 81 LWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA--IAHRDLKSKNILV--KKNGQCCIA 155 (301)
T ss_dssp EEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE--EECSCCCGGGEEE--CTTSCEEEC
T ss_pred eEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC--eecCCCChHhEEE--cCCCCEEEe
Confidence 8999999999999999965 47999999999999999999999 877 9999999999999 888999999
Q ss_pred cCCCcccccccCccceeeccCCcccccccCccccCcC------CCCCchhHHHHHHHHHHHHhC----------CCCCCC
Q 020888 187 DFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR------KYDKKVDVFSFAMILYEMLEG----------EPPLAN 250 (320)
Q Consensus 187 dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~~l~~ll~g----------~~p~~~ 250 (320)
|||++..................+|+.|+|||++.+. .++.++||||||+++|+|++| ..||..
T Consensus 156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~ 235 (301)
T 3q4u_A 156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235 (301)
T ss_dssp CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence 9999977655443333233445789999999999876 345799999999999999999 888865
Q ss_pred CCh-----HHHHHHHHhCCCCCCCC-----CCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHH
Q 020888 251 YEP-----YEAAKYVAEGHRPFFRA-----KGFTPELRELTEKCWAADMNQRPSFLDILKRLEKI 305 (320)
Q Consensus 251 ~~~-----~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~ 305 (320)
... ................+ ...+.++.+++.+||+.||.+|||+.++++.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 236 VVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 321 22222222222111111 22457899999999999999999999999999876
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=315.79 Aligned_cols=250 Identities=27% Similarity=0.434 Sum_probs=214.8
Q ss_pred CcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEE
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 118 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 118 (320)
..+|.+.+.||+|++|+||++.+. ++.+|+|.+....... ...+.+|+++++.++|+||+++++++...+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFR---DSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLV 84 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccc---hHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEE
Confidence 458999999999999999999985 8899999986543222 25788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEee-CCCCcEEEecCCCccccccc
Q 020888 119 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN-SSADHLKVGDFGLSKLIKVQ 197 (320)
Q Consensus 119 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~-~~~~~~~L~dfg~~~~~~~~ 197 (320)
|||+++++|.+++...+.+++..++.++.|++.||.|||+.| ++|+||||+||++.. +.++.++|+|||++......
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 162 (304)
T 2jam_A 85 MQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG--IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG 162 (304)
T ss_dssp ECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB
T ss_pred EEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC
Confidence 999999999999988888999999999999999999999998 999999999999832 45678999999998654321
Q ss_pred CccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCC--CCCCCCH
Q 020888 198 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFF--RAKGFTP 275 (320)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 275 (320)
......+++.|+|||.+.+..++.++|+||||+++|+|++|..||...........+..+..... ....+++
T Consensus 163 ------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 236 (304)
T 2jam_A 163 ------IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISE 236 (304)
T ss_dssp ------TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCH
T ss_pred ------ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCH
Confidence 11234578999999999999999999999999999999999999999888777777777653322 2256899
Q ss_pred HHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 276 ELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 276 ~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
+++++|.+||..||++|||+++++++
T Consensus 237 ~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 237 SAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp HHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 99999999999999999999999875
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=314.35 Aligned_cols=251 Identities=27% Similarity=0.437 Sum_probs=210.1
Q ss_pred CCcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEE
Q 020888 40 SELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLML 117 (320)
Q Consensus 40 ~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 117 (320)
...+|.+.+.||+|++|.||++.+. ++.+++|.+...........+.+.+|+.+++.++|+||+++++++...+..++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM 88 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence 3458999999999999999999986 88999998854322222234678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccccccc
Q 020888 118 ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 197 (320)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~ 197 (320)
||||+++++|.+++...+.+++..++.++.|++.||.+||++| ++|+||+|+||++ +.++.++|+|||++......
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~--~~~~~~~l~dfg~~~~~~~~ 164 (276)
T 2h6d_A 89 VMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM--VVHRDLKPENVLL--DAHMNAKIADFGLSNMMSDG 164 (276)
T ss_dssp EEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHC--SSCCCCCGGGEEE--CTTSCEEECCCCGGGCCCC-
T ss_pred EEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChhhEEE--CCCCCEEEeecccccccCCC
Confidence 9999999999999998888999999999999999999999998 9999999999999 88899999999998765432
Q ss_pred CccceeeccCCcccccccCccccCcCCC-CCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHH
Q 020888 198 NSHDVYKMTGETGSYRYMAPEVFKHRKY-DKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPE 276 (320)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (320)
. ......+++.|+|||.+.+..+ +.++|+||||+++++|++|..||...........+...... .+..++.+
T Consensus 165 ~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 237 (276)
T 2h6d_A 165 E-----FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFY--IPEYLNRS 237 (276)
T ss_dssp -----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC--CCTTSCHH
T ss_pred c-----ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccc--CchhcCHH
Confidence 2 1223467899999999988765 58999999999999999999999988877777766665433 23557999
Q ss_pred HHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 277 LRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 277 l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
+++++.+||+.||.+|||+++++++
T Consensus 238 l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 238 VATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHccCChhhCCCHHHHHhC
Confidence 9999999999999999999999986
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=321.24 Aligned_cols=262 Identities=29% Similarity=0.524 Sum_probs=218.0
Q ss_pred CCcccCccceecccCceEEEEEEEC-------CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcccceeeeEEe
Q 020888 40 SELDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTE 111 (320)
Q Consensus 40 ~~~~y~~~~~lg~g~~~~vy~~~~~-------~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 111 (320)
...+|.+.+.||+|+||+||++.+. ++.||+|.+.... .....+.+.+|+++++++ +|+||+++++++..
T Consensus 25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 102 (316)
T 2xir_A 25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTK 102 (316)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEec
Confidence 3568999999999999999999852 4789999886543 233447889999999999 69999999999876
Q ss_pred CC-ceEEEEecCCCCCHHHHHHHhCC----------------CCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEE
Q 020888 112 RK-PLMLITEYLRGGDLHKYLKEKGA----------------LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVL 174 (320)
Q Consensus 112 ~~-~~~iv~e~~~~~~L~~~~~~~~~----------------l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~ 174 (320)
.+ ..++||||+++++|.+++..... +++..++.++.|++.||.|||+.| ++|+||||+||+
T Consensus 103 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp~Nil 180 (316)
T 2xir_A 103 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNIL 180 (316)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEE
T ss_pred CCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC--cccccCccceEE
Confidence 54 58999999999999999987543 899999999999999999999998 999999999999
Q ss_pred EeeCCCCcEEEecCCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCh
Q 020888 175 LVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEP 253 (320)
Q Consensus 175 ~~~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~ 253 (320)
+ +.++.++|+|||++........ ........+++.|+|||++.+..++.++||||||+++|+|++ |..||.....
T Consensus 181 ~--~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~ 256 (316)
T 2xir_A 181 L--SEKNVVKICDFGLARDIYKDPD--YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 256 (316)
T ss_dssp E--CGGGCEEECCCGGGSCTTTCTT--SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred E--CCCCCEEECCCccccccccCcc--ceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccch
Confidence 9 7888999999999976644321 122234457889999999999999999999999999999998 9999987664
Q ss_pred HH-HHHHHHhCCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcCC
Q 020888 254 YE-AAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLP 310 (320)
Q Consensus 254 ~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~ 310 (320)
.. ....+..+... ..+..+++++.+++.+||+.||.+|||+.+++++|+.+.....
T Consensus 257 ~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 313 (316)
T 2xir_A 257 DEEFCRRLKEGTRM-RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 313 (316)
T ss_dssp SHHHHHHHHHTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred hHHHHHHhccCccC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 43 33444444333 3345589999999999999999999999999999999876543
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=323.60 Aligned_cols=259 Identities=29% Similarity=0.538 Sum_probs=215.1
Q ss_pred CCcccCccceecccCceEEEEEEEC--CCc----eEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCC
Q 020888 40 SELDFSSSAIIGKGSFGEILKAYWR--GTP----VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK 113 (320)
Q Consensus 40 ~~~~y~~~~~lg~g~~~~vy~~~~~--~~~----~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 113 (320)
...+|.+.+.||+|+||+||++.+. ++. +++|.+....... ....+.+|+.+++.++|+||+++++++. ++
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~ 87 (325)
T 3kex_A 11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQ--SFQAVTDHMLAIGSLDHAHIVRLLGLCP-GS 87 (325)
T ss_dssp CTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCS--CBCSCCHHHHHHHTCCCTTBCCEEEEEC-BS
T ss_pred CHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHH--HHHHHHHHHHHHhcCCCCCcCeEEEEEc-CC
Confidence 3458999999999999999999975 443 7777764432221 1246678999999999999999999886 45
Q ss_pred ceEEEEecCCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcc
Q 020888 114 PLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 192 (320)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~ 192 (320)
..++|+||+++++|.+++... +.+++..++.++.|++.||.|||+.| ++|+||||+||++ +.++.++|+|||++.
T Consensus 88 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~--~~~~~~kl~Dfg~a~ 163 (325)
T 3kex_A 88 SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG--MVHRNLAARNVLL--KSPSQVQVADFGVAD 163 (325)
T ss_dssp SEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTT--CCCSCCSSTTEEE--SSSSCEEECSCSGGG
T ss_pred ccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCC--CCCCccchheEEE--CCCCeEEECCCCccc
Confidence 689999999999999999763 57999999999999999999999999 9999999999999 888999999999998
Q ss_pred cccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCC
Q 020888 193 LIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAK 271 (320)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 271 (320)
......... ......++..|+|||++.+..++.++||||||+++|++++ |..||......+....+........ +.
T Consensus 164 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~ 240 (325)
T 3kex_A 164 LLPPDDKQL--LYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQ-PQ 240 (325)
T ss_dssp GSCCCTTCC--C-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCC-CT
T ss_pred ccCcccccc--cccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCC-CC
Confidence 765433211 2233457789999999999999999999999999999999 9999998887777776666554433 34
Q ss_pred CCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhc
Q 020888 272 GFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKET 308 (320)
Q Consensus 272 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 308 (320)
.++.++.+++.+||..||.+|||+.+++++|+++...
T Consensus 241 ~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 241 ICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp TBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred cCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 4788999999999999999999999999999998653
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=336.07 Aligned_cols=255 Identities=29% Similarity=0.492 Sum_probs=214.5
Q ss_pred cccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEE
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 119 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 119 (320)
.+|.+++.||+|+||+||++.+. +..+|+|++......... ...+.+|+++++.++||||+++++++.....+|+||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSS-NSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CT-THHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchH-HHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 37999999999999999999986 788999998765432222 367889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEee-CCCCcEEEecCCCcccccccC
Q 020888 120 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN-SSADHLKVGDFGLSKLIKVQN 198 (320)
Q Consensus 120 e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~-~~~~~~~L~dfg~~~~~~~~~ 198 (320)
||+++++|.+++.....+++..++.++.|++.||.|||++| |+|+||||+||++.. +.++.++|+|||++.......
T Consensus 116 e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~ 193 (494)
T 3lij_A 116 ECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN--IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK 193 (494)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc
Confidence 99999999999988888999999999999999999999999 999999999999932 224569999999997765432
Q ss_pred ccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCC--CCCCHH
Q 020888 199 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA--KGFTPE 276 (320)
Q Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 276 (320)
......+|+.|+|||++. ..++.++|||||||++|+|++|..||......+....+..+......+ ..++++
T Consensus 194 -----~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 267 (494)
T 3lij_A 194 -----KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEG 267 (494)
T ss_dssp -----CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHH
T ss_pred -----cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHH
Confidence 233456899999999986 468999999999999999999999999999888888887776443332 468999
Q ss_pred HHHHHHHHhhcCCCCCCCHHHHHHH--HHHH
Q 020888 277 LRELTEKCWAADMNQRPSFLDILKR--LEKI 305 (320)
Q Consensus 277 l~~li~~~l~~dp~~Rps~~~ll~~--L~~~ 305 (320)
++++|.+||..||.+|||+.+++++ +...
T Consensus 268 ~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 298 (494)
T 3lij_A 268 AKDLIKQMLQFDSQRRISAQQALEHPWIKEM 298 (494)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred HHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence 9999999999999999999999976 4443
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=314.03 Aligned_cols=250 Identities=32% Similarity=0.552 Sum_probs=218.8
Q ss_pred CcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEE
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 118 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 118 (320)
...|.+.+.||+|++|.||++.+. ++.||+|++....... ..+.+.+|+.+++.++|+||+++++++..++..++|
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 98 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED--EIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII 98 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCST--THHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHH--HHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence 356999999999999999999875 7889999886554332 247889999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccC
Q 020888 119 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 198 (320)
Q Consensus 119 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~ 198 (320)
|||+++++|.+++.. +.+++..++.++.|++.||.+||+.| ++|+||+|+||++ +.++.++|+|||.+.......
T Consensus 99 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~--~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 99 MEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLL--SEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp EECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--CTTSCEEECCCTTCEECBTTB
T ss_pred EEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChheEEE--CCCCCEEEeecccceecCccc
Confidence 999999999999875 57999999999999999999999999 9999999999999 888999999999997665432
Q ss_pred ccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHH
Q 020888 199 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 278 (320)
Q Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 278 (320)
. ......+++.|+|||.+.+..++.++|+||||+++++|++|..||...........+.....+.. ...++.++.
T Consensus 174 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~ 248 (303)
T 3a7i_A 174 I----KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTL-EGNYSKPLK 248 (303)
T ss_dssp C----CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC-CSSCCHHHH
T ss_pred c----ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCC-ccccCHHHH
Confidence 1 22345689999999999999999999999999999999999999999888777776666654433 345899999
Q ss_pred HHHHHHhhcCCCCCCCHHHHHHHH
Q 020888 279 ELTEKCWAADMNQRPSFLDILKRL 302 (320)
Q Consensus 279 ~li~~~l~~dp~~Rps~~~ll~~L 302 (320)
+++.+||..||.+|||+.+++++.
T Consensus 249 ~li~~~l~~dp~~Rps~~~ll~~~ 272 (303)
T 3a7i_A 249 EFVEACLNKEPSFRPTAKELLKHK 272 (303)
T ss_dssp HHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred HHHHHHcCCChhhCcCHHHHhhCh
Confidence 999999999999999999999874
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-45 Score=322.43 Aligned_cols=256 Identities=23% Similarity=0.363 Sum_probs=209.3
Q ss_pred CCCCCcccCccceecccCceEEEEEEEC-CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCC--CcccceeeeEEeCC
Q 020888 37 IDPSELDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH--PNIVQFLGAVTERK 113 (320)
Q Consensus 37 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~-~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~ 113 (320)
+...+.+|.+.+.||+|+||.||++.+. ++.||+|.+..... .....+.+.+|++++..++| +||+++++++..+.
T Consensus 4 i~~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~ 82 (343)
T 3dbq_A 4 ISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 82 (343)
T ss_dssp EESSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred eeeecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeecccc-chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCC
Confidence 4556789999999999999999999876 77899998865543 34455788999999999976 99999999999999
Q ss_pred ceEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccc
Q 020888 114 PLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 193 (320)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~ 193 (320)
..++|||+. +++|.+++...+.+++..+..++.|++.||.|||+.| |+|+||||+||++ + ++.++|+|||++..
T Consensus 83 ~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~--iiHrDikp~NIll--~-~~~~kl~DFG~a~~ 156 (343)
T 3dbq_A 83 YIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLI--V-DGMLKLIDFGIANQ 156 (343)
T ss_dssp EEEEEECCC-SEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE--E-TTEEEECCCSSSCC
T ss_pred EEEEEEeCC-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEE--E-CCcEEEeecccccc
Confidence 999999954 7799999998888999999999999999999999998 9999999999999 4 56899999999986
Q ss_pred ccccCccceeeccCCcccccccCccccCc-----------CCCCCchhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHH
Q 020888 194 IKVQNSHDVYKMTGETGSYRYMAPEVFKH-----------RKYDKKVDVFSFAMILYEMLEGEPPLANYEP-YEAAKYVA 261 (320)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----------~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~-~~~~~~~~ 261 (320)
...... ........||+.|+|||++.+ ..++.++||||||+++|+|++|..||..... ......+.
T Consensus 157 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~ 234 (343)
T 3dbq_A 157 MQPDTT--SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII 234 (343)
T ss_dssp C--------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH
T ss_pred cCcccc--cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHh
Confidence 643321 112234568999999999865 6788999999999999999999999987543 33444444
Q ss_pred hCCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 262 EGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 262 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
........+...+.++.+++..||..||.+|||+.+++++
T Consensus 235 ~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 235 DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 4444444455578899999999999999999999999887
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=339.94 Aligned_cols=253 Identities=31% Similarity=0.516 Sum_probs=221.0
Q ss_pred CcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEE
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 118 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 118 (320)
..+|.+.+.||+|+||.||++.+. ++.||+|++.............+.+|++++++++||||+++++++...+..++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 358999999999999999999986 789999998765544333447889999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEee-CCCCcEEEecCCCccccccc
Q 020888 119 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN-SSADHLKVGDFGLSKLIKVQ 197 (320)
Q Consensus 119 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~-~~~~~~~L~dfg~~~~~~~~ 197 (320)
|||+++++|.+++...+.+++..++.++.|++.||.|||++| |+|+||||+||++.. +.++.++|+|||++......
T Consensus 105 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 182 (484)
T 3nyv_A 105 GEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK--IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 182 (484)
T ss_dssp ECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc
Confidence 999999999999988888999999999999999999999999 999999999999932 35678999999998766443
Q ss_pred CccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCC--CCCCH
Q 020888 198 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA--KGFTP 275 (320)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 275 (320)
. ......+|+.|+|||++.+ .++.++||||||+++|+|++|..||...+..+....+..+......+ ..+++
T Consensus 183 ~-----~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 256 (484)
T 3nyv_A 183 K-----KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSE 256 (484)
T ss_dssp C-----SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCH
T ss_pred c-----ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCH
Confidence 2 1233468999999999876 68999999999999999999999999999888888887776443322 45799
Q ss_pred HHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 276 ELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 276 ~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
+++++|.+||..||.+|||+.+++++
T Consensus 257 ~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 257 SAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 99999999999999999999999986
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=335.74 Aligned_cols=263 Identities=29% Similarity=0.579 Sum_probs=225.0
Q ss_pred CCCCcCCCCCcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeE
Q 020888 32 KCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAV 109 (320)
Q Consensus 32 ~~~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 109 (320)
...|++. ..+|.+.+.||+|+||.||++.+. +..||+|.+...... .+.+.+|++++++++|+||+++++++
T Consensus 212 ~~~~~~~--~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~l~~~~ 285 (495)
T 1opk_A 212 YDKWEME--RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVC 285 (495)
T ss_dssp SSCCBCC--GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccccccC--HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc----hHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 3445543 567999999999999999999987 788999998654332 36788999999999999999999999
Q ss_pred EeCCceEEEEecCCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEec
Q 020888 110 TERKPLMLITEYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGD 187 (320)
Q Consensus 110 ~~~~~~~iv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~d 187 (320)
...+..++||||+++++|.+++... ..+++..++.++.|++.||.|||++| |+|+||||+||++ +.++.++|+|
T Consensus 286 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll--~~~~~~kl~D 361 (495)
T 1opk_A 286 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRNLAARNCLV--GENHLVKVAD 361 (495)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--CGGGCEEECC
T ss_pred ecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChhhEEE--CCCCcEEEee
Confidence 9999999999999999999999863 35899999999999999999999998 9999999999999 8888999999
Q ss_pred CCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCC
Q 020888 188 FGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRP 266 (320)
Q Consensus 188 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~ 266 (320)
||++....... ........++..|+|||++.+..++.++||||||+++|+|++ |..||...+..+....+......
T Consensus 362 FG~a~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~ 438 (495)
T 1opk_A 362 FGLSRLMTGDT---YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM 438 (495)
T ss_dssp TTCEECCTTCC---EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC
T ss_pred cccceeccCCc---eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 99998654321 112233446778999999998899999999999999999999 99999998887777777665544
Q ss_pred CCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhc
Q 020888 267 FFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKET 308 (320)
Q Consensus 267 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 308 (320)
. .+..+++++.+++.+||+.||.+|||+.++++.|+.+...
T Consensus 439 ~-~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 439 E-RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp C-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred C-CCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence 3 3456899999999999999999999999999999877543
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=322.70 Aligned_cols=250 Identities=26% Similarity=0.484 Sum_probs=216.2
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCc-----HHHHHHHHHHHHHHHhC-CCCcccceeeeEEeCCc
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDD-----RLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKP 114 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~-----~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 114 (320)
+|.+.+.||+|++|.||++.+. ++.||+|++....... ....+.+.+|+.+++++ +|+||+++++++.....
T Consensus 95 ~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 174 (365)
T 2y7j_A 95 KYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSF 174 (365)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSE
T ss_pred hcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCE
Confidence 6899999999999999999985 8899999886554221 22346788999999999 79999999999999999
Q ss_pred eEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccc
Q 020888 115 LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 194 (320)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~ 194 (320)
.++||||++|++|.+++.....+++..+..++.|++.||.|||+.| ++|+||||+||++ +.++.++|+|||++..+
T Consensus 175 ~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~g--i~H~Dlkp~NIl~--~~~~~ikl~DfG~~~~~ 250 (365)
T 2y7j_A 175 MFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANN--IVHRDLKPENILL--DDNMQIRLSDFGFSCHL 250 (365)
T ss_dssp EEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--CTTCCEEECCCTTCEEC
T ss_pred EEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEE--CCCCCEEEEecCccccc
Confidence 9999999999999999998888999999999999999999999999 9999999999999 88899999999998876
Q ss_pred cccCccceeeccCCcccccccCccccCc------CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCC
Q 020888 195 KVQNSHDVYKMTGETGSYRYMAPEVFKH------RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFF 268 (320)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 268 (320)
.... ......+|+.|+|||++.+ ..++.++||||||+++|+|++|..||...........+..+.....
T Consensus 251 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 325 (365)
T 2y7j_A 251 EPGE-----KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFS 325 (365)
T ss_dssp CTTC-----CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred CCCc-----ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence 5432 2234578999999999864 3578899999999999999999999998887777777766654433
Q ss_pred CC--CCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 269 RA--KGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 269 ~~--~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
.+ ..++.++.+++.+||..||++|||+++++++
T Consensus 326 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 326 SPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp HHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 22 4578999999999999999999999999875
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=336.14 Aligned_cols=252 Identities=31% Similarity=0.530 Sum_probs=216.3
Q ss_pred CcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEE
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 118 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 118 (320)
..+|.+.+.||+|+||+||++.+. ++.||+|++........ ....+.+|++++++++||||+++++++......++|
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCS-CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccch-HHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 348999999999999999999986 78999998854322211 136788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEee-CCCCcEEEecCCCccccccc
Q 020888 119 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN-SSADHLKVGDFGLSKLIKVQ 197 (320)
Q Consensus 119 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~-~~~~~~~L~dfg~~~~~~~~ 197 (320)
|||+++++|.+.+...+.+++..+..++.|++.||.|||++| |+|+||||+||++.. +.++.++|+|||++......
T Consensus 100 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 177 (486)
T 3mwu_A 100 GELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (486)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC
T ss_pred EEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC
Confidence 999999999999988888999999999999999999999999 999999999999932 23457999999999765433
Q ss_pred CccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCC--CCCCH
Q 020888 198 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA--KGFTP 275 (320)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 275 (320)
. ......+|+.|+|||++.+ .++.++|||||||++|+|++|..||......+....+..+......+ ..+++
T Consensus 178 ~-----~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 251 (486)
T 3mwu_A 178 T-----KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISD 251 (486)
T ss_dssp ---------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCH
T ss_pred C-----ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCH
Confidence 2 2334568999999999876 58999999999999999999999999998888888777765443322 45799
Q ss_pred HHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 276 ELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 276 ~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
+++++|.+||..||.+|||+.+++++
T Consensus 252 ~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 252 DAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 99999999999999999999999987
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=317.26 Aligned_cols=252 Identities=27% Similarity=0.455 Sum_probs=190.1
Q ss_pred CCcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEE
Q 020888 40 SELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLML 117 (320)
Q Consensus 40 ~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 117 (320)
...+|.+.+.||+|+||.||++.+. ++.+|+|.+...........+.+.+|+++++.++|+||+++++++...+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence 4458999999999999999999974 88999998854322222224678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccc
Q 020888 118 ITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 196 (320)
Q Consensus 118 v~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~ 196 (320)
||||+++++|.+++... ..+++..++.++.|++.||.|||+.| ++|+||+|+||++ +.++.++|+|||.+.....
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nili--~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG--ILHRDLTLSNLLL--TRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSSCCGGGEEE--CTTCCEEECCCTTCEECC-
T ss_pred EEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEE--cCCCCEEEEeecceeeccC
Confidence 99999999999999875 57999999999999999999999998 9999999999999 8889999999999876643
Q ss_pred cCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHH
Q 020888 197 QNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPE 276 (320)
Q Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (320)
... ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||...........+.... ...+..++.+
T Consensus 165 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 238 (278)
T 3cok_A 165 PHE----KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLAD--YEMPSFLSIE 238 (278)
T ss_dssp -------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSC--CCCCTTSCHH
T ss_pred CCC----cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcc--cCCccccCHH
Confidence 221 1223467899999999999999999999999999999999999998765444333222211 2233557999
Q ss_pred HHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 277 LRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 277 l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
+++++.+||..||.+|||+++++++
T Consensus 239 ~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 239 AKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred HHHHHHHHcccCHhhCCCHHHHhcC
Confidence 9999999999999999999999875
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=318.42 Aligned_cols=263 Identities=27% Similarity=0.463 Sum_probs=215.2
Q ss_pred cccCccceecccCceEEEEEEE------CCCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEe--CC
Q 020888 42 LDFSSSAIIGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE--RK 113 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~------~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~ 113 (320)
..|.+++.||+|+||+||++.. +++.||+|++... ......+.+.+|+++++.++|+||+++++++.+ ..
T Consensus 31 r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (318)
T 3lxp_A 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD--AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAA 108 (318)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTT
T ss_pred HHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc--cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCc
Confidence 3459999999999999988764 3678999998654 233445789999999999999999999999987 45
Q ss_pred ceEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccc
Q 020888 114 PLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 193 (320)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~ 193 (320)
..++||||+++++|.+++... .+++..++.++.|++.||.+||+.| ++|+||||+||++ +.++.++|+|||++..
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~--ivH~Dikp~Nil~--~~~~~~kl~Dfg~a~~ 183 (318)
T 3lxp_A 109 SLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQH--YIHRDLAARNVLL--DNDRLVKIGDFGLAKA 183 (318)
T ss_dssp EEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--CTTCCEEECCGGGCEE
T ss_pred eEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEE--cCCCCEEECCcccccc
Confidence 689999999999999999765 5899999999999999999999999 9999999999999 8889999999999987
Q ss_pred ccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH--------------HHHHH
Q 020888 194 IKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPY--------------EAAKY 259 (320)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~--------------~~~~~ 259 (320)
....... ........++..|+|||++.+..++.++||||||+++|+|++|..||...... .....
T Consensus 184 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (318)
T 3lxp_A 184 VPEGHEY-YRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTE 262 (318)
T ss_dssp CCTTCSE-EEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHH
T ss_pred ccccccc-cccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHH
Confidence 6543221 11223345788899999999989999999999999999999999998753211 11122
Q ss_pred HHhCCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcCCCC
Q 020888 260 VAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPTD 312 (320)
Q Consensus 260 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~ 312 (320)
..........+..++.++.+++.+||+.||.+|||+.++++.|+.+.+....+
T Consensus 263 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~ 315 (318)
T 3lxp_A 263 LLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQ 315 (318)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC-
T ss_pred HHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccC
Confidence 22333333345568999999999999999999999999999999998876543
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=332.18 Aligned_cols=256 Identities=24% Similarity=0.368 Sum_probs=213.8
Q ss_pred CCCCcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCce
Q 020888 38 DPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL 115 (320)
Q Consensus 38 ~~~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 115 (320)
.....+|.+.+.||+|+||+||++.++ ++.||+|++.+...........+.+|..++..++|++|+++++++.+.+.+
T Consensus 57 ~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~ 136 (412)
T 2vd5_A 57 RLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYL 136 (412)
T ss_dssp SCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred cCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEE
Confidence 345678999999999999999999985 889999988543221222234578899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccc
Q 020888 116 MLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 194 (320)
Q Consensus 116 ~iv~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~ 194 (320)
|+||||++|++|.+++.+.+ .+++..+..++.|++.||+|||++| |+|+||||+||++ +.++.++|+|||++...
T Consensus 137 ~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILl--d~~g~vkL~DFGla~~~ 212 (412)
T 2vd5_A 137 YLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG--YVHRDIKPDNILL--DRCGHIRLADFGSCLKL 212 (412)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--CTTSCEEECCCTTCEEC
T ss_pred EEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccCHHHeee--cCCCCEEEeechhheec
Confidence 99999999999999998754 7999999999999999999999999 9999999999999 88999999999999876
Q ss_pred cccCccceeeccCCcccccccCccccC-------cCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCC---
Q 020888 195 KVQNSHDVYKMTGETGSYRYMAPEVFK-------HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH--- 264 (320)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~--- 264 (320)
..... ......+||+.|+|||++. +..++.++|+|||||++|+|++|..||...+..+....+....
T Consensus 213 ~~~~~---~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~ 289 (412)
T 2vd5_A 213 RADGT---VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHL 289 (412)
T ss_dssp CTTSC---EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC
T ss_pred cCCCc---cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCc
Confidence 54321 1223457999999999987 3568999999999999999999999999988877766665421
Q ss_pred CCCCCCCCCCHHHHHHHHHHhhcCCCCC---CCHHHHHHH
Q 020888 265 RPFFRAKGFTPELRELTEKCWAADMNQR---PSFLDILKR 301 (320)
Q Consensus 265 ~~~~~~~~~~~~l~~li~~~l~~dp~~R---ps~~~ll~~ 301 (320)
..+.....++++++++|++||. +|.+| |+++++++|
T Consensus 290 ~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 290 SLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp CCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred CCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 1222234689999999999999 99998 599999876
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=315.33 Aligned_cols=255 Identities=28% Similarity=0.471 Sum_probs=214.3
Q ss_pred CCcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEE--eCCce
Q 020888 40 SELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVT--ERKPL 115 (320)
Q Consensus 40 ~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~ 115 (320)
...+|.+.+.||+|++|.||++.+. ++.+++|.+...... ....+.+.+|++++++++|+||+++++++. .....
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 82 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 82 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEE
T ss_pred chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceE
Confidence 4568999999999999999999985 788999988765443 334578999999999999999999999874 46678
Q ss_pred EEEEecCCCCCHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHhcCC---CCeEecCCCCCcEEEeeCCCCcEEEecC
Q 020888 116 MLITEYLRGGDLHKYLKEK----GALSPSTAVNFALDIARGMAYLHNEP---NVIIHRDLKPRNVLLVNSSADHLKVGDF 188 (320)
Q Consensus 116 ~iv~e~~~~~~L~~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~g---~~ivH~di~p~nI~~~~~~~~~~~L~df 188 (320)
++||||+++++|.+++... ..+++..++.++.|++.||.|||+.| .+++|+||+|+||++ +.++.++|+||
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~--~~~~~~kl~df 160 (279)
T 2w5a_A 83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL--DGKQNVKLGDF 160 (279)
T ss_dssp EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEE--CSSSCEEECCC
T ss_pred EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEE--cCCCCEEEecC
Confidence 9999999999999999753 34999999999999999999999965 239999999999999 88899999999
Q ss_pred CCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCC
Q 020888 189 GLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFF 268 (320)
Q Consensus 189 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 268 (320)
|.+........ ......+++.|+|||++.+..++.++|+||||+++|+|++|..||...+..+....+..+.....
T Consensus 161 g~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~ 236 (279)
T 2w5a_A 161 GLARILNHDTS----FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRI 236 (279)
T ss_dssp CHHHHC---CH----HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred chheeeccccc----cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccC
Confidence 99876543221 11234578999999999999999999999999999999999999999888877777777665443
Q ss_pred CCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHH
Q 020888 269 RAKGFTPELRELTEKCWAADMNQRPSFLDILKRL 302 (320)
Q Consensus 269 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 302 (320)
+..++.++.+++.+||+.||.+|||++++++++
T Consensus 237 -~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~ 269 (279)
T 2w5a_A 237 -PYRYSDELNEIITRMLNLKDYHRPSVEEILENP 269 (279)
T ss_dssp -CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred -CcccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence 345899999999999999999999999999874
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=315.83 Aligned_cols=254 Identities=27% Similarity=0.417 Sum_probs=203.2
Q ss_pred CcccCcc-ceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcccceeeeEEeCCceE
Q 020888 41 ELDFSSS-AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLM 116 (320)
Q Consensus 41 ~~~y~~~-~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 116 (320)
...|.+. +.||+|+||+||++.+. ++.||+|++....... ...+.+|++++.++ +|+||+++++++..++..+
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~ 87 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHI---RSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFY 87 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCC---HHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchh---HHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence 3467774 78999999999999875 8899999986553332 36788999999995 7999999999999999999
Q ss_pred EEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCc---EEEecCCCccc
Q 020888 117 LITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH---LKVGDFGLSKL 193 (320)
Q Consensus 117 iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~---~~L~dfg~~~~ 193 (320)
+||||+++++|.+++...+.+++..++.++.|++.||.|||++| ++|+||||+||++ +.++. ++|+|||++..
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nil~--~~~~~~~~~kl~Dfg~~~~ 163 (316)
T 2ac3_A 88 LVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKG--IAHRDLKPENILC--EHPNQVSPVKICDFDLGSG 163 (316)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE--SCSSSSCSEEECCTTCCC-
T ss_pred EEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEE--ccCCCcCceEEEEccCccc
Confidence 99999999999999998888999999999999999999999998 9999999999999 55554 99999999876
Q ss_pred ccccCccc---eeeccCCcccccccCccccCc-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCh------------
Q 020888 194 IKVQNSHD---VYKMTGETGSYRYMAPEVFKH-----RKYDKKVDVFSFAMILYEMLEGEPPLANYEP------------ 253 (320)
Q Consensus 194 ~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~------------ 253 (320)
........ ........+++.|+|||++.+ ..++.++||||||+++|+|++|..||.....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 243 (316)
T 2ac3_A 164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACP 243 (316)
T ss_dssp ------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCH
T ss_pred cccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccch
Confidence 64322111 111223458999999999875 4578999999999999999999999976542
Q ss_pred ---HHHHHHHHhCCCCCCCC--CCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 254 ---YEAAKYVAEGHRPFFRA--KGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 254 ---~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
......+.......... ..++.+++++|.+||..||.+|||+++++++
T Consensus 244 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 244 ACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 22344444444322211 3578999999999999999999999999986
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=321.57 Aligned_cols=269 Identities=28% Similarity=0.439 Sum_probs=214.2
Q ss_pred CCCCCCCCCCcCCCCCcccCccceecccCceEEEEEEEC-CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccc
Q 020888 26 PPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQ 104 (320)
Q Consensus 26 ~~~~~~~~~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~-~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 104 (320)
....+.++.-.+.....+|.+.+.||+|+||+||++.+. ++.||+|.+........ ...+.+|+++++.++|+||++
T Consensus 14 ~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~ 91 (326)
T 3uim_A 14 LGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGG--ELQFQTEVEMISMAVHRNLLR 91 (326)
T ss_dssp -CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----C--CCHHHHHHHGGGTCCCTTBCC
T ss_pred cCccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchH--HHHHHHHHHHHHhccCCCccc
Confidence 334455555567777889999999999999999999875 78899998865433221 136889999999999999999
Q ss_pred eeeeEEeCCceEEEEecCCCCCHHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHhcC---CCCeEecCCCCCcEEEee
Q 020888 105 FLGAVTERKPLMLITEYLRGGDLHKYLKEKG----ALSPSTAVNFALDIARGMAYLHNE---PNVIIHRDLKPRNVLLVN 177 (320)
Q Consensus 105 ~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH~~---g~~ivH~di~p~nI~~~~ 177 (320)
+++++...+..++||||+++++|.+++.... .+++..++.++.|++.||.|||+. | ++|+||||+||++
T Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~--ivH~Dlkp~Nil~-- 167 (326)
T 3uim_A 92 LRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK--IIHRDVKAANILL-- 167 (326)
T ss_dssp CCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC--EECCCCSGGGEEE--
T ss_pred eEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeCCCchhhEEE--
Confidence 9999999999999999999999999998633 489999999999999999999998 8 9999999999999
Q ss_pred CCCCcEEEecCCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCC-----C
Q 020888 178 SSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANY-----E 252 (320)
Q Consensus 178 ~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~-----~ 252 (320)
+.++.++|+|||++........ .......+|+.|+|||.+.+..++.++||||||+++|+|++|..||... .
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 244 (326)
T 3uim_A 168 DEEFEAVVGDFGLAKLMDYKDT---HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDD 244 (326)
T ss_dssp CTTCCEEECCCSSCEECCSSSS---CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTS
T ss_pred CCCCCEEeccCccccccCcccc---cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccccccccccc
Confidence 8889999999999986643322 1223345899999999999889999999999999999999999999521 1
Q ss_pred hHHHHHHHHhCCCCCC-------------CCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHH
Q 020888 253 PYEAAKYVAEGHRPFF-------------RAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEK 304 (320)
Q Consensus 253 ~~~~~~~~~~~~~~~~-------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 304 (320)
....... ........ .....+.++.+++.+||+.||.+|||+.+++++|+.
T Consensus 245 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 245 DVMLLDW-VKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp CSBHHHH-HTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred chhHHHH-HHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 1111111 11110000 011123779999999999999999999999999975
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-46 Score=337.73 Aligned_cols=257 Identities=23% Similarity=0.366 Sum_probs=215.7
Q ss_pred CCCCcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCce
Q 020888 38 DPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL 115 (320)
Q Consensus 38 ~~~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 115 (320)
.....+|.+.+.||+|+||+||++.+. ++.+|+|++.+...........+.+|..++..++|+||+++++++.+++.+
T Consensus 70 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~ 149 (437)
T 4aw2_A 70 RLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNL 149 (437)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred cCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEE
Confidence 345568999999999999999999986 678999988542111111123478899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccc
Q 020888 116 MLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 194 (320)
Q Consensus 116 ~iv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~ 194 (320)
|+||||++||+|.+++.. .+.+++..+..++.|++.||.|||++| |+||||||+||++ +.++.++|+|||++...
T Consensus 150 ~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILl--~~~g~vkL~DFGla~~~ 225 (437)
T 4aw2_A 150 YLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILM--DMNGHIRLADFGSCLKL 225 (437)
T ss_dssp EEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--CTTSCEEECCCTTCEEC
T ss_pred EEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeeE--cCCCCEEEcchhhhhhc
Confidence 999999999999999987 468999999999999999999999999 9999999999999 89999999999999766
Q ss_pred cccCccceeeccCCcccccccCccccC-----cCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCC---CC
Q 020888 195 KVQNSHDVYKMTGETGSYRYMAPEVFK-----HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH---RP 266 (320)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~---~~ 266 (320)
..... ......+||+.|+|||++. ...++.++|+|||||++|+|++|..||...+..+....+.... ..
T Consensus 226 ~~~~~---~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~ 302 (437)
T 4aw2_A 226 MEDGT---VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQF 302 (437)
T ss_dssp CTTSC---EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCC
T ss_pred ccCCC---cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccC
Confidence 43321 2233457999999999986 4568999999999999999999999999988887776665421 22
Q ss_pred CCCCCCCCHHHHHHHHHHhhcCCCC--CCCHHHHHHH
Q 020888 267 FFRAKGFTPELRELTEKCWAADMNQ--RPSFLDILKR 301 (320)
Q Consensus 267 ~~~~~~~~~~l~~li~~~l~~dp~~--Rps~~~ll~~ 301 (320)
+.....++++++++|++||..+|++ |+++++++++
T Consensus 303 p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 303 PTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp CSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred CcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 2222458999999999999888887 9999999886
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=318.42 Aligned_cols=262 Identities=28% Similarity=0.490 Sum_probs=214.1
Q ss_pred CCcccCccceecccCceEEEEEEE------CCCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEE--e
Q 020888 40 SELDFSSSAIIGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVT--E 111 (320)
Q Consensus 40 ~~~~y~~~~~lg~g~~~~vy~~~~------~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~ 111 (320)
...+|.+.+.||+|+||.||++.. +++.||+|.+... .....+.+.+|+++++.++|+||+++++++. +
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 97 (327)
T 3lxl_A 21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS---GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPG 97 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred chhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC---CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC
Confidence 456899999999999999999984 3678999988643 3344577899999999999999999999886 4
Q ss_pred CCceEEEEecCCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCC
Q 020888 112 RKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGL 190 (320)
Q Consensus 112 ~~~~~iv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~ 190 (320)
....++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.| ++|+||||+||++ +.++.++|+|||+
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~--~~~~~~kl~Dfg~ 173 (327)
T 3lxl_A 98 RQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR--CVHRDLAARNILV--ESEAHVKIADFGL 173 (327)
T ss_dssp SCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--EETTEEEECCGGG
T ss_pred CceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChhhEEE--CCCCCEEEccccc
Confidence 5668999999999999999986 446999999999999999999999998 9999999999999 7788999999999
Q ss_pred cccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH---------------H
Q 020888 191 SKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPY---------------E 255 (320)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~---------------~ 255 (320)
+........ .........+++.|+|||++.+..++.++||||||+++|+|++|..||...... .
T Consensus 174 ~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 252 (327)
T 3lxl_A 174 AKLLPLDKD-YYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSR 252 (327)
T ss_dssp CEECCTTCS-EEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHH
T ss_pred ceecccCCc-cceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHH
Confidence 987654322 112233445788899999999988999999999999999999999998543321 2
Q ss_pred HHHHHHhCCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcCC
Q 020888 256 AAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLP 310 (320)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~ 310 (320)
....+.... ....+..+++++++++.+||+.||.+|||+.+++++|+.+.....
T Consensus 253 ~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 306 (327)
T 3lxl_A 253 LLELLEEGQ-RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR 306 (327)
T ss_dssp HHHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-----
T ss_pred HHHHhhccc-CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 222333333 333455689999999999999999999999999999999876554
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=311.35 Aligned_cols=252 Identities=29% Similarity=0.442 Sum_probs=212.1
Q ss_pred cccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEE
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 119 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 119 (320)
.+|.+.+.||+|++|.||++.+. ++.+|+|.+....... ..+.+.+|+.+++.++|+||+++++++..++..++|+
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTT--HHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchh--hhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 47999999999999999999986 7889999886543332 3478889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCc
Q 020888 120 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 199 (320)
Q Consensus 120 e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~ 199 (320)
||+++++|.+++.....+++..++.++.|++.||.+||+.| ++|+||+|+||++ +.++.++|+|||.+........
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~--~~~~~~kl~dfg~~~~~~~~~~ 160 (276)
T 2yex_A 85 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLL--DERDNLKISDFGLATVFRYNNR 160 (276)
T ss_dssp ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--CTTCCEEECCCTTCEECEETTE
T ss_pred EecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCChHHEEE--ccCCCEEEeeCCCccccCCCcc
Confidence 99999999999987778999999999999999999999998 9999999999999 8889999999999986644321
Q ss_pred cceeeccCCcccccccCccccCcCCC-CCchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHhCCCCCCCCCCCCHHH
Q 020888 200 HDVYKMTGETGSYRYMAPEVFKHRKY-DKKVDVFSFAMILYEMLEGEPPLANYEPY-EAAKYVAEGHRPFFRAKGFTPEL 277 (320)
Q Consensus 200 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~ll~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l 277 (320)
. .......+++.|+|||.+.+..+ +.++|+||||+++|+|++|..||...... ..................+++++
T Consensus 161 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (276)
T 2yex_A 161 E--RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 238 (276)
T ss_dssp E--CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHH
T ss_pred h--hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHH
Confidence 1 12234568999999999987765 67999999999999999999999876543 22333333333322334579999
Q ss_pred HHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 278 RELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 278 ~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
.+++.+||..||.+|||+++++++
T Consensus 239 ~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 239 LALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHHHHCCCCchhCCCHHHHhcC
Confidence 999999999999999999999875
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-45 Score=321.60 Aligned_cols=253 Identities=29% Similarity=0.389 Sum_probs=202.0
Q ss_pred CcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEE
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 118 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 118 (320)
..+|.+.+.||+|+||+||++.+. ++.||+|++....... .....+.+|+++++.++|+||+++++++..++..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEE-GVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccccc-ccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 348999999999999999999875 7889999986553322 2336677899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEee---CCCCcEEEecCCCccccc
Q 020888 119 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN---SSADHLKVGDFGLSKLIK 195 (320)
Q Consensus 119 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~---~~~~~~~L~dfg~~~~~~ 195 (320)
|||+++ +|.+++...+.+++..++.++.||+.||.|||++| |+|+||||+||++.. +..+.++|+|||++....
T Consensus 112 ~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~ 188 (329)
T 3gbz_A 112 FEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR--CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG 188 (329)
T ss_dssp EECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC
T ss_pred EecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EECCCCCHHHEEEecCCCCccceEEECcCCCccccC
Confidence 999975 99999998888999999999999999999999998 999999999999932 234459999999998664
Q ss_pred ccCccceeeccCCcccccccCccccCcC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCC-----
Q 020888 196 VQNSHDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR----- 269 (320)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~----- 269 (320)
.... ......+++.|+|||++.+. .++.++||||||+++|+|++|..||......+....+......+..
T Consensus 189 ~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (329)
T 3gbz_A 189 IPIR----QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPG 264 (329)
T ss_dssp ---------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred Cccc----ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhh
Confidence 3221 22334679999999999875 4899999999999999999999999988877666555432111000
Q ss_pred -----------------------CCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 270 -----------------------AKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 270 -----------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
...++++++++|.+||+.||.+|||+++++++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 265 VTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp GGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 01167899999999999999999999999875
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=318.24 Aligned_cols=262 Identities=28% Similarity=0.468 Sum_probs=217.6
Q ss_pred CCcccCccceecccCceEEEEEEE-------CCCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeC
Q 020888 40 SELDFSSSAIIGKGSFGEILKAYW-------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER 112 (320)
Q Consensus 40 ~~~~y~~~~~lg~g~~~~vy~~~~-------~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 112 (320)
...+|.+.+.||+|+||.||++.+ +++.||+|.+.... .......+.+|+.++++++|+||+++++++...
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 105 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc--chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC
Confidence 356899999999999999999983 25689999886432 334446788999999999999999999999999
Q ss_pred CceEEEEecCCCCCHHHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeC-CCCcEE
Q 020888 113 KPLMLITEYLRGGDLHKYLKEKG-------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS-SADHLK 184 (320)
Q Consensus 113 ~~~~iv~e~~~~~~L~~~~~~~~-------~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~-~~~~~~ 184 (320)
+..++||||+++++|.+++.... .+++..++.++.|++.||.|||+.| ++|+||||+||++..+ .+..++
T Consensus 106 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 106 LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEE
T ss_pred CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eecCcCCHhHEEEecCCCcceEE
Confidence 99999999999999999998752 4899999999999999999999998 9999999999999321 345699
Q ss_pred EecCCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhC
Q 020888 185 VGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEG 263 (320)
Q Consensus 185 L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~ 263 (320)
|+|||++......... .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||......+....+...
T Consensus 184 l~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~ 261 (327)
T 2yfx_A 184 IGDFGMARDIYRASYY--RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 261 (327)
T ss_dssp ECCCHHHHHHHC--------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT
T ss_pred ECcccccccccccccc--ccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcC
Confidence 9999998765433211 11223456889999999999999999999999999999998 99999988887777777666
Q ss_pred CCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhc
Q 020888 264 HRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKET 308 (320)
Q Consensus 264 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 308 (320)
..... +..++..+.+++.+||+.||.+|||+.+++++|..+...
T Consensus 262 ~~~~~-~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 262 GRMDP-PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp CCCCC-CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCCC-CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 54433 345899999999999999999999999999999988754
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=317.32 Aligned_cols=256 Identities=23% Similarity=0.400 Sum_probs=207.3
Q ss_pred CCcccCccceecccCceEEEEEEEC--C-------CceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEE
Q 020888 40 SELDFSSSAIIGKGSFGEILKAYWR--G-------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVT 110 (320)
Q Consensus 40 ~~~~y~~~~~lg~g~~~~vy~~~~~--~-------~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 110 (320)
...+|.+.+.||+|+||+||++.+. + ..+++|.+..... ...+.+.+|++++++++|+||+++++++.
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 82 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR---NYSESFFEAASMMSKLSHKHLVLNYGVCV 82 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGG---GGHHHHHHHHHHHHTSCCTTBCCEEEEEC
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccH---HHHHHHHHHHHHHHhCCCCCEeEEEEEEE
Confidence 3568999999999999999999875 3 4699998854332 23377899999999999999999999999
Q ss_pred eCCceEEEEecCCCCCHHHHHHHhCC-CCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCc-------
Q 020888 111 ERKPLMLITEYLRGGDLHKYLKEKGA-LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH------- 182 (320)
Q Consensus 111 ~~~~~~iv~e~~~~~~L~~~~~~~~~-l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~------- 182 (320)
.++..++||||+++++|.+++...+. +++..++.++.|++.||.|||++| ++|+||||+||++ +.++.
T Consensus 83 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll--~~~~~~~~~~~~ 158 (289)
T 4fvq_A 83 CGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT--LIHGNVCAKNILL--IREEDRKTGNPP 158 (289)
T ss_dssp CTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE--EECCBGGGTBCC
T ss_pred eCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCC--eECCCcCcceEEE--ecCCcccccccc
Confidence 99999999999999999999987543 999999999999999999999998 9999999999999 55554
Q ss_pred -EEEecCCCcccccccCccceeeccCCcccccccCccccCc-CCCCCchhHHHHHHHHHHHHhC-CCCCCCCChHHHHHH
Q 020888 183 -LKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEG-EPPLANYEPYEAAKY 259 (320)
Q Consensus 183 -~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g-~~p~~~~~~~~~~~~ 259 (320)
++|+|||.+...... ....+++.|+|||++.+ ..++.++||||||+++|+|++| ..||...+.......
T Consensus 159 ~~kl~Dfg~~~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~ 230 (289)
T 4fvq_A 159 FIKLSDPGISITVLPK--------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQF 230 (289)
T ss_dssp EEEECCCCSCTTTSCH--------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH
T ss_pred eeeeccCcccccccCc--------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHH
Confidence 999999998654322 12346788999999987 6789999999999999999995 555555555444443
Q ss_pred HHhCCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcCCCCC
Q 020888 260 VAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPTDH 313 (320)
Q Consensus 260 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~~ 313 (320)
...... .+...++++++++.+||+.||.+|||+.+++++|+++........
T Consensus 231 ~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~~~ 281 (289)
T 4fvq_A 231 YEDRHQ---LPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPR 281 (289)
T ss_dssp HHTTCC---CCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-------
T ss_pred hhccCC---CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCCCC
Confidence 333222 223457889999999999999999999999999999877655543
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=320.94 Aligned_cols=247 Identities=28% Similarity=0.437 Sum_probs=202.2
Q ss_pred CcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCC-----
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK----- 113 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----- 113 (320)
..+|.+.+.||+|+||.||++.+. ++.||+|.+..... .....+.+.+|+++++.++|+||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCcccc-CHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 458999999999999999999985 88999998865443 3344578889999999999999999999987653
Q ss_pred -ceEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcc
Q 020888 114 -PLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 192 (320)
Q Consensus 114 -~~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~ 192 (320)
.+|+||||+ +++|.++++. ..+++..+..++.|++.||.|||++| ++|+||||+||++ +.++.++|+|||++.
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~NIll--~~~~~~kl~Dfg~a~ 176 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAV--NEDCELKILDFGLAR 176 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEE--CTTCCEEECCCTTCE
T ss_pred ceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCHHHEEE--cCCCCEEEEeeeccc
Confidence 469999999 7799999987 57999999999999999999999999 9999999999999 888999999999998
Q ss_pred cccccCccceeeccCCcccccccCccccCc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCC------
Q 020888 193 LIKVQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHR------ 265 (320)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~------ 265 (320)
..... .....+|+.|+|||++.+ ..++.++|||||||++++|++|+.||...+..+....+.....
T Consensus 177 ~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~ 249 (367)
T 1cm8_A 177 QADSE-------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF 249 (367)
T ss_dssp ECCSS-------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred ccccc-------cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 65321 234568999999999877 6799999999999999999999999998876655444332100
Q ss_pred ---------------------C--CCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 266 ---------------------P--FFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 266 ---------------------~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
. .......++++.+++.+||..||.+|||+++++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 250 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 0 00113568999999999999999999999999986
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-44 Score=312.82 Aligned_cols=249 Identities=26% Similarity=0.496 Sum_probs=210.3
Q ss_pred CCcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEE
Q 020888 40 SELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLML 117 (320)
Q Consensus 40 ~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 117 (320)
...+|.+.+.||+|+||.||++.+. ++.||+|.+..... .+.+.+|+++++.++|+||+++++++...+..++
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-----LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWI 101 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC-----CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH-----HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence 3557999999999999999999986 78999998865432 2578889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccc
Q 020888 118 ITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 196 (320)
Q Consensus 118 v~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~ 196 (320)
||||+++++|.+++.. ...+++..++.++.|++.||.+||+.| ++|+||+|+||++ +.++.++|+|||.+.....
T Consensus 102 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dl~p~Nil~--~~~~~~kl~dfg~~~~~~~ 177 (314)
T 3com_A 102 VMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR--KIHRDIKAGNILL--NTEGHAKLADFGVAGQLTD 177 (314)
T ss_dssp EEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--CTTCCEEECCCTTCEECBT
T ss_pred EeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCcCHHHEEE--CCCCCEEEeecccchhhhh
Confidence 9999999999999974 567999999999999999999999999 9999999999999 8889999999999976643
Q ss_pred cCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCC-CCCCCCH
Q 020888 197 QNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFF-RAKGFTP 275 (320)
Q Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 275 (320)
... ......+++.|+|||.+.+..++.++||||||+++|+|++|..||...........+........ .+..++.
T Consensus 178 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (314)
T 3com_A 178 TMA----KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSD 253 (314)
T ss_dssp TBS----CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCH
T ss_pred hcc----ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCH
Confidence 321 22345688999999999999999999999999999999999999998887766655555543332 2345799
Q ss_pred HHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 276 ELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 276 ~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
++.+++.+||..||.+|||+.+++++
T Consensus 254 ~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 254 NFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp HHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred HHHHHHHHHccCChhhCcCHHHHHhC
Confidence 99999999999999999999999875
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=320.83 Aligned_cols=248 Identities=27% Similarity=0.478 Sum_probs=209.6
Q ss_pred CcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcccceeeeEEeCCceEE
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLML 117 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~i 117 (320)
..+|.+.+.||+|+||.||++.++ ++.+|+|++...... ..+|++++.++ +||||+++++++.+++..|+
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~l 93 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD-------PTEEIEILLRYGQHPNIITLKDVYDDGKYVYV 93 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC-------CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC-------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEE
Confidence 347999999999999999999986 788999998665432 23577888887 79999999999999999999
Q ss_pred EEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCC--CcEEEecCCCccccc
Q 020888 118 ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSA--DHLKVGDFGLSKLIK 195 (320)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~--~~~~L~dfg~~~~~~ 195 (320)
||||++|++|.+++...+.+++..+..++.|++.||.|||++| |+|+||||+||++.++.+ +.++|+|||++....
T Consensus 94 v~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~g--ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~ 171 (342)
T 2qr7_A 94 VTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQG--VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR 171 (342)
T ss_dssp EECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence 9999999999999998888999999999999999999999999 999999999999843222 359999999998665
Q ss_pred ccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCC---ChHHHHHHHHhCCCCCCC--C
Q 020888 196 VQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANY---EPYEAAKYVAEGHRPFFR--A 270 (320)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~---~~~~~~~~~~~~~~~~~~--~ 270 (320)
.... .....++|+.|+|||++.+..++.++|+||||+++|+|++|..||... ...+....+..+...... .
T Consensus 172 ~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 247 (342)
T 2qr7_A 172 AENG----LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYW 247 (342)
T ss_dssp CTTC----CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTT
T ss_pred CCCC----ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCcccc
Confidence 4321 223457899999999998888899999999999999999999999863 445566666665544322 2
Q ss_pred CCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 271 KGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 271 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
..++++++++|.+||..||.+|||+.+++++
T Consensus 248 ~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 248 NSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred ccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 4689999999999999999999999999886
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=313.90 Aligned_cols=245 Identities=27% Similarity=0.357 Sum_probs=200.1
Q ss_pred cccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcccceeeeEEeCCceEEE
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLI 118 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~iv 118 (320)
.+|.+.+.||+|+||+||++.+. ++.||+|++.......... .....|+..+..+ +|+||+++++++.+++..++|
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~-~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDR-ARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHH-HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHH-HHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 57999999999999999999986 7899999887655544444 3444455555554 899999999999999999999
Q ss_pred EecCCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccccccc
Q 020888 119 TEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 197 (320)
Q Consensus 119 ~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~ 197 (320)
|||+ +++|.+++... ..+++..++.++.|++.||.|||+.| |+|+||||+||++ +.++.++|+|||++......
T Consensus 136 ~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll--~~~~~~kl~DFG~a~~~~~~ 210 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG--LVHLDVKPANIFL--GPRGRCKLGDFGLLVELGTA 210 (311)
T ss_dssp EECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--CGGGCEEECCCTTCEECC--
T ss_pred Eecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEE--CCCCCEEEccceeeeecccC
Confidence 9999 66999988764 46999999999999999999999998 9999999999999 88889999999998765432
Q ss_pred CccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHH
Q 020888 198 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPEL 277 (320)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 277 (320)
. ......||+.|+|||++.+ .++.++||||||+++++|++|..|+.... ....+.....+......+++++
T Consensus 211 ~-----~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l 281 (311)
T 3p1a_A 211 G-----AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE---GWQQLRQGYLPPEFTAGLSSEL 281 (311)
T ss_dssp ---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH---HHHHHTTTCCCHHHHTTSCHHH
T ss_pred C-----CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc---HHHHHhccCCCcccccCCCHHH
Confidence 2 1233468999999999876 78999999999999999999977665432 2333444443333345689999
Q ss_pred HHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 278 RELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 278 ~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
.+++.+||+.||++|||+++++++
T Consensus 282 ~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 282 RSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHcCCChhhCcCHHHHHhC
Confidence 999999999999999999999874
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=314.29 Aligned_cols=258 Identities=25% Similarity=0.442 Sum_probs=208.7
Q ss_pred cCccceecccCceEEEEEEECCCceEEEEccCCCC-CcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEecC
Q 020888 44 FSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLS-DDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYL 122 (320)
Q Consensus 44 y~~~~~lg~g~~~~vy~~~~~~~~~~~K~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~ 122 (320)
|...+.||+|+||+||++.++++.+|+|.+..... ......+.+.+|+++++.++|+||+++++++...+..++||||+
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 112 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYM 112 (307)
T ss_dssp TTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred cccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEec
Confidence 44558999999999999999999999998865432 23344578999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCc
Q 020888 123 RGGDLHKYLKE---KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 199 (320)
Q Consensus 123 ~~~~L~~~~~~---~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~ 199 (320)
++++|.+++.. ...+++..++.++.|++.||.|||+.| ++|+||||+||++ +.++.++|+|||++........
T Consensus 113 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nili--~~~~~~kl~Dfg~~~~~~~~~~ 188 (307)
T 2nru_A 113 PNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH--HIHRDIKSANILL--DEAFTAKISDFGLARASEKFAQ 188 (307)
T ss_dssp TTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEE--CTTCCEEECCCTTCEECCSCSS
T ss_pred CCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEE--cCCCcEEEeecccccccccccc
Confidence 99999999974 346999999999999999999999998 9999999999999 8889999999999876543221
Q ss_pred cceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHH----HHHHHHhCC---------CC
Q 020888 200 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYE----AAKYVAEGH---------RP 266 (320)
Q Consensus 200 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~----~~~~~~~~~---------~~ 266 (320)
........+++.|+|||.+.+ .++.++|+||||+++|+|++|..||....... ....+.... ..
T Consensus 189 --~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (307)
T 2nru_A 189 --TVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKM 265 (307)
T ss_dssp --CEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSC
T ss_pred --cccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccc
Confidence 112234568999999999875 47899999999999999999999997654321 111111111 01
Q ss_pred CCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhc
Q 020888 267 FFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKET 308 (320)
Q Consensus 267 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 308 (320)
.......++.+.+++.+||..||.+|||+.+++++|+++.++
T Consensus 266 ~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~s 307 (307)
T 2nru_A 266 NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 307 (307)
T ss_dssp SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC--
T ss_pred cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhcC
Confidence 111123457899999999999999999999999999998653
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=316.91 Aligned_cols=259 Identities=24% Similarity=0.366 Sum_probs=208.6
Q ss_pred CCcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCC--ce
Q 020888 40 SELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK--PL 115 (320)
Q Consensus 40 ~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~ 115 (320)
...+|.+.+.||+|+||+||++.+. ++.||+|++....... ..+.+.+|++++++++|+||+++++++.... ..
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 84 (319)
T 4euu_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (319)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS--CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccc--hHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceE
Confidence 3568999999999999999999987 7899999886543222 2367788999999999999999999987655 77
Q ss_pred EEEEecCCCCCHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEee--CCCCcEEEecCCC
Q 020888 116 MLITEYLRGGDLHKYLKEKG---ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN--SSADHLKVGDFGL 190 (320)
Q Consensus 116 ~iv~e~~~~~~L~~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~--~~~~~~~L~dfg~ 190 (320)
++||||+++++|.+++.... .+++..++.++.|++.||.|||+.| ++|+||||+||++.. +.++.++|+|||+
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~ 162 (319)
T 4euu_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (319)
T ss_dssp EEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred EEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence 99999999999999998643 3899999999999999999999999 999999999998732 3445699999999
Q ss_pred cccccccCccceeeccCCcccccccCccccC--------cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh----HHHHH
Q 020888 191 SKLIKVQNSHDVYKMTGETGSYRYMAPEVFK--------HRKYDKKVDVFSFAMILYEMLEGEPPLANYEP----YEAAK 258 (320)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~----~~~~~ 258 (320)
+....... ......+++.|+|||++. +..++.++||||||+++|+|++|..||..... .+...
T Consensus 163 a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 237 (319)
T 4euu_A 163 ARELEDDE-----QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237 (319)
T ss_dssp CEECCTTC-----CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHH
T ss_pred ceecCCCC-----ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHH
Confidence 98765432 123356899999999986 56788999999999999999999999975432 23333
Q ss_pred HHHhCCCCC-----------------------CCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHh
Q 020888 259 YVAEGHRPF-----------------------FRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKE 307 (320)
Q Consensus 259 ~~~~~~~~~-----------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 307 (320)
.+..+.... .....++..+.+++.+||+.||++|||++|++++...-..
T Consensus 238 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~ 309 (319)
T 4euu_A 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (319)
T ss_dssp HHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC
T ss_pred HHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhh
Confidence 333322110 1112345689999999999999999999999999876543
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-45 Score=320.90 Aligned_cols=243 Identities=27% Similarity=0.455 Sum_probs=185.7
Q ss_pred cceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCC-CCcccceeeeEEeCCceEEEEecCC
Q 020888 47 SAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLMLITEYLR 123 (320)
Q Consensus 47 ~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~iv~e~~~ 123 (320)
.+.||+|+||+||++.+. ++.||+|++... ....+.+|+.+++.+. ||||+++++++.++...|+||||++
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~ 89 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLN 89 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccC
Confidence 378999999999999986 788999988542 2256778999999997 9999999999999999999999999
Q ss_pred CCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCC-CCcEEEecCCCcccccccCccce
Q 020888 124 GGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS-ADHLKVGDFGLSKLIKVQNSHDV 202 (320)
Q Consensus 124 ~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~-~~~~~L~dfg~~~~~~~~~~~~~ 202 (320)
|++|.+++...+.+++..+..++.|++.||.|||++| |+|+||||+||++..+. +..++|+|||++........
T Consensus 90 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~--- 164 (325)
T 3kn6_A 90 GGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ--- 164 (325)
T ss_dssp SCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC---
Confidence 9999999998888999999999999999999999998 99999999999993321 22899999999976543221
Q ss_pred eeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh-------HHHHHHHHhCCCCCCCC--CCC
Q 020888 203 YKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEP-------YEAAKYVAEGHRPFFRA--KGF 273 (320)
Q Consensus 203 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~--~~~ 273 (320)
......+|+.|+|||++.+..++.++||||||+++|+|++|..||...+. .+....+..+....... ..+
T Consensus 165 -~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (325)
T 3kn6_A 165 -PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNV 243 (325)
T ss_dssp --------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTS
T ss_pred -cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCC
Confidence 22345679999999999999999999999999999999999999986433 34444444443322211 357
Q ss_pred CHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 274 TPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 274 ~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
+++++++|.+||..||.+|||+++++++
T Consensus 244 s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 244 SQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp CHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred CHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 9999999999999999999999998865
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-44 Score=315.93 Aligned_cols=260 Identities=28% Similarity=0.466 Sum_probs=205.8
Q ss_pred CcccCccceecccCceEEEEEEECCCceEEEEccCCCCCcHHHHHHHHHHHHHHHhC--CCCcccceeeeEEeC----Cc
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL--RHPNIVQFLGAVTER----KP 114 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l--~h~~i~~~~~~~~~~----~~ 114 (320)
..+|.+.+.||+|+||.||++.++++.||+|++.... ......|.+++... +|+||+++++++... ..
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 109 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTE------EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ 109 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCE
T ss_pred ccceEEEeEeecCCCeEEEEEEECCceEEEEEEeccc------cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCc
Confidence 3589999999999999999999999999999884321 13444555665554 899999999998876 67
Q ss_pred eEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcC--------CCCeEecCCCCCcEEEeeCCCCcEEEe
Q 020888 115 LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE--------PNVIIHRDLKPRNVLLVNSSADHLKVG 186 (320)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~--------g~~ivH~di~p~nI~~~~~~~~~~~L~ 186 (320)
.++||||+++++|.++++.. .+++..++.++.|++.||.|||+. | ++|+||||+||++ +.++.++|+
T Consensus 110 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dikp~Nill--~~~~~~kl~ 184 (337)
T 3mdy_A 110 LYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA--IAHRDLKSKNILV--KKNGTCCIA 184 (337)
T ss_dssp EEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC--EECSCCCGGGEEE--CTTSCEEEC
T ss_pred eEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC--EEecccchHHEEE--CCCCCEEEE
Confidence 89999999999999999764 699999999999999999999998 7 9999999999999 888999999
Q ss_pred cCCCcccccccCccceeeccCCcccccccCccccCcCCCCCc------hhHHHHHHHHHHHHhC----------CCCCCC
Q 020888 187 DFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKK------VDVFSFAMILYEMLEG----------EPPLAN 250 (320)
Q Consensus 187 dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~------~Di~slG~~l~~ll~g----------~~p~~~ 250 (320)
|||++..................+|+.|+|||++.+...... +||||||+++|+|++| ..||..
T Consensus 185 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~ 264 (337)
T 3mdy_A 185 DLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD 264 (337)
T ss_dssp CCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhh
Confidence 999997765543333333345678999999999988776665 9999999999999999 777765
Q ss_pred CCh-----HHHHHHHHhCCCCCCCC-----CCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcCCC
Q 020888 251 YEP-----YEAAKYVAEGHRPFFRA-----KGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPT 311 (320)
Q Consensus 251 ~~~-----~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~ 311 (320)
... ................+ ..+++++.+++.+||+.||.+|||+.+++++|+++.++...
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~ 335 (337)
T 3mdy_A 265 LVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQDI 335 (337)
T ss_dssp TSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTTTC
T ss_pred hcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhccc
Confidence 321 12222222222111111 24567899999999999999999999999999999987654
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=311.64 Aligned_cols=253 Identities=24% Similarity=0.443 Sum_probs=200.7
Q ss_pred CCCCcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCce
Q 020888 38 DPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL 115 (320)
Q Consensus 38 ~~~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 115 (320)
+....+|++.+.||+|+||+||++.+. ++.||+|.+...... ....+.+.++...++.++|+||+++++++..++..
T Consensus 3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~ 81 (290)
T 3fme_A 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNS-QEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDV 81 (290)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CH-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSE
T ss_pred cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCc-HHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCE
Confidence 445678999999999999999999984 888999988654332 23334455556667888999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHhcC-CCCeEecCCCCCcEEEeeCCCCcEEEecCCC
Q 020888 116 MLITEYLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLHNE-PNVIIHRDLKPRNVLLVNSSADHLKVGDFGL 190 (320)
Q Consensus 116 ~iv~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~~l~~~l~~lH~~-g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~ 190 (320)
++||||+++ +|.+++.. ...+++..++.++.|++.||.|||++ | ++|+||||+||++ +.++.++|+|||+
T Consensus 82 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dlkp~Nil~--~~~~~~kl~Dfg~ 156 (290)
T 3fme_A 82 WICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLI--NALGQVKMCDFGI 156 (290)
T ss_dssp EEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC--CCCCCCSGGGCEE--CTTCCEEBCCC--
T ss_pred EEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEE--CCCCCEEEeecCC
Confidence 999999975 88887754 45799999999999999999999997 8 9999999999999 8889999999999
Q ss_pred cccccccCccceeeccCCcccccccCcccc----CcCCCCCchhHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHhCCC
Q 020888 191 SKLIKVQNSHDVYKMTGETGSYRYMAPEVF----KHRKYDKKVDVFSFAMILYEMLEGEPPLANY-EPYEAAKYVAEGHR 265 (320)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~-~~~~~~~~~~~~~~ 265 (320)
+....... ......+++.|+|||++ .+..++.++||||||+++|++++|..||... ..............
T Consensus 157 ~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 231 (290)
T 3fme_A 157 SGYLVDDV-----AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPS 231 (290)
T ss_dssp ------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCC
T ss_pred cccccccc-----cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCC
Confidence 87664432 12234689999999996 5667889999999999999999999999873 44455555666666
Q ss_pred CCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 266 PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 266 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
+......+++++.+++.+||+.||++|||+.+++++
T Consensus 232 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 232 PQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp CCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence 665566789999999999999999999999999985
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=322.30 Aligned_cols=270 Identities=28% Similarity=0.515 Sum_probs=218.5
Q ss_pred CCCcCCCCCcccCccceecccCceEEEEEEECCCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeC
Q 020888 33 CDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER 112 (320)
Q Consensus 33 ~~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 112 (320)
..|.++ ..+|.+.+.||+|+||.||++.+.+ .+++|.+........ ..+.+.+|++++++++|+||+++++++...
T Consensus 26 ~~~~i~--~~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 101 (319)
T 2y4i_B 26 QEWDIP--FEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNED-QLKAFKREVMAYRQTRHENVVLFMGACMSP 101 (319)
T ss_dssp GGSSSC--CSCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSCCCC-CCCCCCTTGGGGTTCCCTTBCCCCEEEECS
T ss_pred ccccCC--HHHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCCCCHH-HHHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence 344443 5689999999999999999998865 599998865433221 225677899999999999999999999999
Q ss_pred CceEEEEecCCCCCHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCc
Q 020888 113 KPLMLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 191 (320)
Q Consensus 113 ~~~~iv~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~ 191 (320)
+..++|+||+++++|.+++...+ .+++..++.++.|++.||.|||++| ++|+||||+||++ + ++.++|+|||++
T Consensus 102 ~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~NIl~--~-~~~~~l~Dfg~~ 176 (319)
T 2y4i_B 102 PHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG--ILHKDLKSKNVFY--D-NGKVVITDFGLF 176 (319)
T ss_dssp SCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSTTEEE--C---CCEECCCSCC
T ss_pred CceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChhhEEE--e-CCCEEEeecCCc
Confidence 99999999999999999998654 6999999999999999999999998 9999999999999 5 579999999998
Q ss_pred ccccccCcc-ceeeccCCcccccccCccccCc---------CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 020888 192 KLIKVQNSH-DVYKMTGETGSYRYMAPEVFKH---------RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA 261 (320)
Q Consensus 192 ~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~---------~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~ 261 (320)
......... .........+++.|+|||++.+ ..++.++||||||+++|+|++|..||...........+.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~ 256 (319)
T 2y4i_B 177 SISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMG 256 (319)
T ss_dssp C----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHH
T ss_pred cccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhc
Confidence 755332111 1112233458899999999875 357889999999999999999999999988888888887
Q ss_pred hCCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcCCC
Q 020888 262 EGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPT 311 (320)
Q Consensus 262 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~ 311 (320)
....+......++.++.+++.+||..||.+|||+.++++.|+.+......
T Consensus 257 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~ 306 (319)
T 2y4i_B 257 TGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRR 306 (319)
T ss_dssp TTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC------
T ss_pred cCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 77777666667899999999999999999999999999999988876543
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-45 Score=318.33 Aligned_cols=269 Identities=23% Similarity=0.352 Sum_probs=211.4
Q ss_pred CCCcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEE----eC
Q 020888 39 PSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVT----ER 112 (320)
Q Consensus 39 ~~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~----~~ 112 (320)
....+|.+.+.||+|+||.||++.+. ++.||+|.+... .....+.+.+|+++++.++|+||+++++++. ..
T Consensus 26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (317)
T 2buj_A 26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAK 102 (317)
T ss_dssp ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTE
T ss_pred ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC---CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCC
Confidence 34678999999999999999999974 889999988542 3345578899999999999999999999986 24
Q ss_pred CceEEEEecCCCCCHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecC
Q 020888 113 KPLMLITEYLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF 188 (320)
Q Consensus 113 ~~~~iv~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~df 188 (320)
...++|+||+++++|.+++.. ...+++..++.++.|++.||.|||+.| ++|+||||+||++ +.++.++|+||
T Consensus 103 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dlkp~NIl~--~~~~~~kl~df 178 (317)
T 2buj_A 103 HEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG--YAHRDLKPTNILL--GDEGQPVLMDL 178 (317)
T ss_dssp EEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEE--CTTSCEEECCC
T ss_pred ceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEE--cCCCCEEEEec
Confidence 468999999999999999876 457999999999999999999999998 9999999999999 88899999999
Q ss_pred CCcccccccCccc-----eeeccCCcccccccCccccCcCC---CCCchhHHHHHHHHHHHHhCCCCCCCCCh--HHHHH
Q 020888 189 GLSKLIKVQNSHD-----VYKMTGETGSYRYMAPEVFKHRK---YDKKVDVFSFAMILYEMLEGEPPLANYEP--YEAAK 258 (320)
Q Consensus 189 g~~~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~~l~~ll~g~~p~~~~~~--~~~~~ 258 (320)
|.+.......... ........+++.|+|||++.+.. ++.++||||||+++|+|++|..||..... .....
T Consensus 179 g~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~ 258 (317)
T 2buj_A 179 GSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL 258 (317)
T ss_dssp SSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHH
T ss_pred CcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhH
Confidence 9887553211100 00111234688999999987654 68899999999999999999999954211 11111
Q ss_pred HHHhCCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcCCCCCcc
Q 020888 259 YVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPTDHHW 315 (320)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~~~~ 315 (320)
... ..........++.++.+++.+||+.||.+|||+.+++++|+.+....+.+..-
T Consensus 259 ~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~~~~ 314 (317)
T 2buj_A 259 AVQ-NQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQHTT 314 (317)
T ss_dssp HHH-CC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC----
T ss_pred Hhh-ccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCCCCCC
Confidence 222 22222233568999999999999999999999999999999998777766543
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=319.46 Aligned_cols=263 Identities=17% Similarity=0.253 Sum_probs=213.5
Q ss_pred CCCCCcccCccceecccCceEEEEEEEC----------CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccc--
Q 020888 37 IDPSELDFSSSAIIGKGSFGEILKAYWR----------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQ-- 104 (320)
Q Consensus 37 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~----------~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~-- 104 (320)
.+....+|.+.+.||+|+||.||++.+. ++.||+|.+... ..+.+|++++++++|+||++
T Consensus 37 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~ 108 (352)
T 2jii_A 37 TDKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKW 108 (352)
T ss_dssp ECTTSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHH
T ss_pred ecccCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhh
Confidence 3455679999999999999999999975 578999988643 35778999999999999887
Q ss_pred -------------eeeeEEe-CCceEEEEecCCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 020888 105 -------------FLGAVTE-RKPLMLITEYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDL 168 (320)
Q Consensus 105 -------------~~~~~~~-~~~~~iv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di 168 (320)
+++++.. +...++||||+ +++|.+++... ..+++..++.++.|++.||.|||++| ++|+||
T Consensus 109 ~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Di 185 (352)
T 2jii_A 109 KKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE--YVHGNV 185 (352)
T ss_dssp HHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCC
T ss_pred hhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCC
Confidence 5666665 67789999999 88999999875 67999999999999999999999998 999999
Q ss_pred CCCcEEEeeCCCC--cEEEecCCCcccccccCcccee---eccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh
Q 020888 169 KPRNVLLVNSSAD--HLKVGDFGLSKLIKVQNSHDVY---KMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE 243 (320)
Q Consensus 169 ~p~nI~~~~~~~~--~~~L~dfg~~~~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~ 243 (320)
||+||++ +.++ .++|+|||++..+......... ......+++.|+|||++.+..++.++||||||+++|+|++
T Consensus 186 kp~NIl~--~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~ 263 (352)
T 2jii_A 186 TAENIFV--DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLY 263 (352)
T ss_dssp CGGGEEE--ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred CHHHEEE--cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHh
Confidence 9999999 6666 8999999999876543322111 1233478999999999999999999999999999999999
Q ss_pred CCCCCCCCC--hHHHHHH---HHhCCCCCCC----CCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcCCCC
Q 020888 244 GEPPLANYE--PYEAAKY---VAEGHRPFFR----AKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPTD 312 (320)
Q Consensus 244 g~~p~~~~~--~~~~~~~---~~~~~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~ 312 (320)
|..||.... ....... .......... ...++.++.+++.+||..||.+|||++++++.|+++.......
T Consensus 264 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~ 341 (352)
T 2jii_A 264 GFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVS 341 (352)
T ss_dssp SCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred CCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCC
Confidence 999998764 2222221 1222221111 1246999999999999999999999999999999999887644
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=325.42 Aligned_cols=253 Identities=28% Similarity=0.430 Sum_probs=199.0
Q ss_pred cccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCC-CCcccceeeeEEeCC--ceE
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERK--PLM 116 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~--~~~ 116 (320)
.+|.+.+.||+|+||.||++.+. ++.||+|.+...... ......+.+|+.+++.+. |+||+++++++...+ ..|
T Consensus 9 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 87 (388)
T 3oz6_A 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQN-STDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY 87 (388)
T ss_dssp TTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CC-HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred CceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccC-hHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence 47999999999999999999885 789999988654333 334477888999999997 999999999997543 689
Q ss_pred EEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccc
Q 020888 117 LITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 196 (320)
Q Consensus 117 iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~ 196 (320)
+||||+++ +|.+++.. +.+++..+..++.|++.||+|||+.| |+||||||+||++ +.++.++|+|||+++.+..
T Consensus 88 lv~e~~~~-~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll--~~~~~~kl~DFG~a~~~~~ 161 (388)
T 3oz6_A 88 LVFDYMET-DLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGG--LLHRDMKPSNILL--NAECHVKVADFGLSRSFVN 161 (388)
T ss_dssp EEEECCSE-EHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEE--CTTCCEEECCCTTCEESSS
T ss_pred EEecccCc-CHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHeEE--cCCCCEEecCCcccccccc
Confidence 99999964 99999886 47899999999999999999999999 9999999999999 8899999999999986543
Q ss_pred cCc-----------------cceeeccCCcccccccCccccCc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 020888 197 QNS-----------------HDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAK 258 (320)
Q Consensus 197 ~~~-----------------~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~ 258 (320)
... ..........+|+.|+|||++.+ ..++.++|||||||++|+|++|..||...+..+...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~ 241 (388)
T 3oz6_A 162 IRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLE 241 (388)
T ss_dssp CCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred cccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 110 01112334579999999999987 678999999999999999999999999887766555
Q ss_pred HHHhCCCCCC---------------------------------------------CCCCCCHHHHHHHHHHhhcCCCCCC
Q 020888 259 YVAEGHRPFF---------------------------------------------RAKGFTPELRELTEKCWAADMNQRP 293 (320)
Q Consensus 259 ~~~~~~~~~~---------------------------------------------~~~~~~~~l~~li~~~l~~dp~~Rp 293 (320)
.+......+. ....+++++.+||.+||..||.+||
T Consensus 242 ~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~ 321 (388)
T 3oz6_A 242 RIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRI 321 (388)
T ss_dssp HHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSC
T ss_pred HHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCC
Confidence 4432111100 0125789999999999999999999
Q ss_pred CHHHHHHH
Q 020888 294 SFLDILKR 301 (320)
Q Consensus 294 s~~~ll~~ 301 (320)
|++++++|
T Consensus 322 t~~e~l~H 329 (388)
T 3oz6_A 322 SANDALKH 329 (388)
T ss_dssp CHHHHTTS
T ss_pred CHHHHhCC
Confidence 99999987
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=324.57 Aligned_cols=244 Identities=28% Similarity=0.484 Sum_probs=195.7
Q ss_pred CcccCcc-ceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcccceeeeEEe----C
Q 020888 41 ELDFSSS-AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTE----R 112 (320)
Q Consensus 41 ~~~y~~~-~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~----~ 112 (320)
..+|.+. +.||.|+||+||++.+. ++.||+|++... ..+.+|++++.++ +|+||+++++++.. .
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~ 131 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGR 131 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCC
Confidence 3467665 68999999999999986 788999988532 4566788887554 89999999999875 5
Q ss_pred CceEEEEecCCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCC---CCcEEEec
Q 020888 113 KPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS---ADHLKVGD 187 (320)
Q Consensus 113 ~~~~iv~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~---~~~~~L~d 187 (320)
..+|+||||++|++|.+++...+ .+++..+..++.|++.||.|||+.| |+|+||||+||++ +. ++.++|+|
T Consensus 132 ~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill--~~~~~~~~~kl~D 207 (400)
T 1nxk_A 132 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLY--TSKRPNAILKLTD 207 (400)
T ss_dssp EEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEE--SSSSTTCCEEECC
T ss_pred cEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCcceEEE--ecCCCCccEEEEe
Confidence 67899999999999999998643 5999999999999999999999998 9999999999999 54 68899999
Q ss_pred CCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHH----HHHHHHhC
Q 020888 188 FGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYE----AAKYVAEG 263 (320)
Q Consensus 188 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~----~~~~~~~~ 263 (320)
||++....... .....++|+.|+|||++.+..++.++|||||||++|+|++|..||....... ....+..+
T Consensus 208 FG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~ 282 (400)
T 1nxk_A 208 FGFAKETTSHN-----SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG 282 (400)
T ss_dssp CTTCEECC----------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHT
T ss_pred cccccccCCCC-----ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcC
Confidence 99998654322 2234578999999999999999999999999999999999999997654321 22333333
Q ss_pred CCCC--CCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 264 HRPF--FRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 264 ~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
.... .....++++++++|.+||..||++|||+.+++++
T Consensus 283 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 283 QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp CCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 3222 1224589999999999999999999999999987
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-44 Score=322.23 Aligned_cols=256 Identities=23% Similarity=0.366 Sum_probs=209.1
Q ss_pred CCCCCcccCccceecccCceEEEEEEEC-CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCC--CCcccceeeeEEeCC
Q 020888 37 IDPSELDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR--HPNIVQFLGAVTERK 113 (320)
Q Consensus 37 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~-~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~ 113 (320)
+...+.+|.+.+.||+|+||+||++.+. ++.||+|++..... .......+.+|+++++.+. |+||+++++++..++
T Consensus 51 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~ 129 (390)
T 2zmd_A 51 ISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 129 (390)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred ccccCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCC
Confidence 3344567999999999999999999876 78899998866543 3445578999999999996 599999999999999
Q ss_pred ceEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccc
Q 020888 114 PLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 193 (320)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~ 193 (320)
..|+|||+ .+++|.+++.....+++..+..++.||+.||.|||+.| |+|+||||+||++ + ++.++|+|||++..
T Consensus 130 ~~~lv~E~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll--~-~~~~kl~DFG~a~~ 203 (390)
T 2zmd_A 130 YIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLI--V-DGMLKLIDFGIANQ 203 (390)
T ss_dssp EEEEEEEC-CSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCCGGGEEE--S-SSCEEECCCSSSCC
T ss_pred EEEEEEec-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEE--E-CCeEEEEecCcccc
Confidence 99999994 57799999998888999999999999999999999998 9999999999999 4 47899999999987
Q ss_pred ccccCccceeeccCCcccccccCccccCc-----------CCCCCchhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHH
Q 020888 194 IKVQNSHDVYKMTGETGSYRYMAPEVFKH-----------RKYDKKVDVFSFAMILYEMLEGEPPLANYE-PYEAAKYVA 261 (320)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----------~~~~~~~Di~slG~~l~~ll~g~~p~~~~~-~~~~~~~~~ 261 (320)
+..... ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.... .......+.
T Consensus 204 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~ 281 (390)
T 2zmd_A 204 MQPDTT--SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII 281 (390)
T ss_dssp C-----------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHH
T ss_pred ccCCCc--cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHh
Confidence 643321 112234578999999999865 368899999999999999999999998754 334444455
Q ss_pred hCCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 262 EGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 262 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
........+...+.++.++|.+||..||.+|||+.+++++
T Consensus 282 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 282 DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 4443333345568999999999999999999999999876
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-44 Score=310.71 Aligned_cols=252 Identities=25% Similarity=0.447 Sum_probs=216.4
Q ss_pred CcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCc------HHHHHHHHHHHHHHHhCC-CCcccceeeeEEe
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDD------RLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTE 111 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~------~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~ 111 (320)
..+|.+.+.||+|++|.||++.+. ++.||+|++....... ....+.+.+|+++++++. |+||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 458999999999999999999985 6889999986543211 233467889999999995 9999999999999
Q ss_pred CCceEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCc
Q 020888 112 RKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 191 (320)
Q Consensus 112 ~~~~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~ 191 (320)
.+..++||||+++++|.+++.....+++..++.++.|++.||.+||++| ++|+||+|+||++ +.++.++|+|||.+
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~--~~~~~~kl~dfg~~ 171 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILL--DDDMNIKLTDFGFS 171 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--CTTCCEEECCCTTC
T ss_pred CCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEE--cCCCcEEEecccch
Confidence 9999999999999999999998888999999999999999999999999 9999999999999 88899999999998
Q ss_pred ccccccCccceeeccCCcccccccCccccC------cCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCC
Q 020888 192 KLIKVQNSHDVYKMTGETGSYRYMAPEVFK------HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHR 265 (320)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~ 265 (320)
....... ......+++.|+|||++. ...++.++|+||||+++++|++|..||...........+.....
T Consensus 172 ~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 246 (298)
T 1phk_A 172 CQLDPGE-----KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNY 246 (298)
T ss_dssp EECCTTC-----CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred hhcCCCc-----ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCc
Confidence 7665332 223356899999999884 45678999999999999999999999998887777776666554
Q ss_pred CCCCC--CCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 266 PFFRA--KGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 266 ~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
....+ ..++.++++++.+||..||.+|||+.+++++
T Consensus 247 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 247 QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence 33222 3579999999999999999999999999874
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-45 Score=321.51 Aligned_cols=244 Identities=22% Similarity=0.354 Sum_probs=207.5
Q ss_pred CcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcH-----HHHHHHHHHHHHHHhCCCCcccceeeeEEeCC
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDR-----LVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK 113 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 113 (320)
..+|.+.+.||+|+||+||++.+. ++.||+|.+........ .....+.+|+++++.++|+||+++++++...+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 348999999999999999999875 78899998876543221 12246678999999999999999999999999
Q ss_pred ceEEEEecCCCC-CHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcc
Q 020888 114 PLMLITEYLRGG-DLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 192 (320)
Q Consensus 114 ~~~iv~e~~~~~-~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~ 192 (320)
..++|||++.++ +|.+++...+.+++..++.++.|++.||.|||+.| ++|+||||+||++ +.++.++|+|||++.
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll--~~~~~~kL~Dfg~a~ 178 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKD--IIHRDIKDENIVI--AEDFTIKLIDFGSAA 178 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--CTTSCEEECCCTTCE
T ss_pred EEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEEeccCHHHEEE--cCCCcEEEeecccce
Confidence 999999998666 99999998888999999999999999999999998 9999999999999 888999999999998
Q ss_pred cccccCccceeeccCCcccccccCccccCcCCC-CCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCC
Q 020888 193 LIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKY-DKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAK 271 (320)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 271 (320)
....... .....+|+.|+|||++.+..+ +.++||||||+++|+|++|..||...... .. .....+.
T Consensus 179 ~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~--~~~~~~~ 245 (335)
T 3dls_A 179 YLERGKL-----FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------VE--AAIHPPY 245 (335)
T ss_dssp ECCTTCC-----BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------TT--TCCCCSS
T ss_pred ECCCCCc-----eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------Hh--hccCCCc
Confidence 7654321 223468999999999988876 78999999999999999999999764321 11 1122234
Q ss_pred CCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 272 GFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 272 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
.+++++++++..||..||.+|||+++++++
T Consensus 246 ~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 246 LVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp CCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 579999999999999999999999999987
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=335.70 Aligned_cols=266 Identities=31% Similarity=0.516 Sum_probs=225.6
Q ss_pred CCCCcCCCCCcccCccceecccCceEEEEEEEC-CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEE
Q 020888 32 KCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVT 110 (320)
Q Consensus 32 ~~~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~-~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 110 (320)
...|++. ..+|.+.+.||+|+||.||++.+. +..||+|.+...... .+.+.+|++++++++|+||+++++++.
T Consensus 259 ~~~~~i~--~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~ 332 (535)
T 2h8h_A 259 KDAWEIP--RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVS 332 (535)
T ss_dssp TTCSBCC--GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccceecc--hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 3445554 567999999999999999999987 467999988754432 267889999999999999999999987
Q ss_pred eCCceEEEEecCCCCCHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecC
Q 020888 111 ERKPLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF 188 (320)
Q Consensus 111 ~~~~~~iv~e~~~~~~L~~~~~~--~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~df 188 (320)
+ +..++||||+++++|.+++.. ...+++..++.++.||+.||.|||++| |+|+||||+||++ +.++.++|+||
T Consensus 333 ~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll--~~~~~~kl~DF 407 (535)
T 2h8h_A 333 E-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILV--GENLVCKVADF 407 (535)
T ss_dssp S-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE--CGGGCEEECCT
T ss_pred e-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEE--cCCCcEEEccc
Confidence 6 678999999999999999964 346999999999999999999999998 9999999999999 78889999999
Q ss_pred CCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCC
Q 020888 189 GLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPF 267 (320)
Q Consensus 189 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~ 267 (320)
|++..+.... ........++..|+|||++.+..++.++||||||+++|+|++ |..||......+....+..+....
T Consensus 408 G~a~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~ 484 (535)
T 2h8h_A 408 GLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP 484 (535)
T ss_dssp TSTTTCCCHH---HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCC
T ss_pred ccceecCCCc---eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 9997654321 111223346778999999999999999999999999999999 999999998888888777765544
Q ss_pred CCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcCCCC
Q 020888 268 FRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPTD 312 (320)
Q Consensus 268 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~ 312 (320)
. +..+++++.+++.+||..||++|||++++++.|+.+......+
T Consensus 485 ~-~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~~ 528 (535)
T 2h8h_A 485 C-PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 528 (535)
T ss_dssp C-CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSCS
T ss_pred C-CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCcc
Confidence 3 3468999999999999999999999999999999987665443
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=319.67 Aligned_cols=252 Identities=28% Similarity=0.473 Sum_probs=207.7
Q ss_pred CcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEE
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 118 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 118 (320)
..+|.+.+.||+|+||.||++.+. ++.||+|.+..... .....+.+.+|+++++.++|+||+++++++...+..++|
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 102 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD-DKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLV 102 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCC-chHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEE
Confidence 348999999999999999999986 78899998865543 334446788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccC
Q 020888 119 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 198 (320)
Q Consensus 119 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~ 198 (320)
|||+++++|.++....+.+++..++.++.|++.||.+||+.| ++|+||||+||++ +.++.++|+|||++.......
T Consensus 103 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nil~--~~~~~~kl~Dfg~~~~~~~~~ 178 (331)
T 4aaa_A 103 FEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN--IIHRDIKPENILV--SQSGVVKLCDFGFARTLAAPG 178 (331)
T ss_dssp EECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE--CTTSCEEECCCTTC-------
T ss_pred EecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC--EEccCcChheEEE--cCCCcEEEEeCCCceeecCCc
Confidence 999999899988877778999999999999999999999999 9999999999999 888999999999997654432
Q ss_pred ccceeeccCCcccccccCccccCcC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCC------------
Q 020888 199 SHDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHR------------ 265 (320)
Q Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~------------ 265 (320)
. ......+++.|+|||.+.+. .++.++||||||+++|+|++|..||......+....+.....
T Consensus 179 ~----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (331)
T 4aaa_A 179 E----VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNK 254 (331)
T ss_dssp ---------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHH
T ss_pred c----ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhh
Confidence 1 22335689999999999875 789999999999999999999999998876655443331100
Q ss_pred ---------CCC--------CCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 266 ---------PFF--------RAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 266 ---------~~~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
+.. ....+++++.+++.+||..||.+|||+.+++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 255 NPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp CGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000 012478999999999999999999999999875
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-44 Score=312.16 Aligned_cols=252 Identities=26% Similarity=0.381 Sum_probs=203.7
Q ss_pred CCcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCc--HHHHHHHHHHHHHHHhC---CCCcccceeeeEEeC
Q 020888 40 SELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDD--RLVIQDFRHEVNLLVKL---RHPNIVQFLGAVTER 112 (320)
Q Consensus 40 ~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~--~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~ 112 (320)
...+|.+.+.||+|+||+||++.+. ++.||+|.+....... ......+.+|+++++.+ +|+||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 3568999999999999999999964 7899999886432211 00113455666666665 599999999999765
Q ss_pred C-----ceEEEEecCCCCCHHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEE
Q 020888 113 K-----PLMLITEYLRGGDLHKYLKEKGA--LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKV 185 (320)
Q Consensus 113 ~-----~~~iv~e~~~~~~L~~~~~~~~~--l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L 185 (320)
. ..+++||++++ +|.+++..... +++..++.++.|++.||.|||++| ++|+||||+||++ +.++.++|
T Consensus 87 ~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~--~~~~~~kl 161 (308)
T 3g33_A 87 RTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILV--TSGGTVKL 161 (308)
T ss_dssp CSSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCTTTEEE--CTTSCEEE
T ss_pred CCCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEE--cCCCCEEE
Confidence 5 47999999964 99999987543 999999999999999999999999 9999999999999 88899999
Q ss_pred ecCCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCC
Q 020888 186 GDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHR 265 (320)
Q Consensus 186 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~ 265 (320)
+|||++....... ......+|+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+.....
T Consensus 162 ~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~ 236 (308)
T 3g33_A 162 ADFGLARIYSYQM-----ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIG 236 (308)
T ss_dssp CSCSCTTTSTTCC-----CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHC
T ss_pred eeCccccccCCCc-----ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 9999997654322 22345689999999999999999999999999999999999999998887776665543211
Q ss_pred CCC-------------------------CCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 266 PFF-------------------------RAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 266 ~~~-------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
... ....+++++.++|.+||..||.+|||+.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 237 LPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp CCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 000 012478999999999999999999999999876
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=324.63 Aligned_cols=268 Identities=19% Similarity=0.253 Sum_probs=206.1
Q ss_pred CCCCcccCccceecccCceEEEEEEEC-----CCceEEEEccCCCCCcHHH--------HHHHHHHHHHHHhCCCCcccc
Q 020888 38 DPSELDFSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLV--------IQDFRHEVNLLVKLRHPNIVQ 104 (320)
Q Consensus 38 ~~~~~~y~~~~~lg~g~~~~vy~~~~~-----~~~~~~K~~~~~~~~~~~~--------~~~~~~e~~~l~~l~h~~i~~ 104 (320)
+....+|.+.+.||+|+||+||++.+. +..+|+|.+.......... ...+.+|+..++.++|+||++
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~ 112 (345)
T 2v62_A 33 DMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPL 112 (345)
T ss_dssp CTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCC
T ss_pred cccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcce
Confidence 445678999999999999999999984 5789999886543221111 123557888899999999999
Q ss_pred eeeeEEe----CCceEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCC
Q 020888 105 FLGAVTE----RKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSA 180 (320)
Q Consensus 105 ~~~~~~~----~~~~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~ 180 (320)
+++++.. ....|+||||+ +++|.+++...+.+++..++.++.|++.||.|||+.| |+|+||||+||++..+..
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~ 189 (345)
T 2v62_A 113 FYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENE--YVHGDIKAANLLLGYKNP 189 (345)
T ss_dssp EEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEESSST
T ss_pred eecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCcCHHHEEEccCCC
Confidence 9999877 77899999999 8899999987778999999999999999999999998 999999999999944443
Q ss_pred CcEEEecCCCcccccccCccce---eeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCC--ChHH
Q 020888 181 DHLKVGDFGLSKLIKVQNSHDV---YKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANY--EPYE 255 (320)
Q Consensus 181 ~~~~L~dfg~~~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~--~~~~ 255 (320)
+.++|+|||++..+........ .......+++.|+|||++.+..++.++||||||+++|+|++|..||... +...
T Consensus 190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~ 269 (345)
T 2v62_A 190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA 269 (345)
T ss_dssp TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH
T ss_pred CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHH
Confidence 4999999999987654322211 1123457899999999999999999999999999999999999999652 2221
Q ss_pred HHH---HHHhCCCC----CCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhc
Q 020888 256 AAK---YVAEGHRP----FFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKET 308 (320)
Q Consensus 256 ~~~---~~~~~~~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 308 (320)
... ........ ......++.++++++.+||..||.+|||++++++.|+.+...
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 329 (345)
T 2v62_A 270 VQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIP 329 (345)
T ss_dssp HHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCC
T ss_pred HHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCc
Confidence 111 11111111 001125899999999999999999999999999999887653
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=336.47 Aligned_cols=252 Identities=29% Similarity=0.464 Sum_probs=213.8
Q ss_pred CCCcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceE
Q 020888 39 PSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLM 116 (320)
Q Consensus 39 ~~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 116 (320)
....+|.+.+.||+|+||.||++.+. ++.||+|++.............+.+|+++++.++|+||+++++++.+.+.+|
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 260 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 260 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence 44568999999999999999999985 8899999885432222222356788999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccc
Q 020888 117 LITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 194 (320)
Q Consensus 117 iv~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~ 194 (320)
+||||++|++|.+++...+ .+++..++.++.||+.||.|||++| |+|+||||+||++ +.++.++|+|||++...
T Consensus 261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g--IvHrDLKPeNILl--d~~g~vKL~DFGla~~~ 336 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER--IVYRDLKPENILL--DDHGHIRISDLGLAVHV 336 (576)
T ss_dssp EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEE--CTTSCEEECCCTTCEEC
T ss_pred EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCchheEEE--eCCCCeEEEecccceec
Confidence 9999999999999998644 4999999999999999999999999 9999999999999 88999999999999876
Q ss_pred cccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHhCCCCCCCC
Q 020888 195 KVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYE----PYEAAKYVAEGHRPFFRA 270 (320)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~----~~~~~~~~~~~~~~~~~~ 270 (320)
.... .....+||+.|+|||++.+..++.++|+||||+++|+|++|..||.... .......+...... .+
T Consensus 337 ~~~~-----~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~--~p 409 (576)
T 2acx_A 337 PEGQ-----TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEE--YS 409 (576)
T ss_dssp CTTC-----CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCC--CC
T ss_pred ccCc-----cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhccccc--CC
Confidence 4332 1233578999999999999999999999999999999999999998753 33444444443322 23
Q ss_pred CCCCHHHHHHHHHHhhcCCCCCC-----CHHHHHHH
Q 020888 271 KGFTPELRELTEKCWAADMNQRP-----SFLDILKR 301 (320)
Q Consensus 271 ~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~ 301 (320)
..++++++++|.+||..||.+|| +++++++|
T Consensus 410 ~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 410 ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 56899999999999999999999 78999876
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-44 Score=308.92 Aligned_cols=265 Identities=20% Similarity=0.267 Sum_probs=212.5
Q ss_pred CcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeE-EeCCceEE
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAV-TERKPLML 117 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~i 117 (320)
..+|.+.+.||+|++|.||++.+. ++.||+|++...... ..+.+|+++++.++|++++..+..+ ..++..++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC-----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch-----hHHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence 458999999999999999999974 889999988654332 3578899999999987766655554 66777899
Q ss_pred EEecCCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEe-eCCCCcEEEecCCCccccc
Q 020888 118 ITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLV-NSSADHLKVGDFGLSKLIK 195 (320)
Q Consensus 118 v~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~-~~~~~~~~L~dfg~~~~~~ 195 (320)
||||+ +++|.+++.. ...+++..++.++.|++.||.|||++| ++|+||||+||++. .+.++.++|+|||++....
T Consensus 83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 83 VMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 99999 8899999974 457999999999999999999999998 99999999999992 2266789999999998766
Q ss_pred ccCccce---eeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHhC---CCC
Q 020888 196 VQNSHDV---YKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPY---EAAKYVAEG---HRP 266 (320)
Q Consensus 196 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~---~~~~~~~~~---~~~ 266 (320)
....... .......+++.|+|||.+.+..++.++||||||+++|+|++|..||...... .....+... ...
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 239 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch
Confidence 5432211 1123456899999999999999999999999999999999999999864321 111111111 111
Q ss_pred CCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcCCCCC
Q 020888 267 FFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPTDH 313 (320)
Q Consensus 267 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~~ 313 (320)
......+++++.+++.+||+.||.+|||+.++++.|+++........
T Consensus 240 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~ 286 (296)
T 3uzp_A 240 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSY 286 (296)
T ss_dssp HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCS
T ss_pred HHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCcc
Confidence 11124579999999999999999999999999999999998876543
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-44 Score=308.23 Aligned_cols=251 Identities=31% Similarity=0.526 Sum_probs=214.6
Q ss_pred cccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEE
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 119 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 119 (320)
.+|.+.+.||+|++|.||++.+. ++.|++|++........ ....+.+|++++++++|+||+++++++...+..++|+
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchH-HHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence 48999999999999999999985 78899998865433322 2367889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeC-CCCcEEEecCCCcccccccC
Q 020888 120 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS-SADHLKVGDFGLSKLIKVQN 198 (320)
Q Consensus 120 e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~-~~~~~~L~dfg~~~~~~~~~ 198 (320)
|++++++|.+++.....+++..++.++.|++.||.+||++| ++|+||+|+||++..+ .++.++|+|||++.......
T Consensus 101 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~ 178 (287)
T 2wei_A 101 ELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT 178 (287)
T ss_dssp CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCS
T ss_pred EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChhhEEEecCCCcccEEEeccCcceeecCCC
Confidence 99999999999988788999999999999999999999998 9999999999999322 23479999999987654322
Q ss_pred ccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCC--CCCCCHH
Q 020888 199 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR--AKGFTPE 276 (320)
Q Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 276 (320)
......+++.|+|||.+.+. ++.++|+||||+++++|++|..||......+....+..+...... ...++++
T Consensus 179 -----~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (287)
T 2wei_A 179 -----KMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDD 252 (287)
T ss_dssp -----SCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHH
T ss_pred -----ccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHH
Confidence 11233578899999998764 899999999999999999999999998888877777766543322 2568999
Q ss_pred HHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 277 LRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 277 l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
+++++.+||..||.+|||+.+++++
T Consensus 253 ~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 253 AKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHcccChhhCcCHHHHhcC
Confidence 9999999999999999999999985
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=337.91 Aligned_cols=254 Identities=28% Similarity=0.523 Sum_probs=214.1
Q ss_pred ceecccCceEEEEEEEC----CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEecCC
Q 020888 48 AIIGKGSFGEILKAYWR----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLR 123 (320)
Q Consensus 48 ~~lg~g~~~~vy~~~~~----~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 123 (320)
+.||+|+||.||++.+. ++.||+|++...... ....+.+.+|++++++++|+||+++++++.. +..++||||++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~ 452 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND-PALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE 452 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGC-GGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccC
Confidence 47999999999999653 467999988654332 2334789999999999999999999999864 56889999999
Q ss_pred CCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCcccee
Q 020888 124 GGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 203 (320)
Q Consensus 124 ~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~~~~ 203 (320)
+++|.+++...+.+++..++.++.||+.||.|||++| |+|+||||+||++ +.++.++|+|||++..+...... ..
T Consensus 453 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~--iiHrDLkp~NILl--~~~~~~kL~DFGla~~~~~~~~~-~~ 527 (635)
T 4fl3_A 453 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLL--VTQHYAKISDFGLSKALRADENY-YK 527 (635)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE--EETTEEEECCTTHHHHTTC-------
T ss_pred CCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeCCCCChHhEEE--eCCCCEEEEEcCCccccccCccc-cc
Confidence 9999999998888999999999999999999999999 9999999999999 77889999999999876543211 11
Q ss_pred eccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHH
Q 020888 204 KMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTE 282 (320)
Q Consensus 204 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 282 (320)
......+++.|+|||++.+..++.++||||||+++|+|++ |..||......+....+..+..... +..+++++.+++.
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~-p~~~~~~l~~li~ 606 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC-PAGCPREMYDLMN 606 (635)
T ss_dssp -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC-CTTCCHHHHHHHH
T ss_pred cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC-CCCCCHHHHHHHH
Confidence 1222346788999999999999999999999999999998 9999999998888887777765443 4458999999999
Q ss_pred HHhhcCCCCCCCHHHHHHHHHHHHhcC
Q 020888 283 KCWAADMNQRPSFLDILKRLEKIKETL 309 (320)
Q Consensus 283 ~~l~~dp~~Rps~~~ll~~L~~~~~~~ 309 (320)
.||..||++|||++++++.|+.+..++
T Consensus 607 ~cl~~dP~~RPs~~~l~~~L~~~~~~l 633 (635)
T 4fl3_A 607 LCWTYDVENRPGFAAVELRLRNYYYDV 633 (635)
T ss_dssp HHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred HHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 999999999999999999999987654
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-44 Score=316.73 Aligned_cols=256 Identities=25% Similarity=0.391 Sum_probs=209.6
Q ss_pred CCcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEe------
Q 020888 40 SELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE------ 111 (320)
Q Consensus 40 ~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------ 111 (320)
...+|.+.+.||+|+||+||++.+. ++.||+|.+......... ...+.+|+++++.++|+||+++++++..
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGF-PITALREIKILQLLKHENVVNLIEICRTKASPYN 93 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSS-CHHHHHHHHHHHHCCCTTBCCEEEEEEEC-----
T ss_pred cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccc-hHHHHHHHHHHHhccCCCcccHhheeeccccccc
Confidence 3468999999999999999999985 789999988655433321 2567789999999999999999999876
Q ss_pred --CCceEEEEecCCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecC
Q 020888 112 --RKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF 188 (320)
Q Consensus 112 --~~~~~iv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~df 188 (320)
.+..++||||+++ +|.+.+.. ...+++..++.++.|++.||.|||++| ++|+||||+||++ +.++.++|+||
T Consensus 94 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~--~~~~~~kl~Df 168 (351)
T 3mi9_A 94 RCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLI--TRDGVLKLADF 168 (351)
T ss_dssp ---CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--CTTSCEEECCC
T ss_pred cCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEE--cCCCCEEEccc
Confidence 4468999999976 88777765 357999999999999999999999999 9999999999999 88899999999
Q ss_pred CCcccccccCccceeeccCCcccccccCccccCc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCC---
Q 020888 189 GLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH--- 264 (320)
Q Consensus 189 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~--- 264 (320)
|++..+...............+|+.|+|||++.+ ..++.++||||||+++|+|++|..||......+....+....
T Consensus 169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 248 (351)
T 3mi9_A 169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 248 (351)
T ss_dssp TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 9998776444333333445678999999999876 457999999999999999999999999887776655544321
Q ss_pred CCCCCCC---------------------------CCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 265 RPFFRAK---------------------------GFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 265 ~~~~~~~---------------------------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
.+...+. ..+++++++|.+||..||.+|||+++++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 249 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp CTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 1111110 026789999999999999999999999986
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-44 Score=315.45 Aligned_cols=251 Identities=28% Similarity=0.474 Sum_probs=199.7
Q ss_pred cccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCC------
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK------ 113 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------ 113 (320)
.+|.+.+.||+|+||.||++.+. ++.||+|++...... ...+.+.+|++++++++||||+++++++.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRE--LAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTT--THHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 47899999999999999999985 789999998654422 23478899999999999999999999885543
Q ss_pred ---------------------------------------------------ceEEEEecCCCCCHHHHHHHhC---CCCH
Q 020888 114 ---------------------------------------------------PLMLITEYLRGGDLHKYLKEKG---ALSP 139 (320)
Q Consensus 114 ---------------------------------------------------~~~iv~e~~~~~~L~~~~~~~~---~l~~ 139 (320)
..++||||+++++|.++++... ..++
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 163 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence 2799999999999999998754 3566
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCccce--------eeccCCccc
Q 020888 140 STAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDV--------YKMTGETGS 211 (320)
Q Consensus 140 ~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~~~--------~~~~~~~~~ 211 (320)
..++.++.|++.||.|||++| ++|+||||+||++ +.++.++|+|||++........... .......+|
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll--~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt 239 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFF--TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEE--CTTCCEEECCCTTCEECSCC--------------CCCSCC-C
T ss_pred HHHHHHHHHHHHHHHHHHhCC--eeecCCCcccEEE--eCCCCEEEeecCcccccccchhhccccccccccccccccCCC
Confidence 678999999999999999998 9999999999999 8889999999999987654322111 122345689
Q ss_pred ccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHhhcCCCC
Q 020888 212 YRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQ 291 (320)
Q Consensus 212 ~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~ 291 (320)
+.|+|||++.+..++.++||||||+++|+|++|..|+.. .............+. .....++++++++.+||+.||.+
T Consensus 240 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~ 316 (332)
T 3qd2_B 240 KLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNLKFPL-LFTQKYPQEHMMVQDMLSPSPTE 316 (332)
T ss_dssp GGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTTCCCH-HHHHHCHHHHHHHHHHHCSSGGG
T ss_pred cCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhccCCCc-ccccCChhHHHHHHHHccCCCCc
Confidence 999999999999999999999999999999998765421 122222233322221 12335788899999999999999
Q ss_pred CCCHHHHHHH
Q 020888 292 RPSFLDILKR 301 (320)
Q Consensus 292 Rps~~~ll~~ 301 (320)
|||+++++++
T Consensus 317 Rps~~~~l~~ 326 (332)
T 3qd2_B 317 RPEATDIIEN 326 (332)
T ss_dssp SCCHHHHHHS
T ss_pred CCCHHHHhhc
Confidence 9999999875
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-44 Score=315.20 Aligned_cols=272 Identities=24% Similarity=0.374 Sum_probs=201.9
Q ss_pred CCcCCCCCcccCccceecccCceEEEEEEE--CCCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCC-CCcccceeeeEE
Q 020888 34 DWEIDPSELDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVT 110 (320)
Q Consensus 34 ~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~--~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~ 110 (320)
...++....+|.+.+.||+|+||.||++.+ +++.||+|.+... .......+.+|+.+++++. |+||+++++++.
T Consensus 20 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~ 96 (337)
T 3ll6_A 20 GQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN---EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAAS 96 (337)
T ss_dssp TCEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred cceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC---chHHHHHHHHHHHHHHHhccCCChhhcccccc
Confidence 345666678999999999999999999998 4789999987443 3344578889999999995 999999999984
Q ss_pred --------eCCceEEEEecCCCCCHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCC
Q 020888 111 --------ERKPLMLITEYLRGGDLHKYLKE---KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS 179 (320)
Q Consensus 111 --------~~~~~~iv~e~~~~~~L~~~~~~---~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~ 179 (320)
....+++++||++ ++|.+++.. .+.+++..++.++.|++.||.|||+.|.+++|+||||+||++ +.
T Consensus 97 ~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~--~~ 173 (337)
T 3ll6_A 97 IGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLL--SN 173 (337)
T ss_dssp ECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEE--CT
T ss_pred ccccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEE--CC
Confidence 3444799999995 599998865 457999999999999999999999976569999999999999 88
Q ss_pred CCcEEEecCCCcccccccCccce--------eeccCCcccccccCcccc---CcCCCCCchhHHHHHHHHHHHHhCCCCC
Q 020888 180 ADHLKVGDFGLSKLIKVQNSHDV--------YKMTGETGSYRYMAPEVF---KHRKYDKKVDVFSFAMILYEMLEGEPPL 248 (320)
Q Consensus 180 ~~~~~L~dfg~~~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~---~~~~~~~~~Di~slG~~l~~ll~g~~p~ 248 (320)
++.++|+|||++........... .......+++.|+|||++ .+..++.++||||||+++|+|++|..||
T Consensus 174 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~ 253 (337)
T 3ll6_A 174 QGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF 253 (337)
T ss_dssp TSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC
T ss_pred CCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCC
Confidence 88999999999987654322110 011134589999999998 5667889999999999999999999999
Q ss_pred CCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcCCCCCcc
Q 020888 249 ANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPTDHHW 315 (320)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~~~~ 315 (320)
......... ............+..+.+++.+||+.||.+|||+.+++++|+.+..........
T Consensus 254 ~~~~~~~~~----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~~~~ 316 (337)
T 3ll6_A 254 EDGAKLRIV----NGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKS 316 (337)
T ss_dssp ----------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCCTTS
T ss_pred cchhHHHhh----cCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCCCCc
Confidence 865543322 222222333456888999999999999999999999999999998876655443
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=304.86 Aligned_cols=246 Identities=27% Similarity=0.444 Sum_probs=205.9
Q ss_pred CcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcccceeeeEEeCCceEE
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLML 117 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~i 117 (320)
..+|.+.+.||+|++|+||++.+. ++.||+|.+......... ...+.+|+..+..+ +||||+++++++...+..++
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVD-EQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHH-HHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHH-HHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 357999999999999999999985 889999998765444433 36788899999999 89999999999999999999
Q ss_pred EEecCCCCCHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeC---------------
Q 020888 118 ITEYLRGGDLHKYLKEK----GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS--------------- 178 (320)
Q Consensus 118 v~e~~~~~~L~~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~--------------- 178 (320)
||||+++++|.+++... +.+++..++.++.|++.||.|||++| ++|+||||+||++..+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS--LVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 99999999999999764 67999999999999999999999998 9999999999999321
Q ss_pred --CCCcEEEecCCCcccccccCccceeeccCCcccccccCccccCcC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 020888 179 --SADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPYE 255 (320)
Q Consensus 179 --~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~ 255 (320)
....++|+|||.+....... ...+++.|+|||.+.+. .++.++||||||++++++++|..++.....
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~--------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~-- 236 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ--------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ-- 236 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC--------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH--
T ss_pred cCCceEEEEcccccccccCCcc--------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH--
Confidence 44479999999987664322 23589999999999876 566899999999999999999877654432
Q ss_pred HHHHHHhCCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 256 AAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
...+.....+. .+..+++++++++.+||..||++|||+.+++++
T Consensus 237 -~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 237 -WHEIRQGRLPR-IPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp -HHHHHTTCCCC-CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred -HHHHHcCCCCC-CCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 33344444433 345589999999999999999999999999875
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-44 Score=328.52 Aligned_cols=254 Identities=25% Similarity=0.394 Sum_probs=190.7
Q ss_pred cccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEe-----CCc
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE-----RKP 114 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 114 (320)
.+|.+.+.||+|+||+||++.+. ++.||+|.+..... .....+.+.+|+++++.++|+||+++++++.. ...
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFE-DLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhc-CHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 58999999999999999999876 78999998865433 33445788999999999999999999999843 356
Q ss_pred eEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccc
Q 020888 115 LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 194 (320)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~ 194 (320)
.|+|||++ +++|.+++.....+++..+..++.||+.||.|||+.| |+||||||+||++ +.++.++|+|||+++..
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--iiHrDlKp~NILl--~~~~~~kl~DFGla~~~ 206 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAG--ILHRDLKPANCLV--NQDCSVKVCDFGLARTV 206 (458)
T ss_dssp EEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEE--CTTCCEEECCCTTCBCT
T ss_pred EEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCC--cCCCCCChhhEEE--CCCCCEeecccccchhc
Confidence 89999998 5699999988778999999999999999999999999 9999999999999 88899999999999876
Q ss_pred cccCccc-----------------------eeeccCCcccccccCcccc-CcCCCCCchhHHHHHHHHHHHHh-------
Q 020888 195 KVQNSHD-----------------------VYKMTGETGSYRYMAPEVF-KHRKYDKKVDVFSFAMILYEMLE------- 243 (320)
Q Consensus 195 ~~~~~~~-----------------------~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~~ll~------- 243 (320)
....... .......++|+.|+|||++ .+..++.++|||||||++|+|++
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~ 286 (458)
T 3rp9_A 207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVA 286 (458)
T ss_dssp TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCS
T ss_pred cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccc
Confidence 5322110 0123345689999999976 56679999999999999999998
Q ss_pred ----CCCCCCCCCh--------------------HHHHHHHH-----------------------hCCCC------CCCC
Q 020888 244 ----GEPPLANYEP--------------------YEAAKYVA-----------------------EGHRP------FFRA 270 (320)
Q Consensus 244 ----g~~p~~~~~~--------------------~~~~~~~~-----------------------~~~~~------~~~~ 270 (320)
|..+|.+.+. .+....+. ..... ....
T Consensus 287 ~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (458)
T 3rp9_A 287 YHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERF 366 (458)
T ss_dssp SGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGS
T ss_pred ccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHC
Confidence 5666654331 01111110 00000 0011
Q ss_pred CCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 271 KGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 271 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
..+++++.+||.+||..||++|||++++++|
T Consensus 367 ~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~H 397 (458)
T 3rp9_A 367 PASSADAIHLLKRMLVFNPNKRITINECLAH 397 (458)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 3468999999999999999999999999997
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-44 Score=312.32 Aligned_cols=274 Identities=23% Similarity=0.336 Sum_probs=211.0
Q ss_pred CCCCCCCCCCCCCCCCCcCCCCCcccCccceecccCceEEEEEEEC-CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhC
Q 020888 19 HFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL 97 (320)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~-~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l 97 (320)
...|.+.-++.+....-.+...+.+|.+.+.||+|+||.||++.+. ++.+|+|.+...... ......+.+|++++.++
T Consensus 5 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l 83 (313)
T 3cek_A 5 HHHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEAD-NQTLDSYRNEIAYLNKL 83 (313)
T ss_dssp ---------------CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCC-HHHHHHHHHHHHHHHHH
T ss_pred ccccccccCCCCCCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEecccccc-ccchHHHHHHHHHHHhc
Confidence 3445555666667777778888899999999999999999999876 788999988654433 44557889999999999
Q ss_pred C--CCcccceeeeEEeCCceEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE
Q 020888 98 R--HPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLL 175 (320)
Q Consensus 98 ~--h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~ 175 (320)
+ |+||+++++++..++..++|||+ .+++|.+++...+.+++..++.++.|++.||.|||++| ++|+||||+||++
T Consensus 84 ~~~~~~iv~~~~~~~~~~~~~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~ 160 (313)
T 3cek_A 84 QQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLI 160 (313)
T ss_dssp GGGCTTBCCEEEEEECSSEEEEEECC-CSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE
T ss_pred cccCCceEEEEEEeecCCEEEEEEec-CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEE
Confidence 6 59999999999999999999995 47799999998888999999999999999999999998 9999999999999
Q ss_pred eeCCCCcEEEecCCCcccccccCccceeeccCCcccccccCccccCc-----------CCCCCchhHHHHHHHHHHHHhC
Q 020888 176 VNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH-----------RKYDKKVDVFSFAMILYEMLEG 244 (320)
Q Consensus 176 ~~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----------~~~~~~~Di~slG~~l~~ll~g 244 (320)
+ ++.++|+|||++........ ........+++.|+|||.+.+ ..++.++||||||+++|+|++|
T Consensus 161 --~-~~~~kL~Dfg~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g 235 (313)
T 3cek_A 161 --V-DGMLKLIDFGIANQMQPDTT--SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG 235 (313)
T ss_dssp --E-TTEEEECCCSSSCC----------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHS
T ss_pred --E-CCeEEEeeccccccccCccc--cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhC
Confidence 4 37899999999986644321 111233468999999999876 4688899999999999999999
Q ss_pred CCCCCCCCh-HHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 245 EPPLANYEP-YEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 245 ~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
..||..... ................+...+.++.+++.+||..||.+|||+.+++++
T Consensus 236 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 236 KTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp SCTTTTCCSHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCchhhHHHHHHHHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 999987643 333344444333333345568999999999999999999999999986
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=318.10 Aligned_cols=249 Identities=26% Similarity=0.433 Sum_probs=200.7
Q ss_pred cccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEE
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 119 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 119 (320)
.+|.+.+.||+|+||+||++.+. ++.||+|.+....... ....+.+|+++++.++|+||+++++++..++..++||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEG--APCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 79 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccc--cchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEe
Confidence 37999999999999999999986 7889999885433211 1124457999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccC
Q 020888 120 EYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 198 (320)
Q Consensus 120 e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~ 198 (320)
||+++ +|.+++... ..+++..+..++.|++.||.|||+.| |+|+||||+||++ +.++.++|+|||++.......
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dikp~NIl~--~~~~~~kl~Dfg~a~~~~~~~ 154 (324)
T 3mtl_A 80 EYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK--VLHRDLKPQNLLI--NERGELKLADFGLARAKSIPT 154 (324)
T ss_dssp ECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCCGGGEEE--CTTCCEEECSSSEEECC----
T ss_pred ccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCcCHHHEEE--CCCCCEEEccCcccccccCCc
Confidence 99975 999988764 45999999999999999999999999 9999999999999 888999999999987554322
Q ss_pred ccceeeccCCcccccccCccccCc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCC---------
Q 020888 199 SHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFF--------- 268 (320)
Q Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~--------- 268 (320)
. ......+++.|+|||++.+ ..++.++||||||+++|+|++|..||...+..+....+......+.
T Consensus 155 ~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 230 (324)
T 3mtl_A 155 K----TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS 230 (324)
T ss_dssp ------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred c----ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhc
Confidence 1 2233467999999999876 5689999999999999999999999998887766655543211100
Q ss_pred -------------------CCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 269 -------------------RAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 269 -------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
....++++++++|.+||+.||.+|||+++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 231 NEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp CHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred chhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 012468899999999999999999999999986
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-44 Score=332.37 Aligned_cols=253 Identities=28% Similarity=0.428 Sum_probs=213.8
Q ss_pred CCCcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceE
Q 020888 39 PSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLM 116 (320)
Q Consensus 39 ~~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 116 (320)
....+|.+.+.||+|+||+||++.++ ++.||+|++.+...........+.+|+++++.++||||+++++++...+.+|
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 261 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLC 261 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEE
Confidence 34568999999999999999999985 8899999886543222223467888999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcc
Q 020888 117 LITEYLRGGDLHKYLKEK----GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 192 (320)
Q Consensus 117 iv~e~~~~~~L~~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~ 192 (320)
+||||++|++|.+++... ..+++..++.++.||+.||.|||++| |+|+||||+||++ +.++.++|+|||++.
T Consensus 262 lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--IvHrDLKP~NILl--~~~g~vkL~DFGla~ 337 (543)
T 3c4z_A 262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN--IIYRDLKPENVLL--DDDGNVRISDLGLAV 337 (543)
T ss_dssp EEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEE--CTTSCEEECCCTTCE
T ss_pred EEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC--CcccCCChHHEEE--eCCCCEEEeecceee
Confidence 999999999999999763 36999999999999999999999999 9999999999999 889999999999998
Q ss_pred cccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCC----ChHHHHHHHHhCCCCCC
Q 020888 193 LIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANY----EPYEAAKYVAEGHRPFF 268 (320)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~----~~~~~~~~~~~~~~~~~ 268 (320)
.+..... .....+||+.|+|||++.+..++.++|+|||||++|+|++|..||... ...+....+......
T Consensus 338 ~~~~~~~----~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~-- 411 (543)
T 3c4z_A 338 ELKAGQT----KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVT-- 411 (543)
T ss_dssp ECCTTCC----CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCC--
T ss_pred eccCCCc----ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccC--
Confidence 7654321 123357899999999999999999999999999999999999999865 334455555554432
Q ss_pred CCCCCCHHHHHHHHHHhhcCCCCCCCH-----HHHHHH
Q 020888 269 RAKGFTPELRELTEKCWAADMNQRPSF-----LDILKR 301 (320)
Q Consensus 269 ~~~~~~~~l~~li~~~l~~dp~~Rps~-----~~ll~~ 301 (320)
.+..++.+++++|.+||..||.+||++ ++++++
T Consensus 412 ~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H 449 (543)
T 3c4z_A 412 YPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH 449 (543)
T ss_dssp CCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred CCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence 235689999999999999999999964 777764
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=316.13 Aligned_cols=268 Identities=26% Similarity=0.402 Sum_probs=212.0
Q ss_pred CCCCCCCCCCCcCCCCCcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcc
Q 020888 25 VPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 102 (320)
Q Consensus 25 ~~~~~~~~~~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i 102 (320)
++....+...=++-.-+.+|++.+.||+|+||.||++.+. ++.||+|.+... ........+.+|++++++++|+||
T Consensus 10 ~~~~~~~~~~g~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~ni 87 (364)
T 3qyz_A 10 AAAAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF--EHQTYCQRTLREIKILLRFRHENI 87 (364)
T ss_dssp -----CCBCC-CBCCCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT--TCHHHHHHHHHHHHHHHHCCCTTB
T ss_pred HhhcceEEEccEeccccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc--cCcHHHHHHHHHHHHHHhcCCCCC
Confidence 3344444443344444568999999999999999999986 778999988643 234445788899999999999999
Q ss_pred cceeeeEEeC-----CceEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEee
Q 020888 103 VQFLGAVTER-----KPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN 177 (320)
Q Consensus 103 ~~~~~~~~~~-----~~~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~ 177 (320)
+++++++... ...|+|+|++++ +|.++++. +.+++..++.++.|++.||.|||++| |+|+||||+||++
T Consensus 88 v~~~~~~~~~~~~~~~~~~iv~e~~~~-~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~-- 161 (364)
T 3qyz_A 88 IGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLL-- 161 (364)
T ss_dssp CCCCEEECCSSTTTCCCEEEEEECCSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEE--
T ss_pred ccceeEEecCCccccceEEEEEcccCc-CHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChHhEEE--
Confidence 9999998654 468999999965 99999876 46999999999999999999999999 9999999999999
Q ss_pred CCCCcEEEecCCCcccccccCccceeeccCCcccccccCccccCc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 020888 178 SSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEA 256 (320)
Q Consensus 178 ~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~ 256 (320)
+.++.++|+|||++.......... .......+|+.|+|||++.+ ..++.++||||||+++|+|++|..||...+..+.
T Consensus 162 ~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~ 240 (364)
T 3qyz_A 162 NTTCDLKICDFGLARVADPDHDHT-GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ 240 (364)
T ss_dssp CTTCCEEECCCTTCEECCGGGCBC-CTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGH
T ss_pred CCCCCEEEEeCcceEecCCCCCcc-ccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHH
Confidence 888999999999998665432211 11234578999999998654 5589999999999999999999999988776655
Q ss_pred HHHHHhCCCCC------------------------C-----CCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 257 AKYVAEGHRPF------------------------F-----RAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 257 ~~~~~~~~~~~------------------------~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
...+......+ . ....++.++.++|.+||+.||.+|||+.+++++
T Consensus 241 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 241 LNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 44443211000 0 013468999999999999999999999999986
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=315.05 Aligned_cols=258 Identities=27% Similarity=0.433 Sum_probs=210.8
Q ss_pred cccCccceecccCceEEEEEEECCCceEEEEccCCCCCcHHHHHHHHHHHHHHHh--CCCCcccceeeeEEeCC----ce
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVK--LRHPNIVQFLGAVTERK----PL 115 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~~~~----~~ 115 (320)
.+|.+.+.||+|+||.||++.++++.||+|.+... ....+.+|.+++.. ++|+||+++++++.... ..
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~ 115 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR------EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 115 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGG------GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCE
T ss_pred ccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCch------hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcccee
Confidence 58999999999999999999999999999988532 12567778888887 68999999999998765 78
Q ss_pred EEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHh--------cCCCCeEecCCCCCcEEEeeCCCCcEEEec
Q 020888 116 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLH--------NEPNVIIHRDLKPRNVLLVNSSADHLKVGD 187 (320)
Q Consensus 116 ~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH--------~~g~~ivH~di~p~nI~~~~~~~~~~~L~d 187 (320)
++||||+++++|.++++. ..+++..++.++.|++.||.||| +.| ++|+||||+||++ +.++.++|+|
T Consensus 116 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~NIll--~~~~~~kL~D 190 (342)
T 1b6c_B 116 WLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA--IAHRDLKSKNILV--KKNGTCCIAD 190 (342)
T ss_dssp EEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE--EECSCCSGGGEEE--CTTSCEEECC
T ss_pred EEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC--eeeCCCCHHHEEE--CCCCCEEEEE
Confidence 999999999999999976 46899999999999999999999 877 9999999999999 8889999999
Q ss_pred CCCcccccccCccceeeccCCcccccccCccccCcCC------CCCchhHHHHHHHHHHHHhC----------CCCCCCC
Q 020888 188 FGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRK------YDKKVDVFSFAMILYEMLEG----------EPPLANY 251 (320)
Q Consensus 188 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~------~~~~~Di~slG~~l~~ll~g----------~~p~~~~ 251 (320)
||++..................+++.|+|||++.+.. ++.++||||||+++|+|++| ..||...
T Consensus 191 fg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~ 270 (342)
T 1b6c_B 191 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 270 (342)
T ss_dssp CTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcccc
Confidence 9999876554332222334557899999999998763 33689999999999999999 7888765
Q ss_pred C-----hHHHHHHHHhCCCCCCCC-----CCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcCC
Q 020888 252 E-----PYEAAKYVAEGHRPFFRA-----KGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLP 310 (320)
Q Consensus 252 ~-----~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~ 310 (320)
. .......+.........+ ...++.+.+++.+||+.||.+|||+++++++|+++..+..
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~~ 339 (342)
T 1b6c_B 271 VPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 339 (342)
T ss_dssp SCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTTC
T ss_pred CcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHhc
Confidence 3 223333333322222111 1234689999999999999999999999999999987754
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-44 Score=310.42 Aligned_cols=250 Identities=28% Similarity=0.471 Sum_probs=209.3
Q ss_pred CcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEE
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 118 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 118 (320)
..+|++.+.||+|+||.||++.+. ++.+++|.+....... .+.+.+|+++++.++||||+++++++..++..++|
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 94 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE---LEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIM 94 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CC---HHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEE
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHH---HHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEE
Confidence 457999999999999999999986 7889999886543322 36788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccccccc
Q 020888 119 TEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 197 (320)
Q Consensus 119 ~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~ 197 (320)
|||+++++|.+++.. ...+++..++.++.|++.||.|||+.| ++|+||||+||++ +.++.++|+|||++......
T Consensus 95 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~--~~~~~~kl~Dfg~~~~~~~~ 170 (302)
T 2j7t_A 95 IEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR--IIHRDLKAGNVLM--TLEGDIRLADFGVSAKNLKT 170 (302)
T ss_dssp EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEE--CTTSCEEECCCHHHHHHHHH
T ss_pred EEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEE--CCCCCEEEEECCCCcccccc
Confidence 999999999999876 457999999999999999999999998 9999999999999 88899999999987643321
Q ss_pred CccceeeccCCcccccccCcccc-----CcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCC-CCCC
Q 020888 198 NSHDVYKMTGETGSYRYMAPEVF-----KHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPF-FRAK 271 (320)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~ 271 (320)
.. ......+++.|+|||.+ .+..++.++|+||||+++|+|++|..||...+.......+.....+. ..+.
T Consensus 171 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (302)
T 2j7t_A 171 LQ----KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPS 246 (302)
T ss_dssp HH----C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGG
T ss_pred cc----ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCcc
Confidence 11 12234688999999998 46778999999999999999999999999988777766666554433 3345
Q ss_pred CCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 272 GFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 272 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
.++.++.+++.+||..||.+|||+.+++++
T Consensus 247 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 247 KWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp GSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred ccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 689999999999999999999999999864
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-44 Score=342.60 Aligned_cols=251 Identities=27% Similarity=0.428 Sum_probs=218.6
Q ss_pred CcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcccceeeeEEeCCceEE
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLML 117 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~i 117 (320)
..+|.+++.||+|+||+||++.+. ++.||+|++.+.........+.+..|..++..+ +|++|+++++++...+.+|+
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l 419 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 419 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence 347999999999999999999986 678999988653221222236677899999988 69999999999999999999
Q ss_pred EEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccccccc
Q 020888 118 ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 197 (320)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~ 197 (320)
||||++|++|.+++...+.+++..++.++.||+.||+|||++| |+|+||||+||++ +.++.++|+|||++......
T Consensus 420 V~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--IiHrDLKp~NILl--~~~g~ikL~DFGla~~~~~~ 495 (674)
T 3pfq_A 420 VMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVML--DSEGHIKIADFGMCKENIWD 495 (674)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTS--EECCCCCSTTEEE--CSSSCEEECCCTTCEECCCT
T ss_pred EEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeccCChhhEEE--cCCCcEEEeecceeeccccC
Confidence 9999999999999998889999999999999999999999999 9999999999999 88999999999999754332
Q ss_pred CccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHH
Q 020888 198 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPEL 277 (320)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 277 (320)
.. .....+||+.|+|||++.+..++.++|+||||+++|+|++|..||...+..+....+....... +..+++++
T Consensus 496 ~~----~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~--p~~~s~~~ 569 (674)
T 3pfq_A 496 GV----TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY--PKSMSKEA 569 (674)
T ss_dssp TC----CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCC--CTTSCHHH
T ss_pred Cc----ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCC--CccCCHHH
Confidence 21 2344679999999999999999999999999999999999999999999888888888765433 35689999
Q ss_pred HHHHHHHhhcCCCCCCCH-----HHHHHH
Q 020888 278 RELTEKCWAADMNQRPSF-----LDILKR 301 (320)
Q Consensus 278 ~~li~~~l~~dp~~Rps~-----~~ll~~ 301 (320)
++||+.||+.||.+|+++ ++++++
T Consensus 570 ~~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 570 VAICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp HHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred HHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 999999999999999987 777765
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=334.59 Aligned_cols=263 Identities=28% Similarity=0.513 Sum_probs=217.2
Q ss_pred cCccc-eecccCceEEEEEEEC----CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEE
Q 020888 44 FSSSA-IIGKGSFGEILKAYWR----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 118 (320)
Q Consensus 44 y~~~~-~lg~g~~~~vy~~~~~----~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 118 (320)
+.+.. .||+|+||.||++.+. +..||+|++...... ...+.+.+|++++++++|+||+++++++.. +..++|
T Consensus 337 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv 413 (613)
T 2ozo_A 337 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK--ADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 413 (613)
T ss_dssp EEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSS--TTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEE
T ss_pred eeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCCh--HHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEE
Confidence 33434 7999999999999764 456999998764322 224788999999999999999999999876 568999
Q ss_pred EecCCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccccccc
Q 020888 119 TEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 197 (320)
Q Consensus 119 ~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~ 197 (320)
|||+++++|.+++.. ...+++..++.++.|++.||.|||++| |+|+||||+||++ +.++.++|+|||++..+...
T Consensus 414 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiHrDlkp~NILl--~~~~~vkL~DFGla~~~~~~ 489 (613)
T 2ozo_A 414 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRNLAARNVLL--VNRHYAKISDFGLSKALGAD 489 (613)
T ss_dssp EECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE--EETTEEEECCCSTTTTCC--
T ss_pred EEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCcCCHHHEEE--cCCCcEEEeeccCcccccCC
Confidence 999999999999965 346999999999999999999999998 9999999999999 77889999999999876433
Q ss_pred CccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHH
Q 020888 198 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPE 276 (320)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (320)
.... .......+++.|+|||++.+..++.++||||||+++|+|++ |..||...+..+....+..+..... +..++++
T Consensus 490 ~~~~-~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~-p~~~~~~ 567 (613)
T 2ozo_A 490 DSYY-TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC-PPECPPE 567 (613)
T ss_dssp -------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCC-CTTCCHH
T ss_pred Ccee-eeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC-CCcCCHH
Confidence 2111 11122335678999999999999999999999999999998 9999999988888887877765443 3458999
Q ss_pred HHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcCCCCCcc
Q 020888 277 LRELTEKCWAADMNQRPSFLDILKRLEKIKETLPTDHHW 315 (320)
Q Consensus 277 l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~~~~ 315 (320)
+.+++.+||..||++|||+.++++.|+.+..+...+.+.
T Consensus 568 l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~~~~ 606 (613)
T 2ozo_A 568 LYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEG 606 (613)
T ss_dssp HHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCSCCC
T ss_pred HHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhccccCC
Confidence 999999999999999999999999999998877665543
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=306.49 Aligned_cols=249 Identities=31% Similarity=0.525 Sum_probs=207.7
Q ss_pred cccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEe--------
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE-------- 111 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-------- 111 (320)
.+|.+.+.||+|++|.||++.+. ++.+|+|.+.... ..+.+|+++++.++|+||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 47999999999999999999986 8899999886532 356689999999999999999998754
Q ss_pred --------CCceEEEEecCCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCC
Q 020888 112 --------RKPLMLITEYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD 181 (320)
Q Consensus 112 --------~~~~~iv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~ 181 (320)
....++||||+++++|.+++... ..+++..++.++.|++.||.|||+.| ++|+||||+||++ +.++
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~--~~~~ 159 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK--LINRDLKPSNIFL--VDTK 159 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--EETT
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHEEE--cCCC
Confidence 45589999999999999999754 57999999999999999999999998 9999999999999 7788
Q ss_pred cEEEecCCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 020888 182 HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA 261 (320)
Q Consensus 182 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~ 261 (320)
.++|+|||++....... ......+++.|+|||.+.+..++.++|+||||+++|+|++|..|+... ......+.
T Consensus 160 ~~kl~Dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~ 232 (284)
T 2a19_B 160 QVKIGDFGLVTSLKNDG-----KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--SKFFTDLR 232 (284)
T ss_dssp EEEECCCTTCEESSCCS-----CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHH
T ss_pred CEEECcchhheeccccc-----cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhh
Confidence 99999999988765432 122346899999999999999999999999999999999999886432 22233333
Q ss_pred hCCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcCCCC
Q 020888 262 EGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPTD 312 (320)
Q Consensus 262 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~ 312 (320)
... .+..++.++++++.+||..||.+|||+.+++++|..+..+....
T Consensus 233 ~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~~ 279 (284)
T 2a19_B 233 DGI----ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKN 279 (284)
T ss_dssp TTC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-----
T ss_pred ccc----ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCcc
Confidence 322 23457999999999999999999999999999999988765543
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=312.89 Aligned_cols=262 Identities=29% Similarity=0.540 Sum_probs=213.6
Q ss_pred CCCcccCccceecccCceEEEEEEE------CCCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeC
Q 020888 39 PSELDFSSSAIIGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER 112 (320)
Q Consensus 39 ~~~~~y~~~~~lg~g~~~~vy~~~~------~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 112 (320)
....+|.+.+.||+|++|.||++.. +++.||+|.+... .....+.+.+|+++++.++|+||+++++++...
T Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 114 (326)
T 2w1i_A 38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 114 (326)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC---CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-
T ss_pred cCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec
Confidence 3466899999999999999999984 3788999988653 233457899999999999999999999988654
Q ss_pred --CceEEEEecCCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCC
Q 020888 113 --KPLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFG 189 (320)
Q Consensus 113 --~~~~iv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg 189 (320)
...++||||+++++|.+++... ..+++..++.++.|++.||.+||+.| ++|+||||+||++ +.++.++|+|||
T Consensus 115 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli--~~~~~~kL~Dfg 190 (326)
T 2w1i_A 115 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILV--ENENRVKIGDFG 190 (326)
T ss_dssp ---CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEE--EETTEEEECCCT
T ss_pred CCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEE--cCCCcEEEecCc
Confidence 3789999999999999999875 46999999999999999999999998 9999999999999 778899999999
Q ss_pred CcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH---------------
Q 020888 190 LSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPY--------------- 254 (320)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~--------------- 254 (320)
++......... ........++..|+|||.+.+..++.++||||||+++++|++|..||......
T Consensus 191 ~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (326)
T 2w1i_A 191 LTKVLPQDKEY-YKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 269 (326)
T ss_dssp TCEECCSSCSE-EECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHH
T ss_pred chhhccccccc-cccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhH
Confidence 99876543211 11122345677899999999888999999999999999999999887632110
Q ss_pred -HHHHHHHhCCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcC
Q 020888 255 -EAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETL 309 (320)
Q Consensus 255 -~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 309 (320)
.....+..... ...+..+++++.+++.+||+.||.+|||+.++++.|+++.+++
T Consensus 270 ~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l 324 (326)
T 2w1i_A 270 FHLIELLKNNGR-LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM 324 (326)
T ss_dssp HHHHHHHHTTCC-CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHhhcCCC-CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 11222222222 2334568999999999999999999999999999999998765
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=313.34 Aligned_cols=250 Identities=23% Similarity=0.316 Sum_probs=207.7
Q ss_pred CCCCcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCC-----CCcccceeeeEE
Q 020888 38 DPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-----HPNIVQFLGAVT 110 (320)
Q Consensus 38 ~~~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-----h~~i~~~~~~~~ 110 (320)
..-..+|.+.+.||+|+||+||++.+. ++.||+|++... .........|+++++.+. |+||+++++++.
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~ 106 (360)
T 3llt_A 31 MLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI----KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFM 106 (360)
T ss_dssp CEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEE
T ss_pred eEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc----hhhhhhhHHHHHHHHHhcccCCCCCCeecccceee
Confidence 334568999999999999999999984 788999988532 233467788999999996 999999999999
Q ss_pred eCCceEEEEecCCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEee-----------
Q 020888 111 ERKPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN----------- 177 (320)
Q Consensus 111 ~~~~~~iv~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~----------- 177 (320)
..+..++|||++ +++|.+++.... .+++..++.++.||+.||.|||+.| |+|+||||+||++..
T Consensus 107 ~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~~~~~~~~ 183 (360)
T 3llt_A 107 YYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS--LTHTDLKPENILLDDPYFEKSLITVR 183 (360)
T ss_dssp ETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCTTCCEEEEEEE
T ss_pred ECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCcccEEEccccccccccchh
Confidence 999999999999 889999998754 5999999999999999999999999 999999999999932
Q ss_pred ------------CCCCcEEEecCCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCC
Q 020888 178 ------------SSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGE 245 (320)
Q Consensus 178 ------------~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~ 245 (320)
..++.++|+|||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++|.
T Consensus 184 ~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~ 256 (360)
T 3llt_A 184 RVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-------HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGS 256 (360)
T ss_dssp CTTTCCEEEEEEESCCCEEECCCTTCEETTSC-------CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSS
T ss_pred cccccccccccccCCCCEEEEeccCceecCCC-------CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCC
Confidence 13778999999999754322 23456899999999999999999999999999999999999
Q ss_pred CCCCCCChHHHHHHHHhCCCCCCC--------------------------------------------CCCCCHHHHHHH
Q 020888 246 PPLANYEPYEAAKYVAEGHRPFFR--------------------------------------------AKGFTPELRELT 281 (320)
Q Consensus 246 ~p~~~~~~~~~~~~~~~~~~~~~~--------------------------------------------~~~~~~~l~~li 281 (320)
.||...+..+....+.....+... ....++.+.+||
T Consensus 257 ~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 336 (360)
T 3llt_A 257 LLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFL 336 (360)
T ss_dssp CSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHH
T ss_pred CCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHH
Confidence 999988776665544432211110 001237788999
Q ss_pred HHHhhcCCCCCCCHHHHHHH
Q 020888 282 EKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 282 ~~~l~~dp~~Rps~~~ll~~ 301 (320)
.+||+.||.+|||+++++++
T Consensus 337 ~~~L~~dP~~Rpta~elL~h 356 (360)
T 3llt_A 337 YSILQIDPTLRPSPAELLKH 356 (360)
T ss_dssp HHHCCSSGGGSCCHHHHTTS
T ss_pred HHHhcCChhhCCCHHHHhcC
Confidence 99999999999999999864
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=305.59 Aligned_cols=269 Identities=20% Similarity=0.293 Sum_probs=210.7
Q ss_pred CcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeE-EeCCceEE
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAV-TERKPLML 117 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~i 117 (320)
..+|.+.+.||+|+||+||++.+. ++.||+|++...... ..+.+|+++++.++|++++..+..+ ..++..++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C-----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc-----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEE
Confidence 357999999999999999999974 788999986543322 3577899999999887777666555 67778899
Q ss_pred EEecCCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE-eeCCCCcEEEecCCCccccc
Q 020888 118 ITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLL-VNSSADHLKVGDFGLSKLIK 195 (320)
Q Consensus 118 v~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~-~~~~~~~~~L~dfg~~~~~~ 195 (320)
||||+ +++|.+++.. ...+++..++.++.|++.||.|||++| ++|+||||+||++ ..+.++.++|+|||++....
T Consensus 83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 83 VMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp EEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence 99999 8899999985 457999999999999999999999999 9999999999999 23356789999999998765
Q ss_pred ccCccce---eeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHhC---CCC
Q 020888 196 VQNSHDV---YKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPY---EAAKYVAEG---HRP 266 (320)
Q Consensus 196 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~---~~~~~~~~~---~~~ 266 (320)
....... .......+++.|+|||.+.+..++.++||||||+++|+|++|..||...... .....+... ...
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T 4hgt_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 239 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh
Confidence 5432211 1223457899999999999999999999999999999999999999764321 111111111 111
Q ss_pred CCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcCCC----CCcccc
Q 020888 267 FFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPT----DHHWNI 317 (320)
Q Consensus 267 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~----~~~~~~ 317 (320)
......+++++++++.+||+.||++|||+.++++.|+++..+... +.+|+.
T Consensus 240 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~~~~~dw~~ 294 (296)
T 4hgt_A 240 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNM 294 (296)
T ss_dssp HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCTTCCCGGGG
T ss_pred hhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCccCccchhh
Confidence 111245799999999999999999999999999999999987653 345543
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-44 Score=314.43 Aligned_cols=250 Identities=21% Similarity=0.371 Sum_probs=210.5
Q ss_pred cccCcc-ceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCC-CCcccceeeeEEeCCceEE
Q 020888 42 LDFSSS-AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLML 117 (320)
Q Consensus 42 ~~y~~~-~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~i 117 (320)
.+|.+. +.||+|+||+||++.+. ++.||+|++........ ....+.+|+.+++.+. |+||+++++++...+..++
T Consensus 28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~l 106 (327)
T 3lm5_A 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQD-CRAEILHEIAVLELAKSCPRVINLHEVYENTSEIIL 106 (327)
T ss_dssp HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEE-CHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchH-HHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEE
Confidence 467776 89999999999999986 88999998866543332 2367888999999995 7999999999999999999
Q ss_pred EEecCCCCCHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCC---CCcEEEecCCCcc
Q 020888 118 ITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS---ADHLKVGDFGLSK 192 (320)
Q Consensus 118 v~e~~~~~~L~~~~~~--~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~---~~~~~L~dfg~~~ 192 (320)
||||+++++|.+++.. ...+++..++.++.|++.||.|||++| ++|+||||+||++ +. ++.++|+|||++.
T Consensus 107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g--ivH~Dikp~NIl~--~~~~~~~~~kL~Dfg~a~ 182 (327)
T 3lm5_A 107 ILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN--IVHLDLKPQNILL--SSIYPLGDIKIVDFGMSR 182 (327)
T ss_dssp EEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEE--SCBTTBCCEEECCGGGCE
T ss_pred EEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCChHHEEE--ecCCCCCcEEEeeCcccc
Confidence 9999999999999854 357999999999999999999999999 9999999999999 55 6899999999998
Q ss_pred cccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCC--CC
Q 020888 193 LIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFF--RA 270 (320)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~--~~ 270 (320)
...... ......+++.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+........ ..
T Consensus 183 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 257 (327)
T 3lm5_A 183 KIGHAC-----ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETF 257 (327)
T ss_dssp EC--------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTT
T ss_pred ccCCcc-----ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhh
Confidence 664332 12335689999999999999999999999999999999999999999888777666665543322 22
Q ss_pred CCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 271 KGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 271 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
..+++.++++|.+||..||.+|||+++++++
T Consensus 258 ~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 258 SSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred cccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 4689999999999999999999999999876
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=328.84 Aligned_cols=250 Identities=14% Similarity=0.228 Sum_probs=198.0
Q ss_pred CCCcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHH---HHHHhCCCCccccee-------
Q 020888 39 PSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEV---NLLVKLRHPNIVQFL------- 106 (320)
Q Consensus 39 ~~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~---~~l~~l~h~~i~~~~------- 106 (320)
....+|.+.+.||+|+||+||++.+. ++.||+|++...........+.+.+|+ +.++.++||||++++
T Consensus 70 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~ 149 (377)
T 3byv_A 70 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 149 (377)
T ss_dssp CCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCS
T ss_pred CCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhh
Confidence 33568999999999999999999964 889999998765444445568899999 455555799999988
Q ss_pred eeEEeCC-----------------ceEEEEecCCCCCHHHHHHHhCCCCH-------HHHHHHHHHHHHHHHHHhcCCCC
Q 020888 107 GAVTERK-----------------PLMLITEYLRGGDLHKYLKEKGALSP-------STAVNFALDIARGMAYLHNEPNV 162 (320)
Q Consensus 107 ~~~~~~~-----------------~~~iv~e~~~~~~L~~~~~~~~~l~~-------~~~~~i~~~l~~~l~~lH~~g~~ 162 (320)
+++...+ ..|+||||+ +|+|.+++...+.+++ ..++.++.|++.||+|||++|
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-- 226 (377)
T 3byv_A 150 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG-- 226 (377)
T ss_dssp EEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred hhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC--
Confidence 6665543 389999999 5699999987554555 888899999999999999999
Q ss_pred eEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCccceeeccCCcccccccCccccCcC-----------CCCCchhH
Q 020888 163 IIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR-----------KYDKKVDV 231 (320)
Q Consensus 163 ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----------~~~~~~Di 231 (320)
|+|+||||+||++ +.++.++|+|||++..... ......| +.|+|||++.+. .++.++||
T Consensus 227 ivHrDikp~NIll--~~~~~~kL~DFG~a~~~~~-------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Dv 296 (377)
T 3byv_A 227 LVHTYLRPVDIVL--DQRGGVFLTGFEHLVRDGA-------RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDA 296 (377)
T ss_dssp EECSCCCGGGEEE--CTTCCEEECCGGGCEETTC-------EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHH
T ss_pred eecCCCCHHHEEE--cCCCCEEEEechhheecCC-------cccCCCC-cCccChhhhcccccccccccccccCChhhhH
Confidence 9999999999999 8889999999999875322 2233456 899999999887 89999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH--HHHHHh
Q 020888 232 FSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR--LEKIKE 307 (320)
Q Consensus 232 ~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--L~~~~~ 307 (320)
||||+++|+|++|..||...........+.. ....+++++++++.+||+.||++|||+.+++++ ++.+.+
T Consensus 297 wSlG~il~elltg~~Pf~~~~~~~~~~~~~~------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~ 368 (377)
T 3byv_A 297 WALGLVIYWIWCADLPITKDAALGGSEWIFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRT 368 (377)
T ss_dssp HHHHHHHHHHHHSSCCC------CCSGGGGS------SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHHH
T ss_pred HHHHHHHHHHHHCCCCCcccccccchhhhhh------hccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHHH
Confidence 9999999999999999976543322221111 124589999999999999999999999999874 444443
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=313.10 Aligned_cols=255 Identities=27% Similarity=0.506 Sum_probs=195.0
Q ss_pred CcccCccceecccCceEEEEEEE--CCCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEE
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 118 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~--~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 118 (320)
..+|.+.+.||+|++|.||++.+ +++.||+|.+..... ......+.+|+.++++++|+||+++++++...+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 56899999999999999999987 478999998854432 22346788899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHH--------hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCC
Q 020888 119 TEYLRGGDLHKYLKE--------KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGL 190 (320)
Q Consensus 119 ~e~~~~~~L~~~~~~--------~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~ 190 (320)
|||+++++|.+++.. .+.+++..++.++.|++.||.|||+.| ++|+||+|+||++ +.++.++|+|||.
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~--~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG--QIHRDVKAGNILL--GEDGSVQIADFGV 167 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEE--CTTCCEEECCCHH
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCCChhhEEE--cCCCCEEEEeccc
Confidence 999999999999874 345899999999999999999999998 9999999999999 8889999999999
Q ss_pred cccccccCccc-eeeccCCcccccccCccccCc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCC
Q 020888 191 SKLIKVQNSHD-VYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFF 268 (320)
Q Consensus 191 ~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 268 (320)
+.......... ........+++.|+|||.+.+ ..++.++||||||+++|+|++|..||....................
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 247 (303)
T 2vwi_A 168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSL 247 (303)
T ss_dssp HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCT
T ss_pred hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCcc
Confidence 87665432111 111233468999999999876 5689999999999999999999999998776665554444432221
Q ss_pred --------CCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 269 --------RAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 269 --------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
....++.++++++.+||..||.+|||+.+++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 248 ETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp TC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 124578999999999999999999999999985
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=320.19 Aligned_cols=255 Identities=24% Similarity=0.361 Sum_probs=199.7
Q ss_pred CcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeC-----C
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER-----K 113 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~ 113 (320)
..+|.+.+.||+|+||.||++.+. ++.||+|.+..... .....+.+.+|+++++.++|+||+++++++... .
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFE-DLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTT-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhc-ChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 348999999999999999999986 67899998876543 334457889999999999999999999998765 5
Q ss_pred ceEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccc
Q 020888 114 PLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 193 (320)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~ 193 (320)
..|+|||+++ ++|.+++.....+++..++.++.||+.||.|||+.| |+||||||+||++ +.++.++|+|||++..
T Consensus 104 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g--ivHrDlkp~NILl--~~~~~~kL~DFGla~~ 178 (432)
T 3n9x_A 104 ELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESG--IIHRDLKPANCLL--NQDCSVKVCDFGLART 178 (432)
T ss_dssp CEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEE--CTTCCEEECCCTTCEE
T ss_pred eEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCHHHeEE--CCCCCEEEccCCCccc
Confidence 6899999995 599999998778999999999999999999999999 9999999999999 8889999999999987
Q ss_pred ccccCccce------------------eeccCCcccccccCcccc-CcCCCCCchhHHHHHHHHHHHHhCCCCC------
Q 020888 194 IKVQNSHDV------------------YKMTGETGSYRYMAPEVF-KHRKYDKKVDVFSFAMILYEMLEGEPPL------ 248 (320)
Q Consensus 194 ~~~~~~~~~------------------~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~~ll~g~~p~------ 248 (320)
......... .......+|+.|+|||++ .+..++.++|||||||++|+|++|..||
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~ 258 (432)
T 3n9x_A 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTN 258 (432)
T ss_dssp C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGG
T ss_pred ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccc
Confidence 654321100 123456789999999986 5667999999999999999999854443
Q ss_pred -----CCCCh-----------------HH------------------------HHHHHHhCCCCCCC-----CCCCCHHH
Q 020888 249 -----ANYEP-----------------YE------------------------AAKYVAEGHRPFFR-----AKGFTPEL 277 (320)
Q Consensus 249 -----~~~~~-----------------~~------------------------~~~~~~~~~~~~~~-----~~~~~~~l 277 (320)
.+.+. .+ ....+......... ...+++++
T Consensus 259 ~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 338 (432)
T 3n9x_A 259 RFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDG 338 (432)
T ss_dssp CCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHH
T ss_pred ccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHH
Confidence 22210 00 11111111100000 13479999
Q ss_pred HHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 278 RELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 278 ~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
.+||.+||..||.+|||+++++++
T Consensus 339 ~dLl~~mL~~dP~~R~ta~e~L~H 362 (432)
T 3n9x_A 339 INLLESMLKFNPNKRITIDQALDH 362 (432)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHHTC
T ss_pred HHHHHHHhcCCcccCCCHHHHhcC
Confidence 999999999999999999999987
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-44 Score=328.12 Aligned_cols=247 Identities=26% Similarity=0.344 Sum_probs=199.8
Q ss_pred cccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeC------C
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER------K 113 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~ 113 (320)
.+|.+++.||+|+||+||++.+. ++.||+|.+..... .....+.+.+|+++++.++|+||+++++++... .
T Consensus 62 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGG-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECcccc-ChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 57999999999999999999886 78899998865432 334457888999999999999999999998654 3
Q ss_pred ceEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccc
Q 020888 114 PLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 193 (320)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~ 193 (320)
..|+||||+++ +|.+.+.. .+++..+..++.||+.||.|||++| |+||||||+||++ +.++.++|+|||++..
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDlkp~NIll--~~~~~~kl~DFG~a~~ 213 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVV--KSDCTLKILDFGLART 213 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE--CTTSCEEECCCCCC--
T ss_pred eEEEEEeCCCC-CHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChHhEEE--eCCCCEEEEEEEeeee
Confidence 46999999966 67777653 5899999999999999999999999 9999999999999 8889999999999986
Q ss_pred ccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCC------
Q 020888 194 IKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPF------ 267 (320)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~------ 267 (320)
..... ......+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+.+....+
T Consensus 214 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~ 288 (464)
T 3ttj_A 214 AGTSF-----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 288 (464)
T ss_dssp ---CC-----CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred cCCCc-----ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 54322 2334578999999999999999999999999999999999999999887666555443321100
Q ss_pred ---------------CCC--------C-----------CCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 268 ---------------FRA--------K-----------GFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 268 ---------------~~~--------~-----------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
... . ..++++++||.+||..||.+|||++++++|
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 289 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp TSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000 0 014679999999999999999999999987
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=320.29 Aligned_cols=251 Identities=23% Similarity=0.399 Sum_probs=212.6
Q ss_pred CcccCccceecccCceEEEEEEECCCceEEEEccCCCCCcH--------------HHHHHHHHHHHHHHhCCCCccccee
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDR--------------LVIQDFRHEVNLLVKLRHPNIVQFL 106 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~K~~~~~~~~~~--------------~~~~~~~~e~~~l~~l~h~~i~~~~ 106 (320)
..+|.+.+.||+|+||.||++.++++.||+|.+........ ...+.+.+|+++++.++|+||++++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 109 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE 109 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCS
T ss_pred cCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEE
Confidence 35899999999999999999999999999998864322211 1126788999999999999999999
Q ss_pred eeEEeCCceEEEEecCCCCCHHHH------HHH--hCCCCHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCcEEEee
Q 020888 107 GAVTERKPLMLITEYLRGGDLHKY------LKE--KGALSPSTAVNFALDIARGMAYLHN-EPNVIIHRDLKPRNVLLVN 177 (320)
Q Consensus 107 ~~~~~~~~~~iv~e~~~~~~L~~~------~~~--~~~l~~~~~~~i~~~l~~~l~~lH~-~g~~ivH~di~p~nI~~~~ 177 (320)
+++...+..++||||+++++|.++ +.. ...+++..++.++.|++.||.|||+ .| ++|+||+|+||++
T Consensus 110 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dl~p~Nil~-- 185 (348)
T 2pml_X 110 GIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILM-- 185 (348)
T ss_dssp EEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC--EECCCCCGGGEEE--
T ss_pred EEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC--EeecCCChHhEEE--
Confidence 999999999999999999999998 655 5679999999999999999999999 89 9999999999999
Q ss_pred CCCCcEEEecCCCcccccccCccceeeccCCcccccccCccccCcC-CCCC-chhHHHHHHHHHHHHhCCCCCCCCCh-H
Q 020888 178 SSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR-KYDK-KVDVFSFAMILYEMLEGEPPLANYEP-Y 254 (320)
Q Consensus 178 ~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~-~~Di~slG~~l~~ll~g~~p~~~~~~-~ 254 (320)
+.++.++|+|||.+...... ......+++.|+|||++.+. .++. ++||||||+++++|++|..||..... .
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 259 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK------KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV 259 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT------EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH
T ss_pred cCCCcEEEeccccccccccc------cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH
Confidence 88899999999999765432 23345689999999999887 5665 99999999999999999999988766 5
Q ss_pred HHHHHHHhCCCCCCCC-----------------CCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 255 EAAKYVAEGHRPFFRA-----------------KGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 255 ~~~~~~~~~~~~~~~~-----------------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
+....+.......... ..++.++.+++.+||..||.+|||+++++++
T Consensus 260 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 260 ELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp HHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 5555555443322211 4589999999999999999999999999875
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=315.73 Aligned_cols=255 Identities=27% Similarity=0.385 Sum_probs=203.4
Q ss_pred CCCCcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcH--HHHHHHHHHHHHHHhCCCCcccceeeeEEeCC
Q 020888 38 DPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDR--LVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK 113 (320)
Q Consensus 38 ~~~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 113 (320)
.....+|.+.+.||+|+||.||++.+. ++.||+|.+........ .....+.+|+++++.++|+||+++++++...+
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (346)
T 1ua2_A 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS 85 (346)
T ss_dssp -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence 334568999999999999999999985 78899998865432221 11246778999999999999999999999999
Q ss_pred ceEEEEecCCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcc
Q 020888 114 PLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 192 (320)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~ 192 (320)
..++||||+++ +|.+++... ..+++..+..++.|++.||.|||+.| ++|+||||+||++ +.++.++|+|||++.
T Consensus 86 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~--~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 86 NISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLL--DENGVLKLADFGLAK 160 (346)
T ss_dssp CCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE--CTTCCEEECCCGGGS
T ss_pred ceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCCHHHEEE--cCCCCEEEEecccce
Confidence 99999999976 899888764 36899999999999999999999999 9999999999999 888999999999998
Q ss_pred cccccCccceeeccCCcccccccCccccCcC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCC---
Q 020888 193 LIKVQNSHDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFF--- 268 (320)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~--- 268 (320)
....... ......+|+.|+|||++.+. .++.++||||||+++|+|++|..||...+..+....+........
T Consensus 161 ~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~ 236 (346)
T 1ua2_A 161 SFGSPNR----AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQ 236 (346)
T ss_dssp TTTSCCC----CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred eccCCcc----cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhh
Confidence 6643321 22345689999999998764 588999999999999999999999998887766655543210000
Q ss_pred -----------------------CCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 269 -----------------------RAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 269 -----------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
....++++++++|.+||..||.+|||+++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 237 WPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp SSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 013457899999999999999999999999986
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=325.69 Aligned_cols=252 Identities=27% Similarity=0.432 Sum_probs=198.2
Q ss_pred cccCccceecccCceEEEEEEEC--CCceEEEEccCCCCC-----cHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCc
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSD-----DRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP 114 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 114 (320)
.+|.+.+.||+|+||+||++.+. ++.||+|++...... .......+.+|++++++++||||+++++++..+ .
T Consensus 135 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~ 213 (419)
T 3i6u_A 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE-D 213 (419)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEESS-E
T ss_pred ccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEecC-c
Confidence 47999999999999999999986 689999988654221 112224578899999999999999999998644 5
Q ss_pred eEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEee-CCCCcEEEecCCCccc
Q 020888 115 LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN-SSADHLKVGDFGLSKL 193 (320)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~-~~~~~~~L~dfg~~~~ 193 (320)
.++||||+++++|.+++...+.+++..++.++.|++.||.|||++| |+|+||||+||++.. +.+..++|+|||++..
T Consensus 214 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~ 291 (419)
T 3i6u_A 214 YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 291 (419)
T ss_dssp EEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSSSCCEEECCSSTTTS
T ss_pred eEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCCCcceEEEeeccccee
Confidence 7999999999999999988788999999999999999999999998 999999999999932 1233599999999986
Q ss_pred ccccCccceeeccCCcccccccCccccCc---CCCCCchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHhCCCCCCC
Q 020888 194 IKVQNSHDVYKMTGETGSYRYMAPEVFKH---RKYDKKVDVFSFAMILYEMLEGEPPLANYEPY-EAAKYVAEGHRPFFR 269 (320)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~-~~~~~~~~~~~~~~~ 269 (320)
..... ......+|+.|+|||++.+ ..++.++||||||+++|+|++|..||...... .....+..+......
T Consensus 292 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~ 366 (419)
T 3i6u_A 292 LGETS-----LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP 366 (419)
T ss_dssp CC----------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCH
T ss_pred cCCCc-----cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCc
Confidence 64322 2234568999999999864 56788999999999999999999999865433 333444444333221
Q ss_pred --CCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 270 --AKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 270 --~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
...+++++.+++.+||..||.+|||+++++++
T Consensus 367 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 367 EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 14579999999999999999999999999875
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-43 Score=304.33 Aligned_cols=251 Identities=22% Similarity=0.391 Sum_probs=208.9
Q ss_pred cccCccceecccCceEEEEEEEC--CCceEEEEccCCCCC-cHHHHHHHHHHHHHHHhCCCCcccceeeeE--EeCCceE
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSD-DRLVIQDFRHEVNLLVKLRHPNIVQFLGAV--TERKPLM 116 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~~ 116 (320)
.+|.+.+.||+|+||.||++.+. ++.+++|++...... .......+.+|+++++.++|+||+++++++ ......+
T Consensus 5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (305)
T 2wtk_C 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMY 84 (305)
T ss_dssp CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEE
T ss_pred cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEE
Confidence 47999999999999999999985 788999988643211 112347789999999999999999999998 4566889
Q ss_pred EEEecCCCCCHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccc
Q 020888 117 LITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 194 (320)
Q Consensus 117 iv~e~~~~~~L~~~~~~--~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~ 194 (320)
+||||++++ |.+++.. ...+++..++.++.|++.||.|||++| ++|+||||+||++ +.++.++|+|||.+...
T Consensus 85 lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~NIl~--~~~~~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 85 MVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG--IVHKDIKPGNLLL--TTGGTLKISALGVAEAL 159 (305)
T ss_dssp EEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--CTTCCEEECCCTTCEEC
T ss_pred EEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEE--cCCCcEEeecccccccc
Confidence 999999774 8888775 356999999999999999999999998 9999999999999 88899999999999866
Q ss_pred cccCccceeeccCCcccccccCccccCcCCC--CCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCC
Q 020888 195 KVQNSHDVYKMTGETGSYRYMAPEVFKHRKY--DKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKG 272 (320)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (320)
....... ......+++.|+|||++.+... +.++||||||+++|+|++|..||......+....+...... .+..
T Consensus 160 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~--~~~~ 235 (305)
T 2wtk_C 160 HPFAADD--TCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYA--IPGD 235 (305)
T ss_dssp CTTCSSC--EECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCC--CCSS
T ss_pred Ccccccc--ccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCC--CCCc
Confidence 4322211 2234568999999999986543 77999999999999999999999998887777777666533 2345
Q ss_pred CCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 273 FTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 273 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
+++++.+++.+||..||.+|||+++++++
T Consensus 236 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 236 CGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred cCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 79999999999999999999999999987
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-44 Score=314.72 Aligned_cols=261 Identities=28% Similarity=0.432 Sum_probs=199.3
Q ss_pred CcccCccceecccCceEEEEEEECCCceEEEEccCCCCCcHHHHHHHHHHHHH--HHhCCCCcccceeeeEE-----eCC
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNL--LVKLRHPNIVQFLGAVT-----ERK 113 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~--l~~l~h~~i~~~~~~~~-----~~~ 113 (320)
..+|.+.+.||+|+||.||++.++++.||+|++.... ...+..|.++ +..++|+||+++++.+. ...
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 85 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFAN------RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRM 85 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCE
T ss_pred hHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccc------hhhHHHHHHHHHHHhccCcchhhheecccccccCCCc
Confidence 4589999999999999999999999999999885432 1333334444 44578999999998553 233
Q ss_pred ceEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcC---------CCCeEecCCCCCcEEEeeCCCCcEE
Q 020888 114 PLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE---------PNVIIHRDLKPRNVLLVNSSADHLK 184 (320)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~---------g~~ivH~di~p~nI~~~~~~~~~~~ 184 (320)
.+++||||+++++|.++++.. ..++..++.++.|++.||.|||+. | |+|+||||+||++ +.++.++
T Consensus 86 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~--ivH~Dikp~Nill--~~~~~~k 160 (336)
T 3g2f_A 86 EYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA--ISHRDLNSRNVLV--KNDGTCV 160 (336)
T ss_dssp EEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC--EECSSCSGGGEEE--CTTSCEE
T ss_pred eEEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccc--eeecccccceEEE--cCCCcEE
Confidence 578999999999999999765 468999999999999999999998 8 9999999999999 8889999
Q ss_pred EecCCCcccccccCcc----ceeeccCCcccccccCccccCc-------CCCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 020888 185 VGDFGLSKLIKVQNSH----DVYKMTGETGSYRYMAPEVFKH-------RKYDKKVDVFSFAMILYEMLEGEPPLANYEP 253 (320)
Q Consensus 185 L~dfg~~~~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~ 253 (320)
|+|||++..+...... .........+|+.|+|||++.+ ..++.++||||||+++|+|++|..||.....
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 240 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence 9999999876543211 1112234568999999999987 3556789999999999999999777633211
Q ss_pred ------------------HHHHHHHHhCCCCCCCCCC------CCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcC
Q 020888 254 ------------------YEAAKYVAEGHRPFFRAKG------FTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETL 309 (320)
Q Consensus 254 ------------------~~~~~~~~~~~~~~~~~~~------~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 309 (320)
.+..............+.. ++++++++|.+||..||++|||+.++++.|+++....
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~ 320 (336)
T 3g2f_A 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIW 320 (336)
T ss_dssp CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCC
T ss_pred hhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHH
Confidence 1111112222222111211 3457999999999999999999999999999999876
Q ss_pred CCC
Q 020888 310 PTD 312 (320)
Q Consensus 310 ~~~ 312 (320)
...
T Consensus 321 ~~~ 323 (336)
T 3g2f_A 321 ERN 323 (336)
T ss_dssp CC-
T ss_pred Hhc
Confidence 654
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=314.47 Aligned_cols=247 Identities=26% Similarity=0.351 Sum_probs=198.6
Q ss_pred cccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCC------
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK------ 113 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------ 113 (320)
.+|.+.+.||+|+||+||++.+. ++.||+|.+..... .......+.+|+.+++.++|+||+++++++...+
T Consensus 25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccC-ChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 48999999999999999999885 78899998865443 3344577889999999999999999999987654
Q ss_pred ceEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccc
Q 020888 114 PLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 193 (320)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~ 193 (320)
..|+||||+++ +|.+.+. ..+++..+..++.|++.||.|||++| ++|+||||+||++ +.++.++|+|||++..
T Consensus 104 ~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIl~--~~~~~~kl~Dfg~a~~ 176 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVV--KSDCTLKILDFGLART 176 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE--CTTSCEEECCCCC---
T ss_pred ceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEE--cCCCCEEEEEeecccc
Confidence 68999999965 8988886 35899999999999999999999998 9999999999999 8889999999999976
Q ss_pred ccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCC----
Q 020888 194 IKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR---- 269 (320)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~---- 269 (320)
..... ......+|+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+......+..
T Consensus 177 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 251 (371)
T 2xrw_A 177 AGTSF-----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK 251 (371)
T ss_dssp ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHT
T ss_pred ccccc-----ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 54321 223356899999999999999999999999999999999999999988876666555443211100
Q ss_pred ------------------------------C------CCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 270 ------------------------------A------KGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 270 ------------------------------~------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
+ ...+.++++||.+||..||.+|||+++++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 252 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp TSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 0 0015679999999999999999999999987
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=315.60 Aligned_cols=253 Identities=23% Similarity=0.386 Sum_probs=203.4
Q ss_pred CCCCcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEe----
Q 020888 38 DPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE---- 111 (320)
Q Consensus 38 ~~~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---- 111 (320)
+....+|.+.+.||+|+||+||++.+. ++.||+|.+...... ..+|+++++.++|+||+++++++..
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-------~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 75 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-------KNRELDIMKVLDHVNIIKLVDYFYTTGDE 75 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS-------CCHHHHHHTTCCCTTBCCEEEEEEEC---
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch-------HHHHHHHHHHcCCCCccchhheeeecCcc
Confidence 345678999999999999999999884 789999988654322 2369999999999999999998843
Q ss_pred ----------------------------------CCceEEEEecCCCCCHHHHHH----HhCCCCHHHHHHHHHHHHHHH
Q 020888 112 ----------------------------------RKPLMLITEYLRGGDLHKYLK----EKGALSPSTAVNFALDIARGM 153 (320)
Q Consensus 112 ----------------------------------~~~~~iv~e~~~~~~L~~~~~----~~~~l~~~~~~~i~~~l~~~l 153 (320)
....++||||+++ +|.+.+. ....+++..++.++.||+.||
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL 154 (383)
T 3eb0_A 76 EPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAV 154 (383)
T ss_dssp ----------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHH
Confidence 3348899999975 8777665 356799999999999999999
Q ss_pred HHHhcCCCCeEecCCCCCcEEEeeC-CCCcEEEecCCCcccccccCccceeeccCCcccccccCccccCcC-CCCCchhH
Q 020888 154 AYLHNEPNVIIHRDLKPRNVLLVNS-SADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDV 231 (320)
Q Consensus 154 ~~lH~~g~~ivH~di~p~nI~~~~~-~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di 231 (320)
.|||+.| |+|+||||+||++ + .++.++|+|||++....... ......+++.|+|||++.+. .++.++||
T Consensus 155 ~~LH~~g--i~H~Dikp~Nil~--~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di 225 (383)
T 3eb0_A 155 GFIHSLG--ICHRDIKPQNLLV--NSKDNTLKLCDFGSAKKLIPSE-----PSVAYICSRFYRAPELMLGATEYTPSIDL 225 (383)
T ss_dssp HHHHTTT--EECSCCCGGGEEE--ETTTTEEEECCCTTCEECCTTS-----CCCCCCCCSSCCCHHHHTTCSSCCTHHHH
T ss_pred HHHHHCc--CccCccCHHHEEE--cCCCCcEEEEECCCCcccCCCC-----CCcCcccCCCccCHHHhcCCCCCCcchhh
Confidence 9999999 9999999999999 5 57899999999998664432 12335678999999998775 48999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCC-------------------CCC--------CCCCCCHHHHHHHHHH
Q 020888 232 FSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHR-------------------PFF--------RAKGFTPELRELTEKC 284 (320)
Q Consensus 232 ~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~-------------------~~~--------~~~~~~~~l~~li~~~ 284 (320)
|||||++|+|++|..||...+..+....+.+... +.. .+..+++++.+++.+|
T Consensus 226 wslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 305 (383)
T 3eb0_A 226 WSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQI 305 (383)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHH
T ss_pred hhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHH
Confidence 9999999999999999998877766555443100 000 1234789999999999
Q ss_pred hhcCCCCCCCHHHHHHH--HHHHHh
Q 020888 285 WAADMNQRPSFLDILKR--LEKIKE 307 (320)
Q Consensus 285 l~~dp~~Rps~~~ll~~--L~~~~~ 307 (320)
|..||.+|||+.+++++ ++.+..
T Consensus 306 L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (383)
T 3eb0_A 306 LRYEPDLRINPYEAMAHPFFDHLRN 330 (383)
T ss_dssp CCSSGGGSCCHHHHHTSGGGHHHHH
T ss_pred ccCChhhCCCHHHHhcCHHHHHHHh
Confidence 99999999999999976 555544
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=312.30 Aligned_cols=250 Identities=29% Similarity=0.451 Sum_probs=201.4
Q ss_pred cccCccceecccCceEEEEEEEC--CCceEEEEccCCCCC-----cHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCc
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSD-----DRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP 114 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 114 (320)
.+|.+.+.||+|+||.||++.+. ++.||+|++...... .......+.+|+++++.++|+||+++++++..+.
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED- 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence 47999999999999999999985 688999988654321 1222346889999999999999999999987655
Q ss_pred eEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCC---cEEEecCCCc
Q 020888 115 LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD---HLKVGDFGLS 191 (320)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~---~~~L~dfg~~ 191 (320)
.++||||+++++|.+++.....+++..++.++.|++.||.|||++| ++|+||||+||++ +.++ .++|+|||++
T Consensus 89 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~NIl~--~~~~~~~~~kl~Dfg~~ 164 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLL--SSQEEDCLIKITDFGHS 164 (322)
T ss_dssp EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--SSSSSSCCEEECCCTTC
T ss_pred eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEE--ecCCCCCeEEEccCccc
Confidence 8999999999999999988788999999999999999999999998 9999999999999 5444 4999999998
Q ss_pred ccccccCccceeeccCCcccccccCccccC---cCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHhCCCCC
Q 020888 192 KLIKVQNSHDVYKMTGETGSYRYMAPEVFK---HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPY-EAAKYVAEGHRPF 267 (320)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~-~~~~~~~~~~~~~ 267 (320)
....... ......+++.|+|||++. +..++.++||||||+++|+|++|..||...... .....+..+....
T Consensus 165 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 239 (322)
T 2ycf_A 165 KILGETS-----LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF 239 (322)
T ss_dssp EECCCCH-----HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCC
T ss_pred eeccccc-----ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCcccc
Confidence 7654321 112345789999999973 567889999999999999999999999765432 3333344443322
Q ss_pred CC--CCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 268 FR--AKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 268 ~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
.. ...++.++.+++.+||..||.+|||+++++++
T Consensus 240 ~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 240 IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 11 24579999999999999999999999999853
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-43 Score=302.82 Aligned_cols=247 Identities=30% Similarity=0.453 Sum_probs=201.1
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEe
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 120 (320)
+|....+||+|+||+||++.+. ++.||+|.+..... ...+.+.+|+.+++.++|+||+++++++...+..++|||
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 99 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS---RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFME 99 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC------HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCch---HHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEE
Confidence 4555569999999999999985 77899998865432 233678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCC-CCcEEEecCCCcccccc
Q 020888 121 YLRGGDLHKYLKEKG---ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS-ADHLKVGDFGLSKLIKV 196 (320)
Q Consensus 121 ~~~~~~L~~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~-~~~~~L~dfg~~~~~~~ 196 (320)
|+++++|.+++.... .+++..++.++.|++.||.|||+.| ++|+||+|+||++ +. ++.++|+|||.+.....
T Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~--~~~~~~~kl~Dfg~~~~~~~ 175 (295)
T 2clq_A 100 QVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLI--NTYSGVLKISDFGTSKRLAG 175 (295)
T ss_dssp CCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--ETTTCCEEECCTTTCEESCC
T ss_pred eCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC--EEccCCChhhEEE--ECCCCCEEEeecccccccCC
Confidence 999999999998642 4678999999999999999999998 9999999999999 55 78999999999876543
Q ss_pred cCccceeeccCCcccccccCccccCcCC--CCCchhHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHhCCCCCCCCCC
Q 020888 197 QNSHDVYKMTGETGSYRYMAPEVFKHRK--YDKKVDVFSFAMILYEMLEGEPPLANYEPYEA--AKYVAEGHRPFFRAKG 272 (320)
Q Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~ 272 (320)
... ......+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||........ ......... ...+..
T Consensus 176 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~ 250 (295)
T 2clq_A 176 INP----CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVH-PEIPES 250 (295)
T ss_dssp ---------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCC-CCCCTT
T ss_pred CCC----cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcccccc-cccccc
Confidence 211 123346899999999987653 78999999999999999999999976543322 122222222 233456
Q ss_pred CCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 273 FTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 273 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
+++++.+++.+||..||++|||+++++++
T Consensus 251 ~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 251 MSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp SCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 89999999999999999999999999875
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=314.78 Aligned_cols=252 Identities=24% Similarity=0.401 Sum_probs=207.7
Q ss_pred CcccCccceecccCceEEEEEEE-----CCCceEEEEccCCCCC-cHHHHHHHHHHHHHHHhC-CCCcccceeeeEEeCC
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYW-----RGTPVAIKRILPSLSD-DRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERK 113 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~-----~~~~~~~K~~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 113 (320)
..+|.+.+.||+|+||+||++.+ +++.||+|++...... .....+.+.+|+++++.+ +|+||+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 45899999999999999999997 4788999988643211 111124566789999999 6999999999999999
Q ss_pred ceEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccc
Q 020888 114 PLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 193 (320)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~ 193 (320)
..++||||+++++|.+++.....+++..++.++.|++.||.|||++| |+|+||||+||++ +.++.++|+|||++..
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll--~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILL--DSNGHVVLTDFGLSKE 208 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE--CTTSCEEESCSSEEEE
T ss_pred eEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEE--CCCCcEEEeeCCCCee
Confidence 99999999999999999998888999999999999999999999998 9999999999999 8889999999999876
Q ss_pred ccccCccceeeccCCcccccccCccccCcC--CCCCchhHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHhCCCCC
Q 020888 194 IKVQNSHDVYKMTGETGSYRYMAPEVFKHR--KYDKKVDVFSFAMILYEMLEGEPPLANYE----PYEAAKYVAEGHRPF 267 (320)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~ll~g~~p~~~~~----~~~~~~~~~~~~~~~ 267 (320)
....... ......+|+.|+|||++.+. .++.++||||||+++|+|++|..||.... .......+......
T Consensus 209 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~- 284 (355)
T 1vzo_A 209 FVADETE---RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP- 284 (355)
T ss_dssp CCGGGGG---GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCC-
T ss_pred cccCCCC---cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCC-
Confidence 5432211 12234689999999999863 47899999999999999999999997432 33333444433322
Q ss_pred CCCCCCCHHHHHHHHHHhhcCCCCCC-----CHHHHHHH
Q 020888 268 FRAKGFTPELRELTEKCWAADMNQRP-----SFLDILKR 301 (320)
Q Consensus 268 ~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~ 301 (320)
.+..++..++++|.+||..||.+|| |+++++++
T Consensus 285 -~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 285 -YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp -CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred -CCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 2345899999999999999999999 99999886
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=315.21 Aligned_cols=246 Identities=27% Similarity=0.446 Sum_probs=189.6
Q ss_pred cccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeC------C
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER------K 113 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~ 113 (320)
.+|.+.+.||+|+||.||++.+. ++.||+|.+...... ....+.+.+|+++++.++|+||+++++++... .
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS-IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSS-HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 58999999999999999999875 788999988654433 34457888999999999999999999998643 5
Q ss_pred ceEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccc
Q 020888 114 PLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 193 (320)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~ 193 (320)
..|+++|++ +++|.+++.. ..+++..+..++.||+.||.|||+.| ++|+||||+||++ +.++.++|+|||++..
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll--~~~~~~kL~DFG~a~~ 181 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAV--NEDCELKILDFGLARH 181 (367)
T ss_dssp CCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE--CTTCCEEECC------
T ss_pred eEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHhhEEE--CCCCCEEEeecccccc
Confidence 679999999 6799999876 57999999999999999999999999 9999999999999 8889999999999876
Q ss_pred ccccCccceeeccCCcccccccCccccCc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCC--------
Q 020888 194 IKVQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH-------- 264 (320)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~-------- 264 (320)
.... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|..||...+..+....+.+..
T Consensus 182 ~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~ 254 (367)
T 2fst_X 182 TADE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 254 (367)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred cccc-------CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 5422 233568999999999887 678999999999999999999999999887665544433210
Q ss_pred ---------------CCCC------CCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 265 ---------------RPFF------RAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 265 ---------------~~~~------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
.... .....++++.+||.+||..||.+|||+++++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 255 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp TTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 0000 012468899999999999999999999999986
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=305.66 Aligned_cols=243 Identities=21% Similarity=0.383 Sum_probs=199.3
Q ss_pred CcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCC-CCcccceeeeEEe--CCce
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTE--RKPL 115 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~ 115 (320)
..+|++.+.||+|+||+||++.+. ++.||+|++.... .+.+.+|+++++.++ |+||+++++++.. ....
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~ 108 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 108 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCce
Confidence 457999999999999999999875 7899999885321 267889999999997 9999999999987 6778
Q ss_pred EEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCC-cEEEecCCCcccc
Q 020888 116 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD-HLKVGDFGLSKLI 194 (320)
Q Consensus 116 ~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~-~~~L~dfg~~~~~ 194 (320)
++||||+++++|.++++ .+++..+..++.|++.||.|||++| ++|+||||+||++ +.++ .++|+|||++...
T Consensus 109 ~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~--~~~~~~~kl~Dfg~a~~~ 181 (330)
T 3nsz_A 109 ALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMI--DHEHRKLRLIDWGLAEFY 181 (330)
T ss_dssp EEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--ETTTTEEEECCCTTCEEC
T ss_pred EEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEE--cCCCCEEEEEeCCCceEc
Confidence 99999999999999885 3899999999999999999999999 9999999999999 6555 8999999999765
Q ss_pred cccCccceeeccCCcccccccCccccCc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChH-HHHH-------------H
Q 020888 195 KVQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPY-EAAK-------------Y 259 (320)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~-~~~~-------------~ 259 (320)
.... ......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||...... +... .
T Consensus 182 ~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 256 (330)
T 3nsz_A 182 HPGQ-----EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY 256 (330)
T ss_dssp CTTC-----CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHH
T ss_pred CCCC-----ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhH
Confidence 4432 1234568889999999987 67899999999999999999999999544321 1111 1
Q ss_pred HHhCCC----------------------CCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 260 VAEGHR----------------------PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 260 ~~~~~~----------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
+..... .......++++++++|.+||+.||.+|||+++++++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 257 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp HHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 111110 011112278999999999999999999999999986
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=319.97 Aligned_cols=260 Identities=23% Similarity=0.361 Sum_probs=210.2
Q ss_pred CCcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCC--ce
Q 020888 40 SELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK--PL 115 (320)
Q Consensus 40 ~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~ 115 (320)
...+|.+.+.||+|+||+||++.+. ++.||+|++....... ..+.+.+|+++++.++|+||+++++++...+ ..
T Consensus 7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 84 (396)
T 4eut_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (396)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS--CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccc--hHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCee
Confidence 4568999999999999999999986 7899999986543222 2367788999999999999999999988655 67
Q ss_pred EEEEecCCCCCHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEee--CCCCcEEEecCCC
Q 020888 116 MLITEYLRGGDLHKYLKEKG---ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN--SSADHLKVGDFGL 190 (320)
Q Consensus 116 ~iv~e~~~~~~L~~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~--~~~~~~~L~dfg~ 190 (320)
++||||+++++|.+++.... .+++..++.++.|++.||.|||+.| |+|+||||+||++.. +.++.++|+|||+
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~ 162 (396)
T 4eut_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (396)
T ss_dssp EEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred EEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence 99999999999999997533 3999999999999999999999999 999999999999733 3445699999999
Q ss_pred cccccccCccceeeccCCcccccccCccccCc--------CCCCCchhHHHHHHHHHHHHhCCCCCCCC----ChHHHHH
Q 020888 191 SKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH--------RKYDKKVDVFSFAMILYEMLEGEPPLANY----EPYEAAK 258 (320)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~~ll~g~~p~~~~----~~~~~~~ 258 (320)
+....... ......+++.|+|||++.+ ..++.++||||||+++|+|++|..||... ...+...
T Consensus 163 a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~ 237 (396)
T 4eut_A 163 ARELEDDE-----QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237 (396)
T ss_dssp CEECCCGG-----GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHH
T ss_pred ceEccCCC-----ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHH
Confidence 98664432 1234568999999999865 45778999999999999999999999643 2334444
Q ss_pred HHHhCCCCCC-----------------------CCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhc
Q 020888 259 YVAEGHRPFF-----------------------RAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKET 308 (320)
Q Consensus 259 ~~~~~~~~~~-----------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 308 (320)
.+..+..... ....++..+.+++..||+.||++|||+.++++.+..+...
T Consensus 238 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp HHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred HHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 4444432211 0122456789999999999999999999999999988764
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=329.97 Aligned_cols=257 Identities=30% Similarity=0.561 Sum_probs=216.8
Q ss_pred CcccCccceecccCceEEEEEEEC-----CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCce
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL 115 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~-----~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 115 (320)
..+|.+.+.||+|+||+||++.+. +..+|+|.+... ......+.+.+|+.++++++||||+++++++. ++..
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 465 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 465 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST--TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCce
Confidence 457889999999999999999874 345888877543 23444578899999999999999999999985 4568
Q ss_pred EEEEecCCCCCHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccc
Q 020888 116 MLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 194 (320)
Q Consensus 116 ~iv~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~ 194 (320)
++||||+++++|.++++..+ .+++..++.++.|++.||.|||++| |+|+||||+||++ +.++.++|+|||++...
T Consensus 466 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDikp~NILl--~~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 466 WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLV--SSNDCVKLGDFGLSRYM 541 (656)
T ss_dssp EEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE--EETTEEEECCCCCCCSC
T ss_pred EEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchHhEEE--eCCCCEEEEecCCCeec
Confidence 99999999999999998654 6899999999999999999999998 9999999999999 77889999999999876
Q ss_pred cccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCC
Q 020888 195 KVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGF 273 (320)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (320)
..... .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||......+....+..+..... +..+
T Consensus 542 ~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~ 617 (656)
T 2j0j_A 542 EDSTY---YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM-PPNC 617 (656)
T ss_dssp CC-------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCC-CTTC
T ss_pred CCCcc---eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCC-Cccc
Confidence 43321 12223456788999999999999999999999999999997 9999999888888777777665443 3458
Q ss_pred CHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhc
Q 020888 274 TPELRELTEKCWAADMNQRPSFLDILKRLEKIKET 308 (320)
Q Consensus 274 ~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 308 (320)
++++.+++.+||..||.+|||+.++++.|+++.+.
T Consensus 618 ~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 618 PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 99999999999999999999999999999998754
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=309.73 Aligned_cols=257 Identities=19% Similarity=0.247 Sum_probs=209.8
Q ss_pred CCCCCcccCccceecccCceEEEEEE-----E--CCCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCC---CCccccee
Q 020888 37 IDPSELDFSSSAIIGKGSFGEILKAY-----W--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR---HPNIVQFL 106 (320)
Q Consensus 37 ~~~~~~~y~~~~~lg~g~~~~vy~~~-----~--~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~ 106 (320)
+.....+|.+.+.||+|+||+||++. + .++.||+|++.... ...+..|++++..+. |+++++++
T Consensus 60 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~l~~~~~~~iv~~~ 133 (365)
T 3e7e_A 60 FQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------PWEFYIGTQLMERLKPSMQHMFMKFY 133 (365)
T ss_dssp EECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC------HHHHHHHHHHHHHSCGGGGGGBCCEE
T ss_pred EEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------hhHHHHHHHHHHHhhhhhhhhhhhhh
Confidence 34456789999999999999999993 2 37899999886432 246677888888886 89999999
Q ss_pred eeEEeCCceEEEEecCCCCCHHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCC--
Q 020888 107 GAVTERKPLMLITEYLRGGDLHKYLKE-----KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS-- 179 (320)
Q Consensus 107 ~~~~~~~~~~iv~e~~~~~~L~~~~~~-----~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~-- 179 (320)
+.+...+..++||||+++++|.+++.. ...+++..++.++.|++.||+|||++| |+||||||+||++ +.
T Consensus 134 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--ivHrDiKp~NIll--~~~~ 209 (365)
T 3e7e_A 134 SAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE--IIHGDIKPDNFIL--GNGF 209 (365)
T ss_dssp EEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEE--CGGG
T ss_pred eeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEe--cccc
Confidence 999999999999999999999999974 456999999999999999999999998 9999999999999 55
Q ss_pred ---------CCcEEEecCCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 020888 180 ---------ADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLAN 250 (320)
Q Consensus 180 ---------~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~ 250 (320)
++.++|+|||++..+..... ........||+.|+|||++.+..++.++||||||+++|+|++|..||..
T Consensus 210 ~~~~~~~~~~~~~kl~DFG~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 287 (365)
T 3e7e_A 210 LEQDDEDDLSAGLALIDLGQSIDMKLFPK--GTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVK 287 (365)
T ss_dssp TCC------CTTEEECCCTTCEEGGGSCT--TEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEE
T ss_pred cCccccccccCCEEEeeCchhhhhhccCC--CceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCcccc
Confidence 78999999999976543221 1233456799999999999999999999999999999999999999864
Q ss_pred CChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHhhcCCCCC-CCHHHHHHHHHHHHhcCCC
Q 020888 251 YEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQR-PSFLDILKRLEKIKETLPT 311 (320)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R-ps~~~ll~~L~~~~~~~~~ 311 (320)
...... ...........++.+.+++..||+.+|.+| |+++++.+.|+++......
T Consensus 288 ~~~~~~------~~~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~~~ 343 (365)
T 3e7e_A 288 NEGGEC------KPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYT 343 (365)
T ss_dssp EETTEE------EECSCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHHTT
T ss_pred CCCCce------eechhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHhhh
Confidence 432110 001111112247889999999999999999 6888999999888776443
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=317.62 Aligned_cols=264 Identities=21% Similarity=0.281 Sum_probs=213.3
Q ss_pred CcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCC-CcccceeeeEEeCCceEE
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH-PNIVQFLGAVTERKPLML 117 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~i 117 (320)
..+|.+.+.||+|+||.||++.+. ++.||+|++...... ..+.+|+++++.+.| +++..+..++...+..++
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~l 80 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVL 80 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEE
Confidence 358999999999999999999975 889999987554332 356789999999976 566666667778888999
Q ss_pred EEecCCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEe-eCCCCcEEEecCCCccccc
Q 020888 118 ITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLV-NSSADHLKVGDFGLSKLIK 195 (320)
Q Consensus 118 v~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~-~~~~~~~~L~dfg~~~~~~ 195 (320)
||||+ +++|.+++.. ...+++..++.++.||+.||.|||++| |+|+||||+||++. .+.++.++|+|||++....
T Consensus 81 vme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 99999 8899999985 457999999999999999999999999 99999999999993 2366789999999998776
Q ss_pred ccCccc---eeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHhCC---CC
Q 020888 196 VQNSHD---VYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEP---YEAAKYVAEGH---RP 266 (320)
Q Consensus 196 ~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~---~~~~~~~~~~~---~~ 266 (320)
...... ........+++.|+|||++.+..++.++|||||||++|+|++|..||..... ......+.... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI 237 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH
Confidence 543221 1122356789999999999999999999999999999999999999987543 22222222111 11
Q ss_pred CCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcCCCC
Q 020888 267 FFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPTD 312 (320)
Q Consensus 267 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~ 312 (320)
......+++++.+++..||..||++||++.+|++.|+.+......+
T Consensus 238 ~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~ 283 (483)
T 3sv0_A 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQ 283 (483)
T ss_dssp HHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred HHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCC
Confidence 1112457999999999999999999999999999999998876544
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=308.50 Aligned_cols=247 Identities=27% Similarity=0.431 Sum_probs=196.4
Q ss_pred CCCCCcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcH---HHHHHHHHHHHHHHhC----CCCcccceee
Q 020888 37 IDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDR---LVIQDFRHEVNLLVKL----RHPNIVQFLG 107 (320)
Q Consensus 37 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~---~~~~~~~~e~~~l~~l----~h~~i~~~~~ 107 (320)
.+.-..+|.+.+.||+|+||.||++.+. ++.||+|++........ .....+.+|+.++.++ +|+||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 4445668999999999999999999874 78899999866543321 1223456788888888 8999999999
Q ss_pred eEEeCCceEEEEec-CCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeC-CCCcEEE
Q 020888 108 AVTERKPLMLITEY-LRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS-SADHLKV 185 (320)
Q Consensus 108 ~~~~~~~~~iv~e~-~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~-~~~~~~L 185 (320)
++...+..++|+|+ +++++|.+++...+.+++..++.++.|++.||.|||+.| ++|+||||+||++ + .++.++|
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~--~~~~~~~kl 181 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRG--VVHRDIKDENILI--DLRRGCAKL 181 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT--EECCCCSGGGEEE--ETTTTEEEE
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChhhEEE--eCCCCeEEE
Confidence 99998999999999 788999999998888999999999999999999999998 9999999999999 6 7789999
Q ss_pred ecCCCcccccccCccceeeccCCcccccccCccccCcCCCC-CchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCC
Q 020888 186 GDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYD-KKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH 264 (320)
Q Consensus 186 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~ 264 (320)
+|||++....... .....+++.|+|||++.+..+. .++||||||+++|++++|..||..... +....
T Consensus 182 ~dfg~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~ 249 (312)
T 2iwi_A 182 IDFGSGALLHDEP------YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------ILEAE 249 (312)
T ss_dssp CCCSSCEECCSSC------BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHTC
T ss_pred EEcchhhhcccCc------ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH------Hhhhc
Confidence 9999987664322 2335689999999998877664 589999999999999999999975321 12222
Q ss_pred CCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 265 RPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 265 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
. ..+..++.++++++.+||..||++|||+++++++
T Consensus 250 ~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 250 L--HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp C--CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred c--CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1 1234589999999999999999999999999985
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=310.95 Aligned_cols=245 Identities=26% Similarity=0.432 Sum_probs=203.0
Q ss_pred cccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCce----
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL---- 115 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~---- 115 (320)
.+|.+.+.||+|+||+||++.+. ++.||+|.+...... ....+.+.+|+.+++.++|+||+++++++...+..
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQS-EIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSS-HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccc-hhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 48999999999999999999986 789999988765433 34457888999999999999999999999876654
Q ss_pred --EEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccc
Q 020888 116 --MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 193 (320)
Q Consensus 116 --~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~ 193 (320)
++||||++ ++|.+++. ..+++..+..++.|++.||.|||+.| |+|+||||+||++ +.++.++|+|||++..
T Consensus 121 ~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll--~~~~~~kL~Dfg~a~~ 193 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAV--NEDCELKILDFGLARH 193 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE--CTTCCEEECSTTCC--
T ss_pred eEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCcCHHHeEE--CCCCCEEEEecCcccc
Confidence 99999996 58888874 35899999999999999999999998 9999999999999 8889999999999975
Q ss_pred ccccCccceeeccCCcccccccCccccCc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCC-----
Q 020888 194 IKVQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPF----- 267 (320)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~----- 267 (320)
.... .....+|+.|+|||++.+ ..++.++||||||+++|+|++|..||...+..+....+.......
T Consensus 194 ~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 266 (371)
T 4exu_A 194 ADAE-------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFV 266 (371)
T ss_dssp -------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred cccC-------cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHH
Confidence 5322 234567999999999987 678999999999999999999999999887666554443211000
Q ss_pred ------------------C------CCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 268 ------------------F------RAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 268 ------------------~------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
. ....++++++++|.+||+.||.+|||+++++++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 267 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp TTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 0 013468999999999999999999999999987
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=304.73 Aligned_cols=253 Identities=27% Similarity=0.416 Sum_probs=204.6
Q ss_pred CcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeC-----C
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER-----K 113 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~ 113 (320)
..+|.+.+.||+|+||.||++.+. ++.||+|.+... ........+.+|+++++.++|+||+++++++..+ .
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 87 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF--DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN 87 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc--ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence 458999999999999999999986 788999988543 3344456788999999999999999999987654 6
Q ss_pred ceEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccc
Q 020888 114 PLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 193 (320)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~ 193 (320)
..++|+||++ ++|.+++.. +.+++..++.++.|++.||.|||++| ++|+||||+||++ +.++.++|+|||++..
T Consensus 88 ~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~Nil~--~~~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 88 EVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSN--VIHRDLKPSNLLI--NSNCDLKVCDFGLARI 161 (353)
T ss_dssp CEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEE--CTTCCEEECCCTTCEE
T ss_pred eEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEE--cCCCcEEEEecccccc
Confidence 7899999996 499999886 47999999999999999999999998 9999999999999 8889999999999987
Q ss_pred ccccCccce------eeccCCcccccccCccccCc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhC---
Q 020888 194 IKVQNSHDV------YKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEG--- 263 (320)
Q Consensus 194 ~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~--- 263 (320)
......... .......+++.|+|||++.+ ..++.++||||||+++|+|++|..||...+..+....+...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (353)
T 2b9h_A 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT 241 (353)
T ss_dssp CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Confidence 654322111 11223468999999998754 67899999999999999999999999887755444333211
Q ss_pred ---------------------CCCCC------CCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 264 ---------------------HRPFF------RAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 264 ---------------------~~~~~------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
..... ....++++++++|.+||..||.+|||+++++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp CCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00000 013578999999999999999999999999986
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=303.82 Aligned_cols=253 Identities=27% Similarity=0.437 Sum_probs=205.3
Q ss_pred CCCCcccCccceecccCceEEEEEEEC---CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhC---CCCcccceeeeEE-
Q 020888 38 DPSELDFSSSAIIGKGSFGEILKAYWR---GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL---RHPNIVQFLGAVT- 110 (320)
Q Consensus 38 ~~~~~~y~~~~~lg~g~~~~vy~~~~~---~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~- 110 (320)
.....+|.+.+.||+|+||.||++.+. ++.||+|.+......... ...+.+|+.+++.+ +|+||+++++++.
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~ 85 (326)
T 1blx_A 7 CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM-PLSTIREVAVLRHLETFEHPNVVRLFDVCTV 85 (326)
T ss_dssp CCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSC-BCTHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred cCchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccC-CchhhHHHHHHHhhhccCCCCeEeeeeeeee
Confidence 345578999999999999999999983 678999988644322111 12344566666555 8999999999986
Q ss_pred ----eCCceEEEEecCCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEE
Q 020888 111 ----ERKPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLK 184 (320)
Q Consensus 111 ----~~~~~~iv~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~ 184 (320)
.....++||||++ ++|.+++.... .+++..++.++.|++.||.|||+.| ++|+||||+||++ +.++.++
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g--i~H~dlkp~Nili--~~~~~~k 160 (326)
T 1blx_A 86 SRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILV--TSSGQIK 160 (326)
T ss_dssp EECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE--CTTCCEE
T ss_pred cccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHHHeEE--cCCCCEE
Confidence 5567899999997 59999998743 4899999999999999999999999 9999999999999 8889999
Q ss_pred EecCCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCC
Q 020888 185 VGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH 264 (320)
Q Consensus 185 L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~ 264 (320)
|+|||++....... ......+++.|+|||++.+..++.++||||||+++|+|++|..||......+....+....
T Consensus 161 l~Dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~ 235 (326)
T 1blx_A 161 LADFGLARIYSFQM-----ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 235 (326)
T ss_dssp ECSCCSCCCCCGGG-----GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred EecCcccccccCCC-----CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHc
Confidence 99999987654322 2234568999999999999999999999999999999999999999888776655554311
Q ss_pred CC-------------------------CCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 265 RP-------------------------FFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 265 ~~-------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
.. ......++.++++++.+||..||.+|||+.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 236 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp CCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00 00124578999999999999999999999999975
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=313.56 Aligned_cols=245 Identities=28% Similarity=0.359 Sum_probs=203.2
Q ss_pred CcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhC------CCCcccceeeeEEeC
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL------RHPNIVQFLGAVTER 112 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~~ 112 (320)
..+|.+.+.||+|+||+||++.+. ++.||+|++... ......+.+|+++++.+ +|+||+++++.+...
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 171 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE----KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR 171 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc----cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC
Confidence 457999999999999999999886 688999988543 23336677788888777 477999999999999
Q ss_pred CceEEEEecCCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCc--EEEecC
Q 020888 113 KPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH--LKVGDF 188 (320)
Q Consensus 113 ~~~~iv~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~--~~L~df 188 (320)
+..++|||+++ ++|.+++.... .+++..++.++.||+.||.|||+.| |+|+||||+||++ +.++. ++|+||
T Consensus 172 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NILl--~~~~~~~vkL~DF 246 (429)
T 3kvw_A 172 NHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR--IIHCDLKPENILL--KQQGRSGIKVIDF 246 (429)
T ss_dssp TEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT--EECSCCSGGGEEE--SSTTSCCEEECCC
T ss_pred CeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEE--ccCCCcceEEeec
Confidence 99999999995 59999998643 4899999999999999999999998 9999999999999 66665 999999
Q ss_pred CCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCC
Q 020888 189 GLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFF 268 (320)
Q Consensus 189 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 268 (320)
|++...... .....+|+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+......+.
T Consensus 247 G~a~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~ 319 (429)
T 3kvw_A 247 GSSCYEHQR-------VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPS 319 (429)
T ss_dssp TTCEETTCC-------CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred ccceecCCc-------ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 998654321 2335689999999999999999999999999999999999999998877665544442110000
Q ss_pred ---------------------------------------------------------CCCCCCHHHHHHHHHHhhcCCCC
Q 020888 269 ---------------------------------------------------------RAKGFTPELRELTEKCWAADMNQ 291 (320)
Q Consensus 269 ---------------------------------------------------------~~~~~~~~l~~li~~~l~~dp~~ 291 (320)
.....++++.+||.+||+.||.+
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~ 399 (429)
T 3kvw_A 320 QKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAV 399 (429)
T ss_dssp HHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTT
T ss_pred HHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhh
Confidence 00123788999999999999999
Q ss_pred CCCHHHHHHH
Q 020888 292 RPSFLDILKR 301 (320)
Q Consensus 292 Rps~~~ll~~ 301 (320)
|||+++++++
T Consensus 400 Rpta~e~L~H 409 (429)
T 3kvw_A 400 RMTPGQALRH 409 (429)
T ss_dssp SCCHHHHHTS
T ss_pred CCCHHHHhCC
Confidence 9999999986
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=310.33 Aligned_cols=253 Identities=26% Similarity=0.408 Sum_probs=200.8
Q ss_pred CCCcccCccceecccCceEEEEEEEC-CCceEEEEccCCCCC--------cHHHHHHHHHHHHHHHhCCCCcccceeeeE
Q 020888 39 PSELDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSD--------DRLVIQDFRHEVNLLVKLRHPNIVQFLGAV 109 (320)
Q Consensus 39 ~~~~~y~~~~~lg~g~~~~vy~~~~~-~~~~~~K~~~~~~~~--------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 109 (320)
....+|.+.+.||+|+||.||++.+. ++.||+|.+...... .....+.+.+|+++++.++|+||+++++++
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 98 (362)
T 3pg1_A 19 AMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIF 98 (362)
T ss_dssp HTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred HhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeE
Confidence 34568999999999999999999876 788999988554332 233347889999999999999999999998
Q ss_pred Ee-----CCceEEEEecCCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcE
Q 020888 110 TE-----RKPLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHL 183 (320)
Q Consensus 110 ~~-----~~~~~iv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~ 183 (320)
.. ....++||||++| +|.+++... ..+++..++.++.|++.||.|||++| ++|+||||+||++ +.++.+
T Consensus 99 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~--~~~~~~ 173 (362)
T 3pg1_A 99 VHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG--VVHRDLHPGNILL--ADNNDI 173 (362)
T ss_dssp EECCTTTCCEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE--CTTCCE
T ss_pred EeccCCCcceEEEEEccCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCc--CEecCCChHHEEE--cCCCCE
Confidence 43 3357999999974 888888754 46999999999999999999999998 9999999999999 888999
Q ss_pred EEecCCCcccccccCccceeeccCCcccccccCccccCc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh
Q 020888 184 KVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAE 262 (320)
Q Consensus 184 ~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~ 262 (320)
+|+|||++....... ......+++.|+|||++.+ ..++.++||||||+++|+|++|..||......+....+..
T Consensus 174 kl~Dfg~~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~ 248 (362)
T 3pg1_A 174 TICDFNLAREDTADA-----NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVE 248 (362)
T ss_dssp EECCTTC--------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred EEEecCccccccccc-----ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 999999997543322 1233467899999999887 6789999999999999999999999998876665554432
Q ss_pred CCC-----------------------CCC-------CCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 263 GHR-----------------------PFF-------RAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 263 ~~~-----------------------~~~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
... ... ....+++.+.++|.+||..||.+|||+.+++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 249 VVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 110 000 113468899999999999999999999999986
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=304.14 Aligned_cols=251 Identities=25% Similarity=0.424 Sum_probs=199.0
Q ss_pred CcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEE--------
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVT-------- 110 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-------- 110 (320)
..+|.+.+.||+|++|.||++.+. ++.||+|.+... .....+.+.+|+++++.++|+||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 86 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT---DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTD 86 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC---SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC---ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccc
Confidence 358999999999999999999986 788999988543 3445578899999999999999999998873
Q ss_pred ------eCCceEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeC-CCCcE
Q 020888 111 ------ERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS-SADHL 183 (320)
Q Consensus 111 ------~~~~~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~-~~~~~ 183 (320)
.....++||||++ ++|.++++. +++++..++.++.|++.||.|||++| ++|+||||+||++ + .++.+
T Consensus 87 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~--~~~~~~~ 160 (320)
T 2i6l_A 87 DVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANLFI--NTEDLVL 160 (320)
T ss_dssp ----CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEE--ETTTTEE
T ss_pred ccccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEE--cCCCCeE
Confidence 3467899999997 499999875 57899999999999999999999999 9999999999999 5 45689
Q ss_pred EEecCCCcccccccCccceeeccCCcccccccCccccCc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh
Q 020888 184 KVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAE 262 (320)
Q Consensus 184 ~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~ 262 (320)
+|+|||++......... ........+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||......+....+..
T Consensus 161 kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 239 (320)
T 2i6l_A 161 KIGDFGLARIMDPHYSH-KGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILE 239 (320)
T ss_dssp EECCCTTCBCC---------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred EEccCccccccCCCccc-ccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 99999999866432111 111223456889999998865 6789999999999999999999999998876665544443
Q ss_pred CCCCC----------------------------CCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 263 GHRPF----------------------------FRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 263 ~~~~~----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
..... .....++.++++++.+||+.||.+|||+++++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 240 SIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp HSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred hcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 22110 0113579999999999999999999999999986
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=306.05 Aligned_cols=245 Identities=25% Similarity=0.429 Sum_probs=202.1
Q ss_pred cccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCc-----
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP----- 114 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----- 114 (320)
.+|.+.+.||+|+||.||++.+. ++.||+|.+..... .....+.+.+|+.+++.++|+||+++++++.....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ-SEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 47999999999999999999985 78999998866443 33445788899999999999999999999976654
Q ss_pred -eEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccc
Q 020888 115 -LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 193 (320)
Q Consensus 115 -~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~ 193 (320)
.++||||++ ++|.+++.. .+++..++.++.|++.||.|||++| ++|+||||+||++ +.++.++|+|||++..
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~NIl~--~~~~~~kl~Dfg~~~~ 175 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAV--NEDCELKILDFGLARH 175 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEE--CTTCCEEECSTTCTTC
T ss_pred eEEEEecccc-CCHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEeE--CCCCcEEEeecccccC
Confidence 499999996 489887753 5899999999999999999999998 9999999999999 8889999999999876
Q ss_pred ccccCccceeeccCCcccccccCccccCc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhC---------
Q 020888 194 IKVQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEG--------- 263 (320)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~--------- 263 (320)
.... .....+++.|+|||++.+ ..++.++||||||+++|+|++|..||...+..+....+...
T Consensus 176 ~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 248 (353)
T 3coi_A 176 ADAE-------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFV 248 (353)
T ss_dssp ---------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHH
T ss_pred CCCC-------ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 4322 223467999999999887 67899999999999999999999999987766554443321
Q ss_pred --------------C------CCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 264 --------------H------RPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 264 --------------~------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
. ........++++++++|.+||..||.+|||+++++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 249 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp TTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0 0011123578999999999999999999999999986
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=304.26 Aligned_cols=247 Identities=24% Similarity=0.361 Sum_probs=203.1
Q ss_pred CcccCccceecccCceEEEEEEE---CCCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCC------cccceeeeEEe
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYW---RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP------NIVQFLGAVTE 111 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~---~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~------~i~~~~~~~~~ 111 (320)
..+|.+.+.||+|+||+||++.+ +++.||+|++... ....+.+.+|+++++.++|+ +++++++++..
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~ 88 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV----DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH 88 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC----CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc
Confidence 35899999999999999999987 3778999988542 23347788899999888654 48999999999
Q ss_pred CCceEEEEecCCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCC----------
Q 020888 112 RKPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS---------- 179 (320)
Q Consensus 112 ~~~~~iv~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~---------- 179 (320)
.+..++||||+ +++|.+++...+ ++++..++.++.|++.||.|||++| ++|+||||+||++..+.
T Consensus 89 ~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~~~~~ 165 (339)
T 1z57_A 89 HGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYNPKIK 165 (339)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCCCEEEEEC----
T ss_pred CCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEeccccccccCCccc
Confidence 99999999999 779999998765 6899999999999999999999998 99999999999993222
Q ss_pred -------CCcEEEecCCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 020888 180 -------ADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYE 252 (320)
Q Consensus 180 -------~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~ 252 (320)
++.++|+|||++...... .....+|+.|+|||++.+..++.++||||||+++|++++|..||...+
T Consensus 166 ~~~~~~~~~~~kl~Dfg~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 238 (339)
T 1z57_A 166 RDERTLINPDIKVVDFGSATYDDEH-------HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD 238 (339)
T ss_dssp CEEEEESCCCEEECCCSSCEETTSC-------CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSC
T ss_pred cccccccCCCceEeeCcccccCccc-------cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 668999999998754322 223568999999999999999999999999999999999999999877
Q ss_pred hHHHHHHHHhCCCCC------------------------------------------CCCCCCCHHHHHHHHHHhhcCCC
Q 020888 253 PYEAAKYVAEGHRPF------------------------------------------FRAKGFTPELRELTEKCWAADMN 290 (320)
Q Consensus 253 ~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~l~~li~~~l~~dp~ 290 (320)
..+....+.....+. ......++++.++|.+||..||.
T Consensus 239 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 318 (339)
T 1z57_A 239 SKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPA 318 (339)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred hHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcc
Confidence 665544332211100 00112357899999999999999
Q ss_pred CCCCHHHHHHH
Q 020888 291 QRPSFLDILKR 301 (320)
Q Consensus 291 ~Rps~~~ll~~ 301 (320)
+|||+++++++
T Consensus 319 ~Rpt~~ell~h 329 (339)
T 1z57_A 319 KRITLREALKH 329 (339)
T ss_dssp TSCCHHHHTTS
T ss_pred cccCHHHHhcC
Confidence 99999999876
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=314.21 Aligned_cols=249 Identities=12% Similarity=0.133 Sum_probs=187.7
Q ss_pred CcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhC--CCCccccee-------eeE
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL--RHPNIVQFL-------GAV 109 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l--~h~~i~~~~-------~~~ 109 (320)
..+|.+.+.||+|+||.||++.+. ++.||+|++...........+.+.+|+++++.+ +|||+++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 456999999999999999999975 788999999877665556667888885544444 699988754 444
Q ss_pred EeC-----------------CceEEEEecCCCCCHHHHHHHh-CCCCHHHH------HHHHHHHHHHHHHHhcCCCCeEe
Q 020888 110 TER-----------------KPLMLITEYLRGGDLHKYLKEK-GALSPSTA------VNFALDIARGMAYLHNEPNVIIH 165 (320)
Q Consensus 110 ~~~-----------------~~~~iv~e~~~~~~L~~~~~~~-~~l~~~~~------~~i~~~l~~~l~~lH~~g~~ivH 165 (320)
... ...|+||||++ ++|.+++... ..+++... +.++.|++.||.|||++| |+|
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--ivH 217 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG--LVH 217 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT--EEE
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC--Ccc
Confidence 332 33799999997 7999999863 34566666 788899999999999999 999
Q ss_pred cCCCCCcEEEeeCCCCcEEEecCCCcccccccCccceeeccCCcccccccCccccCc--CCCCCchhHHHHHHHHHHHHh
Q 020888 166 RDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH--RKYDKKVDVFSFAMILYEMLE 243 (320)
Q Consensus 166 ~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~ll~ 243 (320)
+||||+||++ +.++.++|+|||++...... .....+++.|+|||++.+ ..++.++||||||+++|+|++
T Consensus 218 rDikp~NIll--~~~~~~kL~DFG~a~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ellt 288 (371)
T 3q60_A 218 GHFTPDNLFI--MPDGRLMLGDVSALWKVGTR-------GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC 288 (371)
T ss_dssp TTCSGGGEEE--CTTSCEEECCGGGEEETTCE-------EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHH
T ss_pred CcCCHHHEEE--CCCCCEEEEecceeeecCCC-------ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHh
Confidence 9999999999 88899999999999865321 113446699999999987 679999999999999999999
Q ss_pred CCCCCCCCChHHHHHH-----HH--hCCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 244 GEPPLANYEPYEAAKY-----VA--EGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 244 g~~p~~~~~~~~~~~~-----~~--~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
|..||........... .. ...........++++++++|.+||..||++|||+.+++++
T Consensus 289 g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 353 (371)
T 3q60_A 289 LFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353 (371)
T ss_dssp SSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred CCCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 9999987643211000 00 0011111124679999999999999999999999999864
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=308.97 Aligned_cols=266 Identities=27% Similarity=0.431 Sum_probs=205.3
Q ss_pred CCCCCCCCCCCCCCCCCCcCCCCCcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcH---HHHHHHHHHHH
Q 020888 18 SHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDR---LVIQDFRHEVN 92 (320)
Q Consensus 18 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~---~~~~~~~~e~~ 92 (320)
.++.|.+...+.........+.-..+|.+.+.||+|+||.||++.+. ++.||+|.+........ .....+.+|+.
T Consensus 19 ~~m~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~ 98 (320)
T 3a99_A 19 SHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 98 (320)
T ss_dssp ---------------------CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHH
T ss_pred ccchhHHHhhhhccCcccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHH
Confidence 33444433333332223344555678999999999999999999874 78899998865533221 11145667899
Q ss_pred HHHhCC--CCcccceeeeEEeCCceEEEEecCCC-CCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 020888 93 LLVKLR--HPNIVQFLGAVTERKPLMLITEYLRG-GDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLK 169 (320)
Q Consensus 93 ~l~~l~--h~~i~~~~~~~~~~~~~~iv~e~~~~-~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~ 169 (320)
+++++. |+||+++++++...+..++|+|++.+ ++|.+++...+.+++..++.++.|++.||.|||+.| ++|+|||
T Consensus 99 ~l~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlk 176 (320)
T 3a99_A 99 LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG--VLHRDIK 176 (320)
T ss_dssp HHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCS
T ss_pred HHHhhccCCCCceEEEEEEecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--cEeCCCC
Confidence 999996 59999999999999999999999975 799999998888999999999999999999999998 9999999
Q ss_pred CCcEEEeeC-CCCcEEEecCCCcccccccCccceeeccCCcccccccCccccCcCCC-CCchhHHHHHHHHHHHHhCCCC
Q 020888 170 PRNVLLVNS-SADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKY-DKKVDVFSFAMILYEMLEGEPP 247 (320)
Q Consensus 170 p~nI~~~~~-~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~ll~g~~p 247 (320)
|+||++ + .++.++|+|||++....... .....+++.|+|||++.+..+ +.++||||||+++|+|++|..|
T Consensus 177 p~NIll--~~~~~~~kL~Dfg~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~p 248 (320)
T 3a99_A 177 DENILI--DLNRGELKLIDFGSGALLKDTV------YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 248 (320)
T ss_dssp GGGEEE--ETTTTEEEECCCTTCEECCSSC------BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCS
T ss_pred HHHEEE--eCCCCCEEEeeCcccccccccc------ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCC
Confidence 999999 6 67899999999987664321 223468999999999987765 6889999999999999999999
Q ss_pred CCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 248 LANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
|..... +..... .....+++++.+++.+||..||.+|||+++++++
T Consensus 249 f~~~~~------~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 249 FEHDEE------IIRGQV--FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp CCSHHH------HHHCCC--CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCChhh------hhcccc--cccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 975321 222222 2235689999999999999999999999999875
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-42 Score=309.04 Aligned_cols=245 Identities=24% Similarity=0.386 Sum_probs=197.8
Q ss_pred CCcccCccceecccCceEEEEEEEC-CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCc----
Q 020888 40 SELDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP---- 114 (320)
Q Consensus 40 ~~~~y~~~~~lg~g~~~~vy~~~~~-~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---- 114 (320)
...+|.+.+.||+|+||+||++.+. +..+|+|.+...... ..+|+++++.++|+||+++++++...+.
T Consensus 38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~-------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~ 110 (394)
T 4e7w_A 38 REIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF-------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDE 110 (394)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS-------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSC
T ss_pred ccceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch-------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCc
Confidence 3458999999999999999999985 556888877544322 2358999999999999999999854333
Q ss_pred --eEEEEecCCCCCHHHHHH----HhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeC-CCCcEEEec
Q 020888 115 --LMLITEYLRGGDLHKYLK----EKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS-SADHLKVGD 187 (320)
Q Consensus 115 --~~iv~e~~~~~~L~~~~~----~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~-~~~~~~L~d 187 (320)
.++||||+++ ++.+.+. ....+++..++.++.|++.||.|||++| |+|+||||+||++ + .++.++|+|
T Consensus 111 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill--~~~~~~~kL~D 185 (394)
T 4e7w_A 111 VFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG--ICHRDIKPQNLLL--DPPSGVLKLID 185 (394)
T ss_dssp EEEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--ETTTTEEEECC
T ss_pred eEEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEE--cCCCCcEEEee
Confidence 7899999977 5444333 2457999999999999999999999999 9999999999999 6 688999999
Q ss_pred CCCcccccccCccceeeccCCcccccccCccccCcC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCC--
Q 020888 188 FGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH-- 264 (320)
Q Consensus 188 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~-- 264 (320)
||++........ .....+++.|+|||++.+. .++.++|||||||++|+|++|..||...+..+....+.+..
T Consensus 186 FG~a~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~ 260 (394)
T 4e7w_A 186 FGSAKILIAGEP-----NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGT 260 (394)
T ss_dssp CTTCEECCTTCC-----CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred CCCcccccCCCC-----CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 999987644321 2335679999999998765 58999999999999999999999999887766554443310
Q ss_pred -----------------CCCC--------CCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 265 -----------------RPFF--------RAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 265 -----------------~~~~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
.+.. ....+++++.++|.+||..||.+|||+.++++|
T Consensus 261 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 261 PSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp CCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 0000 112478999999999999999999999999986
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-42 Score=311.11 Aligned_cols=245 Identities=27% Similarity=0.360 Sum_probs=197.4
Q ss_pred CCcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeC-----
Q 020888 40 SELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER----- 112 (320)
Q Consensus 40 ~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 112 (320)
...+|.+.+.||+|+||.||++.+. ++.||+|.+..... ...+|+++++.++|+||+++++++...
T Consensus 52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~ 124 (420)
T 1j1b_A 52 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKD 124 (420)
T ss_dssp EEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTT
T ss_pred ccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHcCCCCccceeeEEeccCCCCc
Confidence 3447999999999999999999985 78999998865422 223689999999999999999987432
Q ss_pred -CceEEEEecCCCCCHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCC-CCcEEEe
Q 020888 113 -KPLMLITEYLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS-ADHLKVG 186 (320)
Q Consensus 113 -~~~~iv~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~-~~~~~L~ 186 (320)
..+++||||+++ +|.+.+.. ...+++..++.++.||+.||.|||++| |+|+||||+||++ +. .+.++|+
T Consensus 125 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NILl--~~~~~~~kl~ 199 (420)
T 1j1b_A 125 EVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLL--DPDTAVLKLC 199 (420)
T ss_dssp EEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEE--ETTTTEEEEC
T ss_pred ceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChhhEEE--eCCCCeEEec
Confidence 236799999976 77666542 457999999999999999999999999 9999999999999 54 4578999
Q ss_pred cCCCcccccccCccceeeccCCcccccccCccccCcC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhC--
Q 020888 187 DFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEG-- 263 (320)
Q Consensus 187 dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~-- 263 (320)
|||+++.+..... .....+|+.|+|||++.+. .++.++|||||||++|+|++|+.||...+..+....+.+.
T Consensus 200 DFG~a~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg 274 (420)
T 1j1b_A 200 DFGSAKQLVRGEP-----NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLG 274 (420)
T ss_dssp CCTTCEECCTTCC-----CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred cchhhhhcccCCC-----ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 9999986643321 2235689999999998765 7899999999999999999999999988766554433321
Q ss_pred -------------C----CCCC--------CCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 264 -------------H----RPFF--------RAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 264 -------------~----~~~~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
. .+.. ....+++++.+||.+||..||.+|||+.+++++
T Consensus 275 ~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 275 TPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp SCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 0 0000 113468999999999999999999999999976
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=307.21 Aligned_cols=253 Identities=25% Similarity=0.324 Sum_probs=192.8
Q ss_pred CcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCc----
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP---- 114 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---- 114 (320)
..+|.+.+.||+|+||+||++.+. ++.||+|.+....... ....++++.+..++|+||+++++++...+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~ 97 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR----NRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRR 97 (360)
T ss_dssp HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC----CHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTT
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc----HHHHHHHHHHHhcCCCCcccHHHhhhcccccccc
Confidence 448999999999999999999986 7899999886543332 345567888888999999999999865433
Q ss_pred ---eEEEEecCCCCCHHHHHH----HhCCCCHHHHHHHHHHHHHHHHHHh--cCCCCeEecCCCCCcEEEeeCC-CCcEE
Q 020888 115 ---LMLITEYLRGGDLHKYLK----EKGALSPSTAVNFALDIARGMAYLH--NEPNVIIHRDLKPRNVLLVNSS-ADHLK 184 (320)
Q Consensus 115 ---~~iv~e~~~~~~L~~~~~----~~~~l~~~~~~~i~~~l~~~l~~lH--~~g~~ivH~di~p~nI~~~~~~-~~~~~ 184 (320)
.++||||+++ +|.+.+. ....+++..+..++.|++.||.||| +.| |+|+||||+||++ +. ++.++
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~--ivH~Dlkp~NIll--~~~~~~~k 172 (360)
T 3e3p_A 98 DIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN--VCHRDIKPHNVLV--NEADGTLK 172 (360)
T ss_dssp CEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC--CBCSCCCGGGEEE--ETTTTEEE
T ss_pred ceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC--eecCcCCHHHEEE--eCCCCcEE
Confidence 7899999976 6655443 3557899999999999999999999 878 9999999999999 64 78999
Q ss_pred EecCCCcccccccCccceeeccCCcccccccCccccCcCC-CCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhC
Q 020888 185 VGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRK-YDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEG 263 (320)
Q Consensus 185 L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~ 263 (320)
|+|||++........ .....+|+.|+|||++.+.. ++.++||||||+++|+|++|..||...+.......+...
T Consensus 173 l~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~ 247 (360)
T 3e3p_A 173 LCDFGSAKKLSPSEP-----NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRV 247 (360)
T ss_dssp ECCCTTCBCCCTTSC-----CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred EeeCCCceecCCCCC-----cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHH
Confidence 999999986654321 23356799999999987654 899999999999999999999999988777666555431
Q ss_pred CCCC------------------------------CCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH--HHHHHh
Q 020888 264 HRPF------------------------------FRAKGFTPELRELTEKCWAADMNQRPSFLDILKR--LEKIKE 307 (320)
Q Consensus 264 ~~~~------------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--L~~~~~ 307 (320)
.... ......+++++++|.+||+.||.+|||+.+++++ ++.+..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 323 (360)
T 3e3p_A 248 LGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHD 323 (360)
T ss_dssp HCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGC
T ss_pred cCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCC
Confidence 1000 0112257899999999999999999999999987 444433
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=304.66 Aligned_cols=245 Identities=27% Similarity=0.445 Sum_probs=174.6
Q ss_pred cccCcc-ceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEe----CCc
Q 020888 42 LDFSSS-AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE----RKP 114 (320)
Q Consensus 42 ~~y~~~-~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~ 114 (320)
.+|.+. ++||+|+||+||++.+. ++.||+|++... . ....+....++.+.|+||+++++++.. +..
T Consensus 28 ~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~---~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 100 (336)
T 3fhr_A 28 DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----P---KARQEVDHHWQASGGPHIVCILDVYENMHHGKRC 100 (336)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----H---HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----H---HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence 478885 47999999999999986 889999988542 1 222223344566789999999999876 455
Q ss_pred eEEEEecCCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeC-CCCcEEEecCCCc
Q 020888 115 LMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS-SADHLKVGDFGLS 191 (320)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~-~~~~~~L~dfg~~ 191 (320)
.++||||++|++|.+++...+ .+++..++.++.|++.||.|||++| ++|+||||+||++..+ .++.++|+|||++
T Consensus 101 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~--ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 101 LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN--IAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178 (336)
T ss_dssp EEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEEecCCCceEEEeccccc
Confidence 899999999999999998753 6999999999999999999999998 9999999999999321 2456999999998
Q ss_pred ccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHH----HHHhC--CC
Q 020888 192 KLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAK----YVAEG--HR 265 (320)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~----~~~~~--~~ 265 (320)
...... ......+++.|+|||++.+..++.++||||||+++|+|++|..||.......... .+... ..
T Consensus 179 ~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 252 (336)
T 3fhr_A 179 KETTQN------ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGF 252 (336)
T ss_dssp EEC----------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CC
T ss_pred eecccc------ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhcccccc
Confidence 765432 1233467999999999988889999999999999999999999997665433211 11111 11
Q ss_pred CCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 266 PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 266 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
+......+++++++++.+||..||.+|||+++++++
T Consensus 253 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 253 PNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp CTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 222224689999999999999999999999999986
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=298.07 Aligned_cols=252 Identities=25% Similarity=0.459 Sum_probs=192.4
Q ss_pred CCCcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceE
Q 020888 39 PSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLM 116 (320)
Q Consensus 39 ~~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 116 (320)
....+|.+.+.||+|+||.||++.+. ++.||+|.+...... ....+.+.++..+++.++|+||+++++++...+..+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 100 (318)
T 2dyl_A 22 AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNK-EENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVF 100 (318)
T ss_dssp CCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCH-HHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred hhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccc-hHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEE
Confidence 34568999999999999999999985 889999988655332 223344555556778889999999999999999999
Q ss_pred EEEecCCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHhcC-CCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccc
Q 020888 117 LITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNE-PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 194 (320)
Q Consensus 117 iv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~~l~~~l~~lH~~-g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~ 194 (320)
+||||+ ++.+..+... .+.+++..++.++.|++.||.|||++ | ++|+||+|+||++ +.++.++|+|||++...
T Consensus 101 lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dlkp~Nil~--~~~~~~kl~dfg~~~~~ 175 (318)
T 2dyl_A 101 IAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILL--DERGQIKLCDFGISGRL 175 (318)
T ss_dssp EEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHC--CCCCCCCGGGEEE--CTTSCEEECCCTTC---
T ss_pred EEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCC--EEeCCCCHHHEEE--CCCCCEEEEECCCchhc
Confidence 999999 6567666654 46799999999999999999999995 8 9999999999999 88899999999998765
Q ss_pred cccCccceeeccCCcccccccCccccC-----cCCCCCchhHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHhCCCCCC
Q 020888 195 KVQNSHDVYKMTGETGSYRYMAPEVFK-----HRKYDKKVDVFSFAMILYEMLEGEPPLANY-EPYEAAKYVAEGHRPFF 268 (320)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~ll~g~~p~~~~-~~~~~~~~~~~~~~~~~ 268 (320)
..... .....+++.|+|||++. +..++.++||||||+++|+|++|..||... ...+....+.....+..
T Consensus 176 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 250 (318)
T 2dyl_A 176 VDDKA-----KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLL 250 (318)
T ss_dssp ----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCC
T ss_pred cCCcc-----ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCC
Confidence 44321 22346889999999984 456889999999999999999999999874 44455555555544333
Q ss_pred C-CCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 269 R-AKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 269 ~-~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
. ...++.++.+++.+||..||.+|||+++++++
T Consensus 251 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 251 PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 2 24589999999999999999999999999875
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=294.98 Aligned_cols=249 Identities=27% Similarity=0.442 Sum_probs=196.0
Q ss_pred cccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEe--------
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE-------- 111 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-------- 111 (320)
.+|++.+.||+|+||.||++.+. ++.||+|.+.. .....+.+.+|+++++.++|+||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH----TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM 81 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE----EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec----cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence 47999999999999999999975 78999998853 23445788999999999999999999998754
Q ss_pred -----CCceEEEEecCCCCCHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEE
Q 020888 112 -----RKPLMLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKV 185 (320)
Q Consensus 112 -----~~~~~iv~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L 185 (320)
....++||||+++++|.+++...+ .+++..++.++.|++.||.|||++| ++|+||||+||++ +.++.++|
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dlkp~Nil~--~~~~~~kl 157 (303)
T 1zy4_A 82 TAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG--IIHRDLKPMNIFI--DESRNVKI 157 (303)
T ss_dssp ----CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE--CTTSCEEE
T ss_pred cccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCC--eecccCCHHhEEE--cCCCCEEE
Confidence 456899999999999999998643 5788999999999999999999998 9999999999999 88899999
Q ss_pred ecCCCcccccccCcc----------ceeeccCCcccccccCccccCcC-CCCCchhHHHHHHHHHHHHhCCCCCCCC-Ch
Q 020888 186 GDFGLSKLIKVQNSH----------DVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANY-EP 253 (320)
Q Consensus 186 ~dfg~~~~~~~~~~~----------~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~-~~ 253 (320)
+|||.+......... .........+++.|+|||++.+. .++.++||||||+++|+|++ ||... +.
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~ 234 (303)
T 1zy4_A 158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMER 234 (303)
T ss_dssp CCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHH
T ss_pred eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhH
Confidence 999998765432110 01122345688999999999865 68999999999999999998 55432 22
Q ss_pred HHHHHHHHhCC--CCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 254 YEAAKYVAEGH--RPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 254 ~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
......+.... .+.......+..+++++.+||+.||.+|||+++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 235 VNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 23333333322 2222334568889999999999999999999999875
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=302.35 Aligned_cols=250 Identities=26% Similarity=0.505 Sum_probs=182.5
Q ss_pred CCcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHH-HHHhCCCCcccceeeeEEeCCceE
Q 020888 40 SELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVN-LLVKLRHPNIVQFLGAVTERKPLM 116 (320)
Q Consensus 40 ~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~ 116 (320)
...+|.+.+.||+|+||.||++.++ ++.||+|.+..... ......+..|+. +++.++|+||+++++++...+..+
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~ 97 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD--EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCW 97 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC--HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEE
T ss_pred CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC--chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceE
Confidence 3568999999999999999999986 88899998865432 223345555655 667779999999999999999999
Q ss_pred EEEecCCCCCHHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHhcC-CCCeEecCCCCCcEEEeeCCCCcEEEecCCC
Q 020888 117 LITEYLRGGDLHKYLKE-----KGALSPSTAVNFALDIARGMAYLHNE-PNVIIHRDLKPRNVLLVNSSADHLKVGDFGL 190 (320)
Q Consensus 117 iv~e~~~~~~L~~~~~~-----~~~l~~~~~~~i~~~l~~~l~~lH~~-g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~ 190 (320)
+||||+++ +|.+++.. ...+++..+..++.|++.||.|||+. | ++|+||||+||++ +.++.++|+|||+
T Consensus 98 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--ivH~dlkp~NIll--~~~~~~kl~Dfg~ 172 (327)
T 3aln_A 98 ICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILL--DRSGNIKLCDFGI 172 (327)
T ss_dssp EEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS--CCCSCCCGGGEEE--ETTTEEEECCCSS
T ss_pred EEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC--EeECCCCHHHEEE--cCCCCEEEccCCC
Confidence 99999976 88888763 45789999999999999999999998 8 9999999999999 8889999999999
Q ss_pred cccccccCccceeeccCCcccccccCcccc----CcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHhCCC
Q 020888 191 SKLIKVQNSHDVYKMTGETGSYRYMAPEVF----KHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPY-EAAKYVAEGHR 265 (320)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~-~~~~~~~~~~~ 265 (320)
+....... ......+++.|+|||++ .+..++.++||||||+++|+|++|..||...... +....+..+..
T Consensus 173 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 247 (327)
T 3aln_A 173 SGQLVDSI-----AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDP 247 (327)
T ss_dssp SCC-----------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCC
T ss_pred ceeccccc-----ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCC
Confidence 97664332 12233688999999998 4567899999999999999999999999875432 11111112211
Q ss_pred CCCC---CCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 266 PFFR---AKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 266 ~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
+... ...+++++.+++.+||..||.+|||+.+++++
T Consensus 248 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 248 PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp CCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 1111 23579999999999999999999999999875
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=293.23 Aligned_cols=231 Identities=16% Similarity=0.146 Sum_probs=191.6
Q ss_pred cccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEE
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 119 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 119 (320)
.+|.+.+.||+|+||.||++.+. ++.||+|++...........+.+.+|++.++.++|+||+++++++..++..|+||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 57999999999999999999986 7899999998776666666788999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCc
Q 020888 120 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 199 (320)
Q Consensus 120 e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~ 199 (320)
||++|++|.++++.+ .....+..++.|++.||.|||++| |+|+||||+||++ +.++.++|++++
T Consensus 111 e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~g--ivH~Dikp~NIll--~~~g~~kl~~~~---------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAG--VALSIDHPSRVRV--SIDGDVVLAYPA---------- 174 (286)
T ss_dssp ECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEE--ETTSCEEECSCC----------
T ss_pred EecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCC--CccCCCCcccEEE--cCCCCEEEEecc----------
Confidence 999999999999653 456678899999999999999999 9999999999999 788889987543
Q ss_pred cceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHhCCCCC--CCCCCCC
Q 020888 200 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKY---VAEGHRPF--FRAKGFT 274 (320)
Q Consensus 200 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~---~~~~~~~~--~~~~~~~ 274 (320)
|.+ .++.++||||||+++|+|++|..||...+..+.... ........ .....++
T Consensus 175 --------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T 3uqc_A 175 --------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIP 233 (286)
T ss_dssp --------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSC
T ss_pred --------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCC
Confidence 222 358899999999999999999999987654321100 00010000 1124589
Q ss_pred HHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcCC
Q 020888 275 PELRELTEKCWAADMNQRPSFLDILKRLEKIKETLP 310 (320)
Q Consensus 275 ~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~ 310 (320)
+++++++.+||..||.+| |+.++++.|+++.....
T Consensus 234 ~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~ 268 (286)
T 3uqc_A 234 FQISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD 268 (286)
T ss_dssp HHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred HHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence 999999999999999999 99999999999876544
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=302.88 Aligned_cols=247 Identities=29% Similarity=0.373 Sum_probs=202.1
Q ss_pred CcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCC-CC-----cccceeeeEEeC
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HP-----NIVQFLGAVTER 112 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~-----~i~~~~~~~~~~ 112 (320)
..+|.+.+.||+|+||+||++.+. ++.||+|++... ......+..|+++++.++ |+ +++++++++...
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 128 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK----KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR 128 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc----HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence 458999999999999999999986 778999988532 233467778888888874 44 489999999999
Q ss_pred CceEEEEecCCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHhc--CCCCeEecCCCCCcEEEeeCCCCcEEEecC
Q 020888 113 KPLMLITEYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHN--EPNVIIHRDLKPRNVLLVNSSADHLKVGDF 188 (320)
Q Consensus 113 ~~~~iv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~--~g~~ivH~di~p~nI~~~~~~~~~~~L~df 188 (320)
+..++||||+++ +|.+++... ..+++..+..++.|++.||.|||. .| |+|+||||+||++..+.++.++|+||
T Consensus 129 ~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~--ivHrDlkp~NIll~~~~~~~~kL~DF 205 (382)
T 2vx3_A 129 NHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELS--IIHCDLKPENILLCNPKRSAIKIVDF 205 (382)
T ss_dssp TEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTC--EECCCCSGGGEEESSTTSCCEEECCC
T ss_pred CceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCC--EEcCCCCcccEEEecCCCCcEEEEec
Confidence 999999999965 999999864 468999999999999999999995 56 99999999999995555778999999
Q ss_pred CCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCC
Q 020888 189 GLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFF 268 (320)
Q Consensus 189 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 268 (320)
|++...... .....+|+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+......+.
T Consensus 206 G~a~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 278 (382)
T 2vx3_A 206 GSSCQLGQR-------IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPP 278 (382)
T ss_dssp TTCEETTCC-------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCC
T ss_pred cCceecccc-------cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 999766432 2345689999999999999999999999999999999999999998877666555443211000
Q ss_pred ----------------------------------CCC------------------------C----CCHHHHHHHHHHhh
Q 020888 269 ----------------------------------RAK------------------------G----FTPELRELTEKCWA 286 (320)
Q Consensus 269 ----------------------------------~~~------------------------~----~~~~l~~li~~~l~ 286 (320)
.+. . .++++++||.+||+
T Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~ 358 (382)
T 2vx3_A 279 AHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLD 358 (382)
T ss_dssp HHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTC
T ss_pred HHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcC
Confidence 000 0 01478999999999
Q ss_pred cCCCCCCCHHHHHHH
Q 020888 287 ADMNQRPSFLDILKR 301 (320)
Q Consensus 287 ~dp~~Rps~~~ll~~ 301 (320)
.||++|||+++++++
T Consensus 359 ~dP~~Rpta~e~L~h 373 (382)
T 2vx3_A 359 YDPKTRIQPYYALQH 373 (382)
T ss_dssp SCTTTSCCHHHHTTS
T ss_pred CChhhCCCHHHHhcC
Confidence 999999999999875
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=310.00 Aligned_cols=245 Identities=21% Similarity=0.330 Sum_probs=195.8
Q ss_pred CcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCC--------CCcccceeeeEE
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR--------HPNIVQFLGAVT 110 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~--------h~~i~~~~~~~~ 110 (320)
..+|.+.+.||+|+||+||++.+. ++.||+|++... ....+.+.+|+++++.+. |+||+++++.+.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~ 111 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFK 111 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC----CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeeccee
Confidence 358999999999999999999875 788999988533 334477889999999985 788999999987
Q ss_pred ----eCCceEEEEecCCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHhcC-CCCeEecCCCCCcEEEeeCCCC--
Q 020888 111 ----ERKPLMLITEYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNE-PNVIIHRDLKPRNVLLVNSSAD-- 181 (320)
Q Consensus 111 ----~~~~~~iv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~-g~~ivH~di~p~nI~~~~~~~~-- 181 (320)
.+...++||||+ +++|.+.+... ..+++..++.++.||+.||.|||++ | |+|+||||+||++ +.++
T Consensus 112 ~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g--ivHrDikp~NIll--~~~~~~ 186 (397)
T 1wak_A 112 ISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPENILL--SVNEQY 186 (397)
T ss_dssp EEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECCCCSGGGEEE--CCCHHH
T ss_pred ecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHeeE--eccchh
Confidence 556789999999 55777766543 4699999999999999999999998 8 9999999999999 5443
Q ss_pred -----------------------------------------------cEEEecCCCcccccccCccceeeccCCcccccc
Q 020888 182 -----------------------------------------------HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRY 214 (320)
Q Consensus 182 -----------------------------------------------~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y 214 (320)
.++|+|||.+...... .....+|+.|
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-------~~~~~gt~~y 259 (397)
T 1wak_A 187 IRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-------FTEDIQTRQY 259 (397)
T ss_dssp HHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-------SCSCCSCGGG
T ss_pred hhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-------CccCCCCCcc
Confidence 7999999999765432 2335689999
Q ss_pred cCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHh--CCCCC-------------------
Q 020888 215 MAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEP------YEAAKYVAE--GHRPF------------------- 267 (320)
Q Consensus 215 ~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~------~~~~~~~~~--~~~~~------------------- 267 (320)
+|||++.+..++.++|||||||++|+|++|..||...+. .+....+.. +..+.
T Consensus 260 ~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~ 339 (397)
T 1wak_A 260 RSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDL 339 (397)
T ss_dssp CCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSB
T ss_pred cCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccc
Confidence 999999999999999999999999999999999976542 122211111 00000
Q ss_pred -------------------CCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 268 -------------------FRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 268 -------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
......+.++++||.+||+.||++|||+++++++
T Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 340 KHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp SSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred ccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 0011234678999999999999999999999875
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=307.47 Aligned_cols=250 Identities=22% Similarity=0.369 Sum_probs=182.7
Q ss_pred ccCc-cceecccCceEEEEEEEC----CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEe--CCce
Q 020888 43 DFSS-SAIIGKGSFGEILKAYWR----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE--RKPL 115 (320)
Q Consensus 43 ~y~~-~~~lg~g~~~~vy~~~~~----~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 115 (320)
.|.+ .++||+|+||+||++.+. ++.||+|.+...... ..+.+|+++++.++|+||+++++++.. +...
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 95 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS-----MSACREIALLRELKHPNVISLQKVFLSHADRKV 95 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC-----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC-----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeE
Confidence 4555 568999999999999964 678999988654322 467789999999999999999999954 6778
Q ss_pred EEEEecCCCCCHHHHHHHh---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEee--CCCCcEE
Q 020888 116 MLITEYLRGGDLHKYLKEK---------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN--SSADHLK 184 (320)
Q Consensus 116 ~iv~e~~~~~~L~~~~~~~---------~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~--~~~~~~~ 184 (320)
++||||+++ +|.+++... ..+++..++.++.||+.||.|||++| |+|+||||+||++.. +.++.++
T Consensus 96 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~k 172 (405)
T 3rgf_A 96 WLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVK 172 (405)
T ss_dssp EEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECCSSTTTTCEE
T ss_pred EEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeCCCcCHHHeEEecCCCCCCcEE
Confidence 999999965 888887632 14899999999999999999999999 999999999999943 3567899
Q ss_pred EecCCCcccccccCccceeeccCCcccccccCccccCcC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChH---------
Q 020888 185 VGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPY--------- 254 (320)
Q Consensus 185 L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~--------- 254 (320)
|+|||++........ .........+|+.|+|||++.+. .++.++|||||||++|+|++|..||......
T Consensus 173 l~Dfg~a~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~ 251 (405)
T 3rgf_A 173 IADMGFARLFNSPLK-PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHH 251 (405)
T ss_dssp ECCTTCCC-----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCH
T ss_pred EEECCCceecCCCCc-ccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchH
Confidence 999999987653221 11223345789999999999874 5899999999999999999999999754431
Q ss_pred HHHHHHHhCCC-CCC-----------------------------------CCCCCCHHHHHHHHHHhhcCCCCCCCHHHH
Q 020888 255 EAAKYVAEGHR-PFF-----------------------------------RAKGFTPELRELTEKCWAADMNQRPSFLDI 298 (320)
Q Consensus 255 ~~~~~~~~~~~-~~~-----------------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l 298 (320)
+....+..... +.. .....++++.+||.+||..||.+|||++++
T Consensus 252 ~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~ 331 (405)
T 3rgf_A 252 DQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQA 331 (405)
T ss_dssp HHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred HHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHH
Confidence 11111111000 000 001126789999999999999999999999
Q ss_pred HHH
Q 020888 299 LKR 301 (320)
Q Consensus 299 l~~ 301 (320)
+++
T Consensus 332 L~h 334 (405)
T 3rgf_A 332 MQD 334 (405)
T ss_dssp HTS
T ss_pred hcC
Confidence 987
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-41 Score=297.33 Aligned_cols=247 Identities=23% Similarity=0.358 Sum_probs=200.4
Q ss_pred CcccCccceecccCceEEEEEEEC--C-CceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCc------ccceeeeEEe
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--G-TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN------IVQFLGAVTE 111 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~-~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~------i~~~~~~~~~ 111 (320)
..+|.+.+.||+|+||+||++.+. + +.||+|++... ....+.+.+|+++++.+.|++ ++.+.+++..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 93 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV----GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF 93 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc----ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee
Confidence 458999999999999999999985 3 67999988532 233467888999999886554 8899999999
Q ss_pred CCceEEEEecCCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEee------------
Q 020888 112 RKPLMLITEYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN------------ 177 (320)
Q Consensus 112 ~~~~~iv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~------------ 177 (320)
.+..++||||+ +++|.+++... ..+++..++.++.||+.||.|||++| |+|+||||+||++..
T Consensus 94 ~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~~~~~~ 170 (355)
T 2eu9_A 94 HGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ--LTHTDLKPENILFVNSEFETLYNEHKS 170 (355)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred CCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEeccccccccccccc
Confidence 99999999999 55787777654 36999999999999999999999998 999999999999932
Q ss_pred -----CCCCcEEEecCCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 020888 178 -----SSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYE 252 (320)
Q Consensus 178 -----~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~ 252 (320)
+.++.++|+|||++...... .....+|+.|+|||++.+..++.++||||||+++|+|++|..||....
T Consensus 171 ~~~~~~~~~~~kl~Dfg~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 243 (355)
T 2eu9_A 171 CEEKSVKNTSIRVADFGSATFDHEH-------HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHE 243 (355)
T ss_dssp CCEEEESCCCEEECCCTTCEETTSC-------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccccCCCcEEEeecCcccccccc-------ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence 34678999999998754322 233568999999999999999999999999999999999999999877
Q ss_pred hHHHHHHHHhCCCCC------------------------------------------CCCCCCCHHHHHHHHHHhhcCCC
Q 020888 253 PYEAAKYVAEGHRPF------------------------------------------FRAKGFTPELRELTEKCWAADMN 290 (320)
Q Consensus 253 ~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~l~~li~~~l~~dp~ 290 (320)
..+....+.....+. ......+.++.++|.+||..||.
T Consensus 244 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 323 (355)
T 2eu9_A 244 NREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPA 323 (355)
T ss_dssp HHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred HHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChh
Confidence 665443332211100 00111245899999999999999
Q ss_pred CCCCHHHHHHH
Q 020888 291 QRPSFLDILKR 301 (320)
Q Consensus 291 ~Rps~~~ll~~ 301 (320)
+|||+.+++++
T Consensus 324 ~Rpt~~e~l~h 334 (355)
T 2eu9_A 324 QRITLAEALLH 334 (355)
T ss_dssp TSCCHHHHTTS
T ss_pred hCcCHHHHhcC
Confidence 99999999875
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=307.15 Aligned_cols=249 Identities=27% Similarity=0.454 Sum_probs=187.5
Q ss_pred cccCccceecccCceEEEEEE-ECCCceEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcccceeeeEEeCCceEEEE
Q 020888 42 LDFSSSAIIGKGSFGEILKAY-WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLIT 119 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~-~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~iv~ 119 (320)
..|.+.+.||+|+||+||.+. .+++.||+|.+.... .+.+.+|+++++.+ +||||+++++++..++..|+||
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~ 88 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIAL 88 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEE
Confidence 356678999999999997644 358999999875421 25677899999886 8999999999999999999999
Q ss_pred ecCCCCCHHHHHHHhCCC-------CHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeC-----------CCC
Q 020888 120 EYLRGGDLHKYLKEKGAL-------SPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS-----------SAD 181 (320)
Q Consensus 120 e~~~~~~L~~~~~~~~~l-------~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~-----------~~~ 181 (320)
||++ ++|.+++...... ++..++.++.|++.||.|||++| |+|+||||+||++..+ .++
T Consensus 89 E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~~~~~~~~~~~~~ 165 (434)
T 2rio_A 89 ELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENL 165 (434)
T ss_dssp CCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEECCHHHHSCCTTCCCSC
T ss_pred ecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCcccccccccCCCce
Confidence 9996 5999999864322 22345779999999999999998 9999999999999432 345
Q ss_pred cEEEecCCCcccccccCccceeeccCCcccccccCccccCc-------CCCCCchhHHHHHHHHHHHHh-CCCCCCCCCh
Q 020888 182 HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH-------RKYDKKVDVFSFAMILYEMLE-GEPPLANYEP 253 (320)
Q Consensus 182 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~ 253 (320)
.++|+|||++..................||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.....
T Consensus 166 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~ 245 (434)
T 2rio_A 166 RILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245 (434)
T ss_dssp EEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT
T ss_pred EEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh
Confidence 89999999998775443222222334578999999999976 568899999999999999999 9999976554
Q ss_pred HHHHHHHHhCCCCCCC-----CCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 254 YEAAKYVAEGHRPFFR-----AKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 254 ~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
.. ..+..+...... ...+++++++++.+||+.||.+|||+.+++++
T Consensus 246 ~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 246 RE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp HH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 33 223333221111 11245889999999999999999999999863
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=302.38 Aligned_cols=247 Identities=20% Similarity=0.323 Sum_probs=195.9
Q ss_pred CcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCC-----------CCcccceee
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-----------HPNIVQFLG 107 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~i~~~~~ 107 (320)
..+|.+.+.||+|+||+||++.+. ++.||+|++... ......+.+|+++++++. |+||+++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~ 93 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD 93 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC----ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHH
Confidence 458999999999999999999975 788999988542 233467888999998886 789999999
Q ss_pred eEEeCC----ceEEEEecCCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHhcC-CCCeEecCCCCCcEEEee---
Q 020888 108 AVTERK----PLMLITEYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNE-PNVIIHRDLKPRNVLLVN--- 177 (320)
Q Consensus 108 ~~~~~~----~~~iv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~-g~~ivH~di~p~nI~~~~--- 177 (320)
++...+ ..+++||++ +++|.+++... ..+++..++.++.||+.||.|||++ | |+|+||||+||++..
T Consensus 94 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~--ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 94 HFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp EEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEEEEET
T ss_pred HhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChHHeEEeccCC
Confidence 987654 689999999 88999999863 4599999999999999999999998 8 999999999999943
Q ss_pred -CCCCcEEEecCCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH--
Q 020888 178 -SSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPY-- 254 (320)
Q Consensus 178 -~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~-- 254 (320)
+..+.++|+|||++...... .....+|+.|+|||++.+..++.++||||||+++|+|++|..||......
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 243 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDEH-------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSY 243 (373)
T ss_dssp TTTEEEEEECCCTTCEETTBC-------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred CcCcceEEEcccccccccCCC-------CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCccccc
Confidence 23347999999999765432 22346899999999999999999999999999999999999999865421
Q ss_pred ----HHHHHHHhC--CCC--------------------------------------CCCCCCCCHHHHHHHHHHhhcCCC
Q 020888 255 ----EAAKYVAEG--HRP--------------------------------------FFRAKGFTPELRELTEKCWAADMN 290 (320)
Q Consensus 255 ----~~~~~~~~~--~~~--------------------------------------~~~~~~~~~~l~~li~~~l~~dp~ 290 (320)
.....+... ..+ ...+..++.+++++|.+||+.||.
T Consensus 244 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 323 (373)
T 1q8y_A 244 TKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPR 323 (373)
T ss_dssp -CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTT
T ss_pred CChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCcc
Confidence 111111110 000 001122467899999999999999
Q ss_pred CCCCHHHHHHH
Q 020888 291 QRPSFLDILKR 301 (320)
Q Consensus 291 ~Rps~~~ll~~ 301 (320)
+|||+++++++
T Consensus 324 ~Rpt~~ell~h 334 (373)
T 1q8y_A 324 KRADAGGLVNH 334 (373)
T ss_dssp TCBCHHHHHTC
T ss_pred ccCCHHHHhhC
Confidence 99999999986
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=285.97 Aligned_cols=226 Identities=27% Similarity=0.450 Sum_probs=180.7
Q ss_pred CCCCcccCcc-ceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHH-HhCCCCcccceeeeEEe--
Q 020888 38 DPSELDFSSS-AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLL-VKLRHPNIVQFLGAVTE-- 111 (320)
Q Consensus 38 ~~~~~~y~~~-~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l-~~l~h~~i~~~~~~~~~-- 111 (320)
..-..+|.+. +.||+|+||.||++.+. ++.||+|.+... ..+.+|++++ +..+|+||+++++++..
T Consensus 13 ~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~ 84 (299)
T 3m2w_A 13 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLY 84 (299)
T ss_dssp SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred cccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhhc
Confidence 3334578877 78999999999999985 789999988532 4567788887 55589999999999876
Q ss_pred --CCceEEEEecCCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCC---CCcEE
Q 020888 112 --RKPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS---ADHLK 184 (320)
Q Consensus 112 --~~~~~iv~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~---~~~~~ 184 (320)
+...++||||+++++|.+++...+ .+++..++.++.|++.||.|||+.| ++|+||||+||++ +. ++.++
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~--~~~~~~~~~k 160 (299)
T 3m2w_A 85 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLY--TSKRPNAILK 160 (299)
T ss_dssp TTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--SSSSTTCCEE
T ss_pred CCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEE--ecCCCCCcEE
Confidence 677899999999999999998754 6999999999999999999999999 9999999999999 55 77899
Q ss_pred EecCCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCC
Q 020888 185 VGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH 264 (320)
Q Consensus 185 L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~ 264 (320)
|+|||++.... +..++.++||||||+++|+|++|..||................
T Consensus 161 l~Dfg~a~~~~--------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~ 214 (299)
T 3m2w_A 161 LTDFGFAKETT--------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI 214 (299)
T ss_dssp ECCCTTCEECT--------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSS
T ss_pred Eeccccccccc--------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHH
Confidence 99999885432 2345778999999999999999999997655433211111111
Q ss_pred CCC--CCC----CCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 265 RPF--FRA----KGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 265 ~~~--~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
... ..+ ..+++++++++.+||+.||.+|||+.+++++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 215 RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp CTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 000 001 4579999999999999999999999999986
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=306.34 Aligned_cols=254 Identities=28% Similarity=0.436 Sum_probs=192.4
Q ss_pred CCCCcccCccceecccCceEE-EEEEECCCceEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcccceeeeEEeCCce
Q 020888 38 DPSELDFSSSAIIGKGSFGEI-LKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPL 115 (320)
Q Consensus 38 ~~~~~~y~~~~~lg~g~~~~v-y~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 115 (320)
.....+|.+.+.||+|+||+| |.+..+++.||+|.+..... ..+.+|+++++.+ +||||+++++++.+....
T Consensus 20 ~i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 93 (432)
T 3p23_A 20 IVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF------SFADREVQLLRESDEHPNVIRYFCTEKDRQFQ 93 (432)
T ss_dssp EETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE------EECHHHHHHHHHSCCCTTBCCEEEEEEETTEE
T ss_pred EEccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH------HHHHHHHHHHHhccCCCCcCeEEEEEecCCEE
Confidence 344568999999999999985 45555699999998865332 2345799999999 799999999999999999
Q ss_pred EEEEecCCCCCHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEee---CCCCcEEEecCCCc
Q 020888 116 MLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN---SSADHLKVGDFGLS 191 (320)
Q Consensus 116 ~iv~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~---~~~~~~~L~dfg~~ 191 (320)
|+|||+++| +|.+++.... ..+...++.++.|++.||.|||++| |+|+||||+||++.. +....++|+|||++
T Consensus 94 ~lv~E~~~g-~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a 170 (432)
T 3p23_A 94 YIAIELCAA-TLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170 (432)
T ss_dssp EEEEECCSE-EHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTT--CCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred EEEEECCCC-CHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCc--CEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence 999999964 9999998643 4556667899999999999999999 999999999999932 22336889999999
Q ss_pred ccccccCccceeeccCCcccccccCccccC---cCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCC
Q 020888 192 KLIKVQNSHDVYKMTGETGSYRYMAPEVFK---HRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPF 267 (320)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~ 267 (320)
......... ........||+.|+|||++. ...++.++|||||||++|++++ |..||...................
T Consensus 171 ~~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~ 249 (432)
T 3p23_A 171 KKLAVGRHS-FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDC 249 (432)
T ss_dssp ECC-------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTT
T ss_pred eeccCCCcc-eeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccc
Confidence 876543211 11233457899999999997 4567889999999999999999 999997655444333222222111
Q ss_pred CC-CCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 268 FR-AKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 268 ~~-~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
.. ....+..++++|.+||+.||.+|||+++++++
T Consensus 250 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 250 LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 11 12235668999999999999999999999853
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=311.09 Aligned_cols=257 Identities=27% Similarity=0.396 Sum_probs=198.9
Q ss_pred cccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEe------CC
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE------RK 113 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~ 113 (320)
.+|.+.+.||+|+||+||++.+. ++.||+|++.... .....+.+.+|+++++.++||||+++++++.. ++
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC--CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence 47999999999999999999874 7899999886542 34445789999999999999999999998754 67
Q ss_pred ceEEEEecCCCCCHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCC-CCcEEEecCC
Q 020888 114 PLMLITEYLRGGDLHKYLKEKG---ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS-ADHLKVGDFG 189 (320)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~-~~~~~L~dfg 189 (320)
..++||||++|++|.+++.... .+++..++.++.|++.||.|||+.| ++|+||||+||++..+. ...++|+|||
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g--IVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR--IIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT--BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEeecCCCceeEEEcccc
Confidence 7899999999999999998643 5899999999999999999999998 99999999999993222 2249999999
Q ss_pred CcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHH---------HHH
Q 020888 190 LSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAA---------KYV 260 (320)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~---------~~~ 260 (320)
.+....... ......+++.|+|||.+.+..++.++||||||+++|++++|..||......... ...
T Consensus 170 ~a~~~~~~~-----~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~ 244 (676)
T 3qa8_A 170 YAKELDQGE-----LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHI 244 (676)
T ss_dssp CCCBTTSCC-----CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------C
T ss_pred ccccccccc-----ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhh
Confidence 998765432 123456899999999999999999999999999999999999999764322110 000
Q ss_pred H-----hC--------CCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHH-----HHHHHHHHh
Q 020888 261 A-----EG--------HRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDI-----LKRLEKIKE 307 (320)
Q Consensus 261 ~-----~~--------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l-----l~~L~~~~~ 307 (320)
. .+ ..+......+++.+.+++..||..||++|||+.++ .+.+..+..
T Consensus 245 ~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~ 309 (676)
T 3qa8_A 245 VVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS 309 (676)
T ss_dssp CSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred hhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence 0 00 00000112357899999999999999999999884 445555443
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=299.50 Aligned_cols=244 Identities=15% Similarity=0.185 Sum_probs=187.2
Q ss_pred CCCcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCC-Ccccc---------ee
Q 020888 39 PSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH-PNIVQ---------FL 106 (320)
Q Consensus 39 ~~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~---------~~ 106 (320)
....+|...+.||+|+||+||++.+. ++.||+|++...........+.+.+|+.+++.+.| .+... ..
T Consensus 75 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~ 154 (413)
T 3dzo_A 75 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 154 (413)
T ss_dssp SCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCC
T ss_pred CCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccch
Confidence 34456888999999999999999986 89999998875444443445788999999999976 32211 11
Q ss_pred ee------------EEe-----CCceEEEEecCCCCCHHHHHHH-------hCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 020888 107 GA------------VTE-----RKPLMLITEYLRGGDLHKYLKE-------KGALSPSTAVNFALDIARGMAYLHNEPNV 162 (320)
Q Consensus 107 ~~------------~~~-----~~~~~iv~e~~~~~~L~~~~~~-------~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ 162 (320)
+. +.. ...++++|+.+ +++|.++++. ...+++..++.++.|++.||.|||++|
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-- 231 (413)
T 3dzo_A 155 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG-- 231 (413)
T ss_dssp EEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred hhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 11 111 23467888876 6699998852 224788899999999999999999999
Q ss_pred eEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCccceeeccCCcccccccCcccc----------CcCCCCCchhHH
Q 020888 163 IIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF----------KHRKYDKKVDVF 232 (320)
Q Consensus 163 ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------~~~~~~~~~Di~ 232 (320)
|+|+||||+||++ +.++.++|+|||++...... .....| +.|+|||++ .+..++.++|||
T Consensus 232 iiHrDiKp~NILl--~~~~~~kL~DFG~a~~~~~~-------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~Dvw 301 (413)
T 3dzo_A 232 LVHTYLRPVDIVL--DQRGGVFLTGFEHLVRDGAS-------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTW 301 (413)
T ss_dssp EECSCCCGGGEEE--CTTCCEEECCGGGCEETTEE-------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHH
T ss_pred cccCCcccceEEE--ecCCeEEEEeccceeecCCc-------cccCCC-CceeCchhhhccccccccccCcCCCchhhHH
Confidence 9999999999999 88889999999998764432 233456 999999999 555688899999
Q ss_pred HHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 233 SFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 233 slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
||||++|+|++|+.||...........+.. ....+++++++++.+||..||++|||+.+++++
T Consensus 302 SlGvil~elltg~~Pf~~~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~ 364 (413)
T 3dzo_A 302 TLGLAIYWIWCADLPNTDDAALGGSEWIFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 364 (413)
T ss_dssp HHHHHHHHHHHSSCCCCTTGGGSCSGGGGS------SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHHHHHHHHHCCCCCCCcchhhhHHHHHh------hcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 999999999999999987654332222211 123579999999999999999999998887654
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=311.74 Aligned_cols=239 Identities=23% Similarity=0.305 Sum_probs=193.9
Q ss_pred cccCccceecccCceEEEEEEEC---CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCc----
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR---GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP---- 114 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~---~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---- 114 (320)
.+|.+.+.||+|+||+||++.+. ++.||+|.+... ........+.+|++++++++||||+++++++...+.
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS--GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS--CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc--CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 58999999999999999999974 688999988653 234445778899999999999999999999987665
Q ss_pred -eEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccc
Q 020888 115 -LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 193 (320)
Q Consensus 115 -~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~ 193 (320)
.|+||||++|++|.+++.. .+++..++.++.||+.+|.|||++| |+|+||||+||++ +.+ .++|+|||++..
T Consensus 158 ~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~g--iiHrDlkp~NIll--~~~-~~kl~DFG~a~~ 230 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIG--LVYNDLKPENIML--TEE-QLKLIDLGAVSR 230 (681)
T ss_dssp EEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--CSS-CEEECCCTTCEE
T ss_pred eeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCC--CeecccChHHeEE--eCC-cEEEEecccchh
Confidence 7999999999999998765 7999999999999999999999999 9999999999999 543 899999999976
Q ss_pred ccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCC
Q 020888 194 IKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGF 273 (320)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (320)
.... ....||+.|+|||++.+.. +.++||||||+++++|++|..||...... ...........
T Consensus 231 ~~~~--------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~--------~~~~~~~~~~~ 293 (681)
T 2pzi_A 231 INSF--------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVD--------GLPEDDPVLKT 293 (681)
T ss_dssp TTCC--------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECS--------SCCTTCHHHHH
T ss_pred cccC--------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccc--------ccccccccccc
Confidence 5432 3356899999999987654 88999999999999999998887642211 00000001123
Q ss_pred CHHHHHHHHHHhhcCCCCCC-CHHHHHHHHHHHH
Q 020888 274 TPELRELTEKCWAADMNQRP-SFLDILKRLEKIK 306 (320)
Q Consensus 274 ~~~l~~li~~~l~~dp~~Rp-s~~~ll~~L~~~~ 306 (320)
++.+.++|.+||..||.+|| +++++.+.|..+.
T Consensus 294 ~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 294 YDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 67899999999999999999 5777777777664
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=286.36 Aligned_cols=242 Identities=19% Similarity=0.198 Sum_probs=185.0
Q ss_pred CCcccCccceecccCceEEEEEEECCCceEEEEccCCCCC-----cHHHHHHHHHHHHHHHhCC---------CCcc---
Q 020888 40 SELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSD-----DRLVIQDFRHEVNLLVKLR---------HPNI--- 102 (320)
Q Consensus 40 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~K~~~~~~~~-----~~~~~~~~~~e~~~l~~l~---------h~~i--- 102 (320)
...+|.+.+.||+|+||+||++.++++.||+|++...... .....+.+.+|+.+++.++ |+||
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred ccccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 3568999999999999999999999999999998765322 2223367888999888886 5454
Q ss_pred --------------cceeeeEEe-------------CCceEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHH
Q 020888 103 --------------VQFLGAVTE-------------RKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 155 (320)
Q Consensus 103 --------------~~~~~~~~~-------------~~~~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~ 155 (320)
+++++++.. .+..|+||||+++|++.+.+.+ +.+++..++.++.||+.||.|
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~~ 176 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAV 176 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHHH
Confidence 444444443 7789999999998876665544 568999999999999999999
Q ss_pred Hh-cCCCCeEecCCCCCcEEEeeCCCC--------------------cEEEecCCCcccccccCccceeeccCCcccccc
Q 020888 156 LH-NEPNVIIHRDLKPRNVLLVNSSAD--------------------HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRY 214 (320)
Q Consensus 156 lH-~~g~~ivH~di~p~nI~~~~~~~~--------------------~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y 214 (320)
|| ++| |+|+||||+||++ +.++ .++|+|||+++..... ...||+.|
T Consensus 177 lH~~~~--ivHrDlKp~NILl--~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~---------~~~gt~~y 243 (336)
T 2vuw_A 177 AEASLR--FEHRDLHWGNVLL--KKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG---------IVVFCDVS 243 (336)
T ss_dssp HHHHHC--CBCSCCCGGGEEE--EECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT---------EEECCCCT
T ss_pred HHHhCC--EeECCCCHHHEEE--eccCCcceeeeccCccccccCCCceEEEeeccccEecCCC---------cEEEeecc
Confidence 99 888 9999999999999 4444 8999999999865432 23689999
Q ss_pred cCccccCcCCCCCchhHHHHHHH-HHHHHhCCCCCCCCCh-HHHHHHHHhCC-CCCCC----CCCCCHHHHHHHHHHhhc
Q 020888 215 MAPEVFKHRKYDKKVDVFSFAMI-LYEMLEGEPPLANYEP-YEAAKYVAEGH-RPFFR----AKGFTPELRELTEKCWAA 287 (320)
Q Consensus 215 ~aPE~~~~~~~~~~~Di~slG~~-l~~ll~g~~p~~~~~~-~~~~~~~~~~~-~~~~~----~~~~~~~l~~li~~~l~~ 287 (320)
+|||++.+.. +.++|||||+++ .+++++|..||..... ......+.... ..... ...+++++++||.+||+.
T Consensus 244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~ 322 (336)
T 2vuw_A 244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNF 322 (336)
T ss_dssp TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGS
T ss_pred cChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhcc
Confidence 9999998777 899999998777 6678889998854211 11222222221 11111 124678999999999997
Q ss_pred CCCCCCCHHHHH-HH
Q 020888 288 DMNQRPSFLDIL-KR 301 (320)
Q Consensus 288 dp~~Rps~~~ll-~~ 301 (320)
| |+++++ +|
T Consensus 323 d-----sa~e~l~~H 332 (336)
T 2vuw_A 323 S-----SATDLLCQH 332 (336)
T ss_dssp S-----SHHHHHHHC
T ss_pred C-----CHHHHHhcC
Confidence 7 999998 54
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9e-32 Score=252.77 Aligned_cols=204 Identities=16% Similarity=0.122 Sum_probs=138.2
Q ss_pred CCCCCCCcCCCCCcccCc-cceecccCceEEEEEEE--CCCceEEEEccCCCCCc-------HHHHHHHHHHHHHHHhC-
Q 020888 29 LPNKCDWEIDPSELDFSS-SAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDD-------RLVIQDFRHEVNLLVKL- 97 (320)
Q Consensus 29 ~~~~~~~~~~~~~~~y~~-~~~lg~g~~~~vy~~~~--~~~~~~~K~~~~~~~~~-------~~~~~~~~~e~~~l~~l- 97 (320)
..+...|.++.-...|.. ....+.|+.|.+..+.. .++.+++|++....... ....+.+.+|+++|+++
T Consensus 220 ~~s~~~~~~~~~~~~~~~w~~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~ 299 (569)
T 4azs_A 220 LVSNHRVLINDFNQPFQHWQNQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPP 299 (569)
T ss_dssp EEESSEEEETTEEEECSEEECC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCC
T ss_pred eccCccccccchhhhHHhhhhccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcC
Confidence 333444444433333322 12345666666666554 38999999986653221 23346799999999999
Q ss_pred CCCcccceeeeEEeCCceEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEee
Q 020888 98 RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN 177 (320)
Q Consensus 98 ~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~ 177 (320)
.|+||+++++++++++.+|+||||++|++|.+++++.++++.. .|+.||+.||+|+|++| |+||||||+|||+
T Consensus 300 ~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~G--IIHRDIKPeNILL-- 372 (569)
T 4azs_A 300 AGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQG--FWHDDVRPWNVMV-- 372 (569)
T ss_dssp TTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTT--CEESCCCGGGEEE--
T ss_pred CCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCC--ceeccCchHhEEE--
Confidence 6999999999999999999999999999999999998888865 47899999999999999 9999999999999
Q ss_pred CCCCcEEEecCCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhC
Q 020888 178 SSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEG 244 (320)
Q Consensus 178 ~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g 244 (320)
+.+|.+||+|||+++....... .....+||+.|+|||++.+. +..++|+|++|++++++.++
T Consensus 373 ~~dg~vKL~DFGlAr~~~~~~~----~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~ 434 (569)
T 4azs_A 373 DARQHARLIDFGSIVTTPQDCS----WPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQP 434 (569)
T ss_dssp CTTSCEEECCCTTEESCC---C----CSHHHHHHHHHHHHHHC------------------CCCCTT
T ss_pred CCCCCEEEeecccCeeCCCCCc----cccCceechhhccHHHhCCC-CCCcccccccccchhhhccc
Confidence 8899999999999986654321 23345799999999998764 56789999999988776554
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5.4e-28 Score=225.89 Aligned_cols=202 Identities=18% Similarity=0.249 Sum_probs=148.1
Q ss_pred CCcCCCCCccc-CccceecccCceEEEEEEECCCceEEEEccCCCCCcH-----HHHHHHHHHHHHHHhCCCCcccceee
Q 020888 34 DWEIDPSELDF-SSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDR-----LVIQDFRHEVNLLVKLRHPNIVQFLG 107 (320)
Q Consensus 34 ~~~~~~~~~~y-~~~~~lg~g~~~~vy~~~~~~~~~~~K~~~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~ 107 (320)
.|..+.....+ ...+.||+|+||+||++...++.+++|.......... ...+++.+|++++++++|+||+++..
T Consensus 327 ~w~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~ 406 (540)
T 3en9_A 327 NWIKEIKGKKRKIPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYI 406 (540)
T ss_dssp CCC------------------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCE
T ss_pred cccccccccccCCCCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEE
Confidence 45444444444 4567999999999999988899999997655433322 12356899999999999999997766
Q ss_pred eEEeCCceEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEec
Q 020888 108 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGD 187 (320)
Q Consensus 108 ~~~~~~~~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~d 187 (320)
++...+..|+||||++|++|.+++.. +..++.|++.+|.|||++| |+|+||||+||++ +. .++|+|
T Consensus 407 ~~~~~~~~~lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~g--IiHrDiKp~NILl--~~--~~kL~D 472 (540)
T 3en9_A 407 FDVDLDNKRIMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKND--VIHNDLTTSNFIF--DK--DLYIID 472 (540)
T ss_dssp EEEETTTTEEEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTT--EECTTCCTTSEEE--SS--SEEECC
T ss_pred EEEeCCccEEEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCc--CccCCCCHHHEEE--CC--eEEEEE
Confidence 66677788999999999999999875 5689999999999999999 9999999999999 55 999999
Q ss_pred CCCcccccccCccce---eeccCCcccccccCccccCc--CCCCCchhHHHHHHHHHHHHhCCCCCC
Q 020888 188 FGLSKLIKVQNSHDV---YKMTGETGSYRYMAPEVFKH--RKYDKKVDVFSFAMILYEMLEGEPPLA 249 (320)
Q Consensus 188 fg~~~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~ll~g~~p~~ 249 (320)
||+++.......... .......||+.|+|||++.+ ..|+...|+|+..+-.++-+.++.+|.
T Consensus 473 FGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 473 FGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 999987654321110 01224568999999999987 567788899999888888777665553
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=8e-24 Score=182.01 Aligned_cols=136 Identities=19% Similarity=0.205 Sum_probs=108.5
Q ss_pred ccCccceecccCceEEEEEEEC-CCceEEEEccCCCCCcH---------------HHHHHHHHHHHHHHhCCCCccccee
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDR---------------LVIQDFRHEVNLLVKLRHPNIVQFL 106 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~-~~~~~~K~~~~~~~~~~---------------~~~~~~~~e~~~l~~l~h~~i~~~~ 106 (320)
.|.+.+.||+|++|.||++.+. ++.+|+|.+........ .....+.+|+++++.++ | +++.
T Consensus 91 ~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~ 167 (282)
T 1zar_A 91 VDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP 167 (282)
T ss_dssp CSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred EEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence 3446699999999999999985 78999998864322110 23467889999999999 5 6777
Q ss_pred eeEEeCCceEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEe
Q 020888 107 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVG 186 (320)
Q Consensus 107 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~ 186 (320)
+++.. +..|+||||++|++|.+ +.. .....++.|++.||.+||+.| |+|+||||+||++ + ++.++|+
T Consensus 168 ~~~~~-~~~~lvmE~~~g~~L~~-l~~------~~~~~i~~qi~~~l~~lH~~g--iiHrDlkp~NILl--~-~~~vkl~ 234 (282)
T 1zar_A 168 KVYAW-EGNAVLMELIDAKELYR-VRV------ENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLV--S-EEGIWII 234 (282)
T ss_dssp CEEEE-ETTEEEEECCCCEEGGG-CCC------SCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEE--E-TTEEEEC
T ss_pred eEEec-cceEEEEEecCCCcHHH-cch------hhHHHHHHHHHHHHHHHHHCC--CEeCCCCHHHEEE--E-CCcEEEE
Confidence 76554 55699999999999998 421 234579999999999999999 9999999999999 6 8899999
Q ss_pred cCCCcccc
Q 020888 187 DFGLSKLI 194 (320)
Q Consensus 187 dfg~~~~~ 194 (320)
|||++...
T Consensus 235 DFG~a~~~ 242 (282)
T 1zar_A 235 DFPQSVEV 242 (282)
T ss_dssp CCTTCEET
T ss_pred ECCCCeEC
Confidence 99998743
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=4.5e-20 Score=156.68 Aligned_cols=139 Identities=18% Similarity=0.188 Sum_probs=105.9
Q ss_pred ccCccceecccCceEEEEEEE--CCCc--eEEEEccCCCCCc---------------------HHHHHHHHHHHHHHHhC
Q 020888 43 DFSSSAIIGKGSFGEILKAYW--RGTP--VAIKRILPSLSDD---------------------RLVIQDFRHEVNLLVKL 97 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~--~~~~--~~~K~~~~~~~~~---------------------~~~~~~~~~e~~~l~~l 97 (320)
-|.+.+.||+|+||.||++.+ +++. +|+|++....... ......+.+|+..+..+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 467889999999999999998 5888 9999875432110 11123678899999999
Q ss_pred CCCcc--cceeeeEEeCCceEEEEecCCC-C----CHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCC
Q 020888 98 RHPNI--VQFLGAVTERKPLMLITEYLRG-G----DLHKYLKEKGALSPSTAVNFALDIARGMAYLH-NEPNVIIHRDLK 169 (320)
Q Consensus 98 ~h~~i--~~~~~~~~~~~~~~iv~e~~~~-~----~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH-~~g~~ivH~di~ 169 (320)
.|+++ +.+++. ...++||||+++ | +|.++... .++..+..++.|++.+|.+|| +.| |+|+|||
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~g--ivHrDlk 198 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAE--LVHADLS 198 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSC--EECSSCS
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCC--EEeCCCC
Confidence 87754 333332 356899999942 3 67766432 234567889999999999999 988 9999999
Q ss_pred CCcEEEeeCCCCcEEEecCCCcccc
Q 020888 170 PRNVLLVNSSADHLKVGDFGLSKLI 194 (320)
Q Consensus 170 p~nI~~~~~~~~~~~L~dfg~~~~~ 194 (320)
|.||++ +. .++|+|||++...
T Consensus 199 p~NILl--~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 199 EYNIMY--ID--KVYFIDMGQAVTL 219 (258)
T ss_dssp TTSEEE--SS--SEEECCCTTCEET
T ss_pred HHHEEE--cC--cEEEEECcccccC
Confidence 999999 55 8999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.73 E-value=2e-18 Score=152.76 Aligned_cols=145 Identities=12% Similarity=0.099 Sum_probs=99.9
Q ss_pred ccCccceecccCceEEEEEEEC-CCceEEEEccCCCCC------------c---HHHH----HHHHHHHHHHHhCCCCcc
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSD------------D---RLVI----QDFRHEVNLLVKLRHPNI 102 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~-~~~~~~K~~~~~~~~------------~---~~~~----~~~~~e~~~l~~l~h~~i 102 (320)
=|.+...||+|++|.||+|.+. ++.||+|++...... . .... -....|+..|.++.+.++
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 4889999999999999999875 899999987543111 0 0000 112345666666644333
Q ss_pred cceeeeEEeCCceEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCC-
Q 020888 103 VQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD- 181 (320)
Q Consensus 103 ~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~- 181 (320)
. +...+... ..++||||++|++|.++.. ......++.|++.+|.+||+.| ||||||||.||++.++.++
T Consensus 176 ~-vp~p~~~~-~~~LVME~i~G~~L~~l~~------~~~~~~l~~qll~~l~~lH~~g--IVHrDLKp~NILl~~dgd~~ 245 (397)
T 4gyi_A 176 P-VPEPIAQS-RHTIVMSLVDALPMRQVSS------VPDPASLYADLIALILRLAKHG--LIHGDFNEFNILIREEKDAE 245 (397)
T ss_dssp S-CCCEEEEE-TTEEEEECCSCEEGGGCCC------CSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEEEEECSS
T ss_pred C-CCeeeecc-CceEEEEecCCccHhhhcc------cHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEeCCCCcc
Confidence 2 11112222 2379999999988876532 1234568899999999999999 9999999999999544322
Q ss_pred -------cEEEecCCCccccccc
Q 020888 182 -------HLKVGDFGLSKLIKVQ 197 (320)
Q Consensus 182 -------~~~L~dfg~~~~~~~~ 197 (320)
.+.|+||+.+.....+
T Consensus 246 d~~~~~~~~~iID~~Q~V~~~hp 268 (397)
T 4gyi_A 246 DPSSITLTPIIIXFPQMVSMDHP 268 (397)
T ss_dssp CTTSEEEEEEECCCTTCEETTST
T ss_pred cccccccceEEEEeCCcccCCCC
Confidence 3899999988765443
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.47 E-value=1.7e-13 Score=116.15 Aligned_cols=140 Identities=14% Similarity=0.064 Sum_probs=109.3
Q ss_pred ccCccceecccCceEEEEEEECCCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCC-CCcccceeeeEEeCCceEEEEec
Q 020888 43 DFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLMLITEY 121 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~iv~e~ 121 (320)
.|.+...++.|+.+.||++...+..+++|.......... ..+.+|+++++.+. +..++++++++...+..|+||||
T Consensus 15 ~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~~---~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~ 91 (263)
T 3tm0_A 15 KYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTT---YDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp TSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTST---TCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred cceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCCH---HHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEe
Confidence 588888889999999999987789999998765322221 35778999998884 67788999999988899999999
Q ss_pred CCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCC-----------------------------------------
Q 020888 122 LRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP----------------------------------------- 160 (320)
Q Consensus 122 ~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g----------------------------------------- 160 (320)
++|.+|.+.+. +......++.++..+|..||+..
T Consensus 92 i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (263)
T 3tm0_A 92 ADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKD 166 (263)
T ss_dssp CSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSS
T ss_pred cCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCC
Confidence 99999987631 12223467889999999999810
Q ss_pred ----------------CCeEecCCCCCcEEEeeCCCCcEEEecCCCcc
Q 020888 161 ----------------NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 192 (320)
Q Consensus 161 ----------------~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~ 192 (320)
..++|||++|.||++ +.++.+.|+||+.+.
T Consensus 167 ~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~--~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 167 PRELYDFLKTEKPEEELVFSHGDLGDSNIFV--KDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHHHHCCCCCCEEEECSSCCTTSEEE--ETTEEEEECCCTTCE
T ss_pred HHHHHHHHHhcCCCCCceEECCCCCcCcEEE--ECCcEEEEEEchhcc
Confidence 128999999999999 554456699999764
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.27 E-value=1.9e-11 Score=108.47 Aligned_cols=142 Identities=18% Similarity=0.207 Sum_probs=105.0
Q ss_pred CccceecccCceEEEEEEECCCceEEEEcc--CCCCCcHHHHHHHHHHHHHHHhCC--CCcccceeeeEEeC---CceEE
Q 020888 45 SSSAIIGKGSFGEILKAYWRGTPVAIKRIL--PSLSDDRLVIQDFRHEVNLLVKLR--HPNIVQFLGAVTER---KPLML 117 (320)
Q Consensus 45 ~~~~~lg~g~~~~vy~~~~~~~~~~~K~~~--~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~---~~~~i 117 (320)
..++.++.|..+.+|++...+..+++|... ..... .....+.+|+++++.+. +..+++++.++.+. +..|+
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~~--~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~ 118 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKLL--PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY 118 (359)
T ss_dssp CEEEECCC-CCSCEEEEECSSCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred ceEEEcCCcccceEEEEEECCceEEEEeCCCCCCCCC--CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence 346788999999999998888889999765 32211 12257788999999886 44577888888766 45899
Q ss_pred EEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcC--------------------------------------
Q 020888 118 ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE-------------------------------------- 159 (320)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~-------------------------------------- 159 (320)
||||++|.++.+.. ...++......++.++...|..||..
T Consensus 119 vme~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 119 IMEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp EEECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred EEEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 99999998875421 12467788888999999999999972
Q ss_pred ------------------CCCeEecCCCCCcEEEeeCCCC--cEEEecCCCcc
Q 020888 160 ------------------PNVIIHRDLKPRNVLLVNSSAD--HLKVGDFGLSK 192 (320)
Q Consensus 160 ------------------g~~ivH~di~p~nI~~~~~~~~--~~~L~dfg~~~ 192 (320)
...++|||++|.||++ +.++ .+.|+||+.+.
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~--~~~~~~v~~viDwe~a~ 247 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMF--HPTEPRVLAVLDWELST 247 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEE--CSSSSCEEEECCCTTCE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEE--eCCCCcEEEEECccccc
Confidence 1239999999999999 5443 36899999875
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.21 E-value=9.4e-11 Score=98.84 Aligned_cols=134 Identities=19% Similarity=0.147 Sum_probs=95.0
Q ss_pred ccCccceecccCceEEEEEEEC-CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCc--ccceeeeEEeCCceEEEE
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN--IVQFLGAVTERKPLMLIT 119 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~-~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~~~~~~~~~iv~ 119 (320)
.|.+..+.+.|..+.||++... +..+++|....... ..+..|+++++.+.+.+ +.+++++...++..++||
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~~------~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~ 94 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLL 94 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCTT------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEE
T ss_pred CCceEecccCCCCceEEEEecCCCCeEEEEeCCcccc------hhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEE
Confidence 4555444446667999999765 57799998754311 35677888888885334 566888888888899999
Q ss_pred ecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCC---------------------------------------
Q 020888 120 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP--------------------------------------- 160 (320)
Q Consensus 120 e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g--------------------------------------- 160 (320)
||++|.+|. . ...+. ..++.++...|..||+..
T Consensus 95 e~i~G~~l~--~---~~~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (264)
T 1nd4_A 95 GEVPGQDLL--S---SHLAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLA 166 (264)
T ss_dssp ECCSSEETT--T---SCCCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCC
T ss_pred EecCCcccC--c---CcCCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCcc
Confidence 999998884 2 11222 245667777777777642
Q ss_pred -----------------CCeEecCCCCCcEEEeeCCCCcEEEecCCCcc
Q 020888 161 -----------------NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 192 (320)
Q Consensus 161 -----------------~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~ 192 (320)
..++|||++|.||++ +.++.+.|+||+.+.
T Consensus 167 ~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~--~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 167 PAELFARLKARMPDGEDLVVTHGDACLPNIMV--ENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHHHHHHHTCCSSCCEEEECSSCCGGGEEE--ETTEEEEECCCTTCE
T ss_pred HHHHHHHHHHhcCCCCCeEEECCCCCCCcEEE--ECCcEEEEEcchhcc
Confidence 119999999999999 555556699999764
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.01 E-value=3.2e-10 Score=98.10 Aligned_cols=187 Identities=19% Similarity=0.166 Sum_probs=119.0
Q ss_pred cceecccCceEEEEEEECCCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCC-CCc--ccceeeeEEeCC---ceEEEEe
Q 020888 47 SAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPN--IVQFLGAVTERK---PLMLITE 120 (320)
Q Consensus 47 ~~~lg~g~~~~vy~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~--i~~~~~~~~~~~---~~~iv~e 120 (320)
++.++.|..+.||++. ..+++|+.... .....+.+|.++++.+. +.. +.+++.....++ ..|+||+
T Consensus 25 i~~~~~G~~n~v~~v~---~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~ 96 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN---RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFT 96 (304)
T ss_dssp CCEEEECSSEEEEEST---TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEE
T ss_pred eEecCCCCcceEEEEC---CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEc
Confidence 3568999999999983 67999975322 33477889999998873 333 345555443333 3589999
Q ss_pred cCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCC----------------------------------------
Q 020888 121 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP---------------------------------------- 160 (320)
Q Consensus 121 ~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g---------------------------------------- 160 (320)
+++|.+|.+... ..++......++.++...+..||+..
T Consensus 97 ~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 174 (304)
T 3sg8_A 97 KIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD 174 (304)
T ss_dssp CCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred ccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence 999988876433 24677777788888888888888511
Q ss_pred ----------------CCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCccceeeccCCcccccccCccccCc--
Q 020888 161 ----------------NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH-- 222 (320)
Q Consensus 161 ----------------~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-- 222 (320)
..++|||++|.||++.++..+.+.++||+.+..-... . +..... ....-..|+....
T Consensus 175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~-~-Dl~~~~---~~~~~~~~~~~~~~l 249 (304)
T 3sg8_A 175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD-N-DFISLM---EDDEEYGMEFVSKIL 249 (304)
T ss_dssp HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT-H-HHHTTC---CTTTSCCHHHHHHHH
T ss_pred HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH-H-HHHHHH---hhccccCHHHHHHHH
Confidence 1279999999999993322556789999987542110 0 000000 0000012221100
Q ss_pred ---CCC---------CCchhHHHHHHHHHHHHhCCCCC
Q 020888 223 ---RKY---------DKKVDVFSFAMILYEMLEGEPPL 248 (320)
Q Consensus 223 ---~~~---------~~~~Di~slG~~l~~ll~g~~p~ 248 (320)
+.. ....+.|+++.+++.+.+|..+|
T Consensus 250 ~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 250 NHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 001 12368999999999999997664
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.76 E-value=8.8e-08 Score=81.11 Aligned_cols=131 Identities=21% Similarity=0.220 Sum_probs=95.5
Q ss_pred ecccCc-eEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCC-CCcccceeeeEEeCCceEEEEecCCCC
Q 020888 50 IGKGSF-GEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLMLITEYLRGG 125 (320)
Q Consensus 50 lg~g~~-~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~iv~e~~~~~ 125 (320)
+..|.. ..||+.... +..+++|..... ....+.+|...|+.+. +-.+.+++.++.+++..++||++++|.
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~ 105 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK 105 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETH------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCC------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence 344444 468988764 567999976432 2367888999988884 444778899999999999999999999
Q ss_pred CHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCC--------------------------------------------
Q 020888 126 DLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPN-------------------------------------------- 161 (320)
Q Consensus 126 ~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~-------------------------------------------- 161 (320)
++.+..... ......+..++...|..||....
T Consensus 106 ~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (272)
T 4gkh_A 106 TAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK 181 (272)
T ss_dssp EHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred cccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence 988876542 12234566677777777776420
Q ss_pred ------------CeEecCCCCCcEEEeeCCCCcEEEecCCCcc
Q 020888 162 ------------VIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 192 (320)
Q Consensus 162 ------------~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~ 192 (320)
.++|||+.+.||++ +.++.+-|+||+.+.
T Consensus 182 ~l~~~~~~~~~~~l~HGDl~~~Nil~--~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 182 EMHKLLPFSPDSVVTHGDFSLDNLIF--DEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHTTCCCCCCEEEECSCCCTTSEEE--ETTEEEEECCCTTCE
T ss_pred HHHhcccccCCcEEEcCCCCCCeEEE--ECCeEEEEEECcccc
Confidence 17999999999999 666666799999764
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.73 E-value=2.5e-07 Score=79.91 Aligned_cols=134 Identities=20% Similarity=0.168 Sum_probs=90.2
Q ss_pred cceecccCceEEEEEEECCCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCC---cccceeeeEE-eCCceEEEEecC
Q 020888 47 SAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP---NIVQFLGAVT-ERKPLMLITEYL 122 (320)
Q Consensus 47 ~~~lg~g~~~~vy~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~---~i~~~~~~~~-~~~~~~iv~e~~ 122 (320)
++.++.|....||++ +..+++|+.. .......+..|.++++.+.+. .+.+++.+.. ..+..+++|+++
T Consensus 24 v~~l~~G~~n~v~~v---g~~~VlR~~~-----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i 95 (306)
T 3tdw_A 24 VESLGEGFRNYAILV---NGDWVFRFPK-----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKV 95 (306)
T ss_dssp EEEEEECSSEEEEEE---TTTEEEEEES-----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECC
T ss_pred eeecCCCcceeEEEE---CCEEEEEecC-----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEecc
Confidence 456788999999998 7889999742 123347888999999998642 3566676664 456689999999
Q ss_pred CCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCC------------------------------------------
Q 020888 123 RGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP------------------------------------------ 160 (320)
Q Consensus 123 ~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g------------------------------------------ 160 (320)
+|.+|.+..- ..++......++.++...|..||+..
T Consensus 96 ~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 96 QGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp CSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred CCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 9988876321 12333333344444444444444321
Q ss_pred ----------------CCeEecCCCCCcEEEeeCC---CCc-EEEecCCCcc
Q 020888 161 ----------------NVIIHRDLKPRNVLLVNSS---ADH-LKVGDFGLSK 192 (320)
Q Consensus 161 ----------------~~ivH~di~p~nI~~~~~~---~~~-~~L~dfg~~~ 192 (320)
..++|||++|.||++ +. ++. +.|+||+.+.
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~--~~~~~~~~~~~~iD~~~a~ 223 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLT--NLNSRQTPLTGIIDFGDAA 223 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEE--CTTCSSCCEEEECCCTTCE
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEE--ecCCCCCceEEEEehhhcC
Confidence 237999999999999 54 344 5799999765
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.35 E-value=1.4e-06 Score=76.79 Aligned_cols=80 Identities=9% Similarity=0.027 Sum_probs=54.2
Q ss_pred cccee-cccCceEEEEEEEC--------CCceEEEEccCCC---CCcHHHHHHHHHHHHHHHhCC-C--CcccceeeeEE
Q 020888 46 SSAII-GKGSFGEILKAYWR--------GTPVAIKRILPSL---SDDRLVIQDFRHEVNLLVKLR-H--PNIVQFLGAVT 110 (320)
Q Consensus 46 ~~~~l-g~g~~~~vy~~~~~--------~~~~~~K~~~~~~---~~~~~~~~~~~~e~~~l~~l~-h--~~i~~~~~~~~ 110 (320)
..+.| +.|..+.+|++... +..+++|...... .... ..+..|+.+++.+. + -.+.+++.+..
T Consensus 24 ~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~---~~~~~E~~~l~~L~~~~~vpvP~v~~~~~ 100 (357)
T 3ats_A 24 VESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPT---YRLDHQFEVIRLVGELTDVPVPRVRWIET 100 (357)
T ss_dssp EEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSC---CCHHHHHHHHHHHHHHCCSCCCCEEEEEC
T ss_pred EEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCch---hHHHHHHHHHHHHhhcCCCCCCcEEEEcc
Confidence 34667 88888999998765 6789999765432 1011 34566777777773 2 35677787766
Q ss_pred eC---CceEEEEecCCCCCHH
Q 020888 111 ER---KPLMLITEYLRGGDLH 128 (320)
Q Consensus 111 ~~---~~~~iv~e~~~~~~L~ 128 (320)
+. +..++||||++|.++.
T Consensus 101 ~~~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 101 TGDVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp SSTTTSSCEEEEECCCCBCCC
T ss_pred CCCccCCceEEEEecCCCChh
Confidence 54 4578999999886543
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.34 E-value=2e-05 Score=68.68 Aligned_cols=74 Identities=15% Similarity=0.154 Sum_probs=42.7
Q ss_pred cceecccCceEEEEEEECCCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCC--CCcccceee------eEEeCCceEEE
Q 020888 47 SAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR--HPNIVQFLG------AVTERKPLMLI 118 (320)
Q Consensus 47 ~~~lg~g~~~~vy~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~------~~~~~~~~~iv 118 (320)
.+.|+.|..+.+|++...+..+++|..... . ..+..|.+++..+. .-.+++++. +...++..+++
T Consensus 37 ~~~l~gG~~n~~~~v~~~~~~~vlk~~~~~----~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l 109 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTDSGAVCLKRIHRP----E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVV 109 (346)
T ss_dssp EEECC----CEEEEEEETTEEEEEEEECSC----H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEE
T ss_pred eeeccccccCcEEEEEeCCCCEEEEecCCC----H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEE
Confidence 345666778999999877667999987642 1 22333444444442 112344443 22346678999
Q ss_pred EecCCCCCH
Q 020888 119 TEYLRGGDL 127 (320)
Q Consensus 119 ~e~~~~~~L 127 (320)
++|++|.++
T Consensus 110 ~~~i~G~~~ 118 (346)
T 2q83_A 110 YDWIEGRPF 118 (346)
T ss_dssp EECCCCBCC
T ss_pred EEeecCccC
Confidence 999988653
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.21 E-value=6.2e-06 Score=73.79 Aligned_cols=77 Identities=21% Similarity=0.320 Sum_probs=48.1
Q ss_pred cceecccCceEEEEEEE--CCCceEEEEccCCCC--Cc--HHHHHHHHHHHHHHHhCC-C-C-cccceeeeEEeCCceEE
Q 020888 47 SAIIGKGSFGEILKAYW--RGTPVAIKRILPSLS--DD--RLVIQDFRHEVNLLVKLR-H-P-NIVQFLGAVTERKPLML 117 (320)
Q Consensus 47 ~~~lg~g~~~~vy~~~~--~~~~~~~K~~~~~~~--~~--~~~~~~~~~e~~~l~~l~-h-~-~i~~~~~~~~~~~~~~i 117 (320)
.+.+|.|..+.||++.. .++.+++|....... .. .....++..|.++++.+. . + .+++++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 46789999999999964 367899997643211 00 001245667888888773 2 3 34455543 3445689
Q ss_pred EEecCCCC
Q 020888 118 ITEYLRGG 125 (320)
Q Consensus 118 v~e~~~~~ 125 (320)
|||+++|.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999763
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=98.19 E-value=4e-05 Score=61.55 Aligned_cols=145 Identities=14% Similarity=0.154 Sum_probs=95.8
Q ss_pred CCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCccce
Q 020888 125 GDLHKYLKE-KGALSPSTAVNFALDIARGMAYLH-NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDV 202 (320)
Q Consensus 125 ~~L~~~~~~-~~~l~~~~~~~i~~~l~~~l~~lH-~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~~~ 202 (320)
.+|.++++. +.++++.++|.++.|.+.+|..+- .+. -...=+.|..|++ ..+|.|.+.+ +.+.
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~--~~~~i~~~~~i~l--~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQ--PRHRVRSAAQIRV--WRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTC--CCCCCCSGGGEEE--ETTSCEEECC-C-------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhccc--CCceecCCcceEE--ecCCceeccc-cccc----------
Confidence 389999986 458999999999999999988872 221 1122235799999 7888888764 1110
Q ss_pred eeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHH
Q 020888 203 YKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTE 282 (320)
Q Consensus 203 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 282 (320)
.....|.|||... ...+.+.=|||||+++|..+--..| .-.+..+++.|.+||.
T Consensus 98 ------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~-------------------e~eE~eLS~~LE~LL~ 151 (229)
T 2yle_A 98 ------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK-------------------ENEERELSPPLEQLID 151 (229)
T ss_dssp ---------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC-------------------TTEEECCCHHHHHHHH
T ss_pred ------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC-------------------cccchhhCHHHHHHHH
Confidence 1122466787652 4556788999999999988874433 2233568999999999
Q ss_pred HHhhcC-------------------------CCCCCCHHHHHHHHHHHHhcCCCCC
Q 020888 283 KCWAAD-------------------------MNQRPSFLDILKRLEKIKETLPTDH 313 (320)
Q Consensus 283 ~~l~~d-------------------------p~~Rps~~~ll~~L~~~~~~~~~~~ 313 (320)
.|.... +..|.+++++++ .....++++.
T Consensus 152 ~Mt~~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~---~C~~hl~~ps 204 (229)
T 2yle_A 152 HMANTVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMK---LCAAHLPTES 204 (229)
T ss_dssp HHTTCCC--------------------CCSCCCCCCSHHHHHH---HHHTTSSSGG
T ss_pred HHHhcccccccccccccccccccccccccccccCcCCHHHHHH---HHHhhccCcc
Confidence 998662 356788888764 4555555554
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.14 E-value=1.6e-05 Score=68.58 Aligned_cols=75 Identities=21% Similarity=0.118 Sum_probs=60.0
Q ss_pred cceecccCceEEEEEEECCCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCC---CCcccceeeeEEeCCceEEEEecCC
Q 020888 47 SAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR---HPNIVQFLGAVTERKPLMLITEYLR 123 (320)
Q Consensus 47 ~~~lg~g~~~~vy~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~iv~e~~~ 123 (320)
.+.|+.|..+.+|++...+..+++|..... ....+..|.+.|+.+. ...+++++.+....+..++||||++
T Consensus 41 ~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~ 114 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLINDEVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN 114 (312)
T ss_dssp EEEECCSSSSEEEEEESSSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred eEEeCCccceeeeEEEECCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence 467899999999999877888999976532 1366788888888873 3567888888887788999999999
Q ss_pred CCCH
Q 020888 124 GGDL 127 (320)
Q Consensus 124 ~~~L 127 (320)
|.++
T Consensus 115 G~~~ 118 (312)
T 3jr1_A 115 KSKN 118 (312)
T ss_dssp CCCC
T ss_pred CCCC
Confidence 8754
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.10 E-value=3.4e-05 Score=69.52 Aligned_cols=76 Identities=14% Similarity=0.148 Sum_probs=45.0
Q ss_pred cceecccCceEEEEEEECCCceEEEEccCCCC--CcH----HHHHHHHHHHHHHH-hCCCCcccceeeeEEeCCceEEEE
Q 020888 47 SAIIGKGSFGEILKAYWRGTPVAIKRILPSLS--DDR----LVIQDFRHEVNLLV-KLRHPNIVQFLGAVTERKPLMLIT 119 (320)
Q Consensus 47 ~~~lg~g~~~~vy~~~~~~~~~~~K~~~~~~~--~~~----~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~iv~ 119 (320)
.+.+|.|..+.||++...++.+++|....... ... .....+..|+..+. ......+++++.+. .+..++||
T Consensus 39 i~~l~~G~~n~vyrv~~~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~lv~ 116 (420)
T 2pyw_A 39 IKEVGDGNLNFVFIVVGSSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALIGM 116 (420)
T ss_dssp EEECCCSSSCEEEEEECSSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEEEE
T ss_pred EEEccCCCcEEEEEEEcCCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEEEE
Confidence 46789999999999977678899994322111 000 01122333332222 12234566777665 46678999
Q ss_pred ecC-CC
Q 020888 120 EYL-RG 124 (320)
Q Consensus 120 e~~-~~ 124 (320)
||+ +|
T Consensus 117 e~l~~g 122 (420)
T 2pyw_A 117 RYLEPP 122 (420)
T ss_dssp CCCCTT
T ss_pred eecCCc
Confidence 999 76
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.79 E-value=0.00028 Score=59.96 Aligned_cols=78 Identities=19% Similarity=0.149 Sum_probs=53.2
Q ss_pred ccCccceecccCceEEEEEEEC-CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCC-C--CcccceeeeEEeCCceEEE
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-H--PNIVQFLGAVTERKPLMLI 118 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~-~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-h--~~i~~~~~~~~~~~~~~iv 118 (320)
....++.+|.|..+.||++... ++++++|+......... ..+..|.+.|+.+. . -.+++++.. + ..++|
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~---~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~--~~~lv 88 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALD---GLFRAEALGLDWLGRSFGSPVPQVAGW--D--DRTLA 88 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCT---THHHHHHHHHHHHTCSTTCCSCCEEEE--E--TTEEE
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchh---hHHHHHHHHHHHHHhhCCCCcceEEec--c--CceEE
Confidence 3455678899999999999876 78999997654433222 45678888888774 2 234455543 2 24788
Q ss_pred EecCCCCCH
Q 020888 119 TEYLRGGDL 127 (320)
Q Consensus 119 ~e~~~~~~L 127 (320)
|||++++..
T Consensus 89 ~e~l~~~~~ 97 (288)
T 3f7w_A 89 MEWVDERPP 97 (288)
T ss_dssp EECCCCCCC
T ss_pred EEeecccCC
Confidence 999876543
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.62 E-value=0.00045 Score=59.10 Aligned_cols=71 Identities=8% Similarity=0.045 Sum_probs=44.4
Q ss_pred cceecccCceEEEEEEECCCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcc-cceeeeEEeCCceEEEEecC-CC
Q 020888 47 SAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI-VQFLGAVTERKPLMLITEYL-RG 124 (320)
Q Consensus 47 ~~~lg~g~~~~vy~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~iv~e~~-~~ 124 (320)
++.|+.|..+.+|++ ..+++|+........ ....+|+.+++.+...++ .+++... .+.-+++++|+ +|
T Consensus 23 i~~l~gG~tN~~~~~----~~~vlR~~~~~~~~~----~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g 92 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA----GDLCLRIPGKGTEEY----INRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGA 92 (301)
T ss_dssp CEEEESCSSEEEEEE----TTEEEEEECC----C----CCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTC
T ss_pred eeEcCCcccccccee----eeEEEECCCCCccce----eCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCC
Confidence 678999999999999 779999775432111 122346766666642222 4555543 33357899999 76
Q ss_pred CCH
Q 020888 125 GDL 127 (320)
Q Consensus 125 ~~L 127 (320)
.+|
T Consensus 93 ~~l 95 (301)
T 3dxq_A 93 QTM 95 (301)
T ss_dssp EEC
T ss_pred ccC
Confidence 555
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.59 E-value=0.00083 Score=57.90 Aligned_cols=139 Identities=17% Similarity=0.127 Sum_probs=74.8
Q ss_pred cceecccCceEEEEEEECCCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCc--ccceeee------EEeCCceEEE
Q 020888 47 SAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN--IVQFLGA------VTERKPLMLI 118 (320)
Q Consensus 47 ~~~lg~g~~~~vy~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~------~~~~~~~~iv 118 (320)
.+.++.|....+|++...+..+++|........ ..+..|..++..+...+ +.+++.. ...++..+++
T Consensus 27 ~~~i~~G~~n~~~~v~~~~g~~vlk~~~~~~~~-----~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l 101 (322)
T 2ppq_A 27 YKGIAEGVENSNFLLHTTKDPLILTLYEKRVEK-----NDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAAL 101 (322)
T ss_dssp EEEECC---EEEEEEEESSCCEEEEEECC---C-----CHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEE
T ss_pred eeccCCCcccceEEEEeCCccEEEEEeCCCCCH-----HHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEE
Confidence 456777888999999877678999987652111 34445666666553112 3333321 2234567899
Q ss_pred EecCCCCCHH-----H------HHH----HhCCC--------C---HHHHHH------------HHHHHHHHHHHHhc--
Q 020888 119 TEYLRGGDLH-----K------YLK----EKGAL--------S---PSTAVN------------FALDIARGMAYLHN-- 158 (320)
Q Consensus 119 ~e~~~~~~L~-----~------~~~----~~~~l--------~---~~~~~~------------i~~~l~~~l~~lH~-- 158 (320)
++|++|.++. . .+. ....+ . |...+. +...+...+..+..
T Consensus 102 ~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~ 181 (322)
T 2ppq_A 102 ISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHW 181 (322)
T ss_dssp EECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHC
T ss_pred EEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhC
Confidence 9999886431 1 111 10010 1 111000 00012333444431
Q ss_pred ---CCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcc
Q 020888 159 ---EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 192 (320)
Q Consensus 159 ---~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~ 192 (320)
....++|||+.+.||++ +.++.+.++||+.+.
T Consensus 182 ~~~~~~~liHgDl~~~Nil~--~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 182 PKDLPAGVIHADLFQDNVFF--LGDELSGLIDFYFAC 216 (322)
T ss_dssp CCSSCEEEECSCCCGGGEEE--ETTEEEEECCCTTCE
T ss_pred cccCCcccCCCCCCccCEEE--eCCceEEEecchhcc
Confidence 11239999999999999 555455799999764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.58 E-value=0.00042 Score=60.15 Aligned_cols=29 Identities=34% Similarity=0.523 Sum_probs=24.8
Q ss_pred CeEecCCCCCcEEEeeCCC----CcEEEecCCCcc
Q 020888 162 VIIHRDLKPRNVLLVNSSA----DHLKVGDFGLSK 192 (320)
Q Consensus 162 ~ivH~di~p~nI~~~~~~~----~~~~L~dfg~~~ 192 (320)
.++|||+.+.||++ +.+ +.+.++||+.+.
T Consensus 184 ~lvHgD~~~~Nil~--~~~~~~~~~~~lIDf~~a~ 216 (333)
T 3csv_A 184 VFVHRDFHAQNLLW--LPEREGLARVGVIDFQDAK 216 (333)
T ss_dssp EEECSCCSGGGEEE--CTTSCGGGGEEECCCTTCE
T ss_pred eeEeCCcCcccEEe--ccCcCCCCCeEEEeCCCcC
Confidence 49999999999999 443 679999999875
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.57 E-value=0.0008 Score=58.15 Aligned_cols=74 Identities=7% Similarity=0.025 Sum_probs=46.5
Q ss_pred ceecccCceEEEEEEEC-CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCC--Ccccceeee-----EEeCCceEEEE
Q 020888 48 AIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH--PNIVQFLGA-----VTERKPLMLIT 119 (320)
Q Consensus 48 ~~lg~g~~~~vy~~~~~-~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~-----~~~~~~~~iv~ 119 (320)
..++ |....||++... ++.+++|....... .. ..+..|..++..+.. -.+++++.. ...++..++++
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~-~~---~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~ 106 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERW-TA---DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVF 106 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTTS-CH---HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEE
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCCC-CH---HHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEE
Confidence 4566 778899998764 56899998754322 22 455667777766632 123444443 22345668899
Q ss_pred ecCCCCC
Q 020888 120 EYLRGGD 126 (320)
Q Consensus 120 e~~~~~~ 126 (320)
+|++|.+
T Consensus 107 ~~i~G~~ 113 (328)
T 1zyl_A 107 PSVGGRQ 113 (328)
T ss_dssp ECCCCEE
T ss_pred EecCCCC
Confidence 9998744
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.47 E-value=0.00034 Score=61.89 Aligned_cols=138 Identities=19% Similarity=0.243 Sum_probs=77.8
Q ss_pred cceecccCceEEEEEEEC---------CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCC-CCcccceeeeEEeCCceE
Q 020888 47 SAIIGKGSFGEILKAYWR---------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLM 116 (320)
Q Consensus 47 ~~~lg~g~~~~vy~~~~~---------~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 116 (320)
++.+..|-...+|++... ++.+++|+.... ... ...+.+|.++++.+. +.-..++++.+.++
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~---~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g---- 126 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQG---VDSLVLESVMFAILAERSLGPQLYGVFPEG---- 126 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CC---HHHHHHHHHHHHHHHHTTSSCCEEEEETTE----
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cch---HHHHHHHHHHHHHHHhcCCCCeEEEEcCCc----
Confidence 356777888899999863 367999975321 111 245567888888774 32235666665532
Q ss_pred EEEecCCCCCHH--------------HHHHH-h------C-CCC--HHHHHHHHHHHHH-------------------HH
Q 020888 117 LITEYLRGGDLH--------------KYLKE-K------G-ALS--PSTAVNFALDIAR-------------------GM 153 (320)
Q Consensus 117 iv~e~~~~~~L~--------------~~~~~-~------~-~l~--~~~~~~i~~~l~~-------------------~l 153 (320)
+|+||++|.+|. +.+.+ + + ... +.++..+..++.. .+
T Consensus 127 ~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~ 206 (379)
T 3feg_A 127 RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEM 206 (379)
T ss_dssp EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHH
T ss_pred cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHH
Confidence 899999875542 11111 1 1 111 3445555544322 12
Q ss_pred H----HHhcC--CCCeEecCCCCCcEEEeeC--CCCcEEEecCCCcc
Q 020888 154 A----YLHNE--PNVIIHRDLKPRNVLLVNS--SADHLKVGDFGLSK 192 (320)
Q Consensus 154 ~----~lH~~--g~~ivH~di~p~nI~~~~~--~~~~~~L~dfg~~~ 192 (320)
. .|... ...++|+|+.+.||++..+ ..+.+.++||..+.
T Consensus 207 ~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 207 GNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 2 22222 1249999999999999433 23689999999875
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.33 E-value=0.0014 Score=59.47 Aligned_cols=73 Identities=21% Similarity=0.147 Sum_probs=46.0
Q ss_pred cceecccCceEEEEEEECC--CceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcc-cceeeeEEeCCceEEEEecCC
Q 020888 47 SAIIGKGSFGEILKAYWRG--TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI-VQFLGAVTERKPLMLITEYLR 123 (320)
Q Consensus 47 ~~~lg~g~~~~vy~~~~~~--~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~iv~e~~~ 123 (320)
++.|+.|-...+|++...+ ..+++|+......... ...+|..+++.+...++ +++++.+.+ ..|++|++
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i----dR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~ 184 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII----NREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMD 184 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS----CHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc----CHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeC
Confidence 4567888889999998876 7899997743221111 11468888888864444 566666532 25999998
Q ss_pred CCCH
Q 020888 124 GGDL 127 (320)
Q Consensus 124 ~~~L 127 (320)
|.+|
T Consensus 185 G~~l 188 (458)
T 2qg7_A 185 GYAL 188 (458)
T ss_dssp SEEC
T ss_pred CccC
Confidence 7443
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.28 E-value=0.004 Score=54.19 Aligned_cols=29 Identities=24% Similarity=0.449 Sum_probs=25.3
Q ss_pred CeEecCCCCCcEEEeeCCCCcEEEecCCCcc
Q 020888 162 VIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 192 (320)
Q Consensus 162 ~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~ 192 (320)
.++|||+.+.||++ +.++.+.|+||+.+.
T Consensus 207 ~~~HgD~~~~N~l~--~~~~~~~~iD~e~~~ 235 (339)
T 3i1a_A 207 VLCHSDIHAGNVLV--GNEESIYIIDWDEPM 235 (339)
T ss_dssp EEECSCCCGGGEEE--CGGGCEEECCCSSCE
T ss_pred eeEeCCCCcCCEEE--eCCCeEEEEECCCCe
Confidence 39999999999999 666789999998765
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.23 E-value=0.0016 Score=58.66 Aligned_cols=71 Identities=11% Similarity=0.168 Sum_probs=46.6
Q ss_pred cceecccCceEEEEEEEC---------CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcc-cceeeeEEeCCceE
Q 020888 47 SAIIGKGSFGEILKAYWR---------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI-VQFLGAVTERKPLM 116 (320)
Q Consensus 47 ~~~lg~g~~~~vy~~~~~---------~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~ 116 (320)
++.|+.|....+|++... +..+++|+.... ... ..+..|..+++.+...++ +++++.+.+ .
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~---~~li~E~~~l~~L~~~g~~P~l~~~~~~----g 148 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETE---SHLVAESVIFTLLSERHLGPKLYGIFSG----G 148 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCH---HHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcH---HHHHHHHHHHHHHHhCCCCCcEEEEeCC----C
Confidence 457788888999999864 467999987432 111 234468888887743333 566665542 2
Q ss_pred EEEecCCCCC
Q 020888 117 LITEYLRGGD 126 (320)
Q Consensus 117 iv~e~~~~~~ 126 (320)
+|++|++|.+
T Consensus 149 ~v~e~l~G~~ 158 (429)
T 1nw1_A 149 RLEEYIPSRP 158 (429)
T ss_dssp EEECCCCEEE
T ss_pred EEEEEeCCcc
Confidence 8899997643
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.05 E-value=0.0012 Score=58.21 Aligned_cols=73 Identities=16% Similarity=0.156 Sum_probs=42.4
Q ss_pred cceecccCceEEEEEEECC----------CceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCc-ccceeeeEEeCCce
Q 020888 47 SAIIGKGSFGEILKAYWRG----------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN-IVQFLGAVTERKPL 115 (320)
Q Consensus 47 ~~~lg~g~~~~vy~~~~~~----------~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~ 115 (320)
.+.++.|....+|++...+ ..+++|+....... ......|.++++.+...+ ..++++.. . -
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~----~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~ 109 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE----LYNTISEFEVYKTMSKYKIAPQLLNTF--N--G 109 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG----TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--T
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc----eecHHHHHHHHHHHHhcCCCCceEEec--C--C
Confidence 4567788889999998754 68889976442111 112345777777764223 44666543 2 2
Q ss_pred EEEEecCCCCCH
Q 020888 116 MLITEYLRGGDL 127 (320)
Q Consensus 116 ~iv~e~~~~~~L 127 (320)
++|++|++|.++
T Consensus 110 ~~v~e~i~G~~l 121 (369)
T 3c5i_A 110 GRIEEWLYGDPL 121 (369)
T ss_dssp EEEEECCCSEEC
T ss_pred cEEEEEecCCcC
Confidence 689999987543
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=95.66 E-value=0.036 Score=49.33 Aligned_cols=30 Identities=33% Similarity=0.485 Sum_probs=25.0
Q ss_pred eEecCCCCCcEEEee----CCCCcEEEecCCCcc
Q 020888 163 IIHRDLKPRNVLLVN----SSADHLKVGDFGLSK 192 (320)
Q Consensus 163 ivH~di~p~nI~~~~----~~~~~~~L~dfg~~~ 192 (320)
++|+|+.+.||++.. +.+..+.++||..+.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 689999999999943 345679999999875
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.60 E-value=0.056 Score=48.42 Aligned_cols=73 Identities=12% Similarity=0.070 Sum_probs=46.1
Q ss_pred cceecccCceEEEEEEEC---------CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCC-CCcccceeeeEEeCCceE
Q 020888 47 SAIIGKGSFGEILKAYWR---------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLM 116 (320)
Q Consensus 47 ~~~lg~g~~~~vy~~~~~---------~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 116 (320)
++.+..|-...+|++... +..+++++........ ....+|.++++.+. +.-..++++.+. -+
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~----idR~~E~~~l~~L~~~gi~P~l~~~~~----~~ 146 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKF----YDSKVELDVFRYLSNINIAPNIIADFP----EG 146 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CC----CCHHHHHHHHHHHHHTTSSCCEEEEET----TE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchh----cCHHHHHHHHHHHHhcCCCCCEEEEcC----CC
Confidence 456777888999999876 5789999864432111 12245777777664 222345565332 26
Q ss_pred EEEecCCCCCH
Q 020888 117 LITEYLRGGDL 127 (320)
Q Consensus 117 iv~e~~~~~~L 127 (320)
.|++|++|.+|
T Consensus 147 ~I~efI~G~~l 157 (424)
T 3mes_A 147 RIEEFIDGEPL 157 (424)
T ss_dssp EEEECCCSEEC
T ss_pred EEEEEeCCccC
Confidence 88999988653
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=92.90 E-value=0.26 Score=39.38 Aligned_cols=115 Identities=9% Similarity=0.139 Sum_probs=79.6
Q ss_pred CCCcccceeeeEEeCCceEEEEecCC-CCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEe
Q 020888 98 RHPNIVQFLGAVTERKPLMLITEYLR-GGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLV 176 (320)
Q Consensus 98 ~h~~i~~~~~~~~~~~~~~iv~e~~~-~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~ 176 (320)
.+|+++.. .+.+.++.+.+.++.-+ +-++.. ++ .++....++++.+|+....+++. -+|--+.|+||++
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik---~~~~~eKlr~l~ni~~l~~~~~~----r~tf~L~P~NL~f- 112 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IK---SFTKNEKLRYLLNIKNLEEVNRT----RYTFVLAPDELFF- 112 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GG---GSCHHHHHHHHHHGGGGGGGGGS----SEECCCSGGGEEE-
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HH---hcCHHHHHHHHHHHHHHHHHhcC----ceEEEEecceEEE-
Confidence 57888877 56667776666666443 223444 32 46889999999999998855554 4678999999999
Q ss_pred eCCCCcEEEecCCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCC
Q 020888 177 NSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLA 249 (320)
Q Consensus 177 ~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~ 249 (320)
+.++.+++.--|+...+ +|. ..+...-+-..=|++..+++++..|.
T Consensus 113 -~~~~~p~i~~RGik~~l---------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 113 -TRDGLPIAKTRGLQNVV---------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp -CTTSCEEESCCEETTTB---------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred -cCCCCEEEEEccCccCC---------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 99999999876643222 111 12333445677788889999988765
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=92.39 E-value=0.95 Score=36.27 Aligned_cols=114 Identities=11% Similarity=0.120 Sum_probs=77.7
Q ss_pred CCCcccceeeeEEeCCceEEEEecCCCC-CHHHHHHHhCCCCHHHHHHHHHHHHHHHH-HHhcCCCCeEecCCCCCcEEE
Q 020888 98 RHPNIVQFLGAVTERKPLMLITEYLRGG-DLHKYLKEKGALSPSTAVNFALDIARGMA-YLHNEPNVIIHRDLKPRNVLL 175 (320)
Q Consensus 98 ~h~~i~~~~~~~~~~~~~~iv~e~~~~~-~L~~~~~~~~~l~~~~~~~i~~~l~~~l~-~lH~~g~~ivH~di~p~nI~~ 175 (320)
.||++ -..+-..++.+.+.++.-+++ ++.. ++ .++....++++.+|+.... +++. -+|--+.|+||++
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~-i~---~~~~~eKlrll~nl~~L~~~~~~~----r~tf~l~P~NL~f 117 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAA-IR---KTTLLSRIRAAIHLVSKVKHHSAR----RLIFIVCPENLMF 117 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHH-HH---TSCHHHHHHHHHHHHHHHSSCCSS----SEECCCCGGGEEE
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHH-HH---hcCHHHHHHHHHHHHHHHHHhhhC----ceeEEEeCceEEE
Confidence 57777 455557777777777755333 4443 33 4788999999999988766 4544 5688999999999
Q ss_pred eeCCCCcEEEecCCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCC
Q 020888 176 VNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLA 249 (320)
Q Consensus 176 ~~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~ 249 (320)
+.++.+++.-.|.-..+ +|.. .+...=+-+.=|++..++.++..|+
T Consensus 118 --~~~~~p~i~hRGi~~~l---------------------pP~e-----~~ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 118 --NRALEPFFLHVGVKESL---------------------PPDE-----WDDERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp --CTTCCEEESCCEETTTB---------------------SSCS-----CCHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred --eCCCcEEEEEcCCcccC---------------------CCCC-----CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 99999999877754322 2211 1333335567778888998877654
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 320 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 9e-78 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-74 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-71 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-70 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-70 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-69 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-69 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-69 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-69 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 5e-68 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 9e-68 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-67 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-67 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-66 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-66 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 7e-66 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-65 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-65 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 5e-65 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-64 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-64 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-64 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-64 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-64 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-64 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 9e-64 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-63 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-63 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-63 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-62 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-62 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 7e-62 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 6e-61 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-60 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-60 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-58 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-58 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 6e-57 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 6e-56 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-55 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 5e-54 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 6e-54 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-52 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 7e-52 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-51 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-51 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-48 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 7e-48 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-47 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-45 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 9e-45 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-44 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 7e-44 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-42 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-42 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-42 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 6e-40 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-39 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-36 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 5e-34 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-32 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-26 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-19 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 236 bits (604), Expect = 9e-78
Identities = 86/285 (30%), Positives = 143/285 (50%), Gaps = 19/285 (6%)
Query: 34 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNL 93
DWEI ++ IG GSFG + K W G VA+K + + + +Q F++EV +
Sbjct: 2 DWEIPDGQITVGQ--RIGSGSFGTVYKGKWHGD-VAVKMLNVTAPTPQ-QLQAFKNEVGV 57
Query: 94 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARG 152
L K RH NI+ F+G T L ++T++ G L+ +L + ++ A A+G
Sbjct: 58 LRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQG 116
Query: 153 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSY 212
M YLH + IIHRDLK N+ L +K+GDFGL+ + + ++ +GS
Sbjct: 117 MDYLHAKS--IIHRDLKSNNIFL--HEDLTVKIGDFGLATVKSRWSGS--HQFEQLSGSI 170
Query: 213 RYMAPEVFKHRK---YDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKY-VAEGHRPFF 268
+MAPEV + + Y + DV++F ++LYE++ G+ P +N + + V G+
Sbjct: 171 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPD 230
Query: 269 RAK---GFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLP 310
+K ++ L +C ++RP F IL +E + +LP
Sbjct: 231 LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 227 bits (581), Expect = 2e-74
Identities = 90/276 (32%), Positives = 136/276 (49%), Gaps = 23/276 (8%)
Query: 35 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLL 94
W ++ EL IGKG FG+++ +RG VA+K I + Q F E +++
Sbjct: 2 WALNMKELKLLQ--TIGKGEFGDVMLGDYRGNKVAVKCI-----KNDATAQAFLAEASVM 54
Query: 95 VKLRHPNIVQFLGAVTERK-PLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIAR 151
+LRH N+VQ LG + E K L ++TEY+ G L YL+ +G L + F+LD+
Sbjct: 55 TQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 114
Query: 152 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGS 211
M YL +HRDL RNVL+ S + KV DFGL+K
Sbjct: 115 AMEYLEGNN--FVHRDLAARNVLV--SEDNVAKVSDFGLTKEAS-------STQDTGKLP 163
Query: 212 YRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRA 270
++ APE + +K+ K DV+SF ++L+E+ G P + V +G++
Sbjct: 164 VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDA-P 222
Query: 271 KGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIK 306
G P + E+ + CW D RPSFL + ++LE IK
Sbjct: 223 DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 221 bits (564), Expect = 3e-71
Identities = 83/271 (30%), Positives = 120/271 (44%), Gaps = 18/271 (6%)
Query: 35 WEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVN 92
++ DP +L FS IG GSFG + A VAIK++ S QD EV
Sbjct: 9 FKDDPEKL-FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVR 67
Query: 93 LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARG 152
L KLRHPN +Q+ G L+ EY G K L +G
Sbjct: 68 FLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQG 127
Query: 153 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSY 212
+AYLH+ +IHRD+K N+LL S +K+GDFG + ++ G+
Sbjct: 128 LAYLHSHN--MIHRDVKAGNILL--SEPGLVKLGDFGSASIMA--------PANSFVGTP 175
Query: 213 RYMAPEVF---KHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR 269
+MAPEV +YD KVDV+S + E+ E +PPL N A ++A+ P +
Sbjct: 176 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ 235
Query: 270 AKGFTPELRELTEKCWAADMNQRPSFLDILK 300
+ ++ R + C RP+ +LK
Sbjct: 236 SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (553), Expect = 3e-70
Identities = 74/268 (27%), Positives = 125/268 (46%), Gaps = 18/268 (6%)
Query: 35 WEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVN 92
W ++ DF +GKG FG + A + +A+K + + + V R EV
Sbjct: 3 WALE----DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 58
Query: 93 LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARG 152
+ LRHPNI++ G + + LI EY G +++ L++ + ++A
Sbjct: 59 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 118
Query: 153 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSY 212
++Y H+ +IHRD+KP N+LL SA LK+ DFG S + G+
Sbjct: 119 LSYCHS--KRVIHRDIKPENLLL--GSAGELKIADFGWSVHAPSSRRTTL------CGTL 168
Query: 213 RYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKG 272
Y+ PE+ + R +D+KVD++S ++ YE L G+PP E K ++ F
Sbjct: 169 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF--PDF 226
Query: 273 FTPELRELTEKCWAADMNQRPSFLDILK 300
T R+L + + +QRP ++L+
Sbjct: 227 VTEGARDLISRLLKHNPSQRPMLREVLE 254
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (553), Expect = 4e-70
Identities = 79/276 (28%), Positives = 129/276 (46%), Gaps = 19/276 (6%)
Query: 34 DWEIDPSELDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVN 92
+WE+ L +G G FGE+ Y+ T VA+K + + F E N
Sbjct: 7 EWEVPRETLKLVE--RLGAGQFGEVWMGYYNGHTKVAVKSL----KQGSMSPDAFLAEAN 60
Query: 93 LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA--LSPSTAVNFALDIA 150
L+ +L+H +V+ VT+ +P+ +ITEY+ G L +LK L+ + ++ A IA
Sbjct: 61 LMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 119
Query: 151 RGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETG 210
GMA++ IHRDL+ N+L+ ++ K+ DFGL++LI ++ G
Sbjct: 120 EGMAFIEERN--YIHRDLRAANILVSDT--LSCKIADFGLARLI---EDNEYTAREGAKF 172
Query: 211 SYRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKYVAEGHRPFFR 269
++ APE + + K DV+SF ++L E++ G P E + + G+R R
Sbjct: 173 PIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM-VR 231
Query: 270 AKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKI 305
EL +L CW RP+F + LE
Sbjct: 232 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (549), Expect = 1e-69
Identities = 88/275 (32%), Positives = 139/275 (50%), Gaps = 17/275 (6%)
Query: 37 IDPSELDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLV 95
IDPSEL F IG G FG + YW VAIK I + + +DF E +++
Sbjct: 2 IDPSELTFVQ--EIGSGQFGLVHLGYWLNKDKVAIKTI----REGAMSEEDFIEEAEVMM 55
Query: 96 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGAL-SPSTAVNFALDIARGMA 154
KL HP +VQ G E+ P+ L+ E++ G L YL+ + L + T + LD+ GMA
Sbjct: 56 KLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMA 115
Query: 155 YLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRY 214
YL +IHRDL RN L+ +KV DFG+++ + TG ++
Sbjct: 116 YLEEAC--VIHRDLAARNCLV--GENQVIKVSDFGMTRFV---LDDQYTSSTGTKFPVKW 168
Query: 215 MAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKYVAEGHRPFFRAKGF 273
+PEVF +Y K DV+SF ++++E+ EG+ P N E + ++ G R + +
Sbjct: 169 ASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK-PRLA 227
Query: 274 TPELRELTEKCWAADMNQRPSFLDILKRLEKIKET 308
+ + ++ CW RP+F +L++L +I E+
Sbjct: 228 STHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (548), Expect = 2e-69
Identities = 79/259 (30%), Positives = 126/259 (48%), Gaps = 16/259 (6%)
Query: 49 IIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 106
IG+GSF + K T VA + Q F+ E +L L+HPNIV+F
Sbjct: 16 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKS-ERQRFKEEAEMLKGLQHPNIVRFY 74
Query: 107 GA----VTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNV 162
+ V +K ++L+TE + G L YLK + ++ I +G+ +LH
Sbjct: 75 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPP 134
Query: 163 IIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH 222
IIHRDLK N+ + + +K+GD GL+ L + + V G+ +MAPE+++
Sbjct: 135 IIHRDLKCDNIFITGPT-GSVKIGDLGLATLKRASFAKAV------IGTPEFMAPEMYE- 186
Query: 223 RKYDKKVDVFSFAMILYEMLEGEPPLAN-YEPYEAAKYVAEGHRPFFRAKGFTPELRELT 281
KYD+ VDV++F M + EM E P + + + V G +P K PE++E+
Sbjct: 187 EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEII 246
Query: 282 EKCWAADMNQRPSFLDILK 300
E C + ++R S D+L
Sbjct: 247 EGCIRQNKDERYSIKDLLN 265
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (546), Expect = 3e-69
Identities = 75/272 (27%), Positives = 132/272 (48%), Gaps = 17/272 (6%)
Query: 37 IDPSELDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLV 95
IDP +L F +G G FG + WR VAIK I + + +F E +++
Sbjct: 1 IDPKDLTFLK--ELGTGQFGVVKYGKWRGQYDVAIKMI----KEGSMSEDEFIEEAKVMM 54
Query: 96 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK-EKGALSPSTAVNFALDIARGMA 154
L H +VQ G T+++P+ +ITEY+ G L YL+ + + D+ M
Sbjct: 55 NLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAME 114
Query: 155 YLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRY 214
YL ++ +HRDL RN L+ + +KV DFGLS+ + + G R+
Sbjct: 115 YLESKQ--FLHRDLAARNCLV--NDQGVVKVSDFGLSRYV---LDDEYTSSVGSKFPVRW 167
Query: 215 MAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKYVAEGHRPFFRAKGF 273
PEV + K+ K D+++F ++++E+ G+ P + E A+++A+G R + R
Sbjct: 168 SPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY-RPHLA 226
Query: 274 TPELRELTEKCWAADMNQRPSFLDILKRLEKI 305
+ ++ + CW ++RP+F +L + +
Sbjct: 227 SEKVYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (546), Expect = 4e-69
Identities = 76/271 (28%), Positives = 129/271 (47%), Gaps = 14/271 (5%)
Query: 50 IGKGSFGEILKAYWR----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 105
+G G+FG + K Y++ VA+K + +D L + E N++ +L +P IV+
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPAL-KDELLAEANVMQQLDNPYIVRM 73
Query: 106 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 165
+G + E + ML+ E G L+KYL++ + + ++ GM YL +H
Sbjct: 74 IG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN--FVH 130
Query: 166 RDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKY 225
RDL RNVLL + + K+ DFGLSK ++ ++ + G ++ APE + K+
Sbjct: 131 RDLAARNVLL--VTQHYAKISDFGLSKALRADENYYKAQTHG-KWPVKWYAPECINYYKF 187
Query: 226 DKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKC 284
K DV+SF ++++E G+ P + E + +G R G E+ +L C
Sbjct: 188 SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCP-AGCPREMYDLMNLC 246
Query: 285 WAADMNQRPSFLDILKRLEKI-KETLPTDHH 314
W D+ RP F + RL + + HH
Sbjct: 247 WTYDVENRPGFAAVELRLRNYYYDVVNEGHH 277
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (540), Expect = 5e-68
Identities = 80/274 (29%), Positives = 130/274 (47%), Gaps = 18/274 (6%)
Query: 50 IGKGSFGEILKAYWR----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 105
+G G+FG + + +R VAIK + ++ E ++ +L +P IV+
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKAD--TEEMMREAQIMHQLDNPYIVRL 74
Query: 106 LGAVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARGMAYLHNEPNVII 164
+G V + + LML+ E GG LHK+L ++ + S ++ GM YL + +
Sbjct: 75 IG-VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FV 131
Query: 165 HRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRK 224
HRDL RNVLLVN + K+ DFGLSK + +S+ + G ++ APE RK
Sbjct: 132 HRDLAARNVLLVNR--HYAKISDFGLSKALGADDSYYTARSAG-KWPLKWYAPECINFRK 188
Query: 225 YDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEK 283
+ + DV+S+ + ++E L G+ P + E ++ +G R PEL L
Sbjct: 189 FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECP-PECPPELYALMSD 247
Query: 284 CWAADMNQRPSFLDILKRLEKIKETLPTD---HH 314
CW RP FL + +R+ +L + HH
Sbjct: 248 CWIYKWEDRPDFLTVEQRMRACYYSLASKVEGHH 281
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (537), Expect = 9e-68
Identities = 76/269 (28%), Positives = 124/269 (46%), Gaps = 19/269 (7%)
Query: 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 100
D+ IG GS+G K + G + K + + Q EVNLL +L+HP
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEA-EKQMLVSEVNLLRELKHP 63
Query: 101 NIVQFLGAVTER--KPLMLITEYLRGGDLHKYL----KEKGALSPSTAVNFALDIARGMA 154
NIV++ + +R L ++ EY GGDL + KE+ L + + +
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 155 YLH---NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGS 211
H + + ++HRDLKP NV L ++K+GDFGL++++ +HD G+
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGK--QNVKLGDFGLARIL----NHDTSFAKAFVGT 177
Query: 212 YRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAK 271
YM+PE Y++K D++S +LYE+ PP + E A + EG +
Sbjct: 178 PYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR 237
Query: 272 GFTPELRELTEKCWAADMNQRPSFLDILK 300
++ EL E+ + RPS +IL+
Sbjct: 238 -YSDELNEIITRMLNLKDYHRPSVEEILE 265
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (537), Expect = 2e-67
Identities = 78/305 (25%), Positives = 141/305 (46%), Gaps = 16/305 (5%)
Query: 19 HFEPKPVPPPLPNKC-DWEIDPSELDFSSSAIIGKGSFGEILKAYW-----RGTPVAIKR 72
H + + P L I PS L + +IG+G FG + + A+K
Sbjct: 3 HIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS 62
Query: 73 ILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK-PLMLITEYLRGGDLHKYL 131
+ + F E ++ HPN++ LG + +++ Y++ GDL ++
Sbjct: 63 LNRITDIGE--VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 120
Query: 132 K-EKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGL 190
+ E + + F L +A+GM +L ++ +HRDL RN +L +KV DFGL
Sbjct: 121 RNETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCML--DEKFTVKVADFGL 176
Query: 191 SKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLA 249
++ + + V+ TG ++MA E + +K+ K DV+SF ++L+E++ G PP
Sbjct: 177 ARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 236
Query: 250 NYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETL 309
+ ++ Y+ +G R + + L E+ KCW RPSF +++ R+ I T
Sbjct: 237 DVNTFDITVYLLQGRRL-LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 295
Query: 310 PTDHH 314
+H+
Sbjct: 296 IGEHY 300
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (533), Expect = 4e-67
Identities = 83/281 (29%), Positives = 137/281 (48%), Gaps = 20/281 (7%)
Query: 34 DWEIDPSELDFSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFR 88
D+EI ++ IG+G FG++ + + VAIK SD V + F
Sbjct: 1 DYEIQRERIELGR--CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDS--VREKFL 56
Query: 89 HEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFAL 147
E + + HP+IV+ +G +TE P+ +I E G+L +L K +L ++ + +A
Sbjct: 57 QEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAY 115
Query: 148 DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG 207
++ +AYL ++ +HRD+ RNVL+ SS D +K+GDFGLS+ + YK +
Sbjct: 116 QLSTALAYLESKR--FVHRDIAARNVLV--SSNDCVKLGDFGLSRYM---EDSTYYKASK 168
Query: 208 ETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKYVAEGHRP 266
++MAPE R++ DV+ F + ++E+L G P + + + G R
Sbjct: 169 GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL 228
Query: 267 FFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKE 307
P L L KCWA D ++RP F ++ +L I E
Sbjct: 229 PMP-PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 208 bits (530), Expect = 2e-66
Identities = 83/282 (29%), Positives = 137/282 (48%), Gaps = 17/282 (6%)
Query: 34 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRGT-----PVAIKRILPSLSDDRLVIQDFR 88
EID S + +IG G FGE+ + + VAIK + ++ + +DF
Sbjct: 20 AKEIDISCVKIEQ--VIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQ--RRDFL 75
Query: 89 HEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFAL 147
E +++ + HPN++ G VT+ P+M+ITE++ G L +L++ G + V
Sbjct: 76 SEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLR 135
Query: 148 DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY-KMT 206
IA GM YL + +HRDL RN+L+ +S KV DFGLS+ ++ S Y
Sbjct: 136 GIAAGMKYLADMN--YVHRDLAARNILV--NSNLVCKVSDFGLSRFLEDDTSDPTYTSAL 191
Query: 207 GETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKYVAEGHR 265
G R+ APE ++RK+ DV+S+ ++++E++ GE P + + + + +R
Sbjct: 192 GGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYR 251
Query: 266 PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKE 307
L +L CW D N RP F I+ L+K+
Sbjct: 252 LPPP-MDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (529), Expect = 3e-66
Identities = 73/274 (26%), Positives = 127/274 (46%), Gaps = 21/274 (7%)
Query: 36 EIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNL 93
+++P + + +G G+FG++ KA + A K I ++ +D+ E+++
Sbjct: 7 DLNPED-FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEEL---EDYMVEIDI 62
Query: 94 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARG 152
L HPNIV+ L A L ++ E+ GG + + + + L+ S
Sbjct: 63 LASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDA 122
Query: 153 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSY 212
+ YLH+ N IIHRDLK N+L + +K+ DFG+S +N+ + + G+
Sbjct: 123 LNYLHD--NKIIHRDLKAGNILF--TLDGDIKLADFGVSA----KNTRTIQRRDSFIGTP 174
Query: 213 RYMAPEVF-----KHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPF 267
+MAPEV K R YD K DV+S + L EM E EPP P +A+ P
Sbjct: 175 YWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPT 234
Query: 268 FRA-KGFTPELRELTEKCWAADMNQRPSFLDILK 300
++ ++ +KC +++ R + +L+
Sbjct: 235 LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 206 bits (526), Expect = 7e-66
Identities = 78/287 (27%), Positives = 135/287 (47%), Gaps = 17/287 (5%)
Query: 25 VPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRL 82
+ P PN WE++ +++ +G G +GE+ + W+ VA+K + +D +
Sbjct: 2 MDPSSPNYDKWEMERTDITMKH--KLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTM 55
Query: 83 VIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL--KEKGALSPS 140
+++F E ++ +++HPN+VQ LG T P +ITE++ G+L YL + +S
Sbjct: 56 EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAV 115
Query: 141 TAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 200
+ A I+ M YL + IHRDL RN L+ +KV DFGLS+L+
Sbjct: 116 VLLYMATQISSAMEYLEKKN--FIHRDLAARNCLV--GENHLVKVADFGLSRLM---TGD 168
Query: 201 DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYV 260
G ++ APE + K+ K DV++F ++L+E+ +
Sbjct: 169 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL 228
Query: 261 AEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKE 307
E R +G ++ EL CW + + RPSF +I + E + +
Sbjct: 229 LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 207 bits (527), Expect = 2e-65
Identities = 69/283 (24%), Positives = 126/283 (44%), Gaps = 19/283 (6%)
Query: 23 KPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDD 80
+ P P+ K D +D + +G G+FG + + R G A K ++ D
Sbjct: 11 QYYPQPVEIKHDHVLD----HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD 66
Query: 81 RLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL-KEKGALSP 139
+ + R E+ + LRHP +V A + +++I E++ GG+L + + E +S
Sbjct: 67 K---ETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSE 123
Query: 140 STAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 199
AV + + +G+ ++H N +H DLKP N++ ++ LK+ DFGL+ + + S
Sbjct: 124 DEAVEYMRQVCKGLCHMHE--NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 181
Query: 200 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKY 259
V TG+ + APEV + + D++S ++ Y +L G P E +
Sbjct: 182 VKVT-----TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRN 236
Query: 260 VAEGHRPFFRA--KGFTPELRELTEKCWAADMNQRPSFLDILK 300
V + G + + ++ K AD N R + L+
Sbjct: 237 VKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (520), Expect = 4e-65
Identities = 91/281 (32%), Positives = 144/281 (51%), Gaps = 18/281 (6%)
Query: 35 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGT------PVAIKRILPSLSDDRLVIQDFR 88
EI PS + +IG G FGE+ K + + PVAIK + ++ + DF
Sbjct: 2 TEIHPSC--VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQR--VDFL 57
Query: 89 HEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFAL 147
E ++ + H NI++ G +++ KP+M+ITEY+ G L K+L+EK G S V
Sbjct: 58 GEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLR 117
Query: 148 DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG 207
IA GM YL N +HRDL RN+L+ +S KV DFGLS++++ + Y +G
Sbjct: 118 GIAAGMKYLANMN--YVHRDLAARNILV--NSNLVCKVSDFGLSRVLE-DDPEATYTTSG 172
Query: 208 ETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKYVAEGHRP 266
R+ APE +RK+ DV+SF ++++E++ GE P +E K + +G R
Sbjct: 173 GKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL 232
Query: 267 FFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKE 307
+ +L +CW + +RP F DI+ L+K+
Sbjct: 233 PTP-MDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 5e-65
Identities = 62/302 (20%), Positives = 114/302 (37%), Gaps = 55/302 (18%)
Query: 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 100
DF + +G G+ G + K + G +A K I + + E+ +L + P
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPA--IRNQIIRELQVLHECNSP 64
Query: 101 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP 160
IV F GA + + E++ GG L + LK+ G + ++ + +G+ YL +
Sbjct: 65 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK- 123
Query: 161 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF 220
+ I+HRD+KP N+L+ + +K+ DFG+S + G+ YM+PE
Sbjct: 124 HKIMHRDVKPSNILVNSR--GEIKLCDFGVSGQLIDS------MANSFVGTRSYMSPERL 175
Query: 221 KHRKYDKKVDVFSFAMILYEMLEGEPPL-------------------------------- 248
+ Y + D++S + L EM G P+
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235
Query: 249 ----------ANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDI 298
+E Y+ P + F+ E ++ KC + +R +
Sbjct: 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 295
Query: 299 LK 300
+
Sbjct: 296 MV 297
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 1e-64
Identities = 87/292 (29%), Positives = 131/292 (44%), Gaps = 20/292 (6%)
Query: 23 KPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGT-PVAIKRILPSLSDDR 81
KP L K WEI L +G+G FGE+ W GT VAIK + P
Sbjct: 1 KPQTQGLA-KDAWEIPRESLRLEV--KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP- 56
Query: 82 LVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA--LSP 139
+ F E ++ KLRH +VQ V+ +P+ ++TEY+ G L +LK + L
Sbjct: 57 ---EAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGETGKYLRL 112
Query: 140 STAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 199
V+ A IA GMAY+ +HRDL+ N+L+ KV DFGL++LI
Sbjct: 113 PQLVDMAAQIASGMAYVERMN--YVHRDLRAANILV--GENLVCKVADFGLARLI---ED 165
Query: 200 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAK 258
++ G ++ APE + ++ K DV+SF ++L E+ +G P E
Sbjct: 166 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD 225
Query: 259 YVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLP 310
V G+R L +L +CW + +RP+F + LE +
Sbjct: 226 QVERGYRMPCP-PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 276
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 205 bits (522), Expect = 2e-64
Identities = 59/288 (20%), Positives = 121/288 (42%), Gaps = 23/288 (7%)
Query: 18 SHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILP 75
+ P+PV + D + +G G+FG + + + G K I
Sbjct: 13 KKYVPQPVEVKQGSVYD--------YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINT 64
Query: 76 SLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG 135
D+ ++E++++ +L HP ++ A ++ ++LI E+L GG+L + +
Sbjct: 65 PYPLDK---YTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAED 121
Query: 136 -ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 194
+S + +N+ G+ ++H + I+H D+KP N++ A +K+ DFGL+ +
Sbjct: 122 YKMSEAEVINYMRQACEGLKHMHE--HSIVHLDIKPENIMCETKKASSVKIIDFGLATKL 179
Query: 195 KVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPY 254
V T + + APE+ D+++ ++ Y +L G P A +
Sbjct: 180 NPDEIVKVT-----TATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL 234
Query: 255 EAAKYVAEGHRPFFRA--KGFTPELRELTEKCWAADMNQRPSFLDILK 300
E + V F +PE ++ + + +R + D L+
Sbjct: 235 ETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 2e-64
Identities = 80/310 (25%), Positives = 129/310 (41%), Gaps = 42/310 (13%)
Query: 26 PPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGT-------PVAIKRILPSLS 78
WE L+F ++G G+FG+++ A G VA+K +
Sbjct: 23 FREYEYDLKWEFPRENLEFGK--VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD 80
Query: 79 DDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK--- 134
+ E+ ++ +L H NIV LGA T P+ LI EY GDL YL+ K
Sbjct: 81 SSER--EALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREK 138
Query: 135 --------------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVL 174
L+ + FA +A+GM +L + +HRDL RNVL
Sbjct: 139 FSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHRDLAARNVL 196
Query: 175 LVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSF 234
+ + +K+ DFGL++ I +++ V ++MAPE Y K DV+S+
Sbjct: 197 V--THGKVVKICDFGLARDIMSDSNYVV--RGNARLPVKWMAPESLFEGIYTIKSDVWSY 252
Query: 235 AMILYEML-EGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRP 293
++L+E+ G P + + + T E+ + + CWA D +RP
Sbjct: 253 GILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRP 312
Query: 294 SFLDILKRLE 303
SF ++ L
Sbjct: 313 SFPNLTSFLG 322
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (516), Expect = 2e-64
Identities = 70/266 (26%), Positives = 125/266 (46%), Gaps = 16/266 (6%)
Query: 38 DPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLV 95
DP + ++ IG+G+ G + A G VAI+++ + + +E+ ++
Sbjct: 17 DPKK-KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK---ELIINEILVMR 72
Query: 96 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 155
+ ++PNIV +L + L ++ EYL GG L + E + + + +
Sbjct: 73 ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM-DEGQIAAVCRECLQALEF 131
Query: 156 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYM 215
LH+ +IHRD+K N+LL +K+ DFG I + + K + G+ +M
Sbjct: 132 LHSNQ--VIHRDIKSDNILL--GMDGSVKLTDFGFCAQI----TPEQSKRSTMVGTPYWM 183
Query: 216 APEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA-KGFT 274
APEV + Y KVD++S ++ EM+EGEPP N P A +A P + + +
Sbjct: 184 APEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLS 243
Query: 275 PELRELTEKCWAADMNQRPSFLDILK 300
R+ +C D+ +R S ++L+
Sbjct: 244 AIFRDFLNRCLDMDVEKRGSAKELLQ 269
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 2e-64
Identities = 73/271 (26%), Positives = 122/271 (45%), Gaps = 13/271 (4%)
Query: 43 DFSSSAIIGKGSFGEILKAYW-----RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL 97
D +G GSFG + + W + VA+K + P + + DF EVN + L
Sbjct: 9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68
Query: 98 RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKY-LKEKGALSPSTAVNFALDIARGMAYL 156
H N+++ G V P+ ++TE G L K +G T +A+ +A GM YL
Sbjct: 69 DHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 127
Query: 157 HNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMA 216
++ IHRDL RN+LL ++ D +K+GDFGL + + + H V + + A
Sbjct: 128 ESKR--FIHRDLAARNLLL--ATRDLVKIGDFGLMRALPQNDDHYV-MQEHRKVPFAWCA 182
Query: 217 PEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTP 275
PE K R + D + F + L+EM G+ P + + + R +
Sbjct: 183 PESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQ 242
Query: 276 ELRELTEKCWAADMNQRPSFLDILKRLEKIK 306
++ + +CWA RP+F+ + L + +
Sbjct: 243 DIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 3e-64
Identities = 73/262 (27%), Positives = 118/262 (45%), Gaps = 12/262 (4%)
Query: 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 100
D+ +G+G++GE+ A R VA+K + + D ++ + E+ + L H
Sbjct: 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINKMLNHE 63
Query: 101 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP 160
N+V+F G E L EY GG+L ++ + A F + G+ YLH
Sbjct: 64 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-- 121
Query: 161 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF 220
I HRD+KP N+LL D+LK+ DFGL+ + + N + + G+ Y+APE+
Sbjct: 122 IGITHRDIKPENLLL--DERDNLKISDFGLATVFRYNNRERL--LNKMCGTLPYVAPELL 177
Query: 221 KHRKYD-KKVDVFSFAMILYEMLEGEPPL-ANYEPYEAAKYVAEGHRPFFRAKGFTPELR 278
K R++ + VDV+S ++L ML GE P + + E K
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 237
Query: 279 ELTEKCWAADMNQRPSFLDILK 300
L K + + R + DI K
Sbjct: 238 ALLHKILVENPSARITIPDIKK 259
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 9e-64
Identities = 86/307 (28%), Positives = 139/307 (45%), Gaps = 37/307 (12%)
Query: 26 PPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLS 78
P LP WE + L F +G G+FG++++A VA+K + PS
Sbjct: 9 PTQLPYDHKWEFPRNRLSFGK--TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH 66
Query: 79 DDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG-- 135
+ E+ +L L H NIV LGA T P ++ITEY GDL +L+ K
Sbjct: 67 LTE--REALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDS 124
Query: 136 ----------------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS 179
AL ++F+ +A+GMA+L ++ IHRDL RN+LL +
Sbjct: 125 FICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILLTHG- 181
Query: 180 ADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILY 239
K+ DFGL++ IK +++ V ++MAPE + Y + DV+S+ + L+
Sbjct: 182 -RITKICDFGLARDIKNDSNYVVKGNAR--LPVKWMAPESIFNCVYTFESDVWSYGIFLW 238
Query: 240 EML-EGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDI 298
E+ G P + + + E+ ++ + CW AD +RP+F I
Sbjct: 239 ELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQI 298
Query: 299 LKRLEKI 305
++ +EK
Sbjct: 299 VQLIEKQ 305
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (511), Expect = 2e-63
Identities = 75/294 (25%), Positives = 119/294 (40%), Gaps = 43/294 (14%)
Query: 50 IGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAV 109
IGKG FGE+ + WRG VA+K E+ V LRH NI+ F+ A
Sbjct: 11 IGKGRFGEVWRGKWRGEEVAVKIFSSREERSWF----REAEIYQTVMLRHENILGFIAAD 66
Query: 110 TER----KPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE------ 159
+ L L+++Y G L YL ++ + AL A G+A+LH E
Sbjct: 67 NKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-VTVEGMIKLALSTASGLAHLHMEIVGTQG 125
Query: 160 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV 219
I HRDLK +N+L+ + D GL+ G+ RYMAPEV
Sbjct: 126 KPAIAHRDLKSKNILV--KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183
Query: 220 F------KHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKY-------------- 259
KH + K+ D+++ ++ +E+ +E Y+ Y
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 243
Query: 260 --VAEGHRPFFRAKGFTPE----LRELTEKCWAADMNQRPSFLDILKRLEKIKE 307
+ RP + + E + ++ +CW A+ R + L I K L ++ +
Sbjct: 244 VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 200 bits (510), Expect = 3e-63
Identities = 82/306 (26%), Positives = 135/306 (44%), Gaps = 43/306 (14%)
Query: 34 DWEIDPSELDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQD 86
E + +++ IG+G+FG + +A T VA+K + S D + D
Sbjct: 7 SLEYPRNNIEYVR--DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASAD--MQAD 62
Query: 87 FRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG----------- 135
F+ E L+ + +PNIV+ LG KP+ L+ EY+ GDL+++L+
Sbjct: 63 FQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSD 122
Query: 136 -------------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH 182
LS + + A +A GMAYL +HRDL RN L+
Sbjct: 123 LSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDLATRNCLV--GENMV 178
Query: 183 LKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEML 242
+K+ DFGLS+ I + + + R+M PE + +Y + DV+++ ++L+E+
Sbjct: 179 VKIADFGLSRNIYSADYYKA--DGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 236
Query: 243 E-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301
G P E YV +G+ + EL L CW+ RPSF I +
Sbjct: 237 SYGLQPYYGMAHEEVIYYVRDGNILACP-ENCPLELYNLMRLCWSKLPADRPSFCSIHRI 295
Query: 302 LEKIKE 307
L+++ E
Sbjct: 296 LQRMCE 301
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 200 bits (509), Expect = 5e-63
Identities = 68/257 (26%), Positives = 115/257 (44%), Gaps = 14/257 (5%)
Query: 49 IIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 106
++G G+F E++ A + VAIK I + + +E+ +L K++HPNIV
Sbjct: 16 VLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKE--GSMENEIAVLHKIKHPNIVALD 73
Query: 107 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 166
L LI + + GG+L + EKG + A + + YLH+ I+HR
Sbjct: 74 DIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHD--LGIVHR 131
Query: 167 DLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKY 225
DLKP N+L + D + + DFGLSK+ + ++ G+ Y+APEV + Y
Sbjct: 132 DLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS-----VLSTACGTPGYVAPEVLAQKPY 186
Query: 226 DKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA--KGFTPELRELTEK 283
K VD +S +I Y +L G PP + + + + + F + ++
Sbjct: 187 SKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRH 246
Query: 284 CWAADMNQRPSFLDILK 300
D +R + L+
Sbjct: 247 LMEKDPEKRFTCEQALQ 263
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 1e-62
Identities = 64/263 (24%), Positives = 120/263 (45%), Gaps = 10/263 (3%)
Query: 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 100
DF I+G+GSF ++ A AIK + + E +++ +L HP
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 101 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP 160
V+ + + L Y + G+L KY+++ G+ + + +I + YLH
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-- 126
Query: 161 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF 220
IIHRDLKP N+LL + H+++ DFG +K++ ++ + G+ +Y++PE+
Sbjct: 127 KGIIHRDLKPENILL--NEDMHIQITDFGTAKVLSPESKQ--ARANSFVGTAQYVSPELL 182
Query: 221 KHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELREL 280
+ K D+++ I+Y+++ G PP Y + + + F + F P+ R+L
Sbjct: 183 TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF--PEKFFPKARDL 240
Query: 281 TEKCWAADMNQRPSFLDILKRLE 303
EK D +R ++
Sbjct: 241 VEKLLVLDATKRLGCEEMEGYGP 263
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 2e-62
Identities = 69/272 (25%), Positives = 123/272 (45%), Gaps = 16/272 (5%)
Query: 43 DFSSSAIIGKGSFGEILKAYWRGT------PVAIKRILPSLSDDRLVIQDFRHEVNLLVK 96
+F ++G G+FG + K W PVAIK + + S ++ E ++
Sbjct: 10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK--ANKEILDEAYVMAS 67
Query: 97 LRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYL 156
+ +P++ + LG ++ G L + K + +N+ + IA+GM YL
Sbjct: 68 VDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 127
Query: 157 HNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMA 216
+ ++HRDL RNVL+ H+K+ DFGL+KL+ + Y G ++MA
Sbjct: 128 EDRR--LVHRDLAARNVLVKTP--QHVKITDFGLAKLLGAEEKE--YHAEGGKVPIKWMA 181
Query: 217 PEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTP 275
E HR Y + DV+S+ + ++E++ G P E + + +G R T
Sbjct: 182 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQP-PICTI 240
Query: 276 ELRELTEKCWAADMNQRPSFLDILKRLEKIKE 307
++ + KCW D + RP F +++ K+
Sbjct: 241 DVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 7e-62
Identities = 51/283 (18%), Positives = 117/283 (41%), Gaps = 23/283 (8%)
Query: 50 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 107
+G+G FG + + K + +D L + E+++L RH NI+
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL----VKKEISILNIARHRNILHLHE 68
Query: 108 AVTERKPLMLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHR 166
+ + L++I E++ G D+ + + L+ V++ + + +LH+ I H
Sbjct: 69 SFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN--IGHF 126
Query: 167 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYD 226
D++P N++ + +K+ +FG ++ +K ++ + Y APEV +H
Sbjct: 127 DIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTA-----PEYYAPEVHQHDVVS 181
Query: 227 KKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA--KGFTPELRELTEKC 284
D++S ++Y +L G P + + + F K + E + ++
Sbjct: 182 TATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRL 241
Query: 285 WAADMNQRPSFLDIL------KRLEKIK-ETLPTDHHWNIFNA 320
+ R + + L +++E++ + + T H ++
Sbjct: 242 LVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYHT 284
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (495), Expect = 6e-61
Identities = 92/298 (30%), Positives = 138/298 (46%), Gaps = 36/298 (12%)
Query: 36 EIDPSELDFSSSAIIGKGSFGEILKAYWRGT----PVAIKRILPSLSDDRLVIQDFRHEV 91
+D +++ F +IG+G+FG++LKA + AIKR+ S D +DF E+
Sbjct: 6 VLDWNDIKFQD--VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD--HRDFAGEL 61
Query: 92 NLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK---------------- 134
+L KL HPNI+ LGA R L L EY G+L +L++
Sbjct: 62 EVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 121
Query: 135 GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 194
LS ++FA D+ARGM YL + IHRDL RN+L+ K+ DFGLS+
Sbjct: 122 STLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILV--GENYVAKIADFGLSRGQ 177
Query: 195 KVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEP 253
K T R+MA E + Y DV+S+ ++L+E++ G P
Sbjct: 178 -----EVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC 232
Query: 254 YEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPT 311
E + + +G+R E+ +L +CW +RPSF IL L ++ E T
Sbjct: 233 AELYEKLPQGYRLEK-PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 289
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 1e-60
Identities = 91/304 (29%), Positives = 144/304 (47%), Gaps = 38/304 (12%)
Query: 29 LPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGT---------PVAIKRILPSLSD 79
LP WE+ L +G+G+FG+++ A G VA+K + ++
Sbjct: 2 LPEDPRWELPRDRLVLGK--PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE 59
Query: 80 DRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG--- 135
+ D E+ ++ + +H NI+ LGA T+ PL +I EY G+L +YL+ +
Sbjct: 60 KD--LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPG 117
Query: 136 -------------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH 182
LS V+ A +ARGM YL ++ IHRDL RNVL+ + +
Sbjct: 118 LEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLV--TEDNV 173
Query: 183 LKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEML 242
+K+ DFGL++ I + K T ++MAPE R Y + DV+SF ++L+E+
Sbjct: 174 MKIADFGLARDI--HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 231
Query: 243 -EGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301
G P E K + EGHR T EL + CW A +QRP+F +++
Sbjct: 232 TLGGSPYPGVPVEELFKLLKEGHRMDK-PSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290
Query: 302 LEKI 305
L++I
Sbjct: 291 LDRI 294
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 192 bits (488), Expect = 3e-60
Identities = 73/278 (26%), Positives = 122/278 (43%), Gaps = 16/278 (5%)
Query: 39 PSEL--DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLL 94
PS L + I+G G E+ A VA+K + L+ D FR E
Sbjct: 2 PSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNA 61
Query: 95 VKLRHPNIVQFLGAVTERKP----LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIA 150
L HP IV P ++ EY+ G L + +G ++P A+ D
Sbjct: 62 AALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADAC 121
Query: 151 RGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETG 210
+ + + H IIHRD+KP N+++ S+ + +KV DFG+++ I + + V + G
Sbjct: 122 QALNFSHQNG--IIHRDVKPANIMI--SATNAVKVMDFGIARAIA-DSGNSVTQTAAVIG 176
Query: 211 SYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHR--PFF 268
+ +Y++PE + D + DV+S +LYE+L GEPP P A P
Sbjct: 177 TAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSA 236
Query: 269 RAKGFTPELRELTEKCWAADMNQRP-SFLDILKRLEKI 305
R +G + +L + K A + R + ++ L ++
Sbjct: 237 RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 2e-58
Identities = 70/262 (26%), Positives = 123/262 (46%), Gaps = 13/262 (4%)
Query: 43 DFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLL-VKLRH 99
DF ++GKGSFG++ A ++ T AIK + + ++ E +L + H
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 100 PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE 159
P + ++ L + EYL GGDL +++ S A +A +I G+ +LH+
Sbjct: 63 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS- 121
Query: 160 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV 219
I++RDLK N+L H+K+ DFG+ K +N K G+ Y+APE+
Sbjct: 122 -KGIVYRDLKLDNIL--LDKDGHIKIADFGMCK----ENMLGDAKTNTFCGTPDYIAPEI 174
Query: 220 FKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRE 279
+KY+ VD +SF ++LYEML G+ P + E + + + + E ++
Sbjct: 175 LLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFY--PRWLEKEAKD 232
Query: 280 LTEKCWAADMNQRPSFLDILKR 301
L K + + +R +++
Sbjct: 233 LLVKLFVREPEKRLGVRGDIRQ 254
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 2e-58
Identities = 79/292 (27%), Positives = 137/292 (46%), Gaps = 29/292 (9%)
Query: 34 DWEIDPSELDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQD 86
+WE+ ++ S +G+GSFG + + + T VAIK + + S +
Sbjct: 14 EWEVAREKITMSR--ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER--IE 69
Query: 87 FRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG----------A 136
F +E +++ + ++V+ LG V++ +P ++I E + GDL YL+
Sbjct: 70 FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAP 129
Query: 137 LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 196
S S + A +IA GMAYL+ +HRDL RN ++ + +K+GDFG+++ I
Sbjct: 130 PSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMV--AEDFTVKIGDFGMTRDIYE 185
Query: 197 QNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEG-EPPLANYEPYE 255
+ + K R+M+PE K + DV+SF ++L+E+ E P +
Sbjct: 186 TDYY--RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ 243
Query: 256 AAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKE 307
++V EG L EL CW + RPSFL+I+ +++ E
Sbjct: 244 VLRFVMEGGLLDKP-DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 183 bits (465), Expect = 6e-57
Identities = 65/275 (23%), Positives = 118/275 (42%), Gaps = 26/275 (9%)
Query: 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRI------LPSLSDDRLVIQDFRHEVNLL 94
++ I+G+G + + + A+K I S + + + + EV++L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 95 VKLR-HPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGM 153
K+ HPNI+Q L+ + ++ G+L YL EK LS + +
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 123
Query: 154 AYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYR 213
LH I+HRDLKP N+LL ++K+ DFG S + K+ G+
Sbjct: 124 CALHK--LNIVHRDLKPENILL--DDDMNIKLTDFGFSCQLDPGE-----KLREVCGTPS 174
Query: 214 YMAPEVF------KHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPF 267
Y+APE+ H Y K+VD++S +I+Y +L G PP + + + + G+ F
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQF 234
Query: 268 FR--AKGFTPELRELTEKCWAADMNQRPSFLDILK 300
++ +++L + +R + + L
Sbjct: 235 GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 6e-56
Identities = 67/260 (25%), Positives = 115/260 (44%), Gaps = 16/260 (6%)
Query: 50 IGKGSFGEILKAYWR--GTPVAIKRILPSL---SDDRLVIQDFRHEVNLLVKLRHPNIVQ 104
+G G F + K + G A K I S + +D EV++L +++HPN++
Sbjct: 18 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77
Query: 105 FLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVII 164
+ ++LI E + GG+L +L EK +L+ A F I G+ YLH+ I
Sbjct: 78 LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS--LQIA 135
Query: 165 HRDLKPRNVLLV--NSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH 222
H DLKP N++L+ N +K+ DFGL+ I N + G+ ++APE+ +
Sbjct: 136 HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN-----EFKNIFGTPEFVAPEIVNY 190
Query: 223 RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA--KGFTPELREL 280
+ D++S +I Y +L G P E V+ + F + ++
Sbjct: 191 EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDF 250
Query: 281 TEKCWAADMNQRPSFLDILK 300
+ D +R + D L+
Sbjct: 251 IRRLLVKDPKKRMTIQDSLQ 270
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 1e-55
Identities = 68/268 (25%), Positives = 115/268 (42%), Gaps = 31/268 (11%)
Query: 49 IIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQF 105
++G G G++L+ + + A+K + R EV L + + P+IV+
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRI 70
Query: 106 LGA----VTERKPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNE 159
+ RK L+++ E L GG+L ++++G A + A I + YLH+
Sbjct: 71 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS- 129
Query: 160 PNVIIHRDLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPE 218
I HRD+KP N+L + + LK+ DFG +K NS T Y+APE
Sbjct: 130 -INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT-----PYYVAPE 183
Query: 219 VFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHR------PFFRAKG 272
V KYDK D++S +I+Y +L G PP + + + R P
Sbjct: 184 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 243
Query: 273 FTPELRELTEKCWAADMNQRPSFLDILK 300
+ E++ L + QR + + +
Sbjct: 244 VSEEVKMLIRNLLKTEPTQRMTITEFMN 271
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 177 bits (449), Expect = 5e-54
Identities = 68/256 (26%), Positives = 120/256 (46%), Gaps = 15/256 (5%)
Query: 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 100
DF +G GSFG + R G A+K + + ++ E +L + HP
Sbjct: 5 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHP 64
Query: 101 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP 160
I++ G + + + +I +Y+ GG+L L++ A +A ++ + YLH++
Sbjct: 65 FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD 124
Query: 161 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF 220
II+RDLKP N+LL H+K+ DFG +K + G+ Y+APEV
Sbjct: 125 --IIYRDLKPENILL--DKNGHIKITDFGFAKYVP-------DVTYTLCGTPDYIAPEVV 173
Query: 221 KHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELREL 280
+ Y+K +D +SF +++YEML G P + + + + F F ++++L
Sbjct: 174 STKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP--PFFNEDVKDL 231
Query: 281 TEKCWAADMNQRPSFL 296
+ D++QR L
Sbjct: 232 LSRLITRDLSQRLGNL 247
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 6e-54
Identities = 79/306 (25%), Positives = 137/306 (44%), Gaps = 37/306 (12%)
Query: 29 LP-NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGT-------PVAIKRILPSLSDD 80
LP + WE L +G+G+FG++++A G VA+K + +
Sbjct: 1 LPYDASKWEFPRDRLKLGK--PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 58
Query: 81 RLVIQDFRHEVNLLVK-LRHPNIVQFLGAVTE-RKPLMLITEYLRGGDLHKYLKEKG--- 135
+ E+ +L+ H N+V LGA T+ PLM+I E+ + G+L YL+ K
Sbjct: 59 E--HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEF 116
Query: 136 -------------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH 182
L+ + ++ +A+GM +L + IHRDL RN+LL S +
Sbjct: 117 VPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILL--SEKNV 172
Query: 183 LKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEML 242
+K+ DFGL++ I D + ++MAPE R Y + DV+SF ++L+E+
Sbjct: 173 VKICDFGLARDI--YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 230
Query: 243 EG-EPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301
P + E + TPE+ + CW + +QRP+F ++++
Sbjct: 231 SLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290
Query: 302 LEKIKE 307
L + +
Sbjct: 291 LGNLLQ 296
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 173 bits (440), Expect = 3e-52
Identities = 73/259 (28%), Positives = 113/259 (43%), Gaps = 17/259 (6%)
Query: 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVN---LLVKL 97
DFS IIG+G FGE+ G A+K + + +E L+
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 98 RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLH 157
P IV A L I + + GGDLH +L + G S + +A +I G+ ++H
Sbjct: 65 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH 124
Query: 158 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAP 217
N +++RDLKP N+LL H+++ D GL+ + H G++ YMAP
Sbjct: 125 N--RFVVYRDLKPANILL--DEHGHVRISDLGLACDFSKKKPHASV------GTHGYMAP 174
Query: 218 EVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAK-YVAEGHRPFFRAKGFTP 275
EV + YD D FS +L+++L G P ++ + + F+P
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSP 234
Query: 276 ELRELTEKCWAADMNQRPS 294
ELR L E D+N+R
Sbjct: 235 ELRSLLEGLLQRDVNRRLG 253
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 171 bits (433), Expect = 7e-52
Identities = 49/269 (18%), Positives = 90/269 (33%), Gaps = 20/269 (7%)
Query: 50 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 107
IG GSFG+I G VAIK + E + ++ + +
Sbjct: 15 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ-----LHIESKIYKMMQGGVGIPTIR 69
Query: 108 AV-TERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 166
E +++ E L + S T + A + + Y+H+ IHR
Sbjct: 70 WCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS--KNFIHR 127
Query: 167 DLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDV---YKMTGETGSYRYMAPEVFKH 222
D+KP N L+ + + DFGL+K + +H + TG+ RY +
Sbjct: 128 DVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG 187
Query: 223 RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR------AKGFTPE 276
+ ++ D+ S +L G P + + KG+ E
Sbjct: 188 IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSE 247
Query: 277 LRELTEKCWAADMNQRPSFLDILKRLEKI 305
C + + +P + + + +
Sbjct: 248 FATYLNFCRSLRFDDKPDYSYLRQLFRNL 276
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 2e-51
Identities = 64/261 (24%), Positives = 110/261 (42%), Gaps = 26/261 (9%)
Query: 49 IIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQD---FRHEVNLLVKLR--HPN 101
++G G FG + PVAIK + D + + EV LL K+
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 102 IVQFLGAVTERKPLMLITEYLRGG-DLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP 160
+++ L +LI E DL ++ E+GAL A +F + + + HN
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 130
Query: 161 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF 220
++HRD+K N+L+ + + LK+ DFG L+K T G+ Y PE
Sbjct: 131 --VLHRDIKDENILI-DLNRGELKLIDFGSGALLKDTV------YTDFDGTRVYSPPEWI 181
Query: 221 KHRKY-DKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRE 279
++ +Y + V+S ++LY+M+ G+ P + E + + + E +
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR--------QRVSSECQH 233
Query: 280 LTEKCWAADMNQRPSFLDILK 300
L C A + RP+F +I
Sbjct: 234 LIRWCLALRPSDRPTFEEIQN 254
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 4e-51
Identities = 63/254 (24%), Positives = 110/254 (43%), Gaps = 12/254 (4%)
Query: 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 100
DF ++GKG+FG+++ + G A+K + + + + E +L RHP
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 101 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP 160
+ A L + EY GG+L +L + + A + +I + YLH+
Sbjct: 66 FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 125
Query: 161 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF 220
+++RD+K N++L H+K+ DFGL K + M G+ Y+APEV
Sbjct: 126 --VVYRDIKLENLML--DKDGHIKITDFGLCKEGISDGA----TMKTFCGTPEYLAPEVL 177
Query: 221 KHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELREL 280
+ Y + VD + +++YEM+ G P N + + + F + +PE + L
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF--PRTLSPEAKSL 235
Query: 281 TEKCWAADMNQRPS 294
D QR
Sbjct: 236 LAGLLKKDPKQRLG 249
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 163 bits (413), Expect = 3e-48
Identities = 65/265 (24%), Positives = 117/265 (44%), Gaps = 20/265 (7%)
Query: 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 100
F +G GSFG ++ + G A+K + I+ +E +L + P
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 101 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP 160
+V+ + + L ++ EY+ GG++ +L+ G S A +A I YLH+
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS-- 159
Query: 161 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF 220
+I+RDLKP N+L+ +++V DFG +K + G+ +APE+
Sbjct: 160 LDLIYRDLKPENLLIDQQ--GYIQVTDFGFAK-------RVKGRTWTLCGTPEALAPEII 210
Query: 221 KHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELREL 280
+ Y+K VD ++ +++YEM G PP +P + + + G F F+ +L++L
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP--SHFSSDLKDL 268
Query: 281 TEKCWAADMNQR-----PSFLDILK 300
D+ +R DI
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKN 293
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 160 bits (406), Expect = 7e-48
Identities = 55/275 (20%), Positives = 96/275 (34%), Gaps = 22/275 (8%)
Query: 50 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 107
IG+GSFG I + VAIK P SD R E L + +
Sbjct: 13 IGEGSFGVIFEGTNLLNNQQVAIK-FEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVY 67
Query: 108 AVTERKPLMLITEYLRGGDLHKYLKEKGA-LSPSTAVNFALDIARGMAYLHNEPNVIIHR 166
+ ++ L G L L G S T A + + +H +++R
Sbjct: 68 YFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE--KSLVYR 125
Query: 167 DLKPRNVLL---VNSSADHLKVGDFGLSKLIKVQNSHDV---YKMTGETGSYRYMAPEVF 220
D+KP N L+ + +A+ + V DFG+ K + + + +G+ RYM+
Sbjct: 126 DIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTH 185
Query: 221 KHRKYDKKVDVFSFAMILYEMLEGE---PPLANYEPYEAAKYVAEGHRPFFR---AKGFT 274
R+ ++ D+ + + L G L + + + E + GF
Sbjct: 186 LGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFP 245
Query: 275 PELRELTEKCWAADMNQRPSFLDILKRLEKIKETL 309
E + + P + + K+ E L
Sbjct: 246 EEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 2e-47
Identities = 68/283 (24%), Positives = 108/283 (38%), Gaps = 39/283 (13%)
Query: 49 IIGKGSFGEILKAYWR--GTPVAIKRILPSL--SDDRLVIQDFRHEVNLLVKLRHPNIVQ 104
+G+G F + KA + VAIK+I + + E+ LL +L HPNI+
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 105 FLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVII 164
L A + + L+ +++ L+PS + L +G+ YLH + I+
Sbjct: 65 LLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ--HWIL 122
Query: 165 HRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV-FKHR 223
HRDLKP N+LL LK+ DFGL+K T + + Y APE+ F R
Sbjct: 123 HRDLKPNNLLL--DENGVLKLADFGLAKSF----GSPNRAYTHQVVTRWYRAPELLFGAR 176
Query: 224 KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA------------- 270
Y VD+++ IL E+L P L + + E
Sbjct: 177 MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 236
Query: 271 -------------KGFTPELRELTEKCWAADMNQRPSFLDILK 300
+L +L + + + R + LK
Sbjct: 237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 2e-45
Identities = 60/292 (20%), Positives = 103/292 (35%), Gaps = 46/292 (15%)
Query: 50 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 107
IG+G+FGE+ KA R G VA+K++L + I E+ +L L+H N+V +
Sbjct: 18 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPIT-ALREIKILQLLKHENVVNLIE 76
Query: 108 AVTERKP--------LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE 159
+ + L+ ++ + S + G+ Y+H
Sbjct: 77 ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN 136
Query: 160 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV 219
I+HRD+K NVL+ LK+ DFGL++ + + + T + Y PE+
Sbjct: 137 K--ILHRDMKAANVLITRD--GVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPEL 192
Query: 220 F-KHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPF----------- 267
R Y +D++ I+ EM P + +++
Sbjct: 193 LLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNY 252
Query: 268 -------------------FRAKGFTPELRELTEKCWAADMNQRPSFLDILK 300
+A P +L +K D QR D L
Sbjct: 253 ELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 152 bits (384), Expect = 9e-45
Identities = 73/280 (26%), Positives = 118/280 (42%), Gaps = 38/280 (13%)
Query: 50 IGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGA 108
IG+G++G + KA G A+K+I D+ + E+++L +L+H NIV+
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEG-IPSTTIREISILKELKHSNIVKLYDV 68
Query: 109 VTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDL 168
+ +K L+L+ E+L +G L TA +F L + G+AY H+ ++HRDL
Sbjct: 69 IHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDL 126
Query: 169 KPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF-KHRKYDK 227
KP+N+L+ + LK+ DFGL++ V K T E + Y AP+V +KY
Sbjct: 127 KPQNLLI--NREGELKIADFGLARAF----GIPVRKYTHEIVTLWYRAPDVLMGSKKYST 180
Query: 228 KVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA----------------- 270
+D++S I EM+ G P + +
Sbjct: 181 TIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTV 240
Query: 271 ----------KGFTPELRELTEKCWAADMNQRPSFLDILK 300
KG +L K D NQR + L+
Sbjct: 241 YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 1e-44
Identities = 70/288 (24%), Positives = 121/288 (42%), Gaps = 44/288 (15%)
Query: 49 IIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 106
IG+G++G + AY VAIK+I S + + Q E+ +L++ RH NI+
Sbjct: 15 YIGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIN 72
Query: 107 GAV----TERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNV 162
+ E+ + + +L G DL+K LK + LS F I RG+ Y+H+
Sbjct: 73 DIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH-LSNDHICYFLYQILRGLKYIHSAN-- 129
Query: 163 IIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH 222
++HRDLKP N+LL ++ LK+ DFGL+++ + H + +T + Y APE+ +
Sbjct: 130 VLHRDLKPSNLLL--NTTCDLKICDFGLARVADPDHDHTGF-LTEYVATRWYRAPEIMLN 186
Query: 223 -RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA----------- 270
+ Y K +D++S IL EML P + ++ +
Sbjct: 187 SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKAR 246
Query: 271 ------------------KGFTPELRELTEKCWAADMNQRPSFLDILK 300
+ +L +K + ++R L
Sbjct: 247 NYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 7e-44
Identities = 64/300 (21%), Positives = 108/300 (36%), Gaps = 52/300 (17%)
Query: 39 PSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVK 96
P E+ ++ + +IG GSFG + +A G VAIK++L + E+ ++ K
Sbjct: 17 PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRK 69
Query: 97 LRHPNIVQFLGAVTERKP------LMLITEYLRGG---DLHKYLKEKGALSPSTAVNFAL 147
L H NIV+ L L+ +Y+ Y + K L +
Sbjct: 70 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 129
Query: 148 DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG 207
+ R +AY+H+ I HRD+KP+N+LL + LK+ DFG +K + ++
Sbjct: 130 QLFRSLAYIHSFG--ICHRDIKPQNLLL-DPDTAVLKLCDFGSAKQL----VRGEPNVSY 182
Query: 208 ETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPF 267
Y +F Y +DV+S +L E+L G+P + + +
Sbjct: 183 ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP 242
Query: 268 FR---------------------------AKGFTPELRELTEKCWAADMNQRPSFLDILK 300
R PE L + R + L+
Sbjct: 243 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 1e-42
Identities = 65/289 (22%), Positives = 112/289 (38%), Gaps = 40/289 (13%)
Query: 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 100
+F IG+G++G + KA + G VA+K+I + V E++LL +L HP
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEG-VPSTAIREISLLKELNHP 61
Query: 101 NIVQFLGAVTERKPLMLITEYL-RGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE 159
NIV+ L + L L+ E+L + + ++ + +G+A+ H+
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS- 120
Query: 160 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV 219
+ ++HRDLKP+N+L+ ++ +K+ DFGL++ V T E + Y APE+
Sbjct: 121 -HRVLHRDLKPQNLLI--NTEGAIKLADFGLARAF----GVPVRTYTHEVVTLWYRAPEI 173
Query: 220 FKHRKY-DKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA-------- 270
KY VD++S I EM+ + +
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 233
Query: 271 -------------------KGFTPELRELTEKCWAADMNQRPSFLDILK 300
+ R L + D N+R S L
Sbjct: 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 2e-42
Identities = 64/299 (21%), Positives = 116/299 (38%), Gaps = 50/299 (16%)
Query: 50 IGKGSFGEILKAYWR---GTPVAIKRILPSLSDDRLVIQDFR--HEVNLLVKLRHPNIVQ 104
IG+G++G++ KA G VA+KR+ ++ + + R + L HPN+V+
Sbjct: 15 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 74
Query: 105 FLGAVTERKP-----LMLITEYLRGGDL-HKYLKEKGALSPSTAVNFALDIARGMAYLHN 158
T + L L+ E++ + + + T + + RG+ +LH+
Sbjct: 75 LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 134
Query: 159 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPE 218
++HRDLKP+N+L+ +S+ +K+ DFGL+++ +T + Y APE
Sbjct: 135 HR--VVHRDLKPQNILV--TSSGQIKLADFGLARIY-----SFQMALTSVVVTLWYRAPE 185
Query: 219 VFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA-------- 270
V Y VD++S I EM +P + + +
Sbjct: 186 VLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 245
Query: 271 -----------------KGFTPELRELTEKCWAADMNQRPSFLDIL-----KRLEKIKE 307
++L KC + +R S L + LE+ KE
Sbjct: 246 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCKE 304
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 3e-42
Identities = 57/261 (21%), Positives = 105/261 (40%), Gaps = 14/261 (5%)
Query: 43 DFSSSAIIGKGSFGEILKAY-----WRGTPVAIKRILPS-LSDDRLVIQDFRHEVNLLVK 96
+F ++G G++G++ G A+K + + + + R E +L
Sbjct: 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84
Query: 97 LRH-PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 155
+R P +V A L LI +Y+ GG+L +L ++ + + +I + +
Sbjct: 85 IRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEH 144
Query: 156 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYM 215
LH II+RD+K N+LL S H+ + DFGLSK + Y G Y
Sbjct: 145 LHKLG--IIYRDIKLENILL--DSNGHVVLTDFGLSKEFVADETERAYDFCGTIE-YMAP 199
Query: 216 APEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFF--RAKGF 273
+DK VD +S +++YE+L G P + ++ +
Sbjct: 200 DIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEM 259
Query: 274 TPELRELTEKCWAADMNQRPS 294
+ ++L ++ D +R
Sbjct: 260 SALAKDLIQRLLMKDPKKRLG 280
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 6e-40
Identities = 68/306 (22%), Positives = 112/306 (36%), Gaps = 51/306 (16%)
Query: 31 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFR 88
K WE+ + +G G++G + A G VAIK++ + +
Sbjct: 10 TKTAWEVRA---VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFA-KRAY 65
Query: 89 HEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYL----RGGDLHKYLKEKGALSPSTAVN 144
E+ LL +RH N++ L T + L T++ G L + L
Sbjct: 66 RELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQF 125
Query: 145 FALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK 204
+ +G+ Y+H IIHRDLKP N+ + + LK+ DFGL++ +
Sbjct: 126 LVYQMLKGLRYIHA--AGIIHRDLKPGNLAV--NEDCELKILDFGLARQAD-------SE 174
Query: 205 MTGETGSYRYMAPEV-FKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEG 263
MTG + Y APEV +Y + VD++S I+ EM+ G+ + + K + +
Sbjct: 175 MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKV 234
Query: 264 HRPFFRA-----------------------------KGFTPELRELTEKCWAADMNQRPS 294
+P L EK D QR +
Sbjct: 235 TGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVT 294
Query: 295 FLDILK 300
+ L
Sbjct: 295 AGEALA 300
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 1e-39
Identities = 65/282 (23%), Positives = 108/282 (38%), Gaps = 40/282 (14%)
Query: 50 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 107
IG+G++G + KA R VA+KR+ DD V E+ LL +L+H NIV+
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLD-DDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 108 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 167
+ K L L+ E+ + G L P +F + +G+ + H+ ++HRD
Sbjct: 69 VLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRD 126
Query: 168 LKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRK-YD 226
LKP+N+L+ + LK+ +FGL++ V + E + Y P+V K Y
Sbjct: 127 LKPQNLLI--NRNGELKLANFGLARAF----GIPVRCYSAEVVTLWYRPPDVLFGAKLYS 180
Query: 227 KKVDVFSFAMILYEMLEGEPPL----------------------------ANYEPYEAAK 258
+D++S I E+ PL Y+
Sbjct: 181 TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP 240
Query: 259 YVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILK 300
R+L + + QR S + L+
Sbjct: 241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 131 bits (331), Expect = 1e-36
Identities = 56/314 (17%), Positives = 116/314 (36%), Gaps = 65/314 (20%)
Query: 35 WEIDPSELDFSSS------AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQD 86
W+ + +++ + +G+G + E+ +A V +K + P +
Sbjct: 22 WDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK------KK 75
Query: 87 FRHEVNLLVKLR-HPNIVQFLGAVTER--KPLMLITEYLRGGDLHKYLKEKGALSPSTAV 143
+ E+ +L LR PNI+ V + + L+ E++ D + + L+
Sbjct: 76 IKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ---TLTDYDIR 132
Query: 144 NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 203
+ +I + + Y H+ I+HRD+KP NV++ + L++ D+GL++ H
Sbjct: 133 FYMYEILKALDYCHS--MGIMHRDVKPHNVMI-DHEHRKLRLIDWGLAEFY-----HPGQ 184
Query: 204 KMTGETGSYRYMAPEVF-KHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAA----- 257
+ S + PE+ ++ YD +D++S +L M+ + P +
Sbjct: 185 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 244
Query: 258 -------------KYVAEGHRPFFRAKG------------------FTPELRELTEKCWA 286
KY E F G +PE + +K
Sbjct: 245 KVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLR 304
Query: 287 ADMNQRPSFLDILK 300
D R + + ++
Sbjct: 305 YDHQSRLTAREAME 318
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 5e-34
Identities = 62/306 (20%), Positives = 108/306 (35%), Gaps = 51/306 (16%)
Query: 31 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFR 88
NK WE+ + + + +G G++G + A+ G VA+K++ +
Sbjct: 10 NKTIWEVPE---RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-KRTY 65
Query: 89 HEVNLLVKLRHPNIVQFLGAVTERKPLM-----LITEYLRGGDLHKYLKEKGALSPSTAV 143
E+ LL ++H N++ L T + L + +L G D + + L+
Sbjct: 66 RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD-LNNIVKCQKLTDDHVQ 124
Query: 144 NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 203
I RG+ Y+H+ IIHRDLKP N+ + LK+ DFGL+ D
Sbjct: 125 FLIYQILRGLKYIHS--ADIIHRDLKPSNLA--VNEDCELKILDFGLA------RHTDDE 174
Query: 204 KMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEG 263
+ + Y++ VD++S I+ E+L G + + K +
Sbjct: 175 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 234
Query: 264 HRPFFRA-----------------------------KGFTPELRELTEKCWAADMNQRPS 294
G P +L EK D ++R +
Sbjct: 235 VGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 294
Query: 295 FLDILK 300
L
Sbjct: 295 AAQALA 300
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (303), Expect = 2e-32
Identities = 62/276 (22%), Positives = 101/276 (36%), Gaps = 27/276 (9%)
Query: 49 IIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 106
IG G+ G + AY VAIK++ + + E+ L+ + H NI+ L
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA-KRAYRELVLMKCVNHKNIISLL 82
Query: 107 GAVT------ERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP 160
T E + + L+ E + E + G+ +LH+
Sbjct: 83 NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL---DHERMSYLLYQMLCGIKHLHSAG 139
Query: 161 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF 220
IHRDLKP N+++ S LK+ DFGL++ + MT + Y APEV
Sbjct: 140 I--IHRDLKPSNIVV--KSDCTLKILDFGLARTA-----GTSFMMTPYVVTRYYRAPEVI 190
Query: 221 KHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELREL 280
Y + VD++S I+ EM+ + + + V E PE +
Sbjct: 191 LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGT------PCPEFMKK 244
Query: 281 TEKCWAADMNQRPSFLDILKRLEKIKETLPTDHHWN 316
+ + RP + + P D N
Sbjct: 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHN 280
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 105 bits (261), Expect = 2e-26
Identities = 40/216 (18%), Positives = 79/216 (36%), Gaps = 26/216 (12%)
Query: 50 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN------ 101
+G G F + A T VA+K + D++ + E+ LL ++ +
Sbjct: 21 LGWGHFSTVWLAKDMVNNTHVAMKIV----RGDKVYTEAAEDEIKLLQRVNDADNTKEDS 76
Query: 102 -----IVQFLGAVTERKP-----LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIAR 151
I++ L + P +M+ E + + +
Sbjct: 77 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLL 136
Query: 152 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGS 211
G+ Y+H IIH D+KP NVL+ + ++ L + Y + +
Sbjct: 137 GLDYMHRRCG-IIHTDIKPENVLM-EIVDSPENLIQIKIADLGNACWYDEHYTNS--IQT 192
Query: 212 YRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPP 247
Y +PEV + D++S A +++E++ G+
Sbjct: 193 REYRSPEVLLGAPWGCGADIWSTACLIFELITGDFL 228
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 81.8 bits (201), Expect = 3e-19
Identities = 31/211 (14%), Positives = 69/211 (32%), Gaps = 42/211 (19%)
Query: 49 IIGKGSFGEILKAY-WRGTPVAIKRILPSLSDDR---------------LVIQDFRHEVN 92
++G+G + Y + +K + + L I+ R+E
Sbjct: 7 LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66
Query: 93 LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARG 152
L KL+ + + ++ E + +L++ I
Sbjct: 67 ALQKLQGLAVPKVYAWEGN----AVLMELIDAKELYRV-------RVENPDEVLDMILEE 115
Query: 153 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSY 212
+A ++ I+H DL NVL+ S + + + DF S + + ++ +
Sbjct: 116 VAKFYH--RGIVHGDLSQYNVLV---SEEGIWIIDFPQSVEVGEEGWREILERDVRNIIT 170
Query: 213 RYMAPEVFKHRKYDKKVDVFSFAMILYEMLE 243
+ R Y + D+ S + +L+
Sbjct: 171 YF-------SRTYRTEKDINS---AIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 320 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.89 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.84 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.32 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.2 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.56 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.2 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.16 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-57 Score=382.70 Aligned_cols=247 Identities=30% Similarity=0.492 Sum_probs=219.8
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEe
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 120 (320)
+|++.+.||+|+||+||+|.++ ++.||+|++.+.........+.+.+|+++++.++||||+++++++.+++..|+|||
T Consensus 7 dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmE 86 (263)
T d2j4za1 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILE 86 (263)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred HeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEe
Confidence 7999999999999999999986 78899998865432222334678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCcc
Q 020888 121 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 200 (320)
Q Consensus 121 ~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~ 200 (320)
|+++|+|.+++...+.+++..+..++.||+.||+|||++| |+|+||||+||++ +.++.++|+|||++.......
T Consensus 87 y~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~--ivHrDiKp~Nill--~~~~~~kl~DFG~a~~~~~~~-- 160 (263)
T d2j4za1 87 YAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLL--GSAGELKIADFGWSVHAPSSR-- 160 (263)
T ss_dssp CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE--CTTSCEEECCCCSCSCCCCCC--
T ss_pred ecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeeeecccccee--cCCCCEeecccceeeecCCCc--
Confidence 9999999999998889999999999999999999999999 9999999999999 888999999999997654322
Q ss_pred ceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHH
Q 020888 201 DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELREL 280 (320)
Q Consensus 201 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 280 (320)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+...... .+..++++++++
T Consensus 161 ----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~--~p~~~s~~~~~l 234 (263)
T d2j4za1 161 ----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT--FPDFVTEGARDL 234 (263)
T ss_dssp ----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCC--CCTTSCHHHHHH
T ss_pred ----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC--CCccCCHHHHHH
Confidence 23457899999999999999999999999999999999999999998888887777765543 235589999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHH
Q 020888 281 TEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 281 i~~~l~~dp~~Rps~~~ll~~ 301 (320)
|.+||+.||.+|||++|++++
T Consensus 235 i~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 235 ISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp HHHHTCSSGGGSCCHHHHHTC
T ss_pred HHHHccCCHhHCcCHHHHHcC
Confidence 999999999999999999875
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-55 Score=375.89 Aligned_cols=248 Identities=27% Similarity=0.494 Sum_probs=217.5
Q ss_pred cccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEE
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 119 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 119 (320)
.+|++.+.||+|+||+||+|.+. ++.||+|.+....... .+.+.+|++++++++||||+++++++..++.+|+||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 96 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH---HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEE
Confidence 47999999999999999999975 8899999886554333 267889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCc
Q 020888 120 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 199 (320)
Q Consensus 120 e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~ 199 (320)
||++||+|.+++.. +.+++..+..++.||+.||.|||++| |+||||||+||++ +.++.++|+|||++..+.....
T Consensus 97 Ey~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl--~~~~~vkl~DFG~a~~~~~~~~ 171 (293)
T d1yhwa1 97 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILL--GMDGSVKLTDFGFCAQITPEQS 171 (293)
T ss_dssp ECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--CTTCCEEECCCTTCEECCSTTC
T ss_pred EecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCcHHHeEE--CCCCcEeeccchhheeeccccc
Confidence 99999999998876 46999999999999999999999999 9999999999999 8889999999999987654321
Q ss_pred cceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCC-CCCCCCCCCHHHH
Q 020888 200 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHR-PFFRAKGFTPELR 278 (320)
Q Consensus 200 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~ 278 (320)
......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+..... ....+..++++++
T Consensus 172 ----~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 247 (293)
T d1yhwa1 172 ----KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFR 247 (293)
T ss_dssp ----CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHH
T ss_pred ----cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHH
Confidence 23345799999999999999999999999999999999999999998887766655554433 3333456899999
Q ss_pred HHHHHHhhcCCCCCCCHHHHHHH
Q 020888 279 ELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 279 ~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
++|.+||+.||++|||++|+++|
T Consensus 248 ~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 248 DFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp HHHHHHTCSSTTTSCCHHHHTTC
T ss_pred HHHHHHccCChhHCcCHHHHhcC
Confidence 99999999999999999999875
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-55 Score=372.75 Aligned_cols=267 Identities=32% Similarity=0.557 Sum_probs=218.7
Q ss_pred CCcCCCCCcccCccceecccCceEEEEEEECCCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCC
Q 020888 34 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK 113 (320)
Q Consensus 34 ~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 113 (320)
+|+++ ..+|.+.+.||+|+||+||++..++ .||+|++....... ...+.+.+|++++++++||||+++++++. ++
T Consensus 2 dwei~--~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~ 76 (276)
T d1uwha_ 2 DWEIP--DGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTP-QQLQAFKNEVGVLRKTRHVNILLFMGYST-AP 76 (276)
T ss_dssp CCBCC--TTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCT-THHHHHHHHHHHHTTCCCTTBCCEEEEEC-SS
T ss_pred Ccccc--cccEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCH-HHHHHHHHHHHHHHhCCCCCEeeeeEEEe-cc
Confidence 57666 4578999999999999999997654 59999986554333 34588999999999999999999999865 45
Q ss_pred ceEEEEecCCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcc
Q 020888 114 PLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 192 (320)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~ 192 (320)
.+++||||+++|+|.+++... +.+++..+..++.|++.||+|||++| |+||||||+||++ +.++.+||+|||++.
T Consensus 77 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~--ivHrDlKp~NiLl--~~~~~~Kl~DFGla~ 152 (276)
T d1uwha_ 77 QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS--IIHRDLKSNNIFL--HEDLTVKIGDFGLAT 152 (276)
T ss_dssp SCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE--ETTSSEEECCCCCSC
T ss_pred EEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCC--EeccccCHHHEEE--cCCCCEEEcccccee
Confidence 689999999999999999754 56999999999999999999999988 9999999999999 888999999999997
Q ss_pred cccccCccceeeccCCcccccccCccccCcC---CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHhCCCCC-
Q 020888 193 LIKVQNSHDVYKMTGETGSYRYMAPEVFKHR---KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEA-AKYVAEGHRPF- 267 (320)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~-~~~~~~~~~~~- 267 (320)
....... ........||+.|+|||++.+. .++.++|||||||++|||+||+.||.+.+.... ...+..+...+
T Consensus 153 ~~~~~~~--~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~ 230 (276)
T d1uwha_ 153 VKSRWSG--SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPD 230 (276)
T ss_dssp C--------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCC
T ss_pred eccccCC--cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCc
Confidence 6653321 1223445789999999998643 478999999999999999999999998765544 34444444332
Q ss_pred --CCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcCCC
Q 020888 268 --FRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPT 311 (320)
Q Consensus 268 --~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~ 311 (320)
.....+++++++++.+||+.||.+|||+++++++|+.+..++|+
T Consensus 231 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~Pk 276 (276)
T d1uwha_ 231 LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPK 276 (276)
T ss_dssp GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCC
T ss_pred chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCCC
Confidence 22356899999999999999999999999999999999998874
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.3e-55 Score=376.79 Aligned_cols=269 Identities=29% Similarity=0.560 Sum_probs=228.5
Q ss_pred CCCCCCCCCCcCCCCCcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCccc
Q 020888 26 PPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 103 (320)
Q Consensus 26 ~~~~~~~~~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~ 103 (320)
.|+.|+..+|+++. .+|++.+.||+|+||+||+|.+. ++.||+|.+...... .+.+.+|++++++++||||+
T Consensus 3 ~p~~p~~~~wei~~--~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~----~~~~~~E~~il~~l~HpnIv 76 (287)
T d1opja_ 3 DPSSPNYDKWEMER--TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLV 76 (287)
T ss_dssp CTTSTTCCTTBCCG--GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC----HHHHHHHHHHHHHCCCTTBC
T ss_pred CCCCCCCcccEecH--HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch----HHHHHHHHHHHHhCCCCCEe
Confidence 46677888898875 57999999999999999999985 788999988654332 26788999999999999999
Q ss_pred ceeeeEEeCCceEEEEecCCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCC
Q 020888 104 QFLGAVTERKPLMLITEYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD 181 (320)
Q Consensus 104 ~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~ 181 (320)
++++++.+++..++||||+++|+|.+++... ..+++..++.++.|++.||+|||++| |+||||||+||++ +.++
T Consensus 77 ~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~--iiHrDlKp~NILl--~~~~ 152 (287)
T d1opja_ 77 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLV--GENH 152 (287)
T ss_dssp CEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE--CGGG
T ss_pred cCCccEeeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC--cccCccccCeEEE--CCCC
Confidence 9999999999999999999999999999763 46899999999999999999999998 9999999999999 8889
Q ss_pred cEEEecCCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCC-CCCChHHHHHHH
Q 020888 182 HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPL-ANYEPYEAAKYV 260 (320)
Q Consensus 182 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~-~~~~~~~~~~~~ 260 (320)
.+||+|||+++....... .......+++.|+|||++.+..++.++||||||+++|+|++|..|| ...+.......+
T Consensus 153 ~~Kl~DFG~a~~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i 229 (287)
T d1opja_ 153 LVKVADFGLSRLMTGDTY---TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 229 (287)
T ss_dssp CEEECCCCCTTTCCSSSS---EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred cEEEccccceeecCCCCc---eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHH
Confidence 999999999986543321 2233445788999999999999999999999999999999966655 455555555555
Q ss_pred HhCCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhc
Q 020888 261 AEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKET 308 (320)
Q Consensus 261 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 308 (320)
..+..+. .+..+++++++++.+||+.||++|||++++++.|+.+..+
T Consensus 230 ~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 230 EKDYRME-RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp HTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred hcCCCCC-CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 5554443 4456899999999999999999999999999999877543
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.4e-55 Score=378.76 Aligned_cols=248 Identities=32% Similarity=0.468 Sum_probs=223.5
Q ss_pred cccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEE
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 119 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 119 (320)
..|+.++.||+|+||+||+|.+. ++.||+|.+...........+.+.+|++++++++||||+++++++.+++..|+||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 45999999999999999999975 7789999987766666666788999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCc
Q 020888 120 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 199 (320)
Q Consensus 120 e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~ 199 (320)
||+++|+|..+...++++++..++.++.||+.||.|||++| |+||||||+||++ +.++.++|+|||++......
T Consensus 95 E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl--~~~~~~Kl~DFG~a~~~~~~-- 168 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILL--SEPGLVKLGDFGSASIMAPA-- 168 (309)
T ss_dssp ECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEE--ETTTEEEECCCTTCBSSSSB--
T ss_pred EecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEE--CCCCCEEEeecccccccCCC--
Confidence 99999999888777788999999999999999999999999 9999999999999 88899999999999765432
Q ss_pred cceeeccCCcccccccCccccCc---CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHH
Q 020888 200 HDVYKMTGETGSYRYMAPEVFKH---RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPE 276 (320)
Q Consensus 200 ~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (320)
....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+....+....+.....+......++++
T Consensus 169 ------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~ 242 (309)
T d1u5ra_ 169 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEY 242 (309)
T ss_dssp ------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHH
T ss_pred ------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHH
Confidence 23568999999999864 358899999999999999999999999988888888888887777777779999
Q ss_pred HHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 277 LRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 277 l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
+++||.+||+.||.+|||++++++|
T Consensus 243 ~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 243 FRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred HHHHHHHHCcCChhHCcCHHHHHhC
Confidence 9999999999999999999999864
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-55 Score=373.80 Aligned_cols=252 Identities=29% Similarity=0.494 Sum_probs=208.1
Q ss_pred cccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEe--CCceEE
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE--RKPLML 117 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~i 117 (320)
.+|++.+.||+|+||+||++.++ ++.||+|.+....... ...+.+.+|++++++++||||+++++++.+ ++.+|+
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE-AEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCH-HHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCH-HHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 37999999999999999999986 7889999987655443 345789999999999999999999998854 566899
Q ss_pred EEecCCCCCHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHhcCC---CCeEecCCCCCcEEEeeCCCCcEEEecCCC
Q 020888 118 ITEYLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLHNEP---NVIIHRDLKPRNVLLVNSSADHLKVGDFGL 190 (320)
Q Consensus 118 v~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~~l~~~l~~lH~~g---~~ivH~di~p~nI~~~~~~~~~~~L~dfg~ 190 (320)
||||++||+|.+++.+ ++.+++..++.++.|++.||.|||++| ++|+||||||+||++ +.++.++|+|||+
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll--~~~~~vkl~DFG~ 160 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL--DGKQNVKLGDFGL 160 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEE--CTTSCEEECCHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCc--CCCCcEEEeeccc
Confidence 9999999999999864 457999999999999999999999864 349999999999999 8889999999999
Q ss_pred cccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCC
Q 020888 191 SKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA 270 (320)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 270 (320)
+..+..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+..+..+.. +
T Consensus 161 a~~~~~~~~----~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~-~ 235 (269)
T d2java1 161 ARILNHDTS----FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRI-P 235 (269)
T ss_dssp HHHC---------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC-C
T ss_pred eeecccCCC----ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC-C
Confidence 987654321 22346789999999999999999999999999999999999999999988888888877765543 4
Q ss_pred CCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 271 KGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 271 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
..+++++++++.+||+.||++|||++|++++
T Consensus 236 ~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 236 YRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred cccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 5689999999999999999999999999874
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-55 Score=375.37 Aligned_cols=252 Identities=29% Similarity=0.430 Sum_probs=212.5
Q ss_pred cccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEE
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 119 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 119 (320)
.+|++++.||+|+||+||+|.+. ++.||+|++...... +..+.+.+|++++++++||||+++++++.+++..|+||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivm 82 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 82 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc--hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEE
Confidence 37999999999999999999986 789999998654322 22367889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCc
Q 020888 120 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 199 (320)
Q Consensus 120 e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~ 199 (320)
||++||+|.+++...+.+++..+..++.|++.||.|||++| |+||||||+||++ +.++.+||+|||++..+.....
T Consensus 83 Ey~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~--IiHrDiKp~NILl--~~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 83 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLL--DERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEE--CTTCCEEECCCTTCEECEETTE
T ss_pred eccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--CccCcccHHHEEE--CCCCCEEEccchhheeeccCCc
Confidence 99999999999988778999999999999999999999999 9999999999999 8888999999999987654332
Q ss_pred cceeeccCCcccccccCccccCcCCC-CCchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHhCCCCCCCCCCCCHHH
Q 020888 200 HDVYKMTGETGSYRYMAPEVFKHRKY-DKKVDVFSFAMILYEMLEGEPPLANYEPY-EAAKYVAEGHRPFFRAKGFTPEL 277 (320)
Q Consensus 200 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~ll~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l 277 (320)
. ......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...... ..................+++++
T Consensus 159 ~--~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 236 (271)
T d1nvra_ 159 E--RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 236 (271)
T ss_dssp E--CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHH
T ss_pred c--ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHH
Confidence 1 12345679999999999988776 57899999999999999999999765433 33334444443333345689999
Q ss_pred HHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 278 RELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 278 ~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
+++|.+||+.||++|||++|++++
T Consensus 237 ~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 237 LALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHHHHcCCChhHCcCHHHHhcC
Confidence 999999999999999999999875
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-55 Score=379.26 Aligned_cols=252 Identities=25% Similarity=0.438 Sum_probs=218.3
Q ss_pred cccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEE
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 119 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 119 (320)
.+|++++.||+|+||+||+|.++ ++.||+|++...........+.+.+|++++++++||||+++++++.+++.+|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 37999999999999999999985 7899999886543222233467899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCc
Q 020888 120 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 199 (320)
Q Consensus 120 e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~ 199 (320)
||++||+|.+++...+.+++..++.++.|++.||.|||++| |+||||||+||++ +.++.++|+|||++..+.....
T Consensus 88 Ey~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~NIll--~~~~~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILL--NEDMHIQITDFGTAKVLSPESK 163 (288)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--CTTSCEEECCCTTCEECC----
T ss_pred EccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhcccc--EEcCcCCcccccc--CCCceEEecccccceecccCCc
Confidence 99999999999998889999999999999999999999998 9999999999999 8889999999999987653321
Q ss_pred cceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHH
Q 020888 200 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRE 279 (320)
Q Consensus 200 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 279 (320)
........||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+...... .+..+++++++
T Consensus 164 --~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~--~p~~~s~~~~~ 239 (288)
T d1uu3a_ 164 --QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD--FPEKFFPKARD 239 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCC--CCTTCCHHHHH
T ss_pred --ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCC--CCccCCHHHHH
Confidence 11233457999999999999999999999999999999999999999998888887777766533 23568999999
Q ss_pred HHHHHhhcCCCCCCCHHHHHHH
Q 020888 280 LTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 280 li~~~l~~dp~~Rps~~~ll~~ 301 (320)
||.+||+.||.+|||++|++++
T Consensus 240 li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 240 LVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp HHHTTSCSSGGGSTTSGGGTCH
T ss_pred HHHHHccCCHhHCcCHHHHcCC
Confidence 9999999999999999997654
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-54 Score=367.42 Aligned_cols=252 Identities=30% Similarity=0.501 Sum_probs=212.7
Q ss_pred CCcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEe----CC
Q 020888 40 SELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE----RK 113 (320)
Q Consensus 40 ~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~ 113 (320)
+++.|...+.||+|+||+||+|.++ ++.||+|.+...... ....+.+.+|++++++++||||+++++++.. ..
T Consensus 7 ~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~ 85 (270)
T d1t4ha_ 7 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK 85 (270)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCE
T ss_pred CCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCC
Confidence 3444567788999999999999986 678999988665443 3345789999999999999999999999864 35
Q ss_pred ceEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeC-CCCcEEEecCCCcc
Q 020888 114 PLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS-SADHLKVGDFGLSK 192 (320)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~-~~~~~~L~dfg~~~ 192 (320)
.+|+||||+++++|.+++.+.+.+++..+..++.||+.||.|||++|.+|+||||||+||++ + .++.+||+|||++.
T Consensus 86 ~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl--~~~~~~~Kl~DFGla~ 163 (270)
T d1t4ha_ 86 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFI--TGPTGSVKIGDLGLAT 163 (270)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEE--SSTTSCEEECCTTGGG
T ss_pred EEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhcee--eCCCCCEEEeecCcce
Confidence 57999999999999999998889999999999999999999999976669999999999999 5 46789999999997
Q ss_pred cccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHhCCCCCCCCC
Q 020888 193 LIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEP-YEAAKYVAEGHRPFFRAK 271 (320)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~ 271 (320)
..... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||..... ......+..+..+.....
T Consensus 164 ~~~~~------~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~ 236 (270)
T d1t4ha_ 164 LKRAS------FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDK 236 (270)
T ss_dssp GCCTT------SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGG
T ss_pred eccCC------ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCc
Confidence 54322 1234578999999999875 599999999999999999999999987654 444555666655555556
Q ss_pred CCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 272 GFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 272 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
.++++++++|.+||+.||++|||++|+++|
T Consensus 237 ~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 237 VAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp CCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 689999999999999999999999999875
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-54 Score=376.63 Aligned_cols=251 Identities=27% Similarity=0.440 Sum_probs=205.2
Q ss_pred cccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEE
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 119 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 119 (320)
..|++.+.||+|+||+||+|.++ ++.||+|++........ ...+.+|++++++++||||+++++++.+++.+|+||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGK--EGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhH--HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 35999999999999999999986 78899999866543322 256889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEee-CCCCcEEEecCCCcccccccC
Q 020888 120 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN-SSADHLKVGDFGLSKLIKVQN 198 (320)
Q Consensus 120 e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~-~~~~~~~L~dfg~~~~~~~~~ 198 (320)
||++|++|.+++.+.+.+++..+..++.||+.||+|||++| |+|+||||+||++.. +.++.++|+|||++.......
T Consensus 87 E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~ 164 (307)
T d1a06a_ 87 QLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS 164 (307)
T ss_dssp CCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred eccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhce--eeeEEecccceeecccCCCceEEEeccceeEEccCCC
Confidence 99999999999998889999999999999999999999998 999999999999943 356789999999998654332
Q ss_pred ccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCC--CCCCCCHH
Q 020888 199 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFF--RAKGFTPE 276 (320)
Q Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 276 (320)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+....+....+........ ....++++
T Consensus 165 -----~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 239 (307)
T d1a06a_ 165 -----VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDS 239 (307)
T ss_dssp -------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHH
T ss_pred -----eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHH
Confidence 22345799999999999999999999999999999999999999999888888777777654332 23568999
Q ss_pred HHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 277 LRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 277 l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
++++|.+||+.||.+|||++|++++
T Consensus 240 ~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 240 AKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHccCCHhHCcCHHHHhcC
Confidence 9999999999999999999999985
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-54 Score=378.40 Aligned_cols=256 Identities=25% Similarity=0.452 Sum_probs=216.2
Q ss_pred CCCcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceE
Q 020888 39 PSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLM 116 (320)
Q Consensus 39 ~~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 116 (320)
....+|.+++.||+|+||+||+|.+. ++.||+|++...... .....+.+|+.+++.++||||+++++++.+.+..|
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 80 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP--AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 80 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCT--THHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEE
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCH--HHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 44678999999999999999999985 788999998654332 23478899999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcC-CCCeEecCCCCCcEEEeeCCCCcEEEecCCCccccc
Q 020888 117 LITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE-PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 195 (320)
Q Consensus 117 iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~-g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~ 195 (320)
+||||++||+|.+++.+.+.+++..+..++.|++.||.|||++ | |+||||||+||++ +.++.+||+|||++....
T Consensus 81 iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~--IiHRDiKP~NILl--~~~~~vkl~DFGla~~~~ 156 (322)
T d1s9ja_ 81 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILV--NSRGEIKLCDFGVSGQLI 156 (322)
T ss_dssp EEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEE--CTTCCEEECCCCCCHHHH
T ss_pred EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC--EEccccCHHHeeE--CCCCCEEEeeCCCccccC
Confidence 9999999999999999888999999999999999999999974 8 9999999999999 888999999999998765
Q ss_pred ccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHH-------------------
Q 020888 196 VQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEA------------------- 256 (320)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~------------------- 256 (320)
... ....+||+.|+|||++.+..++.++||||+||++|+|++|+.||...+..+.
T Consensus 157 ~~~------~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (322)
T d1s9ja_ 157 DSM------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP 230 (322)
T ss_dssp HHT------C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------
T ss_pred CCc------cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccc
Confidence 432 2345799999999999999999999999999999999999999976543221
Q ss_pred -----------------------HHHHHhCCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH--HHHHH
Q 020888 257 -----------------------AKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR--LEKIK 306 (320)
Q Consensus 257 -----------------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--L~~~~ 306 (320)
...+.....+......++.+++++|.+||..||++|||++|+++| +++..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~ 305 (322)
T d1s9ja_ 231 RTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 305 (322)
T ss_dssp ---------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred ccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCC
Confidence 112222222333334578999999999999999999999999997 55443
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-54 Score=364.41 Aligned_cols=256 Identities=31% Similarity=0.624 Sum_probs=212.7
Q ss_pred CcccCccceecccCceEEEEEEEC-CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEE
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 119 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~-~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 119 (320)
..+|.+.+.||+|+||+||++.+. ++.||+|.+....... +.+.+|++++++++||||+++++++...+..++||
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~----~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~ 79 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF 79 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCH----HHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred hHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcH----HHHHHHHHHHHhcCCCCcccccceeccCCceEEEE
Confidence 347899999999999999999986 6679999986543332 67889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccC
Q 020888 120 EYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 198 (320)
Q Consensus 120 e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~ 198 (320)
||+++|+|.+++... ..+++..++.++.|++.||.|||+++ |+||||||+||++ +.++.+||+|||+++......
T Consensus 80 E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~--iiHrDlKp~Nill--~~~~~~Kl~DFGla~~~~~~~ 155 (263)
T d1sm2a_ 80 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLV--GENQVIKVSDFGMTRFVLDDQ 155 (263)
T ss_dssp ECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCTTCSGGGEEE--CGGGCEEECSCC---------
T ss_pred EecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccc--eeecccchhheee--cCCCCeEecccchheeccCCC
Confidence 999999999998754 56899999999999999999999988 9999999999999 888999999999997664432
Q ss_pred ccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHH
Q 020888 199 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPEL 277 (320)
Q Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 277 (320)
. .......+|+.|+|||++.+..++.++||||||+++|||+| |..||......+....+..+..... +..+++++
T Consensus 156 ~---~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~-p~~~~~~l 231 (263)
T d1sm2a_ 156 Y---TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK-PRLASTHV 231 (263)
T ss_dssp ------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCC-CTTSCHHH
T ss_pred c---eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCC-ccccCHHH
Confidence 1 12233568899999999999999999999999999999999 5666776777777777777665543 45579999
Q ss_pred HHHHHHHhhcCCCCCCCHHHHHHHHHHHHhc
Q 020888 278 RELTEKCWAADMNQRPSFLDILKRLEKIKET 308 (320)
Q Consensus 278 ~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 308 (320)
.+++.+||+.||++|||+++++++|+++.++
T Consensus 232 ~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 232 YQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 9999999999999999999999999998764
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-54 Score=370.36 Aligned_cols=248 Identities=28% Similarity=0.468 Sum_probs=215.6
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEe
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 120 (320)
.|++++.||+|+||+||+|.+. ++.||+|++...... ..+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 13 ~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~---~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE 89 (288)
T d2jfla1 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEE---ELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 89 (288)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSG---GGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHH---HHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEe
Confidence 5899999999999999999985 788999998654322 23678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCc
Q 020888 121 YLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 199 (320)
Q Consensus 121 ~~~~~~L~~~~~~-~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~ 199 (320)
|++||+|.+++.+ .+.+++..+..++.||+.||.|||++| |+|+||||+||++ +.++.+||+|||++.......
T Consensus 90 y~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~--ivHrDiKp~NIll--~~~~~~Kl~DFG~a~~~~~~~- 164 (288)
T d2jfla1 90 FCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK--IIHRDLKAGNILF--TLDGDIKLADFGVSAKNTRTI- 164 (288)
T ss_dssp CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--CTTSCEEECCCTTCEECHHHH-
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEEeecChhheeE--CCCCCEEEEechhhhccCCCc-
Confidence 9999999999765 456999999999999999999999999 9999999999999 888999999999987654321
Q ss_pred cceeeccCCcccccccCccccC-----cCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCC-CCCCCC
Q 020888 200 HDVYKMTGETGSYRYMAPEVFK-----HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPF-FRAKGF 273 (320)
Q Consensus 200 ~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~ 273 (320)
.......||+.|+|||++. +..++.++|||||||++|+|++|..||...+..+....+.....+. ..+..+
T Consensus 165 ---~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 241 (288)
T d2jfla1 165 ---QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRW 241 (288)
T ss_dssp ---HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGS
T ss_pred ---ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccC
Confidence 1233467899999999984 4567899999999999999999999999988888777777665443 334568
Q ss_pred CHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 274 TPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 274 ~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
++++++||.+||+.||.+|||++|++++
T Consensus 242 s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 242 SSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 9999999999999999999999999875
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.2e-53 Score=364.35 Aligned_cols=260 Identities=26% Similarity=0.443 Sum_probs=219.7
Q ss_pred cccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCC----ce
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK----PL 115 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~ 115 (320)
.+|.+.+.||+|+||+||+|.+. ++.||+|++......+......+.+|+++++.++||||+++++++...+ .+
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence 36999999999999999999985 8899999998877777777788999999999999999999999987644 37
Q ss_pred EEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccccc
Q 020888 116 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 195 (320)
Q Consensus 116 ~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~ 195 (320)
|+||||++|++|.+++...+++++..++.++.||+.||+|||++| |+|+||||+||++ +.++.++++|||.+....
T Consensus 87 ~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--iiHrDiKP~NIll--~~~~~~~l~d~~~~~~~~ 162 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMI--SATNAVKVMDFGIARAIA 162 (277)
T ss_dssp EEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--ETTSCEEECCCTTCEECC
T ss_pred EEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCccccCccccc--Cccccceeehhhhhhhhc
Confidence 999999999999999998889999999999999999999999998 9999999999999 888899999999887654
Q ss_pred ccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCC--CCCCCC
Q 020888 196 VQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPF--FRAKGF 273 (320)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~ 273 (320)
.... .........||+.|+|||++.+..++.++|||||||++|+|+||..||...+..+............ .....+
T Consensus 163 ~~~~-~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (277)
T d1o6ya_ 163 DSGN-SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL 241 (277)
T ss_dssp -----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSC
T ss_pred cccc-cccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCC
Confidence 3322 1123344578999999999999999999999999999999999999999988877766666554332 223568
Q ss_pred CHHHHHHHHHHhhcCCCCCC-CHHHHHHHHHHHH
Q 020888 274 TPELRELTEKCWAADMNQRP-SFLDILKRLEKIK 306 (320)
Q Consensus 274 ~~~l~~li~~~l~~dp~~Rp-s~~~ll~~L~~~~ 306 (320)
|++++++|.+||+.||.+|| |++++++.|.++.
T Consensus 242 s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 242 SADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 99999999999999999998 8999999999875
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.1e-53 Score=367.63 Aligned_cols=262 Identities=30% Similarity=0.541 Sum_probs=214.0
Q ss_pred CCcccCccceecccCceEEEEEEEC--CC---ceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCc
Q 020888 40 SELDFSSSAIIGKGSFGEILKAYWR--GT---PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP 114 (320)
Q Consensus 40 ~~~~y~~~~~lg~g~~~~vy~~~~~--~~---~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 114 (320)
...+|.+.+.||+|+||+||++.+. ++ .||+|.+.... .....+.+.+|++++++++||||+++++++..++.
T Consensus 24 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~ 101 (299)
T d1jpaa_ 24 DISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTP 101 (299)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred ChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE
Confidence 3457889999999999999999875 22 47788765433 33445789999999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccc
Q 020888 115 LMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 193 (320)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~ 193 (320)
.++||||+++|+|.+++.. .+.+++..++.++.|++.||.|||++| ++||||||+||++ +.++.+||+|||+++.
T Consensus 102 ~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHrDlKp~NILl--~~~~~~Kl~DFGla~~ 177 (299)
T d1jpaa_ 102 VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN--YVHRDLAARNILV--NSNLVCKVSDFGLSRF 177 (299)
T ss_dssp CEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE--CTTCCEEECCC-----
T ss_pred EEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCC--CccCccccceEEE--CCCCcEEECCcccceE
Confidence 9999999999999998876 457999999999999999999999998 9999999999999 8999999999999987
Q ss_pred ccccCccce-eeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCC
Q 020888 194 IKVQNSHDV-YKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAK 271 (320)
Q Consensus 194 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 271 (320)
+........ .......+|+.|+|||.+.+..++.++|||||||++|||+| |..||.+....+....+..+..++. +.
T Consensus 178 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~-~~ 256 (299)
T d1jpaa_ 178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPP-PM 256 (299)
T ss_dssp ------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC-CT
T ss_pred ccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC-Cc
Confidence 654332221 12223457899999999999999999999999999999998 8999999998888888877765544 44
Q ss_pred CCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhc
Q 020888 272 GFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKET 308 (320)
Q Consensus 272 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 308 (320)
.+++++++++.+||+.||.+|||+.++++.|+++..+
T Consensus 257 ~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 257 DCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred cchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 5899999999999999999999999999999998764
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.6e-53 Score=375.50 Aligned_cols=249 Identities=24% Similarity=0.446 Sum_probs=219.1
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEe
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 120 (320)
+|++++.||+|+||+||+|.+. ++.||+|++.... ....+.+.+|++++++++||||+++++++.+++.+|+|||
T Consensus 27 ~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 103 (350)
T d1koaa2 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 103 (350)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEEC
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc---hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 7999999999999999999986 7899999986542 3344788999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHH-HhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCc
Q 020888 121 YLRGGDLHKYLK-EKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 199 (320)
Q Consensus 121 ~~~~~~L~~~~~-~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~ 199 (320)
|++||+|.+++. ..+++++..+..++.||+.||.|||++| |+|+||||+||++..+.++.++|+|||++..+.....
T Consensus 104 ~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~ 181 (350)
T d1koaa2 104 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 181 (350)
T ss_dssp CCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC
T ss_pred cCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC--CeeeeechhHeeeccCCCCeEEEeecchheecccccc
Confidence 999999999985 4567999999999999999999999999 9999999999999655678999999999987654321
Q ss_pred cceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCC--CCCCCCHHH
Q 020888 200 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFF--RAKGFTPEL 277 (320)
Q Consensus 200 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l 277 (320)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+........ ....+++++
T Consensus 182 -----~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 256 (350)
T d1koaa2 182 -----VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDG 256 (350)
T ss_dssp -----EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHH
T ss_pred -----cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHH
Confidence 2335689999999999999999999999999999999999999998888888877776653322 224589999
Q ss_pred HHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 278 RELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 278 ~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
++||.+||..||++|||++|+++|
T Consensus 257 ~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 257 KDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp HHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHccCChhHCcCHHHHhcC
Confidence 999999999999999999999986
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-53 Score=361.65 Aligned_cols=262 Identities=30% Similarity=0.520 Sum_probs=221.4
Q ss_pred CCCCcCCCCCcccCccceecccCceEEEEEEEC-CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEE
Q 020888 32 KCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVT 110 (320)
Q Consensus 32 ~~~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~-~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 110 (320)
..+|+++. .+|++.+.||+|+||+||++.++ ++.||||.+...... .+.+.+|++++++++||||+++++++.
T Consensus 5 ~~~wei~~--~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~ 78 (272)
T d1qpca_ 5 EDEWEVPR--ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVT 78 (272)
T ss_dssp TCTTBCCG--GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCCeecCH--HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCC----HHHHHHHHHHHHhCCCCCEeEEEeeec
Confidence 35677764 58999999999999999999987 578999988654332 267899999999999999999999875
Q ss_pred eCCceEEEEecCCCCCHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecC
Q 020888 111 ERKPLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF 188 (320)
Q Consensus 111 ~~~~~~iv~e~~~~~~L~~~~~~--~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~df 188 (320)
+ +..++||||+++|+|.+++.. ..++++..++.++.|++.||.|||++| |+||||||+||++ +.++.+||+||
T Consensus 79 ~-~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~--ivHrDiKp~NIll--~~~~~~Kl~DF 153 (272)
T d1qpca_ 79 Q-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILV--SDTLSCKIADF 153 (272)
T ss_dssp S-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--CTTSCEEECCC
T ss_pred c-CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccchhheee--ecccceeeccc
Confidence 4 567899999999999997753 336999999999999999999999988 9999999999999 88999999999
Q ss_pred CCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHhCCCCC
Q 020888 189 GLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGE-PPLANYEPYEAAKYVAEGHRPF 267 (320)
Q Consensus 189 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~-~p~~~~~~~~~~~~~~~~~~~~ 267 (320)
|+++.+.... ........+++.|+|||++.+..++.++||||||+++|||+||. .|+......+....+..+..+.
T Consensus 154 Gla~~~~~~~---~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~ 230 (272)
T d1qpca_ 154 GLARLIEDNE---YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV 230 (272)
T ss_dssp TTCEECSSSC---EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC
T ss_pred cceEEccCCc---cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC
Confidence 9998765322 22234456889999999999899999999999999999999955 4556666666666666665444
Q ss_pred CCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhc
Q 020888 268 FRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKET 308 (320)
Q Consensus 268 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 308 (320)
.+..+++++++++.+||+.||++|||++++++.|+.+..+
T Consensus 231 -~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 231 -RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp -CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -CcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 3456899999999999999999999999999999998765
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-53 Score=373.32 Aligned_cols=250 Identities=25% Similarity=0.435 Sum_probs=222.1
Q ss_pred cccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEE
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 119 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 119 (320)
.+|.+++.||+|+||.||+|.++ ++.||+|++.+.........+.+.+|+++++.++||||+++++++.+.+.+|+||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 47999999999999999999985 8899999986543222223477889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCc
Q 020888 120 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 199 (320)
Q Consensus 120 e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~ 199 (320)
||++||+|.+++...+.+++..++.++.||+.||+|||++| |+||||||+||++ +.+|.++|+|||+++.......
T Consensus 85 ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NILl--~~~g~vkl~DFG~a~~~~~~~~ 160 (337)
T d1o6la_ 85 EYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLML--DKDGHIKITDFGLCKEGISDGA 160 (337)
T ss_dssp ECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEE--CTTSCEEECCCTTCBCSCCTTC
T ss_pred eccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcC--ccccccCHHHeEe--cCCCCEEEeecccccccccCCc
Confidence 99999999999999889999999999999999999999999 9999999999999 8889999999999986543221
Q ss_pred cceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHH
Q 020888 200 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRE 279 (320)
Q Consensus 200 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 279 (320)
.....+||+.|+|||++.+..++.++|+|||||++|+|++|+.||...+..+....+....... +..+++++++
T Consensus 161 ----~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~--p~~~s~~~~d 234 (337)
T d1o6la_ 161 ----TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF--PRTLSPEAKS 234 (337)
T ss_dssp ----CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC--CTTSCHHHHH
T ss_pred ----ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCC--CccCCHHHHH
Confidence 2344679999999999999999999999999999999999999999999888888887766443 4568999999
Q ss_pred HHHHHhhcCCCCCCC-----HHHHHHH
Q 020888 280 LTEKCWAADMNQRPS-----FLDILKR 301 (320)
Q Consensus 280 li~~~l~~dp~~Rps-----~~~ll~~ 301 (320)
||++||+.||.+|++ ++++++|
T Consensus 235 li~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 235 LLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp HHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HHHhhccCCchhhcccccccHHHHHcC
Confidence 999999999999994 8899885
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-53 Score=365.88 Aligned_cols=252 Identities=26% Similarity=0.440 Sum_probs=220.1
Q ss_pred CcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCc---HHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCce
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDD---RLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL 115 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 115 (320)
..+|.+++.||+|+||+||+|.++ ++.||+|++.+..... ....+.+.+|++++++++||||+++++++.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 346999999999999999999985 7899999886543322 12347889999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCC----cEEEecCCCc
Q 020888 116 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD----HLKVGDFGLS 191 (320)
Q Consensus 116 ~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~----~~~L~dfg~~ 191 (320)
|+||||++||+|.+++.+.+.+++..++.++.|++.||+|||++| |+|+||||+||++ +.++ .++|+|||++
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~--ivHrDiKp~Nill--~~~~~~~~~vkl~DfG~a 164 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIML--LDRNVPKPRIKIIDFGLA 164 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--SCSSSSSCCEEECCCTTC
T ss_pred EEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcc--eeecccccceEEE--ecCCCcccceEecchhhh
Confidence 999999999999999998889999999999999999999999998 9999999999999 4444 5999999999
Q ss_pred ccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCC--
Q 020888 192 KLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR-- 269 (320)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~-- 269 (320)
....... ......+++.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+.........
T Consensus 165 ~~~~~~~-----~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 239 (293)
T d1jksa_ 165 HKIDFGN-----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 239 (293)
T ss_dssp EECTTSC-----BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHH
T ss_pred hhcCCCc-----cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchh
Confidence 8765432 223456899999999999999999999999999999999999999998888888777766543322
Q ss_pred CCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 270 AKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 270 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
...++.++++||++||+.||.+|||+++++++
T Consensus 240 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 240 FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 25689999999999999999999999999875
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-53 Score=362.44 Aligned_cols=253 Identities=28% Similarity=0.523 Sum_probs=214.3
Q ss_pred ceecccCceEEEEEEEC----CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEecCC
Q 020888 48 AIIGKGSFGEILKAYWR----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLR 123 (320)
Q Consensus 48 ~~lg~g~~~~vy~~~~~----~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 123 (320)
+.||+|+||+||+|.+. ++.||+|.+...... ....+.+.+|++++++++||||+++++++.. +..++||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND-PALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCC-HHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCC
Confidence 57999999999999764 357999988655433 3344789999999999999999999999864 46789999999
Q ss_pred CCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCcccee
Q 020888 124 GGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 203 (320)
Q Consensus 124 ~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~~~~ 203 (320)
+|+|.+++.....+++..++.++.||+.||.|||++| |+||||||+||++ +.++.++|+|||+++.+...... ..
T Consensus 91 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~--iiHrDlKp~Nill--~~~~~~kl~DFGla~~~~~~~~~-~~ 165 (277)
T d1xbba_ 91 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLL--VTQHYAKISDFGLSKALRADENY-YK 165 (277)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--EETTEEEECCCTTCEECCTTCSE-EE
T ss_pred CCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCC--cccCCCcchhhcc--cccCcccccchhhhhhccccccc-cc
Confidence 9999999998888999999999999999999999998 9999999999999 88899999999999876543221 11
Q ss_pred eccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHH
Q 020888 204 KMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTE 282 (320)
Q Consensus 204 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 282 (320)
......+|+.|+|||.+.+..++.++||||||+++|||+| |..||.+.+..+....+..+..+.. +..+|+++++++.
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~-p~~~~~~~~~li~ 244 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC-PAGCPREMYDLMN 244 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC-CTTCCHHHHHHHH
T ss_pred cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCC-CcccCHHHHHHHH
Confidence 2233568899999999999999999999999999999998 8999999988888887777765544 4568999999999
Q ss_pred HHhhcCCCCCCCHHHHHHHHHHHHhc
Q 020888 283 KCWAADMNQRPSFLDILKRLEKIKET 308 (320)
Q Consensus 283 ~~l~~dp~~Rps~~~ll~~L~~~~~~ 308 (320)
+||+.||++|||++++++.|+....+
T Consensus 245 ~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 245 LCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp HHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred HHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence 99999999999999999988876543
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-53 Score=362.62 Aligned_cols=264 Identities=28% Similarity=0.534 Sum_probs=223.8
Q ss_pred cccCccce-ecccCceEEEEEEEC----CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceE
Q 020888 42 LDFSSSAI-IGKGSFGEILKAYWR----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLM 116 (320)
Q Consensus 42 ~~y~~~~~-lg~g~~~~vy~~~~~----~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 116 (320)
.+|.+... ||+|+||+||+|.+. +..||||++.... .....+.+.+|++++++++||||+++++++.. +.+|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~ 84 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALM 84 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEE
Confidence 46667664 999999999999764 3469999886543 34445789999999999999999999998865 5689
Q ss_pred EEEecCCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccccc
Q 020888 117 LITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 195 (320)
Q Consensus 117 iv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~ 195 (320)
+||||+++|+|.+++.. +..+++..++.++.|++.||.|||++| |+||||||+||++ +.++.+||+|||+++.+.
T Consensus 85 lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~--iiHrDlKp~Nill--~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 85 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLL--VNRHYAKISDFGLSKALG 160 (285)
T ss_dssp EEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--EETTEEEECCCTTCEECT
T ss_pred EEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCcCchhheee--ccCCceeeccchhhhccc
Confidence 99999999999999765 457999999999999999999999998 9999999999999 778899999999998765
Q ss_pred ccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCC
Q 020888 196 VQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFT 274 (320)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (320)
..... ........+|+.|+|||++.+..++.++|||||||++|||+| |..||......+....+..+..+.. +..+|
T Consensus 161 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~-p~~~~ 238 (285)
T d1u59a_ 161 ADDSY-YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC-PPECP 238 (285)
T ss_dssp TCSCE-ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCC-CTTCC
T ss_pred ccccc-cccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC-CCcCC
Confidence 43321 112234568899999999999999999999999999999998 9999999888888888877776554 45689
Q ss_pred HHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcCCCCCc
Q 020888 275 PELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPTDHH 314 (320)
Q Consensus 275 ~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~~~ 314 (320)
+++.+++.+||+.||++|||+.++.+.|+....++.+..+
T Consensus 239 ~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~~~~ 278 (285)
T d1u59a_ 239 PELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE 278 (285)
T ss_dssp HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCS
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhhccc
Confidence 9999999999999999999999999999987766554443
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-53 Score=356.38 Aligned_cols=251 Identities=29% Similarity=0.571 Sum_probs=221.6
Q ss_pred cccCccceecccCceEEEEEEEC-CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEe
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~-~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 120 (320)
++|++.+.||+|+||+||++.++ ++.||+|.+....... +.+.+|++++++++||||+++++++.+++..++|||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~----~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~E 79 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 79 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCH----HHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCH----HHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Confidence 58899999999999999999986 5689999987654432 578899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCc
Q 020888 121 YLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 199 (320)
Q Consensus 121 ~~~~~~L~~~~~~-~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~ 199 (320)
|+++|+|.+++.. ...+++..++.++.|+++||.|||+.| |+||||||+||++ +.++.+||+|||+++.+.....
T Consensus 80 y~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~--iiH~dlk~~Nill--~~~~~~kl~DfG~a~~~~~~~~ 155 (258)
T d1k2pa_ 80 YMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLV--NDQGVVKVSDFGLSRYVLDDEY 155 (258)
T ss_dssp CCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--BCCSCCSGGGEEE--CTTCCEEECCCSSCCBCSSSSC
T ss_pred ccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcC--cccccccceeEEE--cCCCcEEECcchhheeccCCCc
Confidence 9999999999764 457899999999999999999999998 9999999999999 8889999999999976544322
Q ss_pred cceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHH
Q 020888 200 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 278 (320)
Q Consensus 200 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 278 (320)
.......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||......+....+..+.... .+..++++++
T Consensus 156 ---~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~-~p~~~~~~l~ 231 (258)
T d1k2pa_ 156 ---TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY-RPHLASEKVY 231 (258)
T ss_dssp ---CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCC-CCTTCCHHHH
T ss_pred ---eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCC-CcccccHHHH
Confidence 12234568899999999999999999999999999999998 899999999988888888776554 4456899999
Q ss_pred HHHHHHhhcCCCCCCCHHHHHHHHHH
Q 020888 279 ELTEKCWAADMNQRPSFLDILKRLEK 304 (320)
Q Consensus 279 ~li~~~l~~dp~~Rps~~~ll~~L~~ 304 (320)
+++.+||+.||++|||+++++++|.+
T Consensus 232 ~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 232 TIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp HHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred HHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 99999999999999999999999854
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=4e-53 Score=373.16 Aligned_cols=249 Identities=22% Similarity=0.414 Sum_probs=218.4
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEe
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 120 (320)
+|++++.||+|+||+||+|.+. ++.||+|++.... ......+.+|++++++++||||+++++++.+++.+|+|||
T Consensus 30 ~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 106 (352)
T d1koba_ 30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 106 (352)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc---hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 6999999999999999999985 8899999886543 2234678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCc
Q 020888 121 YLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 199 (320)
Q Consensus 121 ~~~~~~L~~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~ 199 (320)
|++||+|.+++... .++++..++.++.||+.||.|||++| |+|+||||+||++....++.++|+|||++..+....
T Consensus 107 ~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~- 183 (352)
T d1koba_ 107 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE- 183 (352)
T ss_dssp CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-
T ss_pred cCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccccccccccccCCCeEEEeecccceecCCCC-
Confidence 99999999987654 46999999999999999999999999 999999999999944467899999999998765432
Q ss_pred cceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCC--CCCCCCHHH
Q 020888 200 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFF--RAKGFTPEL 277 (320)
Q Consensus 200 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l 277 (320)
......+|+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+........ ....+++++
T Consensus 184 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 259 (352)
T d1koba_ 184 ----IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEA 259 (352)
T ss_dssp ----CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHH
T ss_pred ----ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHH
Confidence 12335689999999999999999999999999999999999999999988888877777654322 235689999
Q ss_pred HHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 278 RELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 278 ~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
++||.+||..||.+|||++|+++|
T Consensus 260 ~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 260 KDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHccCChhHCcCHHHHhcC
Confidence 999999999999999999999875
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.5e-53 Score=367.38 Aligned_cols=247 Identities=28% Similarity=0.508 Sum_probs=220.6
Q ss_pred cccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEE
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 119 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 119 (320)
.+|.+++.||+|+||+||+|.++ ++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 47999999999999999999986 7899999986543222233477889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCc
Q 020888 120 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 199 (320)
Q Consensus 120 e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~ 199 (320)
||++|++|.+++.....+++..+..++.||+.||.|||++| |+|+||||+||++ +.++.++|+|||++......
T Consensus 84 E~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NILl--~~~g~vkL~DFG~a~~~~~~-- 157 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILL--DKNGHIKITDFGFAKYVPDV-- 157 (316)
T ss_dssp CCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEE--CTTSCEEECCCSSCEECSSC--
T ss_pred eecCCccccccccccccccccHHHHHHHHHHHhhhhhccCc--EEccccCchheeE--cCCCCEEEecCccceEeccc--
Confidence 99999999999999888999999999999999999999999 9999999999999 88999999999999876432
Q ss_pred cceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHH
Q 020888 200 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRE 279 (320)
Q Consensus 200 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 279 (320)
....+||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+....... +..+++++++
T Consensus 158 -----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~--p~~~s~~~~~ 230 (316)
T d1fota_ 158 -----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF--PPFFNEDVKD 230 (316)
T ss_dssp -----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCC--CTTSCHHHHH
T ss_pred -----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCC--CCCCCHHHHH
Confidence 234679999999999999999999999999999999999999999999888888887765432 3558999999
Q ss_pred HHHHHhhcCCCCCC-----CHHHHHHH
Q 020888 280 LTEKCWAADMNQRP-----SFLDILKR 301 (320)
Q Consensus 280 li~~~l~~dp~~Rp-----s~~~ll~~ 301 (320)
++.+||..||.+|+ |++++++|
T Consensus 231 li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 231 LLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp HHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHHHHhhhCHHhccccchhhHHHHHcC
Confidence 99999999999996 89999886
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-53 Score=368.31 Aligned_cols=260 Identities=30% Similarity=0.489 Sum_probs=216.3
Q ss_pred CCcCCCCCcccCccceecccCceEEEEEEECC-------CceEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcccce
Q 020888 34 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQF 105 (320)
Q Consensus 34 ~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~-------~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~ 105 (320)
.|+++. .+|.+.+.||+|+||+||+|.+.+ ..||+|.+...... .....+.+|+.+++++ +||||+++
T Consensus 31 kwei~~--~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~HpnIv~l 106 (325)
T d1rjba_ 31 KWEFPR--ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS--SEREALMSELKMMTQLGSHENIVNL 106 (325)
T ss_dssp GGBCCG--GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccCCH--HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCH--HHHHHHHHHHHHHHHhcCCCcEeEE
Confidence 355543 478999999999999999998752 25889987654322 2336788999999998 89999999
Q ss_pred eeeEEeCCceEEEEecCCCCCHHHHHHHh-----------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 020888 106 LGAVTERKPLMLITEYLRGGDLHKYLKEK-----------------------GALSPSTAVNFALDIARGMAYLHNEPNV 162 (320)
Q Consensus 106 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~-----------------------~~l~~~~~~~i~~~l~~~l~~lH~~g~~ 162 (320)
++++.+.+..|+||||+++|+|.+++... +.+++..++.++.|++.||.|||++|
T Consensus 107 ~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~-- 184 (325)
T d1rjba_ 107 LGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS-- 184 (325)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred EEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 99999999999999999999999999753 24899999999999999999999998
Q ss_pred eEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHH
Q 020888 163 IIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEML 242 (320)
Q Consensus 163 ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll 242 (320)
|+||||||+||++ +.++.+||+|||+++....... ........+|+.|+|||++.+..++.++|||||||++|+|+
T Consensus 185 IiHRDlKp~Nill--~~~~~~Kl~DFGla~~~~~~~~--~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~eml 260 (325)
T d1rjba_ 185 CVHRDLAARNVLV--THGKVVKICDFGLARDIMSDSN--YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIF 260 (325)
T ss_dssp EEETTCSGGGEEE--ETTTEEEECCCGGGSCGGGCTT--SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHT
T ss_pred eeeccCchhcccc--ccCCeEEEeeccccccccCCCc--eeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHH
Confidence 9999999999999 8889999999999987654332 11233456799999999999999999999999999999999
Q ss_pred h-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHH
Q 020888 243 E-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLE 303 (320)
Q Consensus 243 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~ 303 (320)
| |..||.+.........+.........+..+++++++|+.+||+.||++|||+++|+++|.
T Consensus 261 t~g~~Pf~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 261 SLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp TTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred hCCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 8 899999877665555555554444455668999999999999999999999999999985
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=4e-52 Score=355.40 Aligned_cols=251 Identities=25% Similarity=0.440 Sum_probs=218.4
Q ss_pred cccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCc------HHHHHHHHHHHHHHHhCC-CCcccceeeeEEeC
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDD------RLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTER 112 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~------~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~ 112 (320)
.+|.+.+.||+|+||+||+|.+. ++.+|+|++....... ....+.+.+|++++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 47999999999999999999984 7899999986654332 223456889999999996 99999999999999
Q ss_pred CceEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcc
Q 020888 113 KPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 192 (320)
Q Consensus 113 ~~~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~ 192 (320)
+..|+||||++||+|.+++..++.+++..++.++.||+.||+|||++| |+||||||+||++ +.++.++|+|||++.
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill--~~~~~~kl~DFG~a~ 158 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILL--DDDMNIKLTDFGFSC 158 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--CTTCCEEECCCTTCE
T ss_pred cceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC--CcccccccceEEE--cCCCCeEEccchhee
Confidence 999999999999999999998889999999999999999999999998 9999999999999 899999999999998
Q ss_pred cccccCccceeeccCCcccccccCccccCc------CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCC
Q 020888 193 LIKVQNSHDVYKMTGETGSYRYMAPEVFKH------RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRP 266 (320)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 266 (320)
.+.... ......||+.|.|||.+.+ ..++.++||||+||++|+|++|+.||...+..+....+..+...
T Consensus 159 ~~~~~~-----~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~ 233 (277)
T d1phka_ 159 QLDPGE-----KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ 233 (277)
T ss_dssp ECCTTC-----CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC
T ss_pred EccCCC-----ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCC
Confidence 765432 2234578999999998853 34678999999999999999999999999888877777766533
Q ss_pred C--CCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 267 F--FRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 267 ~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
. .....+|+++++++.+||+.||++|||+++++++
T Consensus 234 ~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 234 FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 2 2234689999999999999999999999999875
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-51 Score=354.49 Aligned_cols=259 Identities=33% Similarity=0.575 Sum_probs=212.3
Q ss_pred cccCccceecccCceEEEEEEECC------CceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCce
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWRG------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL 115 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~~------~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 115 (320)
..|+..++||+|+||.||+|.+++ ..||+|.+..... ......+.+|++++++++||||+++++++...+..
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~ 84 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT--EKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM 84 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccC--hHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCce
Confidence 468899999999999999998752 3699998865433 33346788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccc
Q 020888 116 MLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 194 (320)
Q Consensus 116 ~iv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~ 194 (320)
++||||+.+++|.+++... +.+++..+..++.|++.||.|||++| |+||||||+||++ +.++.+||+|||+++.+
T Consensus 85 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~--iiHrDlKp~NILl--~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 85 MIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILV--NSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp EEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE--CTTCCEEECCCCC----
T ss_pred EEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccc--cccCccccceEEE--CCCCeEEEcccchhhcc
Confidence 9999999999999988754 57999999999999999999999988 9999999999999 88999999999999876
Q ss_pred cccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCC-CCCCCChHHHHHHHHhCCCCCCCCCCC
Q 020888 195 KVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEP-PLANYEPYEAAKYVAEGHRPFFRAKGF 273 (320)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (320)
...... ........+|+.|+|||++.+..++.++||||||+++|||++|.. |+......+....+..+..+.. +..+
T Consensus 161 ~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~-~~~~ 238 (283)
T d1mqba_ 161 EDDPEA-TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPT-PMDC 238 (283)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC-CTTC
T ss_pred cCCCcc-ceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCC-chhh
Confidence 543221 122334567899999999999999999999999999999999544 5555666667777776665544 4558
Q ss_pred CHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhc
Q 020888 274 TPELRELTEKCWAADMNQRPSFLDILKRLEKIKET 308 (320)
Q Consensus 274 ~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 308 (320)
+.++++++.+||+.||++|||+.++++.|+++.+.
T Consensus 239 ~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 239 PSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp BHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 99999999999999999999999999999988753
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.6e-52 Score=367.91 Aligned_cols=247 Identities=27% Similarity=0.462 Sum_probs=220.3
Q ss_pred cccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEE
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 119 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 119 (320)
.+|++++.||+|+||+||+|.++ ++.||+|++.+.........+.+.+|+++++.++||||+++++++......++|+
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 38999999999999999999986 8899999886433222233467889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCc
Q 020888 120 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 199 (320)
Q Consensus 120 e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~ 199 (320)
||+.||+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+||++ +.++.++|+|||+++.+...
T Consensus 121 e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHRDIKP~NILl--~~~g~ikL~DFG~a~~~~~~-- 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLI--DQQGYIQVTDFGFAKRVKGR-- 194 (350)
T ss_dssp ECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--CTTSCEEECCCTTCEECSSC--
T ss_pred ccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCcCCHHHccc--CCCCCEEeeeceeeeecccc--
Confidence 99999999999998889999999999999999999999998 9999999999999 88899999999999876432
Q ss_pred cceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHH
Q 020888 200 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRE 279 (320)
Q Consensus 200 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 279 (320)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+....... +..+++++.+
T Consensus 195 -----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~--p~~~s~~~~~ 267 (350)
T d1rdqe_ 195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF--PSHFSSDLKD 267 (350)
T ss_dssp -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC--CTTCCHHHHH
T ss_pred -----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCC--CccCCHHHHH
Confidence 234568999999999999999999999999999999999999999998888888887776443 3568999999
Q ss_pred HHHHHhhcCCCCCC-----CHHHHHHH
Q 020888 280 LTEKCWAADMNQRP-----SFLDILKR 301 (320)
Q Consensus 280 li~~~l~~dp~~Rp-----s~~~ll~~ 301 (320)
+|++||..||.+|+ |++++++|
T Consensus 268 li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 268 LLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp HHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHHHHhhhCHHhccccccccHHHHHcC
Confidence 99999999999994 89999875
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-52 Score=353.40 Aligned_cols=254 Identities=34% Similarity=0.636 Sum_probs=214.9
Q ss_pred CcCCCCCcccCccceecccCceEEEEEEECCCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEE-eCC
Q 020888 35 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVT-ERK 113 (320)
Q Consensus 35 ~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~ 113 (320)
|+++.+ +|.+.+.||+|+||.||++.++++.||+|.+..+. ..+.+.+|++++++++||||+++++++. ..+
T Consensus 2 w~i~~~--~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~ 74 (262)
T d1byga_ 2 WALNMK--ELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 74 (262)
T ss_dssp CBCCGG--GEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--
T ss_pred CccCHH--HeEEeEEEecCCCeEEEEEEECCeEEEEEEECcHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCC
Confidence 666654 68888999999999999999999999999985432 2367899999999999999999999885 456
Q ss_pred ceEEEEecCCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCc
Q 020888 114 PLMLITEYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 191 (320)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~ 191 (320)
.+++||||+++|+|.+++... ..+++..++.++.|++.||.|||+.+ ++||||||+||++ +.++.++|+|||++
T Consensus 75 ~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~--ivH~dlkp~Nil~--~~~~~~kl~dfg~s 150 (262)
T d1byga_ 75 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLV--SEDNVAKVSDFGLT 150 (262)
T ss_dssp CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE--CTTSCEEECCCCC-
T ss_pred cEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc--eeccccchHhhee--cCCCCEeecccccc
Confidence 689999999999999998653 35899999999999999999999988 9999999999999 88999999999998
Q ss_pred ccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCC
Q 020888 192 KLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRA 270 (320)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 270 (320)
...... .....++..|+|||.+.+..++.++||||||+++|||+| |..||......+....+..+..+...
T Consensus 151 ~~~~~~-------~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~- 222 (262)
T d1byga_ 151 KEASST-------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAP- 222 (262)
T ss_dssp ------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCC-
T ss_pred eecCCC-------CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCC-
Confidence 754332 122356889999999999999999999999999999998 78889888888888887777666554
Q ss_pred CCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHh
Q 020888 271 KGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKE 307 (320)
Q Consensus 271 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 307 (320)
..+++++++++.+||..||.+|||+.+++++|++++.
T Consensus 223 ~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 223 DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 4589999999999999999999999999999999865
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-51 Score=353.09 Aligned_cols=262 Identities=31% Similarity=0.567 Sum_probs=213.6
Q ss_pred CCcCCCCCcccCccceecccCceEEEEEEEC-----CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeee
Q 020888 34 DWEIDPSELDFSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGA 108 (320)
Q Consensus 34 ~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~-----~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 108 (320)
+|+++. .+|.+.+.||+|+||+||+|.+. +..||+|.+... ......+.+.+|++++++++||||++++++
T Consensus 1 ~~ei~~--~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~ 76 (273)
T d1mp8a_ 1 DYEIQR--ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGV 76 (273)
T ss_dssp CCBCCG--GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred CCCcCH--HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc--cCHHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 366664 47999999999999999999874 234777776433 344555789999999999999999999999
Q ss_pred EEeCCceEEEEecCCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEec
Q 020888 109 VTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGD 187 (320)
Q Consensus 109 ~~~~~~~~iv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~d 187 (320)
+. ++..|+||||+++|+|.+++.. ...+++..++.++.|++.||.|||++| ++|+||||+||++ +.++.+||+|
T Consensus 77 ~~-~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDlKp~NIll--~~~~~~Kl~D 151 (273)
T d1mp8a_ 77 IT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLV--SSNDCVKLGD 151 (273)
T ss_dssp EC-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE--EETTEEEECC
T ss_pred Ee-cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccC--eeccccchhheee--cCCCcEEEcc
Confidence 86 4678999999999999998765 457999999999999999999999998 9999999999999 7888999999
Q ss_pred CCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCC
Q 020888 188 FGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRP 266 (320)
Q Consensus 188 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~ 266 (320)
||+++....... .......+|+.|+|||.+.+..++.++|||||||++|+|++ |..||......+....+..+..+
T Consensus 152 fG~a~~~~~~~~---~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~ 228 (273)
T d1mp8a_ 152 FGLSRYMEDSTY---YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL 228 (273)
T ss_dssp ----------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC
T ss_pred chhheeccCCcc---eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC
Confidence 999987654322 12233457899999999999999999999999999999998 89999999888888888877665
Q ss_pred CCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhc
Q 020888 267 FFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKET 308 (320)
Q Consensus 267 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 308 (320)
.. +..+|++++++|.+||+.||++|||+.+++++|+++.+.
T Consensus 229 ~~-~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 229 PM-PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp CC-CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CC-CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 54 446899999999999999999999999999999988654
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-52 Score=364.12 Aligned_cols=248 Identities=19% Similarity=0.332 Sum_probs=217.2
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEe
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 120 (320)
+|.+.+.||+|+||+||+|.++ ++.||+|++.... .....+.+|+++++.++||||+++++++.+++.+|+|||
T Consensus 6 rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE 81 (321)
T d1tkia_ 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc----ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 6999999999999999999986 7889999886532 122568899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCc
Q 020888 121 YLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 199 (320)
Q Consensus 121 ~~~~~~L~~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~ 199 (320)
|++|++|.+++...+ .+++..+..++.||+.||+|||++| |+||||||+||++..+....++|+|||++.......
T Consensus 82 ~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~--iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~- 158 (321)
T d1tkia_ 82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD- 158 (321)
T ss_dssp CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC-
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--CCcccccccceeecCCCceEEEEcccchhhccccCC-
Confidence 999999999998654 7999999999999999999999999 999999999999955566689999999998664332
Q ss_pred cceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCC--CCCCCHHH
Q 020888 200 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR--AKGFTPEL 277 (320)
Q Consensus 200 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l 277 (320)
......+++.|+|||...+..++.++|||||||++|+|++|..||...+..+....+......... ...+++++
T Consensus 159 ----~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 234 (321)
T d1tkia_ 159 ----NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA 234 (321)
T ss_dssp ----EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHH
T ss_pred ----cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHH
Confidence 123346789999999999999999999999999999999999999999888888877776543322 14689999
Q ss_pred HHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 278 RELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 278 ~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
++||.+||..||++|||++|+++|
T Consensus 235 ~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 235 MDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHccCChhHCcCHHHHhcC
Confidence 999999999999999999999986
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-51 Score=353.89 Aligned_cols=264 Identities=31% Similarity=0.497 Sum_probs=216.9
Q ss_pred CCCCcCCCCCcccCccceecccCceEEEEEEEC-CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEE
Q 020888 32 KCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVT 110 (320)
Q Consensus 32 ~~~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~-~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 110 (320)
+.+|+++. .+|++.+.||+|+||+||++.++ ++.||+|++....... +.+.+|+.++++++|+||+++++++.
T Consensus 9 ~~~~~i~~--~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~----~~~~~E~~~l~~l~h~nIv~~~g~~~ 82 (285)
T d1fmka3 9 KDAWEIPR--ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP----EAFLQEAQVMKKLRHEKLVQLYAVVS 82 (285)
T ss_dssp TTCSBCCG--GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCH----HHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CcceEcCH--HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCH----HHHHHHHHHHHhcccCCEeEEEEEEe
Confidence 45678764 58999999999999999999987 5679999986554322 67899999999999999999999985
Q ss_pred eCCceEEEEecCCCCCHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecC
Q 020888 111 ERKPLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF 188 (320)
Q Consensus 111 ~~~~~~iv~e~~~~~~L~~~~~~--~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~df 188 (320)
+ +..++||||+++|+|.+++.. .+.+++..++.++.|++.||+|||++| |+||||||+||++ +.++.++|+||
T Consensus 83 ~-~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~--ivH~DlKp~NIll--~~~~~~kl~Df 157 (285)
T d1fmka3 83 E-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILV--GENLVCKVADF 157 (285)
T ss_dssp S-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE--CGGGCEEECCC
T ss_pred c-CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh--eecccccceEEEE--CCCCcEEEccc
Confidence 5 557899999999999988753 457999999999999999999999998 9999999999999 88899999999
Q ss_pred CCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHhCCCCC
Q 020888 189 GLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPP-LANYEPYEAAKYVAEGHRPF 267 (320)
Q Consensus 189 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p-~~~~~~~~~~~~~~~~~~~~ 267 (320)
|+++.+..... .......+|+.|+|||++.+..++.++||||||+++|+|++|..| +......+....+..+....
T Consensus 158 Gla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~ 234 (285)
T d1fmka3 158 GLARLIEDNEY---TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP 234 (285)
T ss_dssp CTTC-----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC
T ss_pred chhhhccCCCc---eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC
Confidence 99986643321 122335689999999999999999999999999999999996555 45556666666666665544
Q ss_pred CCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcCC
Q 020888 268 FRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLP 310 (320)
Q Consensus 268 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~ 310 (320)
. +..+++++++++.+||+.||++|||++++++.|+....+..
T Consensus 235 ~-~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~ 276 (285)
T d1fmka3 235 C-PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 276 (285)
T ss_dssp C-CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred C-CcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence 3 45689999999999999999999999999999998776654
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-52 Score=353.97 Aligned_cols=259 Identities=29% Similarity=0.545 Sum_probs=212.6
Q ss_pred CcccCccceecccCceEEEEEEEC---C--CceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCce
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR---G--TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL 115 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~---~--~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 115 (320)
..+|++.+.||+|+||+||+|... + ..||+|.+........+..+.+.+|++++++++||||+++++++.+ +..
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 457999999999999999999864 2 3689998877666566666889999999999999999999999965 467
Q ss_pred EEEEecCCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccc
Q 020888 116 MLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 194 (320)
Q Consensus 116 ~iv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~ 194 (320)
++||||+++++|.+++.. .+.+++..++.++.|++.||.|||++| |+||||||+||++ +.++.++|+|||++..+
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDikp~NIll--~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLL--ATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEE--EETTEEEECCCTTCEEC
T ss_pred heeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCC--EeeeeecHHHhcc--ccccceeeccchhhhhc
Confidence 899999999999988765 457999999999999999999999998 9999999999999 77889999999999877
Q ss_pred cccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCC
Q 020888 195 KVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGF 273 (320)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (320)
....... .......++..|+|||.+.+..++.++||||||+++|||+| |..||...+..+....+.........+..+
T Consensus 162 ~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 240 (273)
T d1u46a_ 162 PQNDDHY-VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDC 240 (273)
T ss_dssp CC-CCEE-EC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTC
T ss_pred ccCCCcc-eecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccc
Confidence 5543222 22233456788999999999999999999999999999998 899999999888888887776555566779
Q ss_pred CHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHH
Q 020888 274 TPELRELTEKCWAADMNQRPSFLDILKRLEKI 305 (320)
Q Consensus 274 ~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~ 305 (320)
|+++++++.+||..||++|||+.++++.|.++
T Consensus 241 ~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 241 PQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 99999999999999999999999999988875
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-52 Score=362.05 Aligned_cols=249 Identities=29% Similarity=0.459 Sum_probs=214.9
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHH-hCCCCcccceeeeEEeCCceEEEE
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLV-KLRHPNIVQFLGAVTERKPLMLIT 119 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~iv~ 119 (320)
+|.+++.||+|+||+||+|.+. ++.||+|++.+.........+.+..|..++. .++||||+++++++.+++..|+||
T Consensus 3 dy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivm 82 (320)
T d1xjda_ 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVM 82 (320)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEE
Confidence 6999999999999999999985 8889999986532221222345556666655 689999999999999999999999
Q ss_pred ecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCc
Q 020888 120 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 199 (320)
Q Consensus 120 e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~ 199 (320)
||++||+|.+++...+.+++..+..++.||+.||.|||++| ++|+||||+||++ +.++.++|+|||++........
T Consensus 83 Ey~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~--iiHrDikp~NiL~--~~~~~~kl~DFG~a~~~~~~~~ 158 (320)
T d1xjda_ 83 EYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILL--DKDGHIKIADFGMCKENMLGDA 158 (320)
T ss_dssp ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEE--CTTSCEEECCCTTCBCCCCTTC
T ss_pred eecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCcccceee--cCCCceeccccchhhhcccccc
Confidence 99999999999998889999999999999999999999999 9999999999999 8899999999999986543322
Q ss_pred cceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHH
Q 020888 200 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRE 279 (320)
Q Consensus 200 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 279 (320)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+..+... .+..+++++++
T Consensus 159 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~--~p~~~s~~~~d 232 (320)
T d1xjda_ 159 ----KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPF--YPRWLEKEAKD 232 (320)
T ss_dssp ----CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC--CCTTSCHHHHH
T ss_pred ----cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC--CCccCCHHHHH
Confidence 223457899999999999999999999999999999999999999998888888777766543 34568999999
Q ss_pred HHHHHhhcCCCCCCCHH-HHHHH
Q 020888 280 LTEKCWAADMNQRPSFL-DILKR 301 (320)
Q Consensus 280 li~~~l~~dp~~Rps~~-~ll~~ 301 (320)
||.+||..||.+|||++ ++++|
T Consensus 233 li~~~L~~dP~~R~s~~~~l~~h 255 (320)
T d1xjda_ 233 LLVKLFVREPEKRLGVRGDIRQH 255 (320)
T ss_dssp HHHHHSCSSGGGSBTTBSCGGGS
T ss_pred HHHHhcccCCCCCcCHHHHHHhC
Confidence 99999999999999995 67653
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.2e-51 Score=365.51 Aligned_cols=250 Identities=29% Similarity=0.436 Sum_probs=207.9
Q ss_pred cccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCc---HHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceE
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDD---RLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLM 116 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 116 (320)
.+|.+++.||+|+||+||+|.+. ++.||+|++.+..... ........+++++++.++||||+++++++...+.+|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 47999999999999999999985 7899999885432211 111223334577778888999999999999999999
Q ss_pred EEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccc
Q 020888 117 LITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 196 (320)
Q Consensus 117 iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~ 196 (320)
+||||++||+|.+++.+...+++..++.++.||+.||.|||++| |+|+||||+||++ +.++.+||+|||++..+..
T Consensus 84 ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~--iiHrDlKP~NILl--~~~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILL--DEHGHVRISDLGLACDFSK 159 (364)
T ss_dssp EEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--CSSSCEEECCCTTCEECSS
T ss_pred EEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCC--ccceeeccceeEE--cCCCcEEEeeeceeeecCC
Confidence 99999999999999998889999999999999999999999999 9999999999999 8889999999999986653
Q ss_pred cCccceeeccCCcccccccCccccCc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhC-CCCCCCCCCCC
Q 020888 197 QNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEG-HRPFFRAKGFT 274 (320)
Q Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 274 (320)
.. .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||......+........ ......+..++
T Consensus 160 ~~------~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s 233 (364)
T d1omwa3 160 KK------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFS 233 (364)
T ss_dssp SC------CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSC
T ss_pred Cc------ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCC
Confidence 32 234579999999999864 56899999999999999999999999876544333322222 22333345689
Q ss_pred HHHHHHHHHHhhcCCCCCCC-----HHHHHHH
Q 020888 275 PELRELTEKCWAADMNQRPS-----FLDILKR 301 (320)
Q Consensus 275 ~~l~~li~~~l~~dp~~Rps-----~~~ll~~ 301 (320)
++++++|.+||..||++||| ++++++|
T Consensus 234 ~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 234 PELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp HHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred HHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 99999999999999999998 7899876
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-50 Score=349.34 Aligned_cols=269 Identities=33% Similarity=0.573 Sum_probs=224.8
Q ss_pred CCCCCCcCCCCCcccCccceecccCceEEEEEEECC---------CceEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CC
Q 020888 30 PNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG---------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RH 99 (320)
Q Consensus 30 ~~~~~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~---------~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h 99 (320)
|.-..|.++. .+|.+.+.||+|+||.||++...+ ..||+|.+..... ......+.+|...+.++ +|
T Consensus 3 ~~~~~~~i~~--~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~e~~~l~~~~~H 78 (299)
T d1fgka_ 3 PEDPRWELPR--DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEMMKMIGKH 78 (299)
T ss_dssp CCCTTTBCCG--GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCC--HHHHHHHHHHHHHHHHHCCC
T ss_pred CcCCcCcccH--HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccC--hHHHHHHHHHHHHHHHhcCC
Confidence 4444577664 489999999999999999998642 3699998865432 33457788899999888 79
Q ss_pred CcccceeeeEEeCCceEEEEecCCCCCHHHHHHHh----------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 020888 100 PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK----------------GALSPSTAVNFALDIARGMAYLHNEPNVI 163 (320)
Q Consensus 100 ~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~----------------~~l~~~~~~~i~~~l~~~l~~lH~~g~~i 163 (320)
|||+++++++.+++..++||||+++|+|.+++... ..+++.+++.++.||+.||.|||+.| |
T Consensus 79 pnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~--i 156 (299)
T d1fgka_ 79 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--C 156 (299)
T ss_dssp TTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT--C
T ss_pred CeEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC--E
Confidence 99999999999999999999999999999999743 24899999999999999999999998 9
Q ss_pred EecCCCCCcEEEeeCCCCcEEEecCCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh
Q 020888 164 IHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE 243 (320)
Q Consensus 164 vH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~ 243 (320)
+||||||+||++ +.++.++|+|||.+.......... ......+++.|+|||.+.+..++.++||||||+++|+|++
T Consensus 157 vHrDiKp~NiLl--~~~~~~kl~dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~ 232 (299)
T d1fgka_ 157 IHRDLAARNVLV--TEDNVMKIADFGLARDIHHIDYYK--KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232 (299)
T ss_dssp CCSCCSGGGEEE--CTTCCEEECSTTCCCCGGGCCTTC--CCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred Eeeeecccceee--cCCCCeEeccchhhcccccccccc--ccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhcc
Confidence 999999999999 889999999999998776543222 2234568899999999999999999999999999999998
Q ss_pred -CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcC
Q 020888 244 -GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETL 309 (320)
Q Consensus 244 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 309 (320)
|..||...........+..+..+.. +..+++++++++.+||+.||++|||+.++++.|+++.+.+
T Consensus 233 ~g~~p~~~~~~~~~~~~i~~~~~~~~-p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~~ 298 (299)
T d1fgka_ 233 LGGSPYPGVPVEELFKLLKEGHRMDK-PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT 298 (299)
T ss_dssp TSCCSSTTCCHHHHHHHHHTTCCCCC-CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCCHHHHHHHHHcCCCCCC-CccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhcC
Confidence 7999998888888777777665544 4568999999999999999999999999999999997654
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-50 Score=350.81 Aligned_cols=257 Identities=30% Similarity=0.504 Sum_probs=221.0
Q ss_pred CcccCccceecccCceEEEEEEECC-------CceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCC
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK 113 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~~-------~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 113 (320)
..+|.+.+.||+|+||+||+|+..+ +.||+|.+.... .....+.+.+|+++++.++|+||+++++++...+
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 89 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 89 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcCCCCcccceeeeccCC
Confidence 3479999999999999999998753 579999886543 2344578999999999999999999999999999
Q ss_pred ceEEEEecCCCCCHHHHHHHh------------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 020888 114 PLMLITEYLRGGDLHKYLKEK------------------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLK 169 (320)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~------------------------~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~ 169 (320)
..++++||+++++|.+++... ..+++..++.++.|++.||+|||++| ++|||||
T Consensus 90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~--ivHrDlK 167 (301)
T d1lufa_ 90 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDLA 167 (301)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCS
T ss_pred ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC--eEeeEEc
Confidence 999999999999999998642 23789999999999999999999998 9999999
Q ss_pred CCcEEEeeCCCCcEEEecCCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCC-CCC
Q 020888 170 PRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGE-PPL 248 (320)
Q Consensus 170 p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~-~p~ 248 (320)
|+||++ +.++.+||+|||+++....... ........+++.|+|||.+.+..++.++||||||+++|||++|. .||
T Consensus 168 p~NILl--d~~~~~Kl~DFGls~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~ 243 (301)
T d1lufa_ 168 TRNCLV--GENMVVKIADFGLSRNIYSADY--YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243 (301)
T ss_dssp GGGEEE--CGGGCEEECCCSCHHHHTGGGC--BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred ccceEE--CCCCcEEEccchhheeccCCcc--ccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence 999999 8889999999999986644322 11233456889999999999999999999999999999999985 678
Q ss_pred CCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHH
Q 020888 249 ANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIK 306 (320)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 306 (320)
...+..+....+..+..+.. +..+++++.+++.+||+.||.+|||+.++++.|+++.
T Consensus 244 ~~~~~~e~~~~v~~~~~~~~-p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 244 YGMAHEEVIYYVRDGNILAC-PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TTSCHHHHHHHHHTTCCCCC-CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCHHHHHHHHHcCCCCCC-CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 88888888888887775543 4568999999999999999999999999999998864
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-50 Score=351.87 Aligned_cols=256 Identities=29% Similarity=0.589 Sum_probs=213.7
Q ss_pred cccCccceecccCceEEEEEEEC--CC----ceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCce
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GT----PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL 115 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~----~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 115 (320)
.+|++++.||+|+||+||+|.+. ++ +||+|.+...... ...+.+.+|++++++++||||+++++++.++ ..
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~ 85 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP--KANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 85 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Ce
Confidence 47999999999999999999875 33 5888877543322 2347889999999999999999999999865 56
Q ss_pred EEEEecCCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccc
Q 020888 116 MLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 194 (320)
Q Consensus 116 ~iv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~ 194 (320)
+++++++.+++|.+++.. ...+++..++.++.|++.||.|||++| |+||||||+||++ +.++.+||+|||++..+
T Consensus 86 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~--iiHrDlKp~NIll--~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLV--KTPQHVKITDFGLAKLL 161 (317)
T ss_dssp EEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE--EETTEEEECCCSHHHHT
T ss_pred eEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcC--cccCcchhhccee--CCCCCeEeeccccceec
Confidence 778888889999988876 457999999999999999999999998 9999999999999 88889999999999876
Q ss_pred cccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCC
Q 020888 195 KVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGF 273 (320)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (320)
...... .......+|+.|+|||.+.+..++.++||||||+++|||+| |..||......+....+..+..+.. +..+
T Consensus 162 ~~~~~~--~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~-p~~~ 238 (317)
T d1xkka_ 162 GAEEKE--YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ-PPIC 238 (317)
T ss_dssp TTTCC----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCC-CTTB
T ss_pred cccccc--ccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC-Cccc
Confidence 543221 12233457999999999999999999999999999999998 8999998888888777777765544 3458
Q ss_pred CHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHh
Q 020888 274 TPELRELTEKCWAADMNQRPSFLDILKRLEKIKE 307 (320)
Q Consensus 274 ~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 307 (320)
++++++++.+||..||++|||+.+++++|.++..
T Consensus 239 ~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 239 TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999999999988864
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-50 Score=351.28 Aligned_cols=258 Identities=35% Similarity=0.544 Sum_probs=217.2
Q ss_pred cccCccceecccCceEEEEEEEC--CC--ceEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcccceeeeEEeCCceE
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLM 116 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~--~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 116 (320)
.+|++.+.||+|+||+||+|.++ +. .||+|.+..... ....+.+.+|+++++++ +||||+++++++.+++.++
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~ 87 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS--KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 87 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccC--hHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeE
Confidence 57888999999999999999885 33 467776643322 22346789999999999 7999999999999999999
Q ss_pred EEEecCCCCCHHHHHHHh----------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCC
Q 020888 117 LITEYLRGGDLHKYLKEK----------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSA 180 (320)
Q Consensus 117 iv~e~~~~~~L~~~~~~~----------------~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~ 180 (320)
+||||+++|+|.+++... ..+++..++.++.|++.||.|||+.| ++||||||+||++ +.+
T Consensus 88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~--iiHrDlkp~NIL~--~~~ 163 (309)
T d1fvra_ 88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILV--GEN 163 (309)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--CGG
T ss_pred EEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC--ccccccccceEEE--cCC
Confidence 999999999999998643 46899999999999999999999998 9999999999999 888
Q ss_pred CcEEEecCCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCC-CCCCCCChHHHHHH
Q 020888 181 DHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGE-PPLANYEPYEAAKY 259 (320)
Q Consensus 181 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~-~p~~~~~~~~~~~~ 259 (320)
+.+||+|||+++...... ......+|..|+|||.+.+..++.++||||||+++|+|++|. .||...+..+....
T Consensus 164 ~~~kl~DfG~a~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~ 238 (309)
T d1fvra_ 164 YVAKIADFGLSRGQEVYV-----KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK 238 (309)
T ss_dssp GCEEECCTTCEESSCEEC-----CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH
T ss_pred CceEEccccccccccccc-----cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 899999999987554322 122345789999999999999999999999999999999965 57888888888887
Q ss_pred HHhCCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcCCC
Q 020888 260 VAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPT 311 (320)
Q Consensus 260 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~ 311 (320)
+.++..+.. +..++++++++|.+||+.||++|||+++++++|+++.+..+.
T Consensus 239 i~~~~~~~~-~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~~ 289 (309)
T d1fvra_ 239 LPQGYRLEK-PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 289 (309)
T ss_dssp GGGTCCCCC-CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSC
T ss_pred HHhcCCCCC-CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCcC
Confidence 777665544 345899999999999999999999999999999999876543
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-50 Score=349.69 Aligned_cols=264 Identities=29% Similarity=0.531 Sum_probs=208.2
Q ss_pred CCCcCCCCCcccCccceecccCceEEEEEEEC-------CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcccc
Q 020888 33 CDWEIDPSELDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQ 104 (320)
Q Consensus 33 ~~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~-------~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~ 104 (320)
+.|+++. .+|.+.+.||+|+||.||+|.+. ++.||+|.+..... ....+.+.+|.+.+.++ +|+||+.
T Consensus 6 ~~wei~~--~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~--~~~~~~~~~e~~~l~~~~~h~~iv~ 81 (299)
T d1ywna1 6 SKWEFPR--DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVN 81 (299)
T ss_dssp HHHBCCG--GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----C--HHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred ccccccH--HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccC--cHHHHHHHHHHHHHHhhcCCCeEEE
Confidence 4565553 57999999999999999999864 25699998864432 33346778888888887 5899999
Q ss_pred eeeeEEe-CCceEEEEecCCCCCHHHHHHHh----------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecC
Q 020888 105 FLGAVTE-RKPLMLITEYLRGGDLHKYLKEK----------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 167 (320)
Q Consensus 105 ~~~~~~~-~~~~~iv~e~~~~~~L~~~~~~~----------------~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~d 167 (320)
+++++.. +..+++||||+++|+|.+++... ..+++..++.++.|++.||.|||++| |+|||
T Consensus 82 ~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--ivHrD 159 (299)
T d1ywna1 82 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRD 159 (299)
T ss_dssp EEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT--CCCSC
T ss_pred eeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC--CcCCc
Confidence 9998754 45689999999999999999752 24899999999999999999999998 99999
Q ss_pred CCCCcEEEeeCCCCcEEEecCCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhC-CC
Q 020888 168 LKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEG-EP 246 (320)
Q Consensus 168 i~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g-~~ 246 (320)
|||+||++ +.++.+||+|||+++....... ........||+.|+|||.+.+..++.++|||||||++|+|++| ..
T Consensus 160 lKp~NILl--~~~~~~Kl~DFGla~~~~~~~~--~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~ 235 (299)
T d1ywna1 160 LAARNILL--SEKNVVKICDFGLARDIYKDPD--YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 235 (299)
T ss_dssp CCGGGEEE--CGGGCEEECC------CCSCTT--SCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred CCccceeE--CCCCcEEEccCcchhhcccccc--ccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCC
Confidence 99999999 8889999999999976543322 1123345789999999999999999999999999999999986 56
Q ss_pred CCCCCChHH-HHHHHHhCCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHh
Q 020888 247 PLANYEPYE-AAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKE 307 (320)
Q Consensus 247 p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 307 (320)
||......+ ....+..+..+. .+..+++++++++.+||+.||++|||+++++++|+.+.+
T Consensus 236 p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 236 PYPGVKIDEEFCRRLKEGTRMR-APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp SSTTCCCSHHHHHHHHHTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHhcCCCCC-CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 787765444 344445554443 345689999999999999999999999999999998864
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-49 Score=345.58 Aligned_cols=264 Identities=26% Similarity=0.504 Sum_probs=218.7
Q ss_pred cCccceecccCceEEEEEEECC-----CceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEe-CCceEE
Q 020888 44 FSSSAIIGKGSFGEILKAYWRG-----TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE-RKPLML 117 (320)
Q Consensus 44 y~~~~~lg~g~~~~vy~~~~~~-----~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~i 117 (320)
+...++||+|+||+||+|.+.+ ..||||.+... ......+++.+|++++++++||||+++++++.. +...++
T Consensus 29 ~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~l 106 (311)
T d1r0pa_ 29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 106 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEE
T ss_pred eccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEE
Confidence 3335789999999999998742 25889988542 345556889999999999999999999999865 557899
Q ss_pred EEecCCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccc
Q 020888 118 ITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 196 (320)
Q Consensus 118 v~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~ 196 (320)
||||+++++|.+++... ..+++..++.++.|++.||.|||+.| |+||||||+||++ +.++.++|+|||+++....
T Consensus 107 v~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~--iiHrDLK~~NILl--~~~~~~kL~DFG~~~~~~~ 182 (311)
T d1r0pa_ 107 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCML--DEKFTVKVADFGLARDMYD 182 (311)
T ss_dssp EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE--CTTCCEEECSSGGGCCTTT
T ss_pred EEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccC--cccCCccHHhEeE--CCCCCEEEecccchhhccc
Confidence 99999999999998854 45788899999999999999999988 9999999999999 8889999999999987765
Q ss_pred cCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHhCCCCCCCCCCCCH
Q 020888 197 QNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANY-EPYEAAKYVAEGHRPFFRAKGFTP 275 (320)
Q Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 275 (320)
.............+|+.|+|||.+.+..++.++||||||+++|||++|..||... +..+....+..+..+. .+..+++
T Consensus 183 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~-~p~~~~~ 261 (311)
T d1r0pa_ 183 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL-QPEYCPD 261 (311)
T ss_dssp TTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCC-CCTTCCH
T ss_pred cccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC-CcccCcH
Confidence 5444333444557899999999999999999999999999999999977777653 4444555566665544 4456899
Q ss_pred HHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcCCCCCc
Q 020888 276 ELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPTDHH 314 (320)
Q Consensus 276 ~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~~~ 314 (320)
++.+++.+||..||++|||+.|++++|+++..+...+..
T Consensus 262 ~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~~~~ 300 (311)
T d1r0pa_ 262 PLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHY 300 (311)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCCB
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhhhhc
Confidence 999999999999999999999999999999988766543
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-50 Score=350.85 Aligned_cols=248 Identities=27% Similarity=0.353 Sum_probs=203.1
Q ss_pred ccceecccCceEEEEEEEC--CCceEEEEccCCCCCcH--HHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEec
Q 020888 46 SSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDR--LVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY 121 (320)
Q Consensus 46 ~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 121 (320)
.+++||+|+||+||+|.++ ++.||+|++........ ...+.+.+|++++++++||||+++++++..++..|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 3578999999999999985 78899999865433221 1235688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCccc
Q 020888 122 LRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHD 201 (320)
Q Consensus 122 ~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~~ 201 (320)
++++++..+......+++..+..++.||+.||+|||++| |+|+||||+||++ +.++.+||+|||++........
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDiKp~NIli--~~~~~~KL~DFG~a~~~~~~~~-- 155 (299)
T d1ua2a_ 82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLL--DENGVLKLADFGLAKSFGSPNR-- 155 (299)
T ss_dssp CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE--CTTCCEEECCCGGGSTTTSCCC--
T ss_pred hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccc--eecccCCcceEEe--cCCCccccccCccccccCCCcc--
Confidence 988777777666678999999999999999999999999 9999999999999 8899999999999976544321
Q ss_pred eeeccCCcccccccCccccCcC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCC------------
Q 020888 202 VYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFF------------ 268 (320)
Q Consensus 202 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~------------ 268 (320)
......+|+.|+|||++.+. .++.++|||||||++|+|++|..||......+....+.+....+.
T Consensus 156 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~ 233 (299)
T d1ua2a_ 156 --AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 233 (299)
T ss_dssp --CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred --cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccch
Confidence 22345789999999998654 679999999999999999999999998887776655543210000
Q ss_pred --------------CCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 269 --------------RAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 269 --------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
....+++++.+||.+||..||++|||++|+++|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 012468899999999999999999999999986
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-49 Score=345.65 Aligned_cols=266 Identities=30% Similarity=0.494 Sum_probs=222.4
Q ss_pred CCcCCCCCcccCccceecccCceEEEEEEEC-------CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcccce
Q 020888 34 DWEIDPSELDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQF 105 (320)
Q Consensus 34 ~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~-------~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~ 105 (320)
.|+++. .+|.+.+.||+|+||.||+|.+. ++.||+|.+.... .......+.+|+.+++.+ +||||+++
T Consensus 17 ~~~~~~--~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~ 92 (311)
T d1t46a_ 17 KWEFPR--NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNL 92 (311)
T ss_dssp GGBCCG--GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccCCH--HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc--CHHHHHHHHHHHHHHHhccCCCCEEEE
Confidence 676664 48899999999999999999863 3579999886543 233446788999999999 69999999
Q ss_pred eeeEEeCCceEEEEecCCCCCHHHHHHHhC------------------CCCHHHHHHHHHHHHHHHHHHhcCCCCeEecC
Q 020888 106 LGAVTERKPLMLITEYLRGGDLHKYLKEKG------------------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 167 (320)
Q Consensus 106 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~------------------~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~d 167 (320)
++++.+.+..+++|||+++++|.+++.... .+++..+..++.||+.||+|||++| ++|||
T Consensus 93 ~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~--ivHrD 170 (311)
T d1t46a_ 93 LGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRD 170 (311)
T ss_dssp EEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSC
T ss_pred EEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeecc
Confidence 999999999999999999999999987532 5899999999999999999999998 99999
Q ss_pred CCCCcEEEeeCCCCcEEEecCCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHh-CCC
Q 020888 168 LKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEP 246 (320)
Q Consensus 168 i~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~ 246 (320)
|||+||++ +.++.++++|||.++....... ........+|+.|+|||.+.+..++.++||||||+++|+|+| |..
T Consensus 171 LKp~NIl~--~~~~~~ki~DfG~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p 246 (311)
T d1t46a_ 171 LAARNILL--THGRITKICDFGLARDIKNDSN--YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS 246 (311)
T ss_dssp CSGGGEEE--ETTTEEEECCCGGGSCTTSCTT--SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred cccccccc--cccCcccccccchheeccCCCc--ceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCC
Confidence 99999999 8889999999999987654332 223345678999999999999999999999999999999999 566
Q ss_pred CCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcC
Q 020888 247 PLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETL 309 (320)
Q Consensus 247 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 309 (320)
||......+....+.........+..+++++.+||.+||+.||++|||++++++.|+++....
T Consensus 247 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~~ 309 (311)
T d1t46a_ 247 PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (311)
T ss_dssp SSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred CCCCCCHHHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhccC
Confidence 666666555544444333334445568999999999999999999999999999998876553
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-50 Score=351.56 Aligned_cols=245 Identities=27% Similarity=0.449 Sum_probs=199.8
Q ss_pred cccCcc-ceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcccceeeeEEe----CC
Q 020888 42 LDFSSS-AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTE----RK 113 (320)
Q Consensus 42 ~~y~~~-~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~----~~ 113 (320)
.+|.+. +.||+|+||+||+|.+. ++.||+|++... ..+.+|++++.++ +||||+++++++++ +.
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~ 82 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 82 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCC
Confidence 478876 46999999999999985 789999988532 5677899987665 79999999999875 46
Q ss_pred ceEEEEecCCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeC-CCCcEEEecCCC
Q 020888 114 PLMLITEYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS-SADHLKVGDFGL 190 (320)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~-~~~~~~L~dfg~ 190 (320)
.+|+|||||+||+|.+++.+. ..+++..+..++.||+.||+|||++| |+||||||+||++... ..+.++|+|||+
T Consensus 83 ~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~--iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 83 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC--Cccccccccccccccccccccccccccce
Confidence 689999999999999999864 36999999999999999999999999 9999999999999432 356799999999
Q ss_pred cccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCC----
Q 020888 191 SKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRP---- 266 (320)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~---- 266 (320)
++...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+......
T Consensus 161 a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~ 235 (335)
T d2ozaa1 161 AKETTSHN-----SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 235 (335)
T ss_dssp CEECCCCC-----CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSS
T ss_pred eeeccCCC-----ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCC
Confidence 98765433 223457999999999999999999999999999999999999999876554443333322211
Q ss_pred --CCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 267 --FFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 267 --~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
......+++++++||++||+.||.+|||+++++++
T Consensus 236 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 236 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp CCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 11112478999999999999999999999999986
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-48 Score=339.72 Aligned_cols=263 Identities=30% Similarity=0.500 Sum_probs=225.2
Q ss_pred CCcCCCCCcccCccceecccCceEEEEEEEC-------CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCccccee
Q 020888 34 DWEIDPSELDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 106 (320)
Q Consensus 34 ~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~-------~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 106 (320)
.|+++. .+|.+.+.||+|+||+||+|.+. ++.||||.+.... .......+.+|++++++++|+||++++
T Consensus 14 ~~ei~~--~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~ 89 (308)
T d1p4oa_ 14 EWEVAR--EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLL 89 (308)
T ss_dssp TTBCCG--GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred ceeecH--HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcCCCCEeeee
Confidence 577774 58899999999999999999874 4679999886442 334446789999999999999999999
Q ss_pred eeEEeCCceEEEEecCCCCCHHHHHHHh----------CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEe
Q 020888 107 GAVTERKPLMLITEYLRGGDLHKYLKEK----------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLV 176 (320)
Q Consensus 107 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~----------~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~ 176 (320)
+++..++..++||||+++|+|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+||++
T Consensus 90 ~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~--ivHrDlk~~NiLl- 166 (308)
T d1p4oa_ 90 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMV- 166 (308)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEE-
T ss_pred eEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeeceEcCCceee-
Confidence 9999999999999999999999988642 24689999999999999999999988 9999999999999
Q ss_pred eCCCCcEEEecCCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhC-CCCCCCCChHH
Q 020888 177 NSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEG-EPPLANYEPYE 255 (320)
Q Consensus 177 ~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g-~~p~~~~~~~~ 255 (320)
+.++.+||+|||+++....... ........+++.|+|||.+.+..++.++||||||+++|+|+|| ..||...+..+
T Consensus 167 -d~~~~~Kl~DFGla~~~~~~~~--~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~ 243 (308)
T d1p4oa_ 167 -AEDFTVKIGDFGMTRDIYETDY--YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ 243 (308)
T ss_dssp -CTTCCEEECCTTCCCGGGGGGC--EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH
T ss_pred -cCCceEEEeecccceeccCCcc--eeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHH
Confidence 8999999999999987654322 2223344689999999999999999999999999999999997 58888888888
Q ss_pred HHHHHHhCCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHh
Q 020888 256 AAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKE 307 (320)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 307 (320)
....+..+..+.. +..+++.+.+++.+||+.||.+|||+++++++|++..+
T Consensus 244 ~~~~i~~~~~~~~-p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 244 VLRFVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp HHHHHHTTCCCCC-CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHHHHHhCCCCCC-cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 8887777665543 45589999999999999999999999999999876533
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-50 Score=341.38 Aligned_cols=243 Identities=28% Similarity=0.461 Sum_probs=203.6
Q ss_pred CcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcH---HHHHHHHHHHHHHHhCC--CCcccceeeeEEeCC
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDR---LVIQDFRHEVNLLVKLR--HPNIVQFLGAVTERK 113 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~---~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~ 113 (320)
..+|++.+.||+|+||+||+|.+. ++.||+|++........ ....++.+|+.++++++ ||||+++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 457999999999999999999985 78999998865433221 11134667999999986 899999999999999
Q ss_pred ceEEEEecCCC-CCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeC-CCCcEEEecCCCc
Q 020888 114 PLMLITEYLRG-GDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS-SADHLKVGDFGLS 191 (320)
Q Consensus 114 ~~~iv~e~~~~-~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~-~~~~~~L~dfg~~ 191 (320)
..++|||++.+ +++.+++..+..+++..++.++.||+.||.|||++| |+||||||+||++ + +++.++|+|||++
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NIll--~~~~~~vkl~DFG~a 158 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILI--DLNRGELKLIDFGSG 158 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--ETTTTEEEECCCTTC
T ss_pred eEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CccccCcccceEE--ecCCCeEEECccccc
Confidence 99999999975 688899988889999999999999999999999998 9999999999999 5 3468999999999
Q ss_pred ccccccCccceeeccCCcccccccCccccCcCCC-CCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCC
Q 020888 192 KLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKY-DKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA 270 (320)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 270 (320)
...... ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+ .+..... ..+
T Consensus 159 ~~~~~~------~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~~~--~~~ 224 (273)
T d1xwsa_ 159 ALLKDT------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQV--FFR 224 (273)
T ss_dssp EECCSS------CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCC--CCS
T ss_pred eecccc------cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhccc--CCC
Confidence 765332 2234578999999999987765 577999999999999999999997532 2333332 233
Q ss_pred CCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 271 KGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 271 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
..+|++++++|.+||+.||++|||++|++++
T Consensus 225 ~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 225 QRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 4689999999999999999999999999876
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-49 Score=340.78 Aligned_cols=249 Identities=28% Similarity=0.448 Sum_probs=203.3
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEe
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 120 (320)
+|.+++.||+|+||+||+|.+. ++.||+|++....... .....+.+|++++++++||||+++++++.+++..|+|||
T Consensus 3 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcCh-HHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 7999999999999999999986 7899999986543222 223678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHH-H-hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccC
Q 020888 121 YLRGGDLHKYLK-E-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 198 (320)
Q Consensus 121 ~~~~~~L~~~~~-~-~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~ 198 (320)
|+.+ ++.+++. . ...+++..+..++.|++.||.|||++| |+||||||+||++ +.++.++|+|||.+.......
T Consensus 82 ~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~--IiHrDiKpeNIl~--~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLI--NTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE--CTTSCEEECSTTHHHHHCCCS
T ss_pred ecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC--EEccccCchheee--cccCcceeccCCcceeccCCc
Confidence 9966 5555553 3 346999999999999999999999998 9999999999999 888999999999997664332
Q ss_pred ccceeeccCCcccccccCccccCcCC-CCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCC-----------
Q 020888 199 SHDVYKMTGETGSYRYMAPEVFKHRK-YDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRP----------- 266 (320)
Q Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~----------- 266 (320)
. ......+|+.|+|||...... ++.++|+||||+++|+|++|+.||...+..+....+......
T Consensus 157 ~----~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 232 (298)
T d1gz8a_ 157 R----TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232 (298)
T ss_dssp B----CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred c----cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccc
Confidence 1 233457899999999876655 578999999999999999999999988766655443321000
Q ss_pred ------CC----------CCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 267 ------FF----------RAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 267 ------~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
.. ....++.++++|+++||..||++|||++|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 233 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp STTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 00 012467899999999999999999999999987
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3.7e-49 Score=339.59 Aligned_cols=250 Identities=29% Similarity=0.432 Sum_probs=206.7
Q ss_pred ccCccceecccCceEEEEEEEC-CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEec
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY 121 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~-~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 121 (320)
+|.+++.||+|+||+||+|.++ ++.||+|++....... ...+.+.+|+.++++++||||+++++.+..++..++++++
T Consensus 3 ~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDE-GIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp SEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGG-CCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcCh-HHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 7999999999999999999987 7899999986653322 2237888999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCccc
Q 020888 122 LRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHD 201 (320)
Q Consensus 122 ~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~~ 201 (320)
+.++.+..+.+..+.+++..+..++.|++.||+|||+.| |+|+||||+||++ +.++.++|+|||.+........
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--IvHrDiKp~NIll--~~~~~~kl~DfG~a~~~~~~~~-- 155 (286)
T d1ob3a_ 82 LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLI--NREGELKIADFGLARAFGIPVR-- 155 (286)
T ss_dssp CSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE--CTTSCEEECCTTHHHHHCC-----
T ss_pred ehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCc--EEecCCCCceeeE--cCCCCEEecccccceecccCcc--
Confidence 988667777666778999999999999999999999998 9999999999999 8889999999999887654321
Q ss_pred eeeccCCcccccccCccccCcC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCC--------------
Q 020888 202 VYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRP-------------- 266 (320)
Q Consensus 202 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~-------------- 266 (320)
......+++.|.|||.+.+. .++.++|+|||||++|+|++|+.||...+..+....+......
T Consensus 156 --~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (286)
T d1ob3a_ 156 --KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred --ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhh
Confidence 22334578899999998765 5689999999999999999999999988776655544321000
Q ss_pred -------------CCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 267 -------------FFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 267 -------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
......+++++++||++||..||++|||++|+++|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 01123468899999999999999999999999865
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-48 Score=338.97 Aligned_cols=253 Identities=26% Similarity=0.400 Sum_probs=202.6
Q ss_pred CCCcccCccceecccCceEEEEEEEC---CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhC---CCCcccceeeeEEe-
Q 020888 39 PSELDFSSSAIIGKGSFGEILKAYWR---GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL---RHPNIVQFLGAVTE- 111 (320)
Q Consensus 39 ~~~~~y~~~~~lg~g~~~~vy~~~~~---~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~- 111 (320)
....+|.+++.||+|+||+||+|.+. ++.||+|++......... ...+.+|+.+++.+ +||||+++++++..
T Consensus 4 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~-~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~ 82 (305)
T d1blxa_ 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM-PLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 82 (305)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSC-BCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred CCcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchH-HHHHHHHHHHHHHHhhcCCCCcceeeeeeccc
Confidence 34578999999999999999999984 456899988654332211 12344566665554 79999999998853
Q ss_pred ----CCceEEEEecCCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEe
Q 020888 112 ----RKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVG 186 (320)
Q Consensus 112 ----~~~~~iv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~ 186 (320)
+...++++|+++++.+...... ...+++..++.++.|++.||+|||++| |+||||||+||++ +.++.++|+
T Consensus 83 ~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~--ivHrDiKp~NILi--~~~~~~kl~ 158 (305)
T d1blxa_ 83 RTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILV--TSSGQIKLA 158 (305)
T ss_dssp ECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE--CTTCCEEEC
T ss_pred ccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecCCCccEEEE--cCCCCeeec
Confidence 3468999999988666554443 346899999999999999999999998 9999999999999 888999999
Q ss_pred cCCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCC
Q 020888 187 DFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRP 266 (320)
Q Consensus 187 dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 266 (320)
|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+......
T Consensus 159 dfg~~~~~~~~~-----~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~ 233 (305)
T d1blxa_ 159 DFGLARIYSFQM-----ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL 233 (305)
T ss_dssp SCCSCCCCCGGG-----GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred chhhhhhhcccc-----cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCC
Confidence 999987554322 234567999999999999999999999999999999999999999988877766555431000
Q ss_pred -------------------------CCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 267 -------------------------FFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 267 -------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
......+++++++||.+||+.||++|||++|+++|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 234 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00123578999999999999999999999999886
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-48 Score=336.11 Aligned_cols=256 Identities=23% Similarity=0.343 Sum_probs=203.9
Q ss_pred CcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEe-------
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE------- 111 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------- 111 (320)
..+|.+++.||+|+||+||+|.+. ++.||||++........ ...++.+|+++++.++|+|++++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~-~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~ 87 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEG-FPITALREIKILQLLKHENVVNLIEICRTKASPYNR 87 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTS-SCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchH-HHHHHHHHHHHHHHhcCCCccceEeeeecccccccc
Confidence 468999999999999999999985 78999998865543322 23678889999999999999999998744
Q ss_pred -CCceEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCC
Q 020888 112 -RKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGL 190 (320)
Q Consensus 112 -~~~~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~ 190 (320)
.+..+++||++.++.+..+......+++..++.++.|++.||.|||++| |+||||||+||++ +.++.++|+|||+
T Consensus 88 ~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~--ivHrDlKp~NILl--~~~~~~kl~dfg~ 163 (318)
T d3blha1 88 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLI--TRDGVLKLADFGL 163 (318)
T ss_dssp ---CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEE--CTTSCEEECCCTT
T ss_pred cCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCC--EEecCcCchheee--cCCCcEEeeecce
Confidence 4468999999977666655555667999999999999999999999998 9999999999999 8899999999999
Q ss_pred cccccccCccceeeccCCcccccccCccccCcC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCC
Q 020888 191 SKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR 269 (320)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 269 (320)
+..+...............+|+.|+|||++.+. .++.++|||||||++|+|++|+.||...+..+....+.........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 243 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 987765443333334456799999999998765 6899999999999999999999999988776665544432111000
Q ss_pred ---C---------------------------CCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 270 ---A---------------------------KGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 270 ---~---------------------------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
. ...++++.+||.+||+.||++|||++|+++|
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 0 0125678899999999999999999999987
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-48 Score=334.36 Aligned_cols=262 Identities=27% Similarity=0.401 Sum_probs=202.0
Q ss_pred cccCccceecccCceEEEEEEECCCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCC----ceEE
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK----PLML 117 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~i 117 (320)
.+|.+.+.||+|+||.||++..+++.||+|.+.... . .......|+..+..++||||+++++++...+ ..++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~---~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE---E-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGG---H-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc---h-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 468888999999999999999999999999885431 1 1122334555556779999999999987543 4799
Q ss_pred EEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcC------CCCeEecCCCCCcEEEeeCCCCcEEEecCCCc
Q 020888 118 ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE------PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 191 (320)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~------g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~ 191 (320)
||||+++|+|.+++++. ++++..++.++.+++.||.|+|.. .++|+|+||||+||++ +.++.+||+|||++
T Consensus 79 v~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl--~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV--KKNGTCCIADLGLA 155 (303)
T ss_dssp EEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEE--CTTSCEEECCCTTC
T ss_pred EEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEE--cCCCCeEEEecCcc
Confidence 99999999999999874 689999999999999999999973 1239999999999999 88999999999999
Q ss_pred ccccccCccceeeccCCcccccccCccccCcCC------CCCchhHHHHHHHHHHHHhCCCCCCCC--------------
Q 020888 192 KLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRK------YDKKVDVFSFAMILYEMLEGEPPLANY-------------- 251 (320)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~------~~~~~Di~slG~~l~~ll~g~~p~~~~-------------- 251 (320)
..................||+.|+|||++.+.. ++.++|||||||++|||+||..||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T d1vjya_ 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence 887665443333344567999999999987653 467899999999999999998776321
Q ss_pred -ChHHHHHHHHhCCC-CCCCC----CCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcCC
Q 020888 252 -EPYEAAKYVAEGHR-PFFRA----KGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLP 310 (320)
Q Consensus 252 -~~~~~~~~~~~~~~-~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~ 310 (320)
.............. +.... ...+..+.+++.+||+.||++|||+.|+++.|+++.++..
T Consensus 236 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~ 300 (303)
T d1vjya_ 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 300 (303)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred chHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhcC
Confidence 12223333333222 21111 1123569999999999999999999999999999987654
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=5.9e-47 Score=326.51 Aligned_cols=269 Identities=21% Similarity=0.287 Sum_probs=215.9
Q ss_pred CcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCC-CcccceeeeEEeCCceEE
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH-PNIVQFLGAVTERKPLML 117 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~i 117 (320)
+.+|.+++.||+|+||+||+|.+. ++.||+|++...... ..+.+|++.++.+.| +|++.+++++..+...++
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~ 78 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 78 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc-----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEE
Confidence 468999999999999999999986 788999987554322 356778899999964 899999999999999999
Q ss_pred EEecCCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEee---CCCCcEEEecCCCccc
Q 020888 118 ITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN---SSADHLKVGDFGLSKL 193 (320)
Q Consensus 118 v~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~---~~~~~~~L~dfg~~~~ 193 (320)
|||++ +++|.+++... ..++..++..++.|++.||+|||++| |+||||||+||++.. ...+.++|+|||+++.
T Consensus 79 vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~g--iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 79 VIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred EEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCC--ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 99999 67999998764 46999999999999999999999999 999999999999932 1356899999999987
Q ss_pred ccccCccce---eeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHhC---C
Q 020888 194 IKVQNSHDV---YKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEP---YEAAKYVAEG---H 264 (320)
Q Consensus 194 ~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~---~~~~~~~~~~---~ 264 (320)
......... .......||+.|+|||++.+..++.++||||||+++|+|++|..||..... ......+... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC
Confidence 755432221 223345799999999999999999999999999999999999999975432 2222222211 1
Q ss_pred CCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhcCCC----CCcccc
Q 020888 265 RPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPT----DHHWNI 317 (320)
Q Consensus 265 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~----~~~~~~ 317 (320)
........+|+++.+++..|+..+|++||+++.+.+.|+++..+... +.+|+.
T Consensus 236 ~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~~~~~~Dw~~ 292 (293)
T d1csna_ 236 PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWNL 292 (293)
T ss_dssp CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGGGC
T ss_pred ChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCCCCCCCCCCc
Confidence 11112245899999999999999999999999999988887765543 345654
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-47 Score=333.90 Aligned_cols=251 Identities=28% Similarity=0.432 Sum_probs=200.5
Q ss_pred cccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCC-----c
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK-----P 114 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~ 114 (320)
.+|++++.||+|+||+||+|.++ ++.||||++.... .....+.+.+|+++++.++|+|++++++++.... .
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 36999999999999999999986 8899999986533 3444578899999999999999999999986543 2
Q ss_pred eEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccc
Q 020888 115 LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 194 (320)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~ 194 (320)
+|+++ ++.|++|.++++.+ .+++..+..++.|++.||+|||++| |+||||||+||++ +.++.++|+|||++...
T Consensus 86 ~~l~~-~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~--iiHRDIKp~NILl--~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 86 VYLVT-HLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLL--NTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEEE-ECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEE--CTTCCEEECCCTTCEEC
T ss_pred EEEEE-eecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCcceEEE--CCCCCEEEcccCceeec
Confidence 45554 55688999999764 7999999999999999999999998 9999999999999 88899999999999766
Q ss_pred cccCccceeeccCCcccccccCccccC-cCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCC---------
Q 020888 195 KVQNSHDVYKMTGETGSYRYMAPEVFK-HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH--------- 264 (320)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~--------- 264 (320)
....... .......+++.|+|||++. +..++.++||||+||++|+|++|..||...+..+.........
T Consensus 160 ~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (345)
T d1pmea_ 160 DPDHDHT-GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238 (345)
T ss_dssp CGGGCBC-CTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred cCCCccc-eeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhh
Confidence 5432221 1234467899999999984 4567899999999999999999999998876554443322110
Q ss_pred ---------------CCC-----CCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 265 ---------------RPF-----FRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 265 ---------------~~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
... .....++.++++|+.+||+.||.+|||+++++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 0013467899999999999999999999999986
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-47 Score=333.54 Aligned_cols=250 Identities=28% Similarity=0.440 Sum_probs=201.9
Q ss_pred cccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCC------
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK------ 113 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------ 113 (320)
.+|.+++.||+|+||+||+|.+. ++.||+|++..... .....+.+.+|+++++.++||||+++++++...+
T Consensus 18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhc-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 48999999999999999999986 88999999876543 3344578899999999999999999999987554
Q ss_pred ceEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccc
Q 020888 114 PLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 193 (320)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~ 193 (320)
.+|+||||+ +.+|.++++. +.+++..++.++.||+.||.|||++| |+|+||||+||++ +.++.++|+|||.+..
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~--IiHrDiKp~NIL~--~~~~~~kl~Dfg~a~~ 170 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAV--NEDCELKILDFGLARQ 170 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEE--CTTCCEEECCCTTCEE
T ss_pred eEEEEEecc-cccHHHHHHh-ccccHHHHHHHHHHHHHHHHHHHhCC--CcccccCcchhhc--ccccccccccccceec
Confidence 469999999 6688887765 57999999999999999999999999 9999999999999 8999999999999976
Q ss_pred ccccCccceeeccCCcccccccCccccCcC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCC--------
Q 020888 194 IKVQNSHDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH-------- 264 (320)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~-------- 264 (320)
.... .....+|+.|+|||.+.+. .++.++|||||||++|+|++|..||...+............
T Consensus 171 ~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (346)
T d1cm8a_ 171 ADSE-------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 243 (346)
T ss_dssp CCSS-------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred cCCc-------cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHH
Confidence 5432 2345789999999998764 57899999999999999999999998877655443322110
Q ss_pred ---------------------CCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH--HHHH
Q 020888 265 ---------------------RPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR--LEKI 305 (320)
Q Consensus 265 ---------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--L~~~ 305 (320)
........+++++.+||.+||..||.+|||++|+|+| ++.+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 244 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred hhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 0001123568999999999999999999999999987 5544
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.3e-47 Score=327.25 Aligned_cols=259 Identities=20% Similarity=0.267 Sum_probs=204.6
Q ss_pred cccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcc-cceeeeEEeCCceEEE
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI-VQFLGAVTERKPLMLI 118 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~iv 118 (320)
.+|++++.||+|+||.||+|.+. ++.||+|++...... ..+..|+++++.++|+++ +.+..++..++..++|
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~iv 81 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 81 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC-----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEE
Confidence 46999999999999999999986 789999987654332 356789999999986654 4556666788889999
Q ss_pred EecCCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEe-eCCCCcEEEecCCCcccccc
Q 020888 119 TEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLV-NSSADHLKVGDFGLSKLIKV 196 (320)
Q Consensus 119 ~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~-~~~~~~~~L~dfg~~~~~~~ 196 (320)
|||+ +++|.+.+.. ...+++..+..++.|++.||+|||++| |+|+||||+||++. .+.+..++|+|||+++.+..
T Consensus 82 me~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 82 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred EEEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 9999 5577776654 557999999999999999999999999 99999999999983 23455799999999998765
Q ss_pred cCccce---eeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH---h---CCCCC
Q 020888 197 QNSHDV---YKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA---E---GHRPF 267 (320)
Q Consensus 197 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~---~---~~~~~ 267 (320)
...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||............. . .....
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 238 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHH
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChh
Confidence 433221 22344579999999999999999999999999999999999999998765443221111 1 11111
Q ss_pred CCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhc
Q 020888 268 FRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKET 308 (320)
Q Consensus 268 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 308 (320)
.....+|+++.+++..||+.+|++||++.++.+.|+.+..+
T Consensus 239 ~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 239 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred HhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 12346899999999999999999999999999888887654
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-47 Score=333.92 Aligned_cols=250 Identities=26% Similarity=0.356 Sum_probs=200.0
Q ss_pred CcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEe------C
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE------R 112 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~ 112 (320)
..+|+..++||+|+||+||+|.+. ++.||+|++..... ...+|++++++++|+||+++++++.. .
T Consensus 19 ~~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~ 91 (350)
T d1q5ka_ 19 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE 91 (350)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSC
T ss_pred cCCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCc
Confidence 447999999999999999999985 78999999865432 22369999999999999999999843 2
Q ss_pred CceEEEEecCCCCCHHHHH---HHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCC-cEEEecC
Q 020888 113 KPLMLITEYLRGGDLHKYL---KEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD-HLKVGDF 188 (320)
Q Consensus 113 ~~~~iv~e~~~~~~L~~~~---~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~-~~~L~df 188 (320)
...++||||++++.+..+. .....+++..+..++.||+.||+|||++| |+||||||+||++ +.++ .++|+||
T Consensus 92 ~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~--IiHrDiKp~NILl--~~~~~~~kl~DF 167 (350)
T d1q5ka_ 92 VYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLL--DPDTAVLKLCDF 167 (350)
T ss_dssp CEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEE--CTTTCCEEECCC
T ss_pred eEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC--CcccCCCcceEEE--ecCCCceeEecc
Confidence 3478999999765333332 33557999999999999999999999998 9999999999999 6654 8999999
Q ss_pred CCcccccccCccceeeccCCcccccccCccccCc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhC----
Q 020888 189 GLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEG---- 263 (320)
Q Consensus 189 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~---- 263 (320)
|++..+.... ......+++.|+|||.+.+ ..++.++|||||||++|+|++|..||...+..+....+.+.
T Consensus 168 G~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~ 242 (350)
T d1q5ka_ 168 GSAKQLVRGE-----PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP 242 (350)
T ss_dssp TTCEECCTTS-----CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred cchhhccCCc-----ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 9998765432 2234578999999998765 56899999999999999999999999888766655444321
Q ss_pred ---------------CCCC--------CCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH--HHHHH
Q 020888 264 ---------------HRPF--------FRAKGFTPELRELTEKCWAADMNQRPSFLDILKR--LEKIK 306 (320)
Q Consensus 264 ---------------~~~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--L~~~~ 306 (320)
..+. .....+++++.+||.+||..||++|||+.|+++| ++.+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 243 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp CHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred hHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence 0000 1123468999999999999999999999999986 44443
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-46 Score=323.62 Aligned_cols=250 Identities=25% Similarity=0.385 Sum_probs=207.8
Q ss_pred ccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEeCCceEEEEe
Q 020888 43 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 120 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 120 (320)
+|.+++.||+|+||+||+|.+. ++.||+|++...... .....++.+|+.+++.++|+||+++++++......+++++
T Consensus 3 ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSS-TTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCC-hHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 7999999999999999999985 788999998665433 3345889999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccccccCcc
Q 020888 121 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 200 (320)
Q Consensus 121 ~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~~~~~~~ 200 (320)
++.+++|..++...+.+++..+..++.|++.||+|||++| |+|+||||+||++ +.++.++|+|||.+........
T Consensus 82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~--IvHrDiKP~NIli--~~~~~~kl~DFG~a~~~~~~~~- 156 (292)
T d1unla_ 82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLI--NRNGELKLANFGLARAFGIPVR- 156 (292)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--CTTCCEEECCCTTCEECCSCCS-
T ss_pred eccccccccccccccccchhHHHHHHHHHHHHHHHhhcCC--EeeecccCccccc--ccCCceeeeecchhhcccCCCc-
Confidence 9999999998888888999999999999999999999998 9999999999999 8888999999999987654322
Q ss_pred ceeeccCCcccccccCccccCcCC-CCCchhHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHhC---------------
Q 020888 201 DVYKMTGETGSYRYMAPEVFKHRK-YDKKVDVFSFAMILYEMLEGEPPLANY-EPYEAAKYVAEG--------------- 263 (320)
Q Consensus 201 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~g~~p~~~~-~~~~~~~~~~~~--------------- 263 (320)
......+++.|.|||.+.+.. ++.++|||||||++|+|++|..||... +..+....+...
T Consensus 157 ---~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (292)
T d1unla_ 157 ---CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233 (292)
T ss_dssp ---CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred ---cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhc
Confidence 222345678899999987665 689999999999999999999996543 333333322210
Q ss_pred ------------CCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 264 ------------HRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 264 ------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
.........+++++++||.+||+.||.+|||++|+++|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 01111123468899999999999999999999999875
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-47 Score=334.22 Aligned_cols=251 Identities=24% Similarity=0.395 Sum_probs=206.5
Q ss_pred cccCccceecccCceEEEEEEE-----CCCceEEEEccCCCCC-cHHHHHHHHHHHHHHHhCCC-CcccceeeeEEeCCc
Q 020888 42 LDFSSSAIIGKGSFGEILKAYW-----RGTPVAIKRILPSLSD-DRLVIQDFRHEVNLLVKLRH-PNIVQFLGAVTERKP 114 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~-----~~~~~~~K~~~~~~~~-~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~ 114 (320)
.+|.+++.||+|+||+||+|.+ +++.||+|.+...... +....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 4799999999999999999986 2678999988653221 11223567889999999976 899999999999999
Q ss_pred eEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccc
Q 020888 115 LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 194 (320)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~ 194 (320)
.++++||+.+++|.+++...+.+++..+..++.||+.||.|||++| |+|+||||+||++ +.++.++|+|||++..+
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~--ivHrDiKp~Nill--~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILL--DSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE--CTTSCEEESCSSEEEEC
T ss_pred eeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCC--EEeccCCccceee--cCCCCEEEeeccchhhh
Confidence 9999999999999999999888999999999999999999999998 9999999999999 88899999999998766
Q ss_pred cccCccceeeccCCcccccccCccccCcC--CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHH----HHHHhCCCCCC
Q 020888 195 KVQNSHDVYKMTGETGSYRYMAPEVFKHR--KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAA----KYVAEGHRPFF 268 (320)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~----~~~~~~~~~~~ 268 (320)
...... ......+++.|+|||.+.+. .++.++|||||||++|+|++|..||......+.. ........ .
T Consensus 180 ~~~~~~---~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~--~ 254 (322)
T d1vzoa_ 180 VADETE---RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP--P 254 (322)
T ss_dssp CGGGGG---GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCC--C
T ss_pred cccccc---cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCC--C
Confidence 443221 22345689999999998765 4678999999999999999999999776433322 22222222 2
Q ss_pred CCCCCCHHHHHHHHHHhhcCCCCCC-----CHHHHHHH
Q 020888 269 RAKGFTPELRELTEKCWAADMNQRP-----SFLDILKR 301 (320)
Q Consensus 269 ~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~ 301 (320)
.+..+++++++++.+||..||.+|| |++|+++|
T Consensus 255 ~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 255 YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred CcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 2345899999999999999999998 48999875
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.1e-45 Score=323.82 Aligned_cols=243 Identities=21% Similarity=0.362 Sum_probs=197.3
Q ss_pred CcccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCC-CCcccceeeeEEe--CCce
Q 020888 41 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTE--RKPL 115 (320)
Q Consensus 41 ~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~ 115 (320)
..+|++++.||+|+||+||+|.+. ++.||+|++.... .+.+.+|+++++.+. |+||+++++++.. ....
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~ 107 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 107 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCce
Confidence 347999999999999999999985 8899999985432 267889999999995 9999999999874 4568
Q ss_pred EEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCC-CcEEEecCCCcccc
Q 020888 116 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSA-DHLKVGDFGLSKLI 194 (320)
Q Consensus 116 ~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~-~~~~L~dfg~~~~~ 194 (320)
++||||+++++|.++. ..+++..+..++.||+.||.|||++| |+|+||||+||++ +.+ +.++|+|||++...
T Consensus 108 ~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~g--IvHrDiKp~NILi--~~~~~~vkl~DFG~a~~~ 180 (328)
T d3bqca1 108 ALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMI--DHEHRKLRLIDWGLAEFY 180 (328)
T ss_dssp EEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--ETTTTEEEECCGGGCEEC
T ss_pred eEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcc--cccccccccceEE--cCCCCeeeecccccceec
Confidence 9999999999998764 46999999999999999999999999 9999999999999 544 46999999999866
Q ss_pred cccCccceeeccCCcccccccCccccCcCC-CCCchhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHH-----------
Q 020888 195 KVQNSHDVYKMTGETGSYRYMAPEVFKHRK-YDKKVDVFSFAMILYEMLEGEPPLANYEPYEA-AKYVA----------- 261 (320)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~-~~~~~----------- 261 (320)
.... ......+|+.|+|||.+.+.. ++.++|+||+||+++++++|..||........ ...+.
T Consensus 181 ~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~ 255 (328)
T d3bqca1 181 HPGQ-----EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY 255 (328)
T ss_dssp CTTC-----CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHH
T ss_pred cCCC-----cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhh
Confidence 5432 233456899999999987654 79999999999999999999999976543221 11111
Q ss_pred --hCC----------------------CCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 262 --EGH----------------------RPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 262 --~~~----------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
... ........+++++++||++||..||++|||++|+|+|
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 256 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp HHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 0011113368899999999999999999999999875
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-46 Score=327.58 Aligned_cols=247 Identities=26% Similarity=0.412 Sum_probs=200.3
Q ss_pred cccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEe-----CCc
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE-----RKP 114 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 114 (320)
.+|.+++.||+|+||+||+|.+. ++.||+|++...... ....+++.+|+++++.++|+|++++++++.. +..
T Consensus 18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS-IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSS-HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcC-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 37999999999999999999985 889999998765443 3344678899999999999999999999853 233
Q ss_pred eEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcccc
Q 020888 115 LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 194 (320)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~~ 194 (320)
.+++++++.|++|.+++.. +++++..+..++.||+.||+|||++| |+||||||+||++ +.++.++++|||.+...
T Consensus 97 ~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~g--iiHrDiKp~NILi--~~~~~~kl~dfg~a~~~ 171 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAV--NEDCELKILDFGLARHT 171 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE--CTTCCEEECCC----CC
T ss_pred eEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCC--CcccccCCccccc--cccccccccccchhccc
Confidence 4555666778999999865 47999999999999999999999998 9999999999999 88999999999998754
Q ss_pred cccCccceeeccCCcccccccCccccCcC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCC-----
Q 020888 195 KVQNSHDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFF----- 268 (320)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~----- 268 (320)
... .....+++.|+|||...+. .++.++|||||||++|+|++|..||...+.......+........
T Consensus 172 ~~~-------~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (348)
T d2gfsa1 172 DDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 244 (348)
T ss_dssp TGG-------GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred Ccc-------cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence 332 3345689999999987665 468999999999999999999999988776655444432211100
Q ss_pred ------------------------CCCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 269 ------------------------RAKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 269 ------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
....+++++++||.+||..||++|||++|+++|
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp TCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 013578999999999999999999999999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-46 Score=329.44 Aligned_cols=247 Identities=26% Similarity=0.345 Sum_probs=193.5
Q ss_pred cccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcccceeeeEEe------CC
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE------RK 113 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~ 113 (320)
.+|.+++.||+|+||+||+|.++ ++.||||++...... .....++.+|+.++++++||||+++++++.. ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN-QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSS-HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcC-HHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 47999999999999999999986 899999998765543 4445788999999999999999999999853 46
Q ss_pred ceEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEecCCCccc
Q 020888 114 PLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 193 (320)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~~ 193 (320)
.+|+||||+.+ ++.+.+. ..+++..++.++.|++.||+|||++| |+|+||||+||++ +.++.++++|||.+..
T Consensus 96 ~~~iv~Ey~~~-~l~~~~~--~~~~~~~i~~~~~qil~gl~~LH~~g--iiHrDlKP~Nil~--~~~~~~kl~df~~~~~ 168 (355)
T d2b1pa1 96 DVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVV--KSDCTLKILDFGLART 168 (355)
T ss_dssp EEEEEEECCSE-EHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE--CTTCCEEECCCCC---
T ss_pred eeEEEEeccch-HHHHhhh--cCCCHHHHHHHHHHHHHHHHHhhhcc--cccccCCcccccc--ccccceeeechhhhhc
Confidence 78999999976 4544443 46899999999999999999999999 9999999999999 8889999999998876
Q ss_pred ccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh-----------
Q 020888 194 IKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAE----------- 262 (320)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~----------- 262 (320)
..... ......+|+.|+|||++.+..++.++||||+||++++|++|+.||...+.......+..
T Consensus 169 ~~~~~-----~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~ 243 (355)
T d2b1pa1 169 AGTSF-----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 243 (355)
T ss_dssp -----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred ccccc-----ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHH
Confidence 54432 23345689999999999999999999999999999999999999987765554433321
Q ss_pred -----------CCCCCCC------------------CCCCCHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 020888 263 -----------GHRPFFR------------------AKGFTPELRELTEKCWAADMNQRPSFLDILKR 301 (320)
Q Consensus 263 -----------~~~~~~~------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 301 (320)
....... ....++++++||++||..||++|||++|+|+|
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp TSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 1100000 01135678999999999999999999999987
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.8e-39 Score=286.83 Aligned_cols=247 Identities=20% Similarity=0.295 Sum_probs=182.6
Q ss_pred cccCccceecccCceEEEEEEEC--CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCC-----------CCcccceeee
Q 020888 42 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-----------HPNIVQFLGA 108 (320)
Q Consensus 42 ~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~i~~~~~~ 108 (320)
.+|.+++.||+|+||+||+|.+. ++.||||++... ....+.+.+|+++++.++ |+||++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~----~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~ 88 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 88 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc----ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEE
Confidence 46999999999999999999985 789999998643 222367778888888775 5789999988
Q ss_pred EEe--CCceEEEEecCCCCC-HHHHHH--HhCCCCHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCcEEEeeCCCC-
Q 020888 109 VTE--RKPLMLITEYLRGGD-LHKYLK--EKGALSPSTAVNFALDIARGMAYLHN-EPNVIIHRDLKPRNVLLVNSSAD- 181 (320)
Q Consensus 109 ~~~--~~~~~iv~e~~~~~~-L~~~~~--~~~~l~~~~~~~i~~~l~~~l~~lH~-~g~~ivH~di~p~nI~~~~~~~~- 181 (320)
+.. ....++++.++.... ...... ....+++..+..++.|++.||.|||+ .| |+|+||||+||++..+...
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~--IvHrDlKp~NIll~~~~~~~ 166 (362)
T d1q8ya_ 89 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPE 166 (362)
T ss_dssp EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEEEEETTT
T ss_pred eeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC--cccccCChhHeeeeccCccc
Confidence 754 344556666554433 333332 24578999999999999999999997 78 9999999999999433222
Q ss_pred ---cEEEecCCCcccccccCccceeeccCCcccccccCccccCcCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH----
Q 020888 182 ---HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPY---- 254 (320)
Q Consensus 182 ---~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~---- 254 (320)
.++++|||.+...... .....+|+.|+|||++.+..++.++|+||+||++++|++|+.||...+..
T Consensus 167 ~~~~~kl~dfg~s~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~ 239 (362)
T d1q8ya_ 167 NLIQIKIADLGNACWYDEH-------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 239 (362)
T ss_dssp TEEEEEECCCTTCEETTBC-------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred ccceeeEeecccccccccc-------cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccc
Confidence 4999999998754332 23456899999999999999999999999999999999999999754321
Q ss_pred --HHHHHHHh--C---------------------CCCC-----------------CCCCCCCHHHHHHHHHHhhcCCCCC
Q 020888 255 --EAAKYVAE--G---------------------HRPF-----------------FRAKGFTPELRELTEKCWAADMNQR 292 (320)
Q Consensus 255 --~~~~~~~~--~---------------------~~~~-----------------~~~~~~~~~l~~li~~~l~~dp~~R 292 (320)
+....... + .... ......++++++||.+||..||.+|
T Consensus 240 ~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R 319 (362)
T d1q8ya_ 240 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR 319 (362)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred hhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHC
Confidence 11110000 0 0000 0011235779999999999999999
Q ss_pred CCHHHHHHH
Q 020888 293 PSFLDILKR 301 (320)
Q Consensus 293 ps~~~ll~~ 301 (320)
||++|+|+|
T Consensus 320 pta~e~L~H 328 (362)
T d1q8ya_ 320 ADAGGLVNH 328 (362)
T ss_dssp BCHHHHHTC
T ss_pred cCHHHHhcC
Confidence 999999986
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.89 E-value=3.1e-24 Score=172.18 Aligned_cols=166 Identities=18% Similarity=0.197 Sum_probs=118.9
Q ss_pred cCccceecccCceEEEEEEEC-CCceEEEEccCCCCC---------------cHHHHHHHHHHHHHHHhCCCCcccceee
Q 020888 44 FSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSD---------------DRLVIQDFRHEVNLLVKLRHPNIVQFLG 107 (320)
Q Consensus 44 y~~~~~lg~g~~~~vy~~~~~-~~~~~~K~~~~~~~~---------------~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 107 (320)
+.+.+.||+|+||+||+|.+. ++.||+|++...... ..........|+..+.++.|.+++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 356789999999999999875 889999987543211 0112234567888999999999888775
Q ss_pred eEEeCCceEEEEecCCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEeeCCCCcEEEec
Q 020888 108 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGD 187 (320)
Q Consensus 108 ~~~~~~~~~iv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~~ivH~di~p~nI~~~~~~~~~~~L~d 187 (320)
.. ..+++||++++..+.+ ++......++.|++.++.+||++| |+|+||||+||++ ++ +.++|+|
T Consensus 82 ~~----~~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~g--iiHrDiKP~NILv--~~-~~~~liD 145 (191)
T d1zara2 82 WE----GNAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLV--SE-EGIWIID 145 (191)
T ss_dssp EE----TTEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEE--ET-TEEEECC
T ss_pred ec----CCEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCC--EEEccCChhheee--eC-CCEEEEE
Confidence 43 2379999998865543 345556789999999999999999 9999999999999 44 4599999
Q ss_pred CCCcccccccCccceeeccCCcccccccCcc-----ccCcCCCCCchhHHHHHHH
Q 020888 188 FGLSKLIKVQNSHDVYKMTGETGSYRYMAPE-----VFKHRKYDKKVDVFSFAMI 237 (320)
Q Consensus 188 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE-----~~~~~~~~~~~Di~slG~~ 237 (320)
||.+.....+.... |.... .+....+...+|+||+.--
T Consensus 146 FG~a~~~~~~~~~~------------~l~rd~~~~~~~f~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 146 FPQSVEVGEEGWRE------------ILERDVRNIITYFSRTYRTEKDINSAIDR 188 (191)
T ss_dssp CTTCEETTSTTHHH------------HHHHHHHHHHHHHHHHHCCCCCHHHHHHH
T ss_pred CCCcccCCCCCcHH------------HHHHHHHHHHHHHcCCCCCcccHHHHHHH
Confidence 99997665432211 11110 0123556788999997543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.84 E-value=1.1e-08 Score=84.27 Aligned_cols=140 Identities=14% Similarity=0.070 Sum_probs=95.8
Q ss_pred ccCccceecccCceEEEEEEECCCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCC-CCcccceeeeEEeCCceEEEEec
Q 020888 43 DFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLMLITEY 121 (320)
Q Consensus 43 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~iv~e~ 121 (320)
.|++++..+.++.+.||++...+..+++|.......... ..+.+|...+..+. +--+.+++.+...++..++||++
T Consensus 15 ~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~~~---~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~ 91 (263)
T d1j7la_ 15 KYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTT---YDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp TSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTTST---TCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred ceEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCcccch---hhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEe
Confidence 455555555555678999987788899997755433332 34566777777663 44467888888888899999999
Q ss_pred CCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHhcCCC----------------------------------------
Q 020888 122 LRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPN---------------------------------------- 161 (320)
Q Consensus 122 ~~~~~L~~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~g~---------------------------------------- 161 (320)
++|.++.+.... ......++.++...+..||+...
T Consensus 92 l~G~~~~~~~~~-----~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (263)
T d1j7la_ 92 ADGVLCSEEYED-----EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKD 166 (263)
T ss_dssp CSSEEHHHHTTT-----CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSS
T ss_pred cccccccccccc-----cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchH
Confidence 999888654321 11122344555555666664310
Q ss_pred -----------------CeEecCCCCCcEEEeeCCCCcEEEecCCCcc
Q 020888 162 -----------------VIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 192 (320)
Q Consensus 162 -----------------~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~ 192 (320)
.++|||+.|.||++ ++++.+.|+||+.+.
T Consensus 167 ~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~--~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 167 PRELYDFLKTEKPEEELVFSHGDLGDSNIFV--KDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHHHHSCCCCCEEEECSCCCTTSEEE--ETTEEEEECCCTTCE
T ss_pred HHHHHHHHHhcCCcCCcEEEEeeccCcceee--cCCceEEEeechhcc
Confidence 17999999999999 555556799999774
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.32 E-value=1.4e-06 Score=70.92 Aligned_cols=72 Identities=19% Similarity=0.142 Sum_probs=49.8
Q ss_pred ecccC-ceEEEEEEEC-CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCC--CCcccceeeeEEeCCceEEEEecCCCC
Q 020888 50 IGKGS-FGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR--HPNIVQFLGAVTERKPLMLITEYLRGG 125 (320)
Q Consensus 50 lg~g~-~~~vy~~~~~-~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~iv~e~~~~~ 125 (320)
+..|. .+.||++... +..+++|....... ..+..|.+.++.+. .-.+.+++....+++..++||++++|.
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~ 91 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQ 91 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCTT------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSE
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccCH------hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecc
Confidence 34444 4679999876 55688897655433 23556777776663 234677888888888899999999886
Q ss_pred CH
Q 020888 126 DL 127 (320)
Q Consensus 126 ~L 127 (320)
++
T Consensus 92 ~~ 93 (255)
T d1nd4a_ 92 DL 93 (255)
T ss_dssp ET
T ss_pred cc
Confidence 65
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.20 E-value=6.2e-06 Score=71.54 Aligned_cols=78 Identities=19% Similarity=0.280 Sum_probs=46.9
Q ss_pred cceecccCceEEEEEEEC--CCceEEEEccCCC--CCc--HHHHHHHHHHHHHHHhCC-C--CcccceeeeEEeCCceEE
Q 020888 47 SAIIGKGSFGEILKAYWR--GTPVAIKRILPSL--SDD--RLVIQDFRHEVNLLVKLR-H--PNIVQFLGAVTERKPLML 117 (320)
Q Consensus 47 ~~~lg~g~~~~vy~~~~~--~~~~~~K~~~~~~--~~~--~~~~~~~~~e~~~l~~l~-h--~~i~~~~~~~~~~~~~~i 117 (320)
.+.||.|....||++... ++.+++|.-.... ..+ .....+...|.+.++.+. + ..+++++.+ +.+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 457899999999999764 5678888543210 000 011234556777777662 2 344555543 4455688
Q ss_pred EEecCCCCC
Q 020888 118 ITEYLRGGD 126 (320)
Q Consensus 118 v~e~~~~~~ 126 (320)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997644
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.56 E-value=0.00033 Score=58.62 Aligned_cols=132 Identities=8% Similarity=0.073 Sum_probs=76.1
Q ss_pred cCceEEEEEEEC-CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcc--ccee-----eeEEeCCceEEEEecCCC
Q 020888 53 GSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI--VQFL-----GAVTERKPLMLITEYLRG 124 (320)
Q Consensus 53 g~~~~vy~~~~~-~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i--~~~~-----~~~~~~~~~~iv~e~~~~ 124 (320)
+....||++..+ |+++++|+..+..... +++..|+..+..|...++ +..+ ..+..++..+.++++++|
T Consensus 33 s~EN~vy~v~~~dg~~~VlK~~rp~~~s~----~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 33 SYENRVYQFQDEDRRRFVVKFYRPERWTA----DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp CSSSEEEEECCTTCCCEEEEEECTTTSCH----HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred cccceeEEEEcCCCCEEEEEEeCCCCCCH----HHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence 445789999875 7889999876554332 566778877777642222 1111 123566778999999976
Q ss_pred CCH-----HHH------HHH-------h-----CCCCHH----------------------HHHHHHHHHHHHHHHHhc-
Q 020888 125 GDL-----HKY------LKE-------K-----GALSPS----------------------TAVNFALDIARGMAYLHN- 158 (320)
Q Consensus 125 ~~L-----~~~------~~~-------~-----~~l~~~----------------------~~~~i~~~l~~~l~~lH~- 158 (320)
..+ ..+ +.+ . ...+.. .....+..+...+...-.
T Consensus 109 ~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~ 188 (325)
T d1zyla1 109 RQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWRE 188 (325)
T ss_dssp EECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCS
T ss_pred cCCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccc
Confidence 332 111 110 0 011111 122233334444333321
Q ss_pred -CCCCeEecCCCCCcEEEeeCCCCcEEEecCCCcc
Q 020888 159 -EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 192 (320)
Q Consensus 159 -~g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~ 192 (320)
....++|||+.|.||++ +++ ..++||+.++
T Consensus 189 ~~p~~liHgDlh~~NvL~--~~~--~~~IDFdd~~ 219 (325)
T d1zyla1 189 DFTVLRLHGDCHAGNILW--RDG--PMFVDLDDAR 219 (325)
T ss_dssp CSCCEECCSSCSGGGEEE--SSS--EEECCCTTCC
T ss_pred cCCceeecCCCCcccEEE--eCC--ceEEechhcc
Confidence 11349999999999999 533 4589999875
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.20 E-value=0.00052 Score=59.02 Aligned_cols=72 Identities=13% Similarity=0.119 Sum_probs=47.3
Q ss_pred cceecccCceEEEEEEEC---------CCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCC-CCcccceeeeEEeCCceE
Q 020888 47 SAIIGKGSFGEILKAYWR---------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLM 116 (320)
Q Consensus 47 ~~~lg~g~~~~vy~~~~~---------~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 116 (320)
++.|+.|-...+|++... .+.+++++.-. . ... ....+|.++++.+. +.-.+++++++.+ .
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~-~~~---idr~~E~~i~~~ls~~gl~Pkll~~~~~----g 117 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-P-ETE---SHLVAESVIFTLLSERHLGPKLYGIFSG----G 117 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-C-CCH---HHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-c-chh---hHHHHHHHHHHHHHhCCCCCeEEEEcCC----c
Confidence 367888889999999864 24577776542 1 111 34557888888874 4334567776653 5
Q ss_pred EEEecCCCCCH
Q 020888 117 LITEYLRGGDL 127 (320)
Q Consensus 117 iv~e~~~~~~L 127 (320)
.|++|++|.+|
T Consensus 118 ~I~efi~g~~l 128 (395)
T d1nw1a_ 118 RLEEYIPSRPL 128 (395)
T ss_dssp EEECCCCEEEC
T ss_pred eEEEEeccccC
Confidence 88999987544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.16 E-value=0.00076 Score=55.96 Aligned_cols=139 Identities=15% Similarity=0.059 Sum_probs=72.2
Q ss_pred cceecccCceEEEEEEECCCceEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCC--cccceee------eEEeCCceEEE
Q 020888 47 SAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP--NIVQFLG------AVTERKPLMLI 118 (320)
Q Consensus 47 ~~~lg~g~~~~vy~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~--~i~~~~~------~~~~~~~~~iv 118 (320)
.+.|..|.-.+.|++..++..+++|++..... . +.+..+++++..+... .+...+. +.........+
T Consensus 23 ~~~i~~G~~N~ny~v~t~~g~yVLri~~~~~~-~----~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~~ 97 (316)
T d2ppqa1 23 YKGIAEGVENSNFLLHTTKDPLILTLYEKRVE-K----NDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAAL 97 (316)
T ss_dssp EEEECC---EEEEEEEESSCCEEEEEECC----C----CHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEE
T ss_pred eecCCCCcccCeEEEEECCCcEEEEEcCCCCC-H----HHHHHHHHHHHhhhhccccccccceecCCCcceeeeccccee
Confidence 34556777899999998888899998854321 1 3444456666555321 1222211 12334456666
Q ss_pred EecCCCCCH-----HHH------HHH------------------------------hCCCCHHHHHHHHHHHHHHHHHHh
Q 020888 119 TEYLRGGDL-----HKY------LKE------------------------------KGALSPSTAVNFALDIARGMAYLH 157 (320)
Q Consensus 119 ~e~~~~~~L-----~~~------~~~------------------------------~~~l~~~~~~~i~~~l~~~l~~lH 157 (320)
+.+..|... ... +.. ............+..+...+....
T Consensus 98 ~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 177 (316)
T d2ppqa1 98 ISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHW 177 (316)
T ss_dssp EECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHC
T ss_pred eeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhccC
Confidence 776654321 110 000 000011111222333333334433
Q ss_pred cC--CCCeEecCCCCCcEEEeeCCCCcEEEecCCCcc
Q 020888 158 NE--PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 192 (320)
Q Consensus 158 ~~--g~~ivH~di~p~nI~~~~~~~~~~~L~dfg~~~ 192 (320)
.. ..+++|||+.++||++ +.+...-++||+.+.
T Consensus 178 ~~~L~~giIHgDl~~dNvl~--~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 178 PKDLPAGVIHADLFQDNVFF--LGDELSGLIDFYFAC 212 (316)
T ss_dssp CCSSCEEEECSCCCGGGEEE--ETTEEEEECCCTTCE
T ss_pred ccccccccccCCcchhhhhc--ccccceeEecccccc
Confidence 32 1239999999999999 666666899999875
|